PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Settypalli, TBK; Lamien, CE; Spergser, J; Lelenta, M; Wade, A; Gelaye, E; Loitsch, A; Minoungou, G; Thiaucourt, F; Diallo, A				Settypalli, Tirumala Bharani Kumar; Lamien, Charles Euloge; Spergser, Joachim; Lelenta, Mamadou; Wade, Abel; Gelaye, Esayas; Loitsch, Angelika; Minoungou, Germaine; Thiaucourt, Francois; Diallo, Adama			One-Step Multiplex RT-qPCR Assay for the Detection of Peste des petits ruminants virus, Capripoxvirus, Pasteurella multocida and Mycoplasma capricolum subspecies (ssp.) capripneumoniae	PLOS ONE			English	Article							CONTAGIOUS CAPRINE PLEUROPNEUMONIA; POLYMERASE-CHAIN-REACTION; CLASSICAL SWINE-FEVER; CLINICAL-SAMPLES; MIXED INFECTION; GOATS; SHEEP; PCR; IDENTIFICATION; DIAGNOSIS	Respiratory infections, although showing common clinical symptoms like pneumonia, are caused by bacterial, viral or parasitic agents. These are often reported in sheep and goats populations and cause huge economic losses to the animal owners in developing countries. Detection of these diseases is routinely done using ELISA or microbiological methods which are being reinforced or replaced by molecular based detection methods including multiplex assays, where detection of different pathogens is carried out in a single reaction. In the present study, a one-step multiplex RT-qPCR assay was developed for simultaneous detection of Capripoxvirus (CaPV), Peste de petits ruminants virus (PPRV), Pasteurella multocida (PM) and Mycoplasma capricolum ssp. capripneumonia (Mccp) in pathological samples collected from small ruminants with respiratory disease symptoms. The test performed efficiently without any cross-amplification. The multiplex PCR efficiency was 98.31%, 95.48%, 102.77% and 91.46% whereas the singleplex efficiency was 93.43%, 98.82%, 102.55% and 92.0% for CaPV, PPRV, PM and Mccp, respectively. The correlation coefficient was greater than 0.99 for all the targets in both multiplex and singleplex. Based on cycle threshold values, intra and inter assay variability, ranged between the limits of 2%-4%, except for lower concentrations of Mccp. The detection limits at 95% confidence interval (CI) were 12, 163, 13 and 23 copies/.reaction for CaPV, PPRV, PM and Mccp, respectively. The multiplex assay was able to detect CaPVs from all genotypes, PPRV from the four lineages, PM and Mccp without amplifying the other subspecies of mycoplasmas. The discriminating power of the assay was proven by accurate detection of the targeted pathogen (s) by screening 58 viral and bacterial isolates representing all four targeted pathogens. Furthermore, by screening 81 pathological samples collected from small ruminants showing respiratory disease symptoms, CaPV was detected in 17 samples, PPRV in 45, and PM in six samples. In addition, three samples showed a co-infection of PPRV and PM. Overall, the one-step multiplex RT-qPCR assay developed will be a valuable tool for rapid detection of individual and co-infections of the targeted pathogens with high specificity and sensitivity.	[Settypalli, Tirumala Bharani Kumar; Lamien, Charles Euloge; Lelenta, Mamadou; Gelaye, Esayas; Diallo, Adama] IAEA, Anim Prod & Hlth Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Dept Nucl Sci & Applicat, A-1400 Vienna, Austria; [Spergser, Joachim] Univ Vet Med, Inst Microbiol, Vienna, Austria; [Wade, Abel] Lab Natl Vet LANAVET, Annex Yaounde, Cameroon; [Gelaye, Esayas] Natl Vet Inst, Res & Diagnost Labs, Debre Zeit, Ethiopia; [Loitsch, Angelika] Austrian Agcy Hlth & Food Safety, Inst Vet Dis Control, Modling, Austria; [Minoungou, Germaine] Lab Natl Elevage, Ouagadougou, Burkina Faso; [Thiaucourt, Francois; Diallo, Adama] UMR CMAEE, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; University of Veterinary Medicine Vienna; CIRAD	Settypalli, TBK (corresponding author), IAEA, Anim Prod & Hlth Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Dept Nucl Sci & Applicat, A-1400 Vienna, Austria.	T.B.K.Settypalli@iaea.org		Settypalli, Tirumala Bharani K/0000-0002-9090-8471; LAMIEN, Charles Euloge/0000-0003-1899-7614	International Atomic Energy Agency (IAEA); tripartite FAO/OIE/WHO IDENTIFY Project of the USAID Emergent Pandemic Threats Program	International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); tripartite FAO/OIE/WHO IDENTIFY Project of the USAID Emergent Pandemic Threats Program(United States Agency for International Development (USAID))	This work was supported by the International Atomic Energy Agency (IAEA) project Improvement of Veterinary Laboratory Capacities in Sub-Saharan African Countries and the tripartite FAO/OIE/WHO IDENTIFY Project of the USAID Emergent Pandemic Threats Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero M, 2004, VET RES, V35, P551, DOI 10.1051/vetres:2004031; Arif A, 2007, J ZOO WILDLIFE MED, V38, P93, DOI 10.1638/05-097.1; Ba JY, 2008, J VIROL METHODS, V148, P232, DOI 10.1016/j.jviromet.2007.12.003; Babiuk S, 2008, TRANSBOUND EMERG DIS, V55, P263, DOI 10.1111/j.1865-1682.2008.01043.x; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Brown C, 2011, SMALL RUMINANT RES, V98, P21, DOI 10.1016/j.smallrumres.2011.03.011; Chu YF, 2011, J VET DIAGN INVEST, V23, P786, DOI 10.1177/1040638711407883; Couacy-Hymann E, 2002, J VIROL METHODS, V100, P17, DOI 10.1016/S0166-0934(01)00386-X; Gao J, 2011, J VET DIAGN INVEST, V23, P894, DOI 10.1177/1040638711416964; Gelaye E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075971; Harper M, 2006, FEMS MICROBIOL LETT, V265, P1, DOI 10.1111/j.1574-6968.2006.00442.x; Jiang YH, 2010, VET J, V183, P172, DOI 10.1016/j.tvjl.2008.11.016; Kwiatek O, 2010, J VIROL METHODS, V165, P168, DOI 10.1016/j.jviromet.2010.01.014; Lamien CE, 2011, VET MICROBIOL, V149, P30, DOI 10.1016/j.vetmic.2010.09.038; Libeau G., 2014, Animal Frontiers, V4, P14, DOI 10.2527/af.2014-0003; Manso-Silvan L, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-86; Odugbo MO, 2006, SMALL RUMINANT RES, V66, P273, DOI 10.1016/j.smallrumres.2005.09.003; Ozmen O, 2009, TROP ANIM HEALTH PRO, V41, P951, DOI 10.1007/s11250-008-9284-5; Saeed IK, 2015, TROP ANIM HEALTH PRO, V47, P995, DOI 10.1007/s11250-015-0798-3; Santhamani R, 2013, VET WORLD, V6, P923, DOI 10.14202/vetworld.2013.923-925; Thiaucourt F, 1996, REV SCI TECH OIE, V15, P1397, DOI 10.20506/rst.15.4.990; Thonur L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-37; Townsend KM, 1998, J CLIN MICROBIOL, V36, P1096, DOI 10.1128/JCM.36.4.1096-1100.1998; Valadan M., 2014, Archives of Razi Institute, V69, P47; Venkatesan G, 2014, J VIROL METHODS, V195, P1, DOI 10.1016/j.jviromet.2013.10.009; World Organisation for Animal Health (OIE), 2015, OIE LIST DIS INF INF; Woubit S, 2004, VET MICROBIOL, V104, P125, DOI 10.1016/j.vetmic.2004.08.006	27	16	17	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153688	10.1371/journal.pone.0153688	http://dx.doi.org/10.1371/journal.pone.0153688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123588	Green Published, gold			2022-12-26	WOS:000375211700022
J	Arteaga, A; Pyron, RA; Penafiel, N; Romero-Barreto, P; Culebras, J; Bustamante, L; Yanez-Munoz, MH; Guayasamin, JM				Arteaga, Alejandro; Alexander Pyron, R.; Penafiel, Nicolas; Romero-Barreto, Paulina; Culebras, Jaime; Bustamante, Lucas; Yanez-Munoz, Mario H.; Guayasamin, Juan M.			Comparative Phylogeography Reveals Cryptic Diversity and Repeated Patterns of Cladogenesis for Amphibians and Reptiles in Northwestern Ecuador	PLOS ONE			English	Article							VIPERIDAE BOTHROPS-ASPER; PITVIPERS SERPENTES; MOLECULAR PHYLOGENY; HABITAT SELECTION; CLIMATIC ZONATION; SPECIES RICHNESS; MOUNTAIN PASSES; RAIN-FOREST; SPECIATION; DIVERSIFICATION	Comparative phylogeography allow us to understand how shared historical circumstances have shaped the formation of lineages, by examining a broad spectrum of co-distributed populations of different taxa. However, these types of studies are scarce in the Neotropics, a region that is characterized by high diversity, complex geology, and poorly understood biogeography. Here, we investigate the diversification patterns of five lineages of amphibians and reptiles, co-distributed across the Choco and Andes ecoregions in northwestern Ecuador. Mitochondrial DNA and occurrence records were used to determine the degree of geographic genetic divergence within species. Our results highlight congruent patterns of parapatric speciation and common geographical barriers for distantly related taxa. These comparisons indicate similar biological and demographic characteristics for the included clades, and reveal the existence of two new species of Pristimantis previously subsumed under P. walkeri, which we describe herein. Our data supports the hypothesis that widely distributed Chocoan taxa may generally experience their greatest opportunities for isolation and parapatric speciation across thermal elevational gradients. Finally, our study provides critical information to predict which unstudied lineages may harbor cryptic diversity, and how geology and climate are likely to have shaped their evolutionary history.	[Arteaga, Alejandro; Romero-Barreto, Paulina; Bustamante, Lucas] Trop Herping, Quito, Ecuador; [Arteaga, Alejandro; Penafiel, Nicolas; Culebras, Jaime; Bustamante, Lucas; Guayasamin, Juan M.] Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat BioCamb, Ingn Biodiversidad & Recursos Genet, Fac Ciencias Medio Ambiente, Quito, Ecuador; [Alexander Pyron, R.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Romero-Barreto, Paulina] Fdn EcoCiencia, Programa Conservac Especies & Ecosistemas Amenaza, Quito, Ecuador; [Yanez-Munoz, Mario H.] Museo Ecuatoriano Ciencias Nat, Div Herpetol, Quito, Ecuador	George Washington University	Arteaga, A (corresponding author), Trop Herping, Quito, Ecuador.; Arteaga, A (corresponding author), Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat BioCamb, Ingn Biodiversidad & Recursos Genet, Fac Ciencias Medio Ambiente, Quito, Ecuador.	alejandro@tropicalherping.com	Arteaga, Alejandro/AAL-3432-2020; Pyron, Robert/F-1681-2014	Arteaga, Alejandro/0000-0002-0014-3728; Culebras, Jaime/0000-0003-2211-6605; Guayasamin, Juan/0000-0003-0098-978X; Pyron, Robert/0000-0003-2524-1794	EcoCiencia; Universidad Tecnologica Indoamerica; George Washington University; US NSF [DBI-0905765, DEB-1441719, DEB-114179, DEB-1046408, DEB-1045960, DEB-1045991]; Tropical Herping; U.S. National Science Foundation; Programa de Becas de Investigacion para la Conservacion de la Biodiversidad; Direct For Biological Sciences [1045960] Funding Source: National Science Foundation	EcoCiencia; Universidad Tecnologica Indoamerica; George Washington University; US NSF(National Science Foundation (NSF)); Tropical Herping; U.S. National Science Foundation(National Science Foundation (NSF)); Programa de Becas de Investigacion para la Conservacion de la Biodiversidad; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Fieldwork was funded by: (1) EcoCiencia through a grant given to AA; (2) Universidad Tecnologica Indoamerica (www.uti.edu.ec), through a grant given to JMG; (3) The George Washington University (www.gwu.edu), through a grant given to RAP; and (4) US NSF (www.nsf.gov) grants to RAP (DBI-0905765 & DEB-1441719) and to JMG (DEB-114179, DBI-0905765; Dimensions of Biodiversity grant, DEB-1046408, DEB-1045960 and DEB-1045991). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Tropical Herping provided support in the form of salaries for authors AA, LB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This article was greatly improved by comments of two anonymous reviewers. For granting access to their protected forests, we are grateful to Fundacion Jocotoco, Reserva Itapoa and Reserva de Biodiversidad Mashpi. Special thanks to Paolo Escobar, Daniel Mideros, Angela Leon, Rita Hidalgo, Diana Troya, Carlos Morochz, Silvia Cevallos, Paulina Romero, Chelsea Carson, Javier Aznar, Jose Vieira, Daniel Romero and Rossana Romo for their assistance and companionship in the field. For granting access to specimens under his care, we are grateful to Jorge Valencia. Fieldwork was made possible with the support of the Programa de Becas de Investigacion para la Conservacion de la Biodiversidad. Laboratoy work was carried out at Universidad Tecnologica Indoamerica in Quito. Sequencing was made possible with support of the George Washington University, and the U.S. National Science Foundation.	Almendariz A, 2007, LISTA ACTUALIZADA AN; Amaral A., 1923, Proceedings of the New England Zoological Club, V8, P85; [Anonymous], 2009, TERRESTRIAL BREEDING; [Anonymous], 2011, ECOLOGICAL NICHES GE; [Anonymous], 1999, SNAKE SPECIES WORLD; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Arteaga A, 2013, AMPHIBIANS REPTILES; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Brumfield RT, 2007, EVOLUTION, V61, P346, DOI 10.1111/j.1558-5646.2007.00039.x; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Burbrink FT, 2005, EVOLUTION, V54, P2107; Butantan-British IBothrops/I Systematics Project, 2002, P111; Campbell H.W., 1982, U S FISH AND WILDLIFE SERVICE WILDLIFE RESEARCH REPORT, V13, P193; Campbell J. A., 2004, VENOMOUS REPTILES W; Campbell J.A., 1992, OCCAS PAP MUS TEXAS, V153, P1; Carrasco PA, 2012, ZOOL SCR, V41, P109, DOI 10.1111/j.1463-6409.2011.00511.x; Coyne J.A., 2004, SPECIATION; Cadena CD, 2012, P ROY SOC B-BIOL SCI, V279, P194, DOI 10.1098/rspb.2011.0720; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; Daza JM, 2010, ECOGRAPHY, V33, P343, DOI 10.1111/j.1600-0587.2010.06281.x; De Fraga R, 2013, COPEIA, P684, DOI 10.1643/CE-11-098; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Drummond AJ, 2010, GENEIOUS V5 5 BIOMAT; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elmer KR, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-59; Feldman CR, 2006, MOL ECOL, V15, P2201, DOI 10.1111/j.1365-294X.2006.02930.x; Fenker J, 2014, DIVERS DISTRIB, V20, P1108, DOI 10.1111/ddi.12217; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Freire-Lascano A., 1991, PUBLICACIONES TRABAJ, V2, P1; GARCIAR JC, 2012, PLOS ONE, V0007; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guayasamin Juan M., 2015, Neotropical Biodiversity, V1, P2, DOI 10.1080/23766808.2015.1074407; Guayasamin JM, 2015, ZOOL J LINN SOC-LOND, V173, P913, DOI 10.1111/zoj.12222; Hall JPW, 2005, P ROY SOC B-BIOL SCI, V272, P2457, DOI 10.1098/rspb.2005.3254; Hedges SB, 2008, ZOOTAXA, P1; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; Hendry CR, 2014, J EVOLUTION BIOL, V27, P760, DOI 10.1111/jeb.12349; Hermelin-Vivien ML, 1989, VERTEBRATES COMPLEX; Heyer W.R., 1994, MEASURING MONITORING; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Hutter CR, 2013, ECOL LETT, V16, P1135, DOI 10.1111/ele.12148; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kessler Michael, 2008, P35; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kohler G, 2012, HERPETOL MONOGR, V26, P173, DOI 10.1655/HERPMONOGRAPHS-D-10-00011.1; Kozak KH, 2007, P ROY SOC B-BIOL SCI, V274, P2995, DOI 10.1098/rspb.2007.1106; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2007, BIOL LETTERS, V3, P646, DOI 10.1098/rsbl.2007.0368; Lehr E, 2008, HERPETOLOGICA, V64, P354, DOI 10.1655/07-089.1; Lopez AD, 1998, ESTUIDO DIVERSIDAD H; Lynch J.D., 1980, Breviora, P1; Lynch J.D., 1976, Occasional Papers Mus Nat Hist Univ Kans, VNo. 55, P1; LYNCH J D, 1980, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Lynch JD, 1997, U KANSAS NATURAL HIS, V23, P1, DOI DOI 10.5962/BHL.TITLE.7951; Lynch John D., 2005, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V29, P581; Lynch John D., 1994, Occasional Papers of the Museum of Natural History University of Kansas, V170, P1; Lynch RL, 2014, AMPHIB REPTILE CONSE, V8; MAE, 2012, LIN BAS DEF EC CONT; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, P3, DOI DOI 10.1007/978-3-642-20992-5_1; Miyata K., 1976, ANNOTATED CHECKLIST; Morales MA, 2004, DINAMICA POBLACIONAL; Morales-Mite MA, 2013, HERPETOFAUNA AREAS P; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Ortega-Andrade H. Mauricio, 2010, Check List, V6, P119; Ortega-Andrade HM, 2004, APROXIMACION CONOCIM; Padial JM, 2014, ZOOTAXA, V3825, P1, DOI 10.11646/zootaxa.3825.1.1; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Pellegrino KCM, 2011, BIOL J LINN SOC, V74, P315; Peracca M.G., 1904, BOLLETTINO MUSEI ZOO, V19, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Price T, 2008, SPECIATION BIRDS; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Pyron RA, 2010, J BIOGEOGR, V37, P2005, DOI 10.1111/j.1365-2699.2010.02336.x; Pyron RA, 2013, P R SOC B; Rambaut A., 2003, TRACER VERSION 1 4 1; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2009, J BIOGEOGR, V36, P1211, DOI 10.1111/j.1365-2699.2008.02068.x; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Reyes A., 2008, INVENTARIO HERPETOFA; Ribas CC, 2007, P ROY SOC B-BIOL SCI, V274, P2399, DOI 10.1098/rspb.2007.0613; Rivera-Prieto DA, 2014, ZOOTAXA, V3900, P223, DOI 10.11646/zootaxa.3900.2.3; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; Rolland J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001775; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Savit Aaron Z., 2006, Iguana, V13, P94; SCHATTI B, 1993, REV SUISSE ZOOL, V100, P235, DOI 10.5962/bhl.part.79860; Sedano RE, 2010, J BIOGEOGR, V37, P325, DOI 10.1111/j.1365-2699.2009.02200.x; Sierra R, 1999, PROPUESTA PRELIMINAR; Smith BT, 2014, NATURE, V515, P406, DOI 10.1038/nature13687; Smith SA, 2007, EVOLUTION, V61, P1188, DOI 10.1111/j.1558-5646.2007.00085.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stephens PR, 2003, AM NAT, V161, P112, DOI 10.1086/345091; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Torres-Carvajal O, 2014, J BIOGEOGR, V41, P1883, DOI 10.1111/jbi.12375; Torres-Carvajal O, 2014, ZOOKEYS, P105, DOI 10.3897/zookeys.410.7401; Torres-Carvajal O, 2013, MOL PHYLOGENET EVOL, V68, P212, DOI 10.1016/j.ympev.2013.03.013; Valencia JH, 2011, GUIA ANFIBIOS REPTIL; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Wake D.B., 1976, NAT HIST MUS LOS ANG, V25, P1; Wasko DK, 2012, ZOOLOGY, V115, P179, DOI 10.1016/j.zool.2011.10.001; Wasko DK, 2010, HERPETOLOGICA, V66, P148, DOI 10.1655/08-064R2.1; Weir JT, 2011, MOL ECOL, V20, P4550, DOI 10.1111/j.1365-294X.2011.05294.x; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; Wiens JJ, 1999, EVOLUTION, V53, P1884, DOI 10.1111/j.1558-5646.1999.tb04570.x; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Yanez-Munoz M., 2005, EVALUACION CARACTERI; Yanez-Munoz M, 2004, CARACTERIZACION COMP; Yanez-Munoz MH, 2009, GUIA CAMPO PEQUENOS; Yanez-Munoz MH, 2013, B TECNICO, V11, P125; Zink RM, 2002, INTEGR COMP BIOL, V42, P953, DOI 10.1093/icb/42.5.953	122	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0151746	10.1371/journal.pone.0151746	http://dx.doi.org/10.1371/journal.pone.0151746			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120100	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200006
J	Wang, XL; Zhou, YL; Sun, W; Li, L				Wang, Xiao-Lin; Zhou, Yuan-Li; Sun, Wei; Li, Li			Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-kappa B Pathway	PLOS ONE			English	Article							NF-KAPPA-B; POTENTIAL THERAPEUTIC TARGET; COA REDUCTASE INHIBITORS; ACUTE CORONARY SYNDROMES; HUMAN VASCULAR CELLS; PLAQUE RUPTURE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR-DISEASE; MOLECULAR-MECHANISMS; CD40-CD40 LIGAND	CD40L and statins exhibit pro-inflammatory and anti-inflammatory effects, respectively. They are both pleiotropic and can regulate extracellular matrix (ECM) degeneration in an atherosclerotic plaque. Statins can decrease both the CD40 expression and the resulting inflammation. However, the effects of CD40L and stains on atherosclerotic plaque ECM production and the underlying mechanisms are not well established. Moreover, prolyl-4-hydroxylase alpha 1 (P4H alpha 1) is involved in collagen synthesis but its correlations with CD40L and statins are unknown. In the present study, CD40L suppressed P4H alpha 1 expression in human aortic smooth muscle cells (HASMCs) in a dose-and time-dependent manner, with insignificant changes in MMP2 expression and negative enzymatic activity of MMP9. CD40L increased TRAF6 expression, JNK phosphorylation, NF-kappa B nuclear translocation as well as DNA binding. Furthermore, silencing TRAF6, JNK or NF-kappa B genes abolished CD40L-induced suppression of P4H alpha 1. Lower NF-kappa B nuclear import rates were observed when JNK or TRAF6 silenced HASMCs were stimulated with CD40L compared to HASMCs with active JNK or TRAF6. Together, these results indicate that CD40L suppresses P4H alpha 1 expression in HASMCs by activating the TRAF6-JNK-NF-kappa B pathway. We also found that rosuvastatin inhibits CD40L-induced activation of the TRAF6-JNK-NF-kappa B pathway, thereby significantly rescuing the CD40L stimulated P4H alpha 1 inhibition. The results from this study will help find potential targets for stabilizing vulnerable atherosclerotic plaques.	[Wang, Xiao-Lin; Li, Li] Shandong Univ, Dept Cardiol, Jinan Cent Hosp, Jinan 250013, Shandong, Peoples R China; [Zhou, Yuan-Li] Shandong Univ, Dept Hlth, Jinan Cent Hosp, Jinan 250013, Shandong, Peoples R China; [Sun, Wei] Shandong Acad Med Sci, Dept Cardiol, Jinan 250062, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Li, L (corresponding author), Shandong Univ, Dept Cardiol, Jinan Cent Hosp, Jinan 250013, Shandong, Peoples R China.	lili74@medmail.com.cn	Stefanadis, Christodoulos/ABH-2232-2020; wang, xiao/HGB-7081-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; wang, xiao/0000-0002-4088-3341	National Natural Science Funds for Young Scholar [81200211]; Key R & D program in Shandong Province [2015GGA01027]; Shandong Young Scientists Award Fund [2012BSA01018]; Scientific and Technology Development program of Jinan [20120144]	National Natural Science Funds for Young Scholar; Key R & D program in Shandong Province; Shandong Young Scientists Award Fund; Scientific and Technology Development program of Jinan	This study was supported by the National Natural Science Funds for Young Scholar (No. 81200211), the Key R & D program in Shandong Province (No. 2015GGA01027), grants from the Shandong Young Scientists Award Fund (No. 2012BSA01018) and grants from Scientific and Technology Development program of Jinan (No. 20120144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Chen JW, 2004, J CARDIOVASC PHARM, V44, P446, DOI 10.1097/01.fjc.0000140205.74180.3c; Chen L, 2006, J BIOL CHEM, V281, P10849, DOI 10.1074/jbc.M511237200; Dabek J, 2010, PHARMACOL REP, V62, P778; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Guo HY, 2009, ARCH MED RES, V40, P345, DOI 10.1016/j.arcmed.2009.07.006; Heo SH, 2011, J CLIN NEUROL, V7, P69, DOI 10.3988/jcn.2011.7.2.69; Kampoli AM, 2012, CURR TOP MED CHEM, V12, P1192, DOI 10.2174/1568026611208011192; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022819; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Luan ZX, 2003, ARTERIOSCL THROM VAS, V23, P769, DOI 10.1161/01.ATV.0000068646.76823.AE; Lutgens E, 2002, TRENDS CARDIOVAS MED, V12, P27, DOI 10.1016/S1050-1738(01)00142-6; Lutgens E, 2007, TRENDS CARDIOVAS MED, V17, P118, DOI 10.1016/j.tcm.2007.02.004; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Mach F, 1997, CIRCULATION, V96, P396; Madonna R, 2012, VASC PHARMACOL, V57, P41, DOI 10.1016/j.vph.2012.02.005; Massaro M, 2010, CARDIOVASC RES, V86, P311, DOI 10.1093/cvr/cvp375; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Padro T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038935; Pamukcu B, 2011, THROMB RES, V128, P117, DOI 10.1016/j.thromres.2011.03.025; Pateras I, 2014, EXPERT OPIN THER TAR, V18, P1089, DOI 10.1517/14728222.2014.938051; Pignatelli P, 2012, BIOCHEM PHARMACOL, V84, P1635, DOI 10.1016/j.bcp.2012.09.011; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Schonbeck U, 1997, CIRC RES, V81, P448, DOI 10.1161/01.RES.81.3.448; Schonbeck U, 2002, CIRCULATION, V106, P2888, DOI 10.1161/01.CIR.0000043029.52803.7B; Schonbeck U, 2001, CIRC RES, V89, P1092, DOI 10.1161/hh2401.101272; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Werner N, 2002, BASIC RES CARDIOL, V97, P105, DOI 10.1007/s003950200000; Wu M, 2006, MOL CELL BIOCHEM, V282, P141, DOI 10.1007/s11010-006-1741-8; Ye S, 2006, CARDIOVASC RES, V69, P636, DOI 10.1016/j.cardiores.2005.07.015; Zhang C, 2007, ARTERIOSCL THROM VAS, V27, P1760, DOI 10.1161/ATVBAHA.107.144881; Zhang K, 2013, J MOL CELL CARDIOL, V65, P43, DOI 10.1016/j.yjmcc.2013.09.010	46	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153919	10.1371/journal.pone.0153919	http://dx.doi.org/10.1371/journal.pone.0153919			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120457	Green Submitted, Green Published, gold			2022-12-26	WOS:000374976200039
J	Zhang, LL; Zhou, JK; Han, JX; Hu, B; Hou, NN; Shi, Y; Huang, XX; Lou, X				Zhang, Linlin; Zhou, Jiankui; Han, Jinxiong; Hu, Bian; Hou, Ningning; Shi, Yun; Huang, Xingxu; Lou, Xin			Generation of an Oocyte-Specific Cas9 Transgenic Mouse for Genome Editing	PLOS ONE			English	Article							MODIFIED MICE; DNA; CRISPR-CAS9; SYSTEM; NUCLEASES	The CRISPR/Cas9 system has been developed as an easy-handle and multiplexable approach for engineering eukaryotic genomes by zygote microinjection of Cas9 and sgRNA, while preparing Cas9 for microinjection is laborious and introducing inconsistency into the experiment. Here, we describe a modified strategy for gene targeting through using oocyte-specific Cas9 transgenic mouse. With this mouse line, we successfully achieve precise gene targeting by injection of sgRNAs only into one-cell-stage embryos. Through comprehensive analysis, we also show allele complexity and off-target mutagenesis induced by this strategy is obviously lower than Cas9 mRNA/sgRNA injection. Thus, injection of sgRNAs into oocyte-specific Cas9 transgenic mouse embryo provides a convenient, efficient and reliable approach for mouse genome editing.	[Zhang, Linlin; Zhou, Jiankui; Han, Jinxiong; Hu, Bian; Hou, Ningning; Shi, Yun; Huang, Xingxu; Lou, Xin] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Xingxu] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Nanjing University; ShanghaiTech University	Huang, XX; Lou, X (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China.; Huang, XX (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	xingxuhuang@nju.edu.cn; xin.lou@nju.edu.cn	Shi, Yun S/T-8845-2018; Shi, Yun/B-5623-2009	Shi, Yun/0000-0002-8842-9818; Lou, Xin/0000-0002-6715-0375; huang, xingxu/0000-0001-8934-1247	National Natural Science Foundation of China [NSFC 31471354, NSFC 31471400]; Nanjing University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing University(Nanjing University)	This work was supported by grants from National Natural Science Foundation of China (NSFC 31471354 to X.L. and NSFC 31471400 to X.H.) and starting fund from Nanjing University to X.L.	Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; LIRA SA, 1990, P NATL ACAD SCI USA, V87, P7215, DOI 10.1073/pnas.87.18.7215; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	22	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154364	10.1371/journal.pone.0154364	http://dx.doi.org/10.1371/journal.pone.0154364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119535	gold, Green Published, Green Submitted			2022-12-26	WOS:000374976200063
J	Bueno-Vargas, P; Manzano, M; Diaz-Castro, J; Lopez-Aliaga, I; Rueda, R; Lopez-Pedrosa, JM				Bueno-Vargas, Pilar; Manzano, Manuel; Diaz-Castro, Javier; Lopez-Aliaga, Inmaculada; Rueda, Ricardo; Maria Lopez-Pedrosa, Jose			Maternal Dietary Supplementation with Oligofructose-Enriched Inulin in Gestating/Lactating Rats Preserves Maternal Bone and Improves Bone Microarchitecture in Their Offspring	PLOS ONE			English	Article							CALCIUM SUPPLEMENTATION; SODIUM-BUTYRATE; VITAMIN-D; YOUNG ADOLESCENTS; MINERAL DENSITY; BIRTH-WEIGHT; SHORT-CHAIN; PREGNANCY; LACTATION; ABSORPTION	Nutrition during pregnancy and lactation could exert a key role not only on maternal bone, but also could influence the skeletal development of the offspring. This study was performed in rats to assess the relationship between maternal dietary intake of prebiotic oligofructose-enriched inulin and its role in bone turnover during gestation and lactation, as well as its effect on offspring peak bone mass/architecture during early adulthood. Rat dams were fed either with standard rodent diet (CC group), calcium-fortified diet (Ca group), or prebiotic oligofructose-enriched inulin supplemented diet (Pre group), during the second half of gestation and lactation. Bone mineral density (BMD) and content (BMC), as well as microstructure of dams and offspring at different stages were analysed. Dams in the Pre group had significantly higher trabecular thickness (Tb.Th), trabecular bone volume fraction (BV/TV) and smaller specific bone surface (BS/BV) of the tibia in comparison with CC dams. The Pre group offspring during early adulthood had an increase of the lumbar vertebra BMD when compared with offspring of CC and Ca groups. The Pre group offspring also showed significant increase versus CC in cancellous and cortical structural parameters of the lumbar vertebra 4 such as Tb.Th, cortical BMD and decreased BS/BV. The results indicate that oligofructose-enriched inulin supplementation can be considered as a plausible nutritional option for protecting against maternal bone loss during gestation and lactation preventing bone fragility and for optimizing peak bone mass and architecture of the offspring in order to increase bone strength.	[Bueno-Vargas, Pilar; Manzano, Manuel; Rueda, Ricardo; Maria Lopez-Pedrosa, Jose] Abbott Nutr R&D, Granada, Spain; [Bueno-Vargas, Pilar; Diaz-Castro, Javier; Lopez-Aliaga, Inmaculada] Univ Granada, Fac Pharm, Dept Physiol, E-18071 Granada, Spain; [Bueno-Vargas, Pilar; Diaz-Castro, Javier; Lopez-Aliaga, Inmaculada] Univ Granada, Inst Nutr & Food Technol Jose Mataix, Granada, Spain	University of Granada; University of Granada	Bueno-Vargas, P (corresponding author), Abbott Nutr R&D, Granada, Spain.; Bueno-Vargas, P (corresponding author), Univ Granada, Fac Pharm, Dept Physiol, E-18071 Granada, Spain.; Bueno-Vargas, P (corresponding author), Univ Granada, Inst Nutr & Food Technol Jose Mataix, Granada, Spain.	pilar.bueno@abbott.com	Díaz-Castro, Javier/AAX-6697-2021; Diaz-Castro, Javier/H-2985-2015	Díaz-Castro, Javier/0000-0003-3659-1757; Diaz-Castro, Javier/0000-0003-3659-1757; Bueno-Vargas, Pilar/0000-0002-3733-2047; Lopez-Aliaga, Inmaculada/0000-0001-7627-8760; Manzano, Manuel/0000-0003-2856-6295	Abbott Nutrition RD; Abbott Nutrition	Abbott Nutrition RD; Abbott Nutrition(Abbott Laboratories)	This study was funded by Abbott Nutrition R&D, and co-authors PBV, MM, JMLP and RR receive salary from Abbott Nutrition. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abrams SA, 2005, AM J CLIN NUTR, V82, P471; BARTELS H, 1972, Medizinische Welt, V23, P961; Bosscher D, 2006, INT DAIRY J, V16, P1092, DOI 10.1016/j.idairyj.2005.10.028; Cashman KD, 2006, NUTR REV, V64, P189, DOI 10.1111/j.1753-4887.2006.tb00201.x; Chen TH, 2007, BIOCHEM BIOPH RES CO, V355, P913, DOI 10.1016/j.bbrc.2007.02.057; Cole ZA, 2009, J BONE MINER RES, V24, P663, DOI 10.1359/JBMR.081212; Cooper C, 2009, ADV EXP MED BIOL, V646, P31, DOI 10.1007/978-1-4020-9173-5_3; CORBELLINI CN, 1991, CALCIFIED TISSUE INT, V48, P37, DOI 10.1007/BF02555794; Curtis EM, 2014, CURR OSTEOPOROS REP, V12, P194, DOI 10.1007/s11914-014-0210-7; Davey MR, 2012, JEMDSA, V17, P149, DOI 10.1080/22201009.2012.10872295; Demmer E, 2014, FASEB J S, V28; Devlin MJ, 2013, J ENDOCRINOL, V217, P69, DOI 10.1530/JOE-12-0403; Franck A, 2006, NUTR BULL, V31, P341, DOI 10.1111/j.1467-3010.2006.00584.x; Ganpule A, 2006, J CLIN ENDOCR METAB, V91, P2994, DOI 10.1210/jc.2005-2431; Gibbons MJ, 2004, ASIA PAC J CLIN NUTR, V13, P341; Grieger JA, 2015, NUTRIENTS, V7, P153, DOI 10.3390/nu7010153; Griffin IJ, 2002, BRIT J NUTR, V87, pS187, DOI [10.1079/BJN2001503, 10.1079/BJN/2002536]; Griffin IJ, 2003, NUTR RES, V23, P901, DOI 10.1016/S0271-5317(03)00085-X; GRUBER HE, 1994, BONE, V15, P167, DOI 10.1016/8756-3282(94)90704-8; Hacker AN, 2012, NUTR REV, V70, P397, DOI 10.1111/j.1753-4887.2012.00491.x; Hess MW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138881; Holloway L, 2007, BRIT J NUTR, V97, P365, DOI 10.1017/S000711450733674X; Holroyd C, 2012, OSTEOPOROSIS INT, V23, P401, DOI 10.1007/s00198-011-1671-5; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P138, DOI 10.1111/j.1365-3016.2012.01274.x; IWAMI K, 1993, INT J BIOCHEM, V25, P1631, DOI 10.1016/0020-711X(93)90522-G; Jarjou LMA, 2013, AM J CLIN NUTR, V98, P723, DOI 10.3945/ajcn.113.061630; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; Jones G, 2000, CALCIFIED TISSUE INT, V67, P304, DOI 10.1007/s002230001148; Karlsson C, 2001, OSTEOPOROSIS INT, V12, P828, DOI 10.1007/s001980170033; Katono T, 2008, ARCH ORAL BIOL, V53, P903, DOI 10.1016/j.archoralbio.2008.02.016; Koo WWK, 1999, OBSTET GYNECOL, V94, P577, DOI 10.1016/S0029-7844(99)00371-3; Kovacs CS, 2008, AM J CLIN NUTR, V88, p520S, DOI 10.1093/ajcn/88.2.520S; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; Kovacs CS, 2006, ENDOCRIN METAB CLIN, V35, P21, DOI 10.1016/j.ecl.2005.09.004; Kruger MC, 2003, EXP BIOL MED, V228, P683, DOI 10.1177/153537020322800606; Lapillonne A, 2004, AM J CLIN NUTR, V80, P1595, DOI 10.1093/ajcn/80.6.1595; Liu Z, 2011, ARCH GYNECOL OBSTET, V283, P205, DOI 10.1007/s00404-009-1345-0; Lopez JM, 1996, OSTEOPOROSIS INT, V6, P153, DOI 10.1007/BF01623940; MATKOVIC V, 1992, AM J CLIN NUTR, V55, P992, DOI 10.1093/ajcn/55.5.992; Maurer AD, 2011, BRIT J NUTR, V105, P329, DOI 10.1017/S0007114510003533; Nauta AJ, 2013, AM J CLIN NUTR, V98, p586S, DOI 10.3945/ajcn.112.039644; NIH Consensus Development Panel on Osteoporosis Prevention D Therapy, 2001, JAMA, V285; Nzeusseu A, 2006, BONE, V38, P394, DOI 10.1016/j.bone.2005.09.006; Ohta A, 2002, J NUTR, V132, P2048; Prentice A, 2003, J NUTR, V133, p1693S, DOI 10.1093/jn/133.5.1693S; Prentice A, 2000, AM J CLIN NUTR, V71, p1312S, DOI 10.1093/ajcn/71.5.1312s; Prentice A, 2000, ANNU REV NUTR, V20, P249, DOI 10.1146/annurev.nutr.20.1.249; Prentice A, 2006, P NUTR SOC, V65, P348, DOI 10.1079/PNS2006519; Ramakrishnan U, 1999, NUTR RES, V19, P103, DOI 10.1016/S0271-5317(98)00178-X; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reeves PG, 1997, J NUTR, V127, pS838; Rendina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060569; Roberfroid MB, 2007, J NUTR, V137, p2493S, DOI 10.1093/jn/137.11.2493S; Roberfroid MB, 2002, J NUTR, V132, P3599, DOI 10.1093/jn/132.12.3599; Scholz-Ahrens KE, 2007, J NUTR, V137, p2513S, DOI 10.1093/jn/137.11.2513S; Scholz-Ahrens KE, 2002, BRIT J NUTR, V88, P365, DOI 10.1079/BJN2002661; SHACKELFORD ME, 1994, FOOD CHEM TOXICOL, V32, P255, DOI 10.1016/0278-6915(94)90198-8; Suntornsaratoon P, 2014, AM J PHYSIOL-ENDOC M, V306, pE177, DOI 10.1152/ajpendo.00556.2013; Thomas DW, 2010, PEDIATRICS, V126, P1217, DOI 10.1542/peds.2010-2548; Thomas M, 2006, AM J OBSTET GYNECOL, V194, P937, DOI 10.1016/j.ajog.2005.05.032; TIETZ NW, 1983, J CLIN CHEM CLIN BIO, V21, P731; Tobias JH, 2005, OSTEOPOROSIS INT, V16, P1731, DOI 10.1007/s00198-005-1912-6; van den Heuvel EGHM, 1999, AM J CLIN NUTR, V69, P544; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; World Health Organization, 2004, SUMM M REP; Yang LC, 2013, BRIT J NUTR, V109, P1779, DOI 10.1017/S0007114512003777; Yin J, 2010, EUR J CLIN NUTR, V64, P131, DOI 10.1038/ejcn.2009.117; Zeni SN, 1999, BONE, V25, P681, DOI 10.1016/S8756-3282(99)00228-8	69	10	13	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154120	10.1371/journal.pone.0154120	http://dx.doi.org/10.1371/journal.pone.0154120			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115490	Green Published, gold			2022-12-26	WOS:000374973600044
J	Liu, YL; Tabata, D; Imai, R				Liu, Yuelin; Tabata, Daisuke; Imai, Ryozo			A Cold-Inducible DEAD-Box RNA Helicase from Arabidopsis thaliana Regulates Plant Growth and Development under Low Temperature	PLOS ONE			English	Article							SHOCK DOMAIN PROTEIN-3; RESPONSIVE GENE-REGULATION; 50S RIBOSOMAL-SUBUNITS; ESCHERICHIA-COLI; ABSCISIC-ACID; BIOGENESIS; MUTATIONS; FAMILY; TRANSLATION; RESISTANCE	DEAD-box RNA helicases comprise a large family and are involved in a range of RNA processing events. Here, we identified one of the Arabidopsis thaliana DEAD-box RNA helicases, AtRH7, as an interactor of Arabidopsis COLD SHOCK DOMAIN PROTEIN 3 (AtCSP3), which is an RNA chaperone involved in cold adaptation. Promoter: GUS transgenic plants revealed that AtRH7 is expressed ubiquitously and that its levels of the expression are higher in rapidly growing tissues. Knockout mutant lines displayed several morphological alterations such as disturbed vein pattern, pointed first true leaves, and short roots, which resemble ribosome-related mutants of Arabidopsis. In addition, aberrant floral development was also observed in rh7 mutants. When the mutants were germinated at low temperature (12 degrees C), both radicle and first leaf emergence were severely delayed; after exposure of seedlings to a long period of cold, the mutants developed aberrant, fewer, and smaller leaves. RNA blots and circular RT-PCR revealed that 35S and 18S rRNA precursors accumulated to higher levels in the mutants than in WT under both normal and cold conditions, suggesting the mutants are partially impaired in pre-rRNA processing. Taken together, the results suggest that AtRH7 affects rRNA biogenesis and plays an important role in plant growth under cold.	[Liu, Yuelin; Imai, Ryozo] Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan; [Liu, Yuelin; Tabata, Daisuke; Imai, Ryozo] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan	National Agriculture & Food Research Organization - Japan; Hokkaido University	Imai, R (corresponding author), Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan.; Imai, R (corresponding author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.	rzi@affrc.go.jp						Abbasi N, 2010, PLANT J, V64, P960, DOI 10.1111/j.1365-313X.2010.04393.x; Abdelhaleem M, 2003, GENOMICS, V81, P618, DOI 10.1016/S0888-7543(03)00049-1; Asakura Y, 2012, PLANT PHYSIOL, V159, P961, DOI 10.1104/pp.112.197525; Awano N, 2007, J BACTERIOL, V189, P5808, DOI 10.1128/JB.00655-07; Boudet N, 2001, GENOME RES, V11, P2101, DOI 10.1101/gr.200801; Calo E, 2015, NATURE, V518, P249, DOI 10.1038/nature13923; Charollais J, 2004, NUCLEIC ACIDS RES, V32, P2751, DOI 10.1093/nar/gkh603; Charollais J, 2003, MOL MICROBIOL, V48, P1253, DOI 10.1046/j.1365-2958.2003.03513.x; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; CHERNOFF YO, 1994, EMBO J, V13, P906, DOI 10.1002/j.1460-2075.1994.tb06334.x; Chi W, 2012, PLANT PHYSIOL, V158, P693, DOI 10.1104/pp.111.186775; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Guan QM, 2013, PLANT CELL, V25, P342, DOI 10.1105/tpc.112.108340; GUTHRIE C, 1969, P NATL ACAD SCI USA, V63, P384, DOI 10.1073/pnas.63.2.384; Hang RL, 2014, P NATL ACAD SCI USA, V111, P16190, DOI 10.1073/pnas.1412697111; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; HONORE N, 1994, ANTIMICROB AGENTS CH, V38, P238, DOI 10.1128/AAC.38.2.238; Hsu YF, 2014, PLANT J, V77, P119, DOI 10.1111/tpj.12371; Huang C-K, 2016, PLANT CELL PHYSL, V57, P175; Huang CK, 2010, PLANT CELL PHYSIOL, V51, P694, DOI 10.1093/pcp/pcq045; Huang TS, 2010, PLANT PHYSIOL, V152, P255, DOI 10.1104/pp.109.147983; Hunger K, 2006, J BACTERIOL, V188, P240, DOI 10.1128/JB.188.1.240-248.2006; Jain C, 2008, RNA, V14, P381, DOI 10.1261/rna.800308; Juntawong P, 2013, PLANT J, V74, P1016, DOI 10.1111/tpj.12187; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Karlson D, 2002, J BIOL CHEM, V277, P35248, DOI 10.1074/jbc.M205774200; Kehrenberg C, 2007, ANTIMICROB AGENTS CH, V51, P2244, DOI 10.1128/AAC.00229-07; Khan A, 2014, PLANT J, V79, DOI 10.1111/tpj.12533; Kim JS, 2008, PLANT CELL PHYSIOL, V49, P1563, DOI 10.1093/pcp/pcn125; Kim MH, 2013, FEBS OPEN BIO, V3, P438, DOI 10.1016/j.fob.2013.10.003; Kim MH, 2013, CELL STRESS CHAPERON, V18, P517, DOI 10.1007/s12192-012-0398-3; Kim MH, 2009, J BIOL CHEM, V284, P23454, DOI 10.1074/jbc.M109.025791; Kim SY, 2013, PLANT CELL, V25, P2970, DOI 10.1105/tpc.113.114264; Kohler D, 2010, PLANT MOL BIOL, V72, P459, DOI 10.1007/s11103-009-9584-9; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; Lee KH, 2013, PLANT J, V73, P720, DOI 10.1111/tpj.12055; Linder P, 2013, BBA-GENE REGUL MECH, V1829, P750, DOI 10.1016/j.bbagrm.2013.03.007; Liu M, 2010, J INTEGR PLANT BIOL, V52, P817, DOI 10.1111/j.1744-7909.2010.00972.x; Matthes A, 2007, PLANT PHYSIOL, V145, P1637, DOI 10.1104/pp.107.108076; Mingam A, 2004, PLANT BIOTECHNOL J, V2, P401, DOI 10.1111/j.1467-7652.2004.00084.x; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MORITZ M, 1991, MOL CELL BIOL, V11, P5681, DOI 10.1128/MCB.11.11.5681; Nakaminami K, 2006, P NATL ACAD SCI USA, V103, P10122, DOI 10.1073/pnas.0603168103; Nashchekin D, 2006, J BIOL CHEM, V281, P14263, DOI 10.1074/jbc.M600262200; Nayak NR, 2013, PLANT CELL, V25, P2573, DOI 10.1105/tpc.113.113456; Nishimura K, 2010, PLANT J, V63, P766, DOI 10.1111/j.1365-313X.2010.04276.x; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Petricka JJ, 2007, PLANT PHYSIOL, V144, P173, DOI 10.1104/pp.106.093575; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rodriguez-Galan O, 2013, BBA-GENE REGUL MECH, V1829, P775, DOI 10.1016/j.bbagrm.2013.01.007; Rosado A, 2012, P NATL ACAD SCI USA, V109, P19537, DOI 10.1073/pnas.1214774109; Rosado A, 2010, PLANT CELL, V22, P143, DOI 10.1105/tpc.109.068320; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Sasaki K, 2007, BIOCHEM BIOPH RES CO, V364, P633, DOI 10.1016/j.bbrc.2007.10.059; Sasaki K, 2013, NEW PHYTOL, V198, P95, DOI 10.1111/nph.12118; Scheer Ulrich, 1993, Trends in Cell Biology, V3, P236, DOI 10.1016/0962-8924(93)90123-I; Schmidt S, 2013, PLANT PHYSIOL, V163, P1623, DOI 10.1104/pp.113.223925; Shimizu H, 2005, PLANT CELL PHYSIOL, V46, P1623, DOI 10.1093/pcp/pci178; Shinohara N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00159; TAI PC, 1969, J BACTERIOL, V97, P1298, DOI 10.1128/JB.97.3.1298-1304.1969; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WALDRON C, 1974, MOL GEN GENET, V134, P115, DOI 10.1007/BF00268414; Weis BL, 2014, PLANT J, V80, P1043, DOI 10.1111/tpj.12703; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	75	34	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154040	10.1371/journal.pone.0154040	http://dx.doi.org/10.1371/journal.pone.0154040			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116354	gold, Green Submitted, Green Published			2022-12-26	WOS:000374973600039
J	Tyurin-Kuzmin, PA; Zhdanovskaya, ND; Sukhova, AA; Sagaradze, GD; Albert, EA; Ageeva, LV; Sharonov, GV; Vorotnikov, AV; Tkachuk, VA				Tyurin-Kuzmin, Pyotr A.; Zhdanovskaya, Nadezhda D.; Sukhova, Anna A.; Sagaradze, George D.; Albert, Eugene A.; Ageeva, Ludmila V.; Sharonov, George V.; Vorotnikov, Alexander V.; Tkachuk, Vsevolod A.			Nox4 and Duox1/2 Mediate Redox Activation of Mesenchymal Cell Migration by PDGF	PLOS ONE			English	Article							AKT/PROTEIN KINASE-B; GROWTH-FACTOR; NADPH OXIDASES; MECHANISMS; CHEMOTAXIS; GRADIENT; AKT/PKB; AKT2; PHOSPHORYLATION; PATHWAY	Platelet derived growth factor (PDGF) orchestrates wound healing and tissue regeneration by regulating recruitment of the precursor mesenchymal stromal cells (MSC) and fibroblasts. PDGF stimulates generation of hydrogen peroxide that is required for cell migration, but the sources and intracellular targets of H2O2 remain obscure. Here we demonstrate sustained live responses of H2O2 to PDGF and identify PKB/Akt, but not Erk1/2, as the target for redox regulation in cultured 3T3 fibroblasts and MSC. Apocynin, cell-permeable catalase and LY294002 inhibited PDGF-induced migration and mitotic activity of these cells indicating involvement of PI3-kinase pathway and H2O2. Real-time PCR revealed Nox4 and Duox1/2 as the potential sources of H2O2. Silencing of Duox1/2 in fibroblasts or Nox4 in MSC reduced PDGF-stimulated intracellular H2O2, PKB/Akt phosphorylation and migration, but had no such effect on Erk1/2. In contrast to PDGF, EGF failed to increase cytoplasmic H2O2, phosphorylation of PKB/Akt and migration of fibroblasts and MSC, confirming the critical impact of redox signaling. We conclude that PDGF-induced migration of mesenchymal cells requires Nox4 and Duox1/2 enzymes, which mediate redox-sensitive activation of PI3-kinase pathway and PKB/Akt.	[Tyurin-Kuzmin, Pyotr A.; Zhdanovskaya, Nadezhda D.; Sukhova, Anna A.; Sagaradze, George D.; Albert, Eugene A.; Ageeva, Ludmila V.; Sharonov, George V.; Vorotnikov, Alexander V.; Tkachuk, Vsevolod A.] Moscow MV Lomonosov State Univ, Fac Fundamental Med, Dept Biochem & Mol Med, Moscow, Russia; [Vorotnikov, Alexander V.; Tkachuk, Vsevolod A.] Russian Cardiol Res Ctr, Inst Expt Cardiol, Moscow, Russia; [Sharonov, George V.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Dept Biol Struct, Lab Opt Microscopy & Spect Biomol, Moscow, Russia; [Zhdanovskaya, Nadezhda D.] Univ Roma La Sapienza, Dept Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Albert, Eugene A.] Tech Univ Dresden, Dresden Cluster Excellence, DFG Ctr Regenerat Therapies, Dresden, Germany	Lomonosov Moscow State University; National Medical Research Center of Cardiology; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Sapienza University Rome; German Research Foundation (DFG); Technische Universitat Dresden	Vorotnikov, AV (corresponding author), Moscow MV Lomonosov State Univ, Fac Fundamental Med, Dept Biochem & Mol Med, Moscow, Russia.; Vorotnikov, AV (corresponding author), Russian Cardiol Res Ctr, Inst Expt Cardiol, Moscow, Russia.	a.vorotnikov@cardio.ru	Vorotnikov, Alexander/AAN-3080-2020; Sagaradze, Georgy/AAN-4809-2020; Ageeva, Liudmila/B-2173-2014; Sharonov, George V/B-1323-2014; Zhdanovskaya, Nadezda/AAQ-7504-2021; Tkachuk, Vsevolod/AAE-1136-2022; Tyurin-Kuzmin, Pyotr A./A-8193-2014; Tkachuk, Vsevolod A/J-9357-2012; albert, eugene/AAD-9436-2019	Vorotnikov, Alexander/0000-0002-1460-971X; Sharonov, George V/0000-0001-8610-5054; Zhdanovskaya, Nadezda/0000-0003-1973-1121; Tyurin-Kuzmin, Pyotr A./0000-0002-1901-1637; Tkachuk, Vsevolod/0000-0002-7492-747X; Sagaradze, Georgy/0000-0003-2551-5118	Russian Science Foundation [14-24-00086, 14-35-00026]; Russian Foundation for Basic Research [14-04-01746a]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Russian Science Foundation (http://pH(sic)p(sic)/en/) grants 14-24-00086 (fibroblast migration and proliferation) and 14-35-00026 (microscopy and redox imaging) to VAT, Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng) grant 14-04-01746a to AVV (redox signaling and PKB/Akt phosphorylation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Agarwal NK, 2013, ONCOGENE, V32, P2521, DOI 10.1038/onc.2012.287; AnandApte B, 1997, STEM CELLS, V15, P259, DOI 10.1002/stem.150259; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Corcoran A, 2013, FEBS J, V280, P1944, DOI 10.1111/febs.12224; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; DEUEL TF, 1991, ANNU REV MED, V42, P567, DOI 10.1146/annurev.me.42.020191.003031; Esposito F, 2003, J BIOL CHEM, V278, P20828, DOI 10.1074/jbc.M211841200; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Haugh JM, 2006, BIOPHYS J, V90, P2297, DOI 10.1529/biophysj.105.077610; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang JS, 2013, FREE RADICAL BIO MED, V65, P1246, DOI 10.1016/j.freeradbiomed.2013.09.011; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kong QJ, 2011, EXP CELL RES, V317, P1491, DOI 10.1016/j.yexcr.2011.04.003; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Meng D, 2008, CARDIOVASC RES, V80, P299, DOI 10.1093/cvr/cvn173; Mishina NM, 2011, ANTIOXID REDOX SIGN, V14, P1, DOI 10.1089/ars.2010.3539; Mora-Pale M, 2009, BIOORGAN MED CHEM, V17, P5146, DOI 10.1016/j.bmc.2009.05.061; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; San Martin A, 2010, ANTIOXID REDOX SIGN, V12, P625, DOI 10.1089/ars.2009.2852; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Small JV, 1996, BIOSCIENCE REP, V16, P351, DOI 10.1007/BF01207261; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; VIAU A T, 1986, Journal of Free Radicals in Biology and Medicine, V2, P283, DOI 10.1016/S0748-5514(86)80011-3; Vorotnikov AV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1528, DOI 10.1134/S0006297911130104; Vorotnikov AV, 2014, GENES DIS, V1, P162, DOI 10.1016/j.gendis.2014.09.006; Wani R, 2011, CELL CYCLE, V10, P3263, DOI 10.4161/cc.10.19.17738; Weiger MC, 2009, J CELL SCI, V122, P313, DOI 10.1242/jcs.037564; Woolley JF, 2013, ANTIOXID REDOX SIGN, V19, P1815, DOI 10.1089/ars.2012.5028; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yoeli-Lerner M, 2009, MOL CANCER RES, V7, P425, DOI 10.1158/1541-7786.MCR-08-0342; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	56	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154157	10.1371/journal.pone.0154157	http://dx.doi.org/10.1371/journal.pone.0154157			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110716	gold, Green Submitted, Green Published			2022-12-26	WOS:000374970600039
J	Gomes, TD; Magnet, A; Izquierdo, F; Vaccaro, L; Redondo, F; Bueno, S; Sanchez, ML; Angulo, S; Fenoy, S; Hurtado, C; del Aguila, C				Gomes, Thiago dos Santos; Magnet, Angela; Izquierdo, Fernando; Vaccaro, Lucianna; Redondo, Fernando; Bueno, Sara; Luisa Sanchez, Maria; Angulo, Santiago; Fenoy, Soledad; Hurtado, Carolina; del Aguila, Carmen			Acanthamoeba spp. in Contact Lenses from Healthy Individuals from Madrid, Spain	PLOS ONE			English	Article							WATER CONTAMINATION; AMEBIC KERATITIS; CANARY-ISLANDS; TAP WATER; DIAGNOSIS; IDENTIFICATION; PATHOGENESIS; SPECIMENS; BACTERIAL; TENERIFE	Purpose Acanthamoeba keratitis (AK) is a painful and potentially blinding corneal infection caused by Acanthamoeba spp. In Madrid, environmental studies have demonstrated a high presence of these free-living amoebae in tap water. Since most of AK cases occur in contact lenses (CL) wearers with inadequate hygiene habits, the presence of Acanthamoeba in discarded CL has been studied and compared with other common etiological agents of keratitis, such as Pseudomonas aeruginosa and Staphylococcus aureus. Methods One hundred and seventy-seven healthy individuals from Madrid contributed their discarded CL and answered a questionnaire on hygiene habits. DNA was extracted from the CL solution and analyzed by real-time PCR for Acanthamoeba, Pseudomonas aeruginosa and Staphylococcus aureus. These CL and their solutions were also cultured on non-nutrient agar to isolate Acanthamoeba. Results Among the 177 samples, Acanthamoeba DNA was detected in 87 (49.2%), P. aeruginosa DNA in 14 (7.9%) and S. aureus DNA in 19 (10.7%). Cultivable amoebae, however, were observed in only one sample (0.6%). This isolate was genotyped as T4. The habits reported by this CL owner included some recognized risk factors for AK, but in this study only the practice of "not cleaning the CL case" presented some statistical significant association with Acanthamoeba DNA presence. Detection of the investigated bacterial DNA did not demonstrate statistical significant association with the studied practices, but the presence of P. aeruginosa revealed a possible inhibition of Acanthamoeba in these samples. Conclusions The PCR results suggest a high presence of Acanthamoeba spp. in healthy CL wearers from Madrid, but we can assume that CL solutions are properly disinfecting the CL since only 1.1% of the positive PCR samples correspond to viable amoebae and, after four years, only one participant reported stronger ocular problems. Nevertheless, more studies are necessary to corroborate this hypothesis.	[Gomes, Thiago dos Santos; Magnet, Angela; Izquierdo, Fernando; Vaccaro, Lucianna; Redondo, Fernando; Bueno, Sara; Luisa Sanchez, Maria; Angulo, Santiago; Fenoy, Soledad; Hurtado, Carolina; del Aguila, Carmen] Univ San Pablo CEU, Fac Farm, Urbanizac Monteprincipe, Madrid, Spain; [Gomes, Thiago dos Santos] Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil	San Pablo CEU University; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	del Aguila, C (corresponding author), Univ San Pablo CEU, Fac Farm, Urbanizac Monteprincipe, Madrid, Spain.	cagupue@ceu.es	Redondo, Fernando/T-9254-2018; Sánchez, María Luisa/AAB-5302-2019; del Aguila, Carmen/A-6063-2016; Díaz-Parreño, Santiago Angulo/L-3035-2014; Magnet, Angela/G-5325-2013; Fenoy, Soledad/A-9633-2016; Bueno, Sara/AAB-5304-2019; Hurtado-Marcos, Carolina/AAH-3586-2020; Arias, Fernando Izquierdo/AAE-3073-2019	Redondo, Fernando/0000-0002-9679-1120; Sánchez, María Luisa/0000-0002-2542-0381; del Aguila, Carmen/0000-0003-0063-7899; Magnet, Angela/0000-0002-8642-4343; Fenoy, Soledad/0000-0002-5218-6308; Bueno, Sara/0000-0001-5329-8312; Hurtado-Marcos, Carolina/0000-0003-0364-7742; Arias, Fernando Izquierdo/0000-0003-0367-007X; Vaccaro Munoz, Lucianna/0000-0002-2644-4393; Gomes, Thiago/0000-0001-6781-6969	Instituto de Salud Carlos III (FISS) [PI12/02725]; FEDER; Fundacion Universitaria San Pablo CEU [USPCEU-PC07/2013]; Research Program EADS CASA-Brasil I; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil [BEX 9132/13-9]; FPU of Ministerio de Educacion, Cultura y Deporte, Spain [AP2009-0415]	Instituto de Salud Carlos III (FISS)(Instituto de Salud Carlos III); FEDER(European Commission); Fundacion Universitaria San Pablo CEU; Research Program EADS CASA-Brasil I; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FPU of Ministerio de Educacion, Cultura y Deporte, Spain	This project was supported by grant PI12/02725 from Instituto de Salud Carlos III (FISS) (http://www.isciii.es/) and FEDER and by grant USPCEU-PC07/2013 of the Fundacion Universitaria San Pablo CEU (http://www.ceu.es/). TSG was supported by Research Program EADS CASA-Brasil I and by grant BEX 9132/13-9 of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil (http://www.capes.gov.br/). AM was supported by FPU grant AP2009-0415 of Ministerio de Educacion, Cultura y Deporte, Spain (http://www.mecd.gob.es/portada-mecd/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalich-Montiel F, 2012, J CATARACT REFR SURG, V38, P1853, DOI 10.1016/j.jcrs.2012.08.022; Arnalich-Montiel F, 2014, J CLIN MICROBIOL, V52, P1213, DOI 10.1128/JCM.00031-14; Boggild AK, 2009, J CLIN MICROBIOL, V47, P1314, DOI 10.1128/JCM.00173-09; Boost M, 2008, OPTOMETRY VISION SCI, V85, P526, DOI 10.1097/OPX.0b013e31817dba7c; Booton GC, 2005, J CLIN MICROBIOL, V43, P1689, DOI 10.1128/JCM.43.4.1689-1693.2005; Booton GC, 2002, J CLIN MICROBIOL, V40, P1621, DOI 10.1128/JCM.40.5.1621-1625.2002; Cohen EJ, 1996, CORNEA, V15, P566, DOI 10.1097/00003226-199611000-00005; Cruz M., 2004, ENF EMERG, V6, P98; de Miguel I, 1999, Enferm Infecc Microbiol Clin, V17, P445; Fuerst PA, 2015, J EUKARYOT MICROBIOL, V62, P69, DOI 10.1111/jeu.12186; Gadsby NJ, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.004; Gast RJ, 1996, J EUKARYOT MICROBIOL, V43, P498, DOI 10.1111/j.1550-7408.1996.tb04510.x; Graffi S, 2013, BRIT J OPHTHALMOL, V97, P1382, DOI 10.1136/bjophthalmol-2013-303386; GRAY TB, 1995, BRIT J OPHTHALMOL, V79, P601, DOI 10.1136/bjo.79.6.601; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heredero-Bermejo I, 2015, PARASITOLOGY, V142, P363, DOI 10.1017/S0031182014001140; Jeong Hae Jin, 2005, Korean Journal of Parasitology, V43, P47, DOI 10.3347/kjp.2005.43.2.47; JOHN DT, 1995, PARASITOL RES, V81, P193; Johnston SP, 2009, J CLIN MICROBIOL, V47, P2040, DOI 10.1128/JCM.00575-09; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kilvington S, 2004, INVEST OPHTH VIS SCI, V45, P165, DOI 10.1167/iovs.03-0559; LARKIN DFP, 1990, BRIT J OPHTHALMOL, V74, P133, DOI 10.1136/bjo.74.3.133; Lee S M, 1997, Korean J Ophthalmol, V11, P39; Lopez L, 2000, Enferm Infecc Microbiol Clin, V18, P229; Lorenzo-Morales J, 2005, PARASITOL RES, V95, P273, DOI 10.1007/s00436-005-1301-2; Lorenzo-Morales J, 2007, PARASITOL RES, V102, P167, DOI 10.1007/s00436-007-0754-x; Lorenzo-Morales J, 2015, PARASITE, V22, DOI 10.1051/parasite/2015010; Lorenzo-Morales J, 2013, TRENDS PARASITOL, V29, P181, DOI 10.1016/j.pt.2013.01.006; Lorenzo-Morales J, 2011, CONTACT LENS ANTERIO, V34, P83, DOI 10.1016/j.clae.2010.10.007; Madrigal Sesma MJ, 1982, REV IBERICA PARASITO, VExtra, P124; Magnet A, 2015, SCI TOTAL ENVIRON, V505, P889, DOI 10.1016/j.scitotenv.2014.10.064; Magnet A, 2014, PARASITOL RES, V113, P2845, DOI 10.1007/s00436-014-3945-2; Magnet A, 2013, WATER RES, V47, P6966, DOI 10.1016/j.watres.2013.09.065; Magnet A, 2012, PARASITOL RES, V111, P383, DOI 10.1007/s00436-012-2849-2; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Martin-Navarro CM, 2008, J MED MICROBIOL, V57, P1399, DOI 10.1099/jmm.0.2008/003459-0; Mathers WD, 1998, BRIT J OPHTHALMOL, V82, P1143, DOI 10.1136/bjo.82.10.1143; Moreno-Montanes J, 2011, CASE REP OPHTHALM, V2, P354, DOI 10.1159/000334785; Moriyama AS, 2008, ARQ BRAS OFTALMOL, V71, P32, DOI 10.1590/S0004-27492008000700007; Niyyati M, 2014, IRAN J PARASITOL, V9, P14; Panjwani N, 2010, OCUL SURF, V8, P70, DOI 10.1016/S1542-0124(12)70071-X; Pens CJ, 2008, PARASITOL RES, V103, P1241, DOI 10.1007/s00436-008-1120-3; Perez-Pomata T, 2006, ENFERM INFEC MICR CL, V24, P280, DOI 10.1016/S0213-005X(06)73775-2; Qvarnstrom Y, 2006, J CLIN MICROBIOL, V44, P3589, DOI 10.1128/JCM.00875-06; Risler A, 2013, PARASITOL RES, V112, P3807, DOI 10.1007/s00436-013-3572-3; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Thakur DV, 2014, INDIAN J MED RES, V140, P307; Wang XH, 1997, CURR MICROBIOL, V34, P212, DOI 10.1007/s002849900170; Wu YT, 2011, INVEST OPHTH VIS SCI, V52, P5287, DOI 10.1167/iovs.10-6785; Wu YT, 2010, INVEST OPHTH VIS SCI, V51, P6329, DOI 10.1167/iovs.10-5796; Yu Hak-Sun, 2001, Korean Journal of Parasitology, V39, P161, DOI 10.3347/kjp.2001.39.2.161	51	18	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154246	10.1371/journal.pone.0154246	http://dx.doi.org/10.1371/journal.pone.0154246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105183	gold, Green Submitted, Green Published			2022-12-26	WOS:000374565100062
J	Ro, YS; Shin, SD; Song, KJ; Kim, JY; Lee, EJ; Lee, YJ; Ahn, KO; Hong, KJ				Ro, Young Sun; Shin, Sang Do; Song, Kyoung Jun; Kim, Joo Yeong; Lee, Eui Jung; Lee, Yu Jin; Ahn, Ki Ok; Hong, Ki Jeong		Cardiac Arrest Pursuit Trial	Risk of Diabetes Mellitus on Incidence of Out-of-Hospital Cardiac Arrests: A Case-Control Study	PLOS ONE			English	Article							DEATH; ASSOCIATION; OUTCOMES; EPIDEMIOLOGY; MORTALITY; SURVIVAL; LEVEL; MEN	Background This study aimed to determine the risk of diabetes mellitus (DM) on incidence of out-of-hospital cardiac arrest (OHCA) and to investigate whether difference in effects of DM between therapeutic methods was observed. Methods This study was a case-control study using the Cardiac Arrest Pursuit Trial with Unique Registration and Epidemiologic Surveillance (CAPTURES) project database and 2013 Korean Community Health Survey (CHS). Cases were defined as EMS-treated adult (18 year old and older) OHCA patients with presumed cardiac etiology collected at 27 emergency departments from January to December 2014. OHCA patients whose arrest occurred at nursing homes or clinics and cases with unknown information on DM were excluded. Four controls were matched to one case with strata including age, gender, and county from the Korean CHS database. Multivariable conditional logistic regression analysis was conducted to estimate the risk of DM and treatment modality on incidence of OHCA. Results Total 1,386 OHCA patients and 5,544 community-based controls were analyzed. A total of 370 (26.7%) among cases and 860 (15.5%) among controls were diagnosed with DM. DM was associated with increasing risk of OHCA (AOR: 1.92 (1.65-2.24)). By DM treatment modality comparing with non-DM group, AOR (95% CI) was the highest in non-pharmacotherapy only group (4.65 (2.00-10.84)), followed by no treatment group (4.17 (2.91-5.96)), insulin group (2.69 (1.82-3.96)), and oral hypoglycemic agent group (1.55 (1.31-1.85)). Conclusion DM increased the risk of OHCA, which was the highest in the non-pharmacotherapy group and decreased in magnitude with pharmacotherapy.	[Ro, Young Sun; Shin, Sang Do; Song, Kyoung Jun; Kim, Joo Yeong; Lee, Eui Jung; Lee, Yu Jin; Ahn, Ki Ok; Hong, Ki Jeong] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul 110744, South Korea; [Shin, Sang Do; Song, Kyoung Jun; Lee, Eui Jung; Lee, Yu Jin] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul, South Korea; [Kim, Joo Yeong] Korea Univ, Ansan Hosp, Dept Emergency Med, Ansan, South Korea; [Hong, Ki Jeong] Seoul Natl Univ, Dept Emergency Med, Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Seoul National University Hospital	Shin, SD (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul 110744, South Korea.; Shin, SD (corresponding author), Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul, South Korea.	shinsangdo@medimail.co.kr	안, 기옥/L-5596-2019; Lee, Jae Hyuk/W-5616-2018	안, 기옥/0000-0002-8446-3269; Lee, Jae Hyuk/0000-0003-2429-4085; Hong, Ki Jeong/0000-0003-3334-817X	Korea Centers for Disease Control and Prevention [2013E3300500/2014E3300100]	Korea Centers for Disease Control and Prevention	This study was supported and funded by the Korea Centers for Disease Control and Prevention (2013-2014) (Grant No. 2013E3300500/2014E3300100).	Andersson C, 2012, DIABETOLOGIA, V55, P2348, DOI 10.1007/s00125-012-2584-3; Bergner DW, 2010, CARDIOL J, V17, P117; Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074; Cuddy TE, 2006, CAN J CARDIOL, V22, P205; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Jouven X, 2005, EUR HEART J, V26, P2142, DOI 10.1093/eurheartj/ehi376; Kim MJ, 2015, RESUSCITATION, V97, P115, DOI 10.1016/j.resuscitation.2015.08.019; Kucharska-Newton AM, 2010, ACTA DIABETOL, V47, pS161, DOI 10.1007/s00592-009-0157-9; McEwen LN, 2011, DIABETES CARE, V34, P1529, DOI 10.2337/dc10-2312; McNally B, 2011, MMWR SURVEILL SUMM, V60, P1; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Oh DH, 2013, J KOREAN MED SCI, V28, P128, DOI 10.3346/jkms.2013.28.1.128; Ro YS, 2015, RESUSCITATION, V90, P35, DOI 10.1016/j.resuscitation.2015.02.006; Ro YS, 2013, RESUSCITATION, V84, P547, DOI 10.1016/j.resuscitation.2012.12.020; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Singh JP, 2000, AM J CARDIOL, V86, P309, DOI 10.1016/S0002-9149(00)00920-6; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	22	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154245	10.1371/journal.pone.0154245	http://dx.doi.org/10.1371/journal.pone.0154245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105059	Green Submitted, gold, Green Published			2022-12-26	WOS:000374565100061
J	Sun, YY; Sun, L				Sun, Yuan-yuan; Sun, Li			A Teleost Bactericidal Permeability-Increasing Protein Kills Gram-Negative Bacteria, Modulates Innate Immune Response, and Enhances Resistance against Bacterial and Viral Infection	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; CYNOGLOSSUS-SEMILAEVIS; EXPRESSION ANALYSIS; TONGUE SOLE; MOLECULAR-CLONING; ESCHERICHIA-COLI; TERMINAL DOMAIN; HOST INFECTION; BPI/LBP CDNA; BPI	Bactericidal/permeability-increasing protein (BPI) is an important factor of innate immunity that in mammals is known to take part in the clearance of invading Gram-negative bacteria. In teleost, the function of BPI is unknown. In the present work, we studied the function of tongue sole (Cynoglossus semilaevis) BPI, CsBPI. We found that CsBPI was produced extra-cellularly by peripheral blood leukocytes (PBL). Recombinant CsBPI (rCsBPI) was able to bind to a number of Gram-negative bacteria but not Gram-positive bacteria. Binding to bacteria led to bacterial death through membrane permeabilization and structural destruction, and the bound bacteria were more readily taken up by PBL. In vivo, rCsBPI augmented the expression of a wide arrange of genes involved in antibacterial and antiviral immunity. Furthermore, rCsBPI enhanced the resistance of tongue sole against bacterial as well as viral infection. These results indicate for the first time that a teleost BPI possesses immunoregulatory effect and plays a significant role in antibacterial and antiviral defense.	[Sun, Yuan-yuan; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Sun, Yuan-yuan; Sun, Li] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Sun, Yuan-yuan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.; Sun, L (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	lsun@qdio.ac.cn			National Natural Science Foundation of China [31330081]; National Basic Research Program of China [2012CB114406]; Taishan Scholar Program of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Taishan Scholar Program of Shandong Province	This work was supported by the grants from the National Natural Science Foundation of China (31330081), the National Basic Research Program of China (2012CB114406), and the Taishan Scholar Program of Shandong Province.	Beamer LJ, 1998, PROTEIN SCI, V7, P906; Beamer LJ, 2003, BIOCHEM SOC T, V31, P791, DOI 10.1042/BST0310791; Capodici C, 1996, J IMMUNOL, V156, P4789; Elsbach P, 1998, J LEUKOCYTE BIOL, V64, P14, DOI 10.1002/jlb.64.1.14; ELSBACH P, 1993, IMMUNOBIOLOGY, V187, P417, DOI 10.1016/S0171-2985(11)80354-2; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hu YH, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-23; Inagawa H, 2002, J IMMUNOL, V168, P5638, DOI 10.4049/jimmunol.168.11.5638; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; Iovine NM, 1997, P NATL ACAD SCI USA, V94, P10973, DOI 10.1073/pnas.94.20.10973; KHEMLANI LS, 1994, J LEUKOCYTE BIOL, V56, P784, DOI 10.1002/jlb.56.6.784; Kim JW, 2012, FISH SHELLFISH IMMUN, V33, P75, DOI 10.1016/j.fsi.2012.04.003; Kono T, 2003, MOL IMMUNOL, V40, P269, DOI 10.1016/S0161-5890(03)00103-2; Lamping N, 1996, J IMMUNOL, V157, P4648; Levy O, 2000, INFECT IMMUN, V68, P5120, DOI 10.1128/IAI.68.9.5120-5125.2000; Levy O, 2003, BIOCHEM SOC T, V31, P795, DOI 10.1042/BST0310795; Li MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096222; Li YX, 2012, DEV COMP IMMUNOL, V37, P55, DOI 10.1016/j.dci.2011.12.007; Li YX, 2011, FISH SHELLFISH IMMUN, V31, P446, DOI 10.1016/j.fsi.2011.06.017; LITTLE RG, 1994, J BIOL CHEM, V269, P1865; Long H, 2014, FISH SHELLFISH IMMUN, V37, P66, DOI 10.1016/j.fsi.2014.01.013; Magor BG, 2001, DEV COMP IMMUNOL, V25, P651, DOI 10.1016/S0145-305X(01)00029-5; MANNION BA, 1990, J CLIN INVEST, V85, P853, DOI 10.1172/JCI114512; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Nam BH, 2010, VET IMMUNOL IMMUNOP, V133, P256, DOI 10.1016/j.vetimm.2009.07.010; OOI CE, 1987, J BIOL CHEM, V262, P14891; Srivastava A, 2007, INFECT IMMUN, V75, P342, DOI 10.1128/IAI.01089-06; Stenvik J, 2004, DEV COMP IMMUNOL, V28, P307, DOI 10.1016/j.dci.2003.09.002; Sun YY, 2016, DEV COMP IMMUNOL, V55, P194, DOI 10.1016/j.dci.2015.10.003; Suzuki K, 2009, FISHERIES SCI, V75, P673, DOI 10.1007/s12562-009-0072-6; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Wang JJ, 2015, J PROTEOMICS, V124, P1, DOI 10.1016/j.jprot.2015.04.011; Wang T, 2016, DEV COMP IMMUNOL, V55, P12, DOI 10.1016/j.dci.2015.10.002; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044884; WEINRAUCH Y, 1994, CLIN RES, V42, pA152; WEISS J, 1975, J CLIN INVEST, V55, P33, DOI 10.1172/JCI107915; WEISS J, 1978, J BIOL CHEM, V253, P2664; Xu P, 2005, DEV COMP IMMUNOL, V29, P865, DOI 10.1016/j.dci.2005.03.004; Zarember K, 1997, BLOOD, V89, P672, DOI 10.1182/blood.V89.2.672; Zhang BC, 2015, DEV COMP IMMUNOL, V53, P96, DOI 10.1016/j.dci.2015.07.004; Zhang J, 2015, FISH SHELLFISH IMMUN, V45, P486, DOI 10.1016/j.fsi.2015.05.006; Zhang J, 2015, FISH SHELLFISH IMMUN, V44, P272, DOI 10.1016/j.fsi.2015.02.033; Zhang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106543; Zhou ZJ, 2015, VET MICROBIOL, V177, P332, DOI 10.1016/j.vetmic.2015.03.030; Zhou ZJ, 2015, DEV COMP IMMUNOL, V50, P69, DOI 10.1016/j.dci.2015.01.007	47	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154045	10.1371/journal.pone.0154045	http://dx.doi.org/10.1371/journal.pone.0154045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105425	Green Submitted, Green Published, gold			2022-12-26	WOS:000374565100037
J	Heinritz, SN; Weiss, E; Eklund, M; Aumiller, T; Louis, S; Rings, A; Messner, S; Camarinha-Silva, A; Seifert, J; Bischoff, SC; Mosenthin, R				Heinritz, Sonja N.; Weiss, Eva; Eklund, Meike; Aumiller, Tobias; Louis, Sandrine; Rings, Andreas; Messner, Sabine; Camarinha-Silva, Amelia; Seifert, Jana; Bischoff, Stephan C.; Mosenthin, Rainer			Intestinal Microbiota and Microbial Metabolites Are Changed in a Pig Model Fed a High-Fat/Low-Fiber or a Low-Fat/High-Fiber Diet	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GUT MICROBIOTA; HEALTH-BENEFITS; WEIGHT-GAIN; DIVERSITY; BIFIDOBACTERIA; FERMENTATION; PREDICTION; CHILDREN; BACTERIA	The intestinal microbiota and its metabolites appear to be an important factor for gastrointestinal function and health. However, research is still needed to further elaborate potential relationships between nutrition, gut microbiota and host's health by means of a suitable animal model. The present study examined the effect of two different diets on microbial composition and activity by using the pig as a model for humans. Eight pigs were equally allotted to two treatments, either fed a low-fat/high-fiber (LF), or a high-fat/low-fiber (HF) diet for 7 weeks. Feces were sampled at day 7 of every experimental week. Diet effects on fecal microbiota were assessed using quantitative real-time PCR, DNA fingerprinting and meta-proteomics. Furthermore, fecal short-chain fatty acid (SCFA) profiles and ammonia concentrations were determined. Gene copy numbers of lactobacilli, bifidobacteria (P<0.001) and Faecalibacterium prausnitzii (P<0.05) were higher in the LF pigs, while Enterobacteriaceae were more abundant in the HF pigs (P<0.001). Higher numbers of proteins affiliated to Enterobacteriaceae were also present in the HF samples. Proteins for polysaccharide breakdown did almost exclusively originate from Prevotellaceae. Total and individual fecal SCFA concentrations were higher for pigs of the LF treatment (P<0.05), whereas fecal ammonia concentrations did not differ between treatments (P>0.05). Results provide evidence that beginning from the start of the experiment, the LF diet stimulated beneficial bacteria and SCFA production, especially butyrate (P<0.05), while the HF diet fostered those bacterial groups which have been associated with a negative impact on health conditions. These findings correspond to results in humans and might strengthen the hypothesis that the response of the porcine gut microbiota to a specific dietary modulation is in support of using the pig as suitable animal model for humans to assess diet-gut-microbiota interactions.	[Heinritz, Sonja N.; Weiss, Eva; Eklund, Meike; Aumiller, Tobias; Messner, Sabine; Camarinha-Silva, Amelia; Seifert, Jana; Mosenthin, Rainer] Univ Hohenheim, Inst Anim Sci, Stuttgart, Germany; [Louis, Sandrine; Rings, Andreas; Bischoff, Stephan C.] Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany	University Hohenheim; University Hohenheim	Mosenthin, R (corresponding author), Univ Hohenheim, Inst Anim Sci, Stuttgart, Germany.	rainer.mosenthin@uni-hohenheim.de	Silva, Amélia Camarinha/AAB-5584-2019	Camarinha Silva, Amelia/0000-0001-7814-6569; Aumiller, Tobias/0000-0001-6836-0297; Seifert, Jana/0000-0002-7690-8539	University of Hohenheim	University of Hohenheim	The work was supported by a grant of the University of Hohenheim. There is no specific grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Bublitz DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101456; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Damms-Machado A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/806248; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Drissi F, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.6; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Fava F, 2013, INT J OBESITY, V37, P216, DOI 10.1038/ijo.2012.33; FRASER J. R., 1959, Journal of the Science of Food and Agriculture, V10, P506, DOI 10.1002/jsfa.2740100910; Frese SA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0091-8; Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948; Gonzalez LM, 2015, TRANSL RES, V166, P12, DOI 10.1016/j.trsl.2015.01.004; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Haange SB, 2012, J PROTEOME RES, V11, P5406, DOI 10.1021/pr3006364; Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152; Hermes RG, 2009, J ANIM SCI, V87, P3569, DOI 10.2527/jas.2008-1241; Jehmlich N, 2008, RAPID COMMUN MASS SP, V22, P2889, DOI 10.1002/rcm.3684; Kaczmarczyk MM, 2012, METABOLISM, V61, P1058, DOI 10.1016/j.metabol.2012.01.017; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kailasapathy K, 2000, IMMUNOL CELL BIOL, V78, P80, DOI 10.1046/j.1440-1711.2000.00886.x; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Loh G, 2006, J NUTR, V136, P1198, DOI 10.1093/jn/136.5.1198; Looft T, 2014, ISME J, V8, P1566, DOI 10.1038/ismej.2014.12; Luoto R, 2010, BRIT J NUTR, V103, P1792, DOI 10.1017/S0007114509993898; Matise I, 2000, VET PATHOL, V37, P318, DOI 10.1354/vp.37-4-318; Mikkelsen LL, 2003, APPL ENVIRON MICROB, V69, P654, DOI 10.1128/AEM.69.1.654-658.2003; Millet S, 2010, CRIT REV FOOD SCI, V50, P605, DOI 10.1080/10408390802565939; Million M, 2013, INT J OBESITY, V37, P1460, DOI 10.1038/ijo.2013.20; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Naumann C., 1997, VDLUFA METHODENBUCH, VIII; NOBLET J, 1994, J ANIM SCI, V72, P344, DOI 10.2527/1994.722344x; PALMQUIST DL, 1994, J NUTR, V124, pS1377; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Pedersen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056612; Pettigrew J. E., 1991, Swine Nutrition., P133; Pieper R, 2012, J NUTR, V142, P661, DOI 10.3945/jn.111.156190; Piepho HP, 2004, J COMPUT GRAPH STAT, V13, P456, DOI 10.1198/1061860043515; Pluske JR, 2002, NUTR RES REV, V15, P333, DOI 10.1079/NRR200242; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Remely M, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000253; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shen JA, 2010, ARCH MICROBIOL, V192, P959, DOI 10.1007/s00203-010-0628-y; Simpson PJ, 2003, J BACTERIOL, V185, P2571, DOI 10.1128/JB.185.8.2571-2581.2003; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Smith AG, 2010, LIVEST SCI, V133, P148, DOI 10.1016/j.livsci.2010.06.049; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wagnerberger S, 2012, BRIT J NUTR, V107, P1727, DOI 10.1017/S0007114511004983; Wang J, 2010, CARBOHYD POLYM, V82, P419, DOI 10.1016/j.carbpol.2010.04.082; Wang M, 2015, ILAR J, V56, P63, DOI 10.1093/ilar/ilv006; Weiss E, 2016, J SCI FOOD AGR, V96, P2230, DOI 10.1002/jsfa.7340; Winer BJ, 1991, STATISTICAL PRINCIPL; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; ZIJLSTRA JB, 1977, CLIN CHIM ACTA, V78, P243, DOI 10.1016/0009-8981(77)90312-6; Zumbrun SD, 2013, P NATL ACAD SCI USA, V110, pE2126, DOI 10.1073/pnas.1222014110	71	95	100	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154329	10.1371/journal.pone.0154329	http://dx.doi.org/10.1371/journal.pone.0154329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100182	gold, Green Submitted, Green Published			2022-12-26	WOS:000374898500183
J	Mula, RVR; Machiah, D; Holland, L; Wang, XY; Parihar, H; Sharma, AC; Selvaraj, P; Shashidharamurthy, R				Mula, Ramanjaneya V. R.; Machiah, Deepa; Holland, Lauren; Wang, Xinyu; Parihar, Harish; Sharma, Avadhesh C.; Selvaraj, Periasamy; Shashidharamurthy, Rangaiah			Immune Complex-Induced, Nitric Oxide-Mediated Vascular Endothelial Cell Death by Phagocytes Is Prevented with Decoy Fc gamma Receptors	PLOS ONE			English	Article							NEUTROPHIL RECRUITMENT; EXPRESSION; APOPTOSIS; SYNTHASE; TISSUE; ARTHRITIS; ADHESION; ACTIVATION; DEPOSITION; MOLECULES	Autoimmune vasculitis is an endothelial inflammatory disease that results from the deposition of immune-complexes (ICs) in blood vessels. The interaction between Fcgamma receptors (Fc gamma Rs) expressed on inflammatory cells with ICs is known to cause blood vessel damage. Hence, blocking the interaction of ICs and inflammatory cells is essential to prevent the IC-mediated blood vessel damage. Thus we tested if uncoupling the interaction of Fc gamma Rs and ICs prevents endothelium damage. Herein, we demonstrate that dimeric Fc gamma R-Igs prevented nitric oxide (NO) mediated apoptosis of human umbilical vein endothelial cells (HUVECs) in an in vitro vasculitis model. Dimeric Fc gamma R-Igs significantly inhibited the IC-induced upregulation of inducible nitric oxide synthase (iNOS) and nitric oxide (NO) release by murine monocytic cell line. However, Fc gamma R-Igs did not affect the exogenously added NO-induced upregulation of pro-apoptotic genes such as Bax (15 fold), Bak (35 fold), cytochrome-C (11 fold) and caspase-3 (30 fold) in HUVECs. In conclusion, these data suggest that IC-induced NO could be one of the major inflammatory mediator promoting blood vessel inflammation and endothelial cell death during IC-mediated vasculitis which can be effectively blocked by dimeric decoy Fc gamma Rs.	[Mula, Ramanjaneya V. R.; Holland, Lauren; Wang, Xinyu; Sharma, Avadhesh C.; Shashidharamurthy, Rangaiah] Philadelphia Coll Osteopath Med, Sch Pharm, Dept Pharmaceut Sci, Suwanee, GA USA; [Parihar, Harish] Philadelphia Coll Osteopath Med, Dept Pharm Practice, Sch Pharm, Suwanee, GA USA; [Machiah, Deepa] Yerkes Natl Primate Res Ctr, Dept Mol Pathol Lab, Atlanta, GA USA; [Selvaraj, Periasamy] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Shashidharamurthy, R (corresponding author), Philadelphia Coll Osteopath Med, Sch Pharm, Dept Pharmaceut Sci, Suwanee, GA USA.	rangaiahsh@pcom.edu	WANG, XINYU/J-8507-2019	WANG, XINYU/0000-0003-2085-8824	American Heart Association Award [11SDG5710004]; Philadelphia College of Osteopathic Medicine	American Heart Association Award(American Heart Association); Philadelphia College of Osteopathic Medicine	This work was supported by American Heart Association Award (11SDG5710004) and Chief Scientific Officer (CSO) funding from Philadelphia College of Osteopathic Medicine to RS and XW.	Avdagic N, 2013, BOSNIAN J BASIC MED, V13, P5; Banda NK, 2007, J IMMUNOL, V179, P4101, DOI 10.4049/jimmunol.179.6.4101; Beltran B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602; BREEDVELD FC, 1988, CLIN IMMUNOL IMMUNOP, V48, P202, DOI 10.1016/0090-1229(88)90084-0; Brune B, 2003, CELL DEATH DIFFER, V10, P864, DOI 10.1038/sj.cdd.4401261; Calza L, 1997, P NATL ACAD SCI USA, V94, P3368, DOI 10.1073/pnas.94.7.3368; Clahsen T, 2008, J LEUKOCYTE BIOL, V84, P1521, DOI 10.1189/jlb.0308178; CLARK RAF, 1986, J CELL SCI, V82, P263; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Daeron M, 2014, CURR TOP MICROBIOL, V382, P131, DOI 10.1007/978-3-319-07911-0_7; Dhillon SS, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.17; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Gauley J, 2010, J LEUKOCYTE BIOL, V87, P1115, DOI 10.1189/jlb.0709465; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Hooper DC, 1997, P NATL ACAD SCI USA, V94, P2528, DOI 10.1073/pnas.94.6.2528; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Jea JC, 1998, J LEUKOCYTE BIOL, V64, P451, DOI 10.1002/jlb.64.4.451; Lauterbach M, 2008, J LEUKOCYTE BIOL, V83, P1423, DOI 10.1189/jlb.0607421; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; MCCARTNEYFRANCIS N, 1993, J EXP MED, V178, P749, DOI 10.1084/jem.178.2.749; MOZAFFARIAN N, 1995, J LEUKOCYTE BIOL, V57, P657, DOI 10.1002/jlb.57.4.657; MULLIGAN MS, 1992, BRIT J PHARMACOL, V107, P1159, DOI 10.1111/j.1476-5381.1992.tb13423.x; MULLIGAN MS, 1991, P NATL ACAD SCI USA, V88, P6338, DOI 10.1073/pnas.88.14.6338; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Niarakis A, 2014, CURR TOP MICROBIOL, V382, P69, DOI 10.1007/978-3-319-07911-0_4; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Ohtani H, 2012, NITRIC OXIDE-BIOL CH, V26, P95, DOI 10.1016/j.niox.2011.12.007; Pei H, 2013, J TRADIT CHIN MED, V33, P486, DOI 10.1016/S0254-6272(13)60153-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Shashidharamurthy R, 2012, GENE THER, V19, P877, DOI 10.1038/gt.2011.175; Shashidharamurthy R, 2008, BLOOD, V111, P894, DOI 10.1182/blood-2007-04-085944; Shashidharamurthy R, 2009, J IMMUNOL, V183, P8216, DOI 10.4049/jimmunol.0902550; Shen YH, 1998, FEBS LETT, V433, P125, DOI 10.1016/S0014-5793(98)00844-8; Silvescu CI, 2014, P NATL ACAD SCI USA, V111, P10696, DOI 10.1073/pnas.1320833111; Sioutas A, 2008, FERTIL STERIL, V89, P948, DOI 10.1016/j.fertnstert.2007.04.018; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; SMILEY JD, 1989, AM J MED SCI, V298, P267, DOI 10.1097/00000441-198910000-00012; Stokol T, 2004, J EXP MED, V200, P835, DOI 10.1084/jem.20040501; Suzuki Y, 2003, J IMMUNOL, V170, P3243, DOI 10.4049/jimmunol.170.6.3243; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Taylor EL, 2003, CELL DEATH DIFFER, V10, P418, DOI 10.1038/sj.cdd.4401152; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Vitecek J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/318087; Wang BY, 1999, CIRCULATION, V99, P1236, DOI 10.1161/01.CIR.99.9.1236; WEINBERG JB, 1994, J EXP MED, V179, P651, DOI 10.1084/jem.179.2.651; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Williams MR, 2008, ENDOTHELIUM-J ENDOTH, V15, P73, DOI 10.1080/10623320802092443	56	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153620	10.1371/journal.pone.0153620	http://dx.doi.org/10.1371/journal.pone.0153620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101012	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500045
J	Wang, HL; Lai, HH; Chuang, TH; Shih, YW; Huang, SC; Lee, MJ; Chen, SU				Wang, Huai-Ling; Lai, Hsing-Hua; Chuang, Tzu-Hsuan; Shih, Yu-Wei; Huang, Shih-Chieh; Lee, Meng-Ju; Chen, Shee-Uan			A Patient Friendly Corifollitropin Alfa Protocol without Routine Pituitary Suppression in Normal Responders	PLOS ONE			English	Article							CONTROLLED OVARIAN STIMULATION; LUTEINIZING-HORMONE SURGES; GNRH ANTAGONIST; RECOMBINANT FSH; CETRORELIX; GANIRELIX; HYPERSTIMULATION; COMBINATION; FEEDBACK; FAILURE	The release of corifollitropin alfa simplifies daily injections of short-acting recombinant follicular stimulating hormone (rFSH), and its widely-used protocol involves short-acting gonadotropins supplements and a fixed GnRH antagonist regimen, largely based on follicle size. In this study, the feasibility of corifollitropin alfa without routine pituitary suppression was evaluated. A total of 288 patients were stimulated by corifollitropin alfa on cycle day 3 following with routine serum hormone monitoring and follicle scanning every other day after 5 days of initial stimulation, and a GnRH antagonist (0.25 mg) was only used prophylactically when the luteinizing hormone (LH) was >= 6 IU/L (over half of the definitive LH surge). The incidence of premature LH surge (>= 10 IU/L) was 2.4% (7/288) before the timely injection of a single GnRH antagonist, and the elevated LH level was dropped down from 11.9 IU/L to 2.2 IU/L after the suppression. Two hundred fifty-one patients did not need any antagonist (87.2% [251/288]) throughout the whole stimulation. No adverse effects were observed regarding oocyte competency (fertilization rate: 78%; blastocyst formation rate: 64%). The live birth rate per OPU cycle after the first cryotransfer was 56.3%(161/286), and the cumulative live birth rate per OPU cycle after cyrotransfers was 69.6% (199/286). Of patients who did and did not receive GnRH antagonist during stimulation, no significant difference existed in the cumulative live birth rates (78.4% vs. 68.3%, p = 0.25). The results demonstrated that the routine GnRH antagonist administration is not required in the corifollitropin-alfa cycles using a flexible and hormone-depended antagonist regimen, while the clinical outcome is not compromised. This finding reveals that the use of a GnRH antagonist only occasionally may be needed.	[Wang, Huai-Ling; Lai, Hsing-Hua; Chuang, Tzu-Hsuan; Shih, Yu-Wei; Huang, Shih-Chieh; Lee, Meng-Ju] Stork Ladies Clin, Stork Fertil Ctr, Hsinchu, Taiwan; [Chen, Shee-Uan] Natl Taiwan Univ Hosp & Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital	Chen, SU (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan.	sheeuan@ntu.edu.tw	, 李孟儒/AAO-6724-2021	CHEN, SHEE-UAN/0000-0001-7592-3238; Chuang, Tzu-Hsuan/0000-0003-4263-9374; Lee, Meng Ju/0000-0003-3102-709X				Albano C, 2000, HUM REPROD, V15, P526, DOI 10.1093/humrep/15.3.526; Bhattacharya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082249; Borm G, 2000, HUM REPROD, V15, P1490; de Greef R, 2010, CLIN PHARMACOL THER, V88, P79, DOI 10.1038/clpt.2010.54; Del Gadillo JCB, 2002, EUR J OBSTET GYN R B, V102, P179, DOI 10.1016/S0301-2115(01)00580-2; Devroey P, 2004, J CLIN ENDOCR METAB, V89, P2062, DOI 10.1210/jc.2003-031766; Devroey P, 2009, HUM REPROD, V24, P3063, DOI 10.1093/humrep/dep291; DIEDRICH K, 1994, HUM REPROD, V9, P788, DOI 10.1093/oxfordjournals.humrep.a138597; Fauser BCJM, 2010, REPROD BIOMED ONLINE, V21, P593, DOI 10.1016/j.rbmo.2010.06.032; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Fowler PA, 2003, REPRODUCTION, V126, P689, DOI 10.1530/reprod/126.6.689; FRYDMAN R, 1992, HUM REPROD, V7, P930, DOI 10.1093/oxfordjournals.humrep.a137773; Griesinger G, 2006, FERTIL STERIL, V85, P791, DOI 10.1016/j.fertnstert.2005.08.048; Griesinger G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149615; Lainas T, 2005, HUM REPROD, V20, P2426, DOI 10.1093/humrep/dei106; Messinis IE, 2005, HUM REPROD, V20, P3192, DOI 10.1093/humrep/dei210; Messinis IE, 2006, HUM REPROD UPDATE, V12, P557, DOI 10.1093/humupd/dml020; Messinis IE, 2014, REPROD BIOMED ONLINE, V28, P714, DOI 10.1016/j.rbmo.2014.02.003; Messinis IE, 2010, FERTIL STERIL, V94, P1554, DOI 10.1016/j.fertnstert.2009.12.055; Olivennes F, 2002, HUM REPROD UPDATE, V8, P279, DOI 10.1093/humupd/8.3.279; Olivennes F, 2003, Reprod Biomed Online, V6, P432; Pouwer AW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009577.pub2; Reichman DE, 2014, FERTIL STERIL, V102, P99, DOI 10.1016/j.fertnstert.2014.04.010; Seyhan A, 2011, INT J WOMENS HEALTH, V3, P243, DOI 10.2147/IJWH.S15002; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Tarlatzis BC, 2006, HUM REPROD UPDATE, V12, P333, DOI 10.1093/humupd/dml001; Wilcox J, 2005, FERTIL STERIL, V84, P108, DOI 10.1016/j.fertnstert.2005.03.016; WILDT L, 1986, HUM REPROD, V1, P15, DOI 10.1093/oxfordjournals.humrep.a136334; Xiao JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106854	29	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154123	10.1371/journal.pone.0154123	http://dx.doi.org/10.1371/journal.pone.0154123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100388	Green Published, gold			2022-12-26	WOS:000374898500149
J	Zanotto, A; Dashnamoorthy, R; Loranc, E; de Souza, LHT; Moreira, JCF; Suresh, U; Chen, YD; Bishop, AJR				Zanotto-Filho, Alfeu; Dashnamoorthy, Ravi; Loranc, Eva; de Souza, Luis H. T.; Moreira, Jose C. F.; Suresh, Uthra; Chen, Yidong; Bishop, Alexander J. R.			Combined Gene Expression and RNAi Screening to Identify Alkylation Damage Survival Pathways from Fly to Human	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CANCER-CELLS; DNA-DAMAGE; RESISTANCE; CISPLATIN; CYCLOPHOSPHAMIDE; INVOLVEMENT; GLUTATHIONE; NRF2	Alkylating agents are a key component of cancer chemotherapy. Several cellular mechanisms are known to be important for its survival, particularly DNA repair and xenobiotic detoxification, yet genomic screens indicate that additional cellular components may be involved. Elucidating these components has value in either identifying key processes that can be modulated to improve chemotherapeutic efficacy or may be altered in some cancers to confer chemoresistance. We therefore set out to reevaluate our prior Drosophila RNAi screening data by comparison to gene expression arrays in order to determine if we could identify any novel processes in alkylation damage survival. We noted a consistent conservation of alkylation survival pathways across platforms and species when the analysis was conducted on a pathway/process level rather than at an individual gene level. Better results were obtained when combining gene lists from two datasets (RNAi screen plus microarray) prior to analysis. In addition to previously identified DNA damage responses (p53 signaling and Nucleotide Excision Repair), DNA-mRNA-protein metabolism (transcription/translation) and proteasome machinery, we also noted a highly conserved cross-species requirement for NRF2, glutathione (GSH)-mediated drug detoxification and Endoplasmic Reticulum stress (ER stress)/Unfolded Protein Responses (UPR) in cells exposed to alkylation. The requirement for GSH, NRF2 and UPR in alkylation survival was validated by metabolomics, protein studies and functional cell assays. From this we conclude that RNAi/gene expression fusion is a valid strategy to rapidly identify key processes that may be extendable to other contexts beyond damage survival.	[Zanotto-Filho, Alfeu; Dashnamoorthy, Ravi; Loranc, Eva; Suresh, Uthra; Chen, Yidong; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Children s Canc Res Inst, San Antonio, TX 78229 USA; [Dashnamoorthy, Ravi] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Dashnamoorthy, Ravi] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Zanotto-Filho, Alfeu; de Souza, Luis H. T.; Moreira, Jose C. F.] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil; [Suresh, Uthra; Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Tufts Medical Center; Tufts University; University of Texas System; University of Texas Health San Antonio; Universidade Federal do Rio Grande do Sul; University of Texas System; University of Texas Health San Antonio	Bishop, AJR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Children s Canc Res Inst, San Antonio, TX 78229 USA.; Bishop, AJR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	bishopa@uthscsa.edu	ZANOTTO-FILHO, ALFEU/A-8172-2016; moreira, jose claudio/AAO-6400-2021	ZANOTTO-FILHO, ALFEU/0000-0002-4188-3095; Bishop, Alexander/0000-0002-5742-4387; Dashnamoorthy, Ravi/0000-0002-6108-2076	National Institutes of Health (NIH) [K22ES012264, 1R15ES019128, 1R01CA152063]; Voelcker Fund Young Investigator Award; GCCRI Ambassador's Circle Research Support Award; San Antonio Area Foundation grant; CPRIT [RP150445]; DOD-CDMRP Breast Cancer Research Program Postdoctoral Fellowship [W81XWH-14-1-0026]; MCTI/CNPq Universal [485758/13-0]; NIH P30 Cancer Center Support Grant [CA054174]; NATIONAL CANCER INSTITUTE [R01CA152063, P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019128, K22ES012264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067761] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker Fund Young Investigator Award; GCCRI Ambassador's Circle Research Support Award; San Antonio Area Foundation grant; CPRIT; DOD-CDMRP Breast Cancer Research Program Postdoctoral Fellowship; MCTI/CNPq Universal; NIH P30 Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was by the National Institutes of Health (NIH) (K22ES012264, 1R15ES019128 and 1R01CA152063), Voelcker Fund Young Investigator Award, GCCRI Ambassador's Circle Research Support Award, San Antonio Area Foundation grant and CPRIT (RP150445) to AJRB; DOD-CDMRP Breast Cancer Research Program Postdoctoral Fellowship (W81XWH-14-1-0026) to AZF, and MCTI/CNPq Universal (485758/13-0) to AZF and JCFM; and a NIH P30 Cancer Center Support Grant (CA054174) to CTRC.; We are grateful to CTRC Office of Scientific Writing for manuscript comments and UTHSCSA/CTRC Metabolomics core. Funding was by the NIH (K22ES012264, 1R15ES019128 and 1R01CA152063), Voelcker Fund Young Investigator Award, GCCRI Ambassador's Circle Research Support Award, San Antonio Area Foundation grant and CPRIT (RP150445) to AJRB; DOD-CDMRP Breast Cancer Research Program Postdoctoral Fellowship (W81XWH-14-1-0026) to AZF, and MCTI/CNPq Universal (485758/13-0) to AZF and JCFM; and a NIH P30 Cancer Center Support Grant (CA054174) to CTRC.	Abdelrahman AM, 2010, J APPL TOXICOL, V30, P15, DOI 10.1002/jat.1465; Anders S, 2014, HTSEQ PYTHON FRAMEWO, DOI [10.1101/ 002824, DOI 10.1101/002824, 10.1101/002824]; Anderson CP, 1997, EUR J CANCER, V33, P2016, DOI 10.1016/S0959-8049(97)00203-7; Bakal C, 2011, BRIEF FUNCT GENOMICS, V10, P197, DOI 10.1093/bfgp/elr015; Carra S, 2010, J BIOL CHEM, V285, P37811, DOI 10.1074/jbc.M110.127498; Castro MAA, 2009, BIOINFORMATICS, V25, P1468, DOI 10.1093/bioinformatics/btp246; Chen Helen H. W., 2010, Metal-Based Drugs, P430939, DOI 10.1155/2010/430939; Chen N, 2008, BRIT J PHARMACOL, V153, P1364, DOI 10.1038/bjp.2008.15; FRIEDMAN HS, 1992, CANCER RES, V52, P5373; Fry RC, 2005, ANNU REV MICROBIOL, V59, P357, DOI 10.1146/annurev.micro.59.031805.133658; Fujimori S, 2004, INT J ONCOL, V25, P413; Goto S, 1999, FREE RADICAL RES, V31, P549, DOI 10.1080/10715769900301121; Hao LH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003235; Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lee HR, 2008, MOL CELL BIOCHEM, V318, P23, DOI 10.1007/s11010-008-9853-y; Lee MW, 2007, YEAST, V24, P145, DOI 10.1002/yea.1446; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; MOORE MJ, 1991, CLIN PHARMACOKINET, V20, P194, DOI 10.2165/00003088-199120030-00002; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sugimoto C, 1996, ANTICANCER RES, V16, P675; Walhout AJM, 2002, CURR BIOL, V12, P1952, DOI 10.1016/S0960-9822(02)01279-4; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441	33	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153970	10.1371/journal.pone.0153970	http://dx.doi.org/10.1371/journal.pone.0153970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100653	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500114
J	Das, JR; Gutkind, JS; Ray, PE				Das, Jharna R.; Gutkind, J. Silvio; Ray, Patricio E.			Circulating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; FACTOR-BINDING-PROTEIN; KAPOSIS-SARCOMA; HIV-1-ASSOCIATED NEPHROPATHY; INFLAMMATORY CYTOKINES; BARRIER PROPERTIES; EPITHELIAL-CELLS; TRANSGENIC RAT; FACTOR VEGF; HEPARIN	Renal endothelial cells (REc) are the first target of HIV-1 in the kidney. The integrity of REc is maintained at least partially by heparin binding growth factors that bind to heparan sulfate proteoglycans located on their cell surface. However, previous studies showed that the accumulation of two heparin-binding growth factors, Vascular Endothelial Cell Growth Factor-A (VEGF-A) and Fibroblast Growth Factor-2 (FGF-2), in combination with the viral protein Tat, can precipitate the progression of HIV-renal diseases. Nonetheless, very little is known about how these factors affect the behavior of REc in HIV+ children. We carried out this study to determine how VEGF-A, FGF-2, and HIV-Tat, modulate the cytoskeletal structure and permeability of cultured REc, identify key signaling pathways involved in this process, and develop a functional REc assay to detect HIV+ children affected by these changes. We found that VEGF-A and FGF-2, acting in synergy with HIV-Tat and heparin, affected the cytoskeletal structure and permeability of REc through changes in Rho-A, Src, and Rac-1 activity. Furthermore, urine samples from HIV+ children with renal diseases, showed high levels of VEGF-A and FGF-2, and induced similar changes in cultured REc and podocytes. These findings suggest that FGF-2, VEGF-A, and HIV-Tat, may affect the glomerular filtration barrier in HIV+ children through the induction of synergistic changes in Rho-A and Src activity. Further studies are needed to define the clinical value of the REc assay described in this study to identify HIV+ children exposed to circulating factors that may induce glomerular injury through similar mechanisms.	[Das, Jharna R.; Ray, Patricio E.] Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC USA; [Gutkind, J. Silvio] Univ Calif San Diego, Dept Pharmacol, Moores Canc Ctr, La Jolla, CA 92093 USA; [Ray, Patricio E.] Childrens Natl Hlth Syst, Div Nephrol, Washington, DC USA; [Ray, Patricio E.] George Washington Univ, Dept Pediat, Washington, DC 20052 USA	Children's National Health System; University of California System; University of California San Diego; Children's National Health System; George Washington University	Ray, PE (corresponding author), Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC USA.; Ray, PE (corresponding author), Childrens Natl Hlth Syst, Div Nephrol, Washington, DC USA.; Ray, PE (corresponding author), George Washington Univ, Dept Pediat, Washington, DC 20052 USA.	Pray@childrensnational.org	Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482	National Institutes of Health [R01-HL102497, R01-DK 49419, R01 DK103564, R01 DK108368]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049419, R01DK108368, R01DK103564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants R01-HL102497, R01-DK 49419, R01 DK103564, and R01 DK108368. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 1996, ONCOGENE, V12, P289; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Babelova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080328; Barillari G, 1999, J IMMUNOL, V163, P1929; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P179, DOI 10.1007/s00418-007-0358-7; Blattner SM, 2013, KIDNEY INT, V84, P920, DOI 10.1038/ki.2013.175; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Conaldi PG, 2002, AM J PATHOL, V161, P53, DOI 10.1016/S0002-9440(10)64156-9; Cornali E, 1996, AM J PATHOL, V149, P1851; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; DAGATI V, 1989, KIDNEY INT, V35, P1358, DOI 10.1038/ki.1989.135; de Paz JL, 2007, CHEM BIOL, V14, P879, DOI 10.1016/j.chembiol.2007.07.007; Doublier S, 2007, AIDS, V21, P423, DOI 10.1097/QAD.0b013e328012c522; DUTT K, 1990, ONCOGENE, V5, P195; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Funderburg NT, 2014, THROMB RES, V133, pS21, DOI 10.1016/j.thromres.2014.03.012; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jerebtsova M, 2015, AM J PHYSIOL-HEART C, V309, pH314, DOI 10.1152/ajpheart.00373.2015; Kim NH, 2005, KIDNEY INT, V67, P167, DOI 10.1111/j.1523-1755.2005.00067.x; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kistler AD, 2012, KIDNEY INT, V81, P1053, DOI 10.1038/ki.2012.12; Korgaonkar SN, 2008, J AM SOC NEPHROL, V19, P877, DOI 10.1681/ASN.2007050629; Liu XH, 2001, KIDNEY INT, V59, P1717, DOI 10.1046/j.1523-1755.2001.0590051717.x; Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; McCulloch MI, 2008, SEMIN NEPHROL, V28, P585, DOI 10.1016/j.semnephrol.2008.09.001; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Murakami M, 2011, J CLIN INVEST, V121, P2668, DOI 10.1172/JCI44762; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Persidsky Y, 2006, BLOOD, V107, P4770, DOI 10.1182/blood-2005-11-4721; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Ray P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133699; Ray PE, 2006, AM J PHYSIOL-REG I, V290, pR105, DOI 10.1152/ajpregu.00492.2005; Ray PE, 2005, PEDIATR NEPHROL, V20, P1401, DOI 10.1007/s00467-005-1950-5; Ray PE, 1998, KIDNEY INT, V53, P1217, DOI 10.1046/j.1523-1755.1998.00900.x; RAY PE, 1994, KIDNEY INT, V46, P759, DOI 10.1038/ki.1994.331; Ray PE, 2003, KIDNEY INT, V63, P2242, DOI 10.1046/j.1523-1755.2003.00028.x; Ray PE, 1999, PEDIATR NEPHROL, V13, P586, DOI 10.1007/s004670050749; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Rosenfeldt Hans, 2006, J Mol Signal, V1, P8, DOI 10.1186/1750-2187-1-8; Rostgaard J, 1997, MICROVASC RES, V53, P1, DOI 10.1006/mvre.1996.1987; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Samaniego F, 1998, AM J PATHOL, V152, P1433; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Satchell SC, 2004, J AM SOC NEPHROL, V15, P566, DOI 10.1097/01.ASN.0000115397.22519.03; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; SEILER MW, 1977, LAB INVEST, V36, P48; Soler-Garcia AA, 2009, KIDNEY INT, V76, P207, DOI 10.1038/ki.2009.115; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Tandon R, 2007, AM J PHYSIOL-RENAL, V292, pF701, DOI 10.1152/ajprenal.00246.2006; Urbinati C, 2009, BLOOD, V114, P3335, DOI 10.1182/blood-2009-01-198945; Urbinati C, 2008, MOLECULES, V13, P2758, DOI 10.3390/molecules13112758; VEHASKARI VM, 1982, KIDNEY INT, V22, P127, DOI 10.1038/ki.1982.144; Wang LM, 2012, KIDNEY INT, V81, P1075, DOI 10.1038/ki.2011.472; Waschke J, 2006, HISTOCHEM CELL BIOL, V125, P397, DOI 10.1007/s00418-005-0080-2; Waschke J, 2005, AM J PHYSIOL-HEART C, V288, pH1296, DOI 10.1152/ajpheart.00687.2004; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Xie XF, 2014, J AM SOC NEPHROL, V25, P1800, DOI 10.1681/ASN.2013070710; Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13; Zakrzewska M, 2009, J BIOL CHEM, V284, P25388, DOI 10.1074/jbc.M109.001289	72	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153837	10.1371/journal.pone.0153837	http://dx.doi.org/10.1371/journal.pone.0153837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097314	gold, Green Submitted, Green Published			2022-12-26	WOS:000374543600061
J	Quitmann, JH; Bullinger, M; Sommer, R; Rohenkohl, AC; Da Silva, NMB				Quitmann, Julia Hannah; Bullinger, Monika; Sommer, Rachel; Rohenkohl, Anja Christine; Bernardino Da Silva, Neuza Maria			Associations between Psychological Problems and Quality of Life in Pediatric Short Stature from Patients' and Parents' Perspectives	PLOS ONE			English	Article							IDIOPATHIC SHORT STATURE; GROWTH-HORMONE DEFICIENCY; CHRONIC HEALTH CONDITIONS; DIFFICULTIES QUESTIONNAIRE; SELF-ESTEEM; PART 2; CHILDREN; ADOLESCENTS; STRENGTHS; HEIGHT	Short stature has been associated with psychosocial impairments, but whether treatments and achieved height impact on health-related quality of life (HrQoL) and psychological functioning of children/adolescents is still controversial. This study aimed to examine the effects of height deviation and treatment status on psychosocial adaptation outcomes and to identify clinical and psychosocial determinants of internalizing/externalizing problems in a large cohort of short statured children/adolescents from seven European countries. Participants were 345 children aged 8-18 years with a clinical diagnosis of short stature and 421 parents of 4-18 year-old patients. Children and parents reported on psychological problems (Strengths and Difficulties Questionnaire), generic (KIDSCREEN) and condition-specific HrQoL (QoLISSY). According to analyses of covariance, children/adolescents with current short stature presented more parent-reported internalizing problems and lower self-and parent-reported condition-specific HrQoL, compared to patients with an achieved height above -2SD. Treated children self-reported better HrQoL than the untreated group. Hierarchical regression analysis showed that, rather than height-related clinical variables, children's sex, younger age and poorer HrQoL were the best predictors of psychological problems, explaining 39% of the variance in patient-and 42% in parent-reported internalizing problems, and 22% of the variance in patient-and 24% in parent-reported externalizing problems. Treatment status also moderated the negative links between patient-reported HrQoL and internalizing problems, explaining 2% of additional variance. These results suggest that children with current short stature are at greater risk for internalizing problems. Routine assessment of HrQoL in pediatric healthcare may help identify children for referral to specialized psychological assessment and intervention.	[Quitmann, Julia Hannah; Bullinger, Monika; Sommer, Rachel; Rohenkohl, Anja Christine; Bernardino Da Silva, Neuza Maria] Univ Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Bernardino Da Silva, Neuza Maria] Univ Coimbra, Cognit & Behav Ctr Res & Intervent, Coimbra, Portugal	University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidade de Coimbra	Quitmann, JH (corresponding author), Univ Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	j.quitmann@uke.de	da Silva, Neuza/A-9883-2013	da Silva, Neuza/0000-0003-4110-9961; Bullinger, Monika/0000-0001-8876-0159	Pfizer Ltd.	Pfizer Ltd.(Pfizer)	The project was funded by Pfizer Ltd. and the authors were provided funding for its conduct. No funding was received for the writing of this paper. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2009, J PAEDIATR CHILD H, V45, P636, DOI 10.1111/j.1440-1754.2009.01586.x; Aiken L. S., 1991, MULTIPLE REGRESSION; Annett RD, 2003, J ASTHMA, V40, P577, DOI 10.1081/JAS-120019030; [Anonymous], 2010, Am Psychol, V65, P493, DOI 10.1037/a0020168; Barlow JH, 2006, CHILD CARE HLTH DEV, V32, P19, DOI 10.1111/j.1365-2214.2006.00591.x; Batty GD, 2009, ECON HUM BIOL, V7, P137, DOI 10.1016/j.ehb.2009.06.004; Becker A, 2004, EUR CHILD ADOLES PSY, V13, P11, DOI 10.1007/s00787-004-2003-5; Bryant J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004440.pub2; Bullinger M, 2006, J PUBLIC HEALTH-HEID, V14, P343, DOI 10.1007/s10389-006-0066-0; Bullinger M, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0236-2; Bullinger M, 2014, HORM RES PAEDIAT, V82, P18, DOI 10.1159/000358832; Bullinger M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-76; Bullinger M, 2009, HORM RES, V72, P74, DOI 10.1159/000232159; Bullinger-Naber M., 2013, QUALITY LIFE SHORT S, V1; Chaplin JE, 2011, HORM RES PAEDIAT, V75, P291, DOI 10.1159/000322937; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen P., 2008, J CLIN ENDOCRINOLOGY, V93; Coste J, 2012, J CLIN ENDOCR METAB, V97, P3231, DOI 10.1210/jc.2012-1543; DeKlyen M, 1998, Clin Child Fam Psychol Rev, V1, P3, DOI 10.1023/A:1021844214633; Downie AB, 1997, BMJ-BRIT MED J, V314, P97, DOI 10.1136/bmj.314.7074.97; Drotar D, 1997, J PEDIATR PSYCHOL, V22, P149; Flouri E, 2008, CHILD CARE HLTH DEV, V34, P152, DOI 10.1111/j.1365-2214.2007.00752.x; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; GORDON M, 1982, J PEDIATR-US, V101, P477, DOI 10.1016/S0022-3476(82)80093-0; HARPER DC, 1991, J PEDIATR PSYCHOL, V16, P533, DOI 10.1093/jpepsy/16.5.533; Hauffa B.P., 2008, NORMALES WACHSTUM WA; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; HOLMES CS, 1985, J DEV BEHAV PEDIATR, V6, P263; Hwang Jun-Won, 2015, Ann Pediatr Endocrinol Metab, V20, P79, DOI 10.6065/apem.2015.20.2.79; Jose P.E., 2013, MODGRAPH 1 PROGRAMME; Keselman A, 2000, J PEDIATR ENDOCR MET, V13, P409; LAW CM, 1987, ARCH DIS CHILD, V62, P855, DOI 10.1136/adc.62.8.855; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lee JM, 2009, PEDIATRICS, V124, P903, DOI 10.1542/peds.2008-0085; Lee MM, 2006, NEW ENGL J MED, V354, P2576, DOI 10.1056/NEJMcp060828; MacKinnon DP, 2008, HEALTH PSYCHOL, V27, pS99, DOI 10.1037/0278-6133.27.2(Suppl.).S99; Meltzer H, 2003, INT REV PSYCHIATR, V15, P185, DOI 10.1080/0954026021000046155; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; PECK MN, 1995, SOC SCI MED, V41, P733, DOI 10.1016/0277-9536(94)00379-8; Quitmann J., 2014, WIE ERLEBEN BETROFFE; Quitmann J, 2015, J CHILD FAM STUD, V24, P703, DOI 10.1007/s10826-013-9880-5; Ranke MB, 1996, HORM RES, V45, P64, DOI 10.1159/000184851; Ranke MB, 2001, HORM RES, V55, P115, DOI 10.1159/000049982; Ravens-Sieberer U, 2010, QUAL LIFE RES, V19, P1487, DOI 10.1007/s11136-010-9706-5; Ravens-Sieberer Ulrike, 2007, Psychosoc Med, V4, pDoc08; Rekers-Mombarg LTM, 1998, ACTA PAEDIATR, V87, P865, DOI 10.1080/080352598750013653; Richmond EJ, 2008, PITUITARY, V11, P115, DOI 10.1007/s11102-008-0105-7; Rohenkohl A., 2015, EUROPEAN J PEDIAT, P1; Rohenkohl A., 2015, BRIEF VERSION QUALIT; Rohenkohl AC, 2014, ACTA CLIN BELG, V69, P177, DOI 10.1179/2295333714Y.0000000024; Ross JL, 2004, J CLIN ENDOCR METAB, V89, P4873, DOI 10.1210/jc.2004-0791; Rush KS, 2004, BEHAV MODIF, V28, P621, DOI 10.1177/0145445503259830; Sandberg DE, 2015, PEDIATR CLIN N AM, V62, P963, DOI 10.1016/j.pcl.2015.04.009; Sandberg DE, 2005, HORM RES, V63, P275, DOI 10.1159/000086593; Sandberg DE, 2002, BEST PRACT RES CL EN, V16, P449, DOI 10.1053/beem.2002.0211; Savage MO, 2009, NAT CLIN PRACT ENDOC, V5, P148, DOI 10.1038/ncpendmet1074; Sheppard L, 2006, HORM RES, V65, P243, DOI 10.1159/000092455; Silva N, 2015, CHILD CARE HLTH DEV, V41, P112, DOI 10.1111/cch.12147; Silver EJ, 1998, J PEDIATR PSYCHOL, V23, P5, DOI 10.1093/jpepsy/23.1.5; Smedje H, 1999, EUR CHILD ADOLES PSY, V8, P63, DOI 10.1007/s007870050086; Sommer R, 2015, EUR J PEDIATR, V174, P875, DOI 10.1007/s00431-014-2480-6; Stabler B., 1998, J PEDIAT, V133; Steinhausen HC, 2000, J DEV BEHAV PEDIATR, V21, P423, DOI 10.1097/00004703-200012000-00004; Tanaka T, 2002, GROWTH HORM IGF RES, V12, P323, DOI 10.1016/S1096-6374(02)00045-X; Theunissen NCM, 2002, J PEDIATR-US, V140, P507, DOI 10.1067/mpd.2002.123766; Ulph F, 2004, ARCH DIS CHILD, V89, P17, DOI 10.1136/adc.2002.010694; Varni James W, 2005, Health Qual Life Outcomes, V3, P34, DOI 10.1186/1477-7525-3-34; Versteegh MM, 2012, VALUE HEALTH, V15, P504, DOI 10.1016/j.jval.2011.12.003; Visser-van Balen H, 2006, ARCH DIS CHILD, V91, P433, DOI 10.1136/adc.2005.086942; Voss LD, 2006, EUR J ENDOCRINOL, V155, pS39, DOI 10.1530/eje.1.02262; Wheeler PG, 2004, ARCH PEDIAT ADOL MED, V158, P236, DOI 10.1001/archpedi.158.3.236; White-Koning M, 2007, PEDIATRICS, V120, pE804, DOI 10.1542/peds.2006-3272; Wit JM, 2008, GROWTH HORM IGF RES, V18, P111, DOI 10.1016/j.ghir.2007.11.003; Wit JM, 2008, GROWTH HORM IGF RES, V18, P89, DOI 10.1016/j.ghir.2007.11.004; Woerner W, 2002, Z KINDER JUG-PSYCH, V30, P105, DOI 10.1024//1422-4917.30.2.105	79	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153953	10.1371/journal.pone.0153953	http://dx.doi.org/10.1371/journal.pone.0153953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27097033	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600075
J	Joshi, S; Kumar, S; Ponnusamy, MP; Batra, SK				Joshi, S.; Kumar, S.; Ponnusamy, M. P.; Batra, S. K.			Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival	ONCOGENE			English	Article							EXPRESSION; GROWTH; METASTASIS; ALPHA; DEATH; ADENOCARCINOMA; ANGIOGENESIS; INHIBITION; STABILIZES; REQUIRES	Pancreatic cancer (PC) and associated pre-neoplastic lesions have been reported to be hypoxic, primarily due to hypovascular nature of PC. Though the presence of hypoxia under cancerous condition has been associated with the overexpression of oncogenic proteins (MUC1), multiple emerging reports have also indicated the growth inhibitory effects of hypoxia. In spite of being recognized as the top-most differentially expressed and established oncogenic protein in PC, MUC4 regulation in terms of micro-environmental stress has not been determined. Herein, for the first time, we are reporting that MUC4 protein stability is drastically affected in PC, under hypoxic condition in a hypoxia inducible factor 1 alpha (HIF-1 alpha)-independent manner. Mechanistically, we have demonstrated that hypoxia-mediated induction of reactive oxygen species (ROS) promotes autophagy by inhibiting pAkt/mTORC1 pathway, one of the central regulators of autophagy. Immunohistofluorescence analyses revealed significant negative correlation (P-value = 0.017) between 8-hydroxy guanosine (8-OHG) and MUC4 in primary pancreatic tumors (n=25). Moreover, we found pronounced colocalization between MUC4 and LAMP1/LC3 (microtubule-associated protein 1A/1B-light chain 3) in PC tissues and also observed their negative relationship in their expression pattern, suggesting that areas with high autophagy rate had less MUC4 expression. We also found that hypoxia and ROS have negative impact on overall cell growth and viability, which was partially, though significantly (P<0.05), rescued in the presence of MUC4. Altogether, hypoxia-mediated oxidative stress induces autophagy in PC, leading to the MUC4 degradation to enhance survival, possibly by offering required metabolites to stressed cells.	[Joshi, S.; Kumar, S.; Ponnusamy, M. P.; Batra, S. K.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Batra, S. K.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Buffett Canc Ctr, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Kumar, S; Batra, SK (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	skumar@unmc.edu; sbatra@unmc.edu		Palanimuthu Ponnusamy, Moorthy/0000-0001-5744-193X	NIH [UO1 CA111294, P50 CA127297, U54 CA163120, RO1 CA183459]; NATIONAL CANCER INSTITUTE [P50CA127297, R01CA183459, U01CA111294, U54CA163120] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Jerred Garrison, Dr Pankaj K Singh and Dr Michael Hollingsworth for providing us hypoxia chamber, HIF-1 alpha Sh RNA constructs and human MUC1 antibody, respectively. We would also like to thank Kavita Mallya, James Talaska, Janice Taylor, Dr Nilesh Wagh and Dr Phillip Hexley for technical support. Finally, we would like to thank RAPID autopsy program and related personnel and UNMC graduate studies fellowship. The work was supported, in parts, by grants from the NIH (UO1 CA111294, P50 CA127297, U54 CA163120 and RO1 CA183459).	Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; Aubert S, 2009, CANCER RES, V69, P5707, DOI 10.1158/0008-5472.CAN-08-4905; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Blanco FF, 2016, ONCOGENE, V35, P2529, DOI 10.1038/onc.2015.325; Chaika NV, 2012, P NATL ACAD SCI USA, V109, P13787, DOI 10.1073/pnas.1203339109; Chandel NS, 2014, NEW ENGL J MED, V371, P177, DOI 10.1056/NEJMcibr1405701; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Dhillon H, 2014, TOXICOL REP, V1, P309, DOI 10.1016/j.toxrep.2014.05.011; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Endo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098858; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Ge PF, 2009, ACTA PHARMACOL SIN, V30, P1046, DOI 10.1038/aps.2009.71; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Greco E, 2010, PANCREAS, V39, P662, DOI 10.1097/MPA.0b013e3181c8b48c; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Hashimoto D, 2014, EUR J CANCER, V50, P1382, DOI 10.1016/j.ejca.2014.01.011; Hinoda Y, 2003, J GASTROENTEROL, V38, P1162, DOI 10.1007/s00535-003-1224-6; Joshi S, 2015, CANCER METAST REV, V34, P593, DOI 10.1007/s10555-015-9549-1; Joshi S, 2014, ONCOTARGET, V5, P7272, DOI 10.18632/oncotarget.2370; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Kasai H, 2002, FREE RADICAL BIO MED, V33, P450, DOI 10.1016/S0891-5849(02)00818-3; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Kim YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098136; Kitamoto S, 2013, ONCOGENE, V32, P4614, DOI 10.1038/onc.2012.478; Kitamoto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044108; Kumar S, 2015, ONCOGENE, V34, P4879, DOI 10.1038/onc.2014.409; Liu C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-622; Liu ZH, 2007, DEV CELL, V12, P484, DOI 10.1016/j.devcel.2007.03.016; Mimeault M, 2010, CANCER LETT, V295, P69, DOI 10.1016/j.canlet.2010.02.015; Moniaux N, 2007, BRIT J CANCER, V97, P345, DOI 10.1038/sj.bjc.6603868; Munafo DB, 2001, J CELL SCI, V114, P3619; Papandreou I, 2005, CANCER RES, V65, P3171, DOI 10.1158/0008-5472.CAN-04-3395; Rachagani S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-68; Rachagani S, 2012, CARCINOGENESIS, V33, P1953, DOI 10.1093/carcin/bgs225; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Senapati S, 2011, CLIN CANCER RES, V17, P267, DOI 10.1158/1078-0432.CCR-10-1937; Sendoel A, 2014, PHYSIOLOGY, V29, P168, DOI 10.1152/physiol.00016.2013; Seshacharyulu P, 2015, ONCOTARGET, V6, P5164, DOI 10.18632/oncotarget.3286; Shao MXG, 2005, J IMMUNOL, V175, P4009, DOI 10.4049/jimmunol.175.6.4009; Siddiqui A, 2007, AM J SURG, V194, P362, DOI 10.1016/j.amjsurg.2007.02.007; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Vasseur Sophie, 2010, Cancers (Basel), V2, P2138, DOI 10.3390/cancers2042138; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang R., 2012, MATH PROBL ENG, V2012, P1, DOI DOI 10.1109/IEVC2012.6183284.URL; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang XW, 2004, CHEMOSPHERE, V55, P1303, DOI 10.1016/j.chemosphere.2003.12.004; Zhi XF, 2014, CANCER LETT, V346, P104, DOI 10.1016/j.canlet.2013.12.021; Zhou J, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-218	52	34	35	0	25	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2016	35	45					5882	5892		10.1038/onc.2016.119	http://dx.doi.org/10.1038/onc.2016.119			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EB7IR	27109098	Green Accepted			2022-12-26	WOS:000387560800007
J	Schrimshaw, EW; Antebi-Gruszka, N; Downing, MJ				Schrimshaw, Eric W.; Antebi-Gruszka, Nadav; Downing, Martin J., Jr.			Viewing of Internet-Based Sexually Explicit Media as a Risk Factor for Condomless Anal Sex among Men Who Have Sex with Men in Four US Cities	PLOS ONE			English	Article							HIV-NEGATIVE MEN; ONLINE MEDIA; PORNOGRAPHY; PREVENTION; TRANSMISSION; BEHAVIORS; SEEKING; STATES; MSM	The last decade has seen a dramatic increase in the availability of sexually explicit media (SEM) on the Internet. Men who have sex with men (MSM) report near universal use of SEM. However, this widespread use of SEM among MSM may contribute to more condomless anal sex. To examine the association of viewing SEM on the Internet and the number of condomless anal sex encounters among MSM, in 2012, an online survey was conducted of 265 MSM from New York, Philadelphia, Baltimore, or Washington D.C. who reported viewing SEM online in the past 3 months. Analyses were performed using negative binomial regression. Nearly all men reported viewing SEM featuring anal sex with (91%) or without (92%) condoms in the past 3 months. Neither viewing more hours of SEM per week or compulsively viewing SEM were associated with more condomless anal sex encounters. Rather, viewing a greater proportion of SEM containing condomless anal sex was associated with engaging in more condomless anal encounters (IRR = 1.25), while viewing a greater proportion of SEM containing anal sex where condoms were used was associated with fewer condomless anal sex encounters (IRR = 0.62). MSM reported that viewing SEM caused changes in their sexual fantasies, desires, and behaviors. These findings provide important insights for health policy and the design of interventions addressing SEM and condomless sex among MSM. The findings suggest that condom use by SEM performers may benefit not only actor health, but also have health implications for SEM viewers.	[Schrimshaw, Eric W.; Antebi-Gruszka, Nadav] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY USA; [Downing, Martin J., Jr.] Publ Hlth Solut Inc, Res & Evaluat, New York, NY USA	Columbia University	Schrimshaw, EW (corresponding author), Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY USA.	es458@cumc.columbia.edu		Schrimshaw, Eric/0000-0003-2755-1796	National Research and Development Institutes; U.S. National Institute on Drug Abuse [T32-DA007233]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007233] Funding Source: NIH RePORTER	National Research and Development Institutes; U.S. National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	EWS and NAG received no external funding for the data collection, analysis, or writing of this work. Data collection efforts for MJD were supported by a postdoctoral fellowship from the National Research and Development Institutes with funding from the U.S. National Institute on Drug Abuse (T32-DA007233). The funder provided support in the form of salary for MJD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of the article is that of the authors and does not necessarily represent the views of the funders - the National Institute of Drug Abuse or the National Institutes of Health.	[Anonymous], SAF SEX; Bandura A., 1969, SOCIAL FDN THOUGHT A; Bishop CJ, 2015, PSYCHOL SEX, V6, P5, DOI 10.1080/19419899.2014.983739; Chiasson MA, 2007, JAIDS-J ACQ IMM DEF, V44, P235, DOI 10.1097/QAI.0b013e31802e298c; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Dines G., 2010, PORNLAND PORN HIJACK; Downing MJ, 2014, ARCH SEX BEHAV, V43, P811, DOI 10.1007/s10508-013-0121-1; Downing MJ, 2014, ADDICT BEHAV, V39, P1126, DOI 10.1016/j.addbeh.2014.03.007; Eaton LA, 2012, SEX HEALTH, V9, P166, DOI 10.1071/SH10092; Escoffier J., 2009, BIGGER LIFE HIST GAY; Grov C, 2012, AIDS BEHAV, V16, P807, DOI 10.1007/s10461-011-9999-6; Grov C, 2010, AIDS BEHAV, V14, P1387, DOI 10.1007/s10461-009-9661-8; Hald GM, 2013, J SEX MED, V10, P757, DOI 10.1111/j.1743-6109.2012.02988.x; Hernandez-Romieu AC, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3342; Hirshfield S, 2015, AM J PUBLIC HEALTH, V105, P1849, DOI 10.2105/AJPH.2014.302346; KALICHMAN SC, 1995, J PERS ASSESS, V65, P586, DOI 10.1207/s15327752jpa6503_16; Kendall CN, 2004, J HOMOSEXUAL, V47, P83, DOI 10.1300/J082v47n03_06; Madden M, 2011, 65 ONLINE ADULTS USE; Nelson KM, 2016, J SEX RES, V53, P588, DOI 10.1080/00224499.2015.1066744; Nelson KM, 2014, ARCH SEX BEHAV, V43, P833, DOI 10.1007/s10508-013-0238-2; Nelson KM, 2014, AIDS CARE, V26, P931, DOI 10.1080/09540121.2013.871219; Rosser BRS, 2013, AIDS BEHAV, V17, P1488, DOI 10.1007/s10461-013-0454-8; Rosser BRS, 2012, AIDS BEHAV, V16, P1373, DOI 10.1007/s10461-012-0135-z; Stein D, 2012, ARCH SEX BEHAV, V41, P411, DOI 10.1007/s10508-011-9789-2; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Sullivan PS, 2013, JAIDS-J ACQ IMM DEF, V63, pS102, DOI 10.1097/QAI.0b013e3182949e85; Vial AC, 2014, AIDS EDUC PREV, V26, P56, DOI 10.1521/aeap.2014.26.1.56; Wilken JA, 2016, MMWR-MORBID MORTAL W, V65, P110, DOI 10.15585/mmwr.mm6505a3; Wright PJ, 2013, J SEX RES, V50, P60, DOI 10.1080/00224499.2011.628132	29	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154439	10.1371/journal.pone.0154439	http://dx.doi.org/10.1371/journal.pone.0154439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119990	gold, Green Submitted, Green Published			2022-12-26	WOS:000374976200075
J	Bao, GQ; Qu, FL; He, L; Zhao, HD; Wang, N; Ji, G; He, XL				Bao, Guoqiang; Qu, Falin; He, Li; Zhao, Huadong; Wang, Nan; Ji, Gang; He, Xianli			Prognostic Significance of Tag SNP rs1045411 in HMGB1 of the Aggressive Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; CELL LUNG-CANCER; GENETIC POLYMORPHISMS; CHROMATIN PROTEIN; TUMOR-CELLS; EXPRESSION; ASSOCIATION; OVEREXPRESSION; CHEMOTHERAPY; SUPPRESSION	Compelling evidences have suggested that high mobility group box-1 (HMGB1) gene plays a crucial role in cancer development and progression. This study aimed to evaluate the effects of single nucleotide polymorphisms (SNPs) in HMGB1 gene on the survival of gastric cancer (GC) patients. Three tag SNPs from HMGB1 gene were selected and genotyped using Sequenom iPEX genotyping system in a cohort of 1030 GC patients (704 in training set, 326 in validation set). Multivariate Cox proportional hazard model and Kaplan-Meier Curve were used for prognosis analysis. AG/AA genotypes of SNP rs1045411 in HMGB1 gene were significantly associated with better overall survival (OS) in a set of 704 GC patients when compared with GG genotypes (HR = 0.77, 95% CI: 0.60-0.97, P = 0.032). This prognostic effect was verified in an independent validation set and pooled analysis (HR = 0.80, 95% CI: 0.62-0.99, P = 0.046; HR = 0.78, 95% CI: 0.55-0.98, P = 0.043, respectively). In stratified analysis, the protective effect of rs1045411 AG/AA genotypes was more prominent in patients with adverse strata, compared with patients with favorable strata. Furthermore, strong joint predictive effects on OS of GC patients were noted between rs1045411 genotypes and Lauren classification, differentiation, stage or adjuvant chemotherapy. Additionally, functional assay indicated a significant effect of rs1045411 on HMGB1 expression. Our results suggest that rs1045411 in HMGB1 is significantly associated with clinical outcomes of Chinese GC patients after surgery, especially in those with aggressive status, which warrants further validation in other ethnic populations.	[Bao, Guoqiang; Qu, Falin; Zhao, Huadong; Wang, Nan; He, Xianli] Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Peoples R China; [He, Li] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Ji, Gang] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Air Force Military Medical University; Emory University; Air Force Military Medical University	Bao, GQ; He, XL (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Peoples R China.	guoqiang@fmmu.edu.cn; wanghe@fmmu.edu.cn	JI, Gang/AAG-9877-2020	JI, Gang/0000-0002-2415-6275	National Natural Science Foundation of China [81272201, 81572916, 81200330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China ( No. 81272201 and No. 81572916 to GB; No. 81200330 to NW).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker KF, 2000, SURG ONCOL, V9, P5, DOI 10.1016/S0960-7404(00)00016-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Catalano V, 2005, CRIT REV ONCOL HEMAT, V54, P209, DOI 10.1016/j.critrevonc.2005.01.002; Choi YR, 2003, CANCER RES, V63, P2188; Chung HW, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-38; Demoulin S, 2015, INT J CANCER, V137, P345, DOI 10.1002/ijc.29389; Dong XD, 2007, J IMMUNOTHER, V30, P596, DOI 10.1097/CJI.0b013e31804efc76; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Evans A, 2004, J SURG ONCOL, V88, P86, DOI 10.1002/jso.20136; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1957, DOI 10.1111/j.1745-7254.2007.00669.x; Kornblit B, 2007, TISSUE ANTIGENS, V70, P151, DOI 10.1111/j.1399-0039.2007.00854.x; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Lee HJ, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0034318; Li QL, 2014, ONCOTARGET, V5, P6387, DOI 10.18632/oncotarget.2201; Liu FR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-135; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; McLean MIH, 2014, NAT REV GASTRO HEPAT, V11, P664, DOI 10.1038/nrgastro.2014.143; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Naumnik W, 2009, FOLIA HISTOCHEM CYTO, V47, P703, DOI 10.2478/v10042-009-0025-z; Pu X, 2013, CANCER RES, V73, P1867, DOI 10.1158/0008-5472.CAN-12-0873; Shen XK, 2009, ONCOL REP, V22, P535, DOI 10.3892/or_00000468; Supic G, 2015, ORAL DIS, V21, P536, DOI 10.1111/odi.12318; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Ueda M, 2014, ANTICANCER RES, V34, P5357; Ulrich CM, 2003, NAT REV CANCER, V3, P912, DOI 10.1038/nrc1233; Volp K, 2006, GUT, V55, P234, DOI 10.1136/gut.2004.062729; Wang ML, 2011, INT J CANCER, V129, P1207, DOI 10.1002/ijc.25740; Wang Y, 2014, CLIN EXP PHARMACOL P, V41, P408, DOI 10.1111/1440-1681.12232; Wild CA, 2012, ORAL ONCOL, V48, P409, DOI 10.1016/j.oraloncology.2011.12.009; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Xiang YY, 1997, INT J CANCER, V74, P1; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Zhang J., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0110734	39	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154378	10.1371/journal.pone.0154378	http://dx.doi.org/10.1371/journal.pone.0154378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116470	Green Published, gold, Green Submitted			2022-12-26	WOS:000374973600064
J	Cui, JY; Good, NM; Hu, B; Yang, J; Wang, QW; Sadilek, M; Yang, S				Cui, Jinyu; Good, Nathan M.; Hu, Bo; Yang, Jing; Wang, Qianwen; Sadilek, Martin; Yang, Song			Metabolomics Revealed an Association of Metabolite Changes and Defective Growth in Methylobacterium extorquens AM1 Overexpressing ecm during Growth on Methanol	PLOS ONE			English	Article							ETHYLMALONYL-COA PATHWAY; TRANSCRIPTIONAL REGULATOR; MASS-SPECTROMETRY; GENE; IDENTIFICATION; DEHYDROGENASE; ACID; METHYLOTROPHY; MEVALONATE; OXIDATION	Methylobacterium extorquens AM1 is a facultative methylotroph capable of growth on both single-carbon and multi-carbon compounds. The ethylmalonyl-CoA (EMC) pathway is one of the central assimilatory pathways in M. extorquens during growth on C1 and C2 substrates. Previous studies had shown that ethylmalonyl-CoA mutase functioned as a control point during the transition from growth on succinate to growth on ethylamine. In this study we overexpressed ecm, phaA, mcmAB and found that upregulating ecm by expressing it from the strong constitutive mxaF promoter caused a 27% decrease in growth rate on methanol compared to the strain with an empty vector. Targeted metabolomics demonstrated that most of the central intermediates in the ecm over-expressing strain did not change significantly compared to the control strain; However, poly-beta-hydroxybutyrate (PHB) was 4.5-fold lower and 3-hydroxybutyryl-CoA was 1.6-fold higher. Moreover, glyoxylate, a toxic and highly regulated essential intermediate, was determined to be 2.6-fold higher when ecm was overexpressed. These results demonstrated that overexpressing ecm can manipulate carbon flux through the EMC pathway and divert it from the carbon and energy storage product PHB, leading to an accumulation of glyoxylate. Furthermore, untargeted metabolomics discovered two unusual metabolites, alanine (Ala)-meso-diaminopimelic acid (mDAP) and Ala-mDAP-Ala, each over 45-fold higher in the ecm over-expressing strain. These two peptides were also found to be highly produced in a dose-dependent manner when glyoxylate was added to the control strain. Overall, this work has explained a direct association of ecm overexpression with glyoxylate accumulation up to a toxic level, which inhibits cell growth on methanol. This research provides useful insight for manipulating the EMC pathway for efficiently producing high-value chemicals in M. extorquens.	[Cui, Jinyu; Yang, Jing; Yang, Song] Qingdao Agr Univ, Sch Life Sci, Shandong Prov Key Lab Appl Mycol, Qingdao, Shandong, Peoples R China; [Cui, Jinyu; Yang, Jing; Yang, Song] Qingdao Int Ctr Microbes Utilizing Biogas, Qingdao, Shandong, Peoples R China; [Good, Nathan M.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Hu, Bo] Kemin Ind, KI Res & Dev, Des Moines, IA USA; [Wang, Qianwen] Qingdao Agr Univ, Cent Lab, Qingdao, Shandong, Peoples R China; [Sadilek, Martin] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Yang, Song] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China	Qingdao Agricultural University; University of Washington; University of Washington Seattle; Qingdao Agricultural University; University of Washington; University of Washington Seattle; Tianjin University	Yang, S (corresponding author), Qingdao Agr Univ, Sch Life Sci, Shandong Prov Key Lab Appl Mycol, Qingdao, Shandong, Peoples R China.; Yang, S (corresponding author), Qingdao Int Ctr Microbes Utilizing Biogas, Qingdao, Shandong, Peoples R China.; Yang, S (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yangsong1209@163.com	Cui, Jinyu/AAV-9450-2020		Petrochemical Joint Fund of National Natural Science Foundation of China [U1462109]; Shandong Province Natural Science Foundation [ZR2013CM024]; Key Laboratory for Industrial Biocatalysis (Tsinghua University) Ministry of Education [2015102]; USA DOE [DE-SC0006871]	Petrochemical Joint Fund of National Natural Science Foundation of China; Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Key Laboratory for Industrial Biocatalysis (Tsinghua University) Ministry of Education; USA DOE(United States Department of Energy (DOE))	This work was supported by a grant from the Petrochemical Joint Fund of National Natural Science Foundation of China (Grant No. U1462109, www.nsfc.gov.cn), a grant from Shandong Province Natural Science Foundation (Grant No. ZR2013CM024), a grant from Key Laboratory for Industrial Biocatalysis (Tsinghua University) Ministry of Education (No. 2015102) to SY, and a grant from USA DOE (Grant No. DE-SC0006871, www.energy.gov/) to MEL. The funder (Grant No. DE-SC0006871) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM A, 1984, MED RES REV, V4, P111, DOI 10.1002/med.2610040202; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Alber BE, 2011, APPL MICROBIOL BIOT, V89, P17, DOI 10.1007/s00253-010-2873-z; Amoroso A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002571; Anthony C., 1982, BIOCH METHYLOTROPHS; Avery EL, 1998, ARCH ENVIRON CON TOX, V35, P229, DOI 10.1007/s002449900371; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bertau M., 2014, METHANOL BASIC CHEM; Bourque D, 1995, APPL MICROBIOL BIOT, V44, P367; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2007, J BACTERIOL, V189, P9076, DOI 10.1128/JB.01229-07; Choi YJ, 2006, APPL ENVIRON MICROB, V72, P7723, DOI 10.1128/AEM.02002-06; Chou HH, 2012, CELL REP, V1, P133, DOI 10.1016/j.celrep.2011.12.003; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Ewald JC, 2013, MOL BIOSYST, V9, P440, DOI 10.1039/c2mb25423a; Gerlich M, 2013, J MASS SPECTROM, V48, P291, DOI 10.1002/jms.3123; Good NM, 2015, J BACTERIOL, V197, P727, DOI 10.1128/JB.02478-14; GOODELL EW, 1985, J BACTERIOL, V162, P391, DOI 10.1128/JB.162.1.391-397.1985; Guo XF, 2006, ARCH MICROBIOL, V186, P139, DOI 10.1007/s00203-006-0131-7; Holman J. D., 2014, BIOINFORMATICS, V46, DOI DOI 10.1002/0471250953.BI1324S46; Hu B, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0156-0; Hu B, 2012, J BACTERIOL, V194, P2802, DOI 10.1128/JB.00061-12; Kalyuzhnaya MG, 2003, J BACTERIOL, V185, P1229, DOI 10.1128/JB.185.4.1229-1235.2003; Kataoka N, 2015, J BIOTECHNOL, V204, P25, DOI 10.1016/j.jbiotec.2015.03.027; Kiefer P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007831; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; NUNN DN, 1986, J BACTERIOL, V166, P581, DOI 10.1128/jb.166.2.581-590.1986; Ochsner AM, 2015, APPL MICROBIOL BIOT, V99, P517, DOI 10.1007/s00253-014-6240-3; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Okubo Y, 2010, J BACTERIOL, V192, P1813, DOI 10.1128/JB.01166-09; Orita I, 2014, APPL MICROBIOL BIOT, V98, P3715, DOI 10.1007/s00253-013-5490-9; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Peyraud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048271; Peyraud R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-189; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Schiesel S, 2010, ANAL BIOANAL CHEM, V396, P1655, DOI 10.1007/s00216-009-3432-2; Schneider K, 2012, J BIOL CHEM, V287, P757, DOI 10.1074/jbc.M111.305219; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; Silva F, 2012, BIOTECHNOL ADV, V30, P691, DOI 10.1016/j.biotechadv.2011.12.005; Skovran E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014091; Smejkalova H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013001; Sonntag F, 2015, METAB ENG, V32, P82, DOI 10.1016/j.ymben.2015.09.004; Sonntag F, 2015, APPL MICROBIOL BIOT, V99, P3407, DOI 10.1007/s00253-015-6418-3; Sonntag F, 2014, APPL MICROBIOL BIOT, V98, P4533, DOI 10.1007/s00253-013-5456-y; Tabata K, 2004, BIOTECHNOL LETT, V26, P1487, DOI 10.1023/B:BILE.0000044449.08268.7d; Van Dien SJ, 2003, BIOTECHNOL BIOENG, V84, P45, DOI 10.1002/bit.10745; von Borzyskowski LS, 2015, ACS SYNTH BIOL, V4, P430, DOI 10.1021/sb500221v; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00070; Yang S, 2009, J CHROMATOGR A, V1216, P3280, DOI 10.1016/j.chroma.2009.02.030; Zhu WL, 2016, APPL MICROBIOL BIOT, V100, P2171, DOI 10.1007/s00253-015-7078-z	56	14	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154043	10.1371/journal.pone.0154043	http://dx.doi.org/10.1371/journal.pone.0154043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116459	gold, Green Published, Green Submitted			2022-12-26	WOS:000374973600040
J	Bayle, N; Patel, AS; Crisan, D; Guo, LJ; Hutin, E; Weisz, DJ; Moore, ST; Gracies, JM				Bayle, Nicolas; Patel, Amar S.; Crisan, Diana; Guo, Lanjun J.; Hutin, Emilie; Weisz, Donald J.; Moore, Steven T.; Gracies, Jean-Michel			Contribution of Step Length to Increase Walking and Turning Speed as a Marker of Parkinson's Disease Progression	PLOS ONE			English	Article							GAIT; DISORDERS; PEOPLE; FORCE; BRADYKINESIA; RELIABILITY; ACCURACY; TASK; BODY	When increasing ambulation speed in Parkinson's disease, step cadence increases more than stride length, indicating movement scaling difficulties that affect step generation in particular. We investigated whether step length variation when increasing ambulation speed was related to disease progression. Patients with Parkinson's disease (N = 39) and controls (N = 152) performed two timed ambulation tasks: at a 'free' (self-selected) pace and then at 'maximal' speed. The total number of steps (including during turns) and time to complete the task were clinically measured. The relative contribution of step length and cadence to increased ambulation speed was determined using two methods: the ratios of change in step length or in cadence to the change in ambulation speed, and the step length index. While the relative contribution of step length and cadence to increased ambulation speed was independent of age in both control and patient groups, in Parkinson's disease there was a negative correlation between time from diagnosis and the ratio of change in step length to change in ambulation speed (R = 0.54; p = 0.0004) and the step length index (R = 0.56, p = 0.0002). In parallel, there was a positive correlation between time since diagnosis and the ratio of change in cadence to change in ambulation speed (R = 0.57; p = 0.0002). The relative contribution of step length and cadence to increased ambulation speed is age invariant but a marker of Parkinson's disease advancement, and can be easily determined in the clinical setting.	[Bayle, Nicolas; Hutin, Emilie; Gracies, Jean-Michel] Univ Paris Est Creteil, Hop Univ Henri Mondor, AP HP, Lab Anal & Restaurat Mouvement,EA BIOTN 7377, Creteil, France; [Patel, Amar S.; Moore, Steven T.; Gracies, Jean-Michel] Mt Sinai Sch Med, Dept Neurol, Robert & John M Bendheim Parkinson & Movement Dis, New York, NY USA; [Crisan, Diana; Guo, Lanjun J.; Weisz, Donald J.] Mt Sinai Sch Med, Neurosurg Dept, New York, NY USA; [Moore, Steven T.] Mt Sinai Sch Med, Dept Neurol, Human Aerosp Lab, New York, NY USA	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bayle, N (corresponding author), Univ Paris Est Creteil, Hop Univ Henri Mondor, AP HP, Lab Anal & Restaurat Mouvement,EA BIOTN 7377, Creteil, France.	nicolas.bayle@aphp.fr	Moore, Steven T/W-2204-2019	Moore, Steven/0000-0003-3995-4912; nicolas, bayle/0000-0002-3726-2712				ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; BLIN O, 1991, J NEUROL SCI, V103, P51, DOI 10.1016/0022-510X(91)90283-D; Canning CG, 2006, ARCH PHYS MED REHAB, V87, P371, DOI 10.1016/j.apmr.2005.11.021; Corcos DM, 1996, ANN NEUROL, V39, P79, DOI 10.1002/ana.410390112; Cunnington R, 2001, MOVEMENT DISORD, V16, P849, DOI 10.1002/mds.1181; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Duncan RP, 2011, DISABIL REHABIL, V33, P1440, DOI 10.3109/09638288.2010.533245; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Guimaraes R M, 1980, Int Rehabil Med, V2, P177; HAGEMAN PA, 1986, PHYS THER, V66, P1382, DOI 10.1093/ptj/66.9.1382; HALLETT M, 1980, BRAIN, V103, P301, DOI 10.1093/brain/103.2.301; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Lang AE, 2006, MOVEMENT DISORD, V21, pS171, DOI 10.1002/mds.20955; Moore ST, 2007, GAIT POSTURE, V26, P200, DOI 10.1016/j.gaitpost.2006.09.011; Moore ST, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-82; Morris M, 1998, MOVEMENT DISORD, V13, P61, DOI 10.1002/mds.870130115; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; MORRIS ME, 1994, J NEUROL NEUROSUR PS, V57, P1532, DOI 10.1136/jnnp.57.12.1532; Morris S, 2001, PHYS THER, V81, P810, DOI 10.1093/ptj/81.2.810; O'Sullivan JD, 1998, MOVEMENT DISORD, V13, P900, DOI 10.1002/mds.870130607; Parkinson J, 1817, ESSAY SHAKING PALSY; Peterson DS, 2015, J NEUROL NEUROSUR PS, V86, P786, DOI 10.1136/jnnp-2014-308840; PHILLIPS JG, 1994, J NEUROL, V241, P439, DOI 10.1007/BF00900963; Post B, 2005, MOVEMENT DISORD, V20, P1577, DOI 10.1002/mds.20640; Rand MK, 2000, NEUROPSYCHOLOGIA, V38, P203, DOI 10.1016/S0028-3932(99)00059-7; Snijders AH, 2007, LANCET NEUROL, V6, P63, DOI 10.1016/S1474-4422(06)70678-0; STELMACH GE, 1989, EXP BRAIN RES, V76, P165; STELMACH GE, 1988, NEUROPSYCHOLOGIA, V26, P93, DOI 10.1016/0028-3932(88)90033-4; Stocchi F, 2013, MOVEMENT DISORD, V28, P3, DOI 10.1002/mds.25337; TEASDALE N, 1990, J NEUROL NEUROSUR PS, V53, P862, DOI 10.1136/jnnp.53.10.862; Teo WP, 2013, EXP BRAIN RES, V227, P323, DOI 10.1007/s00221-013-3491-7; van Loo MA, 2003, DISABIL REHABIL, V25, P1195, DOI 10.1080/09638280310001599989; Zijlstra W, 1998, GAIT POSTURE, V7, P53, DOI 10.1016/S0966-6362(97)00037-4	37	18	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152469	10.1371/journal.pone.0152469	http://dx.doi.org/10.1371/journal.pone.0152469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111531	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600002
J	Malin, SK; Rynders, CA; Weltman, JY; Barrett, EJ; Weltman, A				Malin, Steven K.; Rynders, Corey A.; Weltman, Judy Y.; Barrett, Eugene J.; Weltman, Arthur			Exercise Intensity Modulates Glucose-Stimulated Insulin Secretion when Adjusted for Adipose, Liver and Skeletal Muscle Insulin Resistance	PLOS ONE			English	Article							BETA-CELL FUNCTION; CARBOHYDRATE-METABOLISM; SENSITIVITY; FAT; TOLERANCE; INDEX; RISK; OVERWEIGHT; INCREASES; RECOVERY	Little is known about the effects of exercise intensity on compensatory changes in glucose-stimulated insulin secretion (GSIS) when adjusted for adipose, liver and skeletal muscle insulin resistance (IR). Fifteen participants (8F, Age: 49.9 +/- 3.6yr; BMI: 31.0 +/- 1.5kg/m(2); VO(2)peak: 23.2 +/- 1.2mg/kg/min) with prediabetes (ADA criteria, 75g OGTT and/or HbA(1c)) underwent a time-course matched Control, and isocaloric (200kcal) exercise at moderate (MIE; at lactate threshold (LT)), and high-intensity (HIE; 75% of difference between LT and VO(2)peak). A 75g OGTT was conducted 1 hour post-exercise/Control, and plasma glucose, insulin, C-peptide and free fatty acids were determined for calculations of skeletal muscle (1/Oral Minimal Model; SMIR), hepatic (HOMA(IR)), and adipose (ADIPOSE(IR)) IR. Insulin secretion rates were determined by deconvolution modeling for GSIS, and disposition index (DI; GSIS/IR; DISMIR, DIHOMAIR, DIADIPOSEIR) calculations. Compared to Control, exercise lowered SMIR independent of intensity (P< 0.05), with HIE raising HOMA(IR) and ADIPOSE(IR) compared with Control (P< 0.05). GSIS was not reduced following exercise, but DIHOMAIR and DIADIPOSEIR were lowered more following HIE compared with Control (P< 0.05). However, DISMIR increased in an intensity based manner relative to Control (P< 0.05), which corresponded with lower post-prandial blood glucose levels. Taken together, pancreatic insulin secretion adjusts in an exercise intensity dependent manner to match the level of insulin resistance in skeletal muscle, liver and adipose tissue. Further work is warranted to understand the mechanism by which exercise influences the cross-talk between tissues that regulate blood glucose in people with prediabetes.	[Malin, Steven K.; Weltman, Arthur] Univ Virginia, Dept Kinesiol, Charlottesville, VA USA; [Malin, Steven K.; Barrett, Eugene J.; Weltman, Arthur] Univ Virginia, Div Endocrinol & Metab, Charlottesville, VA USA; [Malin, Steven K.; Weltman, Judy Y.; Weltman, Arthur] Univ Virginia, Exercise Physiol Core Lab, Charlottesville, VA USA; [Rynders, Corey A.] Univ Colorado Anschutz Med Campus, Div Geriatr Med, Aurora, CO USA	University of Virginia; University of Virginia; University of Virginia; University of Colorado System; University of Colorado Anschutz Medical Campus	Malin, SK (corresponding author), Univ Virginia, Dept Kinesiol, Charlottesville, VA USA.; Malin, SK (corresponding author), Univ Virginia, Div Endocrinol & Metab, Charlottesville, VA USA.; Malin, SK (corresponding author), Univ Virginia, Exercise Physiol Core Lab, Charlottesville, VA USA.	skm6n@virginia.edu		Weltman, Arthur/0000-0002-0125-3769; Malin, Steven/0000-0002-7360-6711; Rynders, Corey/0000-0001-5767-6261	Curry School of Education Foundation; Virginia Commonwealth Health Research Board;  [NIH-RR00847]	Curry School of Education Foundation; Virginia Commonwealth Health Research Board; 	This research was supported by the Curry School of Education Foundation (SKM) and Virginia Commonwealth Health Research Board and NIH-RR00847 (AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; [Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; BAHR R, 1991, ACTA PHYSIOL SCAND, V143, P105, DOI 10.1111/j.1748-1716.1991.tb09205.x; Bilet L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09709; Bloem CJ, 2008, J CLIN ENDOCR METAB, V93, P387, DOI 10.1210/jc.2007-1734; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Cobelli C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1, DOI 10.1152/ajpendo.00421.2006; Dalla Man C, 2005, AM J PHYSIOL-ENDOC M, V289, pE954, DOI 10.1152/ajpendo.00076.2005; Davis CL, 2012, JAMA-J AM MED ASSOC, V308, P1103, DOI 10.1001/2012.jama.10762; DeFronzo RA, 2011, J CLIN ENDOCR METAB, V96, P2354, DOI 10.1210/jc.2011-0246; Dela F, 2004, AM J PHYSIOL-ENDOC M, V287, pE1024, DOI 10.1152/ajpendo.00056.2004; Egger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070865; Faerch K, 2010, J PHYSIOL-LONDON, V588, P759, DOI 10.1113/jphysiol.2009.184028; Flier SN, 2001, P NATL ACAD SCI USA, V98, P7475, DOI 10.1073/pnas.131192998; GARETTO LP, 1984, AM J PHYSIOL, V246, pE471, DOI 10.1152/ajpendo.1984.246.6.E471; Hamer M, 2012, CIRC-CARDIOVASC QUAL, V5, P494, DOI 10.1161/CIRCOUTCOMES.112.965434; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; HODGETTS V, 1991, J APPL PHYSIOL, V71, P445, DOI 10.1152/jappl.1991.71.2.445; Honka H, 2014, J CLIN ENDOCR METAB, V99, pE981, DOI 10.1210/jc.2013-4369; Hunt DG, 2002, J APPL PHYSIOL, V93, P1638, DOI 10.1152/japplphysiol.00445.2002; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kanat M, 2011, ACTA DIABETOL, V48, P209, DOI 10.1007/s00592-011-0285-x; Kimber NE, 2003, J PHYSIOL-LONDON, V548, P919, DOI 10.1113/jphysiol.2002.031179; KING DS, 1990, AM J PHYSIOL, V259, pE155, DOI 10.1152/ajpendo.1990.259.2.E155; Knudsen SH, 2015, DIABETES OBES METAB, V17, P207, DOI 10.1111/dom.12413; Knudsen SH, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12114; Lorenzo C, 2013, J CLIN ENDOCR METAB, V98, P1622, DOI 10.1210/jc.2012-3185; MAEHLUM S, 1978, AM J PHYSIOL, V235, pE255, DOI 10.1152/ajpendo.1978.235.3.E255; Magkos F, 2008, CLIN SCI, V114, P59, DOI 10.1042/CS20070134; Malin SK, 2014, DIABETES CARE, V37, P2940, DOI 10.2337/dc13-3011; Malin SK, 2013, AM J PHYSIOL-ENDOC M, V305, pE1248, DOI 10.1152/ajpendo.00260.2013; Malin SK, 2012, DIABETES CARE, V35, P131, DOI 10.2337/dc11-0925; Marion-Latard F, 2003, HORM METAB RES, V35, P97, DOI 10.1055/s-2003-39051; Marliss EB, 2002, DIABETES, V51, pS271, DOI 10.2337/diabetes.51.2007.S271; Mauvais-Jarvis F, 2000, DIABETES, V49, P2126, DOI 10.2337/diabetes.49.12.2126; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Muzumdar R, 2004, DIABETES, V53, P441, DOI 10.2337/diabetes.53.2.441; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; RICHTER EA, 1984, AM J PHYSIOL, V246, pE476, DOI 10.1152/ajpendo.1984.246.6.E476; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Rose AJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE766, DOI 10.1152/ajpendo.2001.281.4.E766; Rynders CA, 2014, J CLIN ENDOCR METAB, V99, P220, DOI 10.1210/jc.2013-2687; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Slentz CA, 2009, DIABETES CARE, V32, P1807, DOI 10.2337/dc09-0032; Solomon TPJ, 2014, AM J PHYSIOL-ENDOC M, V307, pE822, DOI 10.1152/ajpendo.00269.2014; Solomon TPJ, 2010, DIABETES CARE, V33, P1561, DOI 10.2337/dc09-2021; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Stephens BR, 2007, APPL PHYSIOL NUTR ME, V32, P1139, DOI 10.1139/H07-126; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Utzschneider KM, 2004, DIABETES, V53, P2867, DOI 10.2337/diabetes.53.11.2867; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Weltman A, 2006, J APPL PHYSL, V100, P1623	58	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154063	10.1371/journal.pone.0154063	http://dx.doi.org/10.1371/journal.pone.0154063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111219	gold, Green Submitted, Green Published			2022-12-26	WOS:000374970600031
J	McKenzie, M; Duchen, MR				McKenzie, Matthew; Duchen, Michael R.			Impaired Cellular Bioenergetics Causes Mitochondrial Calcium Handling Defects in MT-ND5 Mutant Cybrids	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; DNA MUTATIONS; CELLS; DEATH; ENCEPHALOMYOPATHY; HOMEOSTASIS; APOPTOSIS; NEURONS; MTDNA; GENE	Mutations in mitochondrial DNA (mtDNA) can cause mitochondrial disease, a group of metabolic disorders that affect both children and adults. Interestingly, individual mtDNA mutations can cause very different clinical symptoms, however the factors that determine these phenotypes remain obscure. Defects in mitochondrial oxidative phosphorylation can disrupt cell signaling pathways, which may shape these disease phenotypes. In particular, mitochondria participate closely in cellular calcium signaling, with profound impact on cell function. Here, we examined the effects of a homoplasmic m.13565C>T mutation in MT-ND5 on cellular calcium handling using transmitochondrial cybrids (ND5 mutant cybrids). We found that the oxidation of NADH and mitochondrial membrane potential (Delta psi(m)) were significantly reduced in ND5 mutant cybrids. These metabolic defects were associated with a significant decrease in calcium uptake by ND5 mutant mitochondria in response to a calcium transient. Inhibition of glycolysis with 2-deoxy-D-glucose did not affect cytosolic calcium levels in control cybrids, but caused an increase in cytosolic calcium in ND5 mutant cybrids. This suggests that glycolytically-generated ATP is required not only to maintain Delta psi(m) in ND5 mutant mitochondria but is also critical for regulating cellular calcium homeostasis. We conclude that the m.13565C>T mutation in MT-ND5 causes defects in both mitochondrial oxidative metabolism and mitochondrial calcium sequestration. This disruption of mitochondrial calcium handling, which leads to defects in cellular calcium homeostasis, may be an important contributor to mitochondrial disease pathogenesis.	[McKenzie, Matthew] Hudson Inst Med Res, Ctr Genet Dis, Melbourne, Vic 3168, Australia; [McKenzie, Matthew] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia; [Duchen, Michael R.] UCL, Dept Physiol, Gower St, London WC1E 6BT, England	Hudson Institute of Medical Research; Monash University; University of London; University College London	McKenzie, M (corresponding author), Hudson Inst Med Res, Ctr Genet Dis, Melbourne, Vic 3168, Australia.; McKenzie, M (corresponding author), Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia.	matthew.mckenzie@hudson.org.au	McKenzie, Matthew/H-4926-2019; duchen, michael/A-2116-2009	McKenzie, Matthew/0000-0001-7508-1800; duchen, michael/0000-0003-2548-4294	Wellcome Trust; Medical Research Council; Australian Research Council [FT120100459]; William Buckland Foundation; Monash University; Victorian Government	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Research Council(Australian Research Council); William Buckland Foundation; Monash University(Monash University); Victorian Government	This work was supported by the Wellcome Trust (GB) (wellcome.ac.uk/funding/) to MRD, Medical Research Council (GB) (mrc.ac.uk/funding/) to MRD, Australian Research Council Future Fellowship Scheme (FT120100459) (arc.gov.au/future-fellowships) to MMCK, William Buckland Foundation (eqt.com.au/charities-and-not-for-profits/grants/the-william-buckland-foundation) to MMCK, Monash University (monash.edu) to MMCK and Victorian Government Infrastructure Program (premier.vic.gov.au/funding-to-support-victorias-medical-research-institutes/) to MMCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Bhosale G, 2015, ANN NY ACAD SCI, V1350, P107, DOI 10.1111/nyas.12885; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DILISA F, 1995, J PHYSIOL-LONDON, V486, P1; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Jacobson J, 2004, MOL CELL BIOCHEM, V256, P209, DOI 10.1023/B:MCBI.0000009869.29827.df; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kamer KJ, 2015, NAT REV MOL CELL BIO, V16, P545, DOI 10.1038/nrm4039; Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Manfredi G, 2003, J BIOL CHEM, V278, P5639, DOI 10.1074/jbc.M203080200; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93; MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729; Nicholls DG, 2003, CELL CALCIUM, V34, P407, DOI 10.1016/S0143-4160(03)00144-1; Rajakulendran S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145500; Rommelaere G, 2012, INT J BIOCHEM CELL B, V44, P139, DOI 10.1016/j.biocel.2011.10.009; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szczepanowska J, 2004, FEBS LETT, V578, P316, DOI 10.1016/j.febslet.2004.11.022; Trevelyan AJ, 2010, BRAIN, V133, P787, DOI 10.1093/brain/awq023	28	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154371	10.1371/journal.pone.0154371	http://dx.doi.org/10.1371/journal.pone.0154371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110715	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600061
J	McManus, M; Mick, E; Hudson, R; Mofenson, LM; Sullivan, JL; Somasundaran, M; Luzuriaga, K				McManus, Margaret; Mick, Eric; Hudson, Richard; Mofenson, Lynne M.; Sullivan, John L.; Somasundaran, Mohan; Luzuriaga, Katherine		PACTG 356 Investigators	Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1-INFECTED CHILDREN; LATENT RESERVOIR; IMMUNE-RESPONSES; INFECTION; DYNAMICS; ESTABLISHMENT; PERSISTENCE; ABSENCE; TRIAL	The primary aim of this study was to measure HIV-1 persistence following combination anti-retroviral therapy (cART) in infants and children. Peripheral blood mononuclear cell (PBMC) HIV-1 DNA was quantified prior to and after 1 year of cART in 30 children, stratified by time of initiation (early, age <3 months, ET; late, age >3 months-2 years, LT). Pre-therapy PBMC HIV-1 DNA levels correlated with pre-therapy plasma HIV-1 levels (r = 0.59, p<0.001), remaining statistically significant (p = 0.002) after adjustment for prior perinatal antiretroviral exposure and age at cART initiation. PBMC HIV-1 DNA declined significantly after 1 year of cART (Overall: -0.91 +/- 0.08 log(10) copies per million PBMC, p<0.001; ET: -1.04 +/- 0.11 log(10) DNA copies per million PBMC, p<0.001; LT: -0.74 +/- 0.13 log(10) DNA copies per million PBMC, p<0.001) but rates of decline did not differ significantly between ET and LT. HIV-1 replication exposure over the first 12 months of cART, estimated as area-under-the-curve (AUC) of circulating plasma HIV-1 RNA levels, was significantly associated with PBMC HIV-1 DNA at one year (r = 0.51, p = 0.004). In 21 children with sustained virologic suppression after 1 year of cART, PBMC HIV-1 DNA levels continued to decline between years 1 and 4 (slope -0.21 log(10) DNA copies per million PBMC per year); decline slopes did not differ significantly between ET and LT. PBMC HIV-1 DNA levels at 1 year and 4 years of cART correlated with age at cART initiation (1 year: p = 0.04; 4 years: p = 0.03) and age at virologic control (1 and 4 years, p = 0.02). Altogether, these data indicate that reducing exposure to HIV-1 replication and younger age at cART initiation are associated with lower HIV1 DNA levels at and after one year of age, supporting the concept that HIV-1 diagnosis and cART initiation in infants should occur as early as possible.	[McManus, Margaret; Hudson, Richard; Sullivan, John L.; Somasundaran, Mohan; Luzuriaga, Katherine] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Mick, Eric] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Mofenson, Lynne M.] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Luzuriaga, K (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA.	katherine.luzuriaga@umassmed.edu	Mofenson, Lynne/P-9631-2019	Mofenson, Lynne/0000-0002-2818-9808	National Institutes of Health [AI32907, K24-HD01489]; University of Massachusetts Center for AIDS Research [AI428845]; University of Massachusetts Center for Clinical and Translational Science [UL1-TR001453]; International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001489] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068616, U01AI032907, UM1AI068632, UM1AI106716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Center for AIDS Research; University of Massachusetts Center for Clinical and Translational Science; International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI32907, K24-HD01489, the University of Massachusetts Center for AIDS Research (AI428845), and the University of Massachusetts Center for Clinical and Translational Science (UL1-TR001453) to Katherine Luzuriaga. Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2014, AIDS, V28, P1015, DOI 10.1097/QAD.0000000000000178; Greenough TC, 1999, J INFECT DIS, V180, P1790, DOI 10.1086/315128; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Laanani M, 2015, CLIN INFECT DIS, V60, P1715, DOI 10.1093/cid/civ171; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Luzuriaga K, 2004, NEW ENGL J MED, V350, P2471, DOI 10.1056/NEJMoa032706; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; Luzuriaga K, 2016, ANNU REV MED, V67, P201, DOI 10.1146/annurev-med-091114-111159; Martinez-Bonet M, 2015, CLIN INFECT DIS, V61, P1169, DOI 10.1093/cid/civ456; Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, 2016, GUID US ANT AG PED H; Payne H, 2015, LANCET INFECT DIS, V15, P803, DOI 10.1016/S1473-3099(15)00087-0; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Persaud D, 2014, JAMA PEDIATR, V168, P1138, DOI 10.1001/jamapediatrics.2014.1560; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Persaud D, 2012, AIDS, V26, P1483, DOI 10.1097/QAD.0b013e3283553638; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Uprety P, 2015, CLIN INFECT DIS, V61, P1862, DOI 10.1093/cid/civ688; van Zyl GU, 2015, J INFECT DIS, V212, P39, DOI 10.1093/infdis/jiu827; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organization, 2015, GUID START ANT THER; Zanchetta M, 2008, ANTIVIR THER, V13, P47	23	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154391	10.1371/journal.pone.0154391	http://dx.doi.org/10.1371/journal.pone.0154391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104621	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100075
J	Miura, R; Kasakura, K; Nakano, N; Hara, M; Maeda, K; Okumura, K; Ogawa, H; Yashiro, T; Nishiyama, C				Miura, Ryosuke; Kasakura, Kazumi; Nakano, Nobuhiro; Hara, Mutsuko; Maeda, Keiko; Okumura, Ko; Ogawa, Hideoki; Yashiro, Takuya; Nishiyama, Chiharu			Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							TRANSACTIVATOR PROMOTER-III; GENE-EXPRESSION; B-CELL; T-CELL; REQUIREMENT; ACTIVATION; GAMMA	The cofactor CIITA is a master regulator of MHC class II expression and several transcription factors regulating the cell type-specific expression of CIITA have been identified. Although the MHC class II expression in plasmacytoid dendritic cells (pDCs) is also mediated by CIITA, the transcription factors involved in the CIITA expression in pDCs are largely unknown. In the present study, we analyzed the role of a hematopoietic lineage-specific transcription factor, PU.1, in CIITA transcription in pDCs. The introduction of PU.1 siRNA into mouse pDCs and a human pDC cell line, CAL-1, reduced the mRNA levels of MHC class II and CIITA. When the binding of PU.1 to the 3rd promoter of CIITA (pIII) in CAL-1 and mouse pDCs was analyzed by a chromatin immunoprecipitation assay, a significant amount of PU.1 binding to the pIII was detected, which was definitely decreased in PU.1 siRNA-transfected cells. Reporter assays showed that PU.1 knockdown reduced the pIII promoter activity and that three Ets-motifs in the human pIII promoter were candidates of cis-enhancing elements. By electrophoretic mobility shift assays, it was confirmed that two Ets-motifs, GGAA (-181/-178) and AGAA (-114/-111), among three candidates, were directly bound with PU.1. When mouse pDCs and CAL-1 cells were stimulated by GM-CSF, mRNA levels of PU.1, pIII-driven CIITA, total CIITA, MHC class II, and the amount of PU.1 binding to pIII were significantly increased. The GM-CSF-mediated up-regulation of these mRNAs was canceled in PU.1 siRNA-introduced cells. Taking these results together, we conclude that PU.1 transactivates the pIII through direct binding to Ets-motifs in the promoter in pDCs.	[Miura, Ryosuke; Kasakura, Kazumi; Yashiro, Takuya; Nishiyama, Chiharu] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan; [Nakano, Nobuhiro; Hara, Mutsuko; Maeda, Keiko; Okumura, Ko; Ogawa, Hideoki] Juntendo Univ, Atopy Allergy Res Ctr, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan	Tokyo University of Science; Juntendo University	Nishiyama, C (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	chinishi@rs.tus.ac.jp	yashiro, takuya/Y-1543-2019; Nishiyama, Chiharu/GPW-9372-2022	Miura, Ryosuke/0000-0003-1249-7803	Ministry of Education, Culture, Sports, Science and Technology of Japan [LS111]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Atopy (Allergy) Research Center, Juntendo University School of Medicine); Tokyo Biochemical Research Foundation; Tokyo University of Science; Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists) [3241, 10792]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Translational Research Center, Tokyo University of Science)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Atopy (Allergy) Research Center, Juntendo University School of Medicine); Tokyo Biochemical Research Foundation; Tokyo University of Science; Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists); MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Translational Research Center, Tokyo University of Science)	This work was supported by the Funding Program for Next Generation World-Leading Researchers from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to CN, #LS111), the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Atopy (Allergy) Research Center, Juntendo University School of Medicine; Translational Research Center, Tokyo University of Science), and the Tokyo Biochemical Research Foundation. KK is supported by Postdoctoral Fellowships of Tokyo University of Science (from 2014 to 2015) and by Research Fellowships of the Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists #3241; from 2016). TY has been supported by Research Fellowships of the Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists #10792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Baba Y, 2012, J BIOL CHEM, V287, P32689, DOI 10.1074/jbc.M112.374876; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Fukai T, 2009, BIOCHEM BIOPH RES CO, V388, P102, DOI 10.1016/j.bbrc.2009.07.126; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; Ito T, 2005, J IMMUNOL, V174, P376, DOI 10.4049/jimmunol.174.1.376; Ito T, 2009, INT IMMUNOL, V21, P803, DOI 10.1093/intimm/dxp048; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; Kitamura N, 2012, J ALLERGY CLIN IMMUN, V129, P814, DOI 10.1016/j.jaci.2011.10.019; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Lohsen S, 2014, GENES IMMUN, V15, P543, DOI 10.1038/gene.2014.49; Maeda K, 2006, BLOOD, V108, P262, DOI 10.1182/blood-2005-07-2878; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nakano N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.138966; Pai RK, 2002, J IMMUNOL, V169, P1326, DOI 10.4049/jimmunol.169.3.1326; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Smith MA, 2011, J BIOL CHEM, V286, P7893, DOI 10.1074/jbc.M110.165431; van der Stoep N, 2004, BLOOD, V104, P2849, DOI 10.1182/blood-2004-03-0790; Yashiro T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137699; Yoon H, 2010, J IMMUNOL, V184, P5018, DOI 10.4049/jimmunol.1000079	28	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154094	10.1371/journal.pone.0154094	http://dx.doi.org/10.1371/journal.pone.0154094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105023	Green Submitted, Green Published, gold			2022-12-26	WOS:000374565100043
J	Rahimi, S; Mashhadi, HR; Banadaky, MD; Mesgaran, MB				Rahimi, Salman; Mashhadi, Hamid Rahimian; Banadaky, Mehdi Dehghan; Mesgaran, Mohsen Beheshtian			Variation in Weed Seed Fate Fed to Different Holstein Cattle Groups	PLOS ONE			English	Article							FORAGE PARTICLE-SIZE; CHEWING ACTIVITY; DIET QUALITY; RUMINAL PH; RECOVERY; PASSAGE; GERMINATION; MANAGEMENT; DIGESTION; SURVIVAL	Weed seeds may maintain their viability when passing through the digestive tract of cattle and can be therefore dispersed by animal movement or the application of manure. Whether different cattle types of the same species can cause differential weed seed fate is largely unknown to us particularly under non-grazed systems similar to Holstein-Friesian dairy farming. We investigated the effect on the seed survival of four weed species in the digestive tracts of four groups of Holstein cattle: lactating cows, feedlot male calves, dry cows and growing heifers. The weed species used were Cuscuta campestris, Polygonum aviculare, Rumex crispus and Sorghum halepense. Cattle excretion was sampled for recovery and viability of seeds at four 24 hourly intervals after seed intake. The highest seed recovery occurred two days after seed intake in all cattle groups. Averaged over weed species, dry and lactating cows had the lowest and highest seed recovery of 36.4% and 74.4% respectively. No significant differences were observed in seed recovery of the four weed species when their seeds were fed to dry cows. Based on a power model fitted to seed viability data, the estimated time to 50% viability loss after seed intake, over all cattle groups ranged from 65 h (R. crispus) to 76 h (P. aviculare). Recovered seeds from the dung of feedlot male calves showed the highest mortality among cattle groups. Significant correlation was found between seed viability and ruminal pH (r = 0.86; P<0.05). This study shows that management programs aiming to minimize weed infestation caused by livestock should account for the variation amongst cattle groups in seed persistence. Our findings can be used as a guideline for evaluating the potential risk of the spread of weeds via the application of cattle manure.	[Rahimi, Salman; Mashhadi, Hamid Rahimian] Univ Tehran, Dept Agron & Plant Breeding, Coll Agr Sci & Engn, Karaj, Iran; [Banadaky, Mehdi Dehghan] Univ Tehran, Dept Anim Sci, Coll Agr Sci & Engn, Karaj, Iran; [Mesgaran, Mohsen Beheshtian] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Rahimi, Salman] Ferdowsi Univ Mashhad, Fac Agr, Dept Agron, Mashhad, Khorasan Razavi, Iran	University of Tehran; University of Tehran; University of Melbourne; Ferdowsi University Mashhad	Mesgaran, MB (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia.	mohsenm@unimelb.edu.au		Mesgaran, Mohsen/0000-0002-0841-6188	University of Tehran's Vice-President of Research	University of Tehran's Vice-President of Research	This work was supported by a graduate student grant from the University of Tehran's Vice-President of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD RLB, 1990, WEED RES, V30, P81, DOI 10.1111/j.1365-3180.1990.tb01690.x; Barberi P, 2002, WEED RES, V42, P177, DOI 10.1046/j.1365-3180.2002.00277.x; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; BASKIN JM, 1985, WEED SCI, V33, P340, DOI 10.1017/S0043174500082382; BLACKSHAW RE, 1991, WEED SCI, V39, P104, DOI 10.1017/S0043174500057957; Bodmer RE, 2006, LARGE HERBIVORE ECOL; Calsamiglia S, 2008, J ANIM SCI, V86, P702, DOI 10.2527/jas.2007-0146; COLUCCI PE, 1982, J DAIRY SCI, V65, P1445, DOI 10.3168/jds.S0022-0302(82)82367-9; Cook AR, 2007, WEED TECHNOL, V21, P389, DOI 10.1614/WT-06-043.1; Cudney D. W., 1992, California Agriculture, V46, P31; Doucette KM, 2001, J RANGE MANAGE, V54, P575, DOI 10.2307/4003587; Fenner M., 2005, ECOLOGY SEEDS; Frost RA, 2013, RANGELAND ECOL MANAG, V66, P51, DOI 10.2111/REM-D-11-00218.1; GARDENER CJ, 1993, J APPL ECOL, V30, P63, DOI 10.2307/2404271; GARDENER CJ, 1993, J APPL ECOL, V30, P75, DOI 10.2307/2404272; Gokbulak F., 2006, Online Journal of Biological Sciences, V6, P23; Haidar MA, 2010, WEED RES, V50, P467, DOI 10.1111/j.1365-3180.2010.00797.x; HARMON GEORGE W., 1934, JOUR AMER SOC AGRON, V26, P762; Hogan JP, 2011, ANIM PROD SCI, V51, P391, DOI 10.1071/AN10141; International Seed Testing Association, 2003, INT RUL SEED TEST, V2003rd; Iranian Council of Animal Care, 1995, GUIDE CARE USE EXPT; JONES RM, 1987, AUST J EXP AGR, V27, P253, DOI 10.1071/EA9870253; Kennedy P M, 1988, Nutr Res Rev, V1, P189, DOI 10.1079/NRR19880014; Krause KM, 2002, J DAIRY SCI, V85, P1947, DOI 10.3168/jds.S0022-0302(02)74271-9; Kruk BC, 1998, WEED SCI, V46, P83, DOI 10.1017/S0043174500090214; Kukovics S., 2013, Milk and dairy products in human nutrition: production, composition and health, P80; Larney FJ, 2007, BIORESOURCE TECHNOL, V98, P3221, DOI 10.1016/j.biortech.2006.07.005; National Research Council, 2001, NUTR REQ DAIR CATTL, V7th; NETO MS, 1987, AUST J EXP AGR, V27, P239, DOI 10.1071/EA9870239; Nishida T, 1998, JARQ-JPN AGR RES Q, V32, P55; PLEASANT JM, 1994, WEED TECHNOL, V8, P304; Salimi H., 2000, Rostaniha, V1, P33; Scofield DG, 2012, AM NAT, V180, P719, DOI 10.1086/668202; Shepherd MA, 2002, SOIL USE MANAGE, V18, P284, DOI 10.1079/SUM2002134; Tjelele J, 2014, RANGELAND ECOL MANAG, V67, P423, DOI 10.2111/REM-D-13-00115.1; Tuomisto HL, 2012, J ENVIRON MANAGE, V112, P309, DOI 10.1016/j.jenvman.2012.08.018; Van Soest P. J, 1994, NUTR ECOLOGY RUMINAN, DOI DOI 10.7591/9781501732355; WELCH JG, 1982, J ANIM SCI, V54, P885, DOI 10.2527/jas1982.544885x; Whitacre MK, 2006, WEST N AM NATURALIST, V66, P121, DOI 10.3398/1527-0904(2006)66[121:RAGONS]2.0.CO;2; Will H, 2008, J ECOL, V96, P1011, DOI 10.1111/j.1365-2745.2007.01341.x; Yang WZ, 2006, J DAIRY SCI, V89, P217, DOI 10.3168/jds.S0022-0302(06)72086-0; Yang WZ, 2001, J DAIRY SCI, V84, P2203, DOI 10.3168/jds.S0022-0302(01)74667-X; Zand E, 2009, WEED RES J, V1, P83; Zebeli Q, 2007, J DAIRY SCI, V90, P1929, DOI 10.3168/jds.2006-354	45	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154057	10.1371/journal.pone.0154057	http://dx.doi.org/10.1371/journal.pone.0154057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104783	gold, Green Published			2022-12-26	WOS:000374565100041
J	Voukkalis, N; Koutroumani, M; Zarkadas, C; Nikolakaki, E; Vlassi, M; Giannakouros, T				Voukkalis, Nikolaos; Koutroumani, Maria; Zarkadas, Christoforos; Nikolakaki, Eleni; Vlassi, Metaxia; Giannakouros, Thomas			SRPK1 and Akt Protein Kinases Phosphorylate the RS Domain of Lamin B Receptor with Distinct Specificity: A Combined Biochemical and In Silico Approach	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SUBSTRATE SPECIFICITIES; CRYSTAL-STRUCTURE; SPLICING FACTORS; FORCE-FIELD; SR PROTEIN; NUCLEAR; MOTIF; RICH; ASSOCIATION	Activated Akt has been previously implicated in acting on RS domain-containing proteins. However, it has been questioned whether its action is direct or it is mediated by co-existing SR kinase activity. To address this issue we studied in detail the phosphorylation of Lamin B Receptor (LBR) by Akt. Using synthetic peptides and a set of recombinant proteins expressing mutants of the LBR RS domain we now demonstrate that while all serines of the RS domain represent more or less equal phosphoacceptor sites for SRPK1, Ser80 and Ser82 are mainly targeted by Akt. 3D-modeling combined with molecular dynamics (MD) simulations show that amongst short, overlapping LBR RS-containing peptides complying with the minimum Akt recognition consensus sequence, only those bearing phosphosites either at Ser80 or Ser82 are able to fit into the active site of Akt, at least as effectively as its known substrate, GSK3-beta. Combined our results provide evidence that Akt kinases directly phosphorylate an RS domain-containing protein and that both the residues N-terminal the phosphosite and at position + 1 are essential for Akt specificity, with the latter substrate position being compatible with the arginine residue of RS-repeats.	[Voukkalis, Nikolaos; Koutroumani, Maria; Nikolakaki, Eleni; Giannakouros, Thomas] Aristotle Univ Thessaloniki, Dept Chem, Biochem Lab, GR-54006 Thessaloniki, Greece; [Zarkadas, Christoforos; Vlassi, Metaxia] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece	Aristotle University of Thessaloniki; National Centre of Scientific Research "Demokritos"	Giannakouros, T (corresponding author), Aristotle Univ Thessaloniki, Dept Chem, Biochem Lab, GR-54006 Thessaloniki, Greece.; Vlassi, M (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece.	meta@bio.demokritos.gr; giannako@chem.auth.gr	Vlassi, Metaxia/B-8692-2013; GIANNAKOUROS, THOMAS/R-3204-2019	Vlassi, Metaxia/0000-0003-0931-2660	THALES Programme [379440]; European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	THALES Programme(Thales Group); European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	MV and TG were funded by the THALES Programme (http://excellence.minedu.gov.gr/thales; grant number 379440), co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Aubol BE, 2013, BIOCHEMISTRY-US, V52, P7595, DOI 10.1021/bi4010864; Aubol BE, 2013, J MOL BIOL, V425, P2894, DOI 10.1016/j.jmb.2013.05.013; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Hamelberg D, 2007, P NATL ACAD SCI USA, V104, P14947, DOI 10.1073/pnas.0703151104; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilouz R, 2006, J BIOL CHEM, V281, P30621, DOI 10.1074/jbc.M604633200; Jang SW, 2009, J BIOL CHEM, V284, P24512, DOI 10.1074/jbc.M109.026237; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Li CQ, 2014, J PHYS CHEM B, V118, P1273, DOI 10.1021/jp411111g; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lukasiewicz R, 2007, J MOL BIOL, V367, P249, DOI 10.1016/j.jmb.2006.12.031; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mylonis I, 2004, J BIOL CHEM, V279, P11626, DOI 10.1074/jbc.M311949200; Nam SY, 2010, J BIOL CHEM, V285, P31157, DOI 10.1074/jbc.M110.122044; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Nikolakaki E, 1996, J BIOL CHEM, V271, P8365, DOI 10.1074/jbc.271.14.8365; Nikolakaki E, 2008, BBA-GEN SUBJECTS, V1780, P214, DOI 10.1016/j.bbagen.2007.10.014; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Papoutsopoulou S, 1999, BIOCHEM BIOPH RES CO, V255, P602, DOI 10.1006/bbrc.1999.0249; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Sellis D, 2012, BBA-GEN SUBJECTS, V1820, P44, DOI 10.1016/j.bbagen.2011.10.010; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154198	10.1371/journal.pone.0154198	http://dx.doi.org/10.1371/journal.pone.0154198			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105349	Green Published, gold			2022-12-26	WOS:000374565100054
J	Armstrong, C; Samuel, J; Yarlett, A; Cooper, SM; Stembridge, M; Stohr, EJ				Armstrong, Craig; Samuel, Jake; Yarlett, Andrew; Cooper, Stephen-Mark; Stembridge, Mike; Stohr, Eric J.			The Effects of Exercise Intensity vs. Metabolic State on the Variability and Magnitude of Left Ventricular Twist Mechanics during Exercise	PLOS ONE			English	Article							HEART-FAILURE; TORSION; STRESS; HUMANS; PRELOAD; STRAIN; IMPACT; OUTPUT; REST	Increased left ventricular (LV) twist and untwisting rate (LV twist mechanics) are essential responses of the heart to exercise. However, previously a large variability in LV twist mechanics during exercise has been observed, which complicates the interpretation of results. This study aimed to determine some of the physiological sources of variability in LV twist mechanics during exercise. Sixteen healthy males (age: 22 +/- 4 years, (V) over dotO(2peak): 45.5 +/- 6.9 ml.kg(-1).min(-1), range of individual anaerobic threshold (IAT): 32-69% of (V) over dotO(2peak)) were assessed at rest and during exercise at: i) the same relative exercise intensity, 40%(peak), ii) at 2% above IAT, and, iii) at 40%(peak) with hypoxia (40%(peak)+HYP). LV volumes were not significantly different between exercise conditions (P > 0.05). However, the mean margin of error of LV twist was significantly lower (F-2,F-47 = 2.08, P < 0.05) during 40% peak compared with IAT (3.0 vs. 4.1 degrees). Despite the same workload and similar LV volumes, hypoxia increased LV twist and untwisting rate (P < 0.05), but the mean margin of error remained similar to that during 40% peak (3.2 degrees, P > 0.05). Overall, LV twist mechanics were linearly related to rate pressure product. During exercise, the intra-individual variability of LV twist mechanics is smaller at the same relative exercise intensity compared with IAT. However, the absolute magnitude (degrees) of LV twist mechanics appears to be associated with the prevailing rate pressure product. Exercise tests that evaluate LV twist mechanics should be standardised by relative exercise intensity and rate pressure product be taken into account when interpreting results.	[Armstrong, Craig; Samuel, Jake; Yarlett, Andrew; Cooper, Stephen-Mark; Stembridge, Mike; Stohr, Eric J.] Cardiff Metropolitan Univ, Discipline Physiol & Hlth, Cardiff, S Glam, Wales	Cardiff Metropolitan University	Stohr, EJ (corresponding author), Cardiff Metropolitan Univ, Discipline Physiol & Hlth, Cardiff, S Glam, Wales.	estohr@cardiffmet.ac.uk		Stembridge, Mike/0000-0003-0818-6420				American College., 2006, ACSMS GUID EX TEST P; ARTS T, 1984, CARDIOVASC RES, V18, P183, DOI 10.1093/cvr/18.3.183; ASTRAND PO, 1964, J APPL PHYSIOL, V19, P268, DOI 10.1152/jappl.1964.19.2.268; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BEYAR R, 1986, CIRC RES, V58, P664, DOI 10.1161/01.RES.58.5.664; Burns AT, 2010, ECHOCARDIOGR-J CARD, V27, P407, DOI 10.1111/j.1540-8175.2009.01037.x; Campagna JA, 2003, ANESTHESIOLOGY, V98, P1250; Donal E, 2012, EUR HEART J-CARD IMG, V13, P656, DOI 10.1093/ehjci/jes010; Dong SJ, 1999, AM J PHYSIOL-HEART C, V277, pH1053, DOI 10.1152/ajpheart.1999.277.3.H1053; Doucende G, 2010, CIRC-CARDIOVASC IMAG, V3, P586, DOI 10.1161/CIRCIMAGING.110.943522; Duncker DJ, 2015, PROG CARDIOVASC DIS, V57, P409, DOI 10.1016/j.pcad.2014.12.002; Duncker DJ, 1998, CIRC RES, V82, P1312, DOI 10.1161/01.RES.82.12.1312; Esch BT, 2009, J PHYSIOL-LONDON, V587, P2375, DOI 10.1113/jphysiol.2009.170100; Esch BT, 2009, J APPL PHYSIOL, V106, P362, DOI 10.1152/japplphysiol.00144.2008; Goebel B, 2013, INT J CARDIOVAS IMAG, V29, P561, DOI 10.1007/s10554-012-0117-2; Helle-Valle T, 2005, CIRCULATION, V112, P3149, DOI 10.1161/CIRCULATIONAHA.104.531558; HUCKABEE WE, 1961, AM J PHYSIOL, V200, P1169, DOI 10.1152/ajplegacy.1961.200.6.1169; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Notomi Y, 2005, J AM COLL CARDIOL, V45, P2034, DOI 10.1016/j.jacc.2005.02.082; Notomi Y, 2006, CIRCULATION, V113, P2524, DOI 10.1161/CIRCULATIONAHA.105.596502; Opdahl A, 2012, CIRCULATION, V126, P1441, DOI 10.1161/CIRCULATIONAHA.111.080861; Patterson SW, 1914, J PHYSIOL-LONDON, V48, P357; Rognmo O, 2012, CIRCULATION, V126, P1436, DOI 10.1161/CIRCULATIONAHA.112.123117; SAHN SA, 1977, J APPL PHYSIOL, V43, P1019, DOI 10.1152/jappl.1977.43.6.1019; Soullier C, 2012, CIRC-CARDIOVASC IMAG, V5, P324, DOI 10.1161/CIRCIMAGING.111.968859; Stembridge M, 2014, J APPL PHYSIOL, V117, P334, DOI 10.1152/japplphysiol.00233.2014; Stohr EJ, 2015, EXP PHYSIOL, V100, P507, DOI 10.1113/EP085081; Stohr EJ, 2014, AM J PHYSIOL-HEART C, V306, pH225, DOI 10.1152/ajpheart.00938.2012; Stohr EJ, 2012, J PHYSIOL-LONDON, V590, P2107, DOI 10.1113/jphysiol.2012.227850; Stohr EJ, 2011, J APPL PHYSIOL, V111, P891, DOI 10.1152/japplphysiol.00528.2011; Stohr EJ, 2011, AM J PHYSIOL-HEART C, V301, pH478, DOI 10.1152/ajpheart.00314.2011; Stohr EJ, 2011, EXP PHYSIOL, V96, P114, DOI 10.1113/expphysiol.2010.055137; Tan YT, 2009, J AM COLL CARDIOL, V54, P36, DOI 10.1016/j.jacc.2009.03.037; van Mil ACCM, 2016, EXP PHYSL IN PRESS; Vendelin M, 2002, AM J PHYSIOL-HEART C, V283, pH1072, DOI 10.1152/ajpheart.00874.2001; WAGNER PD, 1986, J APPL PHYSIOL, V61, P260, DOI 10.1152/jappl.1986.61.1.260; Wasserman K, 1990, CIRCULATION S2, V81, P1114; Weiner RB, 2012, J PHYSIOL-LONDON, V590, P5141, DOI 10.1113/jphysiol.2012.236166; Weiner RB, 2010, CIRC-CARDIOVASC IMAG, V3, P672, DOI 10.1161/CIRCIMAGING.109.932921	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154065	10.1371/journal.pone.0154065	http://dx.doi.org/10.1371/journal.pone.0154065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100099	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500134
J	Bordoloi, NK; Bhagowati, P; Chaudhuri, MK; Mukherjee, AK				Bordoloi, Naba K.; Bhagowati, Pabitra; Chaudhuri, Mihir K.; Mukherjee, Ashis K.			Proteomics and Metabolomics Analyses to Elucidate the Desulfurization Pathway of Chelatococcus sp.	PLOS ONE			English	Article							ORGANIC SULFUR-COMPOUNDS; RHODOCOCCUS-ERYTHROPOLIS KA2-5-1; MICROBIAL DESULFURIZATION; DEEP-DESULFURIZATION; DIESEL OIL; DIBENZOTHIOPHENE DESULFURIZATION; BACILLUS-SUBTILIS; CRUDE-OIL; BIODESULFURIZATION; OVEREXPRESSION	Desulfurization of dibenzothiophene (DBT) and alkylated DBT derivatives present in transport fuel through specific cleavage of carbon-sulfur (C-S) bonds by a newly isolated bacterium Chelatococcus sp. is reported for the first time. Gas chromatography-mass spectrometry (GC-MS) analysis of the products of DBT degradation by Chelatococcus sp. showed the transient formation of 2-hydroxybiphenyl (2-HBP) which was subsequently converted to 2-methoxybiphenyl (2-MBP) by methylation at the hydroxyl group of 2-HBP. The relative ratio of 2-HBP and 2-MBP formed after 96 h of bacterial growth was determined at 4: 1 suggesting partial conversion of 2-HBP or rapid degradation of 2-MBP. Nevertheless, the enzyme involved in this conversion process remains to be identified. This production of 2-MBP rather than 2-HBP from DBT desulfurization has a significant metabolic advantage for enhancing the growth and sulfur utilization from DBT by Chelatococcus sp. and it also reduces the environmental pollution by 2-HBP. Furthermore, desulfurization of DBT derivatives such as 4-M-DBT and 4, 6-DM-DBT by Chelatococcus sp. resulted in formation of 2-hydroxy-3-methyl-biphenyl and 2-hydroxy -3, 3'-dimethyl-biphenyl, respectively as end product. The GC and X-ray fluorescence studies revealed that Chelatococcus sp. after 24 h of treatment at 37 degrees C reduced the total sulfur content of diesel fuel by 12% by per gram resting cells, without compromising the quality of fuel. The LC-MS/MS analysis of tryptic digested intracellular proteins of Chelatococcus sp. when grown in DBT demonstrated the biosynthesis of 4S pathway desulfurizing enzymes viz. monoxygenases (DszC, DszA), desulfinase (DszB), and an NADH-dependent flavin reductase (DszD). Besides, several other intracellular proteins of Chelatococcus sp. having diverse biological functions were also identified by LC-MS/MS analysis. Many of these enzymes are directly involved with desulfurization process whereas the other enzymes/proteins support growth of bacteria at an expense of DBT. These combined results suggest that Chelatococcus sp. prefers sulfur-specific extended 4S pathway for deep-desulphurization which may have an advantage for its intended future application as a promising biodesulfurizing agent.	[Bordoloi, Naba K.; Bhagowati, Pabitra; Chaudhuri, Mihir K.; Mukherjee, Ashis K.] Tezpur Univ, Dept Mol Biol & Biotechnol, ONGC Ctr Petr Biotechnol, Tezpur 784028, Assam, India	Tezpur University	Chaudhuri, MK; Mukherjee, AK (corresponding author), Tezpur Univ, Dept Mol Biol & Biotechnol, ONGC Ctr Petr Biotechnol, Tezpur 784028, Assam, India.	mkc@tezu.ernet.in; akm@tezu.ernet.in		Mukherjee, Ashis/0000-0001-9869-858X	ONGC-CPBT; DBT, New Delhi	ONGC-CPBT; DBT, New Delhi(Department of Biotechnology (DBT) India)	This research work received partial support from the ONGC-CPBT project entitled-"Proteomics study of aromatic hydrocarbons degradation enzymes of some bacterial strains prospecting strategies for environmental bioremediation" and DBT, New Delhi sponsored the research project entitled "Strengthening of biotechnology teaching, training and research in universities and colleges in the Northeast India" granted to AKM. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Rahman RNZR, 2007, J IND MICROBIOL BIOT, V34, P509, DOI 10.1007/s10295-007-0222-8; Abin-Fuentes A, 2014, BIOTECHNOL BIOENG, V111, P876, DOI 10.1002/bit.25148; Abin-Fuentes A, 2013, APPL ENVIRON MICROB, V79, P7807, DOI 10.1128/AEM.02696-13; Aggarwal S, 2012, MOL BIOSYST, V8, P2724, DOI 10.1039/c2mb25127b; ALONSO JM, 1982, BIOCHIM BIOPHYS ACTA, V719, P165, DOI 10.1016/0304-4165(82)90322-1; Ausubel FM, 1995, SHORT PROTOCOLS MOL, P212; Bordoloi NK, 2014, FUEL PROCESS TECHNOL, V119, P236, DOI 10.1016/j.fuproc.2013.10.014; Bressler DC, 2001, APPL ENVIRON MICROB, V67, P5084, DOI 10.1128/AEM.67.11.5084-5093.2001; Caro A, 2007, BIOCHEM ENG J, V35, P191, DOI 10.1016/j.bej.2007.01.013; de Araujo HWC, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-33; Chen H, 2009, BIORESOURCE TECHNOL, V100, P2085, DOI 10.1016/j.biortech.2008.10.010; Chen H, 2008, BIORESOURCE TECHNOL, V99, P6928, DOI 10.1016/j.biortech.2008.01.033; CRAWFORD DL, 1990, CURR MICROBIOL, V21, P229, DOI 10.1007/BF02092161; Daniel W.W., 2000, BIOSTATISTICS FDN AN, V7th ed., P166; Das K, 2007, BIORESOURCE TECHNOL, V98, P1339, DOI 10.1016/j.biortech.2006.05.032; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; Grossman MJ, 1999, APPL ENVIRON MICROB, V65, P181; Hirasawa K, 2001, BIOSCI BIOTECH BIOCH, V65, P239, DOI 10.1271/bbb.65.239; Kilbane JJ, 2007, APPL MICROBIOL BIOT, V75, P843, DOI 10.1007/s00253-007-0895-y; Kilbane JJ, 2006, CURR OPIN BIOTECH, V17, P305, DOI 10.1016/j.copbio.2006.04.005; Kirimura K, 2002, APPL ENVIRON MICROB, V68, P3867, DOI 10.1128/AEM.68.8.3867-3872.2002; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Li FL, 2003, FEMS MICROBIOL LETT, V223, P301, DOI 10.1016/S0378-1097(03)00397-5; Li FL, 2007, J BIOTECHNOL, V127, P222, DOI 10.1016/j.jbiotec.2006.07.002; Li M, 2010, J PROTEOME RES, V9, P4295, DOI 10.1021/pr100527g; Li W, 2005, FEMS MICROBIOL LETT, V247, P45, DOI 10.1016/j.femsle.2005.04.025; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma T, 2010, MICROBIOL MONOGR, V16, P207, DOI 10.1007/978-3-642-12937-7_8; Matsubara T, 2001, APPL ENVIRON MICROB, V67, P1179, DOI 10.1128/AEM.67.3.1179-1184; Mohamed MES, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00112; Mohebali G, 2008, MICROBIOL-SGM, V154, P2169, DOI 10.1099/mic.0.2008/017608-0; Monticello DJ, 2000, CURR OPIN BIOTECH, V11, P540, DOI 10.1016/S0958-1669(00)00154-3; Mukherjee AK, 2005, FEMS MICROBIOL ECOL, V54, P479, DOI 10.1016/j.femsec.2005.06.003; Mukherjee AK, 2014, THROMB RES, V134, P1150, DOI 10.1016/j.thromres.2014.09.009; Nakayama N, 2002, BBA-PROTEINS PROTEOM, V1598, P122, DOI 10.1016/S0167-4838(02)00365-5; Nejad NF, 2015, PETROL SCI, V12, P330, DOI 10.1007/s12182-015-0020-2; Ohshiro T, 1996, J FERMENT BIOENG, V81, P121, DOI 10.1016/0922-338X(96)87588-X; Ohshiro T, 1999, BIOSCI BIOTECH BIOCH, V63, P1, DOI 10.1271/bbb.63.1; OHSHIRO T, 1994, FEMS MICROBIOL LETT, V118, P341, DOI 10.1016/0378-1097(94)90526-6; Okada H, 2002, J BIOSCI BIOENG, V93, P491, DOI 10.1016/S1389-1723(02)80097-4; Oldfield C, 1998, ANTON LEEUW INT J G, V74, P119, DOI 10.1023/A:1001724516342; Onaka T, 2000, J CHROMATOGR A, V903, P193, DOI 10.1016/S0021-9673(00)00892-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shavandi M, 2009, BIORESOURCE TECHNOL, V100, P475, DOI 10.1016/j.biortech.2008.06.011; Soleimani M, 2007, BIOTECHNOL ADV, V25, P570, DOI 10.1016/j.biotechadv.2007.07.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thakur R, 2015, TOXICON, V100, P1, DOI 10.1016/j.toxicon.2015.03.019; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Vandera E, 2015, J PROTEOMICS, V113, P73, DOI 10.1016/j.jprot.2014.08.018; Vermeij P, 1999, J BACTERIOL, V181, P5833, DOI 10.1128/JB.181.18.5833-5837.1999; Watkins LM, 2003, ARCH BIOCHEM BIOPHYS, V415, P14, DOI 10.1016/S0003-9861(03)00230-3; Yu B, 2006, APPL ENVIRON MICROB, V72, P54, DOI 10.1128/AEM.72.1.54-58.2006; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; Zhang HB, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/315901	56	17	21	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153547	10.1371/journal.pone.0153547	http://dx.doi.org/10.1371/journal.pone.0153547			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100386	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500041
J	Chakraborty, B; Bhakta, S; Sengupta, J				Chakraborty, Biprashekhar; Bhakta, Sayan; Sengupta, Jayati			Mechanistic Insight into the Reactivation of BCAII Enzyme from Denatured and Molten Globule States by Eukaryotic Ribosomes and Domain V rRNAs	PLOS ONE			English	Article							PROTEIN-FOLDING ACTIVITY; CARBONIC-ANHYDRASE-B; ESCHERICHIA-COLI; IN-VITRO; GUANIDINIUM CHLORIDE; 70S RIBOSOME; INTERMEDIATE; AGGREGATION; CHAPERONES; YEAST	In all life forms, decoding of messenger-RNA into polypeptide chain is accomplished by the ribosome. Several protein chaperones are known to bind at the exit of ribosomal tunnel to ensure proper folding of the nascent chain by inhibiting their premature folding in the densely crowded environment of the cell. However, accumulating evidence suggests that ribosome may play a chaperone role in protein folding events in vitro. Ribosome-mediated folding of denatured proteins by prokaryotic ribosomes has been studied extensively. The RNA-assisted chaperone activity of the prokaryotic ribosome has been attributed to the domain V, a span of 23S rRNA at the intersubunit side of the large subunit encompassing the Peptidyl Transferase Centre. Evidently, this functional property of ribosome is unrelated to the nascent chain protein folding at the exit of the ribosomal tunnel. Here, we seek to scrutinize whether this unique function is conserved in a primitive kinetoplastid group of eukaryotic species Leishmania donovani where the ribosome structure possesses distinct additional features and appears markedly different compared to other higher eukaryotic ribosomes. Bovine Carbonic Anhydrase II (BCAII) enzyme was considered as the model protein. Our results manifest that domain V of the large subunit rRNA of Leishmania ribosomes preserves chaperone activity suggesting that ribosome-mediated protein folding is, indeed, a conserved phenomenon. Further, we aimed to investigate the mechanism underpinning the ribosome-assisted protein reactivation process. Interestingly, the surface plasmon resonance binding analyses exhibit that rRNA guides productive folding by directly interacting with molten globule-like states of the protein. In contrast, native protein shows no notable affinity to the rRNA. Thus, our study not only confirms conserved, RNA-mediated chaperoning role of ribosome but also provides crucial insight into the mechanism of the process.	[Chakraborty, Biprashekhar; Bhakta, Sayan; Sengupta, Jayati] CSIR, Indian Inst Chem Biol, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Sengupta, J (corresponding author), CSIR, Indian Inst Chem Biol, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	jayati@iicb.res.in			CSIR-Indian Institute of Chemical Biology, Kolkata, India; CSIR Network project 'UNSEEN'; DST (India) [GAP327]	CSIR-Indian Institute of Chemical Biology, Kolkata, India; CSIR Network project 'UNSEEN'; DST (India)(Department of Science & Technology (India))	This work was partially supported by CSIR-Indian Institute of Chemical Biology, Kolkata, India, and CSIR Network project 'UNSEEN' and DST (India) sponsored project GAP327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Barbezier N, 2011, EMBO MOL MED, V3, P35, DOI 10.1002/emmm.201000109; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P598, DOI 10.1016/j.bbrc.2007.11.143; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bonander N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-10; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; CHATTOPADHYAY S, 1994, BIOCHEM J, V300, P717, DOI 10.1042/bj3000717; Choi SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002677; Choi SI, 2009, RNA BIOL, V6, P21, DOI 10.4161/rna.6.1.7441; CLELAND JL, 1990, BIOCHEMISTRY-US, V29, P11072, DOI 10.1021/bi00502a009; Creighton TE, 1997, TRENDS BIOCHEM SCI, V22, P6, DOI 10.1016/S0968-0004(96)20030-1; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das D, 2012, J BIOL CHEM, V287, P37508, DOI 10.1074/jbc.M112.396127; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; Dos Reis S, 2011, BIOCHIMIE, V93, P1047, DOI 10.1016/j.biochi.2011.03.002; GHOSH A, 1994, NUCLEIC ACIDS RES, V22, P1663, DOI 10.1093/nar/22.9.1663; Hammarstrom P, 1999, J BIOL CHEM, V274, P32897, DOI 10.1074/jbc.274.46.32897; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jha SK, 2014, P NATL ACAD SCI USA, V111, P4856, DOI 10.1073/pnas.1315453111; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Katranidis A, 2009, ANGEW CHEM INT EDIT, V48, P1758, DOI 10.1002/anie.200806070; Komar AA, 1997, J BIOL CHEM, V272, P10646; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Malakar D, 2008, BBA-GEN SUBJECTS, V1780, P937, DOI 10.1016/j.bbagen.2008.03.014; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Naeem A, 2011, CELL BIOCHEM BIOPHYS, V61, P237, DOI 10.1007/s12013-011-9200-x; Pal D, 1997, NUCLEIC ACIDS RES, V25, P5047, DOI 10.1093/nar/25.24.5047; Pang YH, 2013, J BIOL CHEM, V288, P19081, DOI 10.1074/jbc.M113.466748; Pathak BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096425; Rajaraman K, 1996, J BIOL CHEM, V271, P27595, DOI 10.1074/jbc.271.44.27595; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; Samanta D, 2009, BIOCHEM BIOPH RES CO, V384, P137, DOI 10.1016/j.bbrc.2009.04.106; Santucci R, 2008, MINI-REV MED CHEM, V8, P57, DOI 10.2174/138955708783331522; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Singh R, 2002, FEBS LETT, V527, P234, DOI 10.1016/S0014-5793(02)03243-X; Sorensen HP, 2004, BIOCHEM BIOPH RES CO, V319, P715, DOI 10.1016/j.bbrc.2004.05.081; Svetlov MS, 2006, PROTEIN SCI, V15, P242, DOI 10.1110/ps.051752506; UVERSKY VN, 1992, FEBS LETT, V314, P89, DOI 10.1016/0014-5793(92)81468-2; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Voisset C, 2011, BIOTECHNOL J, V6, P668, DOI 10.1002/biot.201100021; Voisset Cecile, 2008, Biotechnology Journal, V3, P1033, DOI 10.1002/biot.200800134; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080	51	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153928	10.1371/journal.pone.0153928	http://dx.doi.org/10.1371/journal.pone.0153928			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099964	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500097
J	De Luca, G; Bosello, SL; Gabrielli, FA; Berardi, G; Parisi, F; Rucco, M; Canestrari, G; Loperfido, F; Galiuto, L; Crea, F; Ferraccioli, G				De Luca, Giacomo; Bosello, Silvia Laura; Gabrielli, Francesca Augusta; Berardi, Giorgia; Parisi, Federico; Rucco, Manuela; Canestrari, Giovanni; Loperfido, Francesco; Galiuto, Leonarda; Crea, Filippo; Ferraccioli, Gianfranco			Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; CARDIOVASCULAR MAGNETIC-RESONANCE; PULMONARY ARTERIAL-HYPERTENSION; MYOCARDIAL FIBROSIS; HEART INVOLVEMENT; ARRHYTHMIAS; SCLERODERMA; RISK; ASSOCIATION; DYSFUNCTION	Background Arrhythmias are frequent in Systemic Sclerosis (SSc) and portend a bad prognosis, accounting alone for 6% of total deaths. Many of these patients die suddenly, thus prevention and intensified risk-stratification represent unmet medical needs. The major goal of this study was the definition of ECG indexes of poor prognosis. Methods We performed a prospective cohort study to define the role of 24h-ECG-Holter as an additional risk-stratification technique in the identification of SSc-patients at high risk of life-threatening arrhythmias and sudden cardiac death (SCD). One-hundred SSc-patients with symptoms and/or signs suggestive of cardiac involvement underwent 24h-ECG-Holter. The primary end-point was a composite of SCD or need for implantable cardioverter defibrillator (ICD). Results Fifty-six patients (56%) had 24h-ECG-Holter abnormalities and 24(24%) presented frequent ventricular ectopic beats (VEBs). The number of VEBs correlated with high-sensitive cardiac troponin T (hs-cTnT) levels and inversely correlated with left-ventricular ejection fraction (LV-EF) on echocardiography. During a mean follow-up of 23.1 +/- 16.0 months, 5 patients died suddenly and two required ICD-implantation. The 7 patients who met the composite end-point had a higher number of VEBs, higher levels of hs-cTnT and NT-proBNP and lower LV-EF (p = 0.001 for all correlations). All these 7 patients had frequent VEBs, while LV-EF was not reduced in all and its range was wide. At ROC curve, VEBs> 1190/24h showed 100% of sensitivity and 83% of specificity to predict the primary end-point (AUROC = 0.92, p< 0.0001). Patients with VEBS> 1190/24h had lower LV-EF and higher hs-cTnT levels and, at multivariate analysis, the presence of increased hs-cTnT and of right bundle branch block on ECG emerged as independent predictors of VEBs> 1190/24h. None of demographic or disease-related characteristics emerged as predictors of poor outcome. Conclusions VEBS> 1190/24h identify patients at high risk of life-threatening arrhythmic complications. Thus, 24h-ECG-Holter should be considered a useful additional risk-stratification test to select SSc-patients at high-risk of SCD, in whom an ICD-implantation could represent a potential life-saving intervention.	[De Luca, Giacomo; Bosello, Silvia Laura; Berardi, Giorgia; Parisi, Federico; Rucco, Manuela; Canestrari, Giovanni; Ferraccioli, Gianfranco] Univ Cattolica Sacro Cuore, Inst Rheumatol & Affine Sci, Dept Rheumatol, I-00168 Rome, Italy; [Gabrielli, Francesca Augusta; Loperfido, Francesco; Galiuto, Leonarda] Complesso Integrato Columbus, Div Heart Failure & Cardiac Rehabil, Rome, Italy; [Loperfido, Francesco; Galiuto, Leonarda; Crea, Filippo] Univ Cattolica Sacro Cuore, Inst Cardiol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ferraccioli, G (corresponding author), Univ Cattolica Sacro Cuore, Inst Rheumatol & Affine Sci, Dept Rheumatol, I-00168 Rome, Italy.	gf.ferraccioli@rm.unicatt.it	De+Luca, Giacomo/AAB-2933-2019; Bosello, Silvia L/L-1622-2018	Bosello, Silvia L/0000-0002-4837-447X; Ferraccioli, Gianfranco/0000-0002-6884-4301; De Luca, Giacomo/0000-0002-5306-7714	ASRALES foundation; GILS	ASRALES foundation; GILS	The authors acknowledge the ASRALES foundation and GILS for supporting the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; [Anonymous], 1974, Circulation, V49, P390; Assassi S, 2009, ARTHRIT CARE RES, V61, P1403, DOI 10.1002/art.24734; Ataklte F, 2013, AM J CARDIOL, V112, P1263, DOI 10.1016/j.amjcard.2013.05.065; Barron HV, 1996, J AM COLL CARDIOL, V27, P1053, DOI 10.1016/0735-1097(95)00615-X; Bernardo P, 2011, J RHEUMATOL, V38, P1617, DOI 10.3899/jrheum.100480; Bosello S, 2015, NEW ENGL J MED, V373, P1977, DOI 10.1056/NEJMc1511645; Brisinda D, 2012, CIRC J, V76, P1345, DOI 10.1253/circj.CJ-11-1374; BULKLEY BH, 1976, CIRCULATION, V53, P483, DOI 10.1161/01.CIR.53.3.483; CLEMSON BS, 1992, CHEST, V101, P872, DOI 10.1378/chest.101.3.872; Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301; Cozzolino D, 2002, RHEUMATOLOGY, V41, P586, DOI 10.1093/rheumatology/41.5.586; DESOYZA N, 1979, CIRCULATION, V60, P814, DOI 10.1161/01.CIR.60.4.814; Draeger HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078808; Ferri C, 2005, LUPUS, V14, P702, DOI 10.1191/0961203305lu2204oa; FOLLANSBEE WP, 1993, AM HEART J, V125, P194, DOI 10.1016/0002-8703(93)90075-K; FOLLANSBEE WP, 1990, J RHEUMATOL, V17, P656; Hachulla AL, 2009, ANN RHEUM DIS, V68, P1878, DOI 10.1136/ard.2008.095836; HATLE L, 1981, BRIT HEART J, V45, P157; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; KOSTIS JB, 1988, AM J MED, V84, P1007, DOI 10.1016/0002-9343(88)90305-1; Kuhl U, 1996, HEART, V75, P295, DOI 10.1136/hrt.75.3.295; LEROY EC, 1988, J RHEUMATOL, V15, P202; LOWN B, 1967, J AMER MED ASSOC, V199, P188, DOI 10.1001/jama.199.3.188; Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P46, DOI 10.1016/j.acvd.2009.06.009; Mueller KAL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126707; MYERBURG RJ, 1993, ANN INTERN MED, V119, P1187, DOI 10.7326/0003-4819-119-12-199312150-00006; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Passman R, 2007, CIRCULATION, V116, P561, DOI 10.1161/CIRCULATIONAHA.106.655704; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pieroni M, 2014, SEMIN ARTHRITIS RHEU, V43, P526, DOI 10.1016/j.semarthrit.2013.07.006; Rajdev A, 2012, PROG CARDIOVASC DIS, V55, P180, DOI 10.1016/j.pcad.2012.06.002; Rosato E, 2015, INT J CARDIOL, V182, P20, DOI 10.1016/j.ijcard.2014.12.069; Schumm J, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-14; Smedema JP, 2005, J AM COLL CARDIOL, V45, P1683, DOI 10.1016/j.jacc.2005.01.047; Stack J, 2010, SCAND J RHEUMATOL, V39, P349, DOI 10.3109/03009740903493741; Thakkar V, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3876; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; Tzelepis GE, 2007, ARTHRITIS RHEUM-US, V56, P3827, DOI 10.1002/art.22971; Vacca A, 2013, RHEUMATOLOGY OXFORD; Zipes DP, 2006, EUR HEART J, V27, P2099, DOI 10.1093/eurheartj/ehl199	42	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153012	10.1371/journal.pone.0153012	http://dx.doi.org/10.1371/journal.pone.0153012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101136	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500022
J	Guan, HY; Xu, XB; He, CM; Liu, CX; Liu, Q; Dong, R; Liu, TS; Wang, LM				Guan, Haiying; Xu, Xiangbo; He, Chunmei; Liu, Chunxiao; Liu, Qiang; Dong, Rui; Liu, Tieshan; Wang, Liming			Fine Mapping and Candidate Gene Analysis of the Leaf-Color Gene ygl-1 in Maize	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; CHLOROPHYLL ANTENNA SIZE; B-DEFICIENT MUTANTS; CHLOROPLAST BIOGENESIS; ARABIDOPSIS-THALIANA; THYLAKOID MEMBRANES; FUNCTIONAL-ANALYSIS; PROTEIN-TRANSPORT; CPSRP PATHWAY; RICE	A novel yellow-green leaf mutant yellow-green leaf-1 (ygl-1) was isolated in self-pollinated progenies from the cross of maize inbred lines Ye478 and Yuanwu02. The mutant spontaneously showed yellow-green character throughout the lifespan. Meanwhile, the mutant reduced contents of chlorophyll and Car, arrested chloroplast development and lowered the capacity of photosynthesis compared with the wild-type Lx7226. Genetic analysis revealed that the mutant phenotype was controlled by a recessive nuclear gene. The ygl-1 locus was initially mapped to an interval of about 0.86 Mb in bin 1.01 on the short arm of chromosome 1 using 231 yellow-green leaf individuals of an F2 segregating population from ygl-1/Lx7226. Utilizing four new polymorphic SSR markers, the ygl-1 locus was narrowed down to a region of about 48 kb using 2930 and 2247 individuals of F2 and F3 mapping populations, respectively. Among the three predicted genes annotated within this 48 kb region, GRMZM2G007441, which was predicted to encode a cpSRP43 protein, had a 1-bp nucleotide deletion in the coding region of ygl-1 resulting in a frame shift mutation. Semi-quantitative RT-PCR analysis revealed that YGL-1 was constitutively expressed in all tested tissues and its expression level was not significantly affected in the ygl-1 mutant from early to mature stages, while light intensity regulated its expression both in the ygl-1 mutant and wild type seedlings. Furthermore, the mRNA levels of some genes involved in chloroplast development were affected in the six-week old ygl-1 plants. These findings suggested that YGL-1 plays an important role in chloroplast development of maize.	[Guan, Haiying; Xu, Xiangbo; He, Chunmei; Liu, Chunxiao; Liu, Qiang; Dong, Rui; Liu, Tieshan; Wang, Liming] Shandong Acad Agr Sci, Maize Res Inst, Jinan, Peoples R China; [Guan, Haiying; Xu, Xiangbo; He, Chunmei; Liu, Chunxiao; Liu, Qiang; Dong, Rui; Liu, Tieshan; Wang, Liming] Minist Agr, Key Lab Biol & Genet Improvement North Summer Mai, Jinan, Peoples R China; [Guan, Haiying; Xu, Xiangbo; He, Chunmei; Liu, Chunxiao; Liu, Qiang; Dong, Rui; Liu, Tieshan; Wang, Liming] Natl Maize Improvement Sub Ctr, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Liu, TS; Wang, LM (corresponding author), Shandong Acad Agr Sci, Maize Res Inst, Jinan, Peoples R China.; Liu, TS; Wang, LM (corresponding author), Minist Agr, Key Lab Biol & Genet Improvement North Summer Mai, Jinan, Peoples R China.; Liu, TS; Wang, LM (corresponding author), Natl Maize Improvement Sub Ctr, Jinan, Peoples R China.	gongsi@188.com; lmwang@saas.ac.cn			Post-doctoral Innovative Projects of Shandong Province, China [201403017]	Post-doctoral Innovative Projects of Shandong Province, China	This work was supported by the Post-doctoral Innovative Projects of Shandong Province, China (201403017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge C, 2009, FEBS J, V276, P1177, DOI 10.1111/j.1742-4658.2009.06875.x; Amin P, 1999, PLANT PHYSIOL, V121, P61, DOI 10.1104/pp.121.1.61; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asakura Y, 2004, PLANT CELL, V16, P201, DOI 10.1105/tpc.014787; Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; BEDBROOK JR, 1978, P NATL ACAD SCI USA, V75, P3060, DOI 10.1073/pnas.75.7.3060; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Chen G, 2005, PLANT J, V41, P364, DOI 10.1111/j.1365-313X.2004.02308.x; Chen H, 2013, PLANT CELL REP, V32, P1855, DOI 10.1007/s00299-013-1498-y; Cline K, 1996, ANNU REV CELL DEV BI, V12, P1, DOI 10.1146/annurev.cellbio.12.1.1; Comparot-Moss S, 2009, J EXP BOT, V60, P2481, DOI 10.1093/jxb/erp141; CRAIG E, 1990, ANTON LEEUW INT J G, V58, P137, DOI 10.1007/BF00548924; CROSSLAND LD, 1984, P NATL ACAD SCI-BIOL, V81, P4060, DOI 10.1073/pnas.81.13.4060; Deng XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099564; Falbel TG, 1996, PHYSIOL PLANTARUM, V97, P311, DOI 10.1034/j.1399-3054.1996.970214.x; Falbel TG, 1996, PLANT PHYSIOL, V112, P821, DOI 10.1104/pp.112.2.821; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; GHIRARDI ML, 1988, BIOCHIM BIOPHYS ACTA, V932, P130, DOI 10.1016/0005-2728(88)90147-8; GREENE BA, 1988, PLANT PHYSIOL, V87, P357, DOI 10.1104/pp.87.2.357; HU Z, 1981, Acta Genetica Sinica, V8, P256; Hutin C, 2002, PLANT J, V29, P531, DOI 10.1046/j.0960-7412.2001.01211.x; Jonas-Straube E, 2001, J BIOL CHEM, V276, P24654, DOI 10.1074/jbc.M100153200; Kirst H, 2014, BIOTECHNOL ADV, V32, P66, DOI 10.1016/j.biotechadv.2013.08.018; Kirst H, 2012, PLANT PHYSIOL, V160, P2251, DOI 10.1104/pp.112.206672; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Klimyuk VI, 1995, MOL GEN GENET, V249, P357, DOI 10.1007/BF00287097; KROL M, 1995, PLANT PHYSIOL, V107, P873, DOI 10.1104/pp.107.3.873; Kumar AM, 2000, PLANT PHYSIOL, V122, P49, DOI 10.1104/pp.122.1.49; KYOZUKA J, 1993, PLANT PHYSIOL, V102, P991, DOI 10.1104/pp.102.3.991; Naested H, 2004, J CELL SCI, V117, P4807, DOI 10.1242/jcs.01360; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nussaume L, 2008, NAT CHEM BIOL, V4, P529, DOI 10.1038/nchembio0908-529; Olinares PDB, 2011, BBA-BIOENERGETICS, V1807, P999, DOI 10.1016/j.bbabio.2010.12.003; Pilgrim ML, 1998, PLANT J, V13, P177, DOI 10.1046/j.1365-313X.1998.00021.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sawers RJH, 2006, PLANT MOL BIOL, V60, P95, DOI 10.1007/s11103-005-2880-0; Sawers RJH, 2004, PLANT PHYSIOL, V136, P2771, DOI 10.1104/pp.104.046417; Sawers RJH, 2002, PLANT PHYSIOL, V130, P155, DOI 10.1104/pp.006411; Schnell DJ, 1998, ANNU REV PLANT PHYS, V49, P97, DOI 10.1146/annurev.arplant.49.1.97; Schultes NP, 2000, PLANT J, V21, P317, DOI 10.1046/j.1365-313x.2000.00676.x; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Shi DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080107; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Sun XiaoQiu, 2011, Acta Agronomica Sinica, V37, P991, DOI 10.3724/SP.J.1006.2011.00991; TERAO T, 1985, PLANT CELL PHYSIOL, V26, P1361; Tian XQ, 2013, GENES GENOM, V35, P87, DOI 10.1007/s13258-013-0069-5; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Voelker R, 1995, MOL GEN GENET, V249, P507, DOI 10.1007/BF00290576; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Xing AQ, 2014, PLANT J, V79, P192, DOI 10.1111/tpj.12568; Xing C, 2008, BIOTECHNOLOGY B, V5, P10; Xu J, 2013, DNA RES, V20, P497, DOI 10.1093/dnares/dst026; Yoo SC, 2009, PLANT PHYSIOL, V150, P388, DOI 10.1104/pp.109.136648; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zhang FT, 2013, RICE, V6, DOI 10.1186/1939-8433-6-7; Zhang HT, 2006, PLANT MOL BIOL, V62, P325, DOI 10.1007/s11103-006-9024-z; Zhao Y, 2001, ACTA BOT SIN, V43, P877	59	16	19	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153962	10.1371/journal.pone.0153962	http://dx.doi.org/10.1371/journal.pone.0153962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100184	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500111
J	Bento-Torres, NVO; Rodrigues, AR; Cortes, MIT; Bonci, DMD; Ventura, DF; Silveira, LCD				Oliver Bento-Torres, Natali Valim; Rodrigues, Anderson Raiol; Tentes Cortes, Maria Izabel; de Oliveira Bonci, Daniela Maria; Ventura, Dora Fix; de Lima Silveira, Luiz Carlos			Psychophysical Evaluation of Congenital Colour Vision Deficiency: Discrimination between Protans and Deutans Using Mollon-Reffin's Ellipses and the Farnsworth-Munsell 100-Hue Test	PLOS ONE			English	Article							DESATURATED PANEL D-15; PARKINSONS-DISEASE; IMPAIRMENT; DEFECTS	We have used the Farnsworth-Munsell 100-hue (FM 100) test and Mollon-Reffin (MR) test to evaluate the colour vision of 93 subjects, 30.4 +/- 9.7 years old, who had red-green congenital colour vision deficiencies. All subjects lived in Belem (State of Para, Brazil) and were selected by the State of Para Traffic Department. Selection criteria comprised the absence of visual dysfunctions other than Daltonism and no history of systemic diseases that could impair the visual system performance. Results from colour vision deficient were compared with those from 127 normal trichromats, 29.3 +/- 10.3 years old. For the MR test, measurements were taken around five points of the CIE 1976 colour space, along 20 directions irradiating from each point, in order to determine with high-resolution the corresponding colour discrimination ellipses (MacAdam ellipses). Three parameters were used to compare results obtained from different subjects: diameter of circle with same ellipse area, ratio between ellipse's long and short axes, and ellipse long axis angle. For the FM 100 test, the parameters were: logarithm of the total number of mistakes and positions of mistakes in the FM diagram. Data were also simultaneously analysed in two or three dimensions as well as by using multidimensional cluster analysis. For the MR test, Mollon-Reffin Ellipse #3 (u' = 0.225, v' = 0.415) discriminated more efficiently than the other four ellipses between protans and deutans once it provided larger angular difference in the colour space between protan and deutan confusion lines. The MR test was more sensitive than the FM 100 test. It separated individuals by dysfunctional groups with greater precision, provided a more sophisticated quantitative analysis, and its use is appropriate for a more refined evaluation of different phenotypes of red-green colour vision deficiencies.	[Oliver Bento-Torres, Natali Valim; Rodrigues, Anderson Raiol; de Lima Silveira, Luiz Carlos] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Oliver Bento-Torres, Natali Valim] Fed Univ Para, Inst Ciencias Saude, BR-66059 Belem, Para, Brazil; [Rodrigues, Anderson Raiol; de Lima Silveira, Luiz Carlos] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [Tentes Cortes, Maria Izabel] Univ Fed Amapa, Programa Posgrad Ciencias Saude, Macapa, Amapa, Brazil; [de Oliveira Bonci, Daniela Maria; Ventura, Dora Fix] Univ Sao Paulo, Dept Psicol Expt, Inst Psicol, Sao Paulo, Brazil; [de Lima Silveira, Luiz Carlos] Univ Ceuma, Sao Luis, Maranhao, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Fundacao Universidade Federal do Amapa; Universidade de Sao Paulo; Universidade Ceuma	Silveira, LCD (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.; Silveira, LCD (corresponding author), Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil.; Silveira, LCD (corresponding author), Univ Ceuma, Sao Luis, Maranhao, Brazil.	luiz@ufpa.br	Rodrigues, Anderson Raiol/AAE-4365-2021; Ventura, Dora F/B-9071-2012; Bento-Torres, Natáli Valim Oliver/AAU-7248-2020; Silveira, Luiz Carlos/H-9647-2014	Rodrigues, Anderson Raiol/0000-0002-3115-7903; Ventura, Dora F/0000-0002-7616-4031; Bento-Torres, Natáli Valim Oliver/0000-0003-0978-211X; Silveira, Luiz Carlos/0000-0001-9414-1573	Financiadora de Estudos e Projetos: FINEP IBN-Net [1723]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico: CNPq-PRONEX [1079, 2268]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior: CAPES-PROCAD [0019/01-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: FAPESP [02/12733-8]; FINEP IBN-Net [1723]; CNPq-PRONEX [1079, 2268]; CNPq [471815/2004-7]; CAPES-PROCAD [0019/01-1]; FAPESP [02/12733-8]; CAPES; CNPq	Financiadora de Estudos e Projetos: FINEP IBN-Net(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico: CNPq-PRONEX(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior: CAPES-PROCAD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP IBN-Net(Financiadora de Inovacao e Pesquisa (Finep)); CNPq-PRONEX(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-PROCAD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding provided by Financiadora de Estudos e Projetos (http://www.finep.gov.br): FINEP IBN-Net #1723. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br): CNPq-PRONEX #1079 and #2268, CNPq #471815/2004-7. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br): CAPES-PROCAD #0019/01-1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br): FAPESP #02/12733-8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the following grants: FINEP IBN-Net #1723 (LCLS); CNPq-PRONEX #1079 and #2268 (LCLS); CNPq #471815/2004-7 (LCLS); CAPES-PROCAD #0019/01-1 (DFV); FAPESP #02/12733-8 (DFV). NVOBT, ARR, and DMOB received CAPES or CNPq fellowships for graduate students. DFV and LCLS are CNPq research fellows.	AYRES M., 2003, BIOESTAT3 0 APLICACO; Bailey JE, 2004, VISUAL NEUROSCI, V21, P431, DOI 10.1017/S0952523804213463; Bieber ML, 1998, VISION RES, V38, P3293, DOI 10.1016/S0042-6989(98)00067-4; BIRCH J, 1989, OPHTHAL PHYSL OPT, V9, P156, DOI 10.1111/j.1475-1313.1989.tb00836.x; Birch J., 2001, DIAGNOSIS DEFECTIVE; Brasil A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140169; Chibret J. B. P. L., 1887, REV GENERALE OPHTALM, P49; COLE B L, 1963, Br J Physiol Opt, V20, P113; Cole BL, 2006, CLIN EXP OPTOM, V89, P73, DOI 10.1111/j.1444-0938.2006.00015.x; Costa MF, 2007, AM J HUM GENET, V80, P1064, DOI 10.1086/518127; Dain Stephen J, 2004, Clin Exp Optom, V87, P276; Moura ALD, 2008, VISUAL NEUROSCI, V25, P463, DOI 10.1017/S0952523808080437; DEEB SS, 1992, AM J HUM GENET, V51, P687; Farnsworth D, 1943, J OPT SOC AM, V33, P568, DOI 10.1364/JOSA.33.000568; Farnsworth D, 1947, FARNSWORTH DICHOTOMO; Farnsworth D., 1957, FARNSWORTH MUNSELL 1; Feitosa-Santana C, 2010, OPHTHAL PHYSL OPT, V30, P717, DOI 10.1111/j.1475-1313.2010.00776.x; Ghose S, 2014, INT OPHTHALMOL, V34, P747, DOI 10.1007/s10792-013-9865-9; HARDY LH, 1954, J OPT SOC AM, V44, P509, DOI 10.1364/JOSA.44.000509; Ishihara S., 1997, SERIES PLATES DESIGN; Ishihara S., 1917, TESTS COLOR BLINDNES; Lagerlof O, 1991, COLOR VISION DEFICIE, P241; LAKOWSKI R, 1969, BRIT J IND MED, V26, P265; LAKOWSKI R, 1969, BRIT J IND MED, V26, P173; LANTHONY P, 1978, DOC OPHTHALMOL, V46, P185; LANTHONY P, 1994, J FR OPHTALMOL, V17, P15; Latshaw VV., 1957, AM MATH MON, V64, P685, DOI [10.2307/2309989, DOI 10.2307/2309989]; LINKSZ A, 1966, AM J OPHTHALMOL, V62, P27, DOI 10.1016/0002-9394(66)91673-4; MacAdam DL, 1942, J OPT SOC AM, V32, P247, DOI 10.1364/JOSA.32.000247; MOLLON JD, 1989, J PHYSL, V414, P5; Paramei GV, 2014, J OPT SOC AM A, V31, pA375, DOI 10.1364/JOSAA.31.00A375; Paramei GV, 2012, J OPT SOC AM A, V29, pA290, DOI 10.1364/JOSAA.29.00A290; RAND G, 1956, ARCH OPHTHALMOL-CHIC, V56, P736, DOI 10.1001/archopht.1956.00930040744013; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; Regan BC, 1998, VISION RES, V38, P3427, DOI 10.1016/S0042-6989(97)00402-1; Regan BC, 1993, COLOUR VISION DEFICI, P445; Regan JD., 2000, CAMBRIDGE COLOUR TES; Rodrigues AR, 2007, BRAZ J MED BIOL RES, V40, P415, DOI 10.1590/S0100-879X2007000300018; SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657; Shevell SK, 1998, VISION RES, V38, P3371, DOI 10.1016/S0042-6989(97)00434-3; Silva MF, 2005, BRAIN, V128, P2260, DOI 10.1093/brain/awh581; Silveira LCL, 2003, NORMAL DEFECTIVE COL, P407; Souza GS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01291; Stilling J, 1877, PRUFUNG FARBENSINNES, DOI 10.3931/e-rara-77368/PublicDomainMark; Ventura D. F., 2003, NORMAL DEFECTIVE COL, P395, DOI [10.1093/acprof:oso/9780198525301.003.0042, DOI 10.1093/ACPROF:OSO/9780198525301.003.0042]; VENTURA DF, 2003, NORMAL DEFECTIVE COL, P331	46	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152214	10.1371/journal.pone.0152214	http://dx.doi.org/10.1371/journal.pone.0152214			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101124	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500010
J	Shen, XJ; Yi, L; Jiang, XP; He, TT; Hu, XH; Yang, JC				Shen, Xianjun; Yi, Li; Jiang, Xingpeng; He, Tingting; Hu, Xiaohua; Yang, Jincai			Mining Temporal Protein Complex Based on the Dynamic PIN Weighted with Connected Affinity and Gene Co-Expression	PLOS ONE			English	Article							FUNCTIONAL MODULES; TIME-COURSE; PPI NETWORKS; CONSTRUCTION; ORGANIZATION; DATABASE; CYCLE	The identification of temporal protein complexes would make great contribution to our knowledge of the dynamic organization characteristics in protein interaction networks (PINs). Recent studies have focused on integrating gene expression data into static PIN to construct dynamic PIN which reveals the dynamic evolutionary procedure of protein interactions, but they fail in practice for recognizing the active time points of proteins with low or high expression levels. We construct a Time-Evolving PIN (TEPIN) with a novel method called Deviation Degree, which is designed to identify the active time points of proteins based on the deviation degree of their own expression values. Owing to the differences between protein interactions, moreover, we weight TEPIN with connected affinity and gene co-expression to quantify the degree of these interactions. To validate the efficiencies of our methods, ClusterONE, CAMSE and MCL algorithms are applied on the TEPIN, DPIN (a dynamic PIN constructed with state-of-the-art three-sigma method) and SPIN (the original static PIN) to detect temporal protein complexes. Each algorithm on our TEPIN outperforms that on other networks in terms of match degree, sensitivity, specificity, F-measure and function enrichment etc. In conclusion, our Deviation Degree method successfully eliminates the disadvantages which exist in the previous state-of-the-art dynamic PIN construction methods. Moreover, the biological nature of protein interactions can be well described in our weighted network. Weighted TEPIN is a useful approach for detecting temporal protein complexes and revealing the dynamic protein assembly process for cellular organization.	[Shen, Xianjun; Yi, Li; Jiang, Xingpeng; He, Tingting; Hu, Xiaohua; Yang, Jincai] Cent China Normal Univ, Sch Comp, Wuhan, Peoples R China; [Hu, Xiaohua] Drexel Univ, Coll Comp & Informat, Philadelphia, PA 19104 USA	Central China Normal University; Drexel University	Yang, JC (corresponding author), Cent China Normal Univ, Sch Comp, Wuhan, Peoples R China.	jcyang@mail.ccnu.edu.cn			National Natural Science Foundation of China [61532008]; International Cooperation Project of Hubei Province [2014BHE0017]; Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE [CCNU14A02008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project of Hubei Province; Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE	National Natural Science Foundation of China, No. 61532008, XH; International Cooperation Project of Hubei Province, No. 2014BHE0017, TH; Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE, No. CCNU14A02008, XS.; This research is supported by the National Natural Science Foundation of China (No. 61532008), the International Cooperation Project of Hubei Province (No. 2014BHE0017), and the Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE (No. CCNU14A02008).	Chen BL, 2014, BRIEF BIOINFORM, V15, P177, DOI 10.1093/bib/bbt039; Chen BL, 2013, IEEE T NANOBIOSCI, V12, P165, DOI 10.1109/TNB.2013.2264097; Chen BL, 2013, PROTEOMICS, V13, P269, DOI 10.1002/pmic.201200336; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Dongen SM, 2000, THESIS U UTRECHT NET; He TT, 2014, IEEE INT C BIOINF BI; Kim Y, 2014, BRIEF BIOINFORM, V15, P212, DOI 10.1093/bib/bbt028; Li M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-109; Li P, 2013, IEEE INT C BIOINFORM; Li X, 2007, IEEE COMP SOC BIOINF; Lin CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09386; Liu W, 2014, PROG BIOCHEM BIOPHYS, V41, P115, DOI 10.3724/SP.J.1206.2013.00055; Luo F, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S4; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Srihari S, 2015, FEBS LETT, V589, P2590, DOI 10.1016/j.febslet.2015.04.026; Srihari S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S16; Tang X, 2012, IEEE 6 INT C SYST BI; Tang XW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-339; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wang JX, 2014, PROTEOMICS, V14, P338, DOI 10.1002/pmic.201300257; Wang JX, 2013, PROTEOMICS, V13, P301, DOI 10.1002/pmic.201200277; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yong CH, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015710018; Zhang XF, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-186, 10.1186/1471-2105-15-335]	28	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153967	10.1371/journal.pone.0153967	http://dx.doi.org/10.1371/journal.pone.0153967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100396	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500113
J	Gilroy, KL; Terry, A; Naseer, A; de Ridder, J; Allahyar, A; Wang, WW; Carpenter, E; Mason, A; Wong, GKS; Cameron, ER; Kilbey, A; Neil, JC				Gilroy, Kathryn L.; Terry, Anne; Naseer, Asif; de Ridder, Jeroen; Allahyar, Amin; Wang, Weiwei; Carpenter, Eric; Mason, Andrew; Wong, Gane K-S; Cameron, Ewan R.; Kilbey, Anna; Neil, James C.			Gamma-Retrovirus Integration Marks Cell Type-Specific Cancer Genes: A Novel Profiling Tool in Cancer Genomics	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; INSERTIONAL MUTAGENESIS; REGULATORY ELEMENTS; SUPER-ENHANCERS; HIV-1 INTEGRASE; LEUKEMOGENESIS; IDENTIFICATION; DETERMINANTS; DISRUPTION; MUTATIONS	Retroviruses have been foundational in cancer research since early studies identified protooncogenes as targets for insertional mutagenesis. Integration of murine gamma-retroviruses into the host genome favours promoters and enhancers and entails interaction of viral integrase with host BET/bromodomain factors. We report that this integration pattern is conserved in feline leukaemia virus (FeLV), a gamma-retrovirus that infects many human cell types. Analysis of FeLV insertion sites in the MCF-7 mammary carcinoma cell line revealed strong bias towards active chromatin marks with no evidence of significant post-integration growth selection. The most prominent FeLV integration targets had little overlap with the most abundantly expressed transcripts, but were strongly enriched for annotated cancer genes. A meta-analysis based on several gamma-retrovirus integration profiling (GRIP) studies in human cells (CD34+, K562, HepG2) revealed a similar cancer gene bias but also remarkable cell-type specificity, with prominent exceptions including a universal integration hotspot at the long non-coding RNA MALAT1. Comparison of GRIP targets with databases of super-enhancers from the same cell lines showed that these have only limited overlap and that GRIP provides unique insights into the upstream drivers of cell growth. These observations elucidate the oncogenic potency of the gamma-retroviruses and support the wider application of GRIP to identify the genes and growth regulatory circuits that drive distinct cancer types.	[Gilroy, Kathryn L.; Terry, Anne; Naseer, Asif; Cameron, Ewan R.; Kilbey, Anna; Neil, James C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland; [de Ridder, Jeroen; Allahyar, Amin] Delft Univ Technol, Delft Bioinformat Lab, Fac EEMCS, Delft, Netherlands; [Wang, Weiwei; Carpenter, Eric; Wong, Gane K-S] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Mason, Andrew] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada; [Naseer, Asif] Khyber Med Univ, Phase 5, Peshawar, Kyber Pakhtunkh, Pakistan	University of Glasgow; Delft University of Technology; University of Alberta; University of Alberta; Khyber Medical University	Gilroy, KL; Neil, JC (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland.	Kathryn.Gilroy@glasgow.ac.uk; James.Neil@glasgow.ac.uk	WONG, Gane Ka-Shu/G-5784-2013	WONG, Gane Ka-Shu/0000-0001-6108-5560; Gilroy, Kathryn/0000-0003-4607-194X; Allahyar, Amin/0000-0003-2567-0273	Cancer Research UK [A11951]; Bloodwise [13046]; VENI from NWO (Netherlands Organisation for Scientific Research) [639.021.233]; Canadian Institutes for Health Research [MOP 97798]; Alberta Innovates Technology Futures (AITF); Innovates Centre of Research Excellence (iCORE); Cancer Research UK [11951] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Bloodwise; VENI from NWO (Netherlands Organisation for Scientific Research); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures (AITF); Innovates Centre of Research Excellence (iCORE); Cancer Research UK(Cancer Research UK)	KLG, AT, AN, AK, ERC and JCN were supported by a joint programme from Cancer Research UK and Bloodwise (grant numbers A11951 (CRUK) and 13046 (Bloodwise); URLs are http://www.cancerresearchuk.org/ and https://bloodwise.org.uk/). JdR was funded by a VENI grant (639.021.233) from NWO (Netherlands Organisation for Scientific Research, http://www.nwo.nl/). AM was funded by Canadian Institutes for Health Research (MOP 97798, http://www.cihr-irsc.gc.ca/). GK-SW was funded by Alberta Innovates Technology Futures (AITF, http://www.albertatechfutures.ca/) and Innovates Centre of Research Excellence (iCORE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyer S, 2014, NUCLEIC ACIDS RES, V42, P5917, DOI 10.1093/nar/gku175; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Davie K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004994; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Fan H, 1997, TRENDS MICROBIOL, V5, P74, DOI 10.1016/S0966-842X(96)10076-7; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gupta SS, 2013, J VIROL, V87, P12721, DOI 10.1128/JVI.01942-13; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hanlon L, 2003, J VIROL, V77, P1059, DOI 10.1128/JVI.77.2.1059-1068.2003; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Huser CA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004167; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; JARRETT O, 1969, NATURE, V224, P1208, DOI 10.1038/2241208a0; Khan A, 2016, NUCLEIC ACIDS RES, V44, pD164, DOI 10.1093/nar/gkv1002; Kool J, 2010, CANCER RES, V70, P520, DOI 10.1158/0008-5472.CAN-09-2736; LaFave MC, 2014, NUCLEIC ACIDS RES, V42, P4257, DOI 10.1093/nar/gkt1399; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Mattison J, 2010, CANCER RES, V70, P883, DOI 10.1158/0008-5472.CAN-09-1737; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Naseer A, 2015, VIRUSES-BASEL, V7, P2014, DOI 10.3390/v7042014; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Sorensen KD, 2007, VIROLOGY, V362, P179, DOI 10.1016/j.virol.2006.12.016; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sugai J, 2001, J VIROL, V75, P6841, DOI 10.1128/JVI.75.15.6841-6849.2001; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; TSATSANIS C, 1994, J VIROL, V68, P8296, DOI 10.1128/JVI.68.12.8296-8303.1994; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Wang W, 2015, ALIMENT PHARM THER, V41, P393, DOI 10.1111/apt.13054; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yoshimoto R, 2016, BBA-GENE REGUL MECH, V1859, P192, DOI 10.1016/j.bbagrm.2015.09.012; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao YJ, 2013, J MED CHEM, V56, P7498, DOI 10.1021/jm4014407; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	42	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154070	10.1371/journal.pone.0154070	http://dx.doi.org/10.1371/journal.pone.0154070			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097319	gold, Green Accepted, Green Published			2022-12-26	WOS:000374543600085
J	Elfers, K; Marr, I; Wilkens, MR; Breves, G; Langeheine, M; Brehm, R; Muscher-Banse, AS				Elfers, Kristin; Marr, Isabell; Wilkens, Mirja R.; Breves, Gerhard; Langeheine, Marion; Brehm, Ralph; Muscher-Banse, Alexandra S.			Expression of Tight Junction Proteins and Cadherin 17 in the Small Intestine of Young Goats Offered a Reduced N and/or Ca Diet	PLOS ONE			English	Article							CATION-SELECTIVE CHANNELS; CALCIUM-ABSORPTION; EPITHELIAL-CELLS; PHOSPHATE-TRANSPORT; ZONULA OCCLUDENS; GENE-EXPRESSION; RAT INTESTINE; ZO-1; BARRIER; PERMEABILITY	Diets fed to ruminants should contain nitrogen (N) as low as possible to reduce feed costs and environmental pollution. Though possessing effective N-recycling mechanisms to maintain the N supply for rumen microbial protein synthesis and hence protein supply for the host, an N reduction caused substantial changes in calcium (Ca) and phosphate homeostasis in young goats including decreased intestinal transepithelial Ca absorption as reported for monogastric species. In contrast to the transcellular component of transepithelial Ca transport, the paracellular route has not been investigated in young goats. Therefore, the aim of the present study was to characterise the effects of dietary N and/or Ca reduction on paracellular transport mechanisms in young goats. Electrophysiological properties of intestinal epithelia were investigated by Ussing chamber experiments. The expression of tight junction (TJ) and adherens junction (AJ) proteins in intestinal epithelia were examined on mRNA level by qPCR and on protein level by western blot analysis. Dietary N reduction led to a segment specific increase in tissue conductances in the proximal jejunum which might be linked to concomitantly decreased expression of cadherin 17 mRNA. Expression of occludin (OCLN) and zonula occludens protein 1 was increased in mid jejunal epithelia of N reduced fed goats on mRNA and partly on protein level. Reduced dietary Ca supply resulted in a segment specific increase in claudin 2 and claudin 12 expression and decreased the expression of OCLN which might have been mediated at least in part by calcitriol. These data show that dietary N as well as Ca reduction affected expression of TJ and AJ proteins in a segment specific manner in young goats and may thus be involved in modulation of paracellular Ca permeability.	[Elfers, Kristin; Marr, Isabell; Wilkens, Mirja R.; Breves, Gerhard; Muscher-Banse, Alexandra S.] Univ Vet Med Hannover, Dept Physiol, Bischofsholer Damm 15-102, D-30173 Hannover, Germany; [Langeheine, Marion; Brehm, Ralph] Univ Vet Med Hannover, Inst Anat, Bischofsholer Damm 15-122, D-30173 Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Muscher-Banse, AS (corresponding author), Univ Vet Med Hannover, Dept Physiol, Bischofsholer Damm 15-102, D-30173 Hannover, Germany.	alexandra.muscher@tiho-hannover.de	Muscher-Banse, Alexandra S/V-9687-2018; Breves, Gerhard/ABI-1315-2020	Muscher-Banse, Alexandra S/0000-0002-4149-7987; Wilkens, Mirja/0000-0003-1734-5024; Marr, Isabell/0000-0001-6272-0482	German Research Foundation (DFG) [Mu3585/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG, www.dfg.de/), grant number: Mu3585/1-1.	Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Angst BD, 2001, J CELL SCI, V114, P629; Auchere D, 1998, AM J PHYSIOL-GASTR L, V275, pG951, DOI 10.1152/ajpgi.1998.275.5.G951; Benn BS, 2008, ENDOCRINOLOGY, V149, P3196, DOI 10.1210/en.2007-1655; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Chirayath MV, 1998, AM J PHYSIOL-GASTR L, V274, pG389, DOI 10.1152/ajpgi.1998.274.2.G389; Christakos S, 2010, J STEROID BIOCHEM, V121, P183, DOI 10.1016/j.jsbmb.2010.03.005; Dubois-Ferriere V, 2011, ENDOCRINOLOGY, V152, P1839, DOI 10.1210/en.2010-1079; Elfers K, 2015, J STEROID BIOCH MOL; Elfers K, 2015, BRIT J NUTR, V114, P1949, DOI 10.1017/S000711451500375X; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gaffney-Stomberg E, 2010, ENDOCRINOLOGY, V151, P1071, DOI 10.1210/en.2009-0744; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hwang I, 2013, INT J MOL SCI, V14, P22997, DOI 10.3390/ijms141122997; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; KAMINSKY NI, 1970, J CLIN INVEST, V49, P2387, DOI 10.1172/JCI106458; Kerstetter JE, 1998, AM J CLIN NUTR, V68, P859, DOI 10.1093/ajcn/68.4.859; Ko JA, 2009, CELL BIOCHEM FUNCT, V27, P388, DOI 10.1002/cbf.1587; Kreft B, 1997, J CELL BIOL, V136, P1109, DOI 10.1083/jcb.136.5.1109; Kutuzova GD, 2004, ARCH BIOCHEM BIOPHYS, V432, P152, DOI 10.1016/j.abb.2004.09.004; Markov AG, 2010, J COMP PHYSIOL B, V180, P591, DOI 10.1007/s00360-009-0440-7; MORENO JH, 1975, J GEN PHYSIOL, V66, P97, DOI 10.1085/jgp.66.1.97; Muscher A, 2010, J STEROID BIOCHEM, V121, P304, DOI 10.1016/j.jsbmb.2010.03.084; Muscher AS, 2012, BRIT J NUTR, V108, P628, DOI 10.1017/S0007114511005976; ORWOLL E, 1992, AM J CLIN NUTR, V56, P314, DOI 10.1093/ajcn/56.2.314; Pacheco II, 2008, AM J PHYSIOL-GASTR L, V295, pG748, DOI 10.1152/ajpgi.00560.2007; RUIFROK PG, 1983, BIOCHEM PHARMACOL, V32, P637, DOI 10.1016/0006-2952(83)90487-2; SIMMONS NL, 1976, BIOCHIM BIOPHYS ACTA, V448, P426, DOI 10.1016/0005-2736(76)90298-4; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Todini L, 2007, ANIMAL, V1, P997, DOI 10.1017/S1751731107000262; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; Wilkens MR, 2012, COMP BIOCHEM PHYS A, V163, P396, DOI 10.1016/j.cbpa.2012.06.011; Wilkens MR, 2011, COMP BIOCHEM PHYS B, V158, P199, DOI 10.1016/j.cbpb.2010.11.008; Wilkens MR, 2009, VET J, V182, P294, DOI 10.1016/j.tvjl.2008.06.020; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154311	10.1371/journal.pone.0154311	http://dx.doi.org/10.1371/journal.pone.0154311			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120348	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200058
J	Matsusaka, K; Ishikawa, S; Nakayama, A; Ushiku, T; Nishimoto, A; Urabe, M; Kaneko, N; Kunita, A; Kaneda, A; Aburatani, H; Fujishiro, M; Seto, Y; Fukayama, M				Matsusaka, Keisuke; Ishikawa, Shumpei; Nakayama, Atsuhito; Ushiku, Tetsuo; Nishimoto, Aiko; Urabe, Masayuki; Kaneko, Nobuyuki; Kunita, Akiko; Kaneda, Atsushi; Aburatani, Hiroyuki; Fujishiro, Mitsuhiro; Seto, Yasuyuki; Fukayama, Masashi			Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens	PLOS ONE			English	Article							BREAST-CANCER; CLINICAL ONCOLOGY/COLLEGE; ADJUVANT CHEMOTHERAPY; FORMALIN FIXATION; AMERICAN SOCIETY; C-ERBB-2 PROTEIN; EXPRESSION; RECEPTOR; AMPLIFICATION; OVEREXPRESSION	Evaluating HER2 gene amplification is an essential component of therapeutic decision-making for advanced or metastatic gastric cancer. A simple method that is applicable to small, formalin-fixed, paraffin-embedded biopsy specimens is desirable as an adjunct to or as a substitute for currently used HER2 immunohistochemistry and in situ hybridization protocols. In this study, we developed a microfluidics-based digital PCR method for determining HER2 and chromosome 17 centromere (CEP17) copy numbers and estimating tumor content ratio (TCR). The HER2/CEP17 ratio is determined by three variables-TCR and absolute copy numbers of HER2 and CEP17-by examining tumor cells; only the ratio of the latter two can be obtained by digital PCR using the whole specimen without purifying tumor cells. TCR was determined by semi-automatic image analysis. We developed a Tumor Content chart, which is a plane of rectangular coordinates consisting of HER2/CEP17 digital PCR data and TCR that delineates amplified, non-amplified, and equivocal areas. By applying this method, 44 clinical gastric cancer biopsy samples were classified as amplified (n = 13), non-amplified (n = 25), or equivocal (n = 6). By comparison, 11 samples were positive, 11 were negative, and 22 were equivocally immunohistochemistry. Thus, our novel method reduced the number of equivocal samples from 22 to 6, thereby obviating the need for confirmation by fluorescence or dual-probe in situ hybridization to <30% of cases. Tumor content chart-assisted digital PCR analysis is also applicable to multiple sites in surgically resected tissues. These results indicate that this analysis is a useful alternative to HER2 immunohistochemistry in gastric cancers that can serve as a basis for the automated evaluation of HER2 status.	[Matsusaka, Keisuke; Kaneko, Nobuyuki; Fukayama, Masashi] Tokyo Univ Hosp, Div Diagnost Pathol, Tokyo 113, Japan; [Matsusaka, Keisuke; Urabe, Masayuki; Kaneda, Atsushi] Chiba Univ, Grad Sch Med, Dept Mol Oncol, Chiba, Japan; [Ishikawa, Shumpei; Nakayama, Atsuhito; Ushiku, Tetsuo; Nishimoto, Aiko; Urabe, Masayuki; Kunita, Akiko; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Ishikawa, Shumpei] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo, Japan; [Urabe, Masayuki; Seto, Yasuyuki] Tokyo Univ Hosp, Dept Gastrointestinal Surg, Tokyo 113, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Fujishiro, Mitsuhiro] Tokyo Univ Hosp, Dept Endoscopy & Endoscop Surg, Tokyo 113, Japan	University of Tokyo; Chiba University; University of Tokyo; Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; University of Tokyo	Fukayama, M (corresponding author), Tokyo Univ Hosp, Div Diagnost Pathol, Tokyo 113, Japan.; Fukayama, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan.	mfukayama-tky@unin.ac.jp	Urabe, Masayuki/AAO-1582-2021; 藤城, 光弘/AAN-3131-2020	Nakayama, Atsuhito/0000-0002-9832-9415; Urabe, Masayuki/0000-0002-5558-4184	Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for medical research and development; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [26253021] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for medical research and development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was conducted as a part of the BioBank Japan Project (http://www.src.riken.jp/english/project/person/) that was supported by Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/), Japan Agency for medical research and development (http://www.amed.go.jp/en/), and Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber DA, 2002, APPL IMMUNOHISTO M M, V10, P183, DOI 10.1097/00022744-200206000-00015; Bang YJ, 2010, LANCET, V376, P1302; COOMBS LM, 1991, BRIT J CANCER, V63, P601, DOI 10.1038/bjc.1991.139; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; FALCK VG, 1989, J PATHOL, V159, P107, DOI 10.1002/path.1711590204; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Hanley KZ, 2009, CANCER CYTOPATHOL, V117, P279, DOI 10.1002/cncy.20034; Ibarra JA, 2010, AM J CLIN PATHOL, V134, P594, DOI 10.1309/AJCPAIJPSN4A9MJI; Jacquemier J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-351; Khoury T, 2009, MODERN PATHOL, V22, P1457, DOI 10.1038/modpathol.2009.117; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Koeppen HKW, 2001, HISTOPATHOLOGY, V38, P96, DOI 10.1046/j.1365-2559.2001.01084.x; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; MCCULLOCH PG, 1995, CANCER, V75, P920, DOI 10.1002/1097-0142(19950215)75:4<920::AID-CNCR2820750405>3.0.CO;2-E; Middleton LP, 2009, ARCH PATHOL LAB MED, V133, P775, DOI 10.1043/1543-2165-133.5.775; MOTOJIMA K, 1994, SURGERY, V115, P349; Nakajima M, 1999, CANCER, V85, P1894; Ota S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039954; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; TATEISHI M, 1992, J SURG ONCOL, V49, P209, DOI 10.1002/jso.2930490402; Tong LC, 2011, AM J SURG PATHOL, V35, P545, DOI 10.1097/PAS.0b013e31820e6237; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; UCHINO S, 1993, CANCER, V72, P3179, DOI 10.1002/1097-0142(19931201)72:11<3179::AID-CNCR2820721108>3.0.CO;2-#; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ye P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143207; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622	34	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154430	10.1371/journal.pone.0154430	http://dx.doi.org/10.1371/journal.pone.0154430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119558	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200073
J	Queen, AE; Moerdyk-Schauwecker, M; McKee, LM; Leamy, LJ; Huet, YM				Queen, Ashleigh Everhardt; Moerdyk-Schauwecker, Megan; McKee, Leslie M.; Leamy, Larry J.; Huet, Yvette M.			Differential Expression of Inflammatory Cytokines and Stress Genes in Male and Female Mice in Response to a Lipopolysaccharide Challenge	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; MESSENGER-RNA; MORTALITY; GENDER; MACROPHAGES; INFECTION; LUNG	Background Sex plays a key role in an individual's immune response against pathogenic challenges such that females fare better when infected with certain pathogens. It is thought that sex hormones impact gene expression in immune cells and lead to sexually dimorphic responses to pathogens. We predicted that, in the presence of E. coli gram-negative lipopolysaccharide (LPS), there would be a sexually dimorphic response in proinflammatory cytokine production and acute phase stress gene expression and that these responses might vary among different mouse strains and times in a pattern opposite to that of body temperature associated with LPS-induced shock. Materials and Methods Interleukin-6 (IL-6), macrophage inflammatory protein-I beta (MIP-1 beta), tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) as well as beta-fibrinogen (Fgb) and metallothionein-1 (Mt-1) mRNA expression were measured at four time points (0, 2, 4 and 7 hours) after injection of E. coli LPS in mice from three inbred strains. Results Statistical analysis using analyses of variance (ANOVAs) showed that the levels of the all six traits changed over time, generally peaking at 2 hours after LPS injection. Mt-1, Fgb, and IL-6 showed differences among strains, although these were time-specific. Sexual dimorphism was seen for Fgb and IL6, and was most pronounced at the latest time period (7 hours) where male levels exceeded those for females. Trends for all six cytokine/gene expression traits were negatively correlated with those for body temperatures. Discussion The higher levels of expression of Fgb and IL6 in males compared with females are consistent with the greater vulnerability of males to infection and subsequent inflammation. Temperature appears to be a useful proxy for mortality in endotoxic shock, but sexual dimorphism in cytokine and stress gene expression levels may persist after an LPS challenge even if temperatures in the two sexes are similar and have begun to stabilize.	[Queen, Ashleigh Everhardt] Dept Kinesiol, Williamsburg, VA USA; [Moerdyk-Schauwecker, Megan] Univ Oregon, Dept Biol, Eugene, OR 97403 USA; [McKee, Leslie M.; Huet, Yvette M.] Univ N Carolina, Dept Kinesiol, Charlotte, NC 28223 USA; [Leamy, Larry J.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	University of Oregon; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Huet, YM (corresponding author), Univ N Carolina, Dept Kinesiol, Charlotte, NC 28223 USA.	ymhuet@uncc.edu	Huet, Yvette/J-4901-2013	Huet, Yvette/0000-0002-8783-8679				BAUSS F, 1987, INFECT IMMUN, V55, P1622, DOI 10.1128/IAI.55.7.1622-1625.1987; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Arroyo IC, 2011, CURR TOP MED CHEM, V11, P1661; De Maio A, 1998, SHOCK, V10, P319; DE SK, 1990, J BIOL CHEM, V265, P15267; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Garcia-Gomez E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/928290; Ghoshal K, 2001, MOL CELL BIOL, V21, P8301, DOI 10.1128/MCB.21.24.8301-8317.2001; Imahara SD, 2005, SURGERY, V138, P275, DOI 10.1016/j.surg.2005.03.020; Kanekiyo M, 2002, BIOCHEM J, V361, P363, DOI 10.1042/0264-6021:3610363; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Lin JY, 1996, INT IMMUNOL, V8, P499, DOI 10.1093/intimm/8.4.499; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; McClelland EE, 2011, ARCH IMMUNOL THER EX, V59, P203, DOI 10.1007/s00005-011-0124-3; MCGOWAN JE, 1975, J INFECT DIS, V132, P316, DOI 10.1093/infdis/132.3.316; Merkel SM, 2001, INFECT IMMUN, V69, P6119, DOI 10.1128/IAI.69.10.6119-6122.2001; Miller L, 1998, J IMMUNOL, V160, P5098; Moxley G, 2002, ARTHRITIS RHEUM, V46, P250, DOI 10.1002/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T; Naor R, 2009, BRAIN BEHAV IMMUN, V23, P611, DOI 10.1016/j.bbi.2008.10.001; Oliver JD, 2013, MICROB ECOL, V65, P793, DOI 10.1007/s00248-012-0140-9; Pillet S, 2005, TOXICOLOGY, V209, P289, DOI 10.1016/j.tox.2004.12.007; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Sokal RR, 1995, BIOMETRY; Steuerwald N, 2000, MOL HUM REPROD, V6, P448, DOI 10.1093/molehr/6.5.448; ULICH TR, 1989, AM J PATHOL, V134, P11; Vlach KD, 2000, COMPARATIVE MED, V50, P160; Wichmann MW, 2000, INTENS CARE MED, V26, P167, DOI 10.1007/s001340050041; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368	30	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152289	10.1371/journal.pone.0152289	http://dx.doi.org/10.1371/journal.pone.0152289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120355	Green Submitted, gold, Green Published			2022-12-26	WOS:000374976200008
J	Teng, H; Chen, L; Huang, Q; Wang, JL; Lin, QY; Liu, MX; Lee, WY; Song, HB				Teng, Hui; Chen, Lei; Huang, Qun; Wang, Jinli; Lin, Qiyang; Liu, Mingxin; Lee, Won Young; Song, Hongbo			Ultrasonic-Assisted Extraction of Raspberry Seed Oil and Evaluation of Its Physicochemical Properties, Fatty Acid Compositions and Antioxidant Activities	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; GAMMA-LINOLENIC ACID; VITAMIN-E; ANTHOCYANINS; OPTIMIZATION; PHENOLICS; BERRIES; SOXHLET; WINE	Ultrasonic-assisted extraction was employed for highly efficient separation of aroma oil from raspberry seeds. A central composite design with two variables and five levels was employed and effects of process variables of sonication time and extraction temperature on oil recovery and quality were investigated. Optimal conditions predicted by response surface methodology were sonication time of 37 min and extraction temperature of 54 degrees C. Specifically, ultrasonic-assisted extraction (UAE) was able to provide a higher content of beneficial unsaturated fatty acids, whereas conventional Soxhlet extraction (SE) resulted in a higher amount of saturated fatty acids. Moreover, raspberry seed oil contained abundant amounts of edible linoleic acid and linolenic acid, which suggest raspberry seeds could be valuable edible sources of natural.-linolenic acid products. In comparison with SE, UAE exerted higher free radical scavenging capacities. In addition, UAE significantly blocked H2O2-induced intracellular reactive oxygen species (ROS) generation.	[Teng, Hui; Chen, Lei; Huang, Qun; Wang, Jinli; Lin, Qiyang; Liu, Mingxin; Song, Hongbo] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Peoples R China; [Lee, Won Young] Kyungpook Natl Univ, Food & Bioind Res Inst, Taegu 702701, South Korea; [Lee, Won Young] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, 1370 Sankyunk Dong, Taegu 702701, South Korea	Fujian Agriculture & Forestry University; Kyungpook National University; Kyungpook National University	Chen, L; Song, HB (corresponding author), Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Peoples R China.; Lee, WY (corresponding author), Kyungpook Natl Univ, Food & Bioind Res Inst, Taegu 702701, South Korea.; Lee, WY (corresponding author), Kyungpook Natl Univ, Sch Food Sci & Biotechnol, 1370 Sankyunk Dong, Taegu 702701, South Korea.	chenlei841114@hotmail.com; wonyoung@knu.ac.kr; sghgbode@163.com	Chen, Lei/Y-3308-2019; Lee, Wonyoung/AAL-2780-2021	Lee, Wonyoung/0000-0001-5850-9692; /0000-0003-1930-586X	Construction Project of Top University at Fujian Agriculture and Forestry University of China [612014042]	Construction Project of Top University at Fujian Agriculture and Forestry University of China	This research was supported by the Construction Project of Top University at Fujian Agriculture and Forestry University of China (Grant No. 612014042).	[Anonymous], 1983, J SYST EVOL; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bushman BS, 2004, J AGR FOOD CHEM, V52, P7982, DOI 10.1021/jf049149a; Carnat A, 1978, ANTIOXYDANT ACTIVITY, P119; Celli GB, 2015, ULTRASON SONOCHEM, V27, P449, DOI 10.1016/j.ultsonch.2015.06.014; d'Alessandro LG, 2012, SEP PURIF TECHNOL, V93, P42, DOI 10.1016/j.seppur.2012.03.024; Daubeny H.A., 1996, FRUIT BREEDING, V2; de Castro MDL, 1998, ANAL CHIM ACTA, V369, P1; Hall H, 2009, PLANT BREEDING REV, V32, P353; Intl A, 1995, OFFICIAL METHODS ANA; Jeong JH, 2010, FOOD CHEM, V123, P338, DOI 10.1016/j.foodchem.2010.04.040; Johansson A, 1997, Z LEBENSM UNTERS F A, V204, P300, DOI 10.1007/s002170050081; Kapoor R, 2006, CURR PHARM BIOTECHNO, V7, P531, DOI 10.2174/138920106779116874; Kaufmann B, 2002, PHYTOCHEM ANALYSIS, V13, P105, DOI 10.1002/pca.631; Ku CS, 2008, BIORESOURCE TECHNOL, V99, P2852, DOI 10.1016/j.biortech.2007.06.005; Nohynek LJ, 2006, NUTR CANCER, V54, P18, DOI 10.1207/s15327914nc5401_4; Oh HH, 2007, J AM OIL CHEM SOC, V84, P549, DOI 10.1007/s11746-007-1065-1; Oomah BD, 2000, FOOD CHEM, V69, P187, DOI 10.1016/S0308-8146(99)00260-5; Orak HH, 2007, SCI HORTIC-AMSTERDAM, V111, P235, DOI 10.1016/j.scienta.2006.10.019; Parry J, 2005, J AGR FOOD CHEM, V53, P566, DOI 10.1021/jf048615t; Parry J, 2004, J FOOD SCI, V69, pC189; Peres VF, 2006, J CHROMATOGR A, V1105, P115, DOI 10.1016/j.chroma.2005.07.113; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Stanisavljevic IT, 2007, ULTRASON SONOCHEM, V14, P646, DOI 10.1016/j.ultsonch.2006.10.003; TATE G, 1989, J RHEUMATOL, V16, P729; Teng H, 2014, FOOD ANAL METHOD, P1; Vinatoru M, 2001, ULTRASON SONOCHEM, V8, P303, DOI 10.1016/S1350-4177(01)00071-2; Zigoneanu IG, 2008, BIORESOURCE TECHNOL, V99, P4910, DOI 10.1016/j.biortech.2007.09.067	29	28	31	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153457	10.1371/journal.pone.0153457	http://dx.doi.org/10.1371/journal.pone.0153457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120053	Green Submitted, Green Published, gold			2022-12-26	WOS:000374976200026
J	Audirac-Chalifour, A; Torres-Poveda, K; Bahena-Roman, M; Tellez-Sosa, J; Martinez-Barnetche, J; Cortina-Ceballos, B; Lopez-Estrada, G; Delgado-Romero, K; Burguete-Garcia, AI; Cantu, D; Garcia-Carranca, A; Madrid-Marina, V				Audirac-Chalifour, Astride; Torres-Poveda, Kirvis; Bahena-Roman, Margarita; Tellez-Sosa, Juan; Martinez-Barnetche, Jesus; Cortina-Ceballos, Bernardo; Lopez-Estrada, Guillermina; Delgado-Romero, Karina; Burguete-Garcia, Ana I.; Cantu, David; Garcia-Carranca, Alejandro; Madrid-Marina, Vicente			Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; HUMAN-PAPILLOMAVIRUS INFECTION; FUSOBACTERIUM-NUCLEATUM; BACTERIAL VAGINOSIS; E-CADHERIN; IFN-GAMMA; VAGINAL MICROBIOME; POOLED ANALYSIS; BETA-CATENIN; IL-10 GENE	Cervical cancer (CC) is caused by high-risk human papillomavirus persistence due to the immunosuppressive tumor microenvironment mediated by cytokines. Vaginal microbiota determines the presence of certain cytokines locally. We assessed the association between cervical microbiota diversity and the histopathological diagnosis of each stage of CC, and we evaluated mRNA cervical expression levels of IL-4, IL-6, IL-10, TGF-beta 1, TNF-alpha and IFN-gamma across the histopathological diagnosis and specific bacterial clusters. We determined the cervical microbiota by high throughput sequencing of 16S rDNA amplicons and classified it in community state types (CST). Mean difference analyses between alpha-diversity and histopathological diagnosis were carried out, as well as a beta-diversity analysis within the histological diagnosis. Cervical cytokine mRNA expression was analyzed across the CSTs and the histopathological diagnoses. We found a significant difference in microbiota's diversity in NCLHPV negative women vs those with squamous intraepithelial lesions (SIL) and CC(p = 0.006, p = 0.036). When beta-diversity was evaluated, the CC samples showed the highest variation within groups (p<0.0006) and the largest distance compared to NCL-HPV negative ones (p<0.00001). The predominant bacteria in women with normal cytology were L. crispatus and L. iners, whereas for SIL, it was Sneathia spp. and for CC, Fusobacterium spp. We found higher median cervical levels of IL-4 and TGF-beta 1 mRNA in the CST dominated by Fusobacterium spp. These results suggest that the cervical microbiotamay be implicated in cervical cancer pathology. Further cohort studies are needed to validate these findings.	[Audirac-Chalifour, Astride; Torres-Poveda, Kirvis; Bahena-Roman, Margarita; Tellez-Sosa, Juan; Martinez-Barnetche, Jesus; Cortina-Ceballos, Bernardo; Burguete-Garcia, Ana I.; Madrid-Marina, Vicente] Natl Publ Hlth Inst, Chron Infect Dis & Canc Div, Ctr Res Infect Dis, Cuernavaca, Morelos, Mexico; [Lopez-Estrada, Guillermina] Private Hlth Ctr Gynecol, Cuernavaca, Morelos, Mexico; [Delgado-Romero, Karina] Hlth Serv State Morelos, Ctr Womens Hlth, Ctr Atenc Salud Mujer CAPASAM, Cuernavaca, Morelos, Mexico; [Cantu, David] Inst Nacl Cancerol INCan, Div Clin Res, SS, Mexico City, DF, Mexico; [Garcia-Carranca, Alejandro] Inst Nacl Cancerol INCan, Basic Res Div, SS, Mexico City, DF, Mexico; [Torres-Poveda, Kirvis] Consejo Nacl Ciencia & Tecnol Mexico CONACyT, Mexico City, DF, Mexico; [Garcia-Carranca, Alejandro] Univ Nacl Autonoma Mexico, Unit Biomed Res Canc, Inst Nacl Cancerol INCan, SS, Mexico City 04510, DF, Mexico; [Garcia-Carranca, Alejandro] Univ Nacl Autonoma Mexico, Biomed Res Inst, Mexico City 04510, DF, Mexico	Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Madrid-Marina, V (corresponding author), Natl Publ Hlth Inst, Chron Infect Dis & Canc Div, Ctr Res Infect Dis, Cuernavaca, Morelos, Mexico.	vmarina@insp.mx	; Cantu-de Leon, David/P-7930-2017	Cortina-Ceballos, Bernardo/0000-0003-0227-8885; TORRES-POVEDA, KIRVIS/0000-0001-9608-9617; Martinez-Barnetche, Jesus/0000-0002-5228-3554; Cantu-de Leon, David/0000-0002-0229-7931				Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Alcocer-Gonzalez JM, 2006, VIRAL IMMUNOL, V19, P481, DOI 10.1089/vim.2006.19.481; Almonte M, 2008, VACCINE, V26, pL16, DOI 10.1016/j.vaccine.2008.06.008; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Caixeta RCA, 2015, DIAGN CYTOPATHOL, V43, P780, DOI 10.1002/dc.23301; Auvinen E, 2013, NEOPLASMA, V60, P56, DOI 10.4149/neo_2013_008; Behbakht Kian, 2002, Infect Dis Obstet Gynecol, V10, P181, DOI 10.1155/S1064744902000200; Bermudez-Morales VH, 2011, MOL MED REP, V4, P369, DOI 10.3892/mmr.2011.429; Bermudez-Morales VH, 2008, CANCER INVEST, V26, P1037, DOI 10.1080/07357900802112693; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Branca M, 2006, EUR J GYNAECOL ONCOL, V27, P215; Burns MB, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0177-8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chase D, 2015, GYNECOL ONCOL, V138, P190, DOI 10.1016/j.ygyno.2015.04.036; Chen ZF, 2012, EUR J GYNAECOL ONCOL, V33, P502; Clarke MA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-33; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dols JAM, 2012, DIAGN CYTOPATHOL, V40, P472, DOI 10.1002/dc.21786; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El-Sherif AM, 2001, J PATHOL, V195, P179, DOI 10.1002/path.929; Feng QH, 2012, GYNECOL ONCOL, V127, P412, DOI 10.1016/j.ygyno.2012.07.098; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gao WJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-271; Giannini SL, 1998, CLIN EXP IMMUNOL, V113, P183; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; Girke T, 2013, R LANG ENV STAT COMP; Gosmann C, 2014, J INVEST DERMATOL, V134, P2562, DOI 10.1038/jid.2014.201; GUIJON F, 1992, INT J GYNECOL OBSTET, V37, P185, DOI 10.1016/0020-7292(92)90379-W; Guo YI, 2012, INT J STD AIDS, V23, P581, DOI 10.1258/ijsa.2012.011342; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Harwich MD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S4; Hu T, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0254-8; Huang YE, 2015, MICROB ECOL, V69, P407, DOI 10.1007/s00248-014-0487-1; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; INEGI, 2012, EST MORT CUB DIN CON; Insinga RP, 2011, CANCER EPIDEM BIOMAR, V20, P287, DOI 10.1158/1055-9965.EPI-10-0791; ITO Y, 1980, CANCER RES, V40, P4329; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lee D-H, 2015, ANN CLIN BIOCH INT J; Lee JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063514; Lehtinen M, 2011, SEX TRANSM INFECT, V87, P372, DOI 10.1136/sti.2010.044354; Linhares I. M., 2011, AM J OBSTET GYNECOL, V120, P1, DOI [10.1016/j.ajog.2010.07.010, DOI 10.1016/J.AJOG.2010.07.010, DOI 10.1016/J.AJ0G.2010.07.010]; Louie KS, 2011, CANCER EPIDEM BIOMAR, V20, P1379, DOI 10.1158/1055-9965.EPI-11-0284; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marangon AV, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/146079; Prata TTM, 2015, IMMUNOLOGY, V146, P113, DOI 10.1111/imm.12487; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nawrot R, 2010, EUR J GYNAECOL ONCOL, V31, P425; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Oh H Y, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.02.026; Ohnmacht C, 2015, SCIENCE; Peralta-Zaragoza O, 2006, VIRAL IMMUNOL, V19, P468, DOI 10.1089/vim.2006.19.468; Punt S, 2015, CANCER IMMUNOL IMMUN, V64, P745, DOI 10.1007/s00262-015-1678-4; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rodriguez-Sastre MA, 2005, GYNECOL ONCOL, V97, P330, DOI 10.1016/j.ygyno.2004.12.062; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shah NB, 2010, J INFECTION, V60, P491, DOI 10.1016/j.jinf.2010.02.008; Sheu BC, 2001, J IMMUNOL, V167, P2972, DOI 10.4049/jimmunol.167.5.2972; Shew ML, 2013, J INFECT DIS, V208, P1416, DOI 10.1093/infdis/jit346; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Shondel SM, 2007, INT J GYNECOL CANCER, V17, P1278, DOI 10.1111/j.1525-1438.2007.00705.x; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865; Torres-Poveda K, 2015, BMC CANC UNPUB; Torres-Poveda K, 2014, WORLD J CLIN ONCOL, V5, P753, DOI 10.5306/wjco.v5.i4.753; Torres-Poveda K, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-32; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P2148, DOI 10.1158/1055-9965.EPI-06-0556; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Velsko IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129795; Vriend HJ, 2015, CANCER MED; Yang W, 2013, IMMUNOLOGY, V139, P513, DOI 10.1111/imm.12101; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524, DOI 10.1111/j.1349-7006.1991.tb01882.x; Zhang X, 2014, BJOG-INT J OBSTET GY, V121, P664, DOI 10.1111/1471-0528.12638	86	153	177	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153274	10.1371/journal.pone.0153274	http://dx.doi.org/10.1371/journal.pone.0153274			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115350	Green Submitted, gold, Green Published			2022-12-26	WOS:000374973600019
J	Gallien, L; Thuiller, W; Fort, N; Boleda, M; Alberto, FJ; Rioux, D; Laine, J; Lavergne, S				Gallien, Laure; Thuiller, Wilfried; Fort, Noemie; Boleda, Marti; Alberto, Florian J.; Rioux, Delphine; Laine, Juliette; Lavergne, Sebastien			Is There Any Evidence for Rapid, Genetically-Based, Climatic Niche Expansion in the Invasive Common Ragweed?	PLOS ONE			English	Article							DRY-MATTER CONTENT; AMBROSIA-ARTEMISIIFOLIA; GENE FLOW; EVOLUTION; ADAPTATION; MODELS; DIFFERENTIATION; POPULATIONS; HISTORY; NEUTRALITY	Climatic niche shifts have been documented in a number of invasive species by comparing the native and adventive climatic ranges in which they occur. However, these shifts likely represent changes in the realized climatic niches of invasive species, and may not necessarily be driven by genetic changes in climatic affinities. Until now the role of rapid niche evolution in the spread of invasive species remains a challenging issue with conflicting results. Here, we document a likely genetically-based climatic niche expansion of an annual plant invader, the common ragweed (Ambrosia artemisiifolia L.), a highly allergenic invasive species causing substantial public health issues. To do so, we looked for recent evolutionary change at the upward migration front of its adventive range in the French Alps. Based on species climatic niche models estimated at both global and regional scales we stratified our sampling design to adequately capture the species niche, and localized populations suspected of niche expansion. Using a combination of species niche modeling, landscape genetics models and common garden measurements, we then related the species genetic structure and its phenotypic architecture across the climatic niche. Our results strongly suggest that the common ragweed is rapidly adapting to local climatic conditions at its invasion front and that it currently expands its niche toward colder and formerly unsuitable climates in the French Alps (i.e. in sites where niche models would not predict its occurrence). Such results, showing that species climatic niches can evolve on very short time scales, have important implications for predictive models of biological invasions that do not account for evolutionary processes.	[Gallien, Laure; Thuiller, Wilfried; Boleda, Marti; Alberto, Florian J.; Rioux, Delphine; Laine, Juliette; Lavergne, Sebastien] Univ Grenoble Alpes, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Gallien, Laure; Thuiller, Wilfried; Boleda, Marti; Alberto, Florian J.; Rioux, Delphine; Laine, Juliette; Lavergne, Sebastien] CNRS, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Fort, Noemie] Conservatoire Bot Natl Alpin, F-05000 Domaine De Charance, Gap, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Gallien, L (corresponding author), Univ Grenoble Alpes, Lab Ecol Alpine LECA, F-38000 Grenoble, France.; Gallien, L (corresponding author), CNRS, Lab Ecol Alpine LECA, F-38000 Grenoble, France.	laure.gallien@gmail.com	Thuiller, Wilfried/G-3283-2010; Gallien, Laure/G-8384-2014	Thuiller, Wilfried/0000-0002-5388-5274; Gallien, Laure/0000-0003-4882-1580	French Agence Nationale de la Recherche [ANR-09-PEXT-011]; European Research Council under the European Community [281422]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council under the European Community(European Research Council (ERC))	LG, SL and MB received support from the French Agence Nationale de la Recherche with the project EVORANGE (ANR-09-PEXT-011). The research leading to these results received funding from the European Research Council under the European Community's Seven Framework Programme FP7/2007-2013 grant agreement no. 281422 (TEEMBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CH, 2010, ECOGRAPHY, V33, P1028, DOI 10.1111/j.1600-0587.2010.06421.x; Alexander JM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1446; Alexander JM, 2010, OIKOS, V119, P1377, DOI 10.1111/j.1600-0706.2009.17977.x; Barton NH, 2004, EVOLUTION, V58, P2111; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Calsbeek B, 2009, EVOLUTION, V63, P2627, DOI 10.1111/j.1558-5646.2009.00735.x; Chauvel B, 2006, J BIOGEOGR, V33, P665, DOI 10.1111/j.1365-2699.2005.01401.x; Cheverud JM, 1996, J EVOLUTION BIOL, V9, P5, DOI 10.1046/j.1420-9101.1996.9010005.x; Chun YJ, 2011, MOL ECOL, V20, P1378, DOI 10.1111/j.1365-294X.2011.05013.x; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; de Villemereuil P, 2014, MOL ECOL, V23, P2006, DOI 10.1111/mec.12705; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Friedman J, 2008, ANN BOT-LONDON, V101, P1303, DOI 10.1093/aob/mcn039; Fumanal B, 2007, ANN BOT-LONDON, V100, P305, DOI 10.1093/aob/mcm108; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Gallien L, 2010, DIVERS DISTRIB, V16, P331, DOI 10.1111/j.1472-4642.2010.00652.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI 10.2307/2410956; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Gladieux P, 2011, BIOL INVASIONS, V13, P933, DOI 10.1007/s10530-010-9880-y; Goncalves E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111468; Goudet J, 2006, GENETICS, V172, P1337, DOI 10.1534/genetics.105.050583; Goudet J, 2007, GENETICS, V176, P1371, DOI 10.1534/genetics.106.067173; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MP, 2013, GLOBAL ECOL BIOGEOGR, V22, P942, DOI 10.1111/geb.12059; Hodgins KA, 2011, J EVOLUTION BIOL, V24, P2731, DOI 10.1111/j.1420-9101.2011.02404.x; Hodgins KA, 2013, MOL ECOL, V22, P2496, DOI 10.1111/mec.12179; Hodgson JG, 2011, ANN BOT-LONDON, V108, P1337, DOI 10.1093/aob/mcr225; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Holt RD, 2005, OIKOS, V108, P3, DOI 10.1111/j.0030-1299.2005.13145.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kirkpatrick M, 2009, GENETICA, V136, P271, DOI 10.1007/s10709-008-9302-6; Lankau RA, 2009, P NATL ACAD SCI USA, V106, P15362, DOI 10.1073/pnas.0905446106; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Li XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029350, 10.1371/journal.pone.0051199]; Luo WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071749; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martin G, 2008, GENETICS, V180, P2135, DOI 10.1534/genetics.107.080820; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Pritchard JK, 2000, GENETICS, V155, P945; Reich PB, 2014, P NATL ACAD SCI USA, V111, P13721, DOI 10.1073/pnas.1216053111; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323	55	13	14	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0152867	10.1371/journal.pone.0152867	http://dx.doi.org/10.1371/journal.pone.0152867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116455	gold, Green Published			2022-12-26	WOS:000374973600016
J	Hug, F; Hodges, PW; Carroll, TJ; De Martino, E; Magnard, J; Tucker, K				Hug, Francois; Hodges, Paul W.; Carroll, Timothy J.; De Martino, Enrico; Magnard, Justine; Tucker, Kylie			Motor Adaptations to Pain during a Bilateral Plantarflexion Task: Does the Cost of Using the Non-Painful Limb Matter?	PLOS ONE			English	Article							COORDINATION	During a force-matched bilateral task, when pain is induced in one limb, a shift of load to the non-painful leg is classically observed. This study aimed to test the hypothesis that this adaptation to pain depends on the mechanical efficiency of the non-painful leg. We studied a bilateral plantarflexion task that allowed flexibility in the relative force produced with each leg, but constrained the sum of forces from both legs to match a target. We manipulated the mechanical efficiency of the non-painful leg by imposing scaling factors: 1, 0.75, or 0.25 to decrease mechanical efficiency (Decreased efficiency experiment: 18 participants); and 1, 1.33 or 4 to increase mechanical efficiency (Increased efficiency experiment: 17 participants). Participants performed multiple sets of three submaximal bilateral isometric plantar-flexions with each scaling factor during two conditions (Baseline and Pain). Pain was induced by injection of hypertonic saline into the soleus. Force was equally distributed between legs during the Baseline contractions (laterality index was close to 1; Decreased efficiency experiment: 1.16+/-0.33; Increased efficiency experiment: 1.11+/-0.32), with no significant effect of Scaling factor. The laterality index was affected by Pain such that the painful leg contributed less than the non-painful leg to the total force (Decreased efficiency experiment: 0.90+/-0.41, P< 0.001; Increased efficiency experiment: 0.75+/-0.32, P< 0.001), regardless of the efficiency (scaling factor) of the non-painful leg. When compared to the force produced during Baseline of the corresponding scaling condition, a decrease in force produced by the painful leg was observed for all conditions, except for scaling 0.25. This decrease in force was correlated with a decrease in drive to the soleus muscle. These data highlight that regardless of the overall mechanical cost, the nervous system appears to prefer to alter force sharing between limbs such that force produced by the painful leg is reduced relative to the non-painful leg.	[Hug, Francois; Hodges, Paul W.; De Martino, Enrico; Tucker, Kylie] Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Hug, Francois; Magnard, Justine] Univ Nantes, Lab EA Movement Interact Performance 4334, Nantes, France; [Carroll, Timothy J.] Univ Queensland, Ctr Sensorimotor Performance, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia; [De Martino, Enrico] Univ Siena, Sports Med Specializat Sch, Med Surg & Neurosci Dept, Via Laterina 8, I-53100 Siena, Italy; [Tucker, Kylie] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; Nantes Universite; University of Queensland; University of Siena; University of Queensland	Hug, F (corresponding author), Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.; Hug, F (corresponding author), Univ Nantes, Lab EA Movement Interact Performance 4334, Nantes, France.	francois.hug@univ-nantes.fr	Hug, François/AAV-2415-2020; Hodges, Paul W/B-6578-2008; Carroll, Timothy/C-3513-2008; Tucker, Kylie/M-4887-2013	Hug, François/0000-0002-6432-558X; Hodges, Paul W/0000-0002-1206-9107; Carroll, Timothy/0000-0003-0761-1819; Tucker, Kylie/0000-0003-4976-7483; De Martino, Enrico/0000-0003-3211-3723	National Health and Medical research Council (NHMRC) [ID401599, ID1009410]; Australian Research Council (ARC) [FT120100391]; NHMRC [ID631717]	National Health and Medical research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical research Council (NHMRC; https://www.nhmrc.gov.au/) provide research fellowships for PH: ID401599 and KT: ID1009410. The Australian Research Council (ARC; http://www.arc.gov.au/) provides fellowship support for TC ( FT120100391). Project support was provided by an NHMRC Program grant ( PH: ID631717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank PJM, 2013, EUR J PAIN, V17, P145, DOI 10.1002/j.1532-2149.2012.00186.x; Bernstein N, 1967, COORDINATION REGULAT; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRESSWELL AG, 1995, EXP BRAIN RES, V105, P283; de Rugy A, 2012, J NEUROSCI, V32, P7384, DOI 10.1523/JNEUROSCI.5792-11.2012; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hodges PW, 2013, EUR J PAIN; Hu XG, 2011, J APPL PHYSIOL, V111, P1671, DOI 10.1152/japplphysiol.00760.2011; Hu XG, 2011, J NEUROPHYSIOL, V105, P2169, DOI 10.1152/jn.01086.2010; Hu XG, 2011, NEUROSCI LETT, V490, P121, DOI 10.1016/j.neulet.2010.12.040; Hu XG, 2011, EXP BRAIN RES, V208, P533, DOI 10.1007/s00221-010-2502-1; Hug F, 2014, J APPL PHYSL; Hug F, 2014, J NEUROPHYSIOL, V111, P2298, DOI 10.1152/jn.00911.2013; Hug F, 2014, EUR J APPL PHYSIOL, V114, P1057, DOI 10.1007/s00421-014-2840-y; Hug F, 2013, J ELECTROMYOGR KINES, V23, P1413, DOI 10.1016/j.jelekin.2013.08.014; LUND JP, 1991, CAN J PHYSIOL PHARM, V69, P683, DOI 10.1139/y91-102; Mochizuki G, 2006, EXP BRAIN RES, V175, P584, DOI 10.1007/s00221-006-0575-7; Moseley GL, 2006, BEHAV NEUROSCI, V120, P474, DOI 10.1037/0735-7044.120.2.474; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; Oda S, 1997, JPN J PHYSIOL, V47, P487, DOI 10.2170/jjphysiol.47.487; Prilutsky BI, 2002, EXERC SPORT SCI REV, V30, P32, DOI 10.1097/00003677-200201000-00007; Salimpour Y, 2014, J NEUROSCI, V34, P1806, DOI 10.1523/JNEUROSCI.3095-13.2014; Sarabon N, 2013, EXP BRAIN RES, V227, P121, DOI 10.1007/s00221-013-3494-4; Tucker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091899; Tucker K, 2012, PAIN, V153, P636, DOI 10.1016/j.pain.2011.11.024; WALL PD, 1978, BRAIN, V101, P1, DOI 10.1093/brain/101.1.1; Weerakkody NS, 2003, SOMATOSENS MOT RES, V20, P27, DOI 10.1080/0899022031000083816	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154524	10.1371/journal.pone.0154524	http://dx.doi.org/10.1371/journal.pone.0154524			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115991	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000374973600072
J	Yu, ZY; Zhang, J; Yin, DQ				Yu, ZhenYang; Zhang, Jing; Yin, DaQiang			Multigenerational Effects of Heavy Metals on Feeding, Growth, Initial Reproduction and Antioxidants in Caenorhabditis elegans	PLOS ONE			English	Article							OXIDATIVE STRESS; IN-VIVO; TRADE-OFF; TOXICITY; EXPOSURE; NEMATODE; PROGENY; BEHAVIOR; COPPER; SULFAMETHOXAZOLE	Earlier studies showed that toxicities of excessive metals lasted over generations. Yet, these studies mainly employed one-generation exposure, and the effects of multigenerational challenges need further studies. Presently, Caenorhabditis elegans were exposed to cadmium, copper, lead and zinc for four consecutive generations (G1 to G4) at environmental concentrations. The feeding, growth, initial reproduction, superoxide dismutase (SOD) and catalase (CAT) were determined. All data were represented in the percentage of that in control (POC), and POC in the control was normalized to 100%. In G1 and G2, the POC values in feeding, growth and initial reproduction were generally within 10% of the control (100%), indicating non-significant effects. The POC values in SOD and CAT were significantly higher than 100%, showing stimulatory effects. In G3 and G4, the POC values in feeding, growth and initial reproduction were significantly lower than 100%, showing inhibitory effects which were more severe in G4 than in G3. Meanwhile, SOD and CAT continuously showed stimulatory effects, and the stimulatory effects on SOD increased from G1 to G4. The effects with multigenerational challenges were different from those in one-generation exposure. The effects in later generations demonstrated the importance of multigenerational challenges in judging long-term influences of metals.	[Yu, ZhenYang; Yin, DaQiang] Tongji Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Yangtze River Water Environm, Shanghai 200092, Peoples R China; [Zhang, Jing] Jiaxing Univ, Coll Biol Chem Sci & Engn, Jiaxing 314001, Zhejiang, Peoples R China	Tongji University; Jiaxing University	Zhang, J (corresponding author), Jiaxing Univ, Coll Biol Chem Sci & Engn, Jiaxing 314001, Zhejiang, Peoples R China.	zhjshy@163.com			National Natural Science Foundation of China [21307095, 51278353]; Collaborative Innovation Center for Regional Environmental Quality; Swedish Research Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center for Regional Environmental Quality; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the National Natural Science Foundation of China, No. 21307095, ( https://isisn.nsfc.gov.cn/egrantweb/) to ZYY, The National Natural Science Foundation of China, No. 51278353, ( https://isisn.nsfc.gov.cn/egrantweb/) to DQY, The Collaborative Innovation Center for Regional Environmental Quality to DQY and The Swedish Research Council to the project, No. D0691301, ( http://www.vr.se/) to DQY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonaylo VN, 1999, TOXICOLOGY, V135, P77, DOI 10.1016/S0300-483X(99)00051-7; Anderson GL, 2004, ENVIRON TOXICOL CHEM, V23, P1235, DOI 10.1897/03-264; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P3049, DOI 10.1897/02-565; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P2768, DOI 10.1897/02-573; BRENNER S, 1974, GENETICS, V77, P71; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; Ferreira HS, 2008, TALANTA, V77, P73, DOI 10.1016/j.talanta.2008.05.056; Guo YL, 2009, REPROD TOXICOL, V28, P90, DOI 10.1016/j.reprotox.2009.03.007; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Ibiam U., 2015, Middle East Journal of Scientific Research, V23, P186; Kafel A, 2012, ENVIRON POLLUT, V162, P8, DOI 10.1016/j.envpol.2011.09.034; Kim SW, 2013, ENVIRON SCI TECHNOL, V47, P5393, DOI 10.1021/es304511z; Kim SY, 2011, EVOL ECOL, V25, P461, DOI 10.1007/s10682-010-9426-x; Lane RS, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0566-9; Li HY, 2015, AQUAT TOXICOL, V166, P42, DOI 10.1016/j.aquatox.2015.06.015; Liu SY, 2013, CHEMOSPHERE, V93, P2373, DOI 10.1016/j.chemosphere.2013.08.036; Mohan N, 2010, NANO LETT, V10, P3692, DOI 10.1021/nl1021909; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Monteiro L, 2014, EUR J SOIL BIOL, V62, P1, DOI 10.1016/j.ejsobi.2014.02.005; Niu Y, 2015, B ENVIRON CONTAM TOX, V95, P618, DOI 10.1007/s00128-015-1654-x; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Polkki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038832; Qu Y, 2011, NANO LETT, V11, P3174, DOI 10.1021/nl201391e; Singhal J, 2015, INT J SCI RES, V4, P304; Sirivarasai J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/856319; Smith SW, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0161-8; Tamae THK., 2010, APPL ENV SOIL SCI, V2010; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Wang DY, 2008, ENVIRON POLLUT, V151, P585, DOI 10.1016/j.envpol.2007.04.003; Wang D, 2007, ENVIRON TOXICOL PHAR, V24, P223, DOI 10.1016/j.etap.2007.05.009; Wang Y, 2007, ENVIRON TOXICOL CHEM, V26, P2405, DOI 10.1897/06-646R1.1; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Yu ZY, 2012, CHEMOSPHERE, V87, P1361, DOI 10.1016/j.chemosphere.2012.02.029; Yu ZY, 2015, ECOTOX ENVIRON SAFE, V111, P66, DOI 10.1016/j.ecoenv.2014.09.026; Yu ZY, 2013, J HAZARD MATER, V250, P198, DOI 10.1016/j.jhazmat.2013.01.078; Yu ZY, 2013, ECOTOX ENVIRON SAFE, V88, P178, DOI 10.1016/j.ecoenv.2012.11.012; Yu ZY, 2011, J ENVIRON SCI-CHINA, V23, P294, DOI 10.1016/S1001-0742(10)60436-6; Zanni E, 2012, NANO LETT, V12, P2740, DOI 10.1021/nl204388p; Zhou D, 2016, ENVIRON POLLUT, V208, P767, DOI 10.1016/j.envpol.2015.10.057	40	32	35	7	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154529	10.1371/journal.pone.0154529	http://dx.doi.org/10.1371/journal.pone.0154529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116222	gold, Green Published, Green Submitted			2022-12-26	WOS:000374973600074
J	Blokzijl, A; Chen, LE; Gustafsdottir, SM; Vuu, J; Ullenhag, G; Kampe, O; Landegren, U; Kamali-Moghaddam, M; Hedstrand, H				Blokzijl, Andries; Chen, Lei E.; Gustafsdottir, Sigrun M.; Vuu, Jimmy; Ullenhag, Gustav; Kampe, Olle; Landegren, Ulf; Kamali-Moghaddam, Masood; Hedstrand, Hakan			Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; EXPRESSION; PROTEIN; MAINTENANCE; TUMORS; GENE; DIFFERENTIATION; MARKER; S100B; LIFE	Background The diagnosis of malignant melanoma currently relies on clinical inspection of the skin surface and on the histopathological status of the excised tumor. The serum marker S100B is used for prognostic estimates at later stages of the disease, but analyses are marred by false positives and inadequate sensitivity in predicting relapsing disorder. Objectives To investigate SOX10 as a potential biomarker for melanoma and vitiligo. Methods In this study we have applied proximity ligation assay (PLA) to detect the transcription factor SOX10 as a possible serum marker for melanoma. We studied a cohort of 110 melanoma patients. We further investigated a second cohort of 85 patients with vitiligo, which is a disease that also affects melanocytes. Results The specificity of the SOX10 assay in serum was high, with only 1% of healthy blood donors being positive. In contrast, elevated serum SOX10 was found with high frequency among vitiligo and melanoma patients. In patients with metastases, lack of SOX10 detection was associated with treatment benefit. In two responding patients, a change from SOX10 positivity to undetectable levels was seen before the response was evident clinically. Conclusions We show for the first time that SOX10 represents a promising new serum melanoma marker for detection of early stage disease, complementing the established S100B marker. Our findings imply that SOX10 can be used to monitor responses to treatment and to assess if the treatment is of benefit at stages earlier than what is possible radiologically.	[Blokzijl, Andries; Chen, Lei E.; Gustafsdottir, Sigrun M.; Landegren, Ulf; Kamali-Moghaddam, Masood] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Box 815, SE-75108 Uppsala, Sweden; [Ullenhag, Gustav] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, SE-75108 Uppsala, Sweden; [Vuu, Jimmy; Kampe, Olle; Hedstrand, Hakan] Uppsala Univ, Dept Med Sci, SE-75108 Uppsala, Sweden; [Blokzijl, Andries] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Box 595, SE-75124 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Ludwig Institute for Cancer Research; Uppsala University	Hedstrand, H (corresponding author), Uppsala Univ, Dept Med Sci, SE-75108 Uppsala, Sweden.	hakan.hedstrand@medsci.uu.se	Landegren, Ulf D/A-8197-2019; Chen, Lei/ABC-8660-2020	Chen, Lei/0000-0002-5226-1427; Kampe, Olle/0000-0001-6091-9914	Research Foundation Stiftelsen Onkologiska Klinikens Forskningsfond in Uppsala; Hudfonden; Welanders stiftelse; Hedlunds stiftelse; Selanders stiftelse; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [294409, 316929]; Ludwig institute for cancer research (LICR), Uppsala Branch, Sweden; Uppsala Berzelii Technology Centre for Neurodiagnostics - Swedish Governmental Agency for Innovation Systems; Swedish Research Council; Uppsala University; LiSUM; Novo Nordisk Fonden [NNF14OC0011003, NNF13OC0005975] Funding Source: researchfish	Research Foundation Stiftelsen Onkologiska Klinikens Forskningsfond in Uppsala; Hudfonden; Welanders stiftelse; Hedlunds stiftelse; Selanders stiftelse; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC)); Ludwig institute for cancer research (LICR), Uppsala Branch, Sweden; Uppsala Berzelii Technology Centre for Neurodiagnostics - Swedish Governmental Agency for Innovation Systems; Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University; LiSUM; Novo Nordisk Fonden(Novo Nordisk Foundation)	The Research Foundation Stiftelsen Onkologiska Klinikens Forskningsfond in Uppsala, Hudfonden, Welanders stiftelse, Hedlunds stiftelse, Selanders stiftelse, the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreements No. 294409 (ProteinSeq) and No. 316929 (GastricGlycoExpolorer) and personnel at Department of Oncology, Uppsala and Department of Dermatology at Landstinget in Gavleborg, for kindly supporting this study. AB was partly supported by the Ludwig institute for cancer research (LICR), Uppsala Branch, Sweden and partly supported by the Uppsala Berzelii Technology Centre for Neurodiagnostics, financed by the Swedish Governmental Agency for Innovation Systems, the Swedish Research Council, and Uppsala University during this work. LEC was partly supported by a LiSUM PhD scholarship.	Agnarsdottir M, 2010, MELANOMA RES, V20, P468, DOI 10.1097/CMR.0b013e3283403ccd; Boasberg PD, 2006, J INVEST DERMATOL, V126, P2658, DOI 10.1038/sj.jid.5700545; Bondurand N, 1998, FEBS LETT, V432, P168, DOI 10.1016/S0014-5793(98)00843-6; Cimino-Mathews A, 2013, HUM PATHOL, V44, P959, DOI 10.1016/j.humpath.2012.09.005; Darmanis S, 2010, MOL CELL PROTEOMICS, V9, P327, DOI 10.1074/mcp.M900248-MCP200; Egberts F, 2010, ANTICANCER RES, V30, P1799; FAGNART OC, 1988, CLIN CHEM, V34, P1387; Ferletta M, 2007, MOL CANCER RES, V5, P891, DOI 10.1158/1541-7786.MCR-07-0113; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Grotz TE, 2012, MELANOMA RES, V22, P9, DOI 10.1097/CMR.0b013e32834e1f33; Harris ML, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003644; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hsiao JJ, 2014, ARCH BIOCHEM BIOPHYS, V563, P28, DOI 10.1016/j.abb.2014.07.019; Ivanov SV, 2013, BRIT J CANCER, V109, P444, DOI 10.1038/bjc.2013.326; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Le Gal FA, 2001, J INVEST DERMATOL, V117, P1464, DOI 10.1046/j.0022-202x.2001.01605.x; Miettinen M, 2015, AM J SURG PATHOL, V39, P826, DOI 10.1097/PAS.0000000000000398; Naveh Hadas Prag, 2013, Pigment Cell Melanoma Res, V26, P796, DOI 10.1111/pcmr.12161; Nonaka D, 2008, AM J SURG PATHOL, V32, P1291, DOI 10.1097/PAS.0b013e3181658c14; Ogg GS, 1998, J EXP MED, V188, P1203, DOI 10.1084/jem.188.6.1203; Ohtomo R, 2013, MODERN PATHOL, V26, P1041, DOI 10.1038/modpathol.2013.54; Palermo B, 2001, J INVEST DERMATOL, V117, P326, DOI 10.1046/j.1523-1747.2001.01408.x; Passeron T, 2005, J AUTOIMMUN, V25, P63, DOI 10.1016/j.jaut.2005.10.001; Quaglino P, 2010, ANN ONCOL, V21, P409, DOI 10.1093/annonc/mdp325; Ronnstrand L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0648-y; Schadendorf D, 2014, ANN ONCOL, V25, P700, DOI 10.1093/annonc/mdt580; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154214	10.1371/journal.pone.0154214	http://dx.doi.org/10.1371/journal.pone.0154214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110718	Green Submitted, Green Published, gold			2022-12-26	WOS:000374970600050
J	Cohen, DO; Duchin, S; Feldman, M; Zarivach, R; Aharoni, A; Levy, D				Cohen, Dan Od; Duchin, Shai; Feldman, Michal; Zarivach, Raz; Aharoni, Amir; Levy, Dan			Engineering of Methylation State Specific 3xMBT Domain Using ELISA Screening	PLOS ONE			English	Article							LYSINE METHYLATION; MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; METHYLTRANSFERASE; PROTEINS; IDENTIFICATION; CHROMATIN; PROTEOME; HISTONES; SUBUNIT	The e-amino group of lysine residues may be mono-, di- or tri-methylated by protein lysine methyltransferases. In the past few years it has been highly considered that methylation of both histone and non-histone proteins has fundamental role in development and progression of various human diseases. Thus, the establishment of tools to study lysine methylation that will distinguish between the different states of methylation is required to elucidate their cellular functions. The 3X malignant brain tumor domain (3XMBT) repeats of the Lethal(3) malignant brain tumor-like protein 1 (L3MBTL1) have been utilized in the past as an affinity reagent for the identification of mono-and di-methylated lysine residues on individual proteins and on a proteomic scale. Here, we have utilized the 3XMBT domain to develop an enzyme-linked immunosorbent assay (ELISA) that allows the high-throughput detection of 3XMBT binding to methylated lysines. We demonstrated that this system allows the detection of methylated peptides, methylated proteins and PKMT activity on both peptides and proteins. We also optimized the assay to detect 3XMBT binding in crude E. coli lysates which facilitated the high throughput screening of 3XMBT mutant libraries. We have utilized protein engineering tools and generated a double site saturation 3XMBT library of residues 361 and 411 that were shown before to be important for binding mono and di-methylated substrates and identified variants that can exclusively recognize only di-methylated peptides. Together, our results demonstrate a powerful new approach that will contribute to deeper understanding of lysine methylation biology and that can be utilized for the engineering of domains for specific binders of other post-translational modifications.	[Cohen, Dan Od; Feldman, Michal; Levy, Dan] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [Duchin, Shai; Zarivach, Raz; Aharoni, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Cohen, Dan Od; Duchin, Shai; Feldman, Michal; Zarivach, Raz; Aharoni, Amir; Levy, Dan] Ben Gurion Univ Negev, NIBN, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Levy, D (corresponding author), Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel.; Aharoni, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.; Aharoni, A; Levy, D (corresponding author), Ben Gurion Univ Negev, NIBN, IL-84105 Beer Sheva, Israel.	aaharoni@bgu.ac.il; ledan@post.bgu.ac.il	ZARIVACH, RAZ/F-1671-2012; Levy, Dan/A-3226-2013	ZARIVACH, RAZ/0000-0001-6543-0296; Levy, Dan/0000-0003-0719-0305; Aharoni, Amir/0000-0003-2701-6996	NIBN; Israel Science Foundation [285/14]	NIBN; Israel Science Foundation(Israel Science Foundation)	This work was supported by a grant from the NIBN to AA and DL and by a grant from the Israel Science Foundation (285/14) to DL.	Afjehi-Sadat L, 2013, CURR OPIN CHEM BIOL, V17, P12, DOI 10.1016/j.cbpa.2012.12.023; Beltrao P, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304521; Britton LMP, 2011, EXPERT REV PROTEOMIC, V8, P631, DOI [10.1586/epr.11.47, 10.1586/EPR.11.47]; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Carlson SM, 2014, J MOL BIOL, V426, P3350, DOI 10.1016/j.jmb.2014.04.024; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Chen A., 2016, BIOCH BIOPHYS ACTA; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Duchin S, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0048-y; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Florea M, 2012, CHEM-EUR J, V18, P3521, DOI 10.1002/chem.201103397; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Levy D, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-19; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Liu HD, 2013, MOL CELL, V50, P723, DOI 10.1016/j.molcel.2013.04.025; Lu T, 2015, CANCER RES, V75, P3692, DOI 10.1158/0008-5472.CAN-15-1022; Minguez P, 2015, NUCLEIC ACIDS RES, V43, pD494, DOI 10.1093/nar/gku1081; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Nady N, 2012, J MOL BIOL, V423, P702, DOI 10.1016/j.jmb.2012.08.022; Noberini R, 2015, EPIGENOMICS; Onder O, 2015, EXPERT REV PROTEOMIC, V12, P499, DOI 10.1586/14789450.2015.1084231; Oudhoff MJ, 2013, DEV CELL, V26, P188, DOI 10.1016/j.devcel.2013.05.025; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Pradhan S, 2009, EPIGENETICS, V4, P383, DOI DOI 10.4161/EPI.4.6.9450; Quinn AM, 2010, MOL BIOSYST, V6, P782, DOI 10.1039/b921912a; Sprung R, 2008, J PROTEOME RES, V7, P1001, DOI [10.1021/pr0705338, 10.1021/pr8005155]; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	35	3	3	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154207	10.1371/journal.pone.0154207	http://dx.doi.org/10.1371/journal.pone.0154207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111853	gold, Green Published			2022-12-26	WOS:000374970600048
J	Vazquez-Guerrero, J; Moras, G; Baeza, J; Rodriguez-Jimenez, S				Vazquez-Guerrero, Jairo; Moras, Gerard; Baeza, Jennifer; Rodriguez-Jimenez, Sergio			Force Outputs during Squats Performed Using a Rotational Inertia Device under Stable versus Unstable Conditions with Different Loads	PLOS ONE			English	Article							ELITE SOCCER PLAYERS; BENCH PRESS; ELECTROMYOGRAPHIC ACTIVITY; ECCENTRIC-OVERLOAD; MUSCLE ACTIVATION; RESISTANCE; INSTABILITY; SURFACES; FLYWHEEL; STRENGTH	The purpose of the study was to compare the force outputs achieved during a squat exercise using a rotational inertia device in stable versus unstable conditions with different loads and in concentric and eccentric phases. Thirteen male athletes (mean +/- SD: age 23.7 +/- 3.0 years, height 1.80 +/- 0.08 m, body mass 77.4 +/- 7.9 kg) were assessed while squatting, performing one set of three repetitions with four different loads under stable and unstable conditions at maximum concentric effort. Overall, there were no significant differences between the stable and unstable conditions at each of the loads for any of the dependent variables. Mean force showed significant differences between some of the loads in stable and unstable conditions (P < 0.010) and peak force output differed between all loads for each condition (P < 0.045). Mean force outputs were greater in the concentric than in the eccentric phase under both conditions and with all loads (P < 0.001). There were no significant differences in peak force between concentric and eccentric phases at any load in either stable or unstable conditions. In conclusion, squatting with a rotational inertia device allowed the generation of similar force outputs under stable and unstable conditions at each of the four loads. The study also provides empirical evidence of the different force outputs achieved by adjusting load conditions on the rotational inertia device when performing squats, especially in the case of peak force. Concentric force outputs were significantly higher than eccentric outputs, except for peak force under both conditions. These findings support the use of the rotational inertia device to train the squatting exercise under unstable conditions for strength and conditioning trainers. The device could also be included in injury prevention programs for muscle lesions and ankle and knee joint injuries.	[Vazquez-Guerrero, Jairo; Moras, Gerard; Rodriguez-Jimenez, Sergio] Inst Nacl Educ Fis Catalunya, Sport Performance, Ctr Barcelona, Barcelona, Spain; [Vazquez-Guerrero, Jairo] FCBarcelona, Barcelona, Spain; [Baeza, Jennifer] Fundacio Univ Bages, Barcelona, Spain		Moras, G (corresponding author), Inst Nacl Educ Fis Catalunya, Sport Performance, Ctr Barcelona, Barcelona, Spain.	jairosport.vg@gmail.com	Vázquez-Guerrero, Jairo/AAD-5487-2019		Institut Nacional d'Educacio Fisica de Catalunya (INEFC) de la Generalitat de Catalunya [PRE/2730/2012]; Institut Nacional d'Educacio Fisica de Catalunya (INEFC); FCBarcelona	Institut Nacional d'Educacio Fisica de Catalunya (INEFC) de la Generalitat de Catalunya; Institut Nacional d'Educacio Fisica de Catalunya (INEFC); FCBarcelona	This work was supported by the Institut Nacional d'Educacio Fisica de Catalunya (INEFC) de la Generalitat de Catalunya (PRE/2730/2012). Jairo Vazquez-Guerrero is the recipient of a predoctoral fellowship from the Institut Nacional d'Educacio Fisica de Catalunya (INEFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FCBarcelona provided support in the form of salary for author JVG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Anderson K, 2005, SPORTS MED, V35, P43, DOI 10.2165/00007256-200535010-00004; Anderson KG, 2004, J STRENGTH COND RES, V18, P637; Askling C, 2003, SCAND J MED SCI SPOR, V13, P244, DOI 10.1034/j.1600-0838.2003.00312.x; Balshaw G, 2012, J ELECTROMYOGR KINES, V22, P308, DOI 10.1016/j.jelekin.2011.11.009; Behm D, 2012, INT J SPORTS PHYS TH, V7, P226; Behm DG, 2006, J STRENGTH COND RES, V20, P716; BERG HE, 1994, AVIAT SPACE ENVIR MD, V65, P752; Berg HE, 1998, ACTA ASTRONAUT, V42, P219, DOI 10.1016/S0094-5765(98)00119-2; Blatnik JA, 2012, J STRENGTH COND RES, V26, P3204, DOI 10.1519/JSC.0b013e3182736641; Channell BT, 2008, J STRENGTH COND RES, V22, P1522, DOI 10.1519/JSC.0b013e318181a3d0; Chiu LZF, 2006, J STRENGTH COND RES, V20, P555; Cowley PM, 2007, INT J SPORTS MED, V28, P829, DOI 10.1055/s-2007-964893; de Hoyo M, 2015, INT J SPORT PHYSIOL, V10, P46, DOI 10.1123/ijspp.2013-0547; Drinkwater EJ, 2005, J STRENGTH COND RES, V19, P382; Drinkwater EJ, 2007, INT J SPORT PHYSIOL, V2, P400, DOI 10.1123/ijspp.2.4.400; Hyong IH, 2013, J PHYS THER SCI, V25, P915, DOI 10.1589/jpts.25.915; Kang JH, 2012, J PHYS THER SCI, V24, P1333, DOI 10.1589/jpts.24.1333; Keogh JWL, 2010, J STRENGTH COND RES, V24, P422, DOI 10.1519/JSC.0b013e3181c7c6b9; Kohler JM, 2010, J STRENGTH COND RES, V24, P313, DOI 10.1519/JSC.0b013e3181c8655a; Koshida S, 2008, J STRENGTH COND RES, V22, P1584, DOI 10.1519/JSC.0b013e31817b03a1; McBride JM, 2006, J STRENGTH COND RES, V20, P915; McBride JM, 2010, INT J SPORT PHYSIOL, V5, P177, DOI 10.1123/ijspp.5.2.177; Norrbrand L, 2008, EUR J APPL PHYSIOL, V102, P271, DOI 10.1007/s00421-007-0583-8; Norrbrand L, 2011, AVIAT SPACE ENVIR MD, V82, P13, DOI 10.3357/ASEM.2867.2011; Norrbrand L, 2010, EUR J APPL PHYSIOL, V110, P997, DOI 10.1007/s00421-010-1575-7; Norwood JT, 2007, J STRENGTH COND RES, V21, P343, DOI 10.1519/R-17435.1; Onambele GL, 2008, J BIOMECH, V41, P3133, DOI 10.1016/j.jbiomech.2008.09.004; Romero-Rodriguez D, 2011, PHYS THER SPORT, V12, P43, DOI 10.1016/j.ptsp.2010.10.003; Saeterbakken AH, 2013, J STRENGTH COND RES, V27, P1101, DOI 10.1519/JSC.0b013e3182606d3d; Saeterbakken AH, 2013, J STRENGTH COND RES, V27, P130, DOI 10.1519/JSC.0b013e3182541d43; Tesch PA, 2004, ACTA PHYSIOL SCAND, V180, P89, DOI 10.1046/j.0001-6772.2003.01225.x; Uribe BP, 2010, J STRENGTH COND RES, V24, P1028, DOI 10.1519/JSC.0b013e3181ca4fb8; Zemkova E, 2014, J APPL BIOMECH, V30, P213, DOI 10.1123/jab.2012-0229; Zemkova E, 2012, J STRENGTH COND RES, V26, P3230, DOI 10.1519/JSC.0b013e31824bc197	34	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154346	10.1371/journal.pone.0154346	http://dx.doi.org/10.1371/journal.pone.0154346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111766	gold, Green Submitted, Green Published			2022-12-26	WOS:000374970600058
J	Daskalopoulou, M; George, J; Walters, K; Osborn, DP; Batty, GD; Stogiannis, D; Rapsomaniki, E; Pujades-Rodriguez, M; Denaxas, S; Udumyan, R; Kivimaki, M; Hemingway, H				Daskalopoulou, Marina; George, Julie; Walters, Kate; Osborn, David P.; Batty, G. David; Stogiannis, Dimitris; Rapsomaniki, Eleni; Pujades-Rodriguez, Mar; Denaxas, Spiros; Udumyan, Ruzan; Kivimaki, Mika; Hemingway, Harry			Depression as a Risk Factor for the Initial Presentation of Twelve Cardiac, Cerebrovascular, and Peripheral Arterial Diseases: Data Linkage Study of 1.9 Million Women and Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASES; MYOCARDIAL-INFARCTION; SOCIAL SUPPORT; METAANALYSIS; STROKE; HEALTH; PREVALENCE; DISORDERS; SMOKING	Background Depression is associated with coronary heart disease and stroke, but associations with a range of pathologically diverse cardiovascular diseases are not well understood. We examine the risk of 12 cardiovascular diseases according to depression status (history or new onset). Methods Cohort study of 1,937,360 adult men and women, free from cardiovascular disease at baseline, using linked UK electronic health records between 1997 and 2010. The exposures were new-onset depression (a new GP diagnosis of depression and/or prescription for antidepressants during a one-year baseline), and history of GP-diagnosed depression before baseline. The primary endpoint was initial presentation of 12 cardiovascular diseases after baseline. We used disease-specific Cox proportional hazards models with multiple imputation adjusting for cardiovascular risk factors (age, sex, socioeconomic status, smoking, blood pressure, diabetes, cholesterol). Results Over a median [IQR] 6.9 [2.1-10.5] years of follow-up, 18.9% had a history of depression and 94,432 incident cardiovascular events occurred. After adjustment for cardiovascular risk factors, history of depression was associated with: stable angina (Hazard Ratio = 1.38, 95% CI 1.32-1.45), unstable angina (1.70, 1.60-1.82), myocardial infarction (1.21, 1.16-1.27), unheralded coronary death (1.23, 1.14-1.32), heart failure (1.18, 1.13-1.24), cardiac arrest (1.14, 1.03-1.26), transient ischemic attack (1.31, 1.25-1.38), ischemic stroke (1.26, 1.18-1.34), subarachnoid haemorrhage (1.17, 1.01-1.35), intracerebral haemorrhage (1.30, 1.17-1.45), peripheral arterial disease (1.24, 1.18-1.30), and abdominal aortic aneurysm (1.12,1.01-1.24). New onset depression developed in 2.9% of people, among whom 63,761 cardiovascular events occurred. New onset depression was similarly associated with each of the 12 diseases, with no evidence of stronger associations compared to history of depression. The strength of association between depression and these cardiovascular diseases did not differ between women and men. Conclusion Depression was prospectively associated with cardiac, cerebrovascular, and peripheral diseases, with no evidence of disease specificity. Further research is needed in understanding the specific pathophysiology of heart and vascular disease triggered by depression in healthy populations.	[Daskalopoulou, Marina] UCL, Dept Infect & Populat Hlth, London, England; [George, Julie; Stogiannis, Dimitris; Rapsomaniki, Eleni; Pujades-Rodriguez, Mar; Denaxas, Spiros; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, London, England; [Walters, Kate] UCL, Dept Primary Care & Populat Hlth, London, England; [Osborn, David P.] UCL, Div Psychiat, London, England; [Batty, G. David; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Udumyan, Ruzan] Univ Orebro, Sch Med Sci, Clin Epidemiol & Biostat, SE-70182 Orebro, Sweden	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Orebro University	Daskalopoulou, M (corresponding author), UCL, Dept Infect & Populat Hlth, London, England.	m.daskalopoulou@ucl.ac.uk	Batty, GD/Y-4401-2018; Pujades-Rodriguez, Mar/T-1129-2018; Kivimaki, Mika/B-3607-2012; Udumyan, Ruzan/ABG-1943-2021; Hemingway, Harry/C-1219-2009; Osborn PhD FRCPsych, David/B-8165-2009	Batty, GD/0000-0003-1822-5753; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Kivimaki, Mika/0000-0002-4699-5627; Hemingway, Harry/0000-0003-2279-0624; Walters, Kate/0000-0003-2173-2430; Denaxas, Spiros/0000-0001-9612-7791; Osborn PhD FRCPsych, David/0000-0003-2519-1539	National Institute for Health Research [RP-PG-0407-10314]; Wellcome Trust [086091/Z/08/Z, MR/K006584/1]; Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership [G0902393/99558]; Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; Alzheimer Scotland; University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative [G0700704/ 84698]; BBSRC; EPSRC; ESRC; MRC; UCL Provost's Strategic Development Fund Fellowship; NIHR Doctoral Fellowship [DRF-2009-02-50]; Medical Research Council [K013351]; National Heart, Lung and Blood Institute [HL36310]; National Institute of Aging [AG034454]; NIHR; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1, ES/L007517/1] Funding Source: researchfish; Medical Research Council [MR/K026992/1, MR/K013351/1, MR/L01629X/1, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [DRF-2009-02-50] Funding Source: researchfish; Stroke Association [TSA2008/05] Funding Source: researchfish; ESRC [ES/L007517/1, ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1, MR/L01629X/1] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; Alzheimer Scotland; University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL Provost's Strategic Development Fund Fellowship; NIHR Doctoral Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIHR(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the National Institute for Health Research (HH, RP-PG-0407-10314), Wellcome Trust (HH, 086091/Z/08/Z), and the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (HH, G0902393/99558), and by awards to establish the Farr Institute of Health Informatics Research at UCL Partners (HH, SD), from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (HH, grant MR/K006584/1). This study was carried out on behalf of the CArdiovascular disease research using Linked Bespoke studies and Electronic health Records (CALIBER) programme. GDB is a member of the Alzheimer Scotland Dementia Research Centre funded by Alzheimer Scotland, and the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/ 84698). Funding from the BBSRC, EPSRC, ESRC, and MRC is gratefully acknowledged. SD is supported by a UCL Provost's Strategic Development Fund Fellowship. JG was funded by an NIHR Doctoral Fellowship (DRF-2009-02-50). MK is supported by the Medical Research Council (K013351), the National Heart, Lung and Blood Institute (HL36310), the National Institute of Aging (AG034454), and a professorial fellowship from the Economic and Social Research Council. This article presents independent research funded in part by the NIHR. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Brunner EJ, 2014, EUR J PREV CARDIOL, V21, P340, DOI 10.1177/2047487314520785; Carter CS, 1997, J CLIN PSYCHIAT, V58, P70; COX DR, 1972, J R STAT SOC B, V34, P187; De Rango P, 2014, EUR J VASC ENDOVASC, V47, P243, DOI 10.1016/j.ejvs.2013.12.007; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Funk M., 2008, INT MENT HLTH PRIM C; Germano G, 2012, EUR HEART J, V33, P137; Goff D. C., 2013, CIRCULATION; Health Protection Agency, 2005, HLTH PROT 21 CENT UN; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2013, EUR HEART J-ACUTE CA, V2, P235, DOI 10.1177/2048872613487495; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Idris I, 2006, INT J CLIN PRACT, V60, P48, DOI 10.1111/j.1368-5031.2006.00682.x; Lederle FA, 2003, J VASC SURG, V38, P329, DOI 10.1016/S0741-5214(03)00136-8; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Nabi H, 2010, INT J EPIDEMIOL, V39, P1016, DOI 10.1093/ije/dyq050; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Noble M, 2008, ENGLISH INDICES DEPR; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Rahman I, 2013, EUR J EPIDEMIOL; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; Rapsomaniki E, 2014, LANCET IN PRESS; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Surtees PG, 2008, NEUROLOGY, V70, P788, DOI 10.1212/01.wnl.0000304109.18563.81; The British Psychological Society and The Royal College of Psychiatrists, 2010, DEPR NICE GUID TREAT; Thompson SG, 1997, STAT MED, V16, P2063, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2063::AID-SIM642>3.0.CO;2-8; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Waraich P, 2004, CAN J PSYCHIAT, V49, P124, DOI 10.1177/070674370404900208; Williams SA, 2002, PSYCHOSOM MED, V64, P6, DOI 10.1097/00006842-200201000-00002; Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3	39	83	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153838	10.1371/journal.pone.0153838	http://dx.doi.org/10.1371/journal.pone.0153838			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105076	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100025
J	Lau, A; Barrie, J; Winter, C; Elamy, AH; Tyrrell, G; Long, R				Lau, Angela; Barrie, James; Winter, Christopher; Elamy, Abdel-Halim; Tyrrell, Gregory; Long, Richard			Chest Radiographic Patterns and the Transmission of Tuberculosis: Implications for Automated Systems	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; CONTACT INVESTIGATIONS; CLOSED ENVIRONMENT; SMEAR; EPIDEMIOLOGY; RECOMMENDATIONS; VARIABILITY; INFECTION; AEROSOLS	Background Computer-aided detection to identify and diagnose pulmonary tuberculosis is being explored. While both cavitation on chest radiograph and smear-positivity on microscopy are independent risk factors for the infectiousness of pulmonary tuberculosis it is unknown which radiographic pattern, were it detectable, would provide the greatest public health benefit; i.e. reduced transmission. Herein we provide that evidence. Objectives 1) to determine whether pulmonary tuberculosis in a high income, low incidence country is more likely to present with "typical" adult-type pulmonary tuberculosis radiographic features and 2) to determine whether those with "typical" radiographic features are more likely than those without such features to transmit the organism and/or cause secondary cases. Methods Over a three-year period beginning January 1, 2006 consecutive adults with smear-positive pulmonary tuberculosis in the Province of Alberta, Canada, were identified and their pretreatment radiographs scored by three independent readers as "typical" (having an upper lung zone predominant infiltrate, with or without cavitation but no discernable adenopathy) or "atypical" (all others). Each patient's pre-treatment bacillary burden was carefully documented and, during a 30-month transmission window, each patient's transmission events were recorded. Mycobacteriology, radiology and transmission were compared in those with "typical" versus "atypical" radiographs. Findings A total of 97 smear-positive pulmonary tuberculosis cases were identified, 69 (71.1%) with and 28 (28.9%) without "typical" chest radiographs. "Typical" cases were more likely to have high bacillary burdens and cavitation (Odds Ratios and 95% Confidence Intervals: 2.75 [1.04-7.31] and 9.10 [2.51-32.94], respectively). Typical cases were also responsible for most transmission events-78% of tuberculin skin test conversions (p<0.002) and 95% of secondary cases in reported close contacts (p<0.01); 94% of secondary cases in "unreported" contacts (p<0.02). Conclusion As a group, smear-positive pulmonary tuberculosis patients with typical radiographic features constitute the greatest public health risk. This may have implications for automated detection systems.	[Lau, Angela; Elamy, Abdel-Halim; Long, Richard] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Barrie, James; Winter, Christopher] Univ Alberta, Dept Radiol, Edmonton, AB, Canada; [Long, Richard] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Tyrrell, Gregory] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Tyrrell, Gregory] Alberta Hlth Serv, Prov Lab Publ Hlth, Edmonton, AB, Canada; [Tyrrell, Gregory] Alberta Hlth Serv, Prov Lab Publ Hlth, Calgary, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Alberta Health Services (AHS); Alberta Health Services (AHS); University of Calgary	Long, R (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.; Long, R (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	richard.long@ualberta.ca	Tyrrell, Gregory/ABA-7203-2021					Alberta Health and Wellness, 2007, TUB PREV CONTR GUID; Bailey WC, 2002, JAMA-J AM MED ASSOC, V287, P996, DOI 10.1001/jama.287.8.996; Bark CM, 2011, TUBERCULOSIS, V91, P257, DOI 10.1016/j.tube.2011.01.004; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Breuninger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106381; Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; Canetti G., 1955, TUBERCLE BACILLUS PU; CATANZARO A, 1982, AM REV RESPIR DIS, V125, P559, DOI 10.1164/arrd.1982.125.5.559; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; Diacon AH, 2014, TUBERCULOSIS, V94, P148, DOI 10.1016/j.tube.2013.12.002; Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC; Ferebee SH, 1969, ADV TUBERC RES, V17, P29; Ferguson Robert George, 1955, STUDIES TUBERCULOSIS; Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P26, DOI 10.1080/00039896.1968.10665011; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P4, DOI 10.1080/00039896.1968.10665007; Jensen M, 2012, INT J TUBERC LUNG D, V16, P43, DOI 10.5588/ijtld.11.0374; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; KHAN MA, 1977, AM J MED, V62, P31, DOI 10.1016/0002-9343(77)90346-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LIIPPO KK, 1993, AM REV RESPIR DIS, V148, P235, DOI 10.1164/ajrccm/148.1.235; Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129; LONG R, 1991, CHEST, V99, P123, DOI 10.1378/chest.99.1.123; Long R, 2015, CAN RESPIR J, V22, P317, DOI 10.1155/2015/826035; Long R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098993; Loudon RG, 1969, AM REV RESPIR DIS, V99, P1969; Maduskar P, 2013, INT J TUBERC LUNG D, V17, P1613, DOI 10.5588/ijtld.13.0325; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Medlar EM., 1955, AM REV TUBERC LUNG D; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Parhar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117036; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; SULTAN L, 1960, AM REV RESPIR DIS, V82, P358; The Canadian Lung Association and the Public Health Agency of Canada, 2007, CAN LUNG ASS PUBL HL; Toman K., 1979, TUBERCULOSIS CASE FI; Van Dyck P, 2003, EUR RADIOL, V13, P1771, DOI 10.1007/s00330-002-1612-y; van Ginneken B, 2009, EUR J RADIOL, V72, P226, DOI 10.1016/j.ejrad.2009.05.061; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Xu T, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-3; [No title captured]	42	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154032	10.1371/journal.pone.0154032	http://dx.doi.org/10.1371/journal.pone.0154032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105337	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100036
J	Mu, R; Cutting, AS; Del Rosario, Y; Villarino, N; Stewart, L; Weston, TA; Patras, KA; Doran, KS				Mu, Rong; Cutting, Andrew S.; Del Rosario, Yvette; Villarino, Nicholas; Stewart, Lara; Weston, Thomas A.; Patras, Kathryn A.; Doran, Kelly S.			Identification of CiaR Regulated Genes That Promote Group B Streptococcal Virulence and Interaction with Brain Endothelial Cells	PLOS ONE			English	Article							INTRACELLULAR SURVIVAL; RESPONSE REGULATOR; BETA-HEMOLYSIN/CYTOLYSIN; BARRIER PENETRATION; SIGNAL-TRANSDUCTION; LIPOTEICHOIC ACID; RAB GTPASES; 2-COMPONENT; RESISTANCE; PROTEIN	Group B Streptococcus (GBS) is a major causative agent of neonatal meningitis due to its ability to efficiently cross the blood-brain barrier (BBB) and enter the central nervous system (CNS). It has been demonstrated that GBS can invade human brain microvascular endothelial cells (hBMEC), a primary component of the BBB; however, the mechanism of intracellular survival and trafficking is unclear. We previously identified a two component regulatory system, CiaR/H, which promotes GBS intracellular survival in hBMEC. Here we show that a GBS strain deficient in the response regulator, CiaR, localized more frequently with Rab5, Rab7 and LAMP1 positive vesicles. Further, lysosomes isolated from hBMEC contained fewer viable bacteria following initial infection with the Delta ciaR mutant compared to the WT strain. To characterize the contribution of CiaR-regulated genes, we constructed isogenic mutant strains lacking the two most down-regulated genes in the CiaR-deficient mutant, SAN_2180 and SAN_0039. These genes contributed to bacterial uptake and intracellular survival. Furthermore, competition experiments in mice showed that WT GBS had a significant survival advantage over the Delta 2180 and Delta 0039 mutants in the bloodstream and brain.	[Mu, Rong; Cutting, Andrew S.; Del Rosario, Yvette; Villarino, Nicholas; Stewart, Lara; Weston, Thomas A.; Patras, Kathryn A.; Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Mu, Rong; Cutting, Andrew S.; Del Rosario, Yvette; Villarino, Nicholas; Stewart, Lara; Weston, Thomas A.; Patras, Kathryn A.; Doran, Kelly S.] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Doran, Kelly S.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego	Doran, KS (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.; Doran, KS (corresponding author), San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA.; Doran, KS (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.	kdoran@mail.sdsu.edu	Villarino, Nicholas/HGC-5191-2022; Patras, Kathryn/AAA-3286-2021	Patras, Kathryn/0000-0003-2631-8810; Mu, Rong/0000-0001-6846-3659	Rees Stealy Research Foundation/SDSU Heart Institute Scholarship; San Diego Chapter ARCS Scholarship; NIH/NINDS [R01-NS051247]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	Rees Stealy Research Foundation/SDSU Heart Institute Scholarship; San Diego Chapter ARCS Scholarship; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Rees Stealy Research Foundation/SDSU Heart Institute Scholarship to A.S.C., the San Diego Chapter ARCS Scholarship to K.A.P., and NIH/NINDS R01-NS051247 to K.S.D.	Akesson M, 2007, FEMS MICROBIOL LETT, V270, P155, DOI 10.1111/j.1574-6968.2007.00669.x; Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; Blanchette-Cain K, 2013, MBIO, V4, DOI 10.1128/mBio.00745-13; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Cornacchione P, 1998, IMMUNOLOGY, V93, P86; Cumley NJ, 2012, INFECT IMMUN, V80, P1650, DOI 10.1128/IAI.05443-11; Cutting AS, 2014, J BIOL CHEM, V289, P35711, DOI 10.1074/jbc.M114.588657; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Faralla C, 2014, MBIO, V5, DOI 10.1128/mBio.00870-14; Gargis SR, 2009, APPL ENVIRON MICROB, V75, P6205, DOI 10.1128/AEM.01011-09; Gargis SR, 2009, APPL ENVIRON MICROB, V75, P72, DOI 10.1128/AEM.01647-08; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Klinzing DC, 2013, MICROBIOL-SGM, V159, P1521, DOI 10.1099/mic.0.064444-0; Lai ACY, 2002, FEMS MICROBIOL LETT, V215, P133, DOI 10.1016/S0378-1097(02)00919-9; Lembo A, 2010, MOL MICROBIOL, V77, P431, DOI 10.1111/j.1365-2958.2010.07215.x; Lemire P, 2012, CELL MICROBIOL, V14, P1707, DOI 10.1111/j.1462-5822.2012.01830.x; Lemire P, 2012, MICROBES INFECT, V14, P1064, DOI 10.1016/j.micinf.2012.05.015; Libster R, 2012, PEDIATRICS, V130, pE8, DOI 10.1542/peds.2011-3453; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Mascher T, 2006, J BACTERIOL, V188, P1959, DOI 10.1128/JB.188.5.1959-1968.2006; Mascher T, 2003, J BACTERIOL, V185, P60, DOI 10.1128/JB.185.1.60-70.2003; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mu R, 2014, INFECT IMMUN, V82, P2276, DOI 10.1128/IAI.01559-13; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Qi FX, 2004, INFECT IMMUN, V72, P4895, DOI 10.1128/IAI.72.8.4895-4899.2004; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Sagar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060160; Spellerberg B, 2002, INFECT IMMUN, V70, P2434, DOI 10.1128/IAI.70.5.2434-2440.2002; Stein MP, 2012, TRAFFIC, V13, P1565, DOI 10.1111/tra.12000; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Terebiznik MR, 2006, INFECT IMMUN, V74, P6599, DOI 10.1128/IAI.01085-06; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; ValentinWeigand P, 1996, INFECT IMMUN, V64, P2467, DOI 10.1128/IAI.64.7.2467-2473.1996; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wang LR, 2008, MICROBIOL-SGM, V154, P1900, DOI 10.1099/mic.0.2007/015172-0; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	52	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153891	10.1371/journal.pone.0153891	http://dx.doi.org/10.1371/journal.pone.0153891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100296	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500088
J	Ng, KK; Motoda, Y; Watanabe, S; Othman, AS; Kigawa, T; Kodama, Y; Numata, K				Ng, Kiaw Kiaw; Motoda, Yoko; Watanabe, Satoru; Othman, Ahmad Sofiman; Kigawa, Takanori; Kodama, Yutaka; Numata, Keiji			Intracellular Delivery of Proteins via Fusion Peptides in Intact Plants	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; GENE; INTERNALIZATION; TRANSDUCTION; ARABIDOPSIS; MECHANISMS; BP100	In current plant biotechnology, the introduction of exogenous DNA encoding desired traits is the most common approach used to modify plants. However, general plant transformation methods can cause random integration of exogenous DNA into the plant genome. To avoid these events, alternative methods, such as a direct protein delivery system, are needed to modify the plant. Although there have been reports of the delivery of proteins into cultured plant cells, there are currently no methods for the direct delivery of proteins into intact plants, owing to their hierarchical structures. Here, we demonstrate the efficient fusion-peptide-based delivery of proteins into intact Arabidopsis thaliana. Bovine serum albumin (BSA, 66 kDa) was selected as a model protein to optimize conditions for delivery into the cytosol. The general applicability of our method to large protein cargo was also demonstrated by the delivery of alcohol dehydrogenase (ADH, 150 kDa) into the cytosol. The compatibility of the fusion peptide system with the delivery of proteins to specific cellular organelles was also demonstrated using the fluorescent protein Citrine (27 kDa) conjugated to either a nuclear localization signal (NLS) or a peroxisomal targeting signal (PTS). In conclusion, our designed fusion peptide system can deliver proteins with a wide range of molecular weights (27 to 150 kDa) into the cells of intact A. thaliana without interfering with the organelle-targeting peptide conjugated to the protein. We expect that this efficient protein delivery system will be a powerful tool in plant biotechnology.	[Ng, Kiaw Kiaw; Motoda, Yoko; Numata, Keiji] RIKEN Ctr Sustainable Resource Sci, Enzyme Res Team, Biomass Engn Res Div, Wako, Saitama, Japan; [Ng, Kiaw Kiaw; Othman, Ahmad Sofiman] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Motoda, Yoko; Watanabe, Satoru; Kigawa, Takanori] RIKEN Quantitat Biol Ctr QBiC, Lab Biomol Struct & Dynam, Yokohama, Kanagawa, Japan; [Kigawa, Takanori] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan; [Kodama, Yutaka] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi 321, Japan	RIKEN; Universiti Sains Malaysia; RIKEN; Tokyo Institute of Technology; Utsunomiya University	Numata, K (corresponding author), RIKEN Ctr Sustainable Resource Sci, Enzyme Res Team, Biomass Engn Res Div, Wako, Saitama, Japan.	keiji.numata@riken.jp	Othman, Ahmad Sofiman/GVT-4237-2022; Numata, Keiji/H-9751-2012; watanabe, satoru s/E-9501-2012; Kigawa, Takanori/A-7679-2010	Othman, Ahmad Sofiman/0000-0002-4944-4177; Numata, Keiji/0000-0003-2199-7420; watanabe, satoru s/0000-0001-5329-9278; Kigawa, Takanori/0000-0003-0146-9719	Cross-ministerial Strategic Innovation Promotion Program (SIP)	Cross-ministerial Strategic Innovation Promotion Program (SIP)	This study was supported financially by Cross-ministerial Strategic Innovation Promotion Program (SIP).	Adler AF, 2010, NANO TODAY, V5, P553, DOI 10.1016/j.nantod.2010.10.007; Alberts B., 2008, MOL BIOL CELL, VFifth; Altman A, 2012, PLANT BIOTECHNOLOGY AND AGRICULTURE: PROSPECTS FOR THE 21ST CENTURY, P1; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Chang M, 2005, PLANT CELL PHYSIOL, V46, P482, DOI 10.1093/pcp/pci046; Chang M, 2007, NEW PHYTOL, V174, P46, DOI 10.1111/j.1469-8137.2007.01977.x; Chang M, 2014, CURR PHARM BIOTECHNO, V15, P267, DOI 10.2174/1389201015666140617095415; Chen QR, 2000, GENE THER, V7, P1698, DOI 10.1038/sj.gt.3301294; Dietz KJ, 2001, PROG BOT, V62, P215; Eggenberger K, 2011, CHEMBIOCHEM, V12, P132, DOI 10.1002/cbic.201000402; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Jain A, 2015, FEBS J, V282, P732, DOI 10.1111/febs.13178; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Lakshmanan M, 2015, PLANT BIOTECHNOL-NAR, V32, P39, DOI 10.5511/plantbiotechnology.14.1210b; Lakshmanan M, 2013, BIOMACROMOLECULES, V14, P10, DOI 10.1021/bm301275g; Lau W, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001879; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Leonetti JP, 1990, BIOCONJUGATE CHEM, V1, P149, DOI 10.1021/bc00002a010; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lu SW, 2010, J AGR FOOD CHEM, V58, P2288, DOI 10.1021/jf903039j; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Mizuno T, 2009, J PEPT SCI, V15, P259, DOI 10.1002/psc.1079; Mori O, 1997, COLLOID SURFACE B, V9, P31, DOI 10.1016/S0927-7765(97)00005-2; Muntz K, 2007, J EXP BOT, V58, P2391, DOI 10.1093/jxb/erm089; Munyendo WL, 2012, BIOMOLECULES, V2, P187, DOI 10.3390/biom2020187; Nielsen KM, 1998, FEMS MICROBIOL REV, V22, P79, DOI 10.1111/j.1574-6976.1998.tb00362.x; Numata K, 2015, POLYM J, V47, P537, DOI 10.1038/pj.2015.35; Numata K, 2014, PLANT BIOTECHNOL J, V12, P1027, DOI 10.1111/pbi.12208; Numata K, 2012, BIOMACROMOLECULES, V13, P3450, DOI 10.1021/bm301276k; Numata K, 2012, MACROMOL BIOSCI, V12, P75, DOI 10.1002/mabi.201100274; Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009; Numata K, 2010, BIOMACROMOLECULES, V11, P3189, DOI 10.1021/bm101055m; Ohtani M, 2013, PLANT CELL, V25, P2056, DOI 10.1105/tpc.113.111922; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Sarker SR, 2014, MOL PHARMACEUT, V11, P164, DOI 10.1021/mp400363z; Scheuring D, 2011, PLANT CELL, V23, P3463, DOI 10.1105/tpc.111.086918; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; Trabulo S, 2010, PHARMACEUTICALS, V3, P961, DOI 10.3390/ph3040961; Wadhwani P, 2014, BBA-BIOMEMBRANES, V1838, P940, DOI 10.1016/j.bbamem.2013.11.001; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P758, DOI 10.1016/j.bbrc.2006.05.205; Xia YJ, 2004, CELL MICROBIOL, V6, P905, DOI 10.1111/j.1462-5822.2004.00438.x; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	49	37	38	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154081	10.1371/journal.pone.0154081	http://dx.doi.org/10.1371/journal.pone.0154081			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100681	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500138
J	Pisani, P; Caporuscio, F; Carlino, L; Rastelli, G				Pisani, Pasquale; Caporuscio, Fabiana; Carlino, Luca; Rastelli, Giulio			Molecular Dynamics Simulations and Classical Multidimensional Scaling Unveil New Metastable States in the Conformational Landscape of CDK2	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; PROTEIN-KINASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVATION LOOP; SRC KINASE; INHIBITORS; PHOSPHORYLATION; MECHANISM; TRANSITIONS	Protein kinases are key regulatory nodes in cellular networks and their function has been shown to be intimately coupled with their structural flexibility. However, understanding the key structural mechanisms of large conformational transitions remains a difficult task. CDK2 is a crucial regulator of cell cycle. Its activity is finely tuned by Cyclin E/A and the catalytic segment phosphorylation, whereas its deregulation occurs in many types of cancer. ATP competitive inhibitors have failed to be approved for clinical use due to toxicity issues raised by a lack of selectivity. However, in the last few years type III allosteric inhibitors have emerged as an alternative strategy to selectively modulate CDK2 activity. In this study we have investigated the conformational variability of CDK2. A low dimensional conformational landscape of CDK2 was modeled using classical multidimensional scaling on a set of 255 crystal structures. Microsecond-scale plain and accelerated MD simulations were used to populate this landscape by using an out-of-sample extension of multidimensional scaling. CDK2 was simulated in the apo-form and in complex with the allosteric inhibitor 8-anilino-1-napthalenesulfonic acid (ANS). The apo-CDK2 landscape analysis showed a conformational equilibrium between an Src-like inactive conformation and an active-like form. These two states are separated by different metastable states that share hybrid structural features with both forms of the kinase. In contrast, the CDK2/ANS complex landscape is compatible with a conformational selection picture where the binding of ANS in proximity of the alpha C helix causes a population shift toward the inactive conformation. Interestingly, the new metastable states could enlarge the pool of candidate structures for the development of selective allosteric CDK2 inhibitors. The method here presented should not be limited to the CDK2 case but could be used to systematically unmask similar mechanisms throughout the human kinome.	[Pisani, Pasquale; Caporuscio, Fabiana; Carlino, Luca; Rastelli, Giulio] Univ Modena & Reggio Emilia, Dept Life Sci, Via Campi 103, I-41125 Modena, Italy	Universita di Modena e Reggio Emilia	Rastelli, G (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Via Campi 103, I-41125 Modena, Italy.	giulio.rastelli@unimore.it	Rastelli, Giulio/D-2224-2015	Rastelli, Giulio/0000-0002-2474-0607	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 15993]; Nando Peretti Foundation [2013-25]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Nando Peretti Foundation	This work was supported by a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC IG 15993) and The Nando Peretti Foundation, Award number 2013-25.	Alexander LT, 2015, ACS CHEM BIOL, V10, P2116, DOI 10.1021/acschembio.5b00398; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Betzi S, 2011, ACS CHEM BIOL, V6, P492, DOI 10.1021/cb100410m; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; D'Abramo M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00128; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vivo M, 2011, FUTURE MED CHEM, V3, P1551, DOI [10.4155/FMC.11.113, 10.4155/fmc.11.113]; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Eckart C, 1936, PSYCHOMETRIKA, V1, P211, DOI 10.1007/BF02288367; Endicott JA, 2013, BIOCHEM SOC T, V41, P1008, DOI 10.1042/BST20130097; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Esposito L, 2013, CURR PHARM DESIGN, V19, P5327, DOI 10.2174/13816128113199990377; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jones E., SCIPY OPEN SOURCE SC; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lawrie AM, 1997, NAT STRUCT BIOL, V4, P796, DOI 10.1038/nsb1097-796; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Levy Y, 2001, J CHEM PHYS, V114, P993, DOI 10.1063/1.1329646; Li Y, 2015, INT J MOL SCI, V16, P9314, DOI 10.3390/ijms16059314; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARDIA KV, 1978, COMMUN STAT A-THEOR, V7, P1233, DOI 10.1080/03610927808827707; Meng YL, 2015, J PHYS CHEM B, V119, P1443, DOI 10.1021/jp511792a; Meng YL, 2014, J MOL BIOL, V426, P423, DOI 10.1016/j.jmb.2013.10.001; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Palmieri L, 2013, DRUG DISCOV TODAY, V18, P407, DOI 10.1016/j.drudis.2012.11.009; Python Software Foundation, 2013, PYTH LANG REF VERS 2; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; Rizzolio F, 2010, CURR DRUG TARGETS, V11, P279, DOI 10.2174/138945010790711978; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shukla D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4397; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401; Trosset MW, 2008, COMPUT STAT DATA AN, V52, P4635, DOI 10.1016/j.csda.2008.02.031; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	51	20	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154066	10.1371/journal.pone.0154066	http://dx.doi.org/10.1371/journal.pone.0154066			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100206	Green Published, gold			2022-12-26	WOS:000374898500135
J	Zhao, ZC; Liu, GB; Li, XY; Huang, J; Xiao, YJ; Du, XY; Yu, M				Zhao, Zhichao; Liu, Guangbin; Li, Xinyun; Huang, Ji; Xiao, Yujing; Du, Xiaoyong; Yu, Mei			Characterization of the Promoter Regions of Two Sheep Keratin-Associated Protein Genes for Hair Cortex-Specific Expression	PLOS ONE			English	Article							HIGH GLYCINE-TYROSINE; TRANSGENIC MICE; KAP GENES; WOOL; FOLLICLE; DOMAIN; ACTIVATION; BINDING; FAMILY; CELLS	The keratin-associated proteins (KAPs) are the structural proteins of hair fibers and are thought to play an important role in determining the physical properties of hair fibers. These proteins are activated in a striking sequential and spatial pattern in the keratinocytes of hair fibers. Thus, it is important to elucidate the mechanism that underlies the specific transcriptional activity of these genes. In this study, sheep KRTAP 3-3 and KRTAP11-1 genes were found to be highly expressed in wool follicles in a tissue-specific manner. Subsequently, the promoter regions of the two genes that contained the 5' flanking/5' untranslated regions and the coding regions were cloned. Using an in vivo transgenic approach, we found that the promoter regions from the two genes exhibited transcriptional activity in hair fibers. A much stronger and more uniformly expressed green fluorescent signal was observed in the KRTAP11-1-ZsGreen1 transgenic mice. In situ hybridization revealed the symmetrical expression of sheep KRTAP11-1 in the entire wool cortex. Consistently, immunohistochemical analysis demonstrated that the pattern of ZsGreen1 expression in the hair cortex of transgenic mice matches that of the endogenous KRTAP11-1 gene, indicating that the cloned promoter region contains elements that are sufficient to govern the wool cortex-specific transcription of KRTAP11-1. Furthermore, regulatory regions in the 50 upstream sequence of the sheep KRTAP11-1 gene that may regulate the observed hair keratinocyte specificity were identified using in vivo reporter assays.	[Zhao, Zhichao; Liu, Guangbin; Li, Xinyun; Huang, Ji; Xiao, Yujing; Yu, Mei] Huazhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan 430070, Peoples R China; [Du, Xiaoyong] Huazhong Agr Univ, Coll Informat, Wuhan 430070, Peoples R China; [Liu, Guangbin] South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; South China Agricultural University	Yu, M (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan 430070, Peoples R China.	yumei@mail.hzau.edu.cn			National High Technology Research and Development Program ("863" Program) of China [2013AA102506]; National Nature Scientific Foundation of China [31402040]; National Program of Transgenic Variety Development of China [2011ZX08009-004]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of Transgenic Variety Development of China	This work was supported by grants from the National High Technology Research and Development Program ("863" Program) of China (2013AA102506), the National Nature Scientific Foundation of China (No. 31402040), and the National Program of Transgenic Variety Development of China (2011ZX08009-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson DL, 2004, GENOMICS, V83, P95, DOI 10.1016/S0888-7543(03)00210-6; Auerbach AB, 2004, ACTA BIOCHIM POL, V51, P9; BYRNE C, 1993, MOL CELL BIOL, V13, P3176, DOI 10.1128/MCB.13.6.3176; Cheng LL, 2010, J BIOL CHEM, V285, P5836, DOI 10.1074/jbc.M109.072124; Dunn SM, 1998, J CELL SCI, V111, P3487; FRENKEL MJ, 1989, GENOMICS, V4, P182, DOI 10.1016/0888-7543(89)90298-X; Fujimoto S, 2014, J DERMATOL SCI, V74, P39, DOI 10.1016/j.jdermsci.2013.12.006; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Gilon M, 2008, DIFFERENTIATION, V76, P518, DOI 10.1111/j.1432-0436.2007.00246.x; Gong H, 2011, MOL BIOL REP, V38, P5429, DOI 10.1007/s11033-011-0697-2; Hong LJ, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114181; KEOUGH R, 1995, J CELL SCI, V108, P957; Khan I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-779; Lanzini J, 2015, BIOCHIMIE, V118, P234, DOI 10.1016/j.biochi.2015.09.029; Lee D, 1999, DEV BIOL, V208, P362, DOI 10.1006/dbio.1999.9221; Liu GB, 2015, INT J MOL SCI, V16, P9152, DOI 10.3390/ijms16059152; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma SH, 1997, GENE EXPRESSION, V6, P361; Marh J, 2012, P NATL ACAD SCI USA, V109, P19184, DOI 10.1073/pnas.1216473109; Matsunaga R, 2013, J STRUCT BIOL, V183, P484, DOI 10.1016/j.jsb.2013.06.005; McLaren RJ, 1997, MAMM GENOME, V8, P938, DOI 10.1007/s003359900616; MCNAB AR, 1990, P NATL ACAD SCI USA, V87, P6848, DOI 10.1073/pnas.87.17.6848; Murakami S, 2014, TOXICOL SCI, V138, P47, DOI 10.1093/toxsci/kft273; NELSON WG, 1983, J CELL BIOL, V97, P244, DOI 10.1083/jcb.97.1.244; Plowman JE, 2007, EXP DERMATOL, V16, P707, DOI 10.1111/j.1600-0625.2007.00576.x; Plowman JE, 2009, J AGR FOOD CHEM, V57, P2174, DOI 10.1021/jf803290h; Potter CS, 2011, J INVEST DERMATOL, V131, P828, DOI 10.1038/jid.2010.391; Powell B C, 1997, EXS, V78, P59; POWELL BC, 1991, ANN NY ACAD SCI, V642, P1; Rogers MA, 2005, J INVEST DERMATOL, V124, pVII, DOI 10.1111/j.0022-202X.2005.23728.x; Rogers MA, 2002, J BIOL CHEM, V277, P48993, DOI 10.1074/jbc.M206422200; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Shimomura Y, 2005, J INVEST DERM SYMP P, V10, P230, DOI 10.1111/j.1087-0024.2005.10112.x; Sinha S, 2000, MOL CELL BIOL, V20, P2543, DOI 10.1128/MCB.20.7.2543-2555.2000; Sugihara TM, 2001, J BIOL CHEM, V276, P33036, DOI 10.1074/jbc.M103000200; Yang Z, 2014, MOL BIOL REP, V41, P6089, DOI 10.1007/s11033-014-3485-y; Yu ZD, 2011, EXP DERMATOL, V20, P582, DOI 10.1111/j.1600-0625.2011.01274.x	38	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153936	10.1371/journal.pone.0153936	http://dx.doi.org/10.1371/journal.pone.0153936			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100288	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500100
J	Endrulat, T; Buchmann, N; Brunner, I				Endrulat, Tina; Buchmann, Nina; Brunner, Ivano			Carbon Allocation into Different Fine-Root Classes of Young Abies alba Trees Is Affected More by Phenology than by Simulated Browsing	PLOS ONE			English	Article							PINE PINUS-SYLVESTRIS; SCOTS PINE; GROWTH; DEFOLIATION; STORAGE; HERBIVORE; SEEDLINGS; SAPLINGS; DYNAMICS; RED	Abies alba (European silver fir) was used to investigate possible effects of simulated browsing on C allocation belowground by (CO2)-C-13 pulse-labelling at spring, summer or autumn, and by harvesting the trees at the same time point of the labelling or at a later season for biomass and for C-13-allocation into the fine-root system. Before budburst in spring, the leader shoots and 50% of all lateral shoots of half of the investigated 5-year old Abies alba saplings were clipped to simulate browsing. At harvest, different fine-root classes were separated, and starch as an important storage compartment was analysed for concentrations. The phenology had a strong effect on the allocation of the C-13-label from shoots to roots. In spring, shoots did not supply the fine-roots with high amounts of the C-13-label, because the fine-roots contained less than 1% of the applied C-13. In summer and autumn, however, shoots allocated relatively high amounts of the C-13-label to the fine roots. The incorporation of the C-13 -label as structural C or as starch into the roots is strongly dependent on the root type and the root diameter. In newly formed fine roots, 3-5% of the applied C-13 was incorporated, whereas 1-3% in the <= 0.5 mm root class and 1-1.5% in the >0.5-1.0 mmroot class were recorded. Highest C-13-enrichment in the starch was recorded in the newly formed fine roots in autumn. The clipping treatment had a significant positive effect on the amount of allocated C-13-label to the fine roots after the spring labelling, with high relative C-13-contents observed in the <= 0.5 mm and the >0.5-1.0 mm fine-root classes of clipped trees. No effects of the clipping were observed after summer and autumn labelling in the C-13-allocation patterns. Overall, our data imply that the season of C assimilation and, thus, the phenology of trees is the main determinant of the C allocation from shoots to roots and is clearly more important than browsing.	[Endrulat, Tina; Brunner, Ivano] Swiss Fed Inst Forest Snow & Landscape Res WSL, Forest Soils & Biogeochem, Birmensdorf, Switzerland; [Endrulat, Tina; Buchmann, Nina] ETH, Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland; [Endrulat, Tina] IfUA Umweltberatung & Gutachten GmbH, Bitterfeld, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich	Brunner, I (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Forest Soils & Biogeochem, Birmensdorf, Switzerland.	ivano.brunner@wsl.ch	Brunner, Ivano L./J-8661-2014; Buchmann, Nina/E-6095-2011	Brunner, Ivano L./0000-0003-3436-995X; Buchmann, Nina/0000-0003-0826-2980	Swiss 'State Secretariat for Education, Research and Innovation' SERI; European Cooperation in Science and Technology (COST) Action [E38]	Swiss 'State Secretariat for Education, Research and Innovation' SERI; European Cooperation in Science and Technology (COST) Action(European Cooperation in Science and Technology (COST))	This study was funded by the Swiss 'State Secretariat for Education, Research and Innovation' SERI, additional support was received from European Cooperation in Science and Technology (COST) Action E38 'Woody Root Processes'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff RZ, 2015, NEW PHYTOL, V205, P1054, DOI 10.1111/nph.13111; Ayres E, 2004, ECOL LETT, V7, P469, DOI 10.1111/j.1461-0248.2004.00604.x; Babst BA, 2005, NEW PHYTOL, V167, P63, DOI 10.1111/j.1469-8137.2005.01388.x; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Blessing CH, 2015, TREE PHYSIOL, V35, P585, DOI 10.1093/treephys/tpv024; Duncan AJ, 1998, FOREST ECOL MANAG, V103, P57, DOI 10.1016/S0378-1127(97)00177-1; EDENIUS L, 1993, OIKOS, V66, P286, DOI 10.2307/3544816; Eiberle K., 1975, Schweizerische Zeitschrift fur Forstwesen, V126, P821; Endrulat T, 2010, TREE PHYSIOL, V30, P1515, DOI 10.1093/treephys/tpq090; Epron D, 2012, TREE PHYSIOL, V32, P776, DOI 10.1093/treephys/tps057; Ericsson T, 1996, BIOMASS BIOENERG, V11, P115, DOI 10.1016/0961-9534(96)00032-3; Frost CJ, 2008, NEW PHYTOL, V178, P835, DOI 10.1111/j.1469-8137.2008.02420.x; Gill R.M.A., 1992, DEER FORESTRY, V65, P145, DOI DOI 10.1093/F0RESTRY/65.2.145; Gottlicher S, 2006, RAPID COMMUN MASS SP, V20, P653, DOI 10.1002/rcm.2352; Hasler H, 2008, FUNCT ECOL, V22, P48, DOI 10.1111/j.1365-2435.2007.01346.x; Hansen J, 1996, TREES-STRUCT FUNCT, V11, P83, DOI 10.1007/PL00009659; Hester A. J., 2006, LARGE HERBIVORE ECOL, P97; Hester AJ, 2004, OIKOS, V105, P536, DOI 10.1111/j.0030-1299.2004.12605.x; HONKANEN T, 1994, FUNCT ECOL, V8, P631, DOI 10.2307/2389926; Huttunen L, 2013, ECOL EVOL, V3, P2783, DOI 10.1002/ece3.665; Jacquet JS, 2014, TREE PHYSIOL, V34, P367, DOI 10.1093/treephys/tpu018; Kagawa A, 2006, NEW PHYTOL, V171, P793, DOI 10.1111/j.1469-8137.2006.01780.x; Keel SG, 2007, PLANT CELL ENVIRON, V30, P963, DOI 10.1111/j.1365-3040.2007.01688.x; Keel SG, 2012, NEW PHYTOL, V194, P972, DOI 10.1111/j.1469-8137.2012.04120.x; Klopotek Y, 2016, PLANT SCI, V243, P10, DOI 10.1016/j.plantsci.2015.11.001; Kosola KR, 2002, TREE PHYSIOL, V22, P741, DOI 10.1093/treephys/22.10.741; Kosola KR, 2001, OECOLOGIA, V129, P65, DOI 10.1007/s004420100694; Kostler J. N., 1968, WURZELN WALDBAUME UN; Kuptz D, 2011, NEW PHYTOL, V191, P160, DOI 10.1111/j.1469-8137.2011.03676.x; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Millard P, 2011, TREE PHYSIOL, V31, P579, DOI 10.1093/treephys/tpr053; Motta R, 1996, FOREST ECOL MANAG, V88, P93, DOI 10.1016/S0378-1127(96)03814-5; Palacio S, 2008, FUNCT ECOL, V22, P808, DOI 10.1111/j.1365-2435.2008.01433.x; Palacio S, 2011, TREE PHYSIOL, V31, P150, DOI 10.1093/treephys/tpq110; Palacio S, 2014, NEW PHYTOL, V201, P1096, DOI 10.1111/nph.12602; Philip LJ, 2008, PLANT SOIL, V308, P23, DOI 10.1007/s11104-008-9603-7; Piper FI, 2014, J ECOL, V102, P1101, DOI 10.1111/1365-2745.12284; Puri E, 2015, TREES-STRUCT FUNCT, V29, P1187, DOI 10.1007/s00468-015-1199-y; Regier N, 2009, PLANT CELL ENVIRON, V32, P1724, DOI 10.1111/j.1365-3040.2009.02030.x; Robakowski P, 2004, FOREST ECOL MANAG, V201, P211, DOI 10.1016/j.foreco.2004.06.029; Ruess RW, 1998, ECOLOGY, V79, P2706, DOI 10.1890/0012-9658(1998)079[2706:ROFRDB]2.0.CO;2; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Tytgat TOG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065502; Vare H, 1996, ECOGRAPHY, V19, P245, DOI 10.1111/j.1600-0587.1996.tb00233.x; WELCH D, 1991, FORESTRY, V64, P61, DOI 10.1093/forestry/64.1.61; Wiley E, 2013, TREE PHYSIOL, V33, P1216, DOI 10.1093/treephys/tpt093; Wiley E, 2012, NEW PHYTOL, V195, P285, DOI 10.1111/j.1469-8137.2012.04180.x	48	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154687	10.1371/journal.pone.0154687	http://dx.doi.org/10.1371/journal.pone.0154687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123860	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700123
J	Torner, N; Martinez, A; Broner, S; Moreno, A; Camps, N; Dominguez, A				Torner, Nuria; Martinez, Ana; Broner, Sonia; Moreno, Antonio; Camps, Neus; Dominguez, Angela		Working Grp Study Acute Viral	Epidemiology of Acute Gastroenteritis Outbreaks Caused by Human Calicivirus (Norovirus and Sapovirus) in Catalonia: A Two Year Prospective Study, 2010-2011	PLOS ONE			English	Article							EXCESS MORTALITY; RISK-FACTORS; DIVERSITY; EMERGENCE; INFECTION; VARIANTS; PROGRESS; PATTERN; ILLNESS; SPAIN	Background The epidemiology of cases of acute gastroenteritis (AGE) of viral etiology is a relevant public health issue. Due to underreporting, the study of outbreaks is an accepted approach to investigate their epidemiology. The objective of this study was to investigate the epidemiological characteristics of AGE outbreaks due to norovirus (NoV) and sapovirus (SV) in Catalonia. Material and Methods Prospective study of AGE outbreaks of possible viral etiology notified during two years in Catalonia. NoV and SV were detected by real time reverse transcription polymerase (RTPCR). Results A total of 101 outbreaks were registered affecting a total of 2756 persons and 12 hospitalizations (hospitalization rate: 0.8x1,000,000 persons-year); 49.5% of outbreaks were foodborne, 45.5% person to person and 5% waterborne. The distribution of outbreaks according to the setting showed a predominance of catering services (39.6%), nursing homes and long term care facilities (26.8%) and schools (11.9%). The median number of cases per outbreak was 17 (range 2-191). The total Incidence rate (IR) was 18.3 per 100,000 personsyears (95% CI: 17.6-19.0). The highest IR was in persons aged >= 65 years (43.6x100,000 (95% CI: 41.0-46.2)) (p<0.001). A total of 1065 samples were analyzed with a positivity rate of 60.8%. 98% of positive samples were NoV (GII 56.3%; GI 4.2%; GII+GI 4.2%; non-typable 33.0%). SV was identified in two person-to-person transmission outbreaks in children. Conclusions These results confirm the relevance of viral AGE outbreaks, both foodborne and person-to-person, especially in institutionalized persons. SV should be taken into account when investigating viral AGE outbreaks.	[Torner, Nuria; Martinez, Ana; Camps, Neus] Publ Hlth Agcy Catalonia, Barcelona, Spain; [Torner, Nuria; Martinez, Ana; Broner, Sonia; Dominguez, Angela] Carlos III Hlth Inst, CIBERESP, CIBER Epidemiol & Salud Publ, Madrid, Spain; [Torner, Nuria; Dominguez, Angela] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain; [Moreno, Antonio] Publ Hlth Agcy Barcelona, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Public Health Agency of Barcelona	Torner, N (corresponding author), Publ Hlth Agcy Catalonia, Barcelona, Spain.; Torner, N (corresponding author), Carlos III Hlth Inst, CIBERESP, CIBER Epidemiol & Salud Publ, Madrid, Spain.; Torner, N (corresponding author), Univ Barcelona, Dept Publ Hlth, Barcelona, Spain.	nuria.torner@gencat.cat	, Nuria/AAG-8951-2019	, Nuria/0000-0003-0143-5295	Catalan Agency for the Management of Grants for University Research (AGAUR) [2014/SGR 43]; Instituto de Salud Carlos III [FIS PS0902516]	Catalan Agency for the Management of Grants for University Research (AGAUR); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Support was provided by the Catalan Agency for the Management of Grants for University Research (AGAUR grant number 2014/SGR 43) (recipients: Angela Dominguez, Nuria Torner) and Instituto de Salud Carlos III (FIS PS0902516) (recipient: Angela Dominguez).	Ahmed Sharia M, 2013, PLoS One, V8, pe75922, DOI 10.1371/journal.pone.0075922; [Anonymous], 2012, REP COMM INF DIS INT; Atmar RL, 2010, FOOD ENVIRON VIROL, V2, P117, DOI 10.1007/s12560-010-9038-1; Bruggink L, 2011, J MICROBIOL IMMUNOL, V44, P241, DOI 10.1016/j.jmii.2010.08.001; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; Dey SK, 2012, EPIDEMIOL INFECT, V140, P74, DOI 10.1017/S0950268811000240; Dominguez A, 2008, J CLIN VIROL, V43, P126, DOI 10.1016/j.jcv.2008.03.016; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Esposito S, 2014, EUR J CLIN MICROBIOL, V33, P285, DOI 10.1007/s10096-013-1967-9; Fernandez J, 2011, AGING CLIN EXP RES, V23, P145, DOI 10.3275/7040; Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008; Franck KT, 2015, J INFECT DIS, V211, P563, DOI 10.1093/infdis/jiu479; Godoy P, 2015, EPIDEMIOL INFECT, V143, P725, DOI 10.1017/S0950268814001204; Gonzalez-Galan V, 2011, CLIN MICROBIOL INFEC, V17, P1895, DOI 10.1111/j.1469-0691.2011.03506.x; Green KY, 2006, FIELDS VIROLOGY, P949; Gustavsson L, 2011, J HOSP INFECT, V79, P27, DOI 10.1016/j.jhin.2011.05.018; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Huhti L, 2011, J INFECT DIS, V203, P1442, DOI 10.1093/infdis/jir039; Jones S, 2011, BRIT J BIOMED SCI, V68, P116; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; KAPLAN JE, 1982, AM J PUBLIC HEALTH, V72, P1329, DOI 10.2105/AJPH.72.12.1329; Koopmans M, 2008, CURR OPIN INFECT DIS, V21, P544, DOI 10.1097/QCO.0b013e3283108965; Lee LE, 2012, EMERG INFECT DIS, V18, P873, DOI 10.3201/eid1805.111843; Li JR, 2012, ANNU REV FOOD SCI T, V3, P331, DOI 10.1146/annurev-food-022811-101234; Matthews JE, 2012, EPIDEMIOL INFECT, V140, P1161, DOI 10.1017/S0950268812000234; Medici MC, 2012, J MED VIROL, V84, P643, DOI 10.1002/jmv.23231; Naito M, 2014, J EPIDEMIOL, V24, P435, DOI 10.2188/jea.JE20140182; NAKATA S, 1983, J CLIN MICROBIOL, V17, P198, DOI 10.1128/JCM.17.2.198-201.1983; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Perez-Sautu U, 2012, ENVIRON MICROBIOL, V14, P494, DOI 10.1111/j.1462-2920.2011.02642.x; Phillips G, 2011, EPIDEMIOL INFECT, V139, P1676, DOI 10.1017/S0950268810002839; Repp KK, 2012, J INFECT DIS, V205, P1639, DOI 10.1093/infdis/jis250; Rohayem J, 2009, CLIN MICROBIOL INFEC, V15, P524, DOI 10.1111/j.1469-0691.2009.02846.x; Rondy M, 2011, EPIDEMIOL INFECT, V139, P453, DOI 10.1017/S0950268810000993; Sala MR, 2014, CLIN MICROBIOL INFEC, V20, P793, DOI 10.1111/1469-0691.12522; Sano D, 2011, APPL ENVIRON MICROB, V77, P1111, DOI 10.1128/AEM.01721-10; Scaioli G, 2013, EUR J PUBLIC HLTH S1, V23; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Surveillance for foodborne disease outbreaks-United States, 2008, MMWR MORB MORTAL WKL, V60, P1197; Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Ueki Y, 2010, MICROBIOL IMMUNOL, V54, P483, DOI 10.1111/j.1348-0421.2010.00239.x; Verhoef L, 2008, EMERG INFECT DIS, V14, P238, DOI 10.3201/eid1402.061567	44	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152503	10.1371/journal.pone.0152503	http://dx.doi.org/10.1371/journal.pone.0152503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120472	Green Submitted, gold, Green Published			2022-12-26	WOS:000374976200009
J	Fadel, F; Zhao, YG; Cousido-Siah, A; Ruiz, FX; Mitschler, A; Podjarny, A				Fadel, Firas; Zhao, Yuguang; Cousido-Siah, Alexandra; Ruiz, Francesc X.; Mitschler, Andre; Podjarny, Alberto			X-Ray Crystal Structure of the Full Length Human Chitotriosidase (CHIT1) Reveals Features of Its Chitin Binding Domain	PLOS ONE			English	Article							BACILLUS-CIRCULANS WL-12; MORITELLA-MARINA; PROTEINS; RESIDUES; MODULE; FAMILY; IDENTIFICATION; INFLAMMATION; DEGRADATION; SPECIFICITY	Chitinases are enzymes that catalyze the hydrolysis of chitin. Human chitotriosidase (CHIT1) is one of the two active human chitinases, involved in the innate immune response and highly expressed in a variety of diseases. CHIT1 is composed of a catalytic domain linked by a hinge to its chitin binding domain (ChBD). This latter domain belongs to the carbohydrate-binding module family 14 (CBM14 family) and facilitates binding to chitin. So far, the available crystal structures of the human chitinase CHIT1 and the Acidic Mammalian Chitinase (AMCase) comprise only their catalytic domain. Here, we report a crystallization strategy combining cross-seeding and micro-seeding cycles which allowed us to obtain the first crystal structure of the full length CHIT1 (CHIT1-FL) at 1.95 angstrom resolution. The CHIT1 chitin binding domain (ChBD(CHIT1)) structure shows a distorted beta-sandwich 3D fold, typical of CBM14 family members. Accordingly, ChBD(CHIT1) presents six conserved cysteine residues forming three disulfide bridges and several exposed aromatic residues that probably are involved in chitin binding, including the highly conserved Trp465 in a surface-exposed conformation. Furthermore, ChBD(CHIT1) presents a positively charged surface which may be involved in electrostatic interactions. Our data highlight the strong structural conservation of CBM14 family members and uncover the structural similarity between the human ChBD(CHIT1), tachycitin and house mite dust allergens. Overall, our new CHIT1-FL structure, determined with an adapted crystallization approach, is one of the few complete bi-modular chitinase structures available and reveals the structural features of a human CBM14 domain.	[Fadel, Firas; Cousido-Siah, Alexandra; Ruiz, Francesc X.; Mitschler, Andre; Podjarny, Alberto] Univ Strasbourg, Inst Genet & Mol & Cellular Biol IGBMC, Dept Integrat Biol, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France; [Zhao, Yuguang] Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med, Oxford, England; [Fadel, Firas] Aix Marseille Univ, Lab Ingn Syst Macromol, UMR7255, CNRS, Case 932, Marseille, France; [Fadel, Firas] Aix Marseille Univ, Architecture & Fonct Macromol Biol, UMR7257, CNRS, Case 932, Marseille, France; [Ruiz, Francesc X.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Rutgers State University New Brunswick	Fadel, F; Podjarny, A (corresponding author), Univ Strasbourg, Inst Genet & Mol & Cellular Biol IGBMC, Dept Integrat Biol, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France.; Fadel, F (corresponding author), Aix Marseille Univ, Lab Ingn Syst Macromol, UMR7255, CNRS, Case 932, Marseille, France.; Fadel, F (corresponding author), Aix Marseille Univ, Architecture & Fonct Macromol Biol, UMR7257, CNRS, Case 932, Marseille, France.	firasfadel1@gmail.com; podjarny@igbmc.fr	Ruiz, Francesc Xavier/AAA-1324-2020	Ruiz, Francesc Xavier/0000-0002-0457-0030; Podjarny, Alberto/0000-0002-7685-1077; Cousido-Siah, Alexandra/0000-0002-3051-1560	CNRS; INSERM; Universite de Strasbourg; Biostruct-X (FP7) [283570]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; Biostruct-X (FP7); French Infrastructure for Integrated Structural Biology (FRISBI)	This work has been supported by the CNRS, the INSERM, the Universite de Strasbourg. The authors wish to acknowledge the following grant funding: Biostruct-X (FP7, contract 283570, http://www.biostruct-x.eu/), and the French Infrastructure for Integrated Structural Biology (FRISBI, ANR-10-INSB-05-01, http://frisbi.eu/).	Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akagi K, 2006, J BIOCHEM, V139, P483, DOI 10.1093/jb/mvj062; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSEN NH, 1993, BIOCHEMISTRY-US, V32, P1407, DOI 10.1021/bi00057a004; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Asensio JL, 2000, CHEM BIOL, V7, P529, DOI 10.1016/S1074-5521(00)00136-8; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bianchetti CM, 2013, J MOL BIOL, V425, P4267, DOI 10.1016/j.jmb.2013.05.030; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brunner F, 1998, PLANT J, V14, P225, DOI 10.1046/j.1365-313X.1998.00116.x; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Di Rosa M, 2014, BONE, V61, P55, DOI 10.1016/j.bone.2014.01.005; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fadel F, 2015, ACTA CRYSTALLOGR D, V71, P1455, DOI 10.1107/S139900471500783X; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gordon-Thomson C, 2009, CELL MOL LIFE SCI, V66, P1116, DOI 10.1007/s00018-009-8765-7; Hashimoto M, 2000, J BACTERIOL, V182, P3045, DOI 10.1128/JB.182.11.3045-3054.2000; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; Jee JG, 2002, J BIOL CHEM, V277, P1388, DOI 10.1074/jbc.M109726200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanneganti Manasa, 2012, J Epithel Biol Pharmacol, V5, P1; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen T, 2014, FEBS LETT, V588, P746, DOI 10.1016/j.febslet.2013.12.035; Lee CG, 2009, YONSEI MED J, V50, P22, DOI 10.3349/ymj.2009.50.1.22; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malaguarnera L, 2006, CELL MOL LIFE SCI, V63, P3018, DOI 10.1007/s00018-006-6269-2; Malecki PH, 2014, ACTA CRYSTALLOGR D, V70, P676, DOI 10.1107/S1399004713032264; Malecki PH, 2013, ACTA CRYSTALLOGR D, V69, P821, DOI 10.1107/S0907444913002011; Marshall KC, 1990, ADV MICROB ECOL, P387, DOI DOI 10.1007/978-1-4684-7612-5_10; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller GA, 2015, CLIN EXPT ALLERGY; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Ohno T, 1996, J BACTERIOL, V178, P5065, DOI 10.1128/jb.178.17.5065-5070.1996; Olland AM, 2009, PROTEIN SCI, V18, P569, DOI 10.1002/pro.63; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Stewart PDS, 2011, CRYST GROWTH DES, V11, P3432, DOI 10.1021/cg2001442; Stockinger LW, 2015, BBA-PROTEINS PROTEOM, V1854, P1494, DOI 10.1016/j.bbapap.2015.06.008; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Suzuki K, 1999, BIOCHEM J, V343, P587, DOI 10.1042/0264-6021:3430587; Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; van den Burg HA, 2004, J BIOL CHEM, V279, P16786, DOI 10.1074/jbc.M312594200; Vandevenne M, 2011, PROTEIN SCI, V20, P1451, DOI 10.1002/pro.676; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994	63	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154190	10.1371/journal.pone.0154190	http://dx.doi.org/10.1371/journal.pone.0154190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111557	Green Published, Green Submitted, gold			2022-12-26	WOS:000374970600045
J	Gottschick, C; Szafranski, SP; Kunze, B; Sztajer, H; Masur, C; Abels, C; Wagner-Dobler, I				Gottschick, Cornelia; Szafranski, Szymon P.; Kunze, Brigitte; Sztajer, Helena; Masur, Clarissa; Abels, Christoph; Wagner-Doebler, Irene			Screening of Compounds against Gardnerella vaginalis Biofilms	PLOS ONE			English	Article							BACTERIAL-VAGINOSIS; IN-VITRO; TRACT INFECTIONS; MICROBIOME; PREVALENCE; RECURRENCE; SUGGESTS; THERAPY; WOMEN; MODEL	Bacterial vaginosis (BV) is a common infection in reproductive age woman and is characterized by dysbiosis of the healthy vaginal flora which is dominated by Lactobacilli, followed by growth of bacteria like Gardnerella vaginalis. The ability of G. vaginalis to form biofilms contributes to the high rates of recurrence that are typical for BV and which unfortunately make repeated antibiotic therapy inevitable. Here we developed a biofilm model for G. vaginalis and screened a large spectrum of compounds for their ability to prevent biofilm formation and to resolve an existing G. vaginalis biofilm. The antibiotics metronidazole and tobramycin were highly effective in preventing biofilm formation, but had no effect on an established biofilm. The application of the amphoteric tenside sodium cocoamphoacetate (SCAA) led to disintegration of existing biofilms, reducing biomass by 51% and viability by 61% and it was able to increase the effect of metronidazole by 40% (biomass) and 61% (viability). Our data show that attacking the biofilm and the bacterial cells by the combination of an amphoteric tenside with the antibiotic metronidazole might be a useful strategy against BV.	[Gottschick, Cornelia; Szafranski, Szymon P.; Kunze, Brigitte; Sztajer, Helena; Wagner-Doebler, Irene] Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Masur, Clarissa; Abels, Christoph] Dr August Wolff GmbH & Co KG Arzneimittel, Sudbrackstr 56, D-33611 Bielefeld, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Gottschick, C (corresponding author), Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany.	Cornelia.Gottschick@helmholtz-hzi.de	Abels, Christoph/GYU-0286-2022; Wagner-Döbler, Irene/Y-1685-2019	Wagner-Dobler, Irene/0000-0001-5883-2502; Szafranski, Szymon/0000-0002-0607-6976	Bundesministerium fur Wirtschaft und Energie (BMWi), Germany [KF3134201MD3]	Bundesministerium fur Wirtschaft und Energie (BMWi), Germany	Authors CA and CM are employed by the commercial company Dr. August Wolff GmbH & Co. KG Arzneimittel. The research, however, was not funded by this company, but instead a grant was applied for by IWD and CA at the Bundesministerium fur Wirtschaft und Energie (BMWi), Germany. Grant number: KF3134201MD3. http://www.zim-bmwi.de/. Therefore the funders (BMWi) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors	Abdelwahab NS, 2015, J CHROMATOGR SCI; Algburi A, 2015, PATHOG DIS      0402; Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Ansorg R, 2003, ARZNEIMITTELFORSCH, V53, P368; Bradshaw CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057688; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Braga PC, 2010, ARZNEIMITTELFORSCH, V60, P675, DOI 10.1055/s-0031-1296346; BURGER RM, 1994, ANTIMICROB AGENTS CH, V38, P886, DOI 10.1128/AAC.38.4.886; Castro J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11640; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Coelho T, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.00330, 10.3389/fmicb.2015.01528]; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Goossens A, 2006, CONTACT DERMATITIS, V55, P302, DOI 10.1111/j.1600-0536.2006.00933.x; Gupta P., 2015, ARCH MICROBIOL; Hardy L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136658; Hooven TA, 2012, J ANTIMICROB CHEMOTH, V67, P2870, DOI 10.1093/jac/dks305; Hymes SR, 2013, J INFECT DIS, V207, P1491, DOI 10.1093/infdis/jit047; Kenyon CR, 2014, CURR OPIN OBSTET GYN, V26, P448, DOI 10.1097/GCO.0000000000000112; Kumon H, 2001, INT J ANTIMICROB AG, V17, P311, DOI 10.1016/S0924-8579(00)00360-5; Machado A, 2015, J INFECT DIS; Machado D, 2015, J MICROBIOL METH, V118, P143, DOI 10.1016/j.mimet.2015.09.007; Malanovic N, 2015, BBA-BIOMEMBRANES, V1848, P2437, DOI 10.1016/j.bbamem.2015.07.010; Mankodi S, 2005, AM J DENT, V18; Mastromarino P, 2013, NEW MICROBIOL, V36, P229; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; MCKENZIE HA, 1991, ADV PROTEIN CHEM, V41, P173; McMillan A, 2011, COLLOID SURFACE B, V86, P58, DOI 10.1016/j.colsurfb.2011.03.016; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Muzny CA, 2015, CLIN INFECT DIS, V61, P601, DOI 10.1093/cid/civ353; Nunn KL, 2015, MBIO, V6, DOI 10.1128/mBio.01084-15; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Palmeira-de-Oliveira R, 2015, ADV DRUG DELIVER REV, V92, P105, DOI 10.1016/j.addr.2015.06.008; Parasion S, 2014, POL J MICROBIOL, V63, P137; Patrone V, 2010, CURR MICROBIOL, V60, P237, DOI 10.1007/s00284-009-9531-7; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Price KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141192; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reichman O, 2009, SEX TRANSM DIS, V36, P732, DOI 10.1097/OLQ.0b013e3181b08456; Reid G, 2008, MICROBIAL ECOLOGY IN, V20; SHEINESS D, 1992, J CLIN MICROBIOL, V30, P642, DOI 10.1128/JCM.30.3.642-648.1992; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Strandberg KL, 2010, ANTIMICROB AGENTS CH, V54, P597, DOI 10.1128/AAC.01151-09; Stute P, 2015, CLIMACTERIC, V18, P582, DOI 10.3109/13697137.2015.1036854; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Swidsinski A, 2015, ARCH GYNECOL OBSTET, V291, P605, DOI 10.1007/s00404-014-3484-1; Swidsinski A, 2011, FEMS IMMUNOL MED MIC, V61, P41, DOI 10.1111/j.1574-695X.2010.00743.x; Twin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076892; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65	54	26	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154086	10.1371/journal.pone.0154086	http://dx.doi.org/10.1371/journal.pone.0154086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111438	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600033
J	Kim, J; Ye, A				Kim, Joomyeong; Ye, An			Phylogenetic and Epigenetic Footprinting of the Putative Enhancers of the Peg3 Domain	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; IMPRINTED GENE; METHYLATION; SEQUENCES; REVEALS; PROTEIN; GROWTH; REGION	The Peg3 (Paternally Expressed Gene 3) imprinted domain is predicted to be regulated through a large number of evolutionarily conserved regions (ECRs) that are localized within its middle 200-kb region. In the current study, we characterized these potential cis-regulatory regions using phylogenetic and epigenetic approaches. According to the results, the majority of these ECRs are potential enhancers for the transcription of the Peg3 domain. Also, these potential enhancers can be divided into two groups based on their histone modification and DNA methylation patterns: ubiquitous and tissue-specific enhancers. Phylogenetic and bioinformatic analyses further revealed that several cis-regulatory motifs are frequently associated with the ECRs, such as the E box, PITX2, NF-kappa B and RFX1 motifs. A series of subsequent ChIP experiments demonstrated that the trans factor MYOD indeed binds to the E box of several ECRs, further suggesting that MYOD may play significant roles in the transcriptional control of the Peg3 domain. Overall, the current study identifies, for the first time, a set of cis-regulatory motifs and corresponding trans factors that may be critical for the transcriptional regulation of the Peg3 domain.	[Kim, Joomyeong; Ye, An] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu			National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretz CL, 2015, EPIGENETICS-US, V10, P1111, DOI 10.1080/15592294.2015.1110672; Broad KD, 2011, P NATL ACAD SCI USA, V108, P15237, DOI 10.1073/pnas.1106022108; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chen MY, 2011, CANCER-AM CANCER SOC, V117, P4424, DOI 10.1002/cncr.26073; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Fong AP, 2013, CURR OPIN GENET DEV, V23, P568, DOI 10.1016/j.gde.2013.05.002; Frey WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144459; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; GUMUCIO DL, 1993, P NATL ACAD SCI USA, V90, P6018, DOI 10.1073/pnas.90.13.6018; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Ivanova E, 2011, J MOL ENDOCRINOL, V47, pR67, DOI 10.1530/JME-11-0065; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim J, 2000, GENOME RES, V10, P1138, DOI 10.1101/gr.10.8.1138; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv867; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee S, 2015, INT J NANOMED, V10, P3, DOI 10.2147/IJN.S91389; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326; Perera BPU, 2016, ANAL BIOCHEM, V494, P82, DOI 10.1016/j.ab.2015.11.006; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Suh H, 2002, DEVELOPMENT, V129, P329; Thiaville MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075417; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Waite MR, 2015, J NEUROSCI RES, V93, P195, DOI 10.1002/jnr.23471; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Ye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108596	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154216	10.1371/journal.pone.0154216	http://dx.doi.org/10.1371/journal.pone.0154216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104590	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100057
J	Shimizu, J; Kubota, T; Takada, E; Takai, K; Fujiwara, N; Arimitsu, N; Ueda, Y; Wakisaka, S; Suzuki, T; Suzuki, N				Shimizu, Jun; Kubota, Takao; Takada, Erika; Takai, Kenji; Fujiwara, Naruyoshi; Arimitsu, Nagisa; Ueda, Yuji; Wakisaka, Sueshige; Suzuki, Tomoko; Suzuki, Noboru			Bifidobacteria Abundance-Featured Gut Microbiota Compositional Change in Patients with Behcet's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHAIN FATTY-ACIDS; T-CELLS; BACTERIA; INTERLEUKIN-17; IL23R-IL12RB2; COLCHICINE; DIVERSITY; GAMMA; IL10	Gutmicrobiota compositional alteration may have an association with immune dysfunction in patients with Behcet's disease (BD). We conducted a fecal metagenomic analysis of BD patients. We analyzed fecal microbiota obtained from 12 patients with BD and 12 normal individuals by sequencing of 16S ribosomal RNA gene. We compared the relative abundance of bacterial taxa. Direct comparison of the relative abundance of bacterial taxa demonstrated that the genera Bifidobacterium and Eggerthella increased significantly and the genera Megamonas and Prevotella decreased significantly in BD patients compared with normal individuals. A linear discriminant analysis of bacterial taxa showed that the phylum Actinobacteria, including Bifidobacterium, and the family Lactobacillaceae exhibited larger positive effect sizes than other bacteria in patients with BD. The phylum Firmicutes and the class Clostridia had large effect sizes in normal individuals. There was no significant difference in annotated species numbers (as numbers of operational taxonomic unit; OTU) and bacterial diversity of each sample (alpha diversity) between BD patients and normal individuals. We next assigned each sample to a position using three axes by principal coordinates analysis of the OTU table. The two groups had a significant distance as beta diversity in the 3-axis space. Fecal sIgA concentrations increased significantly in BD patients but did not correlate with any bacterial taxonomic abundance. These data suggest that the compositional changes of gut microbesmay be one type of dysbiosis (unfavorable microbiota alteration) in patients with BD. The dysbiosis may have an association with the pathophysiology of BD.	[Shimizu, Jun; Takada, Erika; Takai, Kenji; Fujiwara, Naruyoshi; Arimitsu, Nagisa; Ueda, Yuji; Wakisaka, Sueshige; Suzuki, Tomoko; Suzuki, Noboru] St Marianna Univ, Sch Med, Dept Immunol & Med, Kawasaki, Kanagawa, Japan; [Kubota, Takao] Japan Self Def Forces Cent Hosp, Dept Med, Tokyo, Japan	Saint Marianna University	Suzuki, N (corresponding author), St Marianna Univ, Sch Med, Dept Immunol & Med, Kawasaki, Kanagawa, Japan.	n3suzuki@marianna-u.ac.jp			Japan Society for the Promotion of Science [30509964]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research (Grant Number 30509964) of Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhakta BB, 1999, RHEUMATOLOGY, V38, P728, DOI 10.1093/rheumatology/38.8.728; Chi W, 2010, MOL VIS, V16, P880; Consolandi C, 2015, AUTOIMMUN REV, V14, P269, DOI 10.1016/j.autrev.2014.11.009; Cua DJ, 2011, NAT MED, V17, P1055, DOI 10.1038/nm0911-1055; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Fung TC, 2014, IMMUNOL REV, V260, P35, DOI 10.1111/imr.12186; Geri G, 2011, J ALLERGY CLIN IMMUN, V128, P655, DOI 10.1016/j.jaci.2011.05.029; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Hamzaoui K, 2011, MED SCI MONITOR, V17, pCR227, DOI 10.12659/MSM.881720; Hamzaoui K, 2011, J NEUROIMMUNOL, V233, P249, DOI 10.1016/j.jneuroim.2011.01.012; Hatemi G, 2004, ANN RHEUM DIS, V63, P1450, DOI 10.1136/ard.2003.017467; Iacobuzio-Donahue CA, 2001, AM J SURG PATHOL, V25, P1067, DOI 10.1097/00000478-200108000-00012; International Study Group for Beh~et's Disease, 1990, LANCET, V335, P1078, DOI DOI 10.1016/0140-; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaneko S, 1997, CLIN EXP IMMUNOL, V108, P204, DOI 10.1046/j.1365-2249.1997.3611265.x; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Ktsoyan ZA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00002; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Marquet P, 2009, FEMS MICROBIOL LETT, V299, P128, DOI 10.1111/j.1574-6968.2009.01750.x; Miura T, 2005, ORAL MICROBIOL IMMUN, V20, P167, DOI 10.1111/j.1399-302X.2005.00207.x; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Morita H, 2007, MICROBES ENVIRON, V22, P214, DOI 10.1264/jsme2.22.214; Na SY, 2013, CLIN EXP RHEUMATOL, V31, pS32; Nanthakumar NN, 2013, GLYCOBIOLOGY, V23, P1131, DOI 10.1093/glycob/cwt050; Nara K, 2008, CLIN EXP IMMUNOL, V152, P245, DOI 10.1111/j.1365-2249.2008.03626.x; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nielsen OH, 1999, AM J GASTROENTEROL, V94, P2923, DOI 10.1016/S0002-9270(99)00495-5; OHNO S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1455; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seoudi N, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27150; Shimizu J, 2012, CLIN EXP IMMUNOL, V168, P68, DOI 10.1111/j.1365-2249.2011.04543.x; Shimizu J, 2016, CLIN RHEUMATOL, V35, P1857, DOI 10.1007/s10067-015-2966-2; Shimizu J, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/105205; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	48	62	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153746	10.1371/journal.pone.0153746	http://dx.doi.org/10.1371/journal.pone.0153746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105322	gold, Green Published, Green Submitted			2022-12-26	WOS:000374565100018
J	Heuer, A; Schubo, A				Heuer, Anna; Schuboe, Anna			The Focus of Attention in Visual Working Memory: Protection of Focused Representations and Its Individual Variation	PLOS ONE			English	Article							SHORT-TERM-MEMORY; ORIENTING ATTENTION; NEURAL MEASURES; SPATIAL ATTENTION; INFORMATION; MAINTENANCE; MODULATION; CAPACITY; LOCATIONS; STORAGE	Visual working memory can be modulated according to changes in the cued task relevance of maintained items. Here, we investigated the mechanisms underlying this modulation. In particular, we studied the consequences of attentional selection for selected and unselected items, and the role of individual differences in the efficiency with which attention is deployed. To this end, performance in a visual working memory task as well as the CDA/SPCN and the N2pc, ERP components associated with visual working memory and attentional processes, were analysed. Selection during the maintenance stage was manipulated by means of two successively presented retrocues providing spatial information as to which items were most likely to be tested. Results show that attentional selection serves to robustly protect relevant representations in the focus of attention while unselected representations which may become relevant again still remain available. Individuals with larger retrocueing benefits showed higher efficiency of attentional selection, as indicated by the N2pc, and showed stronger maintenance-associated activity (CDA/SPCN). The findings add to converging evidence that focused representations are protected, and highlight the flexibility of visual working memory, in which information can be weighted according its relevance.	[Heuer, Anna; Schuboe, Anna] Univ Marburg, Expt & Biol Psychol, Marburg, Germany	Philipps University Marburg	Heuer, A (corresponding author), Univ Marburg, Expt & Biol Psychol, Marburg, Germany.	anna.heuer@uni-marburg.de		Heuer, Anna/0000-0002-3088-1609	Deutsche Forschungsgemeinschaft (DFG) [60402257]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; IRTG 1901 "The Brain In Action", grant number 60402257) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle D. E., 2009, FRONT HUM NEUROSCI, V3, P1, DOI [DOI 10.3389/NEURO.09.006.2009, 10.3389/neuro.09.006.2009]; Astle DE, 2012, ATTEN PERCEPT PSYCHO, V74, P146, DOI 10.3758/s13414-011-0218-3; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Brown W, 1910, BRIT J PSYCHOL, V3, P296, DOI 10.1111/j.2044-8295.1910.tb00207.x; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; COWAN N, 1993, MEM COGNITION, V21, P162, DOI 10.3758/BF03202728; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Dell'Acqua R, 2010, NEUROPSYCHOLOGIA, V48, P419, DOI 10.1016/j.neuropsychologia.2009.09.033; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Drew T, 2012, J COGNITIVE NEUROSCI, V24, P440, DOI 10.1162/jocn_a_00107; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Fukuda K, 2011, PSYCHOL SCI, V22, P361, DOI 10.1177/0956797611398493; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Gunseli E, 2015, PSYCHON B REV, V22, P1334, DOI 10.3758/s13423-014-0796-x; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Ishihara S, 2010, ISHIHARAS TESTS FOR; Janczyk M, 2008, MEMORY, V16, P374, DOI 10.1080/09658210801941742; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kiyonaga A, 2013, PSYCHON B REV, V20, P228, DOI 10.3758/s13423-012-0359-y; Klaver P, 1999, NEUROREPORT, V10, P2001, DOI 10.1097/00001756-199907130-00002; Kuo BC, 2012, J COGNITIVE NEUROSCI, V24, P51, DOI 10.1162/jocn_a_00087; Kuo BC, 2009, J NEUROSCI, V29, P8032, DOI 10.1523/JNEUROSCI.0952-09.2009; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; LaRocque JJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00005; LaRocque JJ, 2013, J COGNITIVE NEUROSCI, V25, P127, DOI 10.1162/jocn_a_00305; Lepsien J, 2005, NEUROIMAGE, V26, P733, DOI 10.1016/j.neuroimage.2005.02.026; Lepsien J, 2007, CEREB CORTEX, V17, P2072, DOI 10.1093/cercor/bhl116; Lepsien J, 2011, NEUROPSYCHOLOGIA, V49, P1569, DOI 10.1016/j.neuropsychologia.2011.03.011; Lewis-Peacock JA, 2012, J COGNITIVE NEUROSCI, V24, P61, DOI 10.1162/jocn_a_00140; Luck S.J., 2005, INTRO EVENT RELATED; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Machizawa MG, 2012, PSYCHOL SCI, V23, P554, DOI 10.1177/0956797611431988; Makovski T, 2007, PSYCHON B REV, V14, P1072, DOI 10.3758/BF03193093; Matsukura M, 2007, PERCEPT PSYCHOPHYS, V69, P1422, DOI 10.3758/BF03192957; Mayer JS, 2007, NEUROIMAGE, V36, P441, DOI 10.1016/j.neuroimage.2007.03.007; Mazza V, 2013, J COGNITIVE NEUROSCI, V25, P697, DOI 10.1162/jocn_a_00349; Mazza V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017453; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Murray AM, 2013, PSYCHOL SCI, V24, P550, DOI 10.1177/0956797612457782; Nee DE, 2013, NEUROIMAGE, V74, P1, DOI 10.1016/j.neuroimage.2013.02.019; Nee DE, 2009, NEUROIMAGE, V45, P963, DOI 10.1016/j.neuroimage.2009.01.005; Nobre AC, 2004, J COGNITIVE NEUROSCI, V16, P363, DOI 10.1162/089892904322926700; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; Oberauer K, 2012, CURR DIR PSYCHOL SCI, V21, P164, DOI 10.1177/0963721412444727; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; Olivers CNL, 2011, NEUROPSYCHOLOGIA, V49, P1553, DOI 10.1016/j.neuropsychologia.2010.11.033; Pagano S, 2014, BRAIN RES, V1543, P244, DOI 10.1016/j.brainres.2013.11.025; Pagano S, 2012, NEUROPSYCHOLOGIA, V50, P754, DOI 10.1016/j.neuropsychologia.2012.01.009; Pertzov Y, 2013, J EXP PSYCHOL HUMAN, V39, P1224, DOI 10.1037/a0030947; Poch C, 2014, EUR J NEUROSCI, V40, P2399, DOI 10.1111/ejn.12589; Rerko L, 2013, J EXP PSYCHOL LEARN, V39, P1075, DOI 10.1037/a0031172; Robitaille N, 2010, NEUROIMAGE, V53, P1334, DOI 10.1016/j.neuroimage.2010.07.027; Sligte IG, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00175; Sligte IG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001699; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Tamber-Rosenau BJ, 2011, J COGNITIVE NEUROSCI, V23, P2905, DOI 10.1162/jocn.2011.21608; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; van Moorselaar D, 2015, J EXP PSYCHOL LEARN, V41, P1755, DOI 10.1037/xlm0000124; Van Velzen J, 2003, PSYCHOPHYSIOLOGY, V40, P827, DOI 10.1111/1469-8986.00083; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Williams M, 2013, PSYCHON B REV, V20, P348, DOI 10.3758/s13423-012-0354-3; Woodman GF, 2008, PSYCHON B REV, V15, P223, DOI 10.3758/PBR.15.1.223; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zokaei N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00853	73	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154228	10.1371/journal.pone.0154228	http://dx.doi.org/10.1371/journal.pone.0154228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27099938	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500169
J	Hwang, JP; Lim, I; Kong, CB; Jeon, DG; Byun, BH; Kim, BI; Choi, CW; Lim, SM				Hwang, Jae Pil; Lim, Ilhan; Kong, Chang-Bae; Jeon, Dae Geun; Byun, Byung Hyun; Kim, Byung Il; Choi, Chang Woon; Lim, Sang Moo			Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma	PLOS ONE			English	Article							FDG-PET; DIAGNOSTIC-ACCURACY; THERAPY RESPONSE; TUMORS; CANCER; FAMILY; BONE; CHEMOTHERAPY; RECURRENCE; SURVIVAL	Aim The aim of this retrospective study was to determine whether glucose metabolism assessed by using Fluorine-18 (F-18) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) provides prognostic information independent of established prognostic factors in patients with Ewing sarcoma. Methods We retrospectively reviewed the medical records of 34 patients (men, 19; women, 15; mean age, 14.5 +/- 9.7 years) with pathologically proven Ewing sarcoma. They had undergone F-18 FDG PET/CT as part of a pretreatment workup between September 2006 and April 2012. In this analysis, patients were classified by age, sex, initial location, size, and maximum standardized uptake value (SUVmax). The relationship between FDG uptake and survival was analyzed using the Kaplan-Meier method with the log-rank test and Cox's proportional hazards regression model. Results The median survival time for all 34 subjects was 999 days and the median SUV by using PET/CT was 5.8 (range, 2-18.1). Patients with a SUVmax <= 5.8 survived significantly longer than those with a SUVmax > 5.8 (median survival time, 1265 vs. 656 days; p = 0.002). Survival was also found to be significantly related to age (p = 0.024), size (p = 0.03), and initial tumor location (p = 0.036). Multivariate analysis revealed that a higher SUVmax (p = 0.003; confidence interval [CI], 3.63-508.26; hazard ratio [HR], 42.98), older age (p = 0.023; CI, 1.34-54.80; HR, 8.59), and higher stage (p = 0.03; CI, 1.21-43.95; HR, 7.3) were associated with worse overall survival. Conclusions SUVmax measured by pretreatment F-18-FDG PET/CT can predict overall survival in patients with Ewing sarcoma.	[Hwang, Jae Pil] Soonchunhyang Univ, Dept Nucl Med, Bucheon Hosp, Bucheon, South Korea; [Lim, Ilhan; Byun, Byung Hyun; Kim, Byung Il; Choi, Chang Woon; Lim, Sang Moo] Korea Inst Radiol & Med Sci, Dept Nucl Med, Seoul, South Korea; [Lim, Ilhan; Byun, Byung Hyun; Kim, Byung Il; Choi, Chang Woon; Lim, Sang Moo] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea; [Kong, Chang-Bae; Jeon, Dae Geun] Korea Inst Radiol & Med Sci, Dept Orthoped Surg, Seoul, South Korea	Soonchunhyang University; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences	Lim, I (corresponding author), Korea Inst Radiol & Med Sci, Dept Nucl Med, Seoul, South Korea.; Lim, I (corresponding author), Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea.	ilhan@kcch.re.kr			NRF [2011-0030162]; Korea Institute of Radiological and Medical Sciences (KIRAMS); Ministry of Science, ICT and Future Planning, Republic of Korea [1711031799/50441-2016]	NRF; Korea Institute of Radiological and Medical Sciences (KIRAMS); Ministry of Science, ICT and Future Planning, Republic of Korea	This study was partially supported by a grant of the NRF (Grant No. 2011-0030162) and Korea Institute of Radiological and Medical Sciences (KIRAMS), funded by Ministry of Science, ICT and Future Planning, Republic of Korea (1711031799/50441-2016).	Andersen KF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001142; Bestic JM, 2009, RADIOGRAPHICS, V29, P1487, DOI 10.1148/rg.295095024; Delbeke D, 2001, RADIOL CLIN N AM, V39, P883, DOI 10.1016/S0033-8389(05)70319-5; Eary JF, 2002, EUR J NUCL MED MOL I, V29, P1149, DOI 10.1007/s00259-002-0859-5; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Ferrari S, 2007, J PEDIAT HEMATOL ONC, V29, P364, DOI 10.1097/MPH.0b013e3180640d08; Franzius C, 2001, ANN ONCOL, V12, P479, DOI 10.1023/A:1011111322376; Furth C, 2006, PEDIATR BLOOD CANCER, V47, P607, DOI 10.1002/pbc.20662; Gaston LL, 2011, SKELETAL RADIOL, V40, P1007, DOI 10.1007/s00256-011-1096-4; Gupta K, 2011, CLIN NUCL MED, V36, P973, DOI 10.1097/RLU.0b013e31822f684b; Hawkins DE, 2010, PRINCIPLES PRACTICE, P987; Hawkins DS, 2005, J CLIN ONCOL, V23, P8828, DOI 10.1200/JCO.2005.01.7079; Hustinx R, 2002, SEMIN NUCL MED, V32, P35, DOI 10.1053/snuc.2002.29272; Lee J, 2010, CANCER-AM CANCER SOC, V116, P1964, DOI 10.1002/cncr.24937; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; McCarville MB, 2005, AM J ROENTGENOL, V184, P1293, DOI 10.2214/ajr.184.4.01841293; Newman EN, 2013, PEDIATR BLOOD CANCER, V60, P1113, DOI 10.1002/pbc.24406; Raciborska A, 2015, CLIN TRANSL ONCOL; Sharma P, 2013, EUR J NUCL MED MOL I, V40, P1036, DOI 10.1007/s00259-013-2388-9; Treglia G, 2012, SKELETAL RADIOL, V41, P249, DOI 10.1007/s00256-011-1298-9; van Maldegem AM, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-7; Wasilewski-Masker K, 2009, J NATL CANCER I, V101, P1709, DOI 10.1093/jnci/djp417	22	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153281	10.1371/journal.pone.0153281	http://dx.doi.org/10.1371/journal.pone.0153281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100297	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500028
J	Imhoff, S; da Silva, AP; Ghiberto, PJ; Tormena, CA; Pilatti, MA; Libardi, PL				Imhoff, Silvia; da Silva, Alvaro Pires; Ghiberto, Pablo J.; Tormena, Cassio A.; Pilatti, Miguel A.; Libardi, Paulo L.			Physical Quality Indicators and Mechanical Behavior of Agricultural Soils of Argentina	PLOS ONE			English	Article							LIMITING WATER RANGE; ORGANIC-MATTER; BULK-DENSITY; COMPRESSION; COMPACTION; CORN; MOLLISOLS; CAPACITY; TEXTURE; STRESS	Mollisols of Santa Fe have different tilth and load support capacity. Despite the importance of these attributes to achieve a sustainable crop production, few information is available. The objectives of this study are i) to assess soil physical indicators related to plant growth and to soil mechanical behavior; and ii) to establish relationships to estimate the impact of soil loading on the soil quality to plant growth. The study was carried out on Argiudolls and Hapludolls of Santa Fe. Soil samples were collected to determine texture, organic matter content, bulk density, water retention curve, soil resistance to penetration, least limiting water range, critical bulk density for plant growth, compression index, pre-consolidation pressure and soil compressibility. Water retention curve and soil resistance to penetration were linearly and significantly related to clay and organic matter (R-2 = 0.91 and R-2 = 0.84). The pedotransfer functions of water retention curve and soil resistance to penetration allowed the estimation of the least limiting water range and critical bulk density for plant growth. A significant nonlinear relationship was found between critical bulk density for plant growth and clay content (R-2 = 0.98). Compression index was significantly related to bulk density, water content, organic matter and clay plus silt content (R-2 = 0.77). Pre-consolidation pressure was significantly related to organic matter, clay and water content (R-2 = 0.77). Soil compressibility was significantly related to initial soil bulk density, clay and water content. A nonlinear and significantly pedotransfer function (R-2 = 0.88) was developed to predict the maximum acceptable pressure to be applied during tillage operations by introducing critical bulk density for plant growth in the compression model. The developed pedotransfer function provides a useful tool to link the mechanical behavior and tilth of the soils studied.	[Imhoff, Silvia] Consejo Nacl Invest Cient & Tecn, Esperanza, Santa Fe, Argentina; [Imhoff, Silvia; Ghiberto, Pablo J.; Pilatti, Miguel A.] Univ Nacl Litoral, Fac Ciencias Agr, Dept Ciencias Ambiente, Esperanza, Santa Fe, Argentina; [da Silva, Alvaro Pires; Libardi, Paulo L.] Univ Sao Paulo, Dept Ciencia Solo, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil; [Tormena, Cassio A.] Univ Estadual Maringa, Dept Agron, Maringa, Parana, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral; Universidade de Sao Paulo; Universidade Estadual de Maringa	Imhoff, S (corresponding author), Consejo Nacl Invest Cient & Tecn, Esperanza, Santa Fe, Argentina.; Imhoff, S (corresponding author), Univ Nacl Litoral, Fac Ciencias Agr, Dept Ciencias Ambiente, Esperanza, Santa Fe, Argentina.	simhoff@fca.unl.edu.ar	da Silva, Alvaro Pires/C-5973-2012; Tormena, Cassio/X-3091-2018	da Silva, Alvaro Pires/0000-0002-1544-7310; Tormena, Cassio/0000-0003-2351-9289; Imhoff, Silvia/0000-0001-7330-9728	CONICET (National Council of Scientific and Technical Research), Argentina; CNPq (National Council for Scientific and Technological Development), Brazil	CONICET (National Council of Scientific and Technical Research), Argentina; CNPq (National Council for Scientific and Technological Development), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CONICET (National Council of Scientific and Technical Research), Argentina (to SI), www.conicet.gov.ar; and CNPq (National Council for Scientific and Technological Development), Brazil (to APS), www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrou A, 1998, J AGR ENG RES, V71, P75, DOI 10.1006/jaer.1998.0300; An J, 2015, SOIL TILL RES, V145, P216, DOI 10.1016/j.still.2014.09.002; Aragon A, 2000, SOIL TILL RES, V56, P197, DOI 10.1016/S0167-1987(00)00144-6; Arthur E, 2013, GEODERMA, V193, P236, DOI 10.1016/j.geoderma.2012.09.001; Arvidsson J, 1998, SOIL TILL RES, V49, P159, DOI 10.1016/S0167-1987(98)00164-0; Benjamin JG, 2014, BIOENERG RES, V7, P468, DOI 10.1007/s12155-013-9400-x; Benjamin JG, 2013, AGRON J, V105, P713, DOI 10.2134/agronj2012.0104; BLAKE G. R., 1986, METHODS SOIL ANAL PH, P363, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C13; Botta GF, 2006, SOIL TILL RES, V86, P9, DOI 10.1016/j.still.2005.01.014; Bouma J., 1989, Advances in Soil Science, V9, P177; Busscher W. J., 1990, Transactions of the ASAE, V33, P519, DOI 10.13031/2013.31360; Miretti MC, 2010, SCI AGR, V67, P604, DOI 10.1590/S0103-90162010000500015; Chen GH, 2014, SOIL TILL RES, V136, P61, DOI 10.1016/j.still.2013.09.004; Cosentino D.J., 2002, CIENC SUELO, V20, P9; Daddow R.L., 1983, WSDGTN00005 USDA FOR; daSilva AP, 1997, SOIL SCI SOC AM J, V61, P877, DOI 10.2136/sssaj1997.03615995006100030023x; DASILVA AP, 1994, SOIL SCI SOC AM J, V58, P1775, DOI 10.2136/sssaj1994.03615995005800060028x; daSilva AP, 1996, PLANT SOIL, V184, P323, DOI 10.1007/BF00010461; Defossez P, 2002, SOIL TILL RES, V67, P41, DOI 10.1016/S0167-1987(02)00030-2; Diaz-Zorita M, 2000, SOIL TILL RES, V54, P121, DOI 10.1016/S0167-1987(00)00089-1; Fling A.L., 2002, METHODS SOIL ANAL 4, P229, DOI [10.2136/sssabookser5.4.c10, DOI 10.2136/SSSABOOKSER5.4.C10]; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Wilson MG, 2013, GEODERMA, V192, P354, DOI 10.1016/j.geoderma.2012.05.021; Horn R., 1994, Soil compaction in crop production., P45; Imhoff S, 2004, SOIL SCI SOC AM J, V68, P17, DOI 10.2136/sssaj2004.0017; Imhoff S, 2010, GEODERMA, V158, P268, DOI 10.1016/j.geoderma.2010.05.005; JACKSON M.L., 1982, ANALISIS QUIMICO SUE; Ghiberto PJ, 2015, SCI AGR, V72, P167, DOI 10.1590/0103-9016-2013-0414; Kaufmann M, 2010, J PLANT NUTR SOIL SC, V173, P573, DOI 10.1002/jpln.200900129; Keller T, 2007, EUR J SOIL SCI, V58, P1373, DOI 10.1111/j.1365-2389.2007.00944.x; Keller T, 2015, SOIL USE MANAGE, V31, P321, DOI 10.1111/sum.12175; Keller T, 2007, SOIL TILL RES, V92, P45, DOI 10.1016/j.still.2006.01.001; Keller T, 2011, GEODERMA, V163, P13, DOI 10.1016/j.geoderma.2011.02.006; Klute A., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P687; Lapen DR, 2004, SOIL TILL RES, V78, P151, DOI 10.1016/j.still.2004.02.004; LARSON WE, 1980, SOIL SCI SOC AM J, V44, P450, DOI 10.2136/sssaj1980.03615995004400030002x; Lipiec J, 2003, GEODERMA, V116, P107, DOI 10.1016/S0016-7061(03)00097-1; MCBRIDE RA, 1989, SOIL SCI SOC AM J, V53, P178, DOI 10.2136/sssaj1989.03615995005300010033x; McNabb DH, 1996, SOIL SCI SOC AM J, V60, P333, DOI 10.2136/sssaj1996.03615995006000020003x; MORRAS HJM, 1995, GEODERMA, V64, P281, DOI 10.1016/0016-7061(94)00024-5; Mosconi F, 1981, MAPA SUELOS PROVINCI; Mosteller F., 1977, DATA ANAL REGRESSION; Neter J, 1985, APPL LINEAR REGRESSI; OSULLIVAN MF, 1992, SOIL TILL RES, V24, P257, DOI 10.1016/0167-1987(92)90091-O; Pilatti MA, 2000, J SUSTAIN AGR, V17, P89, DOI 10.1300/J064v17n01_08; Rawls WJ, 2003, GEODERMA, V116, P61, DOI 10.1016/S0016-7061(03)00094-6; ROSS PJ, 1991, SOIL SCI SOC AM J, V55, P923, DOI 10.2136/sssaj1991.03615995005500040004x; Safadoust A, 2014, AGR WATER MANAGE, V136, P34, DOI 10.1016/j.agwat.2014.01.007; Saffih-Hdadi K, 2009, SOIL TILL RES, V105, P96, DOI 10.1016/j.still.2009.05.012; SAS Institute Inc, 1991, SAS STAT US GUID VER; Soane B. D., 1994, Soil compaction in crop production., P1; SOANE BD, 1990, SOIL TILL RES, V16, P179, DOI 10.1016/0167-1987(90)90029-D; Soriano A., 1991, ECOSYSTEMS WORLD A, P367; Tang AM, 2009, GEODERMA, V148, P282, DOI 10.1016/j.geoderma.2008.10.012; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; To J, 2005, GEODERMA, V126, P261, DOI 10.1016/j.geoderma.2004.08.006; VEPRASKAS MJ, 1984, SOIL SCI SOC AM J, V48, P1220, DOI 10.2136/sssaj1984.03615995004800060003x; Wosten JHM, 2001, J HYDROL, V251, P123, DOI 10.1016/S0022-1694(01)00464-4; Zhang B, 2005, SOIL SCI SOC AM J, V69, P864, DOI 10.2136/sssaj2003.0256; Zhang HQ, 1997, SOIL SCI SOC AM J, V61, P239, DOI 10.2136/sssaj1997.03615995006100010033x	60	29	32	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153827	10.1371/journal.pone.0153827	http://dx.doi.org/10.1371/journal.pone.0153827			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099925	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500073
J	Inagaki, Y; Fujioka, M; Kanzaki, S; Watanabe, K; Oishi, N; Itakura, G; Yasuda, A; Shibata, S; Nakamura, M; Okano, HJ; Okano, H; Ogawa, K				Inagaki, Yozo; Fujioka, Masato; Kanzaki, Sho; Watanabe, Kotaro; Oishi, Naoki; Itakura, Go; Yasuda, Akimasa; Shibata, Shinsuke; Nakamura, Masaya; Okano, Hirotaka James; Okano, Hideyuki; Ogawa, Kaoru			Sustained Effect of Hyaluronic Acid in Subcutaneous Administration to the Cochlear Spiral Ganglion	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; SPINAL-CORD-INJURY; INNER EAR BARRIER; STEM-CELLS; GENE; EXPRESSION; INJECTION; HANDICAP; DELIVERY; MICE	The spatiotemporal distribution of drugs in the inner ear cannot be precisely evaluated because of its small area and complex structure. In the present study, we used hyaluronic acid (HA)-dispersed luciferin to image transgenic mice and to determine the effect of HA on controlled drug delivery to the cochlea. GFAP-luc mice, which express luciferase in cochlear spiral ganglion cells, were subcutaneously administered HA-luciferin (HA-sc) or luciferin dissolved in saline (NS-sc) or intraperitoneally administered luciferin dissolved in saline (NS-ip). The bioluminescence of luciferin was monitored in vivo in real time. The peak time and half-life of fluorescence emission were significantly increased in HA-sctreated mice compared with those in NS-sc- and NS-ip-treated mice; however, significant differences were not observed in peak photon counts. We detected differences in the pharmacokinetics of luciferin in the inner ear, including its sustained release, in the presence of HA. The results indicate the clinical potential of using HA for controlled drug delivery to the cochlea.	[Inagaki, Yozo; Fujioka, Masato; Kanzaki, Sho; Watanabe, Kotaro; Oishi, Naoki; Ogawa, Kaoru] Keio Univ, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo, Japan; [Itakura, Go; Yasuda, Akimasa; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthoped, Shinjuku Ku, Tokyo, Japan; [Shibata, Shinsuke; Okano, Hirotaka James; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan	Keio University; Keio University; Keio University	Kanzaki, S (corresponding author), Keio Univ, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo, Japan.	skan@a7.keio.jp	Okano, Hideyuki/I-7584-2019; Okano, Hideyuki/X-9131-2019; Shibata, Shinsuke/AAM-6620-2020; Oishi, Naoki/ABG-7065-2020; Nakamura, Masaya/K-4111-2013	Okano, Hideyuki/0000-0001-7482-5935; Oishi, Naoki/0000-0001-8204-9518; Okano, Hirotaka James/0000-0003-4611-7098; Fujioka, Masato/0000-0002-5317-0885; Shibata, Shinsuke/0000-0002-1185-9043	MEXT (Ministry of Education, Culture, Sports, Science and Technology) KAKENHI [25861590, 24592560, 15H04991]; MHLW (Comprehensive Research on Disability Health and Welfare); Takeda Science Foundation; MEXT KAKENHI [25861590, 24592560, 15H04991]	MEXT (Ministry of Education, Culture, Sports, Science and Technology) KAKENHI; MHLW (Comprehensive Research on Disability Health and Welfare); Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a MEXT (Ministry of Education, Culture, Sports, Science and Technology) KAKENHI Grant-in-Aid for Young Scientists (B) (25861590) to Y.I., a MEXT (Ministry of Education, Culture, Sports, Science and Technology) KAKENHI Grant-in-Aid for Scientific Research (C) (24592560) and (B) (15H04991), grants from the MHLW (Comprehensive Research on Disability Health and Welfare) and the Takeda Science Foundation to M.F., and a grant from MEXT (Ministry of Education, Culture, Sports, Science and Technology) KAKENHI to S.K.; We are grateful to Ayano Mitsui for technical assistance and Makoto Hosoya for helpful comments and discussions. This work was supported by a MEXT KAKENHI Grant-in-Aid for Young Scientists (B) (25861590) to Y.I, a MEXT KAKENHI Grant-in-Aid for Scientific Research (C) (24592560) and (B) (15H04991), grants from the MHLW (Comprehensive Research on Disability Health and Welfare) and the Takeda Science Foundation to M.F, and a grant from MEXT KAKENHI to S.K.	Balazs EA, 2008, CURR PHARM BIOTECHNO, V9, P236, DOI 10.2174/138920108785161596; Bear Zachary W, 2014, Mo Med, V111, P352; Borden RC, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000313506; Crane RA, 2015, LARYNGOSCOPE, V125, P209, DOI 10.1002/lary.24834; Dallan I, 2014, J LARYNGOL OTOL, V128, P669, DOI 10.1017/S0022215114001595; Gibbs P, 2011, CANCER CHEMOTH PHARM, V67, P153, DOI 10.1007/s00280-010-1303-3; Goldman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018269; Goto M, 2001, CLIN EXP RHEUMATOL, V19, P377; Gouveris H, 2011, OTOL NEUROTOL, V32, P756, DOI 10.1097/MAO.0b013e31821a3fc3; Iwasaki S, 2013, OTOL NEUROTOL, V34, P644, DOI 10.1097/MAO.0b013e318287f1fe; Kanzaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048480; Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z; Ogawa K, 2002, OTOL NEUROTOL, V23, P665, DOI 10.1097/00129492-200209000-00011; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Saito T, 2001, BRAIN RES, V895, P253, DOI 10.1016/S0006-8993(01)02020-0; Shibata SB, 2012, HUM GENE THER, V23, P302, DOI 10.1089/hum.2011.086; Tomioka K, 2013, QUAL LIFE RES, V22, P1151, DOI 10.1007/s11136-012-0235-2; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Yamazaki M, 2012, NEURORADIOLOGY, V54, P1161, DOI 10.1007/s00234-012-1078-9; Zhang WS, 2003, DRUG METAB DISPOS, V31, P1054, DOI 10.1124/dmd.31.8.1054; Zhang ZJ, 2000, BRAIN RES, V852, P116, DOI 10.1016/S0006-8993(99)02223-4; Zhu LY, 2004, NEUROSCI LETT, V367, P210, DOI 10.1016/j.neulet.2004.06.020	22	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153957	10.1371/journal.pone.0153957	http://dx.doi.org/10.1371/journal.pone.0153957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099926	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500109
J	Linzmeier, BJ; Kozdon, R; Peters, SE; Valley, JW				Linzmeier, Benjamin J.; Kozdon, Reinhard; Peters, Shanan E.; Valley, John W.			Oxygen Isotope Variability within Nautilus Shell Growth Bands	PLOS ONE			English	Article							EARLY-LIFE-HISTORY; WESTERN INTERIOR SEAWAY; CHAMBERED CEPHALOPODS; ARCTICA-ISLANDICA; HABITAT; POMPILIUS; CARBON; FRACTIONATION; MACROMPHALUS; TEMPERATURE	Nautilus is often used as an analogue for the ecology and behavior of extinct externally shelled cephalopods. Nautilus shell grows quickly, has internal growth banding, and is widely believed to precipitate aragonite in oxygen isotope equilibrium with seawater. Pieces of shell from a wild-caught Nautilus macromphalus from New Caledonia and from a Nautilus belauensis reared in an aquarium were cast in epoxy, polished, and then imaged. Growth bands were visible in the outer prismatic layer of both shells. The thicknesses of the bands are consistent with previously reported daily growth rates measured in aquarium reared individuals. In situ analysis of oxygen isotope ratios using secondary ion mass spectrometry (SIMS) with 10 mu m beam-spot size reveals inter-and intra-band delta O-18 variation. In the wild-caught sample, a traverse crosscutting 45 growth bands yielded delta O-18 values ranging 2.5 parts per thousand, from +0.9 to -1.6 parts per thousand (VPDB), a range that is larger than that observed in many serial sampling of entire shells by conventional methods. The maximum range within a single band (similar to 32 mu m) was 1.5 parts per thousand, and 27 out of 41 bands had a range larger than instrumental precision (+/- 2 SD = 0.6 parts per thousand). The results from the wild individual suggest depth migration is recorded by the shell, but are not consistent with a simple sinusoidal, diurnal depth change pattern. To create the observed range of delta O-18, however, this Nautilus must have traversed a temperature gradient of at least similar to 12 degrees C, corresponding to approximately 400 m depth change. Isotopic variation was also measured in the aquarium-reared sample, but the pattern within and between bands likely reflects evaporative enrichment arising from a weekly cycle of refill and replacement of the aquarium water. Overall, this work suggests that depth migration behavior in ancient nektonic mollusks could be elucidated by SIMS analysis across individual growth bands.	[Linzmeier, Benjamin J.; Peters, Shanan E.; Valley, John W.] Univ Wisconsin, Dept Geosci, Madison, WI USA; [Kozdon, Reinhard] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Kozdon, Reinhard; Valley, John W.] Univ Wisconsin, Dept Geosci, WiscSIMS, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Columbia University; University of Wisconsin System; University of Wisconsin Madison	Linzmeier, BJ (corresponding author), Univ Wisconsin, Dept Geosci, Madison, WI USA.	blinzmeier@wisc.edu	Valley, John W./B-3466-2011; Linzmeier, Benjamin J./AAD-5397-2020; Peters, Shanan E/A-5620-2013	Valley, John W./0000-0003-3530-2722; Linzmeier, Benjamin J./0000-0002-3148-4971; Peters, Shanan E/0000-0002-3346-4317	Geoscience Department at UW-Madison; Sigma Xi; U.S. Department of Energy Office of Science, Office of Basic Energy Sciences [DE-FG02-93ER14389]; National Science Foundation [EAR-1053466, EAR-1355590]; Directorate For Geosciences [1355590] Funding Source: National Science Foundation	Geoscience Department at UW-Madison; Sigma Xi; U.S. Department of Energy Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this study came from the Geoscience Department at UW-Madison, Sigma Xi, and the U.S. Department of Energy Office of Science, Office of Basic Energy Sciences under Award Number DE-FG02-93ER14389. WiscSIMS is partially supported by the National Science Foundation (EAR-1053466 and -1355590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Auclair AC, 2004, CHEM GEOL, V207, P91, DOI 10.1016/j.chemgeo.2004.02.006; BARBIN V, 1992, LETHAIA, V25, P391, DOI 10.1111/j.1502-3931.1992.tb01642.x; Basil JA, 2000, J EXP BIOL, V203, P1409; BERRY WILLIAM B. N., 1968, NATURE [LONDON], V217, P938, DOI 10.1038/217938b0; Cappa CD, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003597; Carlson B, 1992, HAWAII SHELL NEWS, pXL; Carlson B, 1991, CHAMBERED NAUT NEWSL; CARLSON BA, 1984, PAC SCI, V38, P183; Cavosie AJ, 2005, EARTH PLANET SC LETT, V235, P663, DOI 10.1016/j.epsl.2005.04.028; Clark GR, 1999, PALAEOGEOGR PALAEOCL, V149, P305, DOI 10.1016/S0031-0182(98)00208-9; CLARK GR, 1974, ANNU REV EARTH PL SC, V2, P77, DOI 10.1146/annurev.ea.02.050174.000453; Cochran JK, 2003, PALAEOGEOGR PALAEOCL, V191, P45, DOI 10.1016/S0031-0182(02)00642-9; COCHRAN JK, 1984, NATURE, V308, P725, DOI 10.1038/308725a0; COCHRAN JK, 1981, PALEOBIOLOGY, V7, P469, DOI 10.1017/S0094837300025525; COPLEN TB, 1988, CHEM GEOL, V72, P293, DOI 10.1016/0168-9622(88)90042-5; CRICK RE, 1985, J MAR BIOL ASSOC UK, V65, P415, DOI 10.1017/S0025315400050517; CROCKER KC, 1985, GEOCHIM COSMOCHIM AC, V49, P2527, DOI 10.1016/0016-7037(85)90120-6; de Aguiar DC, 2012, BIOIKOS, P26; Dennis KJ, 2013, EARTH PLANET SC LETT, V362, P51, DOI 10.1016/j.epsl.2012.11.036; DOGUZHAEVA L, 1982, LETHAIA, V15, P385, DOI 10.1111/j.1502-3931.1982.tb01703.x; Dunstan AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016311; EICHLER R, 1966, SCIENCE, V153, P734, DOI 10.1126/science.153.3737.734; Fatherree JW, 1998, PALAIOS, V13, P376, DOI 10.2307/3515325; Friedmann I, 1977, DATA GEOCHEMISTRY; Goodwin DH, 2001, PALAIOS, V16, P387, DOI 10.2307/3515578; Gregoire C, 1987, ULTRASTRUCTURE NAUTI, P463; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; Guiguer KRRA, 2003, RAPID COMMUN MASS SP, V17, P463, DOI 10.1002/rcm.935; Guzman N, 2007, MICROSC MICROANAL, V13, P397, DOI 10.1017/S1431927607070705; Hamada T., 1987, Topics in Geobiology, P579; House M.R., 1987, Topics in Geobiology, P53; Jackson GD, 2001, MAR BIOL, V138, P819, DOI 10.1007/s002270000496; JONES DS, 1983, AM SCI, V71, P384; JONES DS, 1989, MAR BIOL, V102, P225, DOI 10.1007/BF00428284; JONES DS, 1980, PALEOBIOLOGY, V6, P331, DOI 10.1017/S0094837300006837; KAHN PGK, 1978, NATURE, V275, P606, DOI 10.1038/275606a0; Kampstra P., 2014, PACKAGE BEANPLOT; Kim ST, 2007, CHEM GEOL, V246, P135, DOI 10.1016/j.chemgeo.2007.08.005; Kim ST, 2007, GEOCHIM COSMOCHIM AC, V71, P4704, DOI 10.1016/j.gca.2007.04.019; Kita NT, 2015, J ANAL ATOM SPECTROM, V30, P1207, DOI 10.1039/c4ja00349g; Kita NT, 2009, CHEM GEOL, V264, P43, DOI 10.1016/j.chemgeo.2009.02.012; Kozdon R, 2009, CHEM GEOL, V258, P327, DOI 10.1016/j.chemgeo.2008.10.032; Kozdon R, 2013, PALEOCEANOGRAPHY, V28, P517, DOI 10.1002/palo.20048; Kozdon R, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002056; Kruta I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087479; LANDMAN NH, 1988, EARTH PLANET SC LETT, V89, P28, DOI 10.1016/0012-821X(88)90030-1; LANDMAN NH, 1983, PALEOBIOLOGY, V9, P269, DOI 10.1017/S0094837300007685; LANDMAN NH, 1983, LETHAIA, V16, P248, DOI 10.1111/j.1502-3931.1983.tb01150.x; LANDMAN NH, 1994, PALEOBIOLOGY, V20, P40, DOI 10.1017/S009483730001112X; Lecuyer C., 2006, eEarth, V1, P1; Linzmeier BJ., 2012, THESIS U WISCONSIN M; Locarnini R. A., 2013, WORLD OCEAN ATLAS 20, V1; Loudon ASI, 2012, CURR BIOL, V22, pR570, DOI 10.1016/j.cub.2012.06.023; Lukeneder A, 2015, TOP GEOBIOL, V43, P689, DOI 10.1007/978-94-017-9630-9_18; Lukeneder A, 2010, EARTH PLANET SC LETT, V296, P103, DOI 10.1016/j.epsl.2010.04.053; Martin A.W., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V156, P207; Matta ME, 2013, RAPID COMMUN MASS SP, V27, P691, DOI 10.1002/rcm.6502; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; Meisel DV, 2006, J COMP PSYCHOL, V120, P191, DOI 10.1037/0735-7036.120.3.191; Meyers S., 2014, ASTROCHRON R PACKAGE; Miyaji T, 2010, PALAEOGEOGR PALAEOCL, V286, P107, DOI 10.1016/j.palaeo.2009.11.032; Moriya K, 2003, GEOLOGY, V31, P167, DOI 10.1130/0091-7613(2003)031<0167:DHOLCA>2.0.CO;2; Moriya K, 2015, TOP GEOBIOL, V43, P793, DOI 10.1007/978-94-017-9630-9_19; Mutvei H., 1964, Arkiv for Zoologi, V16, P221; OBA T, 1992, MAR BIOL, V113, P211; Ohno A, 2015, LETHAIA, V48, P332, DOI 10.1111/let.12109; Okamoto Takashi, 1996, Topics in Geobiology, V13, P225; Orland IJ, 2009, QUATERNARY RES, V71, P27, DOI 10.1016/j.yqres.2008.08.005; Orland IJ, 2012, THESIS U WISCONSIN M; Rasband W., 2006, IMAGEJ; Ritterbush KA, 2012, PALEOBIOLOGY, V38, P424, DOI 10.1666/10027.1; Rollion-Bard C, 2003, CORAL REEFS, V22, P405, DOI 10.1007/s00338-003-0347-9; SAUNDERS WB, 1983, PALEOBIOLOGY, V9, P280, DOI 10.1017/S0094837300007697; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P469, DOI 10.1017/S0094837300008472; Schlogl J, 2011, PALAEOGEOGR PALAEOCL, V308, P330, DOI 10.1016/j.palaeo.2011.05.037; Schone BR, 2005, PALAIOS, V20, P78, DOI 10.2110/palo.2003.p03-101; Stevens K, 2015, PALAEOGEOGR PALAEOCL, V417, P164, DOI 10.1016/j.palaeo.2014.10.031; TAYLOR BE, 1983, PALAEOGEOGR PALAEOCL, V41, P1, DOI 10.1016/0031-0182(83)90072-X; THOMPSON I, 1980, MAR BIOL, V57, P25, DOI 10.1007/BF00420964; TOURTELOT HA, 1969, GEOL SOC AM BULL, V80, P1903, DOI 10.1130/0016-7606(1969)80[1903:DOOACI]2.0.CO;2; Valley J.W., 2009, SECONDARY ION MASS S, V41, P19; WARD P, 1984, NATURE, V309, P248, DOI 10.1038/309248a0; WARD P, 1978, J EXP ZOOL, V205, P5, DOI 10.1002/jez.1402050103; WARD PD, 1980, VELIGER, V22, P259; WARD PD, 1985, PALEOBIOLOGY, V11, P438, DOI 10.1017/S0094837300011726; Watanabe T, 2003, GEOCHIM COSMOCHIM AC, V67, P1349, DOI 10.1016/S0016-7037(02)01221-8; Westermann B, 2004, J EXP ZOOL PART A, V301A, P930, DOI 10.1002/jez.a.116; Westermann Gerd E.G., 1996, Topics in Geobiology, V13, P607; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Wilkinson BH, 2002, PALAEOGEOGR PALAEOCL, V185, P95, DOI 10.1016/S0031-0182(02)00279-1; Willey A, 1902, CONTRIBUTION NATURAL; Zakharov YD, 2006, GEOSCI J, V10, P331, DOI 10.1007/BF02910374	93	33	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153890	10.1371/journal.pone.0153890	http://dx.doi.org/10.1371/journal.pone.0153890			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100183	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500087
J	Magalhaes, T; Robles, R; Felder, DL; Mantelatto, FL				Magalhaes, Tatiana; Robles, Rafael; Felder, Darryl L.; Mantelatto, Fernando L.			Integrative Taxonomic Study of the Purse Crab Genus Persephona Leach, 1817 (Brachyura: Leucosiidae): Combining Morphology and Molecular Data	PLOS ONE			English	Article							SAO-PAULO STATE; BENTHIC INVERTEBRATES; PHYLOGENETIC ANALYSIS; MEDITERRANEA HERBST; DECAPOD CRUSTACEANS; MAXIMUM-LIKELIHOOD; MITOCHONDRIAL 16S; SEXUAL-MATURITY; NORTHERN COAST; UBATUBA BAY	Marine crabs of the genus Persephona Leach, 1817 are restricted to American waters of the western Atlantic and eastern Pacific Oceans. Subfamilial assignment of this taxon has varied between authors and its species composition remain in question. We conducted a comparative study based on morphology and molecular phylogenetics for all ten recognized species of Persephona, along with Iliacantha hancocki. We tested whether Persephona finneganae, P. lichtensteinii, and P. crinita represent a single species as suggested by some authors; whether specimens identified as P. punctata, P. mediterranea, and P. aquilonaris warrant treatment as separate species; and whether I. hancocki should be regarded as a junior synonym of P. subovata. Diagnostic morphological characters (of the carapace, chelipeds, and third maxillipeds) were used along with gonopod (male first pleopod 1) features and live coloration. The 16S rRNA and the Cytochrome Oxidase I (COI) (DNA barcoding) mitochondrial genes were used as molecular markers. Both morphological and molecular analyses revealed that putative specimens of P. crinita from Brazil and those assigned to P. finneganae were no different from specimens presently assignable to P. lichtensteinii. P. finneganae is regarded as a junior synonym of P. lichtensteinii, and we apply P. crinita only to specimens we examined from the Gulf of Mexico. Specimens from Brazil previously reported as P. crinita are herewith concluded to represent P. lichtensteinii. Additionally, P. townsendi is a junior synonym of P. orbicularis, Iliacantha hancocki is concluded to be a junior synonym of P. subovata, while P. aquilonaris and P. mediterranea are found to represent separate species. On the basis of our revisions, eight species of Persephona are considered valid, and the reported distribution for P. crinita is restricted.	[Magalhaes, Tatiana; Robles, Rafael; Mantelatto, Fernando L.] Univ Sao Paulo, LBSC, Dept Biol, FFCLRP, Sao Paulo, Brazil; [Felder, Darryl L.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA	Universidade de Sao Paulo; University of Louisiana Lafayette	Mantelatto, FL (corresponding author), Univ Sao Paulo, LBSC, Dept Biol, FFCLRP, Sao Paulo, Brazil.	flmantel@usp.br	Robles, Rafael/F-1967-2010; Magalhães, Tatiana/U-5666-2018; Mantelatto, Fernando/N-9536-2019; Mantelatto, Fernando/GQI-1333-2022; robles, rafael/Y-4087-2019	Robles, Rafael/0000-0003-0531-5557; Magalhães, Tatiana/0000-0003-1573-3533; Mantelatto, Fernando/0000-0002-8497-187X; Mantelatto, Fernando/0000-0002-8497-187X; robles, rafael/0000-0003-0531-5557	CAPES; CNPq [301359/2007-5, 473050/2007-2, 302748/2010-5, 304968/2014-5, 157489/2010-8, 500460/2010-8]; CAPES (Ciencias do Mar II) [2005/2014 - 23038.004308/201414]; Postgraduate Program in Comparative Biology of the FFCLRP/USP via PROAP/CAPES; Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo [2011.1.2642.59.2]; U.S. NSF/AToL [EF-0531603]; U.S. NSF/RAPID [DEB 1045690]; GoMRI [GRI-112-8]; FAPESP [2013/05663-8];  [FAPESP Tematico Biota 2010/50188-8];  [Colecoes Cientificas 2009/54931-0]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Ciencias do Mar II)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Postgraduate Program in Comparative Biology of the FFCLRP/USP via PROAP/CAPES; Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo; U.S. NSF/AToL; U.S. NSF/RAPID; GoMRI; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; 	The present study was part of a master's thesis by TM supported by scientific fellowships from CAPES. Financial support was provided by research grants (FAPESP Tematico Biota 2010/50188-8; Colecoes Cientificas 2009/54931-0), CNPq (Proc. 301359/2007-5; 473050/2007-2; 302748/2010-5; 304968/2014-5), and CAPES (Ciencias do Mar II Proc. 2005/2014 - 23038.004308/201414) to FLM. TM and RR were under continued support by a PhD fellowship from CAPES and post-doctoral fellowships from CNPQ (Proc. 157489/2010-8; 500460/2010-8) and FAPESP (Proc. 2013/05663-8), respectively. We are grateful to the Postgraduate Program in Comparative Biology of the FFCLRP/USP for partial financial support via PROAP/CAPES. Additional funding for work by TM at UL-Lafayette period was provided by grants from Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo (Proc. 2011.1.2642.59.2) to FLM/TM and U.S. NSF/AToL EF-0531603, U.S. NSF/RAPID DEB 1045690, and GoMRI grant GRI-112-8 to DLF.	Abele L, 1970, THESIS FLORIDA STATE; ABELE L G, 1971, Crustaceana (Leiden), V21, P218, DOI 10.1163/156854071X00427; Abele L.G., 1986, TECHNICAL SERIES, V8, P1; Almeida Alexandre O., 2008, Nauplius, V16, P23; Almeida AC, 2013, J MAR BIOL ASSOC UK, V93, P1581, DOI 10.1017/S002531541200197X; Almeida EAB, 2008, APIDOLOGIE, V39, P75, DOI 10.1051/apido:2007063; Alvarez Fernando, 1999, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V70, P1; Anker A, 2011, ZOOTAXA, P63; Ariza Paola, 2008, Bol. Invest. Mar. Cost., V37, P155; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barros MP, 2001, B MUSEU PARAENSE E Z, V17, P15; Behre E. H., 1950, Occasional Papers of the Marine Laboratory Baton Rouge, VNo. 6, P1; BELL T., 1855, T LINNEAN SOC LOND 4, V21, P277, DOI DOI 10.1111/J.1096-3642.1852.TB00464.X; Bertini G, 2004, BIODIVERS CONSERV, V13, P2185, DOI 10.1023/B:BIOC.0000047900.96123.34; Bertini G, 2010, INVERTEBR REPROD DEV, V54, P7, DOI 10.1080/07924259.2010.9652311; Boone L., 1930, Bulletin of the Vanderbilt Marine Museum, V2, P1; Bordin G, 1987, SERIE ZOOLOGIA, V66, P3; Boschi Enrique E., 2000, Revista de Investigacion y Desarrollo Pesquero, V13, P7; Bracken-Grissom HD, 2014, SYST BIOL, V63, P457, DOI 10.1093/sysbio/syu008; Braga Adriane A., 2005, Biota Neotropica, V5, P1; Branco Joaquim Olinto, 2004, Rev. Bras. Zool., V21, P91, DOI 10.1590/S0101-81752004000100016; Brandis D, 1999, J MORPHOL, V239, P157, DOI 10.1002/(SICI)1097-4687(199902)239:2<157::AID-JMOR4>3.0.CO;2-E; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Browne P, 1956, CIVIL NATURAL HIST J; Buhay JE, 2008, J CRUSTACEAN BIOL, V28, P57, DOI 10.1651/07-2827R.1; Buitendijk A. M., 1950, Zoologische Mededeelingen Leiden, V30, P269; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Camp DK, 1998, CHECKLISTS SELECTED; Carvalho F.L., 2010, NAUPLIUS, V18, P109; CERAMEVIVAS MJ, 1966, ECOLOGY, V47, P260, DOI 10.2307/1933773; Coelho P.A., 1981, Revista Nordestina de Biologia, V3, P67; COELHO P. A., 1983, ANAIS SOC NORDESTINA, V1, P133; Coelho P.A., 1972, TRABALHOS INSTITUTO, V13, P133, DOI 10.5914/tropocean.v13i1.2555; COELHO PA, 1986, CADERNOS OMEGA U FED, V2, P79; Coelho PA, 2008, ZOOTAXA, P1; Collins J.S.H., 2009, Scripta Geologica (Leiden), V138, P23; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Compton H, 1962, SURVEY COMMERCIAL SH, V20; Correa-Sandoval F, 1991, CATALOGO BIBLIOGRAFI; Costa FO, CANADIAN J FISHERIES, V64, P272; Crane J, 1937, SCI CONTRIBUTIONS NE, V22, P97; de Abreu J., 1980, Boletim do Instituto Oceanografico, V29, P1; de CASTRO ALCEU LEMOS, 1962, ARQ MUS NAC [RIO DE JANEIRO], V52, P37; del Solar EM, 1970, CATALOGO CRUSTACEOS; Desbonne I, 1867, CRUSTADES GUADELOUPE; DiMauro Jr AA, 1982, REDISCOVERY T BELLS, V76, P155; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fabricius JC., 1798, ENTOMOLOGIAE SYSTE S; Fausto-Filho J, 1968, B SOC CEARENSE AGRON, V9, P462; Fausto-Filho J., 1966, ARQUIVOS ESTACAO BIO, V6, P31; Felder D. L., 2009, GULF MEXICO ORIGIN W, V1, P1, DOI DOI 10.1086/659907; Felder DL., 1973, ANNOTATED KEY CRABS; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng YW, 2011, MOL BIOL REP, V38, P291, DOI 10.1007/s11033-010-0107-1; Finnegan S., 1931, J LINNEAN SOC LONDON, V37, P607, DOI [DOI 10.1111/J.1096-3642.1931.TB02367.X, 10.1111/j.1096-3642.1931.tb02367.x]; Furlan M, 2013, AN ACAD BRAS CIENC, V85, P1345, DOI 10.1590/0001-3765201394812; Garth J. S., 1946, Allan Hancock Pacific Expedition, V5, P341; GARTH JOHN S., 1948, BULL AMER MUS NAT HIST, V92, P1; GARTH JS, 1960, SYST ZOOL, V9, P105, DOI 10.2307/2411960; GARTH JS, 1966, ZOOLOGICA-N Y, V51, P1; Garth JS, 1991, GALAPAGOS MARINE INV; Garth SJ, 1957, LUNDS U ARSSKRIFT, V7, P1; Gibbes L.R, 1850, P AM ASS ADV SCI, V3, P165; Gomes Correa M.M., 1980, Atas da Sociedade de Biologia do Rio de Janeiro, V21, P59; GUINOT-DUMORTIER D., 1959, BULL MUS NATL HIST NAT [PARIS], V31, P423; Hall T, 2005, BIOL SEQUENCE ALIGNM; Harrison JS, 2004, MOL PHYLOGENET EVOL, V30, P743, DOI 10.1016/S1055-7903(03)00250-1; Hay W. P., 1918, Bulletin US Bureau Fisheries, V35; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hendrickx M. E., 1997, CANGREJOS BRAQUIUROS; Hendrickx ME, 1996, REV BIOL TROP, V44, P945; Hendrickx Michel E., 1993, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V64, P1; Hendrickx Michel E., 1995, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V65, P125; Herbst JFW, 1782, BERLIN STRALSUND, V3, P1; Hildebrand HH, 1954, PUBL I MAR SCI U TEX, V3, P229; Hirose GL, 2012, ZOOTAXA, P17, DOI 10.11646/zootaxa.3167.1.2; Holthuis L. B., 1959, ZOOLOGISCHE VERHANDE, V44, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; Kingsley JS, 1878, P ACAD NAT SCI PHILA, V30, P316; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Leach WE, 1817, ZOOLOGICAL MISCELLAN, V3; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lemaitre R, 1991, B INVEST MAR COST, V21, P33; Lichtenstein KH, 1815, MAGAZIN GESELLSCHAFF, V7, P135; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Luederwaldt H., 1919, Revista do Museu Paulista, V11; Magalhaes C, 2010, ZOOTAXA, P52; Mantelatto FLM, 2006, ZOOSYSTEMA, V28, P495; Mantelatto FL, 2003, COMP PARASITOL, V70, P211, DOI 10.1654/4066; Mantelatto FLM, 2000, J SHELLFISH RES, V19, P701; Martin JW, 2009, DECAPOD CRUSTACEAN P; Martinez Gaston, 2009, Pan-American Journal of Aquatic Sciences, V4, P279; Martinez-Iglesias JC, 1986, POEYANA, V332, P5; MAURER D, 1984, J NAT HIST, V18, P47, DOI 10.1080/00222938400770071; Melo GAS, 2006, MAN ID BRACH CAR SIR; Miers EJ., 1886, REPORT SCI RESULTS V; Milne Edwards H., 1837, HIST NATURELLE CRUST, V2; Moreira C., 1901, ARCHIVOMUSEU NACL, V11, P1; Moreira C, 1903, ARCH MUSEU NACL RIO, V12, P119; Moscoso V., 2012, B I MAR PER, V27, P8; Munasinghe DHN, 2003, J CRUSTACEAN BIOL, V23, P402, DOI 10.1651/0278-0372(2003)023[0402:UOMDSF]2.0.CO;2; NEGREIROSFRANSOZO ML, 1989, CRUSTACEANA, V57, P177, DOI 10.1163/156854089X00509; Nei M., 2000, MOL EVOLUTION PHYLOG; Neigel JE, 2009, GULF MEXICO ORIGIN W, V1; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Ocampo EH, 2013, ZOOL J LINN SOC-LOND, V169, P27, DOI 10.1111/zoj.12045; Ortiz M, 2011, RESTAURACION ACTUALI, V4, P45; OVERSTREET RM, 1978, GULF RES REP, V6, P145; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; Parra A, 1787, DESCRIPCION DIFERENT; PAUL R K G, 1980, Bulletin Southern California Academy of Sciences, V79, P109; Pileggi LG, 2014, ZOOKEYS, P109, DOI 10.3897/zookeys.457.6818; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powers L.W., 1977, CONTRIBUTIONS MARINE, V20, P1; Rambaut A., 2007, TRACER V1 4 MCMC TRA; Vieira RRR, 2010, BIOTA NEOTROP, V10, P431, DOI 10.1590/S1676-06032010000300036; Rathbun M. J., 1937, Bulletin United States National Museum, Vno. 166, P1; Rathbun M. J., 1898, P US NATL MUS, V21, P567, DOI [10.5479/si.00963801.21-1162.567, DOI 10.5479/SI.00963801.21-1162.567]; RATHBUN MARY J., 1933, PROC BIOL SOC WASHINGTON, V46, P183; RATHBUN MARY J., 1931, JOUR WASHINGTON ACAD SCI, V21, P125; RATHBUN MARY J., 1935, PROC BIOL SOC WASHINGTON, V48, P1; RATHBUN MARY J., 1935, PROC BIOL SOC WASHINGTON, V48, P49; Rathbun MJ, 1893, P US NATIONAL MUSEUM, V16, P223, DOI DOI 10.5479/SI.00963801.933.223; Rathbun MJ., 1901, B US FISH COMM, V20, P1; Raz-Guzman Andrea, 1992, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V63, P29; Rieger PJ, 1999, NAUPLIUS, V7, P193; Robles R, 2007, MAR BIOL, V150, P1265, DOI 10.1007/s00227-006-0437-7; Rodrigues da Costa H, 1968, RECUEIL TRAVAUX STAT, V43, P333; Rodriguez de la Cruz MC, 1987, CRUSTACEOS DECAPODOS; Rodriguez G, 1980, CRUSTACEOS DECAPODOS; Rouse WL, 1970, Q J FLA ACAD SCI, V32, P127; Ruiz T, 2013, REV MEX BIODIVERS, V84, P280, DOI 10.7550/rmb.27685; Schubart CD, 2006, B FR PECHE PISCIC, P1019, DOI 10.1051/kmae:2006008; Schubart CD, 2000, CRUSTACEAN ISS, V12, P817; Schubart CD, 2000, MAR BIOL, V137, P11, DOI 10.1007/s002270000325; Severino-Rodrigues Evandro, 2002, Boletim do Instituto de Pesca (Sao Paulo), V28, P33; Silva JM, 2012, MARINE ECOLOGY, V34, P157; Sosa-Hernandez P, 1980, ESTUDIO PROSPECTIVE; Souza JAF, 1997, NAUPLIUS, V5, P33; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEVCIC Z, 1973, SYST ZOOL, V22, P625, DOI 10.2307/2412966; STIMPSON W., 1859, ANN LYCEUM NATURAL H, V7, P49, DOI DOI 10.1111/J.1749-6632.1862.TB00142.X; Stimpson W., 1871, B MUS COMP ZOOL HARV, V2, P109; Tabb D. C., 1961, Bulletin of Marine Science of the Gulf and Caribbean, V11, P552; Taissoun NE, 1986, B CENTRO INVESTIGACI, V17, P121; Takeda M, 1983, CRUSTACEANS MOLLUSKS, P19; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAVARES MS, 1993, CRUSTACEAN ISS, V8, P7; TAYLOR AC, 1984, J MAR BIOL ASSOC UK, V64, P7, DOI 10.1017/S0025315400059609; Terossi M, 2012, CRUSTACEANA, V85, P685, DOI 10.1163/156854012X643762; Thoma B. P., 2013, ZOOLOGICAL J LINNEAN, V170, P86, DOI DOI 10.1111/Z0J12093; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres MFA, 1998, THESIS I OCEANOGRAFI; Vargas-Castillo R, 2008, REV BIOL TROP, V56, P105; Vargas-Zamora JA, 2012, REV BIOL TROP, V60, P1763; Vazquez-Bader AR, 1994, PUBLICACIONES ESPECI, V12; von Martens E, 1872, ARCH NATURGESCH, V38, P77; WASS MARVIN L., 1955, QUART JOUR FLORIDA ACAD SCI, V18, P129; Weber LI, 2000, HYDROBIOLOGIA, V420, P211, DOI 10.1023/A:1003905115208; Wehrtmann IS, 2007, REV BIOL TROP, V55, P121; Werding B, 1989, SENCKENBERG BIOL, V70, P405; Williams A.B., 1984, pi; Williams AB, 1965, FISHERY B, V65, P1	164	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152627	10.1371/journal.pone.0152627	http://dx.doi.org/10.1371/journal.pone.0152627			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099956	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500013
J	Rahbar, S; Pan, W; Jonz, MG				Rahbar, Saman; Pan, Wen; Jonz, Michael G.			Purinergic and Cholinergic Drugs Mediate Hyperventilation in Zebrafish: Evidence from a Novel Chemical Screen	PLOS ONE			English	Article							PERIPHERAL ARTERIAL CHEMORECEPTORS; CAROTID-BODY CHEMORECEPTORS; HYPOXIC VENTILATORY RESPONSE; TROUT ONCORHYNCHUS-MYKISS; NEUROEPITHELIAL CELLS; RAINBOW-TROUT; DANIO-RERIO; OXYGEN CHEMORECEPTORS; GILL; FISH	A rapid test to identify drugs that affect autonomic responses to hypoxia holds therapeutic and ecologic value. The zebrafish (Danio rerio) is a convenient animal model for investigating peripheral O-2 chemoreceptors and respiratory reflexes in vertebrates; however, the neurotransmitters and receptors involved in this process are not adequately defined. The goals of the present study were to demonstrate purinergic and cholinergic control of the hyperventilatory response to hypoxia in zebrafish, and to develop a procedure for screening of neurochemicals that affect respiration. Zebrafish larvae were screened in multi-well plates for sensitivity to the cholinergic receptor agonist, nicotine, and antagonist, atropine; and to the purinergic receptor antagonists, suramin and A-317491. Nicotine increased ventilation frequency (f(V)) maximally at 100 mu M (EC50 = 24.5 mu M). Hypoxia elevated f(V) from 93.8 to 145.3 breaths min(-1). Atropine reduced the hypoxic response only at 100 mu M. Suramin and A-317491 maximally reduced f(V) at 50 mu M (EC50 = 30.4 and 10.8 mu M) and abolished the hyperventilatory response to hypoxia. Purinergic P2X3 receptors were identified in neurons and O-2-chemosensory neuroepithelial cells of the gills using immunohistochemistry and confocal microscopy. These studies suggest a role for purinergic and nicotinic receptors in O-2 sensing in fish and implicate ATP and acetylcholine in excitatory neurotransmission, as in the mammalian carotid body. We demonstrate a rapid approach for screening neuroactive chemicals in zebrafish with implications for respiratory medicine and carotid body disease in humans; as well as for preservation of aquatic ecosystems.	[Rahbar, Saman; Pan, Wen; Jonz, Michael G.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of Ottawa	Jonz, MG (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	mjonz@uottawa.ca			Natural Sciences and Engineering Research Council of Canada [342303]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (grant no. 342303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah SJ, 2015, PFLUG ARCH EUR J PHY, V467, P399, DOI 10.1007/s00424-014-1514-2; Brooks BW, 2003, CHEMOSPHERE, V52, P135, DOI 10.1016/S0045-6535(03)00103-6; Buckler KJ, 2007, RESP PHYSIOL NEUROBI, V157, P55, DOI 10.1016/j.resp.2007.02.013; Burleson ML, 2006, BRAIN RES, V1092, P100, DOI 10.1016/j.brainres.2006.03.085; BURLESON ML, 1995, RESP PHYSIOL, V100, P231, DOI 10.1016/0034-5687(95)91595-X; BURLESON ML, 1995, RESP PHYSIOL, V101, P289, DOI 10.1016/0034-5687(95)00029-D; DUNELERB S, 1982, J APPL PHYSIOL, V53, P1342, DOI 10.1152/jappl.1982.53.6.1342; Fu XW, 2001, AM J PHYSIOL-LUNG C, V281, pL931, DOI 10.1152/ajplung.2001.281.4.L931; Gao L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00398; Gauda EB, 2007, RESP PHYSIOL NEUROBI, V157, P162, DOI 10.1016/j.resp.2007.02.016; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; He L, 2006, J APPL PHYSIOL, V100, P157, DOI 10.1152/japplphysiol.00859.2005; Iturriaga R, 2004, BRAIN RES REV, V47, P46, DOI 10.1016/j.brainresrev.2004.05.007; Jonz MG, 2005, J EXP BIOL, V208, P1537, DOI 10.1242/jeb.01564; Jonz MG, 2004, J PHYSIOL-LONDON, V560, P737, DOI 10.1113/jphysiol.2004.069294; Jonz MG, 2003, J COMP NEUROL, V461, P1, DOI 10.1002/cne.10680; Jonz MG, 2015, COMP BIOCHEM PHYS A, V186, P27, DOI 10.1016/j.cbpa.2014.09.002; Jonz MG, 2014, CRC MAR BIOL SER, P149; Kahlin J, 2014, EXP PHYSIOL, V99, P1089, DOI 10.1113/expphysiol.2014.078873; Kermorgant M, 2014, GEN COMP ENDOCR, V205, P176, DOI 10.1016/j.ygcen.2014.03.012; Kinnamon SC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00264; Kokel D, 2011, METHOD CELL BIOL, V105, P517, DOI 10.1016/B978-0-12-381320-6.00022-9; Kumar P, 2012, COMPR PHYSIOL, V2, P141, DOI 10.1002/cphy.c100069; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; Milsom WK, 2007, RESP PHYSIOL NEUROBI, V157, P4, DOI 10.1016/j.resp.2007.02.007; Milsom WK, 2012, RESP PHYSIOL NEUROBI, V184, P326, DOI 10.1016/j.resp.2012.07.013; Nurse CA, 2014, J PHYSIOL-LONDON, V592, P3419, DOI 10.1113/jphysiol.2013.269829; Nurse CA, 2013, SEMIN CELL DEV BIOL, V24, P22, DOI 10.1016/j.semcdb.2012.09.006; Nurse CA, 2010, EXP PHYSIOL, V95, P657, DOI 10.1113/expphysiol.2009.049312; Peers C, 2010, RESP PHYSIOL NEUROBI, V174, P292, DOI 10.1016/j.resp.2010.08.010; Perry SF, 2009, FISH PHYSIOL, V27, P193, DOI 10.1016/S1546-5098(08)00005-8; Porteus CS, 2014, J PHYSIOL-LONDON, V592, P3075, DOI 10.1113/jphysiol.2014.271098; Porteus CS, 2012, RESP PHYSIOL NEUROBI, V184, P316, DOI 10.1016/j.resp.2012.06.019; Porteus CS, 2015, J EXP BIOL IN PRESS; Regan KS, 2011, J EXP BIOL, V214, P2560, DOI 10.1242/jeb.056333; Rennekamp AJ, 2015, CURR OPIN CHEM BIOL, V24, P58, DOI 10.1016/j.cbpa.2014.10.025; Rombough P, 2002, J EXP BIOL, V205, P1787; Saltys HA, 2006, CELL TISSUE RES, V323, P1, DOI 10.1007/s00441-005-0048-5; Shakarchi K, 2013, J EXP BIOL, V216, P869, DOI 10.1242/jeb.079657; Tamplin OJ, 2012, WIRES DEV BIOL, V1, P459, DOI 10.1002/wdev.37; Turesson J, 2006, COMP BIOCHEM PHYS A, V143, P332, DOI 10.1016/j.cbpa.2005.12.008; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Zachar PC, 2012, ACTA HISTOCHEM, V114, P101, DOI 10.1016/j.acthis.2011.03.006; Zhang DP, 2012, PHYSIOL GENOMICS, V44, P1133, DOI 10.1152/physiolgenomics.00079.2012; Zhang L, 2011, J EXP BIOL, V214, P2678, DOI 10.1242/jeb.055541; Zhang L, 2009, RESP PHYSIOL NEUROBI, V168, P261, DOI 10.1016/j.resp.2009.07.011; Zhang M, 2000, J PHYSIOL-LONDON, V525, P143, DOI 10.1111/j.1469-7793.2000.t01-1-00143.x; Zhang M, 2000, BRAIN RES, V872, P199, DOI 10.1016/S0006-8993(00)02499-9; Zhang M, 2003, J PHYSIOL-LONDON, V551, P825, DOI 10.1113/jphysiol.2003.038489	53	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154261	10.1371/journal.pone.0154261	http://dx.doi.org/10.1371/journal.pone.0154261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100625	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500174
J	Urano-Tashiro, Y; Takahashi, Y; Oguchi, R; Konishi, K				Urano-Tashiro, Yumiko; Takahashi, Yukihiro; Oguchi, Riyo; Konishi, Kiyoshi			Two Arginine Residues of Streptococcus gordonii Sialic Acid-Binding Adhesin Hsa Are Essential for Interaction to Host Cell Receptors	PLOS ONE			English	Article							DL1; IDENTIFICATION; GLYCOPROTEIN; ACTINOMYCES; GSPB	Hsa is a large, serine-rich protein of Streptococcus gordonii DL1 that mediates binding to alpha 2-3-linked sialic acid termini of glycoproteins, including platelet glycoprotein Ib alpha, and erythrocyte membrane protein glycophorin A, and band 3. The binding of Hsa to platelet glycoprotein Ib alpha contributes to the pathogenesis of infective endocarditis. This interaction appears to be mediated by a second non-repetitive region (NR2) of Hsa. However, the molecular details of the interaction between the Hsa NR2 region and these glycoproteins are not well understood. In the present study, we identified the amino acid residues of the Hsa NR2 region that are involved in sialic acid recognition. To identify the sialic acid-binding site of Hsa NR2 region, we prepared various mutants of Hsa NR2 fused with glutathione transferase. Fusion proteins harboring Arg340 to Asn (R340N) or Arg365 to Asn (R365N) substitutions in the NR2 domain exhibited significantly reduced binding to human erythrocytes and platelets. A sugar-binding assay showed that these mutant proteins abolished binding to alpha 2-3-linked sialic acid. Furthermore, we established S. gordonii DL1 derivatives that encoded the corresponding Hsa mutant protein. In whole-cell assays, these mutant strains showed significant reductions in hemagglutination, in platelet aggregation, and in adhesion to human leukocytes. These results indicate that the Arg340 and Arg365 residues of Hsa play an important role in the binding of Hsa to alpha 2-3-linked sialic acid-containing glycoproteins.	[Urano-Tashiro, Yumiko; Takahashi, Yukihiro; Konishi, Kiyoshi] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Microbiol, Chiyoda Ku, Tokyo, Japan; [Oguchi, Riyo] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Pediat Dent, Chiyoda Ku, Tokyo, Japan	Nippon Dental University; Nippon Dental University	Urano-Tashiro, Y (corresponding author), Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Microbiol, Chiyoda Ku, Tokyo, Japan.	yumiurano@tky.ndu.ac.jp	Takahashi, Yukihiro/ABA-4333-2020; TASHIRO, Yumiko/AAV-2054-2020	Tashiro, Yumiko/0000-0002-8328-2634				BADDOUR LM, 1994, INFECT IMMUN, V62, P2143, DOI 10.1128/IAI.62.6.2143-2148.1994; BADDOUR LM, 1989, REV INFECT DIS, V11, P452; Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Deng LQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004540; DURACK DT, 1995, NEW ENGL J MED, V332, P38, DOI 10.1056/NEJM199501053320107; Herzberg MC, 1996, CRIT REV ORAL BIOL M, V7, P222, DOI 10.1177/10454411960070030201; Kerrigan SW, 2007, INFECT IMMUN, V75, P5740, DOI 10.1128/IAI.00909-07; Mitchell J, 2009, INFECT IMMUN, V77, P3485, DOI 10.1128/IAI.01573-08; NICE CfCPa, 2008, PROPH INF END ANT PR; PERRY D, 1983, INFECT IMMUN, V41, P722, DOI 10.1128/IAI.41.2.722-727.1983; Petersen HJ, 2010, INFECT IMMUN, V78, P413, DOI 10.1128/IAI.00664-09; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Ruhl S, 2000, INFECT IMMUN, V68, P6346, DOI 10.1128/IAI.68.11.6346-6354.2000; Ruhl S, 2004, J DENT RES, V83, P505, DOI 10.1177/154405910408300614; Seo HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064204; Takahashi Y, 2004, INFECT IMMUN, V72, P3876, DOI 10.1128/IAI.72.7.3876-3882.2004; Takahashi Y, 2002, INFECT IMMUN, V70, P1209, DOI 10.1128/IAI.70.3.1209-1218.2002; Takahashi Y, 1997, INFECT IMMUN, V65, P5042, DOI 10.1128/IAI.65.12.5042-5051.1997; Takahashi Y, 2002, ORAL MICROBIOL IMMUN, V17, P257, DOI 10.1034/j.1399-302X.2002.170409.x; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Urano-Tashiro Y, 2008, INFECT IMMUN, V76, P4686, DOI 10.1128/IAI.00238-08; Urano-Tashiro Y, 2012, ODONTOLOGY, V100, P144, DOI 10.1007/s10266-011-0044-z; Werdan K, 2014, NAT REV CARDIOL, V11, P35, DOI 10.1038/nrcardio.2013.174; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; Yajima A, 2005, MICROBIOL IMMUNOL, V49, P795, DOI 10.1111/j.1348-0421.2005.tb03659.x; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x	28	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154098	10.1371/journal.pone.0154098	http://dx.doi.org/10.1371/journal.pone.0154098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101147	Green Published, gold			2022-12-26	WOS:000374898500142
J	Shah, MY; Martinez-Garcia, E; Phillip, JM; Chambliss, AB; Popovic, R; Ezponda, T; Small, EC; Will, C; Phillip, MP; Neri, P; Bahlis, NJ; Wirtz, D; Licht, JD				Shah, M. Y.; Martinez-Garcia, E.; Phillip, J. M.; Chambliss, A. B.; Popovic, R.; Ezponda, T.; Small, E. C.; Will, C.; Phillip, M. P.; Neri, P.; Bahlis, N. J.; Wirtz, D.; Licht, J. D.			MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents	ONCOGENE			English	Article							DOUBLE-STRAND BREAKS; T(4/14) MULTIPLE-MYELOMA; STEM-CELL TRANSPLANTATION; HISTONE H3; HOMOLOGOUS RECOMBINATION; ALU ELEMENTS; LYSINE 36; CHROMATIN; MMSET; METHYLATION	MMSET/WHSC1 is a histone methyltransferase (HMT) overexpressed in t(4;14)+ multiple myeloma (MM) patients, believed to be the driving factor in the pathogenesis of this MM subtype. MMSET overexpression in MM leads to an increase in histone 3 lysine 36 dimethylation (H3K36me2), and a decrease in histone 3 lysine 27 trimethylation (H3K27me3), as well as changes in proliferation, gene expression and chromatin accessibility. Prior work linked methylation of histones to the ability of cells to undergo DNA damage repair. In addition, t(4;14)+ patients frequently relapse after regimens that include DNA damage-inducing agents, suggesting that MMSET may play a role in DNA damage repair and response. In U2OS cells, we found that MMSET is required for efficient non-homologous end joining as well as homologous recombination. Loss of MMSET led to loss of expression of several DNA repair proteins, as well as decreased recruitment of DNA repair proteins to sites of DNA double-strand breaks (DSBs). By using genetically matched MM cell lines that had either high (pathological) or low (physiological) expression of MMSET, we found that MMSET-high cells had increased damage at baseline. Upon addition of a DNA-damaging agent, MMSET-high cells repaired DNA damage at an enhanced rate and continued to proliferate, whereas MMSET-low cells accumulated DNA damage and entered cell cycle arrest. In a murine xenograft model using t(4;14)+ KMS11 MM cells harboring an inducible MMSET shRNA, depletion of MMSET enhanced the efficacy of chemotherapy, inhibiting tumor growth and extending survival. These findings help explain the poorer prognosis of t(4;14) MM and further validate MMSET as a potential therapeutic target in MM and other cancers.	[Shah, M. Y.; Martinez-Garcia, E.; Popovic, R.; Ezponda, T.; Small, E. C.; Will, C.; Licht, J. D.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, 303 E Super St,Lurie 5-123, Chicago, IL 60611 USA; [Phillip, J. M.; Chambliss, A. B.; Phillip, M. P.; Wirtz, D.] Johns Hopkins Univ, Inst Nanobiotechnol, Dept Chem & Biomol Engn, Baltimore, MD USA; [Neri, P.; Bahlis, N. J.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Neri, P.; Bahlis, N. J.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Neri, P.; Bahlis, N. J.] Tom Baker Canc Clin, Calgary, AB, Canada; [Wirtz, D.] Johns Hopkins Univ, Sch Med, Dept Oncol & Pathol, Baltimore, MD USA	Northwestern University; Feinberg School of Medicine; Johns Hopkins University; University of Calgary; University of Calgary; Tom Baker Cancer Clinic; University of Calgary; Johns Hopkins University	Licht, JD (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, 303 E Super St,Lurie 5-123, Chicago, IL 60611 USA.	j-licht@northwestern.edu	Ezponda, Teresa/AAA-5040-2020; Licht, Jonathan/AAL-9184-2020; Phillip, Jude/AAR-6240-2020	Ezponda, Teresa/0000-0003-3682-7125; Licht, Jonathan/0000-0002-3942-1369; Chambliss, Allison/0000-0002-0461-8137	NIH [R01CA123204, R01CA174388, U54CA143868]; Leukemia & Lymphoma Society Specialized Center for Research Award; Physical Sciences Oncology Center [U54CA143869]; Celgene; Samuel Waxman Cancer Research Foundation; Canadian Institute of Health and Research operating grant [287300]; NATIONAL CANCER INSTITUTE [R01CA195732, U54CA143869, U54CA210173, R01CA123204, R01CA174388, U54CA143868] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society Specialized Center for Research Award; Physical Sciences Oncology Center; Celgene(Bristol-Myers SquibbCelgene Corporation); Samuel Waxman Cancer Research Foundation; Canadian Institute of Health and Research operating grant(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH grant R01CA123204, Leukemia & Lymphoma Society Specialized Center for Research Award, Physical Sciences Oncology Center U54CA143869, Celgene and the Samuel Waxman Cancer Research Foundation (to JDL); NIH grants R01CA174388 and U54CA143868 (to DW); and Canadian Institute of Health and Research operating grant (287300; to NJB). We thank Dr Gaelle Legube for the AsiSI-U2OS cells and members of the Licht lab for their helpful comments.	Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Banath JP, 2009, EXP CELL RES, V315, P1505, DOI 10.1016/j.yexcr.2008.12.007; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Chambliss AB, 2013, FASEB J, V27, P2667, DOI 10.1096/fj.12-227108; Chen WC, 2013, INTEGR BIOL-UK, V5, P523, DOI 10.1039/c2ib20246h; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Cook G, 2014, LANCET ONCOL, V15, P874, DOI 10.1016/S1470-2045(14)70245-1; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; ENGLANDER EW, 1993, J BIOL CHEM, V268, P19565; Englander EW, 1997, MUTAT RES-DNA REPAIR, V385, P31, DOI 10.1016/S0921-8777(97)00036-0; ENGLANDER EW, 1995, J BIOL CHEM, V270, P10091, DOI 10.1074/jbc.270.17.10091; Ezponda T, 2013, ONCOGENE, V32, P2882, DOI 10.1038/onc.2012.297; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Gaymes TJ, 2006, MOL CANCER RES, V4, P563, DOI 10.1158/1541-7786.MCR-06-0111; Goldstein M, 2013, P NATL ACAD SCI USA, V110, P16874, DOI 10.1073/pnas.1306160110; Gourzones-Dmitriev C, 2013, CELL CYCLE, V12, P2760, DOI 10.4161/cc.25951; Guo QY, 2013, BIOMATERIALS, V34, P9365, DOI 10.1016/j.biomaterials.2013.08.061; Hajdu I, 2011, P NATL ACAD SCI USA, V108, P13130, DOI 10.1073/pnas.1110081108; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Hudlebusch HR, 2011, CANCER RES, V71, P4226, DOI 10.1158/0008-5472.CAN-10-3810; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jaksic W, 2005, J CLIN ONCOL, V23, P7069, DOI 10.1200/JCO.2005.17.129; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lans H, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-4; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Li L, 2011, DNA REPAIR HUMAN HLT; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Liao WJ, 2009, METHODS, V48, P46, DOI 10.1016/j.ymeth.2009.02.016; Lupi M, 2006, CANCER CHEMOTH PHARM, V57, P443, DOI 10.1007/s00280-005-0044-1; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Min DJ, 2013, LEUKEMIA, V27, P686, DOI 10.1038/leu.2012.269; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Palumbo A, 2014, NEW ENGL J MED, V371, P895, DOI 10.1056/NEJMoa1402888; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pei HD, 2013, J IMMUNOL, V190, P756, DOI 10.4049/jimmunol.1201811; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; POVIRK LF, 1989, BIOCHEMISTRY-US, V28, P5808, DOI 10.1021/bi00440a016; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Roussel M, 2010, BLOOD, V115, P32, DOI 10.1182/blood-2009-06-229658; Silber JR, 2002, CLIN CANCER RES, V8, P3008; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Sousa MML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055493; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344; Tuzon CT, 2014, CELL REP, V8, P429, DOI 10.1016/j.celrep.2014.06.013; Wang Q, 2016, CANC RES; Zheng YP, 2012, P NATL ACAD SCI USA, V109, P13549, DOI 10.1073/pnas.1205707109	62	56	59	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2016	35	45					5905	5915		10.1038/onc.2016.116	http://dx.doi.org/10.1038/onc.2016.116			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EB7IR	27109101	Green Accepted			2022-12-26	WOS:000387560800009
J	Timar, B; Timar, R; Gaita, L; Oancea, C; Levai, C; Lungeanu, D				Timar, Bogdan; Timar, Romulus; Gaita, Laura; Oancea, Cristian; Levai, Codrina; Lungeanu, Diana			The Impact of Diabetic Neuropathy on Balance and on the Risk of Falls in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study	PLOS ONE			English	Article							CARDIAC AUTONOMIC NEUROPATHY; OLDER-ADULTS; PERIPHERAL NEUROPATHY; PEDAL SENSIBILITY; COMPLICATIONS; IMPAIRMENT; MODELS; GAIT	Introduction Diabetic neuropathy (DN) is a prevalent complication of Type 2 Diabetes Mellitus (T2DM) with a major impact on the health of the affected patient. We hypothesized that mediated by the dysfunctionalities associated with DN's three major components: sensitive (lack of motion associated sensory), motor (impairments in movement coordination) and autonomic (the presence of postural hypotension), the presence of DN may impair the balance in the affected patients. Our study's main aim is to evaluate the possible association between the presence and severity of DN and both the balance impairment and the risk of falls in patients with T2DM. Material and Method In this cross-sectional study we enrolled, according to a consecutive-case population-based setting 198 patients with T2DM. The presence and severity of DN was evaluated using the Michigan Neuropathy Screening Instrument, a tool which allows both diagnosing and severity staging of DN. The balance impairment and the risk of falls were evaluated using four validated and standardized tools: Berg Balance Scale (BBS), Timed-up and Go test (TUG), Single Leg Stand test (SLS) and Fall Efficacy Scale (FES-I). Results The presence of DN was associated with significant decreases in the BBS score (40.5 vs. 43.7 points; p<0.001) and SLS time (9.3 vs. 10.3 seconds; p = 0.003) respectively increases in TUG time (8.9 vs. 7.6 seconds; p = 0.002) and FES-I score (38 vs. 33 points; p = 0.034). The MNSI score was reverse and significantly correlated with both BBS score (Spearman's r = -0.479; p<0.001) and SLS time (Spearman's r = -0.169; p = 0.017). In the multivariate regression model, we observed that patient's age, DN severity and depression's symptoms acted as independent, significant predictors for the risk of falls in patients with T2DM. Conclusions The presence of DN in patients with DM is associated with impaired balance and with a consecutively increase in the risk of falls.	[Timar, Bogdan; Lungeanu, Diana] Victor Babes Univ Med & Pharm, Dept Funct Sci, Timisoara, Romania; [Timar, Romulus] Victor Babes Univ Med & Pharm, Dept Internal Med 2, Timisoara, Romania; [Gaita, Laura] Victor Babes Univ Med & Pharm, Dept Cardiol, Timisoara, Romania; [Oancea, Cristian] Victor Babes Univ Med & Pharm, Dept Infect Dis, Timisoara, Romania; [Levai, Codrina] Victor Babes Univ Med & Pharm, Legal Dept, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Timar, R (corresponding author), Victor Babes Univ Med & Pharm, Dept Internal Med 2, Timisoara, Romania.	timar.romulus@umft.ro	Lungeanu, Diana/AAD-3280-2020	Lungeanu, Diana/0000-0002-0274-1377; Timar, Bogdan/0000-0002-0993-6206	"Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania [PLURINEURODIAB. PII-C4-TC-2016-16441-01]	"Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania	This research was supported by an internal grant, funded by "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania (PLURINEURODIAB. PII-C4-TC-2016-16441-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allet L, 2009, DIABETIC MED, V26, P1003, DOI 10.1111/j.1464-5491.2009.02811.x; Beauchet O, 2011, J NUTR HEALTH AGING, V15, P933, DOI 10.1007/s12603-011-0062-0; Berry Sarah D, 2008, Curr Osteoporos Rep, V6, P149, DOI 10.1007/s11914-008-0026-4; Boulton AJM, 1998, MED CLIN N AM, V82, P909, DOI 10.1016/S0025-7125(05)70029-8; Brown SJ, 2015, DIABETES CARE, V38, P1116, DOI 10.2337/dc14-1982; Dimitropoulos G, 2014, WORLD J DIABETES, V5, P17, DOI 10.4239/wjd.v5.i1.17; Ducic I, 2006, ANN PLAS SURG, V56, P145, DOI 10.1097/01.sap.0000194246.18332.23; Ducic I, 2004, ANN PLAS SURG, V52, P535, DOI 10.1097/01.sap.0000122654.65588.f0; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Greenberg SA, 2012, CLIN NURS RES, V21, P113, DOI 10.1177/1054773811433824; Herman WH, 2012, DIABETIC MED, V29, P937, DOI 10.1111/j.1464-5491.2012.03644.x; Hewston P, 2016, CAN J DIABETES, V40, P6, DOI 10.1016/j.jcjd.2015.08.005; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Karmakar Rathindra Nath, 2011, J Indian Med Assoc, V109, P396; Lagani V, 2013, J DIABETES COMPLICAT, V27, P407, DOI 10.1016/j.jdiacomp.2012.11.003; Lee IH, 2014, J PHYS THER SCI, V26, P1519, DOI 10.1589/jpts.26.1519; Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009; Morrison S, 2014, J DIABETES COMPLICAT, V28, P715, DOI 10.1016/j.jdiacomp.2014.04.007; Mota M, 2016, J DIABETES, V8, P336, DOI 10.1111/1753-0407.12297; Muir SW, 2010, J CLIN EPIDEMIOL, V63, P389, DOI 10.1016/j.jclinepi.2009.06.010; Pop-Busui R, 2012, J CARDIOVASC TRANSL, V5, P463, DOI 10.1007/s12265-012-9367-6; Roman de Mettelinge T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067055; Taguri M, 2014, BIOMETRICS, V70, P724, DOI 10.1111/biom.12165; Tahrani AA, 2014, DIABETOLOGIA, V57, P1249, DOI 10.1007/s00125-014-3211-2; Tesfaye S, 2012, DIABETES-METAB RES, V28, P8, DOI 10.1002/dmrr.2239; Trignano E, 2016, MICROSURG, V36, P37, DOI 10.1002/micr.22378; Vinik AI, 2013, ENDOCRIN METAB CLIN, V42, P747, DOI 10.1016/j.ecl.2013.06.001	28	83	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154654	10.1371/journal.pone.0154654	http://dx.doi.org/10.1371/journal.pone.0154654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119372	Green Submitted, gold, Green Published			2022-12-26	WOS:000374976200092
J	Miyawaki, A; Toyokawa, S; Inoue, K; Miyoshi, Y; Kobayashi, Y				Miyawaki, Atsushi; Toyokawa, Satoshi; Inoue, Kazuo; Miyoshi, Yuji; Kobayashi, Yasuki			Self-Reported Periodontitis and Incident Type 2 Diabetes among Male Workers from a 5-Year Follow-Up to MY Health Up Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; IMPAIRED FASTING GLUCOSE; C-REACTIVE PROTEIN; DIAGNOSTIC-CRITERIA; ALCOHOL-CONSUMPTION; NATIONAL-HEALTH; JAPANESE; DISEASE; RISK; MELLITUS	Aims The purpose of this study was to examine whether periodontitis is associated with incident type 2 diabetes in a Japanese male worker cohort. Methods The study participants were Japanese men, aged 36-55 years, without diabetes. Data were extracted from the MY Health Up study, consisting of self-administered questionnaire surveys at baseline and following annual health examinations for an insurance company in Japan. The oral health status of the participants was classified by two self-reported indicators: (1) gingival hemorrhage and (2) tooth loosening. Type 2 diabetes incidence was determined by self-reporting or blood test data. Modified Poisson regression approach was used to estimate the relative risks and the 95% confidence intervals of incident diabetes with periodontitis. Covariates included age, body mass index, family history of diabetes, hypertension, current smoking habits, alcohol use, dyslipidemia, and exercise habits. Results Of the 2895 candidates identified at baseline in 2004, 2469 men were eligible for follow-up analysis, 133 of whom were diagnosed with diabetes during the 5-year follow-up period. Tooth loosening was associated with incident diabetes [adjusted relative risk = 1.73, 95% confidence interval = 1.14-2.64] after adjusting for other confounding factors. Gingival hemorrhage displayed a similar trend but was not significantly associated with incident diabetes [adjusted relative risk = 1.32, 95% confidence interval = 0.95-1.85]. Conclusions Tooth loosening is an independent predictor of incident type 2 diabetes in Japanese men.	[Miyawaki, Atsushi; Toyokawa, Satoshi; Kobayashi, Yasuki] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Miyoshi, Yuji] Meiji Yasuda Life Insurance Co, Tokyo, Japan	University of Tokyo; Teikyo University	Toyokawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan.	toyokawa@m.u-tokyo.ac.jp	Miyawaki, Atsushi/GWR-2569-2022	Miyawaki, Atsushi/0000-0001-6126-1464	Meiji Yasuda Life Company	Meiji Yasuda Life Company	The Meiji Yasuda Life Company provided financial support in the form of YM salaries, and provided opportunity to use the screening dataset secondarily to contribute to public health concerns. Distribution and retrieval of questionnaires, and data input were handled by the Meiji Yasuda Life Insurance Company. The study does not contribute to company profit.	Aguiree F., 2013, IDF DIABETES ATLAS; Al-Zahrani MS, 2005, J DENT, V33, P703, DOI 10.1016/j.jdent.2005.01.004; Alhazmi A, 2012, J AM COLL NUTR, V31, P243, DOI 10.1080/07315724.2012.10720425; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Arora N, 2014, J CLIN PERIODONTOL, V41, P643, DOI 10.1111/jcpe.12258; Buhlin K, 2002, COMMUNITY DENT ORAL, V30, P431, DOI 10.1034/j.1600-0528.2002.00014.x; Artese HPC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128344; Chalmers J, 1999, J HYPERTENS, V17, P151; Choi YH, 2011, DIABETES CARE, V34, P381, DOI 10.2337/dc10-1354; Demmer RT, 2008, DIABETES CARE, V31, P1373, DOI 10.2337/dc08-0026; Demmer RT, 2010, DIABETES CARE, V33, P1037, DOI 10.2337/dc09-1778; Dietrich T, 2004, J PERIODONTOL, V75, P16, DOI 10.1902/jop.2004.75.1.16; Dotevall A, 2004, DIABETIC MED, V21, P615, DOI 10.1111/j.1464-5491.2004.01189.x; Ide R, 2011, J DENT RES, V90, P41, DOI 10.1177/0022034510381902; Inoue K, 2009, DIABETIC MED, V26, P1175, DOI 10.1111/j.1464-5491.2009.02850.x; Inoue M, 2007, J OCCUP HEALTH, V49, P376, DOI 10.1539/joh.49.376; JIN LJ, 1992, J CLIN PERIODONTOL, V19, P92, DOI 10.1111/j.1600-051X.1992.tb00446.x; Kadowaki Takashi, 2008, Journal of the Japan Diabetes Society, V51, P281; Kaneto C, 2013, DIABETES RES CLIN PR, V102, P138, DOI 10.1016/j.diabres.2013.08.011; Lin YS, 2005, ANN EPIDEMIOL, V15, P590, DOI 10.1016/j.annepidem.2004.10.010; Ministry of Health and Welfare, TOKY REP SURV DENT D; Natti J, 2009, EUR J PUBLIC HEALTH, V19, P150, DOI 10.1093/eurpub/ckp002; Nesto R, 2004, DIABETIC MED, V21, P810, DOI 10.1111/j.1464-5491.2004.01296.x; Noguchi S, 2015, J PUBLIC HEALTH-UK, V37, P605, DOI 10.1093/pubmed/fdu076; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Rabi DM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-124; Ripsin CM, 2009, AM FAM PHYSICIAN, V79, P29; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Teeuw WJ, 2010, DIABETES CARE, V33, P421, DOI 10.2337/dc09-1378; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P155, DOI 10.5551/jat.E537; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yamamoto T, 2009, J OCCUP HEALTH, V51, P137, DOI 10.1539/joh.L8108; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	37	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153464	10.1371/journal.pone.0153464	http://dx.doi.org/10.1371/journal.pone.0153464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115749	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600022
J	Tong, HI; Kang, W; Davy, PMC; Shi, YL; Sun, S; Allsopp, RC; Lu, YA				Tong, Hsin-I; Kang, Wen; Davy, Philip M. C.; Shi, Yingli; Sun, Si; Allsopp, Richard C.; Lu, Yuanan			Monocyte Trafficking, Engraftment, and Delivery of Nanoparticles and an Exogenous Gene into the Acutely Inflamed Brain Tissue - Evaluations on Monocyte-Based Delivery System for the Central Nervous System	PLOS ONE			English	Article							DEFECTIVE LENTIVIRAL VECTORS; BLOOD MONOCYTES; BONE-MARROW; INFLAMMATORY RESPONSE; ANTIRETROVIRAL DRUG; MACROPHAGE DELIVERY; MURINE MODEL; STEM-CELLS; IN-VIVO; MICROGLIA	The ability of monocytes and monocyte-derived macrophages (MDM) to travel towards chemotactic gradient, traverse tissue barriers, and accumulate precisely at diseased sites makes them attractive candidates as drug carriers and therapeutic gene delivery vehicles targeting the brain, where treatments are often hampered by the blockade of the blood brain barrier (BBB). This study was designed to fully establish an optimized cell-based delivery system using monocytes and MDM, by evaluating their homing efficiency, engraftment potential, as well as carriage and delivery ability to transport nano-scaled particles and exogenous genes into the brain, following the non-invasive intravenous (IV) cell adoptive transfer in an acute neuroinflammation mouse model induced by intracranial injection of Escherichia coli lipopolysaccharides. We demonstrated that freshly isolated monocytes had superior inflamed-brain homing ability over MDM cultured in the presence of macrophage colony stimulating factor. In addition, brain trafficking of IV infused monocytes was positively correlated with the number of adoptive transferred cells, and could be further enhanced by transient disruption of the BBB with IV administration of Mannitol, Bradykinin or Serotonin right before cell infusion. A small portion of transmigrated cells was detected to differentiate into IBA-1 positive cells with microglia morphology in the brain. Finally, with the use of superparamagnetic iron oxide nanoparticles SHP30, the ability of nanoscale agent-carriage monocytes to enter the inflamed brain region was validated. In addition, lentiviral vector DHIV-101 was used to introduce green fluorescent protein (GFP) gene into monocytes, and the exogenous GFP gene was detected in the brain at 48 hours following IV infusion of the transduced monocytes. All together, our study has set up the optimized conditions for the more-in-depth tests and development of monocyte-mediated delivery, and our data supported the notion to use monocytes as a non-invasive cell-based delivery system for the brain.	[Tong, Hsin-I; Kang, Wen; Shi, Yingli; Sun, Si; Lu, Yuanan] Univ Hawaii Manoa, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Tong, Hsin-I] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Davy, Philip M. C.; Allsopp, Richard C.] Univ Hawaii Manoa, Inst Biogenesis Res, Honolulu, HI 96822 USA; [Kang, Wen] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi, Peoples R China; [Shi, Yingli] Chinese Acad Sci, Inst Oceanol, Qingdao, Shandong, Peoples R China	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Air Force Military Medical University; Chinese Academy of Sciences; Institute of Oceanology, CAS	Lu, YA (corresponding author), Univ Hawaii Manoa, Off Publ Hlth Studies, Honolulu, HI 96822 USA.	yuanan@hawaii.edu		Tong, Hsin-I/0000-0002-1567-5006	National Institute of Mental Health of National Institutes of Health [R01 MH079717]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079717] Funding Source: NIH RePORTER	National Institute of Mental Health of National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the National Institute of Mental Health of National Institutes of Health (R01 MH079717). https://www.nimh.nih.gov/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Andreesen R, 1998, J LEUKOCYTE BIOL, V64, P419, DOI 10.1002/jlb.64.4.419; Bechmann I, 2005, FASEB J, V19, P647, DOI 10.1096/fj.04-2599fje; Brynskikh AM, 2010, NANOMEDICINE-UK, V5, P379, DOI [10.2217/nnm.10.7, 10.2217/NNM.10.7]; Burke B, 2003, EXPERT OPIN BIOL TH, V3, P919, DOI 10.1517/14712598.3.6.919; Burke B., 2002, MACROPHAGE; Colgan J, 2005, J IMMUNOL, V174, P6030, DOI 10.4049/jimmunol.174.10.6030; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dou HY, 2009, J IMMUNOL, V183, P661, DOI 10.4049/jimmunol.0900274; Fiala M, 1998, MOL MED, V4, P480, DOI 10.1007/BF03401753; Fidler I J, 1994, Adv Pharmacol, V30, P271, DOI 10.1016/S1054-3589(08)60177-5; Francke A, 2011, J HISTOCHEM CYTOCHEM, V59, P813, DOI 10.1369/0022155411416007; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Kennedy DW, 1998, P NATL ACAD SCI USA, V95, P14944, DOI 10.1073/pnas.95.25.14944; Klimatcheva E, 2001, MOL THER, V3, P928, DOI 10.1006/mthe.2001.0344; Lebson L, 2010, J NEUROSCI, V30, P9651, DOI 10.1523/JNEUROSCI.0329-10.2010; Lech M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/951390; Liu R, 2005, GENE THER, V12, P647, DOI 10.1038/sj.gt.3302445; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; McCarty DM, 2009, GENE THER, V16, P1340, DOI 10.1038/gt.2009.85; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Pardridge William M, 2005, NeuroRx, V2, P3; Persidsky Y, 1999, AM J PATHOL, V155, P1599, DOI 10.1016/S0002-9440(10)65476-4; Pires MD, 2001, ANAL QUANT CYTOL, V23, P427; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Roth JC, 2008, GENE THER, V15, P716, DOI 10.1038/gt.2008.38; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; VANFURTH R, 1973, J EXP MED, V138, P1314, DOI 10.1084/jem.138.6.1314; WINKLER T, 1995, NEUROSCIENCE, V68, P1097, DOI 10.1016/0306-4522(95)00194-N; Wu C, 2007, CELL MOL BIOL, V53, P67, DOI 10.1170/T810; Wu JM, 2006, BRAIN RES, V1098, P79, DOI 10.1016/j.brainres.2006.04.074; Xu HP, 2005, J IMMUNOL, V175, P6915, DOI 10.4049/jimmunol.175.10.6915; Zeng LB, 2006, J GENE MED, V8, P18, DOI 10.1002/jgm.825; Zeng LB, 2006, J VIROL METHODS, V134, P66, DOI 10.1016/j.jviromet.2005.12.006	41	45	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154022	10.1371/journal.pone.0154022	http://dx.doi.org/10.1371/journal.pone.0154022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115998	Green Published, gold			2022-12-26	WOS:000374973600036
J	Heidker, RM; Caiozzi, GC; Ricketts, ML				Heidker, Rebecca M.; Caiozzi, Gianella C.; Ricketts, Marie-Louise			Grape Seed Procyanidins and Cholestyramine Differentially Alter Bile Acid and Cholesterol Homeostatic Gene Expression in Mouse Intestine and Liver	PLOS ONE			English	Article							FARNESOID-X RECEPTOR; LOWERS PLASMA-CHOLESTEROL; LOWER TRIGLYCERIDE LEVELS; MICROSOMAL TRIGLYCERIDE; TRANSFER PROTEIN; CHOLIC-ACID; STEROL 12-ALPHA-HYDROXYLASE; LIPID-ACCUMULATION; NUCLEAR RECEPTOR; FXR	Bile acid (BA) sequestrants, lipid-lowering agents, may be prescribed as a monotherapy or combination therapy to reduce the risk of coronary artery disease. Over 33% of adults in the United States use complementary and alternative medicine strategies, and we recently reported that grape seed procyanidin extract (GSPE) reduces enterohepatic BA recirculation as a means to reduce serum triglyceride (TG) levels. The current study was therefore designed to assess the effects on BA, cholesterol and TG homeostatic gene expression following co-administration with GSPE and the BA sequestrant, cholestyramine (CHY). Eight-week old male C57BL/6 mice were treated for 4 weeks with either a control or 2% CHY-supplemented diet, after which, they were administered vehicle or GSPE for 14 hours. Liver and intestines were harvested and gene expression was analyzed. BA, cholesterol, non-esterified fatty acid and TG levels were also analyzed in serum and feces. Results reveal that GSPE treatment alone, and co-administration with CHY, regulates BA, cholesterol and TG metabolism differently than CHY administration alone. Notably, GSPE decreased intestinal apical sodium-dependent bile acid transporter (Asbt) gene expression, while CHY significantly induced expression. Administration with GSPE or CHY robustly induced hepatic BA biosynthetic gene expression, especially cholesterol 7 alpha-hydroxylase (Cyp7a1), compared to control, while co-administration further enhanced expression. Treatment with CHY induced both intestinal and hepatic cholesterologenic gene expression, while co-administration with GSPE attenuated the CHY-induced increase in the liver but not intestine. CHY also induced hepatic lipogenic gene expression, which was attenuated by co-administration with GSPE. Consequently, a 25% decrease in serum TG levels was observed in the CHY+GSPE group, compared to the CHY group. Collectively, this study presents novel evidence demonstrating that GSPE provides additive and complementary efficacy as a lipid-lowering combination therapy in conjunction with CHY by attenuating hepatic cholesterol synthesis, enhancing BA biosynthesis and decreasing lipogenesis, which warrants further investigation.	[Heidker, Rebecca M.; Caiozzi, Gianella C.; Ricketts, Marie-Louise] Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA; [Caiozzi, Gianella C.] Hosp Urgencia Asistencia Publ, Portugal 125, Santiago, Chile	Nevada System of Higher Education (NSHE); University of Nevada Reno	Ricketts, ML (corresponding author), Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA.	mricketts@cabnr.unr.edu		Ricketts, Marie-Louise/0000-0002-8306-7563	University of Nevada, Reno; USDA National Institute of Food and Agriculture [Hatch-NEV0738, W-3122]; CONICYT Bicentennial Becas-Chile Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103554] Funding Source: NIH RePORTER	University of Nevada, Reno; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); CONICYT Bicentennial Becas-Chile Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the University of Nevada, Reno and USDA National Institute of Food and Agriculture (Hatch-NEV0738 and Multistate project W-3122: Beneficial and Adverse Effects of Natural Chemicals on Human Health and Food Safety) to MLR. GCC was the recipient of a CONICYT Bicentennial Becas-Chile Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNHARDSSON C, 1973, BIOCHEM BIOPH RES CO, V54, P1030, DOI 10.1016/0006-291X(73)90797-3; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; CASSIDY MM, 1980, DIGEST DIS SCI, V25, P504, DOI 10.1007/BF01315212; CASSIDY MM, 1985, DIGEST DIS SCI, V30, P468, DOI 10.1007/BF01318181; CDC, 2015, UNDERLYING CAUSE DEA; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Clarke TC, 2015, NATL HLTH STAT REPOR, P1; CROUSE JR, 1987, AM J MED, V83, P243, DOI 10.1016/0002-9343(87)90692-9; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Del Bas JM, 2008, MOL NUTR FOOD RES, V52, P1172, DOI 10.1002/mnfr.200800054; DIETSCHY JM, 1971, J CLIN INVEST, V50, P872, DOI 10.1172/JCI106559; DIETSCHY JM, 1968, J CLIN INVEST, V47, P166, DOI 10.1172/JCI105725; DIETSCHY JM, 1965, J CLIN INVEST, V44, P1311, DOI 10.1172/JCI105237; DIETSCHY JM, 1971, AM J CLIN NUTR, V24, P70; Downing LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140267; Eggertsen G, 1996, J BIOL CHEM, V271, P32269, DOI 10.1074/jbc.271.50.32269; Feng D, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-40; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hayashi AA, 2011, AM J PHYSIOL-GASTR L, V301, pG326, DOI 10.1152/ajpgi.00425.2010; Heidker RM, 2016, MOL NUTR FOOD RES, V60, P727, DOI 10.1002/mnfr.201500795; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Hou R, 2009, ENDOCRIN METAB CLIN, V38, P79, DOI 10.1016/j.ecl.2008.11.007; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Jahn D, 2015, CYTOKINE GROWTH F R, V26, P625, DOI 10.1016/j.cytogfr.2015.07.016; Kamisako T, 2007, J GASTROEN HEPATOL, V22, P1832, DOI 10.1111/j.1440-1746.2007.04910.x; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Li H, 2005, AM J PHYSIOL-GASTR L, V288, pG60, DOI 10.1152/ajpgi.00170.2004; Li H, 2004, METABOLISM, V53, P927, DOI 10.1016/j.metabol.2004.01.017; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; LINDSEY CA, 1965, J LIPID RES, V6, P173; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Del Bas JM, 2009, MOL NUTR FOOD RES, V53, P805, DOI 10.1002/mnfr.200800364; Modica Salvatore, 2011, Curr Protoc Mouse Biol, V1, P289, DOI 10.1002/9780470942390.mo100226; O'Brien PJ, 2005, CLIN CHEM, V51, P351, DOI 10.1373/clinchem.2004.040824; Out C, 2012, CURR OPIN LIPIDOL, V23, P43, DOI 10.1097/MOL.0b013e32834f0ef3; Pandak WM, 2001, GASTROENTEROLOGY, V120, P1801, DOI 10.1053/gast.2001.24833; Praslickova D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050810; Schmitt J, 2015, LIVER INT, V35, P1133, DOI 10.1111/liv.12456; Schwarz M, 1997, J BIOL CHEM, V272, P23995, DOI 10.1074/jbc.272.38.23995; Seok S, 2013, J BIOL CHEM, V288, P23252, DOI 10.1074/jbc.M113.452037; SHEPHERD J, 1989, CARDIOLOGY, V76, P65, DOI 10.1159/000174548; SRERE PA, 1950, J BIOL CHEM, V182, P629; Sugimoto-Kawabata K, 2013, J LIPID RES, V54, P1255, DOI 10.1194/jlr.M032839; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; van der Vliet HN, 2002, BIOCHEM BIOPH RES CO, V295, P1156, DOI 10.1016/S0006-291X(02)00808-2; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; West KL, 2003, ATHEROSCLEROSIS, V171, P201, DOI 10.1016/j.atherosclerosis.2003.08.019; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WETTERAU JR, 1985, CHEM PHYS LIPIDS, V38, P205, DOI 10.1016/0009-3084(85)90068-4; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P4406, DOI 10.1021/bi00232a006; Yamakoshi J, 2002, FOOD CHEM TOXICOL, V40, P599, DOI 10.1016/S0278-6915(02)00006-6; Yu CD, 2005, J BIOL CHEM, V280, P17707, DOI 10.1074/jbc.M411771200	61	20	20	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154305	10.1371/journal.pone.0154305	http://dx.doi.org/10.1371/journal.pone.0154305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111442	Green Submitted, Green Published, gold			2022-12-26	WOS:000374970600055
J	Huang, SG; Guo, WL; Wang, J; Sheng, M; Lan, XH; Fang, L				Huang, Shun-gen; Guo, Wan-liang; Wang, Jian; Sheng, Mao; Lan, Xing-hao; Fang, Lin			Factors Interfering with Delineation on MRCP of Pancreaticobiliary Maljunction in Paediatric Patients	PLOS ONE			English	Article							MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; COMMON BILE-DUCT; CHOLEDOCHAL CYSTS; BILIARY DILATATION; CHILDREN; DIAGNOSIS; MALFORMATION; JUNCTION; INFANTS	Background The aim of this study was to assess factors for delineating the pancreaticobiliary junction in the presence of pediatric congenital choledochal cysts (CCC) using Magnetic resonance cholangiopancreatography (MRCP). Methods Retrospective review of medical records for 48 patients with CCC was conducted, including demographics, biliary amylase and MRCP findings if available. With univariate and multivariate logistic regression, we measured significant factors affecting pancreaticobiliary maljunction( PBM) diagnoses by MRCP. Results Of the subjects enrolled with CCC. Twenty-eight cases had PBM according to MRCP. Univariate analysis confirmed that age, cyst diameter >30 mm and cysts that descended to the introitus pelvis affected junctional delineation and detection of PBM (P<0.05). Stepwise logistic regression analysis confirmed large cysts in the introitus pelvis predicted pancreaticobiliary junctional delineation in MRCP and these data agreed with the literature. A correlation between cyst diameter and the length of the common channel was found as was cyst diameter and biliary amylase although there were no significant differences between them. Conclusions Age, cyst diameter >30 mm and descending cysts into the introitus pelvis affected junctional delineation of the pancreatic and bile duct in PBM with MRCP. Large cyst descension into the introitus pelvis was an independent factors affecting PBM detection.	[Huang, Shun-gen; Wang, Jian] Soochow Univ, Childrens Hosp, Dept Gen Surg, Suzhou 215003, Peoples R China; [Guo, Wan-liang; Sheng, Mao; Lan, Xing-hao; Fang, Lin] Soochow Univ, Childrens Hosp, Dept Radiol, Suzhou 215003, Peoples R China	Soochow University - China; Soochow University - China	Guo, WL (corresponding author), Soochow Univ, Childrens Hosp, Dept Radiol, Suzhou 215003, Peoples R China.	gwlsuzhou@163.com			Suzhou key clinical disease diagnosis and treatment Projects [LCZX201306]; Suzhou Foundation and Application Grants [SYS201563]; Jiangsu Province Health and Family planning Projects [H201519, H201520]; Jiangsu Province social development program standardized diagnosis and treatment of key disease in clinical [BE2015643]	Suzhou key clinical disease diagnosis and treatment Projects; Suzhou Foundation and Application Grants; Jiangsu Province Health and Family planning Projects; Jiangsu Province social development program standardized diagnosis and treatment of key disease in clinical	This research was supported by Suzhou key clinical disease diagnosis and treatment Projects (#LCZX201306), Suzhou Foundation and Application Grants (No. SYS201563), Jiangsu Province Health and Family planning Projects (H201519, H201520) and Jiangsu Province social development program standardized diagnosis and treatment of key disease in clinical (#BE2015643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CSENDES A, 1979, GASTROENTEROLOGY, V77, P1203; Deng YL, 2011, HEPATOB PANCREAT DIS, V10, P570, DOI 10.1016/S1499-3872(11)60098-2; Diao M, 2014, INT J SURG, V12, P412, DOI 10.1016/j.ijsu.2014.03.007; Fitoz S, 2007, CLIN IMAG, V31, P93, DOI 10.1016/j.clinimag.2006.11.002; Guo WL, 2012, PEDIATR SURG INT, V28, P983, DOI 10.1007/s00383-012-3159-6; Gwal K, 2015, PEDIATR RADIOL, V45, P1153, DOI 10.1007/s00247-015-3296-x; Hung MH, 2011, EUR J PEDIATR, V170, P1179, DOI 10.1007/s00431-011-1429-2; Irie H, 1998, AM J ROENTGENOL, V171, P1381, DOI 10.2214/ajr.171.5.9798883; Kamisawa T, 2007, ABDOM IMAGING, V32, P129, DOI 10.1007/s00261-006-9005-3; Kamisawa T, 2014, J HEPATO-BIL-PAN SCI, V21, P159, DOI 10.1002/jhbp.57; Kamisawa T, 2012, J GASTROENTEROL, V47, P731, DOI 10.1007/s00535-012-0611-2; Kamisawa T, 2009, CLIN GASTROENTEROL H, V7, pS84, DOI 10.1016/j.cgh.2009.08.024; Kim MJ, 2002, AM J ROENTGENOL, V179, P209, DOI 10.2214/ajr.179.1.1790209; Li L, 2003, PEDIATR SURG INT, V19, P180, DOI 10.1007/s00383-002-0914-0; Miyazaki T, 1998, AM J ROENTGENOL, V170, P33, DOI 10.2214/ajr.170.1.9423593; Nagi B, 2003, ABDOM IMAGING, V28, P847, DOI 10.1007/s00261-003-0031-0; Noda Y, 2007, J GASTROENTEROL, V42, P211, DOI 10.1007/s00535-006-1991-y; Saito T, 2011, SURGERY, V149, P569, DOI 10.1016/j.surg.2010.11.004; Siles P, 2014, PEDIATR RADIOL, V44, P1077, DOI 10.1007/s00247-014-2953-9; Sugiyama M, 1998, SURGERY, V123, P391, DOI 10.1067/msy.1998.86581; Suzuki M, 2006, J PEDIATR GASTR NUTR, V42, P539, DOI 10.1097/01.mpg.0000221894.44124.8e; Takuma K, 2012, ADV MED SCI-POLAND, V57, P244, DOI 10.2478/v10039-012-0041-7; Takuma K, 2012, WORLD J GASTROENTERO, V18, P3409, DOI 10.3748/wjg.v18.i26.3409; Tang Y, 2001, COMPUT MED IMAG GRAP, V25, P423, DOI 10.1016/S0895-6111(00)00070-7; Tipnis Neelesh A, 2007, Curr Gastroenterol Rep, V9, P225, DOI 10.1007/s11894-007-0023-2; Tipnis NA, 2008, J PEDIATR GASTR NUTR, V46, P59, DOI 10.1097/01.mpg.0000304455.76928.0e; Yamataka A, 1997, J PEDIATR SURG, V32, P1560, DOI 10.1016/S0022-3468(97)90452-8	27	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154178	10.1371/journal.pone.0154178	http://dx.doi.org/10.1371/journal.pone.0154178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104956	gold, Green Published			2022-12-26	WOS:000374565100051
J	Liu, YD; Bahar, R; Kalia, S; Huang, RY; Phillips, A; Su, MW; Yang, S; Zhang, XJ; Zhou, PY; Zhou, YW				Liu, Yudan; Bahar, Rayeheh; Kalia, Sunil; Huang, Rachel Yuanshen; Phillips, Arlie; Su, Mingwan; Yang, Sen; Zhang, Xuejun; Zhou, Pingyu; Zhou, Youwen			Hyperhidrosis Prevalence and Demographical Characteristics in Dermatology Outpatients in Shanghai and Vancouver	PLOS ONE			English	Article							PALMAR HYPERHIDROSIS; POPULATION	Background There is a wide variation in the reported prevalence of primary hyperhidrosis in the literature. Further, it is unknown if primary hyperhidrosis is a lifelong condition, or if demographical factors influence hyperhidrosis prevalence. Objectives This study aims to examine the prevalence of hyperhidrosis in multiple ethnic groups from two ethnically diverse cities and to determine if the prevalence of primary hyperhidrosis changes according to age, gender, ethnicity, body mass index, and geographical locations. Methods In total, 1010 consecutive subjects attending dermatology outpatient clinics in Shanghai Skin Disease Hospital and 1018 subjects in Skin Care Center of Vancouver General Hospital were invited to fill out a questionnaire on their presenting concerns, demographical information, and sweating symptoms. The subjects were then classified to have primary hyperhidrosis using the criteria of International Hyperhidrosis Society, late-onset hyperhidrosis, or no-hyperhidrosis. The prevalence of primary HH and late-onset HH was calculated for the entire study population and in subgroups stratified according to age of examination, sex, ethnicity, presenting diagnosis, bodymass index, and specific study cities. Multivariate logistic regression analyses were performed to assess the impact of these factors on HH prevalence. Results The prevalence of primary hyperhidrosis is very similar in Shanghai and in Vancouver, at 14.5% and 12.3% respectively. In addition, 4.0% of subjects in Shanghai and 4.4% subjects in Vancouver suffer from late-onset HH. Primary HH has highest prevalence in those younger than 30 years of age, decreasing dramatically in later years. Caucasian subjects are at least 2.5 times more likely to develop axillary hyperhidrosis compared to Chinese subjects. Obesity does not have much influence on primary HH presentation, although it does increase significantly the development of late-onset HH. Finally, there is no major difference of hyperhidrosis between Chinese subjects in Shanghai and Vancouver. Limitations The data were gathered according to patients' self-reports only and the sample size was relatively small in some groups after stratification for gender, ethnicity and age. Conclusion Prevalence of primary HH and late-onset HH is similar in dermatology outpatients independent of geographical locations. However, certain specific HH subtypes can show great variations according to ethnicity, age, body mass index and sex.	[Liu, Yudan; Zhou, Pingyu] Anhui Med Univ, Sch Clin, Shanghai Skin Dis Hosp, Shanghai, Peoples R China; [Bahar, Rayeheh; Kalia, Sunil; Huang, Rachel Yuanshen; Phillips, Arlie; Su, Mingwan; Zhou, Youwen] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Bahar, Rayeheh; Huang, Rachel Yuanshen; Su, Mingwan; Zhou, Youwen] Vancouver Coastal Hlth Res Inst, Mol Med Lab, Vancouver, BC, Canada; [Bahar, Rayeheh; Huang, Rachel Yuanshen; Su, Mingwan; Zhou, Youwen] Vancouver Coastal Hlth Res Inst, Chieng Genom Ctr, Vancouver, BC, Canada; [Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Zhou, Pingyu] Shanghai Skin Dis Hosp, Sexually Transmitted Dis Inst, Shanghai, Peoples R China	Anhui Medical University; University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health Research Institute; Anhui Medical University	Zhou, PY (corresponding author), Anhui Med Univ, Sch Clin, Shanghai Skin Dis Hosp, Shanghai, Peoples R China.; Zhou, YW (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.; Zhou, YW (corresponding author), Vancouver Coastal Hlth Res Inst, Mol Med Lab, Vancouver, BC, Canada.; Zhou, YW (corresponding author), Vancouver Coastal Hlth Res Inst, Chieng Genom Ctr, Vancouver, BC, Canada.; Zhou, PY (corresponding author), Shanghai Skin Dis Hosp, Sexually Transmitted Dis Inst, Shanghai, Peoples R China.	zpyls@yahoo.com; youwen.zhou@ubc.ca	Kalia, Sunil/AAD-8008-2021		Canadian Dermatology Foundation; Canadian Institutes of Health Research [CCI-132563]; National Natural Sciences Foundation of China (NSFC) [81271749, 81361128014]	Canadian Dermatology Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Sciences Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants from Canadian Dermatology Foundation (to YZ), Canadian Institutes of Health Research (CCI-132563 to YZ), and National Natural Sciences Foundation of China (NSFC#81271749 to YZ, and NSFC#81361128014 to SY).	Augustin M, 2013, DERMATOLOGY, V227, P10, DOI 10.1159/000351292; CLOWARD R B, 1957, Hawaii Med J, V16, P381; Fujimoto T, 2013, J DERMATOL, V40, P886, DOI 10.1111/1346-8138.12258; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Gross KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092412; Hoeldtke RD, 2001, DIABETES, V50, P436, DOI 10.2337/diabetes.50.2.436; Hornberger J, 2004, J AM ACAD DERMATOL, V51, P274, DOI 10.1016/j.jaad.2003.12.029; Li X, 2007, CHINESE MED J-PEKING, V120, P2215, DOI 10.1097/00029330-200712020-00011; Manca D, 2000, CLIN NEUROPHYSIOL, V111, P1767, DOI 10.1016/S1388-2457(00)00394-1; SATO K, 1989, J AM ACAD DERMATOL, V20, P713, DOI 10.1016/S0190-9622(89)70081-5; Stashak AB, 2014, CLIN COSMET INVESTI, V7, P285, DOI 10.2147/CCID.S53119; Strutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040	12	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153719	10.1371/journal.pone.0153719	http://dx.doi.org/10.1371/journal.pone.0153719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105064	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100016
J	Mol, JPS; Pires, SF; Chapeaurouge, AD; Perales, J; Santos, RL; Andrade, HM; Lage, AP				Mol, Juliana P. S.; Pires, Simone F.; Chapeaurouge, Alexander D.; Perales, Jonas; Santos, Renato L.; Andrade, Helida M.; Lage, Andrey P.			Proteomic Profile of Brucella abortus-Infected Bovine Chorioallantoic Membrane Explants	PLOS ONE			English	Article							INTRACELLULAR REPLICATION; PROTEINS; LIPOPOLYSACCHARIDE; INFLAMMATION; INHIBITION; ACTIVATION; MATURATION; SECRETION; VIRULENCE; REVEALS	Brucella abortus is the etiological agent of bovine brucellosis, a zoonotic disease that causes significant economic losses worldwide. The differential proteomic profile of bovine chorioallantoic membrane (CAM) explants at early stages of infection with B. abortus (0.5, 2, 4, and 8 h) was determined. Analysis of CAM explants at 0.5 and 4 h showed the highest differences between uninfected and infected CAM explants, and therefore were used for the Differential Gel Electrophoresis (DIGE). A total of 103 spots were present in only one experimental group and were selected for identification by mass spectrometry (MALDI/ToF-ToF). Proteins only identified in extracts of CAM explants infected with B. abortus were related to recognition of PAMPs by TLR, production of reactive oxygen species, intracellular trafficking, and inflammation.	[Mol, Juliana P. S.; Lage, Andrey P.] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Belo Horizonte, MG, Brazil; [Pires, Simone F.; Andrade, Helida M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Chapeaurouge, Alexander D.; Perales, Jonas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Toxinol, Rio De Janeiro, Rio De Janeiro, Brazil; [Santos, Renato L.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Lage, AP (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Belo Horizonte, MG, Brazil.	alage@vet.ufmg.br	de Lima Santos, Renato/A-1134-2008	de Lima Santos, Renato/0000-0002-4830-0470; Mol, Juliana/0000-0002-6946-8213	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - PRONEX); CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - PRONEX)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - PRONEX). JPSM, APL, and RLS have fellowships from CNPq.	Al Dahouk S, 2008, PROTEOMICS, V8, P3862, DOI 10.1002/pmic.200800026; [Anonymous], [No title captured]; Boschiroli ML, 2002, VET MICROBIOL, V90, P341, DOI 10.1016/S0378-1135(02)00219-5; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Campbell-Valois FX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016378; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Celli J, 2005, P NATL ACAD SCI USA, V102, P1673, DOI 10.1073/pnas.0406873102; Celli J, 2004, CURR OPIN MICROBIOL, V7, P93, DOI 10.1016/j.mib.2003.11.001; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; de Almeida LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023135; DelVecchio VG, 2002, VET MICROBIOL, V90, P593, DOI 10.1016/S0378-1135(02)00239-0; Ding Y, 2010, PROTEOMICS, V10, P2620, DOI 10.1002/pmic.200900572; EVANS H E, 1973, Zentralblatt fuer Veterinaermedizin Reihe C, V2, P11; Gee JM, 2005, INFECT IMMUN, V73, P2873, DOI 10.1128/IAI.73.5.2873-2880.2005; Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Hauck SM, 2007, J PROTEOME RES, V6, P2121, DOI 10.1021/pr060668y; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Ikeda N, 2011, DIABETOLOGIA, V54, P2183, DOI 10.1007/s00125-011-2197-2; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Larnontagne J, 2009, J PROTEOME RES, V8, P1594, DOI 10.1021/pr800978p; Lauer SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091706; Liu LX, 2002, MOL BIOL CELL, V13, P4266, DOI 10.1091/mbc.E02-03-0136; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Mol JPS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108606; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Neta AVC, 2008, INFECT IMMUN, V76, P1897, DOI 10.1128/IAI.01554-07; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Richmond JY, 1993, BIOSAFETY MICROBIOLO, P85; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Salcedo SP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00028; Sampaio I.B.M., 1998, ESTATISTICA APLICADA, P221; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Sloane JA, 2010, NEUROMOL MED, V12, P149, DOI 10.1007/s12017-009-8094-x; Srivastava SK, 2011, CHEM-BIOL INTERACT, V191, P330, DOI 10.1016/j.cbi.2011.02.023; Tumurkhuu G, 2006, MICROBIOL IMMUNOL, V50, P421, DOI 10.1111/j.1348-0421.2006.tb03810.x; Wu QL, 2005, J PHARMACOL EXP THER, V313, P705, DOI 10.1124/jpet.104.080416; Wu YP, 2014, ELECTROPHORESIS, V35, P1130, DOI 10.1002/elps.201300378; Xavier MN, 2009, J COMP PATHOL, V140, P149, DOI 10.1016/j.jcpa.2008.10.004; Yadav UCS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006535	42	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154209	10.1371/journal.pone.0154209	http://dx.doi.org/10.1371/journal.pone.0154209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104343	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100056
J	Raza, A; Malik, HJ; Shafiq, M; Amin, I; Scheffler, JA; Scheffler, BE; Mansoor, S				Raza, Amir; Malik, Hassan Jamil; Shafiq, Muhammad; Amin, Imran; Scheffler, Jodi A.; Scheffler, Brian E.; Mansoor, Shahid			RNA Interference based Approach to Down Regulate Osmoregulators of Whitefly (Bemisia tabaci): Potential Technology for the Control of Whitefly	PLOS ONE			English	Article							MANAGING RESISTANCE; CROP PROTECTION; PLANTS; GENE; EXPRESSION; CHALLENGES; COTTON; PESTS	Over the past decade RNA interference (RNAi) technology has emerged as a successful tool not only for functional genomics, but in planta expression of short interfering RNAs (siR-NAs) that could offer great potential for insect pest management. The diet of insects feeding exclusively on phloem sieves contains water and sugars as main components, and the uptake of the liquid food greatly depends on the osmotic pressure within the insect body. Based on this physiological mechanism, transgenic plants of Nicotiana tabacum were generated expressing double stranded RNA (dsRNA) against both aquaporin (AQP) and a sucrase gene, alpha glucosidase (AGLU). These two genes are involved in osmotic pressure maintenance particularly in sap sucking insects, and the aim was to disrupt osmoregulation within the insect ultimately leading to mortality. Real time quantitative PCR (RT-qPCR) was performed to assess the suppression of gene expression in Bemisia tabaci (B. tabaci) and mortality was recorded during transgenic tobacco feeding bioassays. Feeding of insects on plants expressing dsRNA significantly reduced the transcript level of the target genes in B. tabaci after six days of feeding and more than 70% mortality was observed in B. tabaci fed on transgenic plants compared to the control plants. Our data shows that down-regulation of genes related to osmoregulation may find practical applications for the control of this important pest in cotton and other crops.	[Raza, Amir; Malik, Hassan Jamil; Shafiq, Muhammad; Amin, Imran; Mansoor, Shahid] NIBGE, Mol Virol & Gene Silencing Lab, Agr Biotechnol Div, Jhang Rd,POB 577, Faisalabad, Pakistan; [Raza, Amir; Malik, Hassan Jamil; Shafiq, Muhammad] PIEAS, Islamabad, Pakistan; [Scheffler, Jodi A.] USDA ARS, Crop Genet Res Unit, 141 Expt Stn Rd, Stoneville, MS 38776 USA; [Scheffler, Brian E.] USDA ARS, Genom & Bioinformat Res Unit, 141 Expt Stn Rd, Stoneville, MS 38776 USA	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Mansoor, S (corresponding author), NIBGE, Mol Virol & Gene Silencing Lab, Agr Biotechnol Div, Jhang Rd,POB 577, Faisalabad, Pakistan.	shahidmansoor7@gmail.com	Malik, Hassan J/A-1753-2019	Scheffler, Brian/0000-0003-1968-8952; Mansoor, Shahid/0000-0001-7418-1826; Shafiq, Muhammad/0000-0002-1308-1538	Higher Education Commission; Pakistan - United States Cotton Productivity Enhancement Program; United States Department of Agriculture Agricultural Research Service [58-6402-0-178F]; ARS [ARS-0425112] Funding Source: Federal RePORTER	Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Pakistan - United States Cotton Productivity Enhancement Program; United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding provided by Higher Education Commission, AR, MS Pakistan - United States Cotton Productivity Enhancement Program, United States Department of Agriculture Agricultural Research Service Project No. 58-6402-0-178F.	[Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; Burow MD., 1990, PLANT MOL BIOL REP, V8, P124, DOI [10.1007/BF02669766, DOI 10.1007/BF02669766]; Chassy BM, 2010, ISB NEWS REPORT; Christiaens O, 2014, CURR OPIN INSECT SCI, V6, P15, DOI 10.1016/j.cois.2014.09.012; De Barro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025579; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Denholm I, 1998, PHILOS T R SOC B, V353, P1757, DOI 10.1098/rstb.1998.0328; Dhaliwal G. S., 2010, Indian Journal of Ecology, V37, P1; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dutta TK, 2013, FRONTIERS MICROBIOLO, V5; Escobar MA, 2001, P NATL ACAD SCI USA, V98, P13437, DOI 10.1073/pnas.241276898; Gatehouse JA, 2008, PLANT PHYSIOL, V146, P881, DOI 10.1104/pp.107.111096; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Gheysen G, 2007, TRENDS BIOTECHNOL, V25, P89, DOI 10.1016/j.tibtech.2007.01.007; Guerineau F., 1993, Plant molecular biology labfax., P121; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Horowitz AR, 1999, PESTIC SCI, V55, P272, DOI 10.1002/(SICI)1096-9063(199903)55:3&lt;272::AID-PS908&gt;3.0.CO;2-; HOROWITZ AR, 1994, PESTIC SCI, V42, P113, DOI 10.1002/ps.2780420208; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Koch A, 2014, PLANT BIOTECHNOL J, V12, P821, DOI 10.1111/pbi.12226; Kos M, 2009, TRENDS BIOTECHNOL, V27, P621, DOI 10.1016/j.tibtech.2009.08.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mansoor S, 2006, TRENDS PLANT SCI, V11, P559, DOI 10.1016/j.tplants.2006.09.010; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Mehta A, 1998, FEBS LETT, V430, P17, DOI 10.1016/S0014-5793(98)00525-0; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nawaz-Ul-Rehman MS, 2009, FEBS LETT, V583, P1825, DOI 10.1016/j.febslet.2009.05.045; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Roberts AF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00958; Rosell RC, 1997, ANN ENTOMOL SOC AM, V90, P575, DOI 10.1093/aesa/90.5.575; Samih M, 2005, COMMUNICATIONS AGR A, V71, P613; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Upadhyay SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083692; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang J, 2015, SCIENCE, V347, P991, DOI 10.1126/science.1261680; Zotti MJ, 2015, NEOTROP ENTOMOL, V44, P197, DOI 10.1007/s13744-015-0291-8	49	44	44	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153883	10.1371/journal.pone.0153883	http://dx.doi.org/10.1371/journal.pone.0153883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105353	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100027
J	Dhana, K; Koolhaas, CM; van Rossum, EFC; Ikram, MA; Hofman, A; Kavousi, M; Franco, OH				Dhana, Klodian; Koolhaas, Chantal M.; van Rossum, Elisabeth F. C.; Ikram, M. Arfan; Hofman, Albert; Kavousi, Maryam; Franco, Oscar H.			Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly Population	PLOS ONE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; OLDER US; OVERWEIGHT; ASSOCIATION; PREVALENCE; OUTCOMES; MODEL; AGE	Background Whether being metabolically healthy obese (MHO)-defined by the presence of obesity in the absence of metabolic syndrome-is associated with subsequent cardiovascular disease (CVD) remains unclear and may depend on the participants' age. We examined the association of being MHO with CVD risk in the elderly. Methods and Findings This study included 5,314 individuals (mean age 68 years) from the prospective population-based Rotterdam Study. We categorized our population in groups according to body mass index (BMI) and presence and absence of metabolic syndrome, and estimated the hazard ratio (HR) and 95% confidence interval (95% CI) for every group by using Cox proportional hazard models. Among 1048 (19.7%) obese individuals we identified 260 (24.8%) MHO subjects. Over 14 years of follow-up there were 861 incident CVD cases. In the multivariable adjusted analysis, we did not observe an increased CVD risk in MHO individuals (HR 1.07, 95%CI 0.75-1.53), compared to normal weight individuals without metabolic syndrome. CVD risk was increased by the presence of metabolic syndrome in normal weight (HR 1.35, 95%CI 1.02-1.80), overweight (HR 1.32, 95%CI 1.09-1.60) and obese (HR 1.33, 95%CI 1.07-1.66) individuals, compared to those with normal weight without metabolic syndrome. In a mediation analysis, 71.3% of the association between BMI and CVD was explained by the presence of metabolic syndrome. Conclusions In our elderly population, we found that the presence of obesity without metabolic syndrome did not confer a higher CVD risk. However, metabolic syndrome was strongly associated with CVD risk, and was associated with an increased risk in all BMI categories. Therefore, preventive interventions targeting cardiometabolic risk factors could be considered in elderly, regardless of weight status.	[Dhana, Klodian; Koolhaas, Chantal M.; Ikram, M. Arfan; Hofman, Albert; Kavousi, Maryam; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Rossum, Elisabeth F. C.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Hofman, Albert] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health	Dhana, K (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	k.dhana@erasmusmc.nl	van Rossum, Elisabeth/AAP-9388-2020; Ikram, M. Arfan/AAM-5225-2021; Kavousi, Maryam/F-1174-2018; Franco, Óscar H/ABE-2305-2020	Kavousi, Maryam/0000-0001-5976-6519; Franco, Óscar H/0000-0002-4606-4929; Dhana, Klodian/0000-0002-6397-7009	Erasmus MC and Erasmus University, Rotterdam; the Netherlands; Netherlands Organisation for Scientific Research (NWO); Netherlands Organisation for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Erasmus Mundus Western Balkans (ERAWEB); European Commission; Vereniging Trustfonds Erasmus Universiteit Rotterdam; Nestle Nutrition (Nestec Ltd.); Metagenics Inc. Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA Research Fund; Netherlands Heart Foundation [2012T008]	Erasmus MC and Erasmus University, Rotterdam; the Netherlands(Netherlands Government); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Erasmus Mundus Western Balkans (ERAWEB); European Commission(European CommissionEuropean Commission Joint Research Centre); Vereniging Trustfonds Erasmus Universiteit Rotterdam; Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc. Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; AXA Research Fund(AXA Research Fund); Netherlands Heart Foundation(Netherlands Heart Foundation)	The Rotterdam Study is funded by Erasmus MC and Erasmus University, Rotterdam, the Netherlands; the Netherlands Organisation for Scientific Research (NWO); the Netherlands Organisation for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. KD is supported by Erasmus Mundus Western Balkans (ERAWEB), a project funded by the European Commission and received additional funding from Vereniging Trustfonds Erasmus Universiteit Rotterdam. CMK and OHF work in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.) and Metagenics Inc. Nestle Nutrition (Nestec Ltd.) and Metagenics Inc. MK is supported by the AXA Research Fund. MAI is supported by the Netherlands Heart Foundation (2012T008). These funding sources had no role in design and conduct of this manuscript; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript.	Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bos MJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001634; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; CASPERSEN CJ, 1991, AM J EPIDEMIOL, V133, P1078, DOI 10.1093/oxfordjournals.aje.a115821; Chapman I., 2008, OBESITY IN OLD AGE; Chapman IM, 2010, INTERD T GERONT GERI, V37, P20, DOI 10.1159/000319992; Dhana K, 2015, HEART, V101, P377, DOI 10.1136/heartjnl-2014-306704; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; Hinnouho GM, 2015, EUR HEART J, V36, P551, DOI 10.1093/eurheartj/ehu123; Hofman A, 2015, EUR J EPIDEMIOL, V30, P661, DOI 10.1007/s10654-015-0082-x; Janssen I, 2004, ANN EPIDEMIOL, V14, P585, DOI 10.1016/j.annepidem.2004.01.007; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Koller MT, 2012, ANN INTERN MED, V157, P389, DOI 10.7326/0003-4819-157-6-201209180-00002; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Leening MJG, 2012, EUR J EPIDEMIOL, V27, P173, DOI 10.1007/s10654-012-9668-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Myint PK, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1214; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; ROCHE AF, 1981, AM J CLIN NUTR, V34, P2831, DOI 10.1093/ajcn/34.12.2831; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Song YQ, 2007, AM J CARDIOL, V100, P1654, DOI 10.1016/j.amjcard.2007.06.073; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wildman RP, 2009, CURR OPIN CLIN NUTR, V12, P438, DOI 10.1097/MCO.0b013e32832c6db7	35	35	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154273	10.1371/journal.pone.0154273	http://dx.doi.org/10.1371/journal.pone.0154273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100779	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500175
J	Ghadiry, M; Gholami, M; Lai, CK; Ahmad, H; Chong, WY				Ghadiry, Mahdiar; Gholami, Mehrdad; Lai, C. K.; Ahmad, Harith; Chong, W. Y.			Ultra-Sensitive Humidity Sensor Based on Optical Properties of Graphene Oxide and Nano-Anatase TiO2	PLOS ONE			English	Article							RELATIVE-HUMIDITY; LINEAR-RESPONSE	Generally, in a waveguide-based humidity sensors, increasing the relative humidity (RH) causes the cladding refractive index (RI) to increase due to cladding water absorption. However, if graphene oxide (GO) is used, a reverse phenomenon is seen due to a gap increase in graphene layers. In this paper, this interesting property is applied in order to fabricate differential humidity sensor using the difference between RI of reduced GO (rGO) and nano-anatase TiO2 in a chip. First, a new approach is proposed to prepare high quality nano-anatase TiO2 in solution form making the fabrication process simple and straightforward. Then, the resulted solutions (TiO2 and GO) are effortlessly drop casted and reduced on SU8 two channels waveguide and extensively examined against several humid conditions. Investigating the sensitivity and performance (response time) of the device, reveals a great linearity in a wide range of RH (35% to 98%) and a variation of more than 30 dB in transmitted optical power with a response time of only similar to 0.7 sec. The effect of coating concentration and UV treatment are studied on the performance and repeatability of the sensor and the attributed mechanisms explained. In addition, we report that using the current approach, devices with high sensitivity and very low response time of only 0.3 sec can be fabricated. Also, the proposed device was comprehensively compared with other state of the art proposed sensors in the literature and the results were promising. Since high sensitivity similar to 0.47dB/% RH and high dynamic performances were demonstrated, this sensor is a proper choice for biomedical applications.	[Ghadiry, Mahdiar; Lai, C. K.; Ahmad, Harith; Chong, W. Y.] Univ Malaya, Photon Res Ctr, Kuala Lumpur 50603, Malaysia; [Gholami, Mehrdad] Islamic Azad Univ, Marvdasht Branch, Dept Chem, POB 465, Marvdasht, Iran	Universiti Malaya; Islamic Azad University	Ghadiry, M (corresponding author), Univ Malaya, Photon Res Ctr, Kuala Lumpur 50603, Malaysia.	mahdiar@um.edu.my	Chong, Wu Yi/AAE-3826-2022; Gholami, Mehrdad/GNP-4688-2022; Ahmad, Harith/A-3387-2009; Chong, Wu Yi/I-1174-2014; Lai, Choon Kong/AAZ-1792-2021	Ahmad, Harith/0000-0002-9599-2086; Chong, Wu Yi/0000-0002-2053-7783; Lai, Choon Kong/0000-0002-1807-859X	University of Malaya [GA010-2014, UM.C/625/1/HIR/MOHE/SCI/29]	University of Malaya(Universiti Malaya)	The authors would like to acknowledge the full support from University of Malaya through their funding LRGS (2015), NGOD/um/KPT, GA010-2014, UM.C/625/1/HIR/MOHE/SCI/29.	Alvarez-Herrero A, 2004, IEEE SENS J, V4, P52, DOI 10.1109/JSEN.2003.822214; Aneesh R, 2012, APPL OPTICS, V51, P2164, DOI 10.1364/AO.51.002164; Aneesh R, 2011, APPL OPTICS, V50, P5310, DOI 10.1364/AO.50.005310; Ansari ZA, 1997, THIN SOLID FILMS, V305, P330, DOI 10.1016/S0040-6090(97)00146-6; Basu S, 2012, SENSOR ACTUAT B-CHEM, V173, P1, DOI 10.1016/j.snb.2012.07.092; Borini S, 2013, ACS NANO, V7, P11166, DOI 10.1021/nn404889b; Corres JM, 2008, IEEE SENS J, V8, P281, DOI 10.1109/JSEN.2008.917487; Gaston A, 2003, IEEE SENS J, V3, P806, DOI 10.1109/JSEN.2003.820349; Ghadiry M, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010039; Guo CY, 2015, SENSOR ACTUAT B-CHEM, V206, P407, DOI 10.1016/j.snb.2014.09.058; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Huang NM, 2011, INT J NANOMED, V6, P3443, DOI 10.2147/IJN.S26812; Kuang Q, 2007, J AM CHEM SOC, V129, P6070, DOI 10.1021/ja070788m; Lim WH, 2014, SENSORS-BASEL, V14, P24329, DOI 10.3390/s141224329; Liu DZJ, 2015, INT J CLIN PHARM TH, V53, P172, DOI 10.5414/CP202146; Liu Y, 2007, IEEE PHOTONIC TECH L, V19, P880, DOI 10.1109/LPT.2007.897551; Lu GH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/44/445502; Mathew J., 2013, THESIS DUBLIN I TECH; Lopez-Higuera JM, 2011, J LIGHTWAVE TECHNOL, V29, P587, DOI 10.1109/JLT.2011.2106479; Mogera U, 2014, SCI REP-UK, V4, DOI 10.1038/srep04103; Ren YT, 2001, SENSOR ACTUAT B-CHEM, V75, P76, DOI 10.1016/S0925-4005(01)00538-X; Shibata T, 2003, J PHYS CHEM B, V107, P10696, DOI 10.1021/jp0357830; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; STEWART G, 1993, SENSOR ACTUAT B-CHEM, V11, P521, DOI 10.1016/0925-4005(93)85297-N; Su PG, 2007, SENSOR ACTUAT B-CHEM, V123, P501, DOI 10.1016/j.snb.2006.09.052; Tan KM, 2005, SENSOR ACTUAT B-CHEM, V110, P335, DOI 10.1016/j.snb.2005.02.012; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Vijayan A, 2008, SENSOR ACTUAT B-CHEM, V129, P106, DOI 10.1016/j.snb.2007.07.113; Wei N, 2014, ACS APPL MATER INTER, V6, P5877, DOI 10.1021/am500777b; Xie LJ, 2014, ANAL BIOANAL CHEM, V406, P377, DOI 10.1007/s00216-013-7302-6; Xie X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02117; Yao BC, 2014, SENSOR ACTUAT B-CHEM, V194, P142, DOI 10.1016/j.snb.2013.12.085; Yeo TL, 2008, SENSOR ACTUAT A-PHYS, V144, P280, DOI 10.1016/j.sna.2008.01.017; Yeo TL, 2005, SENSOR ACTUAT B-CHEM, V110, P148, DOI 10.1016/j.snb.2005.01.033; Zhang DZ, 2014, SENSOR ACTUAT B-CHEM, V197, P66, DOI 10.1016/j.snb.2014.02.078; Zhang YS, 2005, APPL SURF SCI, V242, P212, DOI 10.1016/j.apsusc.2004.08.013	36	27	29	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153949	10.1371/journal.pone.0153949	http://dx.doi.org/10.1371/journal.pone.0153949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101247	gold, Green Published			2022-12-26	WOS:000374898500107
J	Han, LH; Zhang, ML; Wang, MM; Jia, JC; Zhao, MY; Fan, YM; Li, XR				Han, Longhui; Zhang, Minglian; Wang, Mengmeng; Jia, Jinchen; Zhao, Miying; Fan, Yiming; Li, Xiaorong			High Mobility Group Box-1 Promotes Inflammation-Induced Lymphangiogenesis via Toll-Like Receptor 4-Dependent Signalling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-C; KAPPA-B; HMGB1; MACROPHAGES; PROTEIN; EXPRESSION; CANCER; METASTASIS; CELLS; ACTIVATION	Lymphangiogenesis in inflammation has received considerable attention in recent years. Administration of modulating lymphangiogenesis provides more possibilities of treating inflammation-associated diseases. However, the main mediators and factors governing inflammation-induced lymphangiogenesis (ILA) are yet to be defined. Here, we explored the role of HMGB1-TLR4 signalling pathway in modulating inflammation-induced lymphangiogenesis and its underlying mechanisms using an ILA mouse model and 2 cell lines. Our results show that HMGB1 promoted VEGF-C-induced HDLECs proliferation in a dose-dependent manner and TLR4 mediates HMGB1-induced LECs proliferation and tube formation in vitro. And in vivo, rHMGB1 treatment significantly promoted ILA, and the promoting effects was inhibited notably when HMGB1-TLR4 was blocked. HMGB1-associated ILA is primarily dependent on TLR4 but not on TLR2. In mechanisms, the recruitment and activation of CD11b+ cells are important cellular mechanisms in HMGB1-TLR4 associated ILA, and multiple key pro-lymphangiogenesis molecules mediates HMGB1-TLR4 associated ILA, including VEGF-C/VEGFR3, inflammatory factors IL-1 beta and TNF-alpha, MMP-2 and MMP-9 and NF-kappa B p65. In conclusion, HMGB1-associated ILA is primarily dependent on TLR4, and CD11b+ cells and multiple molecular mechanisms mediate HMGB1-TLR4 associated ILA. Furthermore, the ILA can be effectively modulated by HMGB1-TLR4 signalling. Consequently, administration of modulating ILA through HMGB1-TLR4 pathway may provide us more possibilities of treating inflammation and lymphangiogenesis associated diseases.	[Han, Longhui; Li, Xiaorong] Tianjin Med Univ, Hosp Eye, Sch Optometry & Ophthalmol, Inst Eye, Tianjin, Peoples R China; [Han, Longhui; Zhang, Minglian; Wang, Mengmeng; Jia, Jinchen; Zhao, Miying; Fan, Yiming] Hebei Prov Eye Hosp, Hebei Prov Eye Inst, Hebei Prov Key Lab Ophthalmol, Xingtai, Hebei, Peoples R China	Tianjin Medical University	Han, LH (corresponding author), Tianjin Med Univ, Hosp Eye, Sch Optometry & Ophthalmol, Inst Eye, Tianjin, Peoples R China.; Han, LH (corresponding author), Hebei Prov Eye Hosp, Hebei Prov Eye Inst, Hebei Prov Key Lab Ophthalmol, Xingtai, Hebei, Peoples R China.	han-longhui@163.com		Wang, Mengmeng/0000-0002-4939-611X				Attout T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008234; BACK A, 1995, BLOOD, V85, P1017, DOI 10.1182/blood.V85.4.1017.bloodjournal8541017; Bennuru S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000688; Cai JJ, 2015, ARTERIOSCL THROM VAS, V35, P2579, DOI 10.1161/ATVBAHA.115.305789; Cao RH, 2011, NAT PROTOC, V6, P817, DOI 10.1038/nprot.2011.359; CHEN Y, 2015, NANOSCALE RES LETT, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0140918; Corliss BA, 2016, MICROCIRCULATION, V23, P95, DOI 10.1111/micc.12259; Coso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039558; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Cursiefen C, 2011, J EXP MED, V208, P1083, DOI 10.1084/jem.20092277; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Hall KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031794; Han LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108931; HICKSTEIN DD, 1988, J BIOL CHEM, V263, P13863; HICKSTEIN DD, 1989, J BIOL CHEM, V264, P21812; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Li Y, 2015, J INT MED RES, V43, P494, DOI 10.1177/0300060515581671; Liao S, 2014, ANGIOGENESIS, V17, P325, DOI 10.1007/s10456-014-9416-7; Liu AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035379; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Miyamoto A, 2014, J ANIM SCI, V92, P1834, DOI 10.2527/jas.2013-7332; Nadatani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080130; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Qiu YY, 2012, MED ONCOL, V29, P358, DOI 10.1007/s12032-010-9778-7; Ran Sophia, 2012, Cancers (Basel), V4, P618, DOI 10.3390/cancers4030618; Sasahira T, 2008, CANCER SCI, V99, P1806, DOI 10.1111/j.1349-7006.2008.00894.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tan KW, 2013, BLOOD, V122, P3666, DOI 10.1182/blood-2012-11-466532; van Zoelen MAD, 2009, SHOCK, V31, P280, DOI 10.1097/SHK.0b013e318186262d; Van't HEF, 2014, ONCOIMMUNOLOGY, V3, DOI DOI 10.4161/ONCI.29080; Velegraki M, 2012, J CLIN IMMUNOL, V32, P312, DOI 10.1007/s10875-011-9620-9; Vitali R, 2011, AM J GASTROENTEROL, V106, P2029, DOI 10.1038/ajg.2011.231; Volk-Draper L, 2014, CANCER RES, V74, P5421, DOI 10.1158/0008-5472.CAN-14-0067; Wang FL, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-284; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Wang J, 2009, BIOCHEM PHARMACOL, V78, P178, DOI 10.1016/j.bcp.2009.03.031; Wu WQ, 2012, ASIAN PAC J CANCER P, V13, P991, DOI 10.7314/APJCP.2012.13.3.991; Yan HX, 2013, J HEPATOL, V59, P762, DOI 10.1016/j.jhep.2013.05.029; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC709, DOI 10.1152/ajpcell.00284.2011; Zampell JC, 2011, AM J PHYSIOL-CELL PH, V300, pC1107, DOI 10.1152/ajpcell.00378.2010; Zhang WQ, 2014, TUMOR BIOL, V35, P2175, DOI 10.1007/s13277-013-1288-8	51	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154187	10.1371/journal.pone.0154187	http://dx.doi.org/10.1371/journal.pone.0154187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100831	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500163
J	Kim, HW; Kwon, SR; Jung, KH; Kim, SK; Baek, HJ; Seo, MR; Bang, SY; Lee, HS; Suh, CH; Jung, JY; Son, CN; Shim, SC; Lee, SH; Lee, SG; Lee, YA; Lee, EY; Kim, TH; Kim, YG				Kim, Hye Won; Kwon, Seong Ryul; Jung, Kyong-Hee; Kim, Seong-Kyu; Baek, Han Joo; Seo, Mi Ryung; Bang, So-Young; Lee, Hye-Soon; Suh, Chang-Hee; Jung, Ju Yang; Son, Chang-Nam; Shim, Seung Cheol; Lee, Sang-Hoon; Lee, Seung-Geun; Lee, Yeon-Ah; Lee, Eun Young; Kim, Tae-Hwan; Kim, Yong-Gil		Korean Soc Spondyloarthrit Res	Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research	PLOS ONE			English	Article							FACTOR ANTAGONISTS; RHEUMATOID-ARTHRITIS; ALPHA INHIBITORS; RISK; THERAPY; INFLIXIMAB; INFECTION; RECOMMENDATIONS; COMPLICATION; REACTIVATION	Backgrounds Patients who develop an active tuberculosis infection during tumor necrosis factor (TNF) inhibitor treatment typically discontinue TNF inhibitor and receive standard anti-tuberculosis treatment. However, there is currently insufficient information on patient outcomes following resumption of TNF inhibitor treatment during ongoing anti-tuberculosis treatment. Our study was designed to investigate the safety of resuming TNF inhibitors in ankylosing spondylitis (AS) patients who developed tuberculosis as a complication of the use of TNF inhibitors. Methods Through the nationwide registry of the Korean Society of Spondyloarthritis Research, 3929 AS patients who were prescribed TNF inhibitors were recruited between June 2003 and June 2014 at fourteen referral hospitals. Clinical information was analyzed about the patients who experienced tuberculosis after exposure to TNF inhibitors. The clinical features of resumers and non-resumers of TNF inhibitors were compared and the outcomes of tuberculosis were surveyed individually. Findings Fifty-six AS patients were treated for tuberculosis associated with TNF inhibitors. Among them, 23 patients resumed TNF inhibitors, and these patients were found to be exposed to TNF inhibitors for a longer period of time and experienced more frequent disease flare-up after discontinuation of TNF inhibitors compared with those who did not resume. Fifteen patients resumed TNF inhibitors during anti-tuberculosis treatment (early resumers) and 8 after completion of anti-tuberculosis treatment (late resumers). Median time to resuming TNF inhibitor from tuberculosis was 3.3 and 9.0 months in the early and late resumers, respectively. Tuberculosis was treated successfully in all resumers and did not relapse in any of them during follow-up (median 33.8 [IQR; 20.8-66.7] months). Conclusions Instances of tuberculosis were treated successfully in our AS patients, even when given concomitantly with TNF inhibitors. We suggest that early resumption of TNF inhibitors in AS patients could be safe under effective coverage of tuberculosis.	[Kim, Hye Won] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med,Div Rheumatol, Seoul, South Korea; [Kwon, Seong Ryul; Jung, Kyong-Hee] Inha Univ, Sch Med, Dept Internal Med, Div Rheumatol, Incheon, South Korea; [Kim, Seong-Kyu] Catholic Univ Daegu, Sch Med, Arthrit & Autoimmun Res Ctr, Div Rheumatol,Dept Internal Med, Daegu, South Korea; [Baek, Han Joo; Seo, Mi Ryung] Gachon Univ, Gil Hosp, Dept Internal Med, Div Rheumatol, Incheon, South Korea; [Bang, So-Young; Lee, Hye-Soon] Hanyang Univ, Guri Hosp, Dept Internal Med, Div Rheumatol, Guri, South Korea; [Suh, Chang-Hee; Jung, Ju Yang] Ajou Univ Hosp, Dept Internal Med, Div Rheumatol, Suwon, South Korea; [Son, Chang-Nam] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Rheumatol, Daegu, South Korea; [Shim, Seung Cheol] Chungnam Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Daejeon, South Korea; [Lee, Sang-Hoon] Kyung Hee Univ Hosp Gangdong, Ctr Arthrit & Rheumatism, Dept Rheumatol, Seoul, South Korea; [Lee, Seung-Geun] Pusan Natl Univ Hosp, Div Rheumatol, Dept Internal Med, Busan, South Korea; [Lee, Yeon-Ah] Kyung Hee Univ, Med Ctr, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Lee, Eun Young] Seoul Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Seoul 110744, South Korea; [Kim, Tae-Hwan] Hanyang Univ Hosp Rheumat Dis, Div Rheumatol, Seoul, South Korea; [Kim, Yong-Gil] Univ Ulsan, Coll Med, Asan Med Ctr, Div Rheumatol,Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Inha University; Catholic University of Daegu; Gachon University; Hanyang University; Ajou University; Ajou University Hospital; Keimyung University; Chungnam National University; Chungnam National University Hospital; Kyung Hee University; Kyung Hee University Hospital; Pusan National University; Pusan National University Hospital; Kyung Hee University; Seoul National University (SNU); Seoul National University Hospital; Hanyang University; Hanyang University Hospital; University of Ulsan; Asan Medical Center	Kim, TH (corresponding author), Hanyang Univ Hosp Rheumat Dis, Div Rheumatol, Seoul, South Korea.; Kim, YG (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Rheumatol,Dept Internal Med, Seoul, South Korea.	thkim@hanyang.ac.kr; bestmd2000@amc.seoul.kr	KWON, SEONG-RYUL/GWN-2603-2022; Song, Young Goo/AGV-5104-2022; Suh, Chang-Hee/H-9723-2019	Song, Young Goo/0000-0002-0733-4156; Suh, Chang-Hee/0000-0001-6156-393X; Park, Min-Chan/0000-0003-1189-7637; Shim, Seung cheol/0000-0002-3199-359X; Lee, Seung-Geun/0000-0002-5205-3978				Abreu C, 2013, J CROHNS COLITIS, V7, P175, DOI [10.1016/j.crohns.2012.04.018, 10.1016/j.crohns.2013.03.004]; [Anonymous], 2005, THORAX, V60, P800, DOI DOI 10.1136/THX.2005.046797; Baraliakos X, 2005, ARTHRITIS RES THER, V7, pR439, DOI 10.1186/ar1693; Baraliakos X, 2012, RHEUMATOLOGY, V51, P1378, DOI 10.1093/rheumatology/kes026; Baronnet L, 2011, JOINT BONE SPINE, V78, P279, DOI 10.1016/j.jbspin.2010.12.004; Brandt J, 2000, ARTHRITIS RHEUM-US, V43, P1346, DOI 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E; Braun J, 2015, EXPERT OPIN EMERG DR, V20, P1, DOI 10.1517/14728214.2015.993378; Cantini F, 2014, J RHEUMATOL, V41, P78, DOI 10.3899/jrheum.140106; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Denis B, 2008, CLIN MICROBIOL INFEC, V14, P183, DOI 10.1111/j.1469-0691.2007.01891.x; Ergun T, 2015, INT J DERMATOL, V54, P594, DOI 10.1111/ijd.12628; Evangelopoulos D, 2015, INT J INFECT DIS, V32, P76, DOI 10.1016/j.ijid.2014.11.028; Gomez-Reino JJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P756, DOI 10.1002/art.22768; Grijalva CG, 2011, JAMA-J AM MED ASSOC, V306, P2331, DOI 10.1001/jama.2011.1692; Joint Committee for the Revision of Korean Guidelines for Tuberculosis KCfDCaP, 2014, JOINT COMMITTEE FOR; Jung SM, 2015, INT J RHEUM DIS, V18, P323, DOI 10.1111/1756-185X.12530; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim HW, 2014, CLIN RHEUMATOL, V33, P1307, DOI 10.1007/s10067-013-2387-z; Kim YJ, 2014, RHEUMATOLOGY, V53, P1477, DOI 10.1093/rheumatology/keu041; Lee YM, 2014, J INFECTION, V69, P165, DOI 10.1016/j.jinf.2014.02.019; Mariette X, 2003, Ann Rheum Dis, V62, P791, DOI 10.1136/ard.62.8.791; Maxwell LJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005468.pub2; Poddubnyy D, 2013, THER ADV MUSCULOSKEL, V5, P45, DOI 10.1177/1759720X12468658; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Suh YS, 2014, J KOREAN MED SCI, V29, P38, DOI 10.3346/jkms.2014.29.1.38; Tam LS, 2010, CLIN EXP RHEUMATOL, V28, P679; Toussi SS, 2013, CLIN INFECT DIS, V57, P1318, DOI 10.1093/cid/cit489; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wallis RS, 2009, CLIN INFECT DIS, V48, P1429, DOI 10.1086/598504; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153816	10.1371/journal.pone.0153816	http://dx.doi.org/10.1371/journal.pone.0153816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101309	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500071
J	Sepsiova, R; Necasova, I; Willcox, S; Prochazkova, K; Gorilak, P; Nosek, J; Hofr, C; Griffith, JD; Tomaska, L				Sepsiova, Regina; Necasova, Ivona; Willcox, Smaranda; Prochazkova, Katarina; Gorilak, Peter; Nosek, Jozef; Hofr, Ctirad; Griffith, Jack D.; Tomaska, Lubomir			Evolution of Telomeres in Schizosaccharomyces pombe and Its Possible Relationship to the Diversification of Telomere Binding Proteins	PLOS ONE			English	Article							MYB-DOMAIN PROTEIN; FISSION YEAST; HUMAN RAP1; USTILAGO-MAYDIS; TAY1 PROTEIN; DNA; TAZ1; TRF2; IDENTIFICATION; SEQUENCE	Telomeres of nuclear chromosomes are usually composed of an array of tandemly repeated sequences that are recognized by specific Myb domain containing DNA-binding proteins (telomere-binding proteins, TBPs). Whereas in many eukaryotes the length and sequence of the telomeric repeat is relatively conserved, telomeric sequences in various yeasts are highly variable. Schizosaccharomyces pombe provides an excellent model for investigation of co-evolution of telomeres and TBPs. First, telomeric repeats of S. pombe differ from the canonical mammalian type TTAGGG sequence. Second, S. pombe telomeres exhibit a high degree of intratelomeric heterogeneity. Third, S. pombe contains all types of known TBPs (Rap1p [a version unable to bind DNA], Tay1p/Teb1p, and Taz1p) that are employed by various yeast species to protect their telomeres. With the aim of reconstructing evolutionary paths leading to a separation of roles between Teb1p and Taz1p, we performed a comparative analysis of the DNA-binding properties of both proteins using combined qualitative and quantitative biochemical approaches. Visualization of DNA-protein complexes by electron microscopy revealed qualitative differences of binding of Teb1p and Taz1p to mammalian type and fission yeast telomeres. Fluorescence anisotropy analysis quantified the binding affinity of Teb1p and Taz1p to three different DNA substrates. Additionally, we carried out electrophoretic mobility shift assays using mammalian type telomeres and native substrates (telomeric repeats, histone-box sequences) as well as their mutated versions. We observed relative DNA sequence binding flexibility of Taz1p and higher binding stringency of Teb1p when both proteins were compared directly to each other. These properties may have driven replacement of Teb1p by Taz1p as the TBP in fission yeast.	[Sepsiova, Regina; Prochazkova, Katarina; Gorilak, Peter; Tomaska, Lubomir] Comenius Univ, Dept Genet, Fac Nat Sci, Ilkovicova 6, Bratislava 84215, Slovakia; [Necasova, Ivona; Hofr, Ctirad] Masaryk Univ, Chromatin Mol Complexes, Cent European Inst Technol, CZ-62500 Brno, Czech Republic; [Necasova, Ivona; Hofr, Ctirad] Masaryk Univ, Lab Funct Genom & Prote, Fac Sci, Natl Ctr Biomol Res, CZ-62500 Brno, Czech Republic; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Nosek, Jozef] Comenius Univ, Dept Biochem, Fac Nat Sci, Ilkovicova 6, Bratislava 84215, Slovakia	Comenius University Bratislava; Masaryk University Brno; Masaryk University Brno; University of North Carolina; University of North Carolina Chapel Hill; Comenius University Bratislava	Tomaska, L (corresponding author), Comenius Univ, Dept Genet, Fac Nat Sci, Ilkovicova 6, Bratislava 84215, Slovakia.	tomaska@fns.uniba.sk	Nečasová, Ivona/ABB-7674-2020; Prochazkova, Katarina/ABE-1222-2021; Tomaska, Lubomir/I-3071-2014; Nosek, Jozef/A-7581-2008; Gorilák, Peter/O-3519-2017	Prochazkova, Katarina/0000-0003-4147-6577; Tomaska, Lubomir/0000-0003-4886-1910; Nosek, Jozef/0000-0002-1020-5451; Gorilák, Peter/0000-0002-5119-7144; Sepsiova, Regina/0000-0002-8709-7882	Slovak grant agencies APVV [0035-11, 14-0253]; VEGA [1/0311/12, 1/0052/16, 1/0333/15]; National Institutes of Health [2R01ES013773-06A1, GM31819]; Czech Science Foundation [GACR P205/12/0550]; Ministry of Education, Youth and Sports of Czech Republic [LH13054]; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013773, R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	Slovak grant agencies APVV(Slovak Research and Development Agency); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Slovak grant agencies APVV (http://www.apvv.sk/agentura?lang=en) [0035-11 (LT) and 14-0253 (JN)], VEGA (https://www.minedu.sk/about-the-ministry/) [1/0311/12 and 1/0052/16 (LT) and 1/0333/15 (JN)], National Institutes of Health (http://www.nih.gov) [2R01ES013773-06A1 and GM31819 (JDG)], the Czech Science Foundation (http://gacr.cz/en/)[GACR P205/12/0550 to CH] and the Ministry of Education, Youth and Sports of Czech Republic (http://www.msmt.cz/?lang=2) [LH13054 to CH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arat NO, 2012, J BIOL CHEM, V287, P41583, DOI 10.1074/jbc.M112.415984; Brevet V, 2003, EMBO J, V22, P1697, DOI 10.1093/emboj/cdg155; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P5086, DOI 10.1128/MCB.8.12.5086; Cisse OH, 2013, MBIO, V4, DOI 10.1128/mBio.00055-13; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Deng W, 2015, CELL RES, V25, P881, DOI 10.1038/cr.2015.76; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunisova S, 2009, RNA, V15, P546, DOI 10.1261/rna.1194009; GUZMAN PA, 1994, MICROBIOL-UK, V140, P551, DOI 10.1099/00221287-140-3-551; Henning KA, 1998, P NATL ACAD SCI USA, V95, P5667, DOI 10.1073/pnas.95.10.5667; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hiraoka Y, 1998, TRENDS BIOCHEM SCI, V23, P126, DOI 10.1016/S0968-0004(98)01176-1; Hogues H, 2008, MOL CELL, V29, P552, DOI 10.1016/j.molcel.2008.02.006; Janouskova E, 2015, NUCLEIC ACIDS RES, V43, P2691, DOI 10.1093/nar/gkv097; Jin Y, 2002, GENETICS, V160, P861; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kinsky S, 2010, CURR GENET, V56, P413, DOI 10.1007/s00294-010-0310-6; Klutstein M, 2015, NAT CELL BIOL, V17, P458, DOI 10.1038/ncb3132; Kramara J, 2010, J BIOL CHEM, V285, P38078, DOI 10.1074/jbc.M110.127605; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lue NF, 2010, TRENDS BIOCHEM SCI, V35, P8, DOI 10.1016/j.tibs.2009.08.006; Lukes J, 2011, IUBMB LIFE, V63, P528, DOI 10.1002/iub.489; Lustig AJ, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00010; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MCEACHERN MJ, 1994, P NATL ACAD SCI USA, V91, P3453, DOI 10.1073/pnas.91.8.3453; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Pitt CW, 2008, J BIOL CHEM, V283, P2693, DOI 10.1074/jbc.M708784200; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rhodin Edso Jenny, 2011, Genome Integr, V2, P2, DOI 10.1186/2041-9414-2-2; Sanchez-Alonso P, 2008, FUNGAL GENET BIOL, V45, pS54, DOI 10.1016/j.fgb.2008.04.009; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Spink KG, 2000, NUCLEIC ACIDS RES, V28, P527, DOI 10.1093/nar/28.2.527; Stansel RM, 2001, EMBO J, V20, P5532; Steinberg-Neifach O, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00162; Steinberg-Neifach O, 2015, NUCLEIC ACIDS RES, V43, P2164, DOI 10.1093/nar/gkv092; Sugawara N. F., 1988, THESIS HARVARD U; Tomaska L, 2004, J BIOL CHEM, V279, P50764, DOI 10.1074/jbc.M409790200; Valente LP, 2013, EMBO J, V32, P450, DOI 10.1038/emboj.2012.339; Vassetzky NS, 1999, NUCLEIC ACIDS RES, V27, P4687, DOI 10.1093/nar/27.24.4687; Visacka K, 2012, J BIOL CHEM, V287, P32206, DOI 10.1074/jbc.M112.385591; Yu EY, 2010, MOL CELL BIOL, V30, P1254, DOI 10.1128/MCB.00986-09	53	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154225	10.1371/journal.pone.0154225	http://dx.doi.org/10.1371/journal.pone.0154225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101289	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500167
J	Fey, T; Schubert, KM; Schneider, H; Fein, E; Kleinert, E; Pohl, U; Dendorfer, A				Fey, Theres; Schubert, Kai Michael; Schneider, Holger; Fein, Evelyn; Kleinert, Eike; Pohl, Ulrich; Dendorfer, Andreas			Impaired endothelial shear stress induces podosome assembly via VEGF up-regulation	FASEB JOURNAL			English	Article						blood flow; matrix metalloproteinases; proteolysis; vascular remodeling	GROWTH-FACTOR; MATRIX METALLOPROTEINASES; CELL-PROLIFERATION; IN-VIVO; MIGRATION; EXPRESSION; ROSETTES; DEGRADATION; INVADOPODIA; INHIBITOR	Podosomes are dynamic cytoskeletal membrane structures with local adhesive and proteolytic activity. They are critically involved in angiogenesis and vascular adaptive growth. Here, we studied in HUVECs and murine small vessels whether shear stress controls podosome assembly and local proteolytic activity. Podosomes were characterized by immunohistochemistry, and their proteolytic activity was assessed as degradation imprints in fluorescent gelatin that was used as growth substrate. Compared with controls (10 dyn/cm(2)), the number of podosomes formed per time was doubled when cells were exposed to low shear stress (0.3 dyn/cm(2)) or even increased 5-fold under static conditions. This was a result of an enhanced expression of VEGF after reduction of shear stress. Consequently, enhanced podosome formation could be prevented by a VEGF receptor antagonist as well by interruption of VEGF signaling via inhibition of PI3K, Src, or p38. Increase of podosome assembly went along with significantly augmented cell motility. In vivo experiments in mouse arteries confirmed increased endothelial podosome numbers when shear stress was abolished by vessel occlusion. We conclude that shear stress, by reducing VEGF release, inhibits podosome assembly. Hence, endothelial cell-mediated matrix proteolysis and migratory activity are inhibited, thereby stabilizing the structure of the vessel wall.	[Fey, Theres; Schubert, Kai Michael; Schneider, Holger; Fein, Evelyn; Kleinert, Eike; Pohl, Ulrich; Dendorfer, Andreas] Univ Munich, Walter Brendel Ctr Expt Med, Marchioninistr 27, D-81377 Munich, Germany; [Pohl, Ulrich; Dendorfer, Andreas] German Ctr Cardiovasc Res DZHK, Munich Heart Alliance, Munich, Germany; [Pohl, Ulrich] Munich Cluster Syst Neurol, Munich, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Fey, T (corresponding author), Univ Munich, Walter Brendel Ctr Expt Med, Marchioninistr 27, D-81377 Munich, Germany.	theres.fey@med.uni-muenchen.de			BioImaging Network of the Ludwig-Maximilians-Universitat Munich; German Centre for Cardiovascular Research (DZHK); Marie Curie Initial Training Network on Small Artery Remodeling (ITN/SMART) of the European Commission [PITN-GA-2013-606998]	BioImaging Network of the Ludwig-Maximilians-Universitat Munich; German Centre for Cardiovascular Research (DZHK); Marie Curie Initial Training Network on Small Artery Remodeling (ITN/SMART) of the European Commission	The authors thank Dr. Elisabeth Deindl, Omary Chillo, and Amelia Caballero-Martinez for providing the ligated and sham-surgery arteries, and Dr. Stephanie Blodow for help with associated experiments. The authors also thank Mei Ping Wu for excellent technical assistance, and Prof. John Davis and Dr. Julian Kirsch for critically reading the manuscript. This work was supported by the BioImaging Network of the Ludwig-Maximilians-Universitat Munich, German Centre for Cardiovascular Research (DZHK), and the Marie Curie Initial Training Network on Small Artery Remodeling (ITN/SMART; Grant PITN-GA-2013-606998) of the European Commission.	Abumiya T, 2002, ARTERIOSCL THROM VAS, V22, P907, DOI 10.1161/01.ATV.0000018300.43492.83; Akimoto S, 2000, CIRC RES, V86, P185, DOI 10.1161/01.RES.86.2.185; Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Bassiouny HS, 1998, CIRCULATION, V98, P157, DOI 10.1161/01.CIR.98.2.157; Billottet C, 2008, EUR J CELL BIOL, V87, P543, DOI 10.1016/j.ejcb.2008.02.006; Bolz SS, 2000, AM J PHYSIOL-HEART C, V279, pH1434, DOI 10.1152/ajpheart.2000.279.3.H1434; Collin O, 2008, CURR BIOL, V18, P1288, DOI 10.1016/j.cub.2008.07.046; Conklin BS, 2002, J SURG RES, V102, P13, DOI 10.1006/jsre.2001.6295; deWit C, 1997, PFLUG ARCH EUR J PHY, V434, P354, DOI 10.1007/s004240050408; Gan LM, 2000, BIOCHEM BIOPH RES CO, V272, P490, DOI 10.1006/bbrc.2000.2663; Garcia-Touchard A, 2005, ARTERIOSCL THROM VAS, V25, P1119, DOI 10.1161/01.ATV.0000164311.48592.da; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Glen K, 2012, J CELL PHYSIOL, V227, P2710, DOI 10.1002/jcp.23015; Gloe T, 2002, J BIOL CHEM, V277, P23453, DOI 10.1074/jbc.M203889200; Godin D, 2000, CIRCULATION, V102, P2861; Goto T, 2002, J BONE MINER METAB, V20, P98, DOI 10.1007/s007740200013; Guiet R, 2012, J BIOL CHEM, V287, P13051, DOI 10.1074/jbc.M111.307124; Haas TL, 2007, AM J PHYSIOL-HEART C, V293, pH2429, DOI 10.1152/ajpheart.00100.2007; Hennig T, 2011, J VASC RES, V48, P453, DOI 10.1159/000327009; Hsu PP, 2001, BIOCHEM BIOPH RES CO, V285, P751, DOI 10.1006/bbrc.2001.5221; Hu YL, 2002, J VASC RES, V39, P465, DOI 10.1159/000067202; Inoue M, 1998, CIRCULATION, V98, P2108, DOI 10.1161/01.CIR.98.20.2108; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Koskinas KC, 2013, ARTERIOSCL THROM VAS, V33, P1494, DOI 10.1161/ATVBAHA.112.300827; Kremerskothen J, 2011, FASEB J, V25, P505, DOI 10.1096/fj.10-155598; Lin K, 2000, P NATL ACAD SCI USA, V97, P9385, DOI 10.1073/pnas.170282597; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osiak AE, 2005, EXP CELL RES, V307, P342, DOI 10.1016/j.yexcr.2005.03.035; Pagel JI, 2012, THROMB HAEMOSTASIS, V107, P562, DOI 10.1160/TH11-07-0490; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Platt MO, 2006, J HEART VALVE DIS, V15, P622; Platt MO, 2006, ARTERIOSCL THROM VAS, V26, P1784, DOI 10.1161/01.ATV.0000227470.72109.2b; Platt MO, 2016, BIOCHIMIE, V122, P314, DOI 10.1016/j.biochi.2015.10.010; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Schachtner H, 2013, CYTOSKELETON, V70, P572, DOI 10.1002/cm.21119; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seano G, 2015, CELL CYCLE, V14, P1370, DOI 10.1080/15384101.2015.1026523; Seano G, 2014, NAT CELL BIOL, V16, P931, DOI 10.1038/ncb3036; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; TANGELDER GJ, 1988, AM J PHYSIOL, V254, pH1059, DOI 10.1152/ajpheart.1988.254.6.H1059; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Tressel SL, 2007, ARTERIOSCL THROM VAS, V27, P2150, DOI 10.1161/ATVBAHA.107.150920; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang J, 2009, ARTERIOSCL THROM VAS, V29, P202, DOI 10.1161/ATVBAHA.108.174391; Warren CM, 2014, NAT CELL BIOL, V16, P928, DOI 10.1038/ncb3044; Watanabe Noboru, 2004, Curr Atheroscler Rep, V6, P112, DOI 10.1007/s11883-004-0099-1; Xiao HL, 2013, J CELL PHYSIOL, V228, P416, DOI 10.1002/jcp.24146; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Zakrzewicz A, 2002, NEWS PHYSIOL SCI, V17, P197, DOI 10.1152/nips.01395.2001	57	9	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2755	2766		10.1096/fj.201500091R	http://dx.doi.org/10.1096/fj.201500091R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27103579				2022-12-26	WOS:000380994000012
J	Thomsen, H; da Silva, MI; Fuchs, M; Ponader, S; von Strandmann, EP; Eisele, L; Herms, S; Hoffmann, P; Engert, A; Hemminki, K; Forsti, A				Thomsen, Hauke; da Silva Filho, Miguel Inacio; Fuchs, Michael; Ponader, Sabine; von Strandmann, Elke Pogge; Eisele, Lewin; Herms, Stefan; Hoffmann, Per; Engert, Andreas; Hemminki, Kari; Forsti, Asta			Evidence of Inbreeding in Hodgkin Lymphoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HOMOZYGOSITY IDENTIFY; EXTENDED TRACTS; CANCER; RISK; RUNS; CONSANGUINITY; DISEASE; LOCI; QUANTIFICATION	Genome-wide association studies (GWASs) have identified several, mainly co-dominantly acting, single-nucleotide polymorphisms (SNPs) associated with Hodgkin lymphoma (HL). We searched for recessively acting disease loci by performing an analysis of runs of homozygosity (ROH) based on windows of homozygous SNP-blocks and by calculating genomic inbreeding coefficients on a SNP-wise basis. We used data from a previous GWAS with 906 cases and 1217 controls from a population with a long history of no matings between relatives. Ten recurrent ROHs were identified among 25 055 ROHs across all individuals but their association with HL was not genome-wide significant. All recurrent ROHs showed significant evidence for natural selection. As a novel finding genomic inbreeding among cases was significantly higher than among controls (P = 2.11*10(-14)) even after correcting for covariates. Higher inbreeding among the cases was mainly based on a group of individuals with a higher average length of ROHs per person. This result suggests a correlation of higher levels of inbreeding with higher cancer incidence and might reflect the existence of recessive alleles causing HL. Genomic inbreeding may result in a higher expression of deleterious recessive genes within a population.	[Thomsen, Hauke; da Silva Filho, Miguel Inacio; Hemminki, Kari; Forsti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol C050, D-69120 Heidelberg, Germany; [Hemminki, Kari; Forsti, Asta] Lund Univ, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden; [Fuchs, Michael; Ponader, Sabine; von Strandmann, Elke Pogge; Engert, Andreas] Univ Hosp Cologne, Dept Internal Med 1, D-50924 Cologne, Germany; [Herms, Stefan; Hoffmann, Per] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Herms, Stefan; Hoffmann, Per] Univ Bonn, Dept Genom, D-53127 Bonn, Germany; [Herms, Stefan; Hoffmann, Per] Univ Basel, Div Med Genet, Dept Biomed, CH-4058 Basel, Switzerland; [Eisele, Lewin] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, D-45122 Essen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; University of Cologne; University of Bonn; University of Bonn; University of Basel; University of Duisburg Essen	Thomsen, H (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol C050, D-69120 Heidelberg, Germany.	h.thomsen@dkfz-heidelberg.de	Thomsen, Hauke/M-6515-2017; Herms, Stefan/J-1949-2014; Hoffmann, Per/A-5149-2010	Thomsen, Hauke/0000-0001-5951-3116; Herms, Stefan/0000-0002-2786-8200; Hoffmann, Per/0000-0002-6573-983X				ABRAMSON JH, 1978, J NATL CANCER I, V61, P307; Assie G, 2008, JAMA-J AM MED ASSOC, V299, P1437, DOI 10.1001/jama.299.12.1437; Bacolod MD, 2008, CANCER RES, V68, P2610, DOI 10.1158/0008-5472.CAN-07-5250; Bener A, 2009, ASIAN PAC J CANCER P, V10, P35; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Cozen W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4856; Cozen W, 2012, BLOOD, V119, P469, DOI 10.1182/blood-2011-03-343921; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Enciso-Mora V, 2010, EUR J HUM GENET, V18, P909, DOI 10.1038/ejhg.2010.53; Fay JC, 2000, GENETICS, V155, P1405; FELDMAN JG, 1976, CANCER, V38, P2548, DOI 10.1002/1097-0142(197612)38:6<2548::AID-CNCR2820380644>3.0.CO;2-Y; Frampton M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3549; Gamsiz ED, 2013, AM J HUM GENET, V93, P103, DOI 10.1016/j.ajhg.2013.06.004; Ghani M, 2013, JAMA NEUROL, V70, P1261, DOI 10.1001/jamaneurol.2013.3545; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Goldin LR, 2005, J MED GENET, V42, P595, DOI 10.1136/jmg.2004.027433; Hemminki K, 2008, ONCOLOGIST, V13, P239, DOI 10.1634/theoncologist.2007-0242; Hosking FJ, 2010, BLOOD, V115, P4472, DOI 10.1182/blood-2009-09-244483; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Kijas James W, 2013, Methods Mol Biol, V1019, P331, DOI 10.1007/978-1-62703-447-0_14; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEBEL RR, 1989, AM J MED GENET, V33, P1, DOI 10.1002/ajmg.1320330102; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li LH, 2006, HUM MUTAT, V27, P1115, DOI 10.1002/humu.20399; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Mok K, 2013, EUR J HUM GENET, V21, P1429, DOI 10.1038/ejhg.2013.59; Nabulsi MM, 2003, AM J MED GENET A, V116A, P342, DOI 10.1002/ajmg.a.10020; Nalls MA, 2009, NEUROGENETICS, V10, P183, DOI 10.1007/s10048-009-0182-4; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; RCore Team, 2020, R LANG ENV STAT COMP; Rudan I, 1999, HUM BIOL, V71, P173; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; Siraj AK, 2012, GENET MED, V14, P720, DOI 10.1038/gim.2012.27; Spain SL, 2009, CANCER RES, V69, P7422, DOI 10.1158/0008-5472.CAN-09-0659; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Sud A, 2017, HEMATOL ONCOL, V35, P34, DOI 10.1002/hon.2235; Sud A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14315; Thomsen H, 2015, EUR J HUM GENET, V23, P824, DOI 10.1038/ejhg.2014.184; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang C, 2013, J BIOMED RES, V27, P208, DOI 10.7555/JBR.27.20130017; Weller JI, 1998, GENETICS, V150, P1699; Werft W, 2010, R J, V2, P39; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang TL, 2010, J CLIN ENDOCR METAB, V95, P3777, DOI 10.1210/jc.2009-1715	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154259	10.1371/journal.pone.0154259	http://dx.doi.org/10.1371/journal.pone.0154259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123581	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700062
J	Vergidis, P; Clancy, CJ; Shields, RK; Park, SY; Wildfeuer, BN; Simmons, RL; Nguyen, MH				Vergidis, Pascalis; Clancy, Cornelius J.; Shields, Ryan K.; Park, Seo Young; Wildfeuer, Brett N.; Simmons, Richard L.; Nguyen, M. Hong			Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment	PLOS ONE			English	Article							ABDOMINAL CANDIDIASIS; NONCULTURE DIAGNOSTICS; INVASIVE CANDIDIASIS; RISK-FACTORS; MANAGEMENT; PERITONITIS; FLUCONAZOLE; MORTALITY; CARE; EPIDEMIOLOGY	Intra-abdominal candidiasis (IAC) is poorly understood compared to candidemia. We described the clinical characteristics, microbiology, treatment and outcomes of IAC, and identified risk factors for mortality. We performed a retrospective study of adults diagnosed with IAC at our center in 2012-2013. Risk factors for mortality were evaluated using multivariable logistic regression. We identified 163 patients with IAC, compared to 161 with candidemia. Types of IAC were intra-abdominal abscesses (55%), secondary peritonitis (33%), primary peritonitis (5%), infected pancreatic necrosis (5%), and cholecystitis/cholangitis (3%). Eighty-three percent and 66% of secondary peritonitis and abscesses, respectively, stemmed from gastrointestinal (GI) tract sources. C. albicans (56%) and C. glabrata (24%) were the most common species. Bacterial co-infections and candidemia occurred in 67% and 6% of patients, respectively. Seventy-two percent of patients underwent an early source control intervention (within 5 days) and 72% received early antifungal treatment. 100-day mortality was 28%, and highest with primary (88%) or secondary (40%) peritonitis. Younger age, abscesses and early source control were independent predictors of survival. Younger age, abscesses and early antifungal treatment were independently associated with survival for IAC stemming from GI tract sources. Infectious diseases (ID) consultations were obtained in only 48% of patients. Consulted patients were significantly more likely to receive antifungal treatment. IAC is a common disease associated with heterogeneous manifestations, which result in poor outcomes. All patients should undergo source control interventions and receive antifungal treatment promptly. It is important for the ID community to become more engaged in treating IAC.	[Vergidis, Pascalis; Clancy, Cornelius J.; Shields, Ryan K.; Wildfeuer, Brett N.; Nguyen, M. Hong] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA; [Clancy, Cornelius J.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Park, Seo Young] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Simmons, Richard L.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vergidis, P (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA.	vergidisp@upmc.edu			National Institutes of Health (NIH) [R21AI107290]; National Center for Advancing Translational Sciences of the NIH [KL2TR000146]; NIH [K08AI114883]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI114883, R21AI107290] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported, in part, by award R21AI107290 (M.H.N.) from the National Institutes of Health (NIH). P.V. is supported by the National Center for Advancing Translational Sciences of the NIH under Award Number KL2TR000146. R.K.S is supported by the NIH under award number K08AI114883. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDEN SM, 1989, AM SURGEON, V55, P45; Bassetti M, 2015, INTENS CARE MED, V41, P776, DOI 10.1007/s00134-015-3719-z; Bassetti M, 2013, INTENS CARE MED, V39, P2092, DOI 10.1007/s00134-013-3109-3; BAYER AS, 1976, AM J MED, V61, P832, DOI 10.1016/0002-9343(76)90407-1; Blot S, 2012, DRUGS, V72, pE17, DOI 10.2165/11599800-000000000-00000; Blot SI, 2007, CURR OPIN CRIT CARE, V13, P195, DOI 10.1097/MCC.0b013e328028fd92; CALANDRA T, 1989, LANCET, V2, P1437, DOI 10.1016/S0140-6736(89)92043-6; Cheng SJ, 2014, INFECT IMMUN, V82, P3015, DOI 10.1128/IAI.00062-14; Cheng SJ, 2013, J INFECT DIS, V208, P1529, DOI 10.1093/infdis/jit335; Clancy CJ, 2014, EXPERT REV ANTI-INFE, V12, P731, DOI 10.1586/14787210.2014.919853; Clancy CJ, 2013, CLIN INFECT DIS, V56, P1284, DOI 10.1093/cid/cit006; Clancy CJ, 2012, CLIN INFECT DIS, V54, P1123, DOI 10.1093/cid/cis023; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dupont H, 2002, ARCH SURG-CHICAGO, V137, P1341, DOI 10.1001/archsurg.137.12.1341; Edwards JE, 1997, CLIN INFECT DIS, V25, P43, DOI 10.1086/514504; Eggimann P, 1999, CRIT CARE MED, V27, P1066, DOI 10.1097/00003246-199906000-00019; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Heisel T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116705; Knitsch W, 2015, CLIN INFECT DIS, V61, P1671, DOI 10.1093/cid/civ707; KUJATH P, 1989, INFECTION, V17, P111, DOI 10.1007/BF01646895; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Lamme B, 2006, WORLD J SURG, V30, P2170, DOI 10.1007/s00268-005-0333-1; Lee SC, 2002, DIAGN MICR INFEC DIS, V44, P23, DOI 10.1016/S0732-8893(02)00419-4; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; MCLAUCHLAN GJ, 1995, BRIT J SURG, V82, P524, DOI 10.1002/bjs.1800820429; Mean M, 2008, CRIT CARE, V12, DOI 10.1186/cc6212; Montravers P, 2006, CRIT CARE MED, V34, P646, DOI 10.1097/01.CCM.0000201889.39443.D2; Montravers P, 2011, CLIN MICROBIOL INFEC, V17, P1061, DOI 10.1111/j.1469-0691.2010.03360.x; Montravers P, 2015, INTENS CARE MED, V41, P1682, DOI 10.1007/s00134-015-3894-y; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Nguyen MH, 2012, CLIN INFECT DIS, V54, P1240, DOI 10.1093/cid/cis200; Nguyen MH, 1996, AM J MED, V100, P617, DOI 10.1016/S0002-9343(95)00010-0; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Rex JH, 2006, CRIT CARE MED, V34, P902, DOI 10.1097/01.CCM.0000202129.19154.64; Sandven P, 2002, CRIT CARE MED, V30, P541, DOI 10.1097/00003246-200203000-00008; Shields RK, 2014, ANTIMICROB AGENTS CH, V58, P7601, DOI 10.1128/AAC.04134-14; SOLOMKIN JS, 1980, SURGERY, V88, P524; Solomkin JS, 2003, CLIN INFECT DIS, V37, P997, DOI 10.1086/378702; Tissot F, 2013, AM J RESP CRIT CARE, V188, P1100, DOI 10.1164/rccm.201211-2069OC	40	78	80	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153247	10.1371/journal.pone.0153247	http://dx.doi.org/10.1371/journal.pone.0153247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123857	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000375211700013
J	Li, GP; Reisig, D; Miao, J; Gould, F; Huang, FN; Feng, HQ				Li, Guoping; Reisig, Dominic; Miao, Jin; Gould, Fred; Huang, Fangneng; Feng, Hongqiang			Frequency of Cry1F Non-Recessive Resistance Alleles in North Carolina Field Populations of Spodoptera frugiperda (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							FALL ARMYWORM LEPIDOPTERA; HELICOVERPA-ZEA LEPIDOPTERA; HYBRIDS EXPRESSING CRY1F; EUROPEAN CORN-BORER; BT TRANSGENIC CORN; UNITED-STATES; PUERTO-RICO; COTTON; MAIZE; SINGLE	Fall armyworm, Spodoptera frugiperda (J.E. Smith) (Lepidoptera: Noctuidae), is a target species of transgenic corn (Zea mays L.) that expresses single and pyramided Bacillus thuringiensis (Bt) toxin. In 2014, S. frugiperda were collected from a light trap in North Carolina, and a total of 212 F-1/F-2 isofemale lines of S. frugiperda were screened for resistance to Bt and non-Bt corn. All of the 212 isolines were susceptible to corn tissue expressing Cry1A.105 + Cry2Ab, Cry1F + Cry1A.105 + Cry2Ab, and Cry1F + Cry1Ab + Vip3Aa20. Growth rate bioassays were performed to isolate non-recessive Bt resistance alleles. Seven individuals out of the 212 isofemale lines carried major non-recessive alleles conferring resistance to Cry1F. A pooled colony was created from the seven individuals. This colony was 151.21 times more resistant to Cry1F than a known-susceptible population and was also resistant to Cry1A.105, but was not resistant to Cry2Ab and Vip3Aa20. The results demonstrate that field populations of S. frugiperda collected from North Carolina are generally susceptible to Cry1F, but that some individuals carry resistant alleles. The data generated in this study can be used as baseline data for resistance monitoring.	[Li, Guoping; Reisig, Dominic; Miao, Jin] N Carolina State Univ, Dept Entomol, Vernon G James Res & Extens Ctr, 207 Res Stn Rd, Plymouth, NC 27962 USA; [Li, Guoping; Miao, Jin; Feng, Hongqiang] Henan Acad Agr Sci, Henan Key Lab Crop Pest Control, MOAS Reg Key Lab Crop IPM Southern Part Northern, Inst Plant Protect, Zhengzhou 450002, Peoples R China; [Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Huang, Fangneng] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA	University of North Carolina; North Carolina State University; Henan Academy of Agricultural Sciences; University of North Carolina; North Carolina State University; Louisiana State University System; Louisiana State University	Reisig, D (corresponding author), N Carolina State Univ, Dept Entomol, Vernon G James Res & Extens Ctr, 207 Res Stn Rd, Plymouth, NC 27962 USA.	ddreisig@ncsu.edu		Reisig, Dominic/0000-0002-9979-5813; Feng, Hongqiang/0000-0002-1171-248X	Reisig laboratory; Key project for Breeding Genetically modified Organisms [2014ZX08012-004, 2016ZX08012004-007, 2016ZX08012-004]; China scholarship Council [2011841039]; Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences [2016YQ15]	Reisig laboratory; Key project for Breeding Genetically modified Organisms; China scholarship Council(China Scholarship Council); Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences	This research was supported by ad-hoc funding of the Reisig laboratory, and the Key project for Breeding Genetically modified Organisms (No. 2014ZX08012-004, 2016ZX08012004-007), China scholarship Council (No. 2011841039) and Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences (Grant no. 2016YQ15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dow AgroSciences for providing Cry1F protein, Monsanto for providing Cry2Ab2 and Cry1A.105 protein, and Syngenta for providing Vip3Aa20 protein. We would like to acknowledge the help of Emily Goldsworthy and Donna Michel for assistance in the laboratory and the research staff at the Vernon James Center in Plymouth for assisting with greenhouse cultivation of the corn plants. This research was supported by ad-hoc funding of the Reisig laboratory, and the Key project for Breeding Genetically modified Organisms (No. 2014ZX08012-004, 2016ZX08012-004), China scholarship Council (No. 2011841039) and Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences (Grant no. 2016YQ15).	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; ALI A, 1989, ENVIRON ENTOMOL, V18, P881, DOI 10.1093/ee/18.5.881; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bourguet D, 2003, THEOR APPL GENET, V106, P1225, DOI 10.1007/s00122-002-1172-1; Brevault T, 2013, P NATL ACAD SCI USA, V110, P5806, DOI 10.1073/pnas.1216719110; BUNTIN GD, 1986, FLA ENTOMOL, V69, P549, DOI 10.2307/3495389; Burd AD, 2003, J ECON ENTOMOL, V96, P137, DOI 10.1603/0022-0493-96.1.137; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Coates BS, 2015, INSECT BIOCHEM MOLEC, V63, P86, DOI 10.1016/j.ibmb.2015.06.003; Dangal V, 2015, J INVERTEBR PATHOL, V127, P81, DOI 10.1016/j.jip.2015.03.004; Fabrick JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097900; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; LeOra Software, 2003, POLO PC US GUID PROB; Li GP, 2004, ENTOMOL EXP APPL, V112, P135, DOI 10.1111/j.0013-8703.2004.00191.x; Li GP, 2007, ECOL ENTOMOL, V32, P366, DOI 10.1111/j.1365-2311.2007.00891.x; MITCHELL ER, 1991, J ENTOMOL SCI, V26, P39, DOI 10.18474/0749-8004-26.1.39; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Niu Y, 2013, FLA ENTOMOL, V96, P701, DOI 10.1653/024.096.0302; PAIR SD, 1987, SOUTHWEST ENTOMOL, V12, P89; PASHLEY DP, 1988, FLA ENTOMOL, V71, P227, DOI 10.2307/3495425; Reisig DD, 2015, J ECON ENTOMOL, V108, P157, DOI 10.1093/jee/tou009; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; *SAS I, 1998, SAS STAT US GUID REL; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Siebert MW, 2008, FLA ENTOMOL, V91, P555; Siebert MW, 2008, J ENTOMOL SCI, V43, P41, DOI 10.18474/0749-8004-43.1.41; Siegfried Blair D., 2007, American Entomologist, V53, P208; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Storer NP, 2003, J ECON ENTOMOL, V96, P156, DOI 10.1603/0022-0493-96.1.156; Storer NP, 2003, J ECON ENTOMOL, V96, P173, DOI 10.1603/0022-0493-96.1.173; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Tay WT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005534; Velez AM, 2013, B ENTOMOL RES, V103, P700, DOI 10.1017/S0007485313000448; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Yang F, 2013, FLA ENTOMOL, V96, P714, DOI 10.1653/024.096.0303	45	54	68	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154492	10.1371/journal.pone.0154492	http://dx.doi.org/10.1371/journal.pone.0154492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119741	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200084
J	Reddy, AT; Lakshmi, SP; Muchumarri, RR; Reddy, RC				Reddy, Aravind T.; Lakshmi, Sowmya P.; Muchumarri, Ramamohan R.; Reddy, Raju C.			Nitrated Fatty Acids Reverse Cigarette Smoke-Induced Alveolar Macrophage Activation and Inhibit Protease Activity via Electrophilic S-Alkylation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NITROLINOLEIC ACID; GAMMA; INFLAMMATION; TRANSDUCTION; ISCHEMIA; CYSTEINE	Nitrated fatty acids (NFAs), endogenous products of nonenzymatic reactions of NO-derived reactive nitrogen species with unsaturated fatty acids, exhibit substantial anti-inflammatory activities. They are both reversible electrophiles and peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists, but the physiological implications of their electrophilic activity are poorly understood. We tested their effects on inflammatory and emphysema-related biomarkers in alveolar macrophages (AMs) of smoke-exposed mice. NFA (10-nitro-oleic acid or 12-nitrolinoleic acid) treatment downregulated expression and activity of the inflammatory transcription factor NF-kappa B while upregulating those of PPAR gamma. It also downregulated production of inflammatory cytokines and chemokines and of the protease cathepsin S (Cat S), a key mediator of emphysematous septal destruction. Cat S downregulation was accompanied by decreased AM elastolytic activity, a major mechanism of septal destruction. NFAs downregulated both Cat S expression and activity in AMs of wild-type mice, but only inhibited its activity in AMs of PPAR. knockout mice, pointing to a PPAR gamma-independent mechanism of enzyme inhibition. We hypothesized that this mechanism was electrophilic S-alkylation of target Cat S cysteines, and found that NFAs bind directly to Cat S following treatment of intact AMs and, as suggested by in silico modeling and calculation of relevant parameters, elicit S-alkylation of Cys25 when incubated with purified Cat S. These results demonstrate that NFAs' electrophilic activity, in addition to their role as PPAR. agonists, underlies their protective effects in chronic obstructive pulmonary disease (COPD) and support their therapeutic potential in this disease.	[Reddy, Aravind T.; Lakshmi, Sowmya P.; Muchumarri, Ramamohan R.; Reddy, Raju C.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Reddy, Aravind T.; Lakshmi, Sowmya P.; Muchumarri, Ramamohan R.; Reddy, Raju C.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Reddy, RC (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA.; Reddy, RC (corresponding author), Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA.	reddyrc@upmc.edu	Reddy, Aravind/P-1847-2018; Lakshmi, Sowmya P./P-1851-2018; Reddy, Raju C/GLR-5338-2022	Reddy, Aravind/0000-0001-8628-3467; Lakshmi, Sowmya P./0000-0003-1708-9462; Reddy, Raju C/0000-0001-7079-1520	U.S. Department of Veterans Affairs; National Institutes of Health [HL093196]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093196] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Merit Review award from the U.S. Department of Veterans Affairs and National Institutes of Health grant HL093196 to RCR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NUMB DEATHS LEAD CAU; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bonacci G, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.225029; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Francois M, 2004, J BIOL CHEM, V279, P28411, DOI 10.1074/jbc.M312708200; Geisler AC, 2012, BBA-GEN SUBJECTS, V1820, P777, DOI 10.1016/j.bbagen.2011.06.014; Gosset P, 1999, J ALLERGY CLIN IMMUN, V103, P289, DOI 10.1016/S0091-6749(99)70504-X; Guo CJ, 2011, NITRIC OXIDE-BIOL CH, V25, P366, DOI 10.1016/j.niox.2011.07.003; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Lakshmi SP, 2014, J BIOL CHEM, V289, P6383, DOI 10.1074/jbc.M113.536805; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Pauly TA, 2003, BIOCHEMISTRY-US, V42, P3203, DOI 10.1021/bi027308i; Reddy AT, 2014, FASEB J, V28, P5299, DOI 10.1096/fj.14-256263; Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487; Reddy AT, 2012, PPAR RES, V2012, DOI 10.1155/2012/617063; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Russell REK, 2002, AM J PHYSIOL-LUNG C, V283, pL867, DOI 10.1152/ajplung.00020.2002; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Tsujita T, 2011, GENES CELLS, V16, P46, DOI 10.1111/j.1365-2443.2010.01466.x; Turkenburg JP, 2002, ACTA CRYSTALLOGR D, V58, P451, DOI 10.1107/S0907444901021825	28	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153336	10.1371/journal.pone.0153336	http://dx.doi.org/10.1371/journal.pone.0153336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119365	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000374976200022
J	Thoret, E; Aramaki, M; Bringoux, L; Ystad, S; Kronland-Martinet, R				Thoret, Etienne; Aramaki, Mitsuko; Bringoux, Lionel; Ystad, Solvi; Kronland-Martinet, Richard			Seeing Circles and Drawing Ellipses: When Sound Biases Reproduction of Visual Motion	PLOS ONE			English	Article							COORDINATION DYNAMICS; PERCEPTION; TRACKING; GAIT	The perception and production of biological movements is characterized by the 1/3 power law, a relation linking the curvature and the velocity of an intended action. In particular, motions are perceived and reproduced distorted when their kinematics deviate from this biological law. Whereas most studies dealing with this perceptual-motor relation focused on visual or kinaesthetic modalities in a unimodal context, in this paper we show that auditory dynamics strikingly biases visuomotor processes. Biologically consistent or inconsistent circular visual motions were used in combination with circular or elliptical auditory motions. Auditory motions were synthesized friction sounds mimicking those produced by the friction of the pen on a paper when someone is drawing. Sounds were presented diotically and the auditory motion velocity was evoked through the friction sound timbre variations without any spatial cues. Remarkably, when subjects were asked to reproduce circular visual motion while listening to sounds that evoked elliptical kinematics without seeing their hand, they drew elliptical shapes. Moreover, distortion induced by inconsistent elliptical kinematics in both visual and auditory modalities added up linearly. These results bring to light the substantial role of auditory dynamics in the visuo-motor coupling in a multisensory context.	[Thoret, Etienne; Aramaki, Mitsuko; Ystad, Solvi; Kronland-Martinet, Richard] Aix Marseille Univ, Lab Mecan & Acoust, CNRS, UPR 7051,Cent Marseille, Marseille, France; [Bringoux, Lionel] Aix Marseille Univ, CNRS, ISM, UMR 7287, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Thoret, E (corresponding author), Aix Marseille Univ, Lab Mecan & Acoust, CNRS, UPR 7051,Cent Marseille, Marseille, France.	etienne.thoret@mcgill.ca	Thoret, Etienne/G-8637-2016; Ystad, Sølvi/AAN-4517-2020	Thoret, Etienne/0000-0002-8214-6278; Ystad, Sølvi/0000-0001-9022-9690	French National Research Agency (ANR) [ANR-10-CORD-0003, ANR-14-CE24-0018]	French National Research Agency (ANR)(French National Research Agency (ANR))	This work was funded by the French National Research Agency (ANR) under the MetaSon: Metaphores Sonores (Sound Metaphors) project (ANR-10-CORD-0003) in the CONTINT 2010 framework and the SoniMove Project (ANR-14-CE24-0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Aramaki M, 2011, IEEE T AUDIO SPEECH, V19, P301, DOI 10.1109/TASL.2010.2047755; Arrighi R, 2009, J VISION, V9, DOI 10.1167/9.4.25; Athenes S, 2004, HUM MOVEMENT SCI, V23, P621, DOI 10.1016/j.humov.2004.10.004; Brooks A, 2007, NEUROPSYCHOLOGIA, V45, P523, DOI 10.1016/j.neuropsychologia.2005.12.012; Campbell JC, 2014, EXP BRAIN RES, V232, P2775, DOI 10.1007/s00221-014-3958-1; Campos JL, 2012, EXP BRAIN RES, V218, P551, DOI 10.1007/s00221-012-3048-1; Campos JL, 2010, EUR J NEUROSCI, V31, P1889, DOI 10.1111/j.1460-9568.2010.07212.x; Chowning J, 1977, COMPUT MUSIC J, V1, P48, DOI [10.2307/3679609, DOI 10.2307/3679609]; Conan S, 2014, COMPUT MUSIC J, V38, P24, DOI 10.1162/COMJ_a_00266; Craig CM, 2000, NATURE, V405, P295, DOI 10.1038/35012690; Danna J, 2015, HUM MOVEMENT SCI, V43, P216, DOI 10.1016/j.humov.2014.12.002; Danna J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128388; Danna J, 2011, HUM MOVEMENT SCI, V30, P698, DOI 10.1016/j.humov.2010.08.019; Dounskaia N, 2000, EXP BRAIN RES, V135, P127, DOI 10.1007/s002210000495; GAVER WW, 1993, ECOL PSYCHOL, V5, P285, DOI 10.1207/s15326969eco0504_2; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Kitagawa N, 2002, NATURE, V416, P172, DOI 10.1038/416172a; Kronland-Martinet R, 2008, EURASIP J AUDIO SPEE, DOI 10.1155/2008/849696; La Scaleia B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093020; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; McGarry LM, 2012, EXP BRAIN RES, V218, P527, DOI 10.1007/s00221-012-3046-3; Merer A, 2013, ACM T APPL PERCEPT, V10, DOI 10.1145/2422105.2422106; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Rodger MWM, 2014, IEEE T NEUR SYS REH, V22, P543, DOI 10.1109/TNSRE.2013.2285410; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Soto-Faraco S, 2003, NEUROPSYCHOLOGIA, V41, P1847, DOI 10.1016/S0028-3932(03)00185-4; Thoret E, 2016, NEUROSCI LETT, V612, P225, DOI 10.1016/j.neulet.2015.12.022; Thoret E, 2014, J EXP PSYCHOL HUMAN, V40, P983, DOI 10.1037/a0035441; van den Doel K, 2001, P ACM SIGGRAPH 2001, DOI [10.1145/383259.383322, DOI 10.1145/383259.383322]; Varlet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044082; Viviani P, 1997, J EXP PSYCHOL HUMAN, V23, P1232, DOI 10.1037/0096-1523.23.4.1232; VIVIANI P, 1989, PERCEPT PSYCHOPHYS, V46, P266, DOI 10.3758/BF03208089; VIVIANI P, 1987, J EXP PSYCHOL HUMAN, V13, P62, DOI 10.1037/0096-1523.13.1.62; Young W, 2013, J EXP PSYCHOL HUMAN, V39, P464, DOI 10.1037/a0029402; Young WR, 2014, NEUROPSYCHOLOGIA, V57, P140, DOI 10.1016/j.neuropsychologia.2014.03.009	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154475	10.1371/journal.pone.0154475	http://dx.doi.org/10.1371/journal.pone.0154475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119411	Green Published, gold			2022-12-26	WOS:000374976200082
J	Chambers, EA; Hebert, PDN				Chambers, E. Anne; Hebert, Paul D. N.			Assessing DNA Barcodes for Species Identification in North American Reptiles and Amphibians in Natural History Collections	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; DIVERSITY; HYBRIDIZATION; CONSERVATION; POPULATION; TAXONOMY; FROGS; UNDERESTIMATION; HERPETOFAUNA; SALAMANDER	Background High rates of species discovery and loss have led to the urgent need for more rapid assessment of species diversity in the herpetofauna. DNA barcoding allows for the preliminary identification of species based on sequence divergence. Prior DNA barcoding work on reptiles and amphibians has revealed higher biodiversity counts than previously estimated due to cases of cryptic and undiscovered species. Past studies have provided DNA barcodes for just 14% of the North American herpetofauna, revealing the need for expanded coverage. Methodology/Principal Findings This study extends the DNA barcode reference library for North American herpetofauna, assesses the utility of this approach in aiding species delimitation, and examines the correspondence between current species boundaries and sequence clusters designated by the BIN system. Sequences were obtained from 730 specimens, representing 274 species (43%) from the North American herpetofauna. Mean intraspecific divergences were 1% and 3%, while average congeneric sequence divergences were 16% and 14% in amphibians and reptiles, respectively. BIN assignments corresponded with current species boundaries in 79% of amphibians, 100% of turtles, and 60% of squamates. Deep divergences (> 2%) were noted in 35% of squamate and 16% of amphibian species, and low divergences (< 2%) occurred in 12% of reptiles and 23% of amphibians, patterns reflected in BIN assignments. Sequence recovery declined with specimen age, and variation in recovery success was noted among collections. Within collections, barcodes effectively flagged seven mislabeled tissues, and barcode fragments were recovered from five formalin-fixed specimens. Conclusions/Significance This study demonstrates that DNA barcodes can effectively flag errors in museum collections, while BIN splits and merges reveal taxa belonging to deeply diverged or hybridizing lineages. This study is the first effort to compile a reference library of DNA barcodes for herpetofauna on a continental scale.	[Chambers, E. Anne] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Chambers, E. Anne; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON N1G 2W1, Canada	University of Texas System; University of Texas Austin; University of Guelph	Chambers, EA (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.; Chambers, EA (corresponding author), Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON N1G 2W1, Canada.	eachambers@utexas.edu			Natural Sciences and Engineering Research Council of Canada (NSERC); Government of Canada through Genome Canada; Ontario Genomics Institute	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	This project was funded, in part, by the Natural Sciences and Engineering Research Council of Canada (NSERC). Sequencing work was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arif IA, 2011, GENET MOL RES, V10, P3559, DOI 10.4238/2011.October.31.3; Blagoev GA, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-44; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Brandley MC, 2012, ZOOL J LINN SOC-LOND, V165, P163, DOI 10.1111/j.1096-3642.2011.00801.x; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Cole CJ, 2010, AM MUS NOVIT, P1, DOI 10.1206/3698.2; Crawford AJ, 2011, ZOOTAXA, P65; Crawford AJ, 2013, MOL ECOL RESOUR, V13, P1005, DOI 10.1111/1755-0998.12054; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; DAUGHERTY CH, 1990, NATURE, V347, P177, DOI 10.1038/347177a0; Dean MD, 2001, ENTOMOL EXP APPL, V98, P279, DOI 10.1023/A:1018963131302; Dubey B, 2011, FORENSIC SCI INT-GEN, V5, P181, DOI 10.1016/j.fsigen.2010.03.001; Fitzpatrick BM, 2008, MOL ECOL, V17, P4107, DOI 10.1111/j.1365-294X.2008.03885.x; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Gehring PS, 2010, SALAMANDRA, V46, P214; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hawlitschek O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073368; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hykin SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141579; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Jeong TJ, 2013, MOL ECOL RESOUR, V13, P1019, DOI 10.1111/1755-0998.12055; Jockusch EL, 2002, BIOL J LINN SOC, V76, P361, DOI 10.1046/j.1095-8312.2002.d01-6.x; KARLIN AA, 1981, COPEIA, P371; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirchman JJ, 2010, BIOL LETTERS, V6, P112, DOI 10.1098/rsbl.2009.0545; LAMB T, 1992, J EVOLUTION BIOL, V5, P465, DOI 10.1046/j.1420-9101.1992.5030465.x; Leache AD, 2007, MOL ECOL, V16, P1035, DOI 10.1111/j.1365-294X.2006.03194.x; Lemmon EM, 2007, MOL PHYLOGENET EVOL, V44, P1068, DOI 10.1016/j.ympev.2007.04.010; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Murphy RW, 2013, MOL ECOL RESOUR, V13, P161, DOI 10.1111/1755-0998.12050; Murphy RW, 2011, ZOOKEYS, P39, DOI 10.3897/zookeys.113.1353; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Nazarov R, 2012, ZOOTAXA, P1; Pincheira-Donoso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059741; Placyk JS, 2012, CONSERV GENET, V13, P649, DOI 10.1007/s10592-012-0315-4; Puillandre N, 2012, MOL ECOL RESOUR, V12, P396, DOI 10.1111/j.1755-0998.2011.03105.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rissler LJ, 2003, MOL PHYLOGENET EVOL, V27, P197, DOI 10.1016/S1055-7903(02)00405-0; Rosenblum EB, 2008, J HERPETOL, V42, P572, DOI 10.1670/07-196.1; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savage WK, 2010, MOL ECOL, V19, P3301, DOI 10.1111/j.1365-294X.2010.04718.x; SHARBEL TF, 1995, COPEIA, P466; Shepard DB, 2011, MOL PHYLOGENET EVOL, V59, P399, DOI 10.1016/j.ympev.2011.03.007; Skage M, 2007, MAR BIOL RES, V3, P289, DOI 10.1080/17451000701473942; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Spinks PQ, 2012, ZOOL J LINN SOC-LOND, V164, P811, DOI 10.1111/j.1096-3642.2011.00788.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor HL, 2006, J HERPETOL, V40, P294, DOI 10.1670/0022-1511(2006)40[294:PCOAPC]2.0.CO;2; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Vargas SM, 2009, GENET MOL BIOL, V32, P608, DOI 10.1590/S1415-47572009005000050; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences M., 2012, METHODS MOL BIOL, V858, P79, DOI [10.1007/978, DOI 10.1007/978-1-61779-591-6_]; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wilgenbusch J, 2000, SYST BIOL, V49, P592, DOI 10.1080/10635159950127411; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia Y, 2012, MOL ECOL RESOUR, V12, P48, DOI 10.1111/j.1755-0998.2011.03055.x; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	73	53	56	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154363	10.1371/journal.pone.0154363	http://dx.doi.org/10.1371/journal.pone.0154363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116180	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600061
J	Baranowski, A; Klein, A; Ritz, U; Ackermann, A; Anthonissen, J; Kaufmann, KB; Brendel, C; Gotz, H; Rommens, PM; Hofmann, A				Baranowski, Andreas; Klein, Anja; Ritz, Ulrike; Ackermann, Angelika; Anthonissen, Joris; Kaufmann, Kerstin B.; Brendel, Christian; Goetz, Hermann; Rommens, Pol M.; Hofmann, Alexander			Surface Functionalization of Orthopedic Titanium Implants with Bone Sialoprotein	PLOS ONE			English	Article							BIODEGRADABLE COLLOIDAL GELS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; CELL ATTACHMENT; GENE-EXPRESSION; IN-VITRO; COLLAGEN; HYDROXYAPATITE; PROLIFERATION; MECHANISMS	Orthopedic implant failure due to aseptic loosening and mechanical instability remains a major problem in total joint replacement. Improving osseointegration at the bone-implant interface may reduce micromotion and loosening. Bone sialoprotein (BSP) has been shown to enhance bone formation when coated onto titanium femoral implants and in rat calvarial defect models. However, the most appropriate method of BSP coating, the necessary level of BSP coating, and the effect of BSP coating on cell behavior remain largely unknown. In this study, BSP was covalently coupled to titanium surfaces via an aminosilane linker (APTES), and its properties were compared to BSP applied to titanium via physisorption and untreated titanium. Cell functions were examined using primary human osteoblasts (hOBs) and L929 mouse fibroblasts. Gene expression of specific bone turnover markers at the RNA level was detected at different intervals. Cell adhesion to titanium surfaces treated with BSP via physisorption was not significantly different from that of untreated titanium at any time point, whereas BSP application via covalent coupling caused reduced cell adhesion during the first few hours in culture. Cell migration was increased on titanium disks that were treated with higher concentrations of BSP solution, independent of the coating method. During the early phases of hOB proliferation, a suppressive effect of BSP was observed independent of its concentration, particularly when BSP was applied to the titanium surface via physisorption. Although alkaline phosphatase activity was reduced in the BSP-coated titanium groups after 4 days in culture, increased calcium deposition was observed after 21 days. In particular, the gene expression level of RUNX2 was upregulated by BSP. The increase in calcium deposition and the stimulation of cell differentiation induced by BSP highlight its potential as a surface modifier that could enhance the osseointegration of orthopedic implants. Both physisorption and covalent coupling of BSP are similarly effective, feasible methods, although a higher BSP concentration is recommended.	[Baranowski, Andreas; Klein, Anja; Ritz, Ulrike; Ackermann, Angelika; Anthonissen, Joris; Rommens, Pol M.; Hofmann, Alexander] Johannes Gutenberg Univ Mainz, Dept Orthoped & Traumatol, Univ Med Ctr, D-55122 Mainz, Germany; [Kaufmann, Kerstin B.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Brendel, Christian] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA; [Goetz, Hermann] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Platform Biomat Res, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Harvard University; Boston Children's Hospital; Harvard Medical School; Johannes Gutenberg University of Mainz	Hofmann, A (corresponding author), Johannes Gutenberg Univ Mainz, Dept Orthoped & Traumatol, Univ Med Ctr, D-55122 Mainz, Germany.	hofmann.trauma-surgery@gmx.net	Brendel, Christian/HDN-6077-2022; Ritz, Ulrike/N-6871-2016; Hofmann, Alexander/C-3943-2013	Ritz, Ulrike/0000-0001-8936-3227; Kaufmann, Kerstin B./0000-0001-5013-6123; Baranowski, Andreas/0000-0001-7954-5289; Brendel, Christian/0000-0003-4081-4351	Immundiagnostik AG (Bensheim, Germany)	Immundiagnostik AG (Bensheim, Germany)	The research project was funded by Immundiagnostik AG (Bensheim, Germany) (http://www.immundiagnostik.com/en/home.html). The funder was involved in the study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4; Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363; [Anonymous], 2006, J ORTHOPAEDIC RES WI; Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.0.CO;2-J; AUBIN JE, 1992, INT CONGR SER, V1002, P267; Balloni S, 2009, INT J ORAL MAX IMPL, V24, P627; Bellahcene A, 2000, CIRC RES, V86, P885, DOI 10.1161/01.RES.86.8.885; Bernards MT, 2008, J BIOMED MATER RES A, V86A, P779, DOI 10.1002/jbm.a.31650; Boing J., 2003, MODIFIZIERUNG GLAS T; Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8; Boyan BD, 2001, ANN REV MATER RES, V31, P357, DOI 10.1146/annurev.matsci.31.1.357; Brendel C, 2012, GENE THER, V19, P1018, DOI 10.1038/gt.2011.167; Brunski J B, 1999, Adv Dent Res, V13, P99; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Cao Y, 2005, CANCER RES, V65, P1124, DOI 10.1158/0008-5472.CAN-04-2128; Chan WD, 2010, J BIOMED MATER RES A, V94A, P945, DOI 10.1002/jbm.a.32715; Christensen FB, 2000, EUR SPINE J, V9, P97, DOI 10.1007/s005860050218; Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Drees P, 2007, NAT CLIN PRACT RHEUM, V3, P165, DOI 10.1038/ncprheum0428; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1; Forsprecher J, 2011, CELL ADHES MIGR, V5, P65, DOI 10.4161/cam.5.1.13369; Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Graf HL, 2008, INT J ORAL MAX SURG, V37, P634, DOI 10.1016/j.ijom.2008.01.021; HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49; HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9; Hata K, 2007, J BIOMED MATER RES A, V81A, P446, DOI 10.1002/jbm.a.31086; HAZAN R, 1993, BIOMATERIALS, V14, P570, DOI 10.1016/0142-9612(93)90172-X; Hilbig H, 2007, EUR J MED RES, V12, P6; Hoffmann M, 2014, EUR J TRAUMA EMERG S, V40, P273, DOI 10.1007/s00068-014-0412-9; Hofmann A, 2008, BONE, V42, P894, DOI 10.1016/j.bone.2008.01.013; Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Kuhn S, 2014, J MATER SCI-MATER M, V25, P2549, DOI 10.1007/s10856-014-5278-1; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kutty MG, 2004, J MATER SCI-MATER M, V15, P145, DOI 10.1023/B:JMSM.0000011815.50383.bd; Liu F, 1997, EXP CELL RES, V232, P97, DOI 10.1006/excr.1997.3501; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maehata Y, 2006, MATRIX BIOL, V25, P47, DOI 10.1016/j.matbio.2005.09.001; MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202; Misawa H, 2006, CELL TRANSPLANT, V15, P903, DOI 10.3727/000000006783981369; Mizuno M, 2000, CALCIFIED TISSUE INT, V66, P388, DOI 10.1007/s002230010078; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nanci A, 1998, J BIOMED MATER RES, V40, P324; Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3; Pan J, 1996, J BIOMED MATER RES, V30, P393; Peng HS, 2014, J MATER CHEM B, V2, P6435, DOI 10.1039/c4tb00344f; Pierres A., 2002, European Cells & Materials, V3, P31; Pierres A, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P459; Pohler OEM, 2000, INJURY, V31, pS7; Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; Rammelt S, 2004, CELLS TISSUES ORGANS, V178, P146, DOI 10.1159/000082245; Rammelt S, 2004, J ORTHOPAED RES, V22, P1025, DOI 10.1016/j.orthres.2004.02.011; Rapuano BE, 2004, J ORTHOP RES, V22, P353, DOI 10.1016/S0736-0266(03)00180-3; RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702; Schaeren S, 2010, J BIOMED MATER RES A, V92A, P1461, DOI 10.1002/jbm.a.32459; Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x; Shen H, 2008, MECH MATER, V40, P708, DOI 10.1016/j.mechmat.2008.03.009; Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Song FF, 2015, J BIOMED NANOTECHNOL, V11, P40, DOI 10.1166/jbn.2015.1962; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K; Thiele K, 2015, J BONE JOINT SURG AM, V97A, P715, DOI 10.2106/JBJS.M.01534; Tye CE, 2003, J BIOL CHEM, V278, P7949, DOI 10.1074/jbc.M211915200; Valverde P, 2008, J BONE MINER RES, V23, P1775, DOI 10.1359/JBMR.080605; van der Zande M, 2008, J BIOMED MATER RES A, V86A, P788, DOI 10.1002/jbm.a.31645; Wang JX, 2006, CALCIFIED TISSUE INT, V79, P179, DOI 10.1007/s00223-006-0018-2; Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099; Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.TEA.2013.0075, 10.1089/ten.tea.2013.0075]; Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000; Wang Q, 2010, BIOMATERIALS, V31, P4980, DOI 10.1016/j.biomaterials.2010.02.052; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Yang Y, 2010, LANGMUIR, V26, P9848, DOI 10.1021/la100192z; Zhao ZR, 2005, MOL THER, V12, P247, DOI 10.1016/j.ymthe.2005.03.009; ZHOU HY, 1995, CALCIFIED TISSUE INT, V56, P403, DOI 10.1007/BF00301610	85	28	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153978	10.1371/journal.pone.0153978	http://dx.doi.org/10.1371/journal.pone.0153978			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111551	Green Published, Green Submitted, gold			2022-12-26	WOS:000374970600024
J	Yan, HJ; Li, JJ; Raymond, HF; Huan, XP; Guan, WH; Hu, HY; Yang, HT; McFarland, W; Wei, CY				Yan, Hongjing; Li, Jianjun; Raymond, H. Fisher; Huan, Xiping; Guan, Wenhui; Hu, Haiyang; Yang, Haitao; McFarland, Willi; Wei, Chongyi			Increased HIV Testing among Men Who Have Sex with Men from 2008 to 2012, Nanjing, China	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; INFECTION; SURVEILLANCE; SETTINGS; COHORT	Background HIV testing is the first point of HIV treatment entry for HIV-infected individuals and an avenue to engage persons at risk in prevention. In China, where the prevalence of HIV among men who have sex with men (MSM) has been rising over the last decade, uptake of HIV testing has been low. Methods We examined changes in HIV testing in the preceding 12 months through two cross-sectional surveys conducted among MSM in Nanjing, Jiangsu province, China in 2008 and 2012. Respondent-driven sampling (RDS) was used to recruit participants. Questionnaire interviews and venous blood were collected to measure HIV testing, risk behaviors, and prevalence of HIV, syphilis, and HSV-2. Results A total of 430 and 589 MSM were surveyed in 2008 and 2012, respectively, with comparable samples in each round with respect to demographic characteristics. HIV testing in the past 12 months increased significantly from 20.1% (95% CI 13.3-26.8) in 2008 to 46.0% (95% CI 39.3-51.4, p < 0.001) in 2012. HIV prevalence was stable, at 6.6% (95% CI 2.5-11.3) in 2008 and 10.1% (95% CI 6.6-13.9, p = 0.240) in 2012, as was syphilis (14.3% in 2008 vs. 9.9% in 2012, p = 0.240). HSV-2 prevalence (18.6% in 2008 vs. 10.2% in 2012, p = 0.040) and self-reported STI in the last year (24.3% in 2008 vs. 14.3% in 2012, p = 0.020) significantly decreased. Changes in reported sexual behaviors were mixed and the profiles of who did and did not test varied between 2008 and 2012. Conclusions HIV testing uptake more than doubled among MSM in Nanjing from 2008 to 2012 -a period of massive promotion and scale up of testing programs for MSM. However, additional efforts are still needed to further increase the proportion of men being not only tested but also undergoing repeat testing if they engage in continued risk taking behavior.	[Yan, Hongjing; Li, Jianjun; Huan, Xiping; Guan, Wenhui; Hu, Haiyang; Yang, Haitao] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Raymond, H. Fisher; McFarland, Willi; Wei, Chongyi] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Raymond, H. Fisher; McFarland, Willi] San Francisco Dept Publ Hlth, San Francisco, CA USA	Jiangsu Provincial Center for Disease Control & Prevention; University of California System; University of California San Francisco; San Francisco Department of Public Health	Wei, CY (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	Chongyi.Wei@ucsf.edu		Raymond, Henry/0000-0001-8621-2749	Outstanding Medical Academic Leader Program of Jiangsu Provincial Center for Diseases Control and Prevention [JKRC2011003]; Jiangsu Department of Health Program [H201330]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	Outstanding Medical Academic Leader Program of Jiangsu Provincial Center for Diseases Control and Prevention; Jiangsu Department of Health Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Outstanding Medical Academic Leader Program of Jiangsu Provincial Center for Diseases Control and Prevention (JKRC2011003) and the Jiangsu Department of Health Program (H201330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, 2012 CHIN AIDS RESP; [Anonymous], 2015, NOT EST HIV AIDS TRE; [Anonymous], 2012, STAT YB NANJ MUN 201; [Chinese Center for Diseases Prevention and Control National Center for HIV/AIDS/ STD Prevention and Control], 2014, NAT PROT COMPR HIV A; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cumming G, 2009, STAT MED, V28, P205, DOI 10.1002/sim.3471; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Johnston LG, 2013, AIDS BEHAV, V17, P2202, DOI 10.1007/s10461-012-0394-8; Li DL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001829; Li HM, 2009, SEX TRANSM INFEC, V85, P354; Li H, 2010, INT J EPIDEMIOL, V39, pII65, DOI 10.1093/ije/dyq223; Lin W, 2012, WEST PAC SURVEILL RE, V3, P78, DOI [10.5365/WPSAR.2012.3.3.004, 10.5365/wpsar.2012.3.3.004]; Ma X, 2007, J ACQ IMMUN DEF SYND, V45, P581; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Meng XJ, 2013, SEX HEALTH, V10, P211, DOI 10.1071/SH12093; Tao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102812; Wang QQ, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18849; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yan H, 2010, CHIN J AIDS STD, VTD16, P29; Yan HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103146; Yan HJ, 2012, JAIDS-J ACQ IMM DEF, V59, P177, DOI 10.1097/QAI.0b013e318239c947; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; Yin YP, 2012, SEX TRANSM DIS, V39, P354, DOI 10.1097/OLQ.0b013e318244aef0; Zhang DP, 2015, INT J STD AIDS, V26, P402, DOI 10.1177/0956462414542986; Zhang L, 2012, SEX HEALTH, V9, P261, DOI 10.1071/SH11104; Zhao YJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000534	31	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154466	10.1371/journal.pone.0154466	http://dx.doi.org/10.1371/journal.pone.0154466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111540	Green Submitted, gold, Green Published			2022-12-26	WOS:000374970600067
J	Mensing, LA; Rinkel, GJE; Vlak, MHM; van der Schaaf, IC; Ruigrok, YM				Mensing, Liselore A.; Rinkel, Gabriel J. E.; Vlak, Monique H. M.; van der Schaaf, Irene C.; Ruigrok, Ynte M.			Difference in Aneurysm Characteristics between Patients with Familial and Sporadic Aneurysmal Subarachnoid Haemorrhage	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; RISK-FACTORS; RUPTURE; HISTORY; GENETICS; SMOKING; COHORT; FLOW; AGE	Object Patients with familial intracranial aneurysms (IA) have a higher risk of rupture than patients with sporadic IA. We compared geometric and morphological risk factors for aneurysmal rupture between patients with familial and sporadic aneurysmal subarachnoid hemorrhage (aSAH) to analyse if these risk factors contribute to the increased rupture rate of familial IA. Methods Geometric and morphological aneurysm characteristics were studied on CT-angiography in a prospectively collected series of patients with familial and sporadic aSAH, admitted between September 2006 and September 2009, and additional patients with familial aSAH retrieved from the prospectively collected database of familial IA patients of our center. Odds ratios (OR) with corresponding 95% confidence intervals (95% CI) were calculated to compare the aneurysm characteristics between patients with familial and sporadic aSAH. Results We studied 67 patients with familial and 184 with sporadic aSAH. OR's for familial compared with sporadic aSAH were for oval shape 1.16(95% CI: 0.65-2.09), oblong shape 0.26 (95% CI: 0.03-2.13), irregular shape 0.83(95% CI: 0.47-1.49), aspect ratio >= 1.6 0.94(95% CI: 0.54-1.66), contact with the perianeurysmal environment (PAE) 1.15(95% CI: 0.56-2.40), deformation by the PAE 1.05(95% CI: 0.47-2.35) and for dominance of the posterior communicating artery (PCoA) in case of PCoA aneurysms 1.97(95% CI: 0.50-7.83). Conclusions The geometric and morphological risk factors for aneurysm rupture do not have a higher prevalence in familial than in sporadic aSAH and thus do not explain the increased risk of IA rupture in patients with familial IA. We recommend further search for other potential risk factors for rupture of familial IA, such as genetic factors.	[Mensing, Liselore A.; Rinkel, Gabriel J. E.; Ruigrok, Ynte M.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [van der Schaaf, Irene C.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Vlak, Monique H. M.] Med Ctr Haaglanden, Dept Neurol, The Hague, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Haaglanden Medical Center	Mensing, LA (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands.	L.A.Mensing-3@umcutrecht.nl			NWO-VENI grant by the Netherlands Organisation for Scientific Research (NWO) [91610016]	NWO-VENI grant by the Netherlands Organisation for Scientific Research (NWO)	YMR was supported by NWO-VENI grant by the Netherlands Organisation for Scientific Research (NWO) (project no. 91610016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenta PS, 2012, NEUROSURGERY, V70, P693, DOI 10.1227/NEU.0b013e3182354d68; Backes D, 2014, STROKE, V45, P1299, DOI 10.1161/STROKEAHA.113.004421; Bor ASE, 2015, STROKE, V46, P42, DOI 10.1161/STROKEAHA.114.005963; Broderick JP, 2009, STROKE, V40, P1952, DOI 10.1161/STROKEAHA.108.542571; Bromberg JEC, 1996, STROKE, V27, P630, DOI 10.1161/01.STR.27.4.630; Bromberg JEC, 1995, ANN NEUROL, V38, P929, DOI 10.1002/ana.410380614; de Rooij NK, 2009, J NEUROL, V256, P45, DOI 10.1007/s00415-009-0028-x; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Huttunen T, 2010, NEUROSURGERY, V66, P631, DOI 10.1227/01.NEU.0000367634.89384.4B; Lee JS, 2008, J KOREAN NEUROSURG S, V44, P136, DOI 10.3340/jkns.2008.44.3.136; Rasing I, 2012, J NEUROL NEUROSUR PS, V83, P541, DOI 10.1136/jnnp-2011-301147; Ruigrok YM, 2005, LANCET NEUROL, V4, P179, DOI 10.1016/S1474-4422(05)01015-X; Ruigrok YM, 2004, NEUROLOGY, V62, P891, DOI 10.1212/01.WNL.0000115104.19787.8E; Schievink WI, 1997, NEUROSURGERY, V40, P651, DOI 10.1097/00006123-199704000-00001; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Woo D, 2009, NEUROLOGY, V72, P69, DOI 10.1212/01.wnl.0000338567.90260.46; You SH, 2010, J NEUROL NEUROSUR PS, V81, P479, DOI 10.1136/jnnp.2008.169573	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154281	10.1371/journal.pone.0154281	http://dx.doi.org/10.1371/journal.pone.0154281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27112915	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100065
J	Trejo-Soto, C; Costa-Miracle, E; Rodriguez-Villarreal, I; Cid, J; Alarcon, T; Hernandez-Machado, A				Trejo-Soto, C.; Costa-Miracle, E.; Rodriguez-Villarreal, I.; Cid, J.; Alarcon, T.; Hernandez-Machado, Aurora			Capillary Filling at the Microscale: Control of Fluid Front Using Geometry	PLOS ONE			English	Article							MICROFLUIDICS; WATER	We propose an experimental and theoretical framework for the study of capillary filling at the micro-scale. Our methodology enables us to control the fluid flow regime so that we can characterise properties of Newtonian fluids such as their viscosity. In particular, we study a viscous, non-inertial, non-Washburn regime in which the position of the fluid front increases linearly with time for the whole duration of the experiment. The operating shear-rate range of our apparatus extends over nearly two orders of magnitude. Further, we analyse the advancement of a fluid front within a microcapillary in a system of two immiscible Newtonian liquids. We observe a non-Washburn regime in which the front can accelerate or decelerate depending on the viscosity contrast between the two liquids. We then propose a theoretical model which enables us to study and explain both non-Washburn regimes. Furthermore, our theoretical model allows us to put forward ways to control the emergence of these regimes by means of geometrical parameters of the experimental set-up. Our methodology allows us to design and calibrate a micro-viscosimetre which works at constant pressure.	[Trejo-Soto, C.; Hernandez-Machado, Aurora] Univ Barcelona, Fac Fis, Dept ECM, Diagonal 645, E-08028 Barcelona, Spain; [Trejo-Soto, C.; Costa-Miracle, E.; Rodriguez-Villarreal, I.; Alarcon, T.; Hernandez-Machado, Aurora] Ctr Recerca Matemat, Edifici C,Campus Bellaterra, Bellaterra 08193, Barcelona, Spain; [Costa-Miracle, E.; Alarcon, T.] Univ Autonoma Barcelona, Dept Matemat, Bellaterra 08193, Barcelona, Spain; [Costa-Miracle, E.; Alarcon, T.; Hernandez-Machado, Aurora] Barcelona Grad Sch Math BGSMath, Barcelona, Spain; [Cid, J.] Hosp Clin Barcelona, Serv Hemoterapia & Hemostasia, Barcelona, Spain; [Alarcon, T.] ICREA, Barcelona, Spain	University of Barcelona; Centre de Recerca Matematica (CRM); Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; ICREA	Hernandez-Machado, A (corresponding author), Univ Barcelona, Fac Fis, Dept ECM, Diagonal 645, E-08028 Barcelona, Spain.; Hernandez-Machado, A (corresponding author), Ctr Recerca Matemat, Edifici C,Campus Bellaterra, Bellaterra 08193, Barcelona, Spain.; Hernandez-Machado, A (corresponding author), Barcelona Grad Sch Math BGSMath, Barcelona, Spain.	a.hernandezmachado@gmail.com	Rodriguez-Villarreal, Angeles Ivon/K-9205-2014; Trejo-Soto, Claudia Andrea/G-8551-2016; Alarcon, Tomas/D-9083-2013; Hernandez-Machado, Aurora/N-3362-2019; Cid, Joan/F-7778-2016; Alarcon, Tomas/AAW-2908-2021; Hernandez-Machado, Aurora/H-7425-2012	Rodriguez-Villarreal, Angeles Ivon/0000-0001-7563-5113; Trejo-Soto, Claudia Andrea/0000-0003-0267-3359; Alarcon, Tomas/0000-0002-8566-3676; Hernandez-Machado, Aurora/0000-0002-0397-5255; Cid, Joan/0000-0001-5445-4508; Alarcon, Tomas/0000-0002-8566-3676; Hernandez-Machado, Aurora/0000-0002-0397-5255; Costa-Miracle, Enric/0000-0001-8238-1422	Spanish Ministry for Science and Innovation (MICINN) [MTM2011-29342]; Generalitat de Catalunya [2014SGR1307]; MINECO [FIS2013-47949-C2-1-P]; DURSI [2014SGR878]; CONICYT the Chilean Ministry of Education; ICREA Funding Source: Custom	Spanish Ministry for Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); MINECO(Spanish Government); DURSI; CONICYT the Chilean Ministry of Education; ICREA(ICREA)	IRV and TA acknowledge the Spanish Ministry for Science and Innovation (MICINN) for funding MTM2011-29342 and Generalitat de Catalunya for funding under grant 2014SGR1307. AHM gratefully acknowledges partial financial support from MINECO for funding under grant FIS2013-47949-C2-1-P and DURSI for funding under grant 2014SGR878. CTS acknowledges CONICYT the Chilean Ministry of Education for funding PhD fellowship, Becas Chile.	Abate AR, 2010, P NATL ACAD SCI USA, V107, P19163, DOI 10.1073/pnas.1006888107; Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Al-Housseiny TT, 2012, NAT PHYS, V8, P747, DOI [10.1038/NPHYS2396, 10.1038/nphys2396]; Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; Bezagu M, 2014, J AM CHEM SOC, V136, P7205, DOI 10.1021/ja5019354; Bocquet L, 2014, LAB CHIP, V14, P3143, DOI 10.1039/c4lc00325j; Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z; Degre G, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2221501; Global M., 2008, ETHYLENEGLYCOL PRODU; Guillot P, 2006, LANGMUIR, V22, P6438, DOI 10.1021/la060131z; Ledesma-Aguilar R, 2011, NAT MATER, V10, P367, DOI [10.1038/NMAT2998, 10.1038/nmat2998]; Lee W, 2010, P NATL ACAD SCI USA, V107, P22413, DOI 10.1073/pnas.1010297107; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Meiselman H.J., 2007, HDB HEMORHEOLOGY HEM; Queralt-Martin M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.194501; Quere D, 1997, EUROPHYS LETT, V39, P533, DOI 10.1209/epl/i1997-00389-2; Reyssat M, 2008, J FLUID MECH, V615, P335, DOI 10.1017/S0022112008003996; Rodriguez-Villarreal I, 2011, THESIS; Srivastava N, 2005, ANAL CHEM, V77, P383, DOI 10.1021/ac0494681; Tabeling P, 2005, INTRO MICROFLUIDICS; Tas NR, 2004, APPL PHYS LETT, V85, P3274, DOI 10.1063/1.1804602; Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273; Yu FQ, 2013, LAB CHIP, V13, P1911, DOI 10.1039/c3lc41394b	23	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153559	10.1371/journal.pone.0153559	http://dx.doi.org/10.1371/journal.pone.0153559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104734	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100013
J	Arvanitis, M; Li, G; Li, DD; Cotnoir, D; Ganley-Leal, L; Carney, DW; Sello, JK; Mylonakis, E				Arvanitis, Marios; Li, Gang; Li, De-Dong; Cotnoir, Daniel; Ganley-Leal, Lisa; Carney, Daniel W.; Sello, Jason K.; Mylonakis, Eleftherios			A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; ANTIBIOTICS; CLPP; FUTURE; MODEL	Background Cyclic acyldepsipeptides (ADEPs) are a novel class of antibacterial agents, some of which (e.g., ADEP 4) are highly active against Gram-positive bacteria. The focus of these in vivo studies is ADEP B315, a rationally designed compound that has the most potent in vitro activity of any ADEP analog reported to date. Methods In vivo efficacy experiments were performed using lethal intraperitoneal mice infection models with a methicillin-sensitive S. aureus (MSSA) and a methicillin-resistant (MRSA) strain. The infected mice were treated with ADEP B315, a des-methyl analog of ADEP 4, vancomycin, or the vehicle used for the ADEPs and their survival was assessed daily. A subset of MSSA-infected mice was sacrificed soon after inoculation and the bacterial burden was measured in their livers and spleens. The toxicity of ADEP B315 was assessed in viability assays using human whole blood cultures. Results In the MSSA experiments, all mice treated with the vehicle succumbed to the infection within 24 hours. All tested compounds were effective in prolonging survival of infected mice (p<0.001). Mice treated with ADEP B315 had a 39% survival rate by 10 days compared to 7% survival in mice treated with a des-methyl ADEP 4 analog (p = 0.017). Survival of the infected mice treated with ADEP B315 was comparable to those treated with vanocmycin (p = 0.12) at the same dose. Further, bacterial burden in the liver and spleen was significantly lower in mice treated with ADEP B315 compared to controls. In the MRSA experiments, ADEP B315 was able to significantly prolong survival compared to mice treated with either the vehicle (p = 0.001) or vancomycin (p = 0.007). ADEP B315 exhibited no significant toxicity in human whole blood cultures at concentrations up to 25 mu g/ml. Conclusions ADEP B315 is safe and can cure mice that have lethal infections of methicillin-sensitive and -resistant strains of S. aureus.	[Arvanitis, Marios; Li, Gang; Li, De-Dong; Mylonakis, Eleftherios] Rhode Isl Hosp, Div Infect Dis, Providence, RI USA; [Arvanitis, Marios; Li, Gang; Li, De-Dong; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Cotnoir, Daniel; Ganley-Leal, Lisa] Brown Univ, Dept Pediat, Alpert Med Sch, Hasbro Childrens Hosp, Providence, RI 02912 USA; [Carney, Daniel W.; Sello, Jason K.] Brown Univ, Dept Chem, 324 Brook St, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Hasbro Children's Hospital; Brown University	Mylonakis, E (corresponding author), Rhode Isl Hosp, Div Infect Dis, Providence, RI USA.; Mylonakis, E (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.; Sello, JK (corresponding author), Brown Univ, Dept Chem, 324 Brook St, Providence, RI 02912 USA.	Jason_sello@brown.edu; emylonakis@lifespan.org	Li, Dedong/R-7044-2019		National Institutes of Health [P01 AI083214, R21 AI097684, U54 AI057159]; PharmLogic Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, P01AI083214, R21AI097684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PharmLogic Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant P01 AI083214 to EM, grant R21 AI097684 to LGL, grant U54 AI057159 to NERCE, and PharmLogic Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089984; Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Bionda N, 2012, CHEMMEDCHEM, V7, P871, DOI 10.1002/cmdc.201200016; Brotz-Oesterhelt H, 2014, INT J MED MICROBIOL, V304, P23, DOI 10.1016/j.ijmm.2013.09.001; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Carney DW, 2014, J AM CHEM SOC, V136, P1922, DOI 10.1021/ja410385c; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; FRIMODTMOLLER N, 1993, J ANTIMICROB CHEMOTH, V31, P55, DOI 10.1093/jac/31.suppl_D.55; Higgins PG, 2009, ANTIMICROB AGENTS CH, V53, P4556, DOI 10.1128/AAC.00395-09; Hinzen B, 2006, CHEMMEDCHEM, V1, P689, DOI 10.1002/cmdc.200600055; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; KOSHINO H, 1991, TETRAHEDRON LETT, V32, P7707, DOI 10.1016/0040-4039(91)80571-M; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Michel K.H., 1985, US Pat., Patent No. [4492650, 4,492,650]; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Schuch R, 2014, J INFECT DIS, V209, P1469, DOI 10.1093/infdis/jit637; Socha AM, 2010, BIOORGAN MED CHEM, V18, P7193, DOI 10.1016/j.bmc.2010.08.032; Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093; Vaudaux P, 2010, ANTIMICROB AGENTS CH, V54, P3861, DOI 10.1128/AAC.00269-10; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727	21	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153912	10.1371/journal.pone.0153912	http://dx.doi.org/10.1371/journal.pone.0153912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101010	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500093
J	Thomas, JT; Chhuy-Hy, L; Andrykovich, KR; Moos, M				Thomas, J. Terrig; Chhuy-Hy, Lina; Andrykovich, Kristin R.; Moos, Malcolm, Jr.			SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HEPARAN-SULFATE; IN-VITRO; PROTEIN; BMP; ACTIVATION; PRECURSOR; SERUM	In an attempt to identify the cell-associated protein(s) through which SMOC (Secreted Modular Calcium binding protein) induces mitogen-activated protein kinase (MAPK) signaling, the epidermal growth factor receptor (EGFR) became a candidate. However, although in 32D/EGFR cells, the EGFR was phosphorylated in the presence of a commercially available human SMOC-1 (hSMOC-1), only minimal phosphorylation was observed in the presence of Xenopus SMOC-1 (XSMOC-1) or human SMOC-2. Analysis of the commercial hSMOC-1 product demonstrated the presence of pro-EGF as an impurity. When the pro-EGF was removed, only minimal EGFR activation was observed, indicating that SMOC does not signal primarily through EGFR and its receptor remains unidentified. Investigation of SMOC/pro-EGF binding affinity revealed a strong interaction that does not require the C-terminal extracellular calcium-binding (EC) domain of SMOC or the EGF domain of pro-EGF. SMOC does not appear to potentiate or inhibit MAPK signaling in response to pro-EGF, but the interaction could provide a mechanism for retaining soluble pro-EGF at the cell surface.	[Thomas, J. Terrig; Chhuy-Hy, Lina; Andrykovich, Kristin R.; Moos, Malcolm, Jr.] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Thomas, JT (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies, Silver Spring, MD USA.	john.thomas@fda.hhs.gov	Moos, Malcolm C/F-3673-2011	Moos, Malcolm C/0000-0002-9575-9938	FDA	FDA(United States Department of Health & Human Services)	All funding for this study was FDA intramural funding. No grants were received.	Abouzeid H, 2011, AM J HUM GENET, V88, P92, DOI 10.1016/j.ajhg.2010.12.002; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aybay C, 2006, CYTOKINE, V35, P36, DOI 10.1016/j.cyto.2006.07.005; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Deb TB, 2001, J BIOL CHEM, V276, P15554, DOI 10.1074/jbc.M100928200; Gurdon JB, 1967, METHODS DEV BIOL; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; JOHNSON GR, 1994, J BIOL CHEM, V269, P27149; Klemencic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056839; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Li QF, 2001, J BIOL CHEM, V276, P38068; Mummery RS, 2007, GLYCOBIOLOGY, V17, P1094, DOI 10.1093/glycob/cwm082; Novinec M, 2008, PROTEIN EXPRES PURIF, V62, P75, DOI 10.1016/j.pep.2008.07.009; Okada I, 2011, AM J HUM GENET, V88, P30, DOI 10.1016/j.ajhg.2010.11.012; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; PARRIES G, 1995, J BIOL CHEM, V270, P27954, DOI 10.1074/jbc.270.46.27954; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Prince RN, 2010, J CELL SCI, V123, P2308, DOI 10.1242/jcs.058321; Rainger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002114; Sive H, 2000, EARLY DEVELOPMENT OF; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Thomas JT, 2009, J BIOL CHEM, V284, P18994, DOI 10.1074/jbc.M807759200; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yoshioka J, 2005, P NATL ACAD SCI USA, V102, P10622, DOI 10.1073/pnas.0501198102	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154294	10.1371/journal.pone.0154294	http://dx.doi.org/10.1371/journal.pone.0154294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101391	gold, Green Submitted, Green Published			2022-12-26	WOS:000374898500180
J	Mosbacher, JB; Michelsen, A; Stelvig, M; Hendrichsen, DK; Schmidt, NM				Mosbacher, Jesper Bruun; Michelsen, Anders; Stelvig, Mikkel; Hendrichsen, Ditte Katrine; Schmidt, Niels Martin			Show Me Your Rump Hair and I Will Tell You What You Ate - The Dietary History of Muskoxen (Ovibos moschatus) Revealed by Sequential Stable Isotope Analysis of Guard Hairs	PLOS ONE			English	Article							NITROGEN ISOTOPES; MAMMALIAN HERBIVORES; CARBON ISOTOPES; BODY CONDITION; PROTEIN STATUS; PEARY CARIBOU; BANKS ISLAND; DYNAMICS; DELTA-N-15; NUTRITION	The nutritional state of animals is tightly linked to the ambient environment, and for northern ungulates the state strongly influences vital population demographics, such as pregnancy rates. Continuously growing tissues, such as hair, can be viewed as dietary records of animals over longer temporal scales. Using sequential data on nitrogen stable isotopes (delta N-15) in muskox guard hairs from ten individuals in high arctic Northeast Greenland, we were able to reconstruct the dietary history of muskoxen over approximately 2.5 years with a high temporal resolution of app. 9 days. The dietary chronology included almost three full summer and winter periods. The diet showed strong intra-and inter-annual seasonality, and was significantly linked to changes in local environmental conditions (temperature and snow depth). The summer diets were highly similar across years, reflecting a graminoid-dominated diet. In contrast, winter diets were markedly different between years, a pattern apparently linked to snow conditions. Snow-rich winters had markedly higher delta N-15 values than snow-poor winters, indicating that muskoxen had limited access to forage, and relied more heavily on their body stores. Due to the close link between body stores and calf production in northern ungulates, the dietary winter signals could eventually serve as an indicator of calf production the following spring. Our study opens the field for further studies and longer chronologies to test such links. The method of sequential stable isotope analysis of guard hairs thus constitutes a promising candidate for population-level monitoring of animals in remote, arctic areas.	[Mosbacher, Jesper Bruun; Schmidt, Niels Martin] Aarhus Univ, Dept Biosci, Arctic Res Ctr, Frederiksborgvej 399, DK-4000 Roskilde, Denmark; [Michelsen, Anders] Univ Copenhagen, Dept Biol, Univ Pk 15, DK-2100 Copenhagen O, Denmark; [Michelsen, Anders] Univ Copenhagen, Ctr Permafrost, Oster Voldgade 10, DK-1350 Copenhagen K, Denmark; [Stelvig, Mikkel] Copenhagen Zoo, Roskildevej 38, DK-2000 Frederiksberg, Denmark; [Hendrichsen, Ditte Katrine] Norwegian Inst Nat Res, Hogskoleringen 9, NO-7034 Trondheim, Norway	Aarhus University; University of Copenhagen; University of Copenhagen; Norwegian Institute Nature Research	Mosbacher, JB (corresponding author), Aarhus Univ, Dept Biosci, Arctic Res Ctr, Frederiksborgvej 399, DK-4000 Roskilde, Denmark.	jemo@bios.au.dk	Stelvig, Mikkel/ABB-3399-2020; Michelsen, Anders/L-5279-2014; Schmidt, Niels Martin/G-3843-2011	Michelsen, Anders/0000-0002-9541-8658; Schmidt, Niels Martin/0000-0002-4166-6218; Stelvig, Mikkel/0000-0002-2272-7492	15. Juni Fonden [2011-A-74]; Danish Environmental Protection Agency; Danish National Research Foundation [DNRF100]	15. Juni Fonden; Danish Environmental Protection Agency; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by 15. Juni Fonden, 2011-A-74, http://www.15junifonden.dk/, NMS, JBM; Danish Environmental Protection Agency, http://mst.dk/, NMS; The Danish National Research Foundation, DNRF100, http://dg.dk/, AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczewski JZ, 1997, J ZOOL, V241, P245, DOI 10.1111/j.1469-7998.1997.tb01956.x; Adamczewski JZ, 1998, THERIOGENOLOGY, V50, P605, DOI 10.1016/S0093-691X(98)00165-4; Barboza PS, 2004, INT CONGR SER, V1275, P327, DOI 10.1016/j.ics.2004.09.040; Ben-David M, 1998, ECOLOGY, V79, P2567, DOI 10.2307/176846; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Boertmann D, 1990, RANGIFER, V12, P5; Callaghan TV, 2011, AMBIO, V40, P17, DOI 10.1007/s13280-011-0212-y; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Ehrich D, 2015, ECOSYSTEMS, V18, P404, DOI 10.1007/s10021-014-9834-9; Elberling B, 2008, ADV ECOL RES, V40, P223, DOI 10.1016/S0065-2504(07)00010-4; Falk JM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/045001; FLOOD PF, 1989, CAN J ZOOL, V67, P1143, DOI 10.1139/z89-164; Gaye-Siessegger J, 2004, NATURWISSENSCHAFTEN, V91, P90, DOI 10.1007/s00114-003-0496-2; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Gray DR, 1987, MUSKOXEN POLAR BEAR; Gunn A., 1982, P1021; Gustine DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103471; Gustine DD, 2012, J MAMMAL, V93, P778, DOI 10.1644/11-MAMM-A-164.1; Gustine DD, 2011, OIKOS, V120, P1546, DOI 10.1111/j.1600-0706.2011.19215.x; Gustine DD, 2011, J WILDLIFE MANAGE, V75, P178, DOI 10.1002/jwmg.11; Gustine DD, 2010, PHYSIOL BIOCHEM ZOOL, V83, P687, DOI 10.1086/652729; Hansen BU, 2008, ADV ECOL RES, V40, P111, DOI 10.1016/S0065-2504(07)00006-2; Hilderbrand GV, 1999, CAN J ZOOL, V77, P1623, DOI 10.1139/cjz-77-10-1623; Hobbie EA, 2000, OECOLOGIA, V122, P273, DOI 10.1007/PL00008856; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Ims RA, 2013, CONSERVATION ARCTIC; Jingfors K, 1982, J WILDLIFE MANGAEMEN, V64, P450; Kazmin VD, 2009, ZOOL ZH, V88, P990; KLEIN DR, 1991, HOLARCTIC ECOL, V14, P152; KLEIN DR, 1990, HOLARCTIC ECOL, V13, P269; KLEIN DR, 1994, OECOLOGIA, V97, P439, DOI 10.1007/BF00325880; Kristensen DK, 2011, CAN J ZOOL, V89, P892, DOI [10.1139/Z11-073, 10.1139/z11-073]; Larter NC, 2004, POLAR RES-SWEDEN, V23, P131, DOI 10.1111/j.1751-8369.2004.tb00003.x; Larter NC, 2001, APPL VEG SCI, V4, P115, DOI 10.1111/j.1654-109X.2001.tb00242.x; Larter NC, 2001, ARCT ANTARCT ALP RES, V33, P123, DOI 10.2307/1552212; Mannel TT, 2007, GLOBAL ECOL BIOGEOGR, V16, P583, DOI 10.1111/j.1466-8238.2007.00322.x; Mekota AM, 2009, RECHTSMEDIZIN, V19, P431, DOI 10.1007/s00194-009-0630-3; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; Michelsen A, 1998, OECOLOGIA, V115, P406, DOI 10.1007/s004420050535; Mizukami RN, 2005, URSUS, V16, P93, DOI 10.2192/1537-6176(2005)016[0093:EOFHBM]2.0.CO;2; Mosbacher JB, 2016, ARCT ANTARCT ALP RES; Murray JL, 1991, BIOMASS DISTRIBUTION; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Reynolds PE, 1998, J WILDLIFE MANAGE, V62, P734, DOI 10.2307/3802350; Rowell JE, 2001, J ANIM SCI, V79, P1670; Schmidt NM, 2015, POLAR BIOL, V38, P1667, DOI 10.1007/s00300-015-1733-9; Schmidt NM, 2014, ZACKENBERG ECOLOGICA; Schwertl M, 2003, RAPID COMMUN MASS SP, V17, P1312, DOI 10.1002/rcm.1042; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sponheimer M, 2003, INT J OSTEOARCHAEOL, V13, P80, DOI 10.1002/oa.655; Stocker T. F., 2013, CLIMATE CHANGE 2013; Szpak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053763; Tener JS., 1965, MUSKOXEN CANADA BIOL; THING H, 1987, HOLARCTIC ECOL, V10, P95; von Holstein ICC, 2014, RAPID COMMUN MASS SP, V28, P2121, DOI 10.1002/rcm.6999; West AG, 2004, FUNCT ECOL, V18, P616, DOI 10.1111/j.0269-8463.2004.00862.x; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; White RG, 1997, J ZOOL, V243, P13, DOI 10.1111/j.1469-7998.1997.tb05752.x; WHITE RG, 1989, CAN J ZOOL, V67, P1125, DOI 10.1139/z89-162; WILKINSON PF, 1975, J ZOOL, V177, P363, DOI 10.1111/j.1469-7998.1975.tb02239.x; Wittemyer G, 2009, CHEM GEOL, V267, P3, DOI 10.1016/j.chemgeo.2008.08.010; Zazzo A, 2015, RAPID COMMUN MASS SP, V29, P1357, DOI 10.1002/rcm.7228	66	25	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152874	10.1371/journal.pone.0152874	http://dx.doi.org/10.1371/journal.pone.0152874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097032	Green Published, gold			2022-12-26	WOS:000374543600019
J	Parrish, RC; Penley, MJ; Morran, LT				Parrish, Raymond C., II; Penley, McKenna J.; Morran, Levi T.			The Integral Role of Genetic Variation in the Evolution of Outcrossing in the Caenorhabditis elegans-Serratia marcescens Host-Parasite System	PLOS ONE			English	Article							SELF-FERTILIZATION; EXPERIMENTAL COEVOLUTION; INBREEDING DEPRESSION; SEX; SELECTION; MAINTENANCE; ADVANTAGE; PLANTS; COST; PARTHENOGENESIS	Outcrossing is predicted to facilitate more rapid adaptation than self-fertilization as a result of genetic exchange between genetically variable individuals. Such genetic exchange may increase the efficacy of selection by breaking down Hill-Robertson interference, as well as promoting the maintenance of within-lineage genetic diversity. Experimental studies have demonstrated the selective advantage of outcrossing in novel environments. Here, we assess the specific role of genetic variation in the evolution of outcrossing. We experimentally evolved genetically variable and inbred populations of mixed mating (outcrossing and self-fertilizing) Caenorhabditis elegans nematodes under novel ecological conditions-specifically the presence of the virulent parasite Serratia marcescens. Outcrossing rates increased in genetically variable host populations evolved in the presence of the parasite, whereas parasite exposure in inbred populations resulted in reduced rates of host outcrossing. The host populations with genetic variation also exhibited increased fitness in the presence of the parasite over eight generations, whereas inbred populations did not. This increase in fitness was primarily the result of adaptation to the parasite, rather than recovery from initial inbreeding depression. Therefore, the benefits of outcrossing were only manifested in the presence of genetic variation, and outcrossing was favored over self-fertilization as a result. As predicted, the benefits of outcrossing under novel ecological conditions are a product of genetic exchange between genetically diverse lineages.	[Parrish, Raymond C., II; Morran, Levi T.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Penley, McKenna J.; Morran, Levi T.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Parrish, Raymond C., II] Harvard Univ, Sch Med, Boston, MA USA	Indiana University System; Indiana University Bloomington; Emory University; Harvard University; Harvard Medical School	Morran, LT (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN USA.; Morran, LT (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	levi.morran@emory.edu			National Institutes of Health [1F32GM096482]; Emory University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health 1F32GM096482 to LTM (http://www.nih.gov/) and Emory University to LTM (www.emory.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2010, J HERED, V101, pS62, DOI 10.1093/jhered/esq003; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; Becks L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001317; Becks L, 2010, NATURE, V468, P89, DOI 10.1038/nature09449; Bell G, 1982, MASTERPIECE NATURE E; BRENNER S, 1974, GENETICS, V77, P71; CHARLESWORTH B, 1980, J THEOR BIOL, V84, P655, DOI 10.1016/S0022-5193(80)80026-9; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; CROW JF, 1992, J HERED, V83, P169, DOI 10.1093/oxfordjournals.jhered.a111187; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher RA, 1930, GENETICAL THEORY NAT; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Gray JC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-43; Hartfield M, 2012, INTEGR ZOOL, V7, P192, DOI 10.1111/j.1749-4877.2012.00284.x; Heller J., 1979, GENET RES, V8, P269; Jarne P, 2006, EVOLUTION, V60, P1816; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lively CM, 2014, J EVOLUTION BIOL, V27, P1292, DOI 10.1111/jeb.12354; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; LIVELY CM, 1990, AM NAT, V135, P489, DOI 10.1086/285058; Lynch M., 1995, EVOLUTION, V47, P1744; Masri L, 2013, ECOL LETT, V16, P461, DOI 10.1111/ele.12068; Morran LT, 2014, AM NAT, V184, pS91, DOI 10.1086/676930; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Morran LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014473; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; ROSENBLUTH RE, 1983, MUTAT RES, V110, P39, DOI 10.1016/0027-5107(83)90016-7; Schulte RD, 2010, P NATL ACAD SCI USA, V107, P7359, DOI 10.1073/pnas.1003113107; SMITH JM, 1978, EVOLUTION SEX; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Stewart AD, 2002, GENETICS, V160, P975; Szovenyi P, 2014, GENOME BIOL EVOL, V6, P1238, DOI 10.1093/gbe/evu099; Teotonio H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035811; UYENOYAMA MK, 1984, EVOLUTION, V38, P87, DOI 10.1111/j.1558-5646.1984.tb00262.x; Vergara D, 2014, AM NAT, V184, pS22, DOI 10.1086/676886; Verhoeven KJF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-23; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Zeyl C, 1997, NATURE, V388, P465, DOI 10.1038/41312	46	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154463	10.1371/journal.pone.0154463	http://dx.doi.org/10.1371/journal.pone.0154463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119159	gold, Green Submitted, Green Published			2022-12-26	WOS:000374976200080
J	Lacy, BE; Patel, H; Guerin, A; Dea, K; Scopel, JL; Alaghband, R; Wu, EQ; Mody, R				Lacy, Brian E.; Patel, Haridarshan; Guerin, Annie; Dea, Katherine; Scopel, Justin L.; Alaghband, Reza; Wu, Eric Qiong; Mody, Reema			Variation in Care for Patients with Irritable Bowel Syndrome in the United States	PLOS ONE			English	Article							COMMERCIALLY INSURED POPULATION; QUALITY-OF-LIFE; REGIONAL-VARIATION; HEALTH-CARE; GEOGRAPHIC-VARIATION; MYOCARDIAL-INFARCTION; CHRONIC CONSTIPATION; RETROSPECTIVE ANALYSIS; ECONOMIC BURDEN; COSTS	Objectives Irritable bowel syndrome (IBS) affects nearly one in seven Americans. Significant national variations in care may exist, due to a current lack of standardized diagnosis and treatment algorithms; this can translate into a substantial additional economic burden. The study examines healthcare resource utilization in patients with IBS and in the subset of IBS patients with constipation (IBS-C) and analyzes the variation of IBS care for these patients across the United States (US). Methods Healthcare resource use (HRU), including gastrointestinal (GI) procedures and tests, all-cause and intestinal-related medical visits, GI specialist visits, and constipation or diarrhea pharmacy prescriptions for IBS patients enrolled in a large US administrative claims database (2001-2012) were analyzed for the 24-month period surrounding first diagnosis. Multivariate regression models, adjusting for age, gender, year of first diagnosis, insurance type, and Charlson comorbidity index, compared HRU across states (each state vs. the average of all other states). Results Of 201,322 IBS patients included, 77.2% were female. Mean age was 49.4 years. One in three patients had >= 3 distinct GI medical procedures or diagnostic tests; 50.1% visited a GI specialist. Significant HRU differences were observed in individual states compared to the national average. IBS-C patients had more medical visits, procedures, and pharmacy prescriptions for constipation/diarrhea than IBS patients without constipation. Conclusions This study is the first to identify considerable regional variations in IBS healthcare across the US and to note a markedly higher HRU by IBS-C patients than by IBS patients without constipation. Identifying the reasons for these variations may improve quality of care and reduce the economic burden of IBS.	[Lacy, Brian E.] Dartmouth Hitchcock Med Ctr, Div Gastroenterol & Hepatol, Lebanon, NH 03766 USA; [Patel, Haridarshan] Immens Consulting Inc, Chicago, IL USA; [Guerin, Annie; Dea, Katherine; Alaghband, Reza] Anal Grp Inc, Montreal, PQ, Canada; [Scopel, Justin L.] Takeda Pharmaceut Int Inc, US Med Affairs, Deerfield, IL USA; [Wu, Eric Qiong] Anal Grp Inc, Boston, MA USA; [Mody, Reema] Takeda Pharmaceut Int Inc, Global Outcomes & Epidemiol Res, Deerfield, IL USA	Dartmouth College; Analysis Group Inc.; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Analysis Group Inc.; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Guerin, A (corresponding author), Anal Grp Inc, Montreal, PQ, Canada.	Annie.Guerin@analysisgroup.com			Takeda Pharmaceuticals International; Takeda Pharmaceuticals International, Inc.; Immensity Consulting, Inc.; Analysis Group, Inc.	Takeda Pharmaceuticals International(Takeda Pharmaceutical Company Ltd); Takeda Pharmaceuticals International, Inc.(Takeda Pharmaceutical Company Ltd); Immensity Consulting, Inc.; Analysis Group, Inc.	Research for this article was funded by the sponsor, Takeda Pharmaceuticals International. The study was designed by the senior authors (BEL, AG, EQW) and the sponsor employees HP, RM, and JLS. Data were collected by Analysis Group authors KD and RA and analyzed and interpreted in collaboration with all authors. All authors participated in the design of the study and contributed to the manuscript development. Although sponsor employees HP, RM, and JLS were involved in the design, collection, analysis, and interpretation of information, the content of this manuscript, the ultimate interpretation, and the decision to submit it for publication were made by each of the authors independently. All the authors vouch for the accuracy and completeness of the data reported and for the adherence of the study to the protocol. Takeda Pharmaceuticals International, Inc., Immensity Consulting, Inc., and Analysis Group, Inc. provided support in the form of salaries for the authors employed as listed in the 'competing interests' section, but these companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; [Anonymous], 2009, Prescrire Int, V18, P75; Astegiano M, 2008, Minerva Gastroenterol Dietol, V54, P251; Cai Qian, 2014, J Med Econ, V17, P148, DOI 10.3111/13696998.2013.860375; Canavan C, 2014, ALIMENT PHARM THER, V40, P1023, DOI 10.1111/apt.12938; Cary KC, 2015, PROSTATE CANCER P D, V18, P149, DOI 10.1038/pcan.2015.3; Charlson ME, 2008, J CLIN EPIDEMIOL, V61, P1234, DOI 10.1016/j.jclinepi.2008.01.006; Clin Practice Comm, 2002, GASTROENTEROLOGY, V123, P2105, DOI 10.1053/gast.2002.37095; Creed F, 2001, ANN INTERN MED, V134, P860, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00010; Danielson Group, 2014, DAN GROUP; David G, 2013, GASTROENTEROLOGY, V144, pS647; DETSKY AS, 1995, NEW ENGL J MED, V333, P589, DOI 10.1056/NEJM199508313330911; DiBonaventura M, 2011, CURR MED RES OPIN, V27, P2213, DOI 10.1185/03007995.2011.623157; Doshi JA, 2014, J MANAG CARE SPEC PH, V20, P382, DOI 10.18553/jmcp.2014.20.4.382; Fitzgerald John D, 2013, J Hosp Adm, V2, DOI 10.5430/jha.v2n4p71; Gebreab SY, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001673; Guerin Annie, 2014, J Med Econ, V17, P577, DOI 10.3111/13696998.2014.919926; Hsu RK, 2013, CLIN J AM SOC NEPHRO, V8, P1476, DOI 10.2215/CJN.12611212; Hungin APS, 2005, ALIMENT PHARM THER, V21, P1365, DOI 10.1111/j.1365-2036.2005.02463.x; Jung HK, 2014, J NEUROGASTROENTEROL, V20, P242, DOI [10.5056/jnm.2014.20.2.242, 10.5056/jnm.20.2.242]; Kolte D, 2015, CIRCULATION, V131, P1415, DOI 10.1161/CIRCULATIONAHA.114.014542; Kolte D, 2014, CLIN CARDIOL, V37, P204, DOI 10.1002/clc.22250; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Longstreth GF, 2003, AM J GASTROENTEROL, V98, P600, DOI 10.1016/S0002-9270(02)06018-5; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Magner D, 2009, J VASC SURG, V49, P893, DOI 10.1016/j.jvs.2008.11.065; Mitra D, 2011, POSTGRAD MED, V123, P122, DOI 10.3810/pgm.2011.05.2290; Moayyedi P, 2007, AM J GASTROENTEROL, V102, P478, DOI 10.1111/j.1572-0241.2006.00973.x; [National Collaborating Centre for Nursing and Supportive Care National Collaborating Centre for Nursing and Supportive Care ( UK) National Institute for Health and Care Excellence], 2008, IRR BOWL SYNDR AD DI; Nellesen D, J MANAG CARE PHARM, V19, P755; Nyrop KA, 2007, ALIMENT PHARM THERAP, V26, P237, DOI 10.1111/j.1365-2036.2007.03370.x; Pisu M, 2012, EPILEPSIA, V53, P2186, DOI 10.1111/j.1528-1167.2012.03640.x; Reames BN, 2014, J CLIN ONCOL, V32, P3667, DOI 10.1200/JCO.2014.57.1588; Rubin G, 2006, FAM PRACT, V23, P687, DOI 10.1093/fampra/cml050; Sariego J, 2008, AM J SURG, V196, P572, DOI 10.1016/j.amjsurg.2008.06.017; Tillisch Kirsten, 2005, Curr Gastroenterol Rep, V7, P249, DOI 10.1007/s11894-005-0016-y; U. S. Department of Health and Human Services, 2014, DAT BANK NPDB STAT; Viskin S, 1996, NEW ENGL J MED, V334, P194; Wetmore JB, 2014, CLIN J AM SOC NEPHRO, V9, P756, DOI 10.2215/CJN.06980713	40	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154258	10.1371/journal.pone.0154258	http://dx.doi.org/10.1371/journal.pone.0154258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116612	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600053
J	Keller, CJ; Chen, C; Lado, FA; Khodakhah, K				Keller, Corey J.; Chen, Christopher; Lado, Fred A.; Khodakhah, Kamran			The Limited Utility of Multiunit Data in Differentiating Neuronal Population Activity	PLOS ONE			English	Article							LOCAL-FIELD POTENTIALS; GAMMA OSCILLATIONS; SPIKING ACTIVITY; MOVEMENT DIRECTION; VISUAL-CORTEX; FREQUENCY; TETRAPLEGIA; HIPPOCAMPUS; PRIMATE; DEVICES	To date, single neuron recordings remain the gold standard for monitoring the activity of neuronal populations. Since obtaining single neuron recordings is not always possible, high frequency or 'multiunit activity' (MUA) is often used as a surrogate. Although MUA recordings allow one to monitor the activity of a large number of neurons, they do not allow identification of specific neuronal subtypes, the knowledge of which is often critical for understanding electrophysiological processes. Here, we explored whether prior knowledge of the single unit waveform of specific neuron types is sufficient to permit the use of MUA to monitor and distinguish differential activity of individual neuron types. We used an experimental and modeling approach to determine if components of the MUA can monitor medium spiny neurons (MSNs) and fast-spiking interneurons (FSIs) in the mouse dorsal striatum. We demonstrate that when well-isolated spikes are recorded, the MUA at frequencies greater than 100Hz is correlated with single unit spiking, highly dependent on the waveform of each neuron type, and accurately reflects the timing and spectral signature of each neuron. However, in the absence of well-isolated spikes (the norm in most MUA recordings), the MUA did not typically contain sufficient information to permit accurate prediction of the respective population activity of MSNs and FSIs. Thus, even under ideal conditions for the MUA to reliably predict the moment-to-moment activity of specific local neuronal ensembles, knowledge of the spike waveform of the underlying neuronal populations is necessary, but not sufficient.	[Keller, Corey J.; Chen, Christopher; Lado, Fred A.; Khodakhah, Kamran] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Keller, Corey J.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Keller, Corey J.] Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA; [Lado, Fred A.] Montefiore Med Ctr, Dept Neurol, 111 E 210th St, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Stanford University; Stanford University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Keller, CJ (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA.; Keller, CJ (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Keller, CJ (corresponding author), Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA.	coreyjkeller@gmail.com	Keller, Corey/GON-5459-2022	Keller, Corey/0000-0003-0529-3490; Lado, Fred/0000-0003-3648-4812	 [NS079750];  [F31NS080357];  [T32-GM007288]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079750, F31NS080357] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grant numbers NS079750, F31NS080357, T32-GM007288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; BUCHWALD JS, 1970, J NEUROPHYSIOL, V33, P148, DOI 10.1152/jn.1970.33.1.148; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cristianini N, 2000, INTRO SUPPORT VECTOR; David S.V., 2010, COMPUT INTEL NEUROSC, DOI DOI 10.1155/2010/393019; du Hoffmann J, 2011, J NEUROPHYSIOL, V106, P1054, DOI 10.1152/jn.00349.2011; GRAVELAND GA, 1985, BRAIN RES, V327, P307, DOI 10.1016/0006-8993(85)91524-0; Hangya B, 2010, J PHYSIOL-LONDON, V588, P4165, DOI 10.1113/jphysiol.2010.194274; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Jia XX, 2013, NEURON, V77, P762, DOI 10.1016/j.neuron.2012.12.036; Jia XX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001045; Kecman V., 2001, LEARNING SOFT COMPUT; LEGATT AD, 1980, J NEUROSCI METH, V2, P203, DOI 10.1016/0165-0270(80)90061-8; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Maynard EM, 1999, J NEUROSCI, V19, P8083; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Scheffer-Teixeira R, 2013, J NEUROSCI, V33, P1535, DOI 10.1523/JNEUROSCI.4217-12.2013; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Whittingstall K, 2009, NEURON, V64, P281, DOI 10.1016/j.neuron.2009.08.016; Wiltschko AB, 2008, J NEUROSCI METH, V173, P34, DOI 10.1016/j.jneumeth.2008.05.016; Zanos TP, 2011, J NEUROPHYSIOL, V105, P474, DOI 10.1152/jn.00642.2010	30	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153154	10.1371/journal.pone.0153154	http://dx.doi.org/10.1371/journal.pone.0153154			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111446	Green Submitted, Green Published, gold			2022-12-26	WOS:000374970600012
J	Li, W; Li, YC; Huang, QY; Ye, SQ; Rong, TH				Li, Wei; Li, Yongchun; Huang, Qingyuan; Ye, Shengquan; Rong, Tiehua			Short and Long-Term Outcomes of Epidural or Intravenous Analgesia after Esophagectomy: A Propensity-Matched Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONTROLLED-TRIAL; LYMPH-NODES; FOLLOW-UP; CANCER; COMPLICATIONS; CARCINOMA; SURVIVAL; SURGERY; RECURRENCE	Background and Objectives As a well-established technique for postoperative pain relief, the benefits of epidural analgesia (EDA) have been under debate recently. This study aimed to determine whether EDA could improve perioperative outcomes and survival in patients undergoing esophagectomy. Methods From January 2010 to December 2012, 587 consecutive cases undergoing McKeown-type esohpageactomy were retrospectively identified from a prospectively maintained database. Results After propensity-matching, incorporating baseline characteristics, 178 cases were included in each group, and patients characteristics distributions were well-balanced between two groups. Compared with intravenous analgesia, the use of EDA significantly decreased the incidence of pneumonia from 32% to 19.7%(P = 0.008), and anastomotic leakage from 23.0% to 14.0% (P = 0.029). The change in CRP level of EDA group was significantly decreased (preoperative, 6.2 vs. 6.2; POD 1, 108.1 vs. 121.3; POD 3, 131.5 vs. 137.8; POD 7, 69.3 vs. 82.1 mg/L; P = 0.044). EDA patients had a significantly longer duration of indwelling urinary catheter (P< 0.001), and lower levels in both systolic (P = 0.001) and diastolic blood pressure (P< 0.001). There weren't significant differences in overall survival (log-rank P = 0.47) and recurrence (Gray-test P = 0.46) between two groups. Conclusions These findings revealed that EDA could attenuate inflammatory response and reduce the incidence of pneumonia and anastomotic leakage after esophagectomy, at the price of delayed urinary catheter removal and lower blood pressure. EDA remains an important component of multimodal perioperative management after esophagectomy.	[Li, Wei; Li, Yongchun; Ye, Shengquan; Rong, Tiehua] Sun Yat Sen Univ, Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Li, Wei; Li, Yongchun; Ye, Shengquan; Rong, Tiehua] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Li, Wei; Li, Yongchun; Ye, Shengquan; Rong, Tiehua] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Huang, Qingyuan] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai 200030, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Shanghai Jiao Tong University	Li, W (corresponding author), Sun Yat Sen Univ, Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.; Li, W (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Li, W (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	liw@sysucc.org.cn	Huang, Qingyuan/AAC-7164-2019		Guangdong Science and Technology Program [2013B021800172]	Guangdong Science and Technology Program	This work was funded by Guangdong Science and Technology Program (grant number 2013B021800172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2010, BRIT J ANAESTH, V104, P292, DOI 10.1093/bja/aeq006; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Fares KM, 2014, PAIN PHYSICIAN, V17, P305; FOK M, 1994, WORLD J SURG, V18, P355, DOI 10.1007/BF00316814; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Huang QY, 2015, J SURG ONCOL, V111, P365, DOI 10.1002/jso.23837; Huang QY, 2014, CANCER SCI, V105, P1638, DOI 10.1111/cas.12552; Hubner M, 2015, ANN SURG, V261, P648, DOI 10.1097/SLA.0000000000000838; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Kamiyoshihara Mitsuhiro, 2010, Asian Cardiovasc Thorac Ann, V18, P464, DOI 10.1177/0218492310381817; Kusano C, 1997, BRIT J SURG, V84, P252, DOI 10.1046/j.1365-2168.1997.02542.x; Law S, 2004, ANN SURG, V240, P791, DOI 10.1097/01.sla.0000143123.24556.1c; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc5704; Lotan Y, 2005, J CLIN ONCOL, V23, P6533, DOI 10.1200/JCO.2005.05.516; Luketich JD, 2012, ANN SURG, V256, P95, DOI 10.1097/SLA.0b013e3182590603; Michelet P, 2007, ACTA ANAESTH SCAND, V51, P587, DOI 10.1111/j.1399-6576.2007.01290.x; Michelet P, 2005, CHEST, V128, P3461, DOI 10.1378/chest.128.5.3461; Rawal N, 2012, REGION ANESTH PAIN M, V37, P310, DOI 10.1097/AAP.0b013e31825735c6; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Rodriguez MAP, 2008, MINERVA ANESTESIOL, V74, P619; Rudin A, 2005, J CARDIOTHOR VASC AN, V19, P350, DOI 10.1053/j.jvca.2005.03.013; Saeki H, 2009, SURG TODAY, V39, P476, DOI 10.1007/s00595-008-3924-2; URSCHEL JD, 1995, AM J SURG, V169, P634, DOI 10.1016/S0002-9610(99)80238-4; Wang H, 2015, J THORAC CARDIOV SUR, V149, P1006, DOI 10.1016/j.jtcvs.2014.12.063; Wuethrich PY, 2010, ANESTHESIOLOGY, V113, P570, DOI 10.1097/ALN.0b013e3181e4f6ec; Yang H, 2016, DIS ESOPHAGUS, V29, P152, DOI 10.1111/dote.12318	29	25	27	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154380	10.1371/journal.pone.0154380	http://dx.doi.org/10.1371/journal.pone.0154380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110939	gold, Green Published, Green Submitted			2022-12-26	WOS:000374970600062
J	Berman, Y; Ben-Jacob, E; Shapira, Y				Berman, Yonatan; Ben-Jacob, Eshel; Shapira, Yoash			The Dynamics of Wealth Inequality and the Effect of Income Distribution	PLOS ONE			English	Article							KINETIC EXCHANGE MODELS	The rapid increase of wealth inequality in the past few decades is one of the most disturbing social and economic issues of our time. Studying its origin and underlying mechanisms is essential for policy aiming to control and even reverse this trend. In that context, controlling the distribution of income, using income tax or other macroeconomic policy instruments, is generally perceived as effective for regulating the wealth distribution. We provide a theoretical tool, based on the realistic modeling of wealth inequality dynamics, to describe the effects of personal savings and income distribution on wealth inequality. Our theoretical approach incorporates coupled equations, solved using iterated maps to model the dynamics of wealth and income inequality. Notably, using the appropriate historical parameter values we were able to capture the historical dynamics of wealth inequality in the United States during the course of the 20th century. It is found that the effect of personal savings on wealth inequality is substantial, and its major decrease in the past 30 years can be associated with the current wealth inequality surge. In addition, the effect of increasing income tax, though naturally contributing to lowering income inequality, might contribute to a mild increase in wealth inequality and vice versa. Plausible changes in income tax are found to have an insignificant effect on wealth inequality, in practice. In addition, controlling the income inequality, by progressive taxation, for example, is found to have a very small effect on wealth inequality in the short run. The results imply, therefore, that controlling income inequality is an impractical tool for regulating wealth inequality.	[Berman, Yonatan; Ben-Jacob, Eshel; Shapira, Yoash] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University	Berman, Y; Shapira, Y (corresponding author), Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	yonatanb@post.tau.ac.il; yoashshapia@gmail.com		Berman, Yonatan/0000-0001-6969-271X				Alvarez-Cuadrado F., 2012, 7083 IZA; [Anonymous], 2015, OECD STATEXTRACTS DA; [Anonymous], 1998, GROWTH INEQUALITY GL; Atkinson A.B., 2015, INEQUALITY WHAT CAN, P25; Atkinson AB, 2011, J ECON LIT, V49, P3, DOI 10.1257/jel.49.1.3; Bagatella-Flores N, 2015, PHYSICA A, V417, P168, DOI 10.1016/j.physa.2014.07.081; Benhabib J, 2011, ECONOMETRICA, V79, P123, DOI 10.3982/ECTA8416; Benhabib Jess., 2007, DISTRIBUTION WEALTH; Berman Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130181; BOSWORTH B, 1991, BROOKINGS PAP ECO AC, P183; Boyce JK, 2000, DISASTERS, V24, P254, DOI 10.1111/1467-7717.00146; Budria S, 2002, Q REV FEDERAL RESERV, V26, P2; Cagetti M, 2008, MACROECON DYN, V12, P285, DOI 10.1017/S1365100507070150; CARROLL CD, 1994, CARN ROCH CONF SERIE, V40, P133, DOI 10.1016/0167-2231(94)90006-X; Chatterjee A, 2007, EUR PHYS J B, V60, P135, DOI 10.1140/epjb/e2007-00343-8; Davies JB, 2011, ECON J, V121, P223, DOI 10.1111/j.1468-0297.2010.02391.x; De Nardi M, 2004, REV ECON STUD, V71, P743, DOI 10.1111/j.1467-937X.2004.00302.x; Elgar FJ, 2011, EUR J PUBLIC HEALTH, V21, P241, DOI 10.1093/eurpub/ckq068; FISCHER S, 1993, J MONETARY ECON, V32, P485, DOI 10.1016/0304-3932(93)90027-D; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Heckman JJ, 1998, REV ECON DYNAM, V1, P1, DOI 10.1006/redy.1997.0008; Hurst Charles E, 2007, SOCIAL INEQUALITY FO; Ispolatov S, 1998, EUR PHYS J B, V2, P267, DOI 10.1007/s100510050249; Jones CI, 2014, W20742 NBER; Karen D, 2004, J POLIT ECON, V112, P397, DOI [10.1086/381475, DOI 10.1086/381475]; Keister LA, 2000, ANNU REV SOCIOL, V26, P63, DOI 10.1146/annurev.soc.26.1.63; Keister Lisa, 2000, WEALTH AM TRENDS WEA; Kopczuk W, 2015, J ECON PERSPECT, V29, P47, DOI 10.1257/jep.29.1.47; Kuhn M, 2014, 2013 UPDATE US EARNI; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lerman D. L., 1988, POLICY STUDIES REV, V7, P765, DOI DOI 10.1111/J.1541-1338.1988.TB00895.X; Levine R, 1998, AM ECON REV, V88, P537; LEVINE R, 1991, J FINANC, V46, P1445, DOI 10.2307/2328866; Maki DM, 2001, 200121 FEDS; NELSON RR, 1966, AM ECON REV, V56, P69; Ng YK., 2014, 201410 NAN TU EGC; Ohtake F, 2013, GINI PROJ REP; Patriarca M, 2013, AM J PHYS, V81, P618, DOI 10.1119/1.4807852; Peters O, 2015, SOLVING LINEAR UNPUB; Piketty T, 2003, Q J ECON, V118, P1, DOI 10.1162/00335530360535135; Piketty T., 2014, CAPITAL 21 CENTURY; Piketty T, 2007, J ECON PERSPECT, V21, P3, DOI 10.1257/jep.21.1.3; Piketty T, 2014, Q J ECON, V129, P1255, DOI 10.1093/qje/qju018; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Plog S, 2010, P NATL ACAD SCI USA, V107, P19619, DOI 10.1073/pnas.1014985107; Reich RB, 2012, OUTRAGE WHAT HAS GON; Reynolds A., 2006, INCOME WEALTH; Saez E., 2014, W20625 NAT BUR EC RE; Sen A., 1973, EC INEQUALITY; SOLOW RM, 1956, Q J ECON, V70, P65, DOI 10.2307/1884513; Stiglitz JE, 2015, NATL TAX J, V68, P425, DOI 10.17310/ntj.2015.2.09; Stiglitz Joseph E., 2012, PRICE INEQUALITY TOD; Tavoni A, 2011, P NATL ACAD SCI USA, V108, P11825, DOI 10.1073/pnas.1102493108; Thornton DL, 2009, FEDERAL RESERVE BANK, V46; US Congressional Budget Office, 2014, DISTR HOUS INC FED T; Wolff, 2010, 589 LEC EC I; Wolff EN, 2014, OXFORD REV ECON POL, V30, P21, DOI 10.1093/oxrep/gru001; Wolff EN, 1996, REV INCOME WEALTH, P433; World Bank, 2015, WORLD BANK GINI IND; Zentner E, 2014, MORGAN STANLEY REPOR	60	24	25	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154196	10.1371/journal.pone.0154196	http://dx.doi.org/10.1371/journal.pone.0154196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27105224	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100053
J	Chen, YG; Chen, MQ; Guo, YY; Li, SC; Wu, JX; Xu, BH				Chen, Yuan-Gui; Chen, Ming-Qiu; Guo, Yu-Yan; Li, Si-Cong; Wu, Jun-Xin; Xu, Ben-Hua			Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy	PLOS ONE			English	Article							WEIGHTED MAGNETIC-RESONANCE; CHEMORADIATION THERAPY; RADIATION-THERAPY; RADIOCHEMOTHERAPY; CHEMOTHERAPY; MRI	Objective To evaluate the predictive value of the apparent diffusion coefficient (ADC) for pathologic complete response (pCR) to neoadjuvant chemoradiotherapy (NCRT) in locally advanced rectal cancer. Methods A total of 265 patients with rectal adenocarcinoma, whole Diffusion-Weighted MRI (DWI-MRI) images, clinically stage II to III (cT3-4 and/or cN+) and treated with NCRT followed by TME were screened. Fifty patients with pCR and another 50 patients without pCR with similar clinical charcacters and treatment regimens were selected for statistical analysis. All the patients' pre-CRT and post-CRT average ADC values were calculated from the coefficient maps created by DWI-MRI and recorded independently. The difference in the ADC values between the pCR and non-pCR was analyzed by the Mann-Whitney U test. The cut-off ADC value of the receiver operating characteristic (ROC) curve with pCR was then established. Results The mean pre- and post-ADC values in all patients, and in pCR patients and non-pCR patients were 0.879 +/- 0.06 and 1.383 +/- 0.11, 0.859 +/- 0.04 and 1.440 +/- 0.10, 0.899 +/- 0.07 and 1.325 +/- 0.09 (x10(-3)mm(2)/s), respectively. The difference between the pre-and post-ADC values in all patients, pCR patients, and non-pCR patients were considered to be statistically significant. The pre-ADC value was significantly lower in the pCR patients than in the non-pCR patients (p = 0.003), whereas the post-ADC values were significantly higher in the pCR patients than in the non-pCR patients. The percentage increase of the ADC value (Delta ADC%) in the pCR and non-pCR patients were 68% and 48% respectively (p<0.001). The ROC curves of the cut-off value of the pre-CRT patient ADC value was 0.866x10(-3)mm(2)/s. The AUC, sensitivity, specificity, PPV, NPV, and accuracy of diagnosing pCR were 0.670 (95% CI 0.563-0.777), 0.600, 0.640, 60%, 60%, and 60%, respectively. The cut-off value of Delta ADC% was 58%. The corresponding AUC, sensitivity, specificity, PPV, NPV, and accuracy of diagnosing pCR were 0.856 (95% CI 0.783-0.930), 0.800, 0.760, 76.9%, 79.2%, and 78%, respectively. Conclusions DWI-MRI technology can be efficient for predicting pCR for LARC after NCRT. Although the mean pre-CRT ADC value and the Delta ADC% are moderate predictors for pCR, the latter would be more accurate.	[Chen, Yuan-Gui; Chen, Ming-Qiu; Guo, Yu-Yan; Xu, Ben-Hua] Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China; [Li, Si-Cong] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA; [Wu, Jun-Xin] Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University; University of Nebraska System; University of Nebraska Medical Center	Xu, BH (corresponding author), Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China.; Wu, JX (corresponding author), Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China.	junxinwu@126.com; benhuaxu@163.com						[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Cho SH, 2015, ACTA RADIOL, V56, P1042, DOI 10.1177/0284185114550193; Curvo-Semedo L, 2011, RADIOLOGY, V260, P734, DOI 10.1148/radiol.11102467; Dzik-Jurasz A, 2002, LANCET, V360, P307, DOI 10.1016/S0140-6736(02)09520-X; Elmi A, 2013, CLIN RADIOL, V68, pE524, DOI 10.1016/j.crad.2013.05.094; Genovesi D, 2013, EJSO-EUR J SURG ONC, V39, P1071, DOI 10.1016/j.ejso.2013.07.090; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Glimelius B, 2013, ANN ONCOL, V24, P81, DOI 10.1093/annonc/mdt240; Greene FL, 2009, AJCC CANC STAGING MA; Hosonuma Tomonori, 2006, Magn Reson Med Sci, V5, P173, DOI 10.2463/mrms.5.173; Intven M, 2013, STRAHLENTHER ONKOL, V189, P117, DOI 10.1007/s00066-012-0270-5; Joye I, 2014, RADIOTHER ONCOL, V113, P158, DOI 10.1016/j.radonc.2014.11.026; Jung SH, 2012, J MAGN RESON IMAGING, V35, P110, DOI 10.1002/jmri.22749; Kim SH, 2011, EUR RADIOL, V21, P987, DOI 10.1007/s00330-010-1989-y; Lambrecht M, 2012, INT J RADIAT ONCOL, V82, P863, DOI 10.1016/j.ijrobp.2010.12.063; Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8; Meng XJ, 2014, BIOSCI TRENDS, V8, P11, DOI 10.5582/bst.8.11; O'Neill BDP, 2007, LANCET ONCOL, V8, P625, DOI 10.1016/S1470-2045(07)70202-4; Rao SX, 2008, EUR J RADIOL, V65, P299, DOI 10.1016/j.ejrad.2007.04.001; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Stipa F, 2006, ANN SURG ONCOL, V13, P1047, DOI 10.1245/ASO.2006.03.053; Sun YS, 2010, RADIOLOGY, V254, P170, DOI 10.1148/radiol.2541082230; Xie HT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000517; Xu BH, 2014, TUMORI, V100, P149, DOI 10.1700/1491.16399; Yu E, 2015, PRACT RADIAT ONCOL, V5, pE451, DOI 10.1016/j.prro.2015.04.005; Yuangui C, 2015, CHINESE J RAD ONCOLO, V24, P5	28	25	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153944	10.1371/journal.pone.0153944	http://dx.doi.org/10.1371/journal.pone.0153944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100991	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500105
J	Maxwell, DJ; Partridge, JC; Roberts, NW; Boonham, N; Foster, GD				Maxwell, Daniel J.; Partridge, Julian C.; Roberts, Nicholas W.; Boonham, Neil; Foster, Gary D.			The Effects of Plant Virus Infection on Polarization Reflection from Leaves	PLOS ONE			English	Article							MYZUS-PERSICAE SULZ; CUTICULAR WAX; PAPILIO BUTTERFLIES; VECTOR INTERACTIONS; FEEDING-BEHAVIOR; EPICUTICULAR WAX; POTATO PLANTS; ARABIDOPSIS; APHID; TRANSMISSION	Alteration of leaf surface phenotypes due to virus infection has the potential to affect the likelihood of colonisation by insect vectors, or to affect their feeding activities. The aim of this study was to investigate whether viruses that rely on insects for their transmission, and which can be sensitive to the polarization of light, affect the percentage polarization of light reflected from leaves. We also set out to discover whether a correlation exists between the expression of ECERIFERUM (CER) genes involved in cuticular wax synthesis and the polarization of the light reflected from the leaf surfaces. It was found that the aphid-vectored viruses Potato virus Y and Cucumber mosaic virus (CMV) caused significant reductions in the percentage polarization of light reflected from the abaxial surfaces of leaves of Nicotiana tabacum, whereas the non-insect-vectored viruses Tobacco mosaic virus and Pepino mosaic virus did not induce this effect. In Arabidopsis thaliana, there was little difference in the impacts of CMV and the non-insect-vectored Turnip vein clearing virus on polarization reflection, with both viruses increasing the percentage polarization of light reflected from the abaxial surfaces of leaves. There was a trend towards increased accumulation of CER6 transcripts in N. tabacum and A. thaliana when infected with aphid-vectored viruses. No significant effect of infection on trichome densities was found in A. thaliana, suggesting that alterations to the formation of cuticular waxes may be the more likely phenotypic change on the leaf surface contributing to the changes in polarization reflection. The possible impacts and adaptive significance of these effects with regard to viral transmission by insects are discussed.	[Maxwell, Daniel J.; Partridge, Julian C.; Roberts, Nicholas W.; Foster, Gary D.] Univ Bristol, Sch Biol Sci, 24 Tyndall Ave, Bristol BS8 1TQ, Avon, England; [Partridge, Julian C.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Partridge, Julian C.] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Boonham, Neil] Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England	University of Bristol; University of Western Australia; University of Western Australia; Food & Environment Research Agency	Foster, GD (corresponding author), Univ Bristol, Sch Biol Sci, 24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.	gary.foster@bristol.ac.uk	Partridge, Julian C/F-2097-2014; Foster, Gary D/A-7985-2011	Partridge, Julian C/0000-0003-3788-2900; Foster, Gary D/0000-0002-1979-1397; Roberts, Nicholas/0000-0002-4540-6683; Boonham, Neil/0000-0002-8886-5708	Natural Environment Research Council; Central Science Laboratories	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Central Science Laboratories	This work was supported by the Natural Environment Research Council and Central Science Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AE, 2007, ENTOMOL EXP APPL, V125, P135, DOI 10.1111/j.1570-7458.2007.00607.x; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BODNARYK RP, 1992, CAN J PLANT SCI, V72, P1295, DOI 10.4141/cjps92-163; Boquel S, 2011, EUR J PLANT PATHOL, V129, P507, DOI 10.1007/s10658-010-9732-8; Carmo-Sousa M, 2014, VIRUS RES, V186, P38, DOI 10.1016/j.virusres.2013.12.012; CASTLE SJ, 1993, ENTOMOL EXP APPL, V69, P51, DOI 10.1007/BF02380673; Dacke M, 2003, NATURE, V424, P33, DOI 10.1038/424033a; Donaldson JR, 2007, ENVIRON ENTOMOL, V36, P918, DOI 10.1603/0046-225X(2007)36[918:AEOSVO]2.0.CO;2; DUELLI P, 1975, J COMP PHYSIOL, V102, P43, DOI 10.1007/BF00657484; DUELLI P, 1973, J COMP PHYSIOL, V86, P37, DOI 10.1007/BF00694476; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; FERRAR P, 1969, B ENTOMOL RES, V58, P653, DOI 10.1017/S0007485300057370; Foster JJ, 2014, CURR BIOL, V24, P1415, DOI 10.1016/j.cub.2014.05.007; GRANT L, 1987, REMOTE SENS ENVIRON, V22, P309, DOI 10.1016/0034-4257(87)90064-2; GRANT L, 1987, ENVIRON EXP BOT, V27, P139, DOI 10.1016/0098-8472(87)90064-5; GRANT L, 1993, PHYSIOL PLANTARUM, V88, P1, DOI 10.1111/j.1399-3054.1993.tb01753.x; HE XD, 1991, ACM SIGGRAPH COMPUTE, V25, P175, DOI DOI 10.1145/127719; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Horvath G, 2002, J EXP BIOL, V205, P3281; Horvath G., 2004, POLARIZED LIGHT ANIM; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Irwin ME, 2007, APHIDS AS CROP PESTS, P153, DOI 10.1079/9780851998190.0153; Kelber A, 2001, J EXP BIOL, V204, P2469; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Kinoshita M, 2011, PHILOS T R SOC B, V366, P688, DOI 10.1098/rstb.2010.0200; Koch K, 2008, MICRON, V39, P759, DOI 10.1016/j.micron.2007.11.010; KRING JB, 1977, ANN ENTOMOL SOC AM, V70, P855, DOI 10.1093/aesa/70.6.855; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Lightle D, 2014, ENTOMOL EXP APPL; LIN JT, 1993, J INSECT PHYSIOL, V39, P555, DOI 10.1016/0022-1910(93)90037-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SY, 2012, PLANT PHYSIOL, V159, P930, DOI 10.1104/pp.112.198697; Lu SY, 2009, PLANT J, V59, P553, DOI 10.1111/j.1365-313X.2009.03892.x; Martiniere A, 2013, ELIFE, V2, DOI 10.7554/eLife.00183; Mauck KE, 2014, INTEGR COMP BIOL, V54, P193, DOI 10.1093/icb/icu012; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; Mauck KE, 2014, PLANT CELL ENVIRON, V37, P1427, DOI 10.1111/pce.12249; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; McMenemy LS, 2012, ENTOMOL EXP APPL, V144, P56, DOI 10.1111/j.1570-7458.2012.01248.x; Moury B, 2007, P NATL ACAD SCI USA, V104, P17891, DOI 10.1073/pnas.0702739104; Ng JCK, 2006, ANNU REV PHYTOPATHOL, V44, P183, DOI 10.1146/annurev.phyto.44.070505.143325; Nishino K, 2011, OPT EXPRESS, V19, P6020, DOI 10.1364/OE.19.006020; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Powell G, 1999, ENTOMOL EXP APPL, V91, P115, DOI 10.1023/A:1003639225674; Power AG, 1996, ECOLOGY, V77, P1004, DOI 10.2307/2265571; Radcliffe EB, 2002, AM J POTATO RES, V79, P353, DOI 10.1007/BF02870173; Roberts NW, 2011, PHILOS T R SOC B, V366, P627, DOI 10.1098/rstb.2010.0206; ROSSEL S, 1984, J COMP PHYSIOL, V154, P607, DOI 10.1007/BF01350213; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; VANDERBILT VC, 1985, IEEE T GEOSCI REMOTE, V23, P722, DOI 10.1109/TGRS.1985.289390; VANDERBILT VC, 1985, P IEEE, V73, P1012, DOI 10.1109/PROC.1985.13232; Watson MA, 1939, PROC R SOC SER B-BIO, V127, P543, DOI 10.1098/rspb.1939.0039; Whitney HM, 2012, PLOS ONE, V7, P66, DOI 10.1371/journal.pone.0029476; Wildermuth H, 1998, NATURWISSENSCHAFTEN, V85, P297, DOI 10.1007/s001140050504	57	10	11	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152836	10.1371/journal.pone.0152836	http://dx.doi.org/10.1371/journal.pone.0152836			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100188	Green Published, gold			2022-12-26	WOS:000374898500015
J	Plass-Johnson, JG; Taylor, MH; Husain, AAA; Teichberg, MC; Ferse, SCA				Plass-Johnson, Jeremiah G.; Taylor, Marc H.; Husain, Aidah A. A.; Teichberg, Mirta C.; Ferse, Sebastian C. A.			Non-Random Variability in Functional Composition of Coral Reef Fish Communities along an Environmental Gradient	PLOS ONE			English	Article							SPECIES COOCCURRENCE; DIVERSITY INDEXES; STABLE STATES; REDUNDANCY; VULNERABILITY; DEGRADATION; ASSEMBLAGES; COMPLEXITY; FRAMEWORK; ABUNDANCE	Changes in the coral reef complex can affect predator-prey relationships, resource availability and niche utilisation in the associated fish community, which may be reflected in decreased stability of the functional traits present in a community. This is because particular traits may be favoured by a changing environment, or by habitat degradation. Furthermore, other traits can be selected against because degradation can relax the association between fishes and benthic habitat. We characterised six important ecological traits for fish species occurring at seven sites across a disturbed coral reef archipelago in Indonesia, where reefs have been exposed to eutrophication and destructive fishing practices for decades. Functional diversity was assessed using two complementary indices (FRic and RaoQ) and correlated to important environmental factors (live coral cover and rugosity, representing local reef health, and distance from shore, representing a cross-shelf environmental gradient). Indices were examined for both a change in their mean, as well as temporal (short-term; hours) and spatial (cross-shelf) variability, to assess whether fish-habitat association became relaxed along with habitat degradation. Furthermore, variability in individual traits was examined to identify the traits that are most affected by habitat change. Increases in the general reef health indicators, live coral cover and rugosity (correlated with distance from the mainland), were associated with decreases in the variability of functional diversity and with community-level changes in the abundance of several traits (notably home range size, maximum length, microalgae, detritus and small invertebrate feeding and reproductive turnover). A decrease in coral cover increased variability of RaoQ while rugosity and distance both inversely affected variability of FRic; however, averages for these indices did not reveal patterns associated with the environment. These results suggest that increased degradation of coral reefs is associated with increased variability in fish community functional composition resulting from selective impacts on specific traits, thereby affecting the functional response of these communities to increasing perturbations.	[Plass-Johnson, Jeremiah G.; Teichberg, Mirta C.; Ferse, Sebastian C. A.] Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany; [Plass-Johnson, Jeremiah G.] Univ Bremen, Fac Biol & Chem FB2, D-28359 Bremen, Germany; [Plass-Johnson, Jeremiah G.] Univ Nice Sophia Antipolis, Fac Sci, ECOMERS, F-06189 Nice, France; [Taylor, Marc H.] Leibniz Ctr Trop Marine Ecol ZMT, Dept Theoret Ecol & Modelling, Bremen, Germany; [Taylor, Marc H.] Thunen Inst Sea Fisheries, Hamburg, Germany; [Husain, Aidah A. A.] Hasanuddin Univ, Ctr Marine Coastal & Small Isl Res, Makassar, Indonesia; [Ferse, Sebastian C. A.] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; UDICE-French Research Universities; Universite Cote d'Azur; Leibniz Zentrum fur Marine Tropenforschung (ZMT); Johann Heinrich von Thunen Institute; Universitas Hasanuddin; University of Hawaii System; University of Hawaii Manoa	Plass-Johnson, JG (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany.; Plass-Johnson, JG (corresponding author), Univ Bremen, Fac Biol & Chem FB2, D-28359 Bremen, Germany.; Plass-Johnson, JG (corresponding author), Univ Nice Sophia Antipolis, Fac Sci, ECOMERS, F-06189 Nice, France.	jplass@uni-bremen.de	Ferse, Sebastian/AAH-8048-2021; Plass-Johnson, Jeremiah G./H-7215-2019; Taylor, Marc/AAI-6598-2021	Ferse, Sebastian/0000-0003-0930-5356; Plass-Johnson, Jeremiah G./0000-0001-6131-4714; Taylor, Marc/0000-0001-9730-6994	Bundesministerium fur Bildung und Forschung [03F0643A, 01LN1303A]; Open Access Fund of the Leibniz Association	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Open Access Fund of the Leibniz Association	This work was supported by Grant number: 03F0643A Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/en/), recieved by MT; 01LN1303A Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/en/), received by SCAF. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez LJ, 2011, ECOSPHERE, V2, DOI [10.1890/ES11-00104.1, 10.1890/ES11-00185.1]; Ault TR, 1998, ECOL MONOGR, V68, P25, DOI 10.1890/0012-9615(1998)068[0025:SATPFO]2.0.CO;2; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Brandl SJ, 2013, CORAL REEFS, V32, P835, DOI 10.1007/s00338-013-1042-0; Burke L., 2011, REEFS RISK REVISITED; Bythell JC, 2000, MAR ECOL PROG SER, V204, P93, DOI 10.3354/meps204093; CHAPMAN MG, 1995, J EXP MAR BIOL ECOL, V189, P103, DOI 10.1016/0022-0981(95)00017-L; Cleary DFR, 2005, ESTUAR COAST SHELF S, V65, P557, DOI 10.1016/j.ecss.2005.06.025; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; D'agata S, 2014, CURR BIOL, V24, P555, DOI 10.1016/j.cub.2014.01.049; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Eggers SL, 2014, GLOBAL CHANGE BIOL, V20, P713, DOI 10.1111/gcb.12421; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferse SCA, 2008, P 11 INT COR REEF S, P1225; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Fung T, 2011, ECOLOGY, V92, P967, DOI 10.1890/10-0378.1; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; HATCHER BG, 1984, CORAL REEFS, V3, P199, DOI 10.1007/BF00288255; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; KNOWLTON N, 1992, AM ZOOL, V32, P674; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kulbicki M, 2005, CYBIUM, V29, P235; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lindahl U, 2001, MAR POLLUT BULL, V42, P127, DOI 10.1016/S0025-326X(00)00167-3; Lindfield SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092628; Mason NWH, 2008, J ANIM ECOL, V77, P661, DOI 10.1111/j.1365-2656.2008.01379.x; Mason NWH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075219; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; McClanahan TR, 2007, MAR ECOL PROG SER, V340, P221, DOI 10.3354/meps340221; Micheli F, 2014, BIOL CONSERV, V171, P186, DOI 10.1016/j.biocon.2013.12.029; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2007, ESTUAR COAST SHELF S, V71, P443, DOI 10.1016/j.ecss.2006.08.022; Mouillot D, 2014, P NATL ACAD SCI USA, V111, P13757, DOI 10.1073/pnas.1317625111; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Nystrom M, 2006, AMBIO, V35, P30, DOI 10.1639/0044-7447(2006)035[0030:RARDOF]2.0.CO;2; O'Gorman EJ, 2011, P ROY SOC B-BIOL SCI, V278, P1886, DOI 10.1098/rspb.2010.2036; Ohman MC, 1997, ENVIRON BIOL FISH, V49, P45, DOI 10.1023/A:1007309230416; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Plass-Johnson JG, 2015, LIMNOL OCEANOGR, V60, P1382, DOI 10.1002/lno.10105; Plass-Johnson JP, CORAL REEFS, DOI 10.007/s00338-015-1369-9; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Renema W, 2001, PALAEOGEOGR PALAEOCL, V175, P125, DOI 10.1016/S0031-0182(01)00389-3; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; Sale P. F., 2002, CORAL REEF FISHES DY; Sale PF., 1997, AM SCI, V111, P337; Sawall Y, 2011, CORAL REEFS, V30, P841, DOI 10.1007/s00338-011-0764-0; SHEPHERD ARD, 1992, ENVIRON BIOL FISH, V33, P367, DOI 10.1007/BF00010949; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Thomas SM, 2015, J ANIM ECOL, V84, P861, DOI 10.1111/1365-2656.12326; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040679; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wood S., 2012, PACKAGE MGCV R PACKA; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	74	28	29	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154014	10.1371/journal.pone.0154014	http://dx.doi.org/10.1371/journal.pone.0154014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100189	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500123
J	Zhu, L; Cheng, X; Shi, J; Lin, J; Chen, G; Jin, H; Liu, AB; Pyo, H; Ye, J; Zhu, Y; Wang, H; Chen, H; Fang, J; Cai, L; Wang, TC; Yang, CS; Tu, SP				Zhu, L.; Cheng, X.; Shi, J.; Lin, J.; Chen, G.; Jin, H.; Liu, A. B.; Pyo, H.; Ye, J.; Zhu, Y.; Wang, H.; Chen, H.; Fang, J.; Cai, L.; Wang, T. C.; Yang, C. S.; Tu, S. P.			Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; TUMOR-GROWTH; EXPRESSION; MICROENVIRONMENT; FIBROBLASTS; INITIATION; NICHE; STAT3; MICE; IL-6	Bone marrow-derived cells have important roles in cancer development and progression. Our previous studies demonstrated that murine bone marrow-derived myofibroblasts (BMFs) enhanced tumor growth. In this study, we investigated the mechanisms of BMF actions. We found that co-injection of BMFs with gastric cancer cells markedly promoted tumorigenesis. Co-cultured BMFs or BMF-conditioned medium (BMF-CM) induced the formation of spheres, which expressed stem cell signatures and exhibited features of self-renewal, epithelial-to-mesenchymal transition and tumor initiation. Furthermore, CD44(+) fractions in spheres were able to initiate tumorigenesis and re-establish tumors in serially passaged xenografts. In co-culture systems, BMFs secreted high levels of murine interleukin-6 (IL-6) and hepatocyte growth factor (HGF), whereas cancer cells produced high level of transformation growth factor-beta 1 (TGF-beta 1). BMF-CM and IL-6 activated BMFs to produce mHGF, which activated signal transducer and activator of transcription 3 (STAT3) and upregulated TGF-beta 1 in human cancer cells. In return, cancer cell-CM stimulated BMFs to produce IL-6, which was inhibited by anti-TGF-beta 1 neutralizing antibody. Blockade of HGF/Met, Janus kinase 2 (JAK2)/STAT3 and TGF-beta 1 signaling by specific inhibitors inhibited BMF-induced sphere formation. STAT3 knockdown in cancer cells also inhibited BMF-induced sphere formation and tumorigenesis. Moreover, TGF-beta 1 overexpression in cancer cells was co-related with IL-6 and HGF overexpression in stromal cells in human gastric cancer tissues. Our results show that BMF-derived IL-6/HGF and cancer cell-derived TGF-beta 1 mediate the interactions between BMFs and gastric cancer cells, which regulate cancer stemness and promote tumorigenesis. Targeting inhibition of the interactions between BMFs and cancer cells may be a new strategy for cancer therapy.	[Zhu, L.; Cheng, X.; Lin, J.; Chen, G.; Tu, S. P.] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Oncol, Shanghai, Peoples R China; [Zhu, L.; Shi, J.; Chen, G.; Jin, H.; Liu, A. B.; Pyo, H.; Wang, H.; Yang, C. S.; Tu, S. P.] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA; [Ye, J.] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Emergency Med, Shanghai, Peoples R China; [Zhu, Y.] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pathol, Shanghai, Peoples R China; [Chen, H.; Fang, J.] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Cai, L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Wang, T. C.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA	Shanghai Jiao Tong University; Rutgers State University New Brunswick; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Columbia University	Tu, SP (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Oncol, Shanghai, Peoples R China.; Yang, CS; Tu, SP (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA.	csyang@pharmacy.rutgers.edu; tushuiping@yahoo.com	LIN, JIACHENG/ABG-9209-2021	Cai, Li/0000-0003-3344-337X; LIN, JIACHENG/0000-0002-6132-9163; Wang, Timothy/0000-0001-5730-3019	NIH [R21CA149865, RO1 CA133021]; NSFC [81172159, 81272403, 81472727, 91029718, 91429307]; Shanghai Education Committee Key Discipline and Specialty Foundation [J50208]; Science and Technology Commission of Shanghai Municipality [15JC1403100]; NATIONAL CANCER INSTITUTE [R21CA149865, R01CA133021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Education Committee Key Discipline and Specialty Foundation; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project was supported by NIH R21CA149865, NSFC 81172159, NSFC 81272403, NSFC 81472727, NSFC 91029718, NSFC 91429307 and NIH RO1 CA133021; Shanghai Education Committee Key Discipline and Specialty Foundation (J50208), Science and Technology Commission of Shanghai Municipality (15JC1403100). National Laboratory of Oncogene and Cancer-related Genes foundation (90-15-05).	Beppu H, 2008, ONCOGENE, V27, P1063, DOI 10.1038/sj.onc.1210720; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Birkenkamp-Demtroder K, 2011, BRIT J CANCER, V105, P552, DOI 10.1038/bjc.2011.268; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Castano Z, 2012, SEMIN CANCER BIOL, V22, P462, DOI 10.1016/j.semcancer.2012.04.006; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Giraud AS, 2012, EXPERT OPIN THER TAR, V16, P889, DOI 10.1517/14728222.2012.709238; Gomes I, 2005, J ALLERGY CLIN IMMUN, V116, P796, DOI 10.1016/j.jaci.2005.06.031; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; HAMMACHER A, 1994, PROTEIN SCI, V3, P2280, DOI 10.1002/pro.5560031213; Hawinkels LJ, 2012, ONCOGENE, V33, P97, DOI [DOI 10.1038/ONC.2012.536, DOI 10.1038/onc.2012.536]; Hayward SW, 2001, CANCER RES, V61, P8135; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Lecomte J, 2012, NEOPLASIA, V14, P943, DOI 10.1593/neo.121092; Lee BS, 2009, CELL SIGNAL, V21, P419, DOI 10.1016/j.cellsig.2008.11.010; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu XD, 2008, EXPERT OPIN INV DRUG, V17, P997, DOI [10.1517/13543784.17.7.997, 10.1517/13543784.17.7.997 ]; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Powell DW, 2005, AM J PHYSIOL-GASTR L, V289, pG2, DOI 10.1152/ajpgi.00075.2005; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tsai KS, 2011, GASTROENTEROLOGY, V141, P1046, DOI 10.1053/j.gastro.2011.05.045; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Tu SP, 2003, CANCER RES, V63, P7724; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	33	23	24	5	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 13	2016	35	41					5388	5399		10.1038/onc.2016.76	http://dx.doi.org/10.1038/onc.2016.76			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA5QU	27109105	Green Accepted			2022-12-26	WOS:000386677800005
J	Aragones, G; Auguet, T; Berlanga, A; Guiu-Jurado, E; Martinez, S; Armengol, S; Sabench, F; Ras, R; Hernandez, M; Aguilar, C; Colom, J; Sirvent, JJ; Del Castillo, D; Richart, C				Aragones, Gemma; Auguet, Teresa; Berlanga, Alba; Guiu-Jurado, Esther; Martinez, Salome; Armengol, Sandra; Sabench, Fatima; Ras, Rosa; Hernandez, Merce; Aguilar, Carmen; Colom, Josep; Josep Sirvent, Joan; Del Castillo, Daniel; Richart, Cristobal			Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							SCORING SYSTEM; STEATOHEPATITIS; METABOLISM; FIBROSIS; FAILURE	Background Non-alcoholic fatty liver disease (NAFLD) causes a wide spectrum of liver damage, ranging from simple steatosis to cirrhosis. However, simple steatosis (SS) and steatohepatitis (NASH) cannot yet be distinguished by clinical or laboratory features. The aim of this study was to assess the relationship between alpha-ketoglutarate and the degrees of NAFLD in morbidly obese patients. Materials and Methods We used a gas chromatography-quadruple time-of-flight-mass spectrometry analysis to quantify alpha-ketoglutarate in serum from normal-weight subjects (n = 30) and morbidly obese women (n = 97) with or without NAFLD. Results We found that serum levels of alpha-ketoglutarate were significantly higher in morbidly obese women than in normal-weight women. We showed that circulating levels of alpha-ketoglutarate were lower in lean controls and morbidly obese patients without NAFLD. We also found that alpha-ketoglutarate serum levels were higher in both SS and NASH than in normal liver of morbidly obese patients. However, there was no difference between SS and NASH. Moreover, we observed that circulating levels of alpha-ketoglutarate were associated with glucose metabolism parameters, lipid profile, hepatic enzymes and steatosis degree. In addition, diagnostic performance of alpha-ketoglutarate has been analyzed in NAFLD patients. The AUROC curves from patients with liver steatosis exhibited an acceptable clinical utility. Finally, we showed that the combination of biomarkers (AST, ALT and alpha-ketoglutarate) had the highest accuracy in diagnosing liver steatosis. Conclusion These findings suggest that alpha-ketoglutarate can determine the presence of non-alcoholic fatty liver in morbidly obese patients but it is not valid a biomarker for NASH.	[Aragones, Gemma; Auguet, Teresa; Berlanga, Alba; Guiu-Jurado, Esther; Armengol, Sandra; Aguilar, Carmen; Richart, Cristobal] Univ Rovira & Virgili, IISPV, Dept Med & Cirurgia, Grp Recerca GEMMAIR AGAUR Med Aplicada, E-43007 Tarragona, Spain; [Auguet, Teresa; Richart, Cristobal] Hosp Univ Joan XXIII Tarragona, Med Interna Serv, Mallafre Guasch 4, Tarragona 43007, Spain; [Martinez, Salome; Josep Sirvent, Joan] Hosp Univ Joan XXIII Tarragona, Serv Anat Patol, Mallafre Guasch 4, Tarragona 43007, Spain; [Sabench, Fatima; Hernandez, Merce; Del Castillo, Daniel] Univ Rovira & Virgili, Hosp St Joan de Reus, Dept Med & Cirurgia, Serv Cirurgia,IISPV, Avinguda Doctor Josep Laporte 2, Reus 43204, Spain; [Ras, Rosa] Ctr Omic Sci, Grp Res Omic Methodol, Reus, Spain; [Colom, Josep] Univ Rovira & Virgili, Hosp St Joan de Reus, Dept Med & Cirurgia, Serv Med Interna,IISPV, Avinguda Doctor Josep Laporte 2, Reus 43204, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Richart, C (corresponding author), Univ Rovira & Virgili, IISPV, Dept Med & Cirurgia, Grp Recerca GEMMAIR AGAUR Med Aplicada, E-43007 Tarragona, Spain.; Richart, C (corresponding author), Hosp Univ Joan XXIII Tarragona, Med Interna Serv, Mallafre Guasch 4, Tarragona 43007, Spain.	crichart.hj23.ics@gencat.cat	Auguet, Teresa/AAC-5838-2020; RICHART, CRISTOBAL C/S-9158-2017; Aragones, Gemma/A-9693-2013; Guiu-Jurado, Esther/D-4706-2018; Carmen, Aguilar Crespillo/AAC-6209-2020; Salome, Martinez/AAD-1860-2020	Auguet, Teresa/0000-0003-0396-6428; RICHART, CRISTOBAL C/0000-0003-0852-6739; Aragones, Gemma/0000-0002-1924-9231; Guiu-Jurado, Esther/0000-0003-0371-7210; Carmen, Aguilar Crespillo/0000-0002-4440-562X; Salome, Martinez/0000-0001-6185-2889; Guiu-Jurado, Esther/0000-0001-9204-5780; SIRVENT, JUAN JOSE/0000-0002-7486-8916; Del Castillo Dejardin, Daniel/0000-0001-7024-7824; Berlanga, Alba/0000-0002-8650-241X; Del Castillo, Daniel/0000-0003-0456-3102; Sabench, Fatima/0000-0002-9262-8756	Fondo de Investigacion Sanitaria (FEDER) [PI13/00468]; Agencia de Gestio d'Ajuts Universitaris de Recerca [AGAUR 2009 SGR 959]; Grup de Recerca en Medicina Aplicada URV [2010 PFR-URV-B2-14]; Fundacion Biociencia	Fondo de Investigacion Sanitaria (FEDER); Agencia de Gestio d'Ajuts Universitaris de Recerca; Grup de Recerca en Medicina Aplicada URV; Fundacion Biociencia	This study was supported by the Fondo de Investigacion Sanitaria (FEDER, Grant Number PI13/00468 to Teresa Auguet), the Agencia de Gestio d'Ajuts Universitaris de Recerca (AGAUR 2009 SGR 959 to Cristobal Richart), the Grup de Recerca en Medicina Aplicada URV (2010 PFR-URV-B2-14 to Cristobal Richart) and the Fundacion Biociencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2007, NUTR REV, V65, pS57, DOI [10.1111/j.1753-4887.2007.tb00329.x, 10.1301/nr.2007.jun.S57-S63]; Armstrong April W, 2014, F1000Res, V3, P248, DOI 10.12688/f1000research.4709.1; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Brunt EM, 2012, DIGEST DIS, V30, P61, DOI 10.1159/000341127; Campbell C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084260; Campos GM, 2008, HEPATOLOGY, V47, P1916, DOI 10.1002/hep.22241; Chen PA, 2014, BBA-MOL BASIS DIS, V1842, P2120, DOI 10.1016/j.bbadis.2014.07.018; Chen TL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004945; Clarke JD, 2014, DIGEST DIS SCI, V59, P365, DOI 10.1007/s10620-013-2873-9; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Felice MS, 2000, LEUKEMIA LYMPHOMA, V38, P633, DOI 10.3109/10428190009059284; Ho JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148361; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Lake AD, 2011, DRUG METAB DISPOS, V39, P1954, DOI 10.1124/dmd.111.040592; Lean MEJ, 2000, P NUTR SOC, V59, P331, DOI 10.1017/S0029665100000379; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Paredes RM, 2014, INT J NEUROPSYCHOPH, V17, P1139, DOI 10.1017/S1461145714000157; Patterson AD, 2011, CANCER RES, V71, P6590, DOI 10.1158/0008-5472.CAN-11-0885; Poynard T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030325; Rodriguez-Gallego E, 2015, INT J OBESITY, V39, P279, DOI 10.1038/ijo.2014.53; Westin J, 1999, LIVER, V19, P183, DOI 10.1111/j.1478-3231.1999.tb00033.x; Younossi ZM, 2005, LIVER INT, V25, P760, DOI 10.1111/j.1478-3231.2005.01117.x; Zhang MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133788	26	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154601	10.1371/journal.pone.0154601	http://dx.doi.org/10.1371/journal.pone.0154601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123846	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700113
J	Li, ZY; Zhang, ZP; Bi, LJ; Cui, ZQ; Deng, JY; Wang, DB; Zhang, XE				Li, ZhaoYang; Zhang, ZhiPing; Bi, LiJun; Cui, ZongQiang; Deng, JiaoYu; Wang, DianBing; Zhang, Xian-En			Mutagenesis of mNeptune Red-Shifts Emission Spectrum to 681-685 nm	PLOS ONE			English	Article							FLUORESCENT PROTEIN; IN-VIVO; CHROMOPHORE; ISOMERIZATION; VARIANT; WINDOW	GFP-like fluorescent proteins with diverse emission wavelengths have been developed through mutagenesis, offering many possible choices in cellular and tissue imaging, such as multi-targets imaging, deep tissue imaging that require longer emission wavelength. Here, we utilized a combined approach of random mutation and structure-based rational design to develop new NIR fluorescent proteins on the basis of a far-red fluorescent protein, mNeptune (Ex/Em: 600/650 nm). We created a number of new monomeric NIR fluorescent proteins with the emission range of 681-685 nm, which exhibit the largest Stocks shifts (77-80 nm) compared to other fluorescent proteins. Among them, mNeptune681 and mNeptune684 exhibit more than 30 nm redshift in emission relative to mNeptune, owing to the major role of the extensive hydrogen-bond network around the chromophore and contributions of individual mutations to the observed redshift. Furthermore, the two variants still maintain monomeric state in solution, which is a trait crucial for their use as protein tags. In conclusion, our results suggest that there is untapped potential for developing fluorescent proteins with desired properties.	[Bi, LiJun; Wang, DianBing; Zhang, Xian-En] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 10010, Peoples R China; [Li, ZhaoYang; Zhang, ZhiPing; Cui, ZongQiang; Deng, JiaoYu] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, DB; Zhang, XE (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 10010, Peoples R China.	wangdb@moon.ibp.ac.cn; zhangxe@ibp.ac.cn	ZHANG, Xian-En/AAJ-5579-2021; Wang, Dian-Bing/AFQ-6894-2022	Wang, Dian-Bing/0000-0001-6225-7010	Chinese Academy of Sciences [KJZD-EW-TZ-L04]; National High Technology Research and Development Program ("863" Program) of China [2011AA02A114, 2012AA022206]	Chinese Academy of Sciences(Chinese Academy of Sciences); National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China)	This work was supported by the Chinese Academy of Sciences grant KJZD-EW-TZ-L04 to XEZ, and the National High Technology Research and Development Program ("863" Program) of China (No. 2011AA02A114, 2012AA022206) grant to DBW.; The authors thank Dr. Xu-De Wang (Wuhan Institute of Virology, Chinese Academy of Sciences) for kindly providing the valuable suggestions and assistance on protein experiments, and Dr. Ding Gao (Wuhan Institute of Virology, Chinese Academy of Sciences) for his assistance in the protein photobleaching experiments and related analysis. Support of Chinese Academy of Sciences grant (NO. KJZD-EW-TZ-L04) is acknowledged.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chalfie MS, 2005, METHODS BIOCH ANAL G; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Li Z- Y, 2014, ACTA BIOCH BIOPH SIN; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Mena MA, 2006, NAT BIOTECHNOL, V24, P1569, DOI 10.1038/nbt1264; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Piatkevich KD, 2013, SCI REP-UK, V3, DOI 10.1038/srep01847; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Pletnev S, 2012, ACTA CRYSTALLOGR D, V68, P1088, DOI 10.1107/S0907444912020598; Pletneva NV, 2011, PROTEIN SCI, V20, P1265, DOI 10.1002/pro.654; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shu XK, 2009, PROTEIN SCI, V18, P460, DOI 10.1002/pro.66; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123	26	10	11	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0148749	10.1371/journal.pone.0148749	http://dx.doi.org/10.1371/journal.pone.0148749			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119418	Green Submitted, Green Published, gold			2022-12-26	WOS:000374976200002
J	Lim, KL; Hewitt, J; Sitabkhan, A; Eden, JS; Lun, J; Levy, A; Merif, J; Smith, D; Rawlinson, WD; White, PA				Lim, Kun Lee; Hewitt, Joanne; Sitabkhan, Alefiya; Eden, John-Sebastian; Lun, Jennifer; Levy, Avram; Merif, Juan; Smith, David; Rawlinson, William D.; White, Peter A.			A Multi-Site Study of Norovirus Molecular Epidemiology in Australia and New Zealand, 2013-2014	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; UNITED-STATES; GII.4 NOROVIRUS; OUTBREAKS; VARIANT; STRAIN; CHILDREN; RECOMBINATION; EMERGENCE; EVOLUTION	Background Norovirus (NoV) is the major cause of acute gastroenteritis across all age groups. In particular, variants of genogroup II, genotype 4 (GII.4) have been associated with epidemics globally, occurring approximately every three years. The pandemic GII.4 variant, Sydney 2012, was first reported in early 2012 and soon became the predominant circulating NoV strain globally. Despite its broad impact, both clinically and economically, our understanding of the fundamental diversity and mechanisms by which new NoV strains emerge remains limited. In this study, we describe the molecular epidemiological trends of NoV-associated acute gastroenteritis in Australia and New Zealand between January 2013 and June 2014. Methodology Overall, 647 NoV-positive clinical faecal samples from 409 outbreaks and 238 unlinked cases of acute gastroenteritis were examined by RT-PCR and sequencing. Phylogenetic analysis was then performed to identify NoV capsid genotypes and to establish the temporal dominance of circulating pandemic GII.4 variants. Recombinant viruses were also identified based on analysis of the ORF1/2 overlapping region. Findings Peaks in NoV activity were observed, however the timing of these epidemics varied between different regions. Overall, GII.4 NoVs were the dominant cause of both outbreaks and cases of NoV-associated acute gastroenteritis (63.1%, n = 408/647), with Sydney 2012 being the most common GII.4 variant identified (98.8%, n = 403/408). Of the 409 reported NoV outbreaks, aged-care facilities were the most common setting in both Western Australia (87%, n = 20/23) and New Zealand (58.1%, n = 200/344) while most of the NoV outbreaks were reported from hospitals (38%, n = 16/42) in New South Wales, Australia. An analysis of a subset of non-GII.4 viruses from all locations (125/239) showed the majority (56.8%, n = 71/125) were inter-genotype recombinants. These recombinants were surprisingly diverse and could be classified into 18 distinct recombinant types, with GII.P16/GII. 13 (24% of recombinants) the most common. Conclusion This study revealed that following its emergence in 2012, GII.4 Sydney 2012 variant continued to be the predominant cause of NoV-associated acute gastroenteritis in Australia and New Zealand between 2013 and 2014.	[Lim, Kun Lee; Sitabkhan, Alefiya; Lun, Jennifer; Rawlinson, William D.; White, Peter A.] Univ New S Wales, Fac Sci, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Lim, Kun Lee] Singapore Gen Hosp, Mol Lab, Dept Pathol, Singapore, Singapore; [Hewitt, Joanne] Kenepuru Sci Ctr, Inst Environm Sci & Res, Porirua, New Zealand; [Eden, John-Sebastian] Univ Sydney, Sch Biol Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Eden, John-Sebastian] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Levy, Avram; Smith, David] Queen Elizabeth II Med Ctr, PathWest Lab Med WA, Perth, WA, Australia; [Levy, Avram; Smith, David] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Merif, Juan; Rawlinson, William D.] Prince Wales Hosp, Div Virol, SESIAHS, Dept Microbiol, Sydney, NSW, Australia; [Rawlinson, William D.] Univ New S Wales, Sch Med Sci, Fac Med, Sydney, NSW, Australia	University of New South Wales Sydney; Singapore General Hospital; Institute of Environmental Science & Research (ESR) - New Zealand; University of Sydney; University of Sydney; University of Western Australia; University of Western Australia; University of New South Wales Sydney	White, PA (corresponding author), Univ New S Wales, Fac Sci, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	p.white@unsw.edu.au	White, Peter A/C-6573-2012	White, Peter A/0000-0002-6046-9631; Hewitt, Joanne/0000-0003-0370-6394; Smith, David/0000-0002-3107-5182; Levy, Avram/0000-0002-0934-2387; Eden, John-Sebastian/0000-0003-1374-3551	Australian NHMRC [APP1083139]; New Zealand Ministry of Health, as part of ESR's contract; Singapore General Hospital Pte. Ltd.; Australian Postgraduate Award; Water Research Australia Scholarship; NHMRC [1073466]	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); New Zealand Ministry of Health, as part of ESR's contract; Singapore General Hospital Pte. Ltd.; Australian Postgraduate Award(Australian Government); Water Research Australia Scholarship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This project is partially funded through an Australian NHMRC Project Grant APP1083139. The New Zealand component of this study was funded by the New Zealand Ministry of Health, as part of ESR's contract to provide disease surveillance services. KLL acknowledges support through an FY10 SGH Formal Education Scholarship from Singapore General Hospital Pte. Ltd. JL is supported by an Australian Postgraduate Award and a Water Research Australia Scholarship. JSE is supported by an NHMRC Early Career Fellowship (1073466). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER JL, 1969, J INFECT DIS, V119, P668, DOI 10.1093/infdis/119.6.668; Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Ahmed SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075922; [Anonymous], EURO SURVEILL; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Bull RA, 2012, J VIROL, V86, P3219, DOI 10.1128/JVI.06712-11; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; CAUL EO, 1994, LANCET, V343, P1240, DOI 10.1016/S0140-6736(94)92146-6; de Graaf M, 2015, EURO SURVEILL, V20; Debbink K, 2013, J INFECT DIS; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Eden JS, 2014, VIROLOGY, V450, P106, DOI 10.1016/j.virol.2013.12.005; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Eden JS, 2011, J VIROL, V85, P10894, DOI 10.1128/JVI.05562-11; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Estes MK, 2006, CURR OPIN INFECT DIS, V19, P467, DOI 10.1097/01.qco.0000244053.69253.3d; Fu J, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21157; Greening GE, 2012, J MED VIROL, V84, P1449, DOI 10.1002/jmv.23349; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; KAPLAN JE, 1982, AM J EPIDEMIOL, V116, P940, DOI 10.1093/oxfordjournals.aje.a113496; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Koopmans M, 2009, J HOSP INFECT, V73, P331, DOI 10.1016/j.jhin.2009.06.028; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lim KL, 2013, J MED VIROL, V85, P1842, DOI 10.1002/jmv.23669; Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Mahar JE, 2011, J MED VIROL, V83, P2213, DOI 10.1002/jmv.22215; Marshall JA, 2005, J MED VIROL, V75, P321, DOI 10.1002/jmv.20274; Martella V, 2013, J CLIN MICROBIOL, V51, P3855, DOI 10.1128/JCM.01847-13; Mathijs E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-310; Mattison K, 2011, ADV FOOD NUTR RES, V62, P1, DOI 10.1016/B978-0-12-385989-1.00001-6; McAllister G, 2012, EPIDEMIOL INFECT, V140, P2273, DOI 10.1017/S0950268812000052; Medici MC, 2006, J MED VIROL, V78, P1486, DOI 10.1002/jmv.20723; Meijer A, 2012, EUROSURVEILLANCE, V17, P2; Nayak MK, 2009, J CLIN VIROL, V45, P223, DOI 10.1016/j.jcv.2009.04.018; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; Parra GI, 2015, EMERG INFECT DIS, V21, P1477, DOI 10.3201/eid2108.150652; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Svraka S, 2007, J CLIN MICROBIOL, V45, P1389, DOI 10.1128/JCM.02305-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011; Tu ETV, 2008, J CLIN MICROBIOL, V46, P2119, DOI 10.1128/JCM.02198-07; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Tu ETV, 2007, EMERG INFECT DIS, V13, P1128, DOI 10.3201/eid1307.060999; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Verhoef L, 2010, EMERG INFECT DIS, V16, P617, DOI 10.3201/eid1604.090723; Vidal R, 2006, J CLIN MICROBIOL, V44, P2271, DOI 10.1128/JCM.01890-05; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; White P, 2002, J MED VIROL, V68, P113, DOI 10.1002/jmv.10177; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Yoon JS, 2008, J CLIN MICROBIOL, V46, P1474, DOI 10.1128/JCM.02282-07; Yu Y, 2014, BIOMED RES INT, V2014; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	62	32	33	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0145254	10.1371/journal.pone.0145254	http://dx.doi.org/10.1371/journal.pone.0145254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116221	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600002
J	Tumati, S; Burger, H; Martens, S; van der Schouw, YT; Aleman, A				Tumati, Shankar; Burger, Huibert; Martens, Sander; van der Schouw, Yvonne T.; Aleman, Andre			Association between Cognition and Serum Insulin-Like Growth Factor-1 in Middle-Aged & Older Men: An 8 Year Follow-Up Study	PLOS ONE			English	Article							IGF-I; ALZHEIMERS-DISEASE; BINDING PROTEIN-3; SEX-HORMONES; DECLINE; BRAIN; IMPAIRMENT; COMMUNITY; DEMENTIA; PEOPLE	Low levels of insulin-like growth factor-1 (IGF-1), an essential neurotrophic factor, have been associated with worse cognitive function in older adults. However, few studies have assessed the prospective association of serum IGF-1 with cognitive function. We aimed to determine the association between serum IGF-1 on concurrent and prospective cognitive function in a population sample of men aged 40-80 years. Blood samples were assessed for IGF-1 levels at baseline and neuropsychological assessments were performed at baseline (n = 400) and at follow-up after a mean duration of 8.3 years (n = 286). Linear regression analyses were carried out to determine the associations between quintiles of IGF-1 and cognitive function at the baseline and follow-up visits. Results showed that those in the top quintile of IGF-1 had lower processing capacity and global cognition scores at follow-up after controlling for cognitive function at baseline and other confounding factors. Additional analyses exploring associations with IGF-1 separately in middle-aged and older participants, and with quartiles of IGF-1 produced similar results. In those older than 60 years, high IGF-1 levels were also associated with lower baseline processing capacity. These results suggest that high IGF-1 levels are associated with worse long-term cognition in men. Together with past studies, we suggest that both, high and low levels of IGF-1 may be associated with poor cognitive function and that optimum levels of IGF-1 (quintile 2 and 3 in current study) may be associated with better cognitive function.	[Tumati, Shankar; Martens, Sander; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9700 AB Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9713 AV Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, NL-9713 AV Groningen, Netherlands; [van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center	Tumati, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9700 AB Groningen, Netherlands.	s.tumati@umcg.nl	van der Schouw, Yvonne T./F-8327-2014; Tumati, Shankar/AAD-2092-2020	van der Schouw, Yvonne T./0000-0002-4605-435X; Tumati, Shankar/0000-0001-5703-2044; Martens, Sander/0000-0001-8237-7984	International Health Foundation, Geneva, Switzerland; Netherlands organization for health research and development (zonmw.nl) [60-61900-98-146]	International Health Foundation, Geneva, Switzerland; Netherlands organization for health research and development (zonmw.nl)	This work was supported by the International Health Foundation, Geneva, Switzerland; ( baseline measurements) to YTVDS and the Netherlands organization for health research and development (zonmw.nl), grant 60-61900-98-146, follow-up measurements to YTVDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Delaimy WK, 2009, J AM GERIATR SOC, V57, P1441, DOI 10.1111/j.1532-5415.2009.02343.x; Aleman A, 1999, J CLIN ENDOCR METAB, V84, P471, DOI 10.1210/jc.84.2.471; Aleman A, 2001, EXP AGING RES, V27, P283, DOI 10.1080/036107301300208718; Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Angelini A, 2009, ARCH GERONTOL GERIAT, V49, P5, DOI 10.1016/j.archger.2009.09.006; Arwert LI, 2005, GROWTH HORM IGF RES, V15, P416, DOI 10.1016/j.ghir.2005.09.001; Baker LD, 2012, ARCH NEUROL-CHICAGO, V69, P1420, DOI 10.1001/archneurol.2012.1970; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; Bayram F, 2011, ENDOCRINE, V40, P304, DOI 10.1007/s12020-011-9476-z; Bidlingmaier M, 2014, J CLIN ENDOCR METAB, V99, P1712, DOI 10.1210/jc.2013-3059; Davis C, 1999, BRIT J CLIN PSYCHOL, V38, P305, DOI 10.1348/014466599162881; de Bruijn RFAG, 2014, J ALZHEIMERS DIS, V42, P137, DOI 10.3233/JAD-140186; Deak F, 2012, J GERONTOL A-BIOL, V67, P611, DOI 10.1093/gerona/gls118; Deijen Jan Berend, 2011, ISRN Endocrinol, V2011, P249421, DOI 10.5402/2011/249421; Dik MG, 2003, NEUROBIOL AGING, V24, P573, DOI 10.1016/S0197-4580(02)00136-7; Doi T, 2015, NEUROBIOL AGING, V36, P942, DOI 10.1016/j.neurobiolaging.2014.10.035; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; Euser SM, 2008, J GERONTOL A-BIOL, V63, P907, DOI 10.1093/gerona/63.9.907; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Johansson P, 2013, PSYCHONEUROENDOCRINO, V38, P1729, DOI 10.1016/j.psyneuen.2013.02.006; Kalmijn S, 2000, J CLIN ENDOCR METAB, V85, P4551, DOI 10.1210/jc.85.12.4551; Landi F, 2007, GROWTH HORM IGF RES, V17, P58, DOI 10.1016/j.ghir.2006.11.001; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Licht CMM, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/181327; Matousek RH, 2010, HORM BEHAV, V57, P352, DOI 10.1016/j.yhbeh.2010.01.004; Morley JE, 1997, P NATL ACAD SCI USA, V94, P7537, DOI 10.1073/pnas.94.14.7537; Muller M, 2005, NEUROLOGY, V64, P866, DOI 10.1212/01.WNL.0000153072.54068.E3; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; Okereke OI, 2006, J CLIN ENDOCR METAB, V91, P4306, DOI 10.1210/jc.2006-1325; Rollero A, 1998, NEUROPSYCHOBIOLOGY, V38, P73, DOI 10.1159/000026520; Rubin DB, 2009, MULTIPLE IMPUTATION; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Sievers C, 2014, EUR NEUROPSYCHOPHARM, V24, P890, DOI 10.1016/j.euroneuro.2014.01.008; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Sun LY, 2005, NEUROBIOL AGING, V26, P929, DOI 10.1016/j.neurobiolaging.2004.07.010; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Exel E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.08.014; Vardy ERLC, 2007, J ALZHEIMERS DIS, V12, P285; Verhage F., 1964, ONDERZOEK BIJ NEDERL; VOORRIPS LE, 1991, MED SCI SPORT EXER, V23, P974, DOI 10.1249/00005768-199108000-00015; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Westwood AJ, 2014, NEUROLOGY, V82, P1613, DOI 10.1212/WNL.0000000000000382; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	45	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154450	10.1371/journal.pone.0154450	http://dx.doi.org/10.1371/journal.pone.0154450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115487	Green Published, gold			2022-12-26	WOS:000374973600068
J	Zhou, HX; Han, B; Hou, LM; An, TT; Jia, G; Cheng, ZX; Ma, Y; Zhou, YN; Kong, R; Wang, SJ; Wang, YW; Sun, XJ; Pan, SH; Sun, B				Zhou, Hao-xin; Han, Bing; Hou, Li-Min; An, Ting-Ting; Jia, Guang; Cheng, Zhuo-Xin; Ma, Yong; Zhou, Yi-Nan; Kong, Rui; Wang, Shuang-Jia; Wang, Yong-Wei; Sun, Xue-Jun; Pan, Shang-Ha; Sun, Bei			Protective Effects of Hydrogen Gas on Experimental Acute Pancreatitis	PLOS ONE			English	Article							CERULEIN-INDUCED PANCREATITIS; OXIDATIVE STRESS; NITRIC-OXIDE; AR42J CELLS; RATS; INJURY; INHALATION; CYTOKINES; MODEL	Acute pancreatitis (AP) is an inflammatory disease mediated by damage to acinar cells and pancreatic inflammation. In patients with AP, subsequent systemic inflammatory responses and multiple organs dysfunction commonly occur. Interactions between cytokines and oxidative stress greatly contribute to the amplification of uncontrolled inflammatory responses. Molecular hydrogen (H-2) is a potent free radical scavenger that not only ameliorates oxidative stress but also lowers cytokine levels. The aim of the present study was to investigate the protective effects of H-2 gas on AP both in vitro and in vivo. For the in vitro assessment, AR42J cells were treated with cerulein and then incubated in H-2-rich or normal medium for 24 h, and for the in vivo experiment, AP was induced through a retrograde infusion of 5% sodium taurocholate into the pancreatobiliary duct (0.1 mL/100 g body weight). Wistar rats were treated with inhaled air or 2% H-2 gas and sacrificed 12 h following the induction of pancreatitis. Specimens were collected and processed to measure the amylase and lipase activity levels; the myeloperoxidase activity and production levels; the cytokine mRNA expression levels; the 8-hydroxydeoxyguanosine, malondialdehyde, and glutathione levels; and the cell survival rate. Histological examinations and immunohistochemical analyses were then conducted. The results revealed significant reductions in inflammation and oxidative stress both in vitro and in vivo. Furthermore, the beneficial effects of H-2 gas were associated with reductions in AR42J cell and pancreatic tissue damage. In conclusion, our results suggest that H-2 gas is capable of ameliorating damage to the pancreas and AR42J cells and that H-2 exerts protective effects both in vitro and in vivo on subjects with AP. Thus, the results obtained indicate that this gas may represent a novel therapy agent in the management of AP.	[Zhou, Hao-xin; Hou, Li-Min] Harbin Med Univ, Affiliated Hosp 1, Dept Emergency Surg, Harbin, Peoples R China; [Han, Bing; Jia, Guang; Cheng, Zhuo-Xin; Ma, Yong; Zhou, Yi-Nan; Kong, Rui; Wang, Shuang-Jia; Wang, Yong-Wei; Pan, Shang-Ha; Sun, Bei] Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China; [An, Ting-Ting] Harbin Med Univ, Affiliated Hosp 1, Dept Abdominal Ultrasound, Harbin, Peoples R China; [Sun, Xue-Jun] Second Mil Med Univ, Dept Diving Med, Shanghai, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Naval Medical University	Sun, B (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China.	sunbei70@tom.com	shuangjia, wang/AFX-8272-2022; sun, xuejun/A-5561-2010; Sun, Xuejun/GLR-4436-2022	sun, xuejun/0000-0003-2387-5531; Sun, Xuejun/0000-0003-2387-5531	National Natural Scientific Foundation of China [81170431, 81372613]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China No: 81170431, No: 81372613 http://nsfc.biomart.cn/search?name=&applicationabstract=1&applicationkeyword=1& person=%E5%AD%99%E5%A4%87&participant=&company=&no=&subject=&type=&money1=&money2=&startTime=1955&endTime=2015&redract_url=&submit=advSearch. BS designed the study. This work was also supported by the National Natural Scientific Foundation of China No: 81101799 http://nsfc.biomart.cn/search?name=&applicationabstract= 1&applicationkeyword=1&person=%E5%AD%94%E7%91%9E&participant=&company=&no=&subject=&type=&money1=&money2=&startTime=1955&endTime=2015&redract_url=&submit=advSearch.RKcontributed reagents and collected data.	Bai XW, 2009, PANCREAS, V38, P515, DOI 10.1097/MPA.0b013e31819cac24; Bettaieb A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113019; Buchholz BM, 2008, AM J TRANSPLANT, V8, P2015, DOI 10.1111/j.1600-6143.2008.02359.x; Carvalho ACS, 2014, PANCREAS, V43, P82, DOI 10.1097/MPA.0b013e3182a63b9d; Chen HG, 2013, INT J SURG, V11, P1060, DOI 10.1016/j.ijsu.2013.10.007; Chen P, 2010, CYTOKINE, V49, P15, DOI 10.1016/j.cyto.2009.09.013; Cheng ZX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023752; Chu JT, 2013, MOL CELL BIOCHEM, V382, P1, DOI 10.1007/s11010-013-1603-0; Chu PY, 2012, HUM EXP TOXICOL, V31, P397, DOI 10.1177/0960327111426583; Escobar J, 2009, CURR PHARM DESIGN, V15, P3027, DOI 10.2174/138161209789058075; Esrefoglu M, 2006, WORLD J GASTROENTERO, V12, P259; Gomez-Cambronero L, 2000, J PHARMACOL EXP THER, V293, P670; Gomez-Cambronero L. G., 2002, Current Drug Targets - Inflammation and Allergy, V1, P393, DOI 10.2174/1568010023344544; Hartman H, 2012, BRIT J SURG, V99, P246, DOI 10.1002/bjs.7775; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Hsu DZ, 2006, SHOCK, V25, P528, DOI 10.1097/01.shk.0000209552.95839.43; Hwang JH, 2005, PANCREAS, V31, P332, DOI 10.1097/01.mpa.0000183377.04295.c3; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P11, DOI 10.1016/j.bbrc.2009.05.117; Li GM, 2013, J SURG RES, V181, P279, DOI 10.1016/j.jss.2012.06.058; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ozturk F, 2008, FREE RADICAL RES, V42, P289, DOI 10.1080/10715760801930730; Pereda J, 2008, FREE RADICAL BIO MED, V44, P1599, DOI 10.1016/j.freeradbiomed.2008.01.018; Pereda J, 2006, CURR MED CHEM, V13, P2775, DOI 10.2174/092986706778522011; Rakonczay Z, 2003, EUR J PHARMACOL, V464, P217, DOI 10.1016/S0014-2999(03)01380-3; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Sun HY, 2011, J HEPATOL, V54, P471, DOI 10.1016/j.jhep.2010.08.011; Wang F, 2011, J SURG RES, V167, pE339, DOI 10.1016/j.jss.2010.11.005; Wang G, 2013, APOPTOSIS, V18, P28, DOI 10.1007/s10495-012-0770-x; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040160; Xiang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115982; Xue DB, 2009, PANCREAS, V38, pE183, DOI 10.1097/MPA.0b013e3181b65dec; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Zyromski N, 2003, SURGERY, V133, P235, DOI 10.1067/msy.2003.87	33	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154483	10.1371/journal.pone.0154483	http://dx.doi.org/10.1371/journal.pone.0154483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115738	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600070
J	Morgan, KK; Luu, P; Tucker, DM				Morgan, Kyle K.; Luu, Phan; Tucker, Don M.			Changes in P3b Latency and Amplitude Reflect Expertise Acquisition in a Football Visuomotor Learning Task	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; INTRACEREBRAL POTENTIALS; VISUAL-STIMULI; RARE TARGET; CONTEXT; P300; ASSOCIATIONS; MECHANISMS; RESPONSES; COMPONENT	Learning is not a unitary phenomenon. Rather, learning progresses through stages, with the stages reflecting different challenges that require the support of specific cognitive processes that reflect the functions of different brain networks. A theory of general learning proposes that learning can be divided into early and late stages controlled by corticolimbic networks located in frontal and posterior brain regions, respectively. Recent human studies using dense-array EEG (dEEG) support these results by showing progressive increases in P3b amplitude (an Event Related Potential with estimated sources in posterior cingulate cortex and hippocampus) as participants acquire a new visuomotor skill. In the present study, the P3b was used to track the learning and performance of participants as they identify defensive football formations and make an appropriate response. Participants acquired the task over three days, and P3b latency and amplitude significantly changed when participants learned the task. As participants demonstrated further proficiency with extensive training, amplitude and latency changes in the P3b continued to closely mirror performance improvements. Source localization results across all days suggest that an important source generator of the P3b is located in the posterior cingulate cortex. Results from the study support prior findings and further suggest that the careful analysis of covert learning mechanisms and their underlying electrical signatures are a robust index of task competency.	[Morgan, Kyle K.; Luu, Phan; Tucker, Don M.] Elect Geodes Inc, Eugene, OR USA; [Morgan, Kyle K.; Luu, Phan; Tucker, Don M.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Morgan, KK (corresponding author), Elect Geodes Inc, Eugene, OR USA.; Morgan, KK (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	kmorgan@egi.com			Electrical Geodesics, Inc. (EGI)	Electrical Geodesics, Inc. (EGI)	Electrical Geodesics, Inc. (EGI) provided support in the form of salaries for authors KKM, PL, and DMT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aderson JR, 1993, RULES OF MIND; Anderson J.R., 1983, ARCHITECTURE COGNITI; ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Barcelo F, 2000, NEUROPSYCHOLOGIA, V38, P1342, DOI 10.1016/S0028-3932(00)00046-4; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; Bledowski C, 2006, J NEUROSCI, V26, P821, DOI 10.1523/JNEUROSCI.3542-05.2006; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Brankack J, 1996, HIPPOCAMPUS, V6, P475, DOI 10.1002/(SICI)1098-1063(1996)6:5<475::AID-HIPO1>3.0.CO;2-I; Brovelli A, 2008, CEREB CORTEX, V18, P1485, DOI 10.1093/cercor/bhm198; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Ebmeier KP, 1995, ELECTROEN CLIN NEURO, V95, P434, DOI 10.1016/0013-4694(95)00173-5; Ferree TC, 2000, IEEE T BIO-MED ENG, V47, P1584, DOI 10.1109/10.887939; Fitts PM., 1967, HUM PERFORM; FRIEDMAN D, 1993, PSYCHOPHYSIOLOGY, V30, P383, DOI 10.1111/j.1469-8986.1993.tb02060.x; Gabriel M., 2002, ENCY HUMAN BRAIN, P775; Grol MJ, 2006, J NEUROSCI, V26, P117, DOI 10.1523/JNEUROSCI.2786-05.2006; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P229, DOI 10.1016/0013-4694(95)98475-N; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1111/1469-8986.3510023; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KRAMER AF, 1988, BIOL PSYCHOL, V26, P231, DOI 10.1016/0301-0511(88)90022-1; Laberge D., 1981, ATTENTION PERFORM, P173; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Luft CD, 2014, J COGNITIVE NEUROSCI, V26, P1180, DOI 10.1162/jocn_a_00543; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Luu P, 2007, BRAIN RES, V1179, P89, DOI 10.1016/j.brainres.2007.03.092; Luu P, 2009, BRAIN RES, V1247, P100, DOI 10.1016/j.brainres.2008.09.084; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; NEWMAN JP, 1990, PERS INDIV DIFFER, V11, P1101, DOI 10.1016/0191-8869(90)90021-I; Luu P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00159; Pineda JA, 1997, INT J PSYCHOPHYSIOL, V27, P223, DOI 10.1016/S0167-8760(97)00061-5; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shin J, 2011, HIPPOCAMPUS, V21, P744, DOI 10.1002/hipo.20792; SMITH ME, 1990, ELECTROEN CLIN NEURO, V76, P235, DOI 10.1016/0013-4694(90)90018-F; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8	43	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154021	10.1371/journal.pone.0154021	http://dx.doi.org/10.1371/journal.pone.0154021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111898	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600028
J	Gerl, MJ; Bittl, V; Kirchner, S; Sachsenheimer, T; Brunner, HL; Luchtenborg, C; Ozbalci, C; Wiedemann, H; Wegehingel, S; Nickel, W; Haberkant, P; Schultz, C; Kruger, M; Brugger, B				Gerl, Mathias J.; Bittl, Verena; Kirchner, Susanne; Sachsenheimer, Timo; Brunner, Hanna L.; Luechtenborg, Christian; Oezbalci, Cagakan; Wiedemann, Hannah; Wegehingel, Sabine; Nickel, Walter; Haberkant, Per; Schultz, Carsten; Krueger, Marcus; Bruegger, Britta			Sphingosine-1-Phosphate Lyase Deficient Cells as a Tool to Study Protein Lipid Interactions	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; CLICK CHEMISTRY; SPHINGOLIPID INTERACTIONS; QUANTITATIVE-ANALYSIS; MEMBRANE; CRISPR-CAS9; METABOLISM; LIVER; DEHYDROGENASE; PURIFICATION	Cell membranes contain hundreds to thousands of individual lipid species that are of structural importance but also specifically interact with proteins. Due to their highly controlled synthesis and role in signaling events sphingolipids are an intensely studied class of lipids. In order to investigate their metabolism and to study proteins interacting with sphingolipids, metabolic labeling based on photoactivatable sphingoid bases is the most straightforward approach. In order to monitor protein-lipid-crosslink products, sphingosine derivatives containing a reporter moiety, such as a radiolabel or a clickable group, are used. In normal cells, degradation of sphingoid bases via action of the checkpoint enzyme sphingosine-1-phosphate lyase occurs at position C2-C3 of the sphingoid base and channels the resulting hexadecenal into the glycerolipid biosynthesis pathway. In case the functionalized sphingosine looses the reporter moiety during its degradation, specificity towards sphingolipid labeling is maintained. In case degradation of a sphingosine derivative does not remove either the photoactivatable or reporter group from the resulting hexadecenal, specificity towards sphingolipid labeling can be achieved by blocking sphingosine-1-phosphate lyase activity and thus preventing sphingosine derivatives to be channeled into the sphingolipid-to-glycerolipid metabolic pathway. Here we report an approach using clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated nuclease Cas9 to create a sphingosine-1-phosphate lyase (SGPL1) HeLa knockout cell line to disrupt the sphingolipid-to-glycerolipid metabolic pathway. We found that the lipid and protein compositions as well as sphingolipid metabolism of SGPL1 knock-out HeLa cells only show little adaptations, which validates these cells as model systems to study transient protein-sphingolipid interactions.	[Gerl, Mathias J.; Bittl, Verena; Kirchner, Susanne; Sachsenheimer, Timo; Brunner, Hanna L.; Luechtenborg, Christian; Oezbalci, Cagakan; Wiedemann, Hannah; Wegehingel, Sabine; Nickel, Walter; Bruegger, Britta] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany; [Haberkant, Per; Schultz, Carsten] European Mol Biol Lab, Heidelberg, Germany; [Krueger, Marcus] CECAD, Cologne, Germany; [Gerl, Mathias J.] Lipotype GmbH, Tatzberg 47, D-01307 Dresden, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); University of Cologne	Gerl, MJ; Brugger, B (corresponding author), Heidelberg Univ, Biochem Ctr, Heidelberg, Germany.; Gerl, MJ (corresponding author), Lipotype GmbH, Tatzberg 47, D-01307 Dresden, Germany.	Mathias.Gerl@bzh.uni-heidelberg.de; britta.bruegger@bzh.uni-heidelberg.de		Schultz, Carsten/0000-0002-5824-2171; Haberkant, Per/0000-0002-5608-9062; Gerl, Mathias/0000-0002-8074-7221	Deutsche Forschungsgemeinschaft [GE 2516/1-1, TRR 83]; CellNetworks Cluster of Excellence [EXC81]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CellNetworks Cluster of Excellence	MJG was funded by the Deutsche Forschungsgemeinschaft: GE 2516/1-1 (www.dfg.de/en/). BB is supported by a grant from the Deutsche Forschungsgemeinschaft within TRR 83 (http://www.trr83.de) and is investigator of the CellNetworks Cluster of Excellence: EXC81 (http://www.cellnetworks.uni-hd.de).	Aguilar Ana, 2012, Adv Biol Regul, V52, P17; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bibikova M, 2002, GENETICS, V161, P1169; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Carlson M., 2015, R PACKAGE VERSION 3; Colie S, 2009, CANCER RES, V69, P9346, DOI 10.1158/0008-5472.CAN-09-2198; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Damen CWN, 2014, J LIPID RES, V55, P1772, DOI 10.1194/jlr.D047795; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Flores-Martin J, 2013, INT J MOL SCI, V14, P6170, DOI 10.3390/ijms14036170; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Haberkant P, 2008, J LIPID RES, V49, P251, DOI 10.1194/jlr.D700023-JLR200; Haberkant P, 2016, ACS CHEM BIOL, V11, P222, DOI 10.1021/acschembio.5b00810; Haberkant P, 2014, BBA-MOL CELL BIOL L, V1841, P1022, DOI 10.1016/j.bbalip.2014.01.003; Haberkant P, 2013, ANGEW CHEM INT EDIT, V52, P4033, DOI 10.1002/anie.201210178; Hagen N, 2011, CELL DEATH DIFFER, V18, P1356, DOI 10.1038/cdd.2011.7; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Hagen-Euteneuer N, 2012, J BIOL CHEM, V287, P9128, DOI 10.1074/jbc.M111.302380; Hahne F., 2013, R PACKAGE VERSION, V1, P4; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Heal WP, 2012, NAT PROTOC, V7, P105, DOI 10.1038/nprot.2011.425; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Hobo: [DRC, 2015, TEAM KAIST FULL VID; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2; Kim R, 2013, J LIPID RES, V54, P265, DOI 10.1194/jlr.D029207; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Narayanaswamy P, 2014, ANAL CHEM, V86, P3043, DOI 10.1021/ac4039652; Ozbalci C, 2013, METHODS MOL BIOL, V1033, P3, DOI 10.1007/978-1-62703-487-6_1; PALTAUF F, 1994, PROG LIPID RES, V33, P239, DOI 10.1016/0163-7827(94)90028-0; R Development Core Team T, 2011, R LANG ENV STAT COMP; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rohlfing A, 2007, ANAL CHEM, V79, P5793, DOI 10.1021/ac070633x; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Shieh P, 2012, J AM CHEM SOC, V134, P17428, DOI 10.1021/ja308203h; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; STOFFEL W, 1967, H-S Z PHYSIOL CHEM, V348, P941; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Thiele C, 2012, ACS CHEM BIOL, V7, P2004, DOI 10.1021/cb300414v; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yamaji T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088124; Zacherl S, 2015, J BIOL CHEM, V290, P3654, DOI 10.1074/jbc.M114.590067	70	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153009	10.1371/journal.pone.0153009	http://dx.doi.org/10.1371/journal.pone.0153009			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100999	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500021
J	Jiang, L; Zhao, X; Wang, L				Jiang, Lei; Zhao, Xia; Wang, Lu			Long-Range Correlations of Global Sea Surface Temperature	PLOS ONE			English	Article							DETRENDED FLUCTUATION ANALYSIS; SCALING BEHAVIOR; TERM PERSISTENCE; AIR-TEMPERATURE; ATMOSPHERE; AVERAGE; MEMORY	Scaling behaviors of the global monthly sea surface temperature (SST) derived from 1870-2009 average monthly data sets of Hadley Centre Sea Ice and SST (HadISST) are investigated employing detrended fluctuation analysis (DFA). The global SST fluctuations are found to be strong positively long- range correlated at all pertinent time- intervals. The value of scaling exponent is larger in the tropics than those in the intermediate latitudes of the northern and southern hemispheres. DFA leads to the scaling exponent alpha = 0.87 over the globe (60 degrees S similar to 60 degrees N), northern hemisphere (0 degrees N similar to 60 degrees N), and southern hemisphere (0 degrees S similar to 60 degrees S), alpha = 0.84 over the intermediate latitude of southern hemisphere (30 degrees S similar to 60 degrees S), alpha = 0.81 over the intermediate latitude of northern hemisphere (30 degrees N similar to 60 degrees N) and alpha = 0.90 over the tropics 30 degrees-S similar to 30 degrees N [fluctuation F(s) similar to s(alpha)], which the fluctuations of monthly SST anomaly display longterm correlated behaviors. Furthermore, the larger the standard deviation is, the smaller long- range correlations (LRCs) of SST in the corresponding regions, especially in three distinct upwelling areas. After the standard deviation is taken into account, an index chi = alpha* sigma is introduced to obtain the spatial distributions of chi. There exists an obvious change of global SST in central east and northern Pacific and the northwest Atlantic. This may be as a clue on predictability of climate and ocean variabilities.	[Jiang, Lei] Nanjing Univ Informat Sci & Technol, Sch Marine Sci, Nanjing, Jiangsu, Peoples R China; [Jiang, Lei] Jiangsu Res Ctr Ocean Survey Technol, Nanjing, Jiangsu, Peoples R China; [Zhao, Xia] Chinese Acad Sci, Inst Oceanol, Lab Ocean Circulat & Waves, Qingdao, Peoples R China; [Wang, Lu] Minist Environm Protect, Nucl & Radiat Safety Ctr, Beijing, Peoples R China	Nanjing University of Information Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS	Jiang, L (corresponding author), Nanjing Univ Informat Sci & Technol, Sch Marine Sci, Nanjing, Jiangsu, Peoples R China.; Jiang, L (corresponding author), Jiangsu Res Ctr Ocean Survey Technol, Nanjing, Jiangsu, Peoples R China.	jianglei@nuist.edu.cn			Jiangsu Program of Entrepreneurship and Innovation Group; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11010102]; 973 project [2012CB956001]; Startup Foundation for Introducing Talent of NUIST [2014r18]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Jiangsu Program of Entrepreneurship and Innovation Group; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); 973 project(National Basic Research Program of China); Startup Foundation for Introducing Talent of NUIST; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Many thanks are due to supports from the 2015 Jiangsu Program of Entrepreneurship and Innovation Group, the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA11010102), 973 project (2012CB956001), the Startup Foundation for Introducing Talent of NUIST (2014r18) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Alvarez-Ramirez J, 2008, PHYSICA A, V387, P3629, DOI 10.1016/j.physa.2008.02.051; Blender R, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017666; Bunde A, 2000, PHYS REV LETT, V85, P3736, DOI 10.1103/PhysRevLett.85.3736; Bunde A, 2002, PHYSICA A, V314, P15, DOI 10.1016/S0378-4371(02)01050-6; Chen X, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027755; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; DELWORTH T, 1993, J CLIMATE, V6, P1993, DOI 10.1175/1520-0442(1993)006<1993:IVOTTC>2.0.CO;2; Deser C, 2003, J CLIMATE, V16, P57, DOI 10.1175/1520-0442(2003)016<0057:UTPOSS>2.0.CO;2; Deser C, 2010, MARINE SCI, V2; Eichner JF, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046133; Fraedrich K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108501; Frauen C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050520; Gan ZJ, 2007, J ATMOS OCEAN TECH, V24, P681, DOI 10.1175/JTECH1981.1; Goswami BN, 2006, GEOPHYS RES LETT, V33; Govindan RB, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.028501; HALPERN D, 1989, J GEOPHYS RES-OCEANS, V94, P8018, DOI 10.1029/JC094iC06p08018; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Jiang L, 2015, THEOR APPL CLIMATOL, V119, P25, DOI 10.1007/s00704-013-1080-0; Jiang L, 2012, THEOR APPL CLIMATOL, V109, P261, DOI 10.1007/s00704-011-0578-6; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kavasseri RG, 2005, CHAOS SOLITON FRACT, V24, P165, DOI 10.1016/j.chaos.2004.09.004; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Kiraly A, 2005, METEOROL ATMOS PHYS, V88, P119, DOI 10.1007/s00703-004-0078-7; Koscielny-Bunde E, 1998, PHYS REV LETT, V81, P729, DOI 10.1103/PhysRevLett.81.729; KoscielnyBunde E, 1996, PHYSICA A, V231, P393, DOI 10.1016/0378-4371(96)00187-2; Kurnaz ML, 2004, FRACTALS, V12, P365, DOI 10.1142/S0218348X04002665; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Liu YH, 1997, PHYSICA A, V245, P437, DOI 10.1016/S0378-4371(97)00368-3; Luo M, 2015, J CLIMATE, V28, P3122, DOI 10.1175/JCLI-D-13-00743.1; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Monetti RA, 2003, PHYSICA A, V320, P581, DOI 10.1016/S0378-4371(02)01662-X; Oppo DW, 2009, NATURE, V460, P1113, DOI 10.1038/nature08233; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Stanley HE, 1999, PHYSICA A, V270, P309, DOI 10.1016/S0378-4371(99)00230-7; Talkner P, 2000, PHYS REV E, V62, P150, DOI 10.1103/PhysRevE.62.150; Telesca L, 2005, PHYSICA A, V354, P629, DOI 10.1016/j.physa.2005.02.053; Varotsos C, 2005, INT J REMOTE SENS, V26, P3333, DOI 10.1080/01431160500076111; Varotsos C, 2009, ATMOS CHEM PHYS, V9, P677, DOI 10.5194/acp-9-677-2009; Varotsos CA, 2013, ATMOS CHEM PHYS, V13, P5243, DOI 10.5194/acp-13-5243-2013; Vyushin D, 2004, GEOPHYS RES LETT, V31; Weber RO, 2001, J GEOPHYS RES-ATMOS, V106, P20131, DOI 10.1029/2001JD000548; Zhang WF, 2015, PHYSICA A, V428, P314, DOI 10.1016/j.physa.2015.01.081; Zhang YZ, 2013, GLOBAL PLANET CHANGE, V100, P362, DOI 10.1016/j.gloplacha.2012.11.012; Zhu XH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027291; Zhu XH, 2010, J CLIMATE, V23, P5021, DOI 10.1175/2010JCLI3370.1	46	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153774	10.1371/journal.pone.0153774	http://dx.doi.org/10.1371/journal.pone.0153774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100397	Green Submitted, gold, Green Published			2022-12-26	WOS:000374898500065
J	Kang, YE; Kim, JM; Joung, KH; Lee, JH; You, BR; Choi, MJ; Ryu, MJ; Ko, YB; Lee, MA; Lee, J; Ku, BJ; Shong, M; Lee, KH; Kim, HJ				Kang, Yea Eun; Kim, Ji Min; Joung, Kyong Hye; Lee, Ju Hee; You, Bo Ram; Choi, Min Jeong; Ryu, Min Jeong; Ko, Young Bok; Lee, Min A.; Lee, Junguee; Ku, Bon Jeong; Shong, Minho; Lee, Ki Hwan; Kim, Hyun Jin			The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LEPTIN; INFLAMMATION; ADIPONECTIN; ACTIVATION; EXPRESSION; INFILTRATION; SENSITIVITY; PHENOTYPE; MONOCYTES	The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance have been explored in both animal and human studies. However, our current understanding of obesity-associated insulin resistance relies on studies of artificial metabolic extremes. The purpose of this study was to explore the roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in human patients with modest obesity and early metabolic dysfunction. We obtained omental adipose tissue and fasting blood samples from 51 females undergoing gynecologic surgery. We investigated serum concentrations of proinflammatory cytokines and adipokines as well as the mRNA expression of proinflammatory and macrophage phenotype markers in visceral adipose tissue using ELISA and quantitative RT-PCR. We measured adipose tissue inflammation and macrophage infiltration using immunohistochemical analysis. Serum levels of adiponectin and leptin were significantly correlated with HOMA-IR and body mass index. The levels of expression of MCP-1 and TNF-alpha in visceral adipose tissue were also higher in the obese group (body mass index >= 25). The expression of mRNA MCP-1 in visceral adipose tissue was positively correlated with body mass index (r = 0.428, p = 0.037) but not with HOMA-IR, whereas TNF-alpha in visceral adipose tissue was correlated with HOMA-IR (r = 0.462, p = 0.035) but not with body mass index. There was no obvious change in macrophage phenotype or macrophage infiltration in patients with modest obesity or early metabolic dysfunction. Expression of mRNA CD163/CD68 was significantly related to mitochondrial-associated genes and serum inflammatory cytokine levels of resistin and leptin. These results suggest that changes in the production of inflammatory biomolecules precede increased immune cell infiltration and induction of a macrophage phenotype switch in visceral adipose tissue. Furthermore, serum resistin and leptin have specific roles in the regulation of adipose tissue macrophages in patients with modest obesity or early metabolic dysfunction.	[Kang, Yea Eun; Kim, Ji Min; Joung, Kyong Hye; Lee, Ju Hee; You, Bo Ram; Choi, Min Jeong; Ryu, Min Jeong; Ku, Bon Jeong; Shong, Minho; Kim, Hyun Jin] Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea; [Ko, Young Bok; Lee, Min A.; Lee, Ki Hwan] Chungnam Natl Univ, Sch Med, Dept Obstet & Gynecol, Daejeon, South Korea; [Lee, Junguee] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Pathol, Daejeon, South Korea; [Ku, Bon Jeong; Shong, Minho] Chungnam Natl Univ, Sch Med, Dept Internal Med, Daejeon, South Korea	Chungnam National University; Chungnam National University Hospital; Chungnam National University; Catholic University of Korea; Chungnam National University	Kim, HJ (corresponding author), Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea.	kimhj43@cnuh.co.kr	/H-7803-2012	shong, minho/0000-0002-0247-7115; Kim, Hyun Jin/0000-0002-6760-4963; Lee, Ju Hee/0000-0001-5976-7175	National Research Foundation of Korea (NRF) - Ministry of Science [2014R1A1A1006176]; Korea Otsuka Pharmaceuticals, Republic of Korea; Korea Otsuka Pharmaceuticals grant (BJK)	National Research Foundation of Korea (NRF) - Ministry of Science; Korea Otsuka Pharmaceuticals, Republic of Korea; Korea Otsuka Pharmaceuticals grant (BJK)	This research was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science (grant number: 2014R1A1A1006176), and financed with a grant from Korea Otsuka Pharmaceuticals, Republic of Korea. A Korea Otsuka Pharmaceuticals grant (BJK) provided support with lab equipment and reagents that greatly enhanced the initial phase of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Catalan V, 2007, OBES SURG, V17, P1464, DOI 10.1007/s11695-008-9424-z; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; D'souza AM, 2014, ENDOCRINOLOGY, V155, P1268, DOI 10.1210/en.2013-1523; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hoffmann A, 2014, ATHEROSCLEROSIS, V235, pE194, DOI 10.1016/j.atherosclerosis.2014.05.572; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kanazawa M, 2002, ASIA PAC J CLIN NUTR, V11, pS732, DOI 10.1046/j.1440-6047.11.s8.19.x; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Lim S, 2014, ENDOCRINOL METAB, V29, P1, DOI 10.3803/EnM.2014.29.1.1; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Makki K, 2013, ISRN INFLAMMATION, V2013; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; McArdle M. A, 2013, FRONTIERS ENDOCRINOL, V4; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Noto H, 2013, J DIABETES INVEST, V4, P225, DOI 10.1111/jdi.12068; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Oguri S, 2002, CLIN DIAGN LAB IMMUN, V9, P1307, DOI 10.1128/CDLI.9.6.1307-1312.2002; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Sakai S, 2013, J SURG RES, V185, P353, DOI 10.1016/j.jss.2013.06.002; Sanchez-Pozo C, 2003, CLIN EXP IMMUNOL, V134, P464, DOI 10.1111/j.1365-2249.2003.02321.x; Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Segal KR, 1996, DIABETES, V45, P988, DOI 10.2337/diabetes.45.7.988; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	50	181	185	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154003	10.1371/journal.pone.0154003	http://dx.doi.org/10.1371/journal.pone.0154003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101398	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500120
J	Kubota, Y; Kawamura, H; Sakai, M; Tsumuraya, R; Tashiro, M; Yusa, K; Kubo, N; Sato, H; Kawahara, M; Katoh, H; Kanai, T; Ohno, T; Nakano, T				Kubota, Yoshiki; Kawamura, Hidemasa; Sakai, Makoto; Tsumuraya, Ryou; Tashiro, Mutsumi; Yusa, Ken; Kubo, Nobuteru; Sato, Hiro; Kawahara, Masahiro; Katoh, Hiroyuki; Kanai, Tatsuaki; Ohno, Tatsuya; Nakano, Takashi			Changes in Rectal Dose Due to Alterations in Beam Angles for Setup Uncertainty and Range Uncertainty in Carbon-Ion Radiotherapy for Prostate Cancer	PLOS ONE			English	Article							INTENSITY-MODULATED PROTON; RADIATION-THERAPY; ROBUST OPTIMIZATION; ALGORITHM; SPACER; MODEL	Background and Purpose Carbon-ion radiotherapy of prostate cancer is challenging in patients with metal implants in one or both hips. Problems can be circumvented by using fields at oblique angles. To evaluate the influence of setup and range uncertainties accompanying oblique field angles, we calculated rectal dose changes with oblique orthogonal field angles, using a device with fixed fields at 0 degrees and 90 degrees and a rotating patient couch. Material and Methods Dose distributions were calculated at the standard angles of 0 degrees and 90 degrees, and then at 30 degrees and 60 degrees. Setup uncertainty was simulated with changes from -2 mm to +2 mm for fields in the anterior-posterior, left-right, and cranial-caudal directions, and dose changes from range uncertainty were calculated with a 1 mm water-equivalent path length added to the target isocenter in each angle. The dose distributions regarding the passive irradiation method were calculated using the K2 dose algorithm. Results The rectal volumes with 0 degrees, 30 degrees, 60 degrees, and 90 degrees field angles at 95% of the prescription dose were 3.4 +/- 0.9 cm(3), 2.8 +/- 1.1 cm(3), 2.2 +/- 0.8 cm(3), and 3.8 +/- 1.1 cm(3), respectively. As compared with 90 degrees fields, 30 degrees and 60 degrees fields had significant advantages regarding setup uncertainty and significant disadvantages regarding range uncertainty, but were not significantly different from the 90 degrees field setup and range uncertainties. Conclusions The setup and range uncertainties calculated at 30 degrees and 60 degrees field angles were not associated with a significant change in rectal dose relative to those at 90 degrees.	[Kubota, Yoshiki; Kawamura, Hidemasa; Sakai, Makoto; Tsumuraya, Ryou; Tashiro, Mutsumi; Yusa, Ken; Kubo, Nobuteru; Sato, Hiro; Kawahara, Masahiro; Katoh, Hiroyuki; Kanai, Tatsuaki; Ohno, Tatsuya; Nakano, Takashi] Gunma Univ, Heavy Ion Med Ctr, Gunma, Japan	Gunma University	Kubota, Y (corresponding author), Gunma Univ, Heavy Ion Med Ctr, Gunma, Japan.	y_kubota@gunma-u.ac.jp	Sato, Hiro/GWU-7659-2022; Sakai, Makoto/AAW-1902-2020; Kubota, Yoshiki/ABI-7675-2020	Sakai, Makoto/0000-0001-9928-2375; Tashiro, Mutsumi/0000-0003-3253-0527	Grants-in-Aid for Scientific Research [26860396, 25670527, 25461905] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bassler N, 2010, RADIOTHER ONCOL, V95, P87, DOI 10.1016/j.radonc.2010.02.026; Chan TCY, 2013, EUR J OPER RES, V231, P745, DOI 10.1016/j.ejor.2013.06.003; Christodouleas JP, 2013, MED DOSIM, V38, P315, DOI 10.1016/j.meddos.2013.03.002; Chu M, 2005, PHYS MED BIOL, V50, P5463, DOI 10.1088/0031-9155/50/23/003; Huang K, 2012, INT J RADIAT ONCOL, V84, P402, DOI 10.1016/j.ijrobp.2011.12.035; Inaniwa T, 2011, PHYS MED BIOL, V56, P4749, DOI 10.1088/0031-9155/56/15/008; Jakel O, 2007, PHYS MED BIOL, V52, P635, DOI 10.1088/0031-9155/52/3/007; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Kanematsu N, 2003, PHYS MED BIOL, V48, P1053, DOI 10.1088/0031-9155/48/8/307; Kanematsu N, 2008, MED PHYS, V35, P602, DOI 10.1118/1.2829878; Kanematsu N, 2007, MED PHYS, V34, P1907, DOI 10.1118/1.2733812; Kanematsu N, 2006, PHYS MED BIOL, V51, P4807, DOI 10.1088/0031-9155/51/19/006; Kanematsu N, 2011, PHYS MEDICA, V27, P97, DOI 10.1016/j.ejmp.2010.05.001; Kanematsu Nobuyuki, 2003, Igaku Butsuri, V23, P140; Kraft G, 2000, PROG PART NUCL PHYS, V45, pS473, DOI 10.1016/S0146-6410(00)00112-5; Kubota Y, 2015, J APPL CLIN MED PHYS, V16, P100, DOI 10.1120/jacmp.v16i4.5400; Kurosawa Yuji, 2012, Nihon Hoshasen Gijutsu Gakkai Zasshi, V68, P290; Liu W, 2012, MED PHYS, V39, P1079, DOI 10.1118/1.3679340; Mah D, 2002, INT J RADIAT ONCOL, V54, P568, DOI 10.1016/S0360-3016(02)03008-0; Ohno Tatsuya, 2011, Cancers (Basel), V3, P4046, DOI 10.3390/cancers3044046; RENNER TR, 1987, MED PHYS, V14, P825, DOI 10.1118/1.596009; Rucinski A, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0348-1; Tang SK, 2012, INT J RADIAT ONCOL, V83, P408, DOI 10.1016/j.ijrobp.2011.06.1974; Tashiro M, 2013, RADIOL PHYS TECHNOL, V6, P356, DOI 10.1007/s12194-013-0208-3; Weber DC, 2012, INT J RADIAT ONCOL, V84, pE311, DOI 10.1016/j.ijrobp.2012.03.028	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153894	10.1371/journal.pone.0153894	http://dx.doi.org/10.1371/journal.pone.0153894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097041	Green Published, gold			2022-12-26	WOS:000374543600067
J	Altamura, E; Borgatti, M; Finotti, A; Gasparello, J; Gambari, R; Spinelli, M; Castaldo, R; Altamura, N				Altamura, Emiliano; Borgatti, Monica; Finotti, Alessia; Gasparello, Jessica; Gambari, Roberto; Spinelli, Mariangela; Castaldo, Rosa; Altamura, Nicola			Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae	PLOS ONE			English	Article							NONSENSE-MEDIATED DECAY; MESSENGER-RNA DECAY; MPS I-H; STOP CODONS; SACCHAROMYCES-CEREVISIAE; REPORTER SYSTEM; UPF PROTEINS; HUMAN-CELLS; READTHROUGH; MUTATIONS	Nonsense mutations generate in-frame stop codons in mRNA leading to a premature arrest of translation. Functional consequences of premature termination codons (PTCs) include the synthesis of truncated proteins with loss of protein function causing severe inherited or acquired diseases. A therapeutic approach has been recently developed that is based on the use of chemical agents with the ability to suppress PTCs (read-through) restoring the synthesis of a functional full-length protein. Research interest for compounds able to induce read-through requires an efficient high throughput large scale screening system. We present a rapid, sensitive and quantitative method based on a dual-fluorescence reporter expressed in the yeast Saccharomyces cerevisiae to monitor and quantitate read-through at PTCs. We have shown that our novel system works equally well in detecting read-through at all three PTCs UGA, UAG and UAA.	[Altamura, Emiliano] Univ Bari, Dept Chem, Bari, Italy; [Borgatti, Monica; Finotti, Alessia; Gasparello, Jessica; Gambari, Roberto] Univ Ferrara, Biochem & Mol Biol Sect, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Spinelli, Mariangela; Castaldo, Rosa; Altamura, Nicola] CNR, Inst Biomembranes & Bioenerget, Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Ferrara; Consiglio Nazionale delle Ricerche (CNR)	Altamura, E (corresponding author), Univ Bari, Dept Chem, Bari, Italy.; Altamura, N (corresponding author), CNR, Inst Biomembranes & Bioenerget, Bari, Italy.	emiliano.altamura@uniba.it; n.altamura@ibbe.cnr.it	Gasparello, Jessica/N-6975-2018; Finotti, Alessia/C-6268-2012; Borgatti, Monica/G-2611-2015; Altamura, Emiliano/AAN-2309-2020	Gasparello, Jessica/0000-0001-8557-0739; Finotti, Alessia/0000-0002-7638-515X; Borgatti, Monica/0000-0001-8470-2496; Altamura, Emiliano/0000-0003-3171-6645	Italian Cystic Fibrosis Research Foundation [2/2010, 1/2012]; Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo); UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of B-Thalassemia) [306201-FP7-HEALTH-2012-INNOVATION-1]; Telethon [GGP10124]; Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo; LABORATORIO SISTEMA [PONa300369 MIUR]; Ministero della Salute, Italy [098/GR-2009-1596647]	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo)(Fondazione Cariparo); UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of B-Thalassemia); Telethon(Fondazione Telethon); Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo; LABORATORIO SISTEMA; Ministero della Salute, Italy(Ministry of Health, Italy)	Nicola Altamura was funded by Italian Cystic Fibrosis Research Foundation (FFC#2/2010 and FFC#1/2012). Roberto Gambari is funded by Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo), UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of B-Thalassemia; n. 306201-FP7-HEALTH-2012-INNOVATION-1) and Telethon (contract GGP10124). This research activity has been also supported by Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo. Emiliano Altamura was supported by LABORATORIO SISTEMA (PONa300369 MIUR) facilities and the Center for Colloid and Surface Science (CSGI). Monica Borgatti was funded by Ministero della Salute, Italy (contract 098/GR-2009-1596647) and Italian Cystic Fibrosis Research Foundation (FFC#2/2010 and FFC#1/2012). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura N, 2013, J CYST FIBROS, V12, P806, DOI 10.1016/j.jcf.2013.02.007; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; Bhuvanagiri M, 2014, EMBO MOL MED, V6, P1593, DOI 10.15252/emmm.201404461; Bidou L, 2004, GENE THER, V11, P619, DOI 10.1038/sj.gt.3302211; Bidou L, 2000, RNA, V6, P952, DOI 10.1017/S1355838200000443; Bidou L, 2012, TRENDS MOL MED, V18, P679, DOI 10.1016/j.molmed.2012.09.008; Bidou L, 2010, FEMS YEAST RES, V10, P1070, DOI 10.1111/j.1567-1364.2010.00684.x; Du LT, 2013, MOL THER, V21, P1653, DOI 10.1038/mt.2013.150; Du LT, 2009, J EXP MED, V206, P2285, DOI 10.1084/jem.20081940; Floquet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024125; Floquet C, 2011, NUCLEIC ACIDS RES, V39, P3350, DOI 10.1093/nar/gkq1277; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Goldmann T, 2012, EMBO MOL MED, V4, P1186, DOI 10.1002/emmm.201201438; Gonzalez-Hilarion S, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-58; Grentzmann G, 1998, RNA, V4, P479; Gunn G, 2014, MOL GENET METAB, V111, P374, DOI 10.1016/j.ymgme.2013.12.007; Halvey PJ, 2012, FEBS OPEN BIO, V2, P56, DOI 10.1016/j.fob.2012.04.004; Harger JW, 2004, RNA, V10, P1721, DOI 10.1261/rna.7120504; He F, 2001, MOL CELL BIOL, V21, P1515, DOI 10.1128/MCB.21.5.1515-1530.2001; He F, 2015, ANNU REV GENET, V49, P339, DOI 10.1146/annurev-genet-112414-054639; He F, 2013, MOL CELL BIOL, V33, P4672, DOI 10.1128/MCB.01136-13; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Keeling KM, 2012, CRIT REV BIOCHEM MOL, V47, P444, DOI 10.3109/10409238.2012.694846; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; Keppler-Ross S, 2008, GENETICS, V179, P705, DOI 10.1534/genetics.108.087080; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Langedijk J, 2015, DRUG DISCOVERY TODAY; Lee HLR, 2012, PHARMACOL THERAPEUT, V136, P227, DOI 10.1016/j.pharmthera.2012.07.007; Lentini L, 2014, MOL PHARMACEUT, V11, P653, DOI 10.1021/mp400230s; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; McElroy SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001593; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Rakauskaite R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr382; Salvatori F, 2009, AM J HEMATOL, V84, P720, DOI 10.1002/ajh.21539; Shulman E, 2014, J BIOL CHEM, V289, P2318, DOI 10.1074/jbc.M113.533588; Swan SK, 1997, SEMIN NEPHROL, V17, P27; Taguchi A, 2014, CHEMMEDCHEM, V9, P2233, DOI 10.1002/cmdc.201402208; Wang D, 2012, MOL GENET METAB, V105, P116, DOI 10.1016/j.ymgme.2011.10.005; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC	46	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154260	10.1371/journal.pone.0154260	http://dx.doi.org/10.1371/journal.pone.0154260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119736	Green Published, gold			2022-12-26	WOS:000374976200054
J	Altmaier, E; Menni, C; Heier, M; Meisinger, C; Thorand, B; Quell, J; Kobl, M; Romisch-Margl, W; Valdes, AM; Mangino, M; Waldenberger, M; Strauch, K; Illig, T; Adamski, J; Spector, T; Gieger, C; Suhre, K; Kastenmuller, G				Altmaier, Elisabeth; Menni, Cristina; Heier, Margit; Meisinger, Christa; Thorand, Barbara; Quell, Jan; Kobl, Michael; Roemisch-Margl, Werner; Valdes, Ana M.; Mangino, Massimo; Waldenberger, Melanie; Strauch, Konstantin; Illig, Thomas; Adamski, Jerzy; Spector, Tim; Gieger, Christian; Suhre, Karsten; Kastenmuller, Gabi			The Pharmacogenetic Footprint of ACE Inhibition: A Population-Based Metabolomics Study	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; COMPLEMENT C3; HUMAN PLASMA; SYSTEM; HYPERTENSION; ASSOCIATION; DEGRADATION; HYDROLYSIS; ACTIVATION; PEPTIDES	Angiotensin-I-converting enzyme (ACE) inhibitors are an important class of antihypertensives whose action on the human organism is still not fully understood. Although it is known that ACE especially cleaves COOH-terminal dipeptides from active polypeptides, the whole range of substrates and products is still unknown. When analyzing the action of ACE inhibitors, effects of genetic variation on metabolism need to be considered since genetic variance in the ACE gene locus was found to be associated with ACE-concentration in blood as well as with changes in the metabolic profiles of a general population. To investigate the interactions between genetic variance at the ACE-locus and the influence of ACE-therapy on the metabolic status we analyzed 517 metabolites in 1,361 participants from the KORA F4 study. We replicated our results in 1,964 individuals from TwinsUK. We observed differences in the concentration of five dipeptides and three ratios of di- and oligopeptides between ACE inhibitor users and non-users that were genotype dependent. Such changes in the concentration affected major homozygotes, and to a lesser extent heterozygotes, while minor homozygotes showed no or only small changes in the metabolite status. Two of these resulting dipeptides, namely aspartylphenylalanine and phenylalanylserine, showed significant associations with blood pressure which qualifies them-and perhaps also the other dipeptides-as readouts of ACE-activity. Since so far ACE activity measurement is substrate specific due to the usage of only one oligopeptide, taking several dipeptides as potential products of ACE into account may provide a broader picture of the ACE activity.	[Altmaier, Elisabeth; Waldenberger, Melanie; Illig, Thomas; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Menni, Cristina; Valdes, Ana M.; Mangino, Massimo; Spector, Tim; Kastenmuller, Gabi] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Heier, Margit; Meisinger, Christa; Thorand, Barbara; Waldenberger, Melanie] German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Quell, Jan; Roemisch-Margl, Werner; Suhre, Karsten; Kastenmuller, Gabi] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Kobl, Michael; Strauch, Konstantin] German Res Ctr Environm Hlth, Inst Genet Epidemiol, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Strauch, Konstantin] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Genet Epidemiol, Marchionistr 15, D-81377 Munich, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Illig, Thomas] Hannover Med Sch, Inst Human Genet, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Adamski, Jerzy] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Inst Expt Genet, Life & Food Sci Ctr Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Adamski, Jerzy; Kastenmuller, Gabi] German Ctr Diabet Res DZD eV, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Suhre, Karsten] Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Educ City, POB 24144, Doha, Qatar	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; King's College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Kastenmuller, G (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England.; Kastenmuller, G (corresponding author), German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.; Kastenmuller, G (corresponding author), German Ctr Diabet Res DZD eV, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	g.kastenmueller@helmholtz-muenchen.de	Kastenmüller, Gabi/ABF-5987-2020; Waldenberger, Melanie/B-5355-2014; Thorand, Barbara/B-5349-2014; Heier, Margit/AAT-5280-2020; Suhre, Karsten/AAF-1778-2020; Mangino, Massimo/F-5134-2011; Meisinger, Christine/B-5358-2014	Waldenberger, Melanie/0000-0003-0583-5093; Thorand, Barbara/0000-0002-8416-6440; Suhre, Karsten/0000-0001-9638-3912; Mangino, Massimo/0000-0002-2167-7470; Kastenmuller, Gabi/0000-0002-2368-7322; Meisinger, Christa/0000-0002-9026-6544; Valdes, Ana M./0000-0003-1141-4471; Gieger, Christian/0000-0001-6986-9554; Menni, Cristina/0000-0001-9790-0571; Adamski, Jerzy/0000-0001-9259-0199; Quell, Jan D./0000-0003-2620-1532	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH) - German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research (BMBF); Helmholtz Cross Program Initiative "Personalized Medicine (iMed)"; European Union [305280]; German Federal Ministry of Education and Research (BMBF) [01ZX1313A-2014]; "Biomedical Research Program" funds at Weill Cornell Medical College in Qatar - Qatar Foundation; Wellcome Trust; European Community; National Institute for Health Research (NIHR); King's College London; Pfizer; Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH) - German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Cross Program Initiative "Personalized Medicine (iMed)"; European Union(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); "Biomedical Research Program" funds at Weill Cornell Medical College in Qatar - Qatar Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London; Pfizer(Pfizer); Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust	The KORA research platform is financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF; http://www.bmbf.de/) to the German Center for Diabetes Research (DZD e.V.; http://www.dzd-ev.de/) and by the Helmholtz Cross Program Initiative "Personalized Medicine (iMed)". The research leading to these results has partly received funding from the European Union's Seventh Framework Programme (FP7-Health-F5-2012) under grant agreement no 305280 (MIMOmics; http://www.mimomics.eu/). It was also supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (grant 01ZX1313A-2014; http://www.sys-med.de/de/konsortien/eatherosysmed/). K.S. is supported by "Biomedical Research Program" funds at Weill Cornell Medical College in Qatar, a program funded by the Qatar Foundation (http://www.qf.org.qa/). TwinsUK was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013; https://ec.europa.eu/research/fp7/index_en.cfm). The study also receives support from the National Institute for Health Research (NIHR; http://www.nihr.ac.uk/) - funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. SNP Genotyping was performed by The Wellcome Trust Sanger Institute (http://www.sanger.ac.uk/) and National Eye Institute (https://nei.nih.gov/) via NIH/CIDR. Metabolomic analysis was funded by Pfizer (http://www.pfizer.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2000, J CLIN ENDOCR METAB, V85, P1043, DOI 10.1210/jc.85.3.1043; Altmaier E, 2014, EUR J EPIDEMIOL, V29, P325, DOI 10.1007/s10654-014-9910-7; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Arnold M, 2015, BIOINFORMATICS, V31, P1334, DOI 10.1093/bioinformatics/btu779; Barron BA, 1999, CARDIOVASC RES, V43, P13, DOI 10.1016/S0008-6363(99)00112-1; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; Dousset B, 1998, BIOCHEM BIOPH RES CO, V247, P587, DOI 10.1006/bbrc.1998.8834; DUBREUIL P, 1989, BIOCHEM J, V262, P125, DOI 10.1042/bj2620125; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; GANU VS, 1989, MOL IMMUNOL, V26, P939, DOI 10.1016/0161-5890(89)90112-0; Guang C, 2012, ARCH CARDIOVASC DIS, V105, P373, DOI 10.1016/j.acvd.2012.02.010; HARRISON RA, 1988, COMPLEMENT INFLAMMAT, V5, P27, DOI 10.1159/000463028; Krumsiek J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003005; Li GH, 2004, NUTR RES, V24, P469, DOI [10.1016/S0271-5317(04)00058-2, 10.1016/j.nutres.2003.10.014]; Lu┬ffle M., 2003, INFORM BIOMETRIE EPI, P601; MELZIG MF, 1995, PHARMAZIE, V50, P139; MUSCARI A, 1995, AM J MED, V98, P357, DOI 10.1016/S0002-9343(99)80314-3; Nadar SK, 2007, J HUM HYPERTENS, V21, P261, DOI 10.1038/sj.jhh.1002160; Petersen AK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-120; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; SKIDGEL RA, 1985, P NATL ACAD SCI USA, V82, P1025, DOI 10.1073/pnas.82.4.1025; SKIDGEL RA, 1987, CLIN EXP HYPERTENS A, V9, P243, DOI 10.3109/10641968709164184; SKIDGEL RA, 1984, PEPTIDES, V5, P769, DOI 10.1016/0196-9781(84)90020-2; Smith RET, 2007, NAT REV DRUG DISCOV, V6, P597, DOI 10.1038/nrd2354; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tichaczek-Goska D, 2012, ADV CLIN EXP MED, V21, P105; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; ULRICH C, 1985, PEPTIDES, V6, P475, DOI 10.1016/0196-9781(85)90113-5; Yu B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004212; Zhou XL, 2013, AM J PHYSIOL-RENAL, V305, pF957, DOI 10.1152/ajprenal.00344.2013	32	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153163	10.1371/journal.pone.0153163	http://dx.doi.org/10.1371/journal.pone.0153163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120469	gold, Green Published, Green Submitted			2022-12-26	WOS:000374976200019
J	Nalbant, A; Saygili, T				Nalbant, Ayten; Saygili, Tahsin			IL12, IL10, IFN gamma and TNF alpha Expression in Human Primary Monocytes Stimulated with Bacterial Heat Shock GroEL (Hsp64) Protein	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PROINFLAMMATORY CYTOKINE; INTERFERON-GAMMA; MACROPHAGES; CELLS; DIFFERENTIATION; LOCALIZATION; INFECTION; RESPONSES; CONTAINS	Actinobacillus (Aggregatibacter) actinomycetemicomitans (Aa) is a bacterium that lives in the oral cavity and plays an important role in periodontal diseases. The effect of A. actinomycetemcomitans's heat shock family protein GroEL on host or immune cells including monocytes is quite limited. In this study, the recombinant A. actinomycetemcomitans's GroEL protein (rAaGroEL) was used as an antigen and its effects on monocytes of peripheral blood mononuclear cells (PBMCs) was investigated. To do that, PBMCs were stimulated with rAaGroEL protein at different time points (16h to 96h) and the cytokines of CD14+ monocytes were detected with intracellular cytokine staining by Flow cytometry. Data showed that AaGroEL protein has an antigenic effect on human primary monocytes. AaGroEL protein responsive CD14 monocytes stimulates the expression of IL12, IL10, IFN gamma and TNF alpha cytokines with different kinetics and expression profile. Therefore, A. actinomycetemcomitans's heat shock GroEL protein can modulate innate and adaptive immune responses and contribute to an inflammatory diseases pathology.	[Nalbant, Ayten; Saygili, Tahsin] Izmir Inst Technol, Dept Mol Biol & Genet, Mol Immunol & Gene Regulat Lab, TR-35430 Izmir, Turkey; [Saygili, Tahsin] Alex Ilac Ticaret Ltd Sti, Buyukdere Cad 100-102 B Blok Kat 1, TR-34394 Istanbul, Turkey	Izmir Institute of Technology; Alexion Pharmaceuticals in Turkey	Nalbant, A (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Mol Immunol & Gene Regulat Lab, TR-35430 Izmir, Turkey.	aytennalbant@iyte.edu.tr	Ramalho, Lais Vieira/AAH-1596-2019	Ramalho, Lais Vieira/0000-0003-1459-3954	Scientific and Technological Research Council of Turkey (TUBITAK) [106T417]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by a grant from the Scientific and Technological Research Council of Turkey (TUBITAK) (Project# 106T417 to Dr. Ayten Nalbant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2015, VIRULENCE, V6, P188, DOI 10.4161/21505594.2014.982428; Boesze-Battaglia K, 2015, INFECT IMMUN, V83, P4042, DOI 10.1128/IAI.00788-15; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; Gobert AP, 2004, J BIOL CHEM, V279, P245, DOI 10.1074/jbc.M307858200; Goulhen F, 1998, INFECT IMMUN, V66, P5307, DOI 10.1128/IAI.66.11.5307-5313.1998; Graham GM, 2004, BRIT J DERMATOL, V150, P421, DOI 10.1046/j.1365-2133.2004.05762.x; Guerra-Laso JM, 2015, IMMUNOLOGY, V144, P291, DOI 10.1111/imm.12371; Hu YM, 2008, INFECT IMMUN, V76, P1535, DOI 10.1128/IAI.01078-07; KIRBY AC, 1995, J CLIN INVEST, V96, P1185, DOI 10.1172/JCI118150; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Leclerq S, 2002, J MED MICROBIOL, V51, P20, DOI 10.1099/0022-1317-51-1-20; Lewthwaite JC, 2001, INFECT IMMUN, V69, P7349, DOI 10.1128/IAI.69.12.7349-7355.2001; Lin SN, 2005, J MED MICROBIOL, V54, P225, DOI 10.1099/jmm.0.45871-0; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Melton DW, 2015, AUTOIMMUNITY, V48, P161, DOI 10.3109/08916934.2015.1027816; Paju S, 2000, FEMS MICROBIOL LETT, V182, P231, DOI 10.1016/S0378-1097(99)00595-9; RETZLAFF C, 1994, INFECT IMMUN, V62, P5689, DOI 10.1128/IAI.62.12.5689-5693.1994; Saygili T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049252; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sharma SA, 1997, CLIN DIAGN LAB IMMUN, V4, P440, DOI 10.1128/CDLI.4.4.440-446.1997; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Shenker BJ, 2014, CELL MICROBIOL, V16, P1391, DOI 10.1111/cmi.12299; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Ueki K, 2002, CLIN EXP IMMUNOL, V127, P72, DOI 10.1046/j.1365-2249.2002.01723.x	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154085	10.1371/journal.pone.0154085	http://dx.doi.org/10.1371/journal.pone.0154085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119521	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200043
J	Narciso, FV; Barela, JA; Aguiar, SA; Carvalho, ANS; Tufik, S; de Mello, MT				Narciso, Fernanda Veruska; Barela, Jose A.; Aguiar, Stefane A.; Carvalho, Adriana N. S.; Tufik, Sergio; de Mello, Marco Tulio			Effects of Shift Work on the Postural and Psychomotor Performance of Night Workers	PLOS ONE			English	Article							VIGILANCE TEST PVT; SLEEP-DEPRIVATION; COGNITIVE PERFORMANCE; BALANCE CONTROL; TIME AWAKE; COMPONENTS; ALERTNESS; FATIGUE; NURSES; POSTUROGRAPHY	The purpose of the study was to investigate the effects of shift work on the psychomotor and postural performance of night workers. The study included 20 polysomnography technicians working schedule of 12-h night shift by 36-h off. On the first day of protocol, the body mass and height were measured, and an actigraph was placed on the wrist of each participant. On the second day of protocol, sleepiness by Karolinska Sleepiness Scale, postural control by force platform (30 seconds) and psychomotor performance by Psychomotor Vigilance Task (10 minutes) were measured before and after 12-h night work. Results showed that after 12-h night work, sleepiness increased by 59% (p<0.001), postural control variables increased by 9% (p = 0.048), and 14% (p = 0.006). Mean reaction time, and the number of lapses of attention increased by 13% (p = 0.006) and 425% (p = 0.015), respectively, but the mean reciprocal reaction time decreased by 7%. In addition, there were correlations between sleepiness and postural control variables with opened eyes (r = 0.616, 95% confidence interval [CI] = 0.361-0.815; r = 0.538; 95% CI = 0.280-0.748) and closed eyes (r = 0.557; 95% CI = 0.304-0.764, r = 0497; 95% CI = 0.325-0.715) and a pronounced effect of sleepiness on postural sway (R-2 = 0.393; 95% CI = 0.001-0.03). Therefore, 12-h night work system and sleepiness showed a negative impact in postural and psychomotor vigilance performance of night workers. As unexpected, the force platform was feasibility to detect sleepiness in this population, underscoring the possibility of using this method in the workplace to prevent occupational injuries and accidents.	[Narciso, Fernanda Veruska; Tufik, Sergio; de Mello, Marco Tulio] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil; [Barela, Jose A.; Aguiar, Stefane A.] Univ Cruzeiro Sul, Sao Paulo, SP, Brazil; [Carvalho, Adriana N. S.] Assoc Fundo Incent Pesquisa, Sao Paulo, SP, Brazil; [de Mello, Marco Tulio] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Cruzeiro do Sul; Universidade Federal de Minas Gerais	de Mello, MT (corresponding author), Univ Fed Sao Paulo, Sao Paulo, SP, Brazil.; de Mello, MT (corresponding author), Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.	tmello@demello.net.br	Barela, José A/F-4284-2012; Narciso, Fernanda Veruska FVN/O-9869-2015; de Mello, Marco Tulio/G-3237-2010	Barela, José A/0000-0003-0951-254X; de Mello, Marco Tulio/0000-0003-3896-2208; Veruska Narciso, Fernanda/0000-0001-6863-8252				Aguiar SA, 2014, NEUROSCI LETT, V574, P47, DOI 10.1016/j.neulet.2014.05.028; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Avni N, 2006, PSYCHIAT CLIN NEUROS, V60, P340, DOI 10.1111/j.1440-1819.2006.01511.x; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Bougard C, 2011, EXP BRAIN RES, V209, P109, DOI 10.1007/s00221-010-2524-8; de Mello MT, 2008, BRAZ J MED BIOL RES, V41, P1129, DOI 10.1590/S0100-879X2008001200014; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Folkard S, 2006, AM J IND MED, V49, P953, DOI 10.1002/ajim.20307; Forsman P, 2008, IEEE ENG MED BIO, P686, DOI 10.1109/IEMBS.2008.4649245; Forsman P, 2008, J BIOMECH, V41, P2892, DOI 10.1016/j.jbiomech.2008.07.003; Forsman P, 2014, ACCIDENT ANAL PREV, V62, P186, DOI 10.1016/j.aap.2013.09.015; Forsman P, 2010, GAIT POSTURE, V32, P419, DOI 10.1016/j.gaitpost.2010.06.012; Geiger-Brown J, 2012, CHRONOBIOL INT, V29, P211, DOI 10.3109/07420528.2011.645752; Goncalves M, 2015, J SLEEP RES, V24, P242, DOI 10.1111/jsr.12267; Harma M, 2002, J SLEEP RES, V11, P141, DOI 10.1046/j.1365-2869.2002.00294.x; Jackson ML, 2013, ACCIDENT ANAL PREV, V50, P438, DOI 10.1016/j.aap.2012.05.020; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Karhula K, 2013, IND HEALTH, V51, P406; Karita K, 2006, J OCCUP HEALTH, V48, P65, DOI 10.1539/joh.48.65; Lamond N, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.11.e13; Liviya W, 2014, J OCCUP ENVIRON MED, V56, P935, DOI 10.1097/JOM.0000000000000150; Lombardi DA, 2010, CHRONOBIOL INT, V27, P1013, DOI 10.3109/07420528.2010.489466; Morad Y, 2007, AVIAT SPACE ENVIR MD, V78, P859; Niu SF, 2013, BIOL RES NURS, V15, P273, DOI 10.1177/1099800412439459; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Pham Quang-Cuong, 2014, Rev. Bras. Eng. Bioméd., V30, P322, DOI 10.1590/1517-3151.0611; Roach GD, 2006, CHRONOBIOL INT, V23, P1379, DOI 10.1080/07420520601067931; Robillard R, 2011, CLIN NEUROPHYSIOL, V122, P1771, DOI 10.1016/j.clinph.2011.02.010; Roca J, 2012, ACTA PSYCHOL, V140, P164, DOI 10.1016/j.actpsy.2012.03.007; Roge J, 2009, PERCEPT MOTOR SKILL, V109, P270, DOI 10.2466/PMS.109.1.270-284; Sallinen M, 2004, J SLEEP RES, V13, P285, DOI 10.1111/j.1365-2869.2004.00425.x; Sargent C, 2012, ACCIDENT ANAL PREV, V45, P74, DOI 10.1016/j.aap.2011.09.030; Scott LD, 2006, AM J CRIT CARE, V15, P30; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Thomas Maria L., 2003, Thalamus & Related Systems, V2, P199, DOI 10.1017/S1472928803000207; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; Van Dongen HPA, 2005, CLIN SPORT MED, V24, P237, DOI 10.1016/j.csm.2004.12.007; Vetter C, 2012, CHRONOBIOL INT, V29, P1127, DOI 10.3109/07420528.2012.707999; Wehrens SMT, 2012, CHRONOBIOL INT, V29, P537, DOI 10.3109/07420528.2012.675258	40	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0151609	10.1371/journal.pone.0151609	http://dx.doi.org/10.1371/journal.pone.0151609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115868	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600011
J	Cacao, E; Hada, M; Saganti, PB; George, KA; Cucinotta, FA				Cacao, Eliedonna; Hada, Megumi; Saganti, Premkumar B.; George, Kerry A.; Cucinotta, Francis A.			Relative Biological Effectiveness of HZE Particles for Chromosomal Exchanges and Other Surrogate Cancer Risk Endpoints	PLOS ONE			English	Article							SISTER-CHROMATID EXCHANGES; VERY-LOW FLUENCES; ALPHA-PARTICLES; TRACK STRUCTURE; ACCELERATED PARTICLES; MUTATION-INDUCTION; RADIATION QUALITY; ENERGY PROTONS; SPACE; CELLS	The biological effects of high charge and energy (HZE) particle exposures are of interest in space radiation protection of astronauts and cosmonauts, and estimating secondary cancer risks for patients undergoing Hadron therapy for primary cancers. The large number of particles types and energies that makeup primary or secondary radiation in HZE particle exposures precludes tumor induction studies in animal models for all but a few particle types and energies, thus leading to the use of surrogate endpoints to investigate the details of the radiation quality dependence of relative biological effectiveness (RBE) factors. In this report we make detailed RBE predictions of the charge number and energy dependence of RBE's using a parametric track structure model to represent experimental results for the low dose response for chromosomal exchanges in normal human lymphocyte and fibroblast cells with comparison to published data for neoplastic transformation and gene mutation. RBE's are evaluated against acute doses of.-rays for doses near 1 Gy. Models that assume linear or non-targeted effects at low dose are considered. Modest values of RBE (<10) are found for simple exchanges using a linear dose response model, however in the non-targeted effects model for fibroblast cells large RBE values (>10) are predicted at low doses <0.1 Gy. The radiation quality dependence of RBE's against the effects of acute doses.-rays found for neoplastic transformation and gene mutation studies are similar to those found for simple exchanges if a linear response is assumed at low HZE particle doses. Comparisons of the resulting model parameters to those used in the NASA radiation quality factor function are discussed.	[Cacao, Eliedonna; Cucinotta, Francis A.] Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA; [Hada, Megumi; Saganti, Premkumar B.] Prairie View A&M Univ, Radiat Inst Sci & Engn, Prairie View, TX USA; [George, Kerry A.] Wyle, Houston, TX USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Texas A&M University System; Prairie View A&M University	Cucinotta, FA (corresponding author), Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA.	Francis.Cucinotta@unlv.edu	Cucinotta, Francis/AAZ-5941-2020	Saganti, Premkumar/0000-0002-2456-210X	DOE Low Dose Program [DE-AI02-10ER64969]; University of Nevada, Las Vegas	DOE Low Dose Program; University of Nevada, Las Vegas	This work was supported by the DOE Low Dose Program (grant number DE-AI02-10ER64969) to FAC, and the University of Nevada, Las Vegas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALPEN EL, 1993, RADIAT RES, V136, P382, DOI 10.2307/3578551; [Anonymous], 2006, HLTH RISKS EXPOSURE; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; BELLI M, 1992, INT J RADIAT BIOL, V61, P625, DOI 10.1080/09553009214551431; BELLI M, 1993, INT J RADIAT BIOL, V63, P331, DOI 10.1080/09553009314550441; Buonanno M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021540; Burns FJ, 2007, RADIAT ENVIRON BIOPH, V46, P195, DOI 10.1007/s00411-007-0106-3; Chang PY, 2016, RAD RES IN PRESS; Cucinotta FA, 1998, RADIAT RES, V150, P115, DOI 10.2307/3579651; Cucinotta FA, 1996, INT J RADIAT BIOL, V69, P593, DOI 10.1080/095530096145607; Cucinotta FA, 1998, RADIAT ENVIRON BIOPH, V37, P259, DOI 10.1007/s004110050127; Cucinotta FA, 2013, 2013217375 NASA TP; Cucinotta FA, 2016, HEALTH PHYS, V110, P262, DOI 10.1097/HP.0000000000000442; Cucinotta FA, 2015, LIFE SCI SPACE RES, V5, P31, DOI 10.1016/j.lssr.2015.04.002; Cucinotta FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120717; Cucinotta FA, 2014, LIFE SCI SPACE RES, V2, P54, DOI 10.1016/j.lssr.2014.06.003; Cucinotta FA, 2010, MUTAT RES-FUND MOL M, V687, P49, DOI 10.1016/j.mrfmmm.2010.01.012; Dicello JF, 2004, PHYS MED BIOL, V49, P3817, DOI 10.1088/0031-9155/49/16/024; Edwards A. A., 1999, Journal of Radiological Protection, V19, P93, DOI 10.1088/0952-4746/19/2/201; Edwards AA, 2001, PHYS MEDICA, V17, P147; FRY RJM, 1985, RADIAT RES, V104, pS188, DOI 10.2307/3576646; George K, 2007, ADV SPACE RES, V39, P1076, DOI 10.1016/j.asr.2007.01.004; George KA, 2013, RADIAT RES, V180, P25, DOI 10.1667/RR3291.1; GOODHEAD DT, 1989, NUCL TRACKS RAD MEAS, V16, P177; Hada M, 2014, RADIAT RES, V182, P368, DOI 10.1667/RR13721.1; Huo LH, 2001, RADIAT RES, V156, P521, DOI 10.1667/0033-7587(2001)156[0521:HMIIBC]2.0.CO;2; ICRP, 2003, ICRP PUBL; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; KATZ R, 1994, RADIAT RES, V140, P356, DOI 10.2307/3579113; Kawata T, 2001, INT J RADIAT BIOL, V77, P165, DOI 10.1080/09553000010007686; Kiefer J, 2001, RADIAT RES, V156, P607, DOI 10.1667/0033-7587(2001)156[0607:MIMCIB]2.0.CO;2; Kim MHY, 2014, J GEOPHYS RES-PLANET, V119, P1311, DOI 10.1002/2013JE004549; Lehnert BE, 1997, CANCER RES, V57, P2164; Liber HL, 2014, RADIAT RES, V182, P390, DOI 10.1667/RR13817.1; Little JB, 2003, RADIAT RES, V159, P262, DOI 10.1667/0033-7587(2003)159[0262:IOTNEJ]2.0.CO;2; Nagasawa H, 2002, MUTAT RES-FUND MOL M, V508, P121, DOI 10.1016/S0027-5107(02)00193-8; NAGASAWA H, 1992, CANCER RES, V52, P6394; NAS (National Academy of Sciences Space Science Board), 1996, REP TASK GROUP BIOL; NAS/NRC, 2012, TECHNICAL EVALUATION; NCRP, 2014, RAD PROT SPAC ACT SU; NCRP, 1990, 104 NCRP; NCRP, 2006, 153 NCRP NAT COUNC R; Plante I, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125020; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Suman S, 2016, INT J RADIAT ONCOL, V95, P131, DOI 10.1016/j.ijrobp.2015.10.057; Terasawa T, 2009, ANN INTERN MED, V151, P556, DOI 10.7326/0003-4819-151-8-200910200-00145; THACKER J, 1979, INT J RADIAT BIOL, V36, P137, DOI 10.1080/09553007914550891; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, SOURC EFF ION RAD UN; WALIGORSKI MPR, 1987, RADIAT RES, V111, P424, DOI 10.2307/3576928; Weil MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104819; WILSON JW, 1993, NATO ADV SCI INST SE, V243, P295; Yang H, 2011, RADIAT RES, V176, P695, DOI 10.1667/RR2674.1; YANG TCH, 1985, RADIAT RES, V104, pS177, DOI 10.2307/3576645; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989	56	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153998	10.1371/journal.pone.0153998	http://dx.doi.org/10.1371/journal.pone.0153998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111667	Green Submitted, Green Published, gold			2022-12-26	WOS:000374970600025
J	Ameratunga, M; Asadi, K; Lin, XH; Walkiewicz, M; Murone, C; Knight, S; Mitchell, P; Boutros, P; John, T				Ameratunga, Malaka; Asadi, Khashayar; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel; Knight, Simon; Mitchell, Paul; Boutros, Paul; John, Thomas			PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; CD8(+) T-CELLS; LIGAND 1; EXPRESSION; SURVIVAL; RECURRENCE; CD4(+); ADENOCARCINOMA; MUTATIONS; BLOCKADE	Introduction Immune checkpoint inhibition has shifted treatment paradigms in non-small cell lung cancer (NSCLC). Conflicting results have been reported regarding the immune infiltrate and programmed death-ligand 1 (PD-L1) as a prognostic marker. We correlated the immune infiltrate and PD-L1 expression with clinicopathologic characteristics in a cohort of resected NSCLC. Methods A tissue microarray was constructed using triplicate cores from consecutive resected NSCLC. Immunohistochemistry was performed for CD8, FOXP3 and PD-L1. Strong PD-L1 expression was predefined as greater than 50% tumor cell positivity. Matched nodal samples were assessed for concordance of PD-L1 expression. Results Of 522 patients, 346 were node-negative (N0), 72 N1 and 109 N2; 265 were adenocarcinomas (AC), 182 squamous cell cancers (SCC) and 75 other. Strong PD-L1 expression was found in 24% cases. In the overall cohort, PD-L1 expression was not associated with survival. In patients with N2 disease, strong PD-L1 expression was associated with significantly improved disease-free (DFS) and overall survival (OS) in multivariate analysis (HR 0.49, 95% CI 0.36-0.94, p = 0.031; HR 0.46, 95% CI 0.26-0.80, p = 0.006). In this resected cohort only 5% harboured EGFR mutations, whereas 19% harboured KRAS and 23% other. KRAS mutated tumors were more likely to highly express PD-L1 compared to EGFR (22% vs 3%). A stromal CD8 infiltrate was associated with significantly improved DFS in SCC (HR 0.70, 95% CI 0.50-0.97, p = 0.034), but not AC, whereas FOXP3 was not prognostic. Matched nodal specimens (N = 53) were highly concordant for PD-L1 expression (89%). Conclusion PD-L1 expression was not prognostic in the overall cohort. PD-L1 expression in primary tumor and matched nodal specimens were highly concordant. The observed survival benefit in N2 disease requires confirmation.	[Ameratunga, Malaka; Mitchell, Paul; John, Thomas] Austin Hlth, Dept Med Oncol, Olivia Newton John Canc & Wellness Ctr, Heidelberg, Vic, Australia; [Asadi, Khashayar; Murone, Carmel] Austin Hlth, Dept Pathol, Heidelberg, Vic, Australia; [Lin, Xihui; Boutros, Paul] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada; [Walkiewicz, Marzena; Murone, Carmel; John, Thomas] Olivia Newton John Canc Res Inst, Hawthorn, Vic, Australia; [Knight, Simon] Austin Hlth, Dept Thorac, Hawthorn, Vic, Australia; [Boutros, Paul] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [John, Thomas] La Trobe Univ, Sch Canc Med, Bundoora, Vic 3086, Australia; [John, Thomas] Univ Melbourne, Melbourne, Vic 3010, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ontario Institute for Cancer Research; La Trobe University; Olivia Newton-John Cancer Research Institute; Florey Institute of Neuroscience & Mental Health; University of Toronto; University of Toronto; La Trobe University; University of Melbourne	John, T (corresponding author), Austin Hlth, Dept Med Oncol, Olivia Newton John Canc & Wellness Ctr, Heidelberg, Vic, Australia.; John, T (corresponding author), Olivia Newton John Canc Res Inst, Hawthorn, Vic, Australia.; John, T (corresponding author), La Trobe Univ, Sch Canc Med, Bundoora, Vic 3086, Australia.; John, T (corresponding author), Univ Melbourne, Melbourne, Vic 3010, Australia.	tom.john@onjcri.org.au		John, Thomas/0000-0003-3399-5342; Boutros, Paul/0000-0003-0553-7520; Ameratunga, Malaka/0000-0002-7171-6781	National Health and Medical Research Council (NHMRC); Ontario Institute for Cancer Research by the Government of Ontario; Terry Fox Research Institute; Canadian Institutes of Health Research (CIHR); Victorian Government; Cancer Council Victoria	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ontario Institute for Cancer Research by the Government of Ontario; Terry Fox Research Institute; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Victorian Government; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	Thomas John received funding from the National Health and Medical Research Council (NHMRC). This study was conducted with the support of the Ontario Institute for Cancer Research to PCB through funding provided by the Government of Ontario. Dr. Boutros was supported by a Terry Fox Research Institute New Investigator Award and by a Canadian Institutes of Health Research (CIHR) New Investigator Award. The Victorian Cancer Biobank is supported by the Victorian Government. Assoc Prof John is an NHMRC Early Career Scholar and receives funding from the Cancer Council Victoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Andtbacka RH, 2015, J CLIN ONCOLOGY; Antonia SJ, 2014, J CLIN ONCOLOGY, V32; Azuma K, 2014, ANN ONCOL, V25, P1935, DOI 10.1093/annonc/mdu242; Boland JM, 2013, CLIN LUNG CANCER, V14, P157, DOI 10.1016/j.cllc.2012.05.006; Cedres S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121071; Cooper WA, LUNG CANC; D'Incecco A, 2015, BRIT J CANCER, V112, P95, DOI 10.1038/bjc.2014.555; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Donnem T, 2015, CLIN CANC RES; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-1; Garon EB, 2015, NEW ENGLAND J MED; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Horne ZD, 2011, J SURG RES, V171, P1, DOI 10.1016/j.jss.2011.03.068; Ishibashi Y, 2006, ONCOL REP, V15, P1315; John T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067876; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; Kerr KM, 2015, J THORAC ONCOL, V10, P985, DOI 10.1097/JTO.0000000000000526; Kilic A, 2011, J SURG RES, V167, P207, DOI 10.1016/j.jss.2009.08.029; Kim MY, 2015, LUNG CANCER, V88, P24, DOI 10.1016/j.lungcan.2015.01.016; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Liu H, 2012, CANCER IMMUNOL IMMUN, V61, P1849, DOI 10.1007/s00262-012-1231-7; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Mori M, 2000, TOHOKU J EXP MED, V191, P113, DOI 10.1620/tjem.191.113; Pan ZK, 2015, J THORAC DIS, V7, P462, DOI 10.3978/j.issn.2072-1439.2015.02.13; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schalper KA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju435; Schmidt LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136023; Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Tao H, 2014, ANN THORACIC CARDIOV; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Tian CT, 2015, CHINESE MED J-PEKING, V128, P105, DOI 10.4103/0366-6999.147828; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Wakabayashi O, 2003, CANCER SCI, V94, P1003, DOI 10.1111/j.1349-7006.2003.tb01392.x; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yang CY, 2014, EUR J CANCER, V50, P1361, DOI 10.1016/j.ejca.2014.01.018; Zhang GQ, 2012, ASIAN PAC J CANCER P, V13, P3955, DOI 10.7314/APJCP.2012.13.8.3955; Zhang Y, 2010, CELL MOL IMMUNOL, V7, P389, DOI 10.1038/cmi.2010.28; Zhang Y, 2014, ONCOTARGETS THER, V7, P567, DOI 10.2147/OTT.S59959; Zhang YX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000515; Zhuang XW, 2010, APPL IMMUNOHISTO M M, V18, P24, DOI 10.1097/PAI.0b013e3181b6a741	48	53	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153954	10.1371/journal.pone.0153954	http://dx.doi.org/10.1371/journal.pone.0153954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104612	Green Published, gold			2022-12-26	WOS:000374565100030
J	Marton, S; Cleto, F; Krieger, MA; Cardoso, J				Marton, Soledad; Cleto, Fernanda; Krieger, Marco Aurelio; Cardoso, Josiane			Isolation of an Aptamer that Binds Specifically to E. coli	PLOS ONE			English	Article							IN-VITRO SELECTION; WHOLE-CELL SELEX; DNA APTAMERS; SALMONELLA-TYPHIMURIUM; EXPONENTIAL ENRICHMENT; STAPHYLOCOCCUS-AUREUS; SYSTEMATIC EVOLUTION; SSDNA APTAMERS; RNA LIGANDS; IDENTIFICATION	Escherichia coli is a bacterial species found ubiquitously in the intestinal flora of animals, although pathogenic variants cause major public health problems. Aptamers are short oligo-nucleotides that bind to targets with high affinity and specificity, and have great potential for use in diagnostics and therapy. We used cell-based Systematic Evolution of Ligands by EXponential enrichment (cell-SELEX) to isolate four single stranded DNA (ssDNA) aptamers that bind strongly to E. coli cells (ATCC generic strain 25922), with Kd values in the nanomolar range. Fluorescently labeled aptamers label the surface of E. coli cells, as viewed by fluorescent microscopy. Specificity tests with twelve different bacterial species showed that one of the aptamers-called P12-31-is highly specific for E. coli. Importantly, this aptamer binds to Meningitis/sepsis associated E. coli (MNEC) clinical isolates, and is the first aptamer described with potential for use in the diagnosis of MNEC-borne pathologies.	[Marton, Soledad; Cleto, Fernanda; Krieger, Marco Aurelio; Cardoso, Josiane] Inst Biol Mol Parana, Dept Res & Dev, 3375 Prof Algacyr Munhoz Mader St, Curitiba, Parana, Brazil; [Krieger, Marco Aurelio] Inst Carlos Chagas, Lab Genom Funct, 3375 Prof Algacyr Munhoz Mader St, Curitiba, Parana, Brazil		Cardoso, J (corresponding author), Inst Biol Mol Parana, Dept Res & Dev, 3375 Prof Algacyr Munhoz Mader St, Curitiba, Parana, Brazil.	josianec@gmail.com	Krieger, Marco/AAE-8611-2020	Krieger, Marco Aurelio/0000-0003-0030-3952	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Coordenacao de aperfeicoamento de pessoal de nivel superior (CAPES); Fundacao Oswaldo Cruz (FIOCRUZ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de aperfeicoamento de pessoal de nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz (FIOCRUZ)	This investigation received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos (FINEP), Coordenacao de aperfeicoamento de pessoal de nivel superior (CAPES) and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Bruno JG, 2008, FOLIA MICROBIOL, V53, P295, DOI 10.1007/s12223-008-0046-6; Bruno JG, 2010, J FLUORESC, V20, P1211, DOI 10.1007/s10895-010-0670-9; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Dua P, 2013, CANCER RES, V73, P1934, DOI 10.1158/0008-5472.CAN-12-3682; Duan N, 2013, ANAL CHIM ACTA, V804, P151, DOI 10.1016/j.aca.2013.09.047; Duan N, 2013, J MICROBIOL METH, V94, P170, DOI 10.1016/j.mimet.2013.06.016; Duan N, 2013, J AGR FOOD CHEM, V61, P3229, DOI 10.1021/jf400767d; Duan N, 2012, J AGR FOOD CHEM, V60, P4034, DOI 10.1021/jf300395z; Duan N, 2012, ANAL CHIM ACTA, V723, P1, DOI 10.1016/j.aca.2012.02.011; Dwivedi HP, 2013, APPL MICROBIOL BIOT, V97, P3677, DOI 10.1007/s00253-013-4766-4; Dwivedi HP, 2010, APPL MICROBIOL BIOT, V87, P2323, DOI 10.1007/s00253-010-2728-7; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fang ZY, 2014, BIOSENS BIOELECTRON, V56, P192, DOI 10.1016/j.bios.2014.01.015; Ferreira IM, 2014, APPL BIOCHEM BIOTECH, V174, P2548, DOI 10.1007/s12010-014-1206-6; Gopinath SC, 2011, BIOSENS BIOELECTRON, V60, P332; GREEN R, 1990, NATURE, V347, P406, DOI 10.1038/347406a0; Hamula CLA, 2011, ANAL CHEM, V83, P3640, DOI 10.1021/ac200575e; Hernandez R, 2014, BIOSENS BIOELECTRON, V54, P553, DOI 10.1016/j.bios.2013.11.053; Homann M, 1999, NUCLEIC ACIDS RES, V27, P2006, DOI 10.1093/nar/27.9.2006; Hong KL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/419318; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kim SE, 2012, ANAL BIOCHEM, V424, P12, DOI 10.1016/j.ab.2012.02.016; Kim YS, 2014, BIOSENS BIOELECTRON, V54, P195, DOI 10.1016/j.bios.2013.11.003; Kim YS, 2013, ANAL BIOCHEM, V436, P22, DOI 10.1016/j.ab.2013.01.014; Kolovskaya OS, 2013, J MED CHEM, V56, P1564, DOI 10.1021/jm301856j; Labib M, 2012, ANAL CHEM, V84, P8114, DOI 10.1021/ac302217u; Lee YJ, 2012, BIOCHEM BIOPH RES CO, V417, P414, DOI 10.1016/j.bbrc.2011.11.130; Li H, 2011, CAN J MICROBIOL, V57, P453, DOI [10.1139/w11-030, 10.1139/W11-030]; Liu Zhong-Cheng, 2012, Yao Xue Xue Bao, V47, P1605; Ma XY, 2014, J MICROBIOL METH, V98, P94, DOI 10.1016/j.mimet.2014.01.003; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Marton S, 2013, J VIRAL HEPATITIS, V20, P103, DOI 10.1111/j.1365-2893.2012.01629.x; Marton S, 2010, MOLECULES, V15, P4610, DOI 10.3390/molecules15074610; Mayer G, 2010, NAT PROTOC, V5, P1993, DOI 10.1038/nprot.2010.163; Moon J, 2013, J MICROBIOL METH, V95, P162, DOI 10.1016/j.mimet.2013.08.005; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Nagarkatti R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043533; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nutiu R, 2005, METHODS, V37, P16, DOI 10.1016/j.ymeth.2005.07.001; Park HC, 2014, APPL BIOCHEM BIOTECH, V174, P793, DOI 10.1007/s12010-014-1103-z; Park Jinah, 2014, Int J Cell Biol, V2014, P715867, DOI 10.1155/2014/715867; Peng ZH, 2014, J FLUORESC, V24, P1159, DOI 10.1007/s10895-014-1396-x; Pestourie C, 2006, OLIGONUCLEOTIDES, V16, P323, DOI 10.1089/oli.2006.16.323; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Ray P, 2012, J CLIN INVEST, V122, P1734, DOI 10.1172/JCI62385; Savory N, 2014, J MICROBIOL METH, V104, P94, DOI 10.1016/j.mimet.2014.06.016; Savory N, 2013, BIOTECHNOL BIOENG, V110, P2573, DOI 10.1002/bit.24922; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; So HM, 2008, SMALL, V4, P197, DOI 10.1002/smll.200700664; Suh SH, 2014, ANAL BIOCHEM, V459, P39, DOI 10.1016/j.ab.2014.05.006; Suh SH, 2013, J BIOTECHNOL, V167, P454, DOI 10.1016/j.jbiotec.2013.07.027; Sullenger BA, 2003, E SCHERING RES FDN W, V43, P217; Tang XM, 2013, BIOTECHNOL LETT, V35, P909, DOI 10.1007/s10529-013-1154-1; Thiel KW, 2009, OLIGONUCLEOTIDES, V19, P209, DOI 10.1089/oli.2009.0199; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ulrich H, 2006, COMB CHEM HIGH T SCR, V9, P619, DOI 10.2174/138620706778249695; Vivekananda J, 2006, LAB INVEST, V86, P610, DOI 10.1038/labinvest.3700417; Wang KY, 2011, EUR J CLIN MICROBIOL, V30, P273, DOI 10.1007/s10096-010-1074-0; Weigand JE, 2009, APPL MICROBIOL BIOT, V85, P229, DOI 10.1007/s00253-009-2194-2; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x; Wu SJ, 2015, ANAL BIOANAL CHEM, V407, P1303, DOI 10.1007/s00216-014-8378-3; Wu WH, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-658; Wu WH, 2014, ACS APPL MATER INTER, V6, P16974, DOI 10.1021/am5045828; Yang M, 2013, SENSORS-BASEL, V13, P6865, DOI 10.3390/s130506865; Yuan JL, 2014, TALANTA, V127, P163, DOI 10.1016/j.talanta.2014.04.013; Zelada-Guillen GA, 2012, BIOSENS BIOELECTRON, V31, P226, DOI 10.1016/j.bios.2011.10.021; Zelada-Guillen GA, 2010, ANAL CHEM, V82, P9254, DOI 10.1021/ac101739b; Zimbres FM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/731516; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	76	47	48	11	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153637	10.1371/journal.pone.0153637	http://dx.doi.org/10.1371/journal.pone.0153637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104834	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100014
J	da Silva, AFA; Machado, FB; Pavarino, EC; Biselli-Perico, JM; Zampieri, BL; Francisco, RD; Rodrigues, PTM; Machado, DT; Santos-Reboucas, CB; Fernandes, MG; Lopes, SMCD; Rios, AFL; Medina-Acosta, E				Alves da Silva, Antonio Francisco; Machado, Filipe Brum; Pavarino, Erika Cristina; Biselli-Perico, Joice Matos; Zampieri, Bruna Lancia; Francisco Junior, Ronaldo da Silva; Mozer Rodrigues, Pedro Thyago; Machado, Douglas Terra; Santos-Reboucas, Cintia Barros; Fernandes, Maria Gomes; Chuva de Sousa Lopes, Susana Marina; Lopes Rios, Alvaro Fabricio; Medina-Acosta, Enrique			Trisomy 21 Alters DNA Methylation in Parent-of-Origin-Dependent and -Independent Manners	PLOS ONE			English	Article							MATERNAL UNIPARENTAL DISOMY; DOWN-SYNDROME; GENE-EXPRESSION; HUMAN GENOME; PATERNAL AGE; TRANSCRIPTION FACTORS; IMPRINTED GENES; SEQUENCING DATA; STEM-CELLS; CHROMOSOME-21	The supernumerary chromosome 21 in Down syndrome differentially affects the methylation statuses at CpG dinucleotide sites and creates genome-wide transcriptional dysregulation of parental alleles, ultimately causing diverse pathologies. At present, it is unknown whether those effects are dependent or independent of the parental origin of the nondis-joined chromosome 21. Linkage analysis is a standard method for the determination of the parental origin of this aneuploidy, although it is inadequate in cases with deficiency of samples from the progenitors. Here, we assessed the reliability of the epigenetic 5(m)CpG imprints resulting in the maternally (oocyte)-derived allele methylation at a differentially methylated region (DMR) of the candidate imprinted WRB gene for asserting the parental origin of chromosome 21. We developed a methylation-sensitive restriction enzyme-specific PCR assay, based on the WRB DMR, across single nucleotide polymorphisms (SNPs) to examine the methylation statuses in the parental alleles. In genomic DNA from blood cells of either disomic or trisomic subjects, the maternal alleles were consistently methylated, while the paternal alleles were unmethylated. However, the supernumerary chromosome 21 did alter the methylation patterns at the RUNX1 (chromosome 21) and TMEM131 (chromosome 2) CpG sites in a parent-of-origin-independent manner. To evaluate the 5(m)CpG imprints, we conducted a computational comparative epigenomic analysis of transcriptome RNA sequencing (RNA-Seq) and histone modification expression patterns. We found allele fractions consistent with the transcriptional biallelic expression of WRB and ten neighboring genes, despite the similarities in the confluence of both a 17-histone modification activation backbone module and a 5-histone modification repressive module between the WRB DMR and the DMRs of six imprinted genes. We concluded that the maternally inherited 5(m)CpG imprints at the WRB DMR are uncoupled from the parental allele expression of WRB and ten neighboring genes in several tissues and that trisomy 21 alters DNA methylation in parent-of-origin-dependent and -independent manners.	[Alves da Silva, Antonio Francisco; Machado, Filipe Brum; Francisco Junior, Ronaldo da Silva; Mozer Rodrigues, Pedro Thyago; Machado, Douglas Terra; Lopes Rios, Alvaro Fabricio; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Biotechnol Lab, Rio De Janeiro, Brazil; [Alves da Silva, Antonio Francisco; Machado, Filipe Brum; Francisco Junior, Ronaldo da Silva; Mozer Rodrigues, Pedro Thyago; Machado, Douglas Terra; Medina-Acosta, Enrique] Hosp Escola Alvaro Alvim, Mol Identificat & Diagnost Unit, Rio De Janeiro, Brazil; [Alves da Silva, Antonio Francisco; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Grad Program Biosci & Biotechnol, Rio De Janeiro, Brazil; [Machado, Filipe Brum] Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Postgrad Program Biosci & Biotechnol, Rio De Janeiro, Brazil; [Pavarino, Erika Cristina; Biselli-Perico, Joice Matos; Zampieri, Bruna Lancia] Fac Med Sao Jose Rio Preto, Sao Paulo, Brazil; [Santos-Reboucas, Cintia Barros] Univ Estado Rio de Janeiro, Dept Genet, BR-20550011 Rio De Janeiro, Brazil; [Fernandes, Maria Gomes; Chuva de Sousa Lopes, Susana Marina] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Universidade do Estado do Rio de Janeiro; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	da Silva, AFA; Machado, FB; Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Biotechnol Lab, Rio De Janeiro, Brazil.; da Silva, AFA; Machado, FB; Medina-Acosta, E (corresponding author), Hosp Escola Alvaro Alvim, Mol Identificat & Diagnost Unit, Rio De Janeiro, Brazil.; da Silva, AFA; Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Grad Program Biosci & Biotechnol, Rio De Janeiro, Brazil.; Machado, FB (corresponding author), Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Postgrad Program Biosci & Biotechnol, Rio De Janeiro, Brazil.	filipebma@yahoo.com.br; anttonio.allves@gmail.com; quique@uenf.br	Zampieri, Bruna/F-7120-2012; Zampieri, Bruna/GOV-3140-2022; Biselli, Joice/AAZ-6259-2021; Medina-Acosta, E./AAN-9724-2021; Junior, Ronaldo S F/I-4073-2014; Santos-Rebouças, Cíntia Barros/C-2230-2018; Pavarino, Érika C/L-5899-2016; Biselli, Joice Matos/B-6913-2014; Rios, Álvaro Fabrício Lopes/AGN-5862-2022; Medina-Acosta, Enrique/G-3041-2010	Zampieri, Bruna/0000-0003-0091-1894; Zampieri, Bruna/0000-0003-0091-1894; Medina-Acosta, E./0000-0002-2529-0548; Junior, Ronaldo S F/0000-0001-7419-3907; Santos-Rebouças, Cíntia Barros/0000-0003-4729-2373; Pavarino, Érika C/0000-0003-0959-0695; Medina-Acosta, Enrique/0000-0002-2529-0548; Matos Biselli, Joice/0000-0001-5105-9537; Terra Machado, Douglas/0000-0002-6580-7628	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/110.775/2011, E-26/111.715/2012, E26/010.001036/2015]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301034/2012-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Universidade Estadual do Norte Fluminense	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade Estadual do Norte Fluminense	Research supported by grants #E-26/110.775/2011 and #E-26/111.715/2012 and #E26/010.001036/2015 to EM-A from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/) and #301034/2012-5 to EM-A from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/). AFAS receive a graduate fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. FBM received a postgraduate fellowship form the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. RSFJ received an undergraduate fellowship from Universidade Estadual do Norte Fluminense (http://www.uenf.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; Bacalini MG, 2015, AGING-US, V7, P82; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; BLOUIN JL, 1993, AM J HUM GENET, V53, P1074; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Court F, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-5; CREAUGOLDBERG N, 1987, HUM GENET, V76, P396, DOI 10.1007/BF00272452; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; De Souza E, 2010, ARCH DIS CHILD, V95, P893, DOI 10.1136/adc.2009.176438; Deelen P, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0152-4; Docherty LE, 2014, J MED GENET, V51, P229, DOI 10.1136/jmedgenet-2013-102116; ERICKSON JD, 1981, J MED GENET, V18, P22, DOI 10.1136/jmg.18.1.22; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; GAULDEN ME, 1992, MUTAT RES, V296, P69, DOI 10.1016/0165-1110(92)90033-6; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; HATCH M, 1990, HUM GENET, V85, P355; HENDERSON DJ, 1994, HUM MOL GENET, V3, P1373, DOI 10.1093/hmg/3.8.1373; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Joergensen MW, 2013, PRENATAL DIAG, V33, P1131, DOI 10.1002/pd.4206; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jones MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-58; Kazaura MR, 2002, PAEDIATR PERINAT EP, V16, P314, DOI 10.1046/j.1365-3016.2002.00446.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Liehr T., 2014, UNIPARENTAL DISOMY U; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Machado FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103714; Mansuet-Lupo A, 2009, FORENSIC SCI INT-GEN, V3, P141, DOI 10.1016/j.fsigen.2008.09.010; Rodriguez JM, 2013, NUCLEIC ACIDS RES, V41, pD110, DOI 10.1093/nar/gks1058; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Muranjan M, 2010, INDIAN PEDIATR, V47, P429, DOI 10.1007/s13312-010-0078-2; Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868; Oliver TR, 2009, AM J MED GENET A, V149A, P1685, DOI 10.1002/ajmg.a.32942; Oliver TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000033; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Proudhon C, 2010, BRIEF FUNCT GENOMICS, V9, P374, DOI 10.1093/bfgp/elq020; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; ROBINSON WP, 1994, AM J HUM GENET, V54, P290; Rogan PK, 1999, AM J MED GENET, V83, P69, DOI 10.1002/(SICI)1096-8628(19990305)83:1<69::AID-AJMG14>3.0.CO;2-Q; Sambrook J., 2001, MOL CLONING LAB MANU; Sebastian A, 2014, BIOINFORMATICS, V30, P258, DOI 10.1093/bioinformatics/btt663; Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408; Smith RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-571; Song Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081148; Steyaert S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku847; Stoll C., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P265; SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wang X, 2014, HEREDITY, V113, P156, DOI 10.1038/hdy.2014.18; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]; Wood DLA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126911; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zeng J, 2012, AM J HUM GENET, V91, P455, DOI 10.1016/j.ajhg.2012.07.024; Zigman WB, 2013, DEV DISABIL RES REV, V18, P51, DOI 10.1002/ddrr.1128; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	75	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154108	10.1371/journal.pone.0154108	http://dx.doi.org/10.1371/journal.pone.0154108			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100087	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500146
J	Bosch-Belmar, M; M'Rabet, C; Dhaouadi, R; Chalghaf, M; Yahia, MND; Fuentes, V; Piraino, S; Yahia, OKD				Bosch-Belmar, Mar; M'Rabet, Charaf; Dhaouadi, Raouf; Chalghaf, Mohamed; Yahia, Mohamed Nejib Daly; Fuentes, Veronica; Piraino, Stefano; Yahia, Ons Kefi-Daly			Jellyfish Stings Trigger Gill Disorders and Increased Mortality in Farmed Sparus aurata (Linnaeus, 1758) in the Mediterranean Sea	PLOS ONE			English	Article							PELAGIA-NOCTILUCA CNIDARIA; TENACIBACULUM-MARITIMUM; PERIPHYLLA-PERIPHYLLA; FISH; DISEASE; EPITHELIOCYSTIS; TEMPERATURE; INFECTION; SCYPHOZOA; BEHAVIOR	Jellyfish are of particular concern for marine finfish aquaculture. In recent years repeated mass mortality episodes of farmed fish were caused by blooms of gelatinous cnidarian stingers, as a consequence of a wide range of hemolytic, cytotoxic, and neurotoxic properties of associated cnidocytes venoms. The mauve stinger jellyfish Pelagia noctiluca (Scyphozoa) has been identified as direct causative agent for several documented fish mortality events both in Northern Europe and the Mediterranean Sea aquaculture farms. We investigated the effects of P. noctiluca envenomations on the gilthead sea bream Sparus aurata by in vivo laboratory assays. Fish were incubated for 8 hours with jellyfish at 3 different densities in 300 l experimental tanks. Gill disorders were assessed by histological analyses and histopathological scoring of samples collected at time intervals from 3 hours to 4 weeks after initial exposure. Fish gills showed different extent and severity of gill lesions according to jellyfish density and incubation time, and long after the removal of jellyfish from tanks. Jellyfish envenomation elicits local and systemic inflammation reactions, histopathology and gill cell toxicity, with severe impacts on fish health. Altogether, these results shows P. noctiluca swarms may represent a high risk for Mediterranean finfish aquaculture farms, generating significant gill damage after only a few hours of contact with farmed S. aurata. Due to the growth of the aquaculture sector and the increased frequency of jellyfish blooms in the coastal waters, negative interactions between stinging jellyfish and farmed fish are likely to increase with the potential for significant economic losses.	[Bosch-Belmar, Mar; Piraino, Stefano] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, Lecce, Italy; [M'Rabet, Charaf; Yahia, Ons Kefi-Daly] Natl Agron Inst Tunis, Res Grp Oceanog & Plankton, Tunis, Tunisia; [Dhaouadi, Raouf] Ecole Natl Med Vet, Sidi Thabet Ariana, Tunisia; [Chalghaf, Mohamed] Inst Super Peche & Aquaculture Bizerte, Bizerte, Tunisia; [Yahia, Mohamed Nejib Daly] Fac Sci Bizerte, Jarzouna, Tunisia; [Fuentes, Veronica] CSIC, ICM, Barcelona, Spain; [Bosch-Belmar, Mar; Piraino, Stefano] Consorzio Nazl Interuniv Sci Mare, CONISMA, Rome, Italy	University of Salento; Universite de Carthage; Universite de la Manouba; Universite de Carthage; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); CoNISMa	Bosch-Belmar, M; Piraino, S (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, Lecce, Italy.; Bosch-Belmar, M; Piraino, S (corresponding author), Consorzio Nazl Interuniv Sci Mare, CONISMA, Rome, Italy.	mar.b.belmar@gmail.com; stefano.piraino@unisalento.it	Piraino, Stefano/J-5234-2012	Piraino, Stefano/0000-0002-8752-9390; Kefi Daly Yahia, Ons/0000-0001-9532-8989; Bosch Belmar, Maria del Mar/0000-0002-1712-5745; Mohamed Nejib, DALY YAHIA/0000-0002-1049-2171	EU [I-A/1.3/098, 266445]; CERES project (Climate Change and European Aquatic Resources) [678193]	EU(European Commission); CERES project (Climate Change and European Aquatic Resources)	The present work was developed within the framework of the EU-funded projects MED-JELLYRISK, (www.jellyrisk.eu) (ENPI CBCMED programme, grant no. I-A/1.3/098), and VECTORS, (http://www.marine-vectors.eu) (Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors, grant no. 266445). Moreover, CERES project, (http://ceresproject.eu) (Climate Change and European Aquatic Resources, grant no. 678193) belonging to European Union's Horizon 2020 research and innovation programme has also partially supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATES R M L, 1988, Zoologische Mededelingen (Leiden), V62, P29; Avendano-Herrera R, 2006, DIS AQUAT ORGAN, V71, P255, DOI 10.3354/dao071255; AXIAK V, 1984, UNEP WORKSH JELL BLO, P121; Baxter E.J., 2011, 13 C NAC AC BARC; Baxter EJ, 2011, AQUACULT ENV INTERAC, V1, P245, DOI 10.3354/aei00024; Baxter EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018529; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Bruno DW, 1985, B EUR ASS FISH PATHO, V5, P1984; Byrne M, 2013, INTEGR COMP BIOL, V53, P582, DOI 10.1093/icb/ict049; Canepa Antonio, 2014, P237; Carlson C, 2010, P REL MAINT S; CIESM, 2001, CIESM WORKSHOP SERIE, V14, P112; Colloca F, 2015, SPARUS AURATA; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; D'Ambra I, 2015, MAR BIOL, V162, P247, DOI 10.1007/s00227-014-2569-5; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ 2; Ferguson HW, 2010, J VET DIAGN INVEST, V22, P376, DOI 10.1177/104063871002200305; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; FIS, 2014, JELL KILLS 1000S SAL; Fossa J., 2003, FISK HAVET, V2, P99; FRANQUEVILLE C, 1971, Tethys, V3, P11; He W, 2015, COMP BIOCHEM PHYS A, V187, P232, DOI 10.1016/j.cbpa.2014.05.004; Helmholz H, 2010, HYDROBIOLOGIA, V645, P223, DOI 10.1007/s10750-010-0216-9; HOFFMAN GL, 1969, ANTON VAN LEE J M S, V35, P146, DOI 10.1007/BF02219125; Ingerslev HC, 2010, FISH SHELLFISH IMMUN, V29, P440, DOI 10.1016/j.fsi.2010.05.002; MALEJ A, 1989, J EXP MAR BIOL ECOL, V126, P259, DOI 10.1016/0022-0981(89)90191-3; March MI, 2015, J MATERN-FETAL NEO M, V28, P1285, DOI 10.3109/14767058.2014.951624; dos Santos DCM, 2012, EXP TOXICOL PATHOL, V64, P861, DOI 10.1016/j.etp.2011.03.007; Milisenda G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094600; Mitchell S. O., 2013, Veterinary Record Case Reports, V1, pe100045, DOI 10.1136/vetreccr.100045rep; Mitchell SO, 2011, J FISH DIS, V34, P411, DOI 10.1111/j.1365-2761.2011.01251.x; Mitchell SO, 2012, AQUACULT INT, V20, P813, DOI 10.1007/s10499-012-9504-x; Nowak BF, 2006, J FISH DIS, V29, P573, DOI 10.1111/j.1365-2761.2006.00747.x; Park IS, 2011, LAB ANIMAL, V40, P45, DOI 10.1038/laban0211-45; Powell MD, 2005, DIS AQUAT ORGAN, V63, P169, DOI 10.3354/dao063169; Purcell JE, 2013, WOODHEAD PUBL FOOD S, P404, DOI 10.1533/9780857097460.2.404; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Rodger HD, 2011, REV FISH BIOL FISHER, V21, P423, DOI 10.1007/s11160-010-9182-6; Rosa S, 2013, J MARINE SYST, V111, P97, DOI 10.1016/j.jmarsys.2012.10.001; Ruane N. M., 2012, FISH VET J, V13, P17; Seaton D.D., 1989, Aquaculture Information Series, P1; Sornes TA, 2007, J PLANKTON RES, V29, P157, DOI 10.1093/plankt/fbm003; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Youngbluth MJ, 2001, HYDROBIOLOGIA, V451, P321, DOI 10.1023/A:1011874828960; ZAVODNIK D, 1987, MAR BIOL, V94, P265, DOI 10.1007/BF00392939	48	23	23	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154239	10.1371/journal.pone.0154239	http://dx.doi.org/10.1371/journal.pone.0154239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100175	gold, Green Submitted, Green Published			2022-12-26	WOS:000374898500171
J	Cuperlovic-Culf, M; Wang, LP; Forseille, L; Boyle, K; Merkley, N; Burton, I; Fobert, PR				Cuperlovic-Culf, Miroslava; Wang, Lipu; Forseille, Lily; Boyle, Kerry; Merkley, Nadine; Burton, Ian; Fobert, Pierre R.			Metabolic Biomarker Panels of Response to Fusarium Head Blight Infection in Different Wheat Varieties	PLOS ONE			English	Article							SPECTROMETRY-BASED METABOLOMICS; RESISTANCE-RELATED METABOLITES; RESOLVED NMR-SPECTRA; RED SPRING WHEAT; MASS-SPECTROMETRY; QUANTITATIVE RESISTANCE; GENE-EXPRESSION; GRAMINEARUM; BARLEY; IDENTIFICATION	Metabolic changes in spikelets of wheat varieties FL62R1, Stettler, Muchmore and Sumai3 following Fusarium graminearum infection were explored using NMR analysis. Extensive 1D and 2D H-1 NMR measurements provided information for detailed metabolite assignment and quantification leading to possible metabolic markers discriminating resistance level in wheat subtypes. In addition, metabolic changes that are observed in all studied varieties as well as wheat variety specific changes have been determined and discussed. A new method for metabolite quantification from NMR data that automatically aligns spectra of standards and samples prior to quantification using multivariate linear regression optimization of spectra of assigned metabolites to samples' 1D spectra is described and utilized. Fusarium infection-induced metabolic changes in different wheat varieties are discussed in the context of metabolic network and resistance.	[Cuperlovic-Culf, Miroslava] Natl Res Council Canada, Ottawa, ON, Canada; [Wang, Lipu; Forseille, Lily; Boyle, Kerry; Fobert, Pierre R.] Natl Res Council Canada, Saskatoon, SK, Canada; [Merkley, Nadine; Burton, Ian] Natl Res Council Canada, Halifax, NS, Canada	National Research Council Canada; National Research Council Canada; International Business Machines (IBM); National Research Council Canada	Cuperlovic-Culf, M (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	miroslava.cuperlovic-culf@nrc-cnrc.gc.ca	Cuperlovic-Culf, Miroslava/C-7876-2016	Cuperlovic-Culf, Miroslava/0000-0002-9483-8159	Canadian Goverment through National Research Council	Canadian Goverment through National Research Council	The authors received no specific funding for this work other than regular funding of the Canadian Goverment through National Research Council Programs and Projects.	Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Bollina V, 2011, PLANT MOL BIOL, V77, P355, DOI 10.1007/s11103-011-9815-8; Bollina V, 2010, MOL PLANT PATHOL, V11, P769, DOI 10.1111/j.1364-3703.2010.00643.x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Boutigny AL, 2008, EUR J PLANT PATHOL, V121, P411, DOI 10.1007/s10658-007-9266-x; Brown NA, 2010, FUNGAL BIOL-UK, V114, P555, DOI 10.1016/j.funbio.2010.04.006; Chamarthi SK, 2014, EUR J PLANT PATHOL, V138, P67, DOI 10.1007/s10658-013-0302-8; Comeau A., 2011, Plant Breeding and Seed Science, V63, P39, DOI 10.2478/v10129-011-0014-1; Crampton BG, 2009, MOL PLANT PATHOL, V10, P291, DOI 10.1111/j.1364-3703.2008.00532.x; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Cuperlovic-Culf M, 2012, J BIOL CHEM, V287, P20164, DOI 10.1074/jbc.M111.337196; DePauw RM, 2011, CAN J PLANT SCI, V91, P797, DOI [10.4141/cjps10188, 10.4141/CJPS10188]; DePauw RM, 2009, CAN J PLANT SCI, V89, P945, DOI 10.4141/CJPS08227; Gonzalez-Lamothe R, 2009, INT J MOL SCI, V10, P3400, DOI 10.3390/ijms10083400; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Gunnaiah R, 2014, PLANT PHYSIOL BIOCH, V83, P40, DOI 10.1016/j.plaphy.2014.07.002; Hamzehzarghani H, 2005, PHYSIOL MOL PLANT P, V66, P119, DOI 10.1016/j.pmpp.2005.05.005; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Kumaraswamy KG, 2011, J CHEM ECOL, V37, P846, DOI 10.1007/s10886-011-9989-1; Lefort N, 2013, J PHARM BIOMED ANAL, V93, P77, DOI DOI 10.1016/J.JPBA.2013.08.017; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Morin PJ, 2013, J PROTEOME RES, V12, P2165, DOI 10.1021/pr400026q; Paranidharan V, 2008, BOTANY, V86, P1168, DOI 10.1139/B08-052; Parsons HM, 2009, MAGN RESON CHEM, V47, pS86, DOI 10.1002/mrc.2501; Pasquet JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-629; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Scharf DH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003859; Shanker AK, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, pIX; Shelp BJ, 2012, PLANT SCI, V193, P130, DOI 10.1016/j.plantsci.2012.06.001; Shimizu M, 2010, APPL ENVIRON MICROB, V76, P1507, DOI 10.1128/AEM.02135-09; Smolinska A, 2012, ANAL CHIM ACTA, V750, P82, DOI 10.1016/j.aca.2012.05.049; Taylor NL, 2004, PLANT PHYSIOL, V134, P838, DOI 10.1104/pp.103.035675; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walter S, 2010, NEW PHYTOL, V185, P54, DOI 10.1111/j.1469-8137.2009.03041.x; Wong JWH, 2005, ANAL CHEM, V77, P5655, DOI 10.1021/ac050619p	37	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153642	10.1371/journal.pone.0153642	http://dx.doi.org/10.1371/journal.pone.0153642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101152	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500046
J	Mamedov, T; Chichester, JA; Jones, RM; Ghosh, A; Coffin, MV; Herschbach, K; Prokhnevsky, AI; Streatfield, SJ; Yusibov, V				Mamedov, Tarlan; Chichester, Jessica A.; Jones, R. Mark; Ghosh, Ananya; Coffin, Megan V.; Herschbach, Kristina; Prokhnevsky, Alexey I.; Streatfield, Stephen J.; Yusibov, Vidadi			Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; INHALATION ANTHRAX; VACCINE; CHALLENGE; EFFICACY; IMMUNITY; RABBITS; MICE; EXPRESSION; CORRELATE	Bacillus anthracis has long been considered a potential biological warfare agent, and therefore, there is a need for a safe, low-cost and highly efficient anthrax vaccine with demonstrated long-term stability for mass vaccination in case of an emergency. Many efforts have been made towards developing an anthrax vaccine based on recombinant protective antigen (rPA) of B. anthracis, a key component of the anthrax toxin, produced using different expression systems. Plants represent a promising recombinant protein production platform due to their relatively low cost, rapid scalability and favorable safety profile. Previous studies have shown that full-length rPA produced in Nicotiana benthamiana (pp-PA83) is immunogenic and can provide full protection against lethal spore challenge; however, further improvement in the potency and stability of the vaccine candidate is necessary. PA of B. anthracis is not a glycoprotein in its native host; however, this protein contains potential N-linked glycosylation sites, which can be aberrantly glycosylated during expression in eukaryotic systems including plants. This glycosylation could affect the availability of certain key epitopes either due to masking or misfolding of the protein. Therefore, a non-glycosylated form of pp-PA83 was engineered and produced in N. benthamiana using an in vivo deglycosylation approach based on co-expression of peptide-N-glycosidase F (PNGase F) from Flavobacterium meningosepticum. For comparison, versions of pp-PA83 containing point mutations in six potential N-glycosylation sites were also engineered and expressed in N. benthamiana. The in vivo deglycosylated pp-PA83 (pp-dPA83) was shown to have in vitro activity, in contrast to glycosylated pp-PA83, and to induce significantly higher levels of toxin-neutralizing antibody responses in mice compared with glycosylated pp-PA83, in vitro deglycosylated pp-PA83 or the mutated versions of pp-PA83. These results suggest that pp-dPA83 may offer advantages in terms of dose sparing and enhanced immunogenicity as a promising candidate for a safe, effective and low-cost subunit vaccine against anthrax.	[Mamedov, Tarlan; Chichester, Jessica A.; Jones, R. Mark; Ghosh, Ananya; Coffin, Megan V.; Herschbach, Kristina; Prokhnevsky, Alexey I.; Streatfield, Stephen J.; Yusibov, Vidadi] Fraunhofer USA Ctr Mol Biotechnol, Newark, DE USA; [Mamedov, Tarlan] Akdeniz Univ, Dept Agr Biotechnol, TR-07985 Antalya, Turkey; [Ghosh, Ananya] Siemens Healthcare, 500 Gbc Dr, Newark, DE 19702 USA; [Herschbach, Kristina] Merck Millipore, Frankfurter Str 250, D-64293 Darmstadt, Germany	Akdeniz University; Siemens AG; Merck KGaA; MilliporeSigma	Mamedov, T (corresponding author), Fraunhofer USA Ctr Mol Biotechnol, Newark, DE USA.; Mamedov, T (corresponding author), Akdeniz Univ, Dept Agr Biotechnol, TR-07985 Antalya, Turkey.	tmammedov@gmail.com; Vidadi.Yusibov@fhcmb.org	Yusibov, Vidadi/AAA-7408-2019; Mammedov, Tarlan/J-3853-2013		Fraunhofer USA Center for Molecular Biotechnology	Fraunhofer USA Center for Molecular Biotechnology	This study was supported by Fraunhofer USA Center for Molecular Biotechnology.	Aziz MA, 2002, BIOCHEM BIOPH RES CO, V299, P345, DOI 10.1016/S0006-291X(02)02625-6; BRACHMAN PS, 1960, AM J HYG, V72, P6, DOI 10.1093/oxfordjournals.aje.a120135; Campbell JD, 2007, HUM VACCINES, V3, P205, DOI 10.4161/hv.3.5.4459; Chichester JA, 2007, VACCINE, V25, P3111, DOI 10.1016/j.vaccine.2007.01.068; Chichester JA, 2013, HUM VACC IMMUNOTHER, V9, P544, DOI 10.4161/hv.23233; Fellows PF, 2001, VACCINE, V19, P3241, DOI 10.1016/S0264-410X(01)00021-4; Fowler K, 1999, J APPL MICROBIOL, V87, P305, DOI 10.1046/j.1365-2672.1999.00898.x; Friedlander AM, 1999, JAMA-J AM MED ASSOC, V282, P2104, DOI 10.1001/jama.282.22.2104; Gomord V, 2004, CURR OPIN PLANT BIOL, V7, P171, DOI 10.1016/j.pbi.2004.01.015; Gorantala J, 2011, VACCINE, V29, P4521, DOI 10.1016/j.vaccine.2011.03.082; Gorse GJ, 2006, VACCINE, V24, P5950, DOI 10.1016/j.vaccine.2006.05.044; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; Hepler RW, 2006, VACCINE, V24, P1501, DOI 10.1016/j.vaccine.2005.10.018; Hull AK, 2005, VACCINE, V23, P2082, DOI 10.1016/j.vaccine.2005.01.013; Ivins BE, 1998, VACCINE, V16, P1141, DOI 10.1016/S0264-410X(98)80112-6; Keitel WA, 2006, EXPERT REV VACCINES, V5, P417, DOI 10.1586/14760584.5.4.417; Klimyuk V, 2014, CURR TOP MICROBIOL, V375, P127, DOI 10.1007/82_2012_212; Koya V, 2005, INFECT IMMUN, V73, P8266, DOI 10.1128/IAI.73.12.8266-8274.2005; Krenek P, 2015, BIOTECHNOL ADV, V33, P1024, DOI 10.1016/j.biotechadv.2015.03.012; Laird MW, 2004, PROTEIN EXPRES PURIF, V38, P145, DOI 10.1016/j.pep.2004.08.007; Little SF, 2006, VACCINE, V24, P2530, DOI 10.1016/j.vaccine.2005.12.028; Little SF, 2004, VACCINE, V22, P422, DOI 10.1016/j.vaccine.2003.07.004; Mamedov T, 2012, PLANT BIOTECHNOL J, V10, P773, DOI 10.1111/j.1467-7652.2012.00694.x; Mett V, 2011, HUM VACCINES, V7, P183, DOI 10.4161/hv.7.0.14586; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Musiychuk K, 2007, INFLUENZA OTHER RESP, V1, P19, DOI 10.1111/j.1750-2659.2006.00005.x; Pitt MLM, 2001, VACCINE, V19, P4768, DOI 10.1016/S0264-410X(01)00234-1; Prokhnevsky A, 2015, MOL BIOTECHNOL, V57, P101, DOI 10.1007/s12033-014-9806-5; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Schneemann A, 2009, FUTURE MICROBIOL, V4, P35, DOI 10.2217/17460913.4.1.35; Shamloul M, 2014, JOVE-J VIS EXP   APR, V86, DOI DOI 10.3791/51204; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Skoble J, 2009, INFECT IMMUN, V77, P1649, DOI 10.1128/IAI.00530-08; Thuenemann EC, 2013, CURR PHARM DESIGN, V19, P5564, DOI 10.2174/1381612811319310011; Wang Julia Y, 2005, Med Immunol, V4, P4, DOI 10.1186/1476-9433-4-4; Williamson ED, 2005, INFECT IMMUN, V73, P5978, DOI 10.1128/IAI.73.9.5978-5987.2005; Yusibov V, 2015, EXPERT REV VACCINES, V14, P519, DOI 10.1586/14760584.2015.989988; Yusibov V, 2013, CURR PHARM DESIGN, V19, P5574, DOI 10.2174/13816128113199990335; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207	39	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153956	10.1371/journal.pone.0153956	http://dx.doi.org/10.1371/journal.pone.0153956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101370	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500108
J	Niu, CT; Zhu, LJ; Xu, X; Li, Q				Niu, Chengtuo; Zhu, Linjiang; Xu, Xin; Li, Qi			Rational Design of Disulfide Bonds Increases Thermostability of a Mesophilic 1,3-1,4-beta-Glucanase from Bacillus terquilensis	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; MOLECULAR-DYNAMICS; HYBRID (1-3,1-4)-BETA-GLUCANASES; CLOSTRIDIUM-THERMOCELLUM; PROTEIN THERMOSTABILITY; ALPHA-AMYLASE; STABILITY; ENZYME; BETA-1,3-1,4-GLUCANASE; STABILIZATION	1,3-1,4-beta-glucanase is an important biocatalyst in brewing industry and animal feed industry, while its low thermostability often reduces its application performance. In this study, the thermostability of a mesophilic beta-glucanase from Bacillus terquilensis was enhanced by rational design and engineering of disulfide bonds in the protein structure. Protein spatial configuration was analyzed to pre-exclude the residues pairs which negatively conflicted with the protein structure and ensure the contact of catalytic center. The changes in protein overall and local flexibility among the wild-type enzyme and the designated mutants were predicted to select the potential disulfide bonds for enhancement of thermostability. Two residue pairs (N31C-T187C and P102C-N125C) were chosen as engineering targets and both of them were proved to significantly enhance the protein thermostability. After combinational mutagenesis, the double mutant N31C-T187C/P102C-N125C showed a 48.3% increase in half-life value at 60 degrees C and a 4.1 degrees C rise in melting temperature (T-m) compared to wild-type enzyme. The catalytic property of N31C-T187C/P102C-N125C mutant was similar to that of wild-type enzyme. Interestingly, the optimal pH of double mutant was shifted from pH6.5 to pH6.0, which could also increase its industrial application. By comparison with mutants with single-Cys substitutions, the introduction of disulfide bonds and the induced new hydrogen bonds were proved to result in both local and overall rigidification and should be responsible for the improved thermostability. Therefore, the introduction of disulfide bonds for thermostability improvement could be rationally and highly-effectively designed by combination with spatial configuration analysis and molecular dynamics simulation.	[Niu, Chengtuo; Zhu, Linjiang; Xu, Xin; Li, Qi] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Li, Qi] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University	Li, Q (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China.; Li, Q (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	liqi@jiangnan.edu.cn		Zhu, Linjiang/0000-0001-7077-160X	National Science Foundation [31271919]; Fundamental Research Funds for the Central Universities [JUSRP51504, JUDCF13008, JUSRP51402A]; National High Technology Research Program of China [2013AA102106]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program of Introducing Talents of Discipline to Universities [111-2-06]	National Science Foundation(National Science Foundation (NSF)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National High Technology Research Program of China(National High Technology Research and Development Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions; Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was financially supported by the program for National Science Foundation (No. 31271919)(http://www.nsfc.gov.cn/), the Fundamental Research Funds for the Central Universities (JUSRP51504 & JUDCF13008 & JUSRP51402A)(http://yjsb.jiangnan.edu.cn/, http://www.moe.gov.cn/), the National High Technology Research Program of China (2013AA102106), the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn/default.aspx), and Program of Introducing Talents of Discipline to Universities (No. 111-2-06)(http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badieyan S, 2012, BIOTECHNOL BIOENG, V109, P31, DOI 10.1002/bit.23280; Beck DAC, 2004, METHODS, V34, P112, DOI 10.1016/j.ymeth.2004.03.008; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brissos V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087209; Chaari F, 2014, PROCESS BIOCHEM, V49, P1040, DOI 10.1016/j.procbio.2014.02.023; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Dodson G, 2006, CELL MOL LIFE SCI, V63, P207, DOI 10.1007/s00018-005-5236-7; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Eijsink VGH, 2001, BIOCATAL BIOTRANSFOR, V19, P443, DOI 10.3109/10242420108992029; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fernandes AT, 2011, J BIOL INORG CHEM, V16, P641, DOI 10.1007/s00775-011-0768-9; HAHN M, 1995, FEBS LETT, V374, P221, DOI 10.1016/0014-5793(95)01111-Q; Han ZL, 2009, APPL MICROBIOL BIOT, V85, P117, DOI 10.1007/s00253-009-2067-8; Hwa KY, 2014, APPL MICROBIOL BIOT, V98, P7825, DOI 10.1007/s00253-014-5731-6; Kumar S, 2000, J BIOMOL STRUCT DYN, P79, DOI 10.1080/07391102.2000.10506606; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu L, 2014, APPL ENVIRON MICROB, V80, P798, DOI 10.1128/AEM.03045-13; Liu YH, 2008, APPL MICROBIOL BIOT, V80, P795, DOI 10.1007/s00253-008-1580-5; Luo ZC, 2014, APPL BIOCHEM BIOTECH, V173, P562, DOI 10.1007/s12010-014-0863-9; Mansfeld J, 1997, J BIOL CHEM, V272, P11152, DOI 10.1074/jbc.272.17.11152; Michael J., 2013, BREWING; Michaux C, 2010, BIOCHIMIE, V92, P1407, DOI 10.1016/j.biochi.2010.07.003; Niu CT, 2015, J AGR FOOD CHEM, V63, P5249, DOI 10.1021/acs.jafc.5b00480; Niu CT, 2014, BIOTECHNOL LETT, V36, P2453, DOI 10.1007/s10529-014-1616-0; OLSEN O, 1991, MOL GEN GENET, V225, P177, DOI 10.1007/BF00269845; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Planas N, 2000, BBA-PROTEIN STRUCT M, V1543, P361, DOI 10.1016/S0167-4838(00)00231-4; POLITZ O, 1993, EUR J BIOCHEM, V216, P829, DOI 10.1111/j.1432-1033.1993.tb18204.x; Quang ATL, 2012, BIOTECHNOL BIOENG, V109, P867, DOI 10.1002/bit.24371; Rader AJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016002; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; SCHIMMING S, 1991, BIOCHEM BIOPH RES CO, V177, P447, DOI 10.1016/0006-291X(91)92004-4; Siadat Omid Ranaei, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-12; Spring P, 1996, POULTRY SCI, V75, P357, DOI 10.3382/ps.0750357; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Umemoto H, 2009, BIOSCI BIOTECH BIOCH, V73, P965, DOI 10.1271/bbb.80869; Wang JJ, 2014, APPL BIOCHEM BIOTECH, V173, P826, DOI 10.1007/s12010-014-0900-8; WELFLE K, 1994, J BIOMOL STRUCT DYN, V11, P1417, DOI 10.1080/07391102.1994.10508076; WELLS JA, 1986, J BIOL CHEM, V261, P6564; WETZEL R, 1988, P NATL ACAD SCI USA, V85, P401, DOI 10.1073/pnas.85.2.401; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yin X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126864; Yu HR, 2014, BIOTECHNOL ADV, V32, P308, DOI 10.1016/j.biotechadv.2013.10.012; Zhang ZG, 2010, BIORESOURCE TECHNOL, V101, P9272, DOI 10.1016/j.biortech.2010.07.060	57	24	27	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154036	10.1371/journal.pone.0154036	http://dx.doi.org/10.1371/journal.pone.0154036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100881	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500128
J	Pulla, S; Riotte, J; Suresh, HS; Dattaraja, HS; Sukumar, R				Pulla, Sandeep; Riotte, Jean; Suresh, H. S.; Dattaraja, H. S.; Sukumar, Raman			Controls of Soil Spatial Variability in a Dry Tropical Forest	PLOS ONE			English	Article							DECIDUOUS FOREST; WEATHERING FLUXES; SOUTH-INDIA; MULE HOLE; NITROGEN-FIXATION; N-MINERALIZATION; CHEMICAL FLUXES; WESTERN-GHATS; NUTRIENTS; EROSION	We examined the roles of lithology, topography, vegetation and fire in generating local-scale (< 1 km(2)) soil spatial variability in a seasonally dry tropical forest (SDTF) in southern India. For this, we mapped soil (available nutrients, Al, total C, pH, moisture and texture in the top 10cm), rock outcrops, topography, all native woody plants >= 1 cm diameter at breast height (DBH), and spatial variation in fire frequency (times burnt during the 17 years preceding soil sampling) in a permanent 50-ha plot. Unlike classic catenas, lower elevation soils had lesser moisture, plant-available Ca, Cu, Mn, Mg, Zn, B, clay and total C. The distribution of plant-available Ca, Cu, Mn and Mg appeared to largely be determined by the whole-rock chemical composition differences between amphibolites and hornblende-biotite gneisses. Amphibolites were associated with summit positions, while gneisses dominated lower elevations, an observation that concurs with other studies in the region which suggest that hillslope-scale topography has been shaped by differential weathering of lithologies. Neither NO3--N nor NH4+-N was explained by the basal area of trees belonging to Fabaceae, a family associated with N-fixing species, and no long-term effects of fire on soil parameters were detected. Local-scale lithological variation is an important first-order control over soil variability at the hillslope scale in this SDTF, by both direct influence on nutrient stocks and indirect influence via control of local relief.	[Pulla, Sandeep; Suresh, H. S.; Dattaraja, H. S.; Sukumar, Raman] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Riotte, Jean] Indian Inst Sci, Indofrench Cell Water Sci, Bangalore 560012, Karnataka, India; [Riotte, Jean] Univ Toulouse 3, CNRS, IRD, Geosci Environm Toulouse, F-31400 Toulouse, France	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Sukumar, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	rsuku@ces.iisc.ernet.in	Raman, Sukumar/C-9809-2013; Riotte, Jean/K-7185-2017; Pulla, Sandeep/AAV-5488-2021; IFCWS, LMI/C-5187-2013	Riotte, Jean/0000-0002-5563-1913; Pulla, Sandeep/0000-0002-2959-8929; 	Ministry of Environment and Forests, Government of India, India; Centre for Tropical Forest Science, Smithsonian Tropical Research Institute, USA; Department of Science and Technology, Ministry of Science and Technology, Government of India, India; Institut National des Sciences de l'Univers (INSU-CNRS); Institut de Recherche pour le Developpement, France	Ministry of Environment and Forests, Government of India, India; Centre for Tropical Forest Science, Smithsonian Tropical Research Institute, USA; Department of Science and Technology, Ministry of Science and Technology, Government of India, India; Institut National des Sciences de l'Univers (INSU-CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut de Recherche pour le Developpement, France	This work was supported by 1) Ministry of Environment and Forests, Government of India, India (http://www.moef.nic.in) (grant recipient: RS); 2) Centre for Tropical Forest Science, Smithsonian Tropical Research Institute, USA (http://www.forestgeo.si.edu); 3) Department of Science and Technology, Ministry of Science and Technology, Government of India, India (http://dst.gov.in) (grant recipient: RS); and 4) Institut National des Sciences de l'Univers (INSU-CNRS) (http://www.insu.cnrs.fr) & Institut de Recherche pour le Developpement (http://www.ird.fr), France (grant recipient: JR).	Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2012.2532, 10.1098/rspb.2013.0548]; Barbiero L, 2010, GEODERMA, V156, P173, DOI 10.1016/j.geoderma.2010.02.014; Barbiero L, 2007, CATENA, V70, P313, DOI 10.1016/j.catena.2006.10.013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bern CR, 2005, ECOLOGY, V86, P626, DOI 10.1890/03-0766; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Binkley D., 1995, Special Publication - Agronomy Society of New Zealand, P1; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; Binkley D., 2012, ECOLOGY MANAGEMENT F, V4th; Braun JJ, 2012, GEOCHIM COSMOCHIM AC, V99, P243, DOI 10.1016/j.gca.2012.09.024; Braun JJ, 2009, GEOCHIM COSMOCHIM AC, V73, P935, DOI 10.1016/j.gca.2008.11.013; Callaham MA, 2008, RESTOR ECOL, V16, P604, DOI 10.1111/j.1526-100X.2008.00490.x; Campo J, 1998, OECOLOGIA, V115, P167, DOI 10.1007/s004420050504; Campo J., 2001, Agrociencia, V35, P245; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Chadwick OA, 2001, GEODERMA, V100, P321, DOI 10.1016/S0016-7061(01)00027-1; Chardon D, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005299; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Cotler H, 2006, CATENA, V65, P107, DOI 10.1016/j.catena.2005.11.004; DeBano LF, 2000, J HYDROL, V231, P195, DOI 10.1016/S0022-1694(00)00194-3; Dockersmith IC, 1999, PLANT SOIL, V209, P137, DOI 10.1023/A:1004503023973; DRECHSEL P, 1991, PLANT SOIL, V131, P29, DOI 10.1007/BF00010417; DRURY SA, 1980, TECTONOPHYSICS, V65, pT1, DOI 10.1016/0040-1951(80)90073-6; Durand N, 2007, QUATERN INT, V162, P35, DOI 10.1016/j.quaint.2006.10.026; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fine PVA, 2005, EVOLUTION, V59, P1464; Fortin M., 2000, B ECOL SOC AM, V81, P201, DOI DOI 10.2307/20168439; Fu P. M., 1999, P 19 ANN ESRI US C, V1, P31; Galicia L, 1999, CATENA, V36, P153, DOI 10.1016/S0341-8162(98)00121-0; GARCIAOLIVA F, 1995, GEODERMA, V68, P135, DOI 10.1016/0016-7061(95)00030-R; George M, 1988, FOREST SOIL VEGETATI; Gessler PE, 2000, SOIL SCI SOC AM J, V64, P2046, DOI 10.2136/sssaj2000.6462046x; Giardina CP, 2000, SOIL SCI SOC AM J, V64, P399, DOI 10.2136/sssaj2000.641399x; Grogan James, 2006, Acta Amaz., V36, P483, DOI 10.1590/S0044-59672006000400009; Gunnell Y, 1998, BASIN RES, V10, P281, DOI 10.1046/j.1365-2117.1998.00072.x; Gunnell Y, 1997, CATENA, V29, P239, DOI 10.1016/S0341-8162(96)00070-7; Gunnell Y, 2014, WOR GEOMORPHOL LANDS, P195, DOI 10.1007/978-94-017-8029-2_20; Hirobe M, 2003, PLANT SOIL, V249, P309, DOI 10.1023/A:1022804326662; Holloway JM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001862; Jenny H., 1941, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Khomo L, 2011, CATENA, V87, P119, DOI 10.1016/j.catena.2011.05.017; Kodandapani N, 2008, FOREST ECOL MANAG, V256, P607, DOI 10.1016/j.foreco.2008.05.006; KUMAR BM, 1992, FOREST ECOL MANAG, V50, P181, DOI 10.1016/0378-1127(92)90335-7; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; LECHOWICZ MJ, 1991, J ECOL, V79, P687, DOI 10.2307/2260661; Maher K, 2011, EARTH PLANET SC LETT, V312, P48, DOI 10.1016/j.epsl.2011.09.040; Montano NM, 2013, REV BIOL TROP, V61, P439; Marechal JC, 2009, J HYDROL, V364, P272, DOI 10.1016/j.jhydrol.2008.11.006; McShea W, 2011, ECOLOGY CONSERVATION, P59; Mehta P, 2014, THESIS JAWAHARLAL NE; Meissner B, 2002, PRECAMBRIAN RES, V114, P149, DOI 10.1016/S0301-9268(01)00222-4; Mengel K, 1982, Principles of plant nutrition.; Mondal N, 2014, CURR SCI INDIA, V107, P1590; MOONEY HA, 1995, SEASONALLY DRY TROPI, P1, DOI DOI 10.1017/CBO9780511753398.001; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; Phillips JD, 2005, GEODERMA, V124, P73, DOI 10.1016/j.geoderma.2004.04.004; Porder S, 2006, ECOLOGY, V87, P594, DOI 10.1890/05-0394; Porder S, 2009, ECOLOGY, V90, P623, DOI 10.1890/07-1739.1; R Core Team, 2021, R LANGUAGE ENV STAT; RAGHUBANSHI AS, 1992, SOIL BIOL BIOCHEM, V24, P145, DOI 10.1016/0038-0717(92)90270-8; Riotte J, 2014, PROCED EARTH PLAN SC, V10, P34, DOI 10.1016/j.proeps.2014.08.007; Riotte J, 2014, GEOCHIM COSMOCHIM AC, V145, P116, DOI 10.1016/j.gca.2014.09.015; Rodriguez A, 2009, GEODERMA, V151, P303, DOI 10.1016/j.geoderma.2009.04.019; ROY S, 1994, J ECOL, V82, P503, DOI 10.2307/2261259; ROY S, 1995, SOIL BIOL BIOCHEM, V27, P33, DOI 10.1016/0038-0717(94)00138-Q; Roy S, 1996, Oecologia Montana, V5, P21; Ruiz L, 2010, J HYDROL, V380, P460, DOI 10.1016/j.jhydrol.2009.11.020; Samuel VO, 2014, PRECAMBRIAN RES, V245, P146, DOI 10.1016/j.precamres.2014.02.002; Schaetzl RJ, 2005, SOILS: GENESIS AND GEOMORPHOLOGY, P1, DOI 10.1017/CBO9780511815560; Schaetzl R.J., 2013, TREATISE GEOMORPHOLO, P145, DOI [10.1016/B978-0-12-374739-6.00074-9, DOI 10.1016/B978-0-12-374739-6.00074-9]; SCHWERTMANN U, 1991, PLANT SOIL, V130, P1, DOI 10.1007/BF00011851; Seibert J, 2007, GEODERMA, V141, P139, DOI 10.1016/j.geoderma.2007.05.013; Sharma A, 2000, CHEM GEOL, V166, P203, DOI 10.1016/S0009-2541(99)00222-3; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Singh Jay Shankar, 2007, Tropical Ecology, V48, P27; SINGH JS, 1989, NATURE, V338, P499, DOI 10.1038/338499a0; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Srikantappa C, 1988, MEMOIR GEOL SOC INDI, V11, P117; Sukumar R., 2005, P510, DOI 10.1017/CBO9780511541971.022; SUKUMAR R, 1992, CURR SCI INDIA, V62, P608; Toledo M, 2012, J ECOL, V100, P253, DOI 10.1111/j.1365-2745.2011.01890.x; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Violette A, 2010, GEOCHIM COSMOCHIM AC, V74, P7059, DOI 10.1016/j.gca.2010.09.006; Violette A, 2010, CHEM GEOL, V277, P42, DOI 10.1016/j.chemgeo.2010.07.009; Vitousek P, 2003, ECOSYSTEMS, V6, P762, DOI 10.1007/s10021-003-0199-8; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601	91	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153212	10.1371/journal.pone.0153212	http://dx.doi.org/10.1371/journal.pone.0153212			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100088	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000374898500026
J	Rasoulzadeh, Z; Ghods, R; Kazemi, T; Mirzadegan, E; Ghaffari-Tabrizi-Wizsy, N; Rezania, S; Kazemnejad, S; Arefi, S; Ghasemi, J; Vafaei, S; Mahmoudi, AR; Zarnani, AH				Rasoulzadeh, Zahra; Ghods, Roya; Kazemi, Tohid; Mirzadegan, Ebrahim; Ghaffari-Tabrizi-Wizsy, Nassim; Rezania, Simin; Kazemnejad, Somaieh; Arefi, Soheila; Ghasemi, Jamileh; Vafaei, Sedigheh; Mahmoudi, Ahmad-Reza; Zarnani, Amir-Hassan			Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells	PLOS ONE			English	Article							METASTASIS-SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTOR; MONOCLONAL-ANTIBODIES; TROPHOBLAST INVASION; GROWTH-FACTOR; STEM-CELLS; EXPRESSION; KISS-1; MIGRATION; MOTILITY	Kisspeptins (KPs) are major regulators of trophoblast and cancer invasion. Thus far, limited and conflicting data are available on KP-mediated modulation of breast cancer (BC) metastasis; mostly based on synthetic KP-10, the most active fragment of KP. Here, we report for the first time comprehensive functional effects of term placental KPs on proliferation, adhesion, Matrigel invasion, motility, MMP activity and pro-inflammatory cytokine production in MDA-MB-231 (estrogen receptor-negative) and MCF-7 (estrogen receptor-positive). KPs were expressed at high level by term placental syncytiotrophoblasts and released in soluble form. Placental explant conditioned medium containing KPs (CM) significantly reduced proliferation of both cell types compared to CM without (w/o) KP (CM-w/o KP) in a dose-and time-dependent manner. In MDA-MB-231 cells, placental KPs significantly reduced adhesive properties, while increased MMP9 and MMP2 activity and stimulated invasion. Increased invasiveness of MDA-MB-231 cells after CM treatment was inhibited by KP receptor antagonist, P-234. CM significantly reduced motility of MCF-7 cells at all time points (2-30 hr), while it stimulated motility of MDA-MB-231 cells. These effects were reversed by P-234. Co-treatment with selective ER modulators, Tamoxifen and Raloxifene, inhibited the effect of CM on motility of MCF-7 cells. The level of IL-6 in supernatant of MCF-7 cells treated with CM was higher compared to those treated with CM-w/o KP. Both cell types produced more IL-8 after treatment with CM compared to those treated with CM-w/o KP. Taken together, our observations suggest that placental KPs differentially modulate vital parameters of estrogen receptor-positive and -negative BC cells possibly through modulation of pro-inflammatory cytokine production.	[Rasoulzadeh, Zahra; Kazemi, Tohid] Tabriz Univ Med Sci, Dept Immunol, Tabriz 5165683146, Iran; [Rasoulzadeh, Zahra; Kazemi, Tohid] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz 5165683146, Iran; [Ghods, Roya] Iran Univ Med Sci, Fac Adv Technol Med, Dept Mol Med, Tehran 1449614535, Iran; [Ghods, Roya] Iran Univ Med Sci, Oncopathol Res Ctr, Tehran 1449614535, Iran; [Mirzadegan, Ebrahim] ACECR, Avicenna Res Inst, Immunobiol Res Ctr, Tehran 117719615, Iran; [Ghaffari-Tabrizi-Wizsy, Nassim] Med Univ Graz, Inst Pathophysiol & Immunol, SFL Chicken CAM Lab, A-8010 Graz, Austria; [Rezania, Simin] Med Univ Graz, Inst Biophys, A-8010 Graz, Austria; [Kazemnejad, Somaieh; Arefi, Soheila] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran 117719615, Iran; [Kazemnejad, Somaieh; Arefi, Soheila; Ghasemi, Jamileh; Vafaei, Sedigheh; Zarnani, Amir-Hassan] ACECR, Avicenna Res Inst, Nanobiotechnol Res Ctr, Tehran 117719615, Iran; [Mahmoudi, Ahmad-Reza] ACECR, Avicenna Res Inst, Monoclonal Antibody Res Ctr, Tehran 117719615, Iran; [Zarnani, Amir-Hassan] Iran Univ Med Sci, Immunol Res Ctr, Tehran 8174673461, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Iran University of Medical Sciences; Iran University of Medical Sciences; Academic Center for Education, Culture & Research (ACECR); Medical University of Graz; Medical University of Graz; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Iran University of Medical Sciences	Kazemi, T (corresponding author), Tabriz Univ Med Sci, Dept Immunol, Tabriz 5165683146, Iran.; Kazemi, T (corresponding author), Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz 5165683146, Iran.; Zarnani, AH (corresponding author), ACECR, Avicenna Res Inst, Nanobiotechnol Res Ctr, Tehran 117719615, Iran.; Zarnani, AH (corresponding author), Iran Univ Med Sci, Immunol Res Ctr, Tehran 8174673461, Iran.	tohid_kazemi@yahoo.com; zarnani@avicenna.ac.ir	Kazemi, Tohid/A-8391-2013; Kazemnejad, Somaieh/O-6577-2018; Kazemi, Tohid/AAF-2444-2019; Ghaffari-Tabrizi-Wizsy, Nassim/J-7333-2017; Kazemnejad, Somaieh/AAD-7963-2019	Kazemi, Tohid/0000-0002-8583-1270; Kazemnejad, Somaieh/0000-0003-1808-8357; Kazemi, Tohid/0000-0002-8583-1270; Ghaffari-Tabrizi-Wizsy, Nassim/0000-0001-6696-8717; 	National Elites Foundation [910112-039]	National Elites Foundation	This research work was supported by a grant (910112-039) from National Elites Foundation. URL: http://en.bmn.ir/. AHZ received the funding.; The results presented here were extracted from MSc. thesis of Mrs. Z. Rasoulzadeh. This research work was supported by a grant (910112-039) from National Elites Foundation and conducted in Avicenna Research Institute.	Arihiro K, 2000, Breast Cancer, V7, P221, DOI 10.1007/BF02967464; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; Chiu JJ, 1996, CLIN CANCER RES, V2, P215; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734; Cvetkovic D, 2013, ENDOCRINOLOGY, V154, P1999, DOI 10.1210/en.2012-2164; Delbandi AA, 2013, FERTIL STERIL, V100, P761, DOI 10.1016/j.fertnstert.2013.04.041; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; Galien R, 1997, NUCLEIC ACIDS RES, V25, P2424, DOI 10.1093/nar/25.12.2424; Ghods R, 2014, BIOTECHNOL APPL BIOC, V61, P363, DOI 10.1002/bab.1177; Harms JF, 2003, CLIN EXP METASTAS, V20, P11, DOI 10.1023/A:1022530100931; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Ji K, 2013, INT J MOL MED, V32, P747, DOI 10.3892/ijmm.2013.1472; Kostadima L, 2007, ANTICANCER RES, V27, P2499; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Le Bellego F, 2009, ISOLATION CULTURE TE, P73; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; LIPPMAN M, 1976, CANCER RES, V36, P4595; Makri A, 2008, CANCER TREAT REV, V34, P682, DOI 10.1016/j.ctrv.2008.05.007; Marot D, 2007, ENDOCR-RELAT CANCER, V14, P691, DOI 10.1677/ERC-07-0012; Martin TA, 2005, CLIN EXP METASTAS, V22, P503, DOI 10.1007/s10585-005-4180-0; Mooez S, 2011, ASIAN PAC J CANCER P, V12, P2785; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Nikoo S, 2014, MOL HUM REPROD, V20, P905, DOI 10.1093/molehr/gau044; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Olbrich T, 2010, GYNECOL ONCOL, V119, P571, DOI 10.1016/j.ygyno.2010.08.018; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Rahimi M, 2014, J BIOMATER APPL, V29, P199, DOI 10.1177/0885328213519835; Rajah TT, 2012, ANTICANCER RES, V32, P1181; Rama S, 2004, MOL CELL ENDOCRINOL, V218, P79, DOI 10.1016/j.mce.2003.12.016; Rashidi Nesa, 2015, J Reprod Infertil, V16, P72; Rezania S, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-54; Rochefort H, 1998, J STEROID BIOCHEM, V65, P163, DOI 10.1016/S0960-0760(98)00010-7; Roy SS, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/654698; Shochet GE, 2015, BREAST CANCER RES TR, V149, P645, DOI 10.1007/s10549-015-3266-x; Shochet GE, 2012, HUM REPROD, V27, P73, DOI 10.1093/humrep/der365; Shojaeian S, 2010, IMMUNOL INVEST, V39, P114, DOI 10.3109/08820130903496785; Sitras V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033294; Taylor AP, 2010, BRIT J CANCER, V103, P82, DOI 10.1038/sj.bjc.6605746; Xie F, 2012, SENSORS-BASEL, V12, P9936, DOI 10.3390/s120709936; Zajac M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021599; Ziegler E, 2013, ONCOL REP, V29, P549, DOI 10.3892/or.2012.2135	49	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153684	10.1371/journal.pone.0153684	http://dx.doi.org/10.1371/journal.pone.0153684			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101408	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500048
J	Regan, S; Meigs, JB; Grinspoon, SK; Triant, VA				Regan, Susan; Meigs, James B.; Grinspoon, Steven K.; Triant, Virginia A.			Determinants of Smoking and Quitting in HIV-Infected Individuals	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION RATES; RISK-FACTORS; ANTIRETROVIRAL THERAPY; CIGARETTE-SMOKING; MENTAL-ILLNESS; TOBACCO USE; IMMUNODEFICIENCY; CESSATION; POPULATION	Background Cigarette smoking is widespread among HIV-infected patients, who confront increased risk of smoking-related co-morbidities. The effects of HIV infection and HIV-related variables on smoking and smoking cessation are incompletely understood. We investigated the correlates of smoking and quitting in an HIV-infected cohort using a validated natural language processor to determine smoking status. Method We developed and validated an algorithm using natural language processing (NLP) to ascertain smoking status from electronic health record data. The algorithm was applied to records for a cohort of 3487 HIV-infected from a large health care system in Boston, USA, and 9446 uninfected control patients matched 3: 1 on age, gender, race and clinical encounters. NLP was used to identify and classify smoking-related portions of free-text notes. These classifications were combined into patient-year smoking status and used to classify patients as ever versus never smokers and current smokers versus non-smokers. Generalized linear models were used to assess associations of HIV with 3 outcomes, ever smoking, current smoking, and current smoking in analyses limited to ever smokers (persistent smoking), while adjusting for demographics, cardiovascular risk factors, and psychiatric illness. Analyses were repeated within the HIV cohort, with the addition of CD4 cell count and HIV viral load to assess associations of these HIV-related factors with the smoking outcomes. Results Using the natural language processing algorithm to assign annual smoking status yielded sensitivity of 92.4, specificity of 86.2, and AUC of 0.89 (95% confidence interval [CI] 0.88-0.91). Ever and current smoking were more common in HIV-infected patients than controls (54% vs. 44% and 42% vs. 30%, respectively, both P< 0.001). In multivariate models HIV was independently associated with ever smoking (adjusted rate ratio [ARR] 1.18, 95% CI 1.13-1.24, P < 0.001), current smoking (ARR 1.33, 95% CI 1.25-1.40, P< 0.001), and persistent smoking (ARR 1.11, 95% CI 1.07-1.15, P< 0.001). Within the HIV cohort, having a detectable HIV RNA was significantly associated with all three smoking outcomes. Conclusions HIV was independently associated with both smoking and not quitting smoking, using a novel algorithm to ascertain smoking status from electronic health record data and accounting for multiple confounding clinical factors. Further research is needed to identify HIV-related barriers to smoking cessation and develop aggressive interventions specific to HIV-infected patients.	[Regan, Susan; Meigs, James B.; Triant, Virginia A.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Regan, Susan; Meigs, James B.; Grinspoon, Steven K.; Triant, Virginia A.] Harvard Univ, Sch Med, Boston, MA USA; [Grinspoon, Steven K.] Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA; [Triant, Virginia A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Regan, S (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.; Regan, S (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	sregan@partners.org	Meigs, James/P-3927-2019	Meigs, James/0000-0002-2439-2657	American Heart Association [10CRP2790003]; National Institutes of Health [K24 DK080140, K24 DK064545, K01 AI073109]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL125029, R21HL122138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI073109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140, K24DK064545] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by American Heart Association 10CRP2790003 (VAT) and National Institutes of Health K24 DK080140 (JBM), K24 DK064545 (SKG), and K01 AI073109 (VAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Clark C, 2008, J AM MED INFORM ASSN, V15, P36, DOI 10.1197/jamia.M2442; Clifford GM, 2012, BRIT J CANCER, V106, P447, DOI 10.1038/bjc.2011.558; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Duval X, 2008, ANTIVIR THER, V13, P389; Elzi L, 2006, ANTIVIR THER, V11, P787; Fiore MC, 2008, TREATING TOBACCO USE; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gritz ER, 2004, NICOTINE TOB RES, V6, P71, DOI 10.1080/14622200310001656885; Grover KW, 2012, ADDICT BEHAV, V37, P682, DOI 10.1016/j.addbeh.2012.01.014; Hazlehurst B, 2005, AM J PREV MED, V29, P434, DOI 10.1016/j.amepre.2005.08.007; Heinze DT, 2008, J AM MED INFORM ASSN, V15, P40, DOI 10.1197/jamia.M2438; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Huber M, 2012, HIV MED, V13, P387, DOI 10.1111/j.1468-1293.2011.00984.x; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; McGinnis KA, 2011, NICOTINE TOB RES, V13, P1233, DOI 10.1093/ntr/ntr206; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Petoumenos K, 2011, HIV MED, V12, P412, DOI 10.1111/j.1468-1293.2010.00901.x; Prochaska JJ, 2011, NEW ENGL J MED, V365, P196, DOI 10.1056/NEJMp1105248; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Savova GK, 2008, J AM MED INFORM ASSN, V15, P25, DOI 10.1197/jamia.M2437; Silverberg MJ, 2014, JAIDS-J ACQ IMM DEF, V65, P160, DOI 10.1097/QAI.0000000000000009; Tipping B, 2007, J NEUROL NEUROSUR PS, V78, P1320, DOI 10.1136/jnnp.2007.116103; Triant VA, 2012, CLIN INFECT DIS, V54, P408, DOI 10.1093/cid/cir829; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; Triant VA, 2010, JAIDS-J ACQ IMM DEF, V55, P615, DOI 10.1097/QAI.0b013e3181f4b752; Vidrine DJ, 2012, NICOTINE TOB RES, V14, P106, DOI 10.1093/ntr/ntr121; Vidrine DJ, 2006, AIDS, V20, P253, DOI 10.1097/01.aids.0000198094.23691.58; Vittecoq D, 2003, AIDS, V17, pS70, DOI 10.1097/00002030-200304001-00010; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	41	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153103	10.1371/journal.pone.0153103	http://dx.doi.org/10.1371/journal.pone.0153103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27099932	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500025
J	Wang, B; Zhang, YH; Hao, BZ; Xu, XX; Zhao, ZG; Wang, ZM; Xue, QW				Wang, Bin; Zhang, Yinghua; Hao, Baozhen; Xu, Xuexin; Zhao, Zhigan; Wang, Zhimin; Xue, Qingwu			Grain Yield and Water Use Efficiency in Extremely-Late Sown Winter Wheat Cultivars under Two Irrigation Regimes in the North China Plain	PLOS ONE			English	Article							NITROGEN DYNAMICS; LEAF SENESCENCE; GROWTH; DATE	Wheat production is threatened by water shortages and groundwater over-draft in the North China Plain (NCP). In recent years, winter wheat has been increasingly sown extremely late in early to mid-November after harvesting cotton or pepper. To improve water use efficiency (WUE) and guide the extremely late sowing practices, a 3-year field experiment was conducted under two irrigation regimes (W1, one-irrigation, 75 mm at jointing; W2, two-irrigation, 75 mm at jointing and 75 mm at anthesis) in 3 cultivars differing in spike size (HS4399, small spike; JM22, medium spike; WM8, large spike). Wheat was sown in early to mid-November at a high seeding rate of 800-850 seeds m(-2). Average yields of 7.42 t ha(-1) and WUE of 1.84 kg m(-3) were achieved with an average seasonal evapotranspiration (ET) of 404 mm. Compared with W2, wheat under W1 did not have yield penalty in 2 of 3 years, and had 7.9% lower seasonal ET and 7.5% higher WUE. The higher WUE and stable yield under W1 was associated with higher 1000-grain weight (TGW) and harvest index (HI). Among the 3 cultivars, JM22 had 5.9%-8.9% higher yield and 4.2%-9.3% higher WUE than WM8 and HS4399. The higher yield in JM22 was attributed mainly to higher HI and TGW due to increased post-anthesis biomass and deeper seasonal soil water extraction. In conclusion, one-irrigation with a medium-sized spike cultivar JM22 could be a useful strategy to maintain yield and high WUE in extremely late-sown winter wheat at a high seeding rate in the NCP.	[Wang, Bin; Zhang, Yinghua; Xu, Xuexin; Zhao, Zhigan; Wang, Zhimin] China Agr Univ, Coll Agron, Beijing 100193, Peoples R China; [Wang, Bin; Xue, Qingwu] Texas A&M AgriLife Res & Extens Ctr Amarillo, Amarillo, TX 79106 USA; [Hao, Baozhen] Xinxiang Univ, Sch Sci & Technol, Xinxiang 453003, Henan, Peoples R China	China Agricultural University; Xinxiang University	Wang, ZM (corresponding author), China Agr Univ, Coll Agron, Beijing 100193, Peoples R China.; Xue, QW (corresponding author), Texas A&M AgriLife Res & Extens Ctr Amarillo, Amarillo, TX 79106 USA.	zhimin206@263.net; qxue@ag.tamu.edu	Zhao, Zhigan/E-8963-2015; Zhang, Yinghua/HGE-7633-2022; Xue, Qingwu/AAE-2431-2020	Zhao, Zhigan/0000-0003-1533-7215; Zhang, Yinghua/0000-0002-1356-6084; Xue, Qingwu/0000-0002-6470-3245	National Basic Research Program of China (973 Program) [2012CB955904]; Special Fund for Agro-scientific Research in the Public Interest in China [201303133]; Earmarked Fund for Modern Agro-Industry Technology Research System [CARS-3]; National Natural Science Foundation of China [31401297]; China Scholarship Council; Science and Technology Innovation Program of Food Crop High Yield and Efficiency	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest in China; Earmarked Fund for Modern Agro-Industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Science and Technology Innovation Program of Food Crop High Yield and Efficiency	This study was supported by the National Basic Research Program of China (973 Program, 2012CB955904), the Special Fund for Agro-scientific Research in the Public Interest in China (201303133), the Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-3), the National Natural Science Foundation of China (31401297), the China Scholarship Council and the Science and Technology Innovation Program of Food Crop High Yield and Efficiency.	[Anonymous], CHINA STAT YB; Araki H, 2012, FIELD CROP RES, V137, P27, DOI 10.1016/j.fcr.2012.09.006; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Cui ZL, 2011, SOIL SCI SOC AM J, V75, P976, DOI 10.2136/sssaj2010.0117; Du TS, 2014, FOOD ENERGY SECUR, V3, P7, DOI 10.1002/fes3.40; Ercoli L, 2008, EUR J AGRON, V28, P138, DOI 10.1016/j.eja.2007.06.002; Fang Y, 2010, EUR J AGRON, V33, P257, DOI 10.1016/j.eja.2010.07.001; Feng B, 2014, J AGRON CROP SCI, V200, P143, DOI 10.1111/jac.12045; HAUN JR, 1973, AGRON J, V65, P116, DOI 10.2134/agronj1973.00021962006500010035x; Hossain MA, 2011, FIELD CROP RES, V123, P100, DOI 10.1016/j.fcr.2011.05.005; Hu YK, 2010, J HYDROL, V393, P219, DOI 10.1016/j.jhydrol.2010.08.017; Jiang D, 2008, PLANT SOIL, V304, P301, DOI 10.1007/s11104-008-9556-x; KIRBY EJM, 1988, FIELD CROP RES, V18, P127, DOI 10.1016/0378-4290(88)90004-4; Li HM, 2005, AGR WATER MANAGE, V76, P8, DOI 10.1016/j.agwat.2005.01.006; Li QQ, 2010, AGR WATER MANAGE, V97, P1676, DOI 10.1016/j.agwat.2010.05.025; Lu DJ, 2015, FIELD CROP RES, V171, P157, DOI 10.1016/j.fcr.2014.10.012; Ma SC, 2008, FIELD CROP RES, V105, P56, DOI 10.1016/j.fcr.2007.07.005; Meng QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068783; Nleya T, 2014, AGRON J, V106, P915, DOI 10.2134/agronj13.0417; Qiu GY, 2008, AGR FOREST METEOROL, V148, P1848, DOI 10.1016/j.agrformet.2008.06.010; Reynolds M, 2009, J EXP BOT, V60, P1899, DOI 10.1093/jxb/erp016; SAS Institute Inc, 2009, SAS STAT 92 US GUID, Vsecond; Sokoto M. B., 2013, American Journal of Plant Sciences, V4, P122; Subedi KD, 1998, FIELD CROP RES, V55, P141, DOI 10.1016/S0378-4290(97)00073-7; Sun HY, 2007, IND CROP PROD, V25, P239, DOI 10.1016/j.indcrop.2006.12.003; Sun HY, 2015, EUR J AGRON, V70, P48, DOI 10.1016/j.eja.2015.07.001; Tapley M, 2013, AGRON J, V105, P509, DOI 10.2134/agronj2012.0379; Wang D, 2013, FIELD CROP RES, V151, P35, DOI 10.1016/j.fcr.2013.07.009; Wang WX, 2014, BEIJING AGR, V6, P58; White RG, 2010, PLANT CELL ENVIRON, V33, P133, DOI 10.1111/j.1365-3040.2009.02059.x; Xue Q, 2014, CROP SCI, V54, P34, DOI 10.2135/cropsci2013.02.0108; Xue QW, 2006, J PLANT PHYSIOL, V163, P154, DOI 10.1016/j.jplph.2005.04.026; Yang JC, 2004, PLANTA, V220, P331, DOI 10.1007/s00425-004-1338-y; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; [张胜全 ZHANG Sheng-Quan], 2009, [生态学报, Acta Ecologica Sinica], V29, P2035; Zhang XY, 2015, AGR WATER MANAGE, V153, P32, DOI 10.1016/j.agwat.2015.02.001; Zhang XY, 2010, AGR WATER MANAGE, V97, P1117, DOI 10.1016/j.agwat.2009.06.003; Zhang XY, 2004, HYDROL PROCESS, V18, P2275, DOI 10.1002/hyp.5533; Zhang YP, 2011, FIELD CROP RES, V123, P187, DOI 10.1016/j.fcr.2011.04.014; Zhong YQW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098850	40	31	40	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153695	10.1371/journal.pone.0153695	http://dx.doi.org/10.1371/journal.pone.0153695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100187	Green Published, gold			2022-12-26	WOS:000374898500051
J	Wei, M; Zhao, X; Liu, M; Niu, MJ; Seif, E; Kleiman, L				Wei, Min; Zhao, Xia; Liu, Mi; Niu, Meijuan; Seif, Elias; Kleiman, Lawrence			Export of Precursor tRNA(Ile) from the Nucleus to the Cytoplasm in Human Cells	PLOS ONE			English	Article							TRANSFER-RNA; IDENTIFICATION; TRANSCRIPTION; TRNA(LYS3); IMPORT	In the current concept, tRNA maturation in vertebrate cells, including splicing of introns, trimming of 5' leader and 3' trailer, and adding of CCA, is thought to occur exclusively in the nucleus. Here we provide evidence to challenge this concept. Unspliced intron-containing precursor tRNAIle was identified in Human Immunodeficiency Virus type 1 (HIV-1) virions, which are synthesized in the cytoplasm. Northern blot, confocal microscopy and quantitative RT-PCR further verified enrichment of this unspliced tRNAIle within the cytoplasm in human cells. In addition to containing an intron, the cytoplasmic precursor tRNAIle also contains a short incompletely processed 5' leader and a 3' trailer, which abundance is around 1000 fold higher than the nuclear precursor tRNAIle with long 5' leader and long 3' trailer. In vitro data also suggest that the cytoplasmic unspliced end-immature precursor tRNAIle could be processed by short isoform of RNase Z, but not long isoform of RNase Z. These data suggest that precursor tRNAs could export from the nucleus to the cytoplasm in human cells, instead of be processed only in the nucleus.	[Wei, Min] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Wei, Min; Zhao, Xia; Niu, Meijuan; Seif, Elias; Kleiman, Lawrence] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3A 2T5, Canada; [Liu, Mi] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Nankai University; Lady Davis Institute; McGill University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wei, M (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.; Wei, M (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3A 2T5, Canada.	weimin@nankai.edu.cn			Canadian Institutes of Health Research (CIHR) [HOP 81389]; Nankai University [ZB15006101]; National Natural Science Foundation of China [81571991]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Nankai University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the Canadian Institutes of Health Research (CIHR, HOP 81389 to L.K.), Nankai University starting fund (ZB15006101 to M. W.), and National Natural Science Foundation of China (81571991 to M. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Eckwahl MJ, 2015, GENE DEV, V29, P646, DOI 10.1101/gad.258731.115; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Hopper AK, 2008, TRENDS CELL BIOL, V18, P98, DOI 10.1016/j.tcb.2008.01.001; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; Hopper AK, 2010, FEBS LETT, V584, P310, DOI 10.1016/j.febslet.2009.11.053; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; Kleiman L, 2004, CURR HIV RES, V2, P163, DOI 10.2174/1570162043484988; Kleiman L, 2002, IUBMB LIFE, V53, P107, DOI 10.1080/15216540211469; Kramer EB, 2013, P NATL ACAD SCI USA, V110, P21042, DOI 10.1073/pnas.1316579110; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Nashimoto M, 1999, NUCLEIC ACIDS RES, V27, P2770, DOI 10.1093/nar/27.13.2770; Negri ED, 1997, CELL, V89, P859, DOI 10.1016/S0092-8674(00)80271-8; Ohira T, 2011, P NATL ACAD SCI USA, V108, P10502, DOI 10.1073/pnas.1105645108; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Schiffer SP, 2002, COMPARATIVE MED, V52, P305; Shaheen HH, 2005, P NATL ACAD SCI USA, V102, P11290, DOI 10.1073/pnas.0503836102; Takahashi M, 2008, FEBS LETT, V582, P2532, DOI 10.1016/j.febslet.2008.06.020; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Takano A, 2005, SCIENCE, V309, P140, DOI 10.1126/science.1113346; Wei M, 2005, J VIROL, V79, P9081, DOI 10.1128/JVI.79.14.9081-9087.2005; Xing L, 2011, J VIROL, V85, P1847, DOI 10.1128/JVI.02010-10; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757	28	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154044	10.1371/journal.pone.0154044	http://dx.doi.org/10.1371/journal.pone.0154044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101286	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500131
J	Lin, HR; Wu, YH; Yen, WC; Yang, CM; Chiu, DTY				Lin, Hsin-Ru; Wu, Yi-Hsuan; Yen, Wei-Chen; Yang, Chuen-Mao; Chiu, Daniel Tsun-Yee			Diminished COX-2/PGE(2)-Mediated Antiviral Response Due to Impaired NOX/MAPK Signaling in G6PD-Knockdown Lung Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; FAMILY NADPH OXIDASES; INDUCED CYCLOOXYGENASE-2 EXPRESSION; ACTIVATED PROTEIN-KINASES; INNATE IMMUNE-RESPONSE; SMOOTH-MUSCLE-CELLS; NOX FAMILY; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; HOST-DEFENSE; COX-2 EXPRESSION	Glucose-6-phosphate dehydrogenase (G6PD) provides the reducing agent NADPH to meet the cellular needs for reductive biosynthesis and the maintenance of redox homeostasis. G6PD-deficient cells experience a high level of oxidative stress and an increased susceptibility to viral infections. Cyclooxygenase-2 (COX-2) is a key mediator in the regulation of viral replication and inflammatory response. In the current study, the role of G6PD on the inflammatory response was determined in both scramble control and G6PD-knockdown (G6PD-kd) A549 cells upon tumor necrosis factor-alpha (TNF-alpha) stimulation. A decreased expression pattern of induced COX-2 and reduced production of downstream PGE2 occurred upon TNF-alpha stimulation in G6PD-kd A549 cells compared with scramble control A549 cells. TNF-alpha-induced antiviral activity revealed that decreased COX-2 expression enhanced the susceptibility to coronavirus 229E infection in G6PD-kd A549 cells and was a result of the decreased phosphorylation levels of MAPK (p38 and ERK1/2) and NF-kappa B. The impaired inflammatory response in G6PD-kd A549 cells was found to be mediated through NADPH oxidase (NOX) signaling as elucidated by cell pretreatment with a NOX2-siRNA or NOX inhibitor, diphenyleneiodonium chloride (DPI). In addition, NOX activity with TNF-alpha treatment in G6PD-kd A549 cells was not up-regulated and was coupled with a decrease in NOX subunit expression at the transcriptional level, implying that TNF-alpha-mediated NOX signaling requires the participation of G6PD. Together, these data suggest that G6PD deficiency affects the cellular inflammatory response and the decreased TNF-alpha-mediated antiviral response in G6PD-kd A549 cells is a result of dysregulated NOX/MAPK/NF-kappa B/COX-2 signaling.	[Lin, Hsin-Ru] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Wu, Yi-Hsuan; Chiu, Daniel Tsun-Yee] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan; [Yen, Wei-Chen] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Yang, Chuen-Mao; Chiu, Daniel Tsun-Yee] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan; [Chiu, Daniel Tsun-Yee] Chang Gung Mem Hosp, Dept Pediat Hematol, Linkou, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chiu, DTY (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan.; Yang, CM; Chiu, DTY (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan.; Yang, CM (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan.; Chiu, DTY (corresponding author), Chang Gung Mem Hosp, Dept Pediat Hematol, Linkou, Taiwan.	chuenmao@mail.cgu.edu.tw; dtychiu@mail.cgu.edu.tw		Yang, Chuen-Mao/0000-0002-3208-5438	Chang Gung University; Chang Gung Memorial Hospital [BMRP098, CMRPD1C0772, CMRPD1C0773, CMRPD3D0161, CMRPD3D0162, CMRPD1B0332, CMRPD1C0562, CMRPD1B0383, CMRPD1C0103]; Ministry of Science and Technology [MOST103-2320-B-182-026-MY2, MOST103-2321-B-182-006, MOST101-2320-B-182-039-MY3]; Ministry of Education of Taiwan [EMRPD1E1651]	Chang Gung University; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education of Taiwan(Ministry of Education, Taiwan)	The work was supported by grants from Chang Gung University and Chang Gung Memorial Hospital (BMRP098, CMRPD1C0772, CMRPD1C0773, CMRPD3D0161 and CMRPD3D0162 to DTYC, CMRPD1B0332 to Healthy Aging Research Center, CMRPD1C0562, CMRPD1B0383 and CMRPD1C0103 to CMY), the Ministry of Science and Technology (MOST103-2320-B-182-026-MY2 to DTYC, MOST103-2321-B-182-006 and MOST101-2320-B-182-039-MY3 to CMY) and the Ministry of Education of Taiwan (EMRPD1E1651 to Chang Gung University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2013, J CLIN DIAGN RES, V7, P3012, DOI 10.7860/JCDR/2013/6159.3892; Azevedo EP, 2015, J BIOL CHEM, V290, P22174, DOI 10.1074/jbc.M115.640094; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Brasier AR, 2014, ADV EXP MED BIOL, V795, P233, DOI 10.1007/978-1-4614-8603-9_15; Carette C, 2011, DIABETES METAB, V37, P79, DOI 10.1016/j.diabet.2010.09.004; Chen CC, 2001, MOL PHARMACOL, V59, P493, DOI 10.1124/mol.59.3.493; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Davis BK, 2014, INFLAMM BOWEL DIS, V20, P2412, DOI 10.1097/MIB.0000000000000151; Del Corno M, 2014, J VIROL, V88, P11045, DOI 10.1128/JVI.00307-14; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Fink K, 2013, CELL RES, V23, P673, DOI 10.1038/cr.2013.47; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Grandvaux N, 2007, BIOCHIMIE, V89, P1113, DOI 10.1016/j.biochi.2007.04.008; Grandvaux N, 2015, CLIN SCI, V128, P337, DOI 10.1042/CS20140321; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Ham M, 2013, MOL CELL BIOL, V33, P2425, DOI 10.1128/MCB.01260-12; Hecker PA, 2013, AM J PHYSIOL-HEART C, V304, pH491, DOI 10.1152/ajpheart.00721.2012; Heymann Anthony D, 2012, Diabetes Care, V35, pe58, DOI 10.2337/dc11-2527; Ho HY, 2014, FREE RADICAL RES, V48, P1028, DOI 10.3109/10715762.2014.913788; Ho HY, 2007, REDOX REP, V12, P109, DOI 10.1179/135100007X200209; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kim HJ, 2013, AM J RESP CELL MOL, V49, P855, DOI 10.1165/rcmb.2013-0003OC; Lee IT, 2013, J NUTR BIOCHEM, V24, P124, DOI 10.1016/j.jnutbio.2012.03.009; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Lin CC, 2004, CELL SIGNAL, V16, P597, DOI 10.1016/j.cellsig.2003.10.002; Lin CJ, 2010, FREE RADICAL BIO MED, V49, P361, DOI 10.1016/j.freeradbiomed.2010.04.019; Lin CK, 2015, BRIT J PHARMACOL, V172, P4481, DOI 10.1111/bph.13233; Lin HR, 2013, J PROTEOME RES, V12, P3434, DOI 10.1021/pr4002959; Liu L, 2012, J BIOL CHEM, V287, P11899, DOI 10.1074/jbc.M111.308064; Matsui R, 2005, CIRCULATION, V112, P257, DOI 10.1161/CIRCULATIONAHA.104.499095; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Ou Jun-Bin, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P751; Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004; Sajjan US, 2013, CURR OPIN PULM MED, V19, P125, DOI 10.1097/MCP.0b013e32835cef10; Segal BH, 2012, FREE RADICAL BIO MED, V53, P72, DOI 10.1016/j.freeradbiomed.2012.04.022; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Strengert M, 2014, ANTIOXID REDOX SIGN, V20, P2695, DOI 10.1089/ars.2013.5353; van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016; van Zwieten R, 2014, FREE RADICAL BIO MED, V67, P377, DOI 10.1016/j.freeradbiomed.2013.11.022; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Wan GH, 2002, ENDOCRINE, V19, P191, DOI 10.1385/ENDO:19:2:191; Wu YH, 2008, J INFECT DIS, V197, P812, DOI 10.1086/528377; Wu YH, 2015, VIRUSES-BASEL, V7, P6689, DOI 10.3390/v7122966; Yang CM, 2009, AM J PHYSIOL-LUNG C, V297, pL892, DOI 10.1152/ajplung.00151.2009; Yang HC, 2011, MICROBES INFECT, V13, P109, DOI 10.1016/j.micinf.2010.10.008; Zhang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049128; Zhou YQ, 2015, VIRUSES-BASEL, V7, P3116, DOI 10.3390/v7062762	56	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153462	10.1371/journal.pone.0153462	http://dx.doi.org/10.1371/journal.pone.0153462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097228	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600036
J	Cross, AM; Wilson, AL; Guerrero, MS; Thomas, KS; Bachir, AI; Kubow, KE; Horwitz, AR; Bouton, AH				Cross, A. M.; Wilson, A. L.; Guerrero, M. S.; Thomas, K. S.; Bachir, A. I.; Kubow, K. E.; Horwitz, A. R.; Bouton, A. H.			Breast cancer antiestrogen resistance 3-p130(Cas) interactions promote adhesion disassembly and invasion in breast cancer cells	ONCOGENE			English	Article							MIGRATION; INTEGRIN; BCAR3; CAS; AND-34/BCAR3; ACTIVATION; EXPRESSION; FAMILY; ASSOCIATION; INDUCTION	Adhesion turnover is critical for cell motility and invasion. We previously demonstrated that the adaptor molecule breast cancer antiestrogen resistance 3 (BCAR3) promotes adhesion disassembly and breast tumor cell invasion. One of two established binding partners of BCAR3 is the adaptor molecule, p130(Cas). In this study, we sought to determine whether signaling through the BCAR3-Cas complex was responsible for the cellular functions of BCAR3. We show that the entire pool of BCAR3 is in complex with Cas in invasive breast tumor cells and that these proteins colocalize in dynamic cellular adhesions. Although accumulation of BCAR3 in adhesions did not require Cas binding, a direct interaction between BCAR3 and Cas was necessary for efficient dissociation of BCAR3 from adhesions. The dissociation rates of Cas and two other adhesion molecules, a-actinin and talin, were also significantly slower in the presence of a Cas-binding mutant of BCAR3, suggesting that turnover of the entire adhesion complex was delayed under these conditions. As was the case for adhesion turnover, BCAR3-Cas interactions were found to be important for BCAR3-mediated breast tumor cell chemotaxis toward serum and invasion in Matrigel. Previous work demonstrated that BCAR3 is a potent activator of Rac1, which in turn is an important regulator of adhesion dynamics and invasion. However, in contrast to wild-type BCAR3, ectopic expression of the Cas-binding mutant of BCAR3 failed to induce Rac1 activity in breast cancer cells. Together, these data show that the ability of BCAR3 to promote adhesion disassembly, tumor cell migration and invasion, and Rac1 activity is dependent on its ability to bind to Cas. The activity of BCAR3-Cas complexes as a functional unit in breast cancer is further supported by the co-expression of these molecules in multiple subtypes of human breast tumors.	[Cross, A. M.; Wilson, A. L.; Thomas, K. S.; Bouton, A. H.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Box 800734, Charlottesville, VA 22908 USA; [Guerrero, M. S.] Fujifilm Diosynth Biotechnol USA Inc, Cary, NC USA; [Bachir, A. I.; Horwitz, A. R.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Kubow, K. E.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA	University of Virginia; Fujifilm Corporation; University of Virginia; James Madison University	Bouton, AH (corresponding author), Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Box 800734, Charlottesville, VA 22908 USA.	ahb8y@virginia.edu		Kubow, Kristopher/0000-0003-0259-882X	NIH [5 T32 CA009109, 1 R01 CA096846, 1 F31 CA165703, 1 F31 CA130168, GM023244]; Department of Defense Breast Cancer Research Program [BC141713]; American Cancer Society [PF-12-136-01-CSM]; Women's Oncology Research Fund; NCI Cancer Center Support Grant from the UVA Cancer Center [P30 CA44579]; NATIONAL CANCER INSTITUTE [T32CA009109, R01CA096846, F31CA130168, F31CA165703, P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023244, R01GM023244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); American Cancer Society(American Cancer Society); Women's Oncology Research Fund; NCI Cancer Center Support Grant from the UVA Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Jessica Zareno for technical assistance with TIRF microscopy and Dr Kristen Atkins for identification and pathological assessment of human breast tumor samples. This work was supported by grants from the NIH (5 T32 CA009109 (ALW, AMC), 1 R01 CA096846 (AHB), 1 F31 CA165703 (ALW), 1 F31 CA130168 (MSG) and GM023244 (ARH)); the Department of Defense Breast Cancer Research Program (BC141713 to AHB); the American Cancer Society (PF-12-136-01-CSM to KEK); and the Women's Oncology Research Fund and NCI Cancer Center Support Grant P30 CA44579 from the UVA Cancer Center. Breast tumor samples were obtained from the UVA tumor bank and stained by the Biorepository and Tissue Research Facility (BTRF).	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; Borre PV, 2011, CELL SIGNAL, V23, P1030, DOI 10.1016/j.cellsig.2011.01.018; Bouton AH, 1997, HYBRIDOMA, V16, P403, DOI 10.1089/hyb.1997.16.403; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cai DP, 1999, J IMMUNOL, V163, P2104; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Lu YM, 1999, J BIOL CHEM, V274, P10047, DOI 10.1074/jbc.274.15.10047; Mace PD, 2011, NAT STRUCT MOL BIOL, V18, P1381, DOI 10.1038/nsmb.2152; Near RI, 2007, J CELL PHYSIOL, V212, P655, DOI 10.1002/jcp.21059; Near RI, 2009, MOL VIS, V15, P685; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Schuh NR, 2010, J BIOL CHEM, V285, P2309, DOI 10.1074/jbc.M109.046631; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; Vervoort VS, 2007, GENE, V391, P161, DOI 10.1016/j.gene.2006.12.016; Wallez Y, 2014, J BIOL CHEM, V289, P10431, DOI 10.1074/jbc.M113.541839; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wilson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065678; Yamazaki D, 2009, ONCOGENE, V28, P1570, DOI 10.1038/onc.2009.2	24	5	5	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2016	35	45					5850	5859		10.1038/onc.2016.123	http://dx.doi.org/10.1038/onc.2016.123			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EB7IR	27109104	Green Accepted			2022-12-26	WOS:000387560800004
J	Tillotson, MD; Quinn, TP				Tillotson, Michael D.; Quinn, Thomas P.			Beyond Correlation in the Detection of Climate Change Impacts: Testing a Mechanistic Hypothesis for Climatic Influence on Sockeye Salmon (Oncorhynchus nerka) Productivity	PLOS ONE			English	Article							SURVIVAL RATES; REACTION NORMS; LIFE-HISTORY; PINK SALMON; MARINE; TRENDS; LAKE; COVARIATION; MIGRATION; FISHERIES	Detecting the biological impacts of climate change is a current focus of ecological research and has important applications in conservation and resource management. Owing to a lack of suitable control systems, measuring correlations between time series of biological attributes and hypothesized environmental covariates is a common method for detecting such impacts. These correlative approaches are particularly common in studies of exploited fish species because rich biological time-series data are often available. However, the utility of species-environment relationships for identifying or predicting biological responses to climate change has been questioned because strong correlations often deteriorate as new data are collected. Specifically stating and critically evaluating the mechanistic relationship (s) linking an environmental driver to a biological response may help to address this problem. Using nearly 60 years of data on sockeye salmon from the Kvichak River, Alaska we tested a mechanistic hypothesis linking water temperatures experienced during freshwater rearing to population productivity by modeling a series of intermediate, deterministic relationships and evaluating temporal trends in biological and environmental time-series. We found that warming waters during freshwater rearing have profoundly altered patterns of growth and life history in this population complex yet there has been no significant correlation between water temperature and metrics of productivity commonly used in fisheries management. These findings demonstrate that pairing correlative approaches with careful consideration of the mechanistic links between populations and their environments can help to both avoid spurious correlations and identify biologically important, but not statistically significant relationships, and ultimately producing more robust conclusions about the biological impacts of climate change.	[Tillotson, Michael D.; Quinn, Thomas P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Tillotson, MD (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	mdt3@uw.edu			University of Washington's IGERT Program on Ocean Change; ARCS foundation; Pacific salmon seafood industry; National Science Foundation (BioComplexity program); Gordon and Betty Moore Foundation; National Science Foundation (Coupled Natural and Human Systems program)	University of Washington's IGERT Program on Ocean Change; ARCS foundation; Pacific salmon seafood industry; National Science Foundation (BioComplexity program)(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation (Coupled Natural and Human Systems program)(National Science Foundation (NSF))	This submission was funded by the University of Washington's IGERT Program on Ocean Change (http://depts.washington.edu/igertpoc/) and the ARCS foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all those who have collected, analyzed and maintained data for the Fisheries Research Institute over the past 60 years, especially Ole Mathisen, Bud Kerns, Pat Poe, Warner Lew, Greg Buck and Harry Rich, Jr., and Daniel Schindler and Warner Lew for important formative discussions on this topic. We also thank the Alaska Department of Fish and Game and LGL Associates for sharing data; especially Matt Nemeth. We are grateful for the funding to MDT provided by the ARCS Foundation and the University of Washington's IGERT Program on Ocean Change. Finally, these long-term data would not be available without the support for the research program provided by the Pacific salmon seafood industry, the National Science Foundation (BioComplexity and Coupled Natural and Human Systems programs), the Gordon and Betty Moore Foundation, and other entities and individuals over the years.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beamish RJ, 1999, CAN J FISH AQUAT SCI, V56, P516, DOI 10.1139/cjfas-56-3-516; Bjornsson BT, 2011, GEN COMP ENDOCR, V170, P290, DOI 10.1016/j.ygcen.2010.07.003; BLAIR GR, 1993, T AM FISH SOC, V122, P550, DOI 10.1577/1548-8659(1993)122&lt;0550:VILHCA&gt;2.3.CO;2; Brostrom G., 2013, GLMMML GEN LINEAR MO; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cass A., 1991, CAN J FISH AQUAT SCI, V48; Chapin III F.S., 2014, CLIMATE CHANGE IMPAC, P514, DOI [DOI 10.7930/J00Z7150, 10.7930/J00Z7150]; Cribari-Neto F, 2009, J STAT SOFTW, V34, P24; Cunningham CJ, 2012, UW FISHERIES RES I R; Dieckmann U, 2007, MAR ECOL PROG SER, V335, P253, DOI 10.3354/meps335253; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dybala KE, 2013, GLOBAL CHANGE BIOL, V19, P2688, DOI 10.1111/gcb.12228; Edmundson JA, 2001, T AM FISH SOC, V130, P644, DOI 10.1577/1548-8659(2001)130&lt;0644:LGOJSS&gt;2.0.CO;2; Fair LF, 2003, ALASKA FISH RES B, V10, P95; Foley AM, 2010, PROG PHYS GEOG, V34, P647, DOI 10.1177/0309133310375654; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hodgkins GA, 2002, INT J CLIMATOL, V22, P1819, DOI 10.1002/joc.857; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hutchings JA, 2011, HEREDITY, V106, P421, DOI 10.1038/hdy.2010.166; Irvine JR, 2011, ICES J MAR SCI, V68, P1122, DOI 10.1093/icesjms/fsq199; Jones M, 2012, 1221 AL DEP FISH GAM, P12; KOENINGS JP, 1993, CAN J FISH AQUAT SCI, V50, P600, DOI 10.1139/f93-069; Koo TSY, 1962, STUDIES ALASKA RED S, P247; Kovach RP, 2014, CAN J FISH AQUAT SCI, V71, P799, DOI 10.1139/cjfas-2013-0577; Kovach RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053807; Lew W., 2003, M AL AM FISH SOC GIR; Litzow MA, 2014, GLOBAL CHANGE BIOL, V20, P38, DOI 10.1111/gcb.12373; MAHNKEN C, 1982, AQUACULTURE, V28, P251, DOI 10.1016/0044-8486(82)90027-8; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martins EG, 2012, REV FISH BIOL FISHER, V22, P887, DOI 10.1007/s11160-012-9271-9; Meacham C., 1987, CAN SPEC PUBL FISH A, V96, P336; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; [National Climate Data Center National Oceanic and Atmospheric Administration], 2014, CLIM DAT ONL; National Oceanic and Atmospheric Administration, 2014, CURR VIEW BER SEA EC; Nemeth MJ, 2014, SOCKEYE SALMON SMOLT; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Peterman RM, 1998, CAN J FISH AQUAT SCI, V55, P2503, DOI 10.1139/cjfas-55-11-2503; Pinheiro J, 2020, R PACKAGE VERSION 31; Poe PH, 1984, ESCAPEMENT GOALS KVI; Pope Kevin L., 2007, P423; Pyper BJ, 2001, CAN J FISH AQUAT SCI, V58, P1501, DOI 10.1139/cjfas-58-8-1501; Quinn Thomas P., 2005, P1; Quinn TP, 2009, AM FISH S S, V69, P23; R Core Team, 2021, R LANGUAGE ENV STAT; Reed TE, 2015, OIKOS, V124, P81, DOI 10.1111/oik.01398; Reed TE, 2013, J ANIM ECOL, V82, P131, DOI 10.1111/j.1365-2656.2012.02020.x; Rich HB, 2009, CAN J FISH AQUAT SCI, V66, P238, DOI 10.1139/F08-210; Rich Jr HB, 2006, EFFECTS CLIMATE DENS; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rogers LA, 2011, GLOBAL CHANGE BIOL, V17, P2546, DOI 10.1111/j.1365-2486.2011.02415.x; Ruggerone GT, 2010, MAR COAST FISH, V2, P306, DOI 10.1577/C09-054.1; Ruggerone GT, 2006, COLLAPSE KVICHAK SOC; Ruggerone GT, 2013, N PACIFIC ANADROMOUS, V9, P210; Scheuerell MD, 2009, J APPL ECOL, V46, P983, DOI 10.1111/j.1365-2664.2009.01693.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schindler DE, 2005, ECOLOGY, V86, P3225, DOI 10.1890/04-1730; Schmitz OJ, 2003, BIOSCIENCE, V53, P1199, DOI 10.1641/0006-3568(2003)053[1199:ERTGCC]2.0.CO;2; Stewart DC, 2006, ECOL FRESHW FISH, V15, P552, DOI 10.1111/j.1600-0633.2006.00197.x; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Westing C, 2006, 0637 AL DEP FISH GAM; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN., 2006, BIOMETRICS, V67, P391, DOI DOI 10.1111/J.1541-0420.2007.00905_3.X	67	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154356	10.1371/journal.pone.0154356	http://dx.doi.org/10.1371/journal.pone.0154356			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123845	gold, Green Published, Green Submitted			2022-12-26	WOS:000375211700073
J	Peter, B; Wijsman, EM; Nato, AQ; Matsushita, MM; Chapman, KL; Stanaway, IB; Wolff, J; Oda, K; Gabo, VB; Raskind, WH				Peter, Beate; Wijsman, Ellen M.; Nato, Alejandro Q., Jr.; Matsushita, Mark M.; Chapman, Kathy L.; Stanaway, Ian B.; Wolff, John; Oda, Kaori; Gabo, Virginia B.; Raskind, Wendy H.		University Washington Ctr	Genetic Candidate Variants in Two Multigenerational Families with Childhood Apraxia of Speech	PLOS ONE			English	Article							RECOGNIZED MICRODELETION SYNDROME; AUTISM SPECTRUM DISORDER; COMPARATIVE GENOMIC HYBRIDIZATION; NUMBER VARIATION DETECTION; SOUND DISORDERS; LINKAGE ANALYSIS; LANGUAGE IMPAIRMENT; EXOME SEQUENCE; LARGE PEDIGREE; CHILDREN	Childhood apraxia of speech (CAS) is a severe and socially debilitating form of speech sound disorder with suspected genetic involvement, but the genetic etiology is not yet well understood. Very few known or putative causal genes have been identified to date, e.g., FOXP2 and BCL11A. Building a knowledge base of the genetic etiology of CAS will make it possible to identify infants at genetic risk and motivate the development of effective very early intervention programs. We investigated the genetic etiology of CAS in two large multi-generational families with familial CAS. Complementary genomic methods included Markov chain Monte Carlo linkage analysis, copy-number analysis, identity-by-descent sharing, and exome sequencing with variant filtering. No overlaps in regions with positive evidence of linkage between the two families were found. In one family, linkage analysis detected two chromosomal regions of interest, 5p15.1-p14.1, and 17p13.1-q11.1, inherited separately from the two founders. Single-point linkage analysis of selected variants identified CDH18 as a primary gene of interest and additionally, MYO10, NIPBL, GLP2R, NCOR1, FLCN, SMCR8, NEK8, and ANKRD12, possibly with additive effects. Linkage analysis in the second family detected five regions with LOD scores approaching the highest values possible in the family. A gene of interest was C4orf21 (ZGRF1) on 4q25-q28.2. Evidence for previously described causal copy-number variations and validated or suspected genes was not found. Results are consistent with a heterogeneous CAS etiology, as is expected in many neurogenic disorders. Future studies will investigate genome variants in these and other families with CAS.	[Peter, Beate] Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA; [Peter, Beate] St Louis Univ, Dept Commun Sci & Disorders, St Louis, MO 63103 USA; [Peter, Beate] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Wijsman, Ellen M.; Nato, Alejandro Q., Jr.; Matsushita, Mark M.; Wolff, John; Oda, Kaori; Gabo, Virginia B.; Raskind, Wendy H.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Wijsman, Ellen M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Chapman, Kathy L.] Univ Utah, Dept Commun Sci & Disorders, Salt Lake City, UT USA; [Stanaway, Ian B.] Univ Washington, Dept Environm & Occupat Hlth, Environm Toxicol, Seattle, WA 98195 USA; [Raskind, Wendy H.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Arizona State University; Arizona State University-Tempe; Saint Louis University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Peter, B (corresponding author), Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA.; Peter, B (corresponding author), St Louis Univ, Dept Commun Sci & Disorders, St Louis, MO 63103 USA.; Peter, B (corresponding author), Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA.	Beate.Peter@asu.edu	Nato, Alejandro Q/D-9276-2012	Nato, Alejandro Q/0000-0002-8745-9046; Blue, Elizabeth/0000-0002-0633-0305; Peter, Beate/0000-0002-9083-8522	American Speech Language-Hearing Foundation New Century Scholars Research Grant; NIDCD [T32DC00033, R03DC010886, R01HD054562, R01MH094293]; National Human Genome Research Institute; NIH [1U54HG006493]; Environmental Health Sciences of the National Institutes of Health [T32ES015459, 5P01 ES009601]; EPA [RD-83451401]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054562] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, R25HG007153, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009601, T32ES015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000033, R03DC010886] Funding Source: NIH RePORTER	American Speech Language-Hearing Foundation New Century Scholars Research Grant; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Environmental Health Sciences of the National Institutes of Health; EPA(United States Environmental Protection Agency); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The following funding sources are gratefully acknowledged: American Speech Language-Hearing Foundation New Century Scholars Research Grant (B. Peter), NIDCD T32DC00033 (B. Peter), NIDCD R03DC010886 (B. Peter), R01HD054562 (W. H. Raskind), and R01MH094293 (E. Wijsman). SNP genotyping and exome sequencing were provided by the University of Washington Center for Mendelian Genomics (UW CMG) and was funded by the National Human Genome Research Institute and NIH grant 1U54HG006493 to the three UW CMG members, Drs. M. Bamshad, D. Nickerson and J. Shendure. I. Stanaway was supported under grants from the Environmental Health Sciences of the National Institutes of Health (T32ES015459 and 5P01 ES009601) and the EPA (RD-83451401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BALSAMO J, 1995, J CELL BIOL, V129, P1391, DOI 10.1083/jcb.129.5.1391; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Button L, 2013, CLIN LINGUIST PHONET, V27, P192, DOI 10.3109/02699206.2012.744097; Can DD, 2013, BRAIN LANG, V124, P34, DOI 10.1016/j.bandl.2012.10.007; Chabchoub E, 2008, J MED GENET, V45, P189, DOI 10.1136/jmg.2007.056176; Chapman NH, 2015, HUM GENET, V134, P1055, DOI 10.1007/s00439-015-1585-y; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; Crowe Hall B.J., 1991, LANG SPEECH HEAR SER, V22, P334, DOI DOI 10.1044/0161-1461.2201.334; Dawson J. I., 2001, STRUCTURED PHOTOGRAP; De Leeuw N, 2008, J MED GENET, V45, P122, DOI 10.1136/jmg.2007.054049; Dollaghan C, 1998, J SPEECH LANG HEAR R, V41, P1136, DOI 10.1044/jslhr.4105.1136; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; ELSAS LJ, 1995, EUR J PEDIATR, V154, pS21, DOI 10.1007/BF02143798; Felix TM, 2010, AM J MED GENET A, V152A, P2604, DOI 10.1002/ajmg.a.33612; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fisher SE, 2003, ANNU REV NEUROSCI, V26, P57, DOI 10.1146/annurev.neuro.26.041002.131144; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; FLETCHER SG, 1972, J SPEECH HEAR RES, V15, P763, DOI 10.1044/jshr.1504.763; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Frank V, 2013, HUM MOL GENET, V22, P2177, DOI 10.1093/hmg/ddt070; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hancarova M, 2013, AM J MED GENET A, V161A, P865, DOI 10.1002/ajmg.a.35783; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Kim S, 2012, GENET EPIDEMIOL, V36, P488, DOI 10.1002/gepi.21643; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kleensang A, 2010, HUM HERED, V69, P202, DOI 10.1159/000289596; Konig IR, 2011, AM J MED GENET B, V156B, P36, DOI 10.1002/ajmg.b.31135; Korvatska O, 2015, JAMA NEUROL, V72, P920, DOI 10.1001/jamaneurol.2015.0979; Korvatska O, 2013, HUM MOL GENET, V22, P3259, DOI 10.1093/hmg/ddt180; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Laffin JJS, 2012, GENET MED, V14, P928, DOI 10.1038/gim.2012.72; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lewis BA, 2006, J COMMUN DISORD, V39, P139, DOI 10.1016/j.jcomdis.2005.11.003; Lewis BA, 2004, LANG SPEECH HEAR SER, V35, P122, DOI 10.1044/0161-1461(2004/014); Liang JS, 2009, J MED GENET, V46, P645, DOI 10.1136/jmg.2008.059220; Liegeois F, 2011, EUR J PAEDIATR NEURO, V15, P283, DOI 10.1016/j.ejpn.2011.04.006; Liu KC, 2012, MOL BIOL CELL, V23, P1675, DOI 10.1091/mbc.E11-04-0358; Lousada M, 2014, INT J LANG COMM DIS, V49, P584, DOI 10.1111/1460-6984.12095; Marchani EE, 2012, HUM HERED, V74, P153, DOI 10.1159/000346560; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Morris CA, 2015, AM J MED GENET A, V167, P2916, DOI 10.1002/ajmg.a.37340; MORTON NE, 1955, AM J HUM GENET, V7, P277; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Murray E, 2014, AM J SPEECH-LANG PAT, V23, P486, DOI 10.1044/2014_AJSLP-13-0035; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Namasivayam AK, 2015, INT J LANG COMM DIS, V50, P529, DOI 10.1111/1460-6984.12154; Nathan L, 2004, BRIT J EDUC PSYCHOL, V74, P173, DOI 10.1348/000709904773839824; Nato AQ, 2015, BIOINFORMATICS, V31, P3790, DOI 10.1093/bioinformatics/btv444; Newbury DF, 2013, EUR J HUM GENET, V21, P361, DOI 10.1038/ejhg.2012.166; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Pal DK, 2010, GENES BRAIN BEHAV, V9, P1004, DOI 10.1111/j.1601-183X.2010.00648.x; Peter B, 2014, AM J MED GENET A, V164, P2091, DOI 10.1002/ajmg.a.36599; Peter B, 2013, CLIN LINGUIST PHONET, V27, P163, DOI 10.3109/02699206.2012.736011; Peter B, 2012, PSYCHIAT GENET, V22, P226, DOI 10.1097/YPG.0b013e328353ae92; Peter B, 2011, TOP LANG DISORD, V31, P145, DOI 10.1097/TLD.0b013e318217b855; Peter B, 2011, J NEURODEV DISORD, V3, P39, DOI 10.1007/s11689-010-9065-0; Piccione M, 2012, EUR J MED GENET, V55, P238, DOI 10.1016/j.ejmg.2012.01.014; Pliatsikas C, 2014, CEREBELLUM, V13, P55, DOI 10.1007/s12311-013-0515-6; Pourcain BS, 2010, AM J PSYCHIAT, V167, P1364, DOI 10.1176/appi.ajp.2010.09121789; Prontera P, 2011, AM J MED GENET A, V155A, P2473, DOI 10.1002/ajmg.a.33875; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raca G, 2013, EUR J HUM GENET, V21, P455, DOI 10.1038/ejhg.2012.165; Rajcan-Separovic E, 2007, J MED GENET, V44, P269, DOI 10.1136/jmg.2006.045013; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; ROBBINS J, 1987, J SPEECH HEAR DISORD, V52, P271, DOI 10.1044/jshd.5203.271; Shibata T, 1997, J BIOL CHEM, V272, P5236, DOI 10.1074/jbc.272.8.5236; Shriberg LD, 2011, J SPEECH LANG HEAR R, V54, P487, DOI 10.1044/1092-4388(2010/10-0068); Shriberg LD, 2009, J SPEECH LANG HEAR R, V52, P1189, DOI 10.1044/1092-4388(2009/08-0047); Shriberg LD, 2005, J SPEECH LANG HEAR R, V48, P834, DOI 10.1044/1092-4388(2005/058); Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P273, DOI 10.1044/jslhr.4002.273; Sices L, 2007, J DEV BEHAV PEDIATR, V28, P438, DOI 10.1097/DBP.0b013e31811ff8ca; Thevenon J, 2013, EUR J HUM GENET, V21, P82, DOI 10.1038/ejhg.2012.116; THOMPSON EA, 1993, GENET EPIDEMIOL, V10, P677, DOI 10.1002/gepi.1370100658; Thompson E, 2011, HUM HERED, V71, P86, DOI 10.1159/000313555; Tierney C, 2015, J DEV BEHAV PEDIATR, V36, P569, DOI 10.1097/DBP.0000000000000189; Tong LP, 2008, HUM HERED, V65, P142, DOI 10.1159/000109731; Torgesen J.K., 1999, TOWRE TEST WORD READ; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Velleman Shelley L, 2011, Perspect Lang Learn Educ, V18, P108; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vick JC, 2014, J SPEECH LANG HEAR R, V57, P2033, DOI 10.1044/2014_JSLHR-S-12-0193; Wagner RK, 1999, COMPREHENSIVE TEST O; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wechsler D., 2002, WECHSLER INDIVIDUAL; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wiig E., 1992, CLIN EVALUATION LANG; Wolf M, 2004, TEST OF RAPID AUTOMA; Woodcock R, 2001, WOODCOCK JOHNSON TES; Woodcock R.W., 2011, WOODCOCK READING MAS; Worthey EA, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-29; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036988; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Ziegler A, 2010, STAT APPROACH GENETI, Vxxiv	111	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153864	10.1371/journal.pone.0153864	http://dx.doi.org/10.1371/journal.pone.0153864			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120335	Green Submitted, Green Published, gold			2022-12-26	WOS:000374976200038
J	Shah, A; Eikmanns, BJ				Shah, Adnan; Eikmanns, Bernhard J.			Transcriptional Regulation of the beta-Type Carbonic Anhydrase Gene bca by RamA in Corynebacterium glutamicum	PLOS ONE			English	Article							L-VALINE; RIBOSOMAL RECRUITMENT; ACETATE METABOLISM; RALSTONIA-EUTROPHA; ESCHERICHIA-COLI; L-LYSINE; EXPRESSION; GROWTH; INSIGHTS; ETHANOL	Carbonic anhydrase catalyzes the reversible hydration of carbon dioxide to bicarbonate and maintains the balance of CO2/HCO3- in the intracellular environment, specifically for carboxylation/decarboxylation reactions. In Corynebacterium glutamicum, two putative genes, namely the bca (cg2954) and gca (cg0155) genes, coding for beta-type and gamma-type carbonic anhydrase, respectively, have been identified. We here analyze the transcriptional organization of these genes. The transcriptional start site (TSS) of the bca gene was shown to be the first nucleotide "A" of its putative translational start codon (ATG) and thus, bca codes for a leaderless transcript. The TSS of the gca gene was identified as an "A" residue located at position -20 relative to the first nucleotide of the annotated translational start codon of the cg0154 gene, which is located immediately upstream of gca. Comparative expression analysis revealed carbon source-dependent regulation of the bca gene, with 1.5- to 2-fold lower promoter activity in cells grown on acetate as compared to glucose as sole carbon source. Based on higher expression of bca in a mutant deficient of the regulator of acetate metabolism RamA as compared to the wild-type of C. glutamicum and based on the binding of His-tagged RamA protein to the bca promoter region, we here present evidence that RamA negatively regulates expression of bca in C. glutamicum. Functional characterization of a gca deletion mutant of C. glutamicum revealed the same growth characteristics of C. glutamicum Delta gca as that of wild-type C. glutamicum and no effect on expression of the bca gene.	[Shah, Adnan; Eikmanns, Bernhard J.] Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany	Ulm University	Eikmanns, BJ (corresponding author), Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany.	bernhard.eikmanns@uni-ulm.de		Eikmanns, Bernhard/0000-0002-3069-431X	German Academic Exchange Service (DAAD); Higher Education Commission (HEC) Pakistan	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan)	AS obtained a scholarship grant by German Academic Exchange Service (DAAD) and Higher Education Commission (HEC) Pakistan.	Arndt A, 2008, J MOL MICROB BIOTECH, V15, P222, DOI 10.1159/000107370; Auchter M, 2011, J BIOTECHNOL, V154, P126, DOI 10.1016/j.jbiotec.2010.07.001; Auchter M, 2011, J BIOTECHNOL, V152, P77, DOI 10.1016/j.jbiotec.2011.02.003; Blombach B, 2008, APPL MICROBIOL BIOT, V79, P471, DOI 10.1007/s00253-008-1444-z; Blombach B, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00108; Blombach B, 2013, J BIOTECHNOL, V168, P331, DOI 10.1016/j.jbiotec.2013.10.005; Blombach B, 2011, APPL ENVIRON MICROB, V77, P3300, DOI 10.1128/AEM.02972-10; Blombach B, 2009, APPL ENVIRON MICROB, V75, P419, DOI 10.1128/AEM.01844-08; Bott M., 2012, MICROBIOLOGY MONOGRA, P281; Buchholz J, 2013, APPL ENVIRON MICROB, V79, P5566, DOI 10.1128/AEM.01741-13; Buckle-Vallant V, 2014, APPL MICROBIOL BIOT, V98, P297, DOI 10.1007/s00253-013-5310-2; Burghout P, 2010, J BACTERIOL, V192, P4054, DOI 10.1128/JB.00151-10; Cheng YS, 2013, BIOTECHNOL LETT, V35, P735, DOI 10.1007/s10529-013-1138-1; Cottier F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002485; Cramer A, 2006, J BACTERIOL, V188, P2554, DOI 10.1128/JB.188.7.2554-2567.2006; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Eggeling L, 2015, APPL MICROBIOL BIOT, V99, P3387, DOI 10.1007/s00253-015-6508-2; Eikmanns BJ, 2015, CORYNEBACTERIUM GLUTAMICUM: FROM SYSTEMS BIOLOGY TO BIOTECHNOLOGICAL APPLICATIONS, P111; Eikmanns BJ, 2014, BIOPROCESSING OF RENEWABLE RESOURCES TO COMMODITY BIOPRODUCTS, P327; EIKMANNS BJ, 1991, APPL MICROBIOL BIOT, V34, P617, DOI 10.1007/BF00167910; Emmett DH, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI DOI 10.1006/MPEV.1996.0006; Follonier S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-30; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gai CS, 2014, AMB EXPRESS, V4, DOI 10.1186/2191-0855-4-2; Gerstmeir R, 2004, J BACTERIOL, V186, P2798, DOI 10.1128/JB.186.9.2798-2809.2004; Gotz R, 1999, YEAST, V15, P855, DOI 10.1002/(SICI)1097-0061(199907)15:10A<855::AID-YEA425>3.0.CO;2-C; Green MR, 2012, MOL CLONING LAB MANU, V1; Grill S, 2001, FEBS LETT, V495, P167, DOI 10.1016/S0014-5793(01)02378-X; GUILLOTON MB, 1993, J BACTERIOL, V175, P1443, DOI 10.1128/JB.175.5.1443-1451.1993; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hasegawa S, 2013, APPL ENVIRON MICROB, V79, P1250, DOI 10.1128/AEM.02806-12; Heider SAE, 2015, BIOTECHNOL J, V10, P1170, DOI 10.1002/biot.201400590; Heider SAE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-198; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huser AT, 2005, APPL ENVIRON MICROB, V71, P3255, DOI 10.1128/AEM.71.6.3255-3268.2005; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; Jensen JVK, 2015, J BIOTECHNOL, V214, P85, DOI 10.1016/j.jbiotec.2015.09.017; Jo SJ, 2006, J BIOSCI BIOENG, V102, P233, DOI 10.1263/jbb.102.233; Jojima T, 2015, APPL MICROBIOL BIOT, V99, P1165, DOI 10.1007/s00253-014-6223-4; Kaldenhoff R, 2014, BBA-GEN SUBJECTS, V1840, P1592, DOI 10.1016/j.bbagen.2013.09.037; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kaur S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-184; Kaur S, 2009, FEMS MICROBIOL LETT, V299, P149, DOI 10.1111/j.1574-6968.2009.01736.x; Kern D.M., 1960, J CHEM EDUC, V37, P14, DOI [10.1021/ed037p14, DOI 10.1021/ED037P14]; Kind S, 2011, APPL MICROBIOL BIOT, V91, P1287, DOI 10.1007/s00253-011-3457-2; Kinoshita S., 1957, J GEN APPL MICROBIOL, V3, P193, DOI [10.2323/jgam.3.193, DOI 10.2323/JGAM.3.193]; Krause FS, 2010, APPL ENVIRON MICROB, V76, P8053, DOI 10.1128/AEM.01710-10; Kulis-Horn RK, 2014, MICROB BIOTECHNOL, V7, P5, DOI 10.1111/1751-7915.12055; Kumar RSS, 2013, J BACTERIOL, V195, P2262, DOI 10.1128/JB.02288-12; Kusian B, 2002, J BACTERIOL, V184, P5018, DOI 10.1128/JB.184.18.5018-5026.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liebl W, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P796, DOI 10.1007/0-387-30743-5_30; Litsanov B, 2012, MICROB BIOTECHNOL, V5, P116, DOI [10.1111/j.1751-7915.2011.00310.x, 10.1111/j.1751-7915.2012.00347.x]; Lotlikar SR, 2013, MICROBIOL-SGM, V159, P1748, DOI 10.1099/mic.0.066357-0; Merlin C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003; Mimitsuka T, 2007, BIOSCI BIOTECH BIOCH, V71, P2130, DOI 10.1271/bbb.60699; Mitsuhashi S, 2004, APPL MICROBIOL BIOT, V63, P592, DOI 10.1007/s00253-003-1402-8; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nguyen AQD, 2015, METABOLITES, V5, P211, DOI 10.3390/metabo5020211; Nishimori I, 2008, CURR PHARM DESIGN, V14, P622, DOI 10.2174/138161208783877875; Okino S, 2008, APPL MICROBIOL BIOT, V81, P459, DOI 10.1007/s00253-008-1668-y; Oldiges M, 2014, APPL MICROBIOL BIOT, V98, P5859, DOI 10.1007/s00253-014-5782-8; Park SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5618; Patek M, 2003, J BIOTECHNOL, V104, P311, DOI 10.1016/S0168-1656(03)00155-X; Peters-Wendisch PG, 1998, MICROBIOL-UK, V144, P915, DOI 10.1099/00221287-144-4-915; Pfeifer-Sancar K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-888; Rowlett RS, 2010, BBA-PROTEINS PROTEOM, V1804, P362, DOI 10.1016/j.bbapap.2009.08.002; Ruckert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-483; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schneider J, 2011, APPL MICROBIOL BIOT, V91, P17, DOI 10.1007/s00253-011-3252-0; Schneider J, 2010, APPL MICROBIOL BIOT, V88, P859, DOI 10.1007/s00253-010-2778-x; Siebert D, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0269-0; Smith KS, 1999, P NATL ACAD SCI USA, V96, P15184, DOI 10.1073/pnas.96.26.15184; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; Song YY, 2012, APPL MICROBIOL BIOT, V93, P1917, DOI 10.1007/s00253-011-3718-0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Supuran CT, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00034; Takors R, 2007, J BIOTECHNOL, V129, P181, DOI 10.1016/j.jbiotec.2007.01.031; TASHIAN RE, 1989, BIOESSAYS, V10, P186, DOI 10.1002/bies.950100603; Teramoto H, 2011, J BIOTECHNOL, V154, P114, DOI 10.1016/j.jbiotec.2011.01.016; Toyoda K, 2016, APPL MICROBIOL BIOT, V100, P45, DOI 10.1007/s00253-015-7074-3; Toyoda K, 2013, J BACTERIOL, V195, P1718, DOI 10.1128/JB.00016-13; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; Ueda Kenji, 2012, Int J Evol Biol, V2012, P324549, DOI 10.1155/2012/324549; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Vasicova P, 1998, BIOTECHNOL TECH, V12, P743, DOI 10.1023/A:1008827609914; Vertes AA, 2012, ANNU REV MICROBIOL, V66, P521, DOI 10.1146/annurev-micro-010312-105506; Vogt M, 2015, MICROB BIOTECHNOL, V8, P351, DOI 10.1111/1751-7915.12237; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; Wendisch VF, 2015, J BIOTECHNOL, V201, P1, DOI 10.1016/j.jbiotec.2015.02.010; Wieschalka S, 2013, MICROB BIOTECHNOL, V6, P87, DOI 10.1111/1751-7915.12013; Yamamoto S, 2013, BIOTECHNOL BIOENG, V110, P2938, DOI 10.1002/bit.24961; Youn JW, 2008, J BACTERIOL, V190, P6458, DOI 10.1128/JB.00780-08; Zimmerman SA, 2008, CURR PHARM DESIGN, V14, P716, DOI 10.2174/138161208783877929	95	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154382	10.1371/journal.pone.0154382	http://dx.doi.org/10.1371/journal.pone.0154382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119954	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200065
J	Barth, S; Haas, JP; Schlichtiger, J; Molz, J; Bisdorff, B; Michels, H; Hugle, B; Radon, K				Barth, Swaantje; Haas, Johannes-Peter; Schlichtiger, Jenny; Molz, Johannes; Bisdorff, Betty; Michels, Hartmut; Huegle, Boris; Radon, Katja			Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PEDIATRIC RHEUMATOLOGY; EQ-5D QUESTIONNAIRE; FOLLOW-UP; PREDICTORS; CHILDREN; ADULTS; PREVALENCE; MANAGEMENT; OUTCOMES	Objective Aims of the study were to investigate health-related quality of life (HRQOL) in adult patients with former diagnosis of Juvenile Idiopathic Arthritis (JIA), to compare their HRQOL with the general population and to identify factors related to a poor outcome. Methods In 2012, a cross-sectional survey was performed by mailing a questionnaire to a large cohort of former and current patients of the German Centre for Rheumatology in Children and Adolescents. Only adult patients (>= 18 years) with a diagnosis compatible with JIA were included (n = 2592; response 66%). The questionnaire included information about HRQOL (EQ5D), disease-related questions and socio-demographics. Prevalence and 95% confidence intervals (CI) of problems with mobility, self-care, usual activities, pain and anxiety/depression were standardized to the German general population. Factors associated with low HRQOL in JIA patients were identified using logistic regression models. Results Sixty-two percent of the study population was female; age range was 18-73 years. In all dimensions, JIA patients reported statistically significantly more problems than the general population with largest differences in the pain dimension (JIA patients 56%; 95% CI 55-58%; general population 28%; 26-29%) and the anxiety/ depression dimension (28%; 27-29% vs. 4%; 4-5%). Lower HRQOL in JIA patients was associated with female sex, older age, lower level of education, still being under rheumatic treatment and disability. Conclusions HRQOL in adult JIA patients is considerably lower than in the general population. As this cohort includes historic patients the new therapeutic schemes available today are expected to improve HRQOL in future.	[Barth, Swaantje; Schlichtiger, Jenny; Molz, Johannes; Bisdorff, Betty; Radon, Katja] Univ Hosp Munich LMU, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Haas, Johannes-Peter; Michels, Hartmut; Huegle, Boris] German Ctr Rheumatol Children & Adolescents, Garmisch Partenkirchen, Germany	University of Munich	Barth, S (corresponding author), Univ Hosp Munich LMU, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany.	sekretariat-radon@uni-muenchen.de	Hügle, Boris/AAN-3064-2020		Verein Hilfe fur das rheumakranke Kind	Verein Hilfe fur das rheumakranke Kind	The "Verein Hilfe fur das rheumakranke Kind" has provided financial support for this study (http://www.kinderrheuma.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison, 2001, LOGISTIC REGRESSION; Amine B, 2009, RHEUMATOL INT, V29, P275, DOI 10.1007/s00296-008-0672-y; Arkela-Kautiainen M, 2005, ANN RHEUM DIS, V64, P875, DOI 10.1136/ard.2004.026591; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brunner HI, 2004, ARTHRIT RHEUM-ARTHR, V51, P763, DOI 10.1002/art.20689; Brunner HI, 2003, CURR OPIN RHEUMATOL, V15, P602, DOI 10.1097/00002281-200309000-00014; Claes C, 1999, P 15 PLEN M EUROQOL, P13; Dannecker G, 2014, PADIATRISCHE RHEUMAT; Davidson J, 2000, EUR J RADIOL, V33, P128, DOI 10.1016/S0720-048X(99)00161-8; Dueckers G, 2011, KLIN PADIATR, V223, P386, DOI 10.1055/s-0031-1287837; Duffy CM, 2005, ARTHRITIS RHEUM-US, V52, P382, DOI 10.1002/art.20815; EULAR, 1977, EULAR B, V4; Flato B, 2003, J RHEUMATOL, V30, P386; Foster HE, 2003, ARTHRITIS RHEUM-US, V48, P767, DOI 10.1002/art.10863; Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z; Gutierrez-Suarez R, 2007, RHEUMATOLOGY, V46, P314, DOI 10.1093/rheumatology/kel218; Haverman L, 2012, ARTHRIT CARE RES, V64, P694, DOI 10.1002/acr.21609; Hinz A, 2006, PSYCHOTHER PSYCH MED, V56, P42, DOI 10.1055/s-2005-867061; Hugle B, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-3; Hurst NP, 1997, BRIT J RHEUMATOL, V36, P551; Ilowite NT, 2002, PEDIATRICS, V109, P109, DOI 10.1542/peds.109.1.109; J.-Matthias Graf von der Schulenburg CC, 1998, Z GESUNDHEITSWESEN; Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e; Krumpey-Langkammerer M, 2001, J RHEUMATOL, V28, P2544; Manners PJ, 2002, J RHEUMATOL, V29, P1520; Marra CA, 2005, SOC SCI MED, V60, P1571, DOI 10.1016/j.socscimed.2004.08.034; Minden K, 2002, ARTHRITIS RHEUM-US, V46, P2392, DOI 10.1002/art.10444; Minden K, 2000, J RHEUMATOL, V27, P2256; Moock J, 2008, PHYS MED REHAB KUROR, V18, P245, DOI 10.1055/s-0028-1082329; Oen K, 2002, BEST PRACT RES CL RH, V16, P347, DOI 10.1053/berh.2002.0233; Ostile IL, 2009, CLIN EXP RHEUMATOL, V27, P1039; Oliveira S, 2007, ARTHRIT RHEUM-ARTHR, V57, P35, DOI 10.1002/art.22473; Packham JC, 2002, RHEUMATOLOGY, V41, P1428, DOI 10.1093/rheumatology/41.12.1428; Peterson LS, 1997, ARTHRITIS RHEUM, V40, P2235, DOI 10.1002/art.1780401219; Petty RE, 2001, J RHEUMATOL, V2004, P390, DOI DOI 10.1002/ACR.20460; Prince FHM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6434; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Stevanovic D, 2013, QUAL LIFE RES, V22, P607, DOI 10.1007/s11136-012-0172-0; Stinson JN, 2012, PAIN RES MANAG, V17, P391, DOI 10.1155/2012/237258; Strand CV, 1997, WHO ILAR TASKFORCE Q; von Koskull S, 2001, ANN RHEUM DIS, V60, P940, DOI 10.1136/ard.60.10.940; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Wille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-y; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zak M, 2000, RHEUMATOLOGY, V39, P198, DOI 10.1093/rheumatology/39.2.198	45	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153267	10.1371/journal.pone.0153267	http://dx.doi.org/10.1371/journal.pone.0153267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115139	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600018
J	Ahmed, RH; Huri, HZ; Al-Hamodi, Z; Salem, SD; Al-absi, B; Muniandy, S				Ahmed, Radwan H.; Huri, Hasniza Zaman; Al-Hamodi, Zaid; Salem, Sameer D.; Al-absi, Boshra; Muniandy, Sekaran			Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; APOLIPOPROTEIN-B; INSULIN-RESISTANCE; RISK-FACTORS; RHEUMATOID-ARTHRITIS; METABOLIC SYNDROME; LINKING OBESITY; DISEASE; INFLAMMATION; INHIBITOR	Background Genetic polymorphisms of the Dipeptidyl Peptidase 4 (DPP4) gene may play a role in the etiology of type 2 diabetes mellitus (T2DM). This study aimed to investigate the possible association of single nucleotide polymorphisms (SNPs) of the DPP4 gene in Malaysian subjects with T2DM and evaluated whether they had an effect on the serum levels of soluble dipeptidyl peptidase 4 (sDPP-IV). Method Ten DPP4 SNPs were genotyped by TaqMan genotyping assays in 314 subjects with T2DM and 235 controls. Of these, 71 metabolic syndrome (MetS) subjects were excluded from subsequent analysis. The odds ratios (ORs) and their 95% confidence interval (CIs) were calculated using multiple logistic regression for the association between the SNPs of DPP4 and T2DM. In addition, the serum levels of sDPP-IV were investigated to evaluate the association of the SNPs of DPP4 with the sDPP-IV levels. Results Dominant, recessive, and additive genetic models were employed to test the association of DPP4 polymorphisms with T2DM, after adjusting for age, race, gender and BMI. The rs12617656 was associated with T2DM in Malaysian subjects in the recessive genetic model (OR = 1.98, p = 0.006), dominant model (OR = 1.95, p = 0.008), and additive model (OR = 1.63, p = 0.001). This association was more pronounced among Malaysian Indians, recessive (OR = 3.21, p = 0.019), dominant OR = 3.72, p = 0.003) and additive model (OR = 2.29, p = 0.0009). The additive genetic model showed that DPP4 rs4664443 and rs7633162 polymorphisms were associated with T2DM (OR = 1.53, p = 0.039), and (OR = 1.42, p = 0.020), respectively. In addition, the rs4664443 G>A polymorphism was associated with increased sDPP-IV levels (p = 0.042) in T2DM subjects. Conclusions DPP4 polymorphisms were associated with T2DM in Malaysian subjects, and linked to variations in sDPP-IV levels. In addition, these associations were more pronounced among Malaysian Indian subjects.	[Ahmed, Radwan H.; Al-absi, Boshra; Muniandy, Sekaran] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Huri, Hasniza Zaman] Univ Malaya Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia; [Al-Hamodi, Zaid; Salem, Sameer D.] Sanaa Univ, Dept Biochem & Mol Biol, Fac Med, Sanaa, Yemen	Universiti Malaya; Universiti Malaya; Universiti Malaya	Ahmed, RH; Muniandy, S (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	radwanalhamody@yahoo.com; sekaran@um.edu.my	MUNIANDY, SEKARAN/B-5345-2010; HURI, HASNIZA ZAMAN/B-8612-2010; ahmed, radwan/O-3803-2018	MUNIANDY, SEKARAN/0000-0003-1310-3634; HURI, HASNIZA ZAMAN/0000-0002-6423-8515; ahmed, radwan/0000-0003-1398-6772	University of Malaya [PG035-2014A, HIR/420001-E000046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106754] Funding Source: NIH RePORTER	University of Malaya(Universiti Malaya); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the research grants from the University of Malaya, (PPP Grant No. PG035-2014A and HIR/420001-E000046).	Aghili N, 2012, NEUROPEPTIDES, V46, P367, DOI 10.1016/j.npep.2012.10.001; Ahmed RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140618; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Bailey S, 2014, DIABETOLOGIA, V57, P738, DOI 10.1007/s00125-013-3142-3; Basile KJ, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/769671; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchard L, 2009, ACTA DIABETOL, V46, P13, DOI 10.1007/s00592-008-0049-4; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chung SJ, 2011, YONSEI MED J, V52, P113, DOI 10.3349/ymj.2011.52.1.113; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Deacon CF, 2009, ADV THER, V26, P488, DOI 10.1007/s12325-009-0030-9; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DF I, 2013, DIABETES ATLAS; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Faraj M, 2006, DIABETOLOGIA, V49, P1637, DOI 10.1007/s00125-006-0259-7; Horng T, 2011, NAT MED, V17, P164, DOI 10.1038/nm0211-164; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jiang L, 2014, ARTHRITIS RHEUMATOL, V66, P1121, DOI 10.1002/art.38353; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lee SA, 2013, J CLIN ENDOCR METAB, V98, P2553, DOI 10.1210/jc.2012-4288; Ley SH, 2010, CLIN CHEM, V56, P666, DOI 10.1373/clinchem.2009.136994; Lu MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101528; Moonesinghe R, 2012, EUR J HUM GENET, V20, P831, DOI 10.1038/ejhg.2012.15; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Ohnuma K, 2001, J IMMUNOL, V167, P6745, DOI 10.4049/jimmunol.167.12.6745; Ohnuma K, 2008, FRONT BIOSCI-LANDMRK, V13, P2299, DOI 10.2741/2844; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Organization WH, 2006, DEF DIAGN DIAB MELL, P50; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; Rohrborn D, 2014, FEBS LETT, V588, P3870, DOI 10.1016/j.febslet.2014.08.029; Rohrborn D, 2015, FRONTIERS IMMUNOLOGY, P6; Ryoo JH, 2013, ATHEROSCLEROSIS, V226, P496, DOI 10.1016/j.atherosclerosis.2012.11.024; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Sattar N, 2004, CIRCULATION, V110, P2687, DOI 10.1161/01.CIR.0000145660.60487.94; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Silva Junior WSd, 2015, BIOMED RES INT, V2015; Sung KC, 2005, ATHEROSCLEROSIS, V180, P161, DOI 10.1016/j.atherosclerosis.2004.11.009; TORIMOTO Y, 1991, J IMMUNOL, V147, P2514; Turcot V, 2011, OBESITY, V19, P388, DOI 10.1038/oby.2010.198; Vazquez AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123818; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wilson MJ, 2000, J ANDROL, V21, P220; Woodard-Grice AV, 2010, FASEB J, V24; Yang F., 2014, PLOS ONE, V9; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhong JX, 2015, CIRC RES, V116, P1491, DOI 10.1161/CIRCRESAHA.116.305665; Zhong JX, 2014, DIABETES, V63, P1289, DOI 10.2337/db13-1094	53	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154369	10.1371/journal.pone.0154369	http://dx.doi.org/10.1371/journal.pone.0154369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111895	gold, Green Published			2022-12-26	WOS:000374970600060
J	Lee, EC; Kim, H; Ditano, J; Manion, D; King, BL; Strange, K				Lee, Elaine C.; Kim, Heejung; Ditano, Jennifer; Manion, Dacie; King, Benjamin L.; Strange, Kevin			Abnormal Osmotic Avoidance Behavior in C-elegans Is Associated with Increased Hypertonic Stress Resistance and Improved Proteostasis	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; CAENORHABDITIS-ELEGANS; EXPRESSION ANALYSIS; PROTEIN DAMAGE; AGGREGATION; REGULATOR; FAMILY; GENES; BETA; RNAI	Protein function is controlled by the cellular proteostasis network. Proteostasis is energetically costly and those costs must be balanced with the energy needs of other physiological functions. Hypertonic stress causes widespread protein damage in C. elegans. Suppression and management of protein damage is essential for optimal survival under hypertonic conditions. ASH chemosensory neurons allow C. elegans to detect and avoid strongly hypertonic environments. We demonstrate that mutations in osm-9 and osm-12 that disrupt ASH mediated hypertonic avoidance behavior or genetic ablation of ASH neurons are associated with enhanced survival during hypertonic stress. Improved survival is not due to altered systemic volume homeostasis or organic osmolyte accumulation. Instead, we find that osm-9(ok1677) mutant and osm-9(RNAi) worms exhibit reductions in hypertonicity induced protein damage in non-neuronal cells suggesting that enhanced proteostasis capacity may account for improved hypertonic stress resistance in worms with defects in osmotic avoidance behavior. RNA-seq analysis revealed that genes that play roles in managing protein damage are upregulated in osm-9(ok1677) worms. Our findings are consistent with a growing body of work demonstrating that intercellular communication between neuronal and non-neuronal cells plays a critical role in integrating cellular stress resistance with other organismal physiological demands and associated energy costs.	[Lee, Elaine C.; Kim, Heejung; Ditano, Jennifer; Manion, Dacie; King, Benjamin L.; Strange, Kevin] Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA; [Lee, Elaine C.] Univ Connecticut, Storrs, CT 06269 USA	Mount Desert Island Biological Laboratory; University of Connecticut	Strange, K (corresponding author), Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA.	kstrange@mdibl.org	King, Benjamin/AAI-1492-2019	King, Benjamin/0000-0001-6463-1336	National Institutes of Health from the National Institute of Diabetes, Digestive and Kidney Diseases [R01 DK61168]; Institutional Development Award (IDeA) grant [P20 GM103423]; Center of Biomedical Research Excellence (COBRE) grant from the National Institute of General Medical Sciences [P20 GM104318]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104318, P20GM103423] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Diabetes, Digestive and Kidney Diseases; Institutional Development Award (IDeA) grant; Center of Biomedical Research Excellence (COBRE) grant from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01 DK61168 to K.S. from the National Institute of Diabetes, Digestive and Kidney Diseases, and by Institutional Development Award (IDeA) grant P20 GM103423 and Center of Biomedical Research Excellence (COBRE) grant P20 GM104318 from the National Institute of General Medical Sciences. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; [Anonymous], 1988, NEMATODE CAENORHABDI; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bargmann C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Beverly M, 2011, J NEUROSCI, V31, P11718, DOI 10.1523/JNEUROSCI.1098-11.2011; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; BRENNER S, 1974, GENETICS, V77, P71; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Burkewitz K, 2011, AM J PHYSIOL-CELL PH, V301, pC566, DOI 10.1152/ajpcell.00030.2011; Burkewitz K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034153; Calahorro Fernando, 2009, J Vis Exp, DOI 10.3791/1616; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chandler-Brown D, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00316; Choe KP, 2008, AM J PHYSIOL-CELL PH, V295, pC1488, DOI 10.1152/ajpcell.00450.2008; Choi S, 2013, NEURON, V78, P869, DOI 10.1016/j.neuron.2013.04.002; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dubey K, 2014, BIOCHEM BIOPH RES CO, V448, P480, DOI 10.1016/j.bbrc.2014.04.135; Dzamko N, 2014, FRONT MOL NEUROSCI, V7, P57; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Harris TW, 2014, NUCLEIC ACIDS RES, V42, pD789, DOI 10.1093/nar/gkt1063; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kakuyama H, 2005, BIOCHEMISTRY-US, V44, P15602, DOI 10.1021/bi051263e; Kim H, 2013, AM J PHYSIOL-CELL PH, V305, pC1257, DOI 10.1152/ajpcell.00176.2013; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Labbadia John, 2014, F1000Prime Rep, V6, P7, DOI 10.12703/P6-7; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; LAMITINA ST, 2004, AM J PHYSIOL, V288, P467; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; Lee ECH, 2012, AM J PHYSIOL-CELL PH, V303, pC1269, DOI 10.1152/ajpcell.00294.2012; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Luo JH, 2014, J BIOL CHEM, V289, P27766, DOI 10.1074/jbc.M114.574947; Mancuso VP, 2012, DEVELOPMENT, V139, P979, DOI 10.1242/dev.075135; Matilainen O, 2013, CELL REP, V3, P1980, DOI 10.1016/j.celrep.2013.05.012; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muniz JRC, 2013, J MOL BIOL, V425, P3166, DOI 10.1016/j.jmb.2013.06.015; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Oh KH, 2013, P NATL ACAD SCI USA, V110, P19024, DOI 10.1073/pnas.1308866110; Parmar AS, 2012, BIOPOLYMERS, V97, P795, DOI 10.1002/bip.22070; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohlfing AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001267; Rohlfing AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009010; Spaich S, 2012, CIRC RES, V111, P1504, DOI 10.1161/CIRCRESAHA.112.271007; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Wang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000350; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054; Yamanaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093891; Yoshida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1750	73	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154156	10.1371/journal.pone.0154156	http://dx.doi.org/10.1371/journal.pone.0154156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111894	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600038
J	Olsen, JA; Kenna, LA; Spelios, MG; Hessner, MJ; Akirav, EM				Olsen, John A.; Kenna, Lauren A.; Spelios, Michael G.; Hessner, Martin J.; Akirav, Eitan M.			Circulating Differentially Methylated Amylin DNA as a Biomarker of beta- Cell Loss in Type 1 Diabetes	PLOS ONE			English	Article							ISLET AMYLOID POLYPEPTIDE; MICROSATELLITE ALTERATIONS; INSULIN-SECRETION; PANCREATIC-ISLETS; CANCER PATIENTS; PRAMLINTIDE; MELLITUS; EXPRESSION; THERAPY; DEATH	In type 1 diabetes (T1D), beta-cell loss is silent during disease progression. Methylation-sensitive quantitative real-time PCR (qPCR) of beta-cell-derived DNA in the blood can serve as a biomarker of beta-cell death in T1D. Amylin is highly expressed by beta-cells in the islet. Here we examined whether demethylated circulating free amylin DNA (cfDNA) may serve as a biomarker of beta-cell death in T1D. beta-cells showed unique methylation patterns within the amylin coding region that were not observed with other tissues. The design and use of methylation-specific primers yielded a strong signal for demethylated amylin in purified DNA from murine islets when compared with other tissues. Similarly, methylation-specific primers detected high levels of demethylated amylin DNA in human islets and enriched human beta-cells. In vivo testing of the primers revealed an increase in demethylated amylin cfDNA in sera of non-obese diabetic (NOD) mice during T1D progression and following the development of hyperglycemia. This increase in amylin cfDNA did not mirror the increase in insulin cfDNA, suggesting that amylin cfDNA may detect beta-cell loss in serum samples where insulin cfDNA is undetected. Finally, purified cfDNA from recent onset T1D patients yielded a high signal for demethylated amylin cfDNA when compared with matched healthy controls. These findings support the use of demethylated amylin cfDNA for detection of beta-cell-derived DNA. When utilized in conjunction with insulin, this latest assay provides a comprehensive multi-gene approach for the detection of beta-cell loss.	[Olsen, John A.; Kenna, Lauren A.; Spelios, Michael G.; Akirav, Eitan M.] Winthrop Univ Hosp, Res Inst, Islet Biol, Mineola, NY 11501 USA; [Hessner, Martin J.] Childrens Hosp Wisconsin, Childrens Res Inst, Max McGee Natl Res Ctr Juvenile Diabet, Milwaukee, WI 53201 USA; [Hessner, Martin J.] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Akirav, Eitan M.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA	Winthrop University Hospital; Children's Hospital of Wisconsin; Medical College of Wisconsin; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Akirav, EM (corresponding author), Winthrop Univ Hosp, Res Inst, Islet Biol, Mineola, NY 11501 USA.; Akirav, EM (corresponding author), SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA.	eakirav@winthrop.org			Juvenile Diabetes Research Foundation [17-2012-588, 1-PNF-2014-96-Q-R]; National Institutes of Health, National Center for Advancing Translational Sciences [8UL1TR000055]; Winthrop University Hospital Pilot Award; Children's Hospital of Wisconsin Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health, National Center for Advancing Translational Sciences; Winthrop University Hospital Pilot Award; Children's Hospital of Wisconsin Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 1) Juvenile Diabetes Research Foundation (Grant No. 17-2012-588 and 1-PNF-2014-96-Q-R), www.jdrf.org; 2) National Institutes of Health, National Center for Advancing Translational Sciences (8UL1TR000055), www.nih.gov; 3) Winthrop University Hospital Pilot Award, www.winthrop.org; 4) The Children's Hospital of Wisconsin Foundation, www.chw.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav E, 2008, DIABETES, V57, P2883, DOI 10.2337/db07-1817; Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Akirav EM, 2011, DIABETES, V60, P876, DOI 10.2337/db10-0793; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Banerjee M, 2009, DIABETOLOGIA, V52, P621, DOI 10.1007/s00125-009-1259-1; Bassi EJ, 2012, DIABETES, V61, P2534, DOI 10.2337/db11-0844; Bonifacio E, 1999, J IMMUNOL, V163, P525; BrethertonWatt D, 1996, BIOCHEM J, V313, P495, DOI 10.1042/bj3130495; Chen XQ, 1996, NAT MED, V2, P1033; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Fineman M, 2002, HORM METAB RES, V34, P504, DOI 10.1055/s-2002-34790; Fisher MM, 2015, DIABETES, V64, P3867, DOI 10.2337/db15-0430; GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Herold KC, 2015, J CLIN INVEST, V125, P1163, DOI 10.1172/JCI78142; Hollander PA, 2003, DIABETES CARE, V26, P784, DOI 10.2337/diacare.26.3.784; Husseiny MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047942; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lebastchi J, 2013, DIABETES, V62, P1676, DOI 10.2337/db12-1207; LEFFERT JD, 1989, P NATL ACAD SCI USA, V86, P3127, DOI 10.1073/pnas.86.9.3127; Ludvik B, 2003, EUR J CLIN INVEST, V33, P316, DOI 10.1046/j.1365-2362.2003.01142.x; LUKINIUS A, 1989, DIABETOLOGIA, V32, P240, DOI 10.1007/BF00285291; MOSSELMAN S, 1990, FEBS LETT, V271, P33, DOI 10.1016/0014-5793(90)80365-P; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; OBRIEN TD, 1991, DIABETES, V40, P1701, DOI 10.2337/diabetes.40.12.1701; Paulsson JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093053; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Reidelberger RD, 2004, AM J PHYSIOL-REG I, V287, pR568, DOI 10.1152/ajpregu.00213.2004; Riediger T, 2004, AM J PHYSIOL-REG I, V286, pR114, DOI 10.1152/ajpregu.00333.2003; Ryan GJ, 2005, CLIN THER, V27, P1500, DOI 10.1016/j.clinthera.2005.10.009; Spelios MG, 2015, J BIOL CHEM, V290, P15250, DOI 10.1074/jbc.M114.628784; Spelios MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072260; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1987, DIABETOLOGIA, V30, P887; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Whitehouse F, 2002, DIABETES CARE, V25, P724, DOI 10.2337/diacare.25.4.724	39	36	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152662	10.1371/journal.pone.0152662	http://dx.doi.org/10.1371/journal.pone.0152662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111653	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600003
J	Chen, XF; Rateri, DL; Howatt, DA; Balakrishnan, A; Moorleghen, JJ; Cassis, LA; Daugherty, A				Chen, Xiaofeng; Rateri, Debra L.; Howatt, Deborah A.; Balakrishnan, Anju; Moorleghen, Jessica J.; Cassis, Lisa A.; Daugherty, Alan			TGF-beta Neutralization Enhances AngII-Induced Aortic Rupture and Aneurysm in Both Thoracic and Abdominal Regions	PLOS ONE			English	Article							ANGIOTENSIN-II; GROWTH; RECEPTOR; HYPERPLASIA; ATHEROSCLEROSIS; HYPERTROPHY; PROGRESSION; DISRUPTION; EXPRESSION; GAMMA	AngII and TGF-beta interact in development of thoracic and abdominal aortic diseases, although there are many facets of this interaction that have not been clearly defined. The aim of the present study was to determine the effects of TGF-beta neutralization on AngII induced-aortic pathologies. Male C57BL/6J mice were administered with either a rabbit or mouse TGF-beta neutralizing antibody and then infused with AngII. The rabbit TGF-beta antibody modestly reduced serum TGF-beta concentrations, with no significant enhancements to AngII-induced aneurysm or rupture. Administration of this rabbit TGF-beta antibody in mice led to high serum titers against rabbit IgG that may have attenuated the neutralization. In contrast, a mouse TGF-beta antibody (1D11) significantly increased rupture in both the ascending and suprarenal aortic regions, but only at doses that markedly decreased serum TGF-beta concentrations. High doses of 1D11 antibody significantly increased AngII-induced ascending and suprarenal aortic dilatation. To determine whether TGF-beta neutralization had effects in mice previously infused with AngII, the 1D11 antibody was injected into mice that had been infused with AngII for 28 days and were observed during continued infusion for a further 28 days. Despite near ablations of serum TGF-beta concentrations, the mouse TGF-beta antibody had no effect on aortic rupture or dimensions in either ascending or suprarenal region. These data provide further evidence that AngII-induced aortic rupture is enhanced greatly by TGF-beta neutralization when initiated before pathogenesis.	[Chen, Xiaofeng] Wenzhou Med Univ, Taizhou Hosp, Dept Cardiol, Lab Cardiovasc Dis, Wenzhou, Zhejiang, Peoples R China; [Chen, Xiaofeng; Rateri, Debra L.; Howatt, Deborah A.; Balakrishnan, Anju; Moorleghen, Jessica J.; Daugherty, Alan] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA; [Cassis, Lisa A.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Daugherty, Alan] Univ Kentucky, Dept Physiol, Lexington, KY USA	Wenzhou Medical University; University of Kentucky; University of Kentucky; University of Kentucky	Daugherty, A (corresponding author), Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA.; Daugherty, A (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY USA.	Alan.Daugherty@uky.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775	National Marfan Foundation; National Institutes of Health [HL 107319]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107319] Funding Source: NIH RePORTER	National Marfan Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Marfan Foundation: http://www.marfan.org/?gclid=CNKUmZ3frMoCFYwvgQodAqMGTQ, National Institutes of Health - HL 107319 http://www.nih.gov/.	Bush E, 2000, HYPERTENSION, V36, P360, DOI 10.1161/01.HYP.36.3.360; Campbell SE, 1997, J MOL CELL CARDIOL, V29, P1947, DOI 10.1006/jmcc.1997.0435; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Chen XF, 2013, CURR OPIN PHARMACOL, V13, P180, DOI 10.1016/j.coph.2013.01.002; Cook JR, 2015, ARTERIOSCL THROM VAS, V35, P911, DOI 10.1161/ATVBAHA.114.305150; Dai JP, 2005, CIRCULATION, V112, P1008, DOI 10.1161/CIRCULATIONAHA.104.523357; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Davis FM, 2014, HEART, V100, P1498, DOI 10.1136/heartjnl-2014-305648; Gahllo EM, 2014, J CLIN INVEST, V124, P448, DOI 10.1172/JCI69666; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hu JH, 2015, ARTERIOSCL THROM VAS, V35, P2647, DOI 10.1161/ATVBAHA.115.306573; King VL, 2009, CIRCULATION, V119, P426, DOI 10.1161/CIRCULATIONAHA.108.785949; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Liu J, 2015, ARTERIOSCL THROM VAS, V35, P1826, DOI 10.1161/ATVBAHA.115.305482; Lu H, 2015, JOVE-J VIS EXP, DOI 10.3791/53191; Lu H, 2012, CLIN SCI, V123, P531, DOI 10.1042/CS20120097; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Poduri A, 2015, ARTERIOSCL THROM VAS, V35, P1995, DOI 10.1161/ATVBAHA.115.305995; Rateri DL, 2014, AM J PATHOL, V184, P2586, DOI 10.1016/j.ajpath.2014.05.014; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Spin JM, 2011, PHYSIOL GENOMICS, V43, P993, DOI 10.1152/physiolgenomics.00044.2011; Subramanian V, 2012, ARTERIOSCL THROM VAS, V32, P397, DOI 10.1161/ATVBAHA.111.239897; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; Wang Y. X., 2006, HDB MOUSE MODELS CAR, V125; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Zhou YB, 2003, AM J PHYSIOL-HEART C, V285, pH2797, DOI 10.1152/ajpheart.00466.2003	34	50	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153811	10.1371/journal.pone.0153811	http://dx.doi.org/10.1371/journal.pone.0153811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104863	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100023
J	Gallego, A; Mele, M; Balcells, I; Garcia-Ramallo, E; Torruella-Loran, I; Fernandez-Bellon, H; Abello, T; Kondova, I; Bontrop, R; Hvilsom, C; Navarro, A; Marques-Bonet, T; Espinosa-Parrilla, Y				Gallego, Alicia; Mele, Marta; Balcells, Ingrid; Garcia-Ramallo, Eva; Torruella-Loran, Ignasi; Fernandez-Bellon, Hugo; Abello, Teresa; Kondova, Ivanela; Bontrop, Ronald; Hvilsom, Christina; Navarro, Arcadi; Marques-Bonet, Tomas; Espinosa-Parrilla, Yolanda			Functional Implications of Human-Specific Changes in Great Ape microRNAs	PLOS ONE			English	Article							EVOLUTION; GENE; BIOGENESIS; EXPRESSION; CLUSTER; POLYMORPHISM; DIVERSITY; ELEMENTS; ORIGIN; MIRNAS	microRNAs are crucial post-transcriptional regulators of gene expression involved in a wide range of biological processes. Although microRNAs are highly conserved among species, the functional implications of existing lineage-specific changes and their role in determining differences between humans and other great apes have not been specifically addressed. We analyzed the recent evolutionary history of 1,595 human microRNAs by looking at their intra-and inter-species variation in great apes using high-coverage sequenced genomes of 82 individuals including gorillas, orangutans, bonobos, chimpanzees and humans. We explored the strength of purifying selection among microRNA regions and found that the seed and mature regions are under similar and stronger constraint than the precursor region. We further constructed a comprehensive catalogue of microRNA species-specific nucleotide substitutions among great apes and, for the first time, investigated the biological relevance that human-specific changes in microRNAs may have had in great ape evolution. Expression and functional analyses of four microRNAs (miR-299-3p, miR-503-3p, miR508-3p and miR-541-3p) revealed that lineage-specific nucleotide substitutions and changes in the length of these microRNAs alter their expression as well as the repertoires of target genes and regulatory networks. We suggest that the studied molecular changes could have modified crucial microRNA functions shaping phenotypes that, ultimately, became human-specific. Our work provides a frame to study the impact that regulatory changes may have in the recent evolution of our species.	[Gallego, Alicia; Balcells, Ingrid; Garcia-Ramallo, Eva; Torruella-Loran, Ignasi; Navarro, Arcadi; Marques-Bonet, Tomas; Espinosa-Parrilla, Yolanda] Univ Pompeu Fabra, CSIC, IBE, Dept Expt & Hlth Sci, Barcelona, Catalonia, Spain; [Mele, Marta; Navarro, Arcadi] CRG, Barcelona, Catalonia, Spain; [Mele, Marta] Harvard Univ, Dept Stem Cells & Regenerat Biol, Cambridge, MA 02138 USA; [Mele, Marta] Broad Inst MIT & Harvard, Cambridge, MA USA; [Balcells, Ingrid] Univ Helsinki, Dept Biosci, Viikki Bioctr, Helsinki, Finland; [Fernandez-Bellon, Hugo; Abello, Teresa] Parc Zool Barcelona, Barcelona, Catalonia, Spain; [Fernandez-Bellon, Hugo] Univ Autonoma Barcelona, Bellaterra, Catalonia, Spain; [Kondova, Ivanela; Bontrop, Ronald] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Hvilsom, Christina] Copenhagen Zoo, Frederiksberg, Denmark; [Navarro, Arcadi] INB, Barcelona, Catalonia, Spain; [Navarro, Arcadi] Catalan Inst Res & Adv Studies, ICREA, Barcelona, Catalonia, Spain; [Marques-Bonet, Tomas] CNAG, Barcelona, Catalonia, Spain; [Espinosa-Parrilla, Yolanda] Univ Magallanes, Sch Med, Punta Arenas, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Autonomous University of Barcelona; ICREA; Universidad de Magallanes	Espinosa-Parrilla, Y (corresponding author), Univ Pompeu Fabra, CSIC, IBE, Dept Expt & Hlth Sci, Barcelona, Catalonia, Spain.; Espinosa-Parrilla, Y (corresponding author), Univ Magallanes, Sch Med, Punta Arenas, Chile.	yolespinosa@gmail.com	Espinosa-Parrilla, Yolanda/GSN-8107-2022; Marques-Bonet, Tomas/ABF-3734-2020; Espinosa-Parrilla, Yolanda/E-6368-2013; Bontrop, Ronald E/J-3628-2012; Fernández-Bellon, Hugo/M-5925-2019; Gallego, Alicia/L-6653-2017	Espinosa-Parrilla, Yolanda/0000-0002-5441-3113; Marques-Bonet, Tomas/0000-0002-5597-3075; Bontrop, Ronald E/0000-0003-0874-6467; Fernández-Bellon, Hugo/0000-0001-6071-1435; Hvilsom, Christina/0000-0001-7870-6888; Gallego Jimenez, Alicia/0000-0002-2936-7311; mele, marta/0000-0001-8874-6453	Spanish National Institute for Bioinformatics; Ministerio de Ciencia e Innovacion de Espana [BFU2012-38236, BFU2010-18477, BFU2009-06974, CGL2009-09013]; Ministerio de Ciencia e Innovacion de Espana [FPI-MINECO]; Direccio General de Recerca de la Generalitat de Catalunya [2009SGR-1101, 2014SGR-866, SGR2014-1311]; European Union [PIOF-GA-2009-236836, PIRSES-GA-2013-612583]; Ministerio de Educacion, Cultura y Deporte de Espana; FEDER European Regional Development Fund; Parc Zoologic de Barcelona; Copenhagen Zoo; ICREA Funding Source: Custom	Spanish National Institute for Bioinformatics; Ministerio de Ciencia e Innovacion de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion de Espana [FPI-MINECO]; Direccio General de Recerca de la Generalitat de Catalunya(Generalitat de Catalunya); European Union(European Commission); Ministerio de Educacion, Cultura y Deporte de Espana(Spanish Government); FEDER European Regional Development Fund(European Commission); Parc Zoologic de Barcelona; Copenhagen Zoo; ICREA(ICREA)	This work was funded by Spanish National Institute for Bioinformatics (www.inab.org); "Ministerio de Ciencia e Innovacion de Espana" [grant numbers BFU2012-38236, BFU2010-18477, BFU2009-06974, CGL2009-09013 and FPI-MINECO to ITL]; "Direccio General de Recerca de la Generalitat de Catalunya" [2009SGR-1101, 2014SGR-866 and SGR2014-1311]; European Union Seventh Framework Programme [grant number PIOF-GA-2009-236836 and PIRSES-GA-2013-612583]; "Ministerio de Educacion, Cultura y Deporte de Espana" [grant FPU-MEC to AG]; FEDER European Regional Development Fund "A way to build Europe". Three authors of this work were employed by the funding organizations of either the "Parc Zoologic de Barcelona" or the Copenhagen Zoo. The funder "Parc Zoologic de Barcelona" provided support in the form of salaries for authors HFB and TA and the funder Copenhagen Zoo for author CH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The unique role of "Parc Zoologic de Barcelona" and Copenhagen Zoo was to provide support in the form of salaries for authors HFB, TA and CH. These funders did not have any additional role in the study design, data collection and analysis, decisionto publish, or preparation of the manuscript.	Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Brameier Markus, 2010, BMC Res Notes, V3, P64, DOI 10.1186/1756-0500-3-64; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Dannemann M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-116; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Durbin RM, 2010, MAP HUMAN GENOME VAR, DOI [10.1038/nature09534, DOI 10.1038/NATURE09534]; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Friedlander MR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r57; Gallo R, 2002, J CELL BIOL, V158, P731, DOI 10.1083/jcb.200202024; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Guo L, 2014, GENE, V534, P24, DOI 10.1016/j.gene.2013.10.037; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heimberg AM, 2008, P NATL ACAD SCI US; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Iwama H, 2013, MOL BIOL EVOL, V30, P613, DOI 10.1093/molbev/mss262; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Llobet-Navas D, 2014, GENE DEV, V28, P765, DOI 10.1101/gad.237404.114; Londin E, 2015, P NATL ACAD SCI USA, V112, pE1106, DOI 10.1073/pnas.1420955112; Lopez-Valenzuela M, 2012, MOL BIOL EVOL, V29, P1797, DOI 10.1093/molbev/mss023; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Mu XJ, 2011, NUCLEIC ACIDS RES, V39, P7058, DOI 10.1093/nar/gkr342; Muinos-Gimeno M, 2011, BIOL PSYCHIAT, V69, P526, DOI 10.1016/j.biopsych.2010.10.010; Nei M., 1987, MOL EVOLUTIONARY GEN; Nowick K, 2009, P NATL ACAD SCI USA, V106, P22358, DOI 10.1073/pnas.0911376106; Perdomo-Sabogal A, 2014, CURR OPIN GENET DEV, V29, P60, DOI 10.1016/j.gde.2014.08.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; Saba R, 2010, BRAIN RES, V1338, P3, DOI 10.1016/j.brainres.2010.03.107; Salin-Cantegrel A, 2011, J BIOL CHEM, V286, P28456, DOI 10.1074/jbc.M111.226894; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shen Y, 2011, P NATL ACAD SCI USA, V108, P15942, DOI 10.1073/pnas.1110098108; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smit A.F.A., 2015, REPEATMASKER OPEN 4; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yang JS, 2010, CELL CYCLE, V9, P4455, DOI 10.4161/cc.9.22.13958; Zhang J, 2011, CELL BIOCHEM FUNCT, V29, P279, DOI 10.1002/cbf.1747; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhu Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-718	55	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154194	10.1371/journal.pone.0154194	http://dx.doi.org/10.1371/journal.pone.0154194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105073	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100052
J	Godongwana, B				Godongwana, Buntu			Effectiveness Factors and Conversion in a Biocatalytic Membrane Reactor	PLOS ONE			English	Article							BIOREACTOR DESIGN EQUATIONS; SUBSTRATE CONSUMPTION; HOLLOW; TRANSPORT; MASS	Analytical expressions of the effectiveness factor of a biocatalytic membrane reactor, and its asymptote as the Thiele modulus becomes large, are presented. The evaluation of the effectiveness factor is based on the solution of the governing equations for solute transport in the two regions of the reactor, i.e. the lumen and the matrix (with the biofilm immobilized in the matrix). The lumen solution accounts for both axial diffusion and radial convective flow, while the matrix solution is based on Robin-type boundary conditions. The effectiveness factor is shown to be a function of the Thiele modulus, the partition coefficient, the Sherwood number, the Peclet number, and membrane thickness. Three regions of Thiele moduli are defined in the effectiveness factor graphs. These correspond with reaction rate limited, internal-diffusion limited, and external mass transfer limited solute transport. Radial convective flows were shown to only improve the effectiveness factor in the region of internal diffusion limitation. The assumption of first order kinetics is shown to be applicable only in the Thiele modulus regions of internal and external mass transfer limitation. An iteration scheme is also presented for estimating the effectiveness factor when the solute fractional conversion is known. The model is validated with experimental data from a membrane gradostat reactor immobilised with Phanerochaete chrysosporium for the production of lignin and manganese peroxidases. The developed model and experimental data allow for the determination of the Thiele modulus at which the effectiveness factor and fractional conversion are optimal.	[Godongwana, Buntu] Cape Peninsula Univ Technol, Dept Chem Engn, Cape Town, South Africa	Cape Peninsula University of Technology	Godongwana, B (corresponding author), Cape Peninsula Univ Technol, Dept Chem Engn, Cape Town, South Africa.	godongwanab@cput.ac.za		Godongwana, Buntu/0000-0002-5921-0032	National Research Foundation of South Africa [87845]; National Research Foundation (RSA)	National Research Foundation of South Africa(National Research Foundation - South Africa); National Research Foundation (RSA)	The study was funded by the National Research Foundation of South Africa (http://www.nrf.ac.za/), grant number 87845. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank the National Research Foundation (RSA) for supporting this work. Special thanks to Dr S.K. Ntwampe and Dr M.S. Sheldon for making available the data used in Fig 3.	Abramowitz M., 1965, HDB MATH FUNCTIONS; [Anonymous], 1975, MATH THEORY DIFFUSIO; Calabro V, 2002, J MEMBRANE SCI, V206, P217, DOI 10.1016/S0376-7388(01)00766-9; Chang H N, 1991, Adv Biochem Eng Biotechnol, V44, P27; Charcosset C, 2006, BIOTECHNOL ADV, V24, P482, DOI 10.1016/j.biotechadv.2006.03.002; Curcio S, 2006, J MEMBRANE SCI, V273, P129, DOI 10.1016/j.memsci.2005.10.006; DALLBAUMAN L, 1990, BIOTECHNOL BIOENG, V35, P837, DOI 10.1002/bit.260350812; Girono L, 2000, TRENDS BIOTECHNOL, V18, P339, DOI 10.1016/S0167-7799(00)01472-4; Godongwana B, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/810843; Godongwana B, 2010, INT J CHEM ENG, V2010, DOI 10.1155/2010/738482; Gonzo EE, 2007, BIOCHEM ENG J, V37, P80, DOI 10.1016/j.bej.2007.03.011; Jayaraman VK, 1997, CHEM ENG J, V65, P77; JAYARAMAN VK, 1992, BIOTECHNOL PROGR, V8, P462, DOI 10.1021/bp00017a014; Lewandowski Z., 2007, FUNDAMENTALS BIOFILM; Lieb T, 2007, PERRYS CHEM ENG HDB; Nagy E, 2012, ELSEV INSIGHT, P1; Nagy E, 2015, J MEMBRANE SCI, V482, P144, DOI 10.1016/j.memsci.2014.11.060; Ntwampe SKO, 2006, BIOCHEM ENG J, V30, P147, DOI 10.1016/j.bej.2006.03.001; Tanyolac A, 1996, CHEM ENG J BIOCH ENG, V62, P149, DOI 10.1016/0923-0467(95)03066-2; WATERLAND LR, 1974, AICHE J, V20, P50, DOI 10.1002/aic.690200106; WEBSTER IA, 1978, BIOTECHNOL BIOENG, V20, P1541, DOI 10.1002/bit.260201004; WEBSTER IA, 1979, BIOTECHNOL BIOENG, V21, P1725, DOI 10.1002/bit.260211004; Wickramasinghe SR, 2002, J MEMBRANE SCI, V208, P247, DOI 10.1016/S0376-7388(02)00281-8; Willaert R, 1999, BIOTECHNOL TECH, V13, P317, DOI 10.1023/A:1008907024434; Ye H, 2006, J MEMBRANE SCI, V272, P169, DOI 10.1016/j.memsci.2005.07.040	25	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153000	10.1371/journal.pone.0153000	http://dx.doi.org/10.1371/journal.pone.0153000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104954	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100006
J	Chowdhury, B; Porter, EG; Stewart, JC; Ferreira, CR; Schipma, MJ; Dykhuizen, EC				Chowdhury, Basudev; Porter, Elizabeth G.; Stewart, Jane C.; Ferreira, Christina R.; Schipma, Matthew J.; Dykhuizen, Emily C.			PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENRICHMENT ANALYSIS; MASS-SPECTROMETRY; CHOLESTEROL; MECHANISMS; INDUCTION; DYNAMICS; REVEALS; CANCER; ROLES	Polybromo-1 (PBRM1) is a component of the PBAF (Polybromo-associated-BRG1- or BRM-associated factors) chromatin remodeling complex and is the second most frequently mutated gene in clear-cell renal cell Carcinoma (ccRCC). Mutation of PBRM1 is believed to be an early event in carcinogenesis, however its function as a tumor suppressor is not understood. In this study, we have employed Next Generation Sequencing to profile the differentially expressed genes upon PBRM1 re-expression in a cellular model of ccRCC. PBRM1 re-expression led to upregulation of genes involved in cellular adhesion, carbohydrate metabolism, apoptotic process and response to hypoxia, and a downregulation of genes involved in different stages of cell division. The decrease in cellular proliferation upon PBRM1 re-expression was confirmed, validating the functional role of PBRM1 as a tumor suppressor in a cell-based model. In addition, we identified a role for PBRM1 in regulating metabolic pathways known to be important for driving ccRCC, including the regulation of hypoxia response genes, PI3K signaling, glucose uptake, and cholesterol homeostasis. Of particular novelty is the identification of cell adhesion as a major downstream process uniquely regulated by PBRM1 expression. Cytoskeletal reorganization was induced upon PBRM1 reexpression as evidenced from the increase in the number of cells displaying cortical actin, a hallmark of epithelial cells. Genes involved in cell adhesion featured prominently in our transcriptional dataset and overlapped with genes uniquely regulated by PBRM1 in clinical specimens of ccRCC. Genes involved in cell adhesion serve as tumor suppressor and maybe involved in inhibiting cell migration. Here we report for the first time genes linked to cell adhesion serve as downstream targets of PBRM1, and hope to lay the foundation of future studies focusing on the role of chromatin remodelers in bringing about these alterations during malignancies.	[Chowdhury, Basudev; Porter, Elizabeth G.; Stewart, Jane C.; Dykhuizen, Emily C.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Ferreira, Christina R.] Purdue Univ, Metabolite Profiling Facil, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Schipma, Matthew J.] Northwestern Univ, Ctr Genet Med, NUSeq Core Facil, Chicago, IL 60611 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwestern University	Dykhuizen, EC (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	edykhui@purdue.edu	Ferreira, Christina Ramires/F-4744-2012	Ferreira, Christina Ramires/0000-0003-3988-6454; dykhuizen, emily/0000-0003-3072-1469	V scholar award from the V foundation [14109042]; NIH Shared Instrumentation Grant; NCRR [1 S10 RR023734-01A1]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023734] Funding Source: NIH RePORTER	V scholar award from the V foundation; NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Sanger sequencing and Cell cycle/apoptosis data were acquired by the Purdue Genomics Facility and Flow Cytometry Facility supported by P30 CA023168. ECD is supported by a V scholar award (14109042) from the V foundation. NIH Shared Instrumentation Grant, NCRR 1 S10 RR023734-01A1 supported the imaging using Zeiss LSM 710 confocal microscope.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Butz H, 2014, CLIN CHEM, V60, P1314, DOI 10.1373/clinchem.2014.225854; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Cho DC, 2013, CURR CANCER DRUG TAR, V13, P126; CLAYMAN RV, 1983, J UROLOGY, V129, P621, DOI 10.1016/S0022-5347(17)52265-X; COTTLERFOX M, 1980, INT J CANCER, V26, P689, DOI 10.1002/ijc.2910260523; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duns G, 2012, HUM MUTAT, V33, P1059, DOI 10.1002/humu.22090; Ferreira CR, 2015, REPROD FERT DEVELOP, V27, P621, DOI 10.1071/RD14310; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; GEBHARD RL, 1987, J LIPID RES, V28, P1177; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Ilatovskaya DV, 2013, CELL TISSUE RES, V354, P783, DOI 10.1007/s00441-013-1710-y; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kalo P, 2001, J CHROMATOGR A, V935, P237, DOI 10.1016/S0021-9673(01)01315-2; Kenneth NS, 2009, J BIOL CHEM, V284, P4123, DOI 10.1074/jbc.M808491200; Klingner C, 2014, J CELL BIOL, V207, P107, DOI 10.1083/jcb.201402037; KORHONEN M, 1994, CANCER RES, V54, P4532; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lin A, 2014, ONCOGENE, V33, P3183, DOI 10.1038/onc.2013.273; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Motzer Robert J, 2015, J Natl Compr Canc Netw, V13, P151; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pawlowski R, 2013, INT J CANCER, V132, pE11, DOI 10.1002/ijc.27822; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Sena JA, 2013, MOL CELL BIOL, V33, P3849, DOI 10.1128/MCB.00731-13; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shankar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119954; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundelin JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048694; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Zeng ZS, 2014, EXP THER MED, V7, P121, DOI 10.3892/etm.2013.1392	56	44	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153718	10.1371/journal.pone.0153718	http://dx.doi.org/10.1371/journal.pone.0153718			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100670	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500054
J	Guo, WH; Feng, XY				Guo, Weihua; Feng, Xueyang			OM-FBA: Integrate Transcriptomics Data with Flux Balance Analysis to Decipher the Cell Metabolism	PLOS ONE			English	Article							EUKARYOTIC GENE-EXPRESSION; HIGH-THROUGHPUT PROTEOMICS; GENOME-SCALE MODELS; NCBI GEO ARCHIVE; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; FUNCTIONAL GENOMICS; SYSTEMS BIOLOGY; OMICS DATA; RECONSTRUCTION	Constraint-based metabolic modeling such as flux balance analysis (FBA) has been widely used to simulate cell metabolism. Thanks to its simplicity and flexibility, numerous algorithms have been developed based on FBA and successfully predicted the phenotypes of various biological systems. However, their phenotype predictions may not always be accurate in FBA because of using the objective function that is assumed for cell metabolism. To overcome this challenge, we have developed a novel computational framework, namely omFBA, to integrate multi-omics data (e.g. transcriptomics) into FBA to obtain omics-guided objective functions with high accuracy. In general, we first collected transcriptomics data and phenotype data from published database (e.g. GEO database) for different microorganisms such as Saccharomyces cerevisiae. We then developed a "Phenotype Match" algorithm to derive an objective function for FBA that could lead to the most accurate estimation of the known phenotype (e.g. ethanol yield). The derived objective function was next correlated with the transcriptomics data via regression analysis to generate the omics-guided objective function, which was next used to accurately simulate cell metabolism at unknown conditions. We have applied omFBA in studying sugar metabolism of S. cerevisiae and found that the ethanol yield could be accurately predicted in most of the cases tested (>80%) by using transcriptomics data alone, and revealed valuable metabolic insights such as the dynamics of flux ratios. Overall, omFBA presents a novel platform to potentially integrate multi-omics data simultaneously and could be incorporated with other FBA-derived tools by replacing the arbitrary objective function with the omics-guided objective functions.	[Guo, Weihua; Feng, Xueyang] Virginia Polytech Inst & State Univ, Dept Biol Syst Engn, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Feng, XY (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.	xueyang@vt.edu	Guo, Weihua/AGF-9090-2022	Feng, Xueyang/0000-0003-4426-5732	Virginia Tech [175323]	Virginia Tech	This study was supported by start-up fund (#175323) from Virginia Tech.; We thank the writing center in Virginia Tech for improving the language of the paper. This study was supported by start-up fund (#175323) from Virginia Tech.	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Celton M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-317; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; de Jong B, 2012, CURR OPIN BIOTECH, V23, P624, DOI 10.1016/j.copbio.2011.11.021; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; Feng XY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002376; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Hoppe A, 2012, METABOLITES, V2, P614, DOI 10.3390/metabo2030614; Hyduke DR, 2013, MOL BIOSYST, V9, P167, DOI 10.1039/c2mb25453k; Kenny J, 1962, THE STANDARD DEVIATI, V3, P77; Kim J, 2014, CURR OPIN BIOTECH, V29, P34, DOI 10.1016/j.copbio.2014.02.009; Kim MK, 2014, COMPUT STRUCT BIOTEC, V11, P59, DOI 10.1016/j.csbj.2014.08.009; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Lakshmanan M, 2014, BRIEF BIOINFORM, V15, P108, DOI 10.1093/bib/bbs069; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Moxley JF, 2009, P NATL ACAD SCI USA, V106, P6477, DOI 10.1073/pnas.0811091106; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; O'Brien EJ, 2015, CURR OPIN BIOTECH, V34, P125, DOI 10.1016/j.copbio.2014.12.017; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Ott R, 2008, AN INTRODUCTION TO S; Poskar CH, 2014, METHODS MOL BIOL, V1090, P223, DOI 10.1007/978-1-62703-688-7_14; Raghevendran V, 2004, YEAST, V21, P769, DOI 10.1002/yea.1136; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RodriguezTome P, 1996, NUCLEIC ACIDS RES, V24, P6, DOI 10.1093/nar/24.1.6; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; Saha R, 2014, CURR OPIN BIOTECH, V29, P39, DOI 10.1016/j.copbio.2014.02.011; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Schuetz R, SYSTEMATIC EVALUATIO; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Sundararaman Niveda, 2015, BMC Res Notes, V8, P771, DOI 10.1186/s13104-015-1759-7; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wiechert W, 2007, CURR OPIN PLANT BIOL, V10, P323, DOI 10.1016/j.pbi.2007.04.015; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0; Zhang ZR, 2014, ANNU REV ANAL CHEM, V7, P427, DOI 10.1146/annurev-anchem-071213-020216; Zur H, 2010, BIOINFORMATICS, V26, P3140, DOI 10.1093/bioinformatics/btq602	53	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154188	10.1371/journal.pone.0154188	http://dx.doi.org/10.1371/journal.pone.0154188			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100883	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500164
J	Li, YG; Han, BB; Li, F; Yu, JW; Dong, ZF; Niu, GM; Qing, YW; Li, JB; Wei, M; Zhu, W				Li, Yong-Guang; Han, Bei-Bei; Li, Feng; Yu, Jian-Wu; Dong, Zhi-Feng; Niu, Geng-Ming; Qing, Yan-Wei; Li, Jing-Bo; Wei, Meng; Zhu, Wei			High Glucose Induces Down-Regulated GRIM-19 Expression to Activate STAT3 Signaling and Promote Cell Proliferation in Cell Culture	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CANCER-CELLS; HEPG2 CELLS; COMPLEX-I; AMPK; PROTEIN; PHOSPHORYLATION; PATHWAY; RISK; TUMORIGENESIS	Recent studies indicated that Gene Associated with Retinoid-IFN-Induced Mortality 19 (GRIM-19), a newly discovered mitochondria-related protein, can regulate mitochondrial function and modulate cell viability possibly via interacting with STAT3 signal. In the present study we sought to test: 1) whether GRIM-19 is involved in high glucose (HG) induced altered cell metabolism in both cancer and cardiac cells, 2) whether GRIM-19/STAT3 signaling pathway plays a role in HG induced biological effects, especially whether AMPK activity could be involved. Our data showed that HG enhanced cell proliferation of both HeLa and H9C2 cells, which was closely associated with down-regulated GRIM-19 expression and increased phosphorylated STAT3 level. We showed that GRIM-19 knock-down alone in normal glucose cultured cells can also result in an increase in phosphorylated STAT3 level and enhanced proliferation capability, whereas GRIM-19 over-expression can abolished HG induced STAT3 activation and enhanced cell proliferation. Importantly, both down-regulated or over-expression of GRIM-19 increased lactate production in both HeLa and H9C2 cells. The activated STAT3 was responsible for increased cell proliferation as either AG-490, an inhibitor of JAK2, or siRNA targeting STAT3 can attenuate cell proliferation increased by HG. In addition, HG increased lactate acid levels in HeLa cells, which was also observed when GRIM-19 was genetically manipulated. However, HG did not affect the lactate levels in H9C2 cells. Of note, over-expression of GRIM-19 and silencing of STAT3 both increased lactate production in H9C2 cells. As expected, HG resulted in significant decreases in phosphorylated AMPKa levels in H9C2 cells, but not in HeLa cells. Interestingy, activation of AMPKa by metformin was associated with a reversal of the suppressed GRIM-19 expression in H9C2 cells, the fold of changes in GRIM-19 expression by metformin were much less in HeLa cells. Metformin did not affect the phosphorylated STAT3 lelvels, however, decreased its levels in H9C2, especially in the setting of HG culture. Not like HG alone which resulted in no changes in lactate acid in H9C2 cells, metformin can increase lactate acid levels in H9C2 cells. Increased lactate induced by metformin was also observed in HeLa cells.	[Li, Yong-Guang; Han, Bei-Bei; Li, Feng; Dong, Zhi-Feng; Niu, Geng-Ming; Qing, Yan-Wei; Li, Jing-Bo; Wei, Meng; Zhu, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Heart, State Key Discipline Div, Shanghai 200030, Peoples R China; [Yu, Jian-Wu] Zhejiang Prov Peoples Hosp, Div Cardiol, Hangzhou, Zhejiang, Peoples R China; [Zhu, Wei] Zhejiang Univ, Prov Key Lab Cardiovasc Res, Dept Cardiol, Sch Med,Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Zhejiang Provincial People's Hospital; Zhejiang University	Wei, M; Zhu, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Heart, State Key Discipline Div, Shanghai 200030, Peoples R China.; Zhu, W (corresponding author), Zhejiang Univ, Prov Key Lab Cardiovasc Res, Dept Cardiol, Sch Med,Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	weim.sjtu6h@hotmail.com; weizhu65@zju.edu.cn	NIU, NIU/AAA-1523-2022		National Natural Science Foundation of China [81070110, 81370346]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (#81070110 to M. Wei, #81370346 to W. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (#81070110 to M. Wei, #81370346 to W. Zhu).	Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; Bu XM, 2013, GENE, V512, P198, DOI 10.1016/j.gene.2012.10.057; Chen Y, 2012, J BIOL CHEM, V287, P27227, DOI 10.1074/jbc.M112.340315; Garcia-Jimenez C, 2014, J MOL ENDOCRINOL, V52, pR51, DOI 10.1530/JME-13-0152; Gorgani-Firuzjaee S, 2015, FREE RADICAL BIO MED, V89, P679, DOI 10.1016/j.freeradbiomed.2015.10.036; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Guo YL, 2015, BBA-MOL BASIS DIS, V1852, P319, DOI 10.1016/j.bbadis.2014.05.017; He CY, 2013, DIABETES, V62, P1270, DOI 10.2337/db12-0533; Hervouet E, 2005, CARCINOGENESIS, V26, P531, DOI 10.1093/carcin/bgi001; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kalakonda S, 2013, P NATL ACAD SCI USA, V110, pE4213, DOI 10.1073/pnas.1303760110; Kalvakolanu DV, 2010, CYTOKINE, V52, P128, DOI 10.1016/j.cyto.2010.03.009; Kim JE, 2014, CANCERS, V6, P376, DOI 10.3390/cancers6010376; Kostromina E, 2010, ENDOCRINOLOGY, V151, P2050, DOI 10.1210/en.2009-1199; LeRoith D, 2008, EXP CLIN ENDOCR DIAB, V116, pS4, DOI 10.1055/s-2008-1081488; Li YG, 2013, ONCOL REP, V30, P2820, DOI 10.3892/or.2013.2748; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liu Q, 2013, CARCINOGENESIS, V34, P1728, DOI 10.1093/carcin/bgt125; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Mackenzie GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061532; Mashili F, 2013, DIABETES, V62, P457, DOI 10.2337/db12-0337; Do MT, 2013, TOXICOL APPL PHARM, V271, P229, DOI 10.1016/j.taap.2013.05.010; Moon YM, 2014, ARTHRITIS RHEUMATOL, V66, P569, DOI 10.1002/art.38267; Nallar SC, 2013, J BIOL CHEM, V288, P7930, DOI 10.1074/jbc.M112.440610; Okamoto T, 2010, MOL CANCER THER, V9, P2333, DOI 10.1158/1535-7163.MCT-09-1147; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Vieira E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069939; Zhang QF, 2013, J BIOL CHEM, V288, P31280, DOI 10.1074/jbc.M113.505057	33	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153659	10.1371/journal.pone.0153659	http://dx.doi.org/10.1371/journal.pone.0153659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101310	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500047
J	Rautiola, J; Lampinen, A; Mirtti, T; Ristimaki, A; Joensuu, H; Bono, P; Saharinen, P				Rautiola, Juhana; Lampinen, Anita; Mirtti, Tuomas; Ristimaki, Ari; Joensuu, Heikki; Bono, Petri; Saharinen, Pipsa			Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma	PLOS ONE			English	Article							MICROVESSEL DENSITY; TARGETED THERAPY; LUNG METASTASIS; TUMOR-THERAPY; ANGIOGENESIS; CANCER; VEGF; INHIBITORS; BIOMARKERS; GROWTH	The Angiopoietin-2 (Ang2, Angpt2) growth factor is a context-dependent antagonist/agonist ligand of the endothelial Tie2 receptor tyrosine kinase and known to promote tumour angiogenesis and metastasis. Angiopoietin antagonists have been tested in clinical cancer trials in combination with VEGF-based anti-angiogenic therapy, including sunitinib, which is widely used as a first-line therapy for metastatic renal cell carcinoma (mRCC). However, little is known about Ang2 protein expression in human tumours and the correlation of tumour Ang2 expression with tumour vascularization, tumour cell proliferation and response to anti-angiogenic therapies. Here, we evaluated, using immunohistochemistry, the expression of Ang2, CD31 and the cell proliferation marker Ki-67 in the primary kidney cancer from 136 mRCC patients, who received first-line sunitinib after nephrectomy. Ang2 protein expression was restrained to RCC tumour vessels, and correlated with tumour vascularization and response to sunitinib. High pre-therapeutic Ang2 expression, and more strongly, combined high expression of both Ang2 and CD31, were associated with a high clinical benefit rate (CBR). Low cancer Ki-67 expression, but not Ang2 or CD31 expression, was associated with favourable progression-free (PFS) and overall survival (OS) as compared to patients with high Ki-67 expression (PFS 6.5 vs. 10.6 months, P = 0.009; OS, 15.7 vs. 28.5 months, P = 0.015). In summary, in this study to investigate endothelial Ang2 in mRCC patients treated with first-line sunitinib, high cancer Ang2 expression was associated with the CBR, but not PFS or OS, whereas low Ki-67 expression was significantly associated with long PFS and OS.	[Rautiola, Juhana; Joensuu, Heikki; Bono, Petri] Helsinki Univ Hosp, Ctr Comprehens Canc, POB 180, Helsinki 00029, Finland; [Rautiola, Juhana; Joensuu, Heikki; Bono, Petri] Univ Helsinki, FIN-00014 Helsinki, Finland; [Lampinen, Anita; Saharinen, Pipsa] Univ Helsinki, Res Programs Unit, Translat Canc Biol, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland; [Lampinen, Anita; Saharinen, Pipsa] Univ Helsinki, Dept Virol, Haartman Inst, Biomedicum Helsinki, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland; [Saharinen, Pipsa] Biomedicum Helsinki, Wihuri Res Inst, Haartmaninkatu 8, FI-00290 Helsinki, Finland; [Mirtti, Tuomas] Univ Helsinki, Inst Mol Med Finland, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland; [Mirtti, Tuomas; Ristimaki, Ari] Univ Helsinki, Res Programs Unit, Pathol, POB 400, FI-00029 Helsinki, Finland; [Mirtti, Tuomas; Ristimaki, Ari] Univ Helsinki, HUSLAB, POB 400, FI-00029 Helsinki, Finland; [Mirtti, Tuomas; Ristimaki, Ari] Helsinki Univ Hosp, POB 400, FI-00029 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Wihuri Research Institute; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Saharinen, P (corresponding author), Univ Helsinki, Res Programs Unit, Translat Canc Biol, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland.; Saharinen, P (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Biomedicum Helsinki, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland.; Saharinen, P (corresponding author), Biomedicum Helsinki, Wihuri Res Inst, Haartmaninkatu 8, FI-00290 Helsinki, Finland.	Pipsa.Saharinen@Helsinki.fi	Saharinen, Pipsa I/C-9601-2016	Saharinen, Pipsa I/0000-0003-2652-0584; Joensuu, Heikki/0000-0003-0281-2507; Mirtti, Tuomas/0000-0003-0455-9891	Cancer Foundation [271845]; Academy of Finland Centre of Excellence Program	Cancer Foundation; Academy of Finland Centre of Excellence Program(Academy of Finland)	Funded by https://www.cancersociety.fi/grants/cancer-foundation-grants/; Cancer Foundation (PS) and 271845; https://www.aka.fi; Academy of Finland Centre of Excellence Program 2014-2019 (to PS, HJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins MB, 2015, J CLIN ONCOL; Busch J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-295; Cheng SH, 2014, INT J CLIN EXP PATHO, V7, P5855; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Conroy AL, 2012, CRIT CARE MED, V40, P952, DOI 10.1097/CCM.0b013e3182373157; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Currie MJ, 2002, J PATHOL, V198, P502, DOI 10.1002/path.1228; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; del Puerto-Nevado L, 2014, BRIT J CANCER, V110, P2700, DOI 10.1038/bjc.2014.225; Demasi APD, 2012, HEAD NECK PATHOL, V6, P10, DOI 10.1007/s12105-011-0302-y; Dornbusch J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076386; Dudderidge TJ, 2005, CLIN CANCER RES, V11, P2510, DOI 10.1158/1078-0432.CCR-04-1776; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; Escudier B, 2014, ANN ONCOL, V25, P49, DOI 10.1093/annonc/mdu259; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Gayed BA, 2014, BJU INT, V113, P668, DOI 10.1111/bju.12263; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Goede V, 2010, BRIT J CANCER, V103, P1407, DOI 10.1038/sj.bjc.6605925; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Joo HJ, 2004, BJU INT, V93, P291, DOI 10.1111/j.1464-410X.2004.04604.x; Keskin D, 2015, CELL REP, V10, P1066, DOI 10.1016/j.celrep.2015.01.035; Kienast Y, 2013, CLIN CANCER RES, V19, P6730, DOI 10.1158/1078-0432.CCR-13-0081; Kumpers P, 2009, CRIT CARE, V13, DOI 10.1186/cc7866; Li CY, 2013, EUR J DRUG METAB PH, V2013, pII, DOI DOI 10.1371/J0URNAL.P0NE.0075388; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; McIntyre A, 2015, EMBO MOL MED, V7, P368, DOI 10.15252/emmm.201404271; Milam KE, 2015, TISSUE BARRIERS, V3, DOI DOI 10.4161/21688362.2014.957508; Monk BJ, 2014, LANCET ONCOL; Motzer RJ, 2014, CANCER CHEMOTH PHARM, V74, P739, DOI 10.1007/s00280-014-2539-0; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Nakayama T, 2004, HISTOPATHOLOGY, V44, P232, DOI 10.1111/j.0309-0167.2004.01817.x; Ngo TC, 2014, UROL ONCOL-SEMIN ORI, V32, P243, DOI 10.1016/j.urolonc.2013.07.011; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Porta C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-105; Powles T, 2011, BRIT J CANCER, V104, P741, DOI 10.1038/sj.bjc.6606061; Ravaud A, 2013, ANN ONCOL, V24, P2935, DOI 10.1093/annonc/mdt288; Rigamonti N, 2014, CELL REP, V8, P696, DOI 10.1016/j.celrep.2014.06.059; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Sennino B, 2012, NAT REV CANCER, V12, P699, DOI 10.1038/nrc3366; Sfiligoi C, 2003, INT J CANCER, V103, P466, DOI 10.1002/ijc.10851; Sharpe K, 2013, CLIN CANCER RES, V19, P6924, DOI 10.1158/1078-0432.CCR-13-1631; Sounni NE, 2014, CELL METAB, V20, P280, DOI 10.1016/j.cmet.2014.05.022; Srivastava K, 2014, CANCER CELL, V26, P880, DOI 10.1016/j.ccell.2014.11.005; Tollefson MK, 2007, CANCER, V110, P783, DOI 10.1002/cncr.22840; Virman J, 2015, ANTICANCER RES, V35, P921; Wang XE, 2014, TRANSL ONCOL, V7, P188, DOI 10.1016/j.tranon.2014.02.003; Yao X, 2007, CLIN CANCER RES, V13, P161, DOI 10.1158/1078-0432.CCR-06-0774	53	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153745	10.1371/journal.pone.0153745	http://dx.doi.org/10.1371/journal.pone.0153745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100185	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500063
J	van Loon, EPM; Little, R; Prehar, S; Bindels, RJM; Cartwright, EJ; Hoenderop, JGJ				van Loon, Ellen P. M.; Little, Robert; Prehar, Sukhpal; Bindels, Rene J. M.; Cartwright, Elizabeth J.; Hoenderop, Joost G. J.			Calcium Extrusion Pump PMCA4: A New Player in Renal Calcium Handling?	PLOS ONE			English	Article							ACTIVE CA2+ REABSORPTION; EPITHELIAL CA2+; KNOCKOUT MICE; VITAMIN-D; PARATHYROID-HORMONE; COORDINATED CONTROL; TRANSPORT PROTEINS; SPERM MOTILITY; MALE-FERTILITY; KIDNEY	Calcium (Ca2+) is vital for multiple processes in the body, and maintenance of the electrolyte concentration is required for everyday physiological function. In the kidney, and more specifically, in the late distal convoluted tubule and connecting tubule, the fine-tuning of Ca2+ reabsorption from the pro-urine takes place. Here, Ca2+ enters the epithelial cell via the transient receptor potential vanilloid receptor type 5 (TRPV5) channel, diffuses to the basolateral side bound to calbindin-D-28k and is extruded to the blood compartment via the Na+/Ca2+ exchanger 1 (NCX1) and the plasma membrane Ca2+ ATPase (PMCA). Traditionally, PMCA1 was considered to be the primary Ca2+ pump in this process. However, in recent studies TRPV5-expressing tubules were shown to highly express PMCA4. Therefore, PMCA4 may have a predominant role in renal Ca2+ handling. This study aimed to elucidate the role of PMCA4 in Ca2+ homeostasis by characterizing the Ca2+ balance, and renal and duodenal Ca2+-related gene expression in PMCA4 knockout mice. The daily water intake of PMCA4 knockout mice was significantly lower compared to wild type littermates. There was no significant difference in serum Ca2+ level or urinary Ca2+ excretion between groups. In addition, renal and duodenal mRNA expression levels of Ca2+-related genes, including TRPV5, TRPV6, calbindin-D-28k, calbindin-D-9k, NCX1 and PMCA1 were similar in wild type and knockout mice. Serum FGF23 levels were significantly increased in PMCA4 knockout mice. In conclusion, PMCA4 has no discernible role in normal renal Ca2+ handling as no urinary Ca2+ wasting was observed. Further investigation of the exact role of PMCA4 in the distal convoluted tubule and connecting tubule is required.	[van Loon, Ellen P. M.; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Dept Physiol, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Little, Robert; Prehar, Sukhpal; Cartwright, Elizabeth J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Cardiovasc Sci, Manchester, Lancs, England	Radboud University Nijmegen; University of Manchester	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Dept Physiol, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	Joost.Hoenderop@radboudumc.nl	Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; Cartwright, Elizabeth/0000-0002-6836-7795	Dutch Kidney Foundation [CP10.11]; Medical Research Council UK [G1002082]; MRC [G0802004, G1002082] Funding Source: UKRI; Medical Research Council [G1002082, G0802004] Funding Source: researchfish	Dutch Kidney Foundation; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project is part of the NIGRAM consortium, financially supported by the Dutch Kidney Foundation (CP10.11). EPML, RJMB and JGJH received this funding. This project was also funded by the Medical Research Council (G1002082) UK. RL, SP and EJC received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RT, 2015, AM J PHYSIOL-RENAL, V309, pF604, DOI 10.1152/ajprenal.00651.2014; Alexander RT, 2009, J AM SOC NEPHROL, V20, P2371, DOI 10.1681/ASN.2008121273; Bai XY, 2004, ENDOCRINOLOGY, V145, P5269, DOI 10.1210/en.2004-0233; BODEN SD, 1990, ORTHOP CLIN N AM, V21, P31; Bouillon R, 2003, J CELL BIOCHEM, V88, P332, DOI 10.1002/jcb.10360; Brini M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004168; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; Bushinsky DA, 2010, CLIN J AM SOC NEPHRO, V5, pS12, DOI 10.2215/CJN.05970809; Cartwright EJ, 2011, SCI CHINA LIFE SCI, V54, P691, DOI 10.1007/s11427-011-4199-1; Chen J, 2004, NAT IMMUNOL, V5, P651, DOI 10.1038/ni1072; Cho CH, 2000, MOL CELLS, V10, P712; Dimke H, 2010, CLIN SCI, V118, P1, DOI 10.1042/CS20090086; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Gkika D, 2006, J AM SOC NEPHROL, V17, P3020, DOI 10.1681/ASN.2006060676; Hoenderop JGJ, 2000, AM J PHYSIOL-RENAL, V278, pF352, DOI 10.1152/ajprenal.2000.278.3.F352; Hoenderop JGJ, 2000, J AM SOC NEPHROL, V11, P1171, DOI 10.1681/ASN.V1171171; Hoenderop JGJ, 2005, J AM SOC NEPHROL, V16, P15, DOI 10.1681/ASN.2004070523; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Hoenderop JGJ, 2002, ANNU REV PHYSIOL, V64, P529, DOI 10.1146/annurev.physiol.64.081501.155921; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Hoorn EJ, 2013, PEDIATR NEPHROL, V28, P1195, DOI 10.1007/s00467-012-2350-2; HOWARD A, 1993, AM J PHYSIOL, V265, pG917, DOI 10.1152/ajpgi.1993.265.5.G917; Huybers S, 2008, INFLAMM BOWEL DIS, V14, P803, DOI 10.1002/ibd.20385; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Lambers TT, 2006, KIDNEY INT, V69, P650, DOI 10.1038/sj.ki.5000169; Lameris AL, 2015, AM J PHYSIOL-GASTR L, V308, pG206, DOI 10.1152/ajpgi.00093.2014; Lee CT, 2002, KIDNEY INT, V62, P2055, DOI 10.1046/j.1523-1755.2002.00670.x; Mohamed TMA, 2011, J BIOL CHEM, V286, P41520, DOI 10.1074/jbc.M111.290411; Nilius B, 2002, J BIOL CHEM, V277, P30852, DOI 10.1074/jbc.M202418200; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Pulskens WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142510; Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Renkema KY, 2005, J AM SOC NEPHROL, V16, P3188, DOI 10.1681/ASN.2005060632; Ryan ZC, 2015, BIOCHEM BIOPH RES CO, V467, P152, DOI 10.1016/j.bbrc.2015.09.087; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Sooy K, 2000, CURR OPIN NEPHROL HY, V9, P341, DOI 10.1097/00041552-200007000-00004; STAUFFER TP, 1993, J BIOL CHEM, V268, P25993; van Abel M, 2005, KIDNEY INT, V68, P1708, DOI 10.1111/j.1523-1755.2005.00587.x; van der Hagen EAE, 2014, PFLUG ARCH EUR J PHY, V466, P2077, DOI 10.1007/s00424-014-1470-x; van Loon EPM, 2015, AM J PHYSIOL-RENAL, V309, pF359, DOI 10.1152/ajprenal.00240.2014; VanBaal J, 1996, AM J PHYSIOL-RENAL, V271, pF985, DOI 10.1152/ajprenal.1996.271.5.F985; White KE, 1997, J GEN PHYSIOL, V109, P217, DOI 10.1085/jgp.109.2.217; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100; Zheng W, 2004, J BIOL CHEM, V279, P52406, DOI 10.1074/jbc.M405562200	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153483	10.1371/journal.pone.0153483	http://dx.doi.org/10.1371/journal.pone.0153483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101128	gold, Green Submitted, Green Published			2022-12-26	WOS:000374898500034
J	Khan, IA; Yoo, BH; Masson, O; Baron, S; Corkery, D; Dellaire, G; Attardi, LD; Rosen, KV				Khan, I. A.; Yoo, B. H.; Masson, O.; Baron, S.; Corkery, D.; Dellaire, G.; Attardi, L. D.; Rosen, K. V.			ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells	ONCOGENE			English	Article							BCL-X-L; RAS-INDUCED TRANSFORMATION; ERBB SIGNALING NETWORK; P53/P63 TARGET PERP; IN-VIVO; ANOIKIS RESISTANCE; EXTRACELLULAR-MATRIX; PANCREATIC ADENOCARCINOMA; CONFERS RESISTANCE; BASEMENT-MEMBRANE	The ability of breast cancer cells to resist anoikis, apoptosis caused by detachment of the non-malignant epithelial cells from the extracellular matrix (ECM), is thought to be critical for breast tumor growth, invasion and metastasis. ErbB2, an oncoprotein that is often overproduced in breast tumors, can block breast cancer cell anoikis via mechanisms that are understood only in part. In an effort to understand them better we found that detachment of the non-malignant human breast epithelial cells from the ECM upregulates a protein Perp in these cells. Perp is a component of the desmosomes, multiprotein complexes involved in cell-to-cell adhesion. Perp can cause apoptosis via unknown mechanisms. We demonstrated that Perp upregulation by cell detachment is driven by detachment-induced loss of epidermal growth factor receptor (EGFR). We also found that Perp knockdown by RNA interference (RNAi) rescues detached cells from death which indicates that Perp contributes to their anoikis. We observed that ErbB2, when overexpressed in detached breast epithelial cells, causes Perp downregulation. Furthermore, ErbB2-directed RNAi or treatment with lapatinib, an ErbB2/EGFR small-molecule inhibitor used for breast cancer therapy, upregulated Perp in ErbB2positive human breast and ovarian carcinoma cells. We established that ErbB2 downregulates Perp by activating an ErbB2 effector protein kinase Mek that blocks detachment-induced EGFR loss in a manner that requires the presence of a signaling protein Sprouty-2. Finally, we observed that restoration of the wild-type Perp levels in ErbB2-overproducing breast epithelial cells increases their anoikis susceptibility and blocks their clonogenicity in the absence of adhesion to the ECM. In summary, we have identified a novel mechanism of ErbB2-mediated mechanism of anoikis resistance of ErbB2-overproducing breast epithelial cells. This mechanism allows such cells to grow without adhesion to the ECM and is driven by ErbB2-induced activation of Mek, subsequent EGFR upregulation and further EGFR-dependent Perp loss.	[Khan, I. A.; Yoo, B. H.; Masson, O.; Rosen, K. V.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Khan, I. A.; Yoo, B. H.; Masson, O.; Corkery, D.; Dellaire, G.; Rosen, K. V.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Baron, S.; Attardi, L. D.] Stanford Univ, Sch Med, Dept Radiat & Canc Biol, Stanford, CA 94305 USA; [Corkery, D.; Dellaire, G.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Stanford University; Dalhousie University	Rosen, KV (corresponding author), Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, CRC, Rm C-304,5849 Univ Ave,POB 15000, Halifax, NS B3H 4R2, Canada.	kirill.rosen@dal.ca	Dellaire, Graham/L-9948-2014	Dellaire, Graham/0000-0002-3466-6316; Rosen, Kirill/0000-0002-4317-9907; Corkery, Dale/0000-0001-7930-0134	Canadian Breast Cancer Foundation (CBCF) Atlantic Region operating grant [R13 F14]; CBCF Atlantic Region operating grant [R14 F09]; IWK Health Centre Research Associateship; CIBC Graduate Scholarship in Medical Research from Beatrice Hunter Cancer Research Institute	Canadian Breast Cancer Foundation (CBCF) Atlantic Region operating grant; CBCF Atlantic Region operating grant; IWK Health Centre Research Associateship; CIBC Graduate Scholarship in Medical Research from Beatrice Hunter Cancer Research Institute	This study was supported by the Canadian Breast Cancer Foundation (CBCF) Atlantic Region operating grant (R13 F14) awarded to KR. Contribution of GD was supported by the CBCF Atlantic Region operating grant (R14 F09). BY was a recipient of the IWK Health Centre Research Associateship. DC was a recipient of a CIBC Graduate Scholarship in Medical Research from the Beatrice Hunter Cancer Research Institute. We are grateful to Drs P Lee and A Stadnyk for the materials provided for this study.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Attardi LD, 2000, GENE DEV, V14, P704; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Beaudry VG, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001168; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Dusek RL, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3171; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Frankel A, 2001, CANCER RES, V61, P4837; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Goc A, 2015, BBA-MOL CELL RES, V1853, P1626, DOI 10.1016/j.bbamcr.2015.03.016; Grassian AR, 2011, J BIOL CHEM, V286, P79, DOI 10.1074/jbc.M110.169821; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Gudjonsson T, 2002, J CELL SCI, V115, P39; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Ihrie RA, 2005, CELL CYCLE, V4, P873, DOI 10.4161/cc.4.7.1836; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Jost M, 2001, MOL BIOL CELL, V12, P1519, DOI 10.1091/mbc.12.5.1519; Khan AJ, 2002, CLIN CANCER RES, V8, P540; Kong CS, 2013, OR SURG OR MED OR PA, V115, P95, DOI 10.1016/j.oooo.2012.10.017; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Liu ZP, 2006, J BIOL CHEM, V281, P14738, DOI 10.1074/jbc.M508664200; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; LJUBIMOV AV, 1992, INT J CANCER, V50, P562, DOI 10.1002/ijc.2910500412; McDonald J.H., 2014, HDB BIOL STAT; Muschler J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003202; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Recondo G, 2014, WORLD J CLIN ONCOL, V5, P440, DOI 10.5306/wjco.v5.i3.440; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Rosen K, 2002, J BIOL CHEM, V277, P46123, DOI 10.1074/jbc.M207883200; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; Scotlandi K, 2002, CANCER GENE THER, V9, P296, DOI 10.1038/sj.cgt.7700442; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SOULE HD, 1990, CANCER RES, V50, P6075; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Vachon PH, 2002, GASTROENTEROLOGY, V123, P1980, DOI 10.1053/gast.2002.37072; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wilken JA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-7; Xia WY, 1997, CLIN CANCER RES, V3, P3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoo BH, 2012, INT J CANCER, V131, P357, DOI 10.1002/ijc.26368; Yoo BH, 2011, J BIOL CHEM, V286, P38894, DOI 10.1074/jbc.M111.290692	64	19	20	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2016	35	44					5759	5769		10.1038/onc.2016.109	http://dx.doi.org/10.1038/onc.2016.109			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XQ	27109096				2022-12-26	WOS:000386998400007
J	Lamb, F; Ploner, A; Fink, K; Maeurer, M; Bergman, P; Piehl, F; Weibel, D; Sparen, P; Arnheim-Dahlstrom, L				Lamb, Favelle; Ploner, Alexander; Fink, Katharina; Maeurer, Markus; Bergman, Peter; Piehl, Fredrik; Weibel, Daniel; Sparen, Par; Arnheim-Dahlstrom, Lisen			No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination	PLOS ONE			English	Article							PANDEMRIX VACCINATION; H1N1 INFECTION; INFLUENZA; ONSET; ASSOCIATION; ANTIBODIES; DISORDER; CHILDREN	Objectives To investigate disease history before A(H1N1)pdm09 vaccination as a risk factor for narcolepsy. Methods Case-control study in Sweden. Cases included persons referred for a Multiple Sleep Latency Test between 2009 and 2010, identified through diagnostic sleep centres and confirmed through independent review of medical charts. Controls, selected from the total population register, were matched to cases on age, gender, MSLT-referral date and county of residence. Disease history (prescriptions and diagnoses) and vaccination history was collected through telephone interviews and population-based healthcare registers. Conditional logistic regression was used to investigate disease history before A(H1N1)pdm09 vaccination as a risk-factor for narcolepsy. Results In total, 72 narcolepsy cases and 251 controls were included (range 3-69 years mean 19-years). Risk of narcolepsy was increased in individuals with a disease history of nervous system disorders (OR range = 3.6-8.8) and mental and behavioural disorders (OR = 3.8, 95% CI 1.6-8.8) before referral. In a second analysis of vaccinated individuals only, nearly all initial associations were no longer statistically significant and effect sizes were smaller (OR range = 1.3-2.6). A significant effect for antibiotics (OR = 0.4, 95% CI 0.2-0.8) and a marginally significant effect for nervous system disorders was observed. In a third case-only analysis, comparing cases referred before vaccination to those referred after; prescriptions for nervous system disorders (OR = 26.0 95% CI 4.0-170.2) and ADHD (OR = 35.3 95% CI 3.4-369.9) were statistically significant during the vaccination period, suggesting initial associations were due to confounding by indication. Conclusion The findings of this study do not support disease history before A(H1N1)pdm09 vaccination as a risk factor for narcolepsy.	[Lamb, Favelle; Ploner, Alexander; Sparen, Par; Arnheim-Dahlstrom, Lisen] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Fink, Katharina; Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Maeurer, Markus] Karolinska Hosp, CAST Ctr Allogen Stem Cell Transplantat, Stockholm, Sweden; [Maeurer, Markus] LabMed Karolinska Inst, Div Therapeut Immunol TIM, Stockholm, Sweden; [Bergman, Peter] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Huddinge, Sweden; [Bergman, Peter] Karolinska Univ Hosp, Huddinge, Sweden; [Weibel, Daniel] Erasmus Univ, Dept Med Informat, Med Ctr, NL-3000 DR Rotterdam, Netherlands	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC	Arnheim-Dahlstrom, L (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	lisen.arnheim.dahlstrom@ki.se		Ploner, Alexander/0000-0002-5042-8326; Bergman, Peter/0000-0003-3306-3713; Sparen, Par/0000-0002-5184-8971; Maeurer, Markus/0000-0002-8436-8077	Biogen Idec; GlaxoSmithKline; MSD Sanofi Pasteur; Merck Sharp Dome	Biogen Idec(Biogen); GlaxoSmithKline(GlaxoSmithKline); MSD Sanofi Pasteur; Merck Sharp Dome	The authors of this manuscript have the following competing interests: Favelle Lamb and Alexander Ploner have no conflicts of interest, Katharina Fink has received funding for a fellowship in multiple sclerosis research from Biogen Idec, GlaxoSmithKline for studies other than the study presented here. Markus Maeurer, Peter Bergman, Fredrik Piehl and Daniel Weibel have no conflicts of interest. Par Sparen has received funding from GlaxoSmithKline for a register-based study on H1N1 vaccinations and risk of epilepsy and Lisen Arnheim-Dahlstrom has received funding from MSD Sanofi Pasteur, Merck Sharp & Dome and GlaxoSmithKline for studies other than the study presented here. The authors confirm that the information included in the competing interest section does not alter their adherence to PLOS ONE policies on sharing data and materials.	Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033; Ambati A, 2015, J INTERN MED, V278, P264, DOI 10.1111/joim.12355; Ambati A, 2015, IMMUNOLOGY, V145, P357, DOI 10.1111/imm.12448; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bonhoeffer J, 2002, VACCINE, V21, P298, DOI 10.1016/S0264-410X(02)00449-8; European Centre for Disease Prevention and Control, NARC ASS PAND INFL V; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Fitzgerald KT, 2013, TOP COMPANION ANIM M, V28, P2, DOI 10.1053/j.tcam.2013.03.002; GREENLAND S, 1982, AM J EPIDEMIOL, V116, P547, DOI 10.1093/oxfordjournals.aje.a113439; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Han F, 2013, ANN NEUROL, V73, P560, DOI 10.1002/ana.23799; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Lakemedelsverket, 2011, OCC NARC CAT CHILDR; Lakemedelsverket, 2011, REG BAS COMP COH STU; Lind A, 2014, J AUTOIMMUN, V50, P99, DOI 10.1016/j.jaut.2014.01.031; Ludvigsson JF, 2016, EUROPEAN J EPIDEMIOL; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Modestino EJ, 2013, J ATTEN DISORD, V17, P574, DOI 10.1177/1087054713480033; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Oosterloo M, 2006, PSYCHIAT RES, V143, P293, DOI 10.1016/j.psychres.2006.02.009; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Picchioni D, 2007, NEUROEPIDEMIOLOGY, V29, P185, DOI 10.1159/000111581; SCB, 2014, POP STAT; SCB, 2015, STAT DAT; Singh AK, 2013, J AUTOIMMUN, V43, P26, DOI 10.1016/j.jaut.2013.02.003; Socialstyrelsen, 2015, NAT PAT REG NPR INF; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thebault S, 2013, CURR OPIN PULM MED, V19, P587, DOI 10.1097/MCP.0b013e328365af97; Vaarala O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114361	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154296	10.1371/journal.pone.0154296	http://dx.doi.org/10.1371/journal.pone.0154296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120092	Green Published, gold			2022-12-26	WOS:000374976200056
J	Liu, S; Wang, YY; Fan, X; Ma, J; Ma, WB; Wang, RZ; Jiang, T				Liu, Shuai; Wang, Yinyan; Fan, Xing; Ma, Jun; Ma, Wenbin; Wang, Renzhi; Jiang, Tao			Anatomical Involvement of the Subventricular Zone Predicts Poor Survival Outcome in Low-Grade Astrocytomas	PLOS ONE			English	Article							NEURAL STEM-CELLS; AVIAN-SARCOMA VIRUS; GLIOBLASTOMA-MULTIFORME; SUBEPENDYMAL PLATE; ADULT BRAIN; GLIOMA; HETEROGENEITY; IRRADIATION; PRECURSORS; INDUCTION	The subventricular zone (SVZ) has been implicated in the origination, development, and biological behavior of gliomas. Tumor-SVZ contact is also postulated to be a poor prognostic factor in glioblastomas. We aimed to evaluate the prognostic consequence of the anatomical involvement of low-grade gliomas with the SVZ. To that end, we reviewed 143 patients with diffuse astrocytomas, and tumor lesions were manually delineated on magnetic resonance images. We initially investigated the prognostic role of SVZ contact in all patients. Additionally, we investigated the influence of the anatomical proximity of the tumor lesion centroids to the SVZ in the SVZ-involved patient cohorts, as well as location within the SVZ. We found SVZ contact with tumors to be a significant prognostic factor of overall survival in all patients with diffuse astrocytomas (p = 0.027). In the SVZ-involved cohort, a shorter distance from the tumor centroid to the SVZ (<= 30 mm) correlated with shorter overall survival (p = 0.022) on univariate analysis. However, there was no significant difference in overall survival with respect to the SVZ region involved with the tumor (p = 0.930). Multivariate analysis showed that a shorter distance between the tumor centroid and the SVZ (p = 0.039) was significantly associated with poor overall survival in SVZ-involved patients. Hence, this study helps establish the prognostic role of the anatomical interaction of tumors with the SVZ in low-grade astrocytomas.	[Liu, Shuai; Ma, Wenbin; Wang, Renzhi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China; [Liu, Shuai; Ma, Wenbin; Wang, Renzhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Yinyan; Fan, Xing; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wang, Yinyan; Jiang, Tao] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Ma, Jun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China; [Jiang, Tao] Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University	Wang, RZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China.; Wang, RZ (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.; Jiang, T (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Jiang, T (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.; Jiang, T (corresponding author), Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing, Peoples R China.	wangrz@126.com; taojiang1964@163.com	jiang, tao/GWC-7108-2022; Wang, Yinyan/AAJ-1160-2020	Fan, Xing/0000-0003-2622-2210; Liu, Shuai/0000-0001-6233-4055	National 973 Program [2015CB755500]; Research Special Fund for Public Welfare industry of health [201402008]	National 973 Program(National Basic Research Program of China); Research Special Fund for Public Welfare industry of health	Funding for this work was provided by the National 973 Program (No. 2015CB755500) [Tao Jiang], http://www.973.gov.cn; and the Research Special Fund for Public Welfare industry of health (No. 201402008) [Wenbin Ma], http://www.shenjingzhongliu.org.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Adeberg S, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-95; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Barami K, 2009, J CLIN NEUROSCI, V16, P195, DOI 10.1016/j.jocn.2008.03.006; Bohman LE, 2010, NEUROSURGERY, V67, P1319, DOI 10.1227/NEU.0b013e3181f556ab; Bourkoula E, 2014, STEM CELLS, V32, P1239, DOI 10.1002/stem.1605; Chaichana KL, 2013, J CLIN NEUROSCI, V20, P1422, DOI 10.1016/j.jocn.2013.02.007; Chen LD, 2013, INT J RADIAT ONCOL, V86, P616, DOI 10.1016/j.ijrobp.2013.02.014; COPELAND DD, 1977, ACTA NEUROPATHOL, V38, P1, DOI 10.1007/BF00691268; COPELAND DD, 1975, J NEUROPATH EXP NEUR, V34, P340, DOI 10.1097/00005072-197507000-00004; Ellingson BM, 2012, NEUROIMAGE, V59, P908, DOI 10.1016/j.neuroimage.2011.09.076; Evers P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-384; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Giachino C, 2014, STEM CELLS, V32, P70, DOI 10.1002/stem.1520; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Goffart Nicolas, 2013, Cancers (Basel), V5, P1049, DOI 10.3390/cancers5031049; Gupta T, 2012, J NEURO-ONCOL, V109, P195, DOI 10.1007/s11060-012-0887-3; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Holland EC, 2001, CURR OPIN NEUROL, V14, P683, DOI 10.1097/00019052-200112000-00002; Jafri NF, 2013, NEURO-ONCOLOGY, V15, P91, DOI 10.1093/neuonc/nos268; Jeon JY, 2008, EXP MOL MED, V40, P84, DOI 10.3858/emm.2008.40.1.84; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Nabilsi NH, 2014, GENOME RES, V24, P329, DOI 10.1101/gr.161737.113; Pallud J, 2012, NEUROSURGERY, V71, P729, DOI 10.1227/NEU.0b013e31826213de; Rhoton AL, 2002, NEUROSURGERY, V51, pS207, DOI 10.1227/01.NEU.0000028161.91504.4F; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; VICK NA, 1977, ACTA NEUROPATHOL, V40, P63, DOI 10.1007/BF00688574; Young GS, 2011, J NEURO-ONCOL, V104, P261, DOI 10.1007/s11060-010-0477-1; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	39	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154539	10.1371/journal.pone.0154539	http://dx.doi.org/10.1371/journal.pone.0154539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120204	Green Submitted, Green Published, gold			2022-12-26	WOS:000374976200087
J	Munoz-Moreno, R; Cuesta-Geijo, MA; Martinez-Romero, C; Barrado-Gil, L; Galindo, I; Garcia-Sastre, A; Alonso, C				Munoz-Moreno, Raquel; Cuesta-Geijo, Miguel Angel; Martinez-Romero, Carles; Barrado-Gil, Lucia; Galindo, Inmaculada; Garcia-Sastre, Adolfo; Alonso, Covadonga			Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection	PLOS ONE			English	Article							DEPENDENT ENDOCYTOSIS; DENGUE VIRUS; VIRAL ENTRY; CELLS; REPLICATION; MACROPHAGES; INHIBITION; PATHWAY; TARGET; ALPHA	The interferon-induced transmembrane (IFITM) protein family is a group of antiviral restriction factors that impair flexibility and inhibit membrane fusion at the plasma or the endosomal membrane, restricting viral progression at entry. While IFITMs are widely known to inhibit several single-stranded RNA viruses, there are limited reports available regarding their effect in double-stranded DNA viruses. In this work, we have analyzed a possible antiviral function of IFITMs against a double stranded DNA virus, the African swine fever virus (ASFV). Infection with cell-adapted ASFV isolate Ba71V is IFN sensitive and it induces IFITMs expression. Interestingly, high levels of IFITMs caused a collapse of the endosomal pathway to the perinuclear area. Given that ASFV entry is strongly dependent on endocytosis, we investigated whether IFITM expression could impair viral infection. Expression of IFITM1, 2 and 3 reduced virus infectivity in Vero cells, with IFITM2 and IFITM3 having an impact on viral entry/uncoating. The role of IFITM2 in the inhibition of ASFV in Vero cells could be related to impaired endocytosis-mediated viral entry and alterations in the cholesterol efflux, suggesting that IFITM2 is acting at the late endosome, preventing the decapsidation stage of ASFV.	[Munoz-Moreno, Raquel; Cuesta-Geijo, Miguel Angel; Barrado-Gil, Lucia; Galindo, Inmaculada; Alonso, Covadonga] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain; [Munoz-Moreno, Raquel; Martinez-Romero, Carles; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Martinez-Romero, Carles; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Cuesta-Geijo, Miguel Angel] Kings Coll London, Sch Med, Guys Hosp, Dept Infect Dis, London WC2R 2LS, England	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Alonso, C (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.	calonso@inia.es	Alonso, Covadonga/A-8000-2011; Geijo, Miguel Ángel Cuesta/Q-5450-2018; Barrado-Gil, Lucía/H-4691-2015; Galindo, inmaculada/Q-6603-2018	Alonso, Covadonga/0000-0002-0862-6177; Geijo, Miguel Ángel Cuesta/0000-0003-4694-1968; Barrado-Gil, Lucía/0000-0002-1053-2997; Galindo, inmaculada/0000-0001-8257-9797; Martinez-Romero, Carles/0000-0001-8888-7715; Munoz-Moreno, Raquel/0000-0002-4521-0488; Garcia-Sastre, Adolfo/0000-0002-6551-1827	Ministerio de Economia y Competitividad (ES) [AGL2012-34533, AGL2015-69598-R]; National Institute for Allergy and Infectious Diseases (NIAID) [U19AI106754]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106754] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad (ES); National Institute for Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding sources for CA were: Ministerio de Economia y Competitividad (ES); http://www.mineco.gob.es/portal/site/mineco/idi; AGL2012-34533 and AGL2015-69598-R. Funding sources for AG-S were: National Institute for Allergy and Infectious Diseases (NIAID); http://www.niaid.nih.gov/; U19AI106754.	Alonso C, 2013, VIRUS RES, V173, P42, DOI 10.1016/j.virusres.2012.12.006; Altan-Bonnet N, 2012, TRENDS BIOCHEM SCI, V37, P293, DOI 10.1016/j.tibs.2012.03.004; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Cuesta-Geijo MA, 2016, J VIROL, V90, P1534, DOI 10.1128/JVI.02694-15; [Anonymous], 2014, VET REC, V175, P59, DOI 10.1136/vr.g4627; [Anonymous], 2014, AN DIS NOT SYST OUTB; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; BRADBURY LE, 1992, J IMMUNOL, V149, P2841; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001; Correia S, 2013, VIRUS RES, V173, P87, DOI 10.1016/j.virusres.2012.10.013; Cuesta-Geijo MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048853; de Oliveira VL, 2011, ARCH VIROL, V156, P597, DOI 10.1007/s00705-010-0894-7; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; ENJUANES L, 1976, J GEN VIROL, V32, P471, DOI 10.1099/0022-1317-32-3-471; ESPARZA I, 1988, J GEN VIROL, V69, P2973, DOI 10.1099/0022-1317-69-12-2973; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Galindo I, 2015, VIRUS RES, V200, P45, DOI 10.1016/j.virusres.2015.01.022; Hernaez B, 2006, VIROLOGY, V350, P1, DOI 10.1016/j.virol.2006.01.021; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; King DP, 2003, J VIROL METHODS, V107, P53, DOI 10.1016/S0166-0934(02)00189-1; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li D, 2013, INT J MOL SCI, V14, P24242, DOI 10.3390/ijms141224242; Netherton CL, 2009, J VIROL, V83, P2310, DOI 10.1128/JVI.00781-08; PAEZ E, 1990, ARCH VIROL, V112, P115, DOI 10.1007/BF01348989; Pejsak Z, 2014, POL J VET SCI, V17, P665, DOI 10.2478/pjvs-2014-0097; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Salas ML, 2013, VIRUS RES, V173, P29, DOI 10.1016/j.virusres.2012.09.016; Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754; Warren CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096579; Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066; Zhu R, 2013, FISH SHELLFISH IMMUN, V35, P918, DOI 10.1016/j.fsi.2013.07.002	39	40	43	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154366	10.1371/journal.pone.0154366	http://dx.doi.org/10.1371/journal.pone.0154366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116236	Green Published, gold, Green Submitted			2022-12-26	WOS:000374973600062
J	Shioda, K; Cosmas, L; Audi, A; Gregoricus, N; Vinje, J; Parashar, UD; Montgomery, JM; Feikin, DR; Breiman, RF; Hall, AJ				Shioda, Kayoko; Cosmas, Leonard; Audi, Allan; Gregoricus, Nicole; Vinje, Jan; Parashar, Umesh D.; Montgomery, Joel M.; Feikin, Daniel R.; Breiman, Robert F.; Hall, Aron J.			Population-Based Incidence Rates of Diarrheal Disease Associated with Norovirus, Sapovirus, and Astrovirus in Kenya	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; HOSPITAL-BASED SURVEILLANCE; HUMAN ROTAVIRUS VACCINE; UNITED STATES; GASTROENTERITIS; CHILDREN; BURDEN; COMMUNITY; PREVALENCE; ASSAY	Background Diarrheal diseases remain a major cause of mortality in Africa and worldwide. While the burden of rotavirus is well described, population-based rates of disease caused by norovirus, sapovirus, and astrovirus are lacking, particularly in developing countries. Methods Data on diarrhea cases were collected through a population-based surveillance platform including healthcare encounters and household visits in Kenya. We analyzed data from June 2007 to October 2008 in Lwak, a rural site in western Kenya, and from October 2006 to February 2009 in Kibera, an urban slum. Stool specimens from diarrhea cases of all ages who visited study clinics were tested for norovirus, sapovirus, and astrovirus by RT-PCR. Results Of 334 stool specimens from Lwak and 524 from Kibera, 85 (25%) and 159 (30%) were positive for norovirus, 13 (4%) and 31 (6%) for sapovirus, and 28 (8%) and 18 (3%) for astrovirus, respectively. Among norovirus-positive specimens, genogroup II predominated in both sites, detected in 74 (87%) in Lwak and 140 (88%) in Kibera. The adjusted community incidence per 100,000 person-years was the highest for norovirus (Lwak: 9,635; Kibera: 4,116), followed by astrovirus (Lwak: 3,051; Kibera: 440) and sapovirus (Lwak: 1,445; Kibera: 879). For all viruses, the adjusted incidence was higher among children aged <5 years (norovirus: 22,225 in Lwak and 17,511 in Kibera; sapovirus: 5,556 in Lwak and 4,378 in Kibera; astrovirus: 11,113 in Lwak and 2,814 in Kibera) compared to cases aged >= 5 years. Conclusion Although limited by a lack of controls, this is the first study to estimate the outpatient and community incidence rates of norovirus, sapovirus, and astrovirus across the age spectrum in Kenya, suggesting a substantial disease burden imposed by these viruses. By applying adjusted rates, we estimate approximately 2.8-3.3 million, 0.45-0.54 million, and 0.77-0.95 million people become ill with norovirus, sapovirus, and astrovirus, respectively, every year in Kenya.	[Shioda, Kayoko; Gregoricus, Nicole; Vinje, Jan; Parashar, Umesh D.; Feikin, Daniel R.; Hall, Aron J.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Shioda, Kayoko] Oak Ridge Inst Sci & Technol, Oak Ridge, TN USA; [Cosmas, Leonard; Montgomery, Joel M.; Feikin, Daniel R.; Breiman, Robert F.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Nairobi, Kenya; [Audi, Allan] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya; [Breiman, Robert F.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Kenya Medical Research Institute; Emory University	Shioda, K (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.; Shioda, K (corresponding author), Oak Ridge Inst Sci & Technol, Oak Ridge, TN USA.	yji4@cdc.gov	Vinje, Jan/ABE-6336-2020	Vinje, Jan/0000-0002-1530-3675; Audi, Allan/0000-0003-1683-554X				Abebe A, 2014, PEDIATR INFECT DIS J, V33, pS28, DOI 10.1097/INF.0000000000000048; Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Becker-Dreps S, 2014, PEDIATR INFECT DIS J, V33, P1156, DOI 10.1097/INF.0000000000000427; Breiman RF, 2014, PEDIATR INFECT DIS J, V33, pS54, DOI 10.1097/INF.0000000000000094; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Dennehy PH, 2001, J INFECT DIS, V184, P10, DOI 10.1086/321007; DENNEHY PH, 1990, J CLIN MICROBIOL, V28, P1280, DOI 10.1128/JCM.28.6.1280-1283.1990; Feikin DR, 2012, VACCINE, V30, pA52, DOI 10.1016/j.vaccine.2011.08.043; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Groome MJ, 2014, LANCET INFECT DIS, V14, P1096, DOI 10.1016/S1473-3099(14)70940-5; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Hemming M, 2013, EUR J PEDIATR, V172, P739, DOI 10.1007/s00431-013-1945-3; Hill VR, 2010, FOOD ENVIRON VIROL, V2, P218, DOI 10.1007/s12560-010-9049-y; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kenya National Bureau of Statistics, 2010, 2009 KEN POP HOUS CE; Khagayi S, 2014, PEDIATR INFECT DIS J, V33, pS34, DOI 10.1097/INF.0000000000000049; Krieg NR, 1984, BERGEYS MANUAL SYSTE, V1; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Mwenda JM, 2014, PEDIATR INFECT DIS J, V33, pS6, DOI 10.1097/INF.0000000000000174; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ogilvie I, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-62; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Podkolzin AT, 2009, J INFECT DIS, V200, pS228, DOI 10.1086/605054; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Trujillo AA, 2006, J CLIN MICROBIOL, V44, P1405, DOI 10.1128/JCM.44.4.1405-1412.2006; Tsolenyanu E, 2014, PEDIATR INFECT DIS J, V33, pS14, DOI 10.1097/INF.0000000000000046; Verhoef L, 2013, EPIDEMIOL INFECT, V141, P496, DOI 10.1017/S0950268812000799; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220	34	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0145943	10.1371/journal.pone.0145943	http://dx.doi.org/10.1371/journal.pone.0145943			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116458	Green Published, gold, Green Submitted			2022-12-26	WOS:000374973600004
J	Caldwell, ZR; Zgliczynski, BJ; Williams, GJ; Sandin, SA				Caldwell, Zachary R.; Zgliczynski, Brian J.; Williams, Gareth J.; Sandin, Stuart A.			Reef Fish Survey Techniques: Assessing the Potential for Standardizing Methodologies	PLOS ONE			English	Article							UNDERWATER VISUAL CENSUS; STRIP TRANSECT; VIDEO SYSTEM; CORAL; DENSITY; ASSEMBLAGES; ISLANDS; ABUNDANCE; TRAJECTORIES; COLLAPSE	Dramatic changes in populations of fishes living on coral reefs have been documented globally and, in response, the research community has initiated efforts to assess and monitor reef fish assemblages. A variety of visual census techniques are employed, however results are often incomparable due to differential methodological performance. Although comparability of data may promote improved assessment of fish populations, and thus management of often critically important nearshore fisheries, to date no standardized and agreed-upon survey method has emerged. This study describes the use of methods across the research community and identifies potential drivers of method selection. An online survey was distributed to researchers from academic, governmental, and non-governmental organizations internationally. Although many methods were identified, 89% of survey-based projects employed one of three methods-belt transect, stationary point count, and some variation of the timed swim method. The selection of survey method was independent of the research design (i.e., assessment goal) and region of study, but was related to the researcher's home institution. While some researchers expressed willingness to modify their current survey protocols to more standardized protocols (76%), their willingness decreased when methodologies were tied to long-term datasets spanning five or more years. Willingness to modify current methodologies was also less common among academic researchers than resource managers. By understanding both the current application of methods and the reported motivations for method selection, we hope to focus discussions towards increasing the comparability of quantitative reef fish survey data.	[Caldwell, Zachary R.; Zgliczynski, Brian J.; Williams, Gareth J.; Sandin, Stuart A.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Caldwell, Zachary R.] Nature Conservancy, Honolulu, HI USA; [Williams, Gareth J.] Bangor Univ, Sch Ocean Sci, Menai Bridge Anglesey, Wales	University of California System; University of California San Diego; Scripps Institution of Oceanography; Nature Conservancy; Bangor University	Caldwell, ZR (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.; Caldwell, ZR (corresponding author), Nature Conservancy, Honolulu, HI USA.	zcaldwell@tnc.org		Williams, Dr Gareth J./0000-0001-7837-1619				Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; [Anonymous], ARCGIS; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; BELL JD, 1985, CORAL REEFS, V4, P41, DOI 10.1007/BF00302203; BELLWOOD DR, 1988, CORAL REEFS, V7, P23, DOI 10.1007/BF00301978; Bibby C, 1998, EXPEDITION FIELD TEC; Bohnsack JA, 1999, BASELINE DATA EVALUA; Bohnsack JA, 1986, STATIONARY VISUAL CE; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Branden KL, 1986, T ROYAL SOC S AUSTR; Brock RE, 1982, CRITIQUE VISUAL CENS; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Cappo M, 2003, POTENTIAL VIDEO TECH; CHAPMAN CJ, 1974, MAR BIOL, V27, P357, DOI 10.1007/BF00394372; Cheung WWL, 2008, FISH RES, V92, P28, DOI 10.1016/j.fishres.2007.12.018; Colbert KC, 2002, NORTH J APPL FOR, V19, P171, DOI 10.1093/njaf/19.4.171; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Colvocoresses J, 2007, FISH RES, V85, P130, DOI 10.1016/j.fishres.2007.01.012; Curtis RO, 1967, HEIGHT DIAMETER HEIG; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Done TJ, 1981, RAPID LARGE AREA REE; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Guidetti P, 2005, MAR ENVIRON RES, V59, P333, DOI 10.1016/j.marenvres.2004.05.008; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Halford A. R., 1994, VISUAL CENSUS SURVEY; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Hann DW, 1987, HEIGHT DIAM EQ 17 TR; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Hawkins JP, 2007, AQUAT CONSERV, V17, P111, DOI 10.1002/aqc.784; Heenan A, 2016, J APPL ECOL, V53, P699, DOI 10.1111/1365-2664.12633; Helfman GS, 2009, DIVERSITY FISHES, DOI DOI 10.1890/070156; Hill JJ, 2004, METHODS ECOLOGICAL M; Holzwarth SR, 2006, ATOLL RES; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S., 2001, MARINE FISHERIES ECO; Johnson AE, 2010, MAR ECOL PROG SER, V415, P201, DOI 10.3354/meps08762; Kaiser MJ, 1998, EFFECTS FISHING MARI, P201; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; King M, 2013, FISHERIES MANAGEMENT, P273, DOI [10.1002/9781118688038, DOI 10.1002/9781118688038.CH6]; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M, 1999, AQUAT LIVING RESOUR, V12, P315, DOI 10.1016/S0990-7440(99)00116-3; Kulbicki M, 2010, J EXP MAR BIOL ECOL, V387, P15, DOI 10.1016/j.jembe.2010.03.003; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Lindfield SJ, 2014, METHODS ECOL EVOL, V5, P1061, DOI 10.1111/2041-210X.12262; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; Mapstone B. D., 1998, INVESTIGATION OPTIMU; McCauley DJ, 2012, ECOL APPL, V22, P385, DOI 10.1890/11-1059.1; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; Menza CW, 2006, GUIDE MONITORING REE; Minte-Vera CV, 2008, MAR ECOL PROG SER, V367, P283, DOI 10.3354/meps07511; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Nevill J, 2005, IMPACTS SPEARFISHING; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Richards BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031374; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; Rizzari JR, 2014, BIOL CONSERV, V176, P39, DOI 10.1016/j.biocon.2014.05.003; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Semmens BX, 1998, J GULF MEXICO SCI; Smith SG, 2011, FISH RES, V109, P25, DOI 10.1016/j.fishres.2011.01.012; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Thomson MJ, 1978, BMS, V28, P179; THRESHER RE, 1986, ENVIRON BIOL FISH, V17, P93, DOI 10.1007/BF00001740; Tissot BN, 2003, CONSERV BIOL, V17, P1759, DOI 10.1111/j.1523-1739.2003.00379.x; Usseglio Paolo, 2015, P270; Wantiez L, 1997, CORAL REEFS, V16, P215, DOI 10.1007/s003380050077; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Williams I. D., 2011, J MAR BIOL, V2011, P14, DOI DOI 10.1155/2011/826234; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2003, MAR ECOL PROG SER, V257, P209, DOI 10.3354/meps257209; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721; Zgliczynski BJ, 2013, CORAL REEFS, V32, P637, DOI 10.1007/s00338-013-1018-0	82	42	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153066	10.1371/journal.pone.0153066	http://dx.doi.org/10.1371/journal.pone.0153066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111085	gold, Green Submitted, Green Published			2022-12-26	WOS:000374970600009
J	Cong, XM; Xu, WL; Janton, S; Henderson, WA; Matson, A; McGrath, JM; Maas, K; Graf, J				Cong, Xiaomei; Xu, Wanli; Janton, Susan; Henderson, Wendy A.; Matson, Adam; McGrath, Jacqueline M.; Maas, Kendra; Graf, Joerg			Gut Microbiome Developmental Patterns in Early Life of Preterm Infants: Impacts of Feeding and Gender	PLOS ONE			English	Article							NEONATAL RESEARCH NETWORK; NECROTIZING ENTEROCOLITIS; INTESTINAL MICROBIOTA; MILK OLIGOSACCHARIDES; OUTCOMES; AUTOIMMUNITY; LACTATION; DIVERSITY; INFECTION; SEVERITY	Gut microbiota plays a key role in multiple aspects of human health and disease, particularly in early life. Distortions of the gut microbiota have been found to correlate with fatal diseases in preterm infants, however, developmental patterns of gut microbiome and factors affecting the colonization progress in preterm infants remain unclear. The purpose of this prospective longitudinal study was to explore day-to-day gut microbiome patterns in preterm infants during their first 30 days of life in the neonatal intensive care unit (NICU) and investigate potential factors related to the development of the infant gut microbiome. A total of 378 stool samples were collected daily from 29 stable/healthy preterm infants. DNA extracted from stool was used to sequence the V4 region of the 16S rRNA gene region for community analysis. Operational taxonomic units (OTUs) and alpha-diversity of the community were determined using QIIME software. Proteobacteria was the most abundant phylum, accounting for 54.3% of the total reads. Result showed shift patterns of increasing Clostridium and Bacteroides, and decreasing Staphylococcus and Haemophilus over time during early life. Alpha-diversity significantly increased daily in preterm infants after birth and linear mixe-deffects models showed that postnatal days, feeding types and gender were associated with the a-diversity, p< 0.05-0.01. Male infants were found to begin with a low a-diversity, whereas females tended to have a higher diversity shortly after birth. Female infants were more likely to have higher abundance of Clostridiates, and lower abundance of Enterobacteriales than males during early life. Infants fed mother's own breastmilk (MBM) had a higher diversity of gut microbiome and significantly higher abundance in Clostridiales and Lactobacillales than infants fed non-MBM. Permanova also showed that bacterial compositions were different between males and females and between MBM and non-MBM feeding types. In conclusion, infant postnatal age, gender and feeding type significantly contribute to the dynamic development of the gut microbiome in preterm infants.	[Cong, Xiaomei; Xu, Wanli; McGrath, Jacqueline M.] Univ Connecticut, Sch Nursing, Storrs, CT USA; [Cong, Xiaomei; Graf, Joerg] Univ Connecticut, Inst Syst Genom, Farmington, CT USA; [Janton, Susan; Graf, Joerg] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Henderson, Wendy A.] NINR, Digest Disorders Unit, Biobehav Branch, NIH, Bethesda, MD 20892 USA; [Matson, Adam; McGrath, Jacqueline M.] Connecticut Childrens Med Ctr, Hartford, CT USA; [Maas, Kendra] Univ Connecticut, Microbial Anal Resources & Serv, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); Connecticut Children's Medical Center; University of Connecticut	Cong, XM (corresponding author), Univ Connecticut, Sch Nursing, Storrs, CT USA.; Cong, XM (corresponding author), Univ Connecticut, Inst Syst Genom, Farmington, CT USA.	xiaomei.cong@uconn.edu	Henderson, Wendy A./F-1171-2018; Graf, Joerg/ABI-2447-2020	Henderson, Wendy A./0000-0003-3924-7118; Graf, Joerg/0000-0001-5320-2712; Matson, Adam/0000-0003-4080-0013; Cong, Xiaomei/0000-0002-4992-199X; McGrath, Jacqueline/0000-0002-1731-7181	National Institute of Nursing Research of the National Institutes of Health (NIH-NINR) [K23NR014674]; Affinity Research Collaboratives award through University of Connecticut Institute for Systems Genomics; NATIONAL INSTITUTE OF NURSING RESEARCH [K23NR014674, ZIANR000018] Funding Source: NIH RePORTER	National Institute of Nursing Research of the National Institutes of Health (NIH-NINR); Affinity Research Collaboratives award through University of Connecticut Institute for Systems Genomics; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This publication was supported by the National Institute of Nursing Research of the National Institutes of Health (NIH-NINR) under award number K23NR014674 and Affinity Research Collaboratives award through University of Connecticut Institute for Systems Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleya S, 2012, ANAEROBE; Arboleya S, 2013, ANAEROBE, V19, P9, DOI 10.1016/j.anaerobe.2012.11.001; Arboleya S, 2012, GUT MICROBES, V3, P583, DOI 10.4161/gmic.21942; Arboleya S, 2012, FEMS MICROBIOL ECOL, V79, P763, DOI 10.1111/j.1574-6941.2011.01261.x; Arboleya S, 2011, INT J FOOD MICROBIOL, V149, P28, DOI 10.1016/j.ijfoodmicro.2010.10.036; Aujoulat F, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0325-0; Berrington JE, 2014, CURR OPIN INFECT DIS, V27, P236, DOI 10.1097/QCO.0000000000000061; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Cong X, 2015, ADV NEONATAL CARE; Dinan TG, 2012, PSYCHONEUROENDOCRINO, V37, P1369, DOI 10.1016/j.psyneuen.2012.03.007; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Dominianni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124599; El Aidy S, 2016, ADV EXP MED BIOL, V874, P301, DOI 10.1007/978-3-319-20215-0_15; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; Gabrielli O, 2011, PEDIATRICS, V128, pE1520, DOI 10.1542/peds.2011-1206; Gomez A, 2015, CLIN IMMUNOL, V159, P154, DOI 10.1016/j.clim.2015.04.016; Gritz EC, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00017; Groer MW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-38; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Karunasena E, 2014, APPL ENVIRON MICROB, V80, P4481, DOI 10.1128/AEM.01229-14; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kozyrskyj AL, 2015, J DEV ORIG HLTH DIS, P1; LaTuga MS, 2014, SEMIN REPROD MED, V32, P68, DOI 10.1055/s-0033-1361824; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; McMurtry VE, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0075-8; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Nelson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094249; Poroyko V, 2011, NUTR HOSP, V26, P1283, DOI [10.3305/nh.2011.26.6.5362, 10.1590/S0212-16112011000600015]; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; Rouge C, 2010, ANAEROBE, V16, P362, DOI 10.1016/j.anaerobe.2010.06.002; Shastri P, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0031-0; Sherman MP, 2015, PEDIATR RES, V77, P127, DOI 10.1038/pr.2014.161; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Underwood M. A, 2015, PEDIATR RES; Unger S, 2015, PEDIATR RES, V77, P205, DOI 10.1038/pr.2014.162; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Yu ZT, 2013, GLYCOBIOLOGY, V23, P1281, DOI 10.1093/glycob/cwt065; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zhou YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118632	50	118	123	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152751	10.1371/journal.pone.0152751	http://dx.doi.org/10.1371/journal.pone.0152751			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111847	gold, Green Published			2022-12-26	WOS:000374970600005
J	Sei, H; Oshima, T; Shan, J; Wu, LP; Yamasaki, T; Okugawa, T; Kondo, T; Tomita, T; Fukui, H; Watari, J; Miwa, H				Sei, Hiroo; Oshima, Tadayuki; Shan, Jing; Wu, Liping; Yamasaki, Takahisa; Okugawa, Takuya; Kondo, Takashi; Tomita, Toshihiko; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto			Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; PROTON-PUMP INHIBITORS; FACTOR-KAPPA-B; INTERLEUKIN-8 EXPRESSION; INTERCELLULAR SPACES; DIAGNOSTIC-VALUE; CYTOKINE IL-33; ACID; GERD; HISTOLOGY	Background Interleukin-33 (IL-33) is a tissue-derived cytokine that is constitutively expressed in epithelial cells of tissues exposed to the environment and plays a role in sensing damage caused by inflammatory diseases. IL-33 acts as both a traditional cytokine and as a chromatin-associated nuclear factor in both innate and adaptive immunity. We recently showed that IL-33 in esophageal mucosa is upregulated in reflux esophagitis. However, IL-33 expression in patients with heartburn without mucosal injury and its relationship with intercellular space (ICS) have never been examined. We therefore examined the expression of cytokines and ICS in patients with heartburn. Methods The expression of IL-33 in the middle and distal esophageal mucosa of patients with heartburn without mucosal break and control samples was examined using real-time RT-PCR and immunofluorescence. The mRNA expression of IL-6, IL-8, MCP-1, and RANTES, and ICS was also analyzed. Results IL-33 expression and the mean ICS were significantly increased in the mucosa of patients with heartburn compared to that of the control. IL-33 and ICS were not different between the patients who were taking a PPI and those who were not. The upregulated IL-33 expression in the heartburn group was located in the nuclei of the basal cell layer. Although IL-6, IL-8, MCP-1 and RANTES levels were not different between control and patients with heartburn samples, IL-33 mRNA levels were still significantly correlated with IL-6, IL-8, or MCP-1 mRNA levels. Conclusion Nuclear IL-33 is upregulated in patients with heartburn. Upregulated IL-33 in heartburn patients is related to the symptoms.	[Sei, Hiroo; Oshima, Tadayuki; Shan, Jing; Wu, Liping; Yamasaki, Takahisa; Okugawa, Takuya; Kondo, Takashi; Tomita, Toshihiko; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto] Hyogo Coll Med, Div Gastroenterol, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Shan, Jing; Wu, Liping] Third Peoples Hosp Chengdu, Depertment Gastroenterol, Chengdu, Peoples R China	Hyogo College of Medicine	Oshima, T (corresponding author), Hyogo Coll Med, Div Gastroenterol, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan.	t-oshima@hyo-med.ac.jp		Yamasaki, Takahisa/0000-0002-0679-2147	Japan Society for the Promotion of Science (JSPS) [25460939]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) (25460939 to TO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Altomare A, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01963.x; Arul P, 2014, MALAYS J PATHOL, V36, P181; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Balato A, 2014, ARCH DERMATOL RES, V306, P299, DOI 10.1007/s00403-014-1447-9; Bytzer P, 2012, CLIN GASTROENTEROL H, V10, P1360, DOI 10.1016/j.cgh.2012.06.030; Calabrese C, 2005, AM J GASTROENTEROL, V100, P537, DOI 10.1111/j.1572-0241.2005.40476.x; Caviglia R, 2007, ALIMENT PHARM THER, V25, P629, DOI 10.1111/j.1365-2036.2006.03237.x; Cui R, 2011, DIS ESOPHAGUS, V24, P1, DOI 10.1111/j.1442-2050.2010.01083.x; Dent J, 2007, CLIN GASTROENTEROL H, V5, P4, DOI 10.1016/j.cgh.2006.08.006; Farre R, 2010, GUT, V59, P164, DOI 10.1136/gut.2009.194191; Fiocca R, 2010, AM J GASTROENTEROL, V105, P1015, DOI 10.1038/ajg.2009.631; Fujiwara Y, 2012, INTERNAL MED, V51, P3235, DOI 10.2169/internalmedicine.51.8670; Hershcovici T, 2010, CURR OPIN GASTROEN, V26, P367, DOI 10.1097/MOG.0b013e32833ae2be; Huo XF, 2014, GUT, V63, P1042, DOI 10.1136/gutjnl-2013-305533; Isomoto H, 2004, AM J GASTROENTEROL, V99, P589, DOI 10.1111/j.1572-0241.2004.04110.x; Isomoto H, 2003, AM J GASTROENTEROL, V98, P551, DOI 10.1016/S0002-9270(02)06025-2; Kahrilas PJ, 2015, NEUROGASTROENT MOTIL, V27, P1195, DOI 10.1111/nmo.12644; Kandulski A, 2013, ALIMENT PHARM THER, V38, P643, DOI 10.1111/apt.12428; Knowles CH, 2008, GUT, V57, P674, DOI 10.1136/gut.2007.127886; Kondo T, 2015, CLIN GASTROENTEROL H, V13, P1249, DOI 10.1016/j.cgh.2015.01.014; Krugmann J, 2013, BEST PRACT RES CL GA, V27, P373, DOI 10.1016/j.bpg.2013.06.010; Kusano M, 2015, J GASTROENTEROL, V50, P298, DOI 10.1007/s00535-014-0972-9; Lin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060963; Miwa H, 2013, J GASTROEN HEPATOL, V28, P479, DOI 10.1111/j.1440-1746.2012.07266.x; Miwa Hiroto, 2010, J Neurogastroenterol Motil, V16, P353, DOI 10.5056/jnm.2010.16.4.353; Miwa H, 2008, CLIN J GASTROENTEROL, V1, P133, DOI 10.1007/s12328-008-0039-7; Miwa H, 2010, J GASTROENTEROL, V45, P478, DOI 10.1007/s00535-009-0180-1; Monkemuller K, 2009, DIGESTION, V79, P186, DOI 10.1159/000211714; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Numans ME, 2004, ANN INTERN MED, V140, P518, DOI 10.7326/0003-4819-140-7-200404060-00011; Oh DS, 2007, ARCH SURG-CHICAGO, V142, P554, DOI 10.1001/archsurg.142.6.554; Schindlbeck NE, 1996, GUT, V39, P151, DOI 10.1136/gut.39.2.151; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seidelin JB, 2015, J GASTROENTEROL, V50, P180, DOI 10.1007/s00535-014-0982-7; Shan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151701; Shan J, 2015, J GASTROENTEROL, V50, P414, DOI 10.1007/s00535-014-0988-1; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Tominaga K, 2014, J GASTROENTEROL, V49, P1392, DOI 10.1007/s00535-013-0896-9; Wu LP, 2015, AM J PHYSIOL-GASTR L, V309, pG695, DOI 10.1152/ajpgi.00162.2015; Yoshida N, 2004, SCAND J GASTROENTERO, V39, P816, DOI 10.1080/00365520410006729; Yoshida N, 2007, J CLIN BIOCHEM NUTR, V40, P13, DOI 10.3164/jcbn.40.13; Zentilin P, 2005, AM J GASTROENTEROL, V100, P2299, DOI 10.1111/j.1572-0241.2005.50209.x; Zhong CJ, 2013, J GASTROENTEROL, V48, P601, DOI 10.1007/s00535-012-0689-6	44	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154234	10.1371/journal.pone.0154234	http://dx.doi.org/10.1371/journal.pone.0154234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111066	gold, Green Published			2022-12-26	WOS:000374970600052
J	Klapper, R; Kochmann, J; O'Hara, RB; Karl, H; Kuhn, T				Klapper, Regina; Kochmann, Judith; O'Hara, Robert B.; Karl, Horst; Kuhn, Thomas			Parasites as Biological Tags for Stock Discrimination of Beaked Redfish (Sebastes mentella): Parasite Infra-Communities vs. Limited Resolution of Cytochrome Markers	PLOS ONE			English	Article							MACKEREL TRACHURUS-TRACHURUS; ATLANTIC HORSE MACKEREL; DEEP-WATER REDFISH; GENETIC-STRUCTURE; ANISAKIS SPP.; TAXONOMIC DISTINCTNESS; HOLISTIC APPROACH; MEDITERRANEAN SEA; NORTH-ATLANTIC; HOST	The use of parasites as biological tags for discrimination of fish stocks has become a commonly used approach in fisheries management. Metazoan parasite community analysis and anisakid nematode population genetics based on a mitochondrial cytochrome marker were applied in order to assess the usefulness of the two parasitological methods for stock discrimination of beaked redfish Sebastes mentella of three fishing grounds in the North East Atlantic. Multivariate, model-based approaches demonstrated that the metazoan parasite fauna of beaked redfish from East Greenland differed from Tampen, northern North Sea, and Bear Island, Barents Sea. A joint model (latent variable model) was used to estimate the effects of covariates on parasite species and identified four parasite species as main source of differences among fishing grounds; namely Chondracanthus nodosus, Anisakis simplex s.s., Hysterothylacium aduncum, and Bothriocephalus scorpii. Due to its high abundance and differences between fishing grounds, Anisakis simplex s.s. was considered as a major biological tag for host stock differentiation. Whilst the sole examination of Anisakis simplex s.s. on a population genetic level is only of limited use, anisakid nematodes (in particular, A. simplex s.s.) can serve as biological tags on a parasite community level. This study confirmed the use of multivariate analyses as a tool to evaluate parasite infra-communities and to identify parasite species that might serve as biological tags. The present study suggests that S. mentella in the northern North Sea and Barents Sea is not sub-structured.	[Klapper, Regina; Karl, Horst] Max Rubner Inst, Dept Safety & Qual Milk & Fish Prod, Fed Res Inst Nutr & Food, Hamburg, Germany; [Klapper, Regina; Kochmann, Judith; Kuhn, Thomas] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60054 Frankfurt, Germany; [Klapper, Regina; Kochmann, Judith; O'Hara, Robert B.; Kuhn, Thomas] Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Klapper, R (corresponding author), Max Rubner Inst, Dept Safety & Qual Milk & Fish Prod, Fed Res Inst Nutr & Food, Hamburg, Germany.; Klapper, R (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60054 Frankfurt, Germany.; Klapper, R (corresponding author), Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany.	R.Klapper@em.uni-frankfurt.de	O'Hara, Bob/A-7499-2008; Kochmann, Judith/AAG-3574-2021	O'Hara, Bob/0000-0001-9737-3724; Kochmann, Judith/0000-0001-6312-7859	Goethe University Frankfurt/Main, Institute of Ecology, Evolution and Diversity	Goethe University Frankfurt/Main, Institute of Ecology, Evolution and Diversity	This work was supported by the Goethe University Frankfurt/Main, Institute of Ecology, Evolution and Diversity. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaunza P, 2008, FISH RES, V89, P196, DOI 10.1016/j.fishres.2007.09.022; Abaunza P, 2008, FISH RES, V89, P104, DOI 10.1016/j.fishres.2007.09.020; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Bakay Yu. I., 2011, Journal of Ichthyology, V51, P90, DOI 10.1134/S0032945211010036; Baldwin RE, 2011, J PARASITOL, V97, P545, DOI 10.1645/GE-2690.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017; Begg GA, 1999, FISH RES, V43, P1, DOI 10.1016/S0165-7836(99)00062-4; Begg GA, 1999, FISH RES, V43, P35, DOI 10.1016/S0165-7836(99)00065-X; Blasco-Costa I, 2012, MOL ECOL, V21, P207, DOI 10.1111/j.1365-294X.2011.05374.x; Blazekovic K, 2015, INT J PARASITOL, V45, P17, DOI 10.1016/j.ijpara.2014.07.012; BLOUIN MS, 1995, GENETICS, V141, P1007; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Cadrin SX, 2010, ICES J MAR SCI, V67, P1617, DOI 10.1093/icesjms/fsq046; Catalano Sarah R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P220, DOI 10.1016/j.ijppaw.2013.11.001; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Criscione CD, 2006, ECOLOGY, V87, P823, DOI 10.1890/0012-9658(2006)87[823:PGISPO]2.0.CO;2; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Cross MA, 2007, MAR BIOL, V151, P695, DOI 10.1007/s00227-006-0509-8; Ellingsen KE, 2005, J ANIM ECOL, V74, P1069, DOI 10.1111/j.1365-2656.2005.01004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Froese R., 2015, FISHBASE; FU YX, 1993, GENETICS, V133, P693; Gibson DI, 2005, KEYS TREMATODA; Gonzalez C., 2000, Northwest Atlantic Fisheries Organization Scientific Council Studies, V33, P89; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herrington WC, 1939, 5 US BUR FISH; Hui FK, 2016, METHODS ECOL EVOL; ICES C, 2009, WORKSH REDF STOCK ST, P67; Jones A., 2005, KEYS TREMATODA, V2; KARL H, 1993, ARCH LEBENSMITTELHYG, V44, P124; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Khalil LF, 1994, KEYS CESTODE PARASIT; Klapper R, 2015, VET PARASITOL, V207, P72, DOI 10.1016/j.vetpar.2014.11.017; Klimpel S, 2004, PARASITOL RES, V94, P1, DOI 10.1007/s00436-004-1154-0; Klimpel Sven, 2009, Bulletin of Fish Biology, V10, P25; Kuhn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028642; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Love M. S., 2002, ROCKFISHES NE PACIFI; Luque JL, 2008, J FISH BIOL, V72, P189, DOI 10.1111/j.1095-8649.2007.01695.x; Luque JL, 2004, PARASITOLOGY, V128, P671, DOI 10.1017/S0031182004005050; MacKenzie K, 2008, FISH RES, V89, P136, DOI 10.1016/j.fishres.2007.09.031; Mackenzie K, 2015, PARASITOLOGY, V142, P54, DOI 10.1017/S0031182014000341; MacKenzie K, 2002, PARASITOLOGY, V124, pS153, DOI 10.1017/S0031182002001518; MACKENZIE K, 1987, INT J PARASITOL, V17, P345, DOI 10.1016/0020-7519(87)90109-3; MacKenzie K, 1998, FISH RES, V38, P45, DOI 10.1016/S0165-7836(98)00116-7; Magnusson J, 1996, J FISH BIOL, V49, P182, DOI 10.1111/j.1095-8649.1996.tb06075.x; Magurran A.E, 1988, ECOLOGICAL DIVERSITY, DOI DOI 10.1007/978-94-015-7358-0_4; Marcogliese DJ, 2015, PARASITOLOGY, V142, P68, DOI 10.1017/S0031182014000110; Marcogliese DJ, 2003, FISH B-NOAA, V101, P183; Mattiucci S, 2008, FISH RES, V89, P146, DOI 10.1016/j.fishres.2007.09.032; Mattiucci S, 2015, PARASITOLOGY, V142, P90, DOI 10.1017/S0031182014001103; Mattiucci S, 2008, ADV PARASIT, V66, P47, DOI 10.1016/S0065-308X(08)00202-9; Mes THM, 2003, MOL ECOL, V12, P1555, DOI 10.1046/j.1365-294X.2003.01846.x; Mladineo I, 2014, APPL ENVIRON MICROB, V80, P1281, DOI 10.1128/AEM.03561-13; Mladineo I, 2010, VET PARASITOL, V174, P131, DOI 10.1016/j.vetpar.2010.08.015; Moran JDW, 1996, CAN J FISH AQUAT SCI, V53, P1821, DOI 10.1139/cjfas-53-8-1821; MULVEY M, 1991, EVOLUTION, V45, P1628, DOI [10.2307/2409784, 10.1111/j.1558-5646.1991.tb02668.x]; Munster J, 2015, PARASITOL RES, V114, P2723, DOI 10.1007/s00436-015-4479-y; Nadler SA, 2000, J PARASITOL, V86, P380, DOI 10.1645/0022-3395(2000)086[0380:POTANA]2.0.CO;2; Oliva ME, 2005, FISH RES, V71, P71, DOI 10.1016/j.fishres.2004.07.009; Petursdottir H, 2008, DEEP-SEA RES PT II, V55, P83, DOI 10.1016/j.dsr2.2007.09.003; Planque B, 2013, AQUAT LIVING RESOUR, V26, P293, DOI 10.1051/alr/2013062; Poulin R, 2015, PARASITOLOGY, V142, P145, DOI 10.1017/S0031182013001534; Roques S, 2002, MAR BIOL, V140, P297, DOI 10.1007/s002270100705; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLEMAN W, 1960, J FISH RES BOARD CAN, V17, P9, DOI 10.1139/f60-002; Templeman W, 1959, REDFISH DISTRIBUTION; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Williams H.H., 1992, Reviews in Fish Biology and Fisheries, V2, P144, DOI 10.1007/BF00042882; WILLIAMS IC, 1963, PARASITOLOGY, V53, P501, DOI 10.1017/S0031182000073959	75	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153964	10.1371/journal.pone.0153964	http://dx.doi.org/10.1371/journal.pone.0153964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104735	gold, Green Published, Green Submitted			2022-12-26	WOS:000374565100031
J	Ng, TM; Khong, WX; Harris, PNA; De, PP; Chow, A; Tambyah, PA; Lye, DC				Ng, Tat Ming; Khong, Wendy X.; Harris, Patrick N. A.; De, Partha P.; Chow, Angela; Tambyah, Paul A.; Lye, David C.			Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; RESISTANT ENTEROBACTERIACEAE; NOSOCOMIAL INFECTIONS; ANTIMICROBIAL THERAPY; RISK-FACTORS; SPREAD; PREVALENCE; ORGANISMS	Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are a common cause of bacteraemia in endemic countries and may be associated with high mortality; carbapenems are considered the drug of choice. Limited data suggest piperacillin-tazobactam could be equally effective. We aimed to compare 30-day mortality of patients treated empirically with piperacillin-tazobactam versus a carbapenem in a multi-centre retrospective cohort study in Singapore. Only patients with active empiric monotherapy with piperacillin-tazobactam or a carbapenem were included. A propensity score for empiric carbapenem therapy was derived and an adjusted multivariate analysis of mortality was conducted. A total of 394 patients had ESBL-Escherichia. coli and ESBL-Klebsiella pneumoniae bacteraemia of which 23.1% were community acquired cases. One hundred and fifty-one received initial active monotherapy comprising piperacillin-tazobactam (n = 94) or a carbapenem (n = 57). Patients who received carbapenems were less likely to have health-care associated risk factors and have an unknown source of bacteraemia, but were more likely to have a urinary source. Thirty-day mortality was comparable between those who received empiric piperacillin-tazobactam and a carbapenem (29 [30.9%] vs. 17 [29.8%]), P = 0.89). Those who received empiric piperacillin-tazobactam had a lower 30-day acquisition of multi-drug resistant and fungal infections (7 [7.4%] vs. 14 [24.6%]), P<0.01). After adjusting for con-founders, use of empiric piperacillin-tazobactam was not associated with increased 30-day mortality (OR 1.00, 95% CI; 0.45-2.17). Empiric piperacillin-tazobactam was not associated with increased 30-day mortality and may result in fewer multi-drug resistant and fungal infections when compared with a carbapenem.	[Ng, Tat Ming; Khong, Wendy X.] Tan Tock Seng Hosp, Dept Pharm, Singapore, Singapore; [Harris, Patrick N. A.] Natl Univ Singapore Hosp, Univ Med Cluster, Div Infect Dis, Singapore 117548, Singapore; [Harris, Patrick N. A.; Lye, David C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Harris, Patrick N. A.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [De, Partha P.] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore; [Chow, Angela] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Clin Epidemiol, Singapore, Singapore; [Chow, Angela] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Tambyah, Paul A.] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Lye, David C.] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Infect Dis, Singapore, Singapore	Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; University of Queensland; Tan Tock Seng Hospital; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Tan Tock Seng Hospital	Ng, TM (corresponding author), Tan Tock Seng Hosp, Dept Pharm, Singapore, Singapore.	ngtatming@gmail.com	Harris, Patrick/P-3813-2014; Lye, David/ABF-4402-2021; Ng, Tat Ming/AAI-3040-2021	Harris, Patrick/0000-0002-2895-0345; Lye, David/0000-0003-0324-0205; ng, tat ming/0000-0002-4570-3266; Chow, Angela/0000-0002-4063-736X				Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chaubey Vikas P, 2010, BMC Res Notes, V3, P116, DOI 10.1186/1756-0500-3-116; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Harris PNA, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0541-9; Hsu LY, 2007, EMERG INFECT DIS, V13, P1944, DOI 10.3201/eid1312.070299; Kang CI, 2012, J INFECTION, V64, P533, DOI 10.1016/j.jinf.2012.01.008; Kang CI, 2004, ANTIMICROB AGENTS CH, V48, P4574, DOI 10.1128/AAC.48.12.4574-4581.2004; Kanj SS, 2011, MAYO CLIN PROC, V86, P250, DOI 10.4065/mcp.2010.0674; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Leibovici L, 1998, J INTERN MED, V244, P379; Lopez-Cerero L, 2010, CLIN MICROBIOL INFEC, V16, P132, DOI 10.1111/j.1469-0691.2009.02893.x; Melzer M, 2007, J INFECTION, V55, P254, DOI 10.1016/j.jinf.2007.04.007; Nguyen HM, 2014, J ANTIMICROB CHEMOTH, V69, P871, DOI 10.1093/jac/dkt450; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Ofer-Friedman H, 2015, INFECT CONT HOSP EP, V36, P981, DOI 10.1017/ice.2015.101; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Paterson DL, 2004, CLIN INFECT DIS, V39, P31, DOI 10.1086/420816; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Rodriguez-Bano J, 2012, CLIN INFECT DIS, V54, P167, DOI 10.1093/cid/cir790; Rogers BA, 2011, CLIN INFECT DIS, V53, P49, DOI 10.1093/cid/cir273; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Tamma PD, 2015, CLIN INFECT DIS, V60, P1319, DOI 10.1093/cid/civ003; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Yang K, 2007, ANN PHARMACOTHER, V41, P1427, DOI 10.1345/aph.1K213; Young BE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-298	32	78	83	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153696	10.1371/journal.pone.0153696	http://dx.doi.org/10.1371/journal.pone.0153696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104951	gold, Green Published, Green Submitted			2022-12-26	WOS:000374565100015
J	Park, HS; Lim, SM; Kim, S; Kim, S; Kim, HR; Kwack, K; Lee, MG; Kim, JH; Moon, YW				Park, Hyung Soon; Lim, Sun Min; Kim, Sora; Kim, Sangwoo; Kim, Hye Ryun; Kwack, KyuBum; Lee, Min Goo; Kim, Joo-Hang; Moon, Yong Wha			Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution	PLOS ONE			English	Article							CELL LUNG-CANCER; PRECISION MEDICINE; CLINICAL-TRIALS; MUTATIONS; KINASE; SORAFENIB; SHIVA	We evaluated the preliminary efficacy and feasibility of a next-generation sequencing (NGS)based targeted anticancer therapy in refractory solid tumors at a Korean institution. Thirty-six patients with advanced cancer underwent molecular profiling with NGS with the intent of clinical application of available matched targeted agents. Formalin-fixed paraffin-embedded (FFPE) tumors were sequenced using the Comprehensive Cancer Panel (CCP) or FoundationOne in the Clinical Laboratory Improvement Amendments-certified laboratory in the USA. Response evaluations were performed according to RECIST v1.1. Four specimens did not pass the DNA quality test and 32 specimens were successfully sequenced with CCP (n = 31) and FoundationOne (n = 1). Of the 32 sequenced patients, 10 (31.3%) were <= 40 years. Twelve patients (37.5%) had received <= 3 types of prior systemic therapies. Of 24 patients with actionable mutations, five were given genotype-matched drugs corresponding to actionable mutations: everolimus to PIK3CA mutation in parotid carcinosarcoma (partial response) and tracheal squamous cell carcinoma (stable disease; 21% reduction), sorafenib to PDGFRA mutation in auditory canal adenocarcinoma (partial response), sorafenib to BRAF mutation in microcytic adnexal carcinoma (progressive disease), and afatinib to ERBB2 mutation in esophageal adenocarcinoma (progressive disease). Nineteen of 24 patients with actionable mutations could not undergo targeted therapy based on genomic testing because of declining performance status (10/24, 41.7%), stable disease with previous treatment (5/24, 20.8%), and lack of access to targeted medication (4/24, 16.7%). NGS-based targeted therapy may be a good option in selected patients with refractory solid tumors. To pursue this strategy in Korea, lack of access to clinical-grade NGS assays and a limited number of genotype-matched targeted medications needs to be addressed and resolved.	[Park, Hyung Soon; Lee, Min Goo] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Park, Hyung Soon; Kim, Sora; Kim, Sangwoo; Lee, Min Goo] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Seoul, South Korea; [Park, Hyung Soon; Kim, Hye Ryun] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea; [Lim, Sun Min; Kim, Joo-Hang; Moon, Yong Wha] CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Med Oncol, Songnam, South Korea; [Kim, Sora; Kim, Sangwoo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kwack, KyuBum] CHA Univ, Dept Biomed Sci, Coll Life Sci, Songnam, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; Pochon Cha University	Moon, YW (corresponding author), CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Med Oncol, Songnam, South Korea.	ymoon@cha.ac.kr	Lee, Min Goo/D-5635-2012; Lee, Min Goo/AAS-4636-2020	Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X; Kim, Sangwoo/0000-0001-5356-0827; Kim, Hye Ryun/0000-0002-1842-9070				1000 Genomes Project Consortium, 2012, Nature, V491, P56, DOI 10.1038/nature11632; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Jardim DLF, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv253; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gronych J, 2011, J CLIN INVEST, V121, P1344, DOI 10.1172/JCI44656; Heinrich MC, 2012, MOL CANCER THER, V11, P1770, DOI 10.1158/1535-7163.MCT-12-0223; Herter-Sprie GS, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00086; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Janku F, 2014, CELL REP, V6, P377, DOI 10.1016/j.celrep.2013.12.035; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Janku F, 2012, CLIN CANCER RES, V18, P6356, DOI 10.1158/1078-0432.CCR-12-0178; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; Lee KS, 2015, CANCER RES TREAT, V47, P387, DOI 10.4143/crt.2014.001; Munoz Javier, 2013, Am Soc Clin Oncol Educ Book, P127, DOI 10.1200/EdBook_AM.2013.33.127; Pant S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00078; Parkinson DR, 2012, CLIN CANCER RES, V18, P619, DOI 10.1158/1078-0432.CCR-11-2017; Prat A, 2008, NAT CLIN PRACT ONCOL, V5, P531, DOI 10.1038/ncponc1179; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Roubaud G, 2012, ANN ONCOL, V23, P804, DOI 10.1093/annonc/mdr631; Schwaederle M, 2015, J CLIN ONCOL, V33, P3817, DOI 10.1200/JCO.2015.61.5997; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh RR, 2014, BRIT J CANCER, V111, P2014, DOI 10.1038/bjc.2014.518; Skinner MA, 2003, ANTICANCER RES, V23, P3601; Tsimberidou AM, 2015, LANCET ONCOL, V16, pE579, DOI 10.1016/S1470-2045(15)00397-6; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LH, 2014, NATURE, V511, P241, DOI 10.1038/nature13296; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287	36	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154133	10.1371/journal.pone.0154133	http://dx.doi.org/10.1371/journal.pone.0154133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105424	Green Submitted, gold, Green Published			2022-12-26	WOS:000374565100046
J	Rappaport, SM				Rappaport, Stephen M.			Genetic Factors Are Not the Major Causes of Chronic Diseases	PLOS ONE			English	Article							GLOBAL BURDEN; ENVIRONMENTAL-INFLUENCES; HEART-DISEASE; RISK-FACTORS; CANCER-RISK; FOLLOW-UP; HERITABILITY; SWEDISH; TWIN; METABOLISM	The risk of acquiring a chronic disease is influenced by a person's genetics (G) and exposures received during life (the 'exposome', E) plus their interactions (GxE). Yet, investigators use genome-wide association studies (GWAS) to characterize G while relying on self-reported information to classify E. If E and GxE dominate disease risks, this imbalance obscures important causal factors. To estimate proportions of disease risk attributable to G (plus shared exposures), published data from Western European monozygotic (MZ) twins were used to estimate population attributable fractions (PAFs) for 28 chronic diseases. Genetic PAFs ranged from 3.4% for leukemia to 48.6% for asthma with a median value of 18.5%. Cancers had the lowest PAFs (median = 8.26%) while neurological (median = 26.1%) and lung (median = 33.6%) diseases had the highest PAFs. These PAFs were then linked with Western European mortality statistics to estimate deaths attributable to G for heart disease and nine cancer types. Of 1.53 million Western European deaths in 2000, 0.25 million (16.4%) could be attributed to genetics plus shared exposures. Given the modest influences of G-related factors on the risks of chronic diseases in MZ twins, the disparity in coverage of G and E in etiological research is problematic. To discover causes of disease, GWAS should be complemented with exposome-wide association studies (EWAS) that profile chemicals in biospecimens from incident disease cases and matched controls.	[Rappaport, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rappaport, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	srappaport@berkeley.edu			National Institute for Environmental Health Sciences [P42ES05948, P42ES0470518]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705, P42ES005948] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Partial funding was received from grants P42ES05948 and P42ES0470518 from the National Institute for Environmental Health Sciences.	Algovik M, 2004, ACTA OBSTET GYN SCAN, V83, P832, DOI 10.1111/j.0001-6349.2004.00544.x; Altman D, 2008, EUR UROL, V54, P918, DOI 10.1016/j.eururo.2007.12.004; Bae S, 2014, CANCER RES, V74, P7442, DOI 10.1158/0008-5472.CAN-14-1835; Bak S, 2002, STROKE, V33, P769, DOI 10.1161/hs0302.103619; Bengtson MB, 2006, GUT, V55, P1754, DOI 10.1136/gut.2006.097287; Cameron AJ, 2002, GASTROENTEROLOGY, V122, P55, DOI 10.1053/gast.2002.30301; Chakravarti A, 2003, NATURE, V421, P412, DOI 10.1038/nature01401; Chang CQ, 2014, EUR J HUM GENET, V22, P402, DOI 10.1038/ejhg.2013.161; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Gannett L, 1999, BIOL PHILOS, V14, P349, DOI 10.1023/A:1006583215835; Gatz M, 1997, J GERONTOL A-BIOL, V52, pM117, DOI 10.1093/gerona/52A.2.M117; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Haga SB, 2003, NAT GENET, V34, P347, DOI 10.1038/ng0803-347; Hansen PS, 2006, EUR J ENDOCRINOL, V154, P29, DOI 10.1530/eje.1.02060; Hemminki K, 2002, CANCER EPIDEM BIOMAR, V11, P1638; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Ingebrigtsen T, 2010, RESP MED, V104, P1890, DOI 10.1016/j.rmed.2010.05.004; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Mulder EJ, 2003, TWIN RES, V6, P422, DOI 10.1375/twin.6.5.422; Rappaport SM, 2014, ENVIRON HEALTH PERSP, V122, P769, DOI 10.1289/ehp.1308015; Rappaport SM, 2012, BIOMARKERS, V17, P483, DOI 10.3109/1354750X.2012.691553; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Roberts NJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003380; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Sullivan PF, 2005, PSYCHOL MED, V35, P1327, DOI 10.1017/S0033291705005222; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Thomsen SF, 2010, CLIN EXP ALLERGY, V40, P1054, DOI 10.1111/j.1365-2222.2010.03525.x; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Vineis P, 2006, ANN NY ACAD SCI, V1076, P163, DOI 10.1196/annals.1371.060; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wild CP, 2013, ENVIRON MOL MUTAGEN, V54, P480, DOI 10.1002/em.21777; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Wirdefeldt K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.02.017; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x	45	120	123	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154387	10.1371/journal.pone.0154387	http://dx.doi.org/10.1371/journal.pone.0154387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105432	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100073
J	Chang, ZH; Liu, Y; Dong, H; Teng, K; Han, LB; Zhang, XZ				Chang, Zhihui; Liu, Yang; Dong, Hui; Teng, Ke; Han, Liebao; Zhang, Xunzhong			Effects of Cytokinin and Nitrogen on Drought Tolerance of Creeping Bentgrass	PLOS ONE			English	Article							CELL-MEMBRANE STABILITY; TALL FESCUE CULTIVARS; HEAT-STRESS; ANTIOXIDANT ENZYMES; KENTUCKY BLUEGRASS; HORMONE METABOLISM; LIPID-PEROXIDATION; OXIDATIVE DAMAGE; GENE-EXPRESSION; ABSCISIC-ACID	Cytokinin (CK) is a vital plant hormone that controls many aspects of growth and development in plants. Nitrogen (N) is the indispensable macronutrient needed in plants and also one of the most important limiting factors for plant growth. This study was designed to investigate the simultaneous effects of CK and N on the visual turf quality and antioxidant metabolism of drought-stressed creeping bentgrass (Agrostis stolonifera L.). 'PennA-4' creeping bentgrass treated with trans-zeatin riboside at three rates of CK concentrations of 0, 10 and 100 mu M (designated by CK0, 10, and 100) and two nitrogen rates with 2.5 and 7.5 kg N.ha(-1) every 15 days (designated by low and high N) in a complete factorial arrangement was grown under two soil moisture regimes: well-watered and drought stress. Exogenous CK improved turf quality and delayed leaf wilting under drought stress, especially under high N. The grasses treated with CK10 and CK100 had lower O-2(-) production and H2O2 concentration than those without CK treatment. The CK100 treatment enhanced the activities of superoxide dismutase (SOD), ascorbate peroxidase (APX), catalase (CAT), and guaiacol peroxidase (POD) by 25%, 22%, 17% and 24%, respectively, relative to CK0. Moreover, the activity changes of the antioxidant enzyme isoforms were more significant under high N condition relative to low N condition. Our results demonstrated the beneficial impacts of CK and N on physiological reactions, especially antioxidant metabolism, and foliar application of CK at 10 or 100 muM plus 7.5 kg ha(-1) N biweekly may improve drought stress resistance of creeping bentgrass.	[Chang, Zhihui; Liu, Yang; Dong, Hui; Teng, Ke; Han, Liebao] Beijing Forestry Univ, Coll Forestry, Beijing 100083, Peoples R China; [Zhang, Xunzhong] Virginia Polytech Inst & State Univ, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA	Beijing Forestry University; Virginia Polytechnic Institute & State University	Chang, ZH (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing 100083, Peoples R China.; Zhang, XZ (corresponding author), Virginia Polytech Inst & State Univ, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA.	changzh@bjfu.edu.cn; xuzhang@vt.edu		Teng, Ke/0000-0002-4123-7843	Beijing Higher Education Young Elite Teacher Project [YETP0742]	Beijing Higher Education Young Elite Teacher Project	This study was supported by Beijing Higher Education Young Elite Teacher Project (YETP0742).	Ahmad R, 2014, J PLANT NUTR, V37, P942, DOI 10.1080/01904167.2013.868480; Akram M, 2014, COMMUN SOIL SCI PLAN, V45, P1336, DOI 10.1080/00103624.2013.875199; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BEAUCHAMP CO, 1973, BIOCHIM BIOPHYS ACTA, V317, P50, DOI 10.1016/0005-2795(73)90198-0; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, P735; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Boschma SP, 2015, GRASS FORAGE SCI, V70, P381, DOI 10.1111/gfs.12130; Chai Q, 2010, J AM SOC HORTIC SCI, V135, P125, DOI 10.21273/JASHS.135.2.125; Chance B., 1955, ASSAY CATALASES PERO; Chanda SV, 2003, J PLANT BIOL, V46, P41, DOI 10.1007/BF03030300; Clarke SF, 2002, PHYSIOL PLANTARUM, V114, P157, DOI 10.1034/j.1399-3054.2002.1140201.x; DaCosta M, 2007, J AM SOC HORTIC SCI, V132, P60, DOI 10.21273/JASHS.132.1.60; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; FIELDING JL, 1978, J EXP BOT, V29, P969, DOI 10.1093/jxb/29.4.969; Fu JM, 2003, J PLANT NUTR, V26, P81, DOI 10.1081/PLN-120016498; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; GIDROL X, 1994, EUR J BIOCHEM, V224, P21, DOI 10.1111/j.1432-1033.1994.tb19990.x; Havlova M, 2008, PLANT CELL ENVIRON, V31, P341, DOI 10.1111/j.1365-3040.2007.01766.x; He Xue-li, 2009, Yingyong Shengtai Xuebao, V20, P2118; He YL, 2010, J AM SOC HORTIC SCI, V135, P116, DOI 10.21273/JASHS.135.2.116; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hu LX, 2012, J PLANT PHYSIOL, V169, P146, DOI 10.1016/j.jplph.2011.08.020; Huang BR, 1999, HORTSCIENCE, V34, P897, DOI 10.21273/HORTSCI.34.5.897; Huang JJ, 2011, J PLANT PHYSIOL, V168, P768, DOI 10.1016/j.jplph.2010.10.010; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jiang YW, 2000, CROP SCI, V40, P1358, DOI 10.2135/cropsci2000.4051358x; Jiang YW, 2001, CROP SCI, V41, P436, DOI 10.2135/cropsci2001.412436x; KOCHHAR S, 1979, AM J ENOL VITICULT, V30, P275; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu XH, 2002, CROP SCI, V42, P457, DOI 10.2135/cropsci2002.0457; Liu XH, 2002, CROP SCI, V42, P466, DOI 10.2135/cropsci2002.0466; Lopez-Huertas E, 1999, BIOCHEM J, V337, P531, DOI 10.1042/0264-6021:3370531; Man D, 2011, HORTSCIENCE, V46, P1027, DOI 10.21273/HORTSCI.46.7.1027; Medici LO, 2004, FUNCT PLANT BIOL, V31, P1, DOI 10.1071/FP03130; Pan Y, 2006, PLANT GROWTH REGUL, V49, P157, DOI 10.1007/s10725-006-9101-y; PREMACHANDRA GS, 1990, J AGR SCI-CAMBRIDGE, V115, P63, DOI 10.1017/S0021859600073925; Senthil-Kumar M, 2007, J PLANT PHYSIOL, V164, P111, DOI 10.1016/j.jplph.2006.09.009; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; SKOGQVIST I, 1974, PHYSIOL PLANTARUM, V32, P166, DOI 10.1111/j.1399-3054.1974.tb03746.x; Song XG, 2006, FUNCT PLANT BIOL, V33, P573, DOI 10.1071/FP05232; Srivalli B, 2003, PHYSIOL PLANTARUM, V119, P503, DOI 10.1046/j.1399-3054.2003.00125.x; Wang D, 2008, J INTEGR PLANT BIOL, V50, P1416, DOI 10.1111/j.1744-7909.2008.00748.x; Wang KH, 2007, CROP SCI, V47, P232, DOI 10.2135/cropsci2006.07.0498; Wang KH, 2012, J PLANT PHYSIOL, V169, P492, DOI 10.1016/j.jplph.2011.12.007; Wang KH, 2011, CROP SCI, V51, P2145, DOI 10.2135/cropsci2011.01.0024; WOODBURY W, 1971, ANAL BIOCHEM, V44, P301, DOI 10.1016/0003-2697(71)90375-7; Wu FZ, 2008, ENVIRON EXP BOT, V63, P248, DOI 10.1016/j.envexpbot.2007.11.002; Wu XX, 2015, ENVIRON EXP BOT, V116, P1, DOI 10.1016/j.envexpbot.2015.03.004; Xu LX, 2011, J AM SOC HORTIC SCI, V136, P247, DOI 10.21273/JASHS.136.4.247; Xu S, 2006, ENVIRON EXP BOT, V56, P274, DOI 10.1016/j.envexpbot.2005.03.002; Zavaleta-Mancera HA, 2007, J PLANT PHYSIOL, V164, P1572, DOI 10.1016/j.jplph.2007.02.003; Zhang XZ, 2008, CROP SCI, V48, P364, DOI 10.2135/cropsci2007.05.0262; Zhang XZ, 2009, CROP SCI, V49, P1893, DOI 10.2135/cropsci2008.09.0521; Zhu Y, 2014, CROP J, V2, P223, DOI 10.1016/j.cj.2014.04.005	59	56	62	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154005	10.1371/journal.pone.0154005	http://dx.doi.org/10.1371/journal.pone.0154005			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099963	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500121
J	Malfait, B; Dingenen, B; Smeets, A; Staes, F; Pataky, T; Robinson, MA; Vanrenterghem, J; Verschueren, S				Malfait, Bart; Dingenen, Bart; Smeets, Annemie; Staes, Filip; Pataky, Todd; Robinson, Mark A.; Vanrenterghem, Jos; Verschueren, Sabine			Knee and Hip Joint Kinematics Predict Quadriceps and Hamstrings Neuromuscular Activation Patterns in Drop Jump Landings	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; SCORING SYSTEM LESS; INJURY RISK; MUSCLE ACTIVATION; IMPACT FORCES; VERTICAL JUMP; FEMALE; COCONTRACTION; BIOMECHANICS; BASKETBALL	Purpose The purpose was to assess if variation in sagittal plane landing kinematics is associated with variation in neuromuscular activation patterns of the quadriceps-hamstrings muscle groups during drop vertical jumps (DVJ). Methods Fifty female athletes performed three DVJ. The relationship between peak knee and hip flexion angles and the amplitude of four EMG vectors was investigated with trajectory-level canonical correlation analyses over the entire time period of the landing phase. EMG vectors consisted of the {vastus medialis(VM), vastus lateralis(VL)}, {vastus medialis(VM), hamstring medialis(HM)}, {hamstring medialis(HM), hamstring lateralis(HL)} and the {vastus lateralis(VL), hamstring lateralis(HL)}. To estimate the contribution of each individual muscle, linear regressions were also conducted using one-dimensional statistical parametric mapping. Results The peak knee flexion angle was significantly positively associated with the amplitudes of the {VM, HM} and {HM, HL} during the preparatory and initial contact phase and with the {VL, HL} vector during the peak loading phase (p< 0.05). Small peak knee flexion angles were significantly associated with higher HM amplitudes during the preparatory and initial contact phase (p< 0.001). The amplitudes of the {VM, VL} and {VL, HL} were significantly positively associated with the peak hip flexion angle during the peak loading phase (p< 0.05). Small peak hip flexion angles were significantly associated with higher VL amplitudes during the peak loading phase (p = 0.001). Higher external knee abduction and flexion moments were found in participants landing with less flexed knee and hip joints (p< 0.001). Conclusion This study demonstrated clear associations between neuromuscular activation patterns and landing kinematics in the sagittal plane during specific parts of the landing. These findings have indicated that an erect landing pattern, characterized by less hip and knee flexion, was significantly associated with an increased medial and posterior neuromuscular activation (dominant hamstrings medialis activity) during the preparatory and initial contact phase and an increased lateral neuromuscular activation (dominant vastus lateralis activity) during the peak loading phase.	[Malfait, Bart; Dingenen, Bart; Smeets, Annemie; Staes, Filip; Verschueren, Sabine] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Rehabil Sci & Physiotherapy, Musculoskeletal Rehabil Res Grp, Leuven, Belgium; [Robinson, Mark A.; Vanrenterghem, Jos] Liverpool John Moores Univ, Fac Sci, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Pataky, Todd] Shinshu Univ, Dept Bioengn, Ueda, Nagano, Japan	KU Leuven; Liverpool John Moores University; Shinshu University	Verschueren, S (corresponding author), Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Rehabil Sci & Physiotherapy, Musculoskeletal Rehabil Res Grp, Leuven, Belgium.	sabine.verschueren@faber.kuleuven.be	Smeets, Annemie/ACW-6678-2022; Robinson, Mark A./H-7108-2019; Verschueren, Sabine/K-4213-2015	Smeets, Annemie/0000-0003-4569-8652; Robinson, Mark A./0000-0002-5627-492X; Dingenen, Bart/0000-0002-8684-9931; Vanrenterghem, Jos/0000-0002-1682-8430; Verschueren, Sabine/0000-0003-2592-494X				Adler R., 2007, RANDOM FIELDS GEOMET; BARATTA R, 1988, AM J SPORT MED, V16, P113, DOI 10.1177/036354658801600205; Barendrecht M, 2011, J STRENGTH COND RES, V25, P575, DOI 10.1519/JSC.0b013e3182023bc7; Bates NA, 2013, J BIOMECH, V46, P1237, DOI 10.1016/j.jbiomech.2013.02.024; BEARD DJ, 1994, J BONE JOINT SURG BR, V76B, P654, DOI 10.1302/0301-620X.76B4.8027158; Beaulieu ML, 2009, KNEE SURG SPORT TR A, V17, P968, DOI 10.1007/s00167-009-0821-1; Besier TF, 2003, J BIOMECH, V36, P1159, DOI 10.1016/S0021-9290(03)00087-3; BEYNNON B, 1992, INT ORTHOP, V16, P1; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; Blackburn JT, 2008, CLIN BIOMECH, V23, P313, DOI 10.1016/j.clinbiomech.2007.10.003; Blackburn JT, 2009, J ATHL TRAINING, V44, P174, DOI 10.4085/1062-6050-44.2.174; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Colby S, 2000, AM J SPORT MED, V28, P234, DOI 10.1177/03635465000280021501; Dingenen B, 2015, KNEE, V22, P73, DOI 10.1016/j.knee.2014.12.006; Elias JJ, 2003, AM J SPORT MED, V31, P241, DOI 10.1177/03635465030310021401; Ford KR, 2005, J STRENGTH COND RES, V19, P394, DOI 10.1519/15834.1; Ford KR, 2003, MED SCI SPORT EXER, V35, P1745, DOI 10.1249/01.MSS.0000089346.85744.D9; Gottlob C A, 2000, Am J Orthop (Belle Mead NJ), V29, P472; Griffin LY, 2006, AM J SPORT MED, V34, P1512, DOI 10.1177/0363546506286866; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hewett TE, 1996, AM J SPORT MED, V24, P765, DOI 10.1177/036354659602400611; HIROKAWA S, 1991, J ELECTROMYOGR KINES, V1, P199, DOI 10.1016/1050-6411(91)90035-4; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Li G, 1999, J BIOMECH, V32, P395, DOI 10.1016/S0021-9290(98)00181-X; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Malfait B, 2014, MED SCI SPORT EXER, V46, P678, DOI 10.1249/MSS.0000000000000170; Myer GD, 2005, J ELECTROMYOGR KINES, V15, P181, DOI 10.1016/j.jelekin.2004.08.006; Myer GD, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-39; NOYES FR, 1983, J BONE JOINT SURG AM, V65, P154, DOI 10.2106/00004623-198365020-00003; Padua DA, 2009, AM J SPORT MED, V37, P1996, DOI 10.1177/0363546509343200; Palmieri-Smith RM, 2009, J ATHL TRAINING, V44, P256, DOI 10.4085/1062-6050-44.3.256; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Pataky TC, 2012, COMPUT METHOD BIOMEC, V15, P295, DOI 10.1080/10255842.2010.527837; Pflum MA, 2004, MED SCI SPORT EXER, V36, P1949, DOI 10.1249/01.MSS.0000145467.79916.46; Pollard CD, 2010, CLIN BIOMECH, V25, P142, DOI 10.1016/j.clinbiomech.2009.10.005; Robinson MA, 2015, J ELECTROMYOGR KINES, V25, P14, DOI 10.1016/j.jelekin.2014.10.018; Robinson MA, 2012, J BIOMECH, V45, P1941, DOI 10.1016/j.jbiomech.2012.05.017; Sell TC, 2007, J ORTHOP RES, V25, P1589, DOI 10.1002/jor.20459; Shimokochi Y, 2009, J ATHL TRAINING, V44, P33, DOI 10.4085/1062-6050-44.1.33; Smith HC, 2012, AM J SPORT MED, V40, P521, DOI 10.1177/0363546511429776; Sugimoto D, 2015, BRIT J SPORT MED, V49, P282, DOI 10.1136/bjsports-2014-093461; Vanrenterghem J, 2012, J BIOMECH, V45, P2444, DOI 10.1016/j.jbiomech.2012.06.029; Walsh M, 2012, J ATHL TRAINING, V47, P406, DOI 10.4085/1062-6050-47.4.17; Wikstrom EA, 2006, SPORTS MED, V36, P393, DOI 10.2165/00007256-200636050-00003; Yu B, 2006, CLIN BIOMECH, V21, P297, DOI 10.1016/j.clinbiomech.2005.11.003; Zebis MK, 2009, AM J SPORT MED, V37, P1967, DOI 10.1177/0363546509335000; Zhang LQ, 2001, J BIOMECH, V34, P1107, DOI 10.1016/S0021-9290(01)00080-X	49	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153737	10.1371/journal.pone.0153737	http://dx.doi.org/10.1371/journal.pone.0153737			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101130	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000374898500058
J	Pandey, MS; Miller, CM; Harris, EN; Weigel, PH				Pandey, Madhu S.; Miller, Colton M.; Harris, Edward N.; Weigel, Paul H.			Activation of ERK and NF-kappa B during HARE-Mediated Heparin Uptake Require Only One of the Four Endocytic Motifs	PLOS ONE			English	Article							LIVER ENDOTHELIAL-CELLS; LOW-DENSITY-LIPOPROTEIN; MOLECULAR-WEIGHT HEPARINS; HUMAN HYALURONAN RECEPTOR; CHONDROITIN SULFATE; DERMATAN SULFATE; GENE-EXPRESSION; IN-VITRO; CYTOPLASMIC DOMAIN; CORPSE CLEARANCE	Fifteen different ligands, including heparin (Hep), are cleared from lymph and blood by the Hyaluronan (HA) Receptor for Endocytosis (HARE; derived from Stabilin-2 by proteolysis), which contains four endocytic motifs (M1-M4). Endocytosis of HARE.Hep complexes is targeted to coated pits by M1, M2, and M3 (Pandey et al, Int. J. Cell Biol. 2015, article ID 524707), which activates ERK1/2 and NF-kappa B (Pandey et al J. Biol. Chem. 288, 14068-79, 2013). Here, we used a NF-kappa B promoter-driven luciferase gene assay and cell lines expressing different HARE cytoplasmic domain mutants to identify motifs needed for Hep-mediated signaling. Deletion of M1, M2 or M4 singly had no effect on Hep-mediated ERK1/2 activation, whereas signaling (but not uptake) was eliminated in HARE(Delta M3) cells lacking NPLY2519. ERK1/2 signaling in cells expressing WT HARE(Y2519A) or HARE(Y2519A) lacking M1, M2 and M4 (containing M3-only) was decreased by 75% or eliminated, respectively. Deletion of M3 (but not M1, M2 or M4) also inhibited the formation of HARE.Hep.ERK1/2 complexes by 67%. NF-kappa B activation by HARE-mediated uptake of Hep, HA, dermatan sulfate or acetylated LDL was unaffected in single-motif deletion mutants lacking M1, M2 or M4. In contrast, cells expressing HARE(Delta M3) showed loss of HARE-mediated NF-kappa B activation during uptake of each of these four ligands. NF-kappa B activation by the four signaling ligands was also eliminated in HARE(Y2519A) or HARE(M3-only; Y2519A) cells. We conclude that the HARE NPLY2519 motif is necessary for both ERK1/2 and NF-kappa B signaling and that Tyr(2519) is critical for these functions.	[Pandey, Madhu S.; Weigel, Paul H.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Miller, Colton M.; Harris, Edward N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Nebraska System; University of Nebraska Lincoln	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	paul-weigel@ouhsc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130864] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL130864] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Castelli R, 2004, VASC MED, V9, P205, DOI 10.1191/1358863x04vm566ra; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Easton JB, 2006, J NEUROCHEM, V97, P834, DOI 10.1111/j.1471-4159.2006.03789.x; Eberlein M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-20; ERIKSSON S, 1983, EXP CELL RES, V144, P223, DOI 10.1016/0014-4827(83)90458-5; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; FILARDO EJ, 1995, J CELL BIOL, V130, P441, DOI 10.1083/jcb.130.2.441; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Hare AK, 2015, BIOCHEM BIOPH RES CO, V456, P257, DOI 10.1016/j.bbrc.2014.11.068; Harris E. N., 2009, HEPATIC ENDOCYTOSIS, P210; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2009, AM J PHYSIOL-GASTR L, V296, pG1191, DOI 10.1152/ajpgi.90717.2008; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; JACKSON RL, 1985, FEBS LETT, V190, P297, DOI 10.1016/0014-5793(85)81304-1; Jung MY, 2007, J LEUKOCYTE BIOL, V82, P1156, DOI 10.1189/jlb.0107052; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laurent T.C., 1991, DEGRADATION BIOACTIV, P249; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LAURENT TC, 1986, BIOCHEM J, V234, P653, DOI 10.1042/bj2340653; LEBEL L, 1994, EUR J CLIN INVEST, V24, P621, DOI 10.1111/j.1365-2362.1994.tb01114.x; Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641; MARENGERE LEM, 1994, J CELL SCI, P97; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; Miller C. M., 2016, NUCL ACIDS RES; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Pandey MS, 2008, J BIOL CHEM, V283, P21453, DOI 10.1074/jbc.M800886200; Pandey Madhu S, 2015, Int J Cell Biol, V2015, P524707, DOI 10.1155/2015/524707; Pandey MS, 2014, J BIOL CHEM, V289, P21807, DOI 10.1074/jbc.M114.565846; Pandey MS, 2014, J BIOL CHEM, V289, P1756, DOI 10.1074/jbc.M113.510339; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Park SY, 2008, MOL CELL BIOL, V28, P5288, DOI 10.1128/MCB.01993-07; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Qian H, 2009, BIOCHEM BIOPH RES CO, V390, P883, DOI 10.1016/j.bbrc.2009.10.068; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Saito A, 2007, BBA-GEN SUBJECTS, V1770, P241, DOI 10.1016/j.bbagen.2006.10.015; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; Simpson MA, 2012, INT J CANCER, V131, pE836, DOI 10.1002/ijc.27427; SMEDSROD B, 1988, COLLAGEN REL RES, V8, P375; SMEDSROD B, 1988, CELL TISSUE RES, V253, P39; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Weigel P. H., 2012, STRUCTURE FUNCTION B, P293; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; YOUNG E, 1994, THROMB HAEMOSTASIS, V71, P300; Zhang LJ, 2010, PROG MOL BIOL TRANSL, V93, P1, DOI 10.1016/S1877-1173(10)93001-9; Zhou B, 1999, J BIOL CHEM, V274, P33831, DOI 10.1074/jbc.274.48.33831; Zhou B, 2003, GLYCOBIOLOGY, V13, P339, DOI 10.1093/glycob/cwg029; Zhou B, 2002, MOL BIOL CELL, V13, P2853, DOI 10.1091/mbc.02-03-0048; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200; Ziakas PD, 2010, OBSTET GYNECOL, V115, P1256, DOI 10.1097/AOG.0b013e3181deba40	62	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154124	10.1371/journal.pone.0154124	http://dx.doi.org/10.1371/journal.pone.0154124			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100626	Green Published, gold			2022-12-26	WOS:000374898500150
J	Sahnoun, M; Jemli, S; Trabelsi, S; Ayadi, L; Bejar, S				Sahnoun, Mouna; Jemli, Sonia; Trabelsi, Sahar; Ayadi, Leila; Bejar, Samir			Aspergillus Oryzae S2 alpha-Amylase Domain C Involvement in Activity and Specificity: In Vivo Proteolysis, Molecular and Docking Studies	PLOS ONE			English	Article							ALKALINE PROTEASE; ESCHERICHIA-COLI; STARCH-BINDING; TAKA-AMYLASE; PURIFICATION; NIGER; OPTIMIZATION; CHYMOTRYPSIN; PROTEINASE; STABILITY	We previously reported that Aspergillus oryzae strain S2 had produced two alpha-amylase isoforms named AmyA and AmyB. The apparent molecular masses revealed by SDS-PAGE were 50 and 42 kDa, respectively. Yet AmyB has a higher catalytic efficiency. Based on a monitoring study of the alpha-amylase production in both the presence and absence of different protease inhibitors, a chymotrypsin proteolysis process was detected in vivo generating AmyB. A. oryzae S2 alpha-amylase gene was amplified, cloned and sequenced. The sequence analysis revealed nine exons, eight introns and an encoding open reading frame of 1500 bp corresponding to AmyA isoform. The amino-acid sequence analysis revealed aY371 potential chymotrypsin cleaving site, likely to be the AmyB C-Terminal end and two other potential sites at Y359, and F379. A zymogram with a high acrylamide concentration was used. It highlighted two other closed apparent molecular mass alpha-amylases termed AmyB(1) and AmyB(2) reaching40 kDa and 43 kDa. These isoforms could be possibly generated fromY359, and F379secondary cut, respectively. The molecular modeling study showed that AmyB preserved the (beta/alpha)(8) barrel domain and the domain B but lacked the C-terminal domain C. The contact map analysis and the docking studies strongly suggested a higher activity and substrate binding affinity for AmyB than AmyA which was previously experimentally exhibited. This could be explained by the easy catalytic cleft accessibility.	[Sahnoun, Mouna; Jemli, Sonia; Trabelsi, Sahar; Bejar, Samir] Univ Sfax, CBS, LMBEE, Sidi Mansour Rd Km 6,POB 1177, Sfax 3018, Tunisia; [Ayadi, Leila] Univ Sfax, Preparatory Inst Engn Studies IPEIS, MenzelChaker Rd Km 0-5,POB 3018, Sfax 3018, Tunisia	Centre de Biotechnologie de Sfax; Universite de Sfax; Universite de Sfax	Bejar, S (corresponding author), Univ Sfax, CBS, LMBEE, Sidi Mansour Rd Km 6,POB 1177, Sfax 3018, Tunisia.	samir.bejar@cbs.rnrt.tn		Jemli, Sonia/0000-0001-6265-581X	Tunisian Ministry of Higher Education and Scientific Research [LR15CBS06_2015-2018]	Tunisian Ministry of Higher Education and Scientific Research	This work was supported by a grant from the Tunisian Ministry of Higher Education and Scientific Research contract program CBSLMBEE/code: LR15CBS06_2015-2018. There was no additional external funding received for this study.	Adewale IO, 2009, CARBOHYD POLYM, V77, P105, DOI 10.1016/j.carbpol.2008.12.011; Anandan D, 2007, J IND MICROBIOL BIOT, V34, P339, DOI 10.1007/s10295-006-0201-5; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; BENDER H, 1990, CARBOHYD RES, V206, P257, DOI 10.1016/0008-6215(90)80065-B; BOEL E, 1984, EMBO J, V3, P1097, DOI 10.1002/j.1460-2075.1984.tb01935.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; D'Amico S, 2003, J MOL BIOL, V332, P981, DOI 10.1016/j.jmb.2003.07.014; DAVIDSON R, 1975, BIOCHEM J, V147, P45, DOI 10.1042/bj1470045; Goesaert H, 2009, J CEREAL SCI, V50, P345, DOI 10.1016/j.jcs.2009.04.010; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Housaindokht MR, 2013, J MOL CATAL B-ENZYM, V95, P36, DOI 10.1016/j.molcatb.2013.05.011; Iefuji H, 1996, BIOCHEM J, V318, P989, DOI 10.1042/bj3180989; Janecek S, 2003, EUR J BIOCHEM, V270, P635, DOI 10.1046/j.1432-1033.2003.03404.x; Janecek S, 1997, PROG BIOPHYS MOL BIO, V67, P67, DOI 10.1016/S0079-6107(97)00015-1; Janecek S, 2014, CELL MOL LIFE SCI, V71, P1149, DOI 10.1007/s00018-013-1388-z; Janecek S, 2012, FEBS LETT, V586, P3360, DOI 10.1016/j.febslet.2012.07.020; Janecek S, 2011, PROTEIN J, V30, P429, DOI 10.1007/s10930-011-9348-7; Janecek Stefan, 2000, P19; Jemli S, 2015, CRIT REV BIOTECHNOL, V8, P1; JONES RL, 1991, INT REV CYTOL, V126, P49; Kammoun R, 2008, BIORESOURCE TECHNOL, V99, P5602, DOI 10.1016/j.biortech.2007.10.045; KIMURA K, 1989, BIOCHEM BIOPH RES CO, V161, P1273, DOI 10.1016/0006-291X(89)91380-6; KOLODZEJSKA MV, 1977, UKR BIOKHIM ZH+, V49, P42; KU HC, 1972, BIOCHIM BIOPHYS ACTA, V268, P225, DOI 10.1016/0005-2744(72)90219-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin LL, 1997, J APPL MICROBIOL, V82, P325, DOI 10.1046/j.1365-2672.1997.00364.x; Mar SS, 2003, BIOSCI BIOTECH BIOCH, V67, P1080, DOI 10.1271/bbb.67.1080; Mehta D, 2014, APPL MICROBIOL BIOT, V98, P4503, DOI 10.1007/s00253-013-5459-8; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Monhemi H, 2012, J SUPERCRIT FLUID, V72, P161, DOI 10.1016/j.supflu.2012.08.020; Murakami S, 2008, ENZYME MICROB TECH, V43, P321, DOI 10.1016/j.enzmictec.2008.05.006; Nguyen QD, 2002, ENZYME MICROB TECH, V31, P345, DOI 10.1016/S0141-0229(02)00128-X; Nirmala M, 2003, PHYTOCHEMISTRY, V62, P21, DOI 10.1016/S0031-9422(02)00443-0; Ohdan K, 1999, APPL ENVIRON MICROB, V65, P4652; Prakash B, 2009, PROCESS BIOCHEM, V44, P210, DOI 10.1016/j.procbio.2008.10.013; Ravi-Kumar K, 2007, APPL MICROBIOL BIOT, V74, P1011, DOI 10.1007/s00253-006-0742-6; Ravi-Kumar K, 2004, FEBS LETT, V557, P239, DOI 10.1016/S0014-5793(03)01510-2; REICHARD U, 1990, J MED MICROBIOL, V33, P243, DOI 10.1099/00222615-33-4-243; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; ROGERS JC, 1985, J BIOL CHEM, V260, P3731; Sahnoun M, 2015, INT J BIOL MACROMOL, V75, P73, DOI 10.1016/j.ijbiomac.2015.01.026; Sahnoun M, 2012, PROCESS BIOCHEM, V47, P18, DOI 10.1016/j.procbio.2011.09.016; Sambrook J, 1989, MOL CLONING LAB MANU, P431; Sanoja RR, 2000, APPL ENVIRON MICROB, V66, P3350, DOI 10.1128/AEM.66.8.3350-3356.2000; SCHWERT GW, 1955, BIOCHIM BIOPHYS ACTA, V16, P570, DOI 10.1016/0006-3002(55)90280-8; SOGAARD M, 1991, P NATL ACAD SCI USA, V88, P8140, DOI 10.1073/pnas.88.18.8140; Suarez-Dieguez T, 2009, CARBOHYD POLYM, V75, P538, DOI 10.1016/j.carbpol.2008.09.015; SWIFT HJ, 1991, ACTA CRYSTALLOGR B, V47, P535, DOI 10.1107/S0108768191001970; Tremacoldi CR, 2007, WORLD J MICROB BIOT, V23, P295, DOI 10.1007/s11274-006-9211-8; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vujicic-Zagar A, 2006, ACTA CRYSTALLOGR F, V62, P716, DOI 10.1107/S1744309106024729; Wu AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100498; Xian L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121531; Yadav SK, 2015, BIOCATAL AGRIC BIOTE, V4, P667, DOI 10.1016/j.bcab.2015.08.007; YAMANE K, 1984, J BIOCHEM-TOKYO, V96, P1849, DOI 10.1093/oxfordjournals.jbchem.a135019; Yoshizaki Y, 2010, J BIOSCI BIOENG, V110, P670, DOI 10.1016/j.jbiosc.2010.07.005	59	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153868	10.1371/journal.pone.0153868	http://dx.doi.org/10.1371/journal.pone.0153868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101008	Green Published, gold			2022-12-26	WOS:000374898500081
J	Claassen, J; Rahman, SA; Huang, YX; Frey, HP; Schmidt, JM; Albers, D; Falo, CM; Park, S; Agarwal, S; Connolly, ES; Kleinberg, S				Claassen, Jan; Rahman, Shah Atiqur; Huang, Yuxiao; Frey, Hans-Peter; Schmidt, J. Michael; Albers, David; Falo, Cristina Maria; Park, Soojin; Agarwal, Sachin; Connolly, E. Sander; Kleinberg, Samantha			Causal Structure of Brain Physiology after Brain Injury from Subarachnoid Hemorrhage	PLOS ONE			English	Article							MULTIDISCIPLINARY CONSENSUS CONFERENCE; NEUROCRITICAL CARE SOCIETY; GLOBAL CEREBRAL EDEMA; INTRACRANIAL HYPERTENSION; NONCONVULSIVE SEIZURES; COMATOSE PATIENTS; MICRODIALYSIS; PROFESSIONALS; METABOLISM; MANAGEMENT	High frequency physiologic data are routinely generated for intensive care patients. While massive amounts of data make it difficult for clinicians to extract meaningful signals, these data could provide insight into the state of critically ill patients and guide interventions. We develop uniquely customized computational methods to uncover the causal structure within systemic and brain physiologic measures recorded in a neurological intensive care unit after subarachnoid hemorrhage. While the data have many missing values, poor signal-to-noise ratio, and are composed from a heterogeneous patient population, our advanced imputation and causal inference techniques enable physiologic models to be learned for individuals. Our analyses confirm that complex physiologic relationships including demand and supply of oxygen underlie brain oxygen measurements and that mechanisms for brain swelling early after injury may differ from those that develop in a delayed fashion. These inference methods will enable wider use of ICU data to understand patient physiology.	[Claassen, Jan; Frey, Hans-Peter; Schmidt, J. Michael; Falo, Cristina Maria; Park, Soojin; Agarwal, Sachin] Columbia Univ, Dept Neurol, Div Crit Care Neurol, New York, NY USA; [Rahman, Shah Atiqur; Huang, Yuxiao; Kleinberg, Samantha] Stevens Inst Technol, Dept Comp Sci, Hoboken, NJ 07030 USA; [Albers, David] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Connolly, E. Sander] Columbia Univ, Dept Neurosurg, New York, NY USA	Columbia University; Stevens Institute of Technology; Columbia University; Columbia University	Claassen, J (corresponding author), Columbia Univ, Dept Neurol, Div Crit Care Neurol, New York, NY USA.	jc1439@columbia.edu	Claassen, Jan/AAA-5451-2020	Frey, Hans-Peter/0000-0002-1026-008X; Schmidt, J. Michael/0000-0001-8141-2944	NLM of the NIH [R01LM011826]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000040, UL1 RR024156]; National Library of Medicine [R01 LM006910]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006910, R01LM011826] Funding Source: NIH RePORTER	NLM of the NIH; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This publication was supported by the NLM of the NIH under Award Number R01LM011826 (SK, YH, JC). Additional support for this work included a grant from the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number UL1 TR000040, formerly the National Center for Research Resources, Grant Number UL1 RR024156 (JC) and a grant from the National Library of Medicine under Award Number R01 LM006910 (DA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.; We thank the nurses, attendings, fellows, and neurology and neurosurgery residents of the Neuroscience ICU for their overall support of this project. This publication was supported by the NLM of the NIH under Award Number R01LM011826 (SK, YH, JC). Additional support for this work included a grant from the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number UL1 TR000040, formerly the National Center for Research Resources, Grant Number UL1 RR024156 (JC) and a grant from the National Library of Medicine under Award Number R01 LM006910 (DA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Badjatia N, 2011, STROKE, V42, P2436, DOI 10.1161/STROKEAHA.111.614685; Baradaran H, 2015, AJNR AM J NEURORADIO; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Buchman TG, 2002, NATURE, V420, P246, DOI 10.1038/nature01260; Bui N YJ, 2015, INT C SOC COMP BEH C; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Claassen J, 2014, ANN NEUROL, V75, P771, DOI 10.1002/ana.24166; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; Helbok R, 2011, STROKE, V42, P1534, DOI 10.1161/STROKEAHA.110.604488; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Klein AM, 2013, CLIN NEUROL NEUROSUR, V115, P2136, DOI 10.1016/j.clineuro.2013.08.004; Kleinberg S., CAUSALITY PROBABILIT, Vvii; Kleinberg S, 2011, P 22 INT JOINT C ART; Kleinberg Samantha, 2013, AMIA Annu Symp Proc, V2013, P786; Ko SB, 2012, ANN NEUROL, V72, P344, DOI 10.1002/ana.23619; Komotar RJ, 2009, NEUROSURGERY, V64, P397, DOI 10.1227/01.NEU.0000338946.42939.C7; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Miller C, 2014, NEUROCRIT CARE, V21, P121, DOI 10.1007/s12028-014-0021-9; Mocco J, 2007, Neurosurg Focus, V22, pE7; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Provencio JJ, 2014, NEUROCRIT CARE, V21, P177, DOI 10.1007/s12028-014-0038-0; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Rahman SA, 2015, J BIOMEDICAL INFORM; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sedigh-Sarvestani M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002788; Taccone FS, 2014, NEUROCRIT CARE, V21, P38, DOI 10.1007/s12028-014-0033-5; Ullah G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000776; Wibral M., 2014, TRANSFER ENTROPY NEU	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0149878	10.1371/journal.pone.0149878	http://dx.doi.org/10.1371/journal.pone.0149878			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123582	gold, Green Published, Green Submitted			2022-12-26	WOS:000375211700002
J	El Zaatari, S; Grine, FE; Ungar, PS; Hublin, JJ				El Zaatari, Sireen; Grine, Frederick E.; Ungar, Peter S.; Hublin, Jean-Jacques			Neandertal versus Modern Human Dietary Responses to Climatic Fluctuations	PLOS ONE			English	Article							MICROWEAR TEXTURE ANALYSIS; ISOTOPIC EVIDENCE; GENOME SEQUENCE; CAVE; MIDDLE; REMAINS; EXPLOITATION; CHARENTE; COLLAGEN; EUROPE	The Neandertal lineage developed successfully throughout western Eurasia and effectively survived the harsh and severely changing environments of the alternating glacial/interglacial cycles from the middle of the Pleistocene until Marine Isotope Stage 3. Yet, towards the end of this stage, at the time of deteriorating climatic conditions that eventually led to the Last Glacial Maximum, and soon after modern humans entered western Eurasia, the Neandertals disappeared. Western Eurasia was by then exclusively occupied by modern humans. We use occlusal molar microwear texture analysis to examine aspects of diet in western Eurasian Paleolithic hominins in relation to fluctuations in food supplies that resulted from the oscillating climatic conditions of the Pleistocene. There is demonstrable evidence for differences in behavior that distinguish Upper Paleolithic humans from members of the Neandertal lineage. Specifically, whereas the Neandertals altered their diets in response to changing paleoecological conditions, the diets of Upper Paleolithic humans seem to have been less affected by slight changes in vegetation/climatic conditions but were linked to changes in their technological complexes. The results of this study also indicate differences in resource exploitation strategies between these two hominin groups. We argue that these differences in subsistence strategies, if they had already been established at the time of the first contact between these two hominin taxa, may have given modern humans an advantage over the Neandertals, and may have contributed to the persistence of our species despite habitat-related changes in food availabilities associated with climate fluctuations.	[El Zaatari, Sireen] Univ Tubingen, Paleoanthropol, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany; [El Zaatari, Sireen; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Grine, Frederick E.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY USA; [Grine, Frederick E.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY USA; [Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Max Planck Society; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Arkansas System; University of Arkansas Fayetteville	El Zaatari, S (corresponding author), Univ Tubingen, Paleoanthropol, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany.; El Zaatari, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	sireen.el-zaatari@uni.tuebingen.de	El-Zaatari, Sireen/AAE-7645-2020		Max Planck Society; Wenner Gren Foundation [8554]; National Science Foundation [0452155, 0315157]; LSB Leakey Foundation [800320]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Wenner Gren Foundation; National Science Foundation(National Science Foundation (NSF)); LSB Leakey Foundation	This study was supported by Max Planck Society, Wenner Gren Foundation through a Hunt Post-Doctoral Fellowship to SEZ (8554), the National Science Foundation to FEG and SEZ and PSU (0452155; 0315157), and the LSB Leakey Foundation to SEZ and FEG (800320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, HUNTERS GOLDEN AGE M; Antunes M.T., 2000, LAST NEANDERTHALS PO, V38, P259; Aranguren B, 2007, ANTIQUITY, V81, P845, DOI 10.1017/S0003598X00095946; Bailey S, 2002, THESIS ARIZONA STATE; Barton Nick, 2000, P211; Blasco R, 2012, CR PALEVOL, V11, P265, DOI 10.1016/j.crpv.2012.01.003; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; BOCHERENS H, 1991, J HUM EVOL, V20, P481, DOI 10.1016/0047-2484(91)90021-M; Bocherens Herve, 2003, BAR International Series, V1105, P1; Bocherens H, 2014, QUATERN INT, V339, P112, DOI 10.1016/j.quaint.2013.06.026; Bocherens H, 2014, J HUM EVOL, V69, P31, DOI 10.1016/j.jhevol.2013.12.015; Bright J, 2002, WORLD ARCHAEOL, V34, P164, DOI 10.1080/00438240220134304; Brown K, 2011, INTERD CONTRIB ARCH, P247, DOI 10.1007/978-1-4419-8219-3_10; Cook RJ, 1996, J ROY STAT SOC A STA, V159, P93, DOI 10.2307/2983471; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; El Zaatari S, 2013, SUBSISTENCE EC SOC G, P55; El Zaatari S, 2014, CAM S BIO EVOL ANTHR, V68, P120; El Zaatari S, 2014, AM J PHYS ANTHROPOL, V153, P570, DOI 10.1002/ajpa.22457; El Zaatari S, 2011, J HUM EVOL, V61, P411, DOI 10.1016/j.jhevol.2011.05.004; El-Zaatari S, 2010, INT J OSTEOARCHAEOL, V20, P67, DOI 10.1002/oa.1027; Elefanti P, 2008, EURASIAN PREHISTORY, V5, P77; Finlayson C., 2001, PREMIERS HOMES MODER, P117; Finlayson C., 2004, NEANDERTHALS MODERN; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Fiorenza L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014769; FIZET M, 1995, J ARCHAEOL SCI, V22, P67, DOI 10.1016/S0305-4403(95)80163-4; Freidline SE, 2012, J HUM EVOL, V63, P723, DOI 10.1016/j.jhevol.2012.08.002; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gilpin W, 2016, P NATL ACAD SCI USA, V113, P2134, DOI 10.1073/pnas.1524861113; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Harvati K, 2013, J HUM EVOL, V64, P486, DOI 10.1016/j.jhevol.2013.02.002; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; Hua LC, 2015, AM J PHYS ANTHROPOL, V158, P769, DOI 10.1002/ajpa.22823; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P13471, DOI 10.1073/pnas.1211082109; KEELEY LH, 1988, J ANTHROPOL ARCHAEOL, V7, P373, DOI 10.1016/0278-4165(88)90003-7; Lowe J, 2015, RECONSTRUCTING QUATERNARY ENVIRONMENTS, 3RD EDITION; MASON SLR, 1994, ANTIQUITY, V68, P48, DOI 10.1017/S0003598X00046184; Merceron G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009542; Michel V, 2013, QUAT GEOCHRONOL, V15, P20, DOI 10.1016/j.quageo.2012.12.008; Neff N. A., 1980, SURVEY MULTIVARIATE; O'Connell James F., 2006, P43; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Revedin A, 2015, QUATERN INT, V359, P77, DOI 10.1016/j.quaint.2014.09.066; Richards MP, 2008, J HUM EVOL, V55, P179, DOI 10.1016/j.jhevol.2008.02.007; Richards MP, 2008, ANTIQUITY, V82, P553, DOI 10.1017/S0003598X00097210; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Richards MP, 2000, P NATL ACAD SCI USA, V97, P7663, DOI 10.1073/pnas.120178997; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Rougier H., 2003, THESIS U BORDEAUX 1; Salazar-Garcia DC, 2013, QUATERN INT, V318, P3, DOI 10.1016/j.quaint.2013.06.007; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2012, AM J PHYS ANTHROPOL, V147, P551, DOI 10.1002/ajpa.22007; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sokal R.R., 2012, BIOMETRY; Stiner MC, 2010, FARMING, V3, P1; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P73, DOI 10.1002/ajpa.1330800109; Ungar Peter S., 2007, Journal of Mammalian Evolution, V14, P163, DOI 10.1007/s10914-007-9050-x; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5; Withnell CB, 2014, MAMMALIA, V78, P409, DOI 10.1515/mammalia-2013-0121; Wood RE, 2013, ARCHAEOMETRY, V55, P148, DOI 10.1111/j.1475-4754.2012.00671.x; Zilhao J, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P407, DOI 10.1007/978-0-387-76487-0_27	70	47	47	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153277	10.1371/journal.pone.0153277	http://dx.doi.org/10.1371/journal.pone.0153277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DK5QZ	27119336	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200021
J	Qualai, J; Li, LX; Cantero, J; Tarrats, A; Fernandez, MA; Sumoy, L; Rodolosse, A; McSorley, SJ; Genesca, M				Qualai, Jamal; Li, Lin-Xi; Cantero, Jon; Tarrats, Antoni; Antonio Fernandez, Marco; Sumoy, Lauro; Rodolosse, Annie; McSorley, Stephen J.; Genesca, Meritxell			Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential	PLOS ONE			English	Article							INDUCTION	CD11c is an a integrin classically employed to define myeloid dendritic cells. Although there is little information about CD11c expression on human T cells, mouse models have shown an association of CD11c expression with functionally relevant T cell subsets. In the context of genital tract infection, we have previously observed increased expression of CD11c in circulating T cells from mice and women. Microarray analyses of activated effector T cells expressing CD11c derived from naive mice demonstrated enrichment for natural killer (NK) associated genes. Here we find that murine CD11c(+) T cells analyzed by flow cytometry display markers associated with non-conventional T cell subsets, including gamma delta T cells and invariant natural killer T (iNKT) cells. However, in women, only gamma delta T cells and CD8(+) T cells were enriched within the CD11c fraction of blood and cervical tissue. These CD11c+ cells were highly activated and had greater interferon (IFN)-gamma secretory capacity than CD11c(-) T cells. Furthermore, circulating CD11c(+) T cells were associated with the expression of multiple adhesion molecules in women, suggesting that these cells have high tissue homing potential. These data suggest that CD11c expression distinguishes a population of circulating T cells during bacterial infection with innate capacity and mucosal homing potential.	[Qualai, Jamal; Cantero, Jon; Genesca, Meritxell] AIDS Res Inst IrsiCaixa HIVACAT, Mucosal Immunol Unit, Inst Invest Ciencies Salut Germans Trias & Pujol, Can Ruti Campus, Badalona, Spain; [Li, Lin-Xi] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Tarrats, Antoni] Univ Hosp Germans Trias & Pujol, Dept Obstet & Gynecol, Can Ruti Campus, Badalona, Spain; [Antonio Fernandez, Marco] Inst Invest Ciencies Salut Germans Trias & Pujol, Flow Cytometry Unit, Badalona, Spain; [Sumoy, Lauro] IMPPC, Genom & Bioinformat Grp, Can Ruti Campus, Badalona, Spain; [Rodolosse, Annie] Inst Res Biomed IRB Barcelona, Funct Genom Core, Barcelona, Spain; [McSorley, Stephen J.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Ctr Comparat Med, Davis, CA 95616 USA	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; University of Arkansas System; University of Arkansas Medical Sciences; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of California System; University of California Davis	Genesca, M (corresponding author), AIDS Res Inst IrsiCaixa HIVACAT, Mucosal Immunol Unit, Inst Invest Ciencies Salut Germans Trias & Pujol, Can Ruti Campus, Badalona, Spain.	mgenesca@igtp.cat	Fernandez, Marco/R-3964-2019; Genescà, Meritxell/AFT-2336-2022; Sumoy, Lauro/AGZ-3186-2022; Sumoy, Lauro/K-1680-2013; Genescà, Meritxell/AAF-9074-2020	Fernandez, Marco/0000-0002-3921-2209; Genescà, Meritxell/0000-0001-6413-3812; Sumoy, Lauro/0000-0003-0005-4618; Sumoy, Lauro/0000-0003-0005-4618; Li, Lin-Xi/0000-0002-5526-8966; McSorley, Stephen/0000-0002-6363-3222; Cantero, Jon/0000-0003-4844-6143	Marie Curie Career Integration Grant (CIG); European Commission; Dexeus foundation for women's health research; Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117303, R01AI103422] Funding Source: NIH RePORTER	Marie Curie Career Integration Grant (CIG); European Commission(European CommissionEuropean Commission Joint Research Centre); Dexeus foundation for women's health research; Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Marie Curie Career Integration Grant (CIG), from the European Commission and a fellowship award, from the Dexeus foundation for women's health research. MG is currently supported by a Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakelyan A, 2014, METHODS MOL BIOL, V1087, P233, DOI 10.1007/978-1-62703-670-2_19; Beyer M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-70; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Bullard DC, 2007, AM J PATHOL, V170, P2001, DOI 10.2353/ajpath.2007.061016; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Chen ZB, 2013, J IMMUNOL, V190, P6145, DOI 10.4049/jimmunol.1300060; Cooney LA, 2013, INFECT IMMUN, V81, P4171, DOI 10.1128/IAI.00871-13; Del Campo J, 2010, VACCINE, V28, P1193, DOI 10.1016/j.vaccine.2009.11.035; DeNucci CC, 2009, CRIT REV IMMUNOL, V29, P87, DOI 10.1615/CritRevImmunol.v29.i2.10; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; Egan CE, 2009, MUCOSAL IMMUNOL, V2, P527, DOI 10.1038/mi.2009.105; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Fujiwara D, 2011, AM J PHYSIOL-GASTR L, V300, pG939, DOI 10.1152/ajpgi.00032.2010; Fuller JM, 2013, J AM CHEM SOC, V135, P8947, DOI 10.1021/ja402019c; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Kim YH, 2005, CELL IMMUNOL, V238, P76, DOI 10.1016/j.cellimm.2006.01.004; Kubota K, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00026; Kuka M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2223; Li LX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003707; Ljutic B, 2005, J IMMUNOL, V174, P4789, DOI 10.4049/jimmunol.174.8.4789; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Paul S, 2015, J LEUKOCYTE BIOL, V97, P259, DOI 10.1189/jlb.3RU0914-443R; Pennington DJ, 2005, ADV IMMUNOL, V87, P27, DOI 10.1016/S0065-2776(05)87002-6; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Romagnoli PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056999; Sadhu C, 2007, J LEUKOCYTE BIOL, V81, P1395, DOI 10.1189/jlb.1106680; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Trifonova RT, 2014, AM J REPROD IMMUNOL, V71, P252, DOI 10.1111/aji.12198; Tsai S, 2011, CELL MOL LIFE SCI, V68, P3781, DOI 10.1007/s00018-011-0738-y; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Williams DM, 1996, INFECT IMMUN, V64, P3916, DOI 10.1128/IAI.64.9.3916-3919.1996	42	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154253	10.1371/journal.pone.0154253	http://dx.doi.org/10.1371/journal.pone.0154253			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119555	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200053
J	Rabovsky, M; Stein, T; Rahman, RA				Rabovsky, Milena; Stein, Timo; Rahman, Rasha Abdel			Access to Awareness for Faces during Continuous Flash Suppression Is Not Modulated by Affective Knowledge	PLOS ONE			English	Article							PERSONALITY; EXPRESSIONS; SEE	It is a controversially debated topic whether stimuli can be analyzed up to the semantic level when they are suppressed from visual awareness during continuous flash suppression (CFS). Here, we investigated whether affective knowledge, i.e., affective biographical information about faces, influences the time it takes for initially invisible faces with neutral expressions to overcome suppression and break into consciousness. To test this, we used negative, positive, and neutral famous faces as well as initially unfamiliar faces, which were associated with negative, positive or neutral biographical information. Affective knowledge influenced ratings of facial expressions, corroborating recent evidence and indicating the success of our affective learning paradigm. Furthermore, we replicated shorter suppression durations for upright than for inverted faces, demonstrating the suitability of our CFS paradigm. However, affective biographical information did not modulate suppression durations for newly learned faces, and even though suppression durations for famous faces were influenced by affective knowledge, these effects did not differ between upright and inverted faces, indicating that they might have been due to low-level visual differences. Thus, we did not obtain unequivocal evidence for genuine influences of affective biographical information on access to visual awareness for faces during CFS.	[Rabovsky, Milena; Rahman, Rasha Abdel] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Rabovsky, Milena] Stanford Univ, Dept Psychol, Stanford, CA USA; [Stein, Timo] Univ Trento, Ctr Mind Brain Sci, Trento, Italy	Humboldt University of Berlin; Stanford University; University of Trento	Rabovsky, M (corresponding author), Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany.; Rabovsky, M (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA USA.	rabovsky@stanford.edu	; Abdel Rahman, Rasha/J-4687-2015	Stein, Timo/0000-0002-8484-0933; Rabovsky, Milena/0000-0001-7729-1027; Abdel Rahman, Rasha/0000-0002-8438-1570	German Research Foundation grant [AB 277-6, STE 2239/1-1]; European Union [329363]	German Research Foundation grant; European Union(European Commission)	This work was funded by the German Research Foundation grant AB 277-6 to RAR and grant STE 2239/1-1 to TS (http://www.dfg.de/). In addition, the research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA Grant Agreement 329363 (http://ec.europa.eu/research/mariecurieactions/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 2011, SCIENCE, V332, P1446, DOI 10.1126/science.1201574; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Bates D, 2012, LME4 LINEAR MIXED EF; Baumeister RF, 2004, REV GEN PSYCHOL, V8, P111, DOI 10.1037/1089-2680.8.2.111; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bliss-Moreau E, 2008, EMOTION, V8, P479, DOI 10.1037/1528-3542.8.4.479; Borkenau P., 2008, NEOFUNF FAKTOREN INV, V2nd; Chen YC, 2012, CONSCIOUS COGN, V21, P1703, DOI 10.1016/j.concog.2012.10.001; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Costello P, 2009, CONSCIOUS COGN, V18, P375, DOI 10.1016/j.concog.2009.02.003; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Gayet S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00460; Gobbini MI, 2013, CONSCIOUS COGN, V22, P765, DOI 10.1016/j.concog.2013.05.002; Gobbini MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066620; Gray KLH, 2013, EMOTION, V13, P537, DOI 10.1037/a0031403; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Heyman T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104719; Jensen-Campbell LA, 2003, J PERS, V71, P1059, DOI 10.1111/1467-6494.7106007; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; Lupyan G, 2013, P NATL ACAD SCI USA, V110, P14196, DOI 10.1073/pnas.1303312110; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Mudrik L, 2011, PSYCHOL SCI, V22, P764, DOI 10.1177/0956797611408736; Pinto Y, 2015, J VISION, V15, DOI 10.1167/15.8.13; Rahman RA, 2011, EMOTION, V11, P1397, DOI 10.1037/a0024717; Shimaoka D, 2011, VISION RES, V51, P521, DOI 10.1016/j.visres.2011.01.009; Sklar AY, 2012, P NATL ACAD SCI USA, V109, P19614, DOI 10.1073/pnas.1211645109; Stein T, 2015, J VISION, V15; Stein T, 2015, J EXP PSYCHOL GEN, V144, P1089, DOI 10.1037/xge0000109; Stein T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00582; Stein T, 2014, PSYCHOL SCI, V25, P566, DOI 10.1177/0956797613512509; Stein T, 2012, EMOTION, V12, P988, DOI 10.1037/a0026944; Stein T, 2012, COGNITION, V125, P64, DOI 10.1016/j.cognition.2012.06.005; Stein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029361; Stein T, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00167; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Stewart LH, 2012, J EXP PSYCHOL GEN, V141, P715, DOI 10.1037/a0027950; Suess F, 2014, SOC COGN AFFECT NEUR; Tobin RM, 2000, J PERS SOC PSYCHOL, V79, P656, DOI 10.1037//0022-3514.79.4.656; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P195, DOI 10.1093/scan/nsn013; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Yang E, 2012, J VISION, V12, DOI 10.1167/12.3.8; Yang YH, 2011, CONSCIOUS COGN, V20, P223, DOI 10.1016/j.concog.2010.07.005; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	48	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0150931	10.1371/journal.pone.0150931	http://dx.doi.org/10.1371/journal.pone.0150931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119743	gold, Green Published			2022-12-26	WOS:000374976200004
J	Selwyn, JD; Hogan, JD; Downey-Wall, AM; Gurski, LM; Portnoy, DS; Heath, DD				Selwyn, Jason D.; Hogan, J. Derek; Downey-Wall, Alan M.; Gurski, Lauren M.; Portnoy, David S.; Heath, Daniel D.			Kin-Aggregations Explain Chaotic Genetic Patchiness, a Commonly Observed Genetic Pattern, in a Marine Fish	PLOS ONE			English	Article							R-PACKAGE; POPULATIONS; REEF; RELATEDNESS; DISPERSAL; PARENTAGE; DRIVERS	The phenomenon of chaotic genetic patchiness is a pattern commonly seen in marine organisms, particularly those with demersal adults and pelagic larvae. This pattern is usually associated with sweepstakes recruitment and variable reproductive success. Here we investigate the biological underpinnings of this pattern in a species of marine goby Coryphopterus personatus. We find that populations of this species show tell-tale signs of chaotic genetic patchiness including: small, but significant, differences in genetic structure over short distances; a non-equilibrium or "chaotic" pattern of differentiation among locations in space; and within locus, within population deviations from the expectations of Hardy-Weinberg equilibrium (HWE). We show that despite having a pelagic larval stage, and a wide distribution across Caribbean coral reefs, this species forms groups of highly related individuals at small spatial scales (<10 metres). These spatially clustered family groups cause the observed deviations from HWE and local population differentiation, a finding that is rarely demonstrated, but could be more common than previously thought.	[Selwyn, Jason D.; Hogan, J. Derek; Gurski, Lauren M.] Texas A&M Univ, Dept Life Sci, HoBi Lab, Corpus Christi, TX USA; [Downey-Wall, Alan M.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [Portnoy, David S.] Texas A&M Univ, Dept Life Sci, Marine Genom Lab, Corpus Christi, TX USA; [Heath, Daniel D.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada	Texas A&M University System; Northeastern University; Texas A&M University System; University of Windsor	Selwyn, JD (corresponding author), Texas A&M Univ, Dept Life Sci, HoBi Lab, Corpus Christi, TX USA.	jason.selwyn@tamucc.edu		Selwyn, Jason/0000-0002-9100-217X	Natural Sciences and Engineering Research Council of Canada CRO grant [227965]; Natural Sciences and Engineering Research Council Tier I Canada Research Chair grant; University of Windsor; Texas A&M University - Corpus Christi start-up funds; NSF [1429518]	Natural Sciences and Engineering Research Council of Canada CRO grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council Tier I Canada Research Chair grant; University of Windsor; Texas A&M University - Corpus Christi start-up funds; NSF(National Science Foundation (NSF))	This work was supported by the Natural Sciences and Engineering Research Council of Canada CRO grant# 227965 awarded to P.F. Sale, a Global Environment Facility Coral Reef Targeted Research project and by a Natural Sciences and Engineering Research Council Tier I Canada Research Chair grant to DDH; a Great Lakes Institute for Environmental Research post-doctoral fellowship from the University of Windsor and Texas A&M University - Corpus Christi start-up funds to JDH.; We thank K. Pennoyer, S. Furiness, and C. van Slyck for manuscript edits. P. Sale, R. Hepburn, J. Kritzer, S. Ludsin, P. Chittaro, C. Mora and P. Usseglio for field collections. G. Nanninga and two anonymous reviewers for helpful comments to improve the manuscript. The Institute of Marine Studies at the University of Belize for field support. NSF Award 1429518 for high power computing services.	Bernardi G, 2004, MAR BIOL, V145, P803, DOI 10.1007/s00227-004-1355-1; Broquet T, 2013, EVOLUTION, V67, P1660, DOI 10.1111/j.1558-5646.2012.01826.x; Buston PM, 2009, MOL ECOL, V18, P4707, DOI 10.1111/j.1365-294X.2009.04383.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dyer R. J., 2014, GSTUDIO ANAL FUNCTIO; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Engels B., 2014, HWXTEST EXACT TESTS; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HAMNER WM, 1988, B MAR SCI, V42, P459; HEDGECOCK D, 1994, CAL COOP OCEAN FISH, V35, P73; Hepburn RI, 2005, CONSERV GENET, V6, P1059, DOI 10.1007/s10592-005-9088-3; Hewitt R.P., 1981, CONSEIL INT EXPLORAT, V178, P229; Hogan JD, 2010, MAR ECOL PROG SER, V417, P263, DOI 10.3354/meps08793; Hogan JD, 2010, MOL ECOL RESOUR; Hunter J. R, 1980, FISH BEHAV ITS USE C, V5, P287; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; Jolly MT, 2003, HELGOLAND MAR RES, V56, P238, DOI 10.1007/s10152-002-0123-1; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kolaczyk ED., 2014, STAT ANAL NETWORK DA; Larson RJ, 1999, CAL COOP OCEAN FISH, V40, P94; Marino IAM, 2010, ESTUAR COAST SHELF S, V87, P135, DOI 10.1016/j.ecss.2010.01.003; Medvinsky AB, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021915; Pew J, 2015, MOL ECOL RESOUR, V15, P557, DOI 10.1111/1755-0998.12323; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Renyi Alfred, 1959, PUBL MATH, V6, P5; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Shapiro D.Y., 1983, Symposia Series for Undersea Research, V1, P39; Thresher RE, 1984, REPROD REEF FISHES; Wang J, 2007, HEREDITY, V99, P205, DOI 10.1038/sj.hdy.6800984; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798	39	37	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153381	10.1371/journal.pone.0153381	http://dx.doi.org/10.1371/journal.pone.0153381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119659	Green Published, gold			2022-12-26	WOS:000374976200024
J	Xie, F; Li, ZP; Wang, HW; Fei, X; Jiao, ZY; Tang, WB; Tang, J; Luo, YK				Xie, Fang; Li, Zhi-Ping; Wang, Hong-Wei; Fei, Xiang; Jiao, Zi-Yu; Tang, Wen-Bo; Tang, Jie; Luo, Yu-Kun			Evaluation of Liver Ischemia-Reperfusion Injury in Rabbits Using a Nanoscale Ultrasound Contrast Agent Targeting ICAM-1	PLOS ONE			English	Article							SINUSOIDAL ENDOTHELIAL-CELL; ENHANCED ULTRASOUND; ADHESION MOLECULE-1; P-SELECTIN; SHEAR-FLOW; TRANSPLANTATION; MICROBUBBLES; DIAGNOSIS; INFLAMMATION; STORAGE	Objective To assess the feasibility of ultrasound molecular imaging in the early diagnosis of liver ischemia-reperfusion injury (IRI) using a nanoscale contrast agent targeting anti-intracellular adhesion molecule-1 (anti-ICAM-1). Methods The targeted nanobubbles containing anti-ICAM-1 antibody were prepared using the avidin-biotin binding method. Human hepatic sinusoidal endothelial cells (HHSECs) were cultured at the circumstances of hypoxia/reoxygenation (H/R) and low temperature. The rabbit liver IRI model (I/R group) was established using the Pringle's maneuver. The time-intensity curve of the liver contrast ultrasonographic images was plotted and the peak intensity, time to peak, and time of duration were calculated. Results The size of the targeted nanobubbles were 148.15 +/- 39.75 nm and the concentration was 3.6-7.4 x 10(9)/ml, and bound well with the H/R HHSECs. Animal contrast enhanced ultrasound images showed that the peak intensity and time of duration of the targeted nanobubbles were significantly higher than that of common nanobubbles in the I/R group, and the peak intensity and time of duration of the targeted nanobubbles in the I/R group were also significantly higher than that in the SO group. Conclusion The targeted nanobubbles have small particle size, stable characteristic, and good targeting ability, which can assess hepatic ischemia-reperfusion injury specifically, noninvasively, and quantitatively at the molecular level.	[Xie, Fang; Wang, Hong-Wei; Fei, Xiang; Jiao, Zi-Yu; Tang, Wen-Bo; Tang, Jie; Luo, Yu-Kun] Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound, Beijing 100853, Peoples R China; [Xie, Fang] North China Univ Sci & Technol, Affiliated Hosp, Dept Ultrasound, Tangshan, Peoples R China; [Li, Zhi-Ping] Beijing Inst Pharmacol & Toxicol, Pharmacol Res Dept, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; North China University of Science & Technology; Academy of Military Medical Sciences - China	Tang, J; Luo, YK (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound, Beijing 100853, Peoples R China.	txiner@vip.sina.com; lyk301@163.com		Luo, Yukun/0000-0002-5944-8198	National Natural Science Foundation of China [81271588]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81271588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann C, 2006, GASTROENTEROLOGY, V130, P8, DOI 10.1053/j.gastro.2005.11.009; CALDWELLKENKEL JC, 1989, HEPATOLOGY, V10, P292, DOI 10.1002/hep.1840100307; Caraceni P, 2005, J SURG RES, V124, P160, DOI 10.1016/j.jss.2004.10.007; Corbitt N, 2013, AM J PATHOL, V182, P180, DOI 10.1016/j.ajpath.2012.09.010; Correas JM, 2000, INVEST RADIOL, V35, P72, DOI 10.1097/00004424-200001000-00008; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Deshpande N, 2010, CLIN RADIOL, V65, P567, DOI 10.1016/j.crad.2010.02.013; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Garcia-Criado A, 2015, EUR RADIOL, V25, P196, DOI 10.1007/s00330-014-3377-5; Gorce JM, 2000, INVEST RADIOL, V35, P661, DOI 10.1097/00004424-200011000-00003; Gorina R, 2014, J IMMUNOL, V192, P324, DOI 10.4049/jimmunol.1300858; Gracia-Sancho J, 2010, TRANSPLANTATION, V90, P142, DOI 10.1097/TP.0b013e3181e228db; Harvey CJ, 2001, EUR RADIOL, V11, P675, DOI 10.1007/s003300000624; Huet PM, 2004, HEPATOLOGY, V39, P1110, DOI 10.1002/hep.20157; Imamura H, 2002, LANCET, V360, P2049, DOI 10.1016/S0140-6736(02)11995-7; Ivanov A. N., 2014, Uspekhi Fiziologicheskikh Nauk, V45, P34; Jacobs W, 1997, PARASITOL RES, V83, P405, DOI 10.1007/s004360050273; Kaufmann BA, 2007, EUR HEART J, V28, P2011, DOI 10.1093/eurheartj/ehm176; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Langer K, 2000, EUR J PHARM BIOPHARM, V49, P303, DOI 10.1016/S0939-6411(00)00068-0; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee SJ, 2013, J CLIN ULTRASOUND, V41, P305, DOI 10.1002/jcu.22044; Lindner JR, 2001, CIRCULATION, V104, P2107, DOI 10.1161/hc4201.097061; Lu Q, 2012, EUR J RADIOL, V81, pE338, DOI 10.1016/j.ejrad.2011.11.015; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Park YS, 2012, RADIOLOGY, V265, P617, DOI 10.1148/radiol.12112042; Rennert J, 2012, J GASTROINTEST LIVER, V21, P407; Suzuki R, 2010, J CONTROL RELEASE, V142, P245, DOI 10.1016/j.jconrel.2009.10.027; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Takalkar AM, 2004, J CONTROL RELEASE, V96, P473, DOI 10.1016/j.jconrel.2004.03.002; Tazaki T, 2010, HEPATOLOGY, V52, P1089, DOI 10.1002/hep.23767; Theruvath TP, 2006, TRANSPL P, V38, P3351, DOI 10.1016/j.transproceed.2006.10.171; Yang H, 2011, INT J NANOMED, V6, P2043, DOI 10.2147/IJN.S24808	33	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153805	10.1371/journal.pone.0153805	http://dx.doi.org/10.1371/journal.pone.0153805			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120181	gold, Green Published, Green Submitted			2022-12-26	WOS:000374976200037
J	Charles, JP; Cappellari, O; Spence, AJ; Hutchinson, JR; Wells, DJ				Charles, James P.; Cappellari, Ornella; Spence, Andrew J.; Hutchinson, John R.; Wells, Dominic J.			Musculoskeletal Geometry, Muscle Architecture and Functional Specialisations of the Mouse Hindlimb	PLOS ONE			English	Article							SOFT-TISSUE ANATOMY; PELVIC LIMB; SKELETAL-MUSCLE; COMPUTED-TOMOGRAPHY; MUSCULAR-DYSTROPHY; ENHANCED MICROCT; RABBIT HINDLIMB; UNIQUE ACTION; MOMENT ARMS; FIBER TYPES	Mice are one of the most commonly used laboratory animals, with an extensive array of disease models in existence, including for many neuromuscular diseases. The hindlimb is of particular interest due to several close muscle analogues/homologues to humans and other species. A detailed anatomical study describing the adult morphology is lacking, however. This study describes in detail the musculoskeletal geometry and skeletal muscle architecture of the mouse hindlimb and pelvis, determining the extent to which the muscles are adapted for their function, as inferred from their architecture. Using I2KI enhanced microCT scanning and digital segmentation, it was possible to identify 39 distinct muscles of the hindlimb and pelvis belonging to nine functional groups. The architecture of each of these muscles was determined through microdissections, revealing strong architectural specialisations between the functional groups. The hip extensors and hip adductors showed significantly stronger adaptations towards high contraction velocities and joint control relative to the distal functional groups, which exhibited larger physiological cross sectional areas and longer tendons, adaptations for high force output and elastic energy savings. These results suggest that a proximo-distal gradient in muscle architecture exists in the mouse hindlimb. Such a gradient has been purported to function in aiding locomotor stability and efficiency. The data presented here will be especially valuable to any research with a focus on the architecture or gross anatomy of the mouse hindlimb and pelvis musculature, but also of use to anyone interested in the functional significance of muscle design in relation to quadrupedal locomotion.	[Charles, James P.; Cappellari, Ornella; Wells, Dominic J.] Univ London Royal Vet Coll, Neuromuscular Dis Grp, Comparat Biomed Sci, 4 Royal Coll St, London NW1 0TU, England; [Cappellari, Ornella; Spence, Andrew J.; Hutchinson, John R.] Univ London Royal Vet Coll, Struct & Mot Lab, Comparat Biomed Sci, Hawkshead Lane, Hatfield AL9 7TA, Herts, England; [Spence, Andrew J.] Temple Univ, Coll Engn, Dept Bioengn, 1947 N 12th St, Philadelphia, PA 19122 USA	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Wells, DJ (corresponding author), Univ London Royal Vet Coll, Neuromuscular Dis Grp, Comparat Biomed Sci, 4 Royal Coll St, London NW1 0TU, England.	dwells@rvc.ac.uk	Hutchinson, John/AAH-1593-2020; Cappellari, Ornella/ABD-6840-2020	Cappellari, Ornella/0000-0002-1882-3502; Hutchinson, John/0000-0002-6767-7038; Wells, Dominic/0000-0002-1425-6344	Biotechnology and Biological Sciences Research Council [BB/J021504/1]; US Army Research Office [64929EG]; BBSRC [BB/J021504/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US Army Research Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) BB/J021504/1 and US Army Research Office (http://www.arl.army.mil/) 64929EG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1991, J EXP BIOL, V160, P55; Allen V, 2014, J ANAT, V225, P569, DOI 10.1111/joa.12245; Allen V, 2010, J ANAT, V216, P423, DOI 10.1111/j.1469-7580.2009.01202.x; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; BARNETT C H, 1953, Ann Phys Med, V1, P177; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Biewener AA, 1998, J EXP BIOL, V201, P1681; Biewener AA, 2007, J EXP BIOL, V210, P2949, DOI 10.1242/jeb.005801; BODINE SC, 1982, J NEUROPHYSIOL, V48, P192, DOI 10.1152/jn.1982.48.1.192; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Charles JP, J ANAT IN PRESS; Cox PG, 2011, ANAT REC, V294, P915, DOI 10.1002/ar.21381; Daley MA, 2007, J EXP BIOL, V210, P383, DOI 10.1242/jeb.02668; DeLaurier A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-83; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; During DN, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-1; Eng CM, 2008, J EXP BIOL, V211, P2336, DOI 10.1242/jeb.017640; FEDAK MA, 1982, J EXP BIOL, V97, P23; FRIEDERICH JA, 1990, J BIOMECH, V23, P91, DOI 10.1016/0021-9290(90)90373-B; Gignac PM, 2014, J EXP ZOOL PART B, V322, P166, DOI 10.1002/jez.b.22561; Gillis GB, 2005, J EXP BIOL, V208, P4599, DOI 10.1242/jeb.01940; Gillis GB, 2002, J APPL PHYSIOL, V93, P1731, DOI 10.1152/japplphysiol.00489.2002; GRIFFITHS RI, 1991, J PHYSIOL-LONDON, V436, P219, DOI 10.1113/jphysiol.1991.sp018547; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Heier CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112477; Henriques A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015445; Herdina AN, 2015, J ANAT, V226, P229, DOI 10.1111/joa.12274; Herdina AN, 2010, ANAT REC, V293, P1248, DOI 10.1002/ar.21148; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Lamas LP, 2014, PEERJ, V2, DOI 10.7717/peerj.716; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; LIEBER RL, 1989, J MORPHOL, V199, P93, DOI 10.1002/jmor.1051990108; Malerba A, 2011, MOL THER, V19, P345, DOI 10.1038/mt.2010.261; Mathewson MA, 2012, J ANAT, V221, P443, DOI 10.1111/j.1469-7580.2012.01559.x; MENDEZ J, 1960, METABOLISM, V9, P184; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Partridge TA, 2013, FEBS J, V280, P4177, DOI 10.1111/febs.12267; Paxton H, 2010, J ANAT, V217, P153, DOI 10.1111/j.1469-7580.2010.01251.x; Payne RC, 2005, J ANAT, V206, P557, DOI 10.1111/j.1469-7580.2005.00420.x; Payne RC, 2005, J ANAT, V206, P193, DOI 10.1111/j.1469-7580.2005.00353.x; POWELL PL, 1984, J APPL PHYSIOL, V57, P1715, DOI 10.1152/jappl.1984.57.6.1715; Reeves ND, 2003, J APPL PHYSIOL, V95, P1090, DOI 10.1152/japplphysiol.01046.2002; SACKS RD, 1982, J MORPHOL, V173, P185, DOI 10.1002/jmor.1051730206; SCHENAU GJV, 1989, HUM MOVEMENT SCI, V8, P301; SCHENAU GJV, 1987, J ANAT, V155, P1; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Spence AJ, 2012, CURR BIOL, V22, pR309, DOI 10.1016/j.cub.2012.03.017; Spence AJ, 2009, CURR BIOL, V19, pR57, DOI 10.1016/j.cub.2008.10.042; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Ward SR, 2005, J BIOMECH, V38, P2317, DOI 10.1016/j.jbiomech.2004.10.001; Wickiewicz TL, 1983, CLIN ORTHOP RELAT RE, P275; Williams SB, 2008, J ANAT, V213, P361, DOI [10.1111/j.1469-7580.2008.00961.x, 10.1111/j.1469-7580.2008.00962.x]; Williams SB, 2007, J ANAT, V210, P472, DOI 10.1111/j.1469-7580.2007.00704.x; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; Winters TM, 2011, J BIOMECH, V44, P109, DOI 10.1016/j.jbiomech.2010.08.033; YOUNG RP, 1993, EXP BRAIN RES, V96, P141, DOI 10.1007/BF00230447; ZAJAC FE, 1989, EXERCISE SPORT SCI R, V17, P187	64	64	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0147669	10.1371/journal.pone.0147669	http://dx.doi.org/10.1371/journal.pone.0147669			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115354	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600007
J	Lyngwi, NA; Nongkhlaw, M; Kalita, D; Joshi, SR				Lyngwi, Nathaniel A.; Nongkhlaw, Macmillan; Kalita, Debajit; Joshi, Santa Ram			Bioprospecting of Plant Growth Promoting Bacilli and Related Genera Prevalent in Soils of Pristine Sacred Groves: Biochemical and Molecular Approach	PLOS ONE			English	Article							PHOSPHATE SOLUBILIZING BACTERIA; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE; ACC DEAMINASE; GENOME SEQUENCE; KEY ENZYME; RHIZOBACTERIA; BIOSYNTHESIS; PETROBACTIN; EVOLUTION; GENETICS	Bacillus spp. and related genera native to soils of the pristine sacred groves from Meghalaya, India were characterized using biochemical and 16S rRNA gene analysis which revealed dominance of Bacillus, Paenibacillus, Lysinibacillus and Viridibacillus in the groves. Biochemical estimation was carried out for in vitro testing of plant growth promoting traits present in these isolates. PCR screening were performed for plant growth-promoting related genes involved in the biosynthesis of acid phosphatase (AcPho), indolepyruvate decarboxylase (ipdC), 1-aminocyclopropane-1-carboxylate deaminase (accd) and siderophore biosynthesis protein (asbA). 76% of the sacred grove isolates gave an amplified fragment for AcPho. Three of the isolates gave an amplified fragment for IpdC gene. Apart from 2 isolates, all the other isolates including the reference strains were positive for the amplification of the accd gene indicating their potential to produce ACC deaminase enzyme. 42% of the isolates gave an amplified fragment for asbA gene indicating the potential ability of these isolates to produce the catechol type siderophore, petrobactin. Overall findings indicated multiple PGP genetic traits present in these isolates which suggested that these isolates are capable of expressing multiple PGP traits. Phylogenetic and sequence analysis of accd and asbA genes from the isolates revealed that asbA genes from Paenibacillus taichungiensis SG3 and Paenibacillus tylopili SG24 indicated the occurrence of intergeneric horizontal transfer between Paenibacillus and Bacillus.	[Lyngwi, Nathaniel A.; Nongkhlaw, Macmillan; Kalita, Debajit; Joshi, Santa Ram] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Microbiol Lab, Shillong, Meghalaya, India	North Eastern Hill University	Joshi, SR (corresponding author), North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Microbiol Lab, Shillong, Meghalaya, India.	srjoshi2006@yahoo.co.in	Kalita, Debajit/H-9488-2014; Joshi/F-2097-2015	Joshi, Santa Ram/0000-0001-8080-484X	North Eastern Council, Government of India [NEC.ST/MG/693/2013]; DST-INSPIRE	North Eastern Council, Government of India(North Eastern Council, Government of India); DST-INSPIRE(Department of Science & Technology (India))	The authors thank North Eastern Council, Government of India for the financial support to carry out the study (Sanction No. NEC.ST/MG/693/2013 dated 22nd March 2013). MN thanks DST-INSPIRE for fellowship support.	Abeles F, 1992, ETHYLENE PLANT BIOL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnow LE, 1937, J BIOL CHEM, V118, P531; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Belimov AA, 2005, SOIL BIOL BIOCHEM, V37, P241, DOI 10.1016/j.soilbio.2004.07.033; Bhagobaty RK, 2011, FOR SCI TECHNOL, V7, P151, DOI 10.1080/21580103.2011.621381; BISHOP ML, 1994, SOIL SCI, V157, P238, DOI 10.1097/00010694-199404000-00006; BROWN ME, 1974, ANNU REV PHYTOPATHOL, V12, P181, DOI 10.1146/annurev.py.12.090174.001145; Bruto M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06261; Carney KM, 2006, MICROB ECOL, V52, P226, DOI 10.1007/s00248-006-9115-z; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen YP, 2006, APPL SOIL ECOL, V34, P33, DOI 10.1016/j.apsoil.2005.12.002; Clark FE, 1997, SOIL MICROBIOLOGY BI, P340; Collins CH, 2001, MICROBIOLOGICAL METH, P98; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; El-Sawah M.M.A., 1993, J AGR SCI, V18, P2775; FELLER C, 1994, CAN J SOIL SCI, V74, P121, DOI 10.4141/cjss94-019; Fujino A, 2004, J MOL BIOL, V341, P999, DOI 10.1016/j.jmb.2004.06.062; Gamalero E, 2011, BACTERIA IN AGROBIOLOGY: PLANT NUTRIENT MANAGEMENT, P17, DOI 10.1007/978-3-642-21061-7_2; GARCIA C, 1992, SOIL BIOL BIOCHEM, V25, P361; Glick BR, 2014, MICROBIOL RES, V169, P30, DOI 10.1016/j.micres.2013.09.009; GLICK BR, 1999, BIOCH GENETIC MECH U, P45; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Grichko VP, 2001, PLANT PHYSIOL BIOCH, V39, P11, DOI 10.1016/S0981-9428(00)01212-2; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Holt J, 1994, BERGEYS MANUAL DETER, V9th; HONMA M, 1978, AGR BIOL CHEM TOKYO, V42, P1825, DOI 10.1080/00021369.1978.10863261; Hontzeas N, 2005, APPL ENVIRON MICROB, V71, P7556, DOI 10.1128/AEM.71.11.7556-7558.2005; Hontzeas N, 2004, BBA-PROTEINS PROTEOM, V1703, P11, DOI 10.1016/j.bbapap.2004.09.015; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Joung KB, 2002, J APPL MICROBIOL, V92, P97, DOI 10.1046/j.1365-2672.2002.01507.x; Kawaguchi M, 1996, PLANT CELL PHYSIOL, V37, P1043, DOI 10.1093/oxfordjournals.pcp.a029051; Kayang H., 2006, ASIAN J MICROBIOLOGY, V8, P521; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KNUDSEN D, 1988, N CENTRAL REGIONAL P, V221, P12; Koppisch AT, 2008, BIOMETALS, V21, P581, DOI 10.1007/s10534-008-9144-9; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; Lee JC, 2008, INT J SYST EVOL MICR, V58, P612, DOI 10.1099/ijs.0.65350-0; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lynch J. M., 1990, The rhizosphere., P177; Lyngwi NA, 2015, INDIAN J TRADIT KNOW, V14, P474; Lyngwi NA, 2013, REV BIOL TROP, V61, P467; MarekKozaczuk M, 1996, PLANT SOIL, V179, P269, DOI 10.1007/BF00009337; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; MAYAK S, 2004, PLANT PHYSIOL BIOCH, V167, P650; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Nongkhlaw M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048199; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Prescott LM, 2002, MICROBIOLOGY, P34; Raddadi N, 2008, ANN MICROBIOL, V58, P47, DOI 10.1007/BF03179444; Ragan MA, 2001, CURR OPIN GENET DEV, V11, P620, DOI 10.1016/S0959-437X(00)00244-6; Rodriguez H, 2006, PLANT SOIL, V287, P15, DOI 10.1007/s11104-006-9056-9; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Schutz A, 2003, EUR J BIOCHEM, V270, P2322, DOI 10.1046/j.1432-1033.2003.03602.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Seshadri R, 2015, SCI REP-UK, V5, DOI 10.1038/srep16825; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Wahyudi A. T., 2011, Journal of Microbiology and Antimicrobials, V3, P34; Wang CX, 2000, CAN J MICROBIOL, V46, P898, DOI 10.1139/cjm-46-10-898; Wilson MK, 2010, BIOMETALS, V23, P129, DOI 10.1007/s10534-009-9272-x; XU JG, 1995, PLANT SOIL, V173, P3, DOI 10.1007/BF00155512	69	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152951	10.1371/journal.pone.0152951	http://dx.doi.org/10.1371/journal.pone.0152951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111883	Green Submitted, Green Published, gold			2022-12-26	WOS:000374970600006
J	Wong, KK; Zhu, F; Khatri, I; Huo, Q; Spaner, DE; Gorczynski, RM				Wong, Karrie K.; Zhu, Fang; Khatri, Ismat; Huo, Qiang; Spaner, David E.; Gorczynski, Reginald M.			Characterization of CD200 Ectodomain Shedding	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; L-SELECTIN CD62L; SOLUBLE CD200; CLEAVAGE; CELLS; INHIBITOR; RECEPTOR; FORM; PROTEASES; PATHWAYS	We have previously reported the existence of a soluble form of CD200 (sCD200) in human plasma, and found sCD200 to be elevated in the plasma of Chronic Lymphocytic Leukemia (CLL) patients. CLL cells release CD200 at a constitutive level, which could be attenuated partially by ADAM28 silencing. In this study, we further explored mechanisms of CD200 shedding beyond that of ADAM28, and performed biochemical analysis of sCD200 using materials derived from purified CLL cells and Hek293 cells stably transfected with CD200, and antibodies generated specifically against either the extracellular or cytoplasmic regions of CD200. CD200 shedding was enhanced by PMA stimulation, and the loss of cell surface CD200 could be monitored as a reduction in CD200 cell surface expression by flow cytometry, in parallel with an increase in the detection of sCD200 in the supernatant. Western blot analyses and functional studies using CD200R1 expressing Hek293 cells showed that the shed CD200 detected in CLL and Hek293-hCD200 supernatants lacked the cytoplasmic domain of CD200 but retained the functional extracellular domain required for binding to, and phosphorylation of, CD200R. These data confirms that a functionally active CD200 extracellular moiety can be cleaved from the surface of CD200 expressing cells following ectodomain shedding.	[Wong, Karrie K.; Zhu, Fang; Gorczynski, Reginald M.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Zhu, Fang; Khatri, Ismat; Huo, Qiang; Gorczynski, Reginald M.] Univ Hlth Network, Transplant Res Div, Toronto, ON, Canada; [Zhu, Fang; Khatri, Ismat; Huo, Qiang; Gorczynski, Reginald M.] Univ Toronto, Toronto, ON, Canada; [Spaner, David E.] Univ Toronto, Sunnybrook Res Inst, Div Mol & Cellular Biol, Toronto, ON, Canada; [Wong, Karrie K.] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Gorczynski, RM (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Gorczynski, RM (corresponding author), Univ Hlth Network, Transplant Res Div, Toronto, ON, Canada.; Gorczynski, RM (corresponding author), Univ Toronto, Toronto, ON, Canada.	rgorczynski@uhnres.utoronto.ca	Wong, Karrie/F-8105-2017; Zhu, Fang/L-3411-2016; Gorczynski, Reginald/AAA-1435-2019	Wong, Karrie/0000-0002-3192-6872; 	Canadian Institutes of Health Research (CIHR) [190633]; Canadian Institutes of Health Research Regenerative Medicine Graduate Fellowship; CIHR [190633]; Leukemia and Lymphoma Society of Canada (LLSC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087746] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Regenerative Medicine Graduate Fellowship(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society of Canada (LLSC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the Canadian Institutes of Health Research (CIHR) (#190633) for RG, the Canadian Institutes of Health Research Regenerative Medicine Graduate Fellowship for KW, CIHR (#190633) and the Leukemia and Lymphoma Society of Canada (LLSC) (to DES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Ashiru O, 2010, CANCER RES, V70, P481, DOI 10.1158/0008-5472.CAN-09-1688; Borland G, 1999, J BIOL CHEM, V274, P2810, DOI 10.1074/jbc.274.5.2810; Brenneman F., 2011, SOLUBLE CD200 UNPUB; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chen ZQ, 2008, TRANSPLANTATION, V86, P1116, DOI 10.1097/TP.0b013e318186fec2; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Fourie AM, 2003, J BIOL CHEM, V278, P30469, DOI 10.1074/jbc.M213157200; Frigola X, 2011, CLIN CANCER RES, V17, P1915, DOI 10.1158/1078-0432.CCR-10-0250; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gasbarri A, 2003, MELANOMA RES, V13, P325, DOI 10.1097/00008390-200308000-00001; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gorczynski Reginald M, 2005, Curr Opin Investig Drugs, V6, P483; Gu B, 1998, BLOOD, V92, P946; Hargreaves PG, 1998, BRIT J HAEMATOL, V101, P694, DOI 10.1046/j.1365-2141.1998.00754.x; Khatri Ismat B I, 2012, OPEN J IMMUNOLOGY, V2, P15; Kos O, 2014, BONE, V60, P33, DOI 10.1016/j.bone.2013.12.004; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lesesve J F, 2001, Hematol J, V2, P355, DOI 10.1038/sj.thj.6200129; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moreaux J, 2008, BIOCHEM BIOPH RES CO, V366, P117, DOI 10.1016/j.bbrc.2007.11.103; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Oaks MK, 2000, CELL IMMUNOL, V201, P144, DOI 10.1006/cimm.2000.1649; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schwager SLU, 1999, BIOCHEMISTRY-US, V38, P10388, DOI 10.1021/bi990357j; Schwarzmeier JD, 2002, LEUKEMIA LYMPHOMA, V43, P549, DOI 10.1080/10428190210323; Seiffert M, 2010, BLOOD, V116, P4223, DOI 10.1182/blood-2010-05-284505; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Stumpfova M, 2010, CANCER RES, V70, P2962, DOI 10.1158/0008-5472.CAN-09-4380; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Twito T, 2013, LEUKEMIA RES, V37, P816, DOI 10.1016/j.leukres.2013.04.014; Walker DG, 2013, FUTUR NEUROL, V8, P321, DOI [10.2217/fnl.13.14, 10.2217/FNL.13.14]; Wong KK, 2012, CANCER RES, V72, P4931, DOI 10.1158/0008-5472.CAN-12-1390; Wong KK, 2010, J LEUKOCYTE BIOL, V88, P361, DOI 10.1189/jlb.1009686; Zhang GB, 2009, LUNG CANCER, V66, P245, DOI 10.1016/j.lungcan.2009.01.017; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200	49	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152073	10.1371/journal.pone.0152073	http://dx.doi.org/10.1371/journal.pone.0152073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111430	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600001
J	Mercier, A; Sun, Z; Parrish, CC; Hamel, JF				Mercier, Annie; Sun, Zhao; Parrish, Christopher C.; Hamel, Jean-Francois			Remarkable Shifts in Offspring Provisioning during Gestation in a Live-Bearing Cnidarian	PLOS ONE			English	Article							PARENTAL CARE; FETAL NUTRITION; SIZE; EVOLUTION; VIVIPARITY; CONFLICT; FISH; SPECIALIZATIONS; PLACENTOTROPHY; MATROTROPHY	Animals display diverse means of producing and provisioning offspring, from eggs to embryos and juveniles. While external development predominates, many forms of embryonic incubation have evolved, including placentation in mammals and a number of understudied variants in basal metazoans that could help understand evolutionary diversification. Here we studied the brooding sea anemone Aulactinia stella, using behavioural, morphological and biochemical indicators of offspring phenotype to characterize gestation and elucidate parental and sibling relationships. The pronounced variance in juvenile weight within broods was not strongly related to any of the typical external predictors (adult weight, clutch size, sampling date, environmental conditions). Lipid concentration was significantly higher in the tissues of the small juveniles than in those of large juveniles or adult, and fatty acid profiles tended to set small juveniles apart. Finally, intra-brood feeding on external resources was documented in larger juveniles. These results are consistent with ontogenetic shifts in nutrition, from vitellogenic provisioning to post-zygotic nourishment to a prenatal form of nursing upon acquisition of feeding organs, highlighting matrotrophic and conflict-driven mechanisms acting on offspring phenotype during gestation.	[Mercier, Annie; Sun, Zhao; Parrish, Christopher C.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada; [Hamel, Jean-Francois] SEVE, Portugal Cove St Philips, NF, Canada	Memorial University Newfoundland	Mercier, A (corresponding author), Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada.	amercier@mun.ca	Mercier, Annie/B-4254-2012		Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) and Canada Foundation for Innovation (http://www.innovation.ca/) grants to AM and CCP.	Ala-Honkola O, 2011, J EVOLUTION BIOL, V24, P2600, DOI 10.1111/j.1420-9101.2011.02383.x; Avise JC, 2011, P NATL ACAD SCI USA, V108, P11512, DOI 10.1073/pnas.1109216108; Beekey MA, 2000, CAN J ZOOL, V78, P1697, DOI 10.1139/cjz-78-10-1697; Blackburn DG, 2015, J MORPHOL, V276, P961, DOI 10.1002/jmor.20272; BLACKBURN DG, 1992, AM ZOOL, V32, P313; Bocharova ES, 2015, HYDROBIOLOGIA, V759, P27, DOI 10.1007/s10750-015-2250-0; Brante A, 2003, MAR ECOL PROG SER, V251, P221, DOI 10.3354/meps251221; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Collin R, 2012, BIOL BULL-US, V223, P268, DOI 10.1086/BBLv223n3p268; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Fernandez M, 2000, ECOL LETT, V3, P487, DOI 10.1046/j.1461-0248.2000.00172.x; Guralnick R, 2004, J MOLLUS STUD, V70, P341, DOI 10.1093/mollus/70.4.341; HALL SJ, 1986, J MOLLUS STUD, V52, P193, DOI 10.1093/mollus/52.3.193; Heras H, 2000, LIPIDS, V35, P645, DOI 10.1007/s11745-000-0569-z; Jacobs MW, 2010, INTEGR COMP BIOL, V50, P630, DOI 10.1093/icb/icq091; Jorgensen C, 2011, AM NAT, V177, pE119, DOI 10.1086/659622; Kalinka AT, 2015, BIOESSAYS, V37, P721, DOI 10.1002/bies.201400200; Kaliszewicz A, 2012, POLAR BIOL, V35, P1911, DOI 10.1007/s00300-012-1232-1; Kamel SJ, 2010, INTEGR COMP BIOL, V50, P619, DOI 10.1093/icb/icq104; Kamel SJ, 2010, TRENDS ECOL EVOL, V25, P442, DOI 10.1016/j.tree.2010.05.008; Kolliker M, 2012, EVOLUTION OF PARENTAL CARE, P285; Lode T, 2012, REPROD BIOL, V12, P259, DOI 10.1016/j.repbio.2012.09.001; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; Mercier A, 2011, P ROY SOC B-BIOL SCI, V278, P3517, DOI 10.1098/rspb.2011.0605; Mercier A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1749, DOI 10.1007/s00265-010-0987-z; Mock D. W., 1997, EVOLUTION SIBLING RI; Monteith KM, 2012, J EVOLUTION BIOL, V25, P1815, DOI 10.1111/j.1420-9101.2012.02567.x; Ostrovsky AN, 2016, BIOL REV, V91, P673, DOI 10.1111/brv.12189; Ostrovsky AN, 2013, EVOLUTION, V67, P1368, DOI 10.1111/evo.12039; Ostrovsky AN, 2009, MAR ECOL PROG SER, V378, P113, DOI 10.3354/meps07850; Parrish CC, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P4; Parrish CC, 2009, MAR ECOL PROG SER, V391, P33, DOI 10.3354/meps08148; Pollux BJA, 2014, NATURE, V513, P233, DOI 10.1038/nature13451; Pollux BJA, 2011, FUNCT ECOL, V25, P747, DOI 10.1111/j.1365-2435.2011.01831.x; Rollinson N, 2011, OECOLOGIA, V166, P889, DOI 10.1007/s00442-011-1945-9; Rosa R, 2003, AQUACULTURE, V221, P507, DOI 10.1016/S0044-8486(03)00117-0; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Schrader M, 2005, COPEIA, P649; Schrader M, 2012, EVOLUTION, V66, P272, DOI 10.1111/j.1558-5646.2011.01422.x; SHINE R, 1989, AM NAT, V134, P311, DOI 10.1086/284982; SHINE R, 1978, J THEOR BIOL, V75, P417, DOI 10.1016/0022-5193(78)90353-3; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; Smiseth PT, 2007, EVOLUTION, V61, P2331, DOI 10.1111/j.1558-5646.2007.00192.x; Sun Z, 2015, ECOL EVOL, V5, P1117, DOI 10.1002/ece3.1320; Sun Z, 2012, AM NAT, V180, pE151, DOI 10.1086/667862; Trexler JC, 2003, AM NAT, V162, P574, DOI 10.1086/378822; TRIVERS RL, 1974, AM ZOOL, V14, P249; Trumbo Stephen T., 1996, Advances in the Study of Behavior, V25, P3; Van Dyke JU, 2014, AM NAT, V184, P198, DOI 10.1086/677138; Wehrtmann IS, 1998, COMP BIOCHEM PHYS B, V121, P457, DOI 10.1016/S0305-0491(98)10141-4	52	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154051	10.1371/journal.pone.0154051	http://dx.doi.org/10.1371/journal.pone.0154051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104375	Green Published, gold			2022-12-26	WOS:000374565100039
J	Ramjee, G; Moonsamy, S; Abbai, NS; Wand, H				Ramjee, Gita; Moonsamy, Suri; Abbai, Nathlee Samantha; Wand, Handan			Individual and Population Level Impact of Key HIV Risk Factors on HIV Incidence Rates in Durban, South Africa	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PREEXPOSURE PROPHYLAXIS; GENITAL-TRACT; WOMEN; PREVENTION	We aimed to estimate the individual and joint impact of age, marital status and diagnosis with sexually transmitted infections (STIs) on HIV acquisition among young women at a population level in Durban, KwaZulu-Natal, South Africa. A total of 3,978 HIV seronegative women were recruited for four biomedical intervention trials from 2002-2009. Point and interval estimates of partial population attributable risk (PAR) were used to quantify the proportion of HIV seroconversions which can be prevented if a combination of risk factors is eliminated from a target population. More than 70% of the observed HIV acquisitions were collectively attributed to the three risk factors: younger age (<25 years old), unmarried and not cohabiting with a stable/regular partner and diagnosis with STIs. Addressing these risks requires targeted structural, behavioural, biomedical and cultural interventions in order to impact on unacceptably high HIV incidence rates among young women and the population as a whole.	[Ramjee, Gita; Moonsamy, Suri; Abbai, Nathlee Samantha] MRC, HIV Prevent Res Unit, Durban, South Africa; [Ramjee, Gita] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Ramjee, Gita] Univ Washington, Sch Med, Dept Global Hlth, Washington, DC USA; [Wand, Handan] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of London; London School of Hygiene & Tropical Medicine; University of Washington; University of New South Wales Sydney; Kirby Institute	Ramjee, G (corresponding author), MRC, HIV Prevent Res Unit, Durban, South Africa.; Ramjee, G (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.; Ramjee, G (corresponding author), Univ Washington, Sch Med, Dept Global Hlth, Washington, DC USA.	Gita.Ramjee@mrc.ac.za	abbai, nathlee/Q-5097-2019	Abbai, Nathlee/0000-0003-2392-0574				Balkus JE, 2015, JAIDS-J ACQ IMM DEF, V70, P212, DOI 10.1097/QAI.0000000000000715; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Corneli A, 2014, JAIDS-J ACQ IMM DEF, V67, P555, DOI 10.1097/QAI.0000000000000362; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Fichorova RN, 2015, MBIO, V6, DOI 10.1128/mBio.00221-15; Jewkes R, 2015, LANCET, V385, P1580, DOI 10.1016/S0140-6736(14)61683-4; Karim Q, 2015, IMPACT CONDITIONAL C; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kleppa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098593; Losina E., 2010, PLOS ONE, V5, P1; Mabala R, 2006, ENVIRON URBAN, V18, P407, DOI 10.1177/0956247806069624; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298; Naicker N, 2015, AIDS BEHAV, V19, P1305, DOI 10.1007/s10461-015-1002-5; Naidoo S, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-31; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Pettifor A, 2015, HPTN 068 CONDITIONAL; Plan NS, 2011, NATL STRATEGIC PLAN; Ramjee G, 2005, JAIDS-J ACQ IMM DEF, V39, P333, DOI 10.1097/01.qai.0000144445.44518.ea; Ramjee G, 2012, B WORLD HEALTH ORGAN, V90, P785; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Ramjee G, 2012, AIDS BEHAV, V16, P2062, DOI 10.1007/s10461-011-0043-7; Reddy BS, 2004, CLIN EXP IMMUNOL, V137, P552, DOI 10.1111/j.1365-2249.2004.02564.x; Rees H, 2015, C RETR OPP INF SEATT, p26LB; Santelli JS, 2013, JAIDS-J ACQ IMM DEF, V63, P393, DOI 10.1097/QAI.0b013e3182926795; Shisana O, 2009, S AFRICAN NATL HIV P; Shisana O, 2014, S AFRICAN NATL HIV P; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Sperling R, 2013, J REPROD IMMUNOL, V99, P80, DOI 10.1016/j.jri.2013.07.003; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Street RA, 2016, INT J STD AIDS, V27, P746, DOI 10.1177/0956462415592325; UNAIDS, 2012, EV MIN YOUNG WOM IS; UNAIDS, 2016, GLOB REP GLOB AIDS E; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Wand Handan, 2015, J Int AIDS Soc, V18, P19866, DOI 10.7448/IAS.18.1.19866; Wand H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000285; Wand H, 2011, AIDS BEHAV, V15, P479, DOI 10.1007/s10461-010-9845-2; Wilkinson D, 1998, SEX TRANSM DIS, V25, P20, DOI 10.1097/00007435-199801000-00005	40	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153969	10.1371/journal.pone.0153969	http://dx.doi.org/10.1371/journal.pone.0153969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104835	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100032
J	Come, C; Cvrljevic, A; Khan, MM; Treise, I; Adler, T; Aguilar-Pimentel, JA; Au-Yeung, B; Sittig, E; Laajala, TD; Chen, YL; Oeder, S; Calzada-Wack, J; Horsch, M; Aittokallio, T; Busch, DH; Ollert, MW; Neff, F; Beckers, J; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Chen, Z; Lahesmaa, R; Westermarck, J				Come, Christophe; Cvrljevic, Anna; Khan, Mohd Moin; Treise, Irina; Adler, Thure; Aguilar-Pimentel, Juan Antonio; Au-Yeung, Byron; Sittig, Eleonora; Laajala, Teemu Daniel; Chen, Yiling; Oeder, Sebastian; Calzada-Wack, Julia; Horsch, Marion; Aittokallio, Tero; Busch, Dirk H.; Ollert, Markus W.; Neff, Frauke; Beckers, Johannes; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Chen, Zhi; Lahesmaa, Riitta; Westermarck, Jukka			CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes Infection	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; CATALYTIC-ACTIVITY; CANCER; APOPTOSIS; PP2A; ONCOPROTEIN; INHIBITOR; KINASE; ZAP70	The oncoprotein Cancerous Inhibitor of Protein Phosphatase 2A ( CIP2A) is overexpressed in most malignancies and is an obvious candidate target protein for future cancer therapies. However, the physiological importance of CIP2A-mediated PP2A inhibition is largely unknown. As PP2A regulates immune responses, we investigated the role of CIP2A in normal immune system development and during immune response in vivo. We show that CIP2A-deficient mice (CIP2A(HOZ)) present a normal immune system development and function in unchallenged conditions. However when challenged with Listeria monocytogenes, CIP2A(HOZ) mice display an impaired adaptive immune response that is combined with decreased frequency of both CD4(+) T-cells and CD8(+) effector T-cells. Importantly, the cell autonomous effect of CIP2A deficiency for T-cell activation was confirmed. Induction of CIP2A expression during T-cell activation was dependent on Zap70 activity. Thus, we reveal CIP2A as a hitherto unrecognized mediator of T-cell activation during adaptive immune response. These results also reveal CIP2A(HOZ) as a possible novel mouse model for studying the role of PP2A activity in immune regulation. On the other hand, the results also indicate that CIP2A targeting cancer therapies would not cause serious immunological side-effects.	[Come, Christophe; Cvrljevic, Anna; Khan, Mohd Moin; Sittig, Eleonora; Laajala, Teemu Daniel; Chen, Zhi; Lahesmaa, Riitta; Westermarck, Jukka] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Come, Christophe; Cvrljevic, Anna; Khan, Mohd Moin; Sittig, Eleonora; Laajala, Teemu Daniel; Chen, Zhi; Lahesmaa, Riitta; Westermarck, Jukka] Abo Akad Univ, Turku, Finland; [Khan, Mohd Moin] Univ Turku, Turku Doctoral Programme Mol Med TuDMM, Fac Med, Turku, Finland; [Treise, Irina; Adler, Thure; Aguilar-Pimentel, Juan Antonio; Calzada-Wack, Julia; Horsch, Marion; Neff, Frauke; Beckers, Johannes; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany; [Treise, Irina; Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Aguilar-Pimentel, Juan Antonio] Tech Univ Munich, Klinikum Rechts Isar, Biederstein, Dept Dermatol & Allergy, D-80290 Munich, Germany; [Au-Yeung, Byron; Chen, Yiling] Univ Calif San Francisco, Dept Med, Dept Microbiol & Immunol, Howard Hughes Med Inst,Rosalind Russell Med Res C, San Francisco, CA USA; [Laajala, Teemu Daniel] Univ Turku, Dept Math & Stat, Turku, Finland; [Oeder, Sebastian] Tech Univ Munich, Ctr Allergy & Environm Munich ZAUM, D-80290 Munich, Germany; [Oeder, Sebastian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Allergy Res, Munich, Germany; [Oeder, Sebastian] Kuhne Fdn, Christine Kuhne Ctr Allergy Res & Educ CKCARE, Munich, Germany; [Calzada-Wack, Julia; Neff, Frauke] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Treise, Irina; Horsch, Marion; Beckers, Johannes; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Aittokallio, Tero] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Ollert, Markus W.] Tech Univ Munich, Ctr Allergy & Environm Munich ZAUM, Clin Res Grp Mol Allergol, D-80290 Munich, Germany; [Ollert, Markus W.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Allergy Res, Munich, Germany; [Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany; [Westermarck, Jukka] Univ Turku, Dept Pathol, Turku, Finland	University of Turku; Abo Akademi University; University of Turku; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Turku; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Helsinki; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Turku	Come, C (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.; Come, C (corresponding author), Abo Akad Univ, Turku, Finland.	christophe.come@bric.ku.dk	Chen, Yi/HIR-2608-2022; Westermarck, Jukka/AAL-6464-2020; de Angelis, Martin Hrabe/F-5531-2012; Aittokallio, Tero/B-6583-2009; Beckers, Johannes/K-7237-2012; Khan, Mohd Moin/GYQ-7170-2022; Gailus-Durner, Valerie/M-7337-2014; Come, Christophe/E-8395-2016	Westermarck, Jukka/0000-0001-7478-3018; de Angelis, Martin Hrabe/0000-0002-7898-2353; Aittokallio, Tero/0000-0002-0886-9769; Beckers, Johannes/0000-0001-7874-3822; Au-Yeung, Byron/0000-0002-6446-9102; Chen, Zhi/0000-0002-4658-7463; Calzada, Julia/0000-0003-0816-9305; Cvrljevic, Anna/0000-0003-2851-8701; Ollert, Markus W./0000-0002-8055-0103; Laajala, Teemu Daniel/0000-0002-7016-7354; Come, Christophe/0000-0001-5229-4440	Academy of Finland [121413, 122546, 258313, 137687, 133227, 140880, 269862, 272437]; Sigrid Juselius Foundation; Turku Doctoral Programme of Molecular Medicine (TuDMM); Foundation for the Finnish Cancer Institute; German Federal Ministry of Education and Research; Infrafrontier [01KX1012]; German National Genome Research Network (BMBF-NGFN project) [01GS0868]; Seventh Framework Programme of the European Commission [FP7-SYBILLA-201106]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR065481] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku Doctoral Programme of Molecular Medicine (TuDMM); Foundation for the Finnish Cancer Institute; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Infrafrontier; German National Genome Research Network (BMBF-NGFN project); Seventh Framework Programme of the European Commission(European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the Academy of Finland (http://www.aka.fi/fi/; grants 121413, 122546, 258313 and 137687, 133227, 140880, 269862, 272437), Sigrid Juselius Foundation (http://sigridjuselius.net/), Turku Doctoral Programme of Molecular Medicine (TuDMM; http://www.utu.fi/en/units/med/studying/postgrad/doctoral/doctoralprogrammes/ tudmm/Pages/home.aspx), Foundation for the Finnish Cancer Institute (http://syopasaatio.fi/), the German Federal Ministry of Education and Research (http://www.bmbf.de/; Infrafrontier grant 01KX1012), German National Genome Research Network (BMBF-NGFN project 01GS0868 to MO) and the Seventh Framework Programme of the European Commission (http://cordis.europa.eu/fp7/home_en.html; FP7-SYBILLA-201106).	Apostolidis SA, 2013, J BIOL CHEM, V288, P26775, DOI 10.1074/jbc.M113.483743; Au-Yeung BB, 2014, NATURE IMMUNOL UNPUB; Au-Yeung BB, 2014, NAT IMMUNOL, V15, P687, DOI 10.1038/ni.2918; Au-Yeung BB, 2010, NAT IMMUNOL, V11, P1085, DOI 10.1038/ni.1955; Bandukwala HS, 2012, P NATL ACAD SCI USA, V109, P14532, DOI 10.1073/pnas.1212264109; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Collison A, 2013, NAT MED, V19, P232, DOI 10.1038/nm.3049; Crispin JC, 2012, J IMMUNOL, V188, P3567, DOI 10.4049/jimmunol.1200143; Crispin JC, 2011, P NATL ACAD SCI USA, V108, P12443, DOI 10.1073/pnas.1103915108; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Homsi J, SUPPORTIVE CARE CANC, V8, P487; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2013, CANCER RES, V73, P6548, DOI 10.1158/0008-5472.CAN-13-1994; Kugler JE, 2013, J BIOL CHEM, V288, P16690, DOI 10.1074/jbc.M113.463315; Laine A, 2013, CANCER DISCOV, V3, P182, DOI 10.1158/2159-8290.CD-12-0292; LANGERMANS JAM, 1994, IMMUNOLOGY, V81, P192; Niemela M, 2012, ONCOGENE, V31, P4266, DOI 10.1038/onc.2011.599; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Peng B, 2015, MOL BIOSYST, V11, P105, DOI 10.1039/c4mb00513a; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Puustinen P, 2014, AUTOPHAGY, V10, P1352, DOI 10.4161/auto.29076; Puustinen P, 2014, J CELL BIOL, V204, P713, DOI 10.1083/jcb.201304012; Roncagalli R, 2014, NAT IMMUNOL, V15, P384, DOI 10.1038/ni.2843; Stosor V, 2014, INFECT COMPLICATIONS; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Ventela S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033209; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wang J, 2011, INT J LAB HEMATOLOGY; Weaver JL, 2002, TOXICOL MECH METHOD, V12, P95, DOI 10.1080/10517230290075341; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; Zembower TR, 2014, CANCER TREAT RES, V161, P43, DOI 10.1007/978-3-319-04220-6_2; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152996	10.1371/journal.pone.0152996	http://dx.doi.org/10.1371/journal.pone.0152996			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100879	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500020
J	Le, HTMD; Angotzi, AR; Ebbesson, LOE; Karlsen, O; Ronnestad, I				Le, Hoang T. M. D.; Angotzi, Anna Rita; Ebbesson, Lars O. E.; Karlsen, Orjan; Ronnestad, Ivar			The Ontogeny and Brain Distribution Dynamics of the Appetite Regulators NPY, CART and pOX in Larval Atlantic Cod (Gadus morhua L.)	PLOS ONE			English	Article							NEUROPEPTIDE-Y NPY; HALIBUT HIPPOGLOSSUS-HIPPOGLOSSUS; MELANIN-CONCENTRATING HORMONE; MESSENGER-RNA EXPRESSION; ORANGE-SPOTTED GROUPER; SALMON SALMO-SALAR; TRANSCRIPT CART; MOLECULAR-CLONING; FEEDING-BEHAVIOR; FOOD-INTAKE	Similar to many marine teleost species, Atlantic cod undergo remarkable physiological changes during the early life stages with concurrent and profound changes in feeding biology and ecology. In contrast to the digestive system, very little is known about the ontogeny and the localization of the centers that control appetite and feed ingestion in the developing brain of fish. We examined the expression patterns of three appetite regulating factors (orexigenic: neuropeptide Y, NPY; prepro-orexin, pOX and anorexigenic: cocaine-and amphetamine-regulated transcript, CART) in discrete brain regions of developing Atlantic cod using chromogenic and double fluorescent in situ hybridization. Differential temporal and spatial expression patterns for each appetite regulator were found from first feeding (4 days post hatch; dph) to juvenile stage (76 dph). Neurons expressing NPY mRNA were detected in the telencephalon (highest expression), diencephalon, and optic tectum from 4 dph onward. CART mRNA expression had a wider distribution along the anterior-posterior brain axis, including both telencephalon and diencephalon from 4 dph. From 46 dph, CART transcripts were also detected in the olfactory bulb, region of the nucleus of medial longitudinal fascicle, optic tectum and midbrain tegmentum. At 4 and 20 dph, pOX mRNA expression was exclusively found in the preoptic region, but extended to the hypothalamus at 46 and 76 dph. Co-expression of both CART and pOX genes were also observed in several hypothalamic neurons throughout larval development. Our results show that both orexigenic and anorexigenic factors are present in the telencephalon, diencephalon and mesencephalon in cod larvae. The telencephalon mostly contains key factors of hunger control (NPY), while the diencephalon, and particularly the hypothalamus may have a more complex role in modulating the multifunctional control of appetite in this species. As the larvae develop, the overall progression in temporal and spatial complexity of NPY, CART and pOX mRNAs expression might be correlated to the maturation of appetite control regulation. These observations suggest that teleost larvae continue to develop the regulatory networks underlying appetite control after onset of exogenous feeding.	[Le, Hoang T. M. D.; Angotzi, Anna Rita; Ronnestad, Ivar] Univ Bergen, Dept Biol, Bergen, Norway; [Ebbesson, Lars O. E.] Uni Res AS, Uni Res Environm, Bergen, Norway; [Karlsen, Orjan] Inst Marine Res, Storebo, Norway; [Le, Hoang T. M. D.] Nha Trang Univ, Inst Aquaculture, Nha Trang, Khanh Hoa, Vietnam	University of Bergen; University of Bergen; Institute of Marine Research - Norway; Nha Trang University	Ronnestad, I (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	ivar.ronnestad@uib.no	Karlsen, Ørjan/K-6137-2012; Rønnestad, Ivar/A-1774-2013	Karlsen, Ørjan/0000-0001-5801-4200; Rønnestad, Ivar/0000-0001-8789-0197; Ebbesson, Lars Olof Ebbe/0000-0002-5965-1284; Angotzi, Anna Rita/0000-0002-3824-2350	Research Council of Norway [199482]; NORAD Quota Scheme Scholarship (Norwegian State Educational Loan Fund)	Research Council of Norway(Research Council of Norway); NORAD Quota Scheme Scholarship (Norwegian State Educational Loan Fund)	The study was part of a project on Atlantic cod development (CODE) funded by the Research Council of Norway (www.forskningsradet.no/en/) with project number: 199482. HTMDL was supported by NORAD Quota Scheme Scholarship (Norwegian State Educational Loan Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiya N, 2007, NEUROSCI LETT, V427, P16, DOI 10.1016/j.neulet.2007.07.043; Auditore PJ, 1994, NAFO SCI COUNCIL STU, P7; Barreiro-Iglesias A, 2010, NEUROSCIENCE, V167, P396, DOI 10.1016/j.neuroscience.2010.02.030; Bruin JC, 1980, COMP NEUROLOGY TELEN, P175; Buckley C, 2010, PEPTIDES, V31, P1737, DOI 10.1016/j.peptides.2010.05.017; Castro A, 1999, J COMP NEUROL, V414, P13, DOI 10.1002/(SICI)1096-9861(19991108)414:1<13::AID-CNE2>3.0.CO;2-R; Cerda-Reverter JM, 2000, J CHEM NEUROANAT, V19, P197, DOI 10.1016/S0891-0618(00)00063-6; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P2336, DOI 10.1210/en.2002-0213; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P4552, DOI 10.1210/en.2003-0453; Chen R, 2005, COMP BIOCHEM PHYS B, V142, P79, DOI 10.1016/j.cbpc.2005.06.003; Chiba A, 1996, NEUROSCI LETT, V213, P49, DOI 10.1016/0304-3940(96)12828-7; CHIBA A, 1994, ARCH HISTOL CYTOL, V57, P77, DOI 10.1679/aohc.57.77; Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x; FAO, 2004, CULT AQ SPEC INF PRO; Faraco JH, 2006, J BIOL CHEM, V281, P29753, DOI 10.1074/jbc.M605811200; FERNALD RD, 1985, J COMP NEUROL, V238, P202, DOI 10.1002/cne.902380207; Gomes AS, 2015, COMP BIOCHEM PHYS A, V183, P116, DOI 10.1016/j.cbpa.2015.01.009; Gomes AS, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-11; Huesa G, 2005, J COMP NEUROL, V488, P476, DOI 10.1002/cne.20610; Huffman LS, 2012, J CHEM NEUROANAT, V44, P86, DOI 10.1016/j.jchemneu.2012.05.002; Hunter RG, 2004, TRENDS ENDOCRIN MET, V15, P454, DOI 10.1016/j.tem.2004.09.010; Johansen SD, 2009, NEW BIOTECHNOL, V25, P263, DOI 10.1016/j.nbt.2009.03.014; KAH O, 1989, FISH PHYSIOL BIOCHEM, V7, P69, DOI 10.1007/BF00004691; Kamisaka Y, 2011, MAR BIOL, V158, P233, DOI 10.1007/s00227-010-1554-x; Karlsen O, 2015, PEERJ, V3, DOI 10.7717/peerj.902; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kehoe AS, 2007, COMP BIOCHEM PHYS A, V146, P451, DOI 10.1016/j.cbpa.2006.12.026; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kortner TM, 2011, COMP BIOCHEM PHYS A, V160, P190, DOI 10.1016/j.cbpa.2011.05.033; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kvale A, 2007, AQUACULTURE, V264, P457, DOI 10.1016/j.aquaculture.2006.12.024; KYLE AL, 1987, ANN NY ACAD SCI, V519, P97; Lin XW, 2000, COMP BIOCHEM PHYS A, V126, P415, DOI 10.1016/S1095-6433(00)00230-0; MacDonald E, 2009, HORM BEHAV, V56, P58, DOI 10.1016/j.yhbeh.2009.03.002; MacDonald E, 2009, GEN COMP ENDOCR, V161, P252, DOI 10.1016/j.ygcen.2009.01.021; MacDonald EE, 2010, GEN COMP ENDOCR, V169, P192, DOI 10.1016/j.ygcen.2010.09.014; Mathieu M, 2002, DEV BRAIN RES, V139, P255, DOI 10.1016/S0165-3806(02)00577-1; Meek J., 1998, P759; Mueller T., 2005, ATLAS EARLY ZEBRAFIS; Mukherjee A, 2012, J COMP NEUROL, V520, P770, DOI 10.1002/cne.22779; OIESTAD V, 1985, T AM FISH SOC, V114, P590, DOI 10.1577/1548-8659(1985)114&lt;590:MPOACJ&gt;2.0.CO;2; PENG C, 1994, ENDOCRINOLOGY, V134, P1095, DOI 10.1210/en.134.3.1095; Sirkin DIP, 2013, TISSUE CELL, V45, P452, DOI 10.1016/j.tice.2013.09.001; PETER RE, 1979, FISH PHYSIOL, V8, P121; Ping HC, 2013, J ANIM PHYSL ANIM NU; Pirone A, 2008, ANAT HISTOL EMBRYOL, V37, P231, DOI 10.1111/j.1439-0264.2007.00836.x; PONTET A, 1989, CELL TISSUE RES, V255, P529; Ronnestad I., 2013, INT AQUAFEED MAG MAY, P3; Ronnestad I, 2013, REV AQUACULT, V5, pS59, DOI 10.1111/raq.12010; ROOS J, 1988, J COMP NEUROL, V270, P121, DOI 10.1002/cne.902700110; Sakurai T, 2002, SLEEP MED, V3, pS3, DOI 10.1016/S1389-9457(02)00156-9; Sandbakken M, 2012, J COMP NEUROL, V520, P3727, DOI 10.1002/cne.23125; SCHWASSM.HO, 1965, J COMP NEUROL, V124, P113, DOI 10.1002/cne.901240109; Silverstein JT, 1998, GEN COMP ENDOCR, V110, P157, DOI 10.1006/gcen.1998.7058; Singru PS, 2007, J COMP NEUROL, V502, P215, DOI 10.1002/cne.21295; Subhedar N, 1996, CELL TISSUE RES, V283, P313, DOI 10.1007/s004410050541; Traverso JM, 2003, ANAT HISTOL EMBRYOL, V32, P29, DOI 10.1046/j.1439-0264.2003.00434.x; VALLARINO M, 1988, BRAIN RES, V448, P67, DOI 10.1016/0006-8993(88)91102-X; VALLARINO M, 1995, J COMP NEUROL, V356, P537, DOI 10.1002/cne.903560405; Vallarino M, 1998, NEUROSCI LETT, V254, P5, DOI 10.1016/S0304-3940(98)00607-7; VECINO E, 1994, NEUROREPORT, V6, P127, DOI 10.1097/00001756-199412300-00033; VECINO E, 1990, J COMP NEUROL, V299, P229, DOI 10.1002/cne.902990207; Volkoff H, 2006, COMP BIOCHEM PHYS A, V144, P325, DOI 10.1016/j.cbpa.2005.10.026; Volkoff H, 2001, ENDOCRINOLOGY, V142, P5076, DOI 10.1210/en.142.12.5076; Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Williams KW, 2011, NAT NEUROSCI, V14, P277, DOI 10.1038/nn0311-277; Xu MY, 2007, MOL CELL ENDOCRINOL, V271, P28, DOI 10.1016/j.mce.2007.03.003; Yan AF, 2011, PEPTIDES, V32, P1363, DOI 10.1016/j.peptides.2011.05.004	69	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153743	10.1371/journal.pone.0153743	http://dx.doi.org/10.1371/journal.pone.0153743			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100086	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000374898500062
J	Mohan, A; Singh, RS; Kumari, M; Garg, D; Upadhyay, A; Ecelbarger, CM; Tripathy, S; Tiwari, S				Mohan, Aradhana; Singh, Ravi Shankar; Kumari, Manju; Garg, Devika; Upadhyay, Aditya; Ecelbarger, Carolyn M.; Tripathy, Sucheta; Tiwari, Swasti			Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; MATRIX METALLOPROTEINASES; MESANGIAL CELLS; NONCODING RNAS; EXPRESSION; EXOSOMES/MICROVESICLES; PROLIFERATION; SEQUENCES; MIR-451; MIRNAS	Non-invasive renal signatures can help in serial monitoring of diabetic patients. We tested whether urinary exosomal (UE) microRNA (miR) analysis could non-invasively predict renal pathology in diabetic rats during the course of diabetes. Diabetes mellitus (DM) was induced in male Wistar rats by a single intraperitoneal injection of streptozotocin (STZ, 50 mg/kg body weight). Non-diabetic control (CTRL) rats were injected with vehicle. Insulin (INS) treatment (5U/d, s.c.) was provided to 50% of the DM rats. Urine samples were collected at weeks 3, 6, and 9 following injections and UE prepared. An increase in miR-451-5p and miR-16, observed by pilot small RNA sequencing of UE RNA, was confirmed by quantitative real-time polymerase chain reaction (qPCR) and selected for further study. Subsets of rats were euthanized after 3, 6, and 9 weeks of diabetes for renal pathology analysis, including determination of the tubulointerstitial fibrotic index (TFI) and glomerulosclerotic index (GI) scores. qPCR showed a substantial rise in miR-451-5p in UE from DM rats during the course of diabetes, with a significant rise (median fold change >1000) between 3 and 6 weeks. Moreover, UE miR-451-5p at 6 weeks predicted urine albumin at 9 weeks (r = 0.76). A delayed but significant rise was also observed for miR-16. In contrast, mean urine albumin only increased 21% between 3 and 6 weeks (non-significant rise), and renal TFI and GI were unchanged till 9 weeks. Renal expression of miR-451-5p and miR-16 (at 10 weeks) did not correlate with urine levels, and moreover, was negatively associated with indices of renal pathology (r >= -0.70, p = 0.005 for TFI and r >= -0.6, p <= 0.02 for GI). Overall, a relative elevation in renal miR-451-5p and miR-16 in diabetes appeared protective against diabetes-induced kidney fibrosis; while UE miR-451-5p may hold prognostic value as an early and sensitive non-invasive indicator of renal disease.	[Mohan, Aradhana; Singh, Ravi Shankar; Kumari, Manju; Garg, Devika; Upadhyay, Aditya; Tiwari, Swasti] Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, Lucknow, Uttar Pradesh, India; [Ecelbarger, Carolyn M.] Georgetown Univ, Dept Med, Washington, DC USA; [Tripathy, Sucheta] Indian Inst Chem Biol, CSIR, Struct Biol & Bioinformat Div, Kolkata, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Georgetown University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Tiwari, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, Lucknow, Uttar Pradesh, India.	tiwaris@sgpgi.ac.in	Tripathy, Sucheta/N-3097-2019; Singh, Ravi Shankar/ADM-2908-2022	Tripathy, Sucheta/0000-0003-0611-8088; Singh, Ravi Shankar/0000-0001-8698-4562	Department of Biotechnology, India [BT/PR2698/AGR/36/705/2011]; University Grant Commission, India [F 2-89/98]; Indian Council of Medical Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); University Grant Commission, India(University Grants Commission, India); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was supported by grant to S. Tiwari from Department of Biotechnology, India (BT/PR2698/AGR/36/705/2011) (http://www.dbtindia.nic.in/). AM was supported by a Senior Research Fellowship from University Grant Commission, India (F 2-89/98; SA I) (http://www.ugc.ac.in/). RSS was supported by a Senior Research Fellowship from Indian Council of Medical Research, India (http://www.icmr.nic.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur RB, 2010, NEPHROL DIAL TRANSPL, V25, P2866, DOI 10.1093/ndt/gfq258; Barutta F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073798; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; Chavali V, 2014, CELL BIOCHEM BIOPHYS, V68, P25, DOI 10.1007/s12013-013-9679-4; Chen YQ, 2012, J NEPHROL, V25, P566, DOI 10.5301/jn.5000034; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Cheng YH, 2012, J MOL CELL CARDIOL, V53, P668, DOI 10.1016/j.yjmcc.2012.08.010; Ecelbarger CM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/841343; Gajdosik A, 1999, GEN PHYSIOL BIOPHYS, V18, P54; Gezer U, 2014, CELL BIOL INT, V38, P1076, DOI 10.1002/cbin.10301; Gits CMM, 2014, INT J CANCER, V135, P348, DOI 10.1002/ijc.28694; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Hovind P, 2001, KIDNEY INT, V59, P702, DOI 10.1046/j.1523-1755.2001.059002702.x; Kalani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060177; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Klein Janet D, 2009, J Epithel Biol Pharmacol, V2, P23; Kort EJ, 2008, CANCER RES, V68, P4034, DOI 10.1158/0008-5472.CAN-08-0592; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SO, 2008, J CLIN INVEST, V118, P3714, DOI 10.1172/JCI34922; Li CL, 2006, J AM SOC NEPHROL, V17, P1657, DOI 10.1681/ASN.2005121381; Li HY, 2013, ASIAN PAC J CANCER P, V14, P3631, DOI 10.7314/APJCP.2013.14.6.3631; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Liang Y, 2015, CELL PHYSIOL BIOCHEM, V36, P1793, DOI 10.1159/000430151; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Maric C, 2004, J AM SOC NEPHROL, V15, P1546, DOI 10.1097/01.ASN.0000128219.65330.EA; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Mohan A, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000510; Musante L, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00149; Pandey G, 2015, J BIOL CHEM, V290, P5582, DOI 10.1074/jbc.M114.592741; PARK IS, 1994, PANCREAS, V9, P566, DOI 10.1097/00006676-199409000-00005; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Rosenberger CM, 2012, J IMMUNOL, V189, P5965, DOI 10.4049/jimmunol.1201437; Sato-Kuwabara Y, 2015, INT J ONCOL, V46, P17, DOI 10.3892/ijo.2014.2712; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Sekiuchi M, 2012, CLIN EXP NEPHROL, V16, P863, DOI 10.1007/s10157-012-0633-3; SUZUKI D, 1995, DIABETES, V44, P1233, DOI 10.2337/diabetes.44.10.1233; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Tiwari S, 2013, J AM SOC NEPHROL, V24, P1209, DOI 10.1681/ASN.2012060628; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051140; Wu H, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/920134; Xu X, 2014, CURR MED CHEM, V21, P3244, DOI 10.2174/0929867321666140716092052; Zhang Z, 2012, FEBS LETT, V586, P20, DOI 10.1016/j.febslet.2011.07.042; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021	57	58	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154055	10.1371/journal.pone.0154055	http://dx.doi.org/10.1371/journal.pone.0154055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101382	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500132
J	Stewart, MKG; Plante, I; Penuela, S; Laird, DW				Stewart, Michael K. G.; Plante, Isabelle; Penuela, Silvia; Laird, Dale W.			Loss of Panx1 Impairs Mammary Gland Development at Lactation: Implications for Breast Tumorigenesis	PLOS ONE			English	Article							APOPTOTIC EPITHELIAL-CELLS; PANNEXIN 1; CHANNELS; RELEASE; FAMILY; ATP; DIFFERENTIATION; PROLIFERATION; CONNEXINS; EXPRESSION	Pannexin1 (Panx1) subunits oligomerize to form large-pore channels between the intracellular and extracellular milieu that have been shown to regulate proliferation, differentiation and cell death mechanisms. These key cellular responses are ultimately necessary for normal tissue development and function but the role of Panx1 in development, differentiation and function in many tissues remains unexplored, including that of the breast. Panx1 was identified to be expressed in the mammary gland through western blot and immunofluorescent analysis and is dynamically upregulated during pregnancy and lactation. In order to evaluate the role of Panx1 in the context of mammary gland development and function, Panx1(-/-) mice were evaluated in comparison to wild-type mice in the mammary glands of virgin, lactating and involuting mice. Our results revealed that Panx1 ablation did not affect virgin or involuting mammary glands following histological and whole mount analysis. Panx1 was necessary for timely alveolar development during early lactation based on a decreased number of alveolar lumen following histological analysis and reduced proliferation following Ki67 immunofluorescent labelling. Importantly, the loss of Panx1 in lactating mammary glands did not overtly affect epithelial or secretory differentiation of the mammary gland suggesting that Panx1 is not critical in normal mammary gland function. In addition, PANX1 mRNA expression was correlated with negative clinical outcomes in patients with breast cancer using in silico arrays. Together, our results suggest that Panx1 is necessary for timely alveolar development following the transition from pregnancy to lactation, which may have implications extending to patients with breast cancer.	[Stewart, Michael K. G.; Laird, Dale W.] Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St, London, ON N6A 5C1, Canada; [Plante, Isabelle] Univ Quebec, Inst Armand Frappier, Ctr INRS, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada; [Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, 1151 Richmond St, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); University of Quebec; Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St, London, ON N6A 5C1, Canada.; Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, 1151 Richmond St, London, ON N6A 5C1, Canada.	dale.laird@schulich.uwo.ca	Penuela, Silvia/A-6961-2010; Plante, Isabelle/AAK-5997-2021; Laird, Dale W/AAL-2407-2020	Penuela, Silvia/0000-0003-4829-5517; Plante, Isabelle/0000-0003-2080-6450; Laird, Dale W/0000-0002-4568-3285	Canadian Breast Cancer Foundation; Ontario Graduate Scholarship; Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit; Canadian Institutes of Health Research (CIHR)	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Breast Cancer Foundation (to D. W. L.), and by the Ontario Graduate Scholarship, Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit and the Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer (to M. K. G. S.).	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Blaug S, 2003, AM J PHYSIOL-CELL PH, V284, pC897, DOI 10.1152/ajpcell.00238.2002; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bry C, 2004, DEV BIOL, V267, P418, DOI 10.1016/j.ydbio.2003.11.022; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cowan KN, 2012, CELL COMMUN ADHES, V19, P45, DOI 10.3109/15419061.2012.712575; ENOMOTO K, 1994, PFLUG ARCH EUR J PHY, V427, P533, DOI 10.1007/BF00374271; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Furlow PW, 2015, NAT CELL BIOL, V17, P943, DOI 10.1038/ncb3194; Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Langlois S, 2014, J BIOL CHEM, V289, P30717, DOI 10.1074/jbc.M114.572131; Lee WJ, 2006, BBA-REV CANCER, V1765, P235, DOI 10.1016/j.bbcan.2005.12.001; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li S, 2011, GEN COMP ENDOCR, V174, P202, DOI 10.1016/j.ygcen.2011.08.019; Liong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122633; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Lohman AW, 2012, J VASC RES, V49, P405, DOI 10.1159/000338758; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; O'Brien J, 2012, DEVELOPMENT, V139, P269, DOI 10.1242/dev.071696; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2014, BIOCHEM J, V461, P371, DOI 10.1042/BJ20140447; Penuela S, 2014, J INVEST DERMATOL, V134, P2026, DOI 10.1038/jid.2014.86; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Penuela S, 2012, J BIOL CHEM, V287, P29184, DOI 10.1074/jbc.M112.377176; Plante I, 2008, DEV BIOL, V318, P312, DOI 10.1016/j.ydbio.2008.03.033; Plante Isabelle, 2011, J Vis Exp, DOI 10.3791/2828; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Stewart MKG, 2015, REPRODUCTION, V149, pR279, DOI 10.1530/REP-14-0661; Stewart MKG, 2013, BIOCHEM J, V449, P401, DOI 10.1042/BJ20121070; Teleki I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112541; Tong D, 2007, J CELL SCI, V120, P4016, DOI 10.1242/jcs.011775; TRAURIG HH, 1967, ANAT REC, V159, P239, DOI 10.1002/ar.1091590213; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Wicki-Stordeur LE, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-11; ZWIERZCHOWSKI L, 1984, DIFFERENTIATION, V28, P179, DOI 10.1111/j.1432-0436.1984.tb00281.x	58	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154162	10.1371/journal.pone.0154162	http://dx.doi.org/10.1371/journal.pone.0154162			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099931	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000374898500157
J	Tessem, MB; Bertilsson, H; Angelsen, A; Bathen, TF; Drablos, F; Rye, MB				Tessem, May-Britt; Bertilsson, Helena; Angelsen, Anders; Bathen, Tone F.; Drablos, Finn; Rye, Morten Beck			A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; INHIBITION; DECONVOLUTION; VALIDATION; DISCOVERY; ONCOGENE; SUBTYPES	Molecular analysis of patient tissue samples is essential to characterize the in vivo variability in human cancers which are not accessible in cell-lines or animal models. This applies particularly to studies of tumor metabolism. The challenge is, however, the complex mixture of various tissue types within each sample, such as benign epithelium, stroma and cancer tissue, which can introduce systematic biases when cancers are compared to normal samples. In this study we apply a simple strategy to remove such biases using sample selections where the average content of stroma tissue is balanced between the sample groups. The strategy is applied to a prostate cancer patient cohort where data from MR spectroscopy and gene expression have been collected from and integrated on the exact same tissue samples. We reveal in vivo changes in cancer-relevant metabolic pathways which are otherwise hidden in the data due to tissue confounding. In particular, lowered levels of putrescine are connected to increased expression of SRM, reduced levels of citrate are attributed to upregulation of genes promoting fatty acid synthesis, and increased succinate levels coincide with reduced expression of SUCLA2 and SDHD. In addition, the strategy also highlights important metabolic differences between the stroma, epithelium and prostate cancer. These results show that important in vivo metabolic features of cancer can be revealed from patient data only if the heterogeneous tissue composition is properly accounted for in the analysis.	[Tessem, May-Britt; Rye, Morten Beck] Univ Trondheim Hosp, St Olavs Hosp, Trondheim, Norway; [Tessem, May-Britt; Angelsen, Anders; Bathen, Tone F.] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, MI Lab, Trondheim, Norway; [Bertilsson, Helena; Drablos, Finn; Rye, Morten Beck] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Bertilsson, Helena; Angelsen, Anders] Univ Trondheim Hosp, St Olavs Hosp, Dept Urol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Rye, MB (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Trondheim, Norway.; Rye, MB (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway.	morten.rye@ntnu.no	Drablos, Finn/L-4970-2019	Drablos, Finn/0000-0001-5794-828X	Liaison Committee	Liaison Committee	This work was funded by research grants to MBR and MBT from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertilsson H, 2012, CLIN CANCER RES, V18, P3261, DOI 10.1158/1078-0432.CCR-11-2929; Bertilsson H, 2011, PROSTATE, V71, P461, DOI 10.1002/pros.21260; Bettuzzi S, 2000, CANCER RES, V60, P1472; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Forshell TP, 2010, CANCER PREV RES, V3, P140, DOI 10.1158/1940-6207.CAPR-09-0166; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Giskeodegard GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062375; Jia ZY, 2011, CANCER RES, V71, P2476, DOI 10.1158/0008-5472.CAN-10-2585; Keshari KR, 2013, PROSTATE, V73, P1171, DOI 10.1002/pros.22665; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Lahdesmaki H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-54; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Repsilber D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-27; Rhodes DR, 2002, CANCER RES, V62, P4427; Schoenborn JR, 2013, CLIN CANCER RES, V19, P4058, DOI 10.1158/1078-0432.CCR-12-3606; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; Venet D, 2001, Bioinformatics, V17 Suppl 1, pS279; Wang M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-328; Wang YP, 2010, CANCER RES, V70, P6448, DOI 10.1158/0008-5472.CAN-10-0021; Wu XY, 2014, AM J CLIN EXP UROL, V2, P111; Zhao YD, 2010, GENOME MED, V2, DOI 10.1186/gm214; Zhong Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-89	39	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153727	10.1371/journal.pone.0153727	http://dx.doi.org/10.1371/journal.pone.0153727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100877	gold, Green Published			2022-12-26	WOS:000374898500056
J	Xie, F; Zemlin, CW				Xie, Fei; Zemlin, Christian W.			Effect of Twisted Fiber Anisotropy in Cardiac Tissue on Ablation with Pulsed Electric Fields	PLOS ONE			English	Article							CATHETER ABLATION; ATRIAL-FIBRILLATION; LEFT-VENTRICLE; THERAPY; ELECTROPORATION; COMPLICATIONS; FEASIBILITY; ORIENTATION; PLATFORM; RABBIT	Background Ablation of cardiac tissue with pulsed electric fields is a promising alternative to current thermal ablation methods, and it critically depends on the electric field distribution in the heart. Methods We developed a model that incorporates the twisted anisotropy of cardiac tissue and computed the electric field distribution in the tissue. We also performed experiments in rabbit ventricles to validate our model. We find that the model agrees well with the experimentally determined ablation volume if we assume that all tissue that is exposed to a field greater than 3 kV/cm is ablated. In our numerical analysis, we considered how tissue thickness, degree of anisotropy, and electrode configuration affect the geometry of the ablated volume. We considered two electrode configurations: two parallel needles inserted into the myocardium ("penetrating needles" configuration) and one circular electrode each on epi- and endocardium, opposing each other ("epi-endo" configuration). Results For thick tissues (10 mm) and moderate anisotropy ratio (a = 2), we find that the geometry of the ablated volume is almost unaffected by twisted anisotropy, i.e. it is approximately translationally symmetric from epi- to endocardium, for both electrode configurations. Higher anisotropy ratio (a = 10) leads to substantial variation in ablation width across the wall; these variations were more pronounced for the penetrating needle configuration than for the epi- endo configuration. For thinner tissues (4 mm, typical for human atria) and higher anisotropy ratio (a = 10), the epi- endo configuration yielded approximately translationally symmetric ablation volumes, while the penetrating electrodes configuration was much more sensitive to fiber twist. Conclusions These results suggest that the epi-endo configuration will be reliable for ablation of atrial fibrillation, independently of fiber orientation, while the penetrating electrode configuration may experience problems when the fiber orientation is not consistent across the atrial wall.	[Xie, Fei; Zemlin, Christian W.] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA; [Xie, Fei; Zemlin, Christian W.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA	Old Dominion University; Old Dominion University	Zemlin, CW (corresponding author), Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA.; Zemlin, CW (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA.	czemlin@odu.edu						Arena CB, 2012, BIOPHYS J, V103, P2033, DOI 10.1016/j.bpj.2012.09.017; Beebe SJ, 2011, IEEE ENG MED BIO, P6861, DOI 10.1109/IEMBS.2011.6091692; Bello O, 2009, AFRICAN J PHYS SCI, V2; Bertaglia E, 2007, HEART RHYTHM, V4, P1265, DOI 10.1016/j.hrthm.2007.06.016; Bishop MJ, 2011, IEEE T BIO-MED ENG, V58, P1066, DOI 10.1109/TBME.2010.2096425; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Colman MA, 2014, EUROPACE, V16, P416, DOI 10.1093/europace/eut349; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Healy LJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-74; Ho SY, 2002, CARDIOVASC RES, V54, P325, DOI 10.1016/S0008-6363(02)00226-2; Kearney K, 2014, ANN CARDIOTHORAC SUR, V3, P15, DOI 10.3978/j.issn.2225-319X.2014.01.03; Khan AR, 2014, CIRC-ARRHYTHMIA ELEC, V7, P853, DOI 10.1161/CIRCEP.114.001853; Kim DH, 2012, P NATL ACAD SCI USA, V109, P19910, DOI 10.1073/pnas.1205923109; Lavee J, 2007, HEART SURG FORUM, V10, pE162, DOI 10.1532/HSF98.20061202; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Mankowski J, 2000, IEEE T PLASMA SCI, V28, P102, DOI 10.1109/27.842875; Neven K, 2014, CIRC-ARRHYTHMIA ELEC, V7, P913, DOI 10.1161/CIRCEP.114.001607; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pravdin SF, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-54; Santangeli P, 2014, CIRC-ARRHYTHMIA ELEC, V7, P739, DOI 10.1161/CIRCEP.113.000629; Schwab BC, 2013, IEEE T MED IMAGING, V32, P862, DOI 10.1109/TMI.2013.2240693; Seemann G., 2006, COMP CARDIOL, V33, P801; SEGAL SS, 1986, AM J PHYSIOL, V250, pC474, DOI 10.1152/ajpcell.1986.250.3.C474; Spragg DD, 2008, J CARDIOVASC ELECTR, V19, P627, DOI 10.1111/j.1540-8167.2008.01181.x; STREETER D, 1979, HDB PHYSL; STREETER DD, 1966, ANAT REC, V155, P503, DOI 10.1002/ar.1091550403; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Thiriet M, 2015, DIS CARDIAC PUMP; Wang YT, 2012, AM J PHYSIOL-HEART C, V303, pH439, DOI 10.1152/ajpheart.01121.2011; Winkle RA, 2014, HEART RHYTHM, V11, P963, DOI 10.1016/j.hrthm.2014.03.013; Wittkampf FH, 2011, J CARDIOVASC ELECTR, V22, P302, DOI 10.1111/j.1540-8167.2010.01863.x; Xie F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144833; Zhao JC, 2015, INT J MOL SCI, V16, P10834, DOI 10.3390/ijms160510834; Zhao JC, 2013, IEEE T MED IMAGING, V32, P18, DOI 10.1109/TMI.2012.2227776	36	13	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152262	10.1371/journal.pone.0152262	http://dx.doi.org/10.1371/journal.pone.0152262			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101250	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500011
J	Lou, YJ; Pan, YW; Gao, CY; Jiang, M; Lu, XG; Xu, YJ				Lou, Yanjing; Pan, Yanwen; Gao, Chuanyu; Jiang, Ming; Lu, Xianguo; Xu, Y. Jun			Response of Plant Height, Species Richness and Aboveground Biomass to Flooding Gradient along Vegetation Zones in Floodplain Wetlands, Northeast China	PLOS ONE			English	Article							SANJIANG PLAIN; FUNCTIONAL TRAITS; FEN VEGETATION; WATER DEPTH; ZONATION; GROWTH; PATTERNS; TEMPERATURE; COMPETITION; ECOSYSTEMS	Flooding regime changes resulting from natural and human activity have been projected to affect wetland plant community structures and functions. It is therefore important to conduct investigations across a range of flooding gradients to assess the impact of flooding depth on wetland vegetation. We conducted this study to identify the pattern of plant height, species richness and aboveground biomass variation along the flooding gradient in floodplain wetlands located in Northeast China. We found that the response of dominant species height to the flooding gradient depends on specific species, i.e., a quadratic response for Carex lasiocarpa, a negative correlation for Calamagrostis angustifolia, and no response for Carex appendiculata. Species richness showed an intermediate effect along the vegetation zone from marsh to wet meadow while aboveground biomass increased. When the communities were analysed separately, only the water table depth had significant impact on species richness for two Carex communities and no variable for C. angustifolia community, while height of dominant species influenced aboveground biomass. When the three abovementioned communities were grouped together, variations in species richness were mainly determined by community type, water table depth and community mean height, while variations in aboveground biomass were driven by community type and the height of dominant species. These findings indicate that if habitat drying of these herbaceous wetlands in this region continues, then two Carex marshes would be replaced gradually by C. angustifolia wet meadow in the near future. This will lead to a reduction in biodiversity and an increase in productivity and carbon budget. Meanwhile, functional traits must be considered, and should be a focus of attention in future studies on the species diversity and ecosystem function in this region.	[Lou, Yanjing; Pan, Yanwen; Gao, Chuanyu; Jiang, Ming; Lu, Xianguo] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Xu, Y. Jun] Louisiana State Univ, Ctr Agr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Louisiana State University System; Louisiana State University	Lou, YJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	louyj@iga.ac.cn	Xu, Y. Jun/A-7681-2014; Gao, Chuanyu/O-3946-2019	Xu, Y. Jun/0000-0003-3646-626X; Gao, Chuanyu/0000-0003-2792-5022; lu, xian guo/0000-0001-7638-2787	National Natural Science Foundation of China [41371107]; National Basic Research Program of China [2012CB956103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (no. 41371107) and the National Basic Research Program of China (no. 2012CB956103). The corresponding author, YJL, received the above-mentioned fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WETLAND ECOLOGY PRIN; Bhattacharjee J, 2009, WETLANDS, V29, P690, DOI 10.1672/06-176.1; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chapin FS, 1996, ECOLOGY, V77, P822, DOI 10.2307/2265504; Chytry M, 2003, FOLIA GEOBOT, V38, P429, DOI 10.1007/BF02803250; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cui BS, 2010, PLANT ECOL, V209, P279, DOI 10.1007/s11258-010-9723-z; Dwire KA, 2004, OECOLOGIA, V139, P309, DOI 10.1007/s00442-004-1498-2; Dwire KA, 2006, WETLANDS, V26, P131, DOI 10.1672/0277-5212(2006)26[131:PSDIRT]2.0.CO;2; Fu PY., 1995, CLAVIS PLANTATRUM CH; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; Garssen AG, 2015, GLOBAL CHANGE BIOL, V21, P2881, DOI 10.1111/gcb.12921; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; GLASER PH, 1990, J ECOL, V78, P1021, DOI 10.2307/2260950; Gosselink J.G., 2000, WETLANDS; Grace JB, 2001, OIKOS, V92, P193, DOI 10.1034/j.1600-0706.2001.920201.x; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Kotowski W, 2001, PLANT ECOL, V155, P147, DOI 10.1023/A:1013214716842; Lenssen J, 1999, OIKOS, V86, P523, DOI 10.2307/3546656; Lenssen JPM, 2005, J ECOL, V93, P138, DOI 10.1111/j.1365-2745.2004.00957.x; Li F, 2011, AQUAT ECOL, V45, P89, DOI 10.1007/s10452-010-9334-8; Lou YJ, 2015, J VEG SCI, V26, P643, DOI 10.1111/jvs.12270; Lou YJ, 2013, NORD J BOT, V31, P748, DOI 10.1111/j.1756-1051.2013.01721.x; Luo WB, 2008, WETLANDS, V28, P866, DOI 10.1672/07-225.1; Luo WB, 2009, HYDROBIOLOGIA, V624, P151, DOI 10.1007/s10750-008-9689-1; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; MOORE DRJ, 1989, VEGETATIO, V79, P99; PENNINGS SC, 1992, ECOLOGY, V73, P681, DOI 10.2307/1940774; Seabloom EW, 1998, PLANT ECOL, V138, P203, DOI 10.1023/A:1009711919757; Shaver GR, 1998, ECOL MONOGR, V68, P75, DOI 10.1890/0012-9615(1998)068[0075:BACFIW]2.0.CO;2; Shi FX, 2015, ECOL ENG, V81, P158, DOI 10.1016/j.ecoleng.2015.04.054; SHIPLEY B, 1991, ECOLOGY, V72, P1658, DOI 10.2307/1940965; SHIPLEY B, 1991, CAN J BOT, V69, P1420, DOI 10.1139/b91-184; SMITH T, 1989, VEGETATIO, V83, P49, DOI 10.1007/BF00031680; Timmermann A, 2015, J APPL ECOL, V52, P21, DOI 10.1111/1365-2664.12374; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Venn SE, 2011, PLANT ECOL, V212, P1491, DOI 10.1007/s11258-011-9923-1; Venterink HO, 2001, J ECOL, V89, P1033, DOI 10.1111/j.1365-2745.2001.00616.x; VERMEER JG, 1987, ACTA OECOL-OEC PLANT, V8, P321; Violle C, 2011, OIKOS, V120, P389, DOI 10.1111/j.1600-0706.2010.18525.x; Wang ZM, 2006, ENVIRON MONIT ASSESS, V112, P69, DOI 10.1007/s10661-006-0312-5; Wassen MJ, 2003, PLANT ECOL, V165, P27, DOI 10.1023/A:1021493327180; Weltzin JF, 2000, ECOLOGY, V81, P3464, DOI 10.1890/0012-9658(2000)081[3464:ROBAFP]2.0.CO;2; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WHEELER BD, 1982, J ECOL, V70, P179, DOI 10.2307/2259872; WHEELER BD, 1991, J ECOL, V79, P285, DOI 10.2307/2260713; Whitbeck M, 2006, WETLANDS, V26, P278, DOI 10.1672/0277-5212(2006)26[278:EONMFE]2.0.CO;2; Wu GL, 2013, J HYDROL, V476, P120, DOI 10.1016/j.jhydrol.2012.10.031; Xie YH, 2008, AQUAT BOT, V89, P292, DOI 10.1016/j.aquabot.2008.03.003; Zhang XH, 2014, J FRESHWATER ECOL, V29, P117, DOI 10.1080/02705060.2013.825821	53	35	40	9	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153972	10.1371/journal.pone.0153972	http://dx.doi.org/10.1371/journal.pone.0153972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097325	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600077
J	Shou, P; Chen, Q; Jiang, J; Xu, C; Zhang, J; Zheng, C; Jiang, M; Velletri, T; Cao, W; Huang, Y; Yang, Q; Han, X; Zhang, L; Wei, L; Rabson, AB; Chin, YE; Wang, Y; Shi, Y				Shou, P.; Chen, Q.; Jiang, J.; Xu, C.; Zhang, J.; Zheng, C.; Jiang, M.; Velletri, T.; Cao, W.; Huang, Y.; Yang, Q.; Han, X.; Zhang, L.; Wei, L.; Rabson, A. B.; Chin, Y. E.; Wang, Y.; Shi, Y.			Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells	ONCOGENE			English	Article							NF-KAPPA-B; DOUBLE-EDGED-SWORD; STEM-CELLS; NITRIC-OXIDE; IFN-GAMMA; IMMUNE-RESPONSES; INOS GENE; ALPHA; PHOSPHORYLATION; ACETYLATION	Mesenchymal stromal cells (MSCs) are strongly immunosuppressive via producing nitric oxide (NO) and known to migrate into tumor sites to promote tumor growth, but the underlying mechanisms remain largely elusive. Here, we found that interferon alpha (IFN alpha)-secreting MSCs showed more dramatic inhibition effect on tumor progression than that of IFN alpha alone. Interestingly, IFN alpha primed MSCs could also effectively suppress tumor growth. Mechanistically, we demonstrated that both IFN alpha and IFN beta (type I IFNs) reversed the immunosuppressive effect of MSCs on splenocyte proliferation. This effect of type I IFNs was exerted through inhibiting inducible NO synthase (iNOS) expression in IFN. and TNFa-stimulated MSCs. Notably, only NO production was inhibited by IFN alpha; production of other cytokines or chemokines tested was not suppressed. Furthermore, IFN alpha promoted the switch from signal transducer and activator of transcription 1 (Stat1) homodimers to Stat1-Stat2 heterodimers. Studies using the luciferase reporter system and chromatin immunoprecipitation assay revealed that IFN alpha suppressed iNOS transcription through inhibiting the binding of Stat1 to iNOS promoter. Therefore, the synergistic anti-tumor effects of type I IFNs and MSCs were achieved by inhibiting NO production. This study provides essential information for understanding the mechanisms of MSC-mediated immunosuppression and for the development of better clinical strategies using IFNs and MSCs for cancer immunotherapy.	[Shou, P.; Chen, Q.; Xu, C.; Zheng, C.; Jiang, M.; Velletri, T.; Cao, W.; Huang, Y.; Yang, Q.; Han, X.; Chin, Y. E.; Wang, Y.; Shi, Y.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Shou, P.; Chen, Q.; Xu, C.; Zheng, C.; Jiang, M.; Velletri, T.; Cao, W.; Huang, Y.; Yang, Q.; Han, X.; Chin, Y. E.; Wang, Y.; Shi, Y.] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China; [Chen, Q.; Zhang, L.; Shi, Y.] Soochow Univ, Affiliated Hosp 1, Inst Translat Med, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Jiang, J.] Soochow Univ, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China; [Zhang, J.; Zhang, L.; Rabson, A. B.; Shi, Y.] Rutgers State Univ, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA; [Wei, L.] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai, Peoples R China; [Shou, P.] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Soochow University - China; Soochow University - China; Rutgers State University New Brunswick; Rutgers State University Medical Center; Naval Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, Y (corresponding author), Soochow Univ, Affiliated Hosp 1, Inst Translat Med, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.; Wang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	yingwang@sibs.ac.cn; yfshi@suda.edu.cn	Xu, Chunliang/R-7065-2018; HUANG, YIN/AAH-6871-2020; Shi, Yufang/AAE-4431-2020; Shou, Peishun/J-7985-2014	HUANG, YIN/0000-0001-5602-9871; Shi, Yufang/0000-0001-8964-319X; Shou, Peishun/0000-0001-7685-7471; Wei, Lixin/0000-0002-9526-5348; Chen, Qing/0000-0002-2088-0370; wang, ying/0000-0002-2571-9367	Ministry of Science and Technology of China [2015CB964400, 2012CBA01303]; Scientific Innovation Project of the Chinese Academy of Science [XDA01040110, XDA01040107]; External Cooperation Program of Bureau of International Cooperation, Chinese Academy of Sciences [GJHZ201307]; Programs of National Natural Science of China [81330046, 81171653, 31570877, 31570908]; National Institutes of Health of the United States of America [GM866889]; Robert Wood Johnson Foundation [67038]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM866889] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Scientific Innovation Project of the Chinese Academy of Science; External Cooperation Program of Bureau of International Cooperation, Chinese Academy of Sciences; Programs of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ms Fengying Li and Ms Jingjing Li for technical assistances in breeding the mice; Ms Yanyan Han, Mr Jianchang Cao, Mr Shijia Wang, Ms Qing Li and Ms Chenxi Zhang for technical assistances and helpful discussion. This work was supported by grants from the Ministry of Science and Technology of China (2015CB964400, 2012CBA01303), Scientific Innovation Project of the Chinese Academy of Science (XDA01040110, XDA01040107), the External Cooperation Program of Bureau of International Cooperation, Chinese Academy of Sciences (GJHZ201307), the Programs of National Natural Science of China (81330046, 81171653, 31570877, 31570908), grants from the National Institutes of Health of the United States of America (GM866889) and a grant to the Child Health Institute from the Robert Wood Johnson Foundation (67038).	Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; Burke SJ, 2013, MOL ENDOCRINOL, V27, P1724, DOI 10.1210/me.2013-1159; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Chen Q, 2014, STEM CELLS, V32, P327, DOI 10.1002/stem.1567; De Stefano D, 2006, J MOL MED, V84, P65, DOI 10.1007/s00109-005-0713-x; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Du JC, 2012, INT J BIOCHEM CELL B, V44, P1305, DOI 10.1016/j.biocel.2012.04.015; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elzaouk L, 2006, EXP DERMATOL, V15, P865, DOI 10.1111/j.1600-0625.2006.00479.x; Frasca L, 2011, THESCIENTIFICWORLDJO, V11, P2071, DOI 10.1100/2011/873895; Galderisi Umberto, 2010, World J Stem Cells, V2, P5, DOI 10.4252/wjsc.v2.i1.5; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Ghislain JJ, 2001, J INTERF CYTOK RES, V21, P379, DOI 10.1089/107999001750277853; Guo L, 2007, SURGERY, V142, P156, DOI 10.1016/j.surg.2007.02.016; Han X, 2014, CELL DEATH DIFFER, V21, P1758, DOI 10.1038/cdd.2014.85; Huang Y, 2014, ONCOGENE, V33, P3830, DOI 10.1038/onc.2013.355; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kim MO, 2004, J NEUROCHEM, V90, P297, DOI 10.1111/j.1471-4159.2004.02487.x; Kleinert H, 1998, BRIT J PHARMACOL, V125, P193, DOI 10.1038/sj.bjp.0702039; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; KretzRemy C, 1996, J CELL BIOL, V133, P1083, DOI 10.1083/jcb.133.5.1083; Lee ST, 2002, BRIT J HAEMATOL, V118, P1128, DOI 10.1046/j.1365-2141.2002.03767.x; Li W, 2012, CELL DEATH DIFFER, V19, P1505, DOI 10.1038/cdd.2012.26; Li YZ, 2005, J BIOL CHEM, V280, P10001, DOI 10.1074/jbc.M410972200; Liu H, 2006, J IMMUNOL, V176, P2864, DOI 10.4049/jimmunol.176.5.2864; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Ohkouchi S, 2012, MOL THER, V20, P417, DOI 10.1038/mt.2011.259; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qiao L, 2008, CANCER LETT, V269, P67, DOI 10.1016/j.canlet.2008.04.032; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Ren CC, 2008, STEM CELLS, V26, P2332, DOI 10.1634/stemcells.2008-0084; Ren G, 2014, ONCOGENE, V33, P4016, DOI 10.1038/onc.2013.387; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Salam MT, 2012, J ALLERGY CLIN IMMUN, V129, P232, DOI 10.1016/j.jaci.2011.09.037; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Torrone DZ, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-3; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uddin S, 2000, J BIOL CHEM, V275, P27634; Wang KW, 2011, BBA-MOL CELL RES, V1813, P1395, DOI 10.1016/j.bbamcr.2011.04.004; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Wieczorek M, 2012, CYTOKINE GROWTH F R, V23, P293, DOI 10.1016/j.cytogfr.2012.06.005; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Xu C, 2014, ONCOGENE, V33, P5047, DOI 10.1038/onc.2013.458; Xu CL, 2014, J IMMUNOL, V192, P103, DOI 10.4049/jimmunol.1302164; Yu ZY, 2006, AM J PHYSIOL-RENAL, V290, pF496, DOI 10.1152/ajprenal.00316.2005; Zou WB, 2012, CANCER RES, V72, P2980, DOI 10.1158/0008-5472.CAN-11-4216	55	20	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 17	2016	35	46					5953	5962		10.1038/onc.2016.128	http://dx.doi.org/10.1038/onc.2016.128			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CA	27109100	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000388509400003
J	Cole, MA; Jamil, AHA; Heather, LC; Murray, AJ; Sutton, ER; Slingo, M; Sebag-Montefiore, L; Tan, SC; Aksentijevic, D; Gildea, OS; Stuckey, DJ; Yeoh, KK; Carr, CA; Evans, RD; Aasum, E; Schofield, CJ; Ratcliffe, PJ; Neubauer, S; Robbins, PA; Clarke, K				Cole, Mark A.; Jamil, Amira H. Abd; Heather, Lisa C.; Murray, Andrew J.; Sutton, Elizabeth R.; Slingo, Mary; Sebag-Montefiore, Liam; Tan, Suat Cheng; Aksentijevic, Dunja; Gildea, Ottilie S.; Stuckey, Daniel J.; Yeoh, Kar Kheng; Carr, Carolyn A.; Evans, Rhys D.; Aasum, Ellen; Schofield, Christopher J.; Ratcliffe, Peter J.; Neubauer, Stefan; Robbins, Peter A.; Clarke, Kieran			On the pivotal role of PPAR alpha in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury	FASEB JOURNAL			English	Article						cardiac contractile function; HIF; myocardial energy metabolism; P-31 MRS; substrate metabolism	ACTIVATED-RECEPTOR-ALPHA; PATHOLOGICAL CARDIAC-HYPERTROPHY; CHRONIC HYPOBARIC HYPOXIA; HIGH-ALTITUDE ADAPTATION; RETINOID-X-RECEPTOR; INFARCTED RAT-HEART; ENERGY-METABOLISM; DECREASED EFFICIENCY; UNCOUPLING PROTEINS; INSULIN-RESISTANCE	The role of peroxisome proliferator-activated receptor alpha (PPAR alpha)-mediated metabolic remodeling in cardiac adaptation to hypoxia has yet to be defined. Here, mice were housed in hypoxia for 3 wk before in vivo contractile function was measured using cine MRI. In isolated, perfused hearts, energetics were measured using P-31 magnetic resonance spectroscopy (MRS), and glycolysis and fatty acid oxidation were measured using [H-3] labeling. Compared with a nor-moxic, chow-fed control mouse heart, hypoxia decreased PPAR alpha expression, fatty acid oxidation, and mitochondrial uncouplingprotein 3 (UCP3) levels, while increasing glycolysis, all of which served to maintain normal ATP concentrations ([ATP]) and thereby, ejection fractions. A high-fat diet increased cardiac PPAR alpha expression, fatty acid oxidation, and UCP3 levels with decreased glycolysis. Hypoxia was unable to alter the high PPAR alpha expression or reverse the metabolic changes caused by the high-fat diet, with the result that [ATP] and contractile function decreased significantly. The adaptive metabolic changes caused by hypoxia in control mouse hearts were found to have occurred already in PPAR alpha-deficient (PPAR alpha(-/-)) mouse hearts and sustained function in hypoxia despite an inability for further metabolic remodeling. We conclude that decreased cardiac PPAR alpha expression is essential for adaptive metabolic remodeling in hypoxia, but is prevented by dietary fat.	[Cole, Mark A.; Jamil, Amira H. Abd; Heather, Lisa C.; Murray, Andrew J.; Sutton, Elizabeth R.; Slingo, Mary; Tan, Suat Cheng; Gildea, Ottilie S.; Stuckey, Daniel J.; Carr, Carolyn A.; Evans, Rhys D.; Aasum, Ellen; Robbins, Peter A.; Clarke, Kieran] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Physiol Anat & Genet, Oxford, England; [Sebag-Montefiore, Liam; Aksentijevic, Dunja; Neubauer, Stefan] Univ Oxford, Wellcome Trust Ctr Human Genet, Chem Res Lab, Oxford, England; [Ratcliffe, Peter J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Clin Med, Oxford, England; [Sebag-Montefiore, Liam; Aksentijevic, Dunja; Neubauer, Stefan] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Cole, Mark A.] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham, England; [Jamil, Amira H. Abd] Int Islamic Univ Malaysia, Fac Pharm, Dept Basic Med Sci, Med Campus, Pahang, Malaysia; [Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Sutton, Elizabeth R.] Univ Oxford, Dept Zool, Oxford, England; [Tan, Suat Cheng] Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kelantan, Malaysia; [Aksentijevic, Dunja] St Thomas Hosp, Kings Coll London, British Heart Fdn Ctr Res Excellence, Rayne Inst, London, England; [Stuckey, Daniel J.] UCL, Ctr Adv Biomed Engn, London, England; [Yeoh, Kar Kheng] Univ Sains Malaysia, Sch Chem Sci, George Town, Malaysia; [Aasum, Ellen] UiT Arctic Univ Norway, Cardiovasc Res Grp, Dept Med Biol, Fac Hlth Sci, Tromso, Norway	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Nottingham; International Islamic University Malaysia; University of Cambridge; University of Oxford; Universiti Sains Malaysia; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; Universiti Sains Malaysia; UiT The Arctic University of Tromso	Clarke, K (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	kieran.clarke@dpag.ox.ac.uk	Abd Jamil, Amira Hajirah/N-7519-2015	Abd Jamil, Amira Hajirah/0000-0002-3999-1505; Schofield, Christopher/0000-0002-0290-6565; Murray, Andrew/0000-0002-0929-9315; Aksentijevic, Dunja/0000-0002-8480-6727; Heather, Lisa/0000-0002-7246-1338; stuckey, daniel/0000-0001-8888-627X; Ratcliffe, Peter/0000-0002-2853-806X; Cole, Mark/0000-0002-0727-7833; Tan, Suat Cheng/0000-0001-5869-6096	British Heart Foundation [RG/07/004/22659]; Diabetes UK [11/0004175]; Wellcome Trust; Malaysian Ministry of Higher Education; Biotechnology and Biological Sciences Research Council [BB/D011523/1] Funding Source: researchfish; British Heart Foundation [RG/11/1/28684, FS/15/33/31608, PG/13/34/30216] Funding Source: researchfish; Cancer Research UK [18245] Funding Source: researchfish; BBSRC [BB/D011523/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome TrustEuropean Commission); Malaysian Ministry of Higher Education; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the British Heart Foundation Grant RG/07/004/22659, Diabetes UK Grant 11/0004175, and the Wellcome Trust. A.H.A.J. was funded by the Malaysian Ministry of Higher Education. P.J.R. and C.J.S. are scientific cofounders of, and hold equity in, ReOx, Ltd., a University of Oxford spin-out company that is developing HIF hydroxylase inhibitors. The remaining authors declare no conflicts of interest.	Aksentijevic D, 2010, EUR J HEART FAIL, V12, P1282, DOI 10.1093/eurjhf/hfq174; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Caudwell Xtreme Everest Research Group, 2014, PLOS ONE, V9; Chen RL, 2014, J NEUROCHEM, V131, P177, DOI 10.1111/jnc.12804; Clark R, 2012, DIABETOLOGIA, V55, P1195, DOI 10.1007/s00125-011-2428-6; CLARKE K, 1987, AM J PHYSIOL, V253, pH412, DOI 10.1152/ajpheart.1987.253.2.H412; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Essop MF, 2007, J PHYSIOL-LONDON, V584, P715, DOI 10.1113/jphysiol.2007.143511; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Ge RL, 2012, MOL GENET METAB, V106, P244, DOI 10.1016/j.ymgme.2012.03.003; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P1215, DOI 10.1073/pnas.93.3.1215; HOLDEN JE, 1995, J APPL PHYSIOL, V79, P222, DOI 10.1152/jappl.1995.79.1.222; Holloway CJ, 2011, FASEB J, V25, P792, DOI 10.1096/fj.10-172999; Holloway CJ, 2011, AM J CLIN NUTR, V93, P748, DOI 10.3945/ajcn.110.002758; Hoppeler H, 2001, J EXP BIOL, V204, P3133; HURFORD WE, 1990, J NUCL MED, V31, P1344; Huss JM, 2001, J BIOL CHEM, V276, P27605, DOI 10.1074/jbc.M100277200; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kennedy SL, 2001, J APPL PHYSIOL, V90, P17, DOI 10.1152/jappl.2001.90.1.17; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Luptak I, 2005, CIRCULATION, V112, P2339, DOI 10.1161/CIRCULATIONAHA.105.534594; Matsushima S, 2013, CIRC RES, V112, P1135, DOI 10.1161/CIRCRESAHA.111.300171; McCarthy J, 2011, J CELL PHYSIOL, V226, P2457, DOI 10.1002/jcp.22592; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Murray AJ, 2006, CARDIOVASC RES, V71, P149, DOI 10.1016/j.cardiores.2006.02.031; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ngumbela KC, 2003, MOL CELL BIOCHEM, V250, P151, DOI 10.1023/A:1024921329885; Panagia M, 2005, AM J PHYSIOL-HEART C, V288, pH2677, DOI 10.1152/ajpheart.00200.2004; Razeghi P, 2001, BIOCHEM BIOPH RES CO, V287, P5, DOI 10.1006/bbrc.2001.5541; Roberts AC, 1996, J APPL PHYSIOL, V81, P1762, DOI 10.1152/jappl.1996.81.4.1762; Sambandam N, 2006, AM J PHYSIOL-HEART C, V290, pH87, DOI 10.1152/ajpheart.00285.2005; Sidell RJ, 2002, DIABETES, V51, P1110, DOI 10.2337/diabetes.51.4.1110; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Stubbs CJ, 2009, J MED CHEM, V52, P2799, DOI 10.1021/jm900285r; Thalhammer A., 2012, DRUG DISCOV TODAY TH, V9, pe91; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Willam C, 2006, J MOL CELL CARDIOL, V41, P68, DOI 10.1016/j.yjmcc.2006.04.009; Wu RX, 2014, J CLIN INVEST, V124, P4795, DOI 10.1172/JCI76737; Young ME, 2001, J BIOL CHEM, V276, P44390, DOI 10.1074/jbc.M103826200	52	39	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2684	2697		10.1096/fj.201500094R	http://dx.doi.org/10.1096/fj.201500094R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27103577	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000380994000006
J	Andersen, T; Baranov, V; Hagenlund, LK; Ivkovic, M; Kvifte, GM; Pavlek, M				Andersen, Trond; Baranov, Viktor; Hagenlund, Linn Katrine; Ivkovic, Marija; Kvifte, Gunnar Mikalsen; Pavlek, Martina			Blind Flight? A New Troglobiotic Orthoclad (Diptera, Chironomidae) from the Lukina Jama - Trojama Cave in Croatia	PLOS ONE			English	Article							BLOCKS; SYSTEM	The genus Troglocladius Andersen, Baranov et Hagenlund, gen. n. is erected based on T. hajdi Andersen, Baranov et Hagenlund, sp. n. collected at 980 m depth in the Lukina jama-Trojama cave system in Croatia. Morphological features such as pale color, strongly reduced eyes and very long legs make it a typical cave animal. Surprisingly, it has also retained large wings and appears to be capable of flight which would make T. hajdi the first flying troglobiont worldwide, disproving previous beliefs that bats are the only animals capable of flying in complete darkness. Morphologically the new species does not readily fit within any described genus, but shares characteristics with genera both in the tribes "Metriocnemini" and "Orthocladiini". Bayesian molecular phylogenetic analysis using the markers COI, 18S rDNAs, 28S rDNA, CADI, and CADIV groups it with the genera Tvetenia, Cardiocladius and Eukiefferiella in the tribe "Metriocnemini". Troglocladius hajdi may be parthenogenetic, as only females were collected. The discovery confirms the position of the Dinaric arch as a highly important hotspot of subterranean biodiversity.	[Andersen, Trond; Hagenlund, Linn Katrine; Kvifte, Gunnar Mikalsen] Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway; [Baranov, Viktor] Lebniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Ivkovic, Marija] Univ Zagreb, Fac Sci, Div Biol, Dept Zool, Zagreb 41000, Croatia; [Kvifte, Gunnar Mikalsen] Univ Kassel, Inst Biol, Dept Zool, D-34125 Kassel, Germany; [Pavlek, Martina] Rudjer Boskovic Inst, Zagreb, Croatia; [Pavlek, Martina] Croatian Biospeleol Soc, Zagreb, Croatia	University of Bergen; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Zagreb; Universitat Kassel; Rudjer Boskovic Institute	Hagenlund, LK (corresponding author), Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway.	linn.hagenlund@uib.no	Pavlek, Martina/AAD-9359-2019; Baranov, Viktor/H-5733-2019; Ivković, Marija/AAB-1756-2020	Baranov, Viktor/0000-0003-1893-3215; Ivkovic, Marija/0000-0003-3188-5676; Kvifte, Gunnar Mikalsen/0000-0002-3210-5857; Pavlek, Martina/0000-0001-6710-0581				Armitage P.D., 1995, P194; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Copeland RS, 2011, AFR INVERTEBR, V52, P363, DOI 10.5733/afin.052.0211; Cranston P., 1985, BRIT ANTARCTIC SURVE, V66, P35; Cranston PS, 2012, SYST ENTOMOL, V37, P172, DOI 10.1111/j.1365-3113.2011.00603.x; Cukovic T, 2014, SUBTERRANEA CROATICA, V16, P13; Donato M, 2008, AQUAT INSECT, V30, P51, DOI 10.1080/01650420701829633; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FREEMAN PAUL, 1962, PACIFIC INSECTS, V4, P129; Gibert J, 2012, ENCY CAVES, P219; Gunn J, 2000, AQUAT CONSERV, V10, P353, DOI 10.1002/1099-0755(200009/10)10:5<353::AID-AQC413>3.0.CO;2-S; Juberthie C., 1994, ENCY BIOSPEOLOGICA, VI; Matile Loic, 1994, P341; Paar D, 2013, P 16 INT C SPEL, V2, P442; PECK SB, 1988, CAN J ZOOL, V66, P1197, DOI 10.1139/z88-176; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pricop Emilian, 2009, ELBA Bioflux, V1, P41; Reeves Will K., 2000, Journal of the Elisha Mitchell Scientific Society, V116, P334; Reeves Will K., 2000, Journal of Cave and Karst Studies, V62, P169; Rohacek J., 2000, Annales Historico-Naturales Musei Nationalis Hungarici, V92, P215; Rohacek Jindrich, 2014, Casopis Slezskeho Zemskeho Muzea Serie A Vedy Prirodni, V63, P97; Saether O. A., 1969, Bulletin Fisheries Research Board of Canada, V170, P1; Saether O.A., 1977, B FISHERIES RES BOAR, V197, P1, DOI DOI 10.11646/ZOOTAXA.1806.1.1; Saether O. A., 1980, ENTOMOL SCAND, V14, P1; Saether OA, 2011, ZOOTAXA, P1; Sket B, 2004, BALKAN BIODIVERSITY: PATTERN AND PROCESS IN THE EUROPEAN HOTSPOT, P309; Sket B, 2001, ZOOL SCR, V30, P223, DOI 10.1046/j.1463-6409.2001.00065.x; Sket B., 2012, ENCY CAVES, P228, DOI [DOI 10.1016/B978-0-12-383832-2.00031-1, 10.1016/b978-0-12-383832-2.00031-1]; Sket B, 2008, J NAT HIST, V42, P1549, DOI 10.1080/00222930801995762; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trajano Eleonora, 1992, Revista Brasileira de Zoologia, V7, P383, DOI 10.1590/S0101-81751990000300017; Vandel A, 1966, BIOSPELEOLOGY BIOL C; Weber D, 2013, HOHLENFAUNA LUXEMBUR, V69; Weigand Alexander M., 2013, Subterranean Biology, V11, P45, DOI 10.3897/subtbiol.11.5966; Zavrel Jan, 1943, ARCH HYDRO BIOL, V40, P250	38	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152884	10.1371/journal.pone.0152884	http://dx.doi.org/10.1371/journal.pone.0152884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119557	Green Published, gold			2022-12-26	WOS:000374976200013
J	Witkowski, O; Ikegami, T				Witkowski, Olaf; Ikegami, Takashi			Emergence of Swarming Behavior: Foraging Agents Evolve Collective Motion Based on Signaling	PLOS ONE			English	Article							SYSTEM	Swarming behavior is common in biology, from cell colonies to insect swarms and bird flocks. However, the conditions leading to the emergence of such behavior are still subject to research. Since Reynolds' boids, many artificial models have reproduced swarming behavior, focusing on details ranging from obstacle avoidance to the introduction of fixed leaders. This paper presents a model of evolved artificial agents, able to develop swarming using only their ability to listen to each other's signals. The model simulates a population of agents looking for a vital resource they cannot directly detect, in a 3D environment. Instead of a centralized algorithm, each agent is controlled by an artificial neural network, whose weights are encoded in a genotype and adapted by an original asynchronous genetic algorithm. The results demonstrate that agents progressively evolve the ability to use the information exchanged between each other via signaling to establish temporary leader-follower relations. These relations allow agents to form swarming patterns, emerging as a transient behavior that improves the agents' ability to forage for the resource. Once they have acquired the ability to swarm, the individuals are able to outperform the non-swarmers at finding the resource. The population hence reaches a neutral evolutionary space which leads to a genetic drift of the genotypes. This reductionist approach to signal-based swarming not only contributes to shed light on the minimal conditions for the evolution of a swarming behavior, but also more generally it exemplifies the effect communication can have on optimal search patterns in collective groups of individuals.	[Witkowski, Olaf; Ikegami, Takashi] Univ Tokyo, Dept Interdisciplinary Studies, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan; [Witkowski, Olaf] Tokyo Inst Technol, ELSI Origins Network, Earth Life Sci Inst, 2-12-1-IE-1 Ookayama, Tokyo 1528550, Japan	University of Tokyo; Tokyo Institute of Technology	Witkowski, O (corresponding author), Univ Tokyo, Dept Interdisciplinary Studies, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.; Witkowski, O (corresponding author), Tokyo Inst Technol, ELSI Origins Network, Earth Life Sci Inst, 2-12-1-IE-1 Ookayama, Tokyo 1528550, Japan.	olaf@sacral.c.u-tokyo.ac.jp	Witkowski, Olaf/AGP-5019-2022	Witkowski, Olaf/0000-0002-2101-2428				Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Berdahl A, 2016, FISH FISH, V17, P525, DOI 10.1111/faf.12084; Blondel VD, 2005, IEEE DECIS CONTR P, P2996; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Bremermann HJ, 1962, SELF ORG SYSTEMS, P93; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Cucker F., 2008, MATHS ACTION, V1, P1, DOI DOI 10.5802/MSIA.1; Czirok A., 1997, CONDMAT9712154 ARXIV; D'Orsogna MR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.104302; Eberhart R., 1995, P 6 INT S MICR MACH, P39; FRASER A. S., 1960, AUSTRALIAN JOUR BIOL SCI, V13, P344; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Haldane J. B. S., 1990, CAUSES EVOLUTION; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hartman C, 2006, COMPUT ANIMAT VIRT W, V17, P199, DOI 10.1002/cav.123; Hidalgo J, 2014, P NATL ACAD SCI USA, V111, P10095, DOI 10.1073/pnas.1319166111; Holland J.H., 1975, ADAPTATION NATURAL A; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; MATARIC MJ, 1992, IEEE T ROBOTIC AUTOM, V8, P304, DOI 10.1109/70.143349; Mueller T, 2013, SCIENCE, V341, P999, DOI 10.1126/science.1237139; Nishimura Shin I., 1997, Artificial Life, V3, P243, DOI 10.1162/artl.1997.3.4.243; Olson RS, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0305; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; PARTRIDGE BL, 1982, SCI AM, V246, P114, DOI 10.1038/scientificamerican0682-114; Pearson K, 1901, LONDON EDINBURGH DUB, V6, P559, DOI [10.1080/14786440109462720, DOI 10.1080/14786440109462720]; PITCHER TJ, 1979, MAR BIOL, V54, P383, DOI 10.1007/BF00395444; Polin M, 2009, SCIENCE, V325, P487, DOI 10.1126/science.1172667; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Sayama H, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P577, DOI 10.1145/2330163.2330245; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shimoyama N, 1996, PHYS REV LETT, V76, P3870, DOI 10.1103/PhysRevLett.76.3870; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Su HS, 2009, IEEE T AUTOMAT CONTR, V54, P293, DOI 10.1109/TAC.2008.2010897; Syswerda G., 1991, FDN GENETIC ALGORITH, V1, P94, DOI DOI 10.1016/B978-0-08-050684-5.50009-4; Torney CJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002194; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Ward CR, 2001, ARTIF LIFE, V7, P191, DOI 10.1162/106454601753139005; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wright S ., 1932, ROLES MUTATION INBRE, V1; Xiaoyuan Tu, 1994, Computer Graphics Proceedings. Annual Conference Series 1994. SIGGRAPH 94 Conference Proceedings, P43; Yu WW, 2010, SYST CONTROL LETT, V59, P543, DOI 10.1016/j.sysconle.2010.06.014; Zaera N., 1996, P INT C SIM AD BEH C	50	20	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152756	10.1371/journal.pone.0152756	http://dx.doi.org/10.1371/journal.pone.0152756			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119340	gold, Green Submitted, Green Published			2022-12-26	WOS:000374976200011
J	Brencic, M				Brencic, Mihael			Statistical Analysis of Categorical Time Series of Atmospheric Elementary Circulation Mechanisms - Dzerdzeevski Classification for the Northern Hemisphere	PLOS ONE			English	Article							PATTERNS	Northern hemisphere elementary circulation mechanisms, defined with the Dzerdzeevski classification and published on a daily basis from 1899-2012, are analysed with statistical methods as continuous categorical time series. Classification consists of 41 elementary circulation mechanisms (ECM), which are assigned to calendar days. Empirical marginal probabilities of each ECM were determined. Seasonality and the periodicity effect were investigated with moving dispersion filters and randomisation procedure on the ECM categories as well as with the time analyses of the ECM mode. The time series were determined as being non-stationary with strong time-dependent trends. During the investigated period, periodicity interchanges with periods when no seasonality is present. In the time series structure, the strongest division is visible at the milestone of 1986, showing that the atmospheric circulation pattern reflected in the ECM has significantly changed. This change is result of the change in the frequency of ECM categories; before 1986, the appearance of ECM was more diverse, and afterwards fewer ECMs appear. The statistical approach applied to the categorical climatic time series opens up new potential insight into climate variability and change studies that have to be performed in the future.	[Brencic, Mihael] Univ Ljubljana, Fac Nat Sci & Engn, Dept Geol, Ljubljana, Slovenia; [Brencic, Mihael] Geol Survey Slovenia, Ljubljana, Slovenia	University of Ljubljana	Brencic, M (corresponding author), Univ Ljubljana, Fac Nat Sci & Engn, Dept Geol, Ljubljana, Slovenia.; Brencic, M (corresponding author), Geol Survey Slovenia, Ljubljana, Slovenia.	mihael.brencic@ntf.uni-lj.si			research programme "Groundwater and Geochemistry" of the Geological Survey of Slovenia of Republic of Slovenia [P 0020]; Slovenia Federation [BI-RU/12-13-024, BI-RU/14-15-040]; Russia Federation [BI-RU/12-13-024, BI-RU/14-15-040]; Slovenian Research Agency	research programme "Groundwater and Geochemistry" of the Geological Survey of Slovenia of Republic of Slovenia; Slovenia Federation; Russia Federation; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The results were obtained through the research programme "Groundwater and Geochemistry" (P 0020) of the Geological Survey of Slovenia of Republic of Slovenia and through the bilateral project between Slovenia and Russia Federation BI-RU/12-13-024 and BI-RU/14-15-040 lead by Polona Vreca - Jozef Stefan Institute. All activities were financially supported by the Slovenian Research Agency.	Brencic M., ACTA GEOPHY IN PRESS; Brencic M, 2015, J HYDROL, V529, P1422, DOI 10.1016/j.jhydrol.2015.08.040; DZERDZEEVSKII B, 1962, TELLUS, V14, P328; Dzerdzeevskii BL, 1946, CLASSIFICATION CIRCU; Girs AA, 1972, MACROCIRCULATION MET; Huth R, 2008, ANN NY ACAD SCI, V1146, P105, DOI 10.1196/annals.1446.019; Johnson NL, 1994, CONTINOUS UNIVARIATE, V1; Kader GD, 2007, J STAT EDUC, V15, DOI 10.1080/10691898.2007.11889465; Kononova N, 2013, NO HEMISPHERE ATMOSP; Kononova N.K., 2009, CLASSIFICATION CIRCU; Kononova Nina, 2010, [Geography, Environment, Sustainability, Geography, Environment, Sustainability], V3, P25; R Core Team, LANG ENV STAT COMP; Sepp M, 2002, BOREAL ENVIRON RES, V7, P273; Stanojevic G, 2010, J GEOGR INST JOVAN C, V60, P27, DOI 10.2298/IJGI1002027S; SWANSON DA, 1976, SOC FORCES, V55, P182, DOI 10.2307/2577102; Wei&beta;, 2009, CATEGORICAL TIME SER; Wei8 CH, 2008, STAT METHODOL, V5, P56, DOI [10.1016/j.stamet.2007.05.001, DOI 10.1016/J.STAMET.2007.05.001]; Weiss CH, 2008, ASTA-ADV STAT ANAL, V92, P71, DOI 10.1007/s10182-008-0055-4; Wilks A. A., 1995, STAT METHODS ATMOSPH	19	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154368	10.1371/journal.pone.0154368	http://dx.doi.org/10.1371/journal.pone.0154368			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116375	gold, Green Published, Green Submitted			2022-12-26	WOS:000374973600063
J	Ning, X; Zhang, T; Wu, YF; Zhang, PH; Zhang, JW; Li, S; Yue, XK; Yuan, JP				Ning, Xin; Zhang, Teng; Wu, Yaofa; Zhang, Pihui; Zhang, Jiawei; Li, Shuai; Yue, Xiaokui; Yuan, Jianping			Coordinated Parameter Identification Technique for the Inertial Parameters of Non-Cooperative Target	PLOS ONE			English	Article								Space operations will be the main space missions in the future. This paper focuses on the precise operations for non-cooperative target, and researches of coordinated parameter identification (CPI) which allows the motion of multi- joints. The contents of this paper are organized: (1) Summarize the inertial parameters identification techniques which have been conducted now, and the technique based on momentum conservation is selected for reliability and realizability; (2) Elaborate the basic principles and primary algorithm of coordinated parameter identification, and analyze some special problems in calculation (3) Numerical simulation of coordinated identification technique by an case study on non-cooperative target of spacecraft mounting dual-arm with six joints is done. The results show that the coordinated parameter identification technique could get all the inertial parameters of the target in 3D by one-time identification, and does not need special configuration or driven joints, moreover the results are highly precise and save much more time than traditional ones.	[Ning, Xin; Zhang, Teng; Wu, Yaofa; Zhang, Pihui; Zhang, Jiawei; Li, Shuai; Yue, Xiaokui; Yuan, Jianping] Northwestern Polytech Univ, Coll Astronaut, Xian 710072, Shaan Xi, Peoples R China; [Ning, Xin] Univ Calgary, Dept Mech & Mfg Engn, Schulich Sch Engn, Calgary, AB, Canada	Northwestern Polytechnical University; University of Calgary	Ning, X (corresponding author), Northwestern Polytech Univ, Coll Astronaut, Xian 710072, Shaan Xi, Peoples R China.; Ning, X (corresponding author), Univ Calgary, Dept Mech & Mfg Engn, Schulich Sch Engn, Calgary, AB, Canada.	ning_nwpu@126.com			National Science Foundation of China [11402200]; Key Laboratory of Precision Navigation and Timing Technology [2014PNTT02]; Fundamental Research Funds for the Central Universities; China Aerospace Science and Industry Corporation [2015-HT-XGD]; China Aerospace Science and Technology Corporation [GSR1572001]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Precision Navigation and Timing Technology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Aerospace Science and Industry Corporation; China Aerospace Science and Technology Corporation	The authors are grateful for the support and funding from National Science Foundation of China (No. 11402200, XN); Open Fund of Key Laboratory of Precision Navigation and Timing Technology (No. 2014PNTT02, XN); Fundamental Research Funds for the Central Universities; Space Supporting Fund from China Aerospace Science and Industry Corporation (No. 2015-HT-XGD, XN); Innovation Fund from China Aerospace Science and Technology Corporation (No. GSR1572001, XN).	Chen E-W, 2006, 2006 IEEE INT C IEEE; [干方建 Gan Fangjian], 2002, [中国科学技术大学学报, Journal of University of Science and Technology of China], V32, P353; Goncalves J., 2002, Computer Assisted Mechanics and Engineering Sciences, V9, P373; MUROTSU Y, 1994, J GUID CONTROL DYNAM, V17, P488, DOI 10.2514/3.21225; Sun G. Q., 2015, SCI REPORTS, V5; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Nguyen-Huynh TC, 2013, J GUID CONTROL DYNAM, V36, P404, DOI 10.2514/1.57856; Nguyen-Huynh TC, 2011, IEEE INT CONF ROBOT; Yoshida K, 2000, ROBOTICS RESEARCH, P449; Yoshida K., 2002, P AIAA GUID NAV CONT	11	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153604	10.1371/journal.pone.0153604	http://dx.doi.org/10.1371/journal.pone.0153604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116187	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600025
J	Wigg, S; Stafford, LD				Wigg, Sophie; Stafford, Lorenzo D.			Health Warnings on Alcoholic Beverages: Perceptions of the Health Risks and Intentions towards Alcohol Consumption	PLOS ONE			English	Article							PICTORIAL WARNINGS; FEAR APPEALS; LABELS; IMPACT	Objectives Research has demonstrated that packaging which includes pictorial health warnings are more effective in altering smokers' perceptions and intentions as well as changing smoking behaviours compared to text-only health warnings. However, very few studies have investigated the effectiveness of health warnings on alcoholic beverages Methods Participants (N = 60) viewed alcoholic beverages presenting one of three health warnings (No health warning, Text-only, Pictorial) and then responded to questions relating to level of fear arousal and their perceptions toward alcohol use. Results We found that pictorial health warnings were associated with significantly higher fear arousal, increased perceptions of the health risks of consuming alcohol as well as greater intentions to reduce and quit alcohol consumption compared to the control. Conclusions These novel findings suggest pictorial health warnings on alcoholic beverages may be an important way of making the public aware of the health risks of alcohol consumption.	[Wigg, Sophie; Stafford, Lorenzo D.] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	University of Portsmouth	Stafford, LD (corresponding author), Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England.	lorenzo.Stafford@port.ac.uk		Stafford, Lorenzo Dante/0000-0002-8791-204X				Al-hamdani M, 2015, CANADIAN J PUBLIC HL, V106; [Anonymous], 2012, UK GOVT ALCOHOL STRA; Borland R, 2009, ADDICTION, V104, P669, DOI 10.1111/j.1360-0443.2009.02508.x; de Hoog N, 2007, REV GEN PSYCHOL, V11, P258, DOI 10.1037/1089-2680.11.3.258; Faculty of Public Health, 2008, ALC PUBL HLTH 2008; Glock S, 2013, APPL PSYCHOL-HLTH WE, V5, P332, DOI 10.1111/aphw.12013; Goodall C, 2008, HEALTH COMMUN, V23, P117, DOI 10.1080/10410230801967825; Hammond D, 2004, AM J PUBLIC HEALTH, V94, P1442, DOI 10.2105/AJPH.94.8.1442; Hammond D, 2003, TOB CONTROL, V12, P391, DOI 10.1136/tc.12.4.391; Hammond D, 2011, TOBACCO CONTROL; Health Canada. Tandemar Research Inc, 1996, CIG PACK STUD EV NEW; Hitchman SC, 2013, NICOTINE TOB RES; International Center for Alcohol Policies (ICAP), 2011, HLTH WARN LAB; ITC Project, HLTH WARN TOB PACK I; Kees J, 2010, J PUBLIC POLICY MARK, V29, P265, DOI 10.1509/jppm.29.2.265; Lang P.J., 1988, INT AFFECTIVE PICTUR; Li L, 2014, HLTH ED RES; MEHRABIAN A, 1978, PSYCHOL REP, V43, P803, DOI 10.2466/pr0.1978.43.3.803; NHS, 2013, ALC MIS 2013; Schneider S, 2012, PATIENT EDUC COUNS, V86, P77, DOI 10.1016/j.pec.2011.03.005; Scholes-Balog KE, 2012, AUST NZ J PUBL HEAL, V36, P524, DOI 10.1111/j.1753-6405.2012.00934.x; Services H, 2014, HLTH CONSEQUENCES SM, P17; Stockley C S., 2001, Int J Drug Policy, V12, P153, DOI 10.1016/S0955-3959(01)00077-9; Stockwell T., 2006, REV RES  IMPACTS ALC; Strahan EJ, 2002, TOB CONTROL, V11, P183, DOI 10.1136/tc.11.3.183; Thomas SL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-151; Tobacco Free Center, 2011, PICT WARN LAB COUNTR; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Tversky A, 1989, RATIONAL CHOICE FRAM; UK Department of Health, 2016, UK CHIEF MED OFF LOW; Walker RK, 2013, ALCOHOL CLIN EXP RES, V37, P1253, DOI 10.1111/acer.12109; WHO, 2014, GLOB STAT REP ALC HL; Wilkinson C, 2009, DRUG ALCOHOL REV, V28, P426, DOI 10.1111/j.1465-3362.2009.00055.x; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Yong H-H, 2013, ADULT SMOKERS REACTI; Younie S, 2005, PREVENTING HARMFUL SUBSTANCE USE: THE EVIDENCE BASE FOR POLICY AND PRACTICE, P337, DOI 10.1002/9780470713624.ch28	37	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153027	10.1371/journal.pone.0153027	http://dx.doi.org/10.1371/journal.pone.0153027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27105210	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100008
J	Xu, J; Nakamura, S; Islam, MS; Guo, YJ; Ihara, K; Tomioka, R; Masuda, M; Yoneyama, H; Isogai, E				Xu, Jun; Nakamura, Shuichi; Islam, Md. Shafiqul; Guo, Yijie; Ihara, Kohei; Tomioka, Rintaro; Masuda, Mizuki; Yoneyama, Hiroshi; Isogai, Emiko			Mannose-Binding Lectin Inhibits the Motility of Pathogenic Salmonella by Affecting the Driving Forces of Motility and the Chemotactic Response	PLOS ONE			English	Article							BACTERIAL FLAGELLAR MOTORS; MEMBRANE-POTENTIAL CHANGES; SPIROCHAETA-AURANTIA; PROTEIN FUNCTIONS; INTRACELLULAR PH; ROTARY MOTOR; TYPHIMURIUM; INFECTION; CELL; DISEASE	Mannose-binding lectin (MBL) is a key pattern recognition molecule in the lectin pathway of the complement system, an important component of innate immunity. MBL functions as an opsonin which enhances the sequential immune process such as phagocytosis. We here report an inhibitory effect of MBL on the motility of pathogenic bacteria, which occurs by affecting the energy source required for motility and the signaling pathway of chemotaxis. When Salmonella cells were treated with a physiological concentration of MBL, their motile fraction and free-swimming speed decreased. Rotation assays of a single flagellum showed that the flagellar rotation rate was significantly reduced by the addition of MBL. Measurements of the intracellular pH and membrane potential revealed that MBL affected a driving force for the Salmonella flagellum, the electrochemical potential difference of protons. We also found that MBL treatment increased the reversal frequency of Salmonella flagellar rotation, which interfered with the relative positive chemotaxis toward an attractive substrate. We thus propose that the motility inhibition effect of MBL may be secondarily involved in the attack against pathogens, potentially facilitating the primary role of MBL in the complement system.	[Xu, Jun; Ihara, Kohei; Tomioka, Rintaro; Masuda, Mizuki; Yoneyama, Hiroshi; Isogai, Emiko] Tohoku Univ, Grad Sch Agr Sci, Dept Anim Microbiol, Sendai, Miyagi 980, Japan; [Nakamura, Shuichi; Islam, Md. Shafiqul] Tohoku Univ, Dept Appl Phys, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Guo, Yijie] Xi An Jiao Tong Univ, Dept Immunobiol & Pathogen Biol, Xian 710049, Peoples R China	Tohoku University; Tohoku University; Xi'an Jiaotong University	Xu, J (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Anim Microbiol, Sendai, Miyagi 980, Japan.; Nakamura, S (corresponding author), Tohoku Univ, Dept Appl Phys, Grad Sch Engn, Sendai, Miyagi 980, Japan.	xu.jun.r4@dc.tohoku.ac.jp; naka@bp.apph.tohoku.ac.jp	Ihara, Kohei/AFS-0038-2022; Islam, Shafiqul/AAT-3046-2021	GUO, YIJIE/0000-0002-4949-2048; Xu, Jun/0000-0002-1503-5623; Ihara, Kohei/0000-0002-4389-4599; Nakamura, Shuichi/0000-0003-3972-7779	Grants-in-Aid for Scientific Research [16H05036] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bai F, 2009, BIOPHYS J, V96, P3154, DOI 10.1016/j.bpj.2009.01.023; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1995, BIOPHYS J, V68, pS163; Berg HC, 1995, BIOPHYS J S1, V68, p166S; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; COHEN HJ, 1981, BLOOD, V58, P975; Devyatyrova-Johnson M, 2000, INFECT IMMUN, V68, P3894, DOI 10.1128/IAI.68.7.3894-3899.2000; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Faine S., 1982, GUIDELINES CONTROL L; GOULBOURNE EA, 1981, J BACTERIOL, V148, P837, DOI 10.1128/JB.148.3.837-844.1981; GOULBOURNE EA, 1983, J BACTERIOL, V153, P916, DOI 10.1128/JB.153.2.916-920.1983; GROISMAN EA, 1993, P NATL ACAD SCI USA, V90, P1033, DOI 10.1073/pnas.90.3.1033; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Islam MS, 2014, FEMS MICROBIOL LETT, V356, P39, DOI 10.1111/1574-6968.12495; Isogai E, 2005, COMP IMMUNOL MICROB, V28, P363, DOI 10.1016/j.cimid.2005.10.001; JEPRAS RI, 1995, APPL ENVIRON MICROB, V61, P2696, DOI 10.1128/AEM.61.7.2696-2701.1995; JONES BD, 1992, INFECT IMMUN, V60, P2475, DOI 10.1128/IAI.60.6.2475-2480.1992; KAWAKAMI M, 1984, J IMMUNOL, V132, P2578; KIHARA M, 1981, J BACTERIOL, V145, P1209, DOI 10.1128/JB.145.3.1209-1221.1981; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Kumariya R, 2015, BBA-BIOMEMBRANES, V1848, P1367, DOI 10.1016/j.bbamem.2015.03.007; LANDSPERGER WJ, 1994, INFECT IMMUN, V62, P4825, DOI 10.1128/IAI.62.11.4825-4830.1994; LIU SL, 1988, INFECT IMMUN, V56, P1967, DOI 10.1128/IAI.56.8.1967-1973.1988; Luty AJF, 1998, J INFECT DIS, V178, P1221, DOI 10.1086/515690; MACNAB RM, 1977, P NATL ACAD SCI USA, V74, P221, DOI 10.1073/pnas.74.1.221; MAGARIYAMA Y, 1990, J BACTERIOL, V172, P4359, DOI 10.1128/jb.172.8.4359-4369.1990; Matsuo K, 2000, CARBOHYD RES, V328, P517, DOI 10.1016/S0008-6215(00)00143-9; MATSUSHITA M, 1992, BIOCHEM BIOPH RES CO, V183, P645, DOI 10.1016/0006-291X(92)90531-O; MELTON T, 1978, J BACTERIOL, V133, P708, DOI 10.1128/JB.133.2.708-716.1978; Minamino T, 2003, J BACTERIOL, V185, P1190, DOI 10.1128/JB.185.4.1190-1194.2003; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Mowbray SL, 1998, J STRUCT BIOL, V124, P257, DOI 10.1006/jsbi.1998.4043; Nakamura S, 2006, BIOPHYS J, V90, P3019, DOI 10.1529/biophysj.105.074336; Nakamura S, 2009, J MOL BIOL, V386, P332, DOI 10.1016/j.jmb.2008.12.034; NATHAN P, 1986, J MOL BIOL, V191, P433, DOI 10.1016/0022-2836(86)90138-5; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; POOLE PS, 1988, ANAL BIOCHEM, V175, P52, DOI 10.1016/0003-2697(88)90359-4; RAVID S, 1984, J BACTERIOL, V158, P222, DOI 10.1128/JB.158.1.222-230.1984; REPASKE DR, 1981, J BACTERIOL, V145, P1196, DOI 10.1128/JB.145.3.1196-1208.1981; SAGIEISENBERG R, 1983, J MEMBRANE BIOL, V75, P97, DOI 10.1007/BF01995629; SAMUEL ADT, 1995, P NATL ACAD SCI USA, V92, P3502, DOI 10.1073/pnas.92.8.3502; SIITONEN A, 1992, INFECT IMMUN, V60, P3918, DOI 10.1128/IAI.60.9.3918-3920.1992; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Sze CW, 2012, INFECT IMMUN, V80, P2485, DOI 10.1128/IAI.00145-12; Terry K, 2005, INFECT IMMUN, V73, P803, DOI 10.1128/IAI.73.2.803-811.2005; Troelsen LN, 2007, ARTHRITIS RHEUM, V56, P21, DOI 10.1002/art.22302; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Xu J, 2015, MICROBIOL RES, V171, P21, DOI 10.1016/j.micres.2014.12.010	52	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154165	10.1371/journal.pone.0154165	http://dx.doi.org/10.1371/journal.pone.0154165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104738	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100049
J	Longobardi, P; Montenegro, A; Beltrami, H; Eby, M				Longobardi, Patrick; Montenegro, Alvaro; Beltrami, Hugo; Eby, Michael			Deforestation Induced Climate Change: Effects of Spatial Scale	PLOS ONE			English	Article							CARBON-CYCLE; COVER CHANGES; VEGETATION; MODEL; FEEDBACKS; AMAZON; TEMPERATURE; DYNAMICS; IMPACT	Deforestation is associated with increased atmospheric CO2 and alterations to the surface energy and mass balances that can lead to local and global climate changes. Previous modelling studies show that the global surface air temperature (SAT) response to deforestation depends on latitude, with most simulations showing that high latitude deforestation results in cooling, low latitude deforestation causes warming and that the mid latitude response is mixed. These earlier conclusions are based on simulated large scal land cover change, with complete removal of trees from whole latitude bands. Using a global climate model we examine the effects of removing fractions of 5% to 100% of forested areas in the high, mid and low latitudes. All high latitude deforestation scenarios reduce mean global SAT, the opposite occurring for low latitude deforestation, although a decrease in SAT is simulated over low latitude deforested areas. Mid latitude SAT response is mixed. In all simulations deforested areas tend to become drier and have lower SAT, although soil temperatures increase over deforested mid and low latitude grid cells. For high latitude deforestation fractions of 45% and above, larger net primary productivity, in conjunction with colder and drier conditions after deforestation cause an increase in soil carbon large enough to produce a net decrease of atmospheric CO2. Our results reveal the complex interactions between soil carbon dynamics and other climate subsystems in the energy partition responses to land cover change.	[Longobardi, Patrick; Montenegro, Alvaro; Beltrami, Hugo] St Francis Xavier Univ, CASI, Antigonish, NS B2G 1C0, Canada; [Longobardi, Patrick; Beltrami, Hugo] St Francis Xavier Univ, Dept Earth Sci, Antigonish, NS B2G 1C0, Canada; [Montenegro, Alvaro] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Eby, Michael] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Montenegro, Alvaro] Univ Estadual Paulista, Campus Litoral Paulista, Sao Vicente, SP, Brazil	Saint Francis Xavier University - Canada; Saint Francis Xavier University - Canada; University System of Ohio; Ohio State University; University of Victoria; Universidade Estadual Paulista	Montenegro, A (corresponding author), St Francis Xavier Univ, CASI, Antigonish, NS B2G 1C0, Canada.; Montenegro, A (corresponding author), Ohio State Univ, Dept Geog, Columbus, OH 43210 USA.; Montenegro, A (corresponding author), Univ Estadual Paulista, Campus Litoral Paulista, Sao Vicente, SP, Brazil.	montenegro.8@OSU.edu	Eby, Michael/H-5278-2013; Montenegro, Alvaro/B-4744-2013	Montenegro, Alvaro/0000-0001-6848-1996	NSERC; Natural Sciences and Engineering Research Council of Canada Discovery Grant (NSERC) [DG 140576948]; Canada Research Program; Canadian Foundation for Innovation; NSERC-CREATE Training Program in Climate Sciences based at St. Francis Xavier University; ACENET; Univ Estadual Paulista	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada Discovery Grant (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Program; Canadian Foundation for Innovation(Canada Foundation for Innovation); NSERC-CREATE Training Program in Climate Sciences based at St. Francis Xavier University; ACENET; Univ Estadual Paulista	This work was supported by NSERC (http://www.nserc-crsng.gc.ca/).; This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada Discovery Grant (NSERC DG 140576948), The Canada Research Program (c) to H. Beltrami. Computational facilities provided by the Atlantic Computational Excellence Network (ACEnet-Compute Canada) with support from the Canadian Foundation for Innovation. H. Beltrami holds a Canada Research Chair in Climate Dynamics. P.L was funded by graduate fellowships from a NSERC-CREATE Training Program in Climate Sciences based at St. Francis Xavier University and by ACENET. AM was partially supported by the Univ Estadual Paulista International Visiting Professor Fellowship.	Arora VK, 2011, NAT GEOSCI, V4, P514, DOI [10.1038/ngeo1182, 10.1038/NGEO1182]; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Bathiany S, 2010, BIOGEOSCIENCES, V7, P1383, DOI 10.5194/bg-7-1383-2010; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Bonan GB, 2001, J CLIMATE, V14, P2430, DOI 10.1175/1520-0442(2001)014&lt;2430:OEFROD&gt;2.0.CO;2; Bounoua L, 2002, CLIMATIC CHANGE, V52, P29, DOI 10.1023/A:1013051420309; Brovkin V, 1999, GLOBAL ECOL BIOGEOGR, V8, P509, DOI 10.1046/j.1365-2699.1999.00169.x; Brovkin V, 2006, CLIM DYNAM, V26, P587, DOI 10.1007/s00382-005-0092-6; Brovkin V, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037543; Butler R, 2006, AMAZON WORLDS LARGES; Chagnon FJF, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021188; Claussen M, 2001, GEOPHYS RES LETT, V28, P1011, DOI 10.1029/2000GL012471; Cox P. M., 2001, HADLEY CTR TECH NOTE, V24, P1; Cox PM, 1998, J HYDROL, V212, P79, DOI 10.1016/S0022-1694(98)00203-0; Cox PM, 2001, 23 MET OFF HARDL CTR, P1; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; Diochon A, 2009, FOREST ECOL MANAG, V257, P413, DOI 10.1016/j.foreco.2008.09.015; Durieux L, 2003, REMOTE SENS ENVIRON, V86, P132, DOI 10.1016/S0034-4257(03)00095-6; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food of the United Nations AO, 2010, GLOB FOR RES ASS 201; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friedlingstein P, 2010, CURR OPIN ENV SUST, V2, P251, DOI 10.1016/j.cosust.2010.06.002; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gotelli NJ, 2003, PRIMER ECOLOGY; Govindasamy B, 2001, GEOPHYS RES LETT, V28, P291, DOI 10.1029/2000GL006121; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Kleidon A, 2000, CLIMATIC CHANGE, V44, P471, DOI 10.1023/A:1005559518889; Larcher W, 2001, PHYSIOLOGICAL PLANT; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Magrin G, 2007, CLIMATE CHANGE 2007, P581; MARLAND G, 2002, NDP030 CDIAC ORNL; Matthews HD, 2004, CLIM DYNAM, V22, P461, DOI 10.1007/s00382-004-0392-2; Meissner KJ, 2003, CLIM DYNAM, V21, P515, DOI 10.1007/s00382-003-0352-2; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Montenegro A, 2009, GLOBAL PLANET CHANGE, V69, P195, DOI 10.1016/j.gloplacha.2009.08.005; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Nave LE, 2010, FOREST ECOL MANAG, V259, P857, DOI 10.1016/j.foreco.2009.12.009; Oschlies A, 1999, GLOBAL BIOGEOCHEM CY, V13, P135, DOI 10.1029/98GB02811; Poeplau C, 2011, GLOBAL CHANGE BIOL, V17, P2415, DOI 10.1111/j.1365-2486.2011.02408.x; Pongratz J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047848; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Roy J., 2001, TERRESTRIAL GLOBAL P, DOI 10.1016/b978-012505290-0/50024-7; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schmittner A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002283; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Walker IJ, 2007, IMPACTS ADAPTATION C, P329; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686; Zhang H, 2001, CLIMATIC CHANGE, V49, P309, DOI 10.1023/A:1010662425950	55	33	33	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153357	10.1371/journal.pone.0153357	http://dx.doi.org/10.1371/journal.pone.0153357			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100667	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500030
J	Pavan, ALM; Dela Rosa, ME; Giacomini, G; Neto, FAB; Yamashita, S; Vulcano, LC; Duarte, SB; Miranda, JRD; de Pina, DR				Menegatti Pavan, Ana Luiza; Dela Rosa, Maria Eugenia; Giacomini, Guilherme; Bacchim Neto, Fernando Antonio; Yamashita, Seizo; Vulcano, Luiz Carlos; Duarte, Sergio Barbosa; de Arruda Miranda, Jose Ricardo; de Pina, Diana Rodrigues			Homogeneous Canine Chest Phantom Construction: A Tool for Image Quality Optimization	PLOS ONE			English	Article							STANDARD PATIENT; SKULL; RADIATION	Digital radiographic imaging is increasing in veterinary practice. The use of radiation demands responsibility to maintain high image quality. Low doses are necessary because workers are requested to restrain the animal. Optimizing digital systems is necessary to avoid unnecessary exposure, causing the phenomenon known as dose creep. Homogeneous phantoms are widely used to optimize image quality and dose. We developed an automatic computational methodology to classify and quantify tissues (i.e., lung tissue, adipose tissue, muscle tissue, and bone) in canine chest computed tomography exams. The thickness of each tissue was converted to simulator materials (i.e., Lucite, aluminum, and air). Dogs were separated into groups of 20 animals each according to weight. Mean weights were 6.5 +/- 2.0 kg, 15.0 +/- 5.0 kg, 32.0 +/- 5.5 kg, and 50.0 +/- 12.0 kg, for the small, medium, large, and giant groups, respectively. The one-way analysis of variance revealed significant differences in all simulator material thicknesses (p < 0.05) quantified between groups. As a result, four phantoms were constructed for dorsoventral and lateral views. In conclusion, the present methodology allows the development of phantoms of the canine chest and possibly other body regions and/or animals. The proposed phantom is a practical tool that may be employed in future work to optimize veterinary X-ray procedures.	[Menegatti Pavan, Ana Luiza; Dela Rosa, Maria Eugenia; Giacomini, Guilherme; Bacchim Neto, Fernando Antonio; de Arruda Miranda, Jose Ricardo] Sao Paulo State Univ, Dept Phys & Biophys, Biosci Inst Botucatu, Sao Paulo, Brazil; [Yamashita, Seizo; de Pina, Diana Rodrigues] Sao Paulo State Univ, Dept Trop Dis & Diagnost Imaging, Botucatu Med Sch, Sao Paulo, Brazil; [Vulcano, Luiz Carlos] Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Anim Reprod & Vet Radiol, Sao Paulo, Brazil; [Duarte, Sergio Barbosa] Brasilian Ctr Phys Res, Rio De Janeiro, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	de Pina, DR (corresponding author), Sao Paulo State Univ, Dept Trop Dis & Diagnost Imaging, Botucatu Med Sch, Sao Paulo, Brazil.	drpina@fmb.unesp.br	Miranda, Jose/HCI-6099-2022; /AAD-1785-2020; Pina, Diana rodrigues/AAL-2422-2020; miranda, jose ricardo arruda/C-2300-2012; Duarte, Sergio/P-3623-2019	Pina, Diana rodrigues/0000-0003-1967-1990; Menegatti Pavan, Ana Luiza/0000-0002-6039-1985; miranda, jose ricardo de arruda/0000-0002-8306-8056	Brazilian agency CAPES; Brazilian agency CNPQ; Brazilian agency FAPESP	Brazilian agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by to the Brazilian agencies CAPES, CNPQ, and FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all of the clinical and technical personnel of our institution radiodiagnostic facility. The authors are also grateful to the Brazilian agencies CAPES, CNPQ, and FAPESP for their financial support.	Barber J, 2012, J SMALL ANIM PRACT, V53, P578, DOI 10.1111/j.1748-5827.2012.01257.x; Chu RYL, 1990, 31 AAPM; Copple C, 2013, VET RADIOL ULTRASOUN, V54, P9, DOI 10.1111/j.1740-8261.2012.01989.x; Alves AFF, 2015, EUR J RADIOL, V84, P1579, DOI 10.1016/j.ejrad.2015.05.015; Flynn M, 2009, EXPOSURE INDICATOR D, V0271-7344; Gibson DJ, 2012, ACAD RADIOL, V19, P458, DOI 10.1016/j.acra.2011.12.003; GOLDSTON RT, 1995, GERIATRICS GERONTOLO; Gray JE, 1983, QUALITY CONTROL DIAG; Hernandez-Ruiz L, 2012, APPL RADIAT ISOTOPES, V71, P44, DOI 10.1016/j.apradiso.2012.06.023; Hupe O, 2011, RADIAT PROT DOSIM, V144, P478, DOI 10.1093/rpd/ncq351; JENNINGS RJ, 1988, MED PHYS, V15, P588, DOI 10.1118/1.596210; Ma WK, 2013, RADIOGRAPHY, V19, P85, DOI [10.1016/j.radi.2012.11.007, 10.1016/j.radi.2013.04.002]; Pavan ALM, 2015, PHYS MEDICA, V31, P1065, DOI 10.1016/j.ejmp.2015.06.010; Pavan ALM, 2014, 6 LAT AM C BIOM ENG; Pina DR, 2006, APPL RADIAT ISOTOPES, V64, P1623, DOI 10.1016/j.apradiso.2006.05.006; Pina DR, 2012, MED PHYS, V39, P1357, DOI 10.1118/1.3685588; Pina DR, 2009, APPL RADIAT ISOTOPES, V67, P61, DOI 10.1016/j.apradiso.2008.07.018; Pina DR, 2004, PHYS MED BIOL, V49, pN215, DOI 10.1088/0031-9155/49/14/N02; Precht H, 2014, J DIGIT IMAGING, V27, P68, DOI 10.1007/s10278-013-9635-2; Ranger NT, 2007, RADIOLOGY, V243, P785, DOI 10.1148/radiol.2433060485; Samei E, 2005, RADIAT PROT DOSIM, V114, P220, DOI 10.1093/rpd/nch562; Uffmann M, 2009, EUR J RADIOL, V72, P202, DOI 10.1016/j.ejrad.2009.05.060; Veneziani GR, 2010, RADIAT MEAS, V45, P733, DOI 10.1016/j.radmeas.2010.02.020; WHITE D R, 1978, Medical Physics (Woodbury), V5, P467, DOI 10.1118/1.594456	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154193	10.1371/journal.pone.0154193	http://dx.doi.org/10.1371/journal.pone.0154193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101001	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500165
J	Mirizzi, G; Giannoni, A; Ripoli, A; Iudice, G; Bramanti, F; Emdin, M; Passino, C				Mirizzi, Gianluca; Giannoni, Alberto; Ripoli, Andrea; Iudice, Giovanni; Bramanti, Francesca; Emdin, Michele; Passino, Claudio			Prediction of the Chemoreflex Gain by Common Clinical Variables in Heart Failure	PLOS ONE			English	Article							INITIATE LIFESAVING TREATMENT; CHEYNE-STOKES RESPIRATION; CENTRAL SLEEP-APNEA; CAROTID-BODY; PERIPHERAL CHEMOSENSITIVITY; BAROREFLEX IMPAIRMENT; HOSPITALIZED-PATIENTS; ORGANIZED PROGRAM; RISK-FACTORS; EXERCISE	Background Peripheral and central chemoreflex sensitivity, assessed by the hypoxic or hypercapnic ventilatory response (HVR and HCVR, respectively), is enhanced in heart failure (HF) patients, is involved in the pathophysiology of the disease, and is under investigation as a potential therapeutic target. Chemoreflex sensitivity assessment is however demanding and, therefore, not easily applicable in the clinical setting. We aimed at evaluating whether common clinical variables, broadly obtained by routine clinical and instrumental evaluation, could predict increased HVR and HCVR. Methods and results 191 patients with systolic HF (left ventricular ejection fraction-LVEF-<50%) underwent chemoreflex assessment by rebreathing technique to assess HVR and HCVR. All patients underwent clinical and neurohormonal evaluation, comprising: echocardiogram, cardiopulmonary exercise test (CPET), daytime cardiorespiratory monitoring for breathing pattern evaluation. Regarding HVR, multivariate penalized logistic regression, Bayesian Model Averaging (BMA) logistic regression and random forest analysis identified, as predictors, the presence of periodic breathing and increased slope of the relation between ventilation and carbon dioxide production (VE/VCO2) during exercise. Again, the above-mentioned statistical tools identified as HCVR predictors plasma levels of N-terminal fragment of proBNP and VE/VCO2 slope. Conclusions In HF patients, the simple assessment of breathing pattern, alongside with ventilatory efficiency during exercise and natriuretic peptides levels identifies a subset of patients presenting with increased chemoreflex sensitivity to either hypoxia or hypercapnia.	[Mirizzi, Gianluca; Giannoni, Alberto; Ripoli, Andrea; Iudice, Giovanni; Bramanti, Francesca; Emdin, Michele; Passino, Claudio] Fdn Toscana G Monasterio, Dept Cardiol & Cardiovasc Med, Pisa, Italy; [Emdin, Michele; Passino, Claudio] Scuola Super Sant Anna, Pisa, Italy	Scuola Superiore Sant'Anna	Mirizzi, G (corresponding author), Fdn Toscana G Monasterio, Dept Cardiol & Cardiovasc Med, Pisa, Italy.	gianlucamiri@gmail.com	Giannoni, Alberto/K-3255-2016	Giannoni, Alberto/0000-0001-9314-2005; PASSINO, Claudio/0000-0002-0723-4753				Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Apostolo A, 2015, INT J CARDIOL, V189, P134, DOI 10.1016/j.ijcard.2015.03.422; Blain GM, 2010, J PHYSIOL-LONDON, V588, P2455, DOI 10.1113/jphysiol.2010.187211; Bradley TD, 2003, CIRCULATION, V107, P1822, DOI 10.1161/01.CIR.0000061758.05044.64; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chenuel BJ, 2006, J APPL PHYSIOL, V101, P76, DOI 10.1152/japplphysiol.01617.2005; Chua TP, 1996, J AM COLL CARDIOL, V27, P650, DOI 10.1016/0735-1097(95)00523-4; Del Rio R, 2013, J AM COLL CARDIOL, V62, P2422, DOI 10.1016/j.jacc.2013.07.079; Dempsey JA, 2012, ADV EXP MED BIOL, V758, P343, DOI 10.1007/978-94-007-4584-1_46; Despas F, 2012, J HYPERTENS, V30, P753, DOI 10.1097/HJH.0b013e328350136c; Ding YF, 2011, J PHYSIOL-LONDON, V589, P245, DOI 10.1113/jphysiol.2010.200584; Duffin J, 2011, RESP PHYSIOL NEUROBI, V177, P71, DOI 10.1016/j.resp.2011.04.009; Emdin M, 2004, CLIN CHEM LAB MED, V42, P627, DOI 10.1515/CCLM.2004.108; Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457; Francis DP, 2000, CIRCULATION, V102, P2214; Gao L, 2007, J APPL PHYSIOL, V102, P37, DOI 10.1152/japplphysiol.00681.2006; Giannoni A, 2008, CLIN SCI, V114, P489, DOI 10.1042/CS20070292; Giannoni A, 2016, INT J CARDIOL, V202, P200, DOI 10.1016/j.ijcard.2015.09.007; Giannoni A, 2009, J AM COLL CARDIOL, V53, P1975, DOI 10.1016/j.jacc.2009.02.030; Javaheri S, 1999, NEW ENGL J MED, V341, P949, DOI 10.1056/NEJM199909233411304; Khoo MCK, 2000, RESP PHYSIOL, V122, P167, DOI 10.1016/S0034-5687(00)00157-2; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li YL, 2006, CARDIOVASC RES, V71, P129, DOI 10.1016/j.cardiores.2006.03.017; Manisty CH, 2006, J PHYSIOL-LONDON, V577, P387, DOI 10.1113/jphysiol.2006.116764; Marcus NJ, 2014, J PHYSIOL-LONDON, V592, P391, DOI 10.1113/jphysiol.2013.266221; Moraes DJA, 2011, AM J PHYSIOL-REG I, V300, pR1476, DOI 10.1152/ajpregu.00825.2010; Nattie E, 2009, J APPL PHYSIOL, V106, P1464, DOI 10.1152/japplphysiol.00112.2008; Niewinski P, 2013, INT J CARDIOL, V168, P2506, DOI 10.1016/j.ijcard.2013.03.011; Niewinski P, 2013, J CARD FAIL, V19, P408, DOI 10.1016/j.cardfail.2013.03.013; O'Connor CM, 2008, AM HEART J, V156, P662, DOI 10.1016/j.ahj.2008.04.030; Paton JFR, 2013, HYPERTENSION, V61, P5, DOI 10.1161/HYPERTENSIONAHA.111.00064; Poletti R, 2009, INT J CARDIOL, V137, P47, DOI 10.1016/j.ijcard.2008.06.028; Ponikowski P, 1999, CIRCULATION, V100, P2418, DOI 10.1161/01.CIR.100.24.2418; Ponikowski P, 2001, CIRCULATION, V104, P544, DOI 10.1161/hc3101.093699; Ponikowski P, 1997, CIRCULATION, V96, P2586, DOI 10.1161/01.CIR.96.8.2586; Rocha I, 2003, EXP PHYSIOL, V88, P309, DOI 10.1113/eph8802476; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101, DOI 10.1164/ajrccm.160.4.9903020; Solin P, 2000, AM J RESP CRIT CARE, V162, P2194, DOI 10.1164/ajrccm.162.6.2002024; Wang DL, 2004, STAT MED, V23, P3451, DOI 10.1002/sim.1930; Wasserman K, 1997, CIRCULATION, V96, P2221, DOI 10.1161/01.cir.96.7.2221; Yamada K, 2004, AM HEART J, V148, P964, DOI 10.1016/j.ahj.2004.05.030; YAMASHIRO Y, 1993, SLEEP, V16, P513, DOI 10.1093/sleep/16.6.513	42	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153510	10.1371/journal.pone.0153510	http://dx.doi.org/10.1371/journal.pone.0153510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099934	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500037
J	Nel, I; Gauler, TC; Bublitz, K; Lazaridis, L; Goergens, A; Giebel, B; Schuler, M; Hoffmann, AC				Nel, Ivonne; Gauler, Thomas C.; Bublitz, Kira; Lazaridis, Lazaros; Goergens, Andre; Giebel, Bernd; Schuler, Martin; Hoffmann, Andreas-Claudius			Circulating Tumor Cell Composition in Renal Cell Carcinoma	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN PERIPHERAL-BLOOD; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; VECTOR SYSTEMS; SOLID TUMORS; LUNG-CANCER; BONE-MARROW; TRANSITION	Purpose Due to their minimal-invasive yet potentially current character circulating tumor cells (CTC) might be useful as a "liquid biopsy" in solid tumors. However, successful application in metastatic renal cell carcinoma (mRCC) has been very limited so far. High plasticity and heterogeneity of CTC morphology challenges currently available enrichment and detection techniques with EpCAM as the usual surface marker being underrepresented in mRCC. We recently described a method that enables us to identify and characterize non-hematopoietic cells in the peripheral blood stream with varying characteristics and define CTC subgroups that distinctly associate to clinical parameters. With this pilot study we wanted to scrutinize feasibility of this approach and its potential usage in clinical studies. Experimental Design Peripheral blood was drawn from 14 consecutive mRCC patients at the West German Cancer Center and CTC profiles were analyzed by Multi-Parameter Immunofluorescence Microscopy (MPIM). Additionally angiogenesis-related genes were measured by quantitative RT-PCR analysis. Results We detected CTC with epithelial, mesenchymal, stem cell-like or mixed-cell characteristics at different time-points during anti-angiogenic therapy. The presence and quantity of N-cadherin-positive or CD133-positive CTC was associated with inferior PFS. There was an inverse correlation between high expression of HIF1A, VEGFA, VEGFR and FGFR and the presence of N-cadherin-positive and CD133-positive CTC. Conclusions Patients with mRCC exhibit distinct CTC profiles that may implicate differences in therapeutic outcome. Prospective evaluation of phenotypic and genetic CTC profiling as prognostic and predictive biomarker in mRCC is warranted.	[Nel, Ivonne; Gauler, Thomas C.; Bublitz, Kira; Lazaridis, Lazaros; Hoffmann, Andreas-Claudius] Univ Duisburg Essen, Mol Oncol Risk Profile Evaluat, Dept Med Oncol, West German Canc Ctr, Essen, Germany; [Nel, Ivonne] ABA GmbH & Co KG, BMZ2, Dortmund, Germany; [Gauler, Thomas C.; Schuler, Martin] Univ Duisburg Essen, Dept Radiotherapy, Essen, Germany; [Goergens, Andre; Giebel, Bernd] Univ Duisburg Essen, Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Schuler, Martin; Hoffmann, Andreas-Claudius] Univ Duisburg Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Hoffmann, AC (corresponding author), Univ Duisburg Essen, Mol Oncol Risk Profile Evaluat, Dept Med Oncol, West German Canc Ctr, Essen, Germany.; Hoffmann, AC (corresponding author), Univ Duisburg Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany.	hoffmann@more-oncology.com	Görgens, André/C-3835-2016; Giebel, Bernd/AAH-1083-2021	Görgens, André/0000-0001-9198-0857; Giebel, Bernd/0000-0003-2446-948X	Central European Society for Anticancer Drug Research - EWIV (CESAR)	Central European Society for Anticancer Drug Research - EWIV (CESAR)	The method described in this manuscript is part of the translational program in two multicenter trials in mRCC, C-II-008 Inhibitors (TKI) in Metastatic Renal Cell Carcinoma (mRCC) (BERAT) Trial, NCT01731158; FLIPPER Phase IV study, NCT01521715, and is sponsored by a grant from the Central European Society for Anticancer Drug Research - EWIV (CESAR).	Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bitting RL, 2013, METHODS, V64, P129, DOI 10.1016/j.ymeth.2013.06.034; Bluemke K, 2009, CANCER EPIDEM BIOMAR, V18, P2190, DOI 10.1158/1055-9965.EPI-08-1178; Cesselli D, 2009, CIRC RES, V104, P1225, DOI 10.1161/CIRCRESAHA.109.195859; Chen S, 2013, J SURG ONCOL, V107, P799, DOI 10.1002/jso.23337; Chong PP, 2012, J ORTHOP RES, V30, P634, DOI 10.1002/jor.21556; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gorgens A, 2014, STEM CELL REP, V3, P1058, DOI 10.1016/j.stemcr.2014.09.016; Gradilone A, 2011, ANTICANCER RES, V31, P4219; Gradilone A, 2011, J CELL MOL MED, V15, P1066, DOI 10.1111/j.1582-4934.2011.01285.x; Gruenwald V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-695; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hernandez-Yanez M, 2012, CURR ONCOL REP, V14, P221, DOI 10.1007/s11912-012-0231-2; Hoffman AC, 2009, CLIN CANCER RES, V15, P5191, DOI 10.1158/1078-0432.CCR-08-2534; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Hoffmann AC, 2010, NEOPLASIA, V12, P628, DOI 10.1593/neo.10402; Jiang YS, 2013, MED HYPOTHESES, V81, P73, DOI 10.1016/j.mehy.2013.03.020; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kassis I, 2006, BONE MARROW TRANSPL, V37, P967, DOI 10.1038/sj.bmt.1705358; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Mullers E, 2011, J VIROL, V85, P1452, DOI 10.1128/JVI.01731-10; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nel I, 2014, TRANSL LUNG CANCER R, V3, P100, DOI 10.3978/j.issn.2218-6751.2014.03.05; Nel I, 2014, HEPATOL INT, V8, P321, DOI 10.1007/s12072-014-9539-3; Nel I, 2014, BIOMARK MED, V8, P687, DOI [10.2217/BMM.14.23, 10.2217/bmm.14.23]; Nel I, 2014, INT J CLIN PHARM TH, V52, P74, DOI 10.5414/CPXCES13EA01; Nel I, 2013, TRANSL ONCOL, V6, P420, DOI 10.1593/tlo.13271; O'Flaherty JD, 2012, LUNG CANCER, V76, P19, DOI 10.1016/j.lungcan.2011.10.018; Pirozzi G, 2013, ONCOL REP, V29, P1763, DOI 10.3892/or.2013.2294; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Weller P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113706; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Yang FC, 1998, BLOOD, V92, P4632, DOI 10.1182/blood.V92.12.4632.424k28_4632_4640; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	45	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153018	10.1371/journal.pone.0153018	http://dx.doi.org/10.1371/journal.pone.0153018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101285	gold, Green Submitted, Green Published			2022-12-26	WOS:000374898500023
J	Parr, EB; Camera, DM; Burke, LM; Phillips, SM; Coffey, VG; Hawley, JA				Parr, Evelyn B.; Camera, Donny M.; Burke, Louise M.; Phillips, Stuart M.; Coffey, Vernon G.; Hawley, John A.			Circulating MicroRNA Responses between 'High' and 'Low' Responders to a 16-Wk Diet and Exercise Weight Loss Intervention	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE	Background Interactions between diet, physical activity and genetic predisposition contribute to variable body mass changes observed in response to weight loss interventions. Circulating microRNAs (c-miRNAs) may act as 'biomarkers' that are associated with the rate of change in weight loss, and/or play a role in regulating the biological variation, in response to energy restriction. Objective To quantify targeted c-miRNAs with putative roles in energy metabolism and exercise adaptations following a 16 wk diet and exercise intervention in individuals with large (high responders; HiRes) versus small (low responders; LoRes) losses in body mass. Methods From 89 male and female overweight/obese participants who completed the intervention (energy restriction from diet, 250 kcal/d, and exercise, 250 kcal/d), subgroups of HiRes (>10% body mass loss, n = 22) and LoRes (<5% body mass loss, n = 18) were identified. From resting plasma samples collected after an overnight fast pre and post intervention, RNA was extracted, quantified and reverse transcribed. Thirteen c-miRNA selected a priori were analysed using a customised 96-well miScript miRNA PCR Array. Results Loss of body mass (-11.0 +/- 2.3 kg vs. -3.0 +/- 1.3 kg; P<0.01) and fat mass (-11.1 +/- 2.6 kg vs. -3.9 +/- 1.6 kg; P<0.01) was greater for HiRes than LoRes (P<0.001). Expression of c-miR-935 was higher in LoRes compared to HiRes pre-(similar to 47%; P = 0.025) and post-(similar to 100%; P<0.01) intervention and was the only c-miRNA differentially expressed at baseline between groups. The abundance of c-miR-221-3p and -223-3p increased pre- to post-intervention in both groups (similar to 57-69% and similar to 25-90%, P<0.05). There was a post-intervention increase in c-miR-140 only in LoRes compared to HiRes (similar to 23%, P = 0.016). Conclusion The differential expression and responses of selected c- miRNAs in overweight/obese individuals to an exercise and diet intervention suggests a putative role for these 'biomarkers' in the prediction or detection of individual variability to weight loss interventions.	[Parr, Evelyn B.; Camera, Donny M.; Burke, Louise M.; Hawley, John A.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Exercise & Nutr, Melbourne, Vic, Australia; [Burke, Louise M.] Australian Inst Sport, Dept Sports Nutr, Canberra, ACT, Australia; [Phillips, Stuart M.] McMaster Univ, Exercise Metab Res Grp, Dept Kinesiol, Hamilton, ON, Canada; [Coffey, Vernon G.] Bond Univ, Bond Inst Hlth & Sport, Gold Coast, Qld, Australia; [Coffey, Vernon G.] Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld, Australia; [Hawley, John A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England	Australian Catholic University; Australian Institute of Sport; McMaster University; Bond University; Bond University; Liverpool John Moores University	Hawley, JA (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Exercise & Nutr, Melbourne, Vic, Australia.; Hawley, JA (corresponding author), Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England.	john.hawley@acu.edu.au	Hawley, John A/U-3814-2018; Camera, Donny/J-1571-2018; Phillips, Stuart/B-2343-2009; Parr, Evelyn/J-1576-2018; Burke, Louise/X-3127-2019; Burke, Louise/ABC-5691-2020	Hawley, John A/0000-0002-0886-9881; Camera, Donny/0000-0002-6494-9472; Phillips, Stuart/0000-0002-1956-4098; Parr, Evelyn/0000-0003-1710-6381; Burke, Louise/0000-0001-8866-5637; 	Dairy Health and Nutrition Consortium, Dairy Innovation Australia Ltd [201134D]	Dairy Health and Nutrition Consortium, Dairy Innovation Australia Ltd	Supported by a grant from the Dairy Health and Nutrition Consortium, Dairy Innovation Australia Ltd (ID# 201134D) to JAH, VGC, SMP and LMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00495; Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bouchard L, 2010, AM J CLIN NUTR, V91, P309, DOI 10.3945/ajcn.2009.28085; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; Capuano Melissa M, 2013, BMC Res Notes, V6, P235, DOI 10.1186/1756-0500-6-235; Frankenfield D, 2005, J AM DIET ASSOC, V105, P775, DOI 10.1016/j.jada.2005.02.005; Guzman-Ruiz R, 2014, INT J OBESITY, V38, P1545, DOI 10.1038/ijo.2014.36; Hainer V, 2008, PHYSIOL RES, V57, pS17, DOI 10.33549/physiolres.931486; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Kilic ID, 2015, GENE, V560, P140, DOI 10.1016/j.gene.2015.01.048; King NA, 2012, BRIT J SPORT MED, V46, P315, DOI 10.1136/bjsm.2010.082495; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li YP, 2014, INT J MED SCI, V11, P522, DOI 10.7150/ijms.8206; Liu Y, 2014, INT J MOL SCI, V15, P10567, DOI 10.3390/ijms150610567; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Milagro FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054319; Milagro FI, 2011, FASEB J, V25, P1378, DOI 10.1096/fj.10-170365; Moleres A, 2013, FASEB J, V27, P2504, DOI 10.1096/fj.12-215566; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Parr EB, OBES SILVER IN PRESS; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Sawada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070823; Wen DZ, 2015, OBES RES CLIN PRACT, V9, P398, DOI 10.1016/j.orcp.2015.01.006; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	30	42	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152545	10.1371/journal.pone.0152545	http://dx.doi.org/10.1371/journal.pone.0152545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101373	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500012
J	Wang, LJ; Xu, XY; Kang, LN; Xiang, WP				Wang, Lingjuan; Xu, Xiaoyan; Kang, Lina; Xiang, Wenpei			Bone Marrow Mesenchymal Stem Cells Attenuate Mitochondria Damage Induced by Hypoxia in Mouse Trophoblasts	PLOS ONE			English	Article							MEDIATED APOPTOSIS; EXPRESSION; STRESS; DEATH; ACTIVATION; PREGNANCY; ISCHEMIA; RESCUE; MODEL	Objective We aimed to observe the change of mitochondrial function and structure as well as the cell function induced by hypoxia in mouse trophoblasts, and moreover, to validate the restoration of these changes after co-culture with bone marrow mesenchymal stem cells (hereinafter referred to as "MSCs"). Further, we explored the mechanism of MSCs attenuating the functional damage of trophoblasts caused by hypoxia. Methods Cells were divided into two groups, trophoblasts and MSCs+ trophoblasts respectively, and the two groups of cells were incubated with normoxia or hypoxia. Chemiluminescence was used to assay the beta-HCG and progesterone in cell culture supernatants quantitatively. Western blotting and PCR were applied to detect the expression of Mfn2, MMP-2, MMP-9 and integrin beta 1 in the two groups. The mitochondrial membrane potential of each group of cells was detected with JC-1 dye and the ATP content was measured by the phosphomolybdic acid colorimetric method. We utilized transmission electron microscopy for observing the ultrastructure of mitochondria in trophoblasts. Finally, we assessed the cell apoptosis with flow cytometry (FCM) and analyzed the expression of the apoptosis related genes-Bcl-2, Bax, Caspase3 and Caspase9 by western blotting. Results The results showed that the Mfn2 expression was reduced after 4 h in hypoxia compared with that in normoxia, but increased in the co-culture group when compared with that in the separated-culture group (p< 0.05). In addition, compared with the separated-culture group, the beta-HCG and progesterone levels in the co-culture group were significantly enhanced (p< 0.05), and so were the expressions of MMP-2, MMP-9 and integrin beta 1 (p< 0.05). Moreover, it exhibited significantly higher in ATP levels and intensified about the mitochondrial membrane potential in the co-culture group. TEM revealed disorders of the mitochondrial cristae and presented short rod-like structure and spheroids in hypoxia, however, in the co-culture group, the mitochondrial cristae had a relatively regular arrangement and the mitochondrial ultrastructure showed hyperfusion. The expression of Bax, Caspase3 and Caspase9 was decreased in the co-culture group when compared with that in trophoblast cells cultured alone (p< 0.05), while the Bcl-2 levels and the Apoptosis Index (AI) were markedly increased in the co-culture group (p< 0.05). Conclusion Bone marrow mesenchymal stem cells can attenuate mitochondria damage and cell apoptosis induced by hypoxia; the mechanism could be upregulating the expression of Mfn2 in mouse trophoblasts and changing mitochondrial structure.	[Wang, Lingjuan; Kang, Lina; Xiang, Wenpei] Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan 430074, Peoples R China; [Xu, Xiaoyan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xiang, WP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan 430074, Peoples R China.	wpxiang2010@gmail.com			Fundamental Research Funds for the Central Universities	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the Fundamental Research Funds for the Central Universities. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuk PTY, 2006, MED HYPOTHESES, V67, P792, DOI 10.1016/j.mehy.2006.04.026; Borbely AU, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-7; Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050; Cai XH, 2014, EXP NEUROL, V257, P148, DOI 10.1016/j.expneurol.2014.04.029; Chen RL, 2015, IND HEALTH, V53, P222, DOI 10.2486/indhealth.2014-0182; Chen WQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136421; Chu PPY, 2012, CYTOTHERAPY, V14, P1064, DOI 10.3109/14653249.2012.697146; Creagh EM, 2014, TRENDS IMMUNOL, V35, P631, DOI 10.1016/j.it.2014.10.004; de Windt TS, 2014, STEM CELL TRANSL MED, V3, P723, DOI 10.5966/sctm.2013-0207; Escobar-Henriques M, 2013, BBA-MOL CELL RES, V1833, P162, DOI 10.1016/j.bbamcr.2012.07.016; Fu X, 2008, CYTOTHERAPY, V10, P353, DOI 10.1080/14653240802035926; Gultice AD, 2006, BIOL REPROD, V74, P1041, DOI 10.1095/biolreprod.105.047845; Guo JQ, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-18; Handschuh K, 2007, PLACENTA, V28, P175, DOI 10.1016/j.placenta.2006.01.019; He Yun-Yun, 2011, Sheng Li Ke Xue Jin Zhan, V42, P419; Hedskog L, 2012, ANTIOXID REDOX SIGN, V16, P1476, DOI 10.1089/ars.2011.4259; Hong JY, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-122; Hou M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085808; Hu JQ, 2015, MOL MED REP, V12, P5701, DOI 10.3892/mmr.2015.4139; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Kim SM, 2008, EXP MOL MED, V40, P261, DOI 10.3858/emm.2008.40.3.261; Lee HJ, 2007, J CLIN ONCOL, V25, P3198, DOI 10.1200/JCO.2006.10.3028; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15271; Li ML, 2014, CELL SIGNAL, V26, P1539, DOI 10.1016/j.cellsig.2014.03.026; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Liu KM, 2014, MICROVASC RES, V92, P10, DOI 10.1016/j.mvr.2014.01.008; Lopez J, 2015, BRIT J CANCER, V112, P957, DOI 10.1038/bjc.2015.85; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Pang W, 2013, PLACENTA, V34, P613, DOI 10.1016/j.placenta.2013.03.013; Park JY, 2011, ARCH TOXICOL, V85, P1057, DOI 10.1007/s00204-011-0645-x; Rasstrigina I. M., 2014, Arkhiv Patologii, V76, P24; Rau TF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047877, 10.1371/journal.pone.0040881]; ROSENBAUM DM, 1994, ANN NEUROL, V36, P864, DOI 10.1002/ana.410360610; Tessier DR, 2015, AM J REPROD IMMUNOL, V74, P1, DOI 10.1111/aji.12345; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; Xiong SB, 2014, PROTEIN CELL, V5, P737, DOI 10.1007/s13238-014-0089-1; Yu B, 2015, INT J CARDIOL, V182, P349, DOI 10.1016/j.ijcard.2014.12.043; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66	38	5	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153729	10.1371/journal.pone.0153729	http://dx.doi.org/10.1371/journal.pone.0153729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100996	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500057
J	Wolf, KJ; Emerson, RO; Pingel, J; Buller, RM; DiPaolo, RJ				Wolf, Kyle J.; Emerson, Ryan O.; Pingel, Jeanette; Buller, R. Mark; DiPaolo, Richard J.			Conventional and Regulatory CD4(+) T Cells That Share Identical TCRs Are Derived from Common Clones	PLOS ONE			English	Article							SELF-ANTIGEN; IN-VIVO; GENERATION; RECOGNITION; EXPRESSION; RESPONSES; SELECTION; MICE	Results from studies comparing the diversity and specificity of the TCR repertoires expressed by conventional (Tconv) and regulatory (Treg) CD4(+) T cell have varied depending on the experimental system employed. We developed a new model in which T cells express a single fixed TCR alpha chain, randomly rearranged endogenous TCR beta chains, and a Foxp3-GFP reporter. We purified CD4(+) Foxp3(-) and CD4(+) Foxp3(+) cells, then performed biased controlled multiplex PCR and high throughput sequencing of endogenous TCR beta chains. We identified > 7,000 different TCR beta sequences in the periphery of 5 individual mice. On average, similar to 12% of TCR sequences were expressed by both conventional and regulatory populations within individual mice. The CD4(+) T cells that expressed shared TCR sequences were present at higher frequencies compared to T cells expressing non-shared TCRs. Furthermore, nearly all (> 90%) of the TCR sequences that were shared within mice were identical at the DNA sequence level, indicating that conventional and regulatory T cells that express shared TCRs are derived from common clones. Analysis of TCR repertoire overlap in the thymus reveals that a large proportion of Tconv and Treg sharing observed in the periphery is due to clonal expansion in the thymus. Together these data show that there are a limited number of TCR sequences shared between Tconv and Tregs. Also, Tconv and Tregs sharing identical TCRs are found at relatively high frequencies and are derived from common progenitors, of which a large portion are generated in the thymus.	[Wolf, Kyle J.; Pingel, Jeanette; Buller, R. Mark; DiPaolo, Richard J.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA; [Emerson, Ryan O.] Adapt Biotechnol Corp, Seattle, WA USA; [Pingel, Jeanette] Washington Univ, Sch Med, Dept Pediat Rheumatol, St Louis, MO USA	Saint Louis University; Washington University (WUSTL)	DiPaolo, RJ (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA.	rdipaolo@slu.edu		Wolf, Kyle/0000-0003-4874-2911	Saint Louis University School of Medicine; Adaptive Biotechnologies	Saint Louis University School of Medicine; Adaptive Biotechnologies	This project was funded by a seed grant from the Saint Louis University School of Medicine. Adaptive Biotechnologies provided support in the form of salaries for author (ROE), but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2007, INT IMMUNOL, V19, P557, DOI 10.1093/intimm/dxm021; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Arnold PY, 2004, J IMMUNOL, V173, P3103, DOI 10.4049/jimmunol.173.5.3103; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bettini M, 2014, J IMMUNOL, V193, P571, DOI 10.4049/jimmunol.1400043; Bettini ML, 2013, NAT PROTOC, V8, P1837, DOI 10.1038/nprot.2013.111; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Clemens EB, 2015, J IMMUNOL, V194, P898, DOI 10.4049/jimmunol.1401792; DiPaolo RJ, 2009, EUR J IMMUNOL, V39, P234, DOI 10.1002/eji.200838772; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Geiger TL, 2012, HUM IMMUNOL, V73, P232, DOI 10.1016/j.humimm.2011.12.012; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Lefranc Marie-Paule, 2004, In Silico Biology, V4, P17; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu X, 2009, IMMUNITY, V31, P909, DOI 10.1016/j.immuni.2009.09.023; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Ochando JC, 2005, J IMMUNOL, V174, P6993, DOI 10.4049/jimmunol.174.11.6993; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032	38	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153705	10.1371/journal.pone.0153705	http://dx.doi.org/10.1371/journal.pone.0153705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100298	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500052
J	Cousins, FL; Kirkwood, PM; Murray, AA; Collins, F; Gibson, DA; Saunders, PTK				Cousins, Fiona L.; Kirkwood, Phoebe M.; Murray, Alison A.; Collins, Frances; Gibson, Douglas A.; Saunders, Philippa T. K.			Androgens regulate scarless repair of the endometrial "wound" in a mouse model of menstruation	FASEB JOURNAL			English	Article						mesenchyme; epithelium; SNAI3; metalloproteinase; dihydrotestosterone	MATRIX METALLOPROTEINASE-3; INTRAUTERINE ADHESIONS; EXPRESSION; RECEPTOR; TISSUE; SKIN; TESTOSTERONE; ESTROGEN; CYCLE; CELL	The human endometrium undergoes regular cycles of synchronous tissue shedding (wounding) and repair that occur during menstruation before estrogen-dependent regeneration. Endometrial repair is normally both rapid and scarless. Androgens regulate cutaneous wound healing, but their role in endometrial repair is unknown. We used a murine model of simulated menses; mice were treated with a single dose of the nonaromatizable androgen dihydrotestosterone (DHT; 200 mu g/mouse) to coincide with initiation of tissue breakdown. DHT altered the duration of vaginal bleeding and delayed restoration of the luminal epithelium. Analysis of uterine mRNAs 24 h after administration of DHT identified significant changes in metalloproteinases (Mmp3 and -9; P < 0.01), a snail family member (Snai3; P < 0.001), and osteopontin (Spp1; P < 0.001). Chromatin immunoprecipitation analysis identified putative androgen receptor (AR) binding sites in the proximal promoters of Mmp9, Snai3, and Spp1. Striking spatial and temporal changes in immunoexpression of matrix metalloproteinase (MMP) 3/9 and caspase 3 were detected after DHT treatment. These data represent a paradigm shift in our understanding of the role of androgens in endometrial repair and suggest that androgens may have direct impacts on endometrial tissue integrity. These studies provide evidence that the AR is a potential target for drug therapy to treat conditions associated with aberrant endometrial repair processes.	[Cousins, Fiona L.; Kirkwood, Phoebe M.; Collins, Frances; Gibson, Douglas A.; Saunders, Philippa T. K.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Murray, Alison A.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Saunders, PTK (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	p.saunders@ed.ac.uk	Cousins, Fiona L/K-3790-2016; Saunders, Philippa TK/C-7489-2013	Cousins, Fiona L/0000-0002-7064-8596; Saunders, Philippa TK/0000-0001-9051-9380; Kirkwood, Phoebe/0000-0002-5245-718X; Gibson, Douglas/0000-0002-9949-1983	Medical Research Council (MRC) [G1100356/1]; MRC Ph.D. studentship; MRC Centenary Award Postdoctoral Fellowship; Medical Research Council [G1100356, 1576764, MR/N024524/1] Funding Source: researchfish; MRC [MR/N024524/1, G1100356] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Ph.D. studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centenary Award Postdoctoral Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a Medical Research Council (MRC) Programme Grant (G1100356/1; to P.T.K.S.). F.L.C. was funded by an MRC Ph.D. studentship and an MRC Centenary Award Postdoctoral Fellowship. The authors declare no conflicts of interest.	ABRAHAM GE, 1974, J CLIN ENDOCR METAB, V39, P340, DOI 10.1210/jcem-39-2-340; Alawadhi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096662; Angadi PV, 2010, ORAL MAXILLOFAC SURG, V14, P133, DOI 10.1007/s10006-010-0209-x; Bauman WA, 2013, ANN INTERN MED, V158, P718, DOI 10.7326/0003-4819-158-10-201305210-00006; Bhasin S, 2006, NAT CLIN PRACT ENDOC, V2, P146, DOI 10.1038/ncpendmet0120; Brasted M, 2003, BIOL REPROD, V69, P1273, DOI 10.1095/biolreprod.103.016550; Bui HN, 2013, STEROIDS, V78, P96, DOI 10.1016/j.steroids.2012.10.010; Chang Chawnshang, 2013, Nucl Recept Signal, V11, pe001, DOI 10.1621/nrs.11001; Chevronnay HPG, 2012, BBA-PROTEINS PROTEOM, V1824, P146, DOI 10.1016/j.bbapap.2011.09.003; Chevronnay HPG, 2009, ENDOCRINOLOGY, V150, P5094, DOI 10.1210/en.2009-0750; Cloke B, 2012, MOL CELL ENDOCRINOL, V358, P166, DOI 10.1016/j.mce.2011.06.031; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; Cousins FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086378; Cox KE, 2000, J SOC GYNECOL INVEST, V7, P242, DOI 10.1016/S1071-5576(00)00062-9; Dalton JT, 2011, J CACHEXIA SARCOPENI, V2, P153, DOI 10.1007/s13539-011-0034-6; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; DAWOOD MY, 1976, AM J OBSTET GYNECOL, V126, P430, DOI 10.1016/0002-9378(76)90632-3; Garry R, 2010, BJOG-INT J OBSTET GY, V117, P1175, DOI 10.1111/j.1471-0528.2010.02630.x; Garry R, 2009, HUM REPROD, V24, P1393, DOI 10.1093/humrep/dep036; Gibson DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19970; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Gilliver SC, 2009, J PATHOL, V217, P73, DOI 10.1002/path.2444; Gilliver SC, 2006, J CELL SCI, V119, P722, DOI 10.1242/jcs.02786; Gilliver SC, 2007, LAB INVEST, V87, P871, DOI 10.1038/labinvest.3700627; HAMPTON AL, 1994, J ENDOCRINOL, V141, pR1, DOI 10.1677/joe.0.141R001; Hart R, 2015, J CLIN ENDOCR METAB, V100, P911, DOI 10.1210/jc.2014-3886; Hewitt SC, 2016, J MOL ENDOCRINOL, V56, pR55, DOI 10.1530/JME-15-0254; Hooker AB, 2014, HUM REPROD UPDATE, V20, P262, DOI 10.1093/humupd/dmt045; Hu JG, 2015, INT J CLIN EXP PATHO, V8, P1525; Kaitu'u-Lino TJ, 2007, ENDOCRINOLOGY, V148, P5105, DOI 10.1210/en.2007-0716; Kajihara T, 2012, FERTIL STERIL, V97, P185, DOI 10.1016/j.fertnstert.2011.10.017; Konerding MA, 2012, INT J MOL MED, V30, P271, DOI 10.3892/ijmm.2012.1005; Kundu S, 2012, J ENDOCRINOL, V215, P151, DOI 10.1530/JOE-11-0486; Kuramoto G, 2015, HUM REPROD, V30, P406, DOI 10.1093/humrep/deu326; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Laplante AF, 2001, FASEB J, V15, P2377, DOI 10.1096/fj.01-0250com; Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781; MARBAIX E, 1992, P NATL ACAD SCI USA, V89, P11789, DOI 10.1073/pnas.89.24.11789; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Markova MS, 2004, J INVEST DERMATOL, V123, P1052, DOI 10.1111/j.0022-202X.2004.23494.x; Marshall E, 2011, J CLIN ENDOCR METAB, V96, pE1746, DOI 10.1210/jc.2011-0272; Massafra C, 2000, J ENDOCRINOL, V167, P447, DOI 10.1677/joe.0.1670447; Matsuura-Sawada R, 2005, HUM REPROD, V20, P1477, DOI 10.1093/humrep/deh783; Minjarez D, 2001, BIOL REPROD, V65, P1378, DOI 10.1095/biolreprod65.5.1378; Narayanan Ramesh, 2008, Nucl Recept Signal, V6, pe010, DOI 10.1621/nrs.06010; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Salamonsen LA, 1998, TRENDS ENDOCRIN MET, V9, P305, DOI 10.1016/S1043-2760(98)00078-2; SHAPIRO SD, 1995, J BIOL CHEM, V270, P6351, DOI 10.1074/jbc.270.11.6351; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Simitsidellis I, 2016, ENDOCRINOLOGY, V157, P2116, DOI 10.1210/en.2015-2032; SMID A, 1980, ZBL GYNAKOL, V102, P380; Toraldo G, 2012, WOUND REPAIR REGEN, V20, P61, DOI 10.1111/j.1524-475X.2011.00757.x; WAHI PN, 1966, BRIT J CANCER, V20, P676, DOI 10.1038/bjc.1966.79; Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009; Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x; Yu D, 2008, FERTIL STERIL, V89, P759, DOI 10.1016/j.fertnstert.2008.02.096; Zhang X, 1996, BIOL REPROD, V55, P519, DOI 10.1095/biolreprod55.3.519	58	20	21	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2802	2811		10.1096/fj.201600078R	http://dx.doi.org/10.1096/fj.201600078R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27121597	Green Published, hybrid			2022-12-26	WOS:000380994000016
J	Bennie, JA; Pedisic, Z; van Uffelen, JGZ; Charity, MJ; Harvey, JT; Banting, LK; Vergeer, I; Biddle, SJH; Eime, RM				Bennie, Jason A.; Pedisic, Zeljko; van Uffelen, Jannique G. Z.; Charity, Melanie J.; Harvey, Jack T.; Banting, Lauren K.; Vergeer, Ineke; Biddle, Stuart J. H.; Eime, Rochelle M.			Pumping Iron in Australia: Prevalence, Trends and Sociodemographic Correlates of Muscle Strengthening Activity Participation from a National Sample of 195,926 Adults	PLOS ONE			English	Article							RISK; METAANALYSIS; BEHAVIOR; IMPACT; SPORT	Objective The current Australian Physical Activity Guidelines recommend that adults engage in regular muscle-strengthening activity (e.g. strength or resistance training). However, public health surveillance studies describing the patterns and trends of population-level muscle-strengthening activity participation are sparse. The aim of this study is to examine the prevalence, trends and sociodemographic correlates of muscle-strengthening activity participation in a national-representative sample of Australians aged 15 years and over. Methods Between 2001 and 2010, quarterly cross-sectional national telephone surveys were conducted as part of the Australian Sports Commission's 'Exercise, Recreation and Sport Survey'. Pooled population-weighted proportions were calculated for reporting: [i] no muscle-strengthening activity; [ii] insufficient muscle-strengthening activity, and [iii] sufficient muscle-strengthening activity. Associations with sociodemographic variables were assessed using multiple logistic regression analyses. Results Out of 195,926 participants, aged 15-98 years, only 10.4%(95% CI: 10.1-10.7) and 9.3% (95% CI: 9.1-9.5) met the muscle-strengthening activity recommendations in the past two weeks and in the past year, respectively. Older adults (50+ years), and those living in socio-economically disadvantaged, outer regional/remote areas and with lower education were less likely to report sufficient muscle-strengthening activity (p<0.001). Over the 10-year monitoring period, there was a significant increase in the prevalence of sufficient muscle-strengthening activity (6.4% to 12.0%, p-value for linear trend <0.001). Conclusions A vast majority of Australian adults did not engage in sufficient muscle-strengthening activity. There is a need for public health strategies to support participation in muscle-strengthening activity in this population. Such strategies should target older and lower educated adults, and those living in socioeconomically disadvantaged, outer regional/remote and areas.	[Bennie, Jason A.; Pedisic, Zeljko; van Uffelen, Jannique G. Z.; Charity, Melanie J.; Harvey, Jack T.; Banting, Lauren K.; Vergeer, Ineke; Biddle, Stuart J. H.; Eime, Rochelle M.] Victoria Univ, ISEAL, Act Living & Publ Hlth Program, Melbourne, Vic 8001, Australia; [Charity, Melanie J.; Harvey, Jack T.; Eime, Rochelle M.] Federat Univ Australia, Fac Hlth, Ballarat, Vic, Australia	Victoria University; Federation University Australia	Bennie, JA (corresponding author), Victoria Univ, ISEAL, Act Living & Publ Hlth Program, Melbourne, Vic 8001, Australia.	jason.bennie@vu.edu.au	van Uffelen, Jannique/AAI-8216-2020; Bennie, Jason/AAY-2915-2020; van Uffelen, Jannique/C-3392-2008	van Uffelen, Jannique/0000-0001-7253-5766; Bennie, Jason/0000-0002-8668-8998; van Uffelen, Jannique/0000-0001-7253-5766; Biddle, Stuart/0000-0002-7663-6895; Vergeer, Ineke/0000-0002-6560-9023; Pedisic, Zeljko/0000-0003-2886-3556; Harvey, Jack/0000-0001-6927-6580; Eime, Rochelle/0000-0002-8614-2813	Fitness Australia; Australia Sports Commission-ISEAL Victoria University Senior Research Fellowship; ISEAL Research Program Strategic Project Grant (project title: Epidemiological assessment of muscle strengthening exercise participation in Australia)	Fitness Australia; Australia Sports Commission-ISEAL Victoria University Senior Research Fellowship; ISEAL Research Program Strategic Project Grant (project title: Epidemiological assessment of muscle strengthening exercise participation in Australia)	JAB declares he has a research fellowship part-funded by Fitness Australia, a not-for-profit, member-based industry association representing the interests of over 30,000 Australian registered exercise professionals, fitness service providers and industry suppliers. SJHB declares he has been a consultant to Fitness First. JGZvU declares she is supported by an Australia Sports Commission-ISEAL Victoria University Senior Research Fellowship. JAB and ZP declare that this study was partially funded by the ISEAL Research Program Strategic Project Grant (project title: Epidemiological assessment of muscle strengthening exercise participation in Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2011, IND REL SOC ADV DIS; [Anonymous], 2014, AUSTR PHYS ACT SED B; Australian Institute of Health and Welfare, 2003, RUR REG REM HLTH GUI; Australian Institute of Health and Welfare, 2014, AUSTR HLTH SER, V14; Australian Sports Commission, 2010, RECR SPORT SURV ERAS; Bennie JA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2736-3; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Churilla JR, 2012, J DIABETES, V4, P77, DOI 10.1111/j.1753-0407.2011.00172.x; Cornelissen VA, 2011, HYPERTENSION, V58, P950, DOI 10.1161/HYPERTENSIONAHA.111.177071; Eime RM, 2015, SPORT MANAGEMENT REV; Eime RM, 2013, RES Q EXERCISE SPORT, V84, P157, DOI 10.1080/02701367.2013.784846; Fitness Australia, 2012, FITN IND WORKF REP; Global Observatory for Physical Activity, 2016, GLOB OBS PHYS ACT CO; Grontved A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001587; Grontved A, 2012, ARCH INTERN MED, V172, P1306, DOI 10.1001/archinternmed.2012.3138; Harada K, 2011, J AGING PHYS ACTIV, V19, P262, DOI 10.1123/japa.19.3.262; Harris CD, 2013, MMWR-MORBID MORTAL W, V62, P326; Kazuhiro H., 2008, International Journal of Sport and Health Science, V6, P66, DOI 10.5432/ijshs.6.66; Kelley GA, 2009, PREV MED, V48, P9, DOI 10.1016/j.ypmed.2008.10.010; Loustalot F, 2013, RES Q EXERCISE SPORT, V84, P30, DOI 10.1080/02701367.2013.762289; Merom D, 2004, J SCI MED SPORT, V7, P32, DOI 10.1016/S1440-2440(04)80041-0; Merom D, 2012, J SCI MED SPORT, V15, pS44; Merom D, 2012, PREV MED, V55, P613, DOI 10.1016/j.ypmed.2012.10.001; Nakamura Y., 2015, PHYS ACTIVITY EXERCI, P29; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Schoenborn Charlotte A, 2013, Vital Health Stat 10, P1; Westcott WL, 2012, CURR SPORT MED REP, V11, P209, DOI 10.1249/JSR.0b013e31825dabb8; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yore MM, 2007, MED SCI SPORT EXER, V39, P1267, DOI 10.1249/mss.0b013e3180618bbe	34	62	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153225	10.1371/journal.pone.0153225	http://dx.doi.org/10.1371/journal.pone.0153225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119145	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000374976200020
J	Nothstein, AK; Eiche, E; Riemann, M; Nick, P; Winkel, LHE; Gottlicher, J; Steininger, R; Brendel, R; von Brasch, M; Konrad, G; Neumann, T				Nothstein, Alexandra K.; Eiche, Elisabeth; Riemann, Michael; Nick, Peter; Winkel, Lenny H. E.; Gottlicher, Jorg; Steininger, Ralph; Brendel, Rita; von Brasch, Matthias; Konrad, Gabriele; Neumann, Thomas			Tracking Se Assimilation and Speciation through the Rice Plant - Nutrient Competition, Toxicity and Distribution	PLOS ONE			English	Article							ORYZA-SATIVA L.; SELENIUM ACCUMULATION; SELENATE; SPECTROSCOPY; FRACTIONS; SULFATE; ROOTS; CHAIN; WHEAT; GRAIN	Up to 1 billion people are affected by low intakes of the essential nutrient selenium (Se) due to low concentrations in crops. Biofortification of this micronutrient in plants is an attractive way of increasing dietary Se levels. We investigated a promising method of Se biofortification of rice seedlings, as rice is the primary staple for 3 billion people, but naturally contains low Se concentrations. We studied hydroponic Se uptake for 0-2500 ppb Se, potential phyto-toxicological effects of Se and the speciation of Se along the shoots and roots as a function of added Se species, concentrations and other nutrients supplied. We found that rice germinating directly in a Se environment increased plant-Se by factor 2-16, but that nutrient supplementation is required to prevent phyto-toxicity. XANES data showed that selenite uptake mainly resulted in the accumulation of organic Se in roots, but that selenate uptake resulted in accumulation of selenate in the higher part of the shoot, which is an essential requirement for Se to be transported to the grain. The amount of organic Se in the plant was positively correlated with applied Se concentration. Our results indicate that biofortification of seedlings with selenate is a successful method to increase Se levels in rice.	[Nothstein, Alexandra K.; Eiche, Elisabeth; von Brasch, Matthias; Konrad, Gabriele; Neumann, Thomas] Karlsruhe Inst Technol, Inst Appl Geosci AGW, Adenauerring 20b, D-76131 Karlsruhe, Germany; [Riemann, Michael; Nick, Peter; Brendel, Rita] Karlsruhe Inst Technol, Mol Cell Biol, Inst Bot, Kaiserstr 2, D-76131 Karlsruhe, Germany; [Riemann, Michael; Nick, Peter; Brendel, Rita] Karlsruhe Inst Technol, Ctr Funct Nanostruct, Kaiserstr 2, D-76131 Karlsruhe, Germany; [Winkel, Lenny H. E.] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Winkel, Lenny H. E.] ETH, Inst Biogeochem & Pollutant Dynam, Univ Str 16, CH-8092 Zurich, Switzerland; [Gottlicher, Jorg; Steininger, Ralph] Karlsruhe Inst Technol, ANKA Synchrotron Radiat Facil, Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Karlsruhe Institute of Technology	Nothstein, AK (corresponding author), Karlsruhe Inst Technol, Inst Appl Geosci AGW, Adenauerring 20b, D-76131 Karlsruhe, Germany.	a.nothstein@kit.edu	Eiche, Elisabeth/G-3768-2011	Riemann, Michael/0000-0003-0287-2112; Winkel, Lenny/0000-0001-7586-7256; Eiche, Elisabeth/0000-0002-1493-9161	Landesgraduiertenfoderung Baden-Wurrtemberg through the Kalrsruhe Institute of Technology Council for Research and Promotion of Young Scientists (CRYS, KIT); Helmholtz Graduate School GRACE (KIT); Graduate School of Climate and Environment at the Karlsruhe Institute of Technology; Young Investigator Group for Selenium Isotopes - Karlsruhe Institute of Technology; Graduate School for Climate and Environment at the Karlsruhe Institute for Technology; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Karlsruhe Institute of Technology	Landesgraduiertenfoderung Baden-Wurrtemberg through the Kalrsruhe Institute of Technology Council for Research and Promotion of Young Scientists (CRYS, KIT); Helmholtz Graduate School GRACE (KIT); Graduate School of Climate and Environment at the Karlsruhe Institute of Technology; Young Investigator Group for Selenium Isotopes - Karlsruhe Institute of Technology; Graduate School for Climate and Environment at the Karlsruhe Institute for Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	This study, which was part of a PhD study, was funded for 2 years by a graduate student grant from the Landesgraduiertenfoderung Baden-Wurrtemberg through the Kalrsruhe Institute of Technology Council for Research and Promotion of Young Scientists (CRYS, KIT) for financial support via Dr. Monika Stelling's YIG and the Helmholtz Graduate School GRACE (KIT). The third year of this PhD study was funded by a graduate student grant from the Graduate School of Climate and Environment at the Karlsruhe Institute of Technology. Lab material was made available through funding by the Young Investigator Group for Selenium Isotopes funded by the Karlsruhe Institute of Technology and the Graduate School for Climate and Environment at the Karlsruhe Institute for Technology. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banuelos GS, 2015, FOOD CHEM, V166, P603, DOI 10.1016/j.foodchem.2014.06.071; BELL PF, 1992, SOIL SCI SOC AM J, V56, P1818, DOI 10.2136/sssaj1992.03615995005600060035x; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; Cantrell RP, 2002, SCIENCE, V296, P53, DOI 10.1126/science.1070721; Carey AM, 2012, ENVIRON SCI TECHNOL, V46, P5557, DOI 10.1021/es203871j; Eiche E, 2015, SCI TOTAL ENVIRON, V505, P952, DOI 10.1016/j.scitotenv.2014.10.080; Finley JW, 2005, NUTR REV, V63, P196, DOI 10.1111/j.1753-4887.2005.tb00137.x; Hartikainen H, 2005, J TRACE ELEM MED BIO, V18, P309, DOI 10.1016/j.jtemb.2005.02.009; Hopper JL, 1999, PLANT SOIL, V210, P199, DOI 10.1023/A:1004639906245; Keskinen R, 2011, NUTR CYCL AGROECOSYS, V91, P17, DOI 10.1007/s10705-011-9435-3; Khan MS, 2014, PLANT CELL MONOGR, V22, P247, DOI 10.1007/978-3-642-41787-0_8; Kikkert J, 2013, PLANT SOIL, V372, P629, DOI 10.1007/s11104-013-1773-2; LAUCHLI A, 1993, BOT ACTA, V106, P455; LeDuc DL, 2004, PLANT PHYSIOL, V135, P377, DOI 10.1104/pp.103.026989; Li HF, 2008, NEW PHYTOL, V178, P92, DOI 10.1111/j.1469-8137.2007.02343.x; Liu KL, 2009, J AGR FOOD CHEM, V57, P695, DOI 10.1021/jf802948k; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pickering IJ, 1999, J BIOL INORG CHEM, V4, P791, DOI 10.1007/s007750050352; Rayman M, 2002, LANCET, V379, P1256; Sun GX, 2010, ENVIRON SCI TECHNOL, V44, P6706, DOI 10.1021/es101843x; Terry N, 2000, ANNU REV PLANT PHYS, V51, P401, DOI 10.1146/annurev.arplant.51.1.401; Wang P, 2015, J EXP BOT, V66, P4795, DOI 10.1093/jxb/erv254; Wang P, 2013, PLANT PHYSIOL, V163, P407, DOI 10.1104/pp.113.222299; Williams PN, 2009, ENVIRON SCI TECHNOL, V43, P6024, DOI 10.1021/es900671m; Zayed A, 1998, PLANTA, V206, P284, DOI 10.1007/s004250050402; Zhao XQ, 2010, PLANT PHYSIOL, V153, P1871, DOI 10.1104/pp.110.157867; Zhu YG, 2009, TRENDS PLANT SCI, V14, P436, DOI 10.1016/j.tplants.2009.06.006	28	25	25	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0152081	10.1371/journal.pone.0152081	http://dx.doi.org/10.1371/journal.pone.0152081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116220	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600014
J	Mo, SS; Slettemeas, JS; Berg, ES; Norstrom, M; Sunde, M				Mo, Solveig Solverod; Slettemeas, Jannice Schau; Berg, Einar Sverre; Norstrom, Madelaine; Sunde, Marianne			Plasmid and Host Strain Characteristics of Escherichia coli Resistant to Extended-Spectrum Cephalosporins in the Norwegian Broiler Production	PLOS ONE			English	Article							BETA-LACTAMASE GENES; CHICKEN MEAT; SALMONELLA-ENTERICA; POULTRY-MEAT; RETAIL MEAT; VIRULENCE; INFECTIONS; ANIMALS; SWEDEN; OVEREXPRESSION	Escherichia coli resistant to extended-spectrum cephalosporins have been detected in the Norwegian broiler production, despite the fact that antimicrobial agents are rarely used. The genetic mechanism responsible for cephalosporin resistance is mainly attributed to the presence of the bla(CMY-2) gene encoding a plasmid-mediated AmpC-beta-lactamase (pAmpC). The aim of this study was to characterize and compare bla(CMY-2) containing Escherichia coli isolated from the intestinal flora of broilers and retail chicken meat (fillets) to identify possible successful clones and/or resistance plasmids widespread in the Norwegian broiler production. Methods used included PCR based phylotyping, conjugation experiments, plasmid replicon typing, pulsed-field gel electrophoresis, multiple locus variable-number tandem-repeats analysis and whole genome sequencing. The nucleotide sequence of an IncK plasmid carrying bla(CMY-2) was determined. Intestinal isolates displayed a higher degree of genetic diversity than meat isolates. A cluster of genetically related isolates belonging to ST38, phylogroup D, carrying bla(CMY-2) containing IncK plasmids was identified. Furthermore, genes encoding plasmid stability systems (relBE/stbDE and pndAC) were identified on the IncK plasmid. Single nucleotide polymorphism (SNP) analysis of a subset of isolates confirmed a close genetic relationship within the two most prevalent STs. The IncK plasmids within these two STs also shared a high degree of similarity. Cephalosporin-resistant E. coli with the same genetic characteristics have been identified in the broiler production in other European countries, and the IncK plasmid characterized in this study showed close homology to a plasmid isolated from retail chicken meat in the Netherlands. The results indicate that both clonal expansion and horizontal transfer of bla(CMY-2) containing plasmids contribute to dissemination of cephalosporin resistant E. coli in the broiler production. The presence of plasmid stability systems may explain why the IncK plasmid containing bla(CMY-2) is maintained and disseminated in the Norwegian broiler production in absence of selection pressure from the use of antimicrobial agents.	[Mo, Solveig Solverod; Slettemeas, Jannice Schau; Sunde, Marianne] Norwegian Vet Inst, Dept Diagnost Serv, Oslo, Norway; [Berg, Einar Sverre] Norwegian Inst Publ Hlth, Dept Foodborne Infect, Oslo, Norway; [Norstrom, Madelaine] Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway; [Sunde, Marianne] Norwegian Inst Publ Hlth, Dept Bacteriol & Immunol, Oslo, Norway	Norwegian Veterinary Institute; Norwegian Institute of Public Health (NIPH); Norwegian Veterinary Institute; Norwegian Institute of Public Health (NIPH)	Mo, SS (corresponding author), Norwegian Vet Inst, Dept Diagnost Serv, Oslo, Norway.	solveig.mo@vetinst.no		Slettemeas, Jannice Schau/0000-0003-2542-6991; Mo, Solveig Solverod/0000-0003-4532-9857; Sunde, Marianne/0000-0002-2326-4338	Research Council of Norway [225165/E40]	Research Council of Norway(Research Council of Norway)	The study was funded by a grant from the Research Council of Norway, www.forskningsradet.no, grant no. 225165/E40. The funders had no role in study design, data collection and analysis, descision to publish, or preparation of the manuscript.	Agerso Y, 2014, FOODBORNE PATHOG DIS, V11, P740, DOI 10.1089/fpd.2014.1742; Animalia, 2016, FORTS NEDG FOR RES B; Anjum MF, 2007, APPL ENVIRON MICROB, V73, P5692, DOI 10.1128/AEM.00419-07; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Berg ES, 2015, HIGHLY SIMILAR CEPHA; Bishop RE, 2000, BBA-PROTEIN STRUCT M, V1482, P73, DOI 10.1016/S0167-4838(00)00138-2; Borjesson S, 2013, CLIN MICROBIOL INFEC, V19, pE309, DOI 10.1111/1469-0691.12192; Borjesson S, 2013, APPL ENVIRON MICROB, V79, P2463, DOI 10.1128/AEM.03893-12; Brolund A, 2014, CLIN MICROBIOL INFEC, V20, pO344, DOI 10.1111/1469-0691.12413; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chattaway MA, 2014, EMERG INFECT DIS, V20, P1935, DOI 10.3201/eid2011.131845; Chung YJ, 2002, J BACTERIOL, V184, P2543, DOI 10.1128/JB.184.9.2543-2545.2002; Coque T M, 2008, Euro Surveill, V13; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Cortes P, 2010, APPL ENVIRON MICROB, V76, P2799, DOI 10.1128/AEM.02421-09; Dale AP, 2015, J INFECTION, V71, P615, DOI 10.1016/j.jinf.2015.09.009; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Doi Y, 2010, CLIN MICROBIOL INFEC, V16, P33, DOI 10.1111/j.1469-0691.2009.03001.x; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Egervarn M, 2014, INT J FOOD MICROBIOL, V171, P8, DOI 10.1016/j.ijfoodmicro.2013.11.005; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Hammerum AM, 2014, J ANTIMICROB CHEMOTH, V69, P2650, DOI 10.1093/jac/dku180; Hossain A, 2004, J ANTIMICROB CHEMOTH, V53, P964, DOI 10.1093/jac/dkh240; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Kang MS, 2006, ANTIMICROB AGENTS CH, V50, P1590, DOI 10.1128/AAC.50.4.1590-1593.2006; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Lazarus B, 2015, CLIN INFECT DIS, V60, P439, DOI 10.1093/cid/ciu785; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Manges AR, 2016, CLIN MICROBIOL INFEC, V22, P122, DOI 10.1016/j.cmi.2015.11.010; Mo SS, 2014, VET MICROBIOL, V171, P315, DOI 10.1016/j.vetmic.2014.02.002; Naseer U, 2010, CLIN MICROBIOL INFEC, V16, P171, DOI 10.1111/j.1469-0691.2009.02861.x; [NORM/NORM-VET NORM/NORM-VET], 2012, NORM NORM VET 2012 U; [NORM/NORM-VET NORM/NORM-VET], 2013, NORM NORM VET 2013 U; [NORM/NORM-VET NORM/NORM-VET], 2006, NORM NORM VET 2006 U; [NORM/NORM-VET NORM/NORM-VET], 2011, NORM NORM VET 2011 U; NORM/NORM-VET. NORM/NORM-VET, 2014, NORM NORM VET 2014 U; NorwegianAgricultureAgency, MARK 2015 PRIS MARK; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Pitout JDD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00009; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P447, DOI 10.1128/AAC.49.1.447-450.2005; Refsum T, 2015, GO MORNING; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Schmidt GV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131672; Sunde M, 2009, J ANTIMICROB CHEMOTH, V63, P215, DOI 10.1093/jac/dkn445; Sunde M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128797; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; Voets GM, 2013, INT J FOOD MICROBIOL, V167, P359, DOI 10.1016/j.ijfoodmicro.2013.10.001; Vogt D, 2014, MICROB DRUG RESIST, V20, P485, DOI 10.1089/mdr.2013.0210; WHO-AGISAR, 2011, CRIT IMP ANT HUM MED; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13	58	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154019	10.1371/journal.pone.0154019	http://dx.doi.org/10.1371/journal.pone.0154019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111852	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600027
J	Wu, YA; Zhou, YM; Lu, CH; Ahmad, H; Zhang, H; He, JT; Zhang, LL; Wang, T				Wu, Yanan; Zhou, Yanmin; Lu, Changhui; Ahmad, Hussain; Zhang, Hao; He, Jintian; Zhang, Lili; Wang, Tian			Influence of Butyrate Loaded Clinoptilolite Dietary Supplementation on Growth Performance, Development of Intestine and Antioxidant Capacity in Broiler Chickens	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SODIUM-BUTYRATE; NITRIC-OXIDE; NATURAL CLINOPTILOLITE; GASTROINTESTINAL-TRACT; ENZYME-ACTIVITIES; MORPHOLOGY; EXPRESSION; 5-FLUOROURACIL; DEALUMINATION	The study was conducted to evaluate the effects of dietary butyrate loaded clinoptilolite (CLI-B) on growth performance, pancreatic digestive enzymes, intestinal development and histomorphology, as well as antioxidant capacity of serum and intestinal mucosal in chickens. Two hundred forty 1-day-old commercial Arbor Acres broilers were randomly assigned to 4 groups: CON group (fed basal diets), SB group (fed basal diet with 0.05% sodium butyrate), CLI group (fed basal diet with 1% clinoptilolite), and CLI-B group (fed basal diet with 1% CLI-B). The results showed that supplementation of CLI-B significantly decreased (P < 0.05) feed conservation ratio at both 21 and 42 days of age, improved the pancreatic digestive enzymes activities (P < 0.05), increased the villus length and villus/crypt ratio (P < 0.05), and decreased the crypt depth of intestine (P < 0.05) as compared to the other experimental groups. Furthermore, the CLI-B environment improved the antioxidant capacity by increasing the antioxidant enzyme activities (P < 0.05) in intestine mucosal, and decreasing the NO content and iNOS activity (P < 0.05) in serum. In addition, CLI-B supplementation had improved the development of intestine and antioxidant capacity of broilers than supplementation with either clinoptilolite or butyrate sodium alone. In conclusion, 1% CLI-B supplementation improved the health status, intestine development and antioxidant capacity in broiler chickens, thus appearing as an important feed additive for the poultry industry.	[Wu, Yanan; Zhou, Yanmin; Lu, Changhui; Ahmad, Hussain; Zhang, Hao; He, Jintian; Zhang, Lili; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, T (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	tianwangnjau@163.com	Ahmad, hussain/AAP-9386-2020					Ahmad H, 2012, J AGR FOOD CHEM, V60, P7111, DOI 10.1021/jf3017207; Armbruster T., 2001, STUDIES SURFACE SCI, VVolume 135, P13, DOI DOI 10.1016/S0167-2991(01)81183-6; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Cao M, 2014, NUTRITION, V30, P1442, DOI 10.1016/j.nut.2014.04.016; Carraro A, 2014, APPL CLAY SCI, V88-89, P92, DOI 10.1016/j.clay.2013.11.028; Choct M, 2009, BRIT POULTRY SCI, V50, P9, DOI 10.1080/00071660802538632; Dong L, 2014, J HISTOCHEM CYTOCHEM, V62, P510, DOI 10.1369/0022155414532655; Evans M, 1989, ZEOLITES DO THEY HAV; FURUSE M, 1991, BRIT POULTRY SCI, V32, P159, DOI 10.1080/00071669108417337; GALFI P, 1990, ACTA VET HUNG, V38, P3; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Garcia-Basabe Y, 2010, MICROPOR MESOPOR MAT, V135, P187, DOI 10.1016/j.micromeso.2010.07.008; Guilloteau P, 2009, J DAIRY SCI, V92, P1038, DOI 10.3168/jds.2008-1213; Halliwell B, 2000, FREE RADICAL RES, V33, P819, DOI 10.1080/10715760000301341; Hu CH, 2012, ANIM FEED SCI TECH, V177, P108, DOI 10.1016/j.anifeedsci.2012.07.028; Hu CH, 2012, BIOL TRACE ELEM RES, V149, P190, DOI 10.1007/s12011-012-9422-9; Hu ZH, 2007, ANIM FEED SCI TECH, V132, P240, DOI 10.1016/j.anifeedsci.2006.03.017; HUME ME, 1993, POULTRY SCI, V72, P786, DOI 10.3382/ps.0720786; HWANG PP, 1993, MAR BIOL, V117, P551, DOI 10.1007/BF00349765; Incharoen T, 2011, J AGR SCI TECHNOLO A, P1284; Jahns F, 2015, MOL CARCINOGEN, V54, P249, DOI 10.1002/mc.22102; Jevtic S, 2012, MICROPOR MESOPOR MAT, V159, P30, DOI 10.1016/j.micromeso.2012.04.014; Jin L, 2014, J INTEGR AGR, V13, P2731, DOI 10.1016/S2095-3119(13)60729-7; Jung BG, 2010, VET MICROBIOL, V143, P117, DOI 10.1016/j.vetmic.2009.11.009; Kanika G, 2015, J BIOCHEM MOL TOXIC, V29, P349, DOI 10.1002/jbt.21698; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; Koide N, 2003, MICROBIOL IMMUNOL, V47, P669, DOI 10.1111/j.1348-0421.2003.tb03430.x; Kotunia A, 2004, J Physiol Pharmacol, V55 Suppl 2, P59; Li ZX, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-30; Matis G, 2015, DOMEST ANIM ENDOCRIN, V50, P26, DOI 10.1016/j.domaniend.2014.07.004; MESSMER UK, 1995, MOL PHARMACOL, V47, P757; MILES RD, 1986, NUTR REP INT, V34, P1097; NABUURS MJA, 1993, RES VET SCI, V55, P78, DOI 10.1016/0034-5288(93)90038-H; Nezamzadeh-Ejhieh A, 2013, J CHEM, V2012; Oguz H., 2011, Eurasian Journal of Veterinary Sciences, V27, P1; Oliveira L, 2014, LIVEST SCI, V167, P227, DOI 10.1016/j.livsci.2014.05.013; Olukosi OA, 2014, J ANIM SCI, V92, P3945, DOI 10.2527/jas.2013-6368; OLVER MD, 1989, BRIT POULTRY SCI, V30, P115, DOI 10.1080/00071668908417130; Orchel Arkadiusz, 2006, Acta Pol Pharm, V63, P441; Papaioannou D, 2005, MICROPOR MESOPOR MAT, V84, P161, DOI 10.1016/j.micromeso.2005.05.030; Pavelic K, 2002, J CANCER RES CLIN, V128, P37, DOI 10.1007/s00432-001-0301-6; Qu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029641; Ricke SC, 2003, POULTRY SCI, V82, P632, DOI 10.1093/ps/82.4.632; ROLAND DA, 1990, POULTRY SCI, V69, P2157, DOI 10.3382/ps.0692157; Rozic M, 2005, J COLLOID INTERF SCI, V284, P48, DOI 10.1016/j.jcis.2004.09.061; SCHEPPACH W, 1992, JPEN-PARENTER ENTER, V16, P43, DOI 10.1177/014860719201600143; Spanakis M, 2014, NANOMED-NANOTECHNOL, V10, P197, DOI 10.1016/j.nano.2013.06.016; Sverko V, 2004, FOOD TECHNOL BIOTECH, V42, P189; Tang ZG, 2014, ANIM FEED SCI TECH, V189, P98, DOI 10.1016/j.anifeedsci.2013.12.014; Thompson JL, 1997, BRIT POULTRY SCI, V38, P59, DOI 10.1080/00071669708417941; Vilaca N, 2013, COLLOID SURFACE B, V112, P237, DOI 10.1016/j.colsurfb.2013.07.042; Wachtershauser A, 2000, EUR J NUTR, V39, P164, DOI 10.1007/s003940070020; Wang O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118135; Wen C, 2012, ANIM FEED SCI TECH, V172, P180, DOI 10.1016/j.anifeedsci.2011.11.012; Wu QJ, 2013, ASIAN AUSTRAL J ANIM, V26, P987, DOI 10.5713/ajas.2012.12545; Wu QJ, 2013, VET IMMUNOL IMMUNOP, V153, P70, DOI 10.1016/j.vetimm.2013.02.006; Wu YA, 2013, BIOL TRACE ELEM RES, V155, P228, DOI 10.1007/s12011-013-9777-6; Xiao M, 2014, BIOMED ENVIRON SCI, V27, P197, DOI 10.3967/bes2014.040; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zarkovic N, 2003, ANTICANCER RES, V23, P1589	60	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154410	10.1371/journal.pone.0154410	http://dx.doi.org/10.1371/journal.pone.0154410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104860	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100077
J	Cigarroa, I; Lalanza, JF; Caimari, A; del Bas, JM; Capdevila, L; Arola, L; Escorihuela, RM				Cigarroa, Igor; Lalanza, Jaume F.; Caimari, Antoni; del Bas, Josep M.; Capdevila, Lluis; Arola, Lluis; Escorihuela, Rosa M.			Treadmill Intervention Attenuates the Cafeteria Diet-Induced Impairment of Stress-Coping Strategies in Young Adult Female Rats	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; NUCLEUS-ACCUMBENS SHELL; INDUCED OBESITY; PSYCHIATRIC-DISORDERS; INSULIN SENSITIVITY; PHYSICAL-EXERCISE; ANIMAL-MODELS; LIPID-CONTENT; LEPTIN; FOOD	The current prevalence of diet-induced overweight and obesity in adolescents and adults is continuously growing. Although the detrimental biochemical and metabolic consequences of obesity are widely studied, its impact on stress-coping behavior and its interaction with specific exercise doses (in terms of intensity, duration and frequency) need further investigation. To this aim, we fed adolescent rats either an obesogenic diet (cafeteria diet, CAF) or standard chow (ST). Each group was subdivided into four subgroups according to the type of treadmill intervention as follows: a sedentary group receiving no manipulation; a control group exposed to a stationary treadmill; a low-intensity treadmill group trained at 12 m/min; and a higher intensity treadmill group trained at 17 m/min. Both the diet and treadmill interventions started at weaning and lasted for 8 weeks. Subjects were tested for anxiety-like behavior in the open field test and for coping strategies in the two-way active avoidance paradigm at week 7 and were sacrificed at week 8 for biometric and metabolic characterization. CAF feeding increased the weight gain, relative retroperitoneal white adipose tissue (RWAT %), and plasma levels of glucose, insulin, triglycerides and leptin and decreased the insulin sensitivity. Treadmill intervention partially reversed the RWAT% and triglyceride alterations; at higher intensity, it decreased the leptin levels of CAF-fed animals. CAF feeding decreased the motor activity and impaired the performance in a two-way active avoidance assessment. Treadmill intervention reduced defecation in the shuttle box, suggesting diminished anxiety. CAF feeding combined with treadmill training at 17 m/min increased the time spent in the center of the open field and more importantly, partially reversed the two-way active avoidance deficit. In conclusion, this study demonstrates that at doses that decreased anxiety-like behavior, treadmill exercise partially improved the coping strategy in terms of active avoidance behavior in the CAF-fed animals. This effect was not observed at lower doses of treadmill training.	[Cigarroa, Igor; Lalanza, Jaume F.; Escorihuela, Rosa M.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Psiquiatria & Med Legal, E-08193 Barcelona, Spain; [Cigarroa, Igor] Univ Santo Tomas, Fac Salud, Carrera Kinesiol, Los Angeles, Region Del Bio, Chile; [Caimari, Antoni; del Bas, Josep M.] CEICS, TECNIO, CTNS, GRNS, Reus, Spain; [Capdevila, Lluis] Univ Autonoma Barcelona, Dept Psicol Basica, Lab Psicol Esport, E-08193 Barcelona, Spain; [Arola, Lluis] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Nutrigen Res Grp, E-43007 Tarragona, Spain; [Arola, Lluis] CEICS, TECNIO, CTNS, Reus, Spain	Autonomous University of Barcelona; Universidad Santo Tomas; Autonomous University of Barcelona; Universitat Rovira i Virgili	Escorihuela, RM (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Psiquiatria & Med Legal, E-08193 Barcelona, Spain.	rosamaria.escorihuela@uab.cat	Arola, Lluís/C-6074-2011; F. Lalanza, Jaume/C-9186-2011; Capdevila, Lluis/I-2530-2015; cigarroa, igor/AAV-3527-2020; Escorihuela, Rosa M/L-4524-2014; del Bas, Josep Maria/K-9310-2019; del Bas, Josep M/K-2327-2014	Arola, Lluís/0000-0003-2767-1974; F. Lalanza, Jaume/0000-0003-2481-2188; Capdevila, Lluis/0000-0002-7319-4745; cigarroa, igor/0000-0003-0418-8787; Escorihuela, Rosa M/0000-0001-9368-5173; del Bas, Josep Maria/0000-0002-0700-2004; del Bas, Josep M/0000-0002-0700-2004; Caimari, Antoni/0000-0001-6144-0294	Spanish Ministry of Economy and Competitiveness [PSI 2011-29807-C02/PSIC]; ACCIO [TECRD11-1-0012, TECRD12-1-0005]; European Union [244995]; Generalitat de Catalunya [FI-DGR 2011]; Universidad Santo Tomas, Chile; CONYCYT/BECA CHILE/PAI [72150035]	Spanish Ministry of Economy and Competitiveness(Spanish Government); ACCIO; European Union(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Universidad Santo Tomas, Chile; CONYCYT/BECA CHILE/PAI	The research leading to these results has received funding from the Spanish Ministry of Economy and Competitiveness (PSI 2011-29807-C02/PSIC), ACCIO (TECRD11-1-0012 and TECRD12-1-0005) and the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement no 244995 (BIOCLAIMS Project). JFL was supported by a pre-doctoral fellowship from the Generalitat de Catalunya (FI-DGR 2011). IC was supported by a pre-doctoral fellowship from Universidad Santo Tomas, Chile and a fellowship from CONYCYT/BECA CHILE/PAI 72150035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alonso M, 2015, NUTR REV, V73, P296, DOI 10.1093/nutrit/nuv002; Alsio J, 2010, NEUROSCIENCE, V171, P779, DOI 10.1016/j.neuroscience.2010.09.046; Alsio J, 2009, GENES BRAIN BEHAV, V8, P193, DOI 10.1111/j.1601-183X.2008.00464.x; Asmundson GJG, 2013, DEPRESS ANXIETY, V30, P362, DOI 10.1002/da.22043; Baldo BA, 2005, BEHAV NEUROSCI, V119, P1195, DOI 10.1037/0735-7044.119.5.1195; Bayod S, 1985, J APPL PHYSIOL, V111, P1380, DOI DOI 10.1152/JAPPLPHYSI0L.00425.2011; Borai A, 2007, ANN CLIN BIOCHEM, V44, P324, DOI 10.1258/000456307780945778; Bourin M, 2015, DIALOGUES CLIN NEURO, V17, P295; Brandt N, 2010, AM J PHYSIOL-ENDOC M, V299, pE215, DOI 10.1152/ajpendo.00098.2010; Buchenauer T, 2009, PHYSIOL BEHAV, V98, P563, DOI 10.1016/j.physbeh.2009.09.003; Burghardt PR, 2004, BRAIN RES, V1019, P84, DOI 10.1016/j.brainres.2004.05.086; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; El Elj N, 2010, ANN ENDOCRINOL-PARIS, V71, P297, DOI 10.1016/j.ando.2010.02.002; Fernandez-Teruel A, 2002, GENOME RES, V12, P618, DOI [10.1101/gr.203402, 10.1101/gr.203402. Article published online before print in March ]; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Fulk LJ, 2004, INT J SPORTS MED, V25, P78; Garcia-Capdevila S, 2009, BEHAV BRAIN RES, V202, P162, DOI 10.1016/j.bbr.2009.03.020; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Goularte JF, 2012, BRIT J NUTR, V108, P1511, DOI 10.1017/S0007114511006933; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hebebrand J, 2014, NEUROSCI BIOBEHAV R, V47, P295, DOI 10.1016/j.neubiorev.2014.08.016; Heyne A, 2009, ADDICT BIOL, V14, P373, DOI 10.1111/j.1369-1600.2009.00175.x; Higa TS, 2014, LIFE SCI, V103, P41, DOI 10.1016/j.lfs.2014.02.039; Horio N, 2010, J PHARMACOL SCI, V112, P8, DOI 10.1254/jphs.09R07FM; Hung YH, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12232; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Lalanza JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep16166; Lalanza JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085049; Lalanza JF, 2012, PSYCHONEUROENDOCRINO, V37, P1745, DOI 10.1016/j.psyneuen.2012.03.008; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR771, DOI 10.1152/ajpregu.00650.2003; Low A, 2015, PSYCHOL SCI, V26, P1706, DOI 10.1177/0956797615597332; Lopresti AL, 2013, PROG NEURO-PSYCHOPH, V45, P92, DOI 10.1016/j.pnpbp.2013.05.005; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58; Maniam J, 2010, PSYCHONEUROENDOCRINO, V35, P717, DOI 10.1016/j.psyneuen.2009.10.013; Martire SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060407; Moscarello JM, 2013, J NEUROSCI, V33, P3815, DOI 10.1523/JNEUROSCI.2596-12.2013; Mul JD, 2012, OBESITY, V20, P612, DOI 10.1038/oby.2011.81; Narayanan NS, 2010, FRONT NEUROENDOCRIN, V31, P104, DOI 10.1016/j.yfrne.2009.10.004; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Patterson CM, 2009, AM J PHYSIOL-REG I, V296, pR537, DOI 10.1152/ajpregu.90859.2008; Perseghin G, 2001, J CLIN ENDOCR METAB, V86, P4776, DOI 10.1210/jc.86.10.4776; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Pietrelli A, 2012, NEUROSCIENCE, V202, P252, DOI 10.1016/j.neuroscience.2011.11.054; Ramirez F, 2015, J NEUROSCI, V35, P3470, DOI 10.1523/JNEUROSCI.1331-14.2015; Reichelt AC, 2015, BRAIN BEHAV IMMUN, V43, P68, DOI 10.1016/j.bbi.2014.07.005; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Salim S, 2010, BEHAV BRAIN RES, V208, P545, DOI 10.1016/j.bbr.2009.12.039; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Scarpace PJ, 2009, AM J PHYSIOL-REG I, V296, pR493, DOI 10.1152/ajpregu.90669.2008; Scheggi S, 2013, NEUROSCIENCE, V236, P320, DOI 10.1016/j.neuroscience.2013.01.027; Schroeder M, 2010, HORM BEHAV, V57, P496, DOI 10.1016/j.yhbeh.2010.02.008; Shafat A, 2009, APPETITE, V52, P34, DOI 10.1016/j.appet.2008.07.004; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Singh M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00925; Souza CG, 2007, LIFE SCI, V81, P198, DOI 10.1016/j.lfs.2007.05.001; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; Stice E, 2013, NEUROSCI BIOBEHAV R, V37, P2047, DOI 10.1016/j.neubiorev.2012.12.001; Vaisy M, 2010, INT J MOL MED, V25, P905, DOI 10.3892/ijmm_00000421; Valladolid-Acebes I, 2011, NEUROBIOL LEARN MEM, V95, P80, DOI 10.1016/j.nlm.2010.11.007; Wall PM, 2001, NEUROSCI BIOBEHAV R, V25, P275, DOI 10.1016/S0149-7634(01)00013-6; Wang J, 2008, ENDOCRINE, V33, P77, DOI 10.1007/s12020-008-9056-z; Warneke W, 2014, PHARMACOL BIOCHEM BE, V116, P45, DOI 10.1016/j.pbb.2013.11.016; Woo J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-144; Wright T, 2011, PHYSIOL BEHAV, V103, P164, DOI 10.1016/j.physbeh.2011.01.008; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Zeeni N, 2013, STRESS, V16, P211, DOI 10.3109/10253890.2012.708952	74	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153687	10.1371/journal.pone.0153687	http://dx.doi.org/10.1371/journal.pone.0153687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099927	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500049
J	Krzywinska, E; Cornillon, A; Allende-Vega, N; Vo, DN; Rene, C; Lu, ZY; Pasero, C; Olive, D; Fegueux, N; Ceballos, P; Hicheri, Y; Sobecki, M; Rossi, JF; Cartron, G; Villalba, M				Krzywinska, Ewelina; Cornillon, Amelie; Allende-Vega, Nerea; Vo, Dang-Nghiem; Rene, Celine; Lu, Zhao-Yang; Pasero, Christine; Olive, Daniel; Fegueux, Nathalie; Ceballos, Patrick; Hicheri, Yosr; Sobecki, Michal; Rossi, Jean-Francois; Cartron, Guillaume; Villalba, Martin			CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASES; HEMATOLOGICAL CANCERS; CELL MATURATION; DEFICIENT MICE; ACTIVATION; METABOLISM; FAMILY; TRANSPLANTATION; CYTOTOXICITY; STIMULATION	The leucocyte-specific phosphatase CD45 is present in two main isoforms: the large CD45RA and the short CD45RO. We have recently shown that distinctive expression of these isoforms distinguishes natural killer (NK) populations. For example, co-expression of both isoforms identifies in vivo the anti tumor NK cells in hematological cancer patients. Here we show that low CD45 expression associates with less mature, CD56(bright), NK cells. Most NK cells in healthy human donors are CD45RA(+)CD45RO(-). The CD45RA(-)RO(+) phenotype, CD45RO cells, is extremely uncommon in B or NK cells, in contrast to T cells. However, healthy donors possess CD45RA(dim)RO(-) (CD45RAdim cells), which show immature markers and are largely expanded in hematopoietic stem cell transplant patients. Blood borne cancer patients also have more CD45RA(dim) cells that carry several features of immature NK cells. However, and in opposition to their association to NK cell progenitors, they do not proliferate and show low expression of the transferrin receptor protein 1/CD71, suggesting low metabolic activity. Moreover, CD45RA(dim) cells properly respond to in vitro encounter with target cells by degranulating or gaining CD69 expression. In summary, they are quiescent NK cells, with low metabolic status that can, however, respond after encounter with target cells.	[Krzywinska, Ewelina; Cornillon, Amelie; Allende-Vega, Nerea; Vo, Dang-Nghiem; Rene, Celine; Lu, Zhao-Yang; Villalba, Martin] Univ Montpellier I, INSERM, U1183, UFR Med, Montpellier, France; [Allende-Vega, Nerea; Villalba, Martin] CHU Montpellier, IRMB, F-34295 Montpellier, France; [Pasero, Christine; Olive, Daniel] Aix Marseille Univ, Ctr Cancerol Marseille, Plateforme Immunomonitoring Cancerol,CNRS, INSERM,U1068,Inst Paoli Calmettes,UM 105,UMR7258, Marseille, France; [Fegueux, Nathalie; Ceballos, Patrick; Hicheri, Yosr; Rossi, Jean-Francois; Cartron, Guillaume] Univ Montpellier I, CHU Montpellier, Dept Hematol Clin, 80 Ave Augustin Fliche, F-34295 Montpellier, France; [Sobecki, Michal] CNRS, UMR9198, Genome Biol Dept, I2BC, Gif Sur Yvette, France; [Cartron, Guillaume] Univ Montpellier, CNRS, UMR5235, F-34059 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Villalba, M (corresponding author), Univ Montpellier I, INSERM, U1183, UFR Med, Montpellier, France.; Villalba, M (corresponding author), CHU Montpellier, IRMB, F-34295 Montpellier, France.	martin.villalba@inserm.fr	Vo, Dang-Nghiem/AAE-8920-2021; villalba, martin/AAG-2604-2020; villalba, martin/N-7123-2017	villalba, martin/0000-0002-4385-4888; villalba, martin/0000-0002-4385-4888; Sobecki, Michal/0000-0002-8177-0327; Cartron, Guillaume/0000-0003-0659-9635; Allende-Vega, Nerea/0000-0001-5569-6461; Krzywinska, Ewelina/0000-0002-4311-2972	scientific program from the "Communaute de Travail des Pyrenees" [CTPP5/12]; charity CIEL; European Community Program SUDOE [CLiNK SOE2/P1/E341]; AOI from the CHU Montpellier [221826]; Fondation de France [0057921]; ARC [DOC20121206007]; La Ligue Contre le Cancer [TDKB13362]; Ministere de l'Enseignement Superieur et de la Recherche (MESR); Region Languedoc Roussillon [HEMODIAG_2020]; charity L'Un pour l'Autre; charity Ensangble	scientific program from the "Communaute de Travail des Pyrenees"; charity CIEL; European Community Program SUDOE; AOI from the CHU Montpellier; Fondation de France(Fondation de France); ARC(Australian Research Council); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France); Region Languedoc Roussillon(Region OccitanieRegion Ile-de-France); charity L'Un pour l'Autre; charity Ensangble	All of the authors' funders are public or charitable organizations. This work was supported by a scientific program from the "Communaute de Travail des Pyrenees" (CTPP5/12 to MV), the charities CIEL, L'Un pour l'Autre and Ensangble (09/2013) (MV), a grant from the European Community Program SUDOE (CLiNK SOE2/P1/E341 to MV and J-FR), an AOI from the CHU Montpellier (No221826) (GC and MV), a grant from Fondation de France (0057921) and fellowships from the ARC (DOC20121206007) and La Ligue Contre le Cancer (TDKB13362) to EK, and Ministere de l'Enseignement Superieur et de la Recherche (MESR) (DNV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FACs analysis was performed at the platform Montpellier Rio Imaging (MRI). The collection of clinical data and samples (HEMODIAG_2020) at the CHRU Montpellier was supported by funding from Region Languedoc Roussillon.	Aguilo JI, 2009, J IMMUNOL, V182, P1972, DOI 10.4049/jimmunol.0801820; Allende-Vega N, 2015, ONCOTARGET, V6, P19228, DOI 10.18632/oncotarget.4653; Baier C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00459; Beziat V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011966; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Catalan E, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.985924; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; Elpek KG, 2010, P NATL ACAD SCI USA, V107, P21647, DOI 10.1073/pnas.1012128107; Freud AG, 2014, SEMIN IMMUNOL, V26, P132, DOI 10.1016/j.smim.2014.02.008; Fu XY, 2011, IMMUNOLOGY, V134, P41, DOI 10.1111/j.1365-2567.2011.03464.x; Grzywacz B, 2007, LEUKEMIA, V21, P356, DOI 10.1038/sj.leu.2404499; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hesslein DGT, 2011, BLOOD, V117, P3087, DOI 10.1182/blood-2010-06-292219; Hesslein DGT, 2006, P NATL ACAD SCI USA, V103, P7012, DOI 10.1073/pnas.0601851103; Huntington ND, 2005, J EXP MED, V201, P1421, DOI 10.1084/jem.20042294; Domaica CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051677; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Krzywinska E, 2015, EBIOMEDICINE, V2, P1364, DOI 10.1016/j.ebiom.2015.08.021; Kung C, 2000, NAT MED, V6, P343; Lajoie L, 2014, J IMMUNOL, V192, P741, DOI 10.4049/jimmunol.1301024; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Mason LH, 2006, J IMMUNOL, V176, P6615, DOI 10.4049/jimmunol.176.11.6615; McKenna DH, 2007, TRANSFUSION, V47, P520, DOI 10.1111/j.1537-2995.2006.01145.x; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Moretta L, 2010, BLOOD, V116, P3689, DOI 10.1182/blood-2010-09-303057; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Ramirez-Comet N, 2014, ONCOIMMUNOLOGY, V3, DOI [10.4161/21624011.2014.948705, DOI 10.4161/21624011.2014.948705]; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Ruggeri L, 2007, CURR OPIN ONCOL, V19, P142, DOI 10.1097/CCO.0b013e3280148a1a; Sanchez-Martinez D, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.991613; Sanchez-Martinez D, 2014, INT J BIOCHEM CELL B, V49, P42, DOI 10.1016/j.biocel.2014.01.003; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Vey N, 2012, BLOOD, V120, P4317, DOI 10.1182/blood-2012-06-437558; Villalba M, 2014, ANTI-CANCER AGENT ME, V14, P223, DOI 10.2174/18715206113136660374; Villalba M, 2013, INT J BIOCHEM CELL B, V45, P106, DOI 10.1016/j.biocel.2012.04.024; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825	41	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0150434	10.1371/journal.pone.0150434	http://dx.doi.org/10.1371/journal.pone.0150434			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100180	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500003
J	Chopra, A; Bond, MJ; Bleiler, M; Yeagley, M; Wright, D; Giardina, C				Chopra, Avijeet; Bond, Michael J.; Bleiler, Marina; Yeagley, Michelle; Wright, Dennis; Giardina, Charles			Efficient Activation of Apoptotic Signaling during Mitotic Arrest with AK301	PLOS ONE			English	Article							CELL-CYCLE CHECKPOINTS; POLYPOSIS-COLI PROTEIN; DOUBLE-STRAND BREAKS; CANCER-CELLS; COLORECTAL-CANCER; ADENOMATOUS POLYPOSIS; CHROMOSOME INSTABILITY; IONIZING-RADIATION; SPINDLE CHECKPOINT; KINASE INHIBITORS	Mitotic inhibitors are widely utilized chemotherapeutic agents that take advantage of mitotic defects in cancer cells. We have identified a novel class of piperazine-based mitotic inhibitors, of which AK301 is the most potent derivative identified to date (EC50 < 200 nM). Colon cancer cells arrested in mitosis with AK301 readily underwent a p53-dependent apoptosis following compound withdrawal and arrest release. This apoptotic response was significantly higher for AK301 than for other mitotic inhibitors tested (colchicine, vincristine, and BI 2536). AK301-treated cells exhibited a robust mitosis-associated DNA damage response, including ATM activation, gamma H2AX phosphorylation and p53 stabilization. The association between mitotic signaling and the DNA damage response was supported by the finding that Aurora B inhibition reduced the level of gamma H2AX staining. Confocal imaging of AK301-treated cells revealed multiple gamma-tubulin microtubule organizing centers attached to microtubules, but with limited centrosome migration, raising the possibility that aberrant microtubule pulling may underlie DNA breakage. AK301 selectively targeted APC-mutant colonocytes and promoted TNF-induced apoptosis in p53-mutant colon cancer cells. Our findings indicate that AK301 induces a mitotic arrest state with a highly active DNA damage response. Together with a reversible arrest state, AK301 is a potent promoter of a mitosis-to-apoptosis transition that can target cancer cells with mitotic defects.	[Chopra, Avijeet; Bond, Michael J.; Bleiler, Marina; Yeagley, Michelle; Giardina, Charles] Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT USA; [Wright, Dennis] Univ Connecticut, Sch Pharm, 69 N Eagleville Rd, Storrs, CT USA	University of Connecticut; University of Connecticut	Giardina, C (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT USA.	charles.giardina@uconn.edu	; Chopra, Avijeet/H-5611-2013	Bond, Michael/0000-0001-9552-4525; Chopra, Avijeet/0000-0001-6020-488X; Wright, Dennis/0000-0003-4634-3351; Bleiler, Marina/0000-0003-2256-589X	National Cancer Institute [R21CA158743]; NATIONAL CANCER INSTITUTE [R21CA158743] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R21CA158743 from the National Cancer Institute to CG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by funding to R21CA158743 to CG.	Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Caldwell CM, 2009, ADV EXP MED BIOL, V656, P51, DOI 10.1007/978-1-4419-1145-2_5; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Chopra A, 2014, J BIOL CHEM, V289, P2978, DOI 10.1074/jbc.M113.499319; Chopra AS, 2013, CANCER BIOL THER, V14, P436, DOI 10.4161/cbt.23787; Chu MLH, 2008, J BIOL CHEM, V283, P21495, DOI 10.1074/jbc.M803026200; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Flatt PM, 2000, DRUG METAB REV, V32, P283, DOI 10.1081/DMR-100102335; Forand A, 2004, BIOL REPROD, V71, P643, DOI 10.1095/biolreprod.104.027466; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Jover R, 2006, GUT, V55, P848, DOI 10.1136/gut.2005.073015; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawakami H, 2015, J GASTROINTEST ONCOL, V6, P676, DOI 10.3978/j.issn.2078-6891.2015.065; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kim M, 2008, CANCER RES, V68, P3440, DOI 10.1158/0008-5472.CAN-08-0014; Klotz DM, 2012, J CELL SCI, V125, P887, DOI 10.1242/jcs.091843; Kuratnik A, 2012, BIOCHEM PHARMACOL, V83, P1217, DOI 10.1016/j.bcp.2012.01.024; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lesko AC, 2014, CURR DRUG TARGETS, V15, P90, DOI 10.2174/1389450114666131108155418; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li SW, 2012, INT J CANCER, V131, P1435, DOI 10.1002/ijc.27344; Liu LH, 2014, FEBS LETT, V588, P929, DOI 10.1016/j.febslet.2014.01.050; Mahmoud NN, 1997, CANCER RES, V57, P5045; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Rigatti MJ, 2012, MOL CARCINOGEN, V51, P363, DOI 10.1002/mc.20795; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Tao Y, 2008, ONCOGENE, V27, P3244, DOI 10.1038/sj.onc.1210990; Verma R, 2010, BIOCHEM PHARMACOL, V79, P565, DOI 10.1016/j.bcp.2009.09.020; Walsby E, 2008, HAEMATOLOGICA, V93, P662, DOI 10.3324/haematol.12148; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Yamada HY, 2006, MOL CANCER THER, V5, P2963, DOI 10.1158/1535-7163.MCT-06-0319	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153818	10.1371/journal.pone.0153818	http://dx.doi.org/10.1371/journal.pone.0153818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097159	Green Published, gold			2022-12-26	WOS:000374543600060
J	Jonscher, KR; Alfonso-Garcia, A; Suhalim, JL; Orlicky, DJ; Potma, EO; Ferguson, VL; Bouxsein, ML; Bateman, TA; Stodieck, LS; Levi, M; Friedman, JE; Gridley, DS; Pecaut, MJ				Jonscher, Karen R.; Alfonso-Garcia, Alba; Suhalim, Jeffrey L.; Orlicky, David J.; Potma, Eric O.; Ferguson, Virginia L.; Bouxsein, Mary L.; Bateman, Ted A.; Stodieck, Louis S.; Levi, Moshe; Friedman, Jacob E.; Gridley, Daila S.; Pecaut, Michael J.			Spaceflight Activates Lipotoxic Pathways in Mouse Liver	PLOS ONE			English	Article							FARNESOID X RECEPTOR; ACYL-COA THIOESTERASES; HEPATIC STELLATE CELLS; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; LIPID-METABOLISM; FATTY-ACIDS; SPACE; EXPRESSION; ALPHA	Spaceflight affects numerous organ systems in the body, leading to metabolic dysfunction that may have long-term consequences. Microgravity-induced alterations in liver metabolism, particularly with respect to lipids, remain largely unexplored. Here we utilize a novel systems biology approach, combining metabolomics and transcriptomics with advanced Raman microscopy, to investigate altered hepatic lipid metabolism in mice following short duration spaceflight. Mice flown aboard Space Transportation System -135, the last Shuttle mission, lose weight but redistribute lipids, particularly to the liver. Intriguingly, spaceflight mice lose retinol from lipid droplets. Both mRNA and metabolite changes suggest the retinol loss is linked to activation of PPAR alpha-mediated pathways and potentially to hepatic stellate cell activation, both of which may be coincident with increased bile acids and early signs of liver injury. Although the 13-day flight duration is too short for frank fibrosis to develop, the retinol loss plus changes in markers of extracellular matrix remodeling raise the concern that longer duration exposure to the space environment may result in progressive liver damage, increasing the risk for nonalcoholic fatty liver disease.	[Jonscher, Karen R.] Univ Colorado Anschutz Med Campus, Dept Anesthesiol, Aurora, CO USA; [Alfonso-Garcia, Alba; Suhalim, Jeffrey L.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Suhalim, Jeffrey L.; Potma, Eric O.] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92715 USA; [Orlicky, David J.] Univ Colorado Anschutz Med Campus, Dept Pathol, Aurora, CO USA; [Ferguson, Virginia L.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Bouxsein, Mary L.] Harvard Univ, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA; [Bateman, Ted A.] Univ N Carolina, Dept Bioengn, Chapel Hill, NC USA; [Stodieck, Louis S.] Univ Colorado, BioServe Space Technol, Boulder, CO 80309 USA; [Levi, Moshe] Univ Colorado Anschutz Med Campus, Dept Med, Aurora, CO USA; [Friedman, Jacob E.] Univ Colorado Anschutz Med Campus, Dept Pediat, Aurora, CO USA; [Gridley, Daila S.; Pecaut, Michael J.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Radiat Res, Loma Linda, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Loma Linda University	Jonscher, KR (corresponding author), Univ Colorado Anschutz Med Campus, Dept Anesthesiol, Aurora, CO USA.	karen.jonscher@ucdenver.edu	Gridley, Daila S/P-7711-2015; Ferguson, Virginia/K-6962-2012; Pecaut, Michael J/P-6481-2015	Ferguson, Virginia/0000-0002-8448-4406; Pecaut, Michael J/0000-0002-2915-9686; Alfonso-Garcia, Alba/0000-0002-6748-3751	National Aeronautics and Space Administration [NNX10AJ31G, NNX10AE39G]; Department of Anesthesiology at the University of Colorado Anschutz Medical Campus; LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Department of Anesthesiology at the University of Colorado Anschutz Medical Campus; LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially funded by the National Aeronautics and Space Administration grant NNX10AJ31G (D.S.G. and M.J.P.; www.nasa.gov) and NNX10AE39G (M.L.B.). Additional support was provided by Department of Anesthesiology at the University of Colorado Anschutz Medical Campus (K.R.J.) and the LLUMC Department of Radiation Medicine (D.S.G., M.J.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ATTILI AF, 1986, MED HYPOTHESES, V19, P57, DOI 10.1016/0306-9877(86)90137-4; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Baroni GS, 1998, HEPATOLOGY, V27, P720; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Carson FL, 1990, HISTOTECHNOLOGY SELF, Vx; Chen GX, 2015, CURR DRUG TARGETS, V16, P1281, DOI 10.2174/1389450116666150325231015; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Cohen DE, 2013, ADIPOCYTE, V2, P3, DOI 10.4161/adip.21853; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; Da Silva MS, 2002, NUTRITION, V18, P805, DOI 10.1016/S0899-9007(02)00915-2; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Di Nunzio M, 2009, LIPIDS, V44, P1073, DOI 10.1007/s11745-009-3362-y; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Failloux N, 2003, APPL SPECTROSC, V57, P1117, DOI 10.1366/00037020360695973; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Herrnberger L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115005; Hsu WH, 2013, J AGR FOOD CHEM, V61, P6873, DOI 10.1021/jf402082g; Hunt MC, 2014, BIOCHIMIE, V98, P45, DOI 10.1016/j.biochi.2013.12.018; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Jiao Y, 2015, ACTA PHARMACOL SIN, V36, P44, DOI 10.1038/aps.2014.116; Kane MA, 2012, BBA-MOL CELL BIOL L, V1821, P10, DOI 10.1016/j.bbalip.2011.09.012; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kulinski A, 2004, J BIOL CHEM, V279, P23916, DOI 10.1074/jbc.M312676200; KWAKYE JB, 1993, J LIPID RES, V34, P95; Lane HW, 1998, NUTR RES, V18, P1923, DOI 10.1016/S0271-5317(98)00162-6; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Liden M, 2006, J BIOL CHEM, V281, P13001, DOI 10.1074/jbc.R500027200; Lin J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655353; Luis PBM, 2011, BIOCHEM PHARMACOL, V82, P1740, DOI 10.1016/j.bcp.2011.07.103; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Mazuy C, 2015, CELL MOL LIFE SCI, V72, P1631, DOI 10.1007/s00018-014-1805-y; Milliano MT, 2005, HEPATOL RES, V33, P225, DOI 10.1016/j.hepres.2005.08.007; Moise AR, 2009, MOL PHARMACOL, V76, P1228, DOI 10.1124/mol.109.060038; Narici MV, 2011, EUR J APPL PHYSIOL, V111, P403, DOI 10.1007/s00421-010-1556-x; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Pasarin M, 2011, J HEPATOL, V55, P1095, DOI 10.1016/j.jhep.2011.01.053; Pollak NM, 2015, J BIOL CHEM, V290, P1295, DOI 10.1074/jbc.M114.604744; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Russell TD, 2007, J LIPID RES, V48, P1463, DOI 10.1194/jlr.M600474-JLR200; Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321; Shaik FB, 2015, INFLAMM RES, V64, P9, DOI 10.1007/s00011-014-0780-y; Sharvit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076541; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Sun GS, 2014, NUTRITION, V30, P125, DOI 10.1016/j.nut.2013.04.005; Sun GS, 2010, NUTRITION, V26, P1163, DOI 10.1016/j.nut.2009.09.018; Sung M, 2013, J MUSCULOSKEL NEURON, V13, P405; TAKASE S, 1992, LIFE SCI, V51, P1459, DOI 10.1016/0024-3205(92)90541-V; Tian J, 2010, J APPL PHYSIOL, V108, P162, DOI 10.1152/japplphysiol.00730.2009; Tobin BW, 2002, NUTRITION, V18, P842, DOI 10.1016/S0899-9007(02)00940-1; Topletz AR, 2015, MOL PHARMACOL, V87, P430, DOI 10.1124/mol.114.096784; Tou J, 2003, NUTRITION, V19, P947, DOI 10.1016/j.nut.2003.08.005; Trevino MB, 2015, DIABETES, V64, P1299, DOI 10.2337/db14-0559; Tsatsoulis A, 2013, METABOLISM, V62, P622, DOI 10.1016/j.metabol.2012.11.004; Wang Z, 2011, HEPATOL RES, V41, P475, DOI 10.1111/j.1872-034X.2011.00794.x; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wu WB, 2015, BIOCHIMIE, V115, P86, DOI 10.1016/j.biochi.2015.05.014; Yamamoto K, 1996, PHARMACOL RES, V33, P337, DOI 10.1006/phrs.1996.0046; Zhou D, 2006, LIPIDS, V41, P213, DOI 10.1007/s11745-006-5090-x	74	43	47	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152877	10.1371/journal.pone.0152877	http://dx.doi.org/10.1371/journal.pone.0152877			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097220	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600020
J	Singh, S; Dubey, VK				Singh, Shalini; Dubey, Vikash Kumar			Quantitative Proteome Analysis of Leishmania donovani under Spermidine Starvation	PLOS ONE			English	Article							MASS-SPECTROMETRY; RADIAL SPOKE; DNA-DAMAGE; PROTEINS; QUANTIFICATION; PARASITE; DATABASE; INSIGHT; DEATH; RNA	We have earlier reported antileishmanial activity of hypericin by spermidine starvation. In the current report, we have used label free proteome quantitation approach to identify differentially modulated proteins after hypericin treatment. A total of 141 proteins were found to be differentially regulated with ANOVA P value less than 0.05 in hypericin treated Leishmania promastigotes. Differentially modulated proteins have been broadly classified under nine major categories. Increase in ribosomal protein S7 protein suggests the repression of translation. Inhibition of proteins related to ubiquitin proteasome system, RNA binding protein and translation initiation factor also suggests altered translation. We have also observed increased expression of Hsp 90, Hsp 83-1 and stress inducible protein 1. Significant decreased level of cyclophilin was observed. These stress related protein could be cellular response of the parasite towards hypericin induced cellular stress. Also, defective metabolism, biosynthesis and replication of nucleic acids, flagellar movement and signalling of the parasite were observed as indicated by altered expression of proteins involved in these pathways. The data was analyzed rigorously to get further insight into hypericin induced parasitic death.	[Singh, Shalini; Dubey, Vikash Kumar] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati 781039, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Dubey, VK (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati 781039, Assam, India.	vdubey@iitg.ernet.in	Dubey, Vikash Kumar/B-3542-2008	Dubey, Vikash Kumar/0000-0002-4281-2504; Dubey, Vikash Kumar/0000-0002-3870-2660; Singh, Shalini/0000-0001-9300-3822	IIT Guwahati; Department of Biotechnology, Government of India [BT/555/NE/U-Excel/2014]	IIT Guwahati; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Research fellowships to SS by IIT Guwahati are acknowledged. Financial support by Department of Biotechnology, Government of India in the form of research grant (Project no: BT/555/NE/U-Excel/2014) to VKD is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research fellowships to SS by IIT Guwahati are acknowledged. Authors acknowledge Centre for Cellular and Molecular Platforms, Indian Institute of Science for helping in proteomics studies. Financial support by Department of Biotechnology, Government of India in the form of research grant (Project no: BT/555/NE/U-Excel/2014) to VKD is also acknowledged. Quantitative proteome data are available via ProteomeXchange Consortium via the PRIDE (http://www.ebi.ac.uk/pride) with identifier PXD003815 (Project DOI: 10.6019/PXD003815)	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bao K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119222; Dey A, 2008, CLIN VACCINE IMMUNOL, V15, P836, DOI 10.1128/CVI.00433-07; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gundry R. L., 2009, CURRENT PROTOCOLS MO; Haqqani Arsalan S., 2008, V439, P241, DOI 10.1007/978-1-59745-188-8_17; Hemnani T, 1998, Indian J Physiol Pharmacol, V42, P440; Islam Md. Saiful, 2015, Genomics & Informatics, V13, P53, DOI 10.5808/GI.2015.13.2.53; Jin BF, 2003, ONCOGENE, V22, P4819, DOI 10.1038/sj.onc.1206738; Kanamarlapudi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037954; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LI YB, 1994, CARCINOGENESIS, V15, P1421, DOI 10.1093/carcin/15.7.1421; Martini EMD, 2002, GENETICS, V160, P1375; Mazandu GK, 2012, INT J MOL SCI, V13, P7283, DOI 10.3390/ijms13067283; Megger DA, 2013, BBA-PROTEINS PROTEOM, V1834, P1581, DOI 10.1016/j.bbapap.2013.04.001; Milman N, 2007, P NATL ACAD SCI USA, V104, P19250, DOI 10.1073/pnas.0706858104; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Qi D, 2012, OMICS, V16, P489, DOI 10.1089/omi.2012.0042; Robert F, 2001, NUCLEIC ACIDS RES, V29, P677, DOI 10.1093/nar/29.3.677; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shukla AK, 2012, EUR J MED CHEM, V54, P49, DOI 10.1016/j.ejmech.2012.04.034; Singh BK, 2008, BMB REP, V41, P444, DOI 10.5483/BMBRep.2008.41.6.444; Singh S, 2015, ANTIMICROB AGENTS CH, V59, P15, DOI 10.1128/AAC.04169-14; Sivashankari S, 2006, BIOINFORMATION, V1, P335, DOI 10.6026/97320630001335; Srivastava P., 2004, CURR PROTOC IMMUNOL; Strassberger V, 2010, J PROTEOMICS, V73, P1954, DOI 10.1016/j.jprot.2010.05.018; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Verma RK, 2012, ACS MED CHEM LETT, V3, P243, DOI 10.1021/ml200280r; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Waghmare S, 2015, J PARASIT DIS, P1; Wirschell M, 2008, CELL MOTIL CYTOSKEL, V65, P238, DOI 10.1002/cm.20257; WOLFF EC, 1990, J BIOL CHEM, V265, P4793; Wong JWH, 2010, METHODS MOL BIOL, V604, P273, DOI 10.1007/978-1-60761-444-9_18; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yang ZH, 2001, MOL CELL BIOL, V21, P2463, DOI 10.1128/MCB.21.7.2463-2466.2001; Zhang R., 2010, J PROTEOM BIOINFORM, V03, P260, DOI [10.4172/jpb.1000149, DOI 10.4172/JPB.1000149]; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518	37	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154262	10.1371/journal.pone.0154262	http://dx.doi.org/10.1371/journal.pone.0154262			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123864	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700063
J	Bursley, JK; Nestor, A; Tarr, MJ; Creswell, JD				Bursley, James K.; Nestor, Adrian; Tarr, Michael J.; Creswell, J. David			Awake, Offline Processing during Associative Learning	PLOS ONE			English	Article							MEMORY CONSOLIDATION; PREFRONTAL CORTEX; POSTENCODING REST; SLEEP; PRECUNEUS; CONNECTIVITY; REACTIVATION; RETRIEVAL; PATTERNS; REPLAY	Offline processing has been shown to strengthen memory traces and enhance learning in the absence of conscious rehearsal or awareness. Here we evaluate whether a brief, two-minute offline processing period can boost associative learning and test a memory reactivation account for these offline processing effects. After encoding paired associates, subjects either completed a distractor task for two minutes or were immediately tested for memory of the pairs in a counterbalanced, within-subjects functional magnetic resonance imaging study. Results showed that brief, awake, offline processing improves memory for associate pairs. Moreover, multi-voxel pattern analysis of the neuroimaging data suggested reactivation of encoded memory representations in dorsolateral prefrontal cortex during offline processing. These results signify the first demonstration of awake, active, offline enhancement of associative memory and suggest that such enhancement is accompanied by the offline reactivation of encoded memory representations.	[Bursley, James K.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Bursley, James K.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Nestor, Adrian] Univ Toronto Scarborough, Dept Psychol, Toronto, ON, Canada; [Tarr, Michael J.; Creswell, J. David] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Tarr, Michael J.; Creswell, J. David] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Harvard University; Harvard University; University of Toronto; University Toronto Scarborough; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bursley, JK (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.; Bursley, JK (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.; Creswell, JD (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.; Creswell, JD (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA.	bursley@fas.harvard.edu; creswell@cmu.edu		Nestor, Adrian/0000-0002-2250-8759; Bursley, James/0000-0001-6543-4713	Rothberg Research Award in Human Brain Imaging	Rothberg Research Award in Human Brain Imaging	This work was supported by a Rothberg Research Award in Human Brain Imaging awarded to JKB and JDC, http://www.cmu.edu/news/archive/2011/July/july7_rothbergawards.shtml. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Bos MW, 2008, J EXP SOC PSYCHOL, V44, P1114, DOI 10.1016/j.jesp.2008.01.001; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; Brown RM, 2007, NAT NEUROSCI, V10, P148, DOI 10.1038/nn1836; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Craig M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093915; Creswell JD, 2013, SOC COGN AFFECT NEUR; Deuker L, 2013, J NEUROSCI, V33, P19373, DOI 10.1523/JNEUROSCI.0414-13.2013; Dewar M, 2012, PSYCHOL SCI, V23, P955, DOI 10.1177/0956797612441220; Dijksterhuis A, 2006, PERSPECT PSYCHOL SCI, V1, P95, DOI 10.1111/j.1745-6916.2006.00007.x; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Geuze E, 2007, PROG BRAIN RES, V167, P293, DOI 10.1016/S0079-6123(07)67026-5; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Groen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019985; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Krause BJ, 1999, BRAIN, V122, P255, DOI 10.1093/brain/122.2.255; Levy BJ, 2013, PERSPECT PSYCHOL SCI, V8, P72, DOI 10.1177/1745691612469031; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Mottaghy FM, 1999, EXP BRAIN RES, V128, P332, DOI 10.1007/s002210050853; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Peters J, 2009, HIPPOCAMPUS, V19, P141, DOI 10.1002/hipo.20490; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sharon T, 2011, P NATL ACAD SCI USA, V108, P1146, DOI 10.1073/pnas.1005238108; SHEA JB, 1979, J EXP PSYCHOL-HUM L, V5, P179, DOI 10.1037/0278-7393.5.2.179; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; Staresina BP, 2013, P NATL ACAD SCI USA, V110, P21159, DOI 10.1073/pnas.1311989110; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Summerfield C, 2006, PLOS BIOL, V4, P855, DOI 10.1371/journal.pbio.0040128; Tambini A, 2013, P NATL ACAD SCI USA, V110, P19591, DOI 10.1073/pnas.1308499110; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Turk-Browne NB, 2006, NEURON, V49, P917, DOI 10.1016/j.neuron.2006.01.030; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107	45	5	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0127522	10.1371/journal.pone.0127522	http://dx.doi.org/10.1371/journal.pone.0127522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119345	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200001
J	Dakin, R; McCrossan, O; Hare, JF; Montgomerie, R; Kane, SA				Dakin, Roslyn; McCrossan, Owen; Hare, James F.; Montgomerie, Robert; Kane, Suzanne Amador			Biomechanics of the Peacock's Display: How Feather Structure and Resonance Influence Multimodal Signaling	PLOS ONE			English	Article							COURTSHIP DISPLAYS; PERFORMANCE; FLUTTER; ARANEAE; SOUNDS	Courtship displays may serve as signals of the quality of motor performance, but little is known about the underlying biomechanics that determines both their signal content and costs. Peacocks (Pavo cristatus) perform a complex, multimodal "train-rattling" display in which they court females by vibrating the iridescent feathers in their elaborate train ornament. Here we study how feather biomechanics influences the performance of this display using a combination of field recordings and laboratory experiments. Using high-speed video, we find that train-rattling peacocks stridulate their tail feathers against the train at 25.6 Hz, on average, generating a broadband, pulsating mechanical sound at that frequency. Laboratory measurements demonstrate that arrays of peacock tail and train feathers have a broad resonant peak in their vibrational spectra at the range of frequencies used for train-rattling during the display, and the motion of feathers is just as expected for feathers shaking near resonance. This indicates that peacocks are able to drive feather vibrations energetically efficiently over a relatively broad range of frequencies, enabling them to modulate the feather vibration frequency of their displays. Using our field data, we show that peacocks with longer trains use slightly higher vibration frequencies on average, even though longer train feathers are heavier and have lower resonant frequencies. Based on these results, we propose hypotheses for future studies of the function and energetics of this display that ask why its dynamic elements might attract and maintain female attention. Finally, we demonstrate how the mechanical structure of the train feathers affects the peacock's visual display by allowing the colorful iridescent eyespots-which strongly influence female mate choice-to remain nearly stationary against a dynamic iridescent background.	[Dakin, Roslyn] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [McCrossan, Owen] Drexel Univ, Philadelphia, PA 19104 USA; [Hare, James F.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Montgomerie, Robert] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Kane, Suzanne Amador] Haverford Coll, Dept Phys, Haverford, PA 19041 USA	University of British Columbia; Drexel University; University of Manitoba; Queens University - Canada; Haverford College	Dakin, R (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.; Kane, SA (corresponding author), Haverford Coll, Dept Phys, Haverford, PA 19041 USA.	roslyn.dakin@gmail.com; samador@haverford.edu			National Sciences and Engineering Research Council of Canada (NSERC); NSERC [RGPIN-2349-08, RGPIN-1542-71]; Haverford College	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Haverford College	This research was supported by a National Sciences and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship (RD), NSERC grants to RM (RGPIN-2349-08) and JFH (RGPIN-1542-71), and funding from Haverford College (SAK).	Andersson Malte, 1994; Bachmann T, 2012, J EXP BIOL, V215, P405, DOI 10.1242/jeb.059451; Bostwick KS, 2010, P R SOC B, V277, P835, DOI 10.1098/rspb.2009.1576; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Clark CJ, 2013, J EXP BIOL, V216, P3395, DOI 10.1242/jeb.080317; Clark CJ, 2013, J EXP BIOL, V216, P3404, DOI 10.1242/jeb.085993; Clark CJ, 2009, P ROY SOC B-BIOL SCI, V276, P3047, DOI 10.1098/rspb.2009.0508; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Corfield JR, 2013, HEARING RES, V304, P111, DOI 10.1016/j.heares.2013.07.004; Dakin R, 2013, BEHAV ECOL, V24, P1048, DOI 10.1093/beheco/art045; Dakin R, 2011, ANIM BEHAV, V82, P21, DOI 10.1016/j.anbehav.2011.03.016; Dakin R, 2009, BEHAV ECOL SOCIOBIOL, V63, P825, DOI 10.1007/s00265-009-0717-6; Darwin C., 1871, P423; Dickerson AK, 2012, J R SOC INTERFACE, V9, P3208, DOI 10.1098/rsif.2012.0429; DOOLING RJ, 1981, J COMP PHYSIOL, V143, P383, DOI 10.1007/BF00611177; Elias DO, 2012, BIOL J LINN SOC, V105, P522, DOI 10.1111/j.1095-8312.2011.01817.x; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; Freeman AR, 2015, ANIM BEHAV, V102, P241, DOI 10.1016/j.anbehav.2015.01.029; Haller NK, 2014, VISION RES, V102, P19, DOI 10.1016/j.visres.2014.07.007; Healy K, 2013, ANIM BEHAV, V86, P685, DOI 10.1016/j.anbehav.2013.06.018; Hebets EA, 1999, ANIM BEHAV, V57, P865, DOI 10.1006/anbe.1998.1048; Iwata T, 2013, AQUATIC MAMMALS, V39; Jung R., 1973, HDB SENSORY PHYSL, VVII/3A, P455; Kleinebeckel D, 1990, THERMOREGULATION PHY, P235; Koch RE, 2015, AUK, V132, P349, DOI 10.1642/AUK-14-63.1; Kovalev A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0988; Liu ZQ, 2015, ACTA BIOMATER, V17, P137, DOI 10.1016/j.actbio.2015.01.035; Loyau A, 2007, BEHAV ECOL, V18, P1123, DOI 10.1093/beheco/arm088; Macho-Stadler E, 2015, EUR J PHYS, V36, DOI 10.1088/0143-0807/36/5/055007; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Neimark MA, 2003, J NEUROSCI, V23, P6499; Ha NS, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/046008; Ortega-Jimenez VM, 2012, J R SOC INTERFACE, V9, P1093, DOI 10.1098/rsif.2011.0608; PACHORI G N, 1970, Annals of Zoology (Agra), V6, P109; Petrie M, 1996, J ZOOL, V238, P365, DOI 10.1111/j.1469-7998.1996.tb05400.x; Potter M.C., 2002, MECH FLUIDS; Program BR, 2011, RAV PROINT SOUND AN; R Core Team, 2015, R LANG DEV ENV STAT; Ridley M.W., 1984, World Pheasant Association Journal, V9, P57; Ros AFH, 2009, J ETHOL, V27, P209, DOI 10.1007/s10164-008-0105-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz A, 2015, J MORPHOL, V276, P33, DOI 10.1002/jmor.20317; Smith WF, 2010, WAVES OSCILLATIONS P; VINCENT JFV, 1986, J ZOOL, V210, P55, DOI 10.1111/j.1469-7998.1986.tb03620.x; Volterra E., 1965, DYNAMICS VIBRATIONS; Weiss IM, 2010, J EXP ZOOL PART A, V313A, P690, DOI 10.1002/jez.641; Williams CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008806; Yorzinski JL, 2013, J EXP BIOL, V216, P3035, DOI 10.1242/jeb.087338	49	12	12	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152759	10.1371/journal.pone.0152759	http://dx.doi.org/10.1371/journal.pone.0152759			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119380	gold, Green Submitted, Green Published			2022-12-26	WOS:000374976200012
J	Forsberg, V; Zhang, RY; Backstrom, J; Dahlstrom, C; Andres, B; Norgren, M; Andersson, M; Hummelgard, M; Olin, H				Forsberg, Viviane; Zhang, Renyun; Backstrom, Joakim; Dahlstrom, Christina; Andres, Britta; Norgren, Magnus; Andersson, Mattias; Hummelgard, Magnus; Olin, Hakan			Exfoliated MoS2 in Water without Additives	PLOS ONE			English	Article							LARGE-SCALE PRODUCTION; LIQUID EXFOLIATION; NANOSHEETS; GRAPHENE; INTERCALATION; DISPERSION; NANOTUBES; CHEMISTRY; RAMAN; MONO	Many solution processing methods of exfoliation of layered materials have been studied during the last few years; most of them are based on organic solvents or rely on surfactants and other funtionalization agents. Pure water should be an ideal solvent, however, it is generally believed, based on solubility theories that stable dispersions of water could not be achieved and systematic studies are lacking. Here we describe the use of water as a solvent and the stabilization process involved therein. We introduce an exfoliation method of molybdenum disulfide (MoS2) in pure water at high concentration (i.e., 0.14 +/- 0.01 g L-1). This was achieved by thinning the bulk MoS2 by mechanical exfoliation between sand papers and dispersing it by liquid exfoliation through probe sonication in water. We observed thin MoS2 nanosheets in water characterized by TEM, AFM and SEM images. The dimensions of the nanosheets were around 200 nm, the same range obtained in organic solvents. Electrophoretic mobility measurements indicated that electrical charges may be responsible for the stabilization of the dispersions. A probability decay equation was proposed to compare the stability of these dispersions with the ones reported in the literature. Water can be used as a solvent to disperse nanosheets and although the stability of the dispersions may not be as high as in organic solvents, the present method could be employed for a number of applications where the dispersions can be produced on site and organic solvents are not desirable.	[Forsberg, Viviane; Zhang, Renyun; Backstrom, Joakim; Dahlstrom, Christina; Andres, Britta; Norgren, Magnus; Andersson, Mattias; Hummelgard, Magnus; Olin, Hakan] Mid Sweden Univ, Dept Nat Sci, Sundsvall, Sweden	Mid-Sweden University	Forsberg, V (corresponding author), Mid Sweden Univ, Dept Nat Sci, Sundsvall, Sweden.	viviane.forsberg@gmail.com	Olin, Håkan/A-8175-2008; Zhang, Renyun/C-6617-2009; Backstrom, Joakim/E-2299-2011	Olin, Håkan/0000-0001-7329-3359; Andres, Britta/0000-0002-2393-3378; Zhang, Renyun/0000-0003-2873-7875; /0000-0003-3407-7973; Backstrom, Joakim/0000-0001-8868-4766	KKS foundation; European regional development fund; Swedish Energy Agency; County Government of Vasternorrland	KKS foundation; European regional development fund(European Commission); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); County Government of Vasternorrland	This work was supported by the KKS foundation, the European regional development fund, Swedish Energy Agency, and County Government of Vasternorrland.	Alecrim V, 2015, PROC NIP 31ST DIGITA, V2015, P192; Backes C, 2015, ANGEW CHEM, V127, P2676, DOI DOI 10.1002/ANGE.201409412; Benavente E, 2002, COORDIN CHEM REV, V224, P87, DOI 10.1016/S0010-8545(01)00392-7; Brauer HE, 1997, PHYS REV B, V55, P10022, DOI 10.1103/PhysRevB.55.10022; Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/NCHEM.1589, 10.1038/nchem.1589]; COEHOORN R, 1987, PHYS REV B, V35, P6203, DOI 10.1103/PhysRevB.35.6203; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Dumcenco D, 2015, ACS NANO, V9, P4611, DOI 10.1021/acsnano.5b01281; Eda G, 2012, ACS NANO, V6, P7311, DOI 10.1021/nn302422x; Hanlon D, 2014, CHEM MATER, V26, P1751, DOI 10.1021/cm500271u; Hansen C.M., 2007, HANSEN SOLUBILITY PA, V2nd, DOI [10.1201/9781420006834, DOI 10.1201/9781420006834]; Ibanez M, 2014, CLAY CLAY MINER, V62, P374, DOI 10.1346/CCMN.2014.0620502; ICDD, 2014, OWDER DIFRACTION FIL; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; JOENSEN P, 1986, MATER RES BULL, V21, P457, DOI 10.1016/0025-5408(86)90011-5; KAM KK, 1982, J PHYS CHEM-US, V86, P463, DOI 10.1021/j100393a010; Kuc A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245213; Lee YH, 2012, ADV MATER, V24, P2320, DOI 10.1002/adma.201104798; Lotya M, 2009, J AM CHEM SOC, V131, P3611, DOI 10.1021/ja807449u; MIREMADI BK, 1987, J CATAL, V103, P334, DOI 10.1016/0021-9517(87)90125-4; Niu LY, 2016, SMALL, V12, P272, DOI 10.1002/smll.201502207; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; O'Neill A, 2012, CHEM MATER, V24, P2414, DOI 10.1021/cm301515z; O'Neill A, 2011, J PHYS CHEM C, V115, P5422, DOI 10.1021/jp110942e; Paton KR, 2014, NAT MATER, V13, P624, DOI [10.1038/nmat3944, 10.1038/NMAT3944]; Pu J, 2012, NANO LETT, V12, P4013, DOI 10.1021/nl301335q; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Smith RJ, 2011, ADV MATER, V23, P3944, DOI 10.1002/adma.201102584; Smoluchowski Mv, 1921, HANDBUCH DER ELEKTRI, VII; Stephenson T, 2014, ENERG ENVIRON SCI, V7, P209, DOI 10.1039/c3ee42591f; Sun Z, 2008, J PHYS CHEM C, V112, P10692, DOI 10.1021/jp8021634; TRIBUTSCH H, 1980, FARADAY DISCUSS, V70, P189, DOI 10.1039/dc9807000189; Varrla E, 2015, CHEM MATER, V27, P1129, DOI 10.1021/cm5044864; Visic B, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-593; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/NNANO.2012.193, 10.1038/nnano.2012.193]; WEIMER M, 1988, PHYS REV B, V37, P4292, DOI 10.1103/PhysRevB.37.4292; WIETING TJ, 1971, PHYS REV B, V3, P4286, DOI 10.1103/PhysRevB.3.4286; Windom BC, 2011, TRIBOL LETT, V42, P301, DOI 10.1007/s11249-011-9774-x; Yao YG, 2012, J MATER CHEM, V22, P13494, DOI 10.1039/c2jm30587a; Yoffe A. D., 1973, 1973 Annual review of materials science, vol.3, P147; Yu Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02697; Zhang WT, 2015, NANOSCALE, V7, P10210, DOI 10.1039/c5nr02253c; Zhou KG, 2011, ANGEW CHEM INT EDIT, V50, P10839, DOI 10.1002/anie.201105364	43	74	74	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154522	10.1371/journal.pone.0154522	http://dx.doi.org/10.1371/journal.pone.0154522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120098	gold, Green Published, Green Submitted			2022-12-26	WOS:000374976200086
J	Bernard, G; Duchene, JC; Romero-Ramirez, A; Lecroart, P; Maire, O; Ciutat, A; Deflandre, B; Gremare, A				Bernard, Guillaume; Duchene, Jean-Claude; Romero-Ramirez, Alicia; Lecroart, Pascal; Maire, Olivier; Ciutat, Aurelie; Deflandre, Bruno; Gremare, Antoine			Experimental Assessment of the Effects of Temperature and Food Availability on Particle Mixing by the Bivalve Abra alba Using New Image Analysis Techniques	PLOS ONE			English	Article							SEDIMENT REWORKING; BIODIFFUSION COEFFICIENT; LUMINOPHORE TRACERS; FEEDING-BEHAVIOR; BIOTURBATION; DEPOSIT; OVATA; QUANTIFICATION; POLYCHAETE; PATTERNS	The effects of temperature and food addition on particle mixing in the deposit-feeding bivalve Abra alba were assessed using an experimental approach allowing for the tracking of individual fluorescent particle (luminophore) displacements. This allowed for the computations of vertical profiles of a set of parameters describing particle mixing. The frequency of luminophore displacements (jumps) was assessed through the measurement of both waiting times (i.e., the time lapses between two consecutive jumps of the same luminophore) and normalized numbers of jumps (i.e., the numbers of jumps detected in a given area divided by the number of luminophores in this area). Jump characteristics included the direction, duration and length of each jump. Particle tracking biodiffusion coefficients (D-b) were also computed. Data originated from 32 experiments carried out under 4 combinations of 2 temperature (Te) and 2 food addition (Fo) levels. For each of these treatments, parameters were computed for 5 experimental durations (Ed). The effects of Se, Fo and Ed were assessed using PERmutational Multivariate ANalyses Of VAriance (PERMANOVAs) carried out on vertical depth profiles of each particle mixing parameter. Inversed waiting times significantly decreased with Ed whereas the normalized number of jumps did not, thereby suggesting that it constitutes a better proxy of jump frequency when assessing particle mixing based on the measure of individual particle displacements. Particle mixing was low during autumn temperature experiments and not affected by Fo, which was attributed to the dominant effect of low temperature. Conversely, particle mixing was high during summer temperature experiments and transitory inhibited by food addition. This last result is coherent with the functional responses (both in terms of activity and particle mixing) already measured for individual of the closely related clam A. ovata originating from temperate populations. It also partly resulted from a transitory switch between deposit-and suspension-feeding caused by the high concentration of suspended particulate organic matter immediately following food addition.	[Bernard, Guillaume; Romero-Ramirez, Alicia; Lecroart, Pascal; Maire, Olivier; Deflandre, Bruno; Gremare, Antoine] Univ Bordeaux, EPOC, UMR 5805, F-33400 Talence, France; [Bernard, Guillaume] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Duchene, Jean-Claude; Romero-Ramirez, Alicia; Ciutat, Aurelie] CNRS, EPOC, UMR 5805, F-33400 Talence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; University of Helsinki; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU)	Bernard, G (corresponding author), Univ Bordeaux, EPOC, UMR 5805, F-33400 Talence, France.; Bernard, G (corresponding author), Univ Helsinki, Tvarminne Zool Stn, Hango, Finland.	g.bernard.epoc@gmail.com		Lecroart, Pascal/0000-0003-3661-2140; deflandre, Bruno/0000-0002-2405-6223	French "Ministere de l'Enseignement Superieur et de la Recherche"; IZOFLUX (ANR blanche) program; BIOMIN (LEFE-CYBER) program; BIOMIN (EC2CO-PNEC) program; Diagnostic de la Qualite des Milieux Littoraux program; "OSQUAR" (Conseil Regional Aquitaine) program	French "Ministere de l'Enseignement Superieur et de la Recherche"; IZOFLUX (ANR blanche) program(French National Research Agency (ANR)); BIOMIN (LEFE-CYBER) program; BIOMIN (EC2CO-PNEC) program; Diagnostic de la Qualite des Milieux Littoraux program; "OSQUAR" (Conseil Regional Aquitaine) program	Guillaume Bernard was supported by a doctoral grant from the French "Ministere de l'Enseignement Superieur et de la Recherche". This work was funded through the IZOFLUX (ANR blanche), BIOMIN (LEFE-CYBER and EC2CO-PNEC), the "Diagnostic de la Qualite des Milieux Littoraux" and the "OSQUAR" (Conseil Regional Aquitaine) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller R.C., 1982, Topics in Geobiology, V2, P53; AMOUROUX JM, 1989, MAR ECOL PROG SER, V51, P87, DOI 10.3354/meps051087; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bernard G, 2014, MAR ECOL PROG SER, V514, P71, DOI 10.3354/meps10961; Bernard G, 2012, J MAR RES, V70, P689, DOI 10.1357/002224012806290705; Borja A, 2004, ELSEV OCEANOGR SERIE, V70, P455; BOUDREAU BP, 1986, AM J SCI, V286, P161, DOI 10.2475/ajs.286.3.161; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Caradec S, 2004, J SEA RES, V52, P199, DOI 10.1016/j.seares.2004.02.002; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; De Backer A, 2011, ESTUAR COAST SHELF S, V91, P306, DOI 10.1016/j.ecss.2010.10.031; Dorgan KM, 2006, OCEANOGR MAR BIOL, V44, P85; Gerino M, 1998, ESTUAR COAST SHELF S, V46, P531, DOI 10.1006/ecss.1997.0298; Gilbert F, 2003, J EXP MAR BIOL ECOL, V285, P251, DOI 10.1016/S0022-0981(02)00531-2; Gle C, 2008, ESTUAR COAST SHELF S, V76, P642, DOI 10.1016/j.ecss.2007.07.043; GOLDBERG ED, 1962, GEOCHIM COSMOCHIM AC, V26, P417, DOI 10.1016/0016-7037(62)90112-6; Gray J.S., 1974, Oceanography mar Biol, V12, P223; Gremare A, 2004, MAR ECOL PROG SER, V267, P195, DOI 10.3354/meps267195; GUINASSO NL, 1975, J GEOPHYS RES-OC ATM, V80, P3032, DOI 10.1029/JC080i021p03032; HUGHES TG, 1975, J EXP MAR BIOL ECOL, V20, P137, DOI 10.1016/0022-0981(75)90020-9; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Lazzari P, 2012, BIOGEOSCIENCES, V9, P217, DOI 10.5194/bg-9-217-2012; Lecroart P, 2007, ESTUAR COAST SHELF S, V72, P543, DOI 10.1016/j.ecss.2006.11.020; Lecroart P, 2010, GEOCHIM COSMOCHIM AC, V74, P6049, DOI 10.1016/j.gca.2010.06.010; LEVINTON JS, 1991, MAR BIOL, V110, P375, DOI 10.1007/BF01344356; LEVINTON JS, 2001, MARINE BIOL FUNCTION; Lindahl O, 1998, ICES J MAR SCI, V55, P723, DOI 10.1006/jmsc.1998.0379; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Maire O, 2007, J EXP MAR BIOL ECOL, V343, P21, DOI 10.1016/j.jembe.2006.10.052; Maire O, 2008, AQUAT BIOL, V2, P219, DOI 10.3354/ab00053; Maire O, 2007, MAR ECOL PROG SER, V351, P139, DOI 10.3354/meps07147; Maire O, 2007, MAR BIOL, V151, P737, DOI 10.1007/s00227-006-0519-6; Maire O, 2006, MAR ECOL PROG SER, V319, P135, DOI 10.3354/meps319135; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Meysman FJR, 2008, AQUAT BIOL, V2, P239, DOI 10.3354/ab00054; Meysman FJR, 2008, GEOCHIM COSMOCHIM AC, V72, P3460, DOI 10.1016/j.gca.2008.04.023; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Meysman FJR, 2010, J MAR RES, V68, P881, DOI 10.1357/002224010796673885; Meysman FJR, 2003, J MAR RES, V61, P391, DOI 10.1357/002224003322201241; Michaud E, 2010, ESTUAR COAST SHELF S, V90, P21, DOI 10.1016/j.ecss.2010.08.005; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Rhoads D.C., 1974, Oceanography mar Biol, V12, P263; Rhoads D.C., 1982, TOPICS GEOBIOLOGY, V100, P3; Riisgard HU, 2001, ECOL STU AN, V151, P73; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; ROSENBERG R, 1993, SARSIA, V78, P119, DOI 10.1080/00364827.1993.10413528; Rowden AA, 1998, CONT SHELF RES, V18, P1347, DOI 10.1016/S0278-4343(98)00047-8; Schiffers K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028028; Solan M, 2004, MAR ECOL PROG SER, V271, P1, DOI 10.3354/meps271001; Stead RA, 2006, J EXP MAR BIOL ECOL, V332, P37, DOI 10.1016/j.jembe.2005.11.001; TAGHON GL, 1992, LIMNOL OCEANOGR, V37, P1370, DOI 10.4319/lo.1992.37.7.1370; TAGHON GL, 1980, SCIENCE, V210, P562, DOI 10.1126/science.210.4469.562; TENORE KR, 1985, LIMNOL OCEANOGR, V30, P1188, DOI 10.4319/lo.1985.30.6.1188; Van Hoey G, 2005, ESTUAR COAST SHELF S, V64, P751, DOI 10.1016/j.ecss.2005.03.022; Venturini N, 2011, J MARINE SYST, V88, P526, DOI 10.1016/j.jmarsys.2011.07.002; WHEATCROFT RA, 1990, J MAR RES, V48, P177, DOI 10.1357/002224090784984560; WHEATCROFT RA, 1992, LIMNOL OCEANOGR, V37, P90, DOI 10.4319/lo.1992.37.1.0090	60	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154270	10.1371/journal.pone.0154270	http://dx.doi.org/10.1371/journal.pone.0154270			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115148	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600054
J	Kaushal, M; Byrnes, C; Khademian, Z; Duncan, N; Luban, NLC; Miller, JL; Fasano, RM; Meier, ER				Kaushal, Megha; Byrnes, Colleen; Khademian, Zarir; Duncan, Natalie; Luban, Naomi L. C.; Miller, Jeffery L.; Fasano, Ross M.; Meier, Emily Riehm			Examination of Reticulocytosis among Chronically Transfused Children with Sickle Cell Anemia	PLOS ONE			English	Article							SILENT CEREBRAL INFARCTS; RED-CELL; CEREBROVASCULAR ACCIDENTS; HYDROXYUREA SWITCH; MOYAMOYA SYNDROME; CNS INFARCTION; DISEASE; ADHESION; STROKE; BLOOD	Sickle cell anemia (SCA) is an inherited hemolytic anemia with compensatory reticulocytosis. Recent studies have shown that increased levels of reticulocytosis during infancy are associated with increased hospitalizations for SCA sequelae as well as cerebrovascular pathologies. In this study, absolute reticulocyte counts (ARC) measured prior to transfusion were analysed among a cohort of 29 pediatric SCA patients receiving chronic transfusion therapy (CTT) for primary and secondary stroke prevention. A cross-sectional flow cytometric analysis of the reticulocyte phenotype was also performed. Mean duration of CTT was 3.1 +/- 2.6 years. Fifteen subjects with magnetic resonance angiography (MRA) - vasculopathy had significantly higher mean ARC prior to initiating CTT compared to 14 subjects without MRA-vasculopathy (427.6 +/- 109.0 K/mu l vs. 324.8 +/- 109.2 K/mu l, p<0.05). No significant differences in hemoglobin or percentage sickle hemoglobin (HbS) were noted between the two groups at baseline. Reticulocyte phenotyping further demonstrated that the percentages of circulating immature [CD36(+), CD71(+)] reticulocytes positively correlated with ARC in both groups. During the first year of CTT, neither group had significant reductions in ARC. Among this group of children with SCA, cerebrovasculopathy on MRA at initiation of CTT was associated with increased reticulocytosis, which was not reduced after 12 months of transfusions.	[Kaushal, Megha; Byrnes, Colleen; Miller, Jeffery L.; Meier, Emily Riehm] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Kaushal, Megha; Luban, Naomi L. C.; Fasano, Ross M.; Meier, Emily Riehm] Childrens Natl Hlth Syst, Ctr Canc & Blood Disorders, Washington, DC USA; [Khademian, Zarir] Childrens Natl Hlth Syst, Div Diagnost Imaging & Radiol, Washington, DC USA; [Kaushal, Megha; Luban, Naomi L. C.; Fasano, Ross M.; Meier, Emily Riehm] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Duncan, Natalie; Meier, Emily Riehm] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA; [Fasano, Ross M.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Ctr Transfus & Cellular Therapies, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's National Health System; Children's National Health System; George Washington University; Indiana Hemophilia & Thrombosis Center; Emory University	Meier, ER (corresponding author), NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA.; Meier, ER (corresponding author), Childrens Natl Hlth Syst, Ctr Canc & Blood Disorders, Washington, DC USA.; Meier, ER (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.; Meier, ER (corresponding author), Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA.	emeier@ihtc.org			Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; National Heart Lung and Blood Institute [HL110841]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110841] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and a T32 from National Heart Lung and Blood Institute [HL110841]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; ANDERSON R, 1963, ARCH INTERN MED, V111, P286, DOI 10.1001/archinte.1963.03620270012003; Borrione P, 2010, INT J LAB HEMATOL, V32, P65, DOI 10.1111/j.1751-553X.2008.01128.x; Browne PV, 1996, J LAB CLIN MED, V127, P340, DOI 10.1016/S0022-2143(96)90181-X; Butthep P, 2015, BLOOD CELL MOL DIS, V54, P170, DOI 10.1016/j.bcmd.2014.11.007; COHEN AR, 1992, BLOOD, V79, P1657; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; Detterich JA, 2013, TRANSFUSION, V53, P1059, DOI 10.1111/j.1537-2995.2012.03961.x; Dobson SR, 2002, BLOOD, V99, P3144, DOI 10.1182/blood.V99.9.3144; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Fasano RM, 2015, BLOOD CELL MOL DIS, V54, P17, DOI 10.1016/j.bcmd.2014.08.007; GABUZDA TG, 1967, BLOOD-J HEMATOL, V29, P126, DOI 10.1182/blood.V29.1.126.126; Gladwin MT, 2007, HAEMATOLOGICA, V93, P1, DOI 10.3324/haematol.12318; Hulbert ML, 2011, BLOOD, V117, P772, DOI 10.1182/blood-2010-01-261123; JONECKIS CC, 1993, BLOOD, V82, P3548; Josephson CD, 2007, TRANSFUS MED REV, V21, P118, DOI 10.1016/j.tmrv.2006.11.003; Kennedy BC, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.10.FOCUS13405; Koury MJ, 2005, BLOOD, V105, P2168, DOI 10.1182/blood-2004-02-0616; LUSHER JM, 1976, AM J HEMATOL, V1, P265, DOI 10.1002/ajh.2830010210; Meier ER, 2014, AM J HEMATOL, V89, P904, DOI 10.1002/ajh.23777; Meier ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070794; Meier ER, 2015, J PEDIAT; Odievre MH, 2008, HAEMATOLOGICA, V93, P502, DOI 10.3324/haematol.12070; Ohene-Frempong K, 1998, BLOOD, V91, P288; PEGELOW CH, 1995, J PEDIATR-US, V126, P896, DOI 10.1016/S0022-3476(95)70204-0; POWARS D, 1978, AM J MED, V65, P461, DOI 10.1016/0002-9343(78)90772-6; RUSSELL MO, 1976, J PEDIATR-US, V88, P382, DOI 10.1016/S0022-3476(76)80251-X; Sakamoto TM, 2013, CLIN BIOCHEM, V46, P1798, DOI 10.1016/j.clinbiochem.2013.09.011; SARNAIK S, 1979, AM J DIS CHILD, V133, P1254, DOI 10.1001/archpedi.1979.02130120046009; Setty BNY, 2002, BLOOD, V99, P1564, DOI 10.1182/blood.V99.5.1564; Silva CM, 2011, PEDIATR BLOOD CANCER, V56, P116, DOI 10.1002/pbc.22680; SUGIHARA K, 1992, BLOOD, V80, P2634; Tancabelic J, 1999, AM J HEMATOL, V60, P121, DOI 10.1002/(SICI)1096-8652(199902)60:2<121::AID-AJH6>3.0.CO;2-2; Telen MJ, 2000, SEMIN HEMATOL, V37, P130, DOI 10.1016/S0037-1963(00)90038-6; Trinh-Trang-Tan MM, 2010, HAEMATOL-HEMATOL J, V95, P730, DOI 10.3324/haematol.2009.017392; Ware RE, 2016, LANCET, V387, P661, DOI 10.1016/S0140-6736(15)01041-7; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Ware RE, 2011, PEDIATR BLOOD CANCER, V57, P1011, DOI 10.1002/pbc.23145; Watkins NA, 2003, BLOOD, V102, P718, DOI 10.1182/blood-2002-11-3497; WAYNE AS, 1993, BLOOD, V81, P1109; WILIMAS J, 1980, J PEDIATR-US, V96, P205, DOI 10.1016/S0022-3476(80)80803-1; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517; Zennadi R, 2008, TRANSFUS CLIN BIOL, V15, P23, DOI 10.1016/j.tracli.2008.04.009	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153244	10.1371/journal.pone.0153244	http://dx.doi.org/10.1371/journal.pone.0153244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116614	gold, Green Published, Green Submitted			2022-12-26	WOS:000374973600017
J	Park, T; Fitzgerald, EMG; Gallagher, SJ; Tomkins, E; Allan, T				Park, Travis; Fitzgerald, Erich M. G.; Gallagher, Stephen J.; Tomkins, Ellyn; Allan, Tony			New Miocene Fossils and the History of Penguins in Australia	PLOS ONE			English	Article							SOUTHERN-OCEAN; SPHENISCIFORMES; EVOLUTION; AVES; PHYLOGENY; PLIOCENE; BASIN; STRATIGRAPHY; BIOGEOGRAPHY; SUCCESSION	Australia has a fossil record of penguins reaching back to the Eocene, yet today is inhabited by just one breeding species, the little penguin Eudyptula minor. The description of recently collected penguin fossils from the re-dated upper Miocene Port Campbell Limestone of Portland (Victoria), in addition to reanalysis of previously described material, has allowed the Cenozoic history of penguins in Australia to be placed into a global context for the first time. Australian pre-Quaternary fossil penguins represent stem taxa phylogenetically disparate from each other and E. minor, implying multiple dispersals and extinctions. Late Eocene penguins from Australia are closest to contemporaneous taxa in Antarctica, New Zealand and South America. Given current material, the Miocene Australian fossil penguin fauna is apparently unique in harbouring 'giant penguins' after they went extinct elsewhere; and including stem taxa until at least 6 Ma, by which time crown penguins dominated elsewhere in the southern hemisphere. Separation of Australia from Antarctica during the Palaeogene, and its subsequent drift north, appears to have been a major event in Australian penguin biogeography. Increasing isolation through the Cenozoic may have limited penguin dispersal to Australia from outside the Australasian region, until intensification of the eastwards-flowing Antarctic Circumpolar Current in the mid-Miocene established a potential new dispersal vector to Australia.	[Park, Travis] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Park, Travis; Fitzgerald, Erich M. G.; Tomkins, Ellyn] Museum Victoria, Palaeontol, Melbourne, Vic, Australia; [Gallagher, Stephen J.; Tomkins, Ellyn] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Allan, Tony] CSIRO Radiogen Isotope Facil, Sydney, NSW, Australia	Monash University; Museum Victoria; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Park, T (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.; Park, T (corresponding author), Museum Victoria, Palaeontol, Melbourne, Vic, Australia.	travis.park@monash.edu	Park, Travis/B-4294-2016; Park, Travis/N-9176-2019	Park, Travis/0000-0002-9492-8859; Park, Travis/0000-0002-9492-8859; Gallagher, Stephen/0000-0002-5593-2740	Australian Research Council [DP0558150]	Australian Research Council(Australian Research Council)	Grant number: DP0558150, Australian Research Council, funder's website: www.arc.gov.au, author who received funding: SJG and ET. Funding was for fieldwork associated with geologic data collection and subsequent stratigraphic analyses only. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hospitaleche CA, 2013, J S AM EARTH SCI, V43, P101, DOI 10.1016/j.jsames.2013.01.006; Acosta Hospitaleche Carolina, 2008, Oryctos, V7, P109; Baker AJ, 2006, P ROY SOC B-BIOL SCI, V273, P11, DOI 10.1098/rspb.2005.3260; Banks Jonathan C., 2002, Notornis, V49, P29; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Bertelli S, 2005, CLADISTICS, V21, P209, DOI 10.1111/j.1096-0031.2005.00065.x; BOUTAKOFF N, 1963, GEOLOGICAL SURVEY VI, V22, P1; Brand L, 2011, J S AM EARTH SCI, V31, P414, DOI 10.1016/j.jsames.2011.02.015; Hoffmeister MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090043; Chavez-Hoffmeister MF, 2014, AMEGHINIANA, V51, P159, DOI 10.5710/AMGH.14.02.2014.637; Clarke JA, 2007, P NATL ACAD SCI USA, V104, P11545, DOI 10.1073/pnas.0611099104; DARRAGH TA, 1985, ALCHERINGA, V9, P83, DOI 10.1080/03115518508618960; Dickinson JA, 2002, J SEDIMENT RES, V72, P288, DOI 10.1306/082701720288; Eagles G, 2014, TECTONOPHYSICS, V611, P28, DOI 10.1016/j.tecto.2013.11.021; Feldmann RM, 2006, NEW ZEAL J GEOL GEOP, V49, P417, DOI 10.1080/00288306.2006.9515178; Finlayson H. H., 1938, Transactions of the Royal Society of South Australia, V62, P14; Fitzgerald Erich M. G., 2004, Memoirs of Museum Victoria, V61, P183; Fitzgerald Erich M. G., 2005, Memoirs of Museum Victoria, V62, P67; Fordyce R. Ewan, 2003, P154; Gallagher SJ, 2000, PALAEOGEOGR PALAEOCL, V156, P19, DOI 10.1016/S0031-0182(99)00130-3; Gallagher SJ, 2001, PALAEOGEOGR PALAEOCL, V172, P53, DOI 10.1016/S0031-0182(01)00271-1; Giannini NP, 2004, AUK, V121, P422, DOI 10.1642/0004-8038(2004)121[0422:POEPBO]2.0.CO;2; Gohlich UB, 2007, ACTA PALAEONTOL POL, V52, P285; Goloboff P, 2008, CLADISTICS, V24, P91; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hoffmeister MC, 2014, POL POLAR RES, V35, P469, DOI 10.2478/popore-2014-0025; Holdgate G.R., 2003, GEOLOGY VICTORIA, V23, P289; Hospitaleche CA, 2008, J PALEONTOL, V82, P565, DOI 10.1666/07-014.1; Hospitaleche CA, 2007, ACTA PALAEONTOL POL, V52, P299; Hospitaleche CA, 2006, REV GEOL CHILE, V33, P327; Houben AJP, 2013, SCIENCE, V340, P341, DOI 10.1126/science.1223646; Huxley T.H., 1859, Q J GEOL SOC LOND, V15, P670, DOI [10.1144/GSL.JGS.1859.015.01-02.73, DOI 10.1144/GSL.JGS.1859.015.01-02.73]; Jadwiszczak Piotr, 2006, Polish Polar Research, V27, P3; Jadwiszczak P, 2013, ANTARCT SCI, V25, P397, DOI 10.1017/S0954102012000909; Jadwiszczak P, 2012, POL POLAR RES, V33, P259, DOI 10.2478/v10183-012-0017-0; Jenkins R.J.F., 1985, P183; JENKINS R J F, 1974, Palaeontology (Oxford), V17, P291; Ksepka DT, 2006, CLADISTICS, V22, P412, DOI 10.1111/j.1096-0031.2006.00116.x; Ksepka DT, 2012, J VERTEBR PALEONTOL, V32, P235, DOI 10.1080/02724634.2012.652051; Ksepka DT, 2012, P ROY SOC B-BIOL SCI, V279, P1027, DOI 10.1098/rspb.2011.1592; Ksepka DT, 2010, B AM MUS NAT HIST, P1; Ksepka DT., 2011, LIVING DINOSAURS EVO, P155, DOI DOI 10.1002/9781119990475.CH6; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Lee TY, 1995, TECTONOPHYSICS, V251, P85, DOI 10.1016/0040-1951(95)00023-2; Lyle M, 2007, GEOLOGY, V35, P691, DOI 10.1130/G23806A.1; MALLETT CW, 1977, THESIS U MELBOURNE; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; McGowran B, 2004, AUST J EARTH SCI, V51, P459, DOI 10.1111/j.1400-0952.2004.01078.x; McLaren S, 2009, AUST J EARTH SCI, V56, P259, DOI 10.1080/08120090802547074; Morecame M, 2004, FIELD GUIDE AUSTR BI, P384; Nelson CS, 2001, NEW ZEAL J GEOL GEOP, V44, P535, DOI 10.1080/00288306.2001.9514954; NORRIS RD, 1994, MAR MICROPALEONTOL, V23, P121, DOI 10.1016/0377-8398(94)90004-3; Park T, 2014, REDESCRIPTI IN PRESS; Park Travis, 2012, Memoirs of Museum Victoria, V69, P309; Piper KJ, 2006, PALAEONTOLOGY, V49, P1237, DOI 10.1111/j.1475-4983.2006.00595.x; SIMPSON G G, 1972, Records of the Canterbury Museum, V9, P159; Simpson G. G., 1970, Mem. natn. Mus. Vict., VNo. 31, P17; SIMPSON G G, 1979, Annals of the South African Museum, V79, P1; Simpson G. G., 1957, Records of the South Australian Museum, V13, P51; Simpson G. G., 1965, Proceedings of the Royal Society of Victoria, V79, P91; Simpson G. G., 1959, Proceedings of the Royal Society of Victoria N S, V71, P113; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Stucchi M., 2007, Cuadernos del Museo Geominero, V8, P367; Subramanian S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0748; Thomas DB, 2013, ZOOL J LINN SOC-LOND, V168, P207, DOI 10.1111/zoj.12024; Thomas DB, 2012, ANAT REC, V295, P249, DOI 10.1002/ar.21538; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; van Tets G.F., 1983, Records of the Queen Victoria Museum, P1; Walsh S.A., 2006, HIST BIOL, V18, P119, DOI [DOI 10.1080/08912960600640796, 10.1080/08912960600640796]; Worthy TH, 2003, J ROY SOC NEW ZEAL, V33, P427, DOI 10.1080/03014223.2003.9517738; Zinsmeister WJ, 1992, J PALEONTOL, V56, P84	72	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153915	10.1371/journal.pone.0153915	http://dx.doi.org/10.1371/journal.pone.0153915			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115739	Green Published, gold, Green Submitted			2022-12-26	WOS:000374973600034
J	Zhang, LJ; Hu, XW; Miao, XM; Chen, XL; Nan, SZ; Fu, H				Zhang, Lijing; Hu, Xiaowei; Miao, Xiumei; Chen, Xiaolong; Nan, Shuzhen; Fu, Hua			Genome-Scale Transcriptome Analysis of the Desert Shrub Artemisia sphaerocephala	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; FATTY-ACID-COMPOSITION; CONJUGATED LINOLEIC-ACID; OMEGA-3-FATTY-ACID DESATURASE GENES; LINUM-USITATISSIMUM L.; SALT-STRESS-RESPONSE; ARABIDOPSIS-THALIANA; ABIOTIC STRESS; TEMPERATURE STRESS; HEAT-SHOCK	Background Artemisia sphaerocephala, a semi-shrub belonging to the Artemisia genus of the Compositae family, is an important pioneer plant that inhabits moving and semi-stable sand dunes in the deserts and steppes of northwest and north-central China. It is very resilient in extreme environments. Additionally, its seeds have excellent nutritional value, and the abundant lipids and polysaccharides in the seeds make this plant a potential valuable source of bioenergy. However, partly due to the scarcity of genetic information, the genetic mechanisms controlling the traits and environmental adaptation capacity of A. sphaerocephala are unknown. Results Here, we present the first in-depth transcriptomic analysis of A. sphaerocephala. To maximize the representation of conditional transcripts, mRNA was obtained from 17 samples, including living tissues of desert-growing A. sphaerocephala, seeds germinated in the laboratory, and calli subjected to no stress (control) and high and low temperature, high and low osmotic, and salt stresses. De novo transcriptome assembly performed using an Illumina HiSeq 2500 platform resulted in the generation of 68,373 unigenes. We analyzed the key genes involved in the unsaturated fatty acid synthesis pathway and identified 26 A. sphaerocephala fad2 genes, which is the largest fad2 gene family reported to date. Furthermore, a set of genes responsible for resistance to extreme temperatures, salt, drought and a combination of stresses was identified. Conclusion The present work provides abundant genomic information for functional dissection of the important traits of A. sphaerocephala and contributes to the current understanding of molecular adaptive mechanisms of A. sphaerocephala in the desert environment. Identification of the key genes in the unsaturated fatty acid synthesis pathway could increase understanding of the biological regulatory mechanisms of fatty acid composition traits in plants and facilitate genetic manipulation of the fatty acid composition of oil crops.	[Zhang, Lijing; Hu, Xiaowei; Miao, Xiumei; Chen, Xiaolong; Nan, Shuzhen; Fu, Hua] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University	Zhang, LJ (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China.	lijingzhang501@hotmail.com			National Basic Research Program of China [2014CB138703]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13019]	National Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research was funded by the National Basic Research Program of China ( 2014CB138703) and the Program for Changjiang Scholars and Innovative Research Team in University ( IRT13019).	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Banik M, 2011, GENOME, V54, P471, DOI [10.1139/g11-013, 10.1139/G11-013]; Baux A, 2008, EUR J AGRON, V29, P102, DOI 10.1016/j.eja.2008.04.005; Bilyeu K, 2005, CROP SCI, V45, P1830, DOI 10.2135/cropsci2004.0632; Bilyeu K, 2006, CROP SCI, V46, P1913, DOI 10.2135/cropsci2005.11-0426; Boerma H. R., 2004, SOYBEANS IMPROVEMENT; Cao SJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-5; Chapman MA, 2012, THEOR APPL GENET, V125, P897, DOI 10.1007/s00122-012-1881-z; CHERIAN G, 1991, POULTRY SCI, V70, P917, DOI 10.3382/ps.0700917; Chi XY, 2011, PLANT CELL REP, V30, P1393, DOI 10.1007/s00299-011-1048-4; Chi XY, 2011, PLANT MOL BIOL REP, V29, P769, DOI 10.1007/s11105-010-0284-z; Crumb D. J., 2011, International Journal of Applied Research in Natural Products, V4, P12; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Dilzer Allison, 2012, Crit Rev Food Sci Nutr, V52, P488, DOI 10.1080/10408398.2010.501409; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; EMKEN EA, 1994, BBA-LIPID LIPID MET, V1213, P277, DOI 10.1016/0005-2760(94)00054-9; Evers D, 2012, PLANT MOL BIOL, V78, P503, DOI 10.1007/s11103-012-9879-0; FALCONE DL, 1994, PLANT PHYSIOL, V106, P1453, DOI 10.1104/pp.106.4.1453; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Gaude N, 2004, J BIOL CHEM, V279, P34624, DOI 10.1074/jbc.M404098200; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan LL, 2014, GENET MOL RES, V13, P6623, DOI [10.4238/2014.August.28.7, 10.4238/2014]; Gutterman Y, 2002, ISR J PLANT SCI, V50, P165, DOI 10.1560/CD1L-0NCF-G2JC-1MHV; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Horiguchi G, 1996, PHYSIOL PLANTARUM, V96, P275, DOI 10.1111/j.1399-3054.1996.tb00214.x; HOWARTH CJ, 1993, NEW PHYTOL, V125, P1, DOI 10.1111/j.1469-8137.1993.tb03862.x; HUGLY S, 1992, PLANT PHYSIOL, V99, P197, DOI 10.1104/pp.99.1.197; Jia JF, 1995, ACTA BOT BOREALI-OCC, V15, P100; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Jung S, 2000, MOL GEN GENET, V263, P796, DOI 10.1007/s004380000244; Kadota Y, 2012, BBA-MOL CELL RES, V1823, P689, DOI 10.1016/j.bbamcr.2011.09.016; Kanauchi O, 2013, SCAND J GASTROENTERO, V48, P387, DOI 10.3109/00365521.2012.741617; Khadake RM, 2009, MOL BIOTECHNOL, V42, P168, DOI 10.1007/s12033-009-9150-3; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Kim JY, 2010, J EXP BOT, V61, P2317, DOI 10.1093/jxb/erq058; KODAMA H, 1994, PLANT PHYSIOL, V105, P601, DOI 10.1104/pp.105.2.601; KODAMA H, 1995, PLANT PHYSIOL, V107, P1177, DOI 10.1104/pp.107.4.1177; Krasowska A, 2007, J AM OIL CHEM SOC, V84, P809, DOI 10.1007/s11746-007-1106-9; La Porta N, 2015, MOL BIOTECHNOL, V57, P407, DOI 10.1007/s12033-014-9833-2; Lehnen TE, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0097-4; Li-Beisson Y, 2010, ARABIDOPSIS BOOK, V11, pe0133; Liu DL, 2006, PLANT PHYSIOL BIOCH, V44, P380, DOI 10.1016/j.plaphy.2006.06.011; Liu MQ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-88; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Liu Q, 2001, AM J BOT, V88, P92, DOI 10.2307/2657130; Lu Q, 2012, DESERT PLANTS IN CHI; Lukonge E, 2007, J SCI FOOD AGR, V87, P340, DOI 10.1002/jsfa.2731; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; Matsuda O, 2001, PLANTA, V213, P833, DOI 10.1007/s004250100575; McNeely JA, 2003, J ARID ENVIRON, V54, P61, DOI 10.1006/jare.2001.0890; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miao XiuMei, 2015, Acta Prataculturae Sinica, V24, P55; Milioni D, 1997, PLANT MOL BIOL, V35, P955, DOI 10.1023/A:1005874521528; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; MIQUEL M, 1993, P NATL ACAD SCI USA, V90, P6208, DOI 10.1073/pnas.90.13.6208; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Nishizawa-Yokoi A, 2010, PLANT CELL PHYSIOL, V51, P486, DOI 10.1093/pcp/pcq015; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Palmquist Donald L, 2005, Adv Food Nutr Res, V50, P179, DOI 10.1016/S1043-4526(05)50006-8; PAREEK A, 1995, PLANT MOL BIOL, V29, P293, DOI 10.1007/BF00043653; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham AT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-195; Pirtle IL, 2001, BBA-GENE STRUCT EXPR, V1522, P122, DOI 10.1016/S0167-4781(01)00312-8; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Priyanka B, 2010, PLANT BIOTECHNOL J, V8, P76, DOI 10.1111/j.1467-7652.2009.00467.x; Puttick D, 2009, LIPIDS, V44, P753, DOI 10.1007/s11745-009-3315-5; Qin LX, 2013, ACTA PHYSIOL PLANT, V35, P1531, DOI 10.1007/s11738-012-1194-5; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Reddy PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089125; Riserus U, 2001, INT J OBESITY, V25, P1129, DOI 10.1038/sj.ijo.0801659; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Rocco M, 2013, MOL BIOSYST, V9, P1257, DOI 10.1039/c3mb70137a; Rodriguez-Vargas S, 2007, APPL ENVIRON MICROB, V73, P110, DOI 10.1128/AEM.01360-06; Roman O, 2013, LWT-FOOD SCI TECHNOL, V52, P49, DOI 10.1016/j.lwt.2012.12.011; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sabudak T, 2007, CHEM NAT COMPD+, V43, P465, DOI 10.1007/s10600-007-0163-5; Sabzalian MR, 2008, J AM OIL CHEM SOC, V85, P717, DOI 10.1007/s11746-008-1254-6; Saidi Y, 2011, NEW PHYTOL, V190, P556, DOI 10.1111/j.1469-8137.2010.03571.x; Sakamoto H, 2000, GENE, V248, P23, DOI 10.1016/S0378-1119(00)00133-5; Sanchez-Garcia A, 2004, EUR J LIPID SCI TECH, V106, P583, DOI 10.1002/ejlt.200401005; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schlueter JA, 2007, CROP SCI, V47, pS14, DOI 10.2135/cropsci2006.06.0382tpg; Sewelam N, 2014, PLANT CELL ENVIRON, V37, P2024, DOI 10.1111/pce.12274; Shahzad MM, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-683; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; SMART CC, 1993, PLANT J, V4, P279, DOI 10.1046/j.1365-313X.1993.04020279.x; Soetaert SSA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-220; Song HX, 1996, J NW U LIGHT IND, V14, P92; State Forestry Administration, 2011, B STATUS QUO DESERTI; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Tan JL, 2013, PHYSIOL PLANTARUM, V149, P310, DOI 10.1111/ppl.12032; Tao W, 2014, INT SOIL WATER CONSE, V2, P34, DOI 10.1016/S2095-6339(15)30056-3; Thouvenot L, 2015, J PLANT PHYSIOL, V175, P113, DOI 10.1016/j.jplph.2014.11.007; Timpson LM, 2013, APPL MICROBIOL BIOT, V97, P195, DOI 10.1007/s00253-012-4074-4; Valdes AE, 2012, PLANT MOL BIOL, V80, P405, DOI 10.1007/s11103-012-9956-4; Velasco L, 1998, EUPHYTICA, V101, P221, DOI 10.1023/A:1018358707847; Venegas-Caleron M, 2006, PLANT PHYSIOL BIOCH, V44, P517, DOI 10.1016/j.plaphy.2006.09.005; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Vrinten P, 2005, PLANT PHYSIOL, V139, P79, DOI 10.1104/pp.105.064451; Wang YL, 2009, MICROB PATHOGENESIS, V47, P78, DOI 10.1016/j.micpath.2009.04.013; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Williams JP, 1997, PHYSIOLOGY BIOCHEMIS; Xiao H, 2009, PLANT J, V59, P789, DOI 10.1111/j.1365-313X.2009.03913.x; Xing XH, 2009, J ETHNOPHARMACOL, V125, P410, DOI 10.1016/j.jep.2009.07.021; Xu D, 2011, PLANTA, V234, P565, DOI 10.1007/s00425-011-1425-9; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; YADAV NS, 1993, PLANT PHYSIOL, V103, P467, DOI 10.1104/pp.103.2.467; Yamada K, 2007, J BIOL CHEM, V282, P37794, DOI 10.1074/jbc.M707168200; Yang QY, 2012, THEOR APPL GENET, V125, P715, DOI 10.1007/s00122-012-1863-1; [杨廷雪 Yang Tingxue], 2014, [生命科学, Chinese Bulletin of Life Sciences], V26, P440; Yang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034597; Yang XJ, 2010, PLANT PHYSIOL BIOCH, V48, P131, DOI 10.1016/j.plaphy.2009.12.006; Yates SA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-2; You F. M., 2014, Journal of Proteomics and Bioinformatics, V7, P310; Yurchenko OP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0312-5; Zhang DY, 2009, PLANT PHYSIOL BIOCH, V47, P462, DOI 10.1016/j.plaphy.2008.12.024; Zhang H, 2012, J INTEGR PLANT BIOL, V54, P500, DOI 10.1111/j.1744-7909.2012.01135.x; Zhang J, 2012, J PET EXPLOR PROD TE, V2, P7, DOI 10.1007/s13202-011-0016-4; Zhang JT, 2009, BIOCHEM BIOPH RES CO, V390, P469, DOI 10.1016/j.bbrc.2009.09.095; Zhang XH, 2011, PLANT CELL TISS ORG, V107, P1, DOI 10.1007/s11240-011-9950-6; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhao PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-872; Zhou R, 2015, ACTA ECOL SIN, V2, P015; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266; Zhou ZJ, 2013, NEW PHYTOL, V198, P699, DOI 10.1111/nph.12211; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	138	12	13	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154300	10.1371/journal.pone.0154300	http://dx.doi.org/10.1371/journal.pone.0154300			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115614	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600057
J	Jones, C; Sadarangani, M; Lewis, S; Payne, I; Saleem, M; Derrick, JP; Pollard, AJ				Jones, Claire; Sadarangani, Manish; Lewis, Susan; Payne, Isabelle; Saleem, Muhammad; Derrick, Jeremy P.; Pollard, Andrew J.			Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4(+) T Cells	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; NEISSERIA-MENINGITIDIS; VACCINE; SEROGROUP; RESPONSES; SEQUENCE; DISEASE; CEACAM1; STRAIN; PROLIFERATION	Opa proteins are major surface-expressed proteins located in the Neisseria meningitidis outer membrane, and are potential meningococcal vaccine candidates. Although Opa proteins elicit high levels of bactericidal antibodies following immunisation in mice, progress towards human clinical trials has been delayed due to previous findings that Opa inhibits T cell proliferation in some in vitro assays. However, results from previous studies are conflicting, with different Opa preparations and culture conditions being used. We investigated the effects of various Opa+ and Opa- antigens from N. meningitidis strain H44/76 in a range of in vitro conditions using peripheral blood mononuclear cells (PBMCs) and purified CD4(+) T cells, measuring T cell proliferation by CFSE dilution using flow cytometry. Wild type recombinant and liposomal Opa proteins inhibited CD4(+) T cell proliferation after stimulation with IL-2, anti-CD3 and anti-CD28, and these effects were reduced by mutation of the CEA-CAM1-binding region of Opa. These effects were not observed in culture with ex vivo PBMCs. Opa+ and Opa- OMVs did not consistently exert a stimulatory or inhibitory effect across different culture conditions. These data do not support a hypothesis that Opa proteins would be inhibitory to T cells if given as a vaccine component, and T cell immune responses to OMV vaccines are unlikely to be significantly affected by the presence of Opa proteins.	[Jones, Claire; Sadarangani, Manish; Lewis, Susan; Payne, Isabelle; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Jones, Claire; Sadarangani, Manish; Lewis, Susan; Payne, Isabelle; Pollard, Andrew J.] Oxford Univ Hosp NHS Trust, NIHR Biomed Res Ctr, Oxford, England; [Saleem, Muhammad; Derrick, Jeremy P.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Manchester	Sadarangani, M (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.; Sadarangani, M (corresponding author), Oxford Univ Hosp NHS Trust, NIHR Biomed Res Ctr, Oxford, England.	manish.sadarangani@paediatrics.ox.ac.uk	Sadarangani, Manish/V-5609-2019; Saleem, Muhammad/W-4014-2017	Saleem, Muhammad/0000-0002-0994-9701; Derrick, Jeremy/0000-0002-4350-5354; Sadarangani, Manish/0000-0002-9985-6452	Action Medical Research through a Research Training Fellowship [RTF1263]; Meningitis UK; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's National Institute of Health Research Biomedical Research Centres funding scheme	Action Medical Research through a Research Training Fellowship; Meningitis UK; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's National Institute of Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR))	This study was funded by Action Medical Research through a Research Training Fellowship awarded to MSad (RTF1263) and Meningitis UK through a project grant awarded to AJP and supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health's National Institute of Health Research Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Arigita C, 2003, VACCINE, V21, P950, DOI 10.1016/S0264-410X(02)00546-7; Baethgen LF, 2008, TROP MED INT HEALTH, V13, P31, DOI 10.1111/j.1365-3156.2007.01970.x; Baker M G, 2001, J Paediatr Child Health, V37, pS13, DOI 10.1046/j.1440-1754.2001.00722.x; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Borrow R, 2001, METH MOLEC MED, V66, P289, DOI 10.1385/1-59259-148-5:289; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Callaghan MJ, 2011, INFECT IMMUN, V79, P2810, DOI 10.1128/IAI.01338-10; CHILSON OP, 1989, EUR J IMMUNOL, V19, P389, DOI 10.1002/eji.1830190225; de Jonge MI, 2003, MOL MICROBIOL, V50, P1005, DOI 10.1046/j.1365-2958.2003.03749.x; DEMORAES JC, 1992, LANCET, V340, P1074; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Gray-Owen SD, 2003, SCAND J INFECT DIS, V35, P614, DOI 10.1080/00365540310016042; Hedges SR, 1999, INFECT IMMUN, V67, P3937, DOI 10.1128/IAI.67.8.3937-3946.1999; KAY JE, 1991, IMMUNOL LETT, V29, P51, DOI 10.1016/0165-2478(91)90198-J; Kennell Amy S M, 2014, BMC Res Notes, V7, P662, DOI 10.1186/1756-0500-7-662; Lee HSW, 2007, INFECT IMMUN, V75, P4449, DOI 10.1128/IAI.00222-07; Lyons AB, 2001, METHOD CELL BIOL, V63, P375; NORONHA CP, 1995, INT J EPIDEMIOL, V24, P1050, DOI 10.1093/ije/24.5.1050; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; PLEBANSKI M, 1994, J IMMUNOL METHODS, V170, P15, DOI 10.1016/0022-1759(94)90241-0; Pollard AJ, 1999, INFECT IMMUN, V67, P2452, DOI 10.1128/IAI.67.5.2452-2463.1999; Ramsay M, 2007, INVASIVE NEISSERIA M; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Sadarangani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051045; Sadarangani M, 2011, FEMS MICROBIOL REV, V35, P498, DOI 10.1111/j.1574-6976.2010.00260.x; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x; WHO, 1998, CONTR EP MEN DIS WHO, V2nd ed.; Wiertz EJHJ, 1996, INFECT IMMUN, V64, P298, DOI 10.1128/IAI.64.1.298-304.1996; WIERTZ EJHJ, 1991, J IMMUNOL, V147, P2012; Youssef AR, 2009, INFECT IMMUN, V77, P5170, DOI 10.1128/IAI.00355-09; Zariri A, 2013, VACCINE, V31, P5585, DOI 10.1016/j.vaccine.2013.07.069	36	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154153	10.1371/journal.pone.0154153	http://dx.doi.org/10.1371/journal.pone.0154153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111850	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600037
J	Kobayashi, T; Ito, S; Kobayashi, D; Shimada, A; Narita, I; Murasawa, A; Nakazono, K; Yoshie, H				Kobayashi, Tetsuo; Ito, Satoshi; Kobayashi, Daisuke; Shimada, Atsushi; Narita, Ichiei; Murasawa, Akira; Nakazono, Kiyoshi; Yoshie, Hiromasa			Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis	PLOS ONE			English	Article							SEDIMENTATION-RATE; ANTI-TNF; PERIODONTITIS; ASSOCIATION; GENES; ALPHA; POLYMORPHISMS; PREDICTORS; RECEPTORS; CYTOKINE	Objectives To determine whether serum immunity to Porphyromonas gingivalis peptidylarginine deiminase (PPAD) affects the clinical response to biological disease-modifying antirheumatic drug (bDMARD) in patients with rheumatoid arthritis (RA). Methods In a retrospective study, rheumatologic and periodontal conditions of 60 patients with RA who had been treated with conventional synthetic DMARD were evaluated before (baseline) and after 3 and 6 months of bDMARD therapy. After serum levels of anti-PPAD immunoglobulin G (IgG) were determined at baseline, the patients were respectively divided into two groups for high and low anti-PPAD IgG titers according to the median measurements. Genotypes at 8 functional single nucleotide polymorphisms (SNPs) related to RA were also determined. Results After 3 and 6 months of therapy, patients with low anti-PPAD IgG titers showed a significantly greater decrease in changes in the Disease Activity Score including 28 joints using C-reactive protein (DAS28-CRP) (P = 0.04 for both) and anti-cyclic citrullinated peptide (CCP) IgG levels (P = 0.03 and P = 0.04) than patients with high anti-PPAD IgG titers, although these parameter values were comparable at baseline. The anti-PPAD IgG titers were significantly positively correlated with changes in the DAS28-CRP (P = 0.01 for both) and the anti-CCP IgG levels (P = 0.02 for both) from baseline to 3 and 6 months later. A multiple regression analysis revealed a significantly positive association between the anti-PPAD IgG titers and changes in the DAS28-CRP after 6 months of bDMARD therapy (P = 0.006), after adjusting for age, gender, smoking, periodontal condition, and RA-related SNPs. Conclusion The serum IgG levels to PPAD affect the clinical response to bDMARD in patients with RA.	[Kobayashi, Tetsuo] Niigata Univ, Gen Dent & Clin Educ Unit, Med & Dent Hosp, Niigata, Japan; [Kobayashi, Tetsuo; Shimada, Atsushi; Yoshie, Hiromasa] Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Dept Oral Biol Sci, Niigata, Japan; [Ito, Satoshi; Kobayashi, Daisuke; Murasawa, Akira; Nakazono, Kiyoshi] Niigata Rheumat Ctr, Dept Rheumatol, Shibata, Japan; [Kobayashi, Daisuke; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Dept Homeostat Regulat Dev, Niigata, Japan	Niigata University; Niigata University; Niigata University	Kobayashi, T (corresponding author), Niigata Univ, Gen Dent & Clin Educ Unit, Med & Dent Hosp, Niigata, Japan.; Kobayashi, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Dept Oral Biol Sci, Niigata, Japan.	kotetsuo@dent.niigata-u.ac.jp	Narita, Ichiei/G-5204-2017; Ito, Satoshi/AAL-9615-2020	Narita, Ichiei/0000-0001-7692-3096; 	Japan Society for the Promotion of Science KAKENHI [24659922, 26463130]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science KAKENHI 24659922 and 26463130. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Bello-Gualtero JM, 2016, J PERIODONTOL, V87, P346, DOI 10.1902/jop.2015.150455; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; de Smit M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4061; Gully N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100838; Gumus P, 2014, J PERIODONTOL, V85, P270, DOI 10.1902/jop.2013.130117; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Han JY, 2012, J PERIODONTAL IMPLAN, V42, P3, DOI 10.5051/jpis.2012.42.1.3; Ikari K, 2005, ARTHRITIS RHEUM, V52, P3054, DOI 10.1002/art.21309; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Klaasen R, 2011, RHEUMATOLOGY, V50, P1487, DOI 10.1093/rheumatology/ker010; Kobayashi Tetsuo, 2015, Curr Oral Health Rep, V2, P1; Kobayashi T, 2010, J PERIODONTOL, V81, P650, DOI 10.1902/jop.2010.090688; Konig MF, 2015, ANN RHEUM DIS, V74, P2054, DOI 10.1136/annrheumdis-2014-205385; Konig MF, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2014-206681; Lappin DF, 2013, J CLIN PERIODONTOL, V40, P907, DOI 10.1111/jcpe.12138; Leech MT, 2015, BEST PRACT RES CL RH, V29, P189, DOI 10.1016/j.berh.2015.03.001; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Maresz KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003627; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mikuls TR, 2014, ARTHRITIS RHEUMATOL, V66, P1090, DOI 10.1002/art.38348; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; Narvaez J, 2016, SEMIN ARTHRITIS RHEU, V45, P386, DOI 10.1016/j.semarthrit.2015.07.001; Nomura S, 2007, J BIOCHEM BIOPH METH, V70, P787, DOI 10.1016/j.jbbm.2007.05.012; O'Rielly DD, 2010, PHARMACOGEN PERS MED, V3, P15; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Payne Jeffrey B, 2015, Curr Oral Health Rep, V2, P20; Pers YM, 2014, RHEUMATOLOGY, V53, P76, DOI 10.1093/rheumatology/ket301; Pocock JM, 2008, RHEUMATOLOGY, V47, P1073, DOI 10.1093/rheumatology/ken204; Potter C, 2009, ANN RHEUM DIS, V68, P69, DOI 10.1136/ard.2007.084715; Pussinen PJ, 2011, J CLIN PERIODONTOL, V38, P405, DOI 10.1111/j.1600-051X.2011.01703.x; Quirke AM, 2014, ANN RHEUM DIS, V73, P263, DOI 10.1136/annrheumdis-2012-202726; Rodriguez-Rodriguez L, 2011, ARTHRITIS RHEUM-US, V63, P365, DOI 10.1002/art.30145; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schoels MM, 2013, ANN RHEUM DIS, V72, P583, DOI 10.1136/annrheumdis-2012-202470; Shidara K, 2011, RHEUMATOL INT, V31, P617, DOI 10.1007/s00296-009-1336-2; Shimada A, 2016, J PERIODONTAL RES, V51, P103, DOI 10.1111/jre.12288; Swierkot J, 2015, JOINT BONE SPINE, V82, P94, DOI 10.1016/j.jbspin.2014.08.006; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; You CG, 2013, CYTOKINE, V61, P133, DOI 10.1016/j.cyto.2012.09.007	45	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154182	10.1371/journal.pone.0154182	http://dx.doi.org/10.1371/journal.pone.0154182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111223	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600042
J	Lenhard, T; Ott, D; Jakob, NJ; Pham, M; Baumer, P; Martinez-Torres, F; Meyding-Lamade, U				Lenhard, Thorsten; Ott, Daniela; Jakob, Nurith J.; Pham, Mirko; Baeumer, Philipp; Martinez-Torres, Francisco; Meyding-Lamade, Uta			Predictors, Neuroimaging Characteristics and Long-Term Outcome of Severe European Tick-Borne Encephalitis: A Prospective Cohort Study	PLOS ONE			English	Article							VIRUS-INFECTION; CLINICAL-COURSE; EPIDEMIOLOGY; GERMANY; DISEASE; SWEDEN; RISK; MRI	Background and Objectives Tick-borne encephalitis (TBE) still represents a considerable medical and health economic problem in Europe and entails a potential threat to travellers. The aim of this study was to characterise the conditions of severe TBE by precisely recording its clinical variants, the related neuroimaging features, and the variant-specific long-term outcome and by identifying predictors for severe courses. Methods A cohort of 111 TBE patients (median age 51, range 17-75 years; 42% females) was analysed prospectively. Data were acquired from the department of neurology, University Hospital Heidelberg, and the infectious diseases registry of the Robert-Koch institute Berlin. Neurological status was ascertained by protocol at admission and discharge and the degree of disability was scored using the modified RANKIN Scale (mRS; clinical score addressing neurological disability, range from 0, healthy to 6, dead) at admission and at follow-up. Follow-up examination was conducted by means of a telephone interview. To identify independent predictors for severe TBE and functional outcome, modelled logistic regression was performed. MRI changes were correlated with infection variants. To assess alpha-motor neuron injury patterns, we used high-resolution magnetic resonance neurography (hrMRN). Analyses were performed at the Department of Neurology, University Hospital, University of Heidelberg from April 2004 through September 2014 Results Acute course: 3.6% of patients died during the acute infection. All patients with a lethal course suffered from meningoencephaloradiculitis (MER, 14.4% of the cohort), which is associated with a significantly higher risk of requiring intensive care (p = 0.004) and mechanical ventilation (p< 0.001) than menigoencephalitis (ME, 27.9% of the cohort). At admission, both MER and ME groups were severely affected, with the MER group having a statistically higher mRS score (median of 5 in the MER groups versus 4 in the ME group; p< 0.001). Long-term outcome: outcome for MER was considerably worse (median mRS = 4) than for ME (mRS = 1, p< 0.0001) and meningitis (mRS = 0, 57.7% of the cohort). Risk factors: advanced age (p< 0.001) and male gender (p = 0.043) are independent risk factors for a severe infection course. Furthermore, we identified pre-existing diabetes mellitus (p = 0.024) as an independent risk factor for MER. In MER, alpha-motor neuron injury accounts for the poor prognosis confirmed by hrMRN. Conclusion and Relevance These data provide critical information for neurologists and other health professionals to use in evaluating TBEV patients who live in or travel to endemic areas. This information can be used to classify clinical presentation and estimate infection-associated complications and individual prognosis. Furthermore, the risk for severe, disabling infections in older patients should prompt general practitioners to recommend and encourage vaccination to those patients living in or travelling to endemic areas.	[Lenhard, Thorsten; Ott, Daniela; Jakob, Nurith J.; Martinez-Torres, Francisco] Univ Heidelberg Hosp, Dept Neurol, Neuroinfectious Dis Grp, Heidelberg, Germany; [Pham, Mirko; Baeumer, Philipp] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany; [Meyding-Lamade, Uta] Krankenhaus Nordwest Frankfurt, Dept Neurol, Frankfurt, Germany; [Jakob, Nurith J.] Psychiat Klin Sanat Kilchberg, Zurich, Switzerland; [Martinez-Torres, Francisco] Merz Pharmaceut GmbH, Frankfurt, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Krankenhaus Nordwest; Merz Pharmaceuticals GmbH	Lenhard, T (corresponding author), Univ Heidelberg Hosp, Dept Neurol, Neuroinfectious Dis Grp, Heidelberg, Germany.	thorsten.lenhard@med.uni-heidelberg.de	Pham, Mirko/AAI-8713-2020					Alkadhi H, 2000, NEURORADIOLOGY, V42, P753, DOI 10.1007/s002340000396; Antonelli A, 2005, DIABETES CARE, V28, P2548, DOI 10.2337/diacare.28.10.2548; Bender A, 2005, J NEUROL NEUROSUR PS, V76, P135, DOI 10.1136/jnnp.2004.040469; Bruno A, 2010, STROKE, V41, P1048, DOI 10.1161/STROKEAHA.109.571562; Czupryna P, 2011, EUR J NEUROL, V18, P673, DOI 10.1111/j.1468-1331.2010.03278.x; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Donoso Mantke O, 2011, EURO SURVEILL, V16; Gan YH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003794; Grossman RI, 2010, TECHNIQUES NEUROIMAG, P1; Gunther G, 1997, J NEUROL, V244, P230, DOI 10.1007/s004150050077; Haglund M, 2003, J MED VIROL, V71, P610, DOI 10.1002/jmv.10497; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; Hellenbrand W, 2013, EPIDEMIOLOGISCHES B, V18, P151; Jadoon NA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-304; Jellinger K, 1981, TICK BORNE ENCEPHALI, P59; Kaiser R, 1996, INFECTION, V24, P398, DOI 10.1007/BF01716094; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Kaiser R, 2012, WIEN MED WOCHENSCHR, V162, P239, DOI 10.1007/s10354-012-0105-0; Karelis G, 2012, EUR J NEUROL, V19, P62, DOI 10.1111/j.1468-1331.2011.03434.x; Kovalev SY, 2009, J GEN VIROL, V90, P2884, DOI 10.1099/vir.0.012419-0; Kupca AM, 2010, TICKS TICK-BORNE DIS, V1, P44, DOI 10.1016/j.ttbdis.2009.11.002; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Marjelund S, 2004, ACTA RADIOL, V45, P88, DOI 10.1080/02841850410003356; Mickiene A, 2002, CLIN INFECT DIS, V35, P650, DOI 10.1086/342059; Montgomery RR, 2015, EXPERT REV ANTI-INFE, V13, P317, DOI 10.1586/14787210.2015.1007043; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069; Pham M, 2014, NEUROLOGY, V82, P598, DOI 10.1212/WNL.0000000000000128; Pham M, 2011, DIABETES CARE, V34, P721, DOI 10.2337/dc10-1491; Schmutzhard E, 2001, J NEUROL, V248, P469, DOI 10.1007/s004150170155; Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; Stahl JP, 2011, MED MALADIES INFECT, V41, P453, DOI 10.1016/j.medmal.2011.05.015; Suss J, 2010, TICKS TICK-BORNE DIS, DOI [DOI 10.1016/J.TTBDIS.2010.10.007, 10.1016/j.ttbdis.2010.10.007]; Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013	35	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154143	10.1371/journal.pone.0154143	http://dx.doi.org/10.1371/journal.pone.0154143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111657	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600035
J	Panesar, P; Jones, A; Aldous, A; Kranzer, K; Halpin, E; Fifer, H; Macrae, B; Curtis, C; Pollara, G				Panesar, Preet; Jones, Alisdair; Aldous, Alicia; Kranzer, Katharina; Halpin, Eamus; Fifer, Helen; Macrae, Bruce; Curtis, Carmel; Pollara, Gabriele			Attitudes and Behaviours to Antimicrobial Prescribing following Introduction of a Smartphone App	PLOS ONE			English	Article							HOSPITALS; COHORT; CARE	Objectives Our hospital replaced the format for delivering portable antimicrobial prescribing guidance from a paper-based pocket guide to a smartphone application (app). We used this opportunity to assess the relationship between its use and the attitudes and behaviours of antimicrobial prescribers. Methods We used 2 structured cross-sectional questionnaires issued just prior to and 3 months following the launch of the smartphone app. Ordinal Likert scale responses to both frequencies of use and agreement statements permitted quantitative assessment of the relationship between variables. Results The smartphone app was used more frequently than the pocket guide it replaced (p < 0.01), and its increased use was associated with sentiments that the app was useful, easy to navigate and its content relevant. Users who used the app more frequently were more likely to agree that the app encouraged them to challenge inappropriate prescribing by their colleagues (p = 0.001) and were more aware of the importance of antimicrobial stewardship (p = 0.005). Reduced use of the app was associated with agreement that senior physicians' preferences for antimicrobial prescribing would irrespectively overrule guideline recommendations (p = 0.0002). Conclusions Smartphone apps are an effective and acceptable format to deliver guidance on antimicrobial prescribing. Our findings suggest that they may empower users to challenge incorrect prescribing, breaking well-established behaviours, and thus supporting vital stewardship efforts in an era of increased antimicrobial resistance. Future work will need to focus on the direct impact on drug prescriptions as well as identifying barriers to implementing smartphone apps in other clinical settings.	[Panesar, Preet; Jones, Alisdair; Aldous, Alicia] Univ Coll London Hosp, Dept Pharm, London, England; [Kranzer, Katharina] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Kranzer, Katharina; Fifer, Helen; Macrae, Bruce; Curtis, Carmel; Pollara, Gabriele] Univ Coll London Hosp, Dept Clin Microbiol, London, England; [Halpin, Eamus] Horizon Strateg Partners, Leeds, W Yorkshire, England; [Pollara, Gabriele] UCL, Div Infect & Immun, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Pollara, G (corresponding author), Univ Coll London Hosp, Dept Clin Microbiol, London, England.; Pollara, G (corresponding author), UCL, Div Infect & Immun, London, England.	g.pollara@ucl.ac.uk	Kranzer, Katharina/O-8845-2014	Kranzer, Katharina/0000-0001-5691-7270	Wellcome Trust Postdoctoral Clinical Research Fellowship [WT101766/Z/13/Z]; Horizon Strategic Partners; National Institute for Health Research [ACF-2010-20-001] Funding Source: researchfish	Wellcome Trust Postdoctoral Clinical Research Fellowship; Horizon Strategic Partners; National Institute for Health Research(National Institute for Health Research (NIHR))	GP is recipient of a Wellcome Trust Postdoctoral Clinical Research Fellowship (WT101766/Z/13/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EH is employed by a commercial company (Horizon Strategic Partners). Horizon Strategic Partners provided support in the form of salary for author EH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], JOHNS HOPK ABX GUID; Braykov NP, 2014, LANCET INFECT DIS, V14, P1220, DOI 10.1016/S1473-3099(14)70952-1; Charani E, 2013, CLIN INFECT DIS, V57, P188, DOI 10.1093/cid/cit212; Charani E, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-29; Charani E, 2011, CLIN INFECT DIS, V53, P651, DOI 10.1093/cid/cir445; Charanil E, 2013, J ANTIMICROB CHEMOTH, V68, P960, DOI 10.1093/jac/dks492; Department of Health, 2011, ANT STEW START SMART; Department of Health and Department of Environment Food and Rural Affairs, 2013, UK 5 YEAR ANT RES ST; Horizon Strategic Partners, MICROGUIDE; Koehler N., 2013, J MOBILE TECHNOLOGY, V2, P3, DOI [10.7309/jmtm.76, DOI 10.7309/JMTM.76, 10.7309/jmtm.2.1.2, DOI 10.7309/JMTM.2.1.2]; Payne KFB, 2014, HEALTH INFORM J, V20, P59, DOI 10.1177/1460458213478812; Shaffer VA, 2013, MED DECIS MAKING, V33, P108, DOI 10.1177/0272989X12453501	12	46	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154202	10.1371/journal.pone.0154202	http://dx.doi.org/10.1371/journal.pone.0154202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111775	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000374970600047
J	Argyropoulos, AJ; Robichaud, P; Balimunkwe, RM; Fisher, GJ; Hammerberg, C; Yan, Y; Quan, T				Argyropoulos, Angela J.; Robichaud, Patrick; Balimunkwe, Rebecca Mutesi; Fisher, Gary J.; Hammerberg, Craig; Yan, Yan; Quan, Taihao			Alterations of Dermal Connective Tissue Collagen in Diabetes: Molecular Basis of Aged-Appearing Skin	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-1 EXPRESSION; HUMAN ENDOTHELIAL-CELLS; HIGH GLUCOSE; FOOT ULCERS; EXTRACELLULAR-MATRIX; CANCER PROGRESSION; UP-REGULATION; FIBROBLASTS; FRAGMENTATION; HEALTHY	Alterations of the collagen, the major structural protein in skin, contribute significantly to human skin connective tissue aging. As aged-appearing skin is more common in diabetes, here we investigated the molecular basis of aged-appearing skin in diabetes. Among all known human matrix metalloproteinases (MMPs), diabetic skin shows elevated levels of MMP-1 and MMP-2. Laser capture microdissection (LCM) coupled real-time PCR indicated that elevated MMPs in diabetic skin were primarily expressed in the dermis. Furthermore, diabetic skin shows increased lysyl oxidase (LOX) expression and higher cross-linked collagens. Atomic force microscopy (AFM) further indicated that collagen fibrils were fragmented/disorganized, and key mechanical properties of traction force and tensile strength were increased in diabetic skin, compared to intact/well-organized collagen fibrils in nondiabetic skin. In in vitro tissue culture system, multiple MMPs including MMP-1 and MM-2 were induced by high glucose (25 mM) exposure to isolated primary human skin dermal fibroblasts, the major cells responsible for collagen homeostasis in skin. The elevation of MMPs and LOX over the years is thought to result in the accumulation of fragmented and cross-linked collagen, and thus impairs dermal collagen structural integrity and mechanical properties in diabetes. Our data partially explain why old-looking skin is more common in diabetic patients.	[Argyropoulos, Angela J.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Robichaud, Patrick; Balimunkwe, Rebecca Mutesi; Fisher, Gary J.; Hammerberg, Craig; Quan, Taihao] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; [Yan, Yan] Chinese Acad Med Sci, Dept Dermatol, Plast Surg Hosp, Beijing 100730, Peoples R China; [Yan, Yan] Peking Union Med Coll, Beijing 100021, Peoples R China	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Quan, T (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA.	thquan@umich.edu		Quan, Taihao/0000-0002-0954-5109	National Institute of Health [AG019364]; Milstein Medical Asian American Partnership Foundation; NATIONAL INSTITUTE ON AGING [R01AG019364] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milstein Medical Asian American Partnership Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Health (AG019364 to G. J. Fisher and T. Quan). Y. Yan is supported by Milstein Medical Asian American Partnership Foundation (2015 Fellowship Award in Skin Disease). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Bank RA, 1997, MATRIX BIOL, V16, P233, DOI 10.1016/S0945-053X(97)90012-3; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Boyko EJ, 1996, DIABETIC MED, V13, P967, DOI 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K; Brennan M, 2003, PHOTOCHEM PHOTOBIOL, V78, P43, DOI 10.1562/0031-8655(2003)078<0043:MMITMC>2.0.CO;2; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Death AK, 2003, ATHEROSCLEROSIS, V168, P263, DOI 10.1016/S0021-9150(03)00140-0; Demirseren DD, 2014, AM J CLIN DERMATOL, V15, P65, DOI 10.1007/s40257-013-0048-2; Du XL, 1999, FREE RADICAL BIO MED, V27, P752, DOI 10.1016/S0891-5849(99)00079-9; Duff Michelle, 2015, Clin Diabetes, V33, P40, DOI 10.2337/diaclin.33.1.40; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fisher GJ, 2008, ARCH DERMATOL, V144, P666, DOI 10.1001/archderm.144.5.666; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; FISHER GJ, 1991, J CELL PHYSIOL, V146, P309, DOI 10.1002/jcp.1041460216; Ho FM, 2007, J CELL BIOCHEM, V101, P442, DOI 10.1002/jcb.21192; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kaminska B, 2000, ACTA NEUROBIOL EXP, V60, P395; Knas M, 2013, PHYSIOL RES, V62, P519, DOI 10.33549/physiolres.932534; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Levy L, 2012, J DIABETES, V4, P68, DOI 10.1111/j.1753-0407.2011.00151.x; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Lopez-Lopez N, 2014, ARCH DERMATOL RES, V306, P809, DOI 10.1007/s00403-014-1494-2; Lu KV, 2004, LAB INVEST, V84, P8, DOI 10.1038/labinvest.3700003; Margolis DJ, 2002, DIABETES CARE, V25, P1835, DOI 10.2337/diacare.25.10.1835; McLennan SV, 2000, KIDNEY INT, V58, pS81, DOI 10.1046/j.1523-1755.2000.07713.x; Muller M, 2008, DIABETIC MED, V25, P419, DOI 10.1111/j.1464-5491.2008.02414.x; Nagai T, 2015, J FOOD SCI TECH MYS, V52, P2344, DOI 10.1007/s13197-014-1266-1; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Pedersen G, 2009, CLIN EXP IMMUNOL, V155, P257, DOI 10.1111/j.1365-2249.2008.03836.x; PEREZ MI, 1994, J AM ACAD DERMATOL, V30, P519, DOI 10.1016/S0190-9622(94)70058-3; Qin ZP, 2014, AGING CELL, V13, P1028, DOI 10.1111/acel.12265; Qin ZP, 2014, AGE, V36, P353, DOI 10.1007/s11357-013-9565-4; Qin ZP, 2013, J BIOL CHEM, V288, P12386, DOI 10.1074/jbc.M112.424358; Quan TH, 2015, GERONTOLOGY, V61, P427, DOI 10.1159/000371708; Quan TH, 2013, J INVEST DERMATOL, V133, P1362, DOI 10.1038/jid.2012.509; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Reiber GE, 1996, DIABETIC MED, V13, pS6, DOI 10.1002/dme.1996.13.s1.6; Spencer VA, 2007, ADV CANCER RES, V97, P275, DOI 10.1016/S0065-230X(06)97012-2; Tsai WC, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-255; UITTO J, 1986, DERMATOL CLIN, V4, P433, DOI 10.1016/S0733-8635(18)30806-4; Varani J, 2004, J INVEST DERMATOL, V122, P1471, DOI 10.1111/j.0022-202X.2004.22614.x; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wilmer WA, 1998, KIDNEY INT, V53, P1172, DOI 10.1046/j.1523-1755.1998.00888.x; Xue SN, 2014, WORLD J EMERG MED, V5, P139, DOI [10.5847/wjem.j.1920-8642.2014.02.011, 10.5847/wjem.j.issn.1920-8642.2014.02.011]; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Zeng W, 2011, J DIABETES COMPLICAT, V25, P398, DOI 10.1016/j.jdiacomp.2011.10.002	52	49	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153806	10.1371/journal.pone.0153806	http://dx.doi.org/10.1371/journal.pone.0153806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104752	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100022
J	Liu, ZJ; Daftarian, P; Kovalski, L; Wang, B; Tian, RX; Castilla, DM; Dikici, E; Perez, VL; Deo, S; Daunert, S; Velazquez, OC				Liu, Zhao-Jun; Daftarian, Pirouz; Kovalski, Leticia; Wang, Bo; Tian, Runxia; Castilla, Diego M.; Dikici, Emre; Perez, Victor L.; Deo, Sapna; Daunert, Sylvia; Velazquez, Omaida C.			Directing and Potentiating Stem Cell-Mediated Angiogenesis and Tissue Repair by Cell Surface E-Selectin Coating	PLOS ONE			English	Article							PRIMARY MELANOMA PROGRESSION; GLYCOPROTEIN LIGAND-1; IN-VIVO; ISCHEMIC CARDIOMYOPATHY; BIOMEDICAL APPLICATIONS; PAMAM DENDRIMERS; RANDOMIZED-TRIAL; T-CELLS; DELIVERY; RECRUITMENT	Stem cell therapy has emerged as a promising approach for treatment of a number of diseases, including delayed and non-healing wounds. However, targeted systemic delivery of therapeutic cells to the dysfunctional tissues remains one formidable challenge. Herein, we present a targeted nanocarrier-mediated cell delivery method by coating the surface of the cell to be delivered with dendrimer nanocarriers modified with adhesion molecules. Infused nanocarrier-coated cells reach to destination via recognition and association with the counterpart adhesion molecules highly or selectively expressed on the activated endothelium in diseased tissues. Once anchored on the activated endothelium, nanocarriers-coated transporting cells undergo transendothelial migration, extravasation and homing to the targeted tissues to execute their therapeutic role. We now demonstrate feasibility, efficacy and safety of our targeted nanocarrier for delivery of bone marrow cells (BMC) to cutaneous wound tissues and grafted corneas and its advantages over conventional BMC transplantation in mouse models for wound healing and neovascularization. This versatile platform is suited for targeted systemic delivery of virtually any type of therapeutic cell.	[Liu, Zhao-Jun; Wang, Bo; Tian, Runxia; Castilla, Diego M.; Velazquez, Omaida C.] Univ Miami, Sch Med, Dept Surg, Coral Gables, FL 33136 USA; [Daftarian, Pirouz; Kovalski, Leticia; Dikici, Emre; Deo, Sapna; Daunert, Sylvia; Velazquez, Omaida C.] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Coral Gables, FL 33136 USA; [Daftarian, Pirouz; Deo, Sapna; Daunert, Sylvia] Univ Miami, Dr JT Macdonald Biomed Nanotechnol Inst, Coral Gables, FL 33136 USA; [Perez, Victor L.] Univ Miami, Bascom Palmer Eye Inst, Dept Ophthalmol, Coral Gables, FL 33136 USA	University of Miami; University of Miami; University of Miami; Bascom Palmer Eye Institute; University of Miami	Velazquez, OC (corresponding author), Univ Miami, Sch Med, Dept Surg, Coral Gables, FL 33136 USA.; Daunert, S; Velazquez, OC (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, Coral Gables, FL 33136 USA.; Daunert, S (corresponding author), Univ Miami, Dr JT Macdonald Biomed Nanotechnol Inst, Coral Gables, FL 33136 USA.	sdaunert@med.miami.edu; ovelazquez@med.miami.edu			National Institutes of Health [R01DK-071084, R01GM081570, R01GM047915]; David Kimmelman Endowed Chair in Vascular Surgery; Lucille P. Markey Chair in Department of Biochemistry and Molecular Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047915, R01GM081570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Kimmelman Endowed Chair in Vascular Surgery; Lucille P. Markey Chair in Department of Biochemistry and Molecular Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01DK-071084 and R01GM081570 to OV and R01GM047915 to SD). OV is grateful for funding from the David Kimmelman Endowed Chair in Vascular Surgery and SD is also grateful for support by the Lucille P. Markey Chair in Department of Biochemistry and Molecular Biology.	Abdulreda MH, 2011, P NATL ACAD SCI USA, V108, P12863, DOI 10.1073/pnas.1105002108; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Blake DA, 2011, JOVE-J VIS EXP, DOI 10.3791/3289; Borges E, 1997, BLOOD, V90, P1934, DOI 10.1182/blood.V90.5.1934; Campbell NG, 2012, J CARDIOVASC TRANSL, V5, P713, DOI 10.1007/s12265-012-9378-3; Daftarian PM, 2013, J INFECT DIS, V208, P1914, DOI 10.1093/infdis/jit378; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Gardikis K, 2012, CURR MED CHEM, V19, P4913; Giel-Moloney M, 2007, GENESIS, V45, P83, DOI 10.1002/dvg.20269; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; He X, 2012, J CONTROL RELEASE, V162, P521, DOI 10.1016/j.jconrel.2012.07.023; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Kato N, 2009, J AM SOC NEPHROL, V20, P1565, DOI 10.1681/ASN.2008090957; Kean TJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/732742; Kolhatkar RB, 2007, BIOCONJUGATE CHEM, V18, P2054, DOI 10.1021/bc0603889; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Liu ZJ, 2011, ANN SURG, V254, P450, DOI 10.1097/SLA.0b013e31822a72dc; Liu ZJ, 2010, ANN SURG, V252, P625, DOI 10.1097/SLA.0b013e3181f5a079; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Martins PD, 2007, ARTERIOSCL THROM VAS, V27, P1023, DOI 10.1161/ATVBAHA.107.140442; Nam HY, 2008, INT J PHARMACEUT, V363, P199, DOI 10.1016/j.ijpharm.2008.07.021; Nam HY, 2009, BIOMATERIALS, V30, P665, DOI 10.1016/j.biomaterials.2008.10.013; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Rivera-Nieves J, 2006, J EXP MED, V203, P907, DOI 10.1084/jem.20052530; Sart S, 2014, BIORESEARCH OPEN ACC, V3, P137, DOI 10.1089/biores.2014.0012; Shao H, 2011, ONCOGENE, V30, P4316, DOI 10.1038/onc.2011.142; Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018; Tan YH, 2012, J IMMUNOL, V188, P5962, DOI 10.4049/jimmunol.1103216; Thatte A, 2002, J LEUKOCYTE BIOL, V72, P470; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Zhu DT, 2013, MOL THER, V21, P1621, DOI 10.1038/mt.2013.123	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154053	10.1371/journal.pone.0154053	http://dx.doi.org/10.1371/journal.pone.0154053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104647	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100040
J	Shoda, H; Adachi, M; Umeda, T				Shoda, Haruka; Adachi, Mayumi; Umeda, Tomohiro			How Live Performance Moves the Human Heart	PLOS ONE			English	Article							CROSS-MODAL INTERACTIONS; RATE-VARIABILITY; MUSIC; PERCEPTION; MOVEMENT; EXPOSURE	We investigated how the audience member's physiological reactions differ as a function of listening context (i.e., live versus recorded music contexts). Thirty-seven audience members were assigned to one of seven pianists' performances and listened to his/her live performances of six pieces (fast and slow pieces by Bach, Schumann, and Debussy). Approximately 10 weeks after the live performance, each of the audience members returned to the same room and listened to the recorded performances of the same pianists' via speakers. We recorded the audience members' electrocardiograms in listening to the performances in both conditions, and analyzed their heart rates and the spectral features of the heart-rate variability (i.e., HF/TF, LF/HF). Results showed that the audience's heart rate was higher for the faster than the slower piece only in the live condition. As compared with the recorded condition, the audience's sympathovagal balance (LF/HF) was less while their vagal nervous system (HF/TF) was activated more in the live condition, which appears to suggest that sharing the ongoing musical moments with the pianist reduces the audience's physiological stress. The results are discussed in terms of the audience's superior attention and temporal entrainment to live performance.	[Shoda, Haruka; Adachi, Mayumi] Hokkaido Univ, Dept Psychol, Sapporo, Hokkaido, Japan; [Umeda, Tomohiro] Nara Med Univ, Kashihara, Nara 634, Japan; [Shoda, Haruka] Ristumeikan Univ, Ristumeikan Global Innovat Res Org, Nojihigashi 1-1-1, Kusastu, Shiga 5258577, Japan	Hokkaido University; Nara Medical University	Shoda, H (corresponding author), Hokkaido Univ, Dept Psychol, Sapporo, Hokkaido, Japan.; Shoda, H (corresponding author), Ristumeikan Univ, Ristumeikan Global Innovat Res Org, Nojihigashi 1-1-1, Kusastu, Shiga 5258577, Japan.	shoda@frontier.hokudai.ac.jp			Japan Society for the Promotion of Science [10J00985]; Grants-in-Aid for Scientific Research [13J03351] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The experiment was conducted as a part of the first author's doctorate study at Hokkaido University, Japan, supported by Grant-in-Aid for JSPS Fellows (10J00985) by Japan Society for the Promotion of Science (https://kaken.nii.ac.jp/d/p/10J00985.en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 1995, COMPUT CARDIOL, P461, DOI 10.1109/CIC.1995.482685; Adachi, 2012, P 12 INT C MUS PERC, P925; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Camm AJ, 1996, CIRCULATION, V93, P1043; Chapados C, 2008, COGNITION, V108, P639, DOI 10.1016/j.cognition.2008.05.008; Davidson JaneW., 1993, PSYCHOL MUSIC, V21, P103, DOI [DOI 10.1177/030573569302100201, 10.1177/030573569302100201]; Ellis RJ, 2015, PHYSIOL MEAS, V36, P1827, DOI 10.1088/0967-3334/36/9/1827; Garunkstiene R, 2014, NORD J MUSIC THER, V23, P71, DOI 10.1080/08098131.2013.809783; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Hodges DA, 2011, HDB MUSIC EMOTION TH, P279; Ito N, 2012, P FALL M JAP SOC MUS, P15; Iwanaga M, 2005, BIOL PSYCHOL, V70, P61, DOI 10.1016/j.biopsycho.2004.11.015; KESELMAN HJ, 1980, PSYCHOPHYSIOLOGY, V17, P499, DOI 10.1111/j.1469-8986.1980.tb00190.x; Koelsch S, 2015, EUR HEART J, V36, P3043, DOI 10.1093/eurheartj/ehv430; KRISTALBONEH E, 1995, SCAND J WORK ENV HEA, V21, P85, DOI 10.5271/sjweh.15; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Larsen PD, 2006, HEART, V92, P433, DOI 10.1136/hrt.2005.071902; Nakahara H, 2009, ANN NY ACAD SCI, V1169, P359, DOI 10.1111/j.1749-6632.2009.04788.x; Ohgushi K, 1996, P 4 INT C MUS PERC C, P269; Peretz I, 1998, MEM COGNITION, V26, P884, DOI 10.3758/BF03201171; Phillips AC, 2006, PSYCHOPHYSIOLOGY, V43, P633, DOI 10.1111/j.1469-8986.2006.00462.x; PORGES SW, 1992, ATTENTION AND INFORMATION PROCESSING IN INFANTS AND ADULTS, P201; Potter R. F., 2012, PSYCHOPHYSIOLOGICAL; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Shoda H, 2010, P 11 INT C MUS PERC, P843; Shoda H, 2012, MUSIC PERCEPT, V29, P237, DOI 10.1525/MP.2012.29.3.237; Vines BW, 2006, COGNITION, V101, P80, DOI 10.1016/j.cognition.2005.09.003; Watanabe T, 1996, RO-MAN '96 - 5TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN COMMUNICATION, PROCEEDINGS, P141, DOI 10.1109/ROMAN.1996.568786; ZANGEMEISTER WH, 1982, EXP NEUROL, V77, P563, DOI 10.1016/0014-4886(82)90228-X	30	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154322	10.1371/journal.pone.0154322	http://dx.doi.org/10.1371/journal.pone.0154322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27104377	gold, Green Submitted, Green Published			2022-12-26	WOS:000374565100066
J	Attayek, PJ; Ahmad, AA; Wang, YL; Williamson, I; Sims, CE; Magness, ST; Allbritton, NL				Attayek, Peter J.; Ahmad, Asad A.; Wang, Yuli; Williamson, Ian; Sims, Christopher E.; Magness, Scott T.; Allbritton, Nancy L.			In Vitro Polarization of Colonoids to Create an Intestinal Stem Cell Compartment	PLOS ONE			English	Article							EXPRESSION PATTERN; SELF-RENEWAL; BETA-CATENIN; WNT; EPITHELIUM; CRYPT; MIGRATION; PLATFORM; CULTURE; NICHE	The polarity of proliferative and differentiated cellular compartments of colonic crypts is believed to be specified by gradients of key mitogens and morphogens. Indirect evidence demonstrates a tight correlation between Wnt-pathway activity and the basal-luminal patterning; however, to date there has been no direct experimental manipulation demonstrating that a chemical gradient of signaling factors can produce similar patterning under controlled conditions. In the current work, colonic organoids (colonoids) derived from cultured, multicellular organoid fragments or single stem cells were exposed in culture to steep linear gradients of two Wnt-signaling ligands, Wnt-3a and R-spondin1. The use of a genetically engineered Sox9-Sox9EGFP:.CAGDsRED reporter gene mouse model and EdU-based labeling enabled crypt patterning to be quantified in the developing colonoids. Colonoids derived from multicellular fragments cultured for 5 days under a Wnt-3a or a combined Wnt-3a and R-spondin1 gradient were highly polarized with proliferative cells localizing to the region of the higher morphogen concentration. In a Wnt-3a gradient, Sox9EGFP polarization was 7.3 times greater than that of colonoids cultured in the absence of a gradient; and the extent of EdU polarization was 2.2 times greater than that in the absence of a gradient. Under a Wnt-3a/R-spondin1 gradient, Sox9EGFP polarization was 8.2 times greater than that of colonoids cultured in the absence of a gradient while the extent of EdU polarization was 10 times greater than that in the absence of a gradient. Colonoids derived from single stem cells cultured in Wnt-3a/R-spondin1 gradients were most highly polarized demonstrated by a Sox9EGFP polarization 20 times that of colonoids grown in the absence of a gradient. This data provides direct evidence that a linear gradient of Wnt signaling factors applied to colonic stem cells is sufficient to direct patterning of the colonoid unit in culture.	[Attayek, Peter J.; Ahmad, Asad A.; Williamson, Ian; Allbritton, Nancy L.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Attayek, Peter J.; Ahmad, Asad A.; Williamson, Ian; Allbritton, Nancy L.] N Carolina State Univ, Raleigh, NC 27695 USA; [Wang, Yuli; Sims, Christopher E.; Allbritton, Nancy L.] Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA; [Magness, Scott T.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Allbritton, NL (corresponding author), Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA.; Allbritton, NL (corresponding author), N Carolina State Univ, Raleigh, NC 27695 USA.; Allbritton, NL (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	nlallbri@unc.edu	Ariel, Pablo/AGJ-4118-2022; Wang, Yuli/C-6297-2011; , Advanced Analytics Core/AAE-5263-2022	Attayek, Peter/0000-0001-7572-6381; Magness, Scott/0000-0002-2746-1224	National Cancer Institute [F31CA183309, CA177993]; National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK34987]; National Institutes Office of the Director [OD0205]; NATIONAL CANCER INSTITUTE [F31CA183309, R01CA177993, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes Office of the Director; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Cancer Institute, Award Numbers: F31CA183309 and CA177993 (http://www.cancer.gov/); National Institute of Diabetes and Digestive and Kidney Diseases, Award Number: P30 DK34987 (http://www.niddk.nih.gov/Pages/default.aspx); and National Institutes Office of the Director, Award Number: OD0205 (http://www.nih.gov/institutes-nih/nih-office-director). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Ahmad AA, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-9; Barker N, 1999, AM J PATHOL, V154, P29, DOI 10.1016/S0002-9440(10)65247-9; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Beta C, 2011, EUR J CELL BIOL, V90, P811, DOI 10.1016/j.ejcb.2011.05.006; BRIGHT DS, 1987, J MICROSC-OXFORD, V146, P191, DOI 10.1111/j.1365-2818.1987.tb01340.x; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Clevers H, 2013, NATURE, V495, P53, DOI 10.1038/nature11958; Crank J., 1979, MATH DIFFUSION; Davies PS, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-57; Du HJ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004285; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Glantz S. A., 2005, PRIMER BIOSTATISTICS; Gracz AD, 2015, NAT CELL BIOL, V17, P340, DOI 10.1038/ncb3104; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Leedham SJ, 2013, GUT, V62, P83, DOI 10.1136/gutjnl-2011-301601; LI CH, 1993, PATTERN RECOGN, V26, P617, DOI 10.1016/0031-3203(93)90115-D; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Miyoshi H, 2013, CELL CYCLE, V12, P387, DOI 10.4161/cc.23552; Pfluger CA, 2013, TISSUE ENG PT A, V19, P649, DOI [10.1089/ten.tea.2012.0153, 10.1089/ten.TEA.2012.0153]; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; Rodriguez LL, 2013, INTEGR BIOL-UK, V5, P1306, DOI 10.1039/c3ib40137e; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007989; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; SCOTT M, 1983, J AM STAT ASSOC, V78, P736, DOI 10.2307/2288155; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shaffiey SA, 2015, REGEN MED; Tehranirokh M, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4826935; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Meer AD, 2012, INTEGR BIOL-UK, V4, P461, DOI 10.1039/c2ib00176d; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; VanDussen KL, 2015, GUT, V64, P911, DOI 10.1136/gutjnl-2013-306651; Wang L, 2010, BIOMATERIALS, V31, P7586, DOI 10.1016/j.biomaterials.2010.06.036; Wang Y, 2013, LAB CHIP, V13, P4625, DOI 10.1039/c3lc50813g; Wrobel MR, 2014, TISSUE ENG PART B-RE, V20, P93, DOI [10.1089/ten.TEB.2013.0233, 10.1089/ten.teb.2013.0233]; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	55	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153795	10.1371/journal.pone.0153795	http://dx.doi.org/10.1371/journal.pone.0153795			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100890	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500068
J	Chen, GW; Ke, ZC; Liang, TF; Liu, L; Wang, G				Chen, Guowei; Ke, Zhengchen; Liang, Tengfang; Liu, Li; Wang, Gang			Shewanella oneidensis MR-1-Induced Fe(III) Reduction Facilitates Roxarsone Transformation	PLOS ONE			English	Article							MICROBIAL REDUCTION; POULTRY LITTER; CHICKEN MANURE; ARSENIC SPECIATION; PROMOTED REDUCTION; REDUCING BACTERIUM; IRON; MR-1; METABOLITES; IRON(III)	Although microbial activity and associated iron (oxy) hydroxides are known in general to affect the environmental dynamics of 4-hydroxy-3-nitrobenzenearsonic acid (roxarsone), the mechanistic understanding of the underlying biophysico-chemical processes remains unclear due to limited experimental information. We studied how Shewanella oneidensis MR-1 - a widely distributed metal-reducing bacterium, in the presence of dissolved Fe(III), affects roxarsone transformations and biogeochemical cycling in a model aqueous system. The results showed that the MR-1 strain was able to anaerobically use roxarsone as a terminal electron acceptor and to convert it to a single product, 3-amino-4-hydroxybenzene arsonic acid (AHBAA). The presence of Fe(III) stimulated roxarsone transformation via MR-1-induced Fe(III) reduction, whereby the resulting Fe(II) acted as an efficient reductant for roxarsone transformation. In addition, the subsequent secondary Fe(III)/Fe(II) mineralization created conditions for adsorption of organoarsenic compounds to the yielded precipitates and thereby led to arsenic immobilization. The study provided direct evidence of Shewanella oneidensis MR-1-induced direct and Fe(II)-associated roxarsone transformation. Quantitative estimations revealed a candidate mechanism for the early-stage environmental dynamics of roxarsone in nature, which is essential for understanding the environmental dynamics of roxarsone and successful risk assessment.	[Chen, Guowei; Ke, Zhengchen; Liang, Tengfang; Liu, Li] Hefei Univ Technol, Sch Civil & Hydraul Engn, Hefei 230009, Peoples R China; [Wang, Gang] China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China	Hefei University of Technology; China Agricultural University	Liu, L (corresponding author), Hefei Univ Technol, Sch Civil & Hydraul Engn, Hefei 230009, Peoples R China.; Wang, G (corresponding author), China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China.	lliu@hfut.edu.cn; gangwang@cau.edu.cn	Chen, Guowei/E-4752-2013; Chen, Guowei/AAW-5419-2020; Wang, Gang/GYJ-1308-2022	Chen, Guowei/0000-0002-3093-9866; Chen, Guowei/0000-0002-3093-9866; Wang, Gang/0000-0002-3201-6950	National Natural Science Foundation of China [41401265, 51479046, 51108148]; Chinese Universities Scientific Fund [2016QC056, 2016ZH001]; Program for Changjiang Scholars and Innovative Research Team in University of P.R. China [IRT0412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund; Program for Changjiang Scholars and Innovative Research Team in University of P.R. China	The authors acknowledge the financial support of the National Natural Science Foundation of China (41401265, 51479046 and 51108148), the Chinese Universities Scientific Fund (2016QC056 and 2016ZH001), and the Program for Changjiang Scholars and Innovative Research Team in University of P.R. China (IRT0412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2003, ENVIRON SCI TECHNOL, V37, P4083, DOI 10.1021/es0340580; Bednar AJ, 2003, SCI TOTAL ENVIRON, V302, P237, DOI 10.1016/S0048-9697(02)00322-4; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Bellows B.C, 2005, ARSENIC POULTRY LITT; Bencheikh-Latmani R, 2005, APPL ENVIRON MICROB, V71, P7453, DOI 10.1128/AEM.71.11.7453-7460.2005; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Campbell KM, 2006, ENVIRON SCI TECHNOL, V40, P5950, DOI 10.1021/es0600476; Chapman HD, 2002, POULTRY SCI, V81, P356, DOI 10.1093/ps/81.3.356; Chen J, 2014, ENVIRON SCI TECHNOL, V48, P1141, DOI 10.1021/es4038319; Chen WR, 2012, J HAZARD MATER, V227, P378, DOI 10.1016/j.jhazmat.2012.05.078; Coker VS, 2006, ENVIRON SCI TECHNOL, V40, P7745, DOI 10.1021/es060990+; Cortinas I, 2006, ENVIRON SCI TECHNOL, V40, P2951, DOI 10.1021/es051981o; Garbarino JR, 2003, ENVIRON SCI TECHNOL, V37, P1509, DOI 10.1021/es026219q; Guo QF, 2013, CHEMOSPHERE, V92, P138, DOI 10.1016/j.chemosphere.2013.02.029; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hohmann C, 2010, ENVIRON SCI TECHNOL, V44, P94, DOI 10.1021/es900708s; Huang LX, 2013, FOOD ADDIT CONTAM A, V30, P1546, DOI 10.1080/19440049.2013.812809; Huang LX, 2014, CHEMOSPHERE, V100, P57, DOI 10.1016/j.chemosphere.2013.12.074; Icopini GA, 2009, APPL ENVIRON MICROB, V75, P3641, DOI 10.1128/AEM.00022-09; Jiang S, 2013, ENVIRON SCI TECHNOL, V47, P8616, DOI 10.1021/es400534z; Jiang Z, 2013, INT BIODETER BIODEGR, V76, P32, DOI 10.1016/j.ibiod.2012.06.010; Kim DH, 2013, ENVIRON SCI TECHNOL, V47, P8709, DOI 10.1021/es401302w; Kocar BD, 2006, ENVIRON SCI TECHNOL, V40, P6715, DOI 10.1021/es061540k; Kwon JH, 2014, MATERIALS, V7, P1880, DOI 10.3390/ma7031880; Lee JH, 2007, GEOMICROBIOL J, V24, P31, DOI 10.1080/01490450601134291; Liang B, 2014, WATER RES, V54, P137, DOI 10.1016/j.watres.2014.01.052; Liang TF, 2014, CHEMOSPHERE, V112, P128, DOI 10.1016/j.chemosphere.2014.03.103; Liu H, 2014, CHEM ENG J, V255, P500, DOI 10.1016/j.cej.2014.06.030; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; Mestrot A, 2013, APPL GEOCHEM, V33, P294, DOI 10.1016/j.apgeochem.2013.02.023; Muehe EM, 2013, ENVIRON SCI TECHNOL, V47, P8297, DOI 10.1021/es400801z; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Ouyang BJ, 2014, GEOCHIM COSMOCHIM AC, V124, P54, DOI 10.1016/j.gca.2013.09.020; Ross DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016649; Stolz JF, 2007, ENVIRON SCI TECHNOL, V41, P818, DOI 10.1021/es061802i; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Tufano KJ, 2008, ENVIRON SCI TECHNOL, V42, P4777, DOI 10.1021/es702625e; Wang YH, 2008, GEOCHIM COSMOCHIM AC, V72, P2573, DOI 10.1016/j.gca.2008.03.011; Wielinga B, 2001, ENVIRON SCI TECHNOL, V35, P522, DOI 10.1021/es001457b; Yao LX, 2013, J AGR FOOD CHEM, V61, P320, DOI 10.1021/jf3045022; Yao LX, 2009, PLANT SOIL, V316, P117, DOI 10.1007/s11104-008-9764-4	41	13	13	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154017	10.1371/journal.pone.0154017	http://dx.doi.org/10.1371/journal.pone.0154017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100323	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500124
J	Morassutto, C; Monasta, L; Ricci, G; Barbone, F; Ronfani, L				Morassutto, Caterina; Monasta, Lorenzo; Ricci, Giuseppe; Barbone, Fabio; Ronfani, Luca			Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study	PLOS ONE			English	Article							DIAGNOSED ENDOMETRIOSIS; PELVIC ENDOMETRIOSIS; ESHRE GUIDELINE; WOMEN; EPIDEMIOLOGY; ULTRASOUND; SYMPTOMS; DISEASE; COHORT; LIFE	Despite being quite frequent and having serious implications in terms of symptomatology and fertility, data on incidence and prevalence of endometriosis and adenomyosis following gold standard definitions are dramatically lacking. The average time from onset of symptoms to diagnosis in industrialized countries still ranges from five to ten years. Using the regional centralized data linkage system, we calculated incidence and prevalence of endometriosis and adenomyosis in the female population of Friuli Venezia Giulia region, Italy, for the years 2011-2013. Cases were defined as new diagnoses from hospital discharge records, following procedures allowing direct visualization for endometriosis and hysterectomy for adenomyosis, with or without histological confirmation. Diagnoses were considered "new" after verifying women had not been diagnosed in the previous ten years. Incidence of endometriosis and adenomyosis in women aged 15-50 years is 0.14%. Prevalence, estimated from incidence, is 2.00%. Adenomyosis, representing 28% of all diagnoses, becomes increasingly prevalent after the age of 50 years. Our results shows how the study of both endometriosis and adenomyosis should not be limited to women of premenopausal age. Further efforts are needed to sensitize women and health professional, and to find new data linkage possibilities to identify undiagnosed cases.	[Morassutto, Caterina; Monasta, Lorenzo; Ronfani, Luca] IRCCS Burlo Garofolo, Clin Epidemiol & Publ Hlth Res Unit, Inst Maternal & Child Hlth, Trieste, Italy; [Ricci, Giuseppe] IRCCS Burlo Garofolo, Dept Obstet & Gynecol, Inst Maternal & Child Hlth, Trieste, Italy; [Ricci, Giuseppe; Barbone, Fabio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Barbone, Fabio] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; University of Trieste; University of Udine	Monasta, L (corresponding author), IRCCS Burlo Garofolo, Clin Epidemiol & Publ Hlth Res Unit, Inst Maternal & Child Hlth, Trieste, Italy.	lorenzo.monasta@burlo.trieste.it	Ronfani, Luca/B-6668-2013; Barbone, Fabio/K-1755-2014; Ricci, Giuseppe/AAC-3332-2022; Monasta, Lorenzo/B-1388-2012	Ronfani, Luca/0000-0001-5710-3914; Barbone, Fabio/0000-0001-8795-9959; Ricci, Giuseppe/0000-0002-8031-1102; Monasta, Lorenzo/0000-0001-7774-548X; Barbone, Fabio/0000-0003-1337-5111	Regional Health Authority of Friuli Venezia Giulia	Regional Health Authority of Friuli Venezia Giulia	This study was supported by a grant from the Regional Health Authority of Friuli Venezia Giulia (Dec. 979/Pren. 16/10/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2012, EUR J OBSTET GYN R B, V160, P79, DOI 10.1016/j.ejogrb.2011.09.041; Acien Pedro, 2013, ISRN Obstet Gynecol, V2013, P242149, DOI 10.1155/2013/242149; Arruda MS, 2003, HUM REPROD, V18, P756, DOI 10.1093/humrep/deg136; Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Benagiano G, 2015, REPROD BIOMED ONLINE, V30, P220, DOI 10.1016/j.rbmo.2014.11.005; Borghese B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/618964; Champaneria R, 2010, ACTA OBSTET GYN SCAN, V89, P1374, DOI 10.3109/00016349.2010.512061; Cockerham AZ, 2012, J MIDWIFERY WOM HEAL, V57, P212, DOI 10.1111/j.1542-2011.2011.00117.x; Draghici IM, 2015, ROM J MORPHOL EMBRYO, V56, P133; Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457; Eggert J, 2008, FERTIL STERIL, V90, P1019, DOI 10.1016/j.fertnstert.2007.07.1345; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Ferrero S, 2010, INT J GYNECOL OBSTET, V110, P203, DOI 10.1016/j.ijgo.2010.03.039; Guo SW, 2006, FERTIL STERIL, V86, P1584, DOI 10.1016/j.fertnstert.2006.04.040; Gylfason JT, 2010, AM J EPIDEMIOL, V172, P237, DOI 10.1093/aje/kwq143; Haas D, 2012, ARCH GYNECOL OBSTET, V286, P667, DOI 10.1007/s00404-012-2361-z; HOUSTON DE, 1987, AM J EPIDEMIOL, V125, P959, DOI 10.1093/oxfordjournals.aje.a114634; Hudelist G, 2012, HUM REPROD, V27, P3412, DOI 10.1093/humrep/des316; Jeon Dong-Su, 2013, J Menopausal Med, V19, P151, DOI 10.6118/jmm.2013.19.3.151; Katz VL, 2012, COMPREHENSIVE GYNECO, P383; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Leibson CL, 2004, FERTIL STERIL, V82, P314, DOI 10.1016/j.fertnstert.2004.01.037; Marwan H, 2015, UTERINE ADENOMYOSIS; Migliaretti G, 2012, GYNECOL OBSTET INVES, V73, P135, DOI 10.1159/000332367; Moen MH, 1997, ACTA OBSTET GYN SCAN, V76, P559, DOI 10.3109/00016349709024584; Moore J, 2002, ULTRASOUND OBST GYN, V20, P630, DOI 10.1046/j.1469-0705.2002.00862.x; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; Parente Barbosa C, 2011, Minerva Ginecol, V63, P375; Rosa-e-Silva JC, 2008, CLIMACTERIC, V11, P525, DOI 10.1080/13697130802490256; VESSEY MP, 1993, BRIT MED J, V306, P182, DOI 10.1136/bmj.306.6871.182	30	86	90	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154227	10.1371/journal.pone.0154227	http://dx.doi.org/10.1371/journal.pone.0154227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101396	Green Published, gold			2022-12-26	WOS:000374898500168
J	Nagasawa, Y; Okuzaki, D; Muso, E; Yamamoto, R; Shinzawa, M; Iwasaki, Y; Iwatani, H; Nakanishi, T; Isaka, Y; Nojima, H				Nagasawa, Yasuyuki; Okuzaki, Daisuke; Muso, Eri; Yamamoto, Ryohei; Shinzawa, Maki; Iwasaki, Yukako; Iwatani, Hirotsugu; Nakanishi, Takeshi; Isaka, Yoshitaka; Nojima, Hiroshi			IFI27 Is a Useful Genetic Marker for Diagnosis of Immunoglobulin A Nephropathy and Membranous Nephropathy Using Peripheral Blood	PLOS ONE			English	Article							INDUCIBLE PROTEIN-27 IFI27; IGA NEPHROPATHY; EXPRESSION; CELLS; MICROARRAY; RECEPTOR; ANTIGEN; SERUM; TLR9	Diagnosis of chronic glomerulonephritis (CGN) depends primarily on renal biopsy, which is expensive and requires hospitalization, creating a demand for noninvasive diagnostic method for this disease. We used DNA microarray analysis to search for genes whose expression levels in peripheral blood mononuclear cells (PBMCs) could distinguish between patients with CGN and healthy volunteers (HVs). We selected immunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) as typical forms of CGN. The mRNA level of the gene encoding interferon (IFN)-alpha-inducible protein 27, IFI27, which is preferentially expressed in podocytes of glomeruli, was lower in PBMCs of IgAN and MN patients than in those of HVs. This result was confirmed by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). Moreover, qRT-PCR analysis revealed that the IFI27 mRNA level was reduced in PBMCs of patients with other types of chronic glomerulonephritis. IFI27 immunohistochemical staining of biopsied specimens also confirmed reduced expression of IFI27 protein in IgAN and MN patients. Based on these results, we propose that IFI27 could serve as a noninvasive diagnostic marker for CGNs using peripheral blood.	[Nagasawa, Yasuyuki; Yamamoto, Ryohei; Shinzawa, Maki; Iwatani, Hirotsugu; Isaka, Yoshitaka] Osaka Univ, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka, Suita, Osaka, Japan; [Nagasawa, Yasuyuki; Nakanishi, Takeshi] Hyogo Coll Med, Dept Internal Med, Div Kidney & Dialysis, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan; [Okuzaki, Daisuke; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, 3-1 Yamadaoka, Suita, Osaka 565, Japan; [Okuzaki, Daisuke; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, 3-1 Yamadaoka, Suita, Osaka 565, Japan; [Muso, Eri; Iwasaki, Yukako] Kitano Hosp, Div Nephrol & Hemodialysis, Tazuke Kofukai Med Res Inst, Kita Ku, 2-4-20 Ohgimachi, Osaka, Japan	Osaka University; Hyogo College of Medicine; Osaka University; Osaka University; Kitano Hospital	Nojima, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, 3-1 Yamadaoka, Suita, Osaka 565, Japan.; Nojima, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, 3-1 Yamadaoka, Suita, Osaka 565, Japan.	snj-0212@biken.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020; YAMAMOTO, Ryohei/AAU-3059-2021	Okuzaki, Daisuke/0000-0002-4552-783X; YAMAMOTO, Ryohei/0000-0003-2610-9824				Baek JE, 2008, NEPHRON CLIN PRACT, V108, pC35, DOI 10.1159/000112527; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; Coppo R, 2010, J NEPHROL, V23, P626; Cuellar LM, 2009, NEPHROLOGY, V14, P94, DOI 10.1111/j.1440-1797.2008.01009.x; Hastings Margaret Colleen, 2013, Expert Opin Med Diagn, V7, P615, DOI 10.1517/17530059.2013.856878; Hsieh WL, 2015, CELL PROLIFERAT, V48, P187, DOI 10.1111/cpr.12168; Iio K, 2010, BIOCHEM BIOPH RES CO, V393, P565, DOI 10.1016/j.bbrc.2010.01.120; Ishii T, 2005, DNA RES, V12, P429, DOI 10.1093/dnares/dsi020; Iwatani H, 2015, CLIN EXP NEPHROL, V19, P216, DOI 10.1007/s10157-014-0968-z; Kiryluk K, 2014, J CLIN INVEST, V124, P2325, DOI 10.1172/JCI74475; Li SQ, 2015, J SURG RES, V193, P255, DOI 10.1016/j.jss.2014.06.055; Li WW, 2014, MOL MED REP, V10, P1469, DOI 10.3892/mmr.2014.2359; Mihalich A, 2012, GYNECOL ENDOCRINOL, V28, P216, DOI 10.3109/09513590.2011.588746; Misaki T, 2015, CLIN EXP NEPHROL, V19, P844, DOI 10.1007/s10157-014-1072-0; Moriyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091756; Muso E, 2013, AUTOIMMUNITY, V46, P513, DOI 10.3109/08916934.2013.822073; Nagasawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081636; Nair R, 2006, KIDNEY INT, V69, P1455, DOI 10.1038/sj.ki.5000292; Okuzaki D, 2012, J MOL BIOMARK DIAGN, V3, P125; Okuzaki D, 2016, SCI REP-UK, V6, DOI 10.1038/srep19456; Okuzaki D, 2010, DNA RES, V17, P369, DOI 10.1093/dnares/dsq025; Park KH, 2016, J INFECT IN PRESS; Pau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036761; Sallustio F, 2015, EUR J HUM GENET, V23, P940, DOI 10.1038/ejhg.2014.208; Serino G, 2012, J AM SOC NEPHROL, V23, P814, DOI 10.1681/ASN.2011060567; Shankland SJ, 2014, SEMIN NEPHROL, V34, P418, DOI 10.1016/j.semnephrol.2014.06.008; Sugimoto T, 2007, INTERNAL MED, V46, P1483, DOI 10.2169/internalmedicine.46.0200; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Suomela S, 2004, J INVEST DERMATOL, V122, P717, DOI 10.1111/j.0022-202X.2004.22322.x; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; SUZUKI S, 1994, LANCET, V343, P12, DOI 10.1016/S0140-6736(94)90875-3; Tantawy MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106392; Tougan T, 2008, DNA RES, V15, P103, DOI 10.1093/dnares/dsm035; Uhrin P, 2013, IMMUNOBIOLOGY, V218, P1207, DOI 10.1016/j.imbio.2013.04.009; VanBeek C, 2015, CLIN NEPHROL, V84, P1, DOI 10.5414/CN108602; Wallace TA, 2014, CARCINOGENESIS, V35, P2074, DOI 10.1093/carcin/bgu114; Wilde B, 2011, KIDNEY INT, V79, P599, DOI 10.1038/ki.2010.472; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yamamoto R, 2012, NEPHROL DIAL TRANSPL, V27, P1020, DOI 10.1093/ndt/gfr369	40	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153252	10.1371/journal.pone.0153252	http://dx.doi.org/10.1371/journal.pone.0153252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100186	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500027
J	Weschke, S; Niedeggen, M				Weschke, Sarah; Niedeggen, Michael			Target and Non-Target Processing during Oddball and Cyberball: A Comparative Event-Related Potential Study	PLOS ONE			English	Article							SOCIAL REJECTION; PHYSICAL PAIN; ANTERIOR CINGULATE; NEURAL ACTIVITY; EXCLUSION; PROBABILITY; OSTRACISM; P300; DISTRESS; CYBEROSTRACISM	The phenomenon of social exclusion can be investigated by using a virtual ball-tossing game called Cyberball. In neuroimaging studies, structures have been identified which are activated during social exclusion. But to date the underlying mechanisms are not fully disclosed. In previous electrophysiological studies it was shown that the P3 complex is sensitive to exclusion manipulations in the Cyberball paradigm and that there is a correlation between P3 amplitude and self-reported social pain. Since this posterior event-related potential (ERP) was widely investigated using the oddball paradigm, we directly compared the ERP effects elicited by the target (Cyberball: "ball possession") and non-target (Cyberball: "ball possession of a co-player) events in both paradigms. Analyses mainly focused on the effect of altered stimulus probabilities of the target and non-target events between two consecutive blocks of the tasks. In the first block, the probability of the target and non-target event was 33% (Cyberball: inclusion), in the second block target probability was reduced to 17%, and accordingly, non-target probability was increased to 66% (Cyberball: exclusion). Our results indicate that ERP amplitude differences between inclusion and exclusion are comparable to ERP amplitude effects in a visual oddball task. We therefore suggest that ERP effects-especially in the P3 range-in the Oddball and Cyberball paradigm rely on similar mechanisms, namely the probability of target and non-target events. Since the simulation of social exclusion (Cyberball) did not trigger a unique ERP response, the idea of an exclusion-specific neural alarm system is not supported. The limitations of an ERP-based approach will be discussed.	[Weschke, Sarah; Niedeggen, Michael] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany	Free University of Berlin	Weschke, S (corresponding author), Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany.	sarah.weschke@fu-berlin.de		Weschke, Sarah/0000-0003-2069-9245				Bernstein MJ, 2012, SOC INFLUENCE, V7, P113, DOI 10.1080/15534510.2012.664326; Bocquillon P, 2014, NEUROSCIENCE, V271, P9, DOI 10.1016/j.neuroscience.2014.04.014; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Crowley MJ, 2010, SOC NEUROSCI-UK, V5, P483, DOI 10.1080/17470919.2010.500169; Crowley MJ, 2009, NEUROREPORT, V20, P1518, DOI 10.1097/WNR.0b013e328330377a; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Eisenberger NI, 2006, PAIN, V126, P132, DOI 10.1016/j.pain.2006.06.024; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gonzalez-Rosa JJ, 2013, INT J PSYCHOPHYSIOL, V89, P37, DOI 10.1016/j.ijpsycho.2013.04.021; Grzyb KR, 2005, THESIS KONSTANZ U KO; Gutz L, 2015, J ABNORM PSYCHOL, V124, P421, DOI 10.1037/a0038614; Gutz L, 2011, NEUROREPORT, V22, P453, DOI 10.1097/WNR.0b013e3283476b67; Iannetti GD, 2013, TRENDS COGN SCI, V17, P371, DOI 10.1016/j.tics.2013.06.002; Katayama J, 1996, EVOKED POTENTIAL, V100, P555, DOI 10.1016/S0168-5597(96)95171-0; Kawamoto T., 2013, NEUROSCI J, V2013, P11, DOI DOI 10.1155/2013/304674; Kerr NL, 2008, GROUP DYN-THEOR RES, V12, P39, DOI 10.1037/1089-2699.12.1.39; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Niedeggen M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00935; Polich J, 1997, INT J PSYCHOPHYSIOL, V25, P169, DOI 10.1016/S0167-8760(96)00742-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Proulx T, 2012, TRENDS COGN SCI, V16, P285, DOI 10.1016/j.tics.2012.04.002; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rosenfeld JP, 2005, PSYCHOPHYSIOLOGY, V42, P356, DOI 10.1111/j.1469-8986.2005.00283.x; Rotge JY, 2015, SOC COGN AFFECT NEUR, V10, P19, DOI 10.1093/scan/nsu110; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Themanson JR, 2015, SOC NEUROSCI-UK, V10, P55, DOI 10.1080/17470919.2014.956899; Themanson JR, 2013, SOC COGN AFFECT NEUR, V8, P727, DOI 10.1093/scan/nss058; Weschke S, 2015, BRAIN RES; Weschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071928; WIJERS AA, 1987, BIOL PSYCHOL, V25, P33, DOI 10.1016/0301-0511(87)90066-4; Williams K. J., 2001, IEE 29th Annual Weekend Meeting - History of Electrical Engineering (Ref. No.01/162), p2/1; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2002, GROUP DYN-THEOR RES, V6, P65, DOI 10.1037//1089-2699.6.1.65; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Woo CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6380; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	42	9	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153941	10.1371/journal.pone.0153941	http://dx.doi.org/10.1371/journal.pone.0153941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100787	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500103
J	Hirve, S; Newman, LP; Paget, J; Azziz-Baumgartner, E; Fitzner, J; Bhat, N; Vandemaele, K; Zhang, WQ				Hirve, Siddhivinayak; Newman, Laura P.; Paget, John; Azziz-Baumgartner, Eduardo; Fitzner, Julia; Bhat, Niranjan; Vandemaele, Katelijn; Zhang, Wenqing			Influenza Seasonality in the Tropics and Subtropics - When to Vaccinate?	PLOS ONE			English	Article							COUNTRIES; VIRUS; RECOMMENDATIONS; SELECTION	Background The timing of the biannual WHO influenza vaccine composition selection and production cycle has been historically directed to the influenza seasonality patterns in the temperate regions of the northern and southern hemispheres. Influenza activity, however, is poorly understood in the tropics with multiple peaks and identifiable year-round activity. The evidence-base needed to take informed decisions on vaccination timing and vaccine formulation is often lacking for the tropics and subtropics. This paper aims to assess influenza seasonality in the tropics and subtropics. It explores geographical grouping of countries into vaccination zones based on optimal timing of influenza vaccination. Methods Influenza seasonality was assessed by different analytic approaches (weekly proportion of positive cases, time series analysis, etc.) using FluNet and national surveillance data. In case of discordance in the seasonality assessment, consensus was built through discussions with in-country experts. Countries with similar onset periods of their primary influenza season were grouped into geographical zones. Results The number and period of peak activity was ascertained for 70 of the 138 countries in the tropics and subtropics. Thirty-seven countries had one and seventeen countries had two distinct peaks. Countries near the equator had secondary peaks or even identifiable year-round activity. The main influenza season in most of South America and Asia started between April and June. The start of the main season varied widely in Africa (October and December in northern Africa, April and June in Southern Africa and a mixed pattern in tropical Africa). Eight "influenza vaccination zones" (two each in America and Asia, and four in Africa and Middle East) were defined with recommendations for vaccination timing and vaccine formulation. The main limitation of our study is that FluNet and national surveillance data may lack the granularity to detect sub-national variability in seasonality patterns. Conclusion Distinct influenza seasonality patterns, though complex, could be ascertained for most countries in the tropics and subtropics using national surveillance data. It may be possible to group countries into zones based on similar recommendations for vaccine timing and formulation.	[Hirve, Siddhivinayak; Fitzner, Julia; Vandemaele, Katelijn; Zhang, Wenqing] World Hlth Org, Global Influenza Program, Geneva, Switzerland; [Newman, Laura P.] Univ Washington, Seattle, WA 98195 USA; [Paget, John] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent, Atlanta, GA USA; [Bhat, Niranjan] Program Appropriate Technol, Seattle, WA USA	World Health Organization; University of Washington; University of Washington Seattle; Netherlands Institute for Health Services Research; Centers for Disease Control & Prevention - USA	Hirve, S (corresponding author), World Hlth Org, Global Influenza Program, Geneva, Switzerland.	hirves@who.int	zhang, wenqing/GYA-0786-2022		Bill and Melinda Gates Foundation, USA [OPP1084574]; WHO grant [2014/430731-0]; Bill and Melinda Gates Foundation, US [OPP1084288]; Sanofi Pasteur grant [GIBS-FLU37-EXT]; WHO grant from the Bill and Melinda Gates Foundation, USA [OPP1084574]; Bill and Melinda Gates Foundation [OPP1084288];  [1U51GH001191-01]	Bill and Melinda Gates Foundation, USA(Bill & Melinda Gates Foundation); WHO grant; Bill and Melinda Gates Foundation, US; Sanofi Pasteur grant; WHO grant from the Bill and Melinda Gates Foundation, USA; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); 	The work was supported by the following: WZ-Grant no. OPP1084574 to the World Health Organization, Geneva from the Bill and Melinda Gates Foundation, USA; JP-Two grants to Netherlands Institute for Health Services Research (WHO grant 2014/430731-0 and an unrestricted Sanofi Pasteur grant GIBS-FLU37-EXT); NB-Grant OPP1084288 to the Program for Appropriate Technology in Health, Seattle, US from the Bill and Melinda Gates Foundation, US; and EAB-grant 1U51GH001191-01 to the Centers for Disease Control and Prevention, Atlanta.; This review was funded through a WHO grant no.OPP1084574 from the Bill and Melinda Gates Foundation, USA. The NIVEL site analysis was supported by two grants (WHO grant 2014/430731-0 and an unrestricted Sanofi Pasteur grant GIBS-FLU37-EXT). The PATH site analysis was financially supported by grant OPP1084288 from the Bill and Melinda Gates Foundation. The CDC site analysis was supported by a grant 1U51GH001191-01 from 2015. The authors would like to acknowledge Lizette Durand (CDC), Francois Seville (NIVEL), Kathy Neuzil, Jessica Fleming (PATH), Loes Soetens, Paulina Sosa and Nesreen Gusbi (WHO) for supporting this work. We acknowledge the expert opinions of country influenza surveillance experts that helped us to resolve discordant seasonality findings. Most of all, we thank the WHO Global Influenza Surveillance and Response System, all the national influenza centres and the national surveillance systems for sharing the surveillance data. Lastly, we thank colleagues in the WHO regional offices and the WHO Global Influenza Program for their support to the collaborative effort. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their institutes.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Ampofo WK, 2015, VACCINE, V33, P4368, DOI 10.1016/j.vaccine.2015.06.090; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; Chadha M, 2014, DYNAMICS INFLU UNPUB; Chadha MS, 2012, INFLUENZA OTHER RESP, V6, P196, DOI 10.1111/j.1750-2659.2011.00293.x; Cox N, 2014, B WORLD HEALTH ORGAN, V92, P311, DOI 10.2471/BLT.14.139428; de Mello WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005095; Durand LO, 2015, TIMING INFLUENZA EPI; DWYER D, 2013, W PAC SURVEILL RESPO, V4, P51, DOI DOI 10.5365/WPSAR.2013.4.1.009; Fedson DS, 2005, VACCINE, V23, P5133, DOI 10.1016/j.vaccine.2005.06.010; Flahault A, 1998, JAMA-J AM MED ASSOC, V280, P1330, DOI 10.1001/jama.280.15.1330; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Hirve S, 2015, SEASONAL INFLUENZA V; Johnson LEA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-209; Katz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098615; Khor CS, 2013, J U MALAYA MED CTR, V16, P18; Matheka DM, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.138.2612; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Ropero-Alvarez AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-361; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Saat Z, 2010, SE ASIAN J TROP MED, V41, P1368; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; van Essen GA, 2003, VACCINE, V21, P1780, DOI 10.1016/S0264-410X(03)00072-0; WHO, 2011, INFL TRANSM ZON; World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P474; World Health Organization, 2012, REP 2 WHO CONS GLOB; World Health Organization, 2015, MAN EST DIS BURD ASS; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552	33	109	111	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153003	10.1371/journal.pone.0153003	http://dx.doi.org/10.1371/journal.pone.0153003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119988	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200015
J	Mullins, CS; Huhns, M; Krohn, M; Peters, S; Cheynet, V; Oriol, G; Guillotte, M; Ducrot, S; Mallet, F; Linnebacher, M				Mullins, Christina S.; Huehns, Maja; Krohn, Mathias; Peters, Sven; Cheynet, Valerie; Oriol, Guy; Guillotte, Michele; Ducrot, Sandrine; Mallet, Francois; Linnebacher, Michael			Generation, Characterization and Application of Antibodies Directed against HERV-H Gag Protein in Colorectal Samples	PLOS ONE			English	Article							HUMAN-ENDOGENOUS-RETROVIRUS; BREAST-CANCER; EXPRESSION; CELLS; INFECTION; SEQUENCE; ELEMENTS; IDENTIFICATION; LYMPHOMA; FAMILY	Introduction A substantial part of the human genome originates from transposable elements, remnants of ancient retroviral infections. Roughly 8% of the human genome consists of about 400,000 LTR elements including human endogenous retrovirus (HERV) sequences. Mainly, the interplay between epigenetic and post-transcriptional mechanisms is thought to silence HERV expression in most physiological contexts. Interestingly, aberrant reactivation of several HERV-H loci appears specific to colorectal carcinoma (CRC). Results The expression of HERV-H Gag proteins (Gag-H) was assessed using novel monoclonal mouse anti Gag-H antibodies. In a flow cytometry screen four antibody clones were tested on a panel of primary CRC cell lines and the most well performing ones were subsequently validated in western blot analysis. Finally, Gag-H protein expression was analyzed by immune histology on cell line cytospins and on clinical samples. There, we found a heterogeneous staining pattern with no background staining of endothelial, stromal and infiltrating immune cells but diffuse staining of the cytoplasm for positive tumor and normal crypt cells of the colonic epithelium. Conclusion Taken together, the Gag-H antibody clone(s) present a valuable tool for staining of cells with colonic origin and thus form the basis for future more detailed investigations. The observed Gag-H protein staining in colonic epithelium crypt cells demands profound analyses of a potential role for Gag-H in the normal physiology of the human gut.	[Mullins, Christina S.; Krohn, Mathias; Peters, Sven; Linnebacher, Michael] Univ Med Rostock, Dept Gen Surg Mol Oncol & Immunotherapy, Schillingallee 69, D-18057 Rostock, Germany; [Huehns, Maja] Univ Med Rostock, Inst Pathol, Strempelstr 14, D-18055 Rostock, Germany; [Cheynet, Valerie; Oriol, Guy; Mallet, Francois] Ctr Hosp Lyon Sud, Canc Biomarkers Res Grp, Joint Unit Hosp Civils Lyon, Batiment 3F, F-69495 Lyon, France; [Guillotte, Michele] BioMerieux, Global R&D Immunoassay, Marcy Letoile, France; [Ducrot, Sandrine] BioMerieux, Raw Mat Dept, R&D Immunoassay, Marcy Letoile, France; [Mallet, Francois] Univ Lyon 1, EA Pathophysiol Injury Induced Immunosuppress, Hosp Civils Lyon, BioMerieux,Hop Edouard Herriot, 5 Pl Arsonval, F-69437 Lyon 3, France	University of Rostock; University of Rostock; bioMerieux; CHU Lyon; bioMerieux; bioMerieux; bioMerieux; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Linnebacher, M (corresponding author), Univ Med Rostock, Dept Gen Surg Mol Oncol & Immunotherapy, Schillingallee 69, D-18057 Rostock, Germany.	michael.linnebacher@med.uni-rostock.de	Mallet, Francois/G-4812-2014; Mullins, Christina/ABG-4821-2021; Linnebacher, Michael/AAT-3763-2021	Mullins, Christina/0000-0003-2296-2027; Linnebacher, Michael/0000-0001-8054-1402; MALLET, Francois/0000-0002-1331-096X	Deutsche Krebshilfe; bioMerieux SA; German Cancer Aid (DKH e.V.) [110943]	Deutsche Krebshilfe(Deutsche Krebshilfe); bioMerieux SA; German Cancer Aid (DKH e.V.)	Deutsche Krebshilfe, http://www.krebshilfe.de, funded CSM with a PostDoc scholarship. This work was supported by bioMerieux SA in the form of salaries for authors [VC, GO, MG, SD and FM]. CSM received a "Mildred Scheel PostDoc Stipendium" from the German Cancer Aid (DKH e.V. #110943). The funder provided support, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn K, 2009, MOL CELLS, V28, P99, DOI 10.1007/s10059-009-0107-y; Alves Pedro M S, 2008, Cancer Immun, V8, P11; Belshaw R, 2005, MOL BIOL EVOL, V22, P814, DOI 10.1093/molbev/msi088; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Bock M, 2000, CURR OPIN GENET DEV, V10, P651, DOI 10.1016/S0959-437X(00)00138-6; Brudek T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-104; Chiang CY, 2005, VIRUS RES, V108, P139, DOI 10.1016/j.virusres.2004.08.022; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gimenez J, 2010, NUCLEIC ACIDS RES, V38, P2229, DOI 10.1093/nar/gkp1214; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kraus B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-21; Kudo-Saito C, 2014, CANCER RES, V74, P1361, DOI 10.1158/0008-5472.CAN-13-1349; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liang QY, 2009, BIOCHEM BIOPH RES CO, V382, P468, DOI 10.1016/j.bbrc.2009.03.058; Maldonado JO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00302; Maletzki C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143194; Maletzki C, 2015, WORLD J GASTROENTERO, V21, P164, DOI 10.3748/wjg.v21.i1.164; Maletzki C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052485; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Miyamoto M, 1991, Med J Osaka Univ, V40, P5; Mullins CS, 2012, WORLD J GASTROENTERO, V18, P6027, DOI 10.3748/wjg.v18.i42.6027; Mullins CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071070; Mullins CS, 2014, J CANC SCI THER, V6. 6, P177, DOI [10.4172/1948-5956.1000269, DOI 10.4172/1948-5956.1000269]; Ostwald C, 2009, INT J ONCOL, V35, P321, DOI 10.3892/ijo_00000343; Perot P, ONCOTARGET IN PRESS; Perot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040194; Sacha JB, 2012, J IMMUNOL, V189, P1467, DOI 10.4049/jimmunol.1200079; Schiavetti F, 2002, CANCER RES, V62, P5510; Stake MS, 2013, VIRUSES-BASEL, V5, P2767, DOI 10.3390/v5112767; Wang DZ, 2013, ANNU REV MED, V64, P131, DOI 10.1146/annurev-med-112211-154330; Wang-Johanning F, 2003, CANCER-AM CANCER SOC, V98, P187, DOI 10.1002/cncr.11451; Wang-Johanning F, 2008, CANCER RES, V68, P5869, DOI 10.1158/0008-5472.CAN-07-6838; Wentzensen N, 2007, INT J CANCER, V121, P1417, DOI 10.1002/ijc.22826	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153349	10.1371/journal.pone.0153349	http://dx.doi.org/10.1371/journal.pone.0153349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119520	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200023
J	Ojima, K; Lin, ZX; de Andrade, IR; Costa, ML; Mermelstein, C				Ojima, Koichi; Lin, Zhong-Xiang; de Andrade, Ivone Rosa; Costa, Manoel Luis; Mermelstein, Claudia			Distinctive Effects of Cytochalasin B in Chick Primary Myoblasts and Fibroblasts	PLOS ONE			English	Article							ACTIN POLYMERIZATION; RHO GTPASES; MYRISTATE ACETATE; FOCAL ADHESIONS; STRIATED-MUSCLE; CELL MOTILITY; IN-VIVO; PROTEINS; FILAMENTS; DYNAMICS	Actin-based structures play fundamental roles in cellular functions. However it remains controversial how cells cope with the absence of F-actin structures. This report focuses on short-and long-term effects of cytochalasin B (CB) on actin-complexes in fibroblasts and myoblasts. Thirty min of CB treatment dispersed subplasma actin cortices, lamellipodia, ruffled membranes, stress fibers and adhesion plaques into actin patches in fibroblasts and muscle cells. In contrast, 72 hrs CB treatment showed distinct morphological effects. Fibroblasts became giant multinucleated-finger shaped with 5 to 10 protrusions, 3-8 mu m in width, and >200 mu m in length. They lacked cortical actin, stress fibers, adhesion plaques and ruffled membranes but contained immense lamelliopodia with abnormal adhesion plaque protein complexes. Muscle cells transformed into multinucleated globular-shaped but contained normal I-Z-I and A-bands, indicating that CB did not interfere with the assembly of myofibrils. Within 30 min after CB removal, finger-shaped fibroblasts returned to their original shape and actin-containing structures rapidly reappeared, whereas muscle cells respond slowly to form elongated myotubes following CB washout. The capacity to grow, complete several nuclear cycles, assemble intermediate filaments and microtubules without a morphologically recognizable actin cytoskeleton raises interesting issues related to the role of the actin compartments in eukaryotic cells.	[Ojima, Koichi] NARO Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki 3050901, Japan; [Lin, Zhong-Xiang] Beijing Med Univ, Beijing Inst Canc Res, Dept Cell Biol, Beijing 100083, Peoples R China; [de Andrade, Ivone Rosa; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil	National Agriculture & Food Research Organization - Japan; Peking University; Universidade Federal do Rio de Janeiro	Mermelstein, C (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil.	mermelstein@histo.ufrj.br	mermelstein, Claudia S/C-1464-2010; Costa, Manoel/B-5009-2010	mermelstein, Claudia S/0000-0002-8897-8526; Costa, Manoel/0000-0002-9037-0085; Ojima, Koichi/0000-0002-5973-1073	Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ) - Brazil [203.185/2015]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Brazil [300787/2013-8]	Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ) - Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by "Cientista do Nosso Estado" Grant Number 203.185/2015 from Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ) - Brazil, and Grant Number 300787/2013-8 from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT J, 1972, DEV BIOL, V28, P430, DOI 10.1016/0012-1606(72)90024-3; Ballestrem C, 1998, J CELL SCI, V111, P1649; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; BRENNER SL, 1980, J BIOL CHEM, V255, P1670; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; CLARKE M, 1977, ANNU REV BIOCHEM, V46, P797, DOI 10.1146/annurev.bi.46.070177.004053; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; CROOP J, 1975, J CELL BIOL, V65, P271, DOI 10.1083/jcb.65.2.271; ESTENSEN RD, 1972, P NATL ACAD SCI USA, V69, P1430, DOI 10.1073/pnas.69.6.1430; FELDER S, 1990, J CELL BIOL, V111, P2513, DOI 10.1083/jcb.111.6.2513; Fowler VM, 1996, CURR OPIN CELL BIOL, V8, P86, DOI 10.1016/S0955-0674(96)80052-4; FOWLER VM, 1990, J CELL BIOL, V111, P471, DOI 10.1083/jcb.111.2.471; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Lin Z, 1998, DEV BIOL, V199, P291, DOI 10.1006/dbio.1998.8920; LIN ZX, 1987, J CELL BIOL, V105, P1365, DOI 10.1083/jcb.105.3.1365; LIN ZX, 1989, J CELL BIOL, V108, P1079, DOI 10.1083/jcb.108.3.1079; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; Millevoi S, 1998, J MOL BIOL, V282, P111, DOI 10.1006/jmbi.1998.1999; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; OBINATA T, 1984, DEV BIOL, V105, P253, DOI 10.1016/0012-1606(84)90283-5; Ojima K, 1999, J CELL SCI, V112, P4101; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SANGER JW, 1974, P NATL ACAD SCI USA, V71, P3621, DOI 10.1073/pnas.71.9.3621; SANGER JW, 1971, NATURE-NEW BIOL, V229, P121, DOI 10.1038/newbio229121a0; Schachtner H, 2013, CYTOSKELETON, V70, P572, DOI 10.1002/cm.21119; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Verkhovsky AB, 1997, J CELL SCI, V110, P1693; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498	40	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154109	10.1371/journal.pone.0154109	http://dx.doi.org/10.1371/journal.pone.0154109			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119825	gold, Green Published, Green Submitted			2022-12-26	WOS:000374976200045
J	Frafjord, K				Frafjord, Karl			Influence of Reproductive Status: Home Range Size in Water Voles (Arvicola amphibius)	PLOS ONE			English	Article							CLETHRIONOMYS-GLAREOLUS; PRAIRIE VOLES; MICROTUS-OCHROGASTER; POPULATION-DYNAMICS; SOCIAL-ORGANIZATION; TERRITORY DEFENSE; ROOT VOLES; BANK VOLES; DISPERSAL; TERRESTRIS	The relationship between home range and reproductive status of water voles (Arvicola amphibius) was studied by radio-tracking on an island off the coast of northern Norway in 2006-2009. The aim was to test assumptions about the species' social structure relative to other microtines. Juveniles used fairly small ranges (about 400 m(2)), with no difference between males and females. Subadults, overwintered voles in April, had ranges similar to juveniles. Reproductively active males (mean 2774.0 m(2)) increased their range seven-fold relative to juvenile males, with ranges on average 3.3 times larger than adult females (mean 848.3 m(2)), which also expanded their range. Most litters were born in May and June, and as reproduction ceased in July adult males reduced their range whilst females did not. Body mass or year did not influence home range size. Overlap of home ranges varied, but could be extensive in both adult males and females. The water vole had a social structure similar to some Microtus species, but females appeared to be non-territorial and males perhaps conditioned territorial and non-territorial.	[Frafjord, Karl] UiT Arctic Univ Norway, Tromso Univ Museum, Dept Nat Sci, Tromso, Norway	UiT The Arctic University of Tromso	Frafjord, K (corresponding author), UiT Arctic Univ Norway, Tromso Univ Museum, Dept Nat Sci, Tromso, Norway.	karl.frafjord@uit.no			Tromso University Museum	Tromso University Museum	This study was funded by Tromso University Museum.	Banks PB, 2004, OIKOS, V106, P176, DOI 10.1111/j.0030-1299.2004.12679.x; BONDRUPNIELSEN S, 1985, ANN ZOOL FENN, V22, P385; Bonesi L, 2002, OIKOS, V99, P220, DOI 10.1034/j.1600-0706.2002.990202.x; BUJALSKA G, 1990, ADV LIF SCI, P155; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; ERLINGE S, 1990, ADV LIF SCI, P45; ERLINGE S, 1990, J MAMMAL, V71, P597, DOI 10.2307/1381799; Forman DW, 2006, AGGRESSIVE BEHAV, V32, P599, DOI 10.1002/ab.20159; Frafjord Karl, 2007, Fauna (Oslo), V59, P144; Frafjord Karl, 2003, Fauna Norvegica, V23, P42; Getz LL, 2005, J MAMMAL, V86, P647, DOI 10.1644/1545-1542(2005)086[0647:FIMDOT]2.0.CO;2; Gliwicz J, 1997, ECOGRAPHY, V20, P383, DOI 10.1111/j.1600-0587.1997.tb00383.x; Gray SJ, 2002, ANIM BEHAV, V63, P531, DOI 10.1006/anbe.2001.1932; Hoffmeyer I, 1985, ANN ZOOL FENN, V22, P269; Hoset KS, 2008, BEHAV ECOL, V19, P139, DOI 10.1093/beheco/arm112; Hoset KS, 2006, THESIS U OSLO OSLO; IMS RA, 1989, ECOLOGY, V70, P607, DOI 10.2307/1940212; JEPPSSON B, 1986, BEHAV ECOL SOCIOBIOL, V19, P293, DOI 10.1007/BF00300644; JEPPSSON B, 1990, ADV LIF SCI, P213; Jeppsson B, 1987, THESIS U LUND LUND; KORN H, 1986, OECOLOGIA, V68, P623, DOI 10.1007/BF00378782; Koskela E, 1997, J ANIM ECOL, V66, P341, DOI 10.2307/5980; Krebs Charles J., 2007, P173; Krebs JR, 1978, BEHAV ECOLOGY EVOLUT; LAMBIN X, 1991, OIKOS, V61, P126, DOI 10.2307/3545414; Le Galliard JF, 2006, BEHAV ECOL, V17, P733, DOI 10.1093/beheco/arl002; Lin YK, 2006, J MAMMAL, V87, P446, DOI 10.1644/05-MAMM-A-201R1.1; Loughran MFE, 2007, ANN ZOOL FENN, V44, P97; MADISON DM, 1990, ADV LIF SCI, P25; MAPPES T, 1995, ECOLOGY, V76, P1276, DOI 10.2307/1940934; McGuire B, 2002, ANIM BEHAV, V64, P645, DOI 10.1006/anbe.2002.3094; MCSHEA WJ, 1990, ANIM BEHAV, V39, P346, DOI 10.1016/S0003-3472(05)80880-2; Moorhouse TP, 2008, J ZOOL, V274, P395, DOI 10.1111/j.1469-7998.2007.00399.x; Moorhouse TP, 2008, J ANIM ECOL, V77, P1288, DOI 10.1111/j.1365-2656.2008.01431.x; Moorhouse TP, 2005, J MAMMAL, V86, P655, DOI 10.1644/1545-1542(2005)086[0655:TPORUI]2.0.CO;2; Pita R, 2010, EUR J WILDLIFE RES, V56, P651, DOI 10.1007/s10344-009-0360-6; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POWELL RA, 1992, BEHAV ECOL, V3, P325, DOI 10.1093/beheco/3.4.325; Remy A, 2011, J ANIM ECOL, V80, P929, DOI 10.1111/j.1365-2656.2011.01849.x; Rosell F, 2008, BEHAV ECOL SOCIOBIOL, V62, P1559, DOI 10.1007/s00265-008-0585-5; SIKORSKI MD, 1990, ADV LIF SCI, P193; Solomon Nancy G., 2007, P42; STODDART DM, 1971, J ANIM ECOL, V40, P487, DOI 10.2307/3257; STODDART DM, 1970, J ANIM ECOL, V39, P403, DOI 10.2307/2979; Tamarin R. H., 1990, SOCIAL SYSTEMS POPUL; Telfer S, 2003, MOL ECOL, V12, P1939, DOI 10.1046/j.1365-294X.2003.01859.x; VIITALA J, 1987, ANN ZOOL FENN, V24, P267; WANG ZX, 1994, ANIM BEHAV, V47, P281, DOI 10.1006/anbe.1994.1040; Waterman Jane, 2007, P27; Wolff J.O., 2007, RODENT SOC ECOLOGICA; WOLFF JO, 1993, OIKOS, V68, P364, DOI 10.2307/3544853; Wolff JO, 1998, ETHOL ECOL EVOL, V10, P227, DOI 10.1080/08927014.1998.9522854; YLONEN H, 1990, ADV LIF SCI, P203; Ylonen H, 1995, ANN ZOOL FENN, V32, P445; YLONEN H, 1990, OECOLOGIA, V83, P333, DOI 10.1007/BF00317556	55	7	9	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154338	10.1371/journal.pone.0154338	http://dx.doi.org/10.1371/journal.pone.0154338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115881	Green Submitted, gold, Green Published			2022-12-26	WOS:000374973600059
J	Maeda, Y; Fang, J; Ikezoe, Y; Pike, DH; Nanda, V; Matsui, H				Maeda, Yoshiaki; Fang, Justin; Ikezoe, Yasuhiro; Pike, Douglas H.; Nanda, Vikas; Matsui, Hiroshi			Molecular Self-Assembly Strategy for Generating Catalytic Hybrid Polypeptides	PLOS ONE			English	Article							AMYLOID PEPTIDE-FRAGMENTS; BINDING POCKET; COMBINATORIAL; DISCOVERY; PROTEINS; DESIGN; PHAGES	Recently, catalytic peptides were introduced that mimicked protease activities and showed promising selectivity of products even in organic solvents where protease cannot perform well. However, their catalytic efficiency was extremely low compared to natural enzyme counterparts presumably due to the lack of stable tertiary fold. We hypothesized that assembling these peptides along with simple hydrophobic pockets, mimicking enzyme active sites, could enhance the catalytic activity. Here we fused the sequence of catalytic peptide CP4, capable of protease and esterase-like activities, into a short amyloidogenic peptide fragment of A beta. When the fused CP4-A beta construct assembled into antiparallel beta-sheets and amyloid fibrils, a 4.0-fold increase in the hydrolysis rate of p-nitrophenyl acetate (p-NPA) compared to neat CP4 peptide was observed. The enhanced catalytic activity of CP4-A beta assembly could be explained both by pre-organization of a catalytically competent Ser-His-acid triad and hydrophobic stabilization of a bound substrate between the triad and p-NPA, indicating that a design strategy for self-assembled peptides is important to accomplish the desired functionality.	[Maeda, Yoshiaki; Fang, Justin; Ikezoe, Yasuhiro; Matsui, Hiroshi] CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA; [Maeda, Yoshiaki; Fang, Justin; Ikezoe, Yasuhiro; Matsui, Hiroshi] CUNY, Grad Ctr, New York, NY USA; [Pike, Douglas H.; Nanda, Vikas] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Biochem, Piscataway, NJ 08854 USA; [Pike, Douglas H.; Nanda, Vikas] Rutgers State Univ, Dept Mol Biol & Biochem, Robert Wood Johnson Med Sch, Piscataway, NJ 08855 USA; [Matsui, Hiroshi] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Cornell University	Matsui, H (corresponding author), CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA.; Matsui, H (corresponding author), CUNY, Grad Ctr, New York, NY USA.; Nanda, V (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Biochem, Piscataway, NJ 08854 USA.; Nanda, V (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Robert Wood Johnson Med Sch, Piscataway, NJ 08855 USA.; Matsui, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.	nanda@cabm.rutgers.edu; hmatsui@hunter.cuny.edu	Maeda, Yoshiaki/H-9910-2013; Ikezoe, Yasuhiro/B-2685-2010	Maeda, Yoshiaki/0000-0001-9206-2601; Pike, Douglas/0000-0001-8880-9485	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG-02-01ER45935]; National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH) [MD007599]; NIH [DP2-OD006478, R01-GM089949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089949] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006478] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All of the work was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Award No. DE-FG-02-01ER45935. Hunter College infrastructure is supported by the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH) (MD007599). VN and DP were supported by NIH DP2-OD006478 and R01-GM089949. YM thanks Japan Society for the Promotion of Science, and the International Training Program provided through Tokyo University of Agriculture and Technology.	Abbineni G, 2010, MOL PHARMACEUT, V7, P1629, DOI 10.1021/mp100052y; BENDER ML, 1957, J AM CHEM SOC, V79, P1652, DOI 10.1021/ja01564a034; Carey C, 2000, CHEM PHYS, V258, P415, DOI 10.1016/S0301-0104(00)00178-6; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castelletto V, 2010, LANGMUIR, V26, P9986, DOI 10.1021/la100110f; Chen CL, 2010, ANGEW CHEM INT EDIT, V49, P1924, DOI 10.1002/anie.200903572; Cui Y, 2012, ACCOUNTS CHEM RES, V45, P696, DOI 10.1021/ar2002057; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Gao Y, 2010, CHEM SOC REV, V39, P3425, DOI 10.1039/b919450a; Giuliano MW, 2015, ADV SYNTH CATAL, V357, P2301, DOI 10.1002/adsc.201500230; Hamley IW, 2008, LANGMUIR, V24, P8210, DOI 10.1021/la8005426; HARTLEY BS, 1954, BIOCHEM J, V56, P288, DOI 10.1042/bj0560288; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Korendovych IV, 2014, CURR OPIN STRUC BIOL, V27, P113, DOI 10.1016/j.sbi.2014.06.006; Krysmann MJ, 2007, SOFT MATTER, V3, P1401, DOI 10.1039/b709889h; LIBBY P, 1978, SCIENCE, V199, P534, DOI 10.1126/science.622552; Ma K, 2013, ADV FUNCT MATER, V23, P1172, DOI 10.1002/adfm.201102963; Maeda Y, 2014, J AM CHEM SOC, V136, P15893, DOI 10.1021/ja509393p; Maeda Y, 2012, SOFT MATTER, V8, P7533, DOI 10.1039/c2sm25352f; Mayo SL, 2004, P NATL ACAD SCI USA, V101, P11566; Melicher MS, 2015, ORG LETT, V17, P4718, DOI 10.1021/acs.orglett.5b02187; Miller SJ, 2015, TOP CURR CHEM, P1; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Nanda V, 2010, NAT CHEM, V2, P15, DOI [10.1038/NCHEM.473, 10.1038/nchem.473]; Oh JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4043; Okuyama K, 2012, BIOPOLYMERS, V97, P607, DOI 10.1002/bip.22048; Pearson AD, 2015, SCIENCE, V347, P863, DOI 10.1126/science.aaa2424; Pike DH, 2015, BIOPOLYMERS, V104, P360, DOI 10.1002/bip.22644; Razkin J, 2007, J AM CHEM SOC, V129, P14752, DOI 10.1021/ja075478i; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; SORENSEN SB, 1993, BIOCHEMISTRY-US, V32, P8994, DOI 10.1021/bi00086a003; SUMMA CM, 2002, THESIS; Wang FK, 2012, CHEM SCI, V3, P2639, DOI 10.1039/c2sc00583b; Wang YQ, 2012, J AM CHEM SOC, V134, P16614, DOI 10.1021/ja305300m; Wei ZY, 2011, ANGEW CHEM INT EDIT, V50, P10585, DOI 10.1002/anie.201102582; Xu F, 2013, J AM CHEM SOC, V135, P18762, DOI 10.1021/ja4106545; Zhou XM, 2014, CHEMCATCHEM, V6, P1961, DOI 10.1002/cctc.201402125	39	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153700	10.1371/journal.pone.0153700	http://dx.doi.org/10.1371/journal.pone.0153700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116246	Green Published, gold			2022-12-26	WOS:000374973600026
J	Seo, J; Singh, NN; Ottesen, EW; Sivanesan, S; Shishimorova, M; Singh, RN				Seo, Joonbae; Singh, Natalia N.; Ottesen, Eric W.; Sivanesan, Senthilkumar; Shishimorova, Maria; Singh, Ravindra N.			Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene	PLOS ONE			English	Article							MOTOR-NEURON GENE; MESSENGER-RNA; SPLICING REGULATION; PARKINSONS-DISEASE; ANIMAL-MODELS; CELL-DEATH; SMN2; SURVIVAL; MOUSE; NEURODEGENERATION	Humans carry two nearly identical copies of Survival Motor Neuron gene: SMN1 and SMN2. Loss of SMN1 leads to spinal muscular atrophy (SMA), the most frequent genetic cause of infant mortality. While SMN2 cannot compensate for the loss of SMN1 due to predominant skipping of exon 7, correction of SMN2 exon 7 splicing holds the promise of a cure for SMA. Previously, we used cell-based models coupled with a multi-exon-skipping detection assay (MESDA) to demonstrate the vulnerability of SMN2 exons to aberrant splicing under the conditions of oxidative stress (OS). Here we employ a transgenic mouse model and MESDA to examine the OS-induced splicing regulation of SMN2 exons. We induced OS using paraquat that is known to trigger production of reactive oxygen species and cause mitochondrial dysfunction. We show an overwhelming co-skipping of SMN2 exon 5 and exon 7 under OS in all tissues except testis. We also show that OS increases skipping of SMN2 exon 3 in all tissues except testis. We uncover several new SMN2 splice isoforms expressed at elevated levels under the conditions of OS. We analyze cis-elements and transacting factors to demonstrate the diversity of mechanisms for splicing misregulation under OS. Our results of proteome analysis reveal downregulation of hnRNP H as one of the potential consequences of OS in brain. Our findings suggest SMN2 as a sensor of OS with implications to SMA and other diseases impacted by low levels of SMN protein.	[Seo, Joonbae; Singh, Natalia N.; Ottesen, Eric W.; Sivanesan, Senthilkumar; Shishimorova, Maria; Singh, Ravindra N.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA	Iowa State University	Singh, RN (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA.	singhr@iastate.edu		Sivanesan, Senthilkumar/0000-0001-5133-7090; Singh, Ravindra/0000-0001-5399-2662	United States National Institutes of Health [R01 NS055925, R21 NS072259, R21 NS080294]; Iowa Center for Advanced Neurotoxicology (ICAN); Salsbury Endowment (Iowa State University, Ames, IA, USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072259, R21NS080294, R01NS055925] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa Center for Advanced Neurotoxicology (ICAN); Salsbury Endowment (Iowa State University, Ames, IA, USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from United States National Institutes of Health (R01 NS055925, R21 NS072259, and R21 NS080294), Iowa Center for Advanced Neurotoxicology (ICAN), and Salsbury Endowment (Iowa State University, Ames, IA, USA) to RNS.	Acsadi G, 2011, J MOL NEUROSCI, V43, P275, DOI 10.1007/s12031-010-9422-1; Ahmad S, 2016, J EXP NEUROSCI, V10, P39, DOI 10.4137/JEN.S33122; Akaike Y, 2014, MOL CELL BIOL, V34, P2857, DOI 10.1128/MCB.00333-14; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bunkar N, 2016, FRONT BIOSCI-LANDMRK, V21, P769, DOI 10.2741/4420; BURGE C, 1999, SPLICING PRECURSORS; Cao WG, 2012, NUCLEIC ACIDS RES, V40, P8059, DOI 10.1093/nar/gks504; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chabot B, 2016, J CELL BIOL, V212, P13, DOI 10.1083/jcb.201510032; Chabot B, 2015, RNA, V21, P582, DOI 10.1261/rna.050617.115; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Chen MT, 2015, MOL CELL BIOL, V35, P3212, DOI 10.1128/MCB.00429-15; Cho SC, 2010, P NATL ACAD SCI USA, V107, P19326, DOI 10.1073/pnas.1005078107; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Disher K, 2007, GENOME, V50, P946, DOI 10.1139/G07-074; Dujardin G, 2014, MOL CELL, V54, P683, DOI 10.1016/j.molcel.2014.03.044; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Fei Q, 2008, J BIOL CHEM, V283, P3357, DOI 10.1074/jbc.M708451200; Genabai NK, 2015, HUM MOL GENET, V24, P6986, DOI 10.1093/hmg/ddv401; Hashimoto M, 2003, J BIOL CHEM, V278, P5044, DOI 10.1074/jbc.M210129200; Howell MD, 2014, FUTURE MED CHEM, V6, P1081, DOI [10.4155/FMC.14.63, 10.4155/fmc.14.63]; Jodelka FM, 2010, HUM MOL GENET, V19, P4906, DOI 10.1093/hmg/ddq425; Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Keil JM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.23; Kim J, 2016, NUCLEIC ACIDS RES, V44, P2378, DOI 10.1093/nar/gkw017; Kolb SJ, 2015, NEUROL CLIN, V33, P831, DOI 10.1016/j.ncl.2015.07.004; Kwok CK, 2015, TRENDS BIOCHEM SCI, V40, P221, DOI 10.1016/j.tibs.2015.02.005; Le WD, 2014, NEUROTHERAPEUTICS, V11, P92, DOI 10.1007/s13311-013-0234-1; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lenzken SC, 2011, HUM MUTAT, V32, P168, DOI 10.1002/humu.21394; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Maracchioni A, 2007, J NEUROCHEM, V100, P142, DOI 10.1111/j.1471-4159.2006.04204.x; Margolin G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-39; Matlin AJ, 2007, ADV EXP MED BIOL, V623, P14, DOI 10.1007/978-0-387-77374-2_2; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470; Mitra S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-163; Mitra S, 2013, TOXICOLOGY, V314, P39, DOI 10.1016/j.tox.2013.09.003; Monani UR, 2014, FUTUR NEUROL, V9, P49, DOI 10.2217/FNL.13.58; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nurputra DK, 2013, ANN HUM GENET, V77, P435, DOI 10.1111/ahg.12031; Ottesen EW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20193; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P797, DOI 10.1089/ars.2009.2913; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Papp LV, 2008, NUCLEIC ACIDS RES, V36, P7192, DOI 10.1093/nar/gkn829; Patel S, 2007, NEUROTOXICOL TERATOL, V29, P578, DOI 10.1016/j.ntt.2007.04.002; Rouget RL, 2005, BIOCHEM J, V385, P433, DOI 10.1042/BJ20041024; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Schmid R, 2013, NUCLEIC ACIDS RES, V41, P10170, DOI 10.1093/nar/gkt811; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Seo J, 2013, BBA-MOL BASIS DIS, V1832, P2180, DOI 10.1016/j.bbadis.2013.08.005; Sharma LK, 2011, HUM MOL GENET, V20, P4605, DOI 10.1093/hmg/ddr395; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NN, 2015, FUTURE MED CHEM, V7, P1793, DOI 10.4155/fmc.15.101; Singh NN, 2015, ANN NY ACAD SCI, V1341, P176, DOI 10.1111/nyas.12727; Singh NN, 2013, NUCLEIC ACIDS RES, V41, P8144, DOI 10.1093/nar/gkt609; Singh NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049595; Singh NN, 2011, RNA BIOL, V8, P600, DOI 10.4161/rna.8.4.16224; Singh NN, 2011, MOL CELL BIOL, V31, P935, DOI 10.1128/MCB.00945-10; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Singh NN, 2004, RNA, V10, P1291, DOI 10.1261/rna.7580704; Singh NN, 2004, BIOCHEM BIOPH RES CO, V315, P381, DOI 10.1016/j.bbrc.2004.01.067; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Tisdale S, 2015, J NEUROSCI, V35, P8691, DOI 10.1523/JNEUROSCI.0417-15.2015; Tranell A, 2010, J BIOL CHEM, V285, P31537, DOI 10.1074/jbc.M109.077453; Tsatsakis AM, 1996, VET HUM TOXICOL, V38, P113; Tsuiji H, 2013, EMBO MOL MED, V5, P221, DOI 10.1002/emmm.201202303; Turner BJ, 2014, NEUROBIOL AGING, V35, P906, DOI 10.1016/j.neurobiolaging.2013.09.030; Vitte J, 2007, AM J PATHOL, V171, P1269, DOI 10.2353/ajpath.2007.070399; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wee CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115205; Xing Y, 2007, ADV EXP MED BIOL, V623, P36, DOI 10.1007/978-0-387-77374-2_3; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yarosh CA, 2015, WIRES RNA, V6, P351, DOI 10.1002/wrna.1280	88	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154390	10.1371/journal.pone.0154390	http://dx.doi.org/10.1371/journal.pone.0154390			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111068	gold, Green Published, Green Submitted			2022-12-26	WOS:000374970600063
J	Klein, AN; Ziehm, T; Tusche, M; Buitenhuis, J; Bartnik, D; Boeddrich, A; Wiglenda, T; Wanker, E; Funke, SA; Brener, O; Gremer, L; Kutzsche, J; Willbold, D				Klein, Antonia Nicole; Ziehm, Tamar; Tusche, Markus; Buitenhuis, Johan; Bartnik, Dirk; Boeddrich, Annett; Wiglenda, Thomas; Wanker, Erich; Funke, Susanne Aileen; Brener, Oleksandr; Gremer, Lothar; Kutzsche, Janine; Willbold, Dieter			Optimization of the All-D Peptide D3 for A beta Oligomer Elimination	PLOS ONE			English	Article							THIOFLAVINE-T INTERACTION; ALZHEIMERS-DISEASE; FLUORESCENT; IMPROVES; PROGRESS	The aggregation of amyloid-beta (A beta) is postulated to be the crucial event in Alzheimer's disease (AD). In particular, small neurotoxic A beta oligomers are considered to be responsible for the development and progression of AD. Therefore, elimination of thesis oligomers represents a potential causal therapy of AD. Starting from the well-characterized D-enantiomeric peptide D3, we identified D3 derivatives that bind monomeric A beta. The underlying hypothesis is that ligands bind monomeric A beta and stabilize these species within the various equilibria with A beta assemblies, leading ultimately to the elimination of A beta oligomers. One of the hereby identified D-peptides, DB3, and a head-to-tail tandem of DB3, DB3DB3, were studied in detail. Both peptides were found to: (i) inhibit the formation of Thioflavin T-positive fibrils; (ii) bind to A beta monomers with micromolar affinities; (iii) eliminate A beta oligomers; (iv) reduce A beta-induced cytotoxicity; and (v) disassemble preformed A beta aggregates. The beneficial effects of DB3 were improved by DB3DB3, which showed highly enhanced efficacy. Our approach yielded A beta monomer-stabilizing ligands that can be investigated as a suitable therapeutic strategy against AD.	[Klein, Antonia Nicole; Ziehm, Tamar; Tusche, Markus; Bartnik, Dirk; Funke, Susanne Aileen; Brener, Oleksandr; Gremer, Lothar; Kutzsche, Janine; Willbold, Dieter] Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Buitenhuis, Johan] Res Ctr Julich, Inst Complex Syst, Soft Matter ICS 3, D-52425 Julich, Germany; [Boeddrich, Annett; Wiglenda, Thomas; Wanker, Erich] Max Delbruck Ctr Mol Med, Neuroproteomforsch & Mol Mech Neurodegenerativer, Berlin, Germany; [Funke, Susanne Aileen] Hsch Angew Wissensch Coburg, Fak Angew Nat Wissensch, Bioanalyt, D-96450 Coburg, Germany; [Brener, Oleksandr; Gremer, Lothar; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany.; Willbold, D (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany.	d.willbold@fz-juelich.de	Gremer, Lothar/H-9128-2013; Kutzsche, Janine/G-6287-2013; Willbold, Dieter/A-6280-2013; Buitenhuis, Johan/G-5228-2013	Gremer, Lothar/0000-0001-7065-5027; Kutzsche, Janine/0000-0003-0271-7390; Willbold, Dieter/0000-0002-0065-7366; Wiglenda, Thomas/0000-0002-8460-9459; Boddrich, Annett/0000-0001-9118-050X; Brener, Oleksandr/0000-0001-9771-7515; Ziehm, Tamar/0000-0003-0957-2518; Wanker, Erich/0000-0001-8072-1630; Buitenhuis, Johan/0000-0001-8849-2596	Portfolio Technology and Medicine; Portfolio Drug Research; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; TT-Fonds of the Technology Transfer Department of the Forschungszentrum Julich	Portfolio Technology and Medicine; Portfolio Drug Research; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; TT-Fonds of the Technology Transfer Department of the Forschungszentrum Julich	D. W. was supported by grants from the "Portfolio Technology and Medicine", the "Portfolio Drug Research" and the Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft. D. W. was also supported by the TT-Fonds of the Technology Transfer Department of the Forschungszentrum Julich.	Bartnik D, 2009, REJUV RES, V13, P202; Brener O, 2015, SCI REP-UK, V5, DOI 10.1038/srep13222; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Foong YM, 2012, CURR OPIN CHEM BIOL, V16, P234, DOI 10.1016/j.cbpa.2011.12.007; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jiang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128553; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Uttamchandani M, 2008, CURR PHARM DESIGN, V14, P2428, DOI 10.2174/138161208785777450; van Groen T, 2013, J ALZHEIMERS DIS, V34, P609, DOI 10.3233/JAD-121792; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; van Groen T, 2009, CHEMMEDCHEM, V4, P276, DOI 10.1002/cmdc.200800289; Wiesehan K, 2008, PROTEIN ENG DES SEL, V21, P241, DOI 10.1093/protein/gzm054; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631	25	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153035	10.1371/journal.pone.0153035	http://dx.doi.org/10.1371/journal.pone.0153035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105346	gold, Green Published, Green Accepted			2022-12-26	WOS:000374565100009
J	Strawbridge, RJ; Laumen, H; Hamsten, A; Breier, M; Grallert, H; Hauner, H; Arner, P; Dahlman, I				Strawbridge, Rona J.; Laumen, Helmut; Hamsten, Anders; Breier, Michaela; Grallert, Harald; Hauner, Hans; Arner, Peter; Dahlman, Ingrid			Effects of Genetic Loci Associated with Central Obesity on Adipocyte Lipolysis	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; KAPPA-B; ADIPOSE; TURNOVER; RESISTANCE; REVEALS; CELLS; WOMEN	Objectives Numerous genetic loci have been associated with measures of central fat accumulation, such as waist-to-hip ratio adjusted for body mass index (WHRadjBMI). However the mechanisms by which genetic variations influence obesity remain largely elusive. Lipolysis is a key process for regulation of lipid storage in adipocytes, thus is implicated in obesity and its metabolic complications. Here, genetic variants at 36 WHRadjBMI-associated loci were examined for their influence on abdominal subcutaneous adipocyte lipolysis. Subjects and Methods Fasting subcutaneous adipose tissue biopsies were collected from 789 volunteers (587 women and 202 men, body mass index (BMI) range 17.7-62.3 kg/m(2)). We quantified subcutaneous adipocyte lipolysis, both spontaneous and stimulated by the catecholamine isoprenaline or a cyclic AMP analogue. DNA was extracted from peripheral blood mononuclear cells and genotyping of SNPs associated with WHRadjBMI conducted. The effects on adipocyte lipolysis measures were assessed for SNPs individually and combined in a SNP score. Results The WHRadjBMI-associated loci CMIP, PLXND1, VEGFA and ZNRF3-KREMEN1 demonstrated nominal associations with spontaneous and/or stimulated lipolysis. Candidate genes in these loci have been reported to influence NF kappa B-signaling, fat cell size and Wnt signalling, all of which may influence lipolysis. Significance This report provides evidence for specific WHRadjBMI-associated loci as candidates to modulate adipocyte lipolysis. Additionally, our data suggests that genetically increased central fat accumulation is unlikely to be a major cause of altered lipolysis in abdominal adipocytes.	[Strawbridge, Rona J.; Hamsten, Anders] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Stockholm, Sweden; [Laumen, Helmut; Hauner, Hans] Tech Univ Munich, Chair Nutr Med, Else Kroner Fresenius Ctr Nutr Med, D-80290 Munich, Germany; [Laumen, Helmut; Hauner, Hans] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, D-80290 Munich, Germany; [Laumen, Helmut; Hauner, Hans] Helmholtz Zentrum Muenchen, Clin Cooperat Grp Nutrigen & Type Diabet 2, Munich, Germany; [Laumen, Helmut; Hauner, Hans] Tech Univ Munich, D-80290 Munich, Germany; [Laumen, Helmut; Breier, Michaela; Grallert, Harald; Hauner, Hans] German Ctr Diabet Res DZD, Neuherberg, Germany; [Laumen, Helmut; Breier, Michaela] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Expt Genet, Neuherberg, Germany; [Breier, Michaela; Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Epidemiol 2, Neuherberg, Germany; [Hauner, Hans] Tech Univ Munich, Klinikum Rechts Isar, Else Kroner Fresenius Ctr Nutr Med, D-80290 Munich, Germany; [Arner, Peter; Dahlman, Ingrid] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Karolinska Institutet	Dahlman, I (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	ingrid.dahlman@ki.se	Grallert, Harald/B-3424-2013; Strawbridge, Rona/H-5422-2012; Laumen, Helmut/M-5140-2013	Strawbridge, Rona/0000-0001-8506-3585; Dahlman, Ingrid/0000-0003-3819-5977; Laumen, Helmut/0000-0002-5885-5242; Arner, Peter/0000-0002-6208-6220	Swedish Research Council; Swedish Diabetes Foundation; Novo-Nordisk Foundation; EASD/lilly program; CIMED; Strategic Research Programme in Diabetes; Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany; Technische Universitat Munchen; SRP Diabetes program at Karolinska Institutet; Novo Nordisk Fonden [NNF15OC0015894] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Novo-Nordisk Foundation(Novo Nordisk Foundation); EASD/lilly program; CIMED; Strategic Research Programme in Diabetes; Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany; Technische Universitat Munchen; SRP Diabetes program at Karolinska Institutet; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Research Council, the Swedish Diabetes Foundation, the Novo-Nordisk Foundation, the EASD/lilly program, CIMED and the Strategic Research Programme in Diabetes. HL, HG and HH acknowledge the grant Clinical Cooperation Group "Nutrigenomics and type 2 diabetes" from the Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany, and the Technische Universitat Munchen. RJS is supported by the SRP Diabetes program at Karolinska Institutet.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arner P, 2014, TRENDS ENDOCRIN MET, V25, P255, DOI 10.1016/j.tem.2014.03.002; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Dahlman I, 2016, DIABETES, V65, P433, DOI 10.2337/db15-0828; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Frayn K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003467; Gao H, 2014, CELL METAB, V19, P981, DOI 10.1016/j.cmet.2014.03.032; Girousse A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001485; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hofker M, 2009, NAT GENET, V41, P139, DOI 10.1038/ng0209-139; Kamal M, 2009, MOL IMMUNOL, V46, P991, DOI 10.1016/j.molimm.2008.09.034; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; LANDIN K, 1990, EUR J CLIN INVEST, V20, P530, DOI 10.1111/j.1365-2362.1990.tb01897.x; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Minchin JEN, 2015, P NATL ACAD SCI USA, V112, P4363, DOI 10.1073/pnas.1416412112; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/s001250050128; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; RODBELL M, 1964, J BIOL CHEM, V239, P375; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ryden M, 2013, J LIPID RES, V54, P2909, DOI 10.1194/jlr.M040345; Schleinitz D, 2014, DIABETOLOGIA, V57, P1276, DOI 10.1007/s00125-014-3214-z; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109	28	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153990	10.1371/journal.pone.0153990	http://dx.doi.org/10.1371/journal.pone.0153990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104953	Green Published, gold, Green Accepted			2022-12-26	WOS:000374565100033
J	Chiu, PY; Tsai, CT; Chen, PK; Chen, WJ; Lai, TJ				Chiu, Pai-Yi; Tsai, Chun-Tang; Chen, Ping-Kun; Chen, Whe-Jen; Lai, Te-Jen			Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study	PLOS ONE			English	Article							AUTOPSY-CONFIRMED DEMENTIA; ALPHA-SYNUCLEIN; PSYCHOLOGICAL SYMPTOMS; PSYCHIATRIC-SYMPTOMS; PREVALENCE; DIAGNOSIS; BETA; CAREGIVERS; BURDEN; TAU	Background and purpose Previous studies on the clinical and pathological manifestations of Parkinson's disease dementia (PDD) have reported findings more similar to dementia with Lewy bodies (DLB) than to Alzheimer's disease (AD). The aim of this study was to investigate the neuropsychiatric symptoms of PDD compared to DLB and AD. Methods We conducted a retrospective case-control study on 125 newly diagnosed consecutive PDD patients and age-and dementia stage-matched controls with either DLB (N = 250) or AD (N = 500) who visited the same hospital over the same period. For each case and control, neuropsychiatric symptoms were assessed using the Neuropsychiatric Inventory (NPI). Results Overall, 513 (58.6%) patients were female and 362 (41.4%) were male. Comparisons of clinical data revealed that the PDD group, similar to the AD group, had a lower NPI total score, NPI caregiver burden score, and rate of antipsychotic use (all p < 0.001) than the DLB group. One or more psychiatric symptoms were reported in 95.2% of the PDD, 99.2% of the DLB, and 96.8% of the AD patients. The PDD group had lower subscores in the items of delusions, hallucinations, agitation, anxiety, irritation, aberrant motor behavior compared to the DLB group. Severe neuropsychiatric symptoms among all dementia patients were associated with younger age, more advanced stage, and a diagnosis of DLB. Conclusion Neuropsychiatric symptoms in PDD were more like those in AD than in DLB. Severe neuropsychiatric symptoms in degenerative dementia were associated with younger age, more advanced stage of dementia, and a diagnosis of DLB.	[Chiu, Pai-Yi; Lai, Te-Jen] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chiu, Pai-Yi] Show Chwan Mem Hosp, Dept Neurol, Changhua, Taiwan; [Tsai, Chun-Tang] Natl Changhua Univ Educ, Dept Guidance & Counseling, Changhua 500, Taiwan; [Chen, Ping-Kun; Chen, Whe-Jen] Lin Shin Hosp, Dept Neurol, Taichung, Taiwan; [Lai, Te-Jen] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung 40201, Taiwan	Chung Shan Medical University; Show Chwan Memorial Hospital; National Changhua University of Education; Chung Shan Medical University; Chung Shan Medical University Hospital	Lai, TJ (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Lai, TJ (corresponding author), Chung Shan Med Univ Hosp, Dept Psychiat, Taichung 40201, Taiwan.	tejenlai@hotmail.com						Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P137, DOI 10.1177/0891988704267470; Aarsland D, 2001, NEUROLOGY, V56, P730, DOI 10.1212/WNL.56.6.730; Aarsland D, 2001, INT J GERIATR PSYCH, V16, P528, DOI 10.1002/gps.389; Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Aarsland D, 2001, INT J GERIATR PSYCH, V16, P184, DOI 10.1002/1099-1166(200102)16:2<184::AID-GPS304>3.0.CO;2-K; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Ballard CG, 2004, AM J PSYCHIAT, V161, P843, DOI 10.1176/appi.ajp.161.5.843; Caputo M, 2008, ACTA PSYCHIAT SCAND, V117, P455, DOI 10.1111/j.1600-0447.2008.01175.x; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Colosimo C, 2003, J NEUROL NEUROSUR PS, V74, P852, DOI 10.1136/jnnp.74.7.852; Cummings J L, 1988, J Geriatr Psychiatry Neurol, V1, P24, DOI 10.1177/089198878800100106; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dugger BN, 2012, MOVEMENT DISORD, V27, P72, DOI 10.1002/mds.24003; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fujishiro H, 2008, J NEUROPATH EXP NEUR, V67, P649, DOI 10.1097/NEN.0b013e31817d7a1d; Hashimoto M, 2015, DEMENT GER COGN D EX, V5, P244, DOI 10.1159/000381800; Huang SS, 2012, ARCH GERONTOL GERIAT, V55, P55, DOI 10.1016/j.archger.2011.04.009; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Johnson DK, 2011, ALZ DIS ASSOC DIS, V25, P326, DOI 10.1097/WAD.0b013e31820d89b6; Kao AW, 2009, ALZ DIS ASSOC DIS, V23, P365, DOI 10.1097/WAD.0b013e3181b5065d; Lee DR, 2013, INT J GERIATR PSYCH, V28, P135, DOI 10.1002/gps.3799; Lin CL, 2016, EXP NEUROL, V275, P84, DOI 10.1016/j.expneurol.2015.10.009; Lopez-Pousa S, 2007, REV NEUROLOGIA, V45, P683, DOI 10.33588/rn.4511.2007535; Martinez-Martin P, 2015, PARKINSONISM RELAT D, V21, P629, DOI 10.1016/j.parkreldis.2015.03.024; McKeith Ian, 2009, Int Psychogeriatr, V21, P220, DOI 10.1017/S1041610208008624; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nambudiri DE, 1997, INT J GERIATR PSYCH, V12, P11, DOI 10.1002/(SICI)1099-1166(199701)12:1<11::AID-GPS435>3.3.CO;2-T; Noe E, 2004, MOVEMENT DISORD, V19, P60, DOI 10.1002/mds.10633; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Sadak TI, 2014, RES GERONTOL NURS, V7, P44, DOI 10.3928/19404921-20130918-01; Savica R, 2013, JAMA NEUROL, V70, P1396, DOI 10.1001/jamaneurol.2013.3579; Starkstein SE, 1996, J NEUROL NEUROSUR PS, V61, P381, DOI 10.1136/jnnp.61.4.381; Suarez-Gonzalez A, 2014, INT PSYCHOGERIATR, V26, P453, DOI 10.1017/S1041610213002068; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602	36	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153989	10.1371/journal.pone.0153989	http://dx.doi.org/10.1371/journal.pone.0153989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101140	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500118
J	Chua, GL; Tan, SM; Bhattacharjya, S				Chua, Geok-Lin; Tan, Suet-Mien; Bhattacharjya, Surajit			NMR Characterization and Membrane Interactions of the Loop Region of Kindlin-3 F1 Subdomain	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; ADHESION DEFICIENCY-III; UBIQUITIN-LIKE DOMAIN; INTEGRIN ACTIVATION; LEUKOCYTE ADHESION; STRUCTURAL BASIS; TALIN HEAD; BINDING; PROTEIN; EXPRESSION	Kindlins-1,2 and 3 are FERM domain-containing cytosolic proteins involved in the activation and regulation of integrin-mediated cell adhesion. Apart from binding to integrin beta cytosolic tails, kindlins and the well characterized integrin-activator talin bind membrane phospholipids. The ubiquitin-like F1 sub-domain of the FERM domain of talin contains a short loop that binds to the lipid membrane. By contrast, the F1 sub-domain of kindlins contains a long loop demonstrated binding to the membrane. Here, we report structural characterization and lipid interactions of the 83-residue F1 loop of kindlin-3 using NMR and optical spectroscopy methods. NMR studies demonstrated that the F1 loop of kindlin-3 is globally unfolded but stretches of residues assuming transient helical conformations could be detected in aqueous solution. We mapped membrane binding interactions of the F1 loop with small unilamellar vesicles (SUVs) containing either zwitterionic lipids or negatively charged lipids using N-15-H-1 HSQC titrations. These experiments revealed that the F1 loop of kindlin-3 preferentially interacted with the negatively charged SUVs employing almost all of the residues. By contrast, only fewer residues appeared to be interacted with SUVs containing neutral lipids. Further, CD and NMR data suggested stabilization of helical conformations and predominant resonance perturbations of the F1 loop in detergent containing solutions. Conformations of an isolated N-terminal peptide fragment, or EK21, of the F1 loop, containing a poly-Lys sequence motif, important for membrane interactions, were also investigated in detergent solutions. EK21 adopted a rather extended or beta-type conformations in complex with negatively charged SDS micelles. To our knowledge, this is the first report describing the conformations and residue-specific interactions of kindlin F1 loop with lipids. These data therefore provide important insights into the interactions of kindlin FERM domain with membrane lipids that contribute toward the integrin activating property.	[Chua, Geok-Lin; Tan, Suet-Mien; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM; Bhattacharjya, S (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	surajit@ntu.edu.sg; SMTan@ntu.edu.sg	Tan, Suet/A-2224-2011	Tan, Suet-Mien/0000-0003-2371-8739	Ministry of Education (MOE), Singapore [ARC18/13]	Ministry of Education (MOE), Singapore(Ministry of Education, Singapore)	This work was supported by a grant from the Ministry of Education (MOE), Singapore (ARC18/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2015, P NATL ACAD SCI USA, V112, P9614, DOI 10.1073/pnas.1512799112; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; Djaafri I, 2014, ONCOTARGET, V5, P8970, DOI 10.18632/oncotarget.2125; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hart R, 2013, J BIOL CHEM, V288, P14852, DOI 10.1074/jbc.M112.434621; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; Kalli AC, 2010, STRUCTURE, V18, P1280, DOI 10.1016/j.str.2010.07.012; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Pluskota E, 2013, BLOOD, V122, P2491, DOI 10.1182/blood-2013-04-497669; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Sossey-Alaoui K, 2014, FASEB J, V28, P2260, DOI 10.1096/fj.13-244004; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8531; Yates LA, 2012, J BIOL CHEM, V287, P43246, DOI 10.1074/jbc.M112.422089; Yu Y, 2013, INT J CANCER, V133, P1368, DOI 10.1002/ijc.28151; YU YW, 2013, PLOS GENET, V9, P71001, DOI DOI 10.1371/JOURNAL.PONE.0063490; Zhan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050313	43	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153501	10.1371/journal.pone.0153501	http://dx.doi.org/10.1371/journal.pone.0153501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101375	Green Published, gold			2022-12-26	WOS:000374898500036
J	Dimitrov, L; Pedersen, D; Ching, KH; Yi, H; Collarini, EJ; Izquierdo, S; van de Lavoir, MC; Leighton, PA				Dimitrov, Lazar; Pedersen, Darlene; Ching, Kathryn H.; Yi, Henry; Collarini, Ellen J.; Izquierdo, Shelley; van de lavoir, Marie-Cecile; Leighton, Philip A.			Germline Gene Editing in Chickens by Efficient CRISPR-Mediated Homologous Recombination in Primordial Germ Cells	PLOS ONE			English	Article							KNOCKOUT; SYSTEM; BIRDS	The CRISPR/Cas9 system has been applied in a large number of animal and plant species for genome editing. In chickens, CRISPR has been used to knockout genes in somatic tissues, but no CRISPR-mediated germline modification has yet been reported. Here we use CRISPR to target the chicken immunoglobulin heavy chain locus in primordial germ cells (PGCs) to produce transgenic progeny. Guide RNAs were co-transfected with a donor vector for homology-directed repair of the double-strand break, and clonal populations were selected. All of the resulting drug-resistant clones contained the correct targeting event. The targeted cells gave rise to healthy progeny containing the CRISPR-targeted locus. The results show that gene-edited chickens can be obtained by modifying PGCs in vitro with the CRISPR/Cas9 system, opening up many potential applications for efficient genetic modification in birds.	[Dimitrov, Lazar; Pedersen, Darlene; Ching, Kathryn H.; Yi, Henry; Collarini, Ellen J.; Izquierdo, Shelley; van de lavoir, Marie-Cecile; Leighton, Philip A.] Crystal Biosci Inc, Emeryville, CA USA		Leighton, PA (corresponding author), Crystal Biosci Inc, Emeryville, CA USA.	pal@crystalbioscience.com		Ching, Kathryn/0000-0002-1932-1504	Crystal Bioscience	Crystal Bioscience	Crystal Bioscience provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Collarini E, 2015, POULTRY SCI, V94, P799, DOI [10.3382/ps.2014-04372, 10.3382/ps.2014-4372]; Doran TJ, 2016, TRANSGENIC RES, V25, P307, DOI 10.1007/s11248-016-9926-8; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jordan BJ, 2014, J BIOTECHNOLOGY; Lai SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146562; Leighton PA, 2008, MOL REPROD DEV, V75, P1163, DOI 10.1002/mrd.20859; Leighton PA, 2016, TRANSGENIC RES, V25, P609, DOI 10.1007/s11248-016-9952-6; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Love J., 1994, NAT BIOTECHNOL, V12, P60; Merkert S, 2016, STEM CELL RES, V16, P377, DOI 10.1016/j.scr.2016.02.027; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Schusser B, 2013, HARNESSING GENE CONV, V8, DOI [10.1371/journal.pone.0080108, DOI 10.1371/JOURNAL.PONE.0080108]; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shimada K, 2014, GEN COMP ENDOCR, V196, P100, DOI 10.1016/j.ygcen.2013.11.001; Song YH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113381; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Tan WF, 2016, TRANSGENIC RES, V25, P273, DOI 10.1007/s11248-016-9932-x; Tyack SG, 2013, TRANSGENIC RES, V22, P1257, DOI 10.1007/s11248-013-9727-2; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13348	25	68	75	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154303	10.1371/journal.pone.0154303	http://dx.doi.org/10.1371/journal.pone.0154303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099923	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500181
J	Maus, GW; Whitney, D				Maus, Gerrit W.; Whitney, David			Motion-Dependent Filling-In of Spatiotemporal Information at the Blind Spot	PLOS ONE			English	Article							VISUAL-MOTION; POSITION; EXTRAPOLATION; REPRESENTATION; PSYCHOPHYSICS; PREDICTION; RETINOTOPY; SCOTOMAS; OBJECTS; PATTERN	We usually do not notice the blind spot, a receptor-free region on the retina. Stimuli extending through the blind spot appear filled in. However, if an object does not reach through but ends in the blind spot, it is perceived as "cut off" at the boundary. Here we show that even when there is no corresponding stimulation at opposing edges of the blind spot, well known motion-induced position shifts also extend into the blind spot and elicit a dynamic filling-in process that allows spatial structure to be extrapolated into the blind spot. We presented observers with sinusoidal gratings that drifted into or out of the blind spot, or flickered in counterphase. Gratings moving into the blind spot were perceived to be longer than those moving out of the blind spot or flickering, revealing motion-dependent filling-in. Further, observers could perceive more of a grating's spatial structure inside the blind spot than would be predicted from simple filling-in of luminance information from the blind spot edge. This is evidence for a dynamic filling-in process that uses spatiotemporal information from the motion system to extrapolate visual percepts into the scotoma of the blind spot. Our findings also provide further support for the notion that an explicit spatial shift of topographic representations contributes to motion-induced position illusions.	[Maus, Gerrit W.] Nanyang Technol Univ, Sch Humanities & Social Sci, Div Psychol, Singapore 639798, Singapore; [Maus, Gerrit W.; Whitney, David] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Whitney, David] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Whitney, David] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Maus, GW (corresponding author), Nanyang Technol Univ, Sch Humanities & Social Sci, Div Psychol, Singapore 639798, Singapore.; Maus, GW (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	maus@ntu.edu.sg	Maus, Gerrit W/A-7542-2011	Maus, Gerrit W/0000-0003-4843-3748	NIH from National Eye Institute [EY018216]; NATIONAL EYE INSTITUTE [R01EY018216] Funding Source: NIH RePORTER	NIH from National Eye Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grant NIH EY018216 from the National Eye Institute to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstis S, 2010, CURR BIOL, V20, pR664, DOI 10.1016/j.cub.2010.06.029; Araragi Y, 2009, SPATIAL VISION, V22, P339, DOI 10.1163/156856809788746273; Arnold DH, 2007, VISION RES, V47, P2403, DOI 10.1016/j.visres.2007.04.025; Arnold DH, 2014, VISION RES, V98, P99, DOI 10.1016/j.visres.2014.03.003; Awater H, 2005, J NEUROPHYSIOL, V94, P3314, DOI 10.1152/jn.01330.2004; Baek Y, 2012, VISION RES, V58, P33, DOI 10.1016/j.visres.2012.01.020; Berens C, 1923, Trans Am Ophthalmol Soc, V21, P271; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; DURGIN FH, 1995, PERCEPTION, V24, P827, DOI 10.1068/p240827; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Fu YX, 2004, J NEUROSCI, V24, P2165, DOI 10.1523/JNEUROSCI.5145-03.2004; Fu YX, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0003.2001; Kaneko S, 2012, J VISION, V12, DOI 10.1167/12.12.1; KAWABATA N, 1982, PERCEPT MOTOR SKILL, V55, P95, DOI 10.2466/pms.1982.55.1.95; Kleiner M, 2007, PERCEPTION, V36, P14; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Maus GW, 2006, VISION RES, V46, P4375, DOI 10.1016/j.visres.2006.08.028; Maus GW, 2013, NEURON, V78, P554, DOI 10.1016/j.neuron.2013.03.010; Maus GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019796; Maus GW, 2008, PSYCHOL SCI, V19, P1087, DOI 10.1111/j.1467-9280.2008.02205.x; Maus GW, 2009, J EXP PSYCHOL HUMAN, V35, P611, DOI 10.1037/a0012317; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Pessoa L., 2003, FILLING IN PERCEPTUA; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; RAMACHANDRAN VS, 1992, SCI AM, V266, P86, DOI 10.1038/scientificamerican0592-86; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Roach NW, 2011, CURR BIOL, V21, P740, DOI 10.1016/j.cub.2011.03.031; SAFRAN AB, 1993, NEURO-OPHTHALMOLOGY, V13, P309, DOI 10.3109/01658109309044579; Schlag J, 2002, NAT REV NEUROSCI, V3, P191, DOI 10.1038/nrn750; SPILLMANN L, 1992, VISION RES, V32, P1941, DOI 10.1016/0042-6989(92)90053-L; Spillmann L, 2006, VISION RES, V46, P4252, DOI 10.1016/j.visres.2006.08.033; Sundberg KA, 2006, NEURON, V49, P447, DOI 10.1016/j.neuron.2005.12.023; TRIPATHY SP, 1995, VISUAL NEUROSCI, V12, P385, DOI 10.1017/S0952523800008051; VIRSU V, 1974, PERCEPTION, V3, P323, DOI 10.1068/p030323; Whitney D, 2003, SCIENCE, V302, P878, DOI 10.1126/science.1087839; Whitney D, 2002, TRENDS COGN SCI, V6, P211, DOI 10.1016/S1364-6613(02)01887-9; Zur D, 2003, VISION RES, V43, P971, DOI 10.1016/S0042-6989(03)00038-5	40	7	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153896	10.1371/journal.pone.0153896	http://dx.doi.org/10.1371/journal.pone.0153896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100795	Green Published, gold			2022-12-26	WOS:000374898500091
J	McVeigh, J; Smith, A; Howie, E; Straker, L				McVeigh, Joanne; Smith, Anne; Howie, Erin; Straker, Leon			Trajectories of Television Watching from Childhood to Early Adulthood and Their Association with Body Composition and Mental Health Outcomes in Young Adults	PLOS ONE			English	Article							ANXIETY STRESS SCALES; PHYSICAL-ACTIVITY; VIEWING TIME; SEDENTARY BEHAVIOR; DEPRESSION; RISK; ADOLESCENCE; VALIDITY; VERSION; WEIGHT	Introduction Prior studies examining longitudinal patterns of television (TV) watching have tended to use analytical approaches which do not allow for heterogeneity in the variation of TV watching over time. In the current study, we used latent class analysis (LCA) to examine the relationships between television watching (from childhood to early adulthood) and body fat percentage (%) and mental health. Methods Data were collected from 2411 participants (50% female) from the Raine Study, a prospective birth cohort study in Australia. Participants were followed up over 15 years and answered questions about hours of TV watching per week at six time-points (5, 8, 10, 14, 17 and 20yrs). Trajectories of television watching were estimated using LCA and appropriate regression models used to test the association of television watching class with percentage body fat (measured by DXA) and mental health (DASS-21) at age 20. Physical activity was used as a covariate. Results Three distinct trajectories of TV watching were identified. Class 1 (47.4%) had consistently high (> 14 hrs/wk) levels of TV watching, Class 2 (37.9%) was characterised by an increase in TV watching over adolescence and Class 3 (14.7%) had consistently lower (< 14 hrs/wk) TV watching over 15 years. Sex was used as an active covariate in the latent class model and was significantly associated with class membership (p< 0.001), with females comprising 45%, 47% and 59% of Class 1, 2 and 3 respectively. In females, membership in Class 2 or 3 was associated with lower body fat % at age 20, compared to Class 1 (p< 0.001). For males, membership in Class 2 was associated with lower body fat % compared with males in Class 1 (p = 0.026). Membership of TV watching class and mental health were not related (p> 0.05). Conclusions TV watching from childhood to young adulthood appears to be a relatively stable behavior for around two thirds of participants, but not everyone tracks consistently. This study identified a subset of participants with low levels of TV watching in childhood and also that this group, despite an increase in TV watching over adolescence, maintained a lower level of body fat in young adulthood.	[McVeigh, Joanne; Smith, Anne; Howie, Erin; Straker, Leon] Curtin Univ, Dept Physiotherapy & Exercise Sci, Perth, WA 6845, Australia	Curtin University	McVeigh, J (corresponding author), Curtin Univ, Dept Physiotherapy & Exercise Sci, Perth, WA 6845, Australia.	Joanne.McVeigh@curtin.edu.au	McVeigh, Joanne/C-9363-2016; Straker, Leon M/B-2407-2013	McVeigh, Joanne/0000-0002-2446-3814; Straker, Leon M/0000-0002-7786-4128; Smith, Anne/0000-0002-4667-7389	University of Western Australia; Curtin University; Telethon Kids Institute; Women and Infants Research Foundation; Raine Medical Research Foundation; Edith Cowan University; NHMRC; CIHR(Canadian Institutes of Health Research) [MOP-82893]	University of Western Australia; Curtin University; Telethon Kids Institute; Women and Infants Research Foundation; Raine Medical Research Foundation; Edith Cowan University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CIHR(Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR))	Core funding for the Raine Study is provided by the University of Western Australia; Curtin University; the Telethon Kids Institute; the Women and Infants Research Foundation; the Raine Medical Research Foundation and Edith Cowan University. The authors thank the NHMRC for their long term contribution to funding the study over the last 25 years. The DXA data in the Yr 20 follow up was funded by CIHR(Canadian Institutes of Health Research) MOP-82893.	Alberga AS, 2012, PEDIATR OBES, V7, P261, DOI 10.1111/j.2047-6310.2011.00046.x; Berkey CS, 2003, PEDIATRICS, V111, P836, DOI 10.1542/peds.111.4.836; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-26; Borghese MM, 2014, APPL PHYSIOL NUTR ME, V39, P937, DOI 10.1139/apnm-2013-0551; Braithwaite I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074263; Certain LK, 2002, PEDIATRICS, V109, P634, DOI 10.1542/peds.109.4.634; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Wit L, 2011, PSYCHIAT RES, V186, P239, DOI 10.1016/j.psychres.2010.07.003; Feldman BJ, 2009, DEV PSYCHOL, V45, P652, DOI 10.1037/a0014851; Francis SL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-100; Gebremariam MK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-104; Hamer M, 2014, MED SCI SPORT EXER, V46, P718, DOI 10.1249/MSS.0000000000000156; Hancox RJ, 2004, LANCET, V364, P257, DOI 10.1016/S0140-6736(04)16675-0; Hands BP, 2011, J SCI MED SPORT, V14, P397, DOI 10.1016/j.jsams.2011.03.011; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Howie EK, 2016, MED SCI SPORTS EXERC; Jago R, 2005, INT J OBESITY, V29, P557, DOI 10.1038/sj.ijo.0802969; Kwon S, 2015, JAMA PEDIATR, V169, P666, DOI 10.1001/jamapediatrics.2015.0327; Lovibond S.H., 1996, MANUAL DEPRESSION AN, DOI DOI 10.1037/T01004-000; Lucas M, 2011, AM J EPIDEMIOL, V174, P1017, DOI 10.1093/aje/kwr218; Mekary RA, 2013, AM J EPIDEMIOL, V178, P474, DOI 10.1093/aje/kws590; Mitchell JA, 2013, INT J OBESITY, V37, P54, DOI 10.1038/ijo.2012.41; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Ng F, 2007, ACTA NEUROPSYCHIATR, V19, P304, DOI 10.1111/j.1601-5215.2007.00217.x; Proctor MH, 2003, INT J OBESITY, V27, P827, DOI 10.1038/sj.ijo.0802294; Rebar AL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1088; Robinson M, 2011, J PAEDIATR CHILD H, V47, P54, DOI 10.1111/j.1440-1754.2010.01891.x; Sanchez-Villegas A, 2008, MED SCI SPORT EXER, V40, P827, DOI 10.1249/MSS.0b013e31816348b9; Smith L, 2014, J EPIDEMIOLOGY COMMU; Sugiyama T, 2008, ANN BEHAV MED, V35, P245, DOI 10.1007/s12160-008-9017-z; Sui XM, 2015, MAYO CLIN PROC, V90, P184, DOI 10.1016/j.mayocp.2014.12.006; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Veerman JL, 2012, BRIT J SPORT MED, V46, P927, DOI [10.1136/bjsports-2011-085662, 10.1136/bjsm.2011.085662]; Viner RM, 2005, J PEDIATR-US, V147, P429, DOI 10.1016/j.jpeds.2005.05.005; Wennberg P, 2014, J EPIDEMIOL COMMUN H, V68, P928, DOI 10.1136/jech-2013-203504; Zick CD, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-84	39	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152879	10.1371/journal.pone.0152879	http://dx.doi.org/10.1371/journal.pone.0152879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27097324	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600021
J	Gupta, A; Hossain, MM; Miller, N; Kerin, M; Callagy, G; Gupta, S				Gupta, A.; Hossain, M. M.; Miller, N.; Kerin, M.; Callagy, G.; Gupta, S.			NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK-eIF2 alpha-ATF4 signalling in breast cancer	ONCOGENE			English	Article							UNFOLDED PROTEIN RESPONSE; STEROID-RECEPTOR COACTIVATOR-3; ENDOPLASMIC-RETICULUM STRESS; CELL FATE DECISIONS; ER STRESS; TRANSLATIONAL REGULATION; MESSENGER-RNA; PERK; ACTIVATION; EXPRESSION	XBP1 is a multitasking transcription factor and a key component of the unfolded protein response (UPR). Despite the wealth of knowledge about the role of XBP1 in luminal/ER-positive breast cancer, not much is known about the effectors of XBP1 in this context. Here we show that NCOA3 is a transcriptional target of XBP1. We observed increased expression of NCOA3 during conditions of UPR and oestrogen (E2) stimulation. Further investigations revealed a role for the IRE1-XBP1 axis in the induction of NCOA3 during UPR and oestrogen signalling. We identify a novel role for NCOA3 in activation of PERK-ATF4 axis during UPR where knockdown of NCOA3 compromised the optimal activation of the PERK-ATF4 pathway. We found that NCOA3 is required for induction of XBP1 during E2 stimulation and uncover a positive feedback regulatory loop that maintains high levels of NCOA3 and XBP1 in breast cancer. Furthermore, upregulated NCOA3 was required for XBP1-mediated resistance to antihormonal agents. Increased expression of NCOA3 was associated with poor prognosis and higher levels of XBP1-S in breast cancer tissues. Our results uncover a novel steroid hormone-independent role for NCOA3 in UPR signalling. Further we identify a positive feedback regulatory loop consisting of XBP1 and NCOA3 that maintains high levels of NCOA3 and XBP1 expression in breast cancer tissues. Taken together our data identify XBP1-NCOA3 axis that regulates cell fate decisions in ER-positive breast cancer cells.	[Gupta, A.; Hossain, M. M.; Callagy, G.; Gupta, S.] Natl Univ Ireland, Lambe Inst Translat Res, Sch Med, Discipline Pathol, Galway, Ireland; [Miller, N.; Kerin, M.] Natl Univ Ireland, Inst Clin Sci, Sch Med, Discipline Surg, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Gupta, S (corresponding author), Natl Univ Ireland, Inst Clin Sci, Sch Med, Discipline Pathol, Galway H91 REW4, Ireland.	sanjeev.gupta@nuigalway.ie	Miller, Nicola/F-4009-2018; gupta, sanjeev/B-2824-2008; Gupta, Sanjeev/AAG-9749-2020	Miller, Nicola/0000-0002-5416-7047; gupta, sanjeev/0000-0002-4691-6853; Gupta, Sanjeev/0000-0002-4691-6853; Kerin, Michael/0000-0003-4164-5561; Gupta, Ananya/0000-0001-8920-0815; Hossain, Muhammad Mosaraf/0000-0002-1308-1116	Health Research Board [HRA_HSR/2010/24]; Breast Cancer campaign [2011PR26]; Breast Cancer Campaign [2011MayPR26] Funding Source: researchfish	Health Research Board; Breast Cancer campaign; Breast Cancer Campaign	This publication has emanated from research conducted with the financial support of Health Research Board (grant number HRA_HSR/2010/24) and Breast Cancer campaign (grant number 2011PR26).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Binet F, 2015, CELL METAB, V22, P560, DOI 10.1016/j.cmet.2015.07.010; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cawley K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073870; Cawley K, 2011, METHOD ENZYMOL, V490, P31, DOI 10.1016/B978-0-12-385114-7.00002-7; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Clarke R, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00140; Coste A, 2006, EMBO J, V25, P2453, DOI 10.1038/sj.emboj.7601106; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Davies MPA, 2008, INT J CANCER, V123, P85, DOI 10.1002/ijc.23479; Ding LH, 2003, NUCLEIC ACIDS RES, V31, P5266, DOI 10.1093/nar/gkg731; Feng YX, 2014, CANCER DISCOV, V4, P702, DOI 10.1158/2159-8290.CD-13-0945; Gomez BP, 2007, FASEB J, V21, P4013, DOI 10.1096/fj.06-7990com; Gupta AK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12522; Gupta A, 2015, METHODS MOL BIOL, V1292, P19, DOI 10.1007/978-1-4939-2522-3_2; Gupta S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.74; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hu R, 2015, MOL CELL BIOL, V35, P379, DOI 10.1128/MCB.00847-14; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Kakiuchi C, 2006, J NEUROCHEM, V97, P545, DOI 10.1111/j.1471-4159.2006.03772.x; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lydon JP, 2011, ENDOCRINOLOGY, V152, P19, DOI 10.1210/en.2010-1012; Mujcic H, 2013, CLIN CANCER RES, V19, P6126, DOI 10.1158/1078-0432.CCR-13-0526; Murphy LC, 2000, CANCER RES, V60, P6266; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Read D.E., 2012, ENDOPLASMIC RETICULU, P143, DOI [10.1007/978-94-007-4351-9_6, DOI 10.1007/978-94-007-4351-9_6]; Reineke EL, 2014, J BIOL CHEM, V289, P17721, DOI 10.1074/jbc.M113.539908; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Sengupta S, 2010, HORM MOL BIOL CLIN I, V2, P235, DOI 10.1515/HMBCI.2010.025; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang H, 2004, CANCER RES, V64, P7169, DOI 10.1158/0008-5472.CAN-04-1176; Zhao C, 2003, CANCER, V98, P18, DOI 10.1002/cncr.11482	48	26	30	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2016	35	45					5860	5871		10.1038/onc.2016.121	http://dx.doi.org/10.1038/onc.2016.121			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EB7IR	27109102	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000387560800005
J	Meplan, C; Johnson, IT; Polley, ACJ; Cockell, S; Bradburn, DM; Commane, DM; Arasaradnam, RP; Mulholland, F; Zupanic, A; Mathers, JC; Hesketh, J				Meplan, Catherine; Johnson, Ian T.; Polley, Abigael C. J.; Cockell, Simon; Bradburn, David M.; Commane, Daniel M.; Arasaradnam, Ramesh P.; Mulholland, Francis; Zupanic, Anze; Mathers, John C.; Hesketh, John			Transcriptomics and proteomics show that selenium affects inflammation, cytoskeleton, and cancer pathways in human rectal biopsies	FASEB JOURNAL			English	Article						selenoprotein; NF kappa B; colorectal; cytokeratin; nutrigenomics	NF-KAPPA-B; GLUTATHIONE-PEROXIDASE 4; COLORECTAL-CANCER; SERUM SELENIUM; EXPRESSION; RISK; DISEASE; MUCOSA; HEALTH; GENES	Epidemiologic studies highlight the potential role of dietary selenium (Se) in colorectal cancer prevention. Our goal was to elucidate whether expression of factors crucial for colorectal homoeostasis is affected by physiologic differences in Se status. Using transcriptomics and proteomics followed by pathway analysis, we identified pathways affected by Se status in rectal biopsies from 22 healthy adults, including 11 controls with optimal status (mean plasma Se = 1.43 mu M) and 11 subjects with suboptimal status (mean plasma Se = 0.86 mu M). We observed that 254 genes and 26 proteins implicated in cancer (80%), immune function and inflammatory response (40%), cell growth and proliferation (70%), cellular movement, and cell death (50%) were differentially expressed between the 2 groups. Expression of 69 genes, including selenoproteins W1 and K, which are genes involved in cytoskeleton remodelling and transcription factor NF kappa B signaling, correlated significantly with Se status. Integrating proteomics and transcriptomics datasets revealed reduced inflammatory and immune responses and cytoskeleton remodelling in the suboptimal Se status group. This is the first study combining omics technologies to describe the impact of differences in Se status on colorectal expression patterns, revealing that suboptimal Se status could alter inflammatory signaling and cytoskeleton in human rectal mucosa and so influence cancer risk.	[Meplan, Catherine; Zupanic, Anze; Hesketh, John] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Meplan, Catherine; Arasaradnam, Ramesh P.] Newcastle Univ, Sch Biomed Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Meplan, Catherine; Commane, Daniel M.; Mathers, John C.; Hesketh, John] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Meplan, Catherine; Hesketh, John] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Cockell, Simon] Newcastle Univ, Bioinformat Support Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Arasaradnam, Ramesh P.; Mathers, John C.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Johnson, Ian T.; Polley, Abigael C. J.; Mulholland, Francis] Inst Food Res, Norwich Res Pk, Norwich, Norfolk, England; [Arasaradnam, Ramesh P.] Wansbeck Gen Hosp, Ashingon, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Meplan, C (corresponding author), Newcastle Univ, Sch Med, Sch Biomed Sci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	catherine.meplan@ncl.ac.uk	Johnson, Ian T/D-2892-2012; Duarte, Graziela Biude Silva/Q-7728-2016; Zupanic, Anze/B-9396-2008	Johnson, Ian T/0000-0002-2353-4609; Zupanic, Anze/0000-0003-3303-9086; Cockell, Simon/0000-0002-6831-9806; Commane, Daniel/0000-0002-0154-8540; Arasaradnam, Ramesh/0000-0002-2231-3062	Newcastle Healthcare Charity; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H011471/1]; United Kingdom Food Standards Agency [N12015]; BBSRC; Biotechnology and Biological Sciences Research Council [BB/H011471/1]; BBSRC [BBS/E/F/00042195, BB/H011471/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00042195] Funding Source: researchfish	Newcastle Healthcare Charity; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Food Standards Agency; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	C.M. was supported by the Newcastle Healthcare Charity and the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/H011471/1). I.T.J., A.C.J.P., and F.M. were supported by a contract from the United Kingdom Food Standards Agency (N12015) and by a BBSRC strategic grant to the Institute of Food Research. A.Z. was supported by funds from Grant BB/H011471/1 from the Biotechnology and Biological Sciences Research Council (awarded to J.E.H. and J.C.M.). The authors declare no conflicts of interest.	Alfonso P, 2005, PROTEOMICS, V5, P2602, DOI 10.1002/pmic.200401196; Banan A, 1999, J PHARMACOL EXP THER, V291, P1075; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Besson D, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.009712-1, 10.1074/mcp.M111.009712]; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Cole-Ezea P, 2012, FREE RADICAL BIO MED, V53, P488, DOI 10.1016/j.freeradbiomed.2012.05.029; Finley JW, 2001, BIOFACTORS, V14, P191, DOI 10.1002/biof.5520140124; Gong G, 2012, GENES NUTR, V7, P167, DOI 10.1007/s12263-011-0256-4; Hasler R, 2012, GENOME RES, V22, P2130, DOI 10.1101/gr.138347.112; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hughes DJ, 2015, INT J CANCER, V136, P1149, DOI 10.1002/ijc.29071; Jacobs ET, 2004, J NATL CANCER I, V96, P1669, DOI 10.1093/jnci/djh310; Jin QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066439; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Kipp AP, 2012, J NUTR BIOCHEM, V23, P1170, DOI 10.1016/j.jnutbio.2011.06.011; Laclaustra M, 2010, ATHEROSCLEROSIS, V210, P643, DOI 10.1016/j.atherosclerosis.2010.01.005; Lee J, 2000, BBA-GENE STRUCT EXPR, V1491, P355, DOI 10.1016/S0167-4781(00)00047-6; Legembre P, 2004, J BIOL CHEM, V279, P46742, DOI 10.1074/jbc.M404334200; Li YX, 2000, DNA CELL BIOL, V19, P113, DOI 10.1089/104454900314627; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Meiler S, 2013, J LEUKOCYTE BIOL, V93, P771, DOI 10.1189/jlb.1212647; Meplan C, 2012, MUTAGENESIS, V27, P177, DOI 10.1093/mutage/ger058; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Niskar AS, 2003, BIOL TRACE ELEM RES, V91, P1, DOI 10.1385/BTER:91:1:1; Nutritional Prevention of Cancer Study Group, 1996, JAMA-J AM MED ASSOC, V276, P1957; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Peters U, 2008, CANCER EPIDEM BIOMAR, V17, P1144, DOI 10.1158/1055-9965.EPI-07-2947; Polley ACJ, 2006, CANCER RES, V66, P6553, DOI 10.1158/0008-5472.CAN-06-0534; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Reddy BS, 1997, JNCI-J NATL CANCER I, V89, P506, DOI 10.1093/jnci/89.7.506; ROGERS KR, 1992, ANN RHEUM DIS, V51, P565, DOI 10.1136/ard.51.4.565; Sakthianandeswaren A, 2011, CANCER RES, V71, P3709, DOI 10.1158/0008-5472.CAN-10-2342; Shinozaki S, 2001, GUT, V48, P623, DOI 10.1136/gut.48.5.623; Slattery ML, 2009, CANCER PREV RES, V2, P922, DOI 10.1158/1940-6207.CAPR-08-0191; Stein MP, 2002, TRENDS CELL BIOL, V12, P374, DOI 10.1016/S0962-8924(02)02331-0; Sunde RA, 2008, BRIT J NUTR, V99, pS37, DOI 10.1017/S0007114508006831; Takata Y, 2011, CANCER EPIDEM BIOMAR, V20, P1822, DOI 10.1158/1055-9965.EPI-11-0364; Takubo T, 2003, EUR J HISTOCHEM, V47, P345; Tapp HS, 2013, AGING CELL, V12, P148, DOI 10.1111/acel.12030; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Wapenaar MC, 2007, IMMUNOGENETICS, V59, P349, DOI 10.1007/s00251-007-0199-5; Zemolin APP, 2012, TOXICOLOGY, V302, P60, DOI 10.1016/j.tox.2012.07.013; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	46	31	34	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2812	+		10.1096/fj.201600251R	http://dx.doi.org/10.1096/fj.201600251R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27103578	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000380994000017
J	Santarem, OLD; de Cleva, R; Sasaya, FM; de Assumpcao, MS; Furtado, MS; Barbato, AJG; Herman, P				de Andrade Santarem, Orlando Luis; de Cleva, Roberto; Sasaya, Flavia Megumi; de Assumpcao, Marianna Siqueira; Furtado, Meive Santos; Guedes Barbato, Alfonso Julio; Herman, Paulo			Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; HEPATOPULMONARY SYNDROME; LIVER-TRANSPLANTATION; AORTIC REGURGITATION; ESOPHAGEAL DOPPLER; CARDIAC-OUTPUT; CIRRHOSIS; DISEASE; ABNORMALITIES; HEMODYNAMICS	Objective The aim of this study was to prospectively investigate the long-term cardiovascular and pulmonary hemodynamic effects of surgical shunt for treatment of portal hypertension (PH) due to Schistosomiasis mansoni. Location The University of Sao Paulo Medical School, Brazil; Public Practice. Methods Hemodynamic evaluation was performed with transesophageal Doppler and contrast-enhanced echocardiography (ECHO) on twenty-eight participants with schistosomal portal hypertension. Participants were divided into two groups according to the surgical procedure used to treat their schistosomal portal hypertension within the last two years: group 1-distal splenorenal shunt (DSRS, n = 13) and group 2-esophagogastric devascularization and splenectomy (EGDS, n = 15). Results The cardiac output (5.08 +/- 0.91 L/min) and systolic volume (60.1 +/- 5.6 ml) were increased (p = 0.001) in the DSRS group. DSRS participants had a significant increase (p < 0.0001) in their left ventricular end-systolic and end-diastolic diameters as well as in their left ventricular end-diastolic and end-systolic volumes (p < 0.001) compared with the preoperative period. No statistically significant difference was found in the patients who underwent EGDS. ECHO revealed intrapulmonary vasodilatation (IPV) in 18 participants (64%), 9 DSRS and 9 EGDS (p > 0.05). Conclusions The late increase in the cardiac output, stroke volume and left ventricular diameters demonstrated left ventricular dilatation after a distal splenorenal shunt. ECHO revealed a greater prevalence for IPV in patients with schistosomiasis than has previously been described in patients with PH from liver cirrhosis.	[de Andrade Santarem, Orlando Luis; de Cleva, Roberto; Sasaya, Flavia Megumi; de Assumpcao, Marianna Siqueira; Herman, Paulo] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil; [Furtado, Meive Santos; Guedes Barbato, Alfonso Julio] Univ Sao Paulo, Sch Med, Dept Radiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Santarem, OLD (corresponding author), Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil.	orlandoluisantarem@hotmail.com	de cleva, roberto/AAG-6927-2019; Herman, Paulo/J-5457-2013; de cleva, roberto/L-8456-2013	de cleva, roberto/0000-0001-8673-9014; Herman, Paulo/0000-0003-2859-5846; de cleva, roberto/0000-0001-8673-9014	FAPESP (Sao Paulo State Research Foundation)	FAPESP (Sao Paulo State Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by FAPESP (Sao Paulo State Research Foundation).	Abbas SM, 2008, ANAESTHESIA, V63, P44, DOI 10.1111/j.1365-2044.2007.05233.x; Abrams GA, 1998, GASTROENTEROLOGY, V114, P305, DOI 10.1016/S0016-5085(98)70481-0; Abrams GA, 1995, GASTROENTEROLOGY, V114, P305; AGUSTI AG, 1989, AM REV RESPIR DIS, V139, P485, DOI 10.1164/ajrccm/139.2.485; Alizadeh AHM, 2006, WORLD J GASTROENTERO, V12, P1954, DOI 10.3748/wjg.v12.i12.1954; Anand A C, 2001, Indian J Gastroenterol, V20, P24; BABBS C, 1988, GUT, V29, P129, DOI 10.1136/gut.29.1.129; Bina José Carlos, 2003, Rev. Soc. Bras. Med. Trop., V36, P211, DOI 10.1590/S0037-86822003000200003; Brussino L, 2003, LANCET, V362, P43, DOI 10.1016/S0140-6736(03)13807-X; CREMONA G, 1995, EUR RESPIR J, V8, P1883, DOI 10.1183/09031936.95.08111883; Cury AA, 1989, REV COL BRAS CIR, V16, P117; DASILVA LC, 1986, ANN SURG, V204, P148, DOI 10.1097/00000658-198608000-00008; De BK, 2002, GASTROENTEROLOGY, V122, P897, DOI 10.1053/gast.2002.32419; De BK, 2000, GASTROENTEROLOGY, V118, P192, DOI 10.1016/S0016-5085(00)70428-8; de Cleva R, 1999, AM J GASTROENTEROL, V94, P1632, DOI 10.1111/j.1572-0241.1999.01086.x; de Cleva R, 2007, WORLD J GASTROENTERO, V13, P5471, DOI 10.3748/wjg.v13.i41.5471; Eldridge MW, 2004, J APPL PHYSIOL, V97, P797, DOI 10.1152/japplphysiol.00137.2004; EZZAT FA, 1990, ANN SURG, V212, P97, DOI 10.1097/00000658-199007000-00013; Fallon MB, 2005, J CLIN GASTROENTEROL, V39, pS138, DOI 10.1097/01.mcg.0000155570.19340.61; FEINBERG MS, 1995, CHEST, V107, P769, DOI 10.1378/chest.107.3.769; Ferraz AAB, 2001, INT SURG, V86, P1; Ferreira FG, 2009, WORLD J SURG, V33, P2136, DOI 10.1007/s00268-009-0196-y; Fuhrmann V, 2006, GASTROENTEROLOGY, V131, P69, DOI 10.1053/j.gastro.2006.04.014; Gupta D, 2001, AM J GASTROENTEROL, V96, P3395; Helmy A, 2003, GUT, V52, P410, DOI 10.1136/gut.52.3.410; HENRY WL, 1980, CIRCULATION, V61, P484, DOI 10.1161/01.CIR.61.3.484; HIND CRK, 1981, GUT, V22, P1042, DOI 10.1136/gut.22.12.1042; INGRAM CW, 1987, CHEST, V92, P1117, DOI 10.1378/chest.92.6.1117; Kaymakoglu S, 2003, DIGEST DIS SCI, V48, P556, DOI 10.1023/A:1022549018807; KELNER S, 1992, MEM I OSWALDO CRUZ, V87, P357, DOI 10.1590/S0074-02761992000800057; Krowka MJ, 2000, CHEST, V118, P615, DOI 10.1378/chest.118.3.615; Krowka MJ, 2005, CLIN CHEST MED, V26, P587, DOI 10.1016/j.ccm.2005.06.010; KROWKA MJ, 1990, CHEST, V97, P1165, DOI 10.1378/chest.97.5.1165; KROWKA MJ, 1994, CHEST, V105, P1528, DOI 10.1378/chest.105.5.1528; Laupland KB, 2002, CAN J ANAESTH, V49, P393, DOI 10.1007/BF03017329; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; Maganty K, 2011, TRANSPL P, V43, P2814, DOI 10.1016/j.transproceed.2011.07.003; Makdissi FF, 2010, WORLD J SURG, V34, P2682, DOI 10.1007/s00268-010-0717-8; Marciniak A, 2009, EUR J ECHOCARDIOGR, V10, P112, DOI 10.1093/ejechocard/jen185; Martinez G, 1999, J HEPATOL, V30, P882, DOI 10.1016/S0168-8278(99)80143-3; MOORE K, 1992, NEW ENGL J MED, V327, P1774, DOI 10.1056/NEJM199212173272502; Morawietz H, 2000, J PHYSIOL-LONDON, V525, P761, DOI 10.1111/j.1469-7793.2000.00761.x; Ori Y, 1996, NEPHROL DIAL TRANSPL, V11, P94; Poeze M, 1999, CRIT CARE MED, V27, P1288, DOI 10.1097/00003246-199907000-00013; RAIA S, 1984, WORLD J SURG, V8, P738, DOI 10.1007/BF01655771; Rodriguez Roisin R, 2008, NEW ENGL J MED, V358, P2378, DOI DOI 10.1056/NEJMRA0707185; Rodriguez-Roisin R, 2004, EUR RESPIR J, V24, P861, DOI 10.1183/09031936.04.00010904; RODRIGUEZROISIN R, 1994, EUR RESPIR J, V7, P839; RODRIGUEZROISIN R, 1992, THORAX, V47, P897, DOI 10.1136/thx.47.11.897; Rolla G, 1997, HEPATOLOGY, V26, P842, DOI 10.1002/hep.510260406; Rosenhek R, 2010, CIRCULATION, V121, P151, DOI 10.1161/CIRCULATIONAHA.109.894170; Schenk P, 2002, GUT, V51, P853, DOI 10.1136/gut.51.6.853; SINGER M, 1991, CRIT CARE MED, V19, P1132, DOI 10.1097/00003246-199109000-00007; SINGER M, 1989, CRIT CARE MED, V17, P447, DOI 10.1097/00003246-198905000-00014; SINGER M, 1989, CRIT CARE MED, V17, P1060, DOI 10.1097/00003246-198910000-00019; STETZ CW, 1982, AM REV RESPIR DIS, V126, P1001; Stickland MK, 2004, J PHYSIOL-LONDON, V561, P321, DOI 10.1113/jphysiol.2004.069302; Tang LP, 2007, AM J PHYSIOL-LUNG C, V292, pL1467, DOI 10.1152/ajplung.00446.2006; Teuber Gerlinde, 2002, Eur J Intern Med, V13, P311, DOI 10.1016/S0953-6205(02)00066-3; Toledo CF, 2009, DIGEST DIS SCI, V54, P1331, DOI [10.1007/s10620-008-0475-8, DOI 10.1007/S10620-008-0475-8]; Tripathi D, 2006, GUT, V55, P1290, DOI 10.1136/gut.2005.077453; van Duijnhoven ECM, 2001, NEPHROL DIAL TRANSPL, V16, P368, DOI 10.1093/ndt/16.2.368; WEST J, 1990, PULMONARY PATHOPHYSI; WHO, 2007, WHO TECH REP SER, V935, P1; WILLIAMS A, 1979, THORAX, V34, P447, DOI 10.1136/thx.34.4.447	65	1	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154011	10.1371/journal.pone.0154011	http://dx.doi.org/10.1371/journal.pone.0154011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119143	Green Published, gold			2022-12-26	WOS:000374976200040
J	Haines, RJ; Beard, RS; Eitner, RA; Chen, LW; Wu, MH				Haines, Ricci J.; Beard, Richard S., Jr.; Eitner, Rebecca A.; Chen, Liwei; Wu, Mack H.			TNF alpha/IFN gamma Mediated Intestinal Epithelial Barrier Dysfunction Is Attenuated by MicroRNA-93 Downregulation of PTK6 in Mouse Colonic Epithelial Cells	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; GENE-EXPRESSION; IFN-GAMMA; ACTIVATION; KINASE; JNK; PERMEABILITY; FAMILY	Since inflammatory bowel diseases (IBD) represent significant morbidity and mortality in the US, the need for defining novel drug targets and inflammatory mechanisms would be of considerable benefit. Although protein tyrosine kinase 6 (PTK6, also known as breast tumor kinase BRK) has been primarily studied in an oncogenic context, it was noted that PTK6 null mice exhibited significantly enhanced colonic epithelial barrier function. Considering that the inflammatory functions of PTK6 have not yet been explored, we hypothesized that cytokines responsible for mediating IBD, such as TNF alpha/IFN gamma, may solicit the action of PTK6 to alter barrier function. After first assessing critical mediators of TNF alpha/IFN gamma driven epithelial barrier dysfunction, we further explored the possibility of PTK6 in this inflammatory context. In this report, we showed that PTK6 siRNA and PTK6 null young adult mouse colonic epithelial cells (YAMC) exhibited significant attenuation of TNF alpha/IFN gamma induced barrier dysfunction as measured by electric cell-substrate impedance sensing (ECIS) assay and permeability assays. In addition, PTK6 null cells transfected with PTK6 cDNA displayed restored barrier dysfunction in response to TNF alpha/IFN gamma, while the cells transfected with vector alone showed similar attenuation of barrier dysfunction. Furthermore, using subcellular fractionation and immunocytochemistry experiments, we found that PTK6 plays a role in FoxO1 nuclear accumulation leading to down-regulation of claudin-3, a tight junction protein. Moreover, we searched for relevant miRNA candidates putative for targeting PTK6 in order to identify and assess the impact of microRNA that target PTK6 with respect to TNF alpha/IFN gamma induced barrier dysfunction. Subsequently, we assayed likely targets and determined their effectiveness in attenuating PTK6 expression as well as cytokine induced barrier dysfunction. Results showed that miR-93 reduced PTK6 expression and attenuated TNF alpha/IFN gamma imposed decrease in transepithelial electrical resistance (TER), as well as excluded FoxO1 from the nucleus. Our results indicate that PTK6 may act as a novel mediator of intestinal epithelial permeability during inflammatory injury, and miR-93 may protect intestinal epithelial barrier function, at least in part, by targeting PTK6.	[Wu, Mack H.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Haines, Ricci J.; Eitner, Rebecca A.; Chen, Liwei; Wu, Mack H.] Univ S Florida, Dept Surg, Morsani Coll Med, Tampa, FL 33620 USA; [Beard, Richard S., Jr.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Wu, MH (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.; Wu, MH (corresponding author), Univ S Florida, Dept Surg, Morsani Coll Med, Tampa, FL 33620 USA.	mwu1@health.usf.edu	Beard, Richard Scott/I-3695-2019; Beard Jr., Richard/E-2051-2013	Beard, Richard Scott/0000-0001-8545-3014; Beard Jr., Richard/0000-0001-8545-3014	U.S. Department of Veterans' Affairs [BX000799]; National Institutes of Health [R01 HL096640, HL120954]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096640, R01HL120954] Funding Source: NIH RePORTER	U.S. Department of Veterans' Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by U.S. Department of Veterans' Affairs (Merit Review BX000799); National Institutes of Health (R01 HL096640 & HL120954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Amin MR, 2006, AM J PHYSIOL-CELL PH, V291, pC887, DOI 10.1152/ajpcell.00630.2005; Beard RS, 2014, J CELL SCI, V127, P1840, DOI 10.1242/jcs.144550; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Cao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061944; Carrozzino F, 2009, AM J PHYSIOL-CELL PH, V297, pC775, DOI 10.1152/ajpcell.00084.2009; Chang MH, 2004, ZOOLOGY, V107, P121, DOI 10.1016/j.zool.2004.03.001; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Ghatak S, 2015, MOL THER, V23, P1201, DOI 10.1038/mt.2015.65; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Haines RJ, 2015, BIOCHEM BIOPH RES CO, V456, P190, DOI 10.1016/j.bbrc.2014.11.057; Hardyman MA, 2013, J ALLERGY CLIN IMMUN, V132, P665, DOI 10.1016/j.jaci.2013.03.005; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jiang LL, 2015, ONCOTARGET, V6, P8286, DOI 10.18632/oncotarget.3221; Lu CM, 2014, GASTROENTEROLOGY, V146, P188, DOI 10.1053/j.gastro.2013.09.006; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; McKay DM, 1997, J IMMUNOL, V159, P2382; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Palka-Hamblin HL, 2010, J CELL SCI, V123, P236, DOI 10.1242/jcs.053264; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Rigor RR, 2013, MED RES REV, V33, P911, DOI 10.1002/med.21270; Seiler F, 2013, J IMMUNOL, V190, P1603, DOI 10.4049/jimmunol.1200596; Shen B, 2010, AM J PHYSIOL-HEART C, V298, pH1048, DOI 10.1152/ajpheart.00826.2009; Sun CX, 2010, CARDIOVASC RES, V87, P348, DOI 10.1093/cvr/cvq060; Terryn C, 2013, CYTOM PART A, V83A, P235, DOI 10.1002/cyto.a.22239; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Wang Y, 2013, ACTA HISTOCHEM, V115, P557, DOI 10.1016/j.acthis.2012.12.005; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Whitehead RH, 2008, J GASTROEN HEPATOL, V23, P1119, DOI 10.1111/j.1440-1746.2008.05308.x; Wicovsky A, 2007, J BIOL CHEM, V282, P2174, DOI 10.1074/jbc.M606167200; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200; Zheng Y, 2013, ONCOGENE, V32, P4304, DOI 10.1038/onc.2012.427; Zhong JL, 2008, MOL CANCER RES, V6, P383, DOI 10.1158/1541-7786.MCR-07-2028	37	30	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154351	10.1371/journal.pone.0154351	http://dx.doi.org/10.1371/journal.pone.0154351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119373	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200062
J	Hong, YF; Kim, H; Kim, HS; Park, WJ; Kim, JY; Chung, DK				Hong, Yi-Fan; Kim, Hangeun; Kim, Hye Sun; Park, Woo Jung; Kim, Joo-Yun; Chung, Dae Kyun			Lactobacillus acidophilus K301 Inhibits Atherogenesis via Induction of 24 (S), 25-Epoxycholesterol-Mediated ABCA1 and ABCG1 Production and Cholesterol Efflux in Macrophages	PLOS ONE			English	Article							LIVER-X-RECEPTOR; LIPOTEICHOIC ACID; PLANTARUM; ATHEROSCLEROSIS; EXPRESSION; 24(S),25-EPOXYCHOLESTEROL; LIPOPOLYSACCHARIDE; MEMBRANE; LIGAND	Lactobacillus acidophilus species are well-known probiotics with the beneficial activity of regulating cholesterol levels. In this study, we showed that L. acidophilus K301 reduced the level of cholesterol through reverse transport in macrophages. L. acidophilus K301 upregulated the mRNA and protein levels of genes such as ATP-binding cassette A1 (ABCA1) and ATP-binding cassette G1 (ABCG1) under the control of liver X receptor (LXR), resulting in increased apoA-I-dependent cholesterol efflux in phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 cells. L. acidophilus K301 induced both ABCA1 and ABCG1 through the endogenous LXR agonist 24(S), 25-epoxcycholesterol, which is synthesized by intracellular cholesterol synthetic pathways. In vivo studies using L. acidophilus K301-treated ApoE(-/-) mice showed reduced accumulation of lipoproteins in the arterial lumen. The inhibitory effects of L. acidophilus K301 on accumulation of lipoprotein in atherosclerotic plaques were mediated by the induction of squalene reductase (SQLE) and oxidosqualene cyclase (OSC) and resulted in ABCA1-mediated cholesterol efflux. Taken together, our findings revealed that Lactobacillus acidophilus K301 regulates the expression of genes related to cholesterol reverse transport via the induction of endogenous LXR agonist, suggesting the therapeutic potential of Lactobacillus acidophilus K301 as an anti-atherosclerotic agent.	[Hong, Yi-Fan; Kim, Hangeun; Kim, Hye Sun; Park, Woo Jung; Kim, Joo-Yun; Chung, Dae Kyun] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea; [Hong, Yi-Fan; Kim, Hangeun; Kim, Hye Sun; Park, Woo Jung; Kim, Joo-Yun; Chung, Dae Kyun] Kyung Hee Univ, Inst Life Sci & Resources, Yongin 446701, South Korea; [Hong, Yi-Fan; Kim, Hangeun; Chung, Dae Kyun] Kyung Hee Univ, Skin Biotechnol Ctr, Yongin 446701, South Korea; [Chung, Dae Kyun] RNA Inc, 308 Life Sceince Bldg, Yongin 446701, South Korea; [Kim, Hye Sun] Ajou Univ, Dept Neurosurg, Sch Med, Suwon 443749, South Korea; [Park, Woo Jung] Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangnung 210702, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Ajou University; Kangnung Wonju National University	Kim, JY; Chung, DK (corresponding author), Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea.; Kim, JY; Chung, DK (corresponding author), Kyung Hee Univ, Inst Life Sci & Resources, Yongin 446701, South Korea.; Chung, DK (corresponding author), Kyung Hee Univ, Skin Biotechnol Ctr, Yongin 446701, South Korea.; Chung, DK (corresponding author), RNA Inc, 308 Life Sceince Bldg, Yongin 446701, South Korea.	99djawl@hanmail.net; dkchung@khu.ac.kr	chung, dae kyun/AAG-1058-2021		Kyung Hee University [KHU-20120816]; RNA Inc.	Kyung Hee University; RNA Inc.	This work was supported by a grant from Kyung Hee University in 2012 (KHU-20120816). RNA Inc. provided support in the form of salaries for authors [DKC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Brown AJ, 2009, INT J BIOCHEM CELL B, V41, P744, DOI 10.1016/j.biocel.2008.05.029; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; DESMET I, 1994, MICROB ECOL HEALTH D, V7, P315, DOI 10.3109/08910609409141371; ERKELENS DW, 1988, DRUGS, V36, P87, DOI 10.2165/00003495-198800363-00018; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; GILLILAND SE, 1977, APPL ENVIRON MICROB, V33, P15, DOI 10.1128/AEM.33.1.15-18.1977; GILLILAND SE, 1985, APPL ENVIRON MICROB, V49, P377, DOI 10.1128/AEM.49.2.377-381.1985; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1979, J BIOL CHEM, V254, P5403; Huang Y, 2014, APPL ENVIRON MICROB, V80, P7496, DOI 10.1128/AEM.02926-14; Jeong JH, 2015, IMMUNOBIOLOGY, V220, P460, DOI 10.1016/j.imbio.2014.11.002; Kannel WB, 1984, CIRCULATION, V70, p155A; Kaplan R, 2002, J LIPID RES, V43, P952; Kawashima RL, 2014, BIOCHEM BIOPH RES CO, V450, P1416, DOI 10.1016/j.bbrc.2014.07.015; Kim H, 2014, J MICROBIOL BIOTECHN, V24, P1051, DOI 10.4014/jmb.1403.03012; Kim JS, 2013, MOL CELLS, V35, P17, DOI 10.1007/s10059-013-2154-7; Kumar M, 2012, EXP DIABETES RES, V2012, DOI [10.1155/2012/902917, DOI 10.1155/2012/902917]; LAW MR, 1994, BMJ-BRIT MED J, V308, P363, DOI 10.1136/bmj.308.6925.363; Lehrke M, 2005, CELL METAB, V1, P297, DOI 10.1016/j.cmet.2005.04.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murthy S, 2002, J LIPID RES, V43, P1054, DOI 10.1194/jlr.M100358-JLR200; Nakaya K, 2007, J ATHEROSCLER THROMB, V14, P133, DOI 10.5551/jat.14.133; Noh DO, 1997, J DAIRY SCI, V80, P3107, DOI 10.3168/jds.S0022-0302(97)76281-7; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Schoonjans K, 2000, J MOL BIOL, V304, P323, DOI 10.1006/jmbi.2000.4218; Slalter J, 1996, NUR FOOD SCI, V96, P29; SUCKLING KE, 1991, ATHEROSCLEROSIS, V89, P183, DOI 10.1016/0021-9150(91)90059-C; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Trasino SE, 2013, J NUTR BIOCHEM, V24, P1931, DOI 10.1016/j.jnutbio.2013.06.001; Usman, 2001, J DAIRY RES, V68, P617, DOI 10.1017/S0022029901005179; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Yoon HS, 2013, J SCI FOOD AGR, V93, P781, DOI 10.1002/jsfa.5797; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1269, DOI 10.1016/j.bbalip.2011.11.009	36	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154302	10.1371/journal.pone.0154302	http://dx.doi.org/10.1371/journal.pone.0154302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120199	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200057
J	McAuley, K; McAullay, D; Strobel, NA; Marriott, R; Atkinson, DN; Marley, JV; Stanley, FJ; Edmond, KM				McAuley, Kimberley; McAullay, Daniel; Strobel, Natalie A.; Marriott, Rhonda; Atkinson, David N.; Marley, Julia V.; Stanley, Fiona J.; Edmond, Karen M.			Hospital Utilisation in Indigenous and Non-Indigenous Infants under 12 Months of Age in Western Australia, Prospective Population Based Data Linkage Study	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT PRESENTATIONS; STRAIT ISLANDER PEOPLE; HEALTH-SERVICES; RETROSPECTIVE COHORT; IDENTIFICATION; PRACTITIONERS; ACCESSIBILITY; QUALITY; RECORDS	Background Indigenous infants (infants aged under 12 months) have the highest hospital admission and emergency department presentation risks in Australia. However, there have been no recent reports comparing hospital utilisation between Indigenous and non-Indigenous infants. Methods Our primary objective was to use a large prospective population-based linked dataset to assess the risk of all-cause hospital admission and emergency department presentation in Indigenous compared to non-Indigenous infants in Western Australia (WA). Secondary objectives were to assess the effect of socio-economic status (Index of Relative Socio-Economic Disadvantage [IRSD]) on hospital utilisation and to understand the causes of hospital utilisation. Findings There were 3,382 (5.4%) Indigenous and 59,583 (94.6%) non-Indigenous live births in WA from 1 January 2010 to 31 December 2011. Indigenous infants had a greater risk of hospital admission (adjusted odds ratio [aOR] 1.90, 95% confidence interval [95% CI] 1.77-2.04, p = <0.001) and emergency department presentation (aOR 2.15, 95% CI 1.98-2.33, p = <0.001) compared to non-Indigenous infants. Fifty nine percent (59.0%) of admissions in Indigenous children were classified as preventable compared to 31.2% of admissions in non-Indigenous infants (aOR 2.12, 95% CI 1.88-2.39). The risk of hospital admission in the most disadvantaged (IRSD 1) infants in the total cohort (35.7%) was similar to the risk in the least disadvantaged (IRSD 5) infants (30.6%) (aOR 1.04, 95% CI 0.96-1.13, p = 0.356). Interpretation WA Indigenous infants have much higher hospital utilisation than non Indigenous infants. WA health services should prioritise Indigenous infants regardless of their socio economic status or where they live.	[McAuley, Kimberley; McAullay, Daniel; Strobel, Natalie A.; Edmond, Karen M.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [McAullay, Daniel] Edith Cowan Univ, Ctr Indigenous Australian Educ & Res, Kurongkurl Katitjin, Perth, WA, Australia; [Marriott, Rhonda] Murdoch Univ, Sch Psychol & Exercise Sci, Perth, WA, Australia; [Atkinson, David N.; Marley, Julia V.] Univ Western Australia, Rural Clin Sch Western Australia, Broome, WA, Australia; [Stanley, Fiona J.] Telethon Kids Inst, Perth, WA, Australia	University of Western Australia; Edith Cowan University; Murdoch University; University of Western Australia; Telethon Kids Institute	McAuley, K (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	kimberley.mcauley@uwa.edu.au	Marley, Julia V/A-9515-2009; Strobel, Natalie A/O-9174-2014	Marley, Julia V/0000-0003-1014-4860; Strobel, Natalie A/0000-0002-2962-5704; Atkinson, David/0000-0001-7069-5555; McAullay, Daniel/0000-0002-0651-899X				AIHW, 2015, PER STAT SER, V31; AIHW, 2013, HLTH WELF EXP SER, V48; AIHW AIFS, 2013, CLOS GAP CLEAR ANN R; Australan Institute of Health and Welfare, 2012, PICT AUSTR CHILDR 20; Australian Institute of Health and Welfare (AIHW), 2011, HLTH WELF AUSTR AB T; Australian Institute of Health and Welfare (AIHW), 2015, HLTH SERV SER, V60; Bar-Zeev SJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-19; COAG, 2009, NAT INT STRAT CLOS G; Commonwealth Department of Health and Aged Care: Measuring remoteness: Accessibility/remoteness index of Australia (ARIA), 2001, INF RES BRANCH OCC P, V14; Costa N, 2008, HEALTH INF MANAG J, V37, P15, DOI 10.1177/183335830803700303; DoH, 2007, EM DEP DAT COLL DAT; Doh, 2013, NAT AB TORR STRAIT I; DoH, 2013, DAT QUAL MIDW NOT SY; DoH, 2010, AB MAT SERV SUPP UN; DoH, 2015, IND AUSTR HLTH PROGR; Downey F., 2007, VALIDATION STUDY W A; Duncan C, 2013, J PAEDIATR CHILD H, V49, pE448, DOI 10.1111/jpc.12225; Freeman T, 2014, AUST NZ J PUBL HEAL, V38, P355, DOI 10.1111/1753-6405.12231; Freeman T, 2011, AUST J PRIM HEALTH, V17, P355, DOI 10.1071/PY11033; Griew R, 2008, LINK PRIMARY HLTH CA; Gruen RL, 2006, LANCET, V368, P130, DOI 10.1016/S0140-6736(06)68812-0; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Joyce A, 2012, W AUSTR MOTHERS BABI; Kearns T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058231; Lawrence D, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-90; Li S. Q., 2011, HOSP ADMISSIONS NO T; Li SQ, 2007, INFANCY YOUNG ADULTH; Mnatzaganian G, 2012, J CLIN EPIDEMIOL, V65, P107, DOI 10.1016/j.jclinepi.2011.03.014; Moore HC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-703; Moorin RE, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-74; NHPA, 2015, HLTH COMM POT PREV H; Pink B, 2008, SOCIOECONOMIC INDEXE; SCRGSP, 2014, OV IND DIS KEY IND 2; Thomas DP, 2008, AUST HEALTH REV, V32, P648, DOI 10.1071/AH080648; Thompson SC, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-133; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th; Zhao YJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-466	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154171	10.1371/journal.pone.0154171	http://dx.doi.org/10.1371/journal.pone.0154171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120331	Green Published, gold			2022-12-26	WOS:000374976200048
J	Wu, MY; He, XY; Hu, CS				Wu, Ming-Yao; He, Xia-Yun; Hu, Chao-Su			Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							CONCURRENT CHEMORADIOTHERAPY; RADIATION-THERAPY; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; NODE METASTASIS; STAGE-III; PHASE-III; CANCER; SURVIVAL; OUTCOMES	Purpose To study tumor regression and failure patterns in T1-T2 non-metastatic nasopharyngeal carcinoma (NPC) after intensity-modulated radiotherapy (IMRT). Methods A retrospective analysis of 139 nasopharyngeal carcinoma patients treated with IMRT between January 2005 and December 2010 in our center was performed. According to the AJCC staging system, all primary lesions were attributed to T1 and T2. The prescription doses were 66 Gy at 30 fractions to gross tumor volume of the nasopharynx and the positive neck nodes, 60 Gy to high-risk clinical target volume and 54 Gy to low-risk clinical target volume. Patients staged III, IV A/B or II (lymph node measured 4 cm or more in diameter) received platinum-based chemotherapy. Results By the end of radiotherapy, 7.2% (10/139), 23.7% (33/139), and 9.4% (13/139) of patients had residual lesions in the nasopharynx, cervical lymph nodes and retropharyngeal lymph nodes, respectively. The majority of patients had complete remission within 6 months of radiotherapy completion. Five months after IMRT, three patients with residual tumors in the cervical lymph nodes underwent surgery. Among these patients, two patients had positive pathological findings, and one patient had negative findings. With a median follow-up of 59 months, the 5-year overall survival, local control, regional control and distant metastasis-free rates were 87.8%, 96.7%, 94.9% and 89.1%, respectively. Fifteen patients developed distant metastases, representing the primary failure pattern. Conclusions Most residual lesions that persisted after IMRT vanished completely in six months. Considering the potential damage to normal structures, clinicians should be cautious when considering the use of boost irradiation after radiotherapy. Distant metastasis was the primary cause of treatment failure, which was significantly higher in N2-3 patients than in N0-1. Additional studies to better understand distant metastases are needed.	[Wu, Ming-Yao; He, Xia-Yun; Hu, Chao-Su] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Wu, Ming-Yao; He, Xia-Yun; Hu, Chao-Su] Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Fudan University	He, XY (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200433, Peoples R China.; He, XY (corresponding author), Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	donganlu270hao@gmail.com		Hu, Chaosu/0000-0002-6503-0951	Department of Radiation Oncology at the Fudan University Shanghai Cancer Center; Department of Radiation Oncology	Department of Radiation Oncology at the Fudan University Shanghai Cancer Center; Department of Radiation Oncology	This work was supported by the Department of Radiation Oncology at the Fudan University Shanghai Cancer Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of Department of Radiation Oncology. The views expressed in this publication are those of the authors.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Chan ATC, 2012, ANN ONCOL, V23, P83, DOI 10.1093/annonc/mds266; Chen J, 2014, INT J CLIN ONCOL, V19, P998, DOI 10.1007/s10147-013-0650-6; Chen Y, 2013, CANCER-AM CANCER SOC, V119, P2230, DOI 10.1002/cncr.28049; Fang FM, 2008, INT J RADIAT ONCOL, V72, P356, DOI 10.1016/j.ijrobp.2007.12.054; Han Lu, 2010, Chin J Cancer, V29, P145; Ho FCH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-98; Kwong DLW, 1999, CANCER, V85, P1446, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1446::AID-CNCR4>3.0.CO;2-3; Lee AWM, 2014, RADIOTHER ONCOL, V110, P377, DOI 10.1016/j.radonc.2014.02.003; Lee AWM, 2012, RADIOTHER ONCOL, V104, P272, DOI 10.1016/j.radonc.2012.08.001; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Li AC, 2015, ONCOTARGET, V6, P24511, DOI 10.18632/oncotarget.4312; Li WF, 2013, INT J RADIAT ONCOL, V86, P249, DOI 10.1016/j.ijrobp.2012.09.003; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Lin SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-39; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Teo P, 1996, INT J RADIAT ONCOL, V36, P291, DOI 10.1016/S0360-3016(96)00323-9; Wang XS, 2014, ORAL ONCOL, V50, P1109, DOI 10.1016/j.oraloncology.2014.08.007; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wong FCS, 2010, INT J RADIAT ONCOL, V76, P138, DOI 10.1016/j.ijrobp.2009.01.084; Xu TT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001457; Yeh SA, 2005, INT J RADIAT ONCOL, V62, P672, DOI 10.1016/j.ijrobp.2004.11.002; Zhang N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-136	27	74	77	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154501	10.1371/journal.pone.0154501	http://dx.doi.org/10.1371/journal.pone.0154501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119991	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200085
J	Singla, S; Harjai, K; Katare, OP; Chhibber, S				Singla, Saloni; Harjai, Kusum; Katare, Om Prakash; Chhibber, Sanjay			Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies	PLOS ONE			English	Article							HUMAN EPITHELIAL-CELLS; KLEBSIELLA-PNEUMONIAE; BACTERIAL BIOFILMS; STAPHYLOCOCCUS-AUREUS; BRUCELLA-ABORTUS; PHAGE THERAPY; CIPROFLOXACIN; STREPTOMYCIN; DELIVERY; PENETRATION	Phage therapy has been a centre of attraction for biomedical scientists to treat infections caused by drug resistant strains. However, ability of phage to act only on extracellular bacteria and probability of interference by anti-phage antibodies in vivo is considered as a important limitation of bacteriophage therapy. To overcome these hurdles, liposome were used as delivery vehicle for phage in this study. Anti-phage antibodies were raised in mice and pooled serum was evaluated for its ability to neutralize free and liposome entrapped phage. Further, ability of phage and liposome-entrapped phage to enter mouse peritoneal macrophages and kill intracellular Klebsiella pneumoniae was compared. Also, an attempt to compare the efficacy of free phage and liposome entrapped phage, alone or in conjunction with amikacin in eradicating mature biofilm was made. The entrapment of phage in liposome provided 100% protection to phage from neutralizing antibody. On the contrary unentrapped phage got neutralized within 3 h of its interaction with antibody. Compared to the inability of free phage to enter macrophages, the liposome were able to deliver entrapped phage inside macrophages and cause 94.6% killing of intracellular K. pneumoniae. Liposome entrapped phage showed synergistic activity along with amikacin to eradicate mature biofilm of K. pneumoniae. Our study reinforces the growing interest in using phage therapy as a means of targeting multidrug resistant bacterial infections as liposome entrapment of phage makes them highly effective in vitro as well as in vivo by overcoming the majority of the hurdles related to clinical use of phage.	[Singla, Saloni; Harjai, Kusum; Chhibber, Sanjay] Panjab Univ, Dept Microbiol, Chandigarh 160014, India; [Katare, Om Prakash] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh 160014, India	Panjab University; Panjab University	Chhibber, S (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	sanjaychhibber8@gmail.com						Adams MH, 1959, LYSOGENY BACTERIOPHA, P365; Ahmed K, 2002, J LIPOSOME RES, V12, P285, DOI 10.1081/LPR-120016195; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; ASHTEKAR D, 1991, J ANTIMICROB CHEMOTH, V28, P615, DOI 10.1093/jac/28.4.615; Beaulac C, 1998, J ANTIMICROB CHEMOTH, V41, P35, DOI 10.1093/jac/41.1.35; Bedi MS, 2009, WORLD J MICROB BIOT, V25, P1145, DOI 10.1007/s11274-009-9991-8; Bhatia A, 2004, J PHARM PHARM SCI, V7, P252; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; Cairns BJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000253; Cano V, 2015, CELL MICROBIOL, V17, P1537, DOI 10.1111/cmi.12466; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; DEES C, 1990, VET IMMUNOL IMMUNOP, V24, P135, DOI 10.1016/0165-2427(90)90016-L; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; Doolittle MM, 1996, J IND MICROBIOL, V16, P331, DOI 10.1007/BF01570111; Fodah RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107394; FOUNTAIN MW, 1985, J INFECT DIS, V152, P529, DOI 10.1093/infdis/152.3.529; Fumagalli O, 1997, INFECT IMMUN, V65, P4445, DOI 10.1128/IAI.65.11.4445-4451.1997; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Hughes KA, 1998, J APPL MICROBIOL, V85, P583, DOI 10.1046/j.1365-2672.1998.853541.x; Kaszuba M, 1997, COLLOID SURFACE B, V8, P321, DOI 10.1016/S0927-7765(97)00007-6; Kysela DT, 2007, J THEOR BIOL, V249, P411, DOI 10.1016/j.jtbi.2007.08.007; Lasic DD., 1997, LIPOSOMES GENE DELIV, P259; Lederberg J, 1996, P NATL ACAD SCI USA, V93, P3167, DOI 10.1073/pnas.93.8.3167; MACLEOD DL, 1988, CAN J VET RES, V52, P445; MAJUMDAR S, 1992, ANTIMICROB AGENTS CH, V36, P2808, DOI 10.1128/AAC.36.12.2808; Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059; Oelschlaeger TA, 1997, INFECT IMMUN, V65, P2950, DOI 10.1128/IAI.65.7.2950-2958.1997; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Sihorkar V, 2001, PHARM RES-DORDR, V18, P1247, DOI 10.1023/A:1013073508318; Singla S, 2015, J INFECT DIS, V212, P325, DOI 10.1093/infdis/jiv029; Stent G., 1963, MOL BIOL BACTERIAL V; STEVENSON M, 1983, ANTIMICROB AGENTS CH, V24, P742, DOI 10.1128/AAC.24.5.742; Tullio V, 2000, J ANTIMICROB CHEMOTH, V46, P241, DOI 10.1093/jac/46.2.241; Verma V, 2010, BIOFOULING, V26, P729, DOI 10.1080/08927014.2010.511196; Verma V, 2009, CURR MICROBIOL, V59, P274, DOI 10.1007/s00284-009-9430-y; Vitas AI, 1996, ANTIMICROB AGENTS CH, V40, P146, DOI 10.1128/AAC.40.1.146	39	61	65	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153777	10.1371/journal.pone.0153777	http://dx.doi.org/10.1371/journal.pone.0153777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115154	gold, Green Published, Green Submitted			2022-12-26	WOS:000374973600030
J	Bano, S; Atia-tul-Wahab; Yousuf, S; Jabeen, A; Mesaik, MA; Atta-ur-Rahman; Choudhary, MI				Bano, Saira; Atia-tul-Wahab; Yousuf, Sammer; Jabeen, Almas; Mesaik, Mohammad Ahmed; Atta-ur-Rahman; Choudhary, M. Iqbal			New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone	PLOS ONE			English	Article							FUNGAL TRANSFORMATION; CUNNINGHAMELLA-BLAKESLEEANA; INHIBITORY-ACTIVITY; BIOTRANSFORMATION	Microbial transformation of the anti-inflammatory steroid medrysone (1) was carried out for the first time with the filamentous fungi Cunninghamella blakesleeana (ATCC 8688a), Neurospora crassa (ATCC 18419), and Rhizopus stolonifer (TSY 0471). The objective was to evaluate the anti-inflammatory potential of the substrate (1) and its metabolites. This yielded seven new metabolites, 14 alpha-hydroxy-6 alpha-methylpregn-4-ene-3,11,20-trione (2), 6 beta-hydroxy-6 alpha-methylpregn-4-ene-3,11,20-trione (3), 15 beta-hydroxy-6 alpha-methylpregn-4-ene-3,11,20-trione (4), 6 beta, 17 alpha-dihydroxy-6 alpha-methylpregn-4-ene-3,11,20-trione (5), 6 beta,20S-dihydroxy-6 alpha-methylpregn-4-ene-3,11-dione (6), 11 beta,16 beta-dihydroxy-6 alpha-methylpregn-4-ene-3,11-dione (7), and 15 beta,20R-dihydroxy-6 alpha-methylpregn-4-ene-3,11-dione (8). Single-crystal X-ray diffraction technique unambiguously established the structures of the metabolites 2, 4, 6, and 8. Fungal transformation of 1 yielded oxidation at the C-6 beta, -11 beta, -14 alpha, -15 beta, -16 beta positions. Various cellular anti-inflammatory assays, including inhibition of phagocyte oxidative burst, T-cell proliferation, and cytokine were performed. Among all the tested compounds, metabolite 6 (IC50 = 30.3 mu g/mL) moderately inhibited the reactive oxygen species (ROS) produced from zymosan-induced human whole blood cells. Compounds 1, 4, 5, 7, and 8 strongly inhibited the proliferation of T-cells with IC50 values between <0.2-10.4 mu g/mL. Compound 7 was found to be the most potent inhibitor (IC50 < 0.2 mu g/mL), whereas compounds 2, 3, and 6 showed moderate levels of inhibition (IC50 = 14.6-20.0 mu g/mL). Compounds 1, and 7 also inhibited the production of pro-inflammatory cytokine TNF-alpha. All these compounds were found to be non-toxic to 3T3 cells (mouse fibroblast), and also showed no activity when tested against HeLa (human epithelial carcinoma), or against PC3 (prostate cancer) cancer cell lines.	[Bano, Saira; Yousuf, Sammer; Atta-ur-Rahman; Choudhary, M. Iqbal] Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem & Biol Sci, Karachi 75270, Pakistan; [Atia-tul-Wahab; Jabeen, Almas; Choudhary, M. Iqbal] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi 75270, Pakistan; [Choudhary, M. Iqbal] King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah 21412, Saudi Arabia; [Mesaik, Mohammad Ahmed] Univ Tabuk, Tabuk Med Coll, Tabuk 71491, Saudi Arabia	University of Karachi; University of Karachi; King Abdulaziz University; University of Tabuk	Choudhary, MI (corresponding author), Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem & Biol Sci, Karachi 75270, Pakistan.; Atia-tul-Wahab; Choudhary, MI (corresponding author), Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi 75270, Pakistan.; Choudhary, MI (corresponding author), King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah 21412, Saudi Arabia.	atiatulwahab@gmail.com; iqbal.choudhary@iccs.edu	Wahab, Atia tul/C-5839-2018; Mesaik, Mohammed Ahmed/GRE-9332-2022; Rahman, Atta-ur/M-3329-2013; Choudhary, M. Iqbal iqbal/C-8633-2012	Wahab, Atia tul/0000-0002-2730-5547; Mesaik, Mohammed Ahmed/0000-0003-2010-2568; Choudhary, M. Iqbal iqbal/0000-0001-5356-3585	Higher Education Commission, Islamabad, Pakistan	Higher Education Commission, Islamabad, Pakistan(Higher Education Commission of Pakistan)	One of the authors, SB, acknowledges the enabling role of the Higher Education Commission, Islamabad, Pakistan, through a financial support under, "Indigenous Ph. D. Fellowship Program (5000 Scholarships)."	Ahmad MS, 2014, STEROIDS, V82, P53, DOI 10.1016/j.steroids.2014.01.001; ALTOMARE A, 1993, J APPL CRYSTALLOGR, V26, P343, DOI 10.1107/S0021889892010331; [Anonymous], 2011, J SCI RES, DOI DOI 10.3329/JSR.V3I2.6221; Azizuddin, 2012, J BIOTECHNOL TECHNOL, V3, P336; Baydoun E, 2014, STEROIDS, V88, P95, DOI 10.1016/j.steroids.2014.06.020; Baydoun E, 2014, STEROIDS, V86, P56, DOI 10.1016/j.steroids.2014.04.012; BETTS RE, 1974, J MED CHEM, V17, P599, DOI 10.1021/jm00252a006; Bhatti HN, 2012, STEROIDS, V77, P1267, DOI 10.1016/j.steroids.2012.07.018; Choudhary MI, 2008, CHEM BIODIVERS, V5, P324, DOI 10.1002/cbdv.200890030; Choudhary MI, 2011, STEROIDS, V76, P1288, DOI 10.1016/j.steroids.2011.06.007; Choudhary MI, 2005, NAT PROD RES, V19, P311, DOI 10.1080/14786410410001729168; Choudhary MI, 2005, CHEM BIODIVERS, V2, P392, DOI 10.1002/cbdv.200590019; Choudhary MI, 2004, NAT PROD RES, V18, P529, DOI 10.1080/14786410310001620628; Choudhary MI, 2002, NAT PROD LETT, V16, P101, DOI 10.1080/10575630290019994; Choudhary MI, 2007, Z NATURFORSCH B, V62, P593; Choudhary MI, 2006, CHEM PHARM BULL, V54, P927, DOI 10.1248/cpb.54.927; Dimas K, 1998, PLANTA MED, V64, P208, DOI 10.1055/s-2006-957410; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Gao JM, 2011, STEROIDS, V76, P43, DOI 10.1016/j.steroids.2010.08.006; Habibi Z, 2012, STEROIDS, V77, P1446, DOI 10.1016/j.steroids.2012.08.010; HELFAND SL, 1982, J EXP MED, V156, P492, DOI 10.1084/jem.156.2.492; Johnson C.K, 1976, ORNL5138 ORTEP; Khan NT, 2014, STEROIDS, V85, P65, DOI 10.1016/j.steroids.2014.04.004; Khan NT, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-153; Krieger NR, 1996, J EXP MED, V184, P2013, DOI 10.1084/jem.184.5.2013; Mesaik MA, 2012, CHEM BIOL DRUG DES, V79, P290, DOI 10.1111/j.1747-0285.2011.01310.x; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Nielsen MB, 1998, EXP CLIN IMMUNOGENET, V15, P61, DOI 10.1159/000019055; PETERSON DH, 1952, J AM CHEM SOC, V74, P5933, DOI 10.1021/ja01143a033; Sheldrick G. M., 1997, SHELXTL PC VERSION 5; Siemens A, 1996, SMART SAINT; Smith C, 2015, STEROIDS, V102, P39, DOI 10.1016/j.steroids.2015.06.008; Spooner R, 2011, INT J MOL SCI, V12, P334, DOI 10.3390/ijms12010334; Swizdor A, 2014, STEROIDS, V82, P44, DOI 10.1016/j.steroids.2014.01.006; Yang CR, 2013, CHINESE J CHEM, V31, P127, DOI 10.1002/cjoc.201201080; Zafar S, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-164; Zafar S, 2013, STEROIDS, V78, P418, DOI 10.1016/j.steroids.2013.01.002; Zafar S, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-109	38	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153951	10.1371/journal.pone.0153951	http://dx.doi.org/10.1371/journal.pone.0153951			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104348	gold, Green Published, Green Submitted			2022-12-26	WOS:000374565100029
J	Moro, A				Moro, Alessandro			Understanding the Dynamics of Violent Political Revolutions in an Agent-Based Framework	PLOS ONE			English	Article								This paper develops an agent-based computational model of violent political revolutions in which a subjugated population of citizens and an armed revolutionary organisation attempt to overthrow a central authority and its loyal forces. The model replicates several patterns of rebellion consistent with major historical revolutions, and provides an explanation for the multiplicity of outcomes that can arise from an uprising. The relevance of the heterogeneity of scenarios predicted by the model can be understood by considering the recent experience of the Arab Spring involving several rebellions that arose in an apparently similar way, but resulted in completely different political outcomes: the successful revolution in Tunisia, the failed protests in Saudi Arabia and Bahrain, and civil war in Syria and Libya.	[Moro, Alessandro] Ca Foscari Univ, Dept Econ, Venice, Italy	Universita Ca Foscari Venezia	Moro, A (corresponding author), Ca Foscari Univ, Dept Econ, Venice, Italy.	alessandro.moro@unive.it		Moro, Alessandro/0000-0002-3610-4691				Acemoglu D, 2001, AM ECON REV, V91, P938, DOI 10.1257/aer.91.4.938; [Anonymous], 1974, PUBLIC CHOICE, DOI [10.1007/BF01718997, DOI 10.1007/BF01718997]; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], PUBLIC CHOICE, V11, P89, DOI 10.1007/BF01726214; Braha D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048596; Collier P, 1998, OXFORD ECON PAP, V50, P563, DOI 10.1093/oep/50.4.563; Collier P, 2004, OXFORD ECON PAP, V56, P563, DOI 10.1093/oep/gpf064; DAVIES JC, 1962, AM SOCIOL REV, V27, P5, DOI 10.2307/2089714; Ellis CJ, 2011, ECON J, V121, P763, DOI 10.1111/j.1468-0297.2010.02401.x; Epstein JM, 2002, P NATL ACAD SCI USA, V99, P7243, DOI 10.1073/pnas.092080199; Fearon JD, 2003, AM POLIT SCI REV, V97, P75, DOI 10.1017/S0003055403000534; Gard-Murray AS, 2015, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-1-4939-1705-1_16; Goldstone JA, 2001, ANNU REV POLIT SCI, V4, P139, DOI 10.1146/annurev.polisci.4.1.139; Goldstone JA, 2011, FOREIGN AFF, V90, P8; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; KIM JW, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI DOI 10.18564/JASSS.1770; KURAN T, 1995, AM J SOCIOL, V100, P1528, DOI 10.1086/230671; KURAN T, 1991, AM ECON REV, V81, P121; KURAN T, 1989, PUBLIC CHOICE, V61, P41, DOI 10.1007/BF00116762; Lagi M., 2011, ARXIV11082455; Leeson PT, 2010, J ECON BEHAV ORGAN, V73, P297, DOI 10.1016/j.jebo.2009.12.003; Lichbach M.I., 1996, COOPERATORS DILEMMA; LICHBACH MI, 1994, RATION SOC, V6, P8, DOI 10.1177/1043463194006001003; Lichbach MI, 1995, REBELS DILEMMA COLLE; Makowsky MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080380; Miguel E, 2004, J POLIT ECON, V112, P725, DOI 10.1086/421174; Rubin J, 2014, J COMP ECON, V42, P340, DOI 10.1016/j.jce.2013.11.002; Skocpol Theda., 1979, STATES SOCIAL REVOLU; Taleb NN, 2015, FOREIGN AFF, V94, P86; WILENSKY U., 2004, NETLOGO REBELLION MO; Wilensky U., 1999, NETLOGO	31	7	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154175	10.1371/journal.pone.0154175	http://dx.doi.org/10.1371/journal.pone.0154175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27104855	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100050
J	Aketi, L; Kashongwe, Z; Kinsiona, C; Fueza, SB; Kokolomami, J; Bolie, G; Lumbala, P; Diayisu, JS				Aketi, Loukia; Kashongwe, Zacharie; Kinsiona, Christian; Fueza, Serge Bisuta; Kokolomami, Jack; Bolie, Grace; Lumbala, Paul; Diayisu, Joseph Shiku			Childhood Tuberculosis in a Sub-Saharan Tertiary Facility: Epidemiology and Factors Associated with Treatment Outcome	PLOS ONE			English	Article							PEDIATRIC TUBERCULOSIS; PULMONARY TUBERCULOSIS; INFECTIOUS-DISEASES; CHILDREN; HIV; DIAGNOSIS; BURDEN; SUSCEPTIBILITY; INTERVENTIONS; CHALLENGES	Childhood tuberculosis (TB) is a diagnostic challenge in developing countries, and patient outcome can be influenced by certain factors. We report the disease course, clinical profile and factors associated with treatment outcome in a tertiary facility of Kinshasa. Documentary and analytical studies were conducted using clinical and exploratory data for children aged up to 15 years who were admitted to the University Clinics of Kinshasa for TB. Data are presented as frequencies and averages, and binary and logistic regression analyses were performed. Of 283 children with TB, 82 (29.0%) had smear-negative TB, 40 (14.1%) had smear-positive TB, 159 (56.1%) had extra-pulmonary TB (EPTB), 2 (0.7%) had multi-drug-resistant TB (MDR-TB), 167 (59.0%) completed treatment, 30 (10.6%) were cured, 7 (2.5%) failed treatment, 4 (1.4%) died, 55 (19.4%) were transferred to health centers nearest their home, and 20 (7.0%) were defaulters. In the binary analysis, reported TB contacts (p = 0.048), type of TB (p = 0.000), HIV status (p = 0.050), Ziehl-Nielsen test result (p = 0.000), Lowenstein culture (p = 0.004) and chest X-ray (p = 0.057) were associated with outcome. In the logistic regression, none of these factors was a significant predictor of outcome. Tertiary level care facilities must improve the diagnosis and care of patients with childhood TB, which justifies the development of alternative diagnostic techniques and the assessment of other factors that potentially affect outcome.	[Aketi, Loukia; Kinsiona, Christian; Bolie, Grace; Lumbala, Paul; Diayisu, Joseph Shiku] Univ Hosp Kinshasa, Dept Pediat, Kinshasa, DEM REP CONGO; [Kashongwe, Zacharie; Fueza, Serge Bisuta] Univ Hosp Kinshasa, Dept Internal Med, Kinshasa, DEM REP CONGO; [Fueza, Serge Bisuta] Natl TB Program, Kinshasa, DEM REP CONGO; [Kokolomami, Jack] Univ Kinshasa, Sch Publ Hlth, Epidemiol & Biostat Dept, Kinshasa, DEM REP CONGO	Universite de Kinshasa	Aketi, L (corresponding author), Univ Hosp Kinshasa, Dept Pediat, Kinshasa, DEM REP CONGO.	akelou@yahoo.fr	Paizanos, Loukia Aketi/AAP-9860-2020					Aagaard C, 2010, NATURE MED, V2285; Adejumo OA, 2015, J TROP PEDIAT; Aketi L, 2008, ARCH PEDIATRIE, V15, P1611, DOI 10.1016/j.arcped.2008.06.020; Alavi SM, 2015, CASP J INTERN MED, V6, P213; Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; [Anonymous], 2008, PROGR NAT LUTT TUB G; Bhutta ZA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-21; Bhutta ZA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-28; Blount RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097267; Brent AJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/865436; Britton Philip, 2013, N S W Public Health Bull, V24, P15, DOI 10.1071/NB12100; Chan PC, 2014, AM J RESP CRIT CARE, V189, P203, DOI 10.1164/rccm.201305-0863OC; Cruz AT, 2013, PEDIATR INFECT DIS J, V32, P937, DOI 10.1097/INF.0b013e3182933214; Dangisso MH, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0461-1; De Onis M, FOOD NUTR B, V25, pS15; Edmonds A, 2009, INT J EPIDEMIOL, P1; Edwards DJ, 2007, INT J TUBERC LUNG D, V11, P263; El Sahly HM, 2004, SCAND J INFECT DIS, V36, P106, DOI 10.1080/00365540310018860; Elhassan MM, 2015, INT J INFECT DIS; Fiebig L, 2014, INT J TUBERC LUNG D, V18, P925, DOI 10.5588/ijtld.13.0578; Hailu D, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-61; Hansen C, 2016, PEDIATR CLIN N AM, V63, P37, DOI 10.1016/j.pcl.2015.08.002; Harries AD, 2002, INT J TUBERC LUNG D, V6, P424; Hatleberg CI, 2014, EUR RESPIR J, V43, P863, DOI 10.1183/09031936.00059913; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Hicks RM, 2014, INT J TUBERC LUNG D, V18, P1074, DOI 10.5588/ijtld.14.0231; Loeffler Ann M, 2003, Semin Respir Infect, V18, P272; Maher D, 2006, INT J TUBERC LUNG D, V10, P1331; Mandalakas AM, 2015, AM J RESP CRIT CARE, V191, P820, DOI 10.1164/rccm.201406-1165OC; Marais BJ, 2006, PEDIATRICS, V118, pE1350, DOI 10.1542/peds.2006-0519; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Mbala L, 2013, ARCH PEDIATR, V21, P13; Mombo LE, 2003, GENES IMMUN, V4, P362, DOI 10.1038/sj.gene.6363979; Mtabho CM, 2010, TROP MED INT HEALTH, V15, P496, DOI 10.1111/j.1365-3156.2010.02481.x; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Oeltmann JE, 2008, INT J TUBERC LUNG D, V12, P186; Osman T, 2014, E MEDITERR HEALTH J, V20, P442, DOI 10.26719/2014.20.7.442; Patel MR, 2013, INT J TUBERC LUNG D, V17, P1206, DOI 10.5588/ijtld.12.0833; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Planting NS, 2014, INT J TUBERC LUNG D, V18, P8, DOI 10.5588/ijtld.13.0132; Rabie H, 2015, J INT AIDS SOC, V18, P35, DOI 10.7448/IAS.18.7.20236; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Ritz N, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14000; Seddon JA, 2014, INFECT DRUG RESIST, V7, P153, DOI 10.2147/IDR.S45090; Stop TB, 2006, INT J TUBERC LUNG D, V10, P1091; Swaminathan S, 2015, CLIN PHARMACOL THER, V98, P240, DOI 10.1002/cpt.175; Tiwari S, 2015, INT J MYCOBACT, V4, P48, DOI 10.1016/j.ijmyco.2014.11.063; Weaver MS, 2015, B WORLD HEALTH ORGAN, V93, P700, DOI 10.2471/BLT.14.147231; *WHO, 2011, GLOB PLAN STOP TB 20; Winston CA, 2012, PEDIATRICS, V130, pE1425, DOI 10.1542/peds.2012-1057; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2012, GLOB REP RES INF DIS; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd	54	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153914	10.1371/journal.pone.0153914	http://dx.doi.org/10.1371/journal.pone.0153914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101146	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500094
J	Kormpakis, I; Linderman, SW; Thomopoulos, S; Gelberman, RH				Kormpakis, Ioannis; Linderman, Stephen W.; Thomopoulos, Stavros; Gelberman, Richard H.			Enhanced Zone II Flexor Tendon Repair through a New Half Hitch Loop Suture Configuration	PLOS ONE			English	Article							KNOT LOCATION; STRENGTH; CORE; MOBILIZATION; EXCURSION; LOCKING; STRANDS; SIZE	This study evaluated the impact of a new half hitch loop suture configuration on flexor tendon repair mechanics. Cadaver canine flexor digitorum profundus tendons were repaired with 4-or 8-strands, 4-0 or 3-0 suture, with and without half hitch loops. An additional group underwent repair with half hitch loops but without the terminal knot. Half hitch loops improved the strength of 8-strand repairs by 21% when 4-0, and 33% when 3-0 suture was used, and caused a shift in failure mode from suture pullout to suture breakage. 8-strand repairs with half hitch loops but without a terminal knot produced equivalent mechanical properties to those without half hitch loops but with a terminal knot. 4-strand repairs were limited by the strength of the suture in all groups and, as a result, the presence of half hitch loops did not alter the mechanical properties. Overall, half hitch loops improved repair mechanics, allowing failure strength to reach the full capability of suture strength. Improving the mechanical properties of flexor tendon repair with half hitch loops has the potential to reduce the postoperative risk of gap formation and catastrophic rupture in the early postoperative period.	[Kormpakis, Ioannis; Linderman, Stephen W.; Gelberman, Richard H.] Washington Univ, Dept Orthopaed Surg, St Louis, MO USA; [Linderman, Stephen W.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Thomopoulos, Stavros] Columbia Univ, Dept Orthoped Surg, New York, NY USA; [Thomopoulos, Stavros] Columbia Univ, Dept Biomed Engn, New York, NY USA	Washington University (WUSTL); Washington University (WUSTL); Columbia University; Columbia University	Gelberman, RH (corresponding author), Washington Univ, Dept Orthopaed Surg, St Louis, MO USA.	gelbermanr@wustl.edu	Linderman, Stephen/GQB-4770-2022	Linderman, Stephen/0000-0002-1797-5870	National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR062947, T32 AR060719, T32 GM007200, P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F30AR069491, T32AR060719, R01AR062947, P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (NIH), specifically the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, http://niams.nih.gov/): R01 AR062947 (to RHG and ST), T32 AR060719 (to SWL), T32 GM007200 (to Medical Scientist Training Program, Washington University in St. Louis), and P30 AR057235 (to Musculoskeletal Research Center, Washington University in St. Louis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINBRIDGE LC, 1994, J HAND SURG-BRIT EUR, V19B, P517, DOI 10.1016/0266-7681(94)90219-4; Barrie KA, 2000, J HAND SURG-AM, V25A, P714, DOI 10.1053/jhsu.2000.9414; Boyer MI, 2001, J BONE JOINT SURG AM, V83A, P891, DOI 10.2106/00004623-200106000-00011; Dong XK, 2016, J HAND SURG-AM, V41, P40, DOI 10.1016/j.jhsa.2015.10.016; Fufa DT, 2012, J HAND SURG-AM, V37A, P2526, DOI 10.1016/j.jhsa.2012.09.012; Gelberman RH, 1999, J BONE JOINT SURG AM, V81A, P975, DOI 10.2106/00004623-199907000-00010; Gelberman RH, 2007, J HAND SURG-AM, V32A, P373, DOI 10.1016/j.jhsa.2006.12.009; Hatanaka H, 2000, CLIN ORTHOP RELAT R, P267; Kelly JD, 2014, CLIN ORTHOP RELAT R, V472, P1930, DOI 10.1007/s11999-014-3478-0; Kim HM, 2010, J HAND SURG-AM, V35A, P1031, DOI 10.1016/j.jhsa.2009.12.044; Lawrence TA, 2005, J HAND SURG-AM, V30A, P836, DOI 10.1016/j.jhsa.2005.03.011; Linderman SW, 2015, ACTA BIOMATER, V23, P229, DOI 10.1016/j.actbio.2015.05.002; Maddox GE, 2015, J HAND SURG-AM, V40, P963, DOI 10.1016/j.jhsa.2015.01.013; McClellan WT, 2011, PLAST RECONSTR SURG, V128, p322E, DOI 10.1097/PRS.0b013e3182268c1f; Miller Timothy, 2010, Orthopedics, V33, P674, DOI 10.3928/01477447-20100722-08; Momose T, 2000, J BIOMED MATER RES, V53, P806, DOI 10.1002/1097-4636(2000)53:6<806::AID-JBM23>3.0.CO;2-P; Nelson GN, 2012, J ORTHOP RES, V30, P1652, DOI 10.1002/jor.22108; Osei DA, 2014, J HAND SURG-AM, V39, P262, DOI 10.1016/j.jhsa.2013.11.001; PENNINGTON DG, 1979, PLAST RECONSTR SURG, V63, P648, DOI 10.1097/00006534-197905000-00007; POTENZA AD, 1962, MIL MED, V127, P34, DOI 10.1093/milmed/127.1.34; Pruitt DL, 1996, J HAND SURG-AM, V21A, P969, DOI 10.1016/S0363-5023(96)80301-7; Tang JB, 2005, J HAND SURG-AM, V30A, P1262, DOI 10.1016/j.jhsa.2005.05.011; Thomopoulos S, 2009, J ORTHOP RES, V27, P1209, DOI 10.1002/jor.20875; Viinikainen A, 2004, J HAND SURG-BRIT EUR, V29B, P536, DOI 10.1016/j.jhsb.2004.05.007; Vizesi F, 2008, J HAND SURG-AM, V33A, P241, DOI 10.1016/j.jhsa.2007.10.011; Winters SC, 1998, J HAND SURG-AM, V23A, P97, DOI 10.1016/S0363-5023(98)80096-8; Wong YR, 2015, J HAND SURG-AM, V40, P1806, DOI 10.1016/j.jhsa.2015.05.007; WOO SLY, 1981, ACTA ORTHOP SCAND, V52, P615, DOI 10.3109/17453678108992156	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153822	10.1371/journal.pone.0153822	http://dx.doi.org/10.1371/journal.pone.0153822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101409	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500072
J	Le, TT; Skak, K; Schroder, K; Schroder, WA; Boyle, GM; Pierce, CJ; Suhrbier, A				Le, Thuy T.; Skak, Kresten; Schroder, Kate; Schroder, Wayne A.; Boyle, Glen M.; Pierce, Carly J.; Suhrbier, Andreas			IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate	PLOS ONE			English	Article							ACTINIC KERATOSIS; TUMOR-GROWTH; RECEPTOR ANTAGONIST; NLRP3 INFLAMMASOME; DOUBLE-BLIND; CELL-DEATH; NEUTROPHILS; GEL; INTERLEUKIN-1-BETA; IL-1-BETA	Ingenol mebutate is approved for the topical treatment of actinic keratoses and may ultimately also find utility in treating skin cancers. Here we show that relapse rates of subcutaneous B16 melanoma tumours treated topically with ingenol mebutate were not significantly different in C57BL/6 and Rag1(-/-) mice, suggesting B and T cells do not play a major role in the anti-cancer efficacy of ingenol mebutate. Relapse rates were, however, significantly increased in MyD88(-/-) mice and in C57BL/6 mice treated with the anti-IL-1 agent, anakinra. Ingenol mebutate treatment induces a pronounced infiltration of neutrophils, which have been shown to have anti-cancer activity in mice. Herein we provide evidence that IL-1 promotes neutrophil recruitment to the tumour, decreases apoptosis of infiltrating neutrophils and increases neutrophil tumour killing activity. These studies suggest IL-1, via its action on neutrophils, promotes the anti-cancer efficacy of ingenol mebutate, with ingenol mebutate treatment causing both IL-1 beta induction and IL-1 alpha released from keratinocytes.	[Le, Thuy T.; Schroder, Wayne A.; Boyle, Glen M.; Pierce, Carly J.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol, Brisbane, Qld, Australia; [Le, Thuy T.; Schroder, Wayne A.; Boyle, Glen M.; Pierce, Carly J.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Canc Drug Mech Labs, Brisbane, Qld, Australia; [Skak, Kresten] Leo Pharma, Copenhagen, Denmark; [Schroder, Kate] Univ Queensland, Inst Mol Biosci, Inflammasome Lab, Brisbane, Qld, Australia; [Schroder, Kate] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; LEO Pharma; University of Queensland; University of Queensland	Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Inflammat Biol, Brisbane, Qld, Australia.; Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Canc Drug Mech Labs, Brisbane, Qld, Australia.	Andreas.Suhrbier@qimrberghofer.edu.au	Schroder, Kate/C-6132-2008; Boyle, Glen/G-1347-2013	Schroder, Kate/0000-0001-9261-3805; Boyle, Glen/0000-0002-1385-529X; Suhrbier, Andreas/0000-0001-8986-9025	Leo Pharma; Australian National Health & Medical Research Council [APP1043104]; Leo; Australian Research Council Future Fellowship [FT130100361]; Queensland Smart Futures Fund	Leo Pharma(LEO Pharma); Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leo(LEO Pharma); Australian Research Council Future Fellowship(Australian Research Council); Queensland Smart Futures Fund	The research was primarily conducted at QIMR Berghofer Medical Research Institute and was largely funded by Leo Pharma, and in part by a grant from the Australian National Health & Medical Research Council (APP1043104). Leo provided support in the form of salaries for TTL and consumables, was involved in the initial study design, but was not involved in data collection and analysis. Leo was involved in the decision to publish, but provided minimal input into the writing of the manuscript. K. Schroder is supported by an Australian Research Council Future Fellowship (FT130100361), and the Queensland Smart Futures Fund. AS is a Principal Research Fellow with the National Health & Medical Research Council, Australia (APP1058391).	Ackerman AB, 2006, BRIT J DERMATOL, V155, P9, DOI 10.1111/j.1365-2133.2005.07121.x; Albanesi M, 2013, BLOOD, V122, P3160, DOI 10.1182/blood-2013-04-497446; Alchin DR, 2014, DERMATOLOGY THER, V4, P157, DOI 10.1007/s13555-014-0061-2; Anderson L, 2009, J AM ACAD DERMATOL, V60, P934, DOI 10.1016/j.jaad.2009.01.008; Bakele M, 2014, J BIOL CHEM, V289, P5320, DOI 10.1074/jbc.M113.505636; Bjorkdahl O, 1997, CANCER IMMUNOL IMMUN, V44, P273, DOI 10.1007/s002620050383; Bjorkdahl O, 2000, CANCER GENE THER, V7, P1365, DOI 10.1038/sj.cgt.0242; Cantisani C, 2014, DERMATOL THER, V27, P352, DOI 10.1111/dth.12148; Cavanagh LL, 1996, CANCER RES, V56, P2607; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; Chen LC, 2012, EMBO MOL MED, V4, P1276, DOI 10.1002/emmm.201201569; COLOTTA F, 1992, BLOOD, V80, P2012; Cozzi SJ, 2013, ARCH DERMATOL RES, V305, P79, DOI 10.1007/s00403-012-1270-0; Cozzi SJ, 2012, J INVEST DERMATOL, V132, P1263, DOI 10.1038/jid.2011.418; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Feng Y, 2010, AM J PHYSIOL-CELL PH, V299, pC760, DOI 10.1152/ajpcell.00155.2010; Freiberger SN, 2015, MOL CANCER THER, V14, P2132, DOI 10.1158/1535-7163.MCT-15-0023-T; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gross O, 2012, METHODS MOL BIOL, V844, P199, DOI 10.1007/978-1-61779-527-5_15; Hampson P, 2008, CANCER IMMUNOL IMMUN, V57, P1241, DOI 10.1007/s00262-008-0458-9; Hayashi T, 2011, MELANOMA RES, V21, P66, DOI 10.1097/CMR.0b013e328340ce6c; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; LALINN M, 1995, J VIROL METHODS, V52, P51; Le TTT, 2009, VACCINE, V27, P3053, DOI 10.1016/j.vaccine.2009.03.025; Lebwohl M, 2013, JAMA DERMATOL, V149, P666, DOI 10.1001/jamadermatol.2013.2766; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Murphy JE, 2003, J IMMUNOL, V170, P5697, DOI 10.4049/jimmunol.170.11.5697; Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631; NEVILLE M E, 1990, Cytokine, V2, P456, DOI 10.1016/1043-4666(90)90055-X; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Ogbourne SM, 2014, FITOTERAPIA, V98, P36, DOI 10.1016/j.fitote.2014.07.002; Otten MA, 2012, EUR J IMMUNOL, V42, P1815, DOI 10.1002/eji.201141982; Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13; Prince LR, 2004, AM J PATHOL, V165, P1819, DOI 10.1016/S0002-9440(10)63437-2; Ramsay JR, 2011, BRIT J DERMATOL, V164, P633, DOI 10.1111/j.1365-2133.2010.10184.x; Rauschmayr T, 1997, P NATL ACAD SCI USA, V94, P5814, DOI 10.1073/pnas.94.11.5814; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Siller G, 2009, AUSTRALAS J DERMATOL, V50, P16, DOI 10.1111/j.1440-0960.2008.00497.x; Siller G, 2010, AUSTRALAS J DERMATOL, V51, P99, DOI 10.1111/j.1440-0960.2010.00626.x; SMITH RJ, 1986, INT J IMMUNOPHARMACO, V8, P33, DOI 10.1016/0192-0561(86)90070-6; Sonego F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103734; Stahlhut M, 2012, J DRUGS DERMATOL, V11, P1181; Toda Y, 2002, J IMMUNOL, V168, P1984, DOI 10.4049/jimmunol.168.4.1984; Triozzi PL, 2010, ANTICANCER RES, V30, P345; Tzogani K, 2014, EUR J DERMATOL, V24, P457, DOI 10.1684/ejd.2014.2368; van Egmond M, 2013, SEMIN CANCER BIOL, V23, P190, DOI 10.1016/j.semcancer.2012.12.002; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; William R, 1998, J IMMUNOL, V161, P957; Winkler S, 2015, SEMIN IMMUNOPATHOL, V37, P419, DOI 10.1007/s00281-015-0494-4; Wu T., 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0072404; YAGISAWA M, 1995, EXP HEMATOL, V23, P603; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zarchi K, 2015, CURR PROBL DERMATOL, V46, P136, DOI 10.1159/000366549; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	62	10	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153975	10.1371/journal.pone.0153975	http://dx.doi.org/10.1371/journal.pone.0153975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100888	Green Published, gold			2022-12-26	WOS:000374898500116
J	Li, JH; Yuan, JM; Miao, ZQ; Song, ZG; Yang, Y; Tian, WX; Guo, YM				Li, Jianhui; Yuan, Jianmin; Miao, Zhiqiang; Song, Zhigang; Yang, Yu; Tian, Wenxia; Guo, Yuming			Effect of Dietary Nutrient Density on Small Intestinal Phosphate Transport and Bone Mineralization of Broilers during the Growing Period	PLOS ONE			English	Article							COTRANSPORTER GENE-EXPRESSION; MITOCHONDRIAL-FUNCTION; GROWTH-PERFORMANCE; FEED-EFFICIENCY; VITAMIN-D; NAPI-IIB; CHICKENS; CALCIUM; PHOSPHORUS; QUALITY	A 2 x 4 factorial experiment was conducted to determine the effects of dietary nutrient density on growth performance, small intestinal epithelial phosphate transporter expression, and bone mineralization of broiler chicks fed with diets with different nutrient densities and nonphytate phosphorus (NPP) levels. The broilers were fed with the same starter diets from 0 to 21 days of age. In the grower phase (day 22 to 42), the broilers were randomly divided into eight groups according to body weight. Relatively high dietary nutrient density (HDND) and low dietary nutrient density (LDND) diets were assigned metabolic energy (ME) values of 3,150 and 2,950 kcal/kg, respectively. Crude protein and essential amino acid levels were maintained in the same proportion as ME to prepare the two diet types. NPP levels were 0.25%, 0.30%, 0.35%, and 0.40% of the diets. Results showed that a HDND diet significantly increased the body weight gain (BWG) of broilers and significantly decreased the feed conversion ratio and NPP consumed per BWG. HDND significantly decreased tibial P content of the broilers. Conversely, mRNA expression of NaPi-IIb and protein expression of calbindin were significantly increased in the intestine of broilers fed a HDND diet. HDND also increased vitamin D receptor (VDR) expression, especially at a relatively low dietary NPP level (0.25%). The mRNA expression of NaPi-IIa in the kidneys was significantly increased at a relatively low dietary NPP level (0.25%) to maintain P balance. Tibial P, calcium, and ash content were significantly decreased, as were calbindin and VDR expression levels in the intestine at a low NPP level. Therefore, HDND improved the growth rate of broilers and increased the expression of phosphate and calcium transporter in the small intestine, but adversely affected bone mineralization.	[Li, Jianhui; Miao, Zhiqiang; Yang, Yu; Tian, Wenxia] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Shanxi, Peoples R China; [Li, Jianhui; Yuan, Jianmin; Guo, Yuming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Song, Zhigang] Shandong Agr Univ, Dept Anim Sci, Tai An 271018, Shandong, Peoples R China	Shanxi Agricultural University; China Agricultural University; Shandong Agricultural University	Guo, YM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	guoyum@cau.edu.cn		Song, Zhigang/0000-0003-1525-5797	Ear-marked fund for Modern Agro-Industry Technology Research System [CARS-42]; National Youth Science Fund Project [31301992]; Shandong Modern Agricultural Technology and Industry System [SDAIT-13-011-08]; National Science and Technology Support Plan projects [2012BAD39B0402]	Ear-marked fund for Modern Agro-Industry Technology Research System; National Youth Science Fund Project; Shandong Modern Agricultural Technology and Industry System; National Science and Technology Support Plan projects	This study was financially supported by the Ear-marked fund for Modern Agro-Industry Technology Research System (CARS-42), the National Youth Science Fund Project (31301992), the Shandong Modern Agricultural Technology and Industry System (SDAIT-13-011-08) and the National Science and Technology Support Plan projects (2012BAD39B0402).	Bar A, 2003, BRIT J NUTR, V89, P51, DOI 10.1079/BJN2002757; Barreiro FR, 2009, POULTRY SCI, V88, P2644, DOI 10.3382/ps.2008-00079; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brickett KE, 2007, POULTRY SCI, V86, P2117, DOI 10.1093/ps/86.10.2117; Bruno LDG, 2000, BRIT POULTRY SCI, V41, P389, DOI 10.1080/713654955; Casirola DM, 2006, FASEB J, V20, pA1274; Gaffney-Stomberg E, 2014, BONE, V68, P46, DOI 10.1016/j.bone.2014.08.002; Guo JY, 2009, EUR J PHARMACOL, V612, P54, DOI 10.1016/j.ejphar.2009.03.076; Han JC, 2009, POULTRY SCI, V88, P323, DOI 10.3382/ps.2008-00252; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; HURWITZ S, 1995, J NUTR, V125, P2679; Kirchner S, 2008, AM J CLIN NUTR, V87, P1028, DOI 10.1093/ajcn/87.4.1028; Kirchner S, 2007, FASEB J, V21, pA1327; Leterrier C, 1998, BRIT POULTRY SCI, V39, P24, DOI 10.1080/00071669889349; Li JH, 2011, THESIS CHINA AGR U B, P55; Li JH, 2012, ASIAN AUSTRAL J ANIM, V25, P552, DOI 10.5713/ajas.2011.11266; Li JianHui, 2011, Journal of Animal Science and Biotechnology, V2, P102; Moghadam AN, 2006, INT J POULTRY SCI, V5, P666; Ojano-Dirain CP, 2004, POULTRY SCI, V83, P1394, DOI 10.1093/ps/83.8.1394; Onyango EM, 2003, POULTRY SCI, V82, P1787, DOI 10.1093/ps/82.11.1787; Ozeraitiene Violeta, 2006, Medicina (Kaunas), V42, P836; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Stauber A, 2005, AM J PHYSL GASTR L, V288, P351; Wang Jue, 2010, Sarcoma, V2010, P454792, DOI 10.1155/2010/454792; Wang Y, 2015, LIVEST SCI, V176, P135, DOI 10.1016/j.livsci.2015.03.010; Wu W, 2013, CHIN J CLIN ELECT ED, V7, P9200; Xu H, 2003, AM J PHYSIOL-CELL PH, V284, pC1262, DOI 10.1152/ajpcell.00456.2002	29	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153859	10.1371/journal.pone.0153859	http://dx.doi.org/10.1371/journal.pone.0153859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100791	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500079
J	Momose, F; Seo, N; Akahori, Y; Sawada, S; Harada, N; Ogura, T; Akiyoshi, K; Shiku, H				Momose, Fumiyasu; Seo, Naohiro; Akahori, Yasushi; Sawada, Shin-ichi; Harada, Naozumi; Ogura, Toru; Akiyoshi, Kazunari; Shiku, Hiroshi			Guanine-Rich Sequences Are a Dominant Feature of Exosomal microRNAs across the Mammalian Species and Cell Types	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; GASTRIC-CANCER; RNA; GROWTH; PROLIFERATION; BIOGENESIS; BINDING; MEMORY; MIRNA	Exosome is an extracellular vesicle released from multivesicular endosomes and contains micro (mi) RNAs and functional proteins derived from the donor cells. Exosomal miRNAs act as an effector during communication with appropriate recipient cells, this can aid in the utilization of the exosomes in a drug delivery system for various disorders including malignancies. Differences in the miRNA distribution pattern between exosomes and donor cells indicate the active translocation of miRNAs into the exosome cargos in a miRNA sequence-dependent manner, although the molecular mechanism is little known. In this study, we statistically analyzed the miRNA microarray data and revealed that the guanine (G)-rich sequence is a dominant feature of exosome-dominant miRNAs, across the mammalian species-specificity and the cell types. Our results provide important information regarding the potential use of exosome cargos to develop miRNA-based drugs for the treatment of human diseases.	[Momose, Fumiyasu; Seo, Naohiro; Akahori, Yasushi; Harada, Naozumi; Shiku, Hiroshi] Mie Univ, Dept Immunogene Therapy, Grad Sch Med, Tsu, Mie 5148507, Japan; [Sawada, Shin-ichi; Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Momose, Fumiyasu; Seo, Naohiro; Akahori, Yasushi; Sawada, Shin-ichi; Harada, Naozumi; Akiyoshi, Kazunari; Shiku, Hiroshi] Japan Sci & Technol Agcy JST, ERATO Bionanotransporter Project, Tokyo 1020076, Japan; [Ogura, Toru] Mie Univ Hosp, Clin Res Support Ctr, Tsu, Mie 5148507, Japan	Mie University; Kyoto University; Japan Science & Technology Agency (JST); Mie University	Seo, N (corresponding author), Mie Univ, Dept Immunogene Therapy, Grad Sch Med, Tsu, Mie 5148507, Japan.; Seo, N; Shiku, H (corresponding author), Japan Sci & Technol Agcy JST, ERATO Bionanotransporter Project, Tokyo 1020076, Japan.	seo-naohiro@clin.medic.mie-u.ac.jp; shiku@clin.medic.mie-u.ac.jp	Shiku, Hiroshi/U-7321-2019	Shiku, Hiroshi/0000-0002-0362-755X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24800033]; Exploratory Research for Advanced Technology of Japan Science and Technology Agency (ERATO Akiyoshi Bio-nanotransporter Project, JST)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Exploratory Research for Advanced Technology of Japan Science and Technology Agency (ERATO Akiyoshi Bio-nanotransporter Project, JST)	This work was supported by grants from Ministry of Education, Culture, Sports, Science and Technology of Japan (24800033) and Exploratory Research for Advanced Technology of Japan Science and Technology Agency (ERATO Akiyoshi Bio-nanotransporter Project, JST).	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cui ZH, 2014, WORLD J GASTROENTERO, V20, P5493, DOI 10.3748/wjg.v20.i18.5493; D'Andrade Petula N, 2012, Methods Mol Biol, V822, P85, DOI 10.1007/978-1-61779-427-8_6; Denoyelle C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.389; Filosa G, 2013, NEUROMOL MED, V15, P661, DOI 10.1007/s12017-013-8256-8; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Greening DW, 2015, SEMIN CELL DEV BIOL, V40, P72, DOI 10.1016/j.semcdb.2015.02.009; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; He D, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0342-0; Hibio N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00996; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Kooijmans SAA, 2013, J CONTROL RELEASE, V172, P229, DOI 10.1016/j.jconrel.2013.08.014; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Lee KH, 2014, BBA-MOL CELL RES, V1843, P2055, DOI 10.1016/j.bbamcr.2014.06.001; Leng RB, 2014, FEBS LETT, V588, P2078, DOI 10.1016/j.febslet.2014.04.040; Leung YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098037; Liu JJ, 2014, CANCER LETT, V347, P98, DOI 10.1016/j.canlet.2014.01.024; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Osborne J.W., 2019, PRACT ASSESS RES EVA, V9, P11, DOI [DOI 10.7275/QF69-7K43, 10.7275/ktzq-jq66]; Qin X, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00357; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Shi Y, 2014, CLIN CANCER RES, V20, P1803, DOI 10.1158/1078-0432.CCR-13-2284; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang XW, 2014, BIOINFORMATICS, V30, P1377, DOI 10.1093/bioinformatics/btu045; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zang WQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0315-3; Zeng H, 2015, FEBS LETT, V589, P812, DOI 10.1016/j.febslet.2015.02.014; Zhao LY, 2014, DIGEST DIS SCI, V59, P1743, DOI 10.1007/s10620-014-3087-5; Zhao Q, 2015, ONCOL REP, V34, P979, DOI 10.3892/or.2015.4013	41	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154134	10.1371/journal.pone.0154134	http://dx.doi.org/10.1371/journal.pone.0154134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101102	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500154
J	Zheng, ZT; Liu, XM; Li, B; Cai, YQ; Zhu, YY; Zhou, MG				Zheng, Zhitian; Liu, Xiumei; Li, Bin; Cai, Yiqiang; Zhu, Yuanye; Zhou, Mingguo			Myosins FaMyo2B and Famyo2 Affect Asexual and Sexual Development, Reduces Pathogenicity, and FaMyo2B Acts Jointly with the Myosin Passenger Protein FaSmy1 to Affect Resistance to Phenamacril in Fusarium asiaticum	PLOS ONE			English	Article							KINESIN-RELATED PROTEIN; HEAD BLIGHT; SACCHAROMYCES-CEREVISIAE; FUNGICIDE JS399-19; GRAMINEARUM CLADE; POLARIZED GROWTH; YEAST; WHEAT; GENE; CYTOSKELETON	We previously reported that mutations occurred in the gene myosin5 were responsible for resistance to the fungicide phenamacril in Fusarium graminearum. Here, we determined whether there is a functional link between phenamacril resistance and the myosin proteins FaMyo2B and Famyo2 in Fusarium asiaticum, which is the major causal agent of Fusarium head blight in China. We found that FaMyo2B acts jointly with FaSmy1 to affect resistance to phenamacril in F. asiaticum. We also found that FaMyo2B disruption mutant and Famyo2 deletion mutant were defective in hyphal branching, conidiation, and sexual reproduction. Delta Famyo2 also had an enhanced sensitivity to cell wall damaging agents and an abnormal distribution of septa and nuclei. In addition, the FaMyo2B and Famyo2 mutants had reduced pathogenicity on wheat coleoptiles and flowering wheat heads. Taken together, these results reveal that FaMyo2B and Famyo2 are required for several F. asiaticum developmental processes and activities, which help us better understand the resistance mechanism and find the most effective approach to control FHB.	[Zheng, Zhitian; Liu, Xiumei; Li, Bin; Cai, Yiqiang; Zhu, Yuanye; Zhou, Mingguo] Nanjing Agr Univ, Coll Plant Protect, Key Lab Pesticide, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, MG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Key Lab Pesticide, Nanjing 210095, Jiangsu, Peoples R China.	mgzhou@njau.edu.cn			Chinese 973 Program [2012CB114000]; National Science Foundation of China [31201543]; Ph.D. Programs Foundation of Ministry of Education of China [20120097120009]	Chinese 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by the Chinese 973 Program (2012CB114000), the National Science Foundation of China (31201543), and The Ph.D. Programs Foundation of Ministry of Education of China (no. 20120097120009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Beningo KA, 2000, MOL BIOL CELL, V11, P691, DOI 10.1091/mbc.11.2.691; Chen Yu, 2007, Journal of Genetics and Genomics, V34, P469, DOI 10.1016/S1673-8527(07)60051-4; Chen Y, 2009, PHYTOPATHOLOGY, V99, P441, DOI 10.1094/PHYTO-99-4-0441; Chesarone-Cataldo M, 2011, DEV CELL, V21, P217, DOI 10.1016/j.devcel.2011.07.004; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; Diaz-Blanco NL, 2007, YEAST, V24, P343, DOI 10.1002/yea.1481; Duan YB, 2013, MOL PLANT PATHOL, V14, P708, DOI 10.1111/mpp.12041; Fagarasanu A, 2010, NAT REV MOL CELL BIO, V11, P644, DOI 10.1038/nrm2960; Gale LR, 2007, PHYTOPATHOLOGY, V97, P1434, DOI 10.1094/PHYTO-97-11-1434; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Hodges AR, 2009, CURR BIOL, V19, P2121, DOI 10.1016/j.cub.2009.10.069; Jenczmionka NJ, 2005, CURR GENET, V47, P29, DOI 10.1007/s00294-004-0547-z; Li HK, 2008, CROP PROT, V27, P90, DOI 10.1016/j.cropro.2007.04.010; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Lillie SH, 1992, SUPPRESSION MYOSIN D; Lu W. Z., 2001, RES WHEAT SCAB; Matsui Y, 2003, INT REV CYTOL, V229, P1, DOI 10.1016/S0074-7696(03)29001-X; Min K, 2012, FEMS MICROBIOL LETT, V334, P66, DOI 10.1111/j.1574-6968.2012.02620.x; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Niessen L, 2007, INT J FOOD MICROBIOL, V119, P38, DOI 10.1016/j.ijfoodmicro.2007.07.023; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Sebe-Pedros A, 2014, GENOME BIOL EVOL, V6, P290, DOI 10.1093/gbe/evu013; Song B, 2013, FUNGAL GENET BIOL, V54, P60, DOI 10.1016/j.fgb.2013.02.010; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Toth B, 2005, EUR J PLANT PATHOL, V113, P35, DOI 10.1007/s10658-005-0296-y; Trail F, 2009, PLANT PHYSIOL, V149, P103, DOI 10.1104/pp.108.129684; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Walther A, 2003, FUNGAL GENET BIOL, V40, P187, DOI 10.1016/j.fgb.2003.08.005; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Wang YQ, 2012, MOL BIOL CELL, V23, P3911, DOI 10.1091/mbc.E12-05-0396; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; Windels CE, 2000, PHYTOPATHOLOGY, V90, P17, DOI 10.1094/PHYTO.2000.90.1.17; Wu AB, 2005, MYCOPATHOLOGIA, V160, P75, DOI 10.1007/s11046-005-1153-4; Xu XM, 2008, EUR J PLANT PATHOL, V120, P21, DOI 10.1007/s10658-007-9189-6; Zhang CQ, 2015, ENVIRON MICROBIOL, V17, P2735, DOI 10.1111/1462-2920.12711; Zhang H, 2009, J MOL BIOL, V392, P228, DOI 10.1016/j.jmb.2009.07.006; Zhang JB, 2007, MYCOL RES, V111, P967, DOI 10.1016/j.mycres.2007.06.008; Zhang YJ, 2010, PESTIC BIOCHEM PHYS, V98, P151, DOI 10.1016/j.pestbp.2010.04.007; Zheng Z, 2015, SCI REPORTS, V5, P82; Zheng ZT, 2014, MOL PLANT PATHOL, V15, P488, DOI 10.1111/mpp.12108	49	9	9	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154058	10.1371/journal.pone.0154058	http://dx.doi.org/10.1371/journal.pone.0154058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099966	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500133
J	Shah, R; Tanriverdi, K; Levy, D; Larson, M; Gerstein, M; Mick, E; Rozowsky, J; Kitchen, R; Murthy, V; Mikalev, E; Freedman, JE				Shah, Ravi; Tanriverdi, Kahraman; Levy, Daniel; Larson, Martin; Gerstein, Mark; Mick, Eric; Rozowsky, Joel; Kitchen, Robert; Murthy, Venkatesh; Mikalev, Ekaterina; Freedman, Jane E.			Discordant Expression of Circulating microRNA from Cellular and Extracellular Sources	PLOS ONE			English	Article							PLATELET; TRANSCRIPTOME; BLOOD	MicroRNA (miRNA) expression has rapidly grown into one of the largest fields for disease characterization and development of clinical biomarkers. Consensus is lacking in regards to the optimal sample source or if different circulating sources are concordant. Here, using miRNA measurements from contemporaneously obtained whole blood-and plasma-derived RNA from 2391 individuals, we demonstrate that plasma and blood miRNA levels are divergent and may reflect different biological processes and disease associations.	[Shah, Ravi] Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA; [Tanriverdi, Kahraman; Mikalev, Ekaterina; Freedman, Jane E.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01605 USA; [Levy, Daniel; Larson, Martin] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Levy, Daniel; Larson, Martin] NHLBI, Populat Sci Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Gerstein, Mark; Rozowsky, Joel; Kitchen, Robert] Yale Univ, Sch Med, Computat Biol & Bioinformat Program, 333 Cedar St, New Haven, CT 06520 USA; [Mick, Eric] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA; [Murthy, Venkatesh] Univ Michigan, Dept Cardiol, 1500 E Med Ctr Dr SPC 5873, Ann Arbor, MI 48109 USA	Harvard University; Beth Israel Deaconess Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Yale University; University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan	Freedman, JE (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01605 USA.	jane.freedman@umassmed.edu	Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Murthy, Venkatesh L./B-3448-2013	Levy, Daniel/0000-0003-1843-8724; Murthy, Venkatesh L./0000-0002-7901-1321; Rozowsky, Joel/0000-0002-3565-0762	National Institutes of Health (NIH) as part of the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director [N01-HC 25195, P01-HL085381, UH2TR000921, U01HL126495]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000921, UL1TR001453, UH3TR000921] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL127099, U01HL126495, ZIAHL006001] Funding Source: NIH RePORTER	National Institutes of Health (NIH) as part of the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants N01-HC 25195, P01-HL085381 (to J.E.F.); UH2TR000921 and U01HL126495 (to J.E.F.; www.nih.gov), as part of the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Freedman Jane E, 2012, F1000Res, V1, P50, DOI 10.12688/f1000research.1-50.v1; Freedman JE, 2011, BLOOD, V118, P3760, DOI 10.1182/blood-2011-05-356600; Freedman JE, 2010, ANN NY ACAD SCI, V1207, P41, DOI 10.1111/j.1749-6632.2010.05731.x; Freedman JE, 2010, CIRCULATION, V122, P119, DOI 10.1161/CIRCULATIONAHA.109.928192; Grasedieck S, 2013, BLOOD, V121, P4977, DOI 10.1182/blood-2013-01-480079; Hammerle-Fickinger A, 2010, BIOTECHNOL LETT, V32, P35, DOI 10.1007/s10529-009-0130-2; McManus DD, 2011, CIRCULATION, V124, P1908, DOI 10.1161/CIRCULATIONAHA.111.062117; Rekker K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081166; Risitano A, 2012, BLOOD, V119, P6288, DOI 10.1182/blood-2011-12-396440; Spornraft M, 2015, BIOTECHNOL LETT, V37, P1165, DOI 10.1007/s10529-015-1788-2; Viprey VF, 2012, ANAL BIOCHEM, V421, P566, DOI 10.1016/j.ab.2011.10.022; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Ward J.A., 2013, FAM MED MED SCI RES, V2, P108, DOI [10.4172/2327-4972.1000108, DOI 10.4172/2327-4972.1000108]; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405	19	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153691	10.1371/journal.pone.0153691	http://dx.doi.org/10.1371/journal.pone.0153691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123852	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700023
J	Divashuk, MG; Khuat, TML; Kroupin, PY; Kirov, IV; Romanov, DV; Kiseleva, AV; Khrustaleva, LI; Alexeev, DG; Zelenin, AS; Klimushina, MV; Razumova, OV; Karlov, GI				Divashuk, Mikhail G.; Khuat, Thi Mai L.; Kroupin, Pavel Yu.; Kirov, Ilya V.; Romanov, Dmitry V.; Kiseleva, Anna V.; Khrustaleva, Ludmila I.; Alexeev, Dmitry G.; Zelenin, Alexandr S.; Klimushina, Marina V.; Razumova, Olga V.; Karlov, Gennady I.			Variation in Copy Number of Ty3/Gypsy Centromeric Retrotransposons in the Genomes of Thinopyrum intermedium and Its Diploid Progenitors	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CHROMOSOMAL DISTRIBUTION; EVOLUTIONARY DYNAMICS; TRANSPOSABLE ELEMENTS; SATELLITE REPEAT; DNA-SEQUENCES; WHEAT; AEGILOPS; PATTERNS; REVEALS	Speciation and allopolyploidization in cereals may be accompanied by dramatic changes in abundance of centromeric repeated transposable elements. Here we demonstrate that the reverse transcriptase part of Ty3/gypsy centromeric retrotransposon (RT-CR) is highly conservative in the segmental hexaploid Thinopyrum intermedium (J(r)J(vs)St) and its possible diploid progenitors Th. bessarabicum (J(b)), Pseudoroegneria spicata (St) and Dasypyrum villosum (V) but the abundance of the repeats varied to a large extent. Fluorescence in situ hybridization (FISH) showed hybridization signals in centromeric region of all chromosomes in the studied species, although the intensity of the signals drastically differed. In Th. intermedium, the strongest signal of RT-CR probe was detected on the chromosomes of J(v), intermediate on J(r) and faint on J(s) and St subgenome suggesting different abundance of RT-CR on the individual chromosomes rather than the sequence specificity of RT-CRs of the subgenomes. RT-CR quantification using real-time PCR revealed that its content per genome in Th. bessarabicum is similar to 2 times and P. spicata is similar to 1,5 times higher than in genome of D. villosum. The possible burst of Ty3/gypsy centromeric retrotransposon in Th. intermedium during allopolyploidization and its role in proper mitotic and meiotic chromosome behavior in a nascent allopolyploid is discussed.	[Divashuk, Mikhail G.; Khuat, Thi Mai L.; Kroupin, Pavel Yu.; Kirov, Ilya V.; Romanov, Dmitry V.; Kiseleva, Anna V.; Khrustaleva, Ludmila I.; Klimushina, Marina V.; Razumova, Olga V.; Karlov, Gennady I.] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Timiryazevskaya St 49, Moscow 127550, Russia; [Alexeev, Dmitry G.; Zelenin, Alexandr S.] FRCC PCM, Moscow, Russia	Russian State Agrarian University - Moscow Timiryazev Agricultural Academy; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency	Divashuk, MG; Karlov, GI (corresponding author), Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Timiryazevskaya St 49, Moscow 127550, Russia.	divashuk@gmail.com; karlovg@gmail.com	Alexeev, Dmitry/A-6167-2013; Karlov, Gennady/F-7403-2013; Klimushina, Marina V/L-2139-2016; Kroupin, Pavel Yu./D-8515-2014; Khrustaleva, Ludmila/J-9508-2013; Divashuk, Mikhail/T-7621-2019; Киров, Илья/G-2570-2019; Razumova, Olga/N-1037-2016; Kiseleva, Anna/J-8709-2017; Romanov, Dmitry/M-1459-2014	Alexeev, Dmitry/0000-0003-0783-1176; Karlov, Gennady/0000-0002-9016-103X; Klimushina, Marina V/0000-0002-7876-9325; Kroupin, Pavel Yu./0000-0001-6858-3941; Khrustaleva, Ludmila/0000-0002-0614-4641; Divashuk, Mikhail/0000-0001-6221-3659; Киров, Илья/0000-0003-3885-3837; Kiseleva, Anna/0000-0003-4765-8021; Razumova, Olga/0000-0001-5157-0087; Romanov, Dmitry/0000-0002-7495-7572				Bao YG, 2014, J GENET GENOMICS, V41, P663, DOI 10.1016/j.jgg.2014.11.003; Belyayev A, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-6; BERNATZKY R, 1986, GENETICS, V112, P887; Chang ZJ, 2010, HEREDITAS, V147, P304, DOI 10.1111/j.1601-5223.2010.02156.x; Chen GX, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0198-2; Chen Q, 1998, GENOME, V41, P580, DOI 10.1139/gen-41-4-580; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Danilova TV, 2014, THEOR APPL GENET, V127, P715, DOI 10.1007/s00122-013-2253-z; Dawe RK, 2005, P NATL ACAD SCI USA, V102, P11573, DOI 10.1073/pnas.0505100102; Deng CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072564; Dong FG, 1998, P NATL ACAD SCI USA, V95, P8135, DOI 10.1073/pnas.95.14.8135; Dvorak J, 2004, GENETICS, V168, P1665, DOI 10.1534/genetics.103.024927; Eilam T, 2008, GENOME, V51, P616, DOI 10.1139/G08-043; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; Gorinsek B, 2005, CYTOGENET GENOME RES, V110, P543, DOI 10.1159/000084987; Gorinsek B, 2004, MOL BIOL EVOL, V21, P781, DOI 10.1093/molbev/msh057; Guzman C, 2011, MOL BREEDING, V28, P403, DOI 10.1007/s11032-010-9493-2; Helfgott DM, 2004, SYST BOT, V29, P850, DOI 10.1600/0363644042451017; Hu LJ, 2011, EUPHYTICA, V177, P169, DOI 10.1007/s10681-010-0216-x; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Ito H, 2007, MOL GENET GENOMICS, V277, P23, DOI 10.1007/s00438-006-0172-2; Jiang JM, 1996, P NATL ACAD SCI USA, V93, P14210, DOI 10.1073/pnas.93.24.14210; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Karlov GI, 2003, EUPHYTICA, V132, P185, DOI 10.1023/A:1024646818324; Kishii M., 2005, Czech Journal of Genetics and Plant Breeding, V41, P92; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; Kordis D, 2005, GENE, V347, P161, DOI 10.1016/j.gene.2004.12.017; Kraitshtein Z, 2010, GENETICS, V186, P801, DOI 10.1534/genetics.110.120790; Kroupin PY, 2011, RUSS J GENET+, V47, P432, DOI 10.1134/S1022795411040077; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; Levy AA, 2002, PLANT PHYSIOL, V130, P1587, DOI 10.1104/pp.015727; Li BC, 2013, PLANT J, V73, P952, DOI 10.1111/tpj.12086; Li GR, 2012, J GENET, V91, P343, DOI 10.1007/s12041-012-0181-3; Liu C, 2009, CEREAL RES COMMUN, V37, P363, DOI 10.1556/CRC.37.2009.3.5; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Lu Kun, 2009, Yichuan, V31, P1141, DOI 10.3724/SP.J.1005.2009.01141; Mahelka V, 2013, MOL BIOL EVOL, V30, P2065, DOI 10.1093/molbev/mst106; Mahelka V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-127; Mathews S, 1996, MOL BIOL EVOL, V13, P1141, DOI 10.1093/oxfordjournals.molbev.a025677; Melters DP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r10; Miller JT, 1998, GENETICS, V150, P1615; Mujeeb-Kazi A, 2013, ADV AGRON, V122, P179, DOI 10.1016/B978-0-12-417187-9.00004-8; Nagaki K, 2005, MOL BIOL EVOL, V22, P845, DOI 10.1093/molbev/msi069; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nagaki K, 2003, GENETICS, V163, P1221; Nagaki K, 2003, GENETICS, V163, P759; Neumann P, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-4; Parisod C., 2012, PLANT TRANSPOSABLE E, V24, P147, DOI [DOI 10.1007/978-3-642-31842-9_9, 10.1007/978-1-62703-568-2]; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Qi LL, 2013, CHROMOSOME RES, V21, P507, DOI 10.1007/s10577-013-9378-4; Salina EA, 2015, EUPHYTICA, V204, P91, DOI 10.1007/s10681-014-1344-5; Salina EA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-99; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang S, 2000, THEOR APPL GENET, V100, P344, DOI 10.1007/s001220050045; Wang RRC, 2015, GENOME, V58, P63, DOI 10.1139/gen-2014-0186; Wang RRC, 2014, J SYST EVOL, V52, P697, DOI 10.1111/jse.12084; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; Yaakov B, 2013, PLANT CELL REP, V32, P1615, DOI 10.1007/s00299-013-1472-8; Zhang XY, 1996, GENOME, V39, P1062, DOI 10.1139/g96-133; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	60	8	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154241	10.1371/journal.pone.0154241	http://dx.doi.org/10.1371/journal.pone.0154241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119343	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200051
J	Teeranaipong, P; Sirivichayakul, S; Mekprasan, S; Ohata, PJ; Avihingsanon, A; Ruxrungtham, K; Putcharoen, O				Teeranaipong, Phairote; Sirivichayakul, Sunee; Mekprasan, Suwanna; Ohata, Pirapon June; Avihingsanon, Anchalee; Ruxrungtham, Kiat; Putcharoen, Opass			Role of Rilpivirine and Etravirine in Efavirenz and Nevirapine-Based Regimens Failure in a Resource-Limited Country: A Cross-Sectional Study	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITOR; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; RESISTANCE; ADULTS; PHASE-3; DUET-1; THRIVE; TRIAL; ECHO	Introduction Etravirine(ETR) can be used for patients who have failed NNRTI-based regimen. In Thailand, ETR is approximately 45 times more expensive than rilpivirine(RPV). However, there are no data of RPV use in NNRTI failure. Therefore, we assessed the susceptibility and mutation patterns of first line NNRTI failure and the possibility of using RPV compared to ETV in patients who have failed efavirenz(EFV)- and nevirapine(NVP)-based regimens. Methods Clinical samples with confirmed virological failure from EFV- or NVP-based regimens were retrospectively analyzed. Resistance-associated mutations (RAMs) were interpreted by IAS-USA Drug Resistance Mutations. Susceptibility of ETR and RPV were interpreted by DUET, Monogram scoring system, and Stanford University HIV Drug Resistance Database. Results 1,279 and 528 patients failed EFV-and NVP-based regimens, respectively. Y181C was the most common NVP-associated RAM (54.3% vs. 14.7%, p<0.01). K103N was the most common EFV-associated RAM (56.5% vs. 19.1%, P<0.01). The results from all three scoring systems were concordant. 165(11.1%) and 161(10.9%) patients who failed NVP-based regimen were susceptible to ETR and RPV, respectively (p = 0.85). 195 (32.2%) and 191 (31.6%) patients who failed EFV-based regimen, were susceptible to ETR and RPV, respectively (p = 0.79). The susceptibility of ETV and RPV in EFV failure was significantly higher than NVP failure (p<0.01). Conclusion The mutation patterns for ETR and RPV were similar but 32% and 11% of patients who failed EFV and NVP -based regimen, respectivly were susceptible to RPV. This finding suggests that RPV can be used as the alternative antiretroviral agent in patients who have failed EFV-based regimen.	[Teeranaipong, Phairote] Chulalongkorn Univ, Fac Med, Dept Parasitol, Bangkok 10330, Thailand; [Sirivichayakul, Sunee; Mekprasan, Suwanna; Avihingsanon, Anchalee; Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Dept Med, Div Allergy & Clin Immunol, Bangkok 10330, Thailand; [Ohata, Pirapon June; Avihingsanon, Anchalee; Ruxrungtham, Kiat] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Putcharoen, Opass] Chulalongkorn Univ, Fac Med, Dept Med, Div Infect Dis, Bangkok 10330, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University	Putcharoen, O (corresponding author), Chulalongkorn Univ, Fac Med, Dept Med, Div Infect Dis, Bangkok 10330, Thailand.	opassid@gmail.com	Ohata, June/K-1542-2014	Ohata, June/0000-0001-6067-3707; Ruxrungtham, Kiat/0000-0001-7348-2352	HIV-NAT, The Thai Red Cross AIDS Research Centre; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand	HIV-NAT, The Thai Red Cross AIDS Research Centre; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand	HIV-NAT, The Thai Red Cross AIDS Research Centre and Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, provided money to conduct the study. The funders developed the study protocol, conducted the study, analyzed the data, wrote the paper and made the decision to submit the paper.	Adolescents PoAGfAa, 2015, GUID USE ANT AG HIV; Anta L, 2013, AIDS, V27, P81, DOI 10.1097/QAD.0b013e3283584500; Barcarolo J, 2012, WHO HIV DRUG RES REP; Bunupuradah T, 2011, ANTIVIR THER, V16, P1113, DOI 10.3851/IMP1906; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Imaz A, 2012, AIDS REV, V14, P268; James C, 2012, AM J HEALTH-SYST PH, V69, P857, DOI 10.2146/ajhp110395; Katlama C, 2010, ANTIVIR THER, V15, P1045, DOI 10.3851/IMP1662; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manosuthi W, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0053-z; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Picchio G, 2011, AIDS RES HUM RETROV, V27, P1272, DOI 10.1089/aid.2011.0049; Porter DP, 2014, JAIDS-J ACQ IMM DEF, V65, P318, DOI 10.1097/QAI.0000000000000017; Rhee SY, 2004, ANTIMICROB AGENTS CH, V48, P3122, DOI 10.1128/AAC.48.8.3122-3126.2004; Rimsky L, 2012, JAIDS-J ACQ IMM DEF, V59, P39, DOI 10.1097/QAI.0b013e31823df4da; Schrijvers R, 2011, LANCET, V378, P201, DOI 10.1016/S0140-6736(11)60992-6; Sharma M, 2013, J ANTIMICROB CHEMOTH, V68, P250, DOI 10.1093/jac/dks404; Sungkanuparph S, 2008, CURR HIV RES, V6, P474, DOI 10.2174/157016208785861230; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Tambuyzer L, 2010, AIDS RES HUM RETROV, V26, P1197, DOI 10.1089/aid.2009.0302; Tang MW, 2012, INTERVIROLOGY, V55, P98, DOI 10.1159/000331998; Vingerhoets J, 2010, AIDS, V24, P503, DOI 10.1097/QAD.0b013e32833677ac; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	24	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154221	10.1371/journal.pone.0154221	http://dx.doi.org/10.1371/journal.pone.0154221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120449	Green Submitted, Green Published, gold			2022-12-26	WOS:000374976200049
J	Bhardwaj, M; Kim, NH; Paul, S; Jakhar, R; Han, J; Kang, SC				Bhardwaj, Monika; Kim, Na-Hyung; Paul, Souren; Jakhar, Rekha; Han, Jaehong; Kang, Sun Chul			5-Hydroxy-7-Methoxyflavone Triggers Mitochondrial-Associated Cell Death via Reactive Oxygen Species Signaling in Human Colon Carcinoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HUMAN COLORECTAL-CANCER; HEPATOMA HEPG2 CELLS; INDUCED APOPTOSIS; CA2+ CONCENTRATION; OXIDATIVE STRESS; ACTIVATION; MEMBRANE; HOMEOSTASIS	Plant-derived compounds are an important source of clinically useful anti-cancer agents. Chrysin, a biologically active flavone found in many plants, has limited usage for cancer chemotherapeutics due to its poor oral bioavailability. 5-Hydroxy-7-methoxyflavone (HMF), an active natural chrysin derivative found in various plant sources, is known to modulate several biological activities. However, the mechanism underlying HMF-induced apoptotic cell death in human colorectal carcinoma cells in vitro is still unknown. Herein, HMF was shown to be capable of inducing cytotoxicity in HCT-116 cells and induced cell death in a dose-dependent manner. Treatment of HCT-116 cells with HMF caused DNA damage and triggered mitochondrial membrane perturbation accompanied by Cyt c release, down-regulation of Bcl-2, activation of BID and Bax, and caspase-3-mediated apoptosis. These results show that ROS generation by HMF was the crucial mediator behind ER stress induction, resulting in intracellular Ca2+ release, JNK phosphorylation, and activation of the mitochondrial apoptosis pathway. Furthermore, time course study also reveals that HMF treatment leads to increase in mitochondrial and cytosolic ROS generation and decrease in antioxidant enzymes expression. Temporal upregulation of IRE1-alpha expression and JNK phosphorylation was noticed after HMF treatment. These results were further confirmed by pretreatment with the ROS scavenger N-acetyl-l-cysteine (NAC), which completely reversed the effects of HMF treatment by preventing lipid peroxidation, followed by abolishment of JNK phosphorylation and attenuation of apoptogenic marker proteins. These results emphasize that ROS generation by HMF treatment regulates the mitochondrial-mediated apoptotic signaling pathway in HCT-116 cells, demonstrating HMF as a promising pro-oxidant therapeutic candidate for targeting colorectal cancer.	[Bhardwaj, Monika; Paul, Souren; Jakhar, Rekha; Kang, Sun Chul] Daegu Univ, Dept Biotechnol, Kyongsan 38453, Kyoungbook, South Korea; [Kim, Na-Hyung] Wonkwang Univ, Dept Oriental Pharm, Iksan 570749, Jeonbuk, South Korea; [Han, Jaehong] Chung Ang Univ, Metalloenzyme Res Grp, Anseong 456756, South Korea; [Han, Jaehong] Chung Ang Univ, Dept Integrat Plant Sci, Anseong 456756, South Korea	Daegu University; Wonkwang University; Chung Ang University; Chung Ang University	Kang, SC (corresponding author), Daegu Univ, Dept Biotechnol, Kyongsan 38453, Kyoungbook, South Korea.	sckang@daegu.ac.kr	Han, Jaehong/C-9230-2011; Shubhakaran, Khichar/AAH-2454-2020; Jakhar, Rekha/O-5722-2017; kim, na-hyung/ABH-1972-2021	Han, Jaehong/0000-0002-5328-3927; Shubhakaran, Khichar/0000-0001-5515-7572; Jakhar, Rekha/0000-0001-6351-2650; kim, na-hyung/0000-0003-1595-5558	Daegu University Research Grant	Daegu University Research Grant	This research was supported by a Daegu University Research Grant, 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASTILHO RF, 1995, FREE RADICAL BIO MED, V18, P479, DOI 10.1016/0891-5849(94)00166-H; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Choi H, 2015, BIOCHIMIE, V115, P108, DOI 10.1016/j.biochi.2015.05.009; Cicek M, 2007, CANCER RES, V67, P10106, DOI 10.1158/0008-5472.CAN-07-1362; Dahan L, 2009, BRIT J PHARMACOL, V158, P610, DOI 10.1111/j.1476-5381.2009.00341.x; Dawson VL, 1996, CELL DEATH DIFFER, V3, P71; Diaz-Ruiz C, 2001, HISTOL HISTOPATHOL, V16, P415, DOI 10.14670/HH-16.415; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Fauzi AN, 2011, FOOD CHEM TOXICOL, V49, P871, DOI 10.1016/j.fct.2010.12.010; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Giorgi C, 2008, CURR MOL MED, V8, P119; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hemachandra LPMP, 2015, CANCER RES, V75, P4973, DOI 10.1158/0008-5472.CAN-14-3799; Hildeman DA, 2003, J CLIN INVEST, V111, P575, DOI 10.1172/JCI200318007; Ji YB, 2011, EXP TOXICOL PATHOL, V63, P69, DOI 10.1016/j.etp.2009.09.010; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Khoo BY, 2010, INT J MOL SCI, V11, P2188, DOI 10.3390/ijms11052188; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kroemer G, 2007, PHYSIOL REV, V87, P519; Papademetrio DL, 2013, REV BRAS FARMACOGN, V23, P455, DOI 10.1590/S0102-695X2013005000025; Lee HH, 2013, INT J ONCOL, V42, P1036, DOI 10.3892/ijo.2013.1762; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Liu M, 2015, J GERIATR CARDIOL, V12, P540, DOI 10.11909/j.issn.1671-5411.2015.05.009; Lu DY, 2012, PHYTOMEDICINE, V19, P1093, DOI 10.1016/j.phymed.2012.06.010; Maddalena F, 2011, CANCER RES, V71, P7659, DOI 10.1158/0008-5472.CAN-11-2172; Mandl J, 2013, MOL ENDOCRINOL, V27, P384, DOI 10.1210/me.2012-1317; Mhaidat N, 2008, APOPTOSIS, V13, P1505, DOI 10.1007/s10495-008-0276-8; Pal HC, 2013, EXP DERMATOL, V22, P470, DOI 10.1111/exd.12181; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Qiu PJ, 2010, MOL NUTR FOOD RES, V54, pS244, DOI 10.1002/mnfr.200900605; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Su CC, 2006, ANTICANCER RES, V26, P4379; SUNDERMAN FW, 1985, ANN CLIN LAB SCI, V15, P229; Ta N, 2007, J STEROID BIOCHEM, V107, P127, DOI 10.1016/j.jsbmb.2007.01.006; Uhl M, 2003, ARCH TOXICOL, V77, P477, DOI 10.1007/s00204-003-0469-4; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Van Cutsem E, 2010, ANN ONCOL, V21, pv93, DOI 10.1093/annonc/mdq222; Walle T, 2001, BRIT J CLIN PHARMACO, V51, P143, DOI 10.1111/j.1365-2125.2001.01317.x; Wang M, 2011, EUR J PHARMACOL, V650, P41, DOI 10.1016/j.ejphar.2010.09.049; Wongsrikaew N, 2011, J KOREAN SOC APPL BI, V54, P1008, DOI 10.3839/jksabc.2011.152; Yang W, 2009, TOXICOL LETT, V191, P203, DOI 10.1016/j.toxlet.2009.08.024; Zhang LB, 2011, EUR J PHARMACOL, V651, P33, DOI 10.1016/j.ejphar.2010.10.067; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089021	53	29	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154525	10.1371/journal.pone.0154525	http://dx.doi.org/10.1371/journal.pone.0154525			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116119	Green Published, gold			2022-12-26	WOS:000374973600073
J	Saverino, A; Waller, D; Rantell, K; Parry, R; Moriarty, A; Playford, ED				Saverino, A.; Waller, D.; Rantell, K.; Parry, R.; Moriarty, A.; Playford, E. D.			The Role of Cognitive Factors in Predicting Balance and Fall Risk in a Neuro-Rehabilitation Setting	PLOS ONE			English	Article							EXECUTIVE FUNCTION; OLDER-ADULTS; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; PROSPECTIVE COHORT; WALKING SPEED; ATTENTION; GAIT; REGRESSION; PEOPLE	Introduction There is a consistent body of evidence supporting the role of cognitive functions, particularly executive function, in the elderly and in neurological conditions which become more frequent with ageing. The aim of our study was to assess the role of different domains of cognitive functions to predict balance and fall risk in a sample of adults with various neurological conditions in a rehabilitation setting. Methods This was a prospective, cohort study conducted in a single centre in the UK. 114 participants consecutively admitted to a Neuro-Rehabilitation Unit were prospectively assessed for fall accidents. Baseline assessment included a measure of balance (Berg Balance Scale) and a battery of standard cognitive tests measuring executive function, speed of information processing, verbal and visual memory, visual perception and intellectual function. The outcomes of interest were the risk of becoming a faller, balance and fall rate. Results Two tests of executive function were significantly associated with fall risk, the Stroop Colour Word Test (IRR 1.01, 95% CI 1.00-1.03) and the number of errors on part B of the Trail Making Test (IRR 1.23, 95% CI 1.03-1.49). Composite scores of executive function, speed of information processing and visual memory domains resulted in 2 to 3 times increased likelihood of having better balance (OR 2.74 95% CI 1.08 to 6.94, OR 2.72 95% CI 1.16 to 6.36 and OR 2.44 95% CI 1.11 to 5.35 respectively). Conclusions Our results show that specific subcomponents of executive functions are able to predict fall risk, while a more global cognitive dysfunction is associated with poorer balance.	[Saverino, A.; Waller, D.; Parry, R.; Moriarty, A.; Playford, E. D.] Natl Hosp Neurol & Neurosurg, Therapy Serv, Queen Sq, London WC1N 3BG, England; [Saverino, A.; Waller, D.; Parry, R.; Moriarty, A.; Playford, E. D.] Natl Hosp Neurol & Neurosurg, Rehabil Serv, Queen Sq, London WC1N 3BG, England; [Saverino, A.] Fdn Salvatore Maugeri, Inst Rehabil, Genoa, Italy; [Saverino, A.] St George Hosp, Wolfson Neurorehabil Ctr, London, England; [Rantell, K.] Joint UCL UCLH Royal Free Hosp, Res Support Ctr, London, England; [Rantell, K.; Playford, E. D.] UCL, Inst Neurol, London, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Istituti Clinici Scientifici Maugeri IRCCS; St Georges University London; University of London; Queen Mary University London; University of London; University College London	Playford, ED (corresponding author), Natl Hosp Neurol & Neurosurg, Therapy Serv, Queen Sq, London WC1N 3BG, England.; Playford, ED (corresponding author), Natl Hosp Neurol & Neurosurg, Rehabil Serv, Queen Sq, London WC1N 3BG, England.; Playford, ED (corresponding author), UCL, Inst Neurol, London, England.	D.Playford@ion.ucl.ac.uk		Playford, E Diane/0000-0001-7314-787X				Alemdaroglu E, 2012, ARCH PHYS MED REHAB, V93, P2244, DOI 10.1016/j.apmr.2012.06.014; Anstey KJ, 2009, NEUROPSYCHOLOGY, V23, P500, DOI 10.1037/a0015389; ARMSTRONG BG, 1989, AM J EPIDEMIOL, V129, P191, DOI 10.1093/oxfordjournals.aje.a115109; Axer H, 2010, CLIN NEUROL NEUROSUR, V112, P265, DOI 10.1016/j.clineuro.2009.12.015; Baddely AD B A, 1994, DOORS PEOPLE TEST VI; BECHTOLDT HP, 1962, PSYCHOL REC, V12, P147, DOI 10.1007/BF03393452; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bergland A, 2004, INJURY PREV, V10, P308, DOI 10.1136/ip.2003.004721; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Campbell GB, 2010, J NURS SCHOLARSHIP, V42, P395, DOI 10.1111/j.1547-5069.2010.01369.x; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; D'Orio VL, 2012, J NEUROL SCI, V316, P42, DOI 10.1016/j.jns.2012.02.003; Coelho FGD, 2012, AGING NEUROPSYCHOL C, V19, P644, DOI 10.1080/13825585.2012.661398; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Gleason CE, 2009, DEMENT GERIATR COGN, V27, P557, DOI 10.1159/000228257; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Grimbergen YAM, 2008, MOVEMENT DISORD, V23, P970, DOI 10.1002/mds.22003; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Hoang PD, 2014, ARCH PHYS MED REHAB, V95, P480, DOI 10.1016/j.apmr.2013.09.017; Holtzer R, 2007, NEUROPSYCHOLOGY, V21, P540, DOI 10.1037/0894-4105.21.5.540; Lee JE, 2008, AM J PHYS MED REHAB, V87, P341, DOI 10.1097/PHM.0b013e31816ddc01; Liu-Ambrose T, 2007, CEREBROVASC DIS, V23, P203, DOI 10.1159/000097642; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; Marshall J., 2012, HDB CLIN NEUROPSYCHO; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Mirelman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040297; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Neumann L, 2013, J NUTR HEALTH AGING, V17, P264, DOI 10.1007/s12603-012-0390-8; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; Pahlman U, 2011, DISABIL REHABIL, V33, P1952, DOI 10.3109/09638288.2011.553703; Reitan R.M., 1992, TRAIL MAKING TEST MA; Saverino A, 2015, DISABIL REHABIL, V37, P355, DOI 10.3109/09638288.2014.923520; Saverino A, 2014, DISABIL REHABIL, V36, P963, DOI 10.3109/09638288.2013.829525; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Sheridan PL, 2003, J AM GERIATR SOC, V51, P1633, DOI 10.1046/j.1532-5415.2003.51516.x; Smith A, 1995, SYMBOL DIGIT MODALIT; Sosnoff JJ, 2013, ARCH PHYS MED REHAB, V94, P1567, DOI 10.1016/j.apmr.2013.02.009; StataCorp, 2011, STAT STAT SOFTW REL, P173; Thurman DJ, 2008, NEUROLOGY, V70, P473, DOI 10.1212/01.wnl.0000299085.18976.20; Warrington E., 1996, CAMDEN MEMORY TESTS; Warrington E.K., 1984, RECOGNITION MEMORY T; Warrington EK., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WECHSLER ADULT INTEL; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	51	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153469	10.1371/journal.pone.0153469	http://dx.doi.org/10.1371/journal.pone.0153469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115880	Green Published, gold			2022-12-26	WOS:000374973600023
J	Bieghs, L; Brohus, M; Kristensen, IB; Abildgaard, N; Bogsted, M; Johnsen, HE; Conover, CA; De Bruyne, E; Vanderkerken, K; Overgaard, MT; Nyegaard, M				Bieghs, Liesbeth; Brohus, Malene; Kristensen, Ida B.; Abildgaard, Niels; Bogsted, Martin; Johnsen, Hans E.; Conover, Cheryl A.; De Bruyne, Elke; Vanderkerken, Karin; Overgaard, Michael T.; Nyegaard, Mette			Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; MURINE MODEL; FACTOR-I; INSULIN; EXPRESSION; RECEPTOR; IGFBP-2; FIBROBLASTS; BORTEZOMIB; RESISTANT	Insulin-like growth factor (IGF) signalling plays a key role in homing, progression, and treatment resistance in multiple myeloma (MM). In the extracellular environment, the majority of IGF molecules are bound to one of six IGF-binding proteins (IGFBP1-6), leaving a minor fraction of total IGF free and accessible for receptor activation. In MM, high IGF-receptor type 1 expression levels correlate with a poor prognosis, but the status and role of IGF and IGFBPs in the pathobiology of MM is unknown. Here we measured total IGF1, IGF2, and intact IGFBP levels in blood and bone marrow samples from MM (n = 17), monoclonal gammopathy of undetermined significance (MGUS) (n = 37), and control individuals (n = 15), using ELISA (IGFs) and I-125-IGF1 Western Ligand Blotting (IGFBPs). MGUS and MM patients displayed a significant increase in intact IGFBP-2 (2.5-3.8 fold) and decrease in intact IGFBP-3 (0.6-0.5 fold) in the circulation compared to control individuals. Further, IGFBP-2 as well as total IGFBP levels were significantly lower in bone marrow compared to circulation in MM and MGUS only, whereas IGF1, IGF2, and IGFBP-3 were equally distributed between the two compartments. In conclusion, the profound change in IGFBP profile strongly suggests an increased IGF bioavailability in the bone marrow microenvironment in MGUS and MM, despite no change in growth factor concentration.	[Bieghs, Liesbeth; Bogsted, Martin; Johnsen, Hans E.] Aalborg Univ, Dept Hematol, Aalborg Hosp, Aalborg, Denmark; [Bieghs, Liesbeth; De Bruyne, Elke; Vanderkerken, Karin] Vrije Univ Brussel, Dept Hematol & Immunol, Myeloma Ctr Brussel, Brussels, Belgium; [Bieghs, Liesbeth; Nyegaard, Mette] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Brohus, Malene; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark; [Kristensen, Ida B.; Abildgaard, Niels] Odense Univ Hosp, Dept Haematol, DK-5000 Odense, Denmark; [Conover, Cheryl A.] Mayo Clin, Div Endocrinol Metab & Nutr, Endocrine Res Unit, Rochester, MN USA	Aalborg University; Aalborg University Hospital; Vrije Universiteit Brussel; Aarhus University; Aalborg University; University of Southern Denmark; Odense University Hospital; Mayo Clinic	Overgaard, MT (corresponding author), Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark.	mto@bio.aau.dk	De Bruyne, Elke/Z-3215-2019; Overgaard, Michael Toft/E-1354-2011; De Bruyne, Elke/R-2145-2019; Nyegaard, Mette/M-3379-2019	De Bruyne, Elke/0000-0003-4012-4617; Overgaard, Michael Toft/0000-0002-1423-2481; Nyegaard, Mette/0000-0003-4973-8543; Kristensen, Ida Bruun/0000-0001-8605-9422; Bogsted, Martin/0000-0001-9192-1814; Johnsen, Hans Erik/0000-0001-8253-2913				Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bataille R, 2005, HAEMATOLOGICA, V90, P706; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Bieghs L, 2014, ONCOTARGET, V5, P11193, DOI 10.18632/oncotarget.1933; Birmann BM, 2012, BLOOD, V120, P4929, DOI 10.1182/blood-2012-03-417253; Boldt HB, 2011, ENDOCRINOLOGY, V152, P1470, DOI 10.1210/en.2010-1095; Bolomsky A, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0105-1; Bret C, 2011, EXP HEMATOL; Chng WJ, 2006, LEUKEMIA, V20, P174, DOI 10.1038/sj.leu.2403997; CONOVER CA, 1993, J CLIN INVEST, V91, P1129, DOI 10.1172/JCI116272; Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007; Fisher MC, 2005, BONE, V37, P741, DOI 10.1016/j.bone.2005.07.024; Fleming JM, 2005, J ENDOCRINOL, V186, P165, DOI 10.1677/joe.1.06164; Grotendorst GR, 2001, J CLIN ENDOCR METAB, V86, P944, DOI 10.1210/jc.86.2.944; Kristensen IB, 2013, EUR J HAEMATOL, V91, P196, DOI 10.1111/ejh.12125; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Lund J, 2014, J MOL ENDOCRINOL, V52, P345, DOI 10.1530/JME-13-0184; Monget P, 2003, BIOL REPROD, V68, P77, DOI 10.1095/biolreprod.102.007609; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; Moreaux J, 2011, BLOOD, V117, P1280, DOI 10.1182/blood-2010-04-279760; OKAZAKI R, 1994, ENDOCRINOLOGY, V134, P126, DOI 10.1210/en.134.1.126; Ryan AJ, 2009, BRIT J CANCER, V101, P278, DOI 10.1038/sj.bjc.6605141; Soh CL, 2014, BRIT J CANCER, V110, P2855, DOI 10.1038/bjc.2014.232; Sprynski AC, 2009, BLOOD, V113, P4614, DOI 10.1182/blood-2008-07-170464; Standal T, 2002, BLOOD, V100, P3925, DOI 10.1182/blood-2002-05-1406; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Yu H, 1999, J CLIN LAB ANAL, V13, P166, DOI 10.1002/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.3.CO;2-O	28	7	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154256	10.1371/journal.pone.0154256	http://dx.doi.org/10.1371/journal.pone.0154256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111220	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600053
J	Wang, XF; Ji, P; Zhang, YH; LaComb, JF; Tian, XY; Li, E; Williams, JL				Wang, Xuefeng; Ji, Ping; Zhang, Yuanhao; LaComb, Joseph F.; Tian, Xinyu; Li, Ellen; Williams, Jennie L.			Aberrant DNA Methylation: Implications in Racial Health Disparity	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RIBOSOMAL-PROTEIN L13A; COLORECTAL-CANCER; COLON-CANCER; DIFFERENTIAL EXPRESSION; MESSENGER-RNAS; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; SIGNALING PATHWAYS; GENE-EXPRESSION	Background Incidence and mortality rates of colorectal carcinoma (CRC) are higher in African Americans (AAs) than in Caucasian Americans (CAs). Deficient micronutrient intake due to dietary restrictions in racial/ethnic populations can alter genetic and molecular profiles leading to dysregulated methylation patterns and the inheritance of somatic to germline mutations. Materials and Methods Total DNA and RNA samples of paired tumor and adjacent normal colon tissues were prepared from AA and CA CRC specimens. Reduced Representation Bisulfite Sequencing (RRBS) and RNA sequencing were employed to evaluate total genome methylation of 5'-regulatory regions and dysregulation of gene expression, respectively. Robust analysis was conducted using a trimming-and-retrieving scheme for RRBS library mapping in conjunction with the BStool toolkit. Results DNA from the tumor of AA CRC patients, compared to adjacent normal tissues, contained 1,588 hypermethylated and 100 hypomethylated differentially methylated regions (DMRs). Whereas, 109 hypermethylated and 4 hypomethylated DMRs were observed in DNA from the tumor of CA CRC patients; representing a 14.6-fold and 25-fold change, respectively. Specifically; CHL1, 4 anti-inflammatory genes (i.e., NELL1, GDF1, ARHGEF4, and ITGA4), and 7 miRNAs (of which miR-9-3p and miR-124-3p have been implicated in CRC) were hypermethylated in DNA samples from AA patients with CRC. From the same sample set, RNAseq analysis revealed 108 downregulated genes (including 14 ribosomal proteins) and 34 upregulated genes (including POLR2B and CYP1B1 [targets of miR-124-3p]) in AA patients with CRC versus CA patients. Conclusion DNA methylation profile and/or products of its downstream targets could serve as biomarker(s) addressing racial health disparity.	[Wang, Xuefeng; Ji, Ping; LaComb, Joseph F.; Williams, Jennie L.] SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA; [Li, Ellen; Williams, Jennie L.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Wang, Xuefeng] SUNY Stony Brook, Dept Biomed Informat, Stony Brook, NY 11794 USA; [Wang, Xuefeng; Zhang, Yuanhao; Tian, Xinyu] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [LaComb, Joseph F.; Williams, Jennie L.] SUNY Stony Brook, Canc Prevent Div, Stony Brook, NY 11794 USA; [Li, Ellen] SUNY Stony Brook, Div Gastroenterol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Williams, JL (corresponding author), SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA.; Williams, JL (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.; Williams, JL (corresponding author), SUNY Stony Brook, Canc Prevent Div, Stony Brook, NY 11794 USA.	Jennie.Williams@stonybrookmedicine.edu		LaComb, Joseph/0000-0002-2981-1072	National Institutes of Health-National Cancer Institute;  [R01CA140487];  [P20CA192994]; NATIONAL CANCER INSTITUTE [R01CA140487, P20CA192994, P30CA045508] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health-National Cancer Institute; http://www.cancer.gov/; grant number R01CA140487 to JLW and award number P20CA192994 to EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsopoulos VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082487; Antoine M, 2005, BIOCHEM BIOPH RES CO, V338, P1248, DOI 10.1016/j.bbrc.2005.10.079; Artero-Castro A, 2009, EXP CELL RES, V315, P1372, DOI 10.1016/j.yexcr.2009.02.007; Artero-Castro A, 2011, HUM PATHOL, V42, P194, DOI 10.1016/j.humpath.2010.04.020; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bao MW, 2015, J PATHOL, V236, P360, DOI 10.1002/path.4523; BARNARD GF, 1993, CANCER RES, V53, P4048; Basu A, 2014, ARTERIOSCL THROM VAS, V34, P533, DOI 10.1161/ATVBAHA.113.302573; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Bibikova E, 2014, BLOOD, V124, P3791, DOI 10.1182/blood-2014-06-584656; Bjursten M, 2005, EUR J IMMUNOL, V35, P2274, DOI 10.1002/eji.200526022; Brawley OW, 2007, CURR PROB CANCER, V31, P114, DOI 10.1016/j.currproblcancer.2007.02.001; Brim H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082185; Carethers J M, 1999, J Assoc Acad Minor Phys, V10, P59; Cekaite L, 2012, NEOPLASIA, V14, P868, DOI 10.1593/neo.121094; Chan H, 2005, CANCER DETECT PREV, V29, P562, DOI 10.1016/j.cdp.2005.09.007; Chien C, 2005, CANCER, V104, P629, DOI 10.1002/cncr.21204; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Cooper GS, 1997, CANCER EPIDEM BIOMAR, V6, P283; Daftuar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068667; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; FRIGERIO JM, 1995, BBA-GENE STRUCT EXPR, V1262, P64, DOI 10.1016/0167-4781(95)00045-I; Gerecke C, 2015, J CANCER RES CLIN, V141, P2097, DOI 10.1007/s00432-015-1972-8; Gillberg L, 2013, ACTA PHYSIOL, V207, P326, DOI 10.1111/apha.12017; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herrinton LJ, 2012, GASTROENTEROLOGY, V143, P382, DOI 10.1053/j.gastro.2012.04.054; Hodgson DC, 2003, J NATL CANCER I, V95, P708, DOI 10.1093/jnci/95.10.708; Hodgson DC, 2001, JNCI-J NATL CANCER I, V93, P501, DOI 10.1093/jnci/93.7.501; Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Kasai H, 2003, J HISTOCHEM CYTOCHEM, V51, P567, DOI 10.1177/002215540305100502; Kitahara O, 2001, CANCER RES, V61, P3544; Kobayashi T, 2006, INT J MOL MED, V18, P161; KONDOH N, 1992, CANCER RES, V52, P791; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; Kumarakulasingham M, 2005, CLIN CANCER RES, V11, P3758, DOI 10.1158/1078-0432.CCR-04-1848; Lai MD, 2007, CURR GENOMICS, V8, P43; Li E, 2014, INT J ONCOL, V45, P587, DOI 10.3892/ijo.2014.2469; Lieberman DA, 2008, JAMA-J AM MED ASSOC, V300, P1417, DOI 10.1001/jama.300.12.1417; Liu JJ, 2006, J CELL PHYSIOL, V207, P287, DOI 10.1002/jcp.20589; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; Martinez VG, 2008, BRIT J CANCER, V98, P564, DOI 10.1038/sj.bjc.6604195; MAYBERRY RM, 1995, J NATL CANCER I, V87, P1686, DOI 10.1093/jnci/87.22.1686; Meng FY, 2015, AM J PHYSIOL-LUNG C, V308, pL452, DOI 10.1152/ajplung.00170.2014; Michiels S, 2007, CARCINOGENESIS, V28, P1731, DOI 10.1093/carcin/bgm111; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Poddar D, 2013, J IMMUNOL, V190, P3600, DOI 10.4049/jimmunol.1201933; Ponicsan SL, 2013, J MOL BIOL, V425, P3625, DOI 10.1016/j.jmb.2013.01.035; RIES LAG, 1997, SEER CANC STAT REV 1; Rochat B, 2001, J PHARMACOL EXP THER, V296, P537; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Salbaum JM, 2012, PROG MOL BIOL TRANSL, V108, P129, DOI 10.1016/B978-0-12-398397-8.00006-X; Samowitz WS, 2008, EXP MOL PATHOL, V85, P64, DOI 10.1016/j.yexmp.2008.03.008; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Shen J, 2013, TISSUE ENG PT A, V19, P2390, DOI [10.1089/ten.tea.2012.0519, 10.1089/ten.TEA.2012.0519]; Slattery M L, 2000, Semin Gastrointest Dis, V11, P142; Slattery ML, 2015, INT J CANCER, V137, P428, DOI 10.1002/ijc.29384; Surovtseva YV, 2011, P NATL ACAD SCI USA, V108, P17921, DOI 10.1073/pnas.1108852108; Taniguchi K, 2015, CANCER LETT, V363, P17, DOI 10.1016/j.canlet.2015.03.026; Teller A, 2015, PATHOL RES PRACT, V211, P62, DOI 10.1016/j.prp.2014.09.005; Tian XQ, 2015, ONCOTARGETS THER, V8, P1691, DOI 10.2147/OTT.S81621; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Wang M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-6; Wang XF, 2015, BIOINFORMATICS, V31, P2040, DOI 10.1093/bioinformatics/btv089; Zhu HL, 2014, BIOCHEM BIOPH RES CO, V450, P857, DOI 10.1016/j.bbrc.2014.06.073; ZIEMIECKI A, 1990, EMBO J, V9, P191, DOI 10.1002/j.1460-2075.1990.tb08095.x	73	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153125	10.1371/journal.pone.0153125	http://dx.doi.org/10.1371/journal.pone.0153125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111221	Green Published, gold			2022-12-26	WOS:000374970600010
J	Ismail, E; Nofal, OKJ; Sakthiswary, R; Shaharir, SS; Sridharan, R				Ismail, Endom; Nofal, Omimah Khaled Jaber; Sakthiswary, Rajalingham; Shaharir, Syahrul Sazliyana; Sridharan, Radhika			The Clinical Significance of Interleukin-1 Receptor Antagonist+2018 Polymorphism in Rheumatoid Arthritis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GENE POLYMORPHISMS; DISEASE SEVERITY; JOINT DAMAGE; SUSCEPTIBILITY; ASSOCIATION; IL-1RA; AGE; PATHWAYS; REGION	Objective Interleukin-1 receptor antagonist (IL-1Ra) acts as an inhibitor of IL-1; which is one of the culprit cytokines in rheumatoid arthritis (RA). Although +2018 polymorphism of IL-1Ra has been implicated in the pathogenesis of RA, its importance remains poorly understood. Hence, the purpose of this study was to determine the clinical significance of interleukin-1 receptor antagonist (IL-1Ra) +2018 polymorphism in RA. Methods Polymerase chain reaction (PCR) and sequencing were used to determine the genotypes of the IL-1Ra +2018 for 77 RA patients and 18 healthy controls. All RA patients were assessed for the disease activity score that includes 28 joints (DAS28) and radiographic disease damage based on Modified Sharp Score (MSS). Results The frequency of the T/T and C/T genotypes did not differ significantly (p = 0.893) between the RA patients and the controls. The C/T genotype had significantly higher mean disease activity (DAS 28) and disease damage (MSS) scores with p values of 0.017 and 0.004, respectively. Additionally, the ESR (erythrocyte sedimentation rate), CRP (C-reactive protein), the number of swollen and tender joints were higher for the C/T individuals. On multivariate analysis the CRP, swollen joint count and MSS remained significant with the following p values i.e. 0.045, 0.046 and less than 0.05. Conclusions C/T genotype of IL-1Ra +2018 prognosticates more aggressive disease in RA.	[Ismail, Endom; Nofal, Omimah Khaled Jaber] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor, Malaysia; [Sakthiswary, Rajalingham; Shaharir, Syahrul Sazliyana] Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Fac Med, Kuala Lumpur 56000, Malaysia; [Sridharan, Radhika] Univ Kebangsaan Malaysia, Med Ctr, Dept Radiol, Fac Med, Kuala Lumpur 56000, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Sakthiswary, R (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Fac Med, Kuala Lumpur 56000, Malaysia.	sakthis5@hotmail.com	Sakthiswary, Rajalingham/E-8565-2017		Universiti Kebangsaan Malaysia [DLP-2013-039]	Universiti Kebangsaan Malaysia	Funded by DLP-2013-039 by Universiti Kebangsaan Malaysia.	AREND WP, 1995, ARTHRITIS RHEUM, V38, P151, DOI 10.1002/art.1780380202; Arman A, 2006, CLIN EXP RHEUMATOL, V24, P643; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; BLAKEMORE AIF, 1994, ARTHRITIS RHEUM, V37, P1380, DOI 10.1002/art.1780370917; Buchs N, 2001, GENES IMMUN, V2, P222, DOI 10.1038/sj.gene.6363766; Cantagrel A, 1999, ARTHRITIS RHEUM, V42, P1093, DOI 10.1002/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO;2-P; Carreira PE, 2005, ARTHRITIS RHEUM-US, V52, P3015, DOI 10.1002/art.21287; Carter MJ, 2004, GENES IMMUN, V5, P8, DOI 10.1038/sj.gene.6364032; Chen Y, 2012, CLIN EXP RHEUMATOL, V30, P894; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Cox A, 1999, HUM MOL GENET, V8, P1707, DOI 10.1093/hmg/8.9.1707; Dalila AS, 2014, KAOHSIUNG J MED SCI, V30, P337, DOI 10.1016/j.kjms.2014.02.010; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Gaafar T, 2013, WORLD APPL SCI J, V27, P574; Harrison P, 2008, RHEUMATOLOGY, V47, P1768, DOI 10.1093/rheumatology/ken374; He YH, 2004, RHEUMATOL INT, V24, P133, DOI 10.1007/s00296-003-0337-9; Huang CM, 2002, CLIN RHEUMATOL, V21, P255, DOI 10.1007/s10067-002-8292-5; Huang CM, 2001, SCAND J RHEUMATOL, V30, P225; John S, 2001, ARTHRITIS RES, V3, P216, DOI 10.1186/ar304; Kapetanovic MC, 2007, J RHEUMATOL, V34, P894; Karlson EW, 2008, ANN RHEUM DIS, V67, P358, DOI 10.1136/ard.2007.071662; Kazkaz L, 2007, ANN RHEUM DIS, V66, P195, DOI 10.1136/ard.2004.033829; Lubbe S, 2008, JOINT BONE SPINE, V75, P422, DOI 10.1016/j.jbspin.2007.09.015; Mino T, 1998, ARTHRITIS RHEUM, V41, P2004, DOI 10.1002/1529-0131(199811)41:11<2004::AID-ART16>3.0.CO;2-Z; Raychaudhuri S, 2010, CURR OPIN RHEUMATOL, V22, P109, DOI 10.1097/BOR.0b013e328336474d; STEINKASSERER A, 1992, GENOMICS, V13, P654, DOI 10.1016/0888-7543(92)90137-H; Swellam M, 2013, IUBMB LIFE, V65, P883, DOI 10.1002/iub.1205; Tan WF, 2010, ARTHRITIS RHEUM-US, V62, P2864, DOI 10.1002/art.27589; Tolusso B, 2006, PHARMACOGENOMICS, V7, P683, DOI 10.2217/14622416.7.5.683; Xue J, 2010, CLIN EXP RHEUMATOL, V28, P654	32	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153752	10.1371/journal.pone.0153752	http://dx.doi.org/10.1371/journal.pone.0153752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105431	gold, Green Published, Green Submitted			2022-12-26	WOS:000374565100019
J	Molloy, SW; Davis, RA; van Etten, EJB				Molloy, Shaun W.; Davis, Robert A.; van Etten, Eddie J. B.			Incorporating Field Studies into Species Distribution and Climate Change Modelling: A Case Study of the Koomal Trichosurus vulpecula hypoleucus (Phalangeridae)	PLOS ONE			English	Article							WESTERN-AUSTRALIA; BRUSHTAIL POSSUM; RANGE; BIODIVERSITY; ADAPTATION; LANDSCAPE; IMPACTS; ABILITY; MAXENT; SPACE	Species distribution models (SDMs) are an effective way of predicting the potential distribution of species and their response to environmental change. Most SDMs apply presence data to a relatively generic set of predictive variables such as climate. However, this weakens the modelling process by overlooking the responses to more cryptic predictive variables. In this paper we demonstrate a means by which data gathered from an intensive animal trapping study can be used to enhance SDMs by combining field data with bioclimatic modelling techniques to determine the future potential distribution for the koomal (Trichosurus vulpecula hypoleucus). The koomal is a geographically isolated subspecies of the common brushtail possum, endemic to south-western Australia. Since European settlement this taxon has undergone a significant reduction in distribution due to its vulnerability to habitat fragmentation, introduced predators and tree/shrub dieback caused by a virulent group of plant pathogens of the genus Phytophthora. An intensive field study found: 1) the home range for the koomal rarely exceeded 1 km in in length at its widest point; 2) areas heavily infested with dieback were not occupied; 3) gap crossing between patches (>400 m) was common behaviour; 4) koomal presence was linked to the extent of suitable vegetation; and 5) where the needs of koomal were met, populations in fragments were demographically similar to those found in contiguous landscapes. We used this information to resolve a more accurate SDM for the koomal than that created from bioclimatic data alone. Specifically, we refined spatial coverages of remnant vegetation and dieback, to develop a set of variables that we combined with selected bioclimatic variables to construct models. We conclude that the utility value of an SDM can be enhanced and given greater resolution by identifying variables that reflect observed, species-specific responses to landscape parameters and incorporating these responses into the model.	[Molloy, Shaun W.; Davis, Robert A.; van Etten, Eddie J. B.] Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia	Edith Cowan University	Molloy, SW (corresponding author), Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia.	shaunecologist@gmail.com	van Etten, Eddie/AAC-2612-2020; Davis, Robert/F-6621-2012	van Etten, Eddie/0000-0002-7311-1794; Davis, Robert/0000-0002-9062-5754; Molloy, Shaun/0000-0002-8659-8992	Holsworth Wildlife Research Endowment; Edith Cowan University	Holsworth Wildlife Research Endowment; Edith Cowan University	Partial funding for this project was provided by the Holsworth Wildlife Research Endowment (http://www.eqt.com.au/not-for-profit-organisations/confirmed-2015-programs/holsworth-grants.aspx). All other funding, in the form of materials and wages, were covered by Edith Cowan University (https://www.ecu.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hosking C, 2011, WILDLIFE RES, V38, P122, DOI 10.1071/WR10156; Anderson P, 2010, FOREST ECOL MANAG, V259, P1033, DOI 10.1016/j.foreco.2009.12.015; [Anonymous], 2010, MAPPING SPECIES DIST; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Benito BM, 2009, BIODIVERS CONSERV, V18, P2509, DOI 10.1007/s10531-009-9604-8; Bi DH, 2013, AUST METEOROL OCEAN, V63, P41, DOI 10.22499/2.6301.004; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Brotons L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111996; Bystriakova N, 2012, SYST BIODIVERS, V10, P305, DOI 10.1080/14772000.2012.705357; Cruz J, 2012, AUSTRAL ECOL, V37, P893, DOI 10.1111/j.1442-9993.2011.02346.x; DEC, 2007, NATUREMAP MAPP W AUS; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fordham DA, 2012, GLOBAL CHANGE BIOL, V18, P2743, DOI 10.1111/j.1365-2486.2012.02742.x; Gibson L, 2010, BIOL CONSERV, V143, P2453, DOI 10.1016/j.biocon.2010.06.011; Giovanelli JGR, 2010, ECOL MODEL, V221, P215, DOI 10.1016/j.ecolmodel.2009.10.009; Government of Western Australia, 2013, 2013 STAT VEG STAT I; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hand BK, 2014, BIODIVERS CONSERV, V23, P2761, DOI 10.1007/s10531-014-0747-x; Hearn R, 2003, BIODIVERISTY AUDIT W, P382; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; HOBBS RJ, 1993, BIOL CONSERV, V64, P183, DOI 10.1016/0006-3207(93)90319-V; Hope P., 2015, SO S W FLATLANDS CLU; How RA, 2000, WILDLIFE RES, V27, P81, DOI 10.1071/WR98064; Huntley B, 2010, ECOGRAPHY, V33, P621, DOI 10.1111/j.1600-0587.2009.06023.x; Jakob D, 2012, W AUSTR WEATH CLIM S; Jones Barbara, 2004, P149; KERLE JA, 1991, AUST J ZOOL, V39, P313, DOI 10.1071/ZO9910313; Kim HM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051644; Meineri E, 2015, BIOL REV, V90, P314, DOI 10.1111/brv.12111; Molloy S, 2013, THESIS E COWAN U; Molloy SW, 2014, ENVIRON CONSERV, V41, P176, DOI 10.1017/S0376892913000337; Office of the Auditor General, 2007, MAN NAT VEG CLEAR AU; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prober SM, 2012, CLIMATIC CHANGE, V110, P227, DOI 10.1007/s10584-011-0092-y; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; SAUNDERS DA, 1990, BIOL CONSERV, V54, P277, DOI 10.1016/0006-3207(90)90057-V; Schroter M, 2014, LESSONS LEARNED SPAT; Shearer B.L., 1989, JARRAH DIEBACK DYNAM; Simova P, 2012, APPL GEOGR, V34, P385, DOI 10.1016/j.apgeog.2012.01.003; Strelein G, 2007, SCRIPT DIEBACK RISK; Urban MC, 2013, ANN NY ACAD SCI, V1297, P44, DOI 10.1111/nyas.12184; Vasconcelos TS, 2012, ECOGRAPHY, V35, P539, DOI 10.1111/j.1600-0587.2011.07050.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Willis SG, 2009, ECOGRAPHY, V32, P5, DOI 10.1111/j.1600-0587.2008.05711.x; WorldClim, 2014, GLOB CLIM DAT BAS 20; Yates CJ, 2010, AUSTRAL ECOL, V35, P374, DOI 10.1111/j.1442-9993.2009.02044.x	53	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154161	10.1371/journal.pone.0154161	http://dx.doi.org/10.1371/journal.pone.0154161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104611	gold, Green Submitted, Green Published			2022-12-26	WOS:000374565100048
J	Rantakokko, M; Portegijs, E; Viljanen, A; Iwarsson, S; Rantanen, T				Rantakokko, Merja; Portegijs, Erja; Viljanen, Anne; Iwarsson, Susanne; Rantanen, Taina			Mobility Modification Alleviates Environmental Influence on Incident Mobility Difficulty among Community-Dwelling Older People: A Two-Year Follow-Up Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; COMPENSATORY STRATEGIES; DISABILITY; WALKING; ADULTS; BARRIERS; WOMEN; GAIT; PERFORMANCE; ADAPTATION	Background Environmental barriers increase risk for mobility difficulties in old age. Mobility difficulty is preceded by a phase where people try to postpone a difficulty through mobility modification. We studied whether perceived environmental mobility barriers outdoors correlate with mobility modification and mobility difficulty, predict development of mobility difficulty over a two-year follow-up, and whether mobility modification alleviates the risk for difficulty. Methods At baseline, 848 people aged 75-90 were interviewed face-to-face. Telephone follow-up interviews were conducted one (n = 816) and two years (n = 761) later. Environmental barriers to mobility were self-reported using a15-item structured questionnaire at baseline, summed and divided into tertiles (0, 1 and 2 or more barriers). Mobility difficulty was assessed as self-reported ability to walk 2 km at all assessment points and categorized into `no difficulty', 'no difficulty but mobility modifications' (reducing frequency, stopping walking, using an aid, slowing down or resting during the performance) and 'difficulty'. Results At baseline, 212 participants reported mobility modifications and 356 mobility difficulties. Those reporting one or multiple environmental barriers had twice the odds for mobility modifications and up to five times the odds for mobility difficulty compared to those reporting no environmental barriers. After multiple adjustments for health and functioning, reporting multiple environmental barriers outdoors continued to predict the development of incident mobility difficulty over the two-year follow-up. Mobility modifications attenuated the association. Conclusion For older people who successfully modify their performance, environmental influence on incident mobility difficulty can be diminished. Older people use mobility modification to alleviate environmental press on mobility.	[Rantakokko, Merja; Portegijs, Erja; Viljanen, Anne; Rantanen, Taina] Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland; [Rantakokko, Merja; Portegijs, Erja; Viljanen, Anne; Rantanen, Taina] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Iwarsson, Susanne] Lund Univ, Dept Hlth Sci, Lund, Sweden	University of Jyvaskyla; University of Jyvaskyla; Lund University	Rantakokko, M (corresponding author), Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland.; Rantakokko, M (corresponding author), Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland.	Merja.rantakokko@jyu.fi	Rantakokko, Merja/I-9779-2019; Rantakokko, Merja/HHC-5689-2022; Rantanen, Taina/O-6579-2016; Iwarsson, Susanne/I-7517-2013	Rantakokko, Merja/0000-0003-3546-1600; Rantanen, Taina/0000-0002-1604-1945; Portegijs, Erja/0000-0002-5205-9616; Viljanen, Anne/0000-0002-8428-3604; Iwarsson, Susanne/0000-0002-6670-7952	Academy of Finland [285747]; Academy of Finland Future of Living and Housing Program (ASU-LIVE) [255403]; Finnish Ministry of Education and Culture; Ribbingska Foundation in Lund, Sweden	Academy of Finland(Academy of Finland); Academy of Finland Future of Living and Housing Program (ASU-LIVE); Finnish Ministry of Education and Culture; Ribbingska Foundation in Lund, Sweden	This work was supported by Academy of Finland (grant number 285747 to [MR]); the Academy of Finland Future of Living and Housing Program (ASU-LIVE) (grant number 255403 to [TR]); the Finnish Ministry of Education and Culture to [TR and EP]; and the Ribbingska Foundation in Lund, Sweden to [SI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfour JL, 2002, AM J EPIDEMIOL, V155, P507, DOI 10.1093/aje/155.6.507; Baltes PB, 1990, SUCCESSFUL AGING PER; Booth ML, 2000, PREV MED, V31, P15, DOI 10.1006/pmed.2000.0661; Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Buchner DM, 2003, AM J PREV MED, V25, P214, DOI 10.1016/S0749-3797(03)00188-0; Clarke P, 2008, AM J EPIDEMIOL, V168, P506, DOI 10.1093/aje/kwn185; Ramos-Pichardo JD, 2014, ARCH GERONTOL GERIAT, V59, P122, DOI 10.1016/j.archger.2014.02.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedman VA, 2014, AM J PUBLIC HEALTH, V104, pE88, DOI 10.2105/AJPH.2013.301687; Fried LP, 2000, J GERONTOL A-BIOL, V55, pM43; Ganesh SP, 2011, ARCH PHYS MED REHAB, V92, P228, DOI 10.1016/j.apmr.2010.10.012; Gignac MAM, 2002, PSYCHOL AGING, V17, P520, DOI 10.1037//0882-7974.17.3.520; Gill TM, 2003, ARCH INTERN MED, V163, P1317, DOI 10.1001/archinte.163.11.1317; Gregory PC, 2011, J GERONTOL A-BIOL, V66, P577, DOI 10.1093/gerona/glr023; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Higgins TJ, 2014, J GERONTOL B-PSYCHOL, V69, P263, DOI 10.1093/geronb/gbt110; Lawton M., 1973, PSYCHOL ADULT DEV AG, P619, DOI DOI 10.1037/10044-020; LAWTON MP, 1968, GERONTOLOGIST, V8, P108, DOI 10.1093/geront/8.2.108; Lien LL, 2015, INT J ENV RES PUB HE, V12, P11954, DOI 10.3390/ijerph120911954; Manty M, 2007, ARCH PHYS MED REHAB, V88, P1108, DOI 10.1016/j.apmr.2007.06.016; Marigold DS, 2008, GAIT POSTURE, V27, P689, DOI 10.1016/j.gaitpost.2007.09.005; Rantakokko M, 2015, QUAL LIFE RES; Rantakokko M, 2014, J GERONTOL A-BIOL, V69, P1562, DOI 10.1093/gerona/glu069; Rantakokko M, 2012, AGE AGEING, V41, P118, DOI 10.1093/ageing/afr136; Rantakokko M, 2009, J AM GERIATR SOC, V57, P634, DOI 10.1111/j.1532-5415.2009.02180.x; Rantanen T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1018; Richardson JK, 2005, ARCH PHYS MED REHAB, V86, P1539, DOI 10.1016/j.apmr.2004.12.032; Rubin G., 1991, J AGING HEALTH, V3, P285, DOI [10.1177/089826439100300210, DOI 10.1177/089826439100300210]; Rush KL, 2011, CLIN NURS RES, V20, P81, DOI 10.1177/1054773810379401; Thies SB, 2005, GAIT POSTURE, V22, P26, DOI 10.1016/j.gaitpost.2004.06.004; Tsai LT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1054; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Weiss CO, 2012, ARCH GERONTOL GERIAT, V54, pE329, DOI 10.1016/j.archger.2011.08.018; Wellmon R, 2013, GAIT POSTURE, V38, P198, DOI 10.1016/j.gaitpost.2012.11.009	34	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154396	10.1371/journal.pone.0154396	http://dx.doi.org/10.1371/journal.pone.0154396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27104750	gold, Green Published, Green Submitted			2022-12-26	WOS:000374565100076
J	Brossel, R; Yahi, A; David, S; Velasquez, LM; Guinebretiere, JM				Brossel, Remy; Yahi, Alexandre; David, Stephane; Velasquez, Laura Moreno; Guinebretiere, Jean-Marc			Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept	PLOS ONE			English	Article							CANCER-CELLS; FRACTAL ANALYSIS; BREAST-CANCER; NUDE-MICE; MECHANOTRANSDUCTION; MICROENVIRONMENT; PHENOTYPE; ARCHITECTURE; METABOLISM; PLASTICITY	In the past ten years, many studies have shown that malignant tissue has been "normalized" in vitro using mechanical signals. We apply the principles of physical oncology (or mechanobiology) in vivo to show the effect of a "constraint field" on tumor growth. The human breast cancer cell line, MDA MB 231, admixed with ferric nanoparticles was grafted subcutaneously in Nude mice. The magnetizable particles rapidly surrounded the growing tumor. Two permanent magnets located on either side of the tumor created a gradient of magnetic field. Magnetic energy is transformed into mechanical energy by the particles acting as "bioactuators", applying a constraint field and, by consequence, biomechanical stress to the tumor. This biomechanical treatment was applied 2 hours/day during 21 days, from Day 18 to Day 39 following tumor implantation. The study lasted 74 days. Palpable tumor was measured two times a week. There was a significant in vivo difference between the median volume of treated tumors and untreated controls in the mice measured up to D 74 (D 59 + population): (529 [346; 966] mm(3) vs 1334 [256; 2106] mm(3); p = 0.015), treated mice having smaller tumors. The difference was not statistically significant in the group of mice measured at least to D 59 (D 59 population). On ex vivo examination, the surface of the tumor mass, measured on histologic sections, was less in the treated group, G1, than in the control groups: G2 (nanoparticles, no magnetic field), G3 (magnetic field, no nanoparticles), G4 (no nanoparticles, no magnetic field) in the D 59 population (Median left surface was significantly lower in G1 (5.6 [3.0; 42.4] mm(2), p = 0.005) than in G2 (20.8 [4.9; 34.3]), G3 (16.5 [13.2; 23.2]) and G4 (14.8 [1.8; 55.5]); Median right surface was significantly lower in G1 (4.7 [1.9; 29.2] mm(2), p = 0.015) than in G2 (25.0 [5.2; 55.0]), G3 (18.0 [14.6; 35.2]) and G4 (12.5 [1.5; 51.8]). There was no statistically significant difference in the day 59+ population. This is the first demonstration of the effect of stress on tumor growth in vivo suggesting that biomechanical intervention may have a high translational potential as a therapy in locally advanced tumors like pancreatic cancer or primary hepatic carcinoma for which no effective therapy is currently available.	[Brossel, Remy] Cell Constraint & Canc Inc CC&C, Le Mas Lhermite, Raphele Les Arl, France; [Yahi, Alexandre; Velasquez, Laura Moreno] Inst Curie, St Cloud, France; [Yahi, Alexandre] Georgia Inst Technol, Sch Elect & Comp Engn, Coll Engn, Atlanta, GA 30332 USA; [Yahi, Alexandre] Supelec, Gif Sur Yvette, France; [David, Stephane] Altran Res, Velizy Villacoublay, France; [Velasquez, Laura Moreno] Fac Med Alexis Carrel, INSERM, U1028, CNRL,CNRS,UMR5292,Physiol Integree Syst Eveil, F-69372 Lyon, France; [Guinebretiere, Jean-Marc] Hop Rene Huguenin, Dept Pathol, Inst Curie, St Cloud, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University System of Georgia; Georgia Institute of Technology; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Brossel, R (corresponding author), Cell Constraint & Canc Inc CC&C, Le Mas Lhermite, Raphele Les Arl, France.	brossel.remy@gmail.com		Moreno Velasquez, Laura/0000-0001-9735-0039	Cell Constraint & Cancer Inc, France; Cell Constraint and Cancer Inc.	Cell Constraint & Cancer Inc, France; Cell Constraint and Cancer Inc.	Cell Constraint & Cancer Inc, France funded the animal experimentation, the pathological analysis and the statistical analysis. The funder (Cell Constraint and Cancer Inc.) provided support in the form of salaries for authors (Remy Brossel, Alexandre Yahi) but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bainer R, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.COMPSYSBIO-PR09; Baish JW, 2000, CANCER RES, V60, P3683; Bizzarri M, 2011, SEMIN CANCER BIOL, V21, P175, DOI 10.1016/j.semcancer.2011.04.002; Burkel B, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.CHTME14-B02; Canetta E, 2014, ACTA BIOMATER, V10, P2043, DOI 10.1016/j.actbio.2013.12.057; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; D'Anselmi F, 2011, INT J BIOCHEM CELL B, V43, P1052, DOI 10.1016/j.biocel.2010.05.002; Faurobert E, 2015, CURR OPIN ONCOL, V27, P64, DOI 10.1097/CCO.0000000000000154; Fernandez-Sanchez ME, 2015, NATURE, V523, P92, DOI 10.1038/nature14329; Fleury V, 2015, EUR PHYS J E, V38, DOI 10.1140/epje/i2015-15006-7; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Fuhrmann A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015007; Indra I, 2012, THESIS WAYNE STATE U; Ingber DE., 1985, GENE EXPRESSION NORM, P13; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jonietz E, 2012, NATURE, V491, pS56, DOI 10.1038/491S56a; Katira P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00145; Lekka M, 2012, MICRON, V43, P1259, DOI 10.1016/j.micron.2012.01.019; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; Murphy MF, 2013, MICROSC RES TECHNIQ, V76, P36, DOI 10.1002/jemt.22132; Nguyen T. V., 2014, NE BIOENG C NEBEC 20, P1; Olcum M, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0102-z; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Plankar M, 2011, PROG BIOPHYS MOL BIO, V106, P380, DOI 10.1016/j.pbiomolbio.2011.04.001; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Pokorny J, 2012, AIP ADV, V2, DOI 10.1063/1.3699057; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Ricca BL, 2013, CURR OPIN CELL BIOL, V25, P558, DOI 10.1016/j.ceb.2013.06.002; SHARKEY FE, 1984, CANCER METAST REV, V3, P341, DOI 10.1007/BF00051459; Simi AK, 2015, CANCER METAST BIOL T, V20, P139; Stein GS, 1999, FASEB J, V13, pS157; Taddei ML, 2013, CANCER LETT, V341, P80, DOI 10.1016/j.canlet.2013.01.042; Tadeo I, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00039; Trepat X, 2011, PHYSICS, V4, P85; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; WATANABE S, 1980, CANCER RES, V40, P2588; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609	42	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152885	10.1371/journal.pone.0152885	http://dx.doi.org/10.1371/journal.pone.0152885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100674	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500018
J	Zhang, XY; Gamarra, J; Castro, S; Carrasco, E; Hernandez, A; Mock, T; Hadaegh, AR; Read, BA				Zhang, Xiaoyu; Gamarra, Jaime; Castro, Steven; Carrasco, Estela; Hernandez, Aaron; Mock, Thomas; Hadaegh, Ahmad R.; Read, Betsy A.			Characterization of the Small RNA Transcriptome of the Marine Coccolithophorid, Emiliania huxleyi	PLOS ONE			English	Article							PIWI-INTERACTING RNAS; DOUBLE-STRANDED-RNA; EXPERIMENTAL VALIDATION; ANTISENSE TRANSCRIPTS; ARGONAUTE PROTEINS; GENE-EXPRESSION; MICRORNAS; BIOGENESIS; GENOME; SIRNA	Small RNAs (smRNAs) control a variety of cellular processes by silencing target genes at the transcriptional or post-transcription level. While extensively studied in plants, relatively little is known about smRNAs and their targets in marine phytoplankton, such as Emiliania huxleyi (E. huxleyi). Deep sequencing was performed of smRNAs extracted at different time points as E. huxleyi cells transition from logarithmic to stationary phase growth in batch culture. Computational analyses predicted 18 E. huxleyi specific miRNAs. The 18 miRNA candidates and their precursors vary in length (18-24 nt and 71-252 nt, respectively), genome copy number (3-1,459), and the number of genes targeted (2-107). Stem-loop real time reverse transcriptase (RT) PCR was used to validate miRNA expression which varied by nearly three orders of magnitude when growth slows and cells enter stationary phase. Stem-loop RT PCR was also used to examine the expression profiles of miRNA in calcifying and non-calcifying cultures, and a small subset was found to be differentially expressed when nutrients become limiting and calcification is enhanced. In addition to miRNAs, endogenous small RNAs such as ra-siRNAs, ta-siRNAs, nat-siRNAs, and piwiRNAs were predicted along with the machinery for the biogenesis and processing of si-RNAs. This study is the first genome-wide investigation smRNAs pathways in E. huxleyi. Results provide new insights into the importance of smRNAs in regulating aspects of physiological growth and adaptation in marine phytoplankton and further challenge the notion that smRNAs evolved with multicellularity, expanding our perspective of these ancient regulatory pathways.	[Zhang, Xiaoyu; Gamarra, Jaime; Hadaegh, Ahmad R.] Calif State Univ, Dept Comp Sci & Informat Syst, San Marcos, CA 92096 USA; [Castro, Steven; Carrasco, Estela; Hernandez, Aaron; Read, Betsy A.] Calif State Univ, Dept Biol Sci, San Marcos, CA 92096 USA; [Mock, Thomas] Univ E Anglia, Sch Environm Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England	California State University System; California State University San Marcos; California State University System; California State University San Marcos; University of East Anglia	Read, BA (corresponding author), Calif State Univ, Dept Biol Sci, San Marcos, CA 92096 USA.	bread@csusm.edu	Zhang, xiaoyu/GXA-3206-2022; Mock, Thomas/A-3127-2008	Mock, Thomas/0000-0001-9604-0362	National Institutes of Health (NIH) Support of Competitive Research (SCORE) Grant [5SC3GM092765]; NERC [NE/M005755/1] Funding Source: UKRI	National Institutes of Health (NIH) Support of Competitive Research (SCORE) Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Support for the work of XZ and BR was provided by National Institutes of Health (NIH) Support of Competitive Research (SCORE) Grant 5SC3GM092765 "Characterization of Small Silencing RNAs in Emiliania Huxleyi". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Billoud B, 2014, NUCLEIC ACIDS RES, V42, P417, DOI 10.1093/nar/gkt856; Bonnet E, 2006, NEW PHYTOL, V171, P451, DOI 10.1111/j.1469-8137.2006.01806.x; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; De Bodt C, 2008, MINERAL MAG, V72, P251, DOI 10.1180/minmag.2008.072.1.251; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Enright AJ, 2004, GENOME BIOL, V5; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Gao ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109997; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Handler D, 2011, EMBO J, V30, P3977, DOI 10.1038/emboj.2011.308; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HOLLIGAN PM, 1983, NATURE, V304, P339, DOI 10.1038/304339a0; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Jain R, 2011, RNA, V17, P429, DOI 10.1261/rna.2500711; Jin H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-6; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kegel JU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080684; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Kramer Martha F, 2011, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1510s95; Kutter C, 2008, RNA BIOL, V5, P181, DOI 10.4161/rna.7227; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Luhur A, 2014, P NATL ACAD SCI USA, V111, P1421, DOI 10.1073/pnas.1318445111; Mackinder L, 2011, ENVIRON MICROBIOL, V13, P3250, DOI 10.1111/j.1462-2920.2011.02561.x; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; MARLOWE IT, 1990, CHEM GEOL, V88, P349, DOI 10.1016/0009-2541(90)90098-R; MARLOWE IT, 1984, BRIT PHYCOL J, V19, P203, DOI 10.1080/00071618400650221; Maurin T, 2012, RNA, V18, P2166, DOI 10.1261/rna.036194.112; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Midura RJ, 1996, GLYCOBIOLOGY, V6, P677, DOI 10.1093/glycob/6.7.677; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Norden-Krichmar TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022870; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Firmino AAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085079; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rokitta SD, 2011, J PHYCOL, V47, P829, DOI 10.1111/j.1529-8817.2011.01014.x; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Shiraiwa Y, 2003, COMP BIOCHEM PHYS B, V136, P775, DOI 10.1016/S1096-4959(03)00221-5; Singh RK, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0364-6; Smit AFA, 2010, REPEATMASKER OPEN 3; Smith S. V., 2013, PARSING OCEANIC CALC; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Strommer J, 1993, ISOLATION CHARACTERI, P49; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Thomassen GOS, 2006, J BIOMED BIOTECHNOL, V2006, P1; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; von Dassow P, 2015, ISME J, V9, P1365, DOI 10.1038/ismej.2014.221; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Yan ZG, 2007, BBA-GEN SUBJECTS, V1770, P1338, DOI 10.1016/j.bbagen.2007.06.018; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang XM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r20; Zhang Y, 2011, BIOINFORMATICS, V27, P771, DOI 10.1093/bioinformatics/btr016; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	88	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154279	10.1371/journal.pone.0154279	http://dx.doi.org/10.1371/journal.pone.0154279			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101007	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500177
J	Mendoza, Y; Mewa, JC; Martinez, AA; Zaldivar, Y; Sosa, N; Arteaga, G; Armien, B; Bautista, CT; Garcia-Morales, C; Tapia-Trejo, D; Avila-Rios, S; Reyes-Teran, G; Bello, G; Pascale, JM				Mendoza, Yaxelis; Mewa, Juan Castillo; Martinez, Alexander A.; Zaldivar, Yamitzel; Sosa, Nestor; Arteaga, Griselda; Armien, Blas; Bautista, Christian T.; Garcia-Morales, Claudia; Tapia-Trejo, Daniela; Avila-Rios, Santiago; Reyes-Teran, Gustavo; Bello, Gonzalo; Pascale, Juan M.			HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naive and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; SUBTYPE B; VIROLOGICAL FAILURE; SURVEILLANCE; EPIDEMIC; INDIVIDUALS; MECHANISM; INFECTION; PATTERNS	The use of antiretroviral therapy in HIV infected subjects prevents AIDS-related illness and delayed occurrence of death. In Panama, rollout of ART started in 1999 and national coverage has reached 62.8% since then. The objective of this study was to determine the level and patterns of acquired drug resistance mutations of clinical relevance (ADR-CRM) and surveillance drug resistance mutations (SDRMs) from 717 HIV-1 pol gene sequences obtained from 467 ARV drug-experienced and 250 ARV drug-naive HIV-1 subtypes B infected subjects during 2007-2013, respectively. The overall prevalence of SDRM and of ADR-CRM during the study period was 9.2% and 87.6%, respectively. The majority of subjects with ADR-CRM had a pattern of mutations that confer resistance to at least two classes of ARV inhibitors. The non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations K103N and P225H were more prevalent in both ARV drug-naive and ARV drug-experienced subjects. The nucleoside reverse transcriptase inhibitor (NRTI) mutation M184V was more frequent in ARV drug-experienced individuals, while T215YFrev and M41L were more frequent in ARV drug-naive subjects. Prevalence of mutations associated to protease inhibitors (PI) was lower than 4.1% in both types of subjects. Therefore, there is a high level of resistance (>73%) to Efavirenz/Nevirapine, Lamivudine and Azidothymidine in ARV drug-experienced subjects, and an intermediate to high level of resistance (5-10%) to Efavirenz/Nevirapine in ARV drug-naive subjects. During the study period, we observed an increasing trend in the prevalence of ADR-CRM in subjects under first-line schemes, but not significant changes in the prevalence of SDRM. These results reinforce the paramount importance of a national surveillance system of ADR-CRM and SDRM for national management policies of subjects living with HIV.	[Mendoza, Yaxelis; Mewa, Juan Castillo; Martinez, Alexander A.; Zaldivar, Yamitzel; Sosa, Nestor; Armien, Blas; Bautista, Christian T.; Pascale, Juan M.] Gorgas Mem Inst Hlth Studies, Direct Res & Technol Dev, Panama City, Panama; [Mendoza, Yaxelis; Martinez, Alexander A.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur City, India; [Mendoza, Yaxelis] Univ Panama, Sch Biol, Dept Genet & Mol Biol, Panama City, Panama; [Mendoza, Yaxelis; Martinez, Alexander A.] Inst Sci Res & High Technol Serv Panama, Panama City, Panama; [Arteaga, Griselda; Pascale, Juan M.] Univ Panama, Sch Med, Dept Microbiol, Panama City, Panama; [Armien, Blas] Univ Interamer Panama, Fac Ciencias Salud, Panama City, Panama; [Garcia-Morales, Claudia; Tapia-Trejo, Daniela; Avila-Rios, Santiago; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico; [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil	Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Universidad de Panama; Universidad de Panama; Fundacao Oswaldo Cruz	Pascale, JM (corresponding author), Gorgas Mem Inst Hlth Studies, Direct Res & Technol Dev, Panama City, Panama.; Pascale, JM (corresponding author), Univ Panama, Sch Med, Dept Microbiol, Panama City, Panama.	jpascale@gorgas.gob.pa	Bentancor, Gonzalo Jose Bello/N-7377-2019; Martínez, Alexander/HHC-2101-2022; Avila-Rios, Santiago/AAB-4383-2020; Bello, Gonzalo/E-6842-2013	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Bautista, Christian/0000-0002-1228-0754; Reyes-Teran, Gustavo/0000-0002-4115-4888	Department of Genomics and Proteomics (ICGES, Panama); Ministry of Health (Panama); International Atomic Energy Agency (IAEA, Austria) [PAN-6011]; Secretaria de Ciencia y Tecnologia (SENACYT, Panama) [ECS11-012]; SENACYT; Instituto para la Formacion de Recursos Humanos (IFARHU)	Department of Genomics and Proteomics (ICGES, Panama); Ministry of Health (Panama); International Atomic Energy Agency (IAEA, Austria)(International Atomic Energy Agency); Secretaria de Ciencia y Tecnologia (SENACYT, Panama); SENACYT; Instituto para la Formacion de Recursos Humanos (IFARHU)	This work was supported by the Department of Genomics and Proteomics (ICGES, Panama), the Ministry of Health (Panama), grants PAN-6011 from the International Atomic Energy Agency (IAEA, Austria) and grants ECS11-012 from Secretaria de Ciencia y Tecnologia (SENACYT, Panama). YM was funded by a fellowship from SENACYT and Instituto para la Formacion de Recursos Humanos (IFARHU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada-Ruiz S, 2008, AIDS RES HUM RETROV, V24, P1461, DOI 10.1089/aid.2008.0153; Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; Altfeld M, 2012, HIV 2012 2013; [Anonymous], 2011, B EST, P113; [Anonymous], 1999, AIDS TREATMENT NEWS; [Anonymous], 2011, NORM MAN TER PERS CO; [Anonymous], 2006, NIV FLUJ REC COST EN; [Anonymous], 2007, NORM MAN TER PERS CO; [Anonymous], 2006, NORM AT INT PERS CON; Avila-Rios S, 2015, AIDS RES HUM RETROV, V31, P401, DOI 10.1089/aid.2014.0057; Avila-Rios S, 2011, REV PANAM SALUD PUBL, V30, P641, DOI 10.1590/S1020-49892011001200024; Avila-Rios S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027812; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045; Castillo J, 2011, REV PANAM SALUD PUBL, V30, P649, DOI 10.1590/S1020-49892011001200025; Comision Nacional para la Prevencion y Control del VIH SIDA C, 2009, PLAN ESTR NAC MULT I, P1; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448; DiazGranados CA, 2010, INT J INFECT DIS, V14, pE298, DOI 10.1016/j.ijid.2009.05.006; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; Holguin A, 2013, CLIN MICROBIOL INFEC, V17, P1469; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Ivetac A, 2009, J MOL BIOL, V388, P644, DOI 10.1016/j.jmb.2009.03.037; Iyidogan P, 2014, VIRUSES-BASEL, V6, P4095, DOI 10.3390/v6104095; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; LARDER BA, 1991, J VIROL, V65, P5232, DOI 10.1128/JVI.65.10.5232-5236.1991; Lessells RJ, 2012, CURR OPIN VIROL, V2, P636, DOI 10.1016/j.coviro.2012.08.006; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Li Z, 2012, AIDS, V26, P877, DOI 10.1097/QAD.0b013e328351430d; Li ZF, 2013, ANTIMICROB AGENTS CH, V57, P5500, DOI 10.1128/AAC.01195-13; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Mendoza Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095360; Mendoza Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085153; Meresse M, 2014, HIV MED, V15, P478, DOI 10.1111/hiv.12140; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Murillo W, 2010, J CLIN VIROL, V49, P239, DOI 10.1016/j.jcv.2010.03.013; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; Nunez A, 2014, INFROM NACL PROGR RE; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ren J, 2000, STRUCTURE, V8, P1089, DOI 10.1016/S0969-2126(00)00513-X; Santoro MM, 2013, ISRN MICROBIOL, V2013, DOI DOI 10.1155/2013/481314; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Sui HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091803; UNAIDS, 2015, FACT SHEET GLOB HIV; Vingerhoets J, 2009, ANTIVIR THER, V14, pA35; Wheeler DA, 2001, JAMA-J AM MED ASSOC, V286, P853, DOI 10.1001/jama.286.7.853; WHO, 2012, WHO GLOB STRAT SURV	53	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154317	10.1371/journal.pone.0154317	http://dx.doi.org/10.1371/journal.pone.0154317			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119150	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200060
J	Fumian, TM; de Andrade, JDR; Leite, JPG; Miagostovich, MP				Fumian, Tulio Machado; Ribeiro de Andrade, Juliana da Silva; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira			Norovirus Recombinant Strains Isolated from Gastroenteritis Outbreaks in Southern Brazil, 2004-2011	PLOS ONE			English	Article							GENETIC DIVERSITY; UNITED-STATES; MOLECULAR EPIDEMIOLOGY; ASYMPTOMATIC CHILDREN; PREVALENCE; EMERGENCE; VARIANT; RNA	Noroviruses are recognized as one of the leading causes of viral acute gastroenteritis, responsible for almost 50% of acute gastroenteritis outbreaks worldwide. The positive single-strand RNA genome of noroviruses presents a high mutation rate and these viruses are constantly evolving by nucleotide mutation and genome recombination. Norovirus recombinant strains have been detected as causing acute gastroenteritis outbreaks in several countries. However, in Brazil, only one report of a norovirus recombinant strain (GII.P7/GII.20) has been described in the northern region so far. For this study, 38 norovirus strains representative of outbreaks, 11 GII.4 and 27 non-GII.4, were randomly selected and amplified at the ORF1/ORF2 junction. Genetic recombination was identified by constructing phylogenetic trees of the polymerase and capsid genes, and further SimPlot and Bootscan analysis of the ORF1/ORF2 overlap. Sequence analysis revealed that 23 out of 27 (85%) non-GII.4 noroviruses were recombinant strains, characterized as: GII.P7/GII. 6 (n = 9); GIIP.g/GII.12 (n = 4); GII.P16/GII.3 (n = 4); GII.Pe/GII.17 (n = 2); GII.P7/GII. 14 (n = 1); GII.P13/GII. 17 (n = 1); GII.P21/GII. 3 (n = 1); and GII.P21/GII. 13 (n = 1). On the other hand, among the GII.4 variants analyzed (Den Haag_2006b and New Orleans_2009) no recombination was observed. These data revealed the great diversity of norovirus recombinant strains associated with outbreaks, and describe for the first time these recombinant types circulating in Brazil. Our results obtained in southern Brazil corroborate the previous report for the northern region, demonstrating that norovirus recombinant strains are circulating more frequently than we expected. In addition, these results emphasize the relevance of including ORF1/ORF2-based analysis in surveillance studies as well as the importance of characterizing strains from other Brazilian regions to obtain epidemiological data for norovirus recombinant strains circulating in the country.	[Fumian, Tulio Machado; Ribeiro de Andrade, Juliana da Silva; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Fumian, TM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, Brazil.	tuliomf@ioc.fiocruz.br	LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020; Fumian, Tulio/AAC-4724-2021		Excellence Program of Research (PROEP-CNPq/IOC); General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health	Excellence Program of Research (PROEP-CNPq/IOC); General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health	This work was funded by Excellence Program of Research (PROEP-CNPq/IOC) and General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health. MP Miagostovich and JPG Leite are CNPq fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragao GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056608; Arana A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098875; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P41; Chan MCW, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00140-12; Chhabra P, 2010, VIRUS RES, V147, P242, DOI 10.1016/j.virusres.2009.11.007; de Graaf M, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.26.21178; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Fajardo A, 2014, INFECT GENET EVOL, V28, P328, DOI 10.1016/j.meegid.2014.10.026; Fioretti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092988; Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008; Fumian TM, 2012, ARCH VIROL, V157, P2389, DOI 10.1007/s00705-012-1428-2; Fumian TM, 2013, J CLIN VIROL, V58, P31, DOI 10.1016/j.jcv.2013.06.043; Giammanco GM, 2012, INFECT GENET EVOL, V12, P169, DOI 10.1016/j.meegid.2011.10.021; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; Green K, FIELDS VIROLOGY, P949; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han TH, 2011, ARCH VIROL, V156, P323, DOI 10.1007/s00705-010-0844-4; Huynen P, 2013, J CLIN VIROL, V58, P515, DOI 10.1016/j.jcv.2013.08.013; JIANG X, 1990, Science (Washington D C), V250, P1580; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lim KL, 2013, J MED VIROL, V85, P1842, DOI 10.1002/jmv.23669; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mahar JE, 2011, J MED VIROL, V83, P2213, DOI 10.1002/jmv.22215; Mans J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-168; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Mathijs E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-310; Medici MC, 2014, VIRUS RES, V188, P142, DOI 10.1016/j.virusres.2014.04.005; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Nahar S, 2013, INFECT GENET EVOL, V20, P325, DOI 10.1016/j.meegid.2013.09.021; Lemes LGN, 2014, J CLIN VIROL, V61, P329, DOI 10.1016/j.jcv.2014.08.004; Puustinen L, 2011, SCAND J INFECT DIS, V43, P804, DOI 10.3109/00365548.2011.588610; de Andrade JDR, 2014, J CLIN VIROL, V61, P345, DOI 10.1016/j.jcv.2014.08.024; Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754; Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088210; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Takanashi S, 2011, J CLIN MICROBIOL, V49, P3234, DOI 10.1128/JCM.00305-11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Vega E, 2011, EMERG INFECT DIS, V17, P1516, DOI 10.3201/eid1708.110025; White PA, 2014, CLIN MICROBIOL INFEC, V20, P741, DOI 10.1111/1469-0691.12746; Wu XF, 2015, ARCH VIROL, V160, P1705, DOI 10.1007/s00705-015-2440-0; Yu YX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/196169; Zeng M, 2011, JPN J INFECT DIS, V64, P417; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	54	29	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0145391	10.1371/journal.pone.0145391	http://dx.doi.org/10.1371/journal.pone.0145391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116353	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600003
J	Kruse, N; Schlossmacher, MG; Schulz-Schaeffer, WJ; Vanmechelen, E; Vanderstichele, H; El-Agnaf, OM; Mollenhauer, B				Kruse, Niels; Schlossmacher, Michael G.; Schulz-Schaeffer, Walter J.; Vanmechelen, Eugeen; Vanderstichele, Hugo; El-Agnaf, Omar M.; Mollenhauer, Brit			A First Tetraplex Assay for the Simultaneous Quantification of Total alpha-Synuclein, Tau, beta-Amyloid(42) and DJ-1 in Human Cerebrospinal Fluid	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; LEWY BODIES; PARKINSONS-DISEASE; COGNITIVE IMPAIRMENT; BIOMARKERS; DEMENTIA; VALIDATION; PROTEIN; BETA; IMMUNOASSAY	The quantification of four distinct proteins (alpha-synuclein, beta-amyloid(1-42), DJ-1, and total tau) in cerebrospinal fluid (CSF) has been proposed as a laboratory-based platform for the diagnosis of Parkinson's disease (PD) and Alzheimer's disease (AD). While there is some clinical utility in measuring these markers individually, their usage in routine clinical testing remains challenging, in part due to substantial overlap of concentrations between healthy controls and diseased subjects. In contrast, measurement of different analytes in a single sample from individual patients in parallel appears to considerably improve the accuracy of AD or PD diagnosis. Here, we report the development and initial characterization of a first, electrochemiluminescence-based multiplex immunoassay for the simultaneous quantification of all four proteins ('tetraplex') in as little as 50 mu l of CSF. In analytical performance experiments, we assessed its sensitivity, spike-recovery rate, parallelism and dilution linearity as well as the intra-and inter-assay variability. Using our in-house calibrators, we recorded a lower limit of detection for alpha-synuclein, beta-amyloid(42), DJ-1, and t-tau of 1.95, 1.24, 5.63, and 4.05 pg/ml, respectively. The corresponding, linear concentration range covered > 3 orders of magnitude. In diluted CSF samples (up to 1: 4), spike-recovery rates ranged from a low of 55% for beta-amyloid(42) to a high of 98% for DJ-1. Hillslopes ranged from 1.03 to 1.30, and inter-assay variability demonstrated very high reproducibility. Our newly established tetraplex assay represents a significant technical advance for fluid-based biomarker studies in neurodegenerative disorders allowing the simultaneous measurement of four pivotal makers in single CSF specimens. It provides exceptional sensitivity, accuracy and speed.	[Kruse, Niels; Schulz-Schaeffer, Walter J.] Univ Med Ctr, Dept Neuropathol, Gottingen, Germany; [Schlossmacher, Michael G.] Univ Ottawa, Ottawa Hosp, Program Neurosci, Brain & Mind Res Inst, Ottawa, ON, Canada; [Schlossmacher, Michael G.] Univ Ottawa, Ottawa Hosp, Div Neurol, Brain & Mind Res Inst, Ottawa, ON, Canada; [Vanmechelen, Eugeen; Vanderstichele, Hugo] ADx NeuroSci, R&D, Ghent, Belgium; [El-Agnaf, Omar M.] HBKU, Qatar Fdn, Neurol Disorders Ctr, Qatar Biomed Res Inst, Doha, Qatar; [El-Agnaf, Omar M.] HBKU, Coll Sci & Engn, Qatar Fdn, Doha, Qatar; [Mollenhauer, Brit] Paracelsus Elena Klin, Kassel, Germany; [Mollenhauer, Brit] Univ Med Ctr, Gottingen, Germany	University of Gottingen; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI); Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; University of Gottingen	Kruse, N (corresponding author), Univ Med Ctr, Dept Neuropathol, Gottingen, Germany.	n.kruse@med.uni-goettingen.de	Vanderstichele, Hugo/AAD-2601-2019; Kruse, Niels/AAN-7037-2020; Vanmechelen, Eugeen/AAA-8005-2019	Schlossmacher, Michael/0000-0002-0394-0300; Vanmechelen, Eugeen/0000-0002-9466-5366	Michael J. Fox Foundation for Parkinson's Research (MJFF); ADx NeuroSciences	Michael J. Fox Foundation for Parkinson's Research (MJFF); ADx NeuroSciences	This work was funded by the Michael J. Fox Foundation for Parkinson's Research (MJFF). Eugeen Vanmechelen and Hugo Vanderstichele are affiliated to ADx NeuroSciences. ADx NeuroSciences provided support in the form of salaries for authors EV and HV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Aerts MB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.001; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Bastarache JA, 2014, J IMMUNOL METHODS, V408, P13, DOI 10.1016/j.jim.2014.04.006; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Clark CM, 2003, ARCH NEUROL-CHICAGO, V60, P1696, DOI 10.1001/archneur.60.12.1696; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ellington AA, 2009, CLIN CHEM, V55, P1092, DOI 10.1373/clinchem.2008.120717; European Medicine Agency, 2011, GUID BIOM METH VAL; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kanemaru K, 2000, NEUROLOGY, V54, P1875, DOI 10.1212/WNL.54.9.1875; Kruse N, 2015, NEUROBIOL AGING, V36, P2587, DOI 10.1016/j.neurobiolaging.2015.05.003; Kruse N, 2012, METHODS, V56, P514, DOI 10.1016/j.ymeth.2012.03.016; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Leviton A, 2013, J CHILD NEUROL, V28, P1637, DOI 10.1177/0883073812463068; Marchese RD, 2009, CLIN VACCINE IMMUNOL, V16, P387, DOI 10.1128/CVI.00415-08; Mattsson N, 2011, ALZHEIMERS DEMENT, V7, P386, DOI 10.1016/j.jalz.2011.05.2243; Mollenhauer B, 2005, DEMENT GERIATR COGN, V19, P164, DOI 10.1159/000083178; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2012, J NEURAL TRANSM, V119, P739, DOI 10.1007/s00702-012-0784-0; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Mollenhauer B, 2010, BIOMARK MED, V4, P683, DOI 10.2217/BMM.10.90; Montine TJ, 2010, MOVEMENT DISORD, V25, P2682, DOI 10.1002/mds.23287; Ostendorff HP, 2013, J IMMUNOL METHODS, V400, P58, DOI 10.1016/j.jim.2013.09.013; Pan C, 2015, J ALZHEIMERS DIS, V45, P709, DOI 10.3233/JAD-143099; Schade S, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0072-3; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Sharma J, 2014, PROSTATE, V74, P820, DOI 10.1002/pros.22788; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Thway T, 2010, J PHARMACEUT BIOMED, V51, P626, DOI 10.1016/j.jpba.2009.09.035; U.S. FDA, 1998, GUIDANCE IND BIOANAL	36	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153564	10.1371/journal.pone.0153564	http://dx.doi.org/10.1371/journal.pone.0153564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116005	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600024
J	Ren, XX; Chen, ZA; Zheng, S; Han, TT; Li, YX; Liu, W; Hu, YM				Ren, Xingxing; Chen, Zeng. ai; Zheng, Shuang; Han, Tingting; Li, Yangxue; Liu, Wei; Hu, Yaomin			Association between Triglyceride to HDL-C Ratio (TG/HDL-C) and Insulin Resistance in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; BETA-CELL FUNCTION; HOMEOSTASIS MODEL ASSESSMENT; GLUCOSE CLAMP TECHNIQUE; CORONARY-HEART-DISEASE; AFRICAN-AMERICANS; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; KOREAN POPULATION; PLASMA-GLUCOSE	Objectives To explore the association between the triglyceride to HDL-C ratio (TG/HDL-C) and insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus. Methods Patients with newly diagnosed type 2 diabetes mellitus (272 men and 288 women) were enrolled and divided into three groups according to TG/HDL-C tertiles. Insulin resistance was defined by homeostatic model assessment of insulin resistance (HOMA-IR). Demographic information and clinical characteristics were obtained. Spearman's correlation was used to estimate the association between TG/HDL-C and other variables. Multiple logistic regression analyses were adopted to obtain probabilities of insulin resistance. A receiver operating characteristic analysis was conducted to evaluate the ability of TG/HDL-C to discriminate insulin resistance. Results TG/HDL-C was associated with insulin resistance in Chinese patients with newly diagnosed T2DM (Spearman's correlation coefficient = 0.21, P < 0.01). Patients in the higher tertiles of TG/HDL-C had significantly higher HOMA-IR values than patients in the lower tertiles [T1: 2.68(1.74-3.70); T2: 2.96(2.29-4.56); T3: 3.09(2.30-4.99)]. Multiple logistic regression analysis showed that TG/HDL-C was significantly associated with HOMA-IR, and patients in the higher TG/HDL-C tertile had a higher OR than those in the lower TG/HDL-C tertile, after adjusting for multiple covariates including indices for central obesity [T1: 1; T2: 4.02 (1.86-8.71); T3: 4.30(1.99-9.29)]. Following stratification of waist circumference into quartiles, the effect of TG/HDL-C on insulin resistance remained significant irrespective of waist circumference. Conclusions TG/HDL-C was associated with insulin resistance independent of waist circumference. Whether it could be a surrogate marker for insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus still needs to be confirmed by more researches.	[Ren, Xingxing; Zheng, Shuang; Han, Tingting; Li, Yangxue; Liu, Wei; Hu, Yaomin] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Endocrinol, Shanghai 200030, Peoples R China; [Chen, Zeng. ai] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Radiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hu, YM (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Endocrinol, Shanghai 200030, Peoples R China.	amin1031@hotmail.com	HAN, TINGTING/GQZ-8692-2022		National Scientific Foundation of China [81270946, 81170758, 30670988]; Foundation from Renji Hospital; Shanghai Jiaotong University [RJZZ14-003]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation from Renji Hospital; Shanghai Jiaotong University	This work was supported by National Scientific Foundation of China ( No. 81270946, 81170758, 30670988), http://www.nsfc.gov.cn/; Foundation from Renji Hospital, Shanghai Jiaotong University (RJZZ14-003), http://www.renji.com/index.aspx, receiver: Yaomi Hu. All sponsors or funders played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aoyama-Sasabe S, 2014, J DIABETES INVEST, V5, P663, DOI 10.1111/jdi.12239; Armato J., 2015, ENDOCR PRACT, V21, P495, DOI [DOI 10.4158/EP14479.OR, 10.4158/EP14479.OR]; Bacopoulou F, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0366-z; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Bittner V, 2009, AM HEART J, V157, P548, DOI 10.1016/j.ahj.2008.11.014; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Bovet P, 2006, ARCH INTERN MED, V166, P1236, DOI 10.1001/archinte.166.11.1236-b; Chen SY, 2014, ENDOCRINE, V46, P496, DOI 10.1007/s12020-013-0079-8; Chen SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074058; Chiang JK, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-93; Colman PG, 1999, NEW ZEAL MED J, V112, P139; Cordero A, 2009, AM J CARDIOL, V104, P1393, DOI 10.1016/j.amjcard.2009.07.008; Coresh J, 1996, JAMA-J AM MED ASSOC, V276, P914, DOI 10.1001/jama.276.11.914; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dobiasova M, 2000, Vnitr Lek, V46, P152; Festa A, 2006, DIABETES, V55, P1114, DOI 10.2337/diabetes.55.04.06.db05-1100; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Gasevic D, 2012, METABOLISM, V61, P583, DOI 10.1016/j.metabol.2011.09.009; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Hadaegh F, 2009, NUTR METAB CARDIOVAS, V19, P401, DOI 10.1016/j.numecd.2008.09.003; Haffner SM, 1999, DIABETES CARE, V22, P562, DOI 10.2337/diacare.22.4.562; He JY, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/105168; He S, 2012, METABOLISM, V61, P30, DOI 10.1016/j.metabol.2011.05.007; Hermans MP, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-88; Hirschler V, 2015, PEDIATR DIABETES, V16, P606, DOI 10.1111/pedi.12228; Hu Y, 2007, J LIPID RES, V48, P1681, DOI 10.1194/jlr.M600382-JLR200; Hu YM, 2006, J LIPID RES, V47, P1908, DOI 10.1194/jlr.M600108-JLR200; Kang HT, 2012, NUTR METAB CARDIOVAS, V22, P1054, DOI 10.1016/j.numecd.2011.01.013; Kim JS, 2012, DIABETES RES CLIN PR, V97, P132, DOI 10.1016/j.diabres.2012.04.022; Kim-Dorner SJ, 2010, METABOLISM, V59, P299, DOI 10.1016/j.metabol.2009.07.027; Kimm H, 2010, CIRC J, V74, P931, DOI 10.1253/circj.CJ-09-0571; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Li CY, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-4; Maruyama Chizuko, 2003, J Atheroscler Thromb, V10, P186; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Molarius A, 1999, INT J OBESITY, V23, P116, DOI 10.1038/sj.ijo.0800772; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Rajappa Medha, 2014, ISRN Endocrinol, V2014, P981524, DOI 10.1155/2014/981524; Ray Sayantan, 2012, Indian J Endocrinol Metab, V16, pS460, DOI 10.4103/2230-8210.104132; Reaven G, 2006, ARCH INTERN MED, V166, P249, DOI 10.1001/archinte.166.2.249-a; Simental-Mendia LE, 2015, EUR J PEDIATR, V174, P597, DOI 10.1007/s00431-014-2426-z; Sumner AE, 2005, ARCH INTERN MED, V165, P1395, DOI 10.1001/archinte.165.12.1395; Sun GZ, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-189; Tanaka S, 2003, ACTA DIABETOL, V40, pS302, DOI 10.1007/s00592-003-0093-z; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang H, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/725731; [邢小燕 Xing Xiaoyan], 2004, [中华糖尿病杂志, Chinese Journal of Diabetes], V12, P182; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171; Zhang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116110; Zheng S, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0018-1	53	56	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154345	10.1371/journal.pone.0154345	http://dx.doi.org/10.1371/journal.pone.0154345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115999	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600060
J	Ann, HW; Jun, S; Shin, NY; Han, S; Ahn, JY; Ahn, MY; Jeon, YD; Jung, IY; Kim, MH; Jeong, WY; Ku, NS; Kim, JM; Smith, DM; Choi, JY				Ann, Hea Won; Jun, Suhnyoung; Shin, Na-Young; Han, Sanghoon; Ahn, Jin Young; Ahn, Mi Young; Jeon, Yong Duk; Jung, In Young; Kim, Moo Hyun; Jeong, Woo Yong; Ku, Nam Su; Kim, June Myung; Smith, Davey M.; Choi, Jun Yong			Characteristics of Resting-State Functional Connectivity in HIV-Associated Neurocognitive Disorder	PLOS ONE			English	Article							ABNORMALITIES; IMPAIRMENT; NETWORK; MEMORY	Background HIV-associated neurocognitive disorder (HAND) can occur in patients without prior AIDS defining illness and can be debilitating. This study aimed to evaluate the difference in the patterns of intrinsic brain activity between patients with or without HAND for deepening our understanding of HAND. Methods We evaluated 24 HIV-infected individuals, 12 with previously diagnosed HAND and 12 previously diagnosed without HAND, and 11 seronegative individuals. These individuals then underwent repeat NP testing and a functional brain MRI scan. For functional MRI analysis, seed-based analysis with bilateral precuneus cortex seed was applied. Results Among the 12 individuals with previously diagnosed HAND, 3 showed improvement of their neurocognitive function and 1 was excluded for worsening liver disease. Among the 12 patients who previously had normal neurocognitive function, 2 showed neurocognitive impairment. Overall, the HAND group, who had impaired cognitive function at the time of MRI scan, showed significant decrease of resting status functional connectivity between bilateral precuneus and prefrontal cortex (PFC) compared with nonHAND group, those who had normal neurocognitive function (Corrected P<0.05). The functional connectivity with the right inferior frontal operculum and right superior frontal gyrus was positively correlated with memory and learning ability. Conclusions This cross-sectional study found a significant difference in fMRI patterns between patients with and without HAND. Decreased functional connectivity between precuneus and PFC could be possible functional substrate for cognitive dysfunction in HIV patients, which should be characterized in a longitudinal study.	[Ann, Hea Won; Ahn, Jin Young; Ahn, Mi Young; Jeon, Yong Duk; Jung, In Young; Kim, Moo Hyun; Jeong, Woo Yong; Ku, Nam Su; Kim, June Myung; Choi, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Ann, Hea Won; Ahn, Jin Young; Ahn, Mi Young; Jeon, Yong Duk; Ku, Nam Su; Kim, June Myung; Choi, Jun Yong] Yonsei Univ, Coll Med, Dept AIDS, Res Inst, Seoul, South Korea; [Jun, Suhnyoung; Han, Sanghoon] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea; [Shin, Na-Young] Ewha Womans Univ, Sch Med, Dept Radiol, Seoul, South Korea; [Smith, Davey M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Ewha Womans University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Choi, JY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Choi, JY (corresponding author), Yonsei Univ, Coll Med, Dept AIDS, Res Inst, Seoul, South Korea.	seran@yuhs.ac	Smith, David/GQQ-8257-2022; Jeon, Yong Duk/AAC-7563-2022	Jeon, Yong Duk/0000-0002-4588-4781; Ku, Nam Su/0000-0002-9717-4327; Ahn, Jin Young/0000-0002-3740-2826; Choi, Jun Yong/0000-0002-2775-3315; Jun, Suhnyoung/0000-0001-7849-0837; Smith, Davey/0000-0003-3603-1733	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2005412]; Chronic Infectious Disease Cohort grant from Korea Centers for Disease Control and Prevention [4800-4859-304-260]; BioNano Health-Guard Research Center - Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project [H-GUARD_2013M3A6B2078953]; Ministry of Health & Welfare, Republic of Korea [HI14C1324]; San Diego Veterans Affairs Healthcare system; National Institutes of Health [AI100665, MH062512, AI036214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI100665, P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Chronic Infectious Disease Cohort grant from Korea Centers for Disease Control and Prevention; BioNano Health-Guard Research Center - Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); San Diego Veterans Affairs Healthcare system; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2005412), a Chronic Infectious Disease Cohort grant (4800-4859-304-260) from the Korea Centers for Disease Control and Prevention, and BioNano Health-Guard Research Center funded by the Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project (Grant H-GUARD_2013M3A6B2078953) and a grant from the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1324). DMS was supported by the San Diego Veterans Affairs Healthcare system and National Institutes of Health grants AI100665, MH062512 and AI036214.	Ances B, 2011, NEUROIMAGE, V54, P2156, DOI 10.1016/j.neuroimage.2010.09.081; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Becker JT, 2012, BRAIN IMAGING BEHAV, V6, P366, DOI 10.1007/s11682-012-9149-4; Chan LG, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000662; Chang YL, 2010, CEREB CORTEX, V20, P1305, DOI 10.1093/cercor/bhp192; Chernoff RA, 2010, J INT NEUROPSYCH SOC, V16, P38, DOI 10.1017/S1355617709990828; Du Plessis S, 2014, AIDS, V28, P803, DOI 10.1097/QAD.0000000000000151; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Hanning U, 2011, ACAD RADIOL, V18, P1144, DOI 10.1016/j.acra.2011.04.013; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Heaton RK, 2014, CLIN INFECT DIS; Ku NS, 2014, HIV MED, V15, P470, DOI 10.1111/hiv.12137; Kuper M, 2011, J NEUROL, V258, P1066, DOI 10.1007/s00415-010-5883-y; Letendre Scott L, 2010, Top HIV Med, V18, P45; Li CX, 2011, NEUROIMAGE, V58, P286, DOI 10.1016/j.neuroimage.2011.05.068; MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Towgood KJ, 2012, CORTEX, V48, P230, DOI 10.1016/j.cortex.2011.03.006; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang Z, 2014, NEUROIMAGE, V89, P45, DOI 10.1016/j.neuroimage.2013.10.039	21	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153493	10.1371/journal.pone.0153493	http://dx.doi.org/10.1371/journal.pone.0153493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104345	Green Submitted, Green Published, gold			2022-12-26	WOS:000374565100011
J	Ericsson, M; Henriksen, R; Belteky, J; Sundman, AS; Shionoya, K; Jensen, P				Ericsson, Maria; Henriksen, Rie; Belteky, Johan; Sundman, Ann-Sofie; Shionoya, Kiseko; Jensen, Per			Long-Term and Transgenerational Effects of Stress Experienced during Different Life Phases in Chickens (Gallus gallus)	PLOS ONE			English	Article							SOCIAL-ISOLATION; GENE-EXPRESSION; FEATHER PECKING; ADRENOCORTICAL-RESPONSE; DEVELOPMENTAL STRESS; SINGLE EXPOSURE; RED JUNGLEFOWL; DOMESTIC-FOWL; BEHAVIOR; RATS	Stress in animals causes not only immediate reactions, but may affect their biology for long periods, even across generations. Particular interest has been paid to perinatal stress, but also adolescence has been shown to be a sensitive period in mammals. So far, no systematic study has been performed of the relative importance of stress encountered during different life phases. In this study, groups of chickens were exposed to a six-day period of repeated stress during three different life phases: early (two weeks), early puberty (eight weeks) and late puberty (17 weeks), and the effects were compared to an unstressed control group. The short-term effects were assessed by behaviour, and the long-term and transgenerational effects were determined by effects on behavior and corticosterone secretion, as well as on hypothalamic gene expression. Short-term effects were strongest in the two week group and the eight week group, whereas long-term and transgenerational effects were detected in all three stress groups. However, stress at different ages affected different aspects of the biology of the chickens, and it was not possible to determine a particularly sensitive life phase. The results show that stress during puberty appears to be at least equally critical as the previously studied early life phase. These findings may have important implications for animal welfare in egg production, since laying hens are often exposed to stress during the three periods pinpointed here.	[Ericsson, Maria; Henriksen, Rie; Belteky, Johan; Sundman, Ann-Sofie; Jensen, Per] Linkoping Univ, AVIAN Behav Physiol & Genom Grp, IFM Biol, Linkoping, Sweden; [Shionoya, Kiseko] Linkoping Univ, Dept Clin & Expt Med, IKE, Div Cell Biol, Linkoping, Sweden	Linkoping University; Linkoping University	Jensen, P (corresponding author), Linkoping Univ, AVIAN Behav Physiol & Genom Grp, IFM Biol, Linkoping, Sweden.	perje@ifm.liu.se			Swedish Research Council [621-2011-4731]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [221-2011-1088]; European Research Council [322206]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); European Research Council(European Research Council (ERC)European Commission)	Funding provided by Swedish Research Council, http://www.vr.se/, Grant no: 621-2011-4731 (PJ), Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, http://www.formas.se/, Grant no: 221-2011-1088 (PJ) and European Research Council, https://erc.europa.eu/, Grant no: 322206 (PJ).	Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Appleby M.C., 2004, POULTRY BEHAV WELFAR; Ball GF, 2013, HORM BEHAV, V64, P211, DOI 10.1016/j.yhbeh.2013.05.002; Barbazanges A, 1996, J NEUROSCI, V16, P7783; Biagini G, 1998, INT J DEV NEUROSCI, V16, P187, DOI 10.1016/S0736-5748(98)00019-7; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Brown GR, 2013, NEUROSCIENCE, V249, P115, DOI 10.1016/j.neuroscience.2012.12.016; Calandreau L, 2011, BEHAV BRAIN RES, V217, P104, DOI 10.1016/j.bbr.2010.10.004; Chaby LE, 2015, BEHAV BRAIN RES, V278, P492, DOI 10.1016/j.bbr.2014.09.003; Chow A, 2005, APPL ANIM BEHAV SCI, V93, P283, DOI 10.1016/j.applanim.2005.01.004; de Haas EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090577; Ericsson M, 2014, PHYSIOL BEHAV, V133, P161, DOI 10.1016/j.physbeh.2014.05.024; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Goerlich VC, 2012, HORM BEHAV, V61, P711, DOI 10.1016/j.yhbeh.2012.03.006; HAGEN P, 1961, BRIT J PHARM CHEMOTH, V17, P267, DOI 10.1111/j.1476-5381.1961.tb01287.x; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Jensen AB, 2006, APPL ANIM BEHAV SCI, V99, P287, DOI 10.1016/j.applanim.2005.10.017; Johnsen PF, 1998, APPL ANIM BEHAV SCI, V60, P25, DOI 10.1016/S0168-1591(98)00149-X; Kanitz E, 2004, BRAIN BEHAV IMMUN, V18, P35, DOI 10.1016/S0889-1591(03)00085-0; Kanitz E, 2009, PHYSIOL BEHAV, V98, P176, DOI 10.1016/j.physbeh.2009.05.007; LEVINE S, 1967, PHYSIOL BEHAV, V2, P55, DOI 10.1016/0031-9384(67)90011-X; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; McCormick CM, 2007, PHARMACOL BIOCHEM BE, V86, P220, DOI 10.1016/j.pbb.2006.07.012; McCormick CM, 2013, HORM BEHAV, V63, P5, DOI 10.1016/j.yhbeh.2012.11.009; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; MCNAUGHTON FJ, 1992, J ENDOCRINOL, V132, P411, DOI 10.1677/joe.0.1320411; Morrissey MD, 2011, NEUROBIOL LEARN MEM, V95, P46, DOI 10.1016/j.nlm.2010.10.007; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Poletto R, 2006, BRAIN RES, V1067, P36, DOI 10.1016/j.brainres.2005.10.001; Pravosudov VV, 2006, GEN COMP ENDOCR, V145, P25, DOI 10.1016/j.ygcen.2005.06.011; Pryce CR, 2002, NEWS PHYSIOL SCI, V17, P150, DOI 10.1152/nips.01367.2001; ROSTAS JAP, 1991, MOL NEUROBIOL, V5, P203, DOI 10.1007/BF02935546; Salvatierra NA, 2009, STRESS, V12, P328, DOI 10.1080/10253890802455433; Satterlee DG, 2006, POULTRY SCI, V85, P1087, DOI 10.1093/ps/85.6.1087; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Spencer KA, 2005, BEHAV ECOL SOCIOBIOL, V58, P423, DOI 10.1007/s00265-005-0927-5; Spencer KA, 2004, P ROY SOC B-BIOL SCI, V271, pS121, DOI 10.1098/rsbl.2003.0122; Spencer KA, 2009, ENDOCRINOLOGY, V150, P1931, DOI 10.1210/en.2008-1471; STANSFIELD SC, 1988, ENDOCRINOLOGY, V123, P787, DOI 10.1210/endo-123-2-787; Suchecki D, 2000, BEHAV BRAIN RES, V111, P99, DOI 10.1016/S0166-4328(00)00148-0; Toth E, 2008, BEHAV BRAIN RES, V190, P135, DOI 10.1016/j.bbr.2008.02.012; Valles A, 2000, AM J PHYSIOL-REG I, V279, pR1138, DOI 10.1152/ajpregu.2000.279.3.R1138; van Oers HJJ, 1998, DEV BRAIN RES, V111, P245, DOI 10.1016/S0165-3806(98)00143-6; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WINGFIELD JC, 1992, J EXP ZOOL, V264, P419, DOI 10.1002/jez.1402640407; Zimmerberg B, 1998, INT J DEV NEUROSCI, V16, P217, DOI 10.1016/S0736-5748(98)00024-0	49	42	42	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153879	10.1371/journal.pone.0153879	http://dx.doi.org/10.1371/journal.pone.0153879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105229	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100026
J	Paradowska, E; Jablonska, A; Studzinska, M; Skowronska, K; Suski, P; Wisniewska-Ligier, M; Wozniakowska-Gesicka, T; Nowakowska, D; Gaj, Z; Wilczynski, J; Lesnikowski, ZJ				Paradowska, Edyta; Jablonska, Agnieszka; Studzinska, Miroslawa; Skowronska, Katarzyna; Suski, Patrycja; Wisniewska-Ligier, Malgorzata; Wozniakowska-Gesicka, Teresa; Nowakowska, Dorota; Gaj, Zuzanna; Wilczynski, Jan; Lesnikowski, Zbigniew J.			TLR9-1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; SINGLE-NUCLEOTIDE POLYMORPHISM; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TLR9 GENE; ADAPTER PROTEIN; GLYCOPROTEIN-B; VIRAL LOAD; DISEASE; TOLL-LIKE-RECEPTOR-9; MYD88	Toll-like receptor 9 (TLR9) recognizes non-methylated viral CpG-containing DNA and serves as a pattern recognition receptor that signals the presence of human cytomegalovirus (HCMV). Here, we present the genotype distribution of single-nucleotide polymorphisms (SNPs) of the TLR9 gene in infants and the relationship between TLR9 polymorphisms and HCMV infection. Four polymorphisms (-1237T/C, rs5743836; -1486T/C, rs187084; 1174G/A, rs352139; and 2848C/T, rs352140) in the TLR9 gene were genotyped in 72 infants with symptomatic HCMV infection and 70 healthy individuals. SNP genotyping was performed by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Digested fragments were separated and identified by capillary electrophoresis. The HCMV DNA copy number was measured by a quantitative real-time PCR assay. We found an increased frequency of heterozygous genotypes TLR9 -1486T/C and 2848C/T in infants with HCMV infection compared with uninfected cases. Heterozygous variants of these two SNPs increased the risk of HCMV disease in children (P = 0.044 and P = 0.029, respectively). In infants with a mutation present in at least one allele of -1486T/C and 2848C/T SNPs, a trend towards increased risk of cytomegaly was confirmed after Bonferroni's correction for multiple testing (Pc = 0.063). The rs352139 GG genotype showed a significantly reduced relative risk for HCMV infection (Pc = 0.006). In contrast, the -1237T/C SNP was not related to viral infection. We found no evidence for linkage disequilibrium with the four examined TLR9 SNPs. The findings suggest that the TLR9 -1486T/C and 2848C/T polymorphisms could be a genetic risk factor for the development of HCMV disease.	[Paradowska, Edyta; Jablonska, Agnieszka; Studzinska, Miroslawa; Skowronska, Katarzyna; Suski, Patrycja; Lesnikowski, Zbigniew J.] Polish Acad Sci, Inst Med Biol, Lab Mol Virol & Biol Chem, Lodz, Poland; [Wisniewska-Ligier, Malgorzata] Polish Mothers Mem Hosp Res Inst, Dept Pediat Immunol & Nephrol, Lodz, Poland; [Wozniakowska-Gesicka, Teresa] Polish Mothers Mem Hosp Res Inst, Dept Pediat 3, Lodz, Poland; [Nowakowska, Dorota; Gaj, Zuzanna] Polish Mothers Mem Hosp Res Inst, Dept Perinatol & Gynecol, Lodz, Poland; [Gaj, Zuzanna] Polish Mothers Mem Hosp Res Inst, Sci Lab, Ctr Med Lab Diagnost, Lodz, Poland; [Wilczynski, Jan] Med Univ Warsaw, Dept Obstet & Gynecol 2, Warsaw, Poland; [Skowronska, Katarzyna] Polish Acad Sci, Dept Neurotoxicol, Mossakowski Med Res Ctr, Warsaw, Poland	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Paradowska, E (corresponding author), Polish Acad Sci, Inst Med Biol, Lab Mol Virol & Biol Chem, Lodz, Poland.	eparadowska@cbm.pan.pl	Skowrońska, Katarzyna/K-8832-2019; Jabłońska, Agnieszka/AAG-8207-2021; Lesnikowski, Zbigniew/AAG-7006-2020; Jabłońska, Agnieszka/AAF-8078-2019; Gaj, Zuzanna/O-3749-2014	Skowrońska, Katarzyna/0000-0002-2612-3186; Lesnikowski, Zbigniew/0000-0003-3158-5796; Jabłońska, Agnieszka/0000-0002-6688-043X; Gaj, Zuzanna/0000-0002-1803-1935; Paradowska, Edyta/0000-0001-9446-0136; Studzinska, Miroslawa/0000-0002-4851-2190	National Science Centre of Poland [2014/13/B/NZ7/02317]; European Regional Development Fund under Operational Programme Innovative Economy [POIG.01.01.02-10-107/09]	National Science Centre of Poland(National Science Centre, Poland); European Regional Development Fund under Operational Programme Innovative Economy	This work was supported by the National Science Centre of Poland (No. 2014/13/B/NZ7/02317) (http://www.ncn.gov.pl/) and by the European Regional Development Fund under Operational Programme Innovative Economy (No. POIG.01.01.02-10-107/09) (http://www.poig.gov.pl/english). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arav-Boger Ravit, 2012, BMC Res Notes, V5, P140, DOI 10.1186/1756-0500-5-140; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Brown RA, 2009, CLIN INFECT DIS, V49, pE96, DOI 10.1086/644501; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Carvalho A, 2012, GENES IMMUN, V13, P197, DOI 10.1038/gene.2011.59; Carvalho A, 2009, EXP HEMATOL, V37, P1022, DOI 10.1016/j.exphem.2009.06.004; Cervera C, 2007, TRANSPLANTATION, V83, P1493, DOI 10.1097/01.tp.0000264999.71318.2b; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fang J, 2013, INVEST OPHTH VIS SCI, V54, P8384, DOI 10.1167/iovs.13-12878; Fiola S, 2010, J IMMUNOL, V185, P3620, DOI 10.4049/jimmunol.0903736; Freguja R, 2012, AIDS, V26, P765, DOI 10.1097/QAD.0b013e3283514350; Hamann L, 2004, J IMMUNOL METHODS, V285, P281, DOI 10.1016/j.jim.2003.12.005; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Iversen AC, 2009, J IMMUNOL, V182, P5672, DOI 10.4049/jimmunol.0801268; Jablonska A, 2014, INT J INFECT DIS, V25, P11, DOI 10.1016/j.ijid.2014.04.001; Kang SH, 2012, J INFECT DIS, V205, P639, DOI 10.1093/infdis/jir819; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339; Kikuchi K, 2005, J AUTOIMMUN, V24, P347, DOI 10.1016/j.jaut.2005.03.002; Kruger B, 2010, CLIN SCI, V119, P535, DOI 10.1042/CS20100190; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Lai ZZ, 2013, J INT MED RES, V41, P1027, DOI 10.1177/0300060513483398; Latz E, 2004, J IMMUNOL, V172, P2431, DOI 10.4049/jimmunol.172.4.2431; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Mollaki V, 2009, J HUM GENET, V54, P655, DOI 10.1038/jhg.2009.90; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ng MW, 2005, RHEUMATOLOGY, V44, P1456, DOI 10.1093/rheumatology/kei120; Novak N, 2007, ALLERGY, V62, P766, DOI 10.1111/j.1398-9995.2007.01358.x; Paradowska E, 2006, APMIS, V114, P764, DOI 10.1111/j.1600-0463.2006.apm_31.x; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pine SO, 2009, AIDS, V23, P2387, DOI 10.1097/QAD.0b013e328330b489; Piotrowski P, 2013, RHEUMATOL INT, V33, P1121, DOI 10.1007/s00296-012-2509-y; Ricci E, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-49; Roszak A, 2012, MOL BIOL REP, V39, P8425, DOI 10.1007/s11033-012-1695-8; Sanders MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-112; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Soriano-Sarabia N, 2008, JAIDS-J ACQ IMM DEF, V49, P128, DOI 10.1097/QAI.0b013e318184fb41; Stagno S., 1995, INFECT DIS FETUS NEW, P312; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Taniguchi R, 2013, INT J INFECT DIS, V17, pE1092, DOI 10.1016/j.ijid.2013.06.004; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Vaidya SA, 2003, CURR OPIN IMMUNOL, V15, P402, DOI 10.1016/S0952-7915(03)00070-0; Varani S, 2007, J IMMUNOL, V179, P7767, DOI 10.4049/jimmunol.179.11.7767; Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Wang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065731; Wu JF, 2012, J INFECT DIS, V206, P662, DOI 10.1093/infdis/jis420; Wujcicka W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122831; Xiao HW, 2014, BONE MARROW TRANSPL, V49, P241, DOI 10.1038/bmt.2013.160; Yang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058444; Yew KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044500	59	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154100	10.1371/journal.pone.0154100	http://dx.doi.org/10.1371/journal.pone.0154100			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105145	Green Submitted, gold, Green Published			2022-12-26	WOS:000374565100044
J	Borzova, VA; Markossian, KA; Chebotareva, NA; Kleymenov, SY; Poliansky, NB; Muranov, KO; Stein-Margolina, VA; Shubin, VV; Markov, DI; Kurganov, BI				Borzova, Vera A.; Markossian, Kira A.; Chebotareva, Natalia A.; Kleymenov, Sergey Yu.; Poliansky, Nikolay B.; Muranov, Konstantin O.; Stein-Margolina, Vita A.; Shubin, Vladimir V.; Markov, Denis I.; Kurganov, Boris I.			Kinetics of Thermal Denaturation and Aggregation of Bovine Serum Albumin	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; DYNAMIC LIGHT-SCATTERING; CIRCULAR-DICHROISM; STRUCTURAL-CHANGES; INCLUSION-BODIES; ANALYTICAL ULTRACENTRIFUGATION; HETEROGENEOUS NUCLEATION; CONFORMATIONAL-CHANGES; FTIR SPECTROSCOPY; DISULFIDE BRIDGES	Thermal aggregation of bovine serum albumin (BSA) has been studied using dynamic light scattering, asymmetric flow field-flow fractionation and analytical ultracentrifugation. The studies were carried out at fixed temperatures (60 degrees C, 65 degrees C, 70 degrees C and 80 degrees C) in 0.1 M phosphate buffer, pH 7.0, at BSA concentration of 1 mg/ml. Thermal denaturation of the protein was studied by differential scanning calorimetry. Analysis of the experimental data shows that at 65 degrees C the stage of protein unfolding and individual stages of protein aggregation are markedly separated in time. This circumstance allowed us to propose the following mechanism of thermal aggregation of BSA. Protein unfolding results in the formation of two forms of the non-native protein with different propensity to aggregation. One of the forms (highly reactive unfolded form, U-hr) is characterized by a high rate of aggregation. Aggregation of U-hr leads to the formation of primary aggregates with the hydrodynamic radius (R-h,R- 1) of 10.3 nm. The second form (low reactive unfolded form, U-lr) participates in the aggregation process by its attachment to the primary aggregates produced by the U-hr form and possesses ability for self-aggregation with formation of stable small-sized aggregates (A(st)). At complete exhaustion of U-lr, secondary aggregates with the hydrodynamic radius (R-h,R- 2) of 12.8 nm are formed. At 60 degrees C the rates of unfolding and aggregation are commensurate, at 70 degrees C the rates of formation of the primary and secondary aggregates are commensurate, at 80 degrees C the registration of the initial stages of aggregation is complicated by formation of large-sized aggregates.	[Borzova, Vera A.; Markossian, Kira A.; Chebotareva, Natalia A.; Kleymenov, Sergey Yu.; Stein-Margolina, Vita A.; Markov, Denis I.; Kurganov, Boris I.] Russian Acad Sci, Dept Struct Biochem Prot, Bach Inst Biochem, Biotechnol Res Ctr, Moscow, Russia; [Kleymenov, Sergey Yu.] Russian Acad Sci, Dept Biophys, Koltsov Inst Dev Biol, Moscow, Russia; [Poliansky, Nikolay B.; Muranov, Konstantin O.] Russian Acad Sci, Dept Chem & Biol Proc Kinet, Emanuel Inst Biochem Phys, Moscow, Russia; [Shubin, Vladimir V.] Russian Acad Sci, Dept Biochem Chloroplast, Bach Inst Biochem, Biotechnol Res Ctr, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Russian Academy of Sciences; Emanuel Institute of Biochemical Physics; Research Center of Biotechnology RAS; Russian Academy of Sciences	Kurganov, BI (corresponding author), Russian Acad Sci, Dept Struct Biochem Prot, Bach Inst Biochem, Biotechnol Res Ctr, Moscow, Russia.	kurganov@inbi.ras.ru	Муранов, Константин/AAF-7887-2019; Kurganov, Boris/M-1286-2019; Borzova, Vera/F-4021-2017; Kleymenov, Sergey/R-1195-2018	Borzova, Vera/0000-0003-1544-8804; Kleymenov, Sergey/0000-0001-5085-0327; Kurganov, Boris/0000-0002-2930-2286	Russian Foundation for Basic Research [14-04-01530-a, 16-04-00997-mol_a, 16-04-00560-a]; Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences)	The work was supported by the following: Russian Foundation for Basic Research, http://www.rfbr.ru, 14-04-01530-a, VAB KAM NAC SYK BIK; Russian Foundation for Basic Research, http://www.rfbr.ru, 16-04-00997-mol_a, VAB; Russian Foundation for Basic Research, http://www.rfbr.ru, 16-04-00560-a, NAC; and Russian Academy of Sciences, http://www.ras.ru, Program "Molecular and Cell Biology", VAB KAM NAC SYK VAS-M DIM BIK. The funders had no role in study design, data collection and analysis decision to publich, or preparation of the manuscript.	Ahmad E, 2011, CELL BIOCHEM BIOPHYS, V61, P313, DOI 10.1007/s12013-011-9214-4; BARONE G, 1992, THERMOCHIM ACTA, V199, P197, DOI 10.1016/0040-6031(92)80263-V; Barone G, 1995, J THERM ANAL, V45, P1255, DOI 10.1007/BF02547420; Borzova VA, 2015, INT J BIOL MACROMOL, V80, P130, DOI 10.1016/j.ijbiomac.2015.06.040; Borzova VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074367; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Bulone D, 2001, BIOPHYS CHEM, V91, P61, DOI 10.1016/S0301-4622(01)00155-7; Dobson CM, 2013, AMYLOID FIBRILS PREF, P1; Donato L, 2005, BIOMACROMOLECULES, V6, P2157, DOI 10.1021/bm050132q; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Eronina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022154; Ferrone FA, 2002, BIOPHYS J, V82, P399, DOI 10.1016/S0006-3495(02)75404-0; GALLIER J, 1987, BIOCHIM BIOPHYS ACTA, V915, P1, DOI 10.1016/0167-4838(87)90119-1; Gayen A, 2008, BIOMACROMOLECULES, V9, P974, DOI 10.1021/bm701144k; Gelamo EL, 2002, BBA-PROTEIN STRUCT M, V1594, P84, DOI 10.1016/S0167-4838(01)00287-4; Giancola C, 1997, INT J BIOL MACROMOL, V20, P193, DOI 10.1016/S0141-8130(97)01159-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gobbo J, 2011, METHODS MOL BIOL, V787, P137, DOI 10.1007/978-1-61779-295-3_11; Golub N, 2007, FEBS LETT, V581, P4223, DOI 10.1016/j.febslet.2007.07.066; Golub NV, 2009, EUR BIOPHYS J BIOPHY, V38, P547, DOI 10.1007/s00249-009-0403-7; Harris J Robin, 2012, Subcell Biochem, V65, P3, DOI 10.1007/978-94-007-5416-4_1; HIRAYAMA K, 1990, BIOCHEM BIOPH RES CO, V173, P639, DOI 10.1016/S0006-291X(05)80083-X; HO JX, 1993, EUR J BIOCHEM, V215, P205, DOI 10.1111/j.1432-1033.1993.tb18024.x; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Honda C, 2000, CHEM PHARM BULL, V48, P464; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; Jun-tao Guo CKH, 2007, COMPUTATIONAL METHOD, P279; KATCHALSKI E, 1957, J AM CHEM SOC, V79, P4096, DOI 10.1021/ja01572a034; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Khanova HA, 2005, BIOCHEMISTRY-US, V44, P15480, DOI 10.1021/bi051175u; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LIN MY, 1989, P ROY SOC LOND A MAT, V423, P71, DOI 10.1098/rspa.1989.0042; Maloletkina OI, 2010, BIOPHYS CHEM, V148, P121, DOI 10.1016/j.bpc.2010.03.005; Markossian K. A., 2006, P89; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; Markossian KA, 2008, BBA-PROTEINS PROTEOM, V1784, P1286, DOI 10.1016/j.bbapap.2008.04.030; Markossian KA, 2006, BIOCHEMISTRY-US, V45, P13375, DOI 10.1021/bi0610707; Markov DI, 2010, INT J MOL SCI, V11, P4194, DOI 10.3390/ijms11114194; Meremyanin AV, 2008, BIOPOLYMERS, V89, P124, DOI 10.1002/bip.20872; Michnik A, 2003, J THERM ANAL CALORIM, V71, P509, DOI 10.1023/A:1022851809481; Militello V, 2004, BIOPHYS CHEM, V107, P175, DOI 10.1016/j.bpc.2003.09.004; Militello V, 2003, BIOPHYS CHEM, V105, P133, DOI 10.1016/S0301-4622(03)00153-4; Moriyama Y, 2008, J PHYS CHEM B, V112, P16585, DOI 10.1021/jp8067624; Nakamura K, 1997, FEBS LETT, V417, P375, DOI 10.1016/S0014-5793(97)01326-4; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; Panyukov Y, 2007, BIOPHYS CHEM, V127, P9, DOI 10.1016/j.bpc.2006.11.006; Paris G, 2012, BIOPOLYMERS, V97, P889, DOI 10.1002/bip.22096; Pearce FG, 2007, J AGR FOOD CHEM, V55, P318, DOI 10.1021/jf062154p; Perutz MF, 1997, NATURE, V385, P773, DOI 10.1038/385773a0; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rombouts I, 2015, SCI REP-UK, V5, DOI 10.1038/srep12210; Rondeau P, 2007, ARCH BIOCHEM BIOPHYS, V460, P141, DOI 10.1016/j.abb.2007.01.014; Rotter MA, 2005, BIOPHYS J, V89, P2677, DOI 10.1529/biophysj.105.067785; SADLER PJ, 1993, EUR J BIOCHEM, V212, P811, DOI 10.1111/j.1432-1033.1993.tb17722.x; Sahin Z, 2016, EUR J PHARM SCI, V86, P115, DOI 10.1016/j.ejps.2016.03.007; Scientist for Experimental Data Fitting, 1995, SCI EXP DAT FITT MIC; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shah D, 2012, BIOTECHNOL PROGR, V28, P223, DOI 10.1002/btpr.710; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; STEINHARDT J, 1971, BIOCHEMISTRY-US, V10, P4005, DOI 10.1021/bi00798a001; Su RX, 2008, FOOD HYDROCOLLOID, V22, P995, DOI 10.1016/j.foodhyd.2007.05.021; VANSTOKKUM IHM, 1995, BIOCHEMISTRY-US, V34, P10508, DOI 10.1021/bi00033a024; Vetri V, 2007, EUR BIOPHYS J BIOPHY, V36, P717, DOI 10.1007/s00249-007-0196-5; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Wen LL, 2015, INT J PHARMACEUT, V478, P753, DOI 10.1016/j.ijpharm.2014.12.038; Yohannes G, 2010, ANAL CHIM ACTA, V675, P191, DOI 10.1016/j.aca.2010.07.016; Zhang HM, 2014, LANGMUIR, V30, P5536, DOI 10.1021/la501129y	71	120	122	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153495	10.1371/journal.pone.0153495	http://dx.doi.org/10.1371/journal.pone.0153495			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101281	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500035
J	Mou, WS; Li, DD; Bu, JW; Jiang, YY; Khan, ZU; Luo, ZS; Mao, LC; Ying, TJ				Mou, Wangshu; Li, Dongdong; Bu, Jianwen; Jiang, Yuanyuan; Khan, Zia Ullah; Luo, Zisheng; Mao, Linchun; Ying, Tiejin			Comprehensive Analysis of ABA Effects on Ethylene Biosynthesis and Signaling during Tomato Fruit Ripening	PLOS ONE			English	Article							ABSCISIC-ACID	ABA has been widely acknowledged to regulate ethylene biosynthesis and signaling during fruit ripening, but the molecular mechanism underlying the interaction between these two hormones are largely unexplored. In the present study, exogenous ABA treatment obviously promoted fruit ripening as well as ethylene emission, whereas NDGA (Nordihydroguaiaretic acid, an inhibitor of ABA biosynthesis) application showed the opposite biological effects. Combined RNA-seq with time-course RT-PCR analysis, our study not only helped to illustrate how ABA regulated itself at the transcription level, but also revealed that ABA can facilitate ethylene production and response probably by regulating some crucial genes such as LeACS4, LeACO1, GR and LeETR6. In addition, investigation on the fruits treated with 1-MCP immediately after ABA exposure revealed that ethylene might be essential for the induction of ABA biosynthesis and signaling at the onset of fruit ripening. Furthermore, some specific transcription factors (TFs) known as regulators of ethylene synthesis and sensibility (e.g. MADS-RIN, TAGL1, CNR and NOR) were also observed to be ABA responsive, which implied that ABA influenced ethylene action possibly through the regulation of these TFs expression. Our comprehensive physiological and molecular-level analysis shed light on the mechanism of cross-talk between ABA and ethylene during the process of tomato fruit ripening.	[Mou, Wangshu; Li, Dongdong; Jiang, Yuanyuan; Luo, Zisheng; Mao, Linchun; Ying, Tiejin] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Zhejiang R&D Ctr Food Technol & Equipment, Coll Biosyst Engn & Food Sci,Fuli Inst Food Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Bu, Jianwen] Shandong Agr & Engn Univ, Dept Food Sci & Engn, Jinan 250100, Peoples R China; [Khan, Zia Ullah] Abdul Wali Khan Univ, Dept Agr, Mardan 23200, KPK, Pakistan	Zhejiang University; Shandong Agriculture & Engineering University; Abdul Wali Khan University	Ying, TJ (corresponding author), Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Zhejiang R&D Ctr Food Technol & Equipment, Coll Biosyst Engn & Food Sci,Fuli Inst Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.	tjying@zju.edu.cn	jiang, anyi/GPT-0379-2022		National Basic Research Program of China [2013CB127101]	National Basic Research Program of China(National Basic Research Program of China)	The research was financially supported by the National Basic Research Program of China (2013CB127101).	Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Babak B, 2013, DNA RES, V20, P315, DOI 10.1093/dnares/dst012; Barickman TC, 2014, J AM SOC HORTIC SCI, V139, P261, DOI 10.21273/JASHS.139.3.261; Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Barry CS, 1996, PLANT J, V9, P525, DOI 10.1046/j.1365-313X.1996.09040525.x; Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Binder BM, 2010, J BIOL CHEM, V285, P37263, DOI 10.1074/jbc.M110.170027; Bisson MMA, 2010, MOL PLANT, V3, P882, DOI 10.1093/mp/ssq036; Blume B, 1997, PLANT J, V12, P731, DOI 10.1046/j.1365-313X.1997.12040731.x; Bouvier F, 2000, EUR J BIOCHEM, V267, P6346, DOI 10.1046/j.1432-1327.2000.01722.x; Bu JW, 2013, POSTHARVEST BIOL TEC, V86, P337, DOI 10.1016/j.postharvbio.2013.07.026; Burbidge A, 1999, PLANT J, V17, P427, DOI 10.1046/j.1365-313X.1999.00386.x; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cutler AJ, 1999, TRENDS PLANT SCI, V4, P472, DOI 10.1016/S1360-1385(99)01497-1; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Diretto G, 2010, PLANT PHYSIOL, V154, P899, DOI 10.1104/pp.110.159368; Dong TT, 2013, PLANT PHYSIOL, V163, P1026, DOI 10.1104/pp.113.224436; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Fujisawa M, 2013, PLANT CELL, V25, P371, DOI 10.1105/tpc.112.108118; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Galpaz N, 2008, PLANT J, V53, P717, DOI 10.1111/j.1365-313X.2007.03362.x; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Ji K, 2014, J EXP BOT, V65, P5243, DOI 10.1093/jxb/eru288; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jiang YM, 2000, J PLANT GROWTH REGUL, V19, P106, DOI 10.1007/s003440000011; Joo S, 2008, PLANT J, V54, P129, DOI 10.1111/j.1365-313X.2008.03404.x; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kang CY, 2013, PLANT CELL, V25, P1960, DOI 10.1105/tpc.113.111732; Karlova R, 2014, J EXP BOT, V65, P4527, DOI 10.1093/jxb/eru316; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; KONDO S, 1991, J JPN SOC HORTIC SCI, V60, P505, DOI 10.2503/jjshs.60.505; Kondo S, 1997, J HORTIC SCI BIOTECH, V72, P221, DOI 10.1080/14620316.1997.11515509; Krochko JE, 1998, PLANT PHYSIOL, V118, P849, DOI 10.1104/pp.118.3.849; Kumar R, 2014, J EXP BOT, V65, P4561, DOI 10.1093/jxb/eru277; Kumar R, 2012, MOL GENET GENOMICS, V287, P189, DOI 10.1007/s00438-011-0671-7; Lara I, 2000, J AM SOC HORTIC SCI, V2, P183; Leng P, 2009, CHINESE SCI BULL, V54, P2830, DOI 10.1007/s11434-009-0486-7; Li XW, 2011, J SCI FOOD AGR, V91, P2684, DOI 10.1002/jsfa.4514; Lim EK, 2005, TETRAHEDRON-ASYMMETR, V16, P143, DOI 10.1016/j.tetasy.2004.11.062; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; Lohani S, 2004, POSTHARVEST BIOL TEC, V31, P119, DOI 10.1016/j.postharvbio.2003.08.001; Ma NN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0351-y; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; MartinezMadrid MC, 1996, PHYTOCHEMISTRY, V43, P323, DOI 10.1016/0031-9422(96)00192-6; McAtee P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00079; MIYAZAKI JH, 1987, PHYSIOL PLANTARUM, V69, P366, DOI 10.1111/j.1399-3054.1987.tb04302.x; MIZRAHI Y, 1975, PLANT PHYSIOL, V56, P544, DOI 10.1104/pp.56.4.544; Mou WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129598; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Osorio S, 2011, PLANT PHYSIOL, V157, P405, DOI 10.1104/pp.111.175463; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Qiu LP, 2012, PLANT PHYSIOL, V159, P1263, DOI 10.1104/pp.112.193979; Resnick JS, 2008, PLANT J, V56, P423, DOI 10.1111/j.1365-313X.2008.03615.x; Rohrmann J, 2011, PLANT J, V68, P999, DOI 10.1111/j.1365-313X.2011.04750.x; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Shima Y, 2013, PLANT MOL BIOL, V82, P427, DOI 10.1007/s11103-013-0071-y; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Sun L, 2012, J EXP BOT, V63, P3097, DOI 10.1093/jxb/ers026; Sun L, 2012, PLANT PHYSIOL, V158, P283, DOI 10.1104/pp.111.186866; Sun LA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-257; Sun Y, 2013, J PLANT GROWTH REGUL, V32, P233, DOI 10.1007/s00344-012-9293-5; Thompson AJ, 2004, PLANT CELL ENVIRON, V27, P459, DOI 10.1111/j.1365-3040.2003.01164.x; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang HC, 2007, PLANT GROWTH REGUL, V52, P189, DOI 10.1007/s10725-007-9189-8; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-841; Wang YP, 2013, PLANT PHYSIOL BIOCH, V64, P70, DOI 10.1016/j.plaphy.2012.12.015; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Yu LJ, 2012, NEW PHYTOL, V195, P97, DOI 10.1111/j.1469-8137.2012.04154.x; Zaharah SS, 2013, POSTHARVEST BIOL TEC, V75, P37, DOI 10.1016/j.postharvbio.2012.07.009; ZEEVAART JAD, 1983, PLANT PHYSIOL, V71, P477, DOI 10.1104/pp.71.3.477; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang M, 2009, MATER TODAY, V12, P12, DOI 10.1016/S1369-7021(09)70176-2; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zouari I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-221; Zouine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084203	99	73	80	10	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154072	10.1371/journal.pone.0154072	http://dx.doi.org/10.1371/journal.pone.0154072			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100326	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500136
J	Nguyen, A; Mamarbachi, M; Turcot, V; Lessard, S; Yu, C; Luo, XY; Lalonge, J; Hayami, D; Gayda, M; Juneau, M; Thorin-Trescases, N; Lettre, G; Nigam, A; Thorin, E				Nguyen, Albert; Mamarbachi, Maya; Turcot, Valerie; Lessard, Samuel; Yu, Carol; Luo, Xiaoyan; Lalonge, Julie; Hayami, Doug; Gayda, Mathieu; Juneau, Martin; Thorin-Trescases, Nathalie; Lettre, Guillaume; Nigam, Anil; Thorin, Eric			Lower Methylation of the ANGPTL2 Gene in Leukocytes from Post-Acute Coronary Syndrome Patients	PLOS ONE			English	Article							ANGIOPOIETIN-LIKE PROTEIN-2; DNA METHYLATION; TOBACCO SMOKING; BLOOD-PRESSURE; INFLAMMATION; EPIGENETICS; ASSOCIATION; RISK; DIAGNOSIS; HEALTH	DNA methylation is believed to regulate gene expression during adulthood in response to the constant changes in environment. The methylome is therefore proposed to be a biomarker of health through age. ANGPTL2 is a circulating pro-inflammatory protein that increases with age and prematurely in patients with coronary artery diseases; integrating the methylation pattern of the promoter may help differentiate age-vs. disease-related change in its expression. We believe that in a pro-inflammatory environment, ANGPTL2 is differentially methylated, regulating ANGPTL2 expression. To test this hypothesis we investigated the changes in promoter methylation of ANGPTL2 gene in leukocytes from patients suffering from post-acute coronary syndrome (ACS). DNA was extracted from circulating leukocytes of post-ACS patients with cardiovascular risk factors and from healthy young and age-matched controls. Methylation sites (CpGs) found in the ANGPTL2 gene were targeted for specific DNA methylation quantification. The functionality of ANGPTL2 methylation was assessed by an in vitro luciferase assay. In post-ACS patients, C-reactive protein and ANGPTL2 circulating levels increased significantly when compared to healthy controls. Decreased methylation of specific CpGs were found in the promoter of ANGPTL2 and allowed to discriminate age vs. disease associated methylation. In vitro DNA methylation of specific CpG lead to inhibition of ANGPTL2 promoter activity. Reduced leukocyte DNA methylation in the promoter region of ANGPTL2 is associated with the pro-inflammatory environment that characterizes patients with post-ACS differently from age-matched healthy controls. Methylation of different CpGs in ANGPTL2 gene may prove to be a reliable biomarker of coronary disease.	[Nguyen, Albert; Mamarbachi, Maya; Turcot, Valerie; Lessard, Samuel; Yu, Carol; Luo, Xiaoyan; Lalonge, Julie; Hayami, Doug; Gayda, Mathieu; Juneau, Martin; Thorin-Trescases, Nathalie; Lettre, Guillaume; Nigam, Anil; Thorin, Eric] Univ Montreal, Res Ctr, Montreal Heart Inst, Montreal, PQ, Canada; [Nguyen, Albert; Yu, Carol] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Lalonge, Julie; Hayami, Doug; Gayda, Mathieu; Juneau, Martin; Nigam, Anil] Univ Montreal, Montreal Heart Inst, Cardiac Rehabil & Prevent Ctr EPIC, Montreal, PQ, Canada; [Hayami, Doug; Gayda, Mathieu; Juneau, Martin; Lettre, Guillaume; Nigam, Anil] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada; [Thorin, Eric] Univ Montreal, Fac Med, Dept Surg, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Nigam, A; Thorin, E (corresponding author), Univ Montreal, Res Ctr, Montreal Heart Inst, Montreal, PQ, Canada.; Nigam, A (corresponding author), Univ Montreal, Montreal Heart Inst, Cardiac Rehabil & Prevent Ctr EPIC, Montreal, PQ, Canada.; Nigam, A (corresponding author), Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada.; Thorin, E (corresponding author), Univ Montreal, Fac Med, Dept Surg, Montreal, PQ H3C 3J7, Canada.	anil.nigam@icm-mhi.org; eric.thorin@umontreal.ca	Thorin, Eric/K-3978-2013; Gayda, Mathieu/U-8520-2019	Thorin, Eric/0000-0001-5827-8935; Gayda, Mathieu/0000-0003-1721-2299	Canadian Institute for Health Research; Montreal Heart Institute; EPIC Foundation; prevention center of the Montreal Heart Institute	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Montreal Heart Institute; EPIC Foundation; prevention center of the Montreal Heart Institute	The work was funded by the Canadian Institute for Health Research (ET). Students were supported through fellowship (VT) and scholarship (SL) of the Canadian Institute for Health Research. GL holds a Canada Research Chair. Clinical research (JL, MG, DH, MJ, A Nigam) and basic research (ET, NTT) teams are supported by an annual grant of the Foundation of the Montreal Heart Institute. Clinical research in prevention is supported by the EPIC Foundation, the prevention center of the Montreal Heart Institute.	Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bauer M, 2016, CLIN EPIGENETICS, V8, DOI [10.1186/s13148-015-0113-1, 10.1186/s13148-016-0249-7]; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Bouwland-Both MI, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0115-z; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Burris HH, 2015, EPIGENETICS-US, V10, P913, DOI 10.1080/15592294.2015.1078963; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Daskalopoulou SS, 2015, CAN J CARDIOL, V31, P549, DOI 10.1016/j.cjca.2015.02.016; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Doi Y, 2013, DIABETES CARE, V36, P98, DOI 10.2337/dc12-0166; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Farhat N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000201; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Horsburgh S, 2015, EXERC IMMUNOL REV, V21, P26; Huang CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138678; Ide S, 2015, ANN SURG ONCOL, V22, P2585, DOI 10.1245/s10434-014-4315-0; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kikuchi R, 2008, CANCER RES, V68, P5067, DOI 10.1158/0008-5472.CAN-08-0062; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; Kim YR, 2012, AM J PHYSIOL-HEART C, V303, pH189, DOI 10.1152/ajpheart.01218.2011; Larouche JF, 2015, CAN J CARDIOL, V31, P1232, DOI 10.1016/j.cjca.2015.01.038; Lee HJ, 2013, BIOCHEM BIOPH RES CO, V430, P981, DOI 10.1016/j.bbrc.2012.11.127; Lee Suee, 2012, Korean J Hematol, V47, P186, DOI 10.5045/kjh.2012.47.3.186; Li Q, 2013, DIABETES RES CLIN PR, V100, P385, DOI 10.1016/j.diabres.2013.03.028; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu X, 2014, ENVIRON MOL MUTAGEN, V55, P223, DOI 10.1002/em.21827; Mansego ML, 2015, INT J MOL SCI, V16, P16816, DOI 10.3390/ijms160816816; Lund G, 2011, CURR ATHEROSCLER REP, V13, P208, DOI 10.1007/s11883-011-0174-3; Malhotra P, 2014, J BIOL CHEM, V289, P23132, DOI 10.1074/jbc.M113.546283; Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6; Meng QX, 2013, EXP THER MED, V5, P1631, DOI 10.3892/etm.2013.1045; Mitra S, 2011, AM J PHYSIOL-HEART C, V301, pH506, DOI 10.1152/ajpheart.00252.2011; Muramoto A, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.16; Nestor CE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004059; Nguyen A, 2016, PLOS ONE IN PRESS; Nguyen A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8627384; Obata Y, 2015, IMMUNOL CELL BIOL, V93, P226, DOI 10.1038/icb.2014.114; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Oike Y, 2009, CIRC J, V73, P2192, DOI 10.1253/circj.CJ-09-0710; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Sasaki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131176; Shimura T, 2015, ANTICANCER RES, V35, P4633; Swain L, 2014, J LEUKOCYTE BIOL, V96, P365, DOI 10.1189/jlb.2HI1013-533R; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Thorin-Trescases N, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.19; Toiyama Y, 2015, CARCINOGENESIS, V36, P1474, DOI 10.1093/carcin/bgv139; Toiyama Y, 2015, ANTICANCER RES, V35, P2849; Toiyama Y, 2014, CLIN CANCER RES, V20, P6175, DOI 10.1158/1078-0432.CCR-14-0007; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Udali S, 2013, MOL ASPECTS MED, V34, P883, DOI 10.1016/j.mam.2012.08.001; van Dijk SJ, 2015, INT J OBESITY, V39, P85, DOI 10.1038/ijo.2014.34; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wang J, 2015, J HUM HYPERTENS, V29, P575, DOI 10.1038/jhh.2014.132; Wang JY, 2015, WORLD J MICROB BIOT, V31, P1235, DOI 10.1007/s11274-015-1873-7; Wang ZQ, 2015, ARCH MED RES, V46, P257, DOI 10.1016/j.arcmed.2015.05.003; Webster ALH, 2013, CAN J CARDIOL, V29, P46, DOI 10.1016/j.cjca.2012.10.023; Wierda RJ, 2010, J CELL MOL MED, V14, P1225, DOI 10.1111/j.1582-4934.2010.01022.x; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Yara S, 2015, EPIGENOMICS-UK, V7, P283, DOI [10.2217/EPI.14.84, 10.2217/epi.14.84]	67	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153920	10.1371/journal.pone.0153920	http://dx.doi.org/10.1371/journal.pone.0153920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101308	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500095
J	Mohan, CD; Srinivasa, V; Rangappa, S; Mervin, L; Mohan, S; Paricharak, S; Baday, S; Li, F; Shanmugam, MK; Chinnathambi, A; Zayed, ME; Alharbi, SA; Bender, A; Sethi, G; Basappa; Rangappa, KS				Mohan, Chakrabhavi Dhananjaya; Srinivasa, V.; Rangappa, Shobith; Mervin, Lewis; Mohan, Surender; Paricharak, Shardul; Baday, Sefer; Li, Feng; Shanmugam, Muthu K.; Chinnathambi, Arunachalam; Zayed, M. E.; Alharbi, Sulaiman Ali; Bender, Andreas; Sethi, Gautam; Basappa; Rangappa, Kanchugarakoppal S.			Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE PATHWAY; CARCINOMA IN-VITRO; INHIBITS GROWTH; ANTICANCER ACTIVITY; PROMOTES APOPTOSIS; SUPPRESSION; ACTIVATION; KINASE; ANGIOGENESIS; DERIVATIVES	Overactivation of PI3K/Akt/mTOR is linked with carcinogenesis and serves a potential molecular therapeutic target in treatment of various cancers. Herein, we report the synthesis of trisubstituted-imidazoles and identified 2-chloro-3-(4, 5-diphenyl-1H-imidazol-2-yl) pyridine (CIP) as lead cytotoxic agent. Naive Base classifier model of in silico target prediction revealed that CIP targets RAC-beta serine/threonine-protein kinase which comprises the Akt. Furthermore, CIP downregulated the phosphorylation of Akt, PDK and mTOR proteins and decreased expression of cyclin D1, Bcl-2, survivin, VEGF, procaspase-3 and increased cleavage of PARP. In addition, CIP significantly downregulated the CXCL12 induced motility of breast cancer cells and molecular docking calculations revealed that all compounds bind to Akt2 kinase with high docking scores compared to the library of previously reported Akt2 inhibitors. In summary, we report the synthesis and biological evaluation of imidazoles that induce apoptosis in breast cancer cells by negatively regulating PI3K/Akt/mTOR signaling pathway.	[Mohan, Chakrabhavi Dhananjaya; Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Srinivasa, V.; Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Cent Coll Campus,Palace Rd, Bangalore 560001, Karnataka, India; [Rangappa, Shobith] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0600808, Japan; [Mervin, Lewis; Paricharak, Shardul; Baday, Sefer; Bender, Andreas] Univ Cambridge, Dept Chem, Ctr Mol Informat, Lensfield Rd, Cambridge CB2 1EW, England; [Mohan, Surender] Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, India; [Paricharak, Shardul] Leiden Univ, Div Med Chem, Leiden Acad Ctr Drug Res, POB 9502, NL-2300 RA Leiden, Netherlands; [Baday, Sefer] Istanbul Tech Univ, Appl Informat Dept, Inst Informat, TR-34469 Istanbul, Turkey; [Li, Feng; Shanmugam, Muthu K.; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Chinnathambi, Arunachalam; Zayed, M. E.; Alharbi, Sulaiman Ali; Sethi, Gautam] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Sethi, Gautam] Curtin Univ, Sch Biomed Sci, CHIRI Biosci Res Precinct, Perth, WA 6009, Australia	University of Mysore; Bangalore University; Hokkaido University; University of Cambridge; Jawaharlal Nehru University, New Delhi; Leiden University; Leiden University - Excl LUMC; Istanbul Technical University; National University of Singapore; King Saud University; Curtin University	Rangappa, KS (corresponding author), Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India.; Basappa (corresponding author), Bangalore Univ, Dept Chem, Biol Chem Lab, Cent Coll Campus,Palace Rd, Bangalore 560001, Karnataka, India.	salundibasappa@gmail.com; rangappaks@yahoo.com	Sethi, Gautam/F-2372-2011; Bender, Andreas/C-6942-2009; Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; Rangappa, Shobith/AAI-2169-2020; baday, sefer/ABA-9111-2020; Mervin, Lewis/B-3759-2016	Sethi, Gautam/0000-0002-8677-8475; Bender, Andreas/0000-0002-6683-7546; Rangappa, Shobith/0000-0002-9800-7192; baday, sefer/0000-0002-2913-6687; Mohan, Chakrabhavi Dhananjaya/0000-0002-6810-9219; Chinnathambi, Arunachalam/0000-0001-5075-5901; Basappa, Basappa/0000-0002-8844-468X; Mervin, Lewis/0000-0002-7271-0824	University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology; Department of Science and Technology [SR/FT/LS-142/2012]; Department of Science and Technology Indo-Korea [INT/Indo-Korea/122/2011-12]; Institution of Excellence, University of Mysore; University of Mysore for Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) Research Associate fellowship; NUHS Bench-to-Bedside-to-Product grant; Netherlands Organisation for Scientific Research (NWO) [NWO-017.009-065]; Prins Bernhard Cultuurfonds; Biotechnology and Biological Sciences Research Council [1372344] Funding Source: researchfish	University Grants Commission(University Grants Commission, India); Vision Group Science and Technology; Department of Science and Technology(Department of Science & Technology (India)); Department of Science and Technology Indo-Korea(Department of Science & Technology (DOST), Philippines); Institution of Excellence, University of Mysore; University of Mysore for Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) Research Associate fellowship; NUHS Bench-to-Bedside-to-Product grant; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Prins Bernhard Cultuurfonds; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by University Grants Commission (41-257-2012-SR), Vision Group Science and Technology, and Department of Science and Technology (NO. SR/FT/LS-142/2012) to Basappa. KSR thanks Department of Science and Technology Indo-Korea [INT/Indo-Korea/122/2011-12] and Institution of Excellence, University of Mysore for financial support and instrumentation facility. CDM thanks the University of Mysore for Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) Research Associate fellowship. This work was supported by NUHS Bench-to-Bedside-to-Product grant to GS. Deanship of Scientific Research, College of Science Research Centre, King Saud University, Kingdom of Saudi Arabia is also acknowledged. SP thanks the Netherlands Organisation for Scientific Research (NWO, grant number NWO-017.009-065) and the Prins Bernhard Cultuurfonds for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Anusha S, 2016, BIOORG MED CHEM LETT, V26, P1056, DOI 10.1016/j.bmcl.2015.12.026; Anusha S, 2014, RSC ADV, V4, P52181, DOI 10.1039/c4ra07839j; Arcaro A, 2007, CURR GENOMICS, V8, P271, DOI 10.2174/138920207782446160; Ashwini N, 2015, BIOORGAN MED CHEM, V23, P6157, DOI 10.1016/j.bmc.2015.07.069; Basappa, 2004, INDIAN J CHEM B, V43, P1954; Basappa, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039444; Baviskar AT, 2011, J MED CHEM, V54, P5013, DOI 10.1021/jm200235u; Bharathkumar H, 2015, ORGANIC BIOMOLECULAR; Bharathkumar H, 2015, BIOORG MED CHEM LETT, V25, P1804, DOI 10.1016/j.bmcl.2015.01.030; Bharathkumar H, 2014, RSC ADV, V4, P45143, DOI 10.1039/c4ra08713e; Brader S, 2004, TUMORI J, V90, P2, DOI 10.1177/030089160409000102; Bratulescu G, 2009, SYNTHESIS-STUTTGART, P2319, DOI 10.1055/s-0029-1216841; Ching CB, 2010, LAB INVEST, V90, P1406, DOI 10.1038/labinvest.2010.133; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies TG, 2007, J MOL BIOL, V367, P882, DOI 10.1016/j.jmb.2007.01.004; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fongmoon D, 2007, J BIOL CHEM, V282, P36895, DOI 10.1074/jbc.M707082200; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Keane KN, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/181643; Keerthy HK, 2014, J BIOL CHEM, V289, P31879, DOI 10.1074/jbc.M114.593855; Kim H.-S., 2013, J NANOMATER, V2013, P4, DOI [10.1155/2013/679758, DOI 10.12826/18333575.2013.0016.KIM]; Kim SW, 2013, PROSTATE, V73, P296, DOI 10.1002/pros.22574; Kumar CA, 2007, MED CHEM, V3, P269; Kumar CA, 2007, INVEST NEW DRUG, V25, P343, DOI 10.1007/s10637-006-9033-4; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Ludwig Joseph A, 2011, Cancers (Basel), V3, P3029, DOI 10.3390/cancers3033029; Makinoshima H, 2015, J BIOL CHEM, V290, P17495, DOI 10.1074/jbc.M115.660498; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; McAuliffe PF, 2010, CLIN BREAST CANCER, V10, pS59, DOI 10.3816/CBC.2010.s.013; Mervin LH, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0098-y; Mohan CD, 2014, J BIOL CHEM, V289, P34296, DOI 10.1074/jbc.M114.601104; Neelgundmath M, 2015, BIOORG MED CHEM LETT, V25, P893, DOI 10.1016/j.bmcl.2014.12.065; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Priya BS, 2007, BIOORG MED CHEM LETT, V17, P2775, DOI 10.1016/j.bmcl.2007.02.074; Rademaker-Lakhai JM, 2004, CLIN CANCER RES, V10, P3717, DOI 10.1158/1078-0432.CCR-03-0746; Rakesh KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107182; Rangappa KS, 2005, J PHYS ORG CHEM, V18, P773, DOI 10.1002/poc.936; Roopashree R, 2015, BIOORG MED CHEM LETT, V25, P2589, DOI 10.1016/j.bmcl.2015.04.010; Sadashiva Maralinganadoddi Panchegowda, 2012, BMC Chemical Biology, V12, P5, DOI 10.1186/1472-6769-12-5; Siddharth S, 2013, ONCOL RES, V21, P1, DOI 10.3727/096504013X13786659070190; Subramaniam A, 2013, BRIT J PHARMACOL, V170, P807, DOI 10.1111/bph.12302; Sun YN, 2014, TUMOR BIOL, V35, P7765, DOI 10.1007/s13277-014-1816-1; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Thimmegowda NR, 2008, BIOORG MED CHEM LETT, V18, P432, DOI 10.1016/j.bmcl.2007.08.078; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Zhao S, 2004, LEUKEMIA, V18, P267, DOI 10.1038/sj.leu.2403220	56	93	95	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153155	10.1371/journal.pone.0153155	http://dx.doi.org/10.1371/journal.pone.0153155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097161	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000374543600028
J	Watts, A; Walters, RW; Hoffman, L; Templin, J				Watts, Amber; Walters, Ryan W.; Hoffman, Lesa; Templin, Jonathan			Intra-Individual Variability of Physical Activity in Older Adults With and Without Mild Alzheimer's Disease	PLOS ONE			English	Article							LOCATION SCALE-MODEL; MOMENTARY ASSESSMENT; SEDENTARY BEHAVIOR; EXERCISE; RISK; DEMENTIA; HEALTH; METAANALYSIS; PATTERNS; PEOPLE	Physical activity shows promise for protection against cognitive decline in older adults with and without Alzheimer's disease (AD). To better understand barriers to adoption of physical activity in this population, a clear understanding of daily and weekly activity patterns is needed. Most accelerometry studies report average physical activity over an entire wear period without considering the potential importance of the variability of physical activity. This study evaluated individual differences in the amount and intra-individual variability of physical activity and determined whether these differences could be predicted by AD status, day of wear, age, gender, education, and cardiorespiratory capacity. Physical activity was measured via accelerometry (Actigraph GT3X+) over one week in 86 older adults with and without AD (n = 33 and n = 53, respectively). Mixed-effects location-scale models were estimated to evaluate and predict individual differences in the amount and intra-individual variability of physical activity. Results indicated that compared to controls, participants with AD averaged 21% less activity, but averaged non-significantly greater intra-individual variability. Women and men averaged similar amounts of physical activity, but women were significantly less variable. The amount of physical activity differed significantly across days of wear. Increased cardiorespiratory capacity was associated with greater average amounts of physical activity. Investigation of individual differences in the amount and intra-individual variability of physical activity provided insight into differences by AD status, days of monitor wear, gender, and cardiovascular capacity. All individuals regardless of AD status were equally consistent in their physical activity, which may have been due to a highly sedentary sample and/or the early disease stage of those participants with AD. These results highlight the value of considering individual differences in both the amount and intra-individual variability of physical activity.	[Watts, Amber] Univ Kansas, Dept Clin Psychol, KU Alzheimers Dis Ctr, Lawrence, KS 66045 USA; [Walters, Ryan W.] Creighton Univ, Dept Med, Omaha, NE 68178 USA; [Hoffman, Lesa] Univ Kansas, Schiefelbusch Inst Lifespan Studies, Res Design & Anal Unit, Lawrence, KS 66045 USA; [Templin, Jonathan] Univ Kansas, Dept Educ Psychol, Lawrence, KS 66045 USA	University of Kansas; Creighton University; University of Kansas; University of Kansas	Watts, A (corresponding author), Univ Kansas, Dept Clin Psychol, KU Alzheimers Dis Ctr, Lawrence, KS 66045 USA.	amberwatts@ku.edu	Watts, Amber/AAL-5754-2020	Watts, Amber/0000-0002-8385-1091; Walters, Ryan/0000-0002-8801-9886; Templin, Jonathan/0000-0001-7616-0973	National Institute on Aging of the National Institutes of Health [NIA 5P30AG035982-3]; Clinical Translational Science Award grant from National Center for Advancing Translational Sciences [UL1TR000001, UL1RR033179]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Clinical Translational Science Award grant from National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging of the National Institutes of Health (NIA 5P30AG035982-3) and a Clinical Translational Science Award grant from National Center for Advancing Translational Sciences awarded to the University of Kansas Medical Center for Frontiers: The Heartland Institute for Clinical and Translational Research (#UL1TR000001; formerly #UL1RR033179). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or NCATS.	Actigraph, 2012, ACTILIFE 6 US MAN; Ainsworth BE, 2000, RES Q EXERCISE SPORT, V71, pS37, DOI 10.1080/02701367.2000.11082784; Bellettiere J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136161; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cavanaugh JT, 2007, J AM GERIATR SOC, V55, P120, DOI 10.1111/j.1532-5415.2006.00997.x; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Dunton GF, 2014, HEALTH PSYCHOL, V33, P255, DOI 10.1037/a0032640; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Gando Y, 2015, PHYS ACTIVITY EXERCI, P51; Grant PM, 2010, J AGING PHYS ACTIV, V18, P171, DOI 10.1123/japa.18.2.171; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Harvey JA, 2013, INT J ENV RES PUB HE, V10, P6645, DOI 10.3390/ijerph10126645; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Healy GN, 2010, REV ESP CARDIOL, V63, P261, DOI 10.1016/S0300-8932(10)70083-X; Hedeker D, 2008, BIOMETRICS, V64, P627, DOI 10.1111/j.1541-0420.2007.00924.x; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hilleras PK, 1999, AGE AGEING, V28, P147, DOI 10.1093/ageing/28.2.147; Hollenberg M, 1998, J GERONTOL A-BIOL, V53, pB259, DOI 10.1093/gerona/53A.4.B259; Hultsch D.F., 2004, NEW FRONTIERS COGNIT, P65, DOI DOI 10.1093/ACPROF:OSO/9780198525691.003.0004; James BD, 2012, ALZ DIS ASSOC DIS, V26, P238, DOI 10.1097/WAD.0b013e31822fc3cb; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lee YS, 2005, J WOMEN AGING, V17, P55, DOI 10.1300/J074v17n01_05; Li X, 2012, STAT MED, V31, P3192, DOI 10.1002/sim.5393; Lord S, 2011, AGE AGEING, V40, P205, DOI 10.1093/ageing/afq166; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Owings TM, 2004, GAIT POSTURE, V20, P26, DOI 10.1016/S0966-6362(03)00088-2; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rast P, 2011, J GERONTOPSYCHOLOGY, V24, P169; Sisson SB, 2009, METAB SYNDR RELAT D, V7, P529, DOI 10.1089/met.2009.0023; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Taraldsen K, 2012, MATURITAS, V71, P13, DOI 10.1016/j.maturitas.2011.11.003; Thune-Boyle ICV, 2012, INT PSYCHOGERIATR, V24, P1046, DOI 10.1017/S1041610211002365; Thyfault JP, 2011, CURR OPIN CLIN NUTR, V14, P374, DOI 10.1097/MCO.0b013e3283468e69; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Vidoni ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131647; Wang LJ, 2012, PSYCHOL METHODS, V17, P567, DOI 10.1037/a0029317; Watts AS, 2013, CLIN GERONTOLOGIST, V36, P356, DOI 10.1080/07317115.2013.788116; Westerterp MR, 2008, PHYSIOL BEHAV, V93, P1039, DOI 10.1016/j.physbeh.2008.01.021; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	41	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153898	10.1371/journal.pone.0153898	http://dx.doi.org/10.1371/journal.pone.0153898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27097226	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600068
J	Murtaza, M; Shan, J; Matigian, N; Todorovic, M; Cook, AL; Ravishankar, S; Dong, LF; Neuzil, J; Silburn, P; Mackay-Sim, A; Mellick, GD; Wood, SA				Murtaza, M.; Shan, J.; Matigian, N.; Todorovic, M.; Cook, A. L.; Ravishankar, S.; Dong, L. F.; Neuzil, J.; Silburn, P.; Mackay-Sim, A.; Mellick, G. D.; Wood, S. A.			Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson's Disease	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX-I; PLURIPOTENT STEM-CELLS; SKIN FIBROBLASTS; OXIDATIVE STRESS; SKELETAL-MUSCLE; NEURODEGENERATIVE DISEASES; CYTOCHROME-C; PATHOGENESIS; HSP27; DEATH	Parkinson's disease is a complex age-related neurodegenerative disorder. Approximately 90% of Parkinson's disease cases are idiopathic, of unknown origin. The aetiology of Parkinson's disease is not fully understood but increasing evidence implies a failure in fundamental cellular processes including mitochondrial dysfunction and increased oxidative stress. To dissect the cellular events underlying idiopathic Parkinson's disease, we use primary cell lines established from the olfactory mucosa of Parkinson's disease patients. Previous metabolic and transcriptomic analyses identified deficiencies in stress response pathways in patient-derived cell lines. The aim of this study was to investigate whether these deficiencies manifested as increased susceptibility, as measured by cell viability, to a range of extrinsic stressors. We identified that patient-derived cells are more sensitive to mitochondrial complex I inhibition and hydrogen peroxide induced oxidative stress, than controls. Exposure to low levels (50 nM) of rotenone led to increased apoptosis in patient-derived cells. We identified an endogenous deficit in mitochondrial complex I in patient-derived cells, but this did not directly correlate with rotenone-sensitivity. We further characterized the sensitivity to rotenone and identified that it was partly associated with heat shock protein 27 levels. Finally, transcriptomic analysis following rotenone exposure revealed that patient-derived cells express a diminished response to rotenone-induced stress compared with cells from healthy controls. Our cellular model of idiopathic Parkinson's disease displays a clear susceptibility phenotype to mitochondrial stress. The determination of molecular mechanisms underpinning this susceptibility may lead to the identification of biomarkers for either disease onset or progression.	[Murtaza, M.; Shan, J.; Matigian, N.; Todorovic, M.; Cook, A. L.; Ravishankar, S.; Silburn, P.; Mackay-Sim, A.; Mellick, G. D.; Wood, S. A.] Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia; [Cook, A. L.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Tas, Australia; [Dong, L. F.; Neuzil, J.] Griffith Univ, Sch Med Sci, Apoptosis Res Grp, Southport, Qld 4215, Australia; [Silburn, P.] Univ Queensland, Asia Pacific Ctr Neuromodulat, Brisbane, Qld, Australia	Griffith University; University of Tasmania; Griffith University; University of Queensland	Mellick, GD; Wood, SA (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia.	g.mellick@griffith.edu.au; s.wood@griffith.edu.au	Matigian, Nicholas/AAF-9390-2020; Wood, Stephen A/E-8357-2011; Mackay-Sim, Alan/C-3431-2008; Cook, Anthony/K-9489-2018; Neuzil, Jiri/H-7204-2014; Mellick, George D./A-7650-2010; Matigian, Nicholas A/A-4935-2009; DONG, LANFENG/S-8805-2019	Matigian, Nicholas/0000-0001-7735-9415; Wood, Stephen A/0000-0002-2576-7457; Mackay-Sim, Alan/0000-0003-4446-5371; Cook, Anthony/0000-0003-1770-7910; Neuzil, Jiri/0000-0002-2478-2460; Mellick, George D./0000-0002-7211-4651; Matigian, Nicholas A/0000-0001-7735-9415; Todorovic, Michael/0000-0003-0806-5610; Dong, Lanfeng/0000-0002-9857-6352; Murtaza, Mariyam/0000-0001-7087-3809	Australian Government Department of Health and Ageing; Hereditary Spastic Paraplegia Research Foundation Inc; National Health and Medical Research Council of Australia; Clem Jones Foundation	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Hereditary Spastic Paraplegia Research Foundation Inc; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Clem Jones Foundation	This work was supported by Australian Government Department of Health and Ageing (AMS); Hereditary Spastic Paraplegia Research Foundation Inc (AMS); National Health and Medical Research Council of Australia (GDM, AMS, SAW, PS and ALC); and The Clem Jones Foundation (GDM, AMS, SAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Ambrosi G, 2014, BBA-MOL BASIS DIS, V1842, P1385, DOI 10.1016/j.bbadis.2014.05.008; Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Beach TG, 2010, ACTA NEUROPATHOL, V119, P689, DOI 10.1007/s00401-010-0664-3; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451; Beretta S, 2006, NEUROBIOL DIS, V24, P308, DOI 10.1016/j.nbd.2006.07.016; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T; BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8; Bogaerts V, 2008, GENES BRAIN BEHAV, V7, P129, DOI 10.1111/j.1601-183X.2007.00342.x; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Cabeza-Arvelaiz Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044700; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chinopoulos C, 2001, J NEUROCHEM, V76, P302, DOI 10.1046/j.1471-4159.2001.00060.x; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Cook AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021907; COOPER JM, 1995, MOVEMENT DISORD, V10, P295, DOI 10.1002/mds.870100311; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; del Hoyo P, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-95; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Drolet RE, 2009, NEUROBIOL DIS, V36, P96, DOI 10.1016/j.nbd.2009.06.017; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; Feron F, 2013, METHODS MOL BIOL, V1059, P107, DOI 10.1007/978-1-62703-574-3_10; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Garrido C, 1997, CANCER RES, V57, P2661; Healy D G, 2008, Pract Neurol, V8, P381, DOI 10.1136/jnnp.2008.162420; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hoepken HH, 2008, EXP NEUROL, V212, P307, DOI 10.1016/j.expneurol.2008.04.004; JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jenner P, 2006, NEUROLOGY, V66, pS24, DOI 10.1212/WNL.66.10_suppl_4.S24; Johnson ME, 2015, NEUROTOXICOLOGY, V46, P101, DOI 10.1016/j.neuro.2014.12.002; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; Matigian N, 2010, DIS MODEL MECH, V3, P785, DOI 10.1242/dmm.005447; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Murai M, 2006, BIOCHEMISTRY-US, V45, P9778, DOI 10.1021/bi060713f; MUSANTI R, 1993, BIOCHEM MED METAB B, V49, P133, DOI 10.1006/bmmb.1993.1016; MYTILINEOU C, 1994, J NEURAL TRANSM-PARK, V8, P223, DOI 10.1007/BF02260943; Okano H, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-22; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Schapira AHV, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/159160; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Schule B, 2009, BBA-MOL BASIS DIS, V1792, P1043, DOI 10.1016/j.bbadis.2009.08.014; Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Tatton WG, 1998, ANN NEUROL, V44, pS134, DOI 10.1002/ana.410440720; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Wiedemann FR, 1999, ANN NY ACAD SCI, V893, P426, DOI 10.1111/j.1749-6632.1999.tb07870.x; Winkler-Stuck K, 2004, J NEUROL SCI, V220, P41, DOI 10.1016/j.jns.2004.02.003	63	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154544	10.1371/journal.pone.0154544	http://dx.doi.org/10.1371/journal.pone.0154544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123847	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700103
J	Faber, TW; van Elk, M; Jonas, KJ				Faber, Tim W.; van Elk, Michiel; Jonas, Kai J.			Complementary Hand Responses Occur in Both Peri- and Extrapersonal Space	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; AUTOMATIC IMITATION; MOTOR IMAGERY; JOINT ACTION; COMPATIBILITY; OBJECTS; SIMULATION; ERP	Human beings have a strong tendency to imitate. Evidence from motor priming paradigms suggests that people automatically tend to imitate observed actions such as hand gestures by performing mirror-congruent movements (e.g., lifting one's right finger upon observing a left finger movement; from a mirror perspective). Many observed actions however, do not require mirror-congruent responses but afford complementary (fitting) responses instead (e.g., handing over a cup; shaking hands). Crucially, whereas mirror-congruent responses don't require physical interaction with another person, complementary actions often do. Given that most experiments studying motor priming have used stimuli devoid of contextual information, this space or interaction-dependency of complementary responses has not yet been assessed. To address this issue, we let participants perform a task in which they had to mirror or complement a hand gesture (fist or open hand) performed by an actor depicted either within or outside of reach. In three studies, we observed faster reaction times and less response errors for complementary relative to mirrored hand movements in response to open hand gestures (i.e., 'hand-shaking') irrespective of the perceived interpersonal distance of the actor. This complementary effect could not be accounted for by a low-level spatial cueing effect. These results demonstrate that humans have a strong and automatic tendency to respond by performing complementary actions. In addition, our findings underline the limitations of manipulations of space in modulating effects of motor priming and the perception of affordances.	[Faber, Tim W.; van Elk, Michiel; Jonas, Kai J.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Amsterdam	Faber, TW (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	T.W.Faber@uva.nl	Jonas, Kai/AAB-3120-2021	Jonas, Kai/0000-0001-6607-1993; Faber, Tim/0000-0002-7910-6566	Netherlands Organisation for Scientific Research [016.135.135]; Kurt Lewin Institute Graduate School through the Netherlands Organisation for Scientific Research	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Kurt Lewin Institute Graduate School through the Netherlands Organisation for Scientific Research	This work was supported by Netherlands Organisation for Scientific Research (grant recipient MvE; grant number: 016.135.135). TF is supported by the Kurt Lewin Institute Graduate School through the Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini E, 2013, EXP BRAIN RES, V229, P197, DOI 10.1007/s00221-013-3607-0; Bertenthal BI, 2006, J EXP PSYCHOL HUMAN, V32, P210, DOI 10.1037/0096-1523.32.2.210; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Cavallo A, 2014, SOC COGN AFFECT NEUR, V9, P1082, DOI 10.1093/scan/nst085; Cesario J, 2006, J PERS SOC PSYCHOL, V90, P893, DOI 10.1037/0022-3514.90.6.893; Cook R, 2010, J EXP PSYCHOL HUMAN, V36, P840, DOI 10.1037/a0019256; Costantini M, 2011, PSYCHON B REV, V18, P302, DOI 10.3758/s13423-011-0054-4; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; Crostella F, 2009, EXP BRAIN RES, V197, P143, DOI 10.1007/s00221-009-1900-8; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Flach R, 2010, BRIT J PSYCHOL, V101, P739, DOI 10.1348/000712609X484595; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GREENWALD AG, 1970, PSYCHOL REV, V77, P73, DOI 10.1037/h0028689; Heed T, 2010, CURR BIOL, V20, P1345, DOI 10.1016/j.cub.2010.05.068; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Jeannerod M, 1999, CURR OPIN NEUROBIOL, V9, P735, DOI 10.1016/S0959-4388(99)00038-0; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jonas KJ, 2006, J PERS SOC PSYCHOL, V90, P709, DOI 10.1037/0022-3514.90.5.709; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Kourtis D, 2010, BIOL LETTERS, V6, P758, DOI 10.1098/rsbl.2010.0478; LAMBERTS K, 1992, ACTA PSYCHOL, V79, P115, DOI 10.1016/0001-6918(92)90028-C; Liepelt R, 2010, COGNITION, V115, P426, DOI 10.1016/j.cognition.2010.03.003; Love J., 2015, JASP VERSION 0 7; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Obhi SS, 2011, EXP BRAIN RES, V211, P329, DOI 10.1007/s00221-011-2721-0; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; Richardson D. C., 2008, P 30 ANN C COGN SCI, P309; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Sartori L, 2015, CORTEX, V70, P169, DOI 10.1016/j.cortex.2015.01.019; Sartori L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00557; Sartori L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00702; Sartori L, 2013, SOC COGN AFFECT NEUR, V8, P662, DOI 10.1093/scan/nss044; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; Sartori L, 2011, EXP BRAIN RES, V211, P557, DOI 10.1007/s00221-011-2650-y; Schilbach L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00278; Sebanz N, 2006, J COGNITIVE NEUROSCI, V18, P859, DOI 10.1162/jocn.2006.18.5.859; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Shibata T, 2011, J VISION, V11, DOI 10.1167/11.8.11; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Turvey M. T., 1992, ECOL PSYCHOL, V4, P173, DOI [10.1207/s15326969eco0403_3, DOI 10.1207/S15326969EC00403_]; Tversky B., 2005, CAMBRIDGE HDB VISUOS, P1, DOI DOI 10.1017/CBO9780511610448.002; Valdes-Conroy B, 2014, NEUROPSYCHOLOGIA, V59, P27, DOI 10.1016/j.neuropsychologia.2014.04.009; van Dam WO, 2012, HUM BRAIN MAPP, V33, P2322, DOI 10.1002/hbm.21365; van Elk M, 2009, J EXP PSYCHOL HUMAN, V35, P1118, DOI 10.1037/a0015024; van Schie HT, 2008, J EXP PSYCHOL HUMAN, V34, P1493, DOI 10.1037/a0011750; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson A, 2014, NOTES FROM TWO SCIEN, V10, P8; Wilson AD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00058; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Yu AB, 2014, J EXP PSYCHOL HUMAN, V40, P1861, DOI 10.1037/a0037397	63	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154457	10.1371/journal.pone.0154457	http://dx.doi.org/10.1371/journal.pone.0154457			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120470	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200079
J	Martins, CS; Leitao, RFC; Costa, DVS; Melo, IM; Santos, GS; Lima, V; Baldim, V; Wong, DVT; Bonfim, LE; Melo, CB; de Oliveira, MG; Brito, GAC				Martins, Conceiao S.; Leitao, Renata F. C.; Costa, Deiziane V. S.; Melo, Iracema M.; Santos, Glaylton S.; Lima, Vilma; Baldim, Victor; Wong, Deysi V. T.; Bonfim, Luana E.; Melo, Cintia B.; de Oliveira, Marcelo G.; Brito, Gerly A. C.			Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats	PLOS ONE			English	Article							NITRIC-OXIDE; S-NITROSOGLUTATHIONE; EXPRESSION; PREVENTION; HYDROGEL; SYNTHASE	S-nitrosoglutathione (GSNO) is a nitric oxide (NO) donor, which exerts antioxidant, anti-inflammatory, and microbicidal actions. Intragingival application of GSNO was already shown to decrease alveolar bone loss, inflammation and oxidative stress in an experimental periodontal disease (EPD) model. In the present study, we evaluated the potential therapeutic effect of topical applications of hydroxypropylmethylcellulose (HPMC)/GSNO solutions on EPD in Wistar rats. EPD was induced by placing a sterilized nylon (3.0) thread ligature around the cervix of the second left upper molar of the animals, which received topical applications of a HPMC solutions containing GSNO 2 or 10 mM or vehicle (HPMC solution), 1 h prior to the placement of the ligature and then twice daily until sacrifice on day 11. Treatment with HPMC/ GSNO 10 mM solution significantly reduced alveolar bone loss, oxidative stress and TNF-alpha e IL-1 beta levels in the surrounding gingival tissue, and led to a decreased transcription of RANK and TNF-alpha genes and elevated bone alkaline phosphatase, compared to the HPMC group. In conclusion, topical application of HPMC/GSNO solution is a potential treatment to reduce inflammation and bone loss in periodontal disease.	[Martins, Conceiao S.; Leitao, Renata F. C.; Costa, Deiziane V. S.; Santos, Glaylton S.; Bonfim, Luana E.; Melo, Cintia B.; Brito, Gerly A. C.] Univ Fed Ceara, Postgrad Program Morphofunct Sci, Dept Morphol, Sch Med, Fortaleza, Ceara, Brazil; [Melo, Iracema M.] Univ Fed Ceara, Dept Clin Dent, Fac Pharm Dent & Nursing, Sch Dent, Fortaleza, Ceara, Brazil; [Lima, Vilma; Wong, Deysi V. T.] Univ Fed Ceara, Dept Physiol & Pharmacol, Sch Med, Fortaleza, Ceara, Brazil; [Baldim, Victor; de Oliveira, Marcelo G.] Univ Estadual Campinas, UNICAMP, Inst Chem, Sao Paulo, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Estadual de Campinas	Brito, GAC (corresponding author), Univ Fed Ceara, Postgrad Program Morphofunct Sci, Dept Morphol, Sch Med, Fortaleza, Ceara, Brazil.; de Oliveira, MG (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Chem, Sao Paulo, Brazil.	mgo@iqm.unicamp; gerlybrito@hotmail.com	Lima, Vilma/ABE-8964-2020; de Castro Brito, Gerly Anne/C-8597-2013; Leitao, Renata/ABG-7682-2020; Costa, Deiziane VS/C-4727-2017; Brito, Gerly/AHB-3965-2022; Wong, Deysi Viviana Tenazoa/AAH-3575-2020; Leitao, Renata/ABF-9158-2020; de Oliveira, Marcelo/B-4709-2013; Leitão, Renata FC/GQI-3555-2022	Lima, Vilma/0000-0002-8652-4133; de Castro Brito, Gerly Anne/0000-0002-8214-4379; Costa, Deiziane VS/0000-0001-6402-8908; Brito, Gerly/0000-0002-8214-4379; Wong, Deysi Viviana Tenazoa/0000-0002-9741-7560; de Oliveira, Marcelo/0000-0002-9371-9975; Leitão, Renata FC/0000-0003-0202-771X; Martins, Conceicao/0000-0001-8710-1856; Baldim, Victor/0000-0002-3003-7328	National Council for Scientific and Technological Development - CNPq [478380/2011-9, 309390/2011-7]	National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Leitao RFC and de Oliveira MG would like to acknowledge grants from The National Council for Scientific and Technological Development - CNPq (http://www.cnpq.br/) (projects #478380/2011-9 and 309390/2011-7, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P6876, DOI 10.1021/bi010066m; de Menezes AMA, 2012, J PERIODONTOL, V83, P514, DOI 10.1902/jop.2011.110332; Assuma R, 1998, J IMMUNOL, V160, P403; Bayer E A, 1980, Methods Biochem Anal, V26, P1; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Cariello AJ, 2010, J ANTIMICROB CHEMOTH, V65, P588, DOI 10.1093/jac/dkp485; Chae HJ, 1997, J PHARM PHARMACOL, V49, P897, DOI 10.1111/j.2042-7158.1997.tb06132.x; Chiueh CC, 1999, FREE RADICAL RES, V31, P641, DOI 10.1080/10715769900301211; COLASANTI M, 1995, J BIOL CHEM, V270, P26731, DOI 10.1074/jbc.270.45.26731; Dahiya Parveen, 2013, J Indian Soc Periodontol, V17, P411, DOI 10.4103/0972-124X.118306; de Lima V, 2000, EUR J ORAL SCI, V108, P123, DOI 10.1034/j.1600-0722.2000.00766.x; Simoes MMDG, 2010, J BIOMED MATER RES B, V93B, P416, DOI 10.1002/jbm.b.31598; DING AH, 1988, J IMMUNOL, V141, P2407; Fini M, 2001, BIOMED PHARMACOTHER, V55, P213, DOI 10.1016/S0753-3322(01)00054-3; de Souza GFP, 2006, NITRIC OXIDE-BIOL CH, V15, P209, DOI 10.1016/j.niox.2006.01.011; Fyfe CA, 1997, MACROMOLECULES, V30, P6230, DOI 10.1021/ma970076o; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P1349, DOI 10.1177/29.11.6172466; Joshi MS, 1999, FREE RADICAL BIO MED, V27, P1357, DOI 10.1016/S0891-5849(99)00179-3; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kinney JS, 2007, ANN NY ACAD SCI, V1098, P230, DOI 10.1196/annals.1384.028; Kuhr A, 2004, J PERIODONTAL RES, V39, P101, DOI 10.1111/j.1600-0765.2004.00710.x; Leitao RFC, 2005, J PERIODONTOL, V76, P956, DOI 10.1902/jop.2005.76.6.956; Leitao RFC, 2004, J PERIODONTOL, V75, P1227, DOI 10.1902/jop.2004.75.9.1227; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Raitapuro-Murray T, 2014, BRIT DENT J, V217, P459, DOI 10.1038/sj.bdj.2014.908; SALLAY K, 1982, J PERIODONTAL RES, V17, P263, DOI 10.1111/j.1600-0765.1982.tb01153.x; Schanuel FS, 2015, COLLOID SURFACE B, V130, P182, DOI 10.1016/j.colsurfb.2015.04.007; Silva SMC, 2008, J COLLOID INTERF SCI, V327, P333, DOI 10.1016/j.jcis.2008.08.056; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Skeff MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113378; Tay JYY, 2004, J DENT RES, V83, P349, DOI 10.1177/154405910408300415; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; WHITBY LG, 1975, CLIN CHIM ACTA, V59, P361, DOI 10.1016/0009-8981(75)90012-1; Wimalawansa SJ, 1997, BONE, V21, P275, DOI 10.1016/S8756-3282(97)00125-7; Wimalawansa SM, 2001, J MUSCULOSKEL NEURON, V1, P141; Wimalawansa SJ, 2008, EXPERT OPIN PHARMACO, V9, P1935, DOI 10.1517/14656566.9.11.1935 ; Wimalawansa SJ, 2007, ANN NY ACAD SCI, V1117, P283, DOI 10.1196/annals.1402.066; Wimalawansa SJ, 2010, ANN NY ACAD SCI, V1192, P391, DOI 10.1111/j.1749-6632.2009.05230.x; Zhang M, 2010, SCI CHINA LIFE SCI, V53, P112, DOI 10.1007/s11427-010-0013-8	45	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153716	10.1371/journal.pone.0153716	http://dx.doi.org/10.1371/journal.pone.0153716			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116554	Green Published, gold			2022-12-26	WOS:000374973600028
J	Prasai, TP; Walsh, KB; Bhattarai, SP; Midmore, DJ; Van, TTH; Moore, RJ; Stanley, D				Prasai, Tanka P.; Walsh, Kerry B.; Bhattarai, Surya P.; Midmore, David J.; Van, Thi T. H.; Moore, Robert J.; Stanley, Dragana			Biochar, Bentonite and Zeolite Supplemented Feeding of Layer Chickens Alters Intestinal Microbiota and Reduces Campylobacter Load	PLOS ONE			English	Article							ENTEROCOCCUS-CECORUM; HELICOBACTER PULLORUM; DIETARY INCLUSION; SODIUM BENTONITE; GROWTH PROMOTERS; LIVER-DISEASE; LAYING HENS; BROILER; PERFORMANCE; SEPIOLITE	A range of feed supplements, including antibiotics, have been commonly used in poultry production to improve health and productivity. Alternative methods are needed to suppress pathogen loads and maintain productivity. As an alternative to antibiotics use, we investigated the ability of biochar, bentonite and zeolite as separate 4% feed additives, to selectively remove pathogens without reducing microbial richness and diversity in the gut. Neither biochar, bentonite nor zeolite made any significant alterations to the overall richness and diversity of intestinal bacterial community. However, reduction of some bacterial species, including some potential pathogens was detected. The microbiota of bentonite fed animals were lacking all members of the order Campylobacterales. Specifically, the following operational taxonomic units (OTUs) were absent: an OTU 100% identical to Campylobacter jejuni; an OTU 99% identical to Helicobacter pullorum; multiple Gallibacterium anatis (> 97%) related OTUs; Bacteroides dorei (99%) and Clostridium aldenense (95%) related OTUs. Biochar and zeolite treatments had similar but milder effects compared to bentonite. Zeolite amended feed was also associated with significant reduction in the phylum Proteobacteria. All three additives showed potential for the control of major poultry zoonotic pathogens.	[Prasai, Tanka P.; Walsh, Kerry B.; Bhattarai, Surya P.; Midmore, David J.; Stanley, Dragana] Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld 4702, Australia; [Van, Thi T. H.; Moore, Robert J.] RMIT Univ, Sch Appl Sci, Bundoora, Vic, Australia; [Van, Thi T. H.; Moore, Robert J.] Hlth Innovat Res Inst, Bundoora, Vic, Australia; [Moore, Robert J.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Central Queensland University; Royal Melbourne Institute of Technology (RMIT); Monash University	Stanley, D (corresponding author), Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld 4702, Australia.	D.Stanley@cqu.edu.au	Midmore, David/I-7657-2019; Stanley, Dragana/AAC-2596-2020; Moore, Robert J/D-8352-2011	Midmore, David/0000-0001-9946-5008; Stanley, Dragana/0000-0001-7019-4726; Moore, Robert J/0000-0002-0776-5861; walsh, kerry/0000-0002-3033-8622; Van, Thi Thu Hao/0000-0002-1559-568X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alzueta C, 2002, ANIM FEED SCI TECH, V97, P169, DOI 10.1016/S0377-8401(02)00030-5; ANGULO E, 1995, ANIM FEED SCI TECH, V53, P233, DOI 10.1016/0377-8401(94)00749-Y; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Belmares J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-4; Boerlin P, 2012, VET MICROBIOL, V157, P405, DOI 10.1016/j.vetmic.2012.01.001; CABEZAS MJ, 1991, J CHEM TECHNOL BIOT, V52, P265; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crawshaw TR, 2015, VET MICROBIOL, V179, P315, DOI 10.1016/j.vetmic.2015.06.008; Daimon Yasushi, 2008, Kansenshogaku Zasshi, V82, P205; Dakovic A, 2005, COLLOID SURFACE B, V46, P20, DOI 10.1016/j.colsurfb.2005.08.013; Damiri H, 2010, J ANIM VET ADV, V9, P2668; Davis-Richardson AG, 2015, DIABETOLOGIA, V58, P1386, DOI 10.1007/s00125-015-3614-8; Davis-Richardson AG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00678; De Baere T, 2000, J CLIN MICROBIOL, V38, P3511, DOI 10.1128/JCM.38.9.3511-3512.2000; Delaunay E., 2015, New Microbes and New Infections, V7, P50, DOI 10.1016/j.nmni.2015.06.004; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eleroglu H, 2011, S AFR J ANIM SCI, V41, P319, DOI 10.4314/sajas.v41i4.1; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; FETHIERE R, 1990, POULTRY SCI, V69, P2195, DOI 10.3382/ps.0692195; FETHIERE R, 1994, POULTRY SCI, V73, P118, DOI 10.3382/ps.0730118; Gerlach H., 2012, ITHAKA J, V2012, P262; Greub G, 1997, EUR J CLIN MICROBIOL, V16, P594, DOI 10.1007/BF02447923; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Hansen R, 2011, FEMS IMMUNOL MED MIC, V61, P1, DOI 10.1111/j.1574-695X.2010.00744.x; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Kana JR, 2010, ADV ANIMAL BIOSCIENC, V1, P462, DOI [10.1017/S2040470010000841, DOI 10.1017/S2040470010000841]; Kutlu HR, 2001, ANIM FEED SCI TECH, V90, P213, DOI 10.1016/S0377-8401(01)00205-X; Laharie D, 2009, ALIMENT PHARM THER, V30, P283, DOI 10.1111/j.1365-2036.2009.04034.x; Lin J, 2013, FOODBORNE PATHOG DIS, V10, P331, DOI 10.1089/fpd.2012.1348; Lone AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075325; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Moghaddam H. N., 2008, Journal of Biological Sciences, V8, P328; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Neubauer C, 2009, AVIAN PATHOL, V38, P1, DOI 10.1080/03079450802577848; Olver M, 1983, S AFRICAN J ANIMAL S; Olver MD, 1997, BRIT POULTRY SCI, V38, P220, DOI 10.1080/00071669708417973; Ouhida I, 2000, ANIM FEED SCI TECH, V85, P183, DOI 10.1016/S0377-8401(00)00148-6; Papaioannou D, 2005, MICROPOR MESOPOR MAT, V84, P161, DOI 10.1016/j.micromeso.2005.05.030; Papaioannou DS, 2002, RES VET SCI, V72, P61, DOI 10.1053/rvsc.2001.0524; Parisini P, 1999, ANIM FEED SCI TECH, V79, P155, DOI 10.1016/S0377-8401(99)00008-5; Pasha TN, 2007, ANIM FEED SCI TECH, V132, P103, DOI 10.1016/j.anifeedsci.2006.03.014; Paudel S, 2014, AVIAN PATHOL, V43, P443, DOI 10.1080/03079457.2014.955782; Prvulovic D, 2008, TURK J VET ANIM SCI, V32, P183; Ruttanavut J., 2009, International Journal of Poultry Science, V8, P229; Safaeikatouli M, 2010, INT J AGRIC BIOL, V12, P877; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; STANLEY J, 1994, MICROBIOL-UK, V140, P3441, DOI 10.1099/13500872-140-12-3441; Steinbrueckner B, 1997, SCAND J INFECT DIS, V29, P315, DOI 10.3109/00365549709019053; Uchida T, 1992, Hinyokika Kiyo, V38, P973; Veijola L, 2007, ANN MED, V39, P554, DOI 10.1080/07853890701545714; Williams OM, 2010, ANAEROBE, V16, P475, DOI 10.1016/j.anaerobe.2010.08.004; Xia MS, 2004, POULTRY SCI, V83, P1868, DOI 10.1093/ps/83.11.1868	57	47	51	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154061	10.1371/journal.pone.0154061	http://dx.doi.org/10.1371/journal.pone.0154061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116607	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600041
J	Chen, Y; Fang, F; Hu, Y; Liu, Q; Bu, DF; Tan, M; Wu, LS; Zhu, P				Chen, Yan; Fang, Fang; Hu, Yang; Liu, Qian; Bu, Dingfang; Tan, Mei; Wu, Liusong; Zhu, Ping			The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; JAK2 EXON-12 MUTATIONS; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; IDIOPATHIC ERYTHROCYTOSIS; ACTIVATING MUTATION; MYELOID METAPLASIA; BLOOD-PRESSURE; MPL MUTATIONS	Objective LNK is an adapter protein negatively regulating the JAK/STAT cell signaling pathway. In this study, we observed the correlation between variation in LNK gene and the clinical type of myeloproliferative neoplasms (MPN). Methods A total of 285 MPN cases were recruited, including essential thrombocythemia (ET) 154 cases, polycythemia vera (PV) 76 cases, primary myelofibrosis (PMF) 19 cases, and chronic myeloid leukemia (CML) 36 cases. Ninety-three healthy individuals were used as normal controls. V617F mutation in JAK2 was identified by allele-specific PCR method, RTPCR was used for the detection of BCR/ABL1 fusion gene, and mutations and variations in coding exons and their flanking sequences of LNK gene were examined by PCR-sequencing. Results Missense mutations of A300V, V402M, and R415H in LNK were found in 8 patients including ET (4 cases, all combined with JAK2-V617F mutation), PV (2 cases, one combined with JAK2-V617F mutation), PMF (one case, combined with JAK2-V617F mutation) and CML (one case, combined with BCR/ABL1 fusion gene). The genotype and allele frequencies of the three SNPs (rs3184504, rs111340708 and rs78894077) in LNK were significantly different between MPN patients and controls. For rs3184504 (T/C, in exon2), the T allele (p.262W) and TT genotype were frequently seen in ET, PV and PMF (P< 0.01), and C allele (p.262R) and CC genotype were frequently seen in CML (P< 0.01). For rs78894077 (T/C, in exon1), the T allele (p.242S) was frequently found in ET (P< 0.05). For rs111340708 (TGGGGx5/TGGGGx4, in intron 5), the TGGGG x4 allele was infrequently found in ET, PMF and CML(P< 0.01). Conclusion Mutations in LNK could be found in some of MPN patients in the presence or absence of JAK2-V617F mutation. Several polymorphisms in LNK gene may affect the clinical type or the genetic predisposition of MPN.	[Chen, Yan; Fang, Fang; Hu, Yang; Liu, Qian; Bu, Dingfang; Zhu, Ping] Peking Univ, Dept Hematol, Hosp 1, Beijing 100871, Peoples R China; [Chen, Yan; Tan, Mei; Wu, Liusong] Zunyi Med Coll, Affiliated Hosp, Zunyi, Guizhou, Peoples R China	Peking University; Zunyi Medical University	Zhu, P (corresponding author), Peking Univ, Dept Hematol, Hosp 1, Beijing 100871, Peoples R China.	zhuping@bjmu.edu.cn		Fang, Fang/0000-0002-0338-5466	National Natural Science Foundation of China [81370612]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the National Natural Science Foundation of China (Grant No. 81370612).	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellosillo B, 2007, LEUKEMIA, V21, P1331, DOI 10.1038/sj.leu.2404649; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Bersenev A, 2010, J CLIN INVEST, V120, P2058, DOI 10.1172/JCI42032; Cario H, 2005, BRIT J HAEMATOL, V130, P800, DOI 10.1111/j.1365-2141.2005.05683.x; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Landgren O, 2008, BLOOD, V112, P2199, DOI 10.1182/blood-2008-03-143602; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; LEVINE RL, 2006, HEMATOL-AM SOC HEMAT, V510, P233, DOI DOI 10.1182/ASHEDUCATI0N-2006.1.233; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu Hong-xing, 2009, Zhonghua Yi Xue Za Zhi, V89, P220; Martinez-Aviles L, 2007, HAEMATOLOGICA, V92, P1717, DOI 10.3324/haematol.12011; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Olcaydu D, 2011, HAEMATOL-HEMATOL J, V96, P367, DOI 10.3324/haematol.2010.034488; Pardanani A, 2010, LEUKEMIA, V24, P1713, DOI 10.1038/leu.2010.163; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Ranjan A, 2013, CLIN GENET, V83, P99, DOI 10.1111/cge.12044; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Saint-Martin C, 2009, BLOOD, V114, P1628, DOI 10.1182/blood-2009-01-197525; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Tefferi A, 2008, LEUKEMIA LYMPHOMA, V49, P388, DOI 10.1080/10428190801895360; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Tong W, 2004, J EXP MED, V200, P569, DOI 10.1084/jem.20040762; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883	36	15	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154183	10.1371/journal.pone.0154183	http://dx.doi.org/10.1371/journal.pone.0154183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111338	Green Submitted, Green Published, gold			2022-12-26	WOS:000374970600043
J	Vogt, LJ; Steveling, A; Meffert, PJ; Kromrey, ML; Kessler, R; Hosten, N; Kruger, J; Gartner, S; Aghdassi, AA; Mayerle, J; Lerch, MM; Kehn, JP				Vogt, Lena J.; Steveling, Antje; Meffert, Peter J.; Kromrey, Marie-Luise; Kessler, Rebecca; Hosten, Norbert; Krueger, Janine; Gaertner, Simone; Aghdassi, Ali A.; Mayerle, Julia; Lerch, Markus M.; Kuehn, Jens-Peter			Magnetic Resonance Imaging of Changes in Abdominal Compartments in Obese Diabetics during a Low-Calorie Weight-Loss Program	PLOS ONE			English	Article							FATTY LIVER-DISEASE; BETA-CELL FUNCTION; BONE-MARROW FAT; INSULIN SENSITIVITY; METABOLIC SYNDROME; QUANTIFICATION; DIET; SARCOPENIA; ADIPOSITY; PANCREAS	Objectives To investigate changes in the fat content of abdominal compartments and muscle area during weight loss using confounder-adjusted chemical-shift-encoded magnetic resonance imaging (MRI) in overweight diabetics. Methods Twenty-nine obese diabetics (10/19 men/women, median age: 59.0 years, median body mass index (BMI): 34.0 kg/m(2)) prospectively joined a standardized 15-week weight-loss program (six weeks of formula diet exclusively, followed by reintroduction of regular food with gradually increasing energy content over nine weeks) over 15 weeks. All subjects underwent a standardized MRI protocol including a confounder-adjusted chemical-shift-encoded MR sequence with water/fat separation before the program as well at the end of the six weeks of formula diet and at the end of the program at 15 weeks. Fat fractions of abdominal organs and vertebral bone marrow as well as volumes of visceral and subcutaneous fat were determined. Furthermore, muscle area was evaluated using the L4/L5 method. Data were compared using the Wilcoxon signed-rank test for paired samples. Results Median BMI decreased significantly from 34.0 kg/m(2) to 29.9 kg/m(2) (p < 0.001) at 15 weeks. Liver fat content was normalized (14.2% to 4.1%, p < 0.001) and vertebral bone marrow fat (57.5% to 53.6%, p = 0.018) decreased significantly throughout the program, while fat content of pancreas (9.0%), spleen (0.0%), and psoas muscle (0.0%) did not (p > 0.15). Visceral fat volume (3.2 L to 1.6 L, p < 0.001) and subcutaneous fat diameter (3.0 cm to 2.2 cm, p < 0.001) also decreased significantly. Muscle area declined by 6.8% from 243.9 cm(2) to 226.8 cm(2). Conclusion MRI allows noninvasive monitoring of changes in abdominal compartments during weight loss. In overweight diabetics, weight loss leads to fat reduction in abdominal compartments, such as visceral fat, as well as liver fat and vertebral bone marrow fat while pancreas fat remains unchanged.	[Vogt, Lena J.; Steveling, Antje; Krueger, Janine; Gaertner, Simone; Aghdassi, Ali A.; Mayerle, Julia; Lerch, Markus M.] Univ Med Greifswald, Dept Med A, Greifswald, Germany; [Meffert, Peter J.] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Kromrey, Marie-Luise; Kessler, Rebecca; Hosten, Norbert; Kuehn, Jens-Peter] Univ Med Greifswald, Dept Radiol & Neuroradiol, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Kehn, JP (corresponding author), Univ Med Greifswald, Dept Radiol & Neuroradiol, Greifswald, Germany.	kuehn@uni-greifswald.de	Lerch, Markus M./E-2206-2016; Aghdassi, Ali/X-5836-2019; Mayerle, Julia/W-7907-2019	Lerch, Markus M./0000-0002-9643-8263; Aghdassi, Ali/0000-0002-0569-7316; Mayerle, Julia/0000-0002-3666-6459	University Medicine Greifswald through an unrestricted educational grant from Baxter Deutschland GmbH (Unterschleissheim, Germany); Medinal GmbH (Greven, Germany); Nutricia GmbH (Erlangen, Germany); Nestle HealthCare Science GmbH	University Medicine Greifswald through an unrestricted educational grant from Baxter Deutschland GmbH (Unterschleissheim, Germany); Medinal GmbH (Greven, Germany); Nutricia GmbH (Erlangen, Germany)(Danone Nutricia); Nestle HealthCare Science GmbH(Nestle SA)	Two authors of this manuscript declare relationships with the following companies: LJV and JK received a Gerhard Domagk scholarship from University Medicine Greifswald made possible through an unrestricted educational grant from Baxter Deutschland GmbH (Unterschleissheim, Germany), Medinal GmbH (Greven, Germany) and Nutricia GmbH (Erlangen, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors have no conflict of interests. In addition, this study has received funding by Nestle HealthCare Science GmbH. The standardized weight-loss program OPTIFAST (R) was used with the consent of Nestle HealthCare Science GmbH. Nestle HealthCare Science GmbH supported the study by granting study participants a 15% discount for the formula diet.	Artz NS, 2015, J MAGN RESON IMAGING, V42, P811, DOI 10.1002/jmri.24842; Asrih M, 2013, J ENDOCRINOL, V218, pR25, DOI 10.1530/JOE-13-0201; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Bischoff SC, 2012, INT J OBESITY, V36, P614, DOI 10.1038/ijo.2011.107; Chang Jerry S, 2006, AJR Am J Roentgenol, V187, pW103, DOI 10.2214/AJR.05.0695; Colles SL, 2006, AM J CLIN NUTR, V84, P304; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Dixon JB, 2004, HEPATOLOGY, V39, P1647, DOI 10.1002/hep.20251; Durand F, 2014, J HEPATOL, V60, P1151, DOI 10.1016/j.jhep.2014.02.026; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fazeli PK, 2010, J CLIN ENDOCR METAB, V95, P407, DOI 10.1210/jc.2009-1152; Fock KM, 2013, J GASTROEN HEPATOL, V28, P59, DOI 10.1111/jgh.12407; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Gastaldelli A, 2002, J CLIN ENDOCR METAB, V87, P5098, DOI 10.1210/jc.2002-020696; Guiu B, 2009, RADIOLOGY, V250, P95, DOI 10.1148/radiol.2493080217; Idoate F, 2015, EUR RADIOL, V25, P2163, DOI 10.1007/s00330-014-3555-5; Iozzo P, 2003, J CLIN ENDOCR METAB, V88, P2055, DOI 10.1210/jc.2002-021446; Kang GH, 2011, J MAGN RESON IMAGING, V34, P928, DOI 10.1002/jmri.22701; Kim HK, 2009, AM J MED SCI, V337, P98, DOI 10.1097/MAJ.0b013e3181812879; Kuhn JP, 2015, RADIOLOGY, V276, P129, DOI 10.1148/radiol.15140446; Kuhn JP, 2014, J MAGN RESON IMAGING, V40, P875, DOI 10.1002/jmri.24457; Kuhn JP, 2014, J MAGN RESON IMAGING, V39, P1494, DOI 10.1002/jmri.24289; Kuhn JP, 2012, RADIOLOGY, V265, P133, DOI 10.1148/radiol.12112520; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Lewis MC, 2006, OBES SURG, V16, P697, DOI 10.1381/096089206777346682; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; Liu CY, 2007, MAGN RESON MED, V58, P354, DOI 10.1002/mrm.21301; Marceau P, 1999, J CLIN ENDOCR METAB, V84, P1513, DOI 10.1210/jc.84.5.1513; Masuda T, 2014, LIVER TRANSPLANT, V20, P401, DOI 10.1002/lt.23811; Meisamy S, 2011, RADIOLOGY, V258, P767, DOI 10.1148/radiol.10100708; Oza N, 2009, J GASTROENTEROL, V44, P1203, DOI 10.1007/s00535-009-0115-x; Patsch JM, 2013, J BONE MINER RES, V28, P1721, DOI 10.1002/jbmr.1950; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Poonawalla AH, 2013, J MAGN RESON IMAGING, V37, P707, DOI 10.1002/jmri.23846; Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741; Reeder SB, 2010, MAGN RESON IMAGING C, V18, P337, DOI 10.1016/j.mric.2010.08.013; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rossi AP, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.5; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Schafer AL, 2015, BONE, V74, P140, DOI 10.1016/j.bone.2015.01.010; Shah K, 2009, OBESITY, V17, P2162, DOI 10.1038/oby.2009.126; Snel M, 2012, OBESITY, V20, P1572, DOI 10.1038/oby.2011.390; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Tsien C, 2013, EUR J GASTROEN HEPAT, V25, P85, DOI 10.1097/MEG.0b013e328359a759; Tushuizen ME, 2007, DIABETES CARE, V30, P2916, DOI 10.2337/dc07-0326; van Geenen EJM, 2010, PANCREAS, V39, P1185, DOI 10.1097/MPA.0b013e3181f6fce2; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Viljanen APM, 2009, J CLIN ENDOCR METAB, V94, P50, DOI 10.1210/jc.2008-1689; Wechsler JG, 2011, ADIPOSITAS, V5, P89; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WHO, 2000, OB PREV MAN GLOB EP; Yip C, 2014, EUR RADIOL, V24, P998, DOI 10.1007/s00330-014-3110-4; Yokoo T, 2011, RADIOLOGY, V258, P749, DOI 10.1148/radiol.10100659; Yu HZ, 2007, J MAGN RESON IMAGING, V26, P1153, DOI 10.1002/jmri.21090	58	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153595	10.1371/journal.pone.0153595	http://dx.doi.org/10.1371/journal.pone.0153595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110719	Green Published, Green Submitted, gold			2022-12-26	WOS:000374970600018
J	Cunha, LP; Lopes, LC; Costa-Cunha, LVF; Costa, CF; Pires, LA; Almeida, ALM; Monteiro, MLR				Cunha, Leonardo Provetti; Lopes, Luciana Cheker; Ferreira Costa-Cunha, Luciana Virgnia; Costa, Carolina Ferreira; Pires, Leopoldo Antonio; Maciel Almeida, Ana Laura; Ribeiro Monteiro, Myrio Luiz			Macular Thickness Measurements with Frequency Domain-OCT for Quantification of Retinal Neural Loss and its Correlation with Cognitive Impairment in Alzheimer's Disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; PSEUDOTUMOR CEREBRI SYNDROME; PATTERN ELECTRORETINOGRAM; NEUROMYELITIS-OPTICA; CHIASMAL COMPRESSION; AUTOMATED PERIMETRY; CHRONIC PAPILLEDEMA; MULTIPLE-SCLEROSIS; ABNORMALITIES	Purpose To evaluate the ability of frequency domain optical coherence tomography (fd-OCT) to estimate retinal neural loss in eyes with Alzheimer's disease (AD). We also verified the existence of a correlation between AD-related cognitive impairment and macular and peripapillary retinal nerve fiber layer (RNFL) thickness measurements. Methods fd-OCT scans were obtained from 45 eyes of 24 patients with AD and 48 control eyes. Peripapillary RNFL, macular full-thickness and segmented inner macular thickness parameters were calculated. The inner macular parameters included macular retinal nerve fiber layer (mRNFL) thickness, ganglion cell layer (GCL) plus inner plexiform layer thickness (GCL+), and RNFL plus GCL+ thickness (GCL++). The Mini-Mental State Examination (MMSE) was used to assess cognition in all subjects. The two groups were compared and the relationship between MMSE scores and fd-OCT measurements was verified. Results Average, superior and inferior quadrant RNFL thickness parameters and all but one of the nine full-thickness macular measurements were significantly reduced in AD patients compared to controls. The segmented layers, GCL+ and GCL++ were significantly reduced in AD eyes. A significant correlation was found between most fd-OCT parameters (especially macular thickness measurements) and MMSE scores. Conclusions Most fd-OCT peripapillary RNFL and macular full-thickness and segmented inner retinal layers parameters were reduced in AD eyes compared to controls. Moreover, neuronal loss, especially as reflected in macular parameters, correlated well with cognitive impairment in AD. Our results suggest that fd-OCT could be a potentially useful diagnostic tool in the evaluation and follow-up of AD patients.	[Cunha, Leonardo Provetti; Lopes, Luciana Cheker] Univ Fed Juiz de Fora, Sch Med, Dept Ophtalmol, Juiz De Fora, MG, Brazil; [Cunha, Leonardo Provetti; Ferreira Costa-Cunha, Luciana Virgnia; Costa, Carolina Ferreira] Juiz de Fora Eye Hosp, Juiz De Fora, MG, Brazil; [Pires, Leopoldo Antonio; Maciel Almeida, Ana Laura] Univ Fed Juiz de Fora, Dept Neurol, Sch Med, Juiz De Fora, MG, Brazil; [Ribeiro Monteiro, Myrio Luiz] Univ Sao Paulo, Sch Med, Div Ophtalmol, Sao Paulo, Brazil	Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade de Sao Paulo	Cunha, LP (corresponding author), Univ Fed Juiz de Fora, Sch Med, Dept Ophtalmol, Juiz De Fora, MG, Brazil.; Cunha, LP (corresponding author), Juiz de Fora Eye Hosp, Juiz De Fora, MG, Brazil.	leonardo_provetti@yahoo.com.br	Lopes-Júnior, Luís Carlos/B-8540-2015; MONTEIRO, MARIO L R/C-8891-2012; Cunha, Leonardo/AAD-3573-2019	Lopes-Júnior, Luís Carlos/0000-0002-2424-6510; MONTEIRO, MARIO L R/0000-0002-7281-2791; Cunha, Leonardo/0000-0001-7984-1790	LPC Programas Institucionais de Bolsas de Iniciacao Cientifica : XXVII BIC/UFJF, Universidade Federal de Juiz de Fora, Minas Gerais, Brazil [30997]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brasilia, Brazil [307393/2014-3]	LPC Programas Institucionais de Bolsas de Iniciacao Cientifica : XXVII BIC/UFJF, Universidade Federal de Juiz de Fora, Minas Gerais, Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	LPC Programas Institucionais de Bolsas de Iniciacao Cientifica : XXVII BIC/UFJF - 2014/2015 (number 30997), Universidade Federal de Juiz de Fora, Minas Gerais, Brazil. (http://www.ufjf.br/propesq) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MLRM Grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (number 307393/2014-3), Brasilia, Brazil (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2015, INVEST OPHTH VIS SCI, V56, P3656, DOI 10.1167/iovs.15-16768; Alexandrov PN, 2011, NEUROREPORT, V22, P623, DOI 10.1097/WNR.0b013e3283497334; Armstrong RA, 1996, OPTOMETRY VISION SCI, V73, P677, DOI 10.1097/00006324-199611000-00001; Ascaso FJ, 2014, J NEUROL, V261, P1522, DOI 10.1007/s00415-014-7374-z; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; Blanks JC, 1996, NEUROBIOL AGING, V17, P377, DOI 10.1016/0197-4580(96)00010-3; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Coppola G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134750; CRONINGOLOMB A, 1995, GERONTOLOGIST, V35, P370, DOI 10.1093/geront/35.3.370; CRONINGOLOMB A, 1991, ANN NEUROL, V29, P41, DOI 10.1002/ana.410290110; CURCIO CA, 1993, ANN NEUROL, V33, P248, DOI 10.1002/ana.410330305; DAVIES DC, 1995, BRIT J OPHTHALMOL, V79, P596, DOI 10.1136/bjo.79.6.596; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; Fernandes DB, 2013, OPHTHALMOLOGY, V120, P387, DOI 10.1016/j.ophtha.2012.07.066; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gao LY, 2015, ARCH GERONTOL GERIAT, V60, P162, DOI 10.1016/j.archger.2014.10.011; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Hood DC, 2014, INVEST OPHTH VIS SCI, V55, P632, DOI 10.1167/iovs.13-13130; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Kirbas S, 2013, J NEURO-OPHTHALMOL, V33, P58, DOI 10.1097/WNO.0b013e318267fd5f; Kromer Robert, 2014, Front Psychiatry, V5, P22, DOI 10.3389/fpsyt.2014.00022; Liu DC, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0268-6; Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Monteiro MLR, 2014, EYE, V28, P390, DOI 10.1038/eye.2013.301; Monteiro MLR, 2014, INVEST OPHTH VIS SCI, V55, P3328, DOI 10.1167/iovs.14-14118; Monteiro MLR, 2012, INVEST OPHTH VIS SCI, V53, P3959, DOI 10.1167/iovs.11-9324; Monteiro MLR, 2009, INVEST OPHTH VIS SCI, V50, P3535, DOI 10.1167/iovs.08-3093; MORRISON JH, 1991, ANN NY ACAD SCI, V640, P36; Moschos MM, 2012, CURR ALZHEIMER RES, V9, P782; Oktem EO, 2015, NEUROL SCI, V36, P1141, DOI 10.1007/s10072-014-2055-3; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; SADUN AA, 1990, OPHTHALMOLOGY, V97, P9; Shi ZY, 2014, J ALZHEIMERS DIS, V40, P277, DOI 10.3233/JAD-131898; Tatrai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030922; Warner CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022947	40	55	55	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153830	10.1371/journal.pone.0153830	http://dx.doi.org/10.1371/journal.pone.0153830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104962	gold, Green Published, Green Submitted			2022-12-26	WOS:000374565100024
J	Talbot, SL; Sage, GK; Rearick, JR; Fowler, MC; Muniz-Salazar, R; Baibak, B; Wyllie-Echeverria, S; Cabello-Pasini, A; Ward, DH				Talbot, Sandra L.; Sage, George K.; Rearick, Jolene R.; Fowler, Meg C.; Muniz-Salazar, Raquel; Baibak, Bethany; Wyllie-Echeverria, Sandy; Cabello-Pasini, Alejandro; Ward, David H.			The Structure of Genetic Diversity in Eelgrass (Zostera marina L.) along the North Pacific and Bering Sea Coasts of Alaska	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; POPULATION-STRUCTURE; MICROSATELLITE LOCI; GLACIAL REFUGIA; HETEROZOSTERA ZOSTERACEAE; HYDROPHILOUS ANGIOSPERMS; REPRODUCTIVE STRATEGIES; GEOGRAPHIC DISTANCE; COALESCENT APPROACH; COMPUTER-PROGRAM	Eelgrass (Zostera marina) populations occupying coastal waters of Alaska are separated by a peninsula and island archipelago into two Large Marine Ecosystems (LMEs). From populations in both LMEs, we characterize genetic diversity, population structure, and polarity in gene flow using nuclear microsatellite fragment and chloroplast and nuclear sequence data. An inverse relationship between genetic diversity and latitude was observed (heterozygosity: R-2 = 0.738, P < 0.001; allelic richness: R-2 = 0.327, P = 0.047), as was significant genetic partitioning across most sampling sites (theta = 0.302, P < 0.0001). Variance in allele frequency was significantly partitioned by region only in cases when a population geographically in the Gulf of Alaska LME (Kinzarof Lagoon) was instead included with populations in the Eastern Bering Sea LME (theta(p) = 0.128-0.172; P < 0.003), suggesting gene flow between the two LMEs in this region. Gene flow among locales was rarely symmetrical, with notable exceptions generally following net coastal ocean current direction. Genetic data failed to support recent proposals that multiple Zostera species (i.e. Z. japonica and Z. angustifolia) are codistributed with Z. marina in Alaska. Comparative analyses also failed to support the hypothesis that eelgrass populations in the North Atlantic derived from eelgrass retained in northeastern Pacific Last Glacial Maximum refugia. These data suggest northeastern Pacific populations are derived from populations expanding northward from temperate populations following climate amelioration at the terminus of the last Pleistocene glaciation.	[Talbot, Sandra L.; Sage, George K.; Rearick, Jolene R.; Fowler, Meg C.; Ward, David H.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Rearick, Jolene R.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Muniz-Salazar, Raquel] Univ Autonoma Baja California, Escuela Ciencias Salud, Ensenada, Baja California, Mexico; [Baibak, Bethany] Humboldt State Univ, Biol Sci, Arcata, CA 95521 USA; [Wyllie-Echeverria, Sandy] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA; [Wyllie-Echeverria, Sandy] Univ Virgin Islands, Ctr Marine & Environm Studies, St Thomas, VI USA; [Cabello-Pasini, Alejandro] Univ Autonoma Baja California, Inst Invest Oceanol, Tijuana, CA, Mexico	United States Department of the Interior; United States Geological Survey; University of New Mexico; California State University System; California State Polytechnic University, Humboldt; University of Washington; University of the Virgin Islands; Universidad Autonoma de Baja California	Talbot, SL (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA.	stalbot@usgs.gov	MUNIZ-SALAZAR, RAQUEL/F-5309-2019	MUNIZ-SALAZAR, RAQUEL/0000-0001-5528-7772	Alaska Science Center, U.S. Geological Survey; Universidad Autonoma de Baja California [4033, 4023]; Ramsar Convention on Wetlands [WFF/00-2/MEX/3]	Alaska Science Center, U.S. Geological Survey(United States Geological Survey); Universidad Autonoma de Baja California; Ramsar Convention on Wetlands	Funding for this research was provided by the Alaska Science Center, U.S. Geological Survey to SLT, the Universidad Autonoma de Baja California (#4033, #4023) to RMS and ACP and Ramsar Convention on Wetlands (WFF/00-2/MEX/3) to DHW.	Arasaki S., 1950, NIPPON SUISAN GAKK, V16, P70, DOI [10.2331/suisan.16.70, DOI 10.2331/SUISAN.16.70]; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Avise J, 2004, MOL MARKERS NATURAL; BACKMAN TWH, 1991, CAN J BOT, V69, P1361, DOI 10.1139/b91-176; BAKKER FT, 1995, J MOL EVOL, V40, P640, DOI 10.1007/BF00160512; BANDELT HJ, 1995, GENETICS, V141, P743; Barilani M, 2007, CONSERV GENET, V8, P343, DOI 10.1007/s10592-006-9174-1; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Becheler R, 2010, MOL ECOL, V19, P2394, DOI 10.1111/j.1365-294X.2010.04649.x; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bennett, 1997, EVOLUTION ECOLOGY PA; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Brower W. A. Jr., 1988, CLIMATIC ATLAS OUTER, V1; Brower WA, 1988, CLIMATIC ATLAS OUTER, V2; Brower WA, 1977, CLIMATIC ATLAS OF TH, VII; Cabello-Pasini A, 1984, TRANSPLANTES ZOSTERA; Campanella JJ, 2010, J HERED, V101, P61, DOI 10.1093/jhered/esp103; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; COACHMAN LK, 1966, LIMNOL OCEANOGR, V11, P44, DOI 10.4319/lo.1966.11.1.0044; Comps B, 2001, GENETICS, V157, P389; Cope JM, 2004, CAN J FISH AQUAT SCI, V61, P332, DOI 10.1139/F04-008; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Coyer JA, 2008, ANN BOT-LONDON, V101, P73, DOI 10.1093/aob/mcm288; Coyer JA, 2001, J PHYCOL, V37, P574, DOI 10.1046/j.1529-8817.2001.037001574.x; Coyer JA, 2011, J BIOGEOGR, V38, P756, DOI 10.1111/j.1365-2699.2010.02437.x; Coyle KO, 2005, FISH OCEANOGR, V14, P77, DOI 10.1111/j.1365-2419.2005.00367.x; CROOM M, 1995, GLOBAL REPRESENTATIV, V4, P55; Cullis-Suzuki S, 2015, AQUAT BOT, V127, P26, DOI 10.1016/j.aquabot.2015.07.001; DEHEIJ H, 1992, J EXP MAR BIOL ECOL, V161, P1, DOI 10.1016/0022-0981(92)90185-D; den Hartog C., 1970, SEAGRASSES WORLD, V59; den Hartog C., 1975, AQUAT BOT, V1, P141, DOI DOI 10.1016/0304-3770(75)90019-4; DENNISON WC, 1986, J EXP MAR BIOL ECOL, V98, P265, DOI 10.1016/0022-0981(86)90217-0; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Ebbesmeyer C., 2003, FARE FLUNG BATHTUB T; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Elven R, 2005, LIDS NORSK FLORA; Elven R., 2007, 230101 02 ZOSTERA MA; ESRI, ARCGIS DESKT; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eyerdam W, 1971, GREAT ALASKA EARTHQU, P69; Farmer M.W., 1989, Proceedings of the Gulf and Caribbean Fisheries Institute, V39, P318; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Green E. P., 2003, WORLD ATLAS OF SEAGR; Haynes RR, 2000, MAGNOLIOPHYTA ALISMA, V22, P90; HEDGECOCK D, 1986, B MAR SCI, V39, P550; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hickerson MJ, 2005, EVOLUTION, V59, P344; Hogrefe KR, 2014, REMOTE SENS-BASEL, V6, P12447, DOI 10.3390/rs61212447; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Ingraham WJ, 1976, FINAL REPORT 357; Jacobs DK, 2004, ANNU REV EARTH PL SC, V32, P601, DOI 10.1146/annurev.earth.32.092203.122436; Johnson MR, 2003, ESTUARIES, V26, P106, DOI 10.1007/BF02691698; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T., 2014, TUTORIAL DISCRIMINAN, P1; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kallstrom B, 2008, AQUAT BOT, V88, P148, DOI 10.1016/j.aquabot.2007.09.005; Kato Y, 2003, GENES GENET SYST, V78, P329, DOI 10.1266/ggs.78.329; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Ladd C, 2005, FISH OCEANOGR, V14, P22, DOI 10.1111/j.1365-2419.2005.00373.x; Langella O., 2010, POPULATIONS 1 2 30 P; Larned ST, 2003, MAR ECOL PROG SER, V254, P69, DOI 10.3354/meps254069; LAUSHMAN RH, 1993, AQUAT BOT, V44, P147, DOI 10.1016/0304-3770(93)90069-9; Lee KM, 2012, MAR BIOL, V159, P1021, DOI 10.1007/s00227-012-1882-0; LES DH, 1988, ANN MO BOT GARD, V75, P819, DOI 10.2307/2399370; Les DH, 2002, SYST BOT, V27, P468; Lewis PO, 2001, GENETIC DATA ANAL GD; Li WT, 2010, ESTUAR COAST SHELF S, V88, P377, DOI 10.1016/j.ecss.2010.04.017; Lucas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029987; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Malaney JL, 2013, MOL ECOL, V22, P6000, DOI 10.1111/mec.12476; Markgraf F., 1972, TAXON, V21, P715; Markgraf F, 1981, NEW FLORA BRIT ISLES; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; MCMILLAN C, 1982, AQUAT BOT, V14, P231, DOI 10.1016/0304-3770(82)90101-2; MCROY CP, 1968, PAC SCI, V22, P507; McRoy CP., 1966, THE STANDING STOCK A; McRoy CP, 1998, EELGRASS SURVEY E PR; Michalakis Y, 1996, GENETICS, V142, P1061; MUEHLSTEIN LK, 1992, CAN J BOT, V70, P2081, DOI 10.1139/b92-258; Muniz-Salazar R, 2006, MAR ECOL PROG SER, V309, P107, DOI 10.3354/meps309107; Muniz-Salazar R, 2005, MOL ECOL, V14, P711, DOI 10.1111/j.1365-294X.2005.02454.x; Murie OJ, 1959, N AM FAUNA, V61, P1; Nacken N, 2000, HELGOLAND MAR RES, V54, P87, DOI 10.1007/s101520050006; Nei M., 1975, N HOLLAND RES MONOGR, DOI [10.1086/408797, DOI 10.1086/408797]; O'Reilly PT, 2004, MOL ECOL, V13, P1799, DOI 10.1111/j.1365-294X.2004.02214.x; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Ort BS, 2012, J HERED, V103, P533, DOI 10.1093/jhered/ess022; ORTH RJ, 1994, ECOLOGY, V75, P1927, DOI 10.2307/1941597; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park S, 2000, MICROSATELLITE TOOLK; Parsons KM, 2013, J HERED, V104, P737, DOI 10.1093/jhered/est037; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Percival SM, 1996, J APPL ECOL, V33, P979, DOI 10.2307/2404679; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; PHILLIPS R. C., 1988, SMITHSONIAN CONTRIBU, V34, P1, DOI DOI 10.1086/277620; PHILLIPS RC, 1983, AQUAT BOT, V16, P1, DOI 10.1016/0304-3770(83)90047-5; Plus M, 2003, AQUAT BOT, V77, P121, DOI 10.1016/S0304-3770(03)00089-5; Poumian-Tapia M, 1999, ESTUARIES, V22, P837, DOI 10.2307/1353065; Procaccini G, 2001, MOL ECOL, V10, P1413, DOI 10.1046/j.1365-294X.2001.01290.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Provan J, 2008, CONSERV GENET, V9, P271, DOI 10.1007/s10592-007-9338-7; Rader RB, 2005, ANIM CONSERV, V8, P239, DOI 10.1017/S1367943005002271; REED A, 1989, J WILDLIFE MANAGE, V53, P720, DOI 10.2307/3809203; Reusch TBH, 1999, MOL ECOL, V8, P317, DOI 10.1046/j.1365-294X.1999.00531.x; Reusch TBH, 2000, MOL ECOL, V9, P127, DOI 10.1046/j.1365-294x.2000.00839.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 1996, GENETICS, V142, P1357; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; ROYER TC, 1975, DEEP-SEA RES, V22, P403, DOI 10.1016/0011-7471(75)90062-5; Ruckelshaus MH, 1996, EVOLUTION, V50, P856, DOI 10.1111/j.1558-5646.1996.tb03894.x; Ruckelshaus MH, 1998, EVOLUTION, V52, P330, DOI 10.1111/j.1558-5646.1998.tb01635.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez MI, 2006, J AVIAN BIOL, V37, P201, DOI 10.1111/j.2006.0908-8857.03719.x; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; SHERMAN K, 1994, MAR ECOL PROG SER, V112, P277, DOI 10.3354/meps112277; Short FT, 1996, ESTUARIES, V19, P730, DOI 10.2307/1352532; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P5, DOI 10.1016/B978-044450891-1/50002-5; SHORT FT, 1987, BIOL BULL, V173, P557, DOI 10.2307/1541701; SLATKIN M, 1995, GENETICS, V139, P457; SOROSPOTTRUFF CL, 1995, INT J PLANT SCI, V156, P143, DOI 10.1086/297236; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Stabeno PJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004705; Stabeno P.J., 2006, SEA, V14, P1177; STABENO PJ, 1991, DEEP-SEA RES, V38, P289, DOI 10.1016/0198-0149(91)90069-R; STABENO PJ, 1992, GEOPHYS RES LETT, V19, P1671, DOI 10.1029/92GL01688; Stace C., 1997, NEW FLORA BRIT ISLES; Sumoski SE, 2012, MAR ECOL PROG SER, V471, P1, DOI 10.3354/meps10145; Talbot SL, 2006, AQUAT BOT, V85, P169, DOI 10.1016/j.aquabot.2006.03.011; Talbot SS, 2006, RHODORA, V108, P249, DOI 10.3119/0035-4902(2006)108[249:VFOINW]2.0.CO;2; Tanaka N, 2003, J PLANT RES, V116, P273, DOI 10.1007/s10265-003-0090-x; Tanaka Norio, 2011, Bulletin of the National Museum of Nature and Science Series B-Botany, V37, P23; Tanaka N, 2011, MAR BIOL, V158, P871, DOI 10.1007/s00227-010-1614-2; Toussaint RK, 2012, CONSERV GENET, V13, P1483, DOI 10.1007/s10592-012-0392-4; Valentine James W., 1993, P341; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Ward DH, 2003, ESTUARIES, V26, P1529, DOI 10.1007/BF02803661; Ward DH, 1997, J WILDLIFE MANAGE, V61, P773, DOI 10.2307/3802184; Ward DH, 1997, AQUAT BOT, V58, P229, DOI 10.1016/S0304-3770(97)00037-5; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams MAJ, 1998, QUATERNARY ENV; Wyllie-Echeverria S., 1999, SEAGRASS BIOME PROTE; Wyllie-Echeverria S, 2010, ESTUAR COAST, V33, P811, DOI 10.1007/s12237-009-9243-z; WYLLIEECHEVERRI.S, 2003, WORLD ATLAS SEAGRASS, P199; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	161	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0152701	10.1371/journal.pone.0152701	http://dx.doi.org/10.1371/journal.pone.0152701			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104836	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100005
J	Kirschner, F; Reppe, K; Andresen, N; Witzenrath, M; Ebstein, F; Kloetzel, PM				Kirschner, Felicia; Reppe, Katrin; Andresen, Nadine; Witzenrath, Martin; Ebstein, Frederic; Kloetzel, Peter-Michael			Proteasome beta 5i Subunit Deficiency Affects Opsonin Synthesis and Aggravates Pneumococcal Pneumonia	PLOS ONE			English	Article							DIFFERENT ENZYMATIC-PROPERTIES; COMMUNITY-ACQUIRED PNEUMONIA; RECOGNITION MOLECULE PTX3; INNATE IMMUNE-RESPONSES; C-REACTIVE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; 20S PROTEASOME; EXPERIMENTAL COLITIS; COMPLEMENT-SYSTEM; LUNG INFECTION	Immunoproteasomes, harboring the active site subunits beta 5i/LMP7, beta 1i/LMP2, and beta 2i/MECL1 exert protective, regulatory or modulating functions during infection-induced immune responses. Immunoproteasomes are constitutively expressed in hematopoietic derived cells, constituting the first line of defense against invading pathogens. To clarify the impact of immunoproteasomes on the innate immune response against Streptococcus pneumoniae, we characterized the progression of disease and analyzed the systemic immune response in beta 5i/LMP7(-/-) mice. Our data show that beta 5i/LMP7 deficiency, which affected the subunit composition of proteasomes in murine macrophages and liver, was accompanied by reduced transcription of genes encoding immune modulating molecules such as pentraxins, ficolins, and collectins. The diminished opsonin expression suggested an impaired humoral immune response against invading pneumococci resulting in an aggravated systemic dissemination of S. pneumoniae in beta 5i/LMP7(-/-) mice. The impaired bacterial elimination in beta 5i/LMP7(-/-) mice was accompanied by an aggravated course of pneumonia with early mortality as a consequence of critical illness during the late phase of disease. In summary our results highlight an unsuspected role for immuno-subunits in modulating the innate immune response to extracellular bacterial infections.	[Kirschner, Felicia; Andresen, Nadine; Ebstein, Frederic; Kloetzel, Peter-Michael] Charite, Inst Biochem, D-13353 Berlin, Germany; [Reppe, Katrin; Witzenrath, Martin] Charite, Dept Infect Dis & Pulm Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kloetzel, PM (corresponding author), Charite, Inst Biochem, D-13353 Berlin, Germany.	p-m.kloetzel@charite.de			German Research Foundation [SFB-TR 84]; German Ministry for Education and Research: CAPSyS	German Research Foundation(German Research Foundation (DFG)); German Ministry for Education and Research: CAPSyS	This study received financial support from the German Research Foundation: SFB-TR 84 TP C3, C4, C6 (www.dfg.de/) and the German Ministry for Education and Research: CAPSyS and TP4 (https://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdein JD, 2013, CLIN EXP IMMUNOL, V174, P193, DOI 10.1111/cei.12170; Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Arnold FW, 2013, RESP MED, V107, P1101, DOI 10.1016/j.rmed.2013.04.003; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; Bergeron Y, 1998, INFECT IMMUN, V66, P912, DOI 10.1128/IAI.66.3.912-922.1998; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Braun JS, 1999, INFECT IMMUN, V67, P3750, DOI 10.1128/IAI.67.8.3750-3756.1999; Brehm A, 2015, SEMIN IMMUNOPATHOL, V37, P323, DOI 10.1007/s00281-015-0486-4; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Cole J, 2014, ADV MICROB PHYSIOL, V65, P125, DOI 10.1016/bs.ampbs.2014.08.004; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Dames C, 2014, AM J RESP CELL MOL, V51, P730, DOI 10.1165/rcmb.2014-0052MA; Doni A, 2012, IMMUNOBIOLOGY, V217, P1122, DOI 10.1016/j.imbio.2012.07.004; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2543, DOI 10.1007/s00018-012-0938-0; Gerber A, 2004, EUR RESPIR J, V24, P40, DOI 10.1183/09031936.04.00079203; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gohlke S, 2014, ANN HEPATOL, V13, P429, DOI 10.1016/S1665-2681(19)30850-6; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Guillaume B, 2010, P NATL ACAD SCI USA, V107, P18599, DOI 10.1073/pnas.1009778107; Henriques-Normark B, 2013, COLD SPRING HARB PER, V3; Hensley SE, 2010, J IMMUNOL, V184, P4115, DOI 10.4049/jimmunol.0903003; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Inforzato A, 2013, SEMIN IMMUNOL, V25, P79, DOI 10.1016/j.smim.2013.05.002; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kerr AR, 2004, MICROB PATHOGENESIS, V36, P303, DOI 10.1016/j.micpath.2004.02.001; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Mishto M, 2014, EUR J IMMUNOL, V44, P3508, DOI 10.1002/eji.201444902; Moalli F, 2011, J IMMUNOL, V186, P5425, DOI 10.4049/jimmunol.1002035; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Olfert E D, 2000, ILAR J, V41, P99; Opitz E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002233; Ortiz-Lazareno PC, 2008, IMMUNOLOGY, V124, P534, DOI 10.1111/j.1365-2567.2008.02806.x; Pfaller MA, 2012, CLIN INFECT DIS, V55, pS187, DOI 10.1093/cid/cis561; Reis J, 2011, CELL BIOCHEM BIOPHYS, V60, P119, DOI 10.1007/s12013-011-9183-7; Remington LT, 2014, CURR OPIN PULM MED, V20, P215, DOI 10.1097/MCP.0000000000000052; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Schmeck B, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-98; Schmidt F, 2006, PROTEOMICS, V6, P4622, DOI 10.1002/pmic.200500920; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Sijts EJAM, 2011, CELL MOL LIFE SCI, V68, P1491, DOI 10.1007/s00018-011-0657-y; Stohwasser R, 1996, FEBS LETT, V383, P109, DOI 10.1016/0014-5793(96)00110-X; Strehl B, 2006, J IMMUNOL, V177, P6238, DOI 10.4049/jimmunol.177.9.6238; Suresh MV, 2007, J IMMUNOL, V178, P1158, DOI 10.4049/jimmunol.178.2.1158; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Vasuri F, 2010, BIOCHEM BIOPH RES CO, V397, P301, DOI 10.1016/j.bbrc.2010.05.104; WATSON DA, 1993, CLIN INFECT DIS, V17, P913, DOI 10.1093/clinids/17.5.913; Weber SE, 2011, J IMMUNOL, V186, P432, DOI 10.4049/jimmunol.1001963; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Yamada T, 1999, CLIN CHEM LAB MED, V37, P381, DOI 10.1515/CCLM.1999.063	57	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153847	10.1371/journal.pone.0153847	http://dx.doi.org/10.1371/journal.pone.0153847			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100179	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500075
J	Li, JJ; Li, YH; Gong, HQ; Liang, PJ; Zhang, PM; Lu, QC				Li, Jia-Jia; Li, Yong-Hua; Gong, Hai-Qing; Liang, Pei-Ji; Zhang, Pu-Ming; Lu, Qin-Chi			The Spatiotemporal Dynamics of Phase Synchronization during Epileptogenesis in Amygdala-Kindling Mice	PLOS ONE			English	Article							MIDLINE THALAMUS; LIMBIC SYSTEM; EPILEPSY; SEIZURE; NETWORK; BRAIN; CONNECTIVITY; OSCILLATIONS; STIMULATION; DISCHARGES	The synchronization among the activities of neural populations in functional regions is one of the most important electrophysiological phenomena in epileptic brains. The spatiotemporal dynamics of phase synchronization was investigated to reveal the reciprocal interaction between different functional regions during epileptogenesis. Local field potentials (LFPs) were recorded simultaneously from the basolateral amygdala (BLA), the cornu ammonis 1 of hippocampus (CA1) and the mediodorsal nucleus of thalamus (MDT) in the mouse amygdala-kindling models during the development of epileptic seizures. The synchronization of LFPs was quantified between BLA, CA1 and MDT using phase-locking value (PLV). During amygdala kindling, behavioral changes (from stage 0 to stage 5) of mice were accompanied by after-discharges (ADs) of similar waveforms appearing almost simultaneously in CA1, MDT, as well as BLA. AD durations were positively related to the intensity of seizures. During seizures at stages 1 similar to 2, PLVs remained relatively low and increased dramatically shortly after the termination of the seizures; by contrast, for stages 3 similar to 5, PLVs remained a relatively low level during the initial period but increased dramatically before the seizure termination. And in the theta band, the degree of PLV enhancement was positively associated with seizure intensity. The results suggested that during epileptogenesis, the functional regions were kept desynchronized rather than hyper-synchronized during either the initial or the entire period of the seizures; so different dynamic patterns of phase synchronization may be involved in different periods of the epileptogenesis, and this might also reflect that during seizures at different stages, the mechanisms underlying the dynamics of phase synchronization were different.	[Li, Jia-Jia; Lu, Qin-Chi] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurol, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Li, Yong-Hua; Gong, Hai-Qing; Liang, Pei-Ji; Zhang, Pu-Ming] Shanghai Jiao Tong Univ, Sch Biomed Engn, 800 Dongchuan Rd, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, QC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurol, 160 Pujian Rd, Shanghai 200127, Peoples R China.; Zhang, PM (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	pmzhang@sjtu.edu.cn; qinchilu@yahoo.com			Key Basic Research Project of Science and Technology Commission of Shanghai [13DJ1400303]; Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications [YG2012ZD08]; Ren Ji Hospital [RJ ZZ13-005]	Key Basic Research Project of Science and Technology Commission of Shanghai; Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications; Ren Ji Hospital	This work was supported by the Key Basic Research Project of Science and Technology Commission of Shanghai (13DJ1400303), Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications (YG2012ZD08), and the Seed Fund of Ren Ji Hospital (RJ ZZ13-005).	Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Benedek K, 2004, EPILEPSIA, V45, P1100, DOI 10.1111/j.0013-9580.2004.43303.x; Bertram E, 2007, EPILEPSIA, V48, P65, DOI 10.1111/j.1528-1167.2007.01068.x; Bertram EH, 2008, EPILEPSIA, V49, P256, DOI 10.1111/j.1528-1167.2007.01408.x; Bertram EH, 2001, EPILEPSIA, V42, P967, DOI 10.1046/j.1528-1157.2001.042008967.x; Blumenfeld H, 2007, EPILEPSIA, V48, P254, DOI 10.1111/j.1528-1167.2006.00934.x; BURCHFIEL JL, 1989, NEUROSCI BIOBEHAV R, V13, P289, DOI 10.1016/S0149-7634(89)80065-X; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Coulter DA, 2002, BRAIN PATHOL, V12, P240; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; D'Antuono M, 2010, EPILEPSIA, V51, P423, DOI 10.1111/j.1528-1167.2009.02273.x; Dominguez LG, 2005, J NEUROSCI, V25, P8077, DOI 10.1523/JNEUROSCI.1046-05.2005; Dominguez LG, 2008, INT J BIFURCAT CHAOS, V18, P429; Douw L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-103; Fraklin KBJ., 2007, MOUSE BRAIN STEREOTA; Gong XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092961; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; Jiruska P, 2013, J PHYSIOL-LONDON, V591, P787, DOI 10.1113/jphysiol.2012.239590; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Li YH, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/675128; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Majumdar K, 2014, BRAIN TOPOGR, V27, P112, DOI 10.1007/s10548-013-0284-z; Margineanu DG, 2000, PHARMACOL RES, V42, P281; McIntyre DC, 2002, EPILEPSY RES, V50, P79, DOI 10.1016/S0920-1211(02)00071-2; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; PARMEGGIANI PL, 1971, BRAIN RES, V30, P357, DOI 10.1016/0006-8993(71)90086-2; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rey HG, 2015, BRAIN RES BULL, V119, P106, DOI 10.1016/j.brainresbull.2015.04.007; SATO M, 1990, ELECTROEN CLIN NEURO, V76, P459, DOI 10.1016/0013-4694(90)90099-6; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Schindler K, 2007, CLIN NEUROPHYSIOL, V118, P1955, DOI 10.1016/j.clinph.2007.06.006; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Sloan DM, 2011, NEUROBIOL DIS, V43, P435, DOI 10.1016/j.nbd.2011.04.017; Sobayo T, 2013, IEEE T BIO-MED ENG, V60, P821, DOI 10.1109/TBME.2012.2189113; Stratton P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038482; SU HS, 1990, J COMP NEUROL, V297, P582, DOI 10.1002/cne.902970410; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; Tan GH, 2012, NAT NEUROSCI, V15, P258, DOI 10.1038/nn.3005; Tassi L, 2009, EPILEPTIC DISORD, V11, P281, DOI 10.1684/epd.2009.0279; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang Y, 2014, BRAIN STRUCT FUNCT, V219, P1685, DOI 10.1007/s00429-013-0594-7; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Zhang DX, 2002, J NEUROSCI, V22, P3277, DOI 10.1523/JNEUROSCI.22-08-03277.2002	51	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153897	10.1371/journal.pone.0153897	http://dx.doi.org/10.1371/journal.pone.0153897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100891	Green Submitted, gold, Green Published			2022-12-26	WOS:000374898500092
J	Liu, ZD; Qin, AZ; Zhao, B; Ata-Ul-Karim, ST; Xiao, JF; Sun, JS; Ning, DF; Liu, ZG; Nan, JQ; Duan, AW				Liu, Zhandong; Qin, Anzhen; Zhao, Ben; Ata-Ul-Karim, Syed Tahir; Xiao, Junfu; Sun, Jingsheng; Ning, Dongfeng; Liu, Zugui; Nan, Jiqin; Duan, Aiwang			Yield Response of Spring Maize to Inter-Row Subsoiling and Soil Water Deficit in Northern China	PLOS ONE			English	Article							USE EFFICIENCY; CONSERVATION TILLAGE; GRAIN-YIELD; ROOT-GROWTH; WHEAT; COMPACTION; VERTISOL; CLIMATE; CARBON	Background Long-term tillage has been shown to induce water stress episode during crop growth period due to low water retention capacity. It is unclear whether integrated water conservation tillage systems, such asspringdeepinter-row subsoiling with annual or biennial repetitions, can be developed to alleviate this issue while improve crop productivity. Methods Experimentswere carried out in a spring maize cropping system on Calcaric-fluvicCambisol-satJiaozuoexperimentstation, northern China, in 2009 to 2014. Effects of threesubsoiling depths (i.e., 30 cm, 40 cm, and 50 cm) in combination with annual and biennial repetitions-wasdetermined in two single-years (i.e., 2012 and 2014) againstthe conventional tillage. The objectives were to investigateyield response to subsoiling depths and soil water deficit (SWD), and to identify the most effective subsoiling treatment using a systematic assessment. Results Annualsubsoiling to 50 cm (AS-50) increased soil water storage (SWS, mm) by an average of8% in 0-20 cm soil depth, 19% in 20-80 cm depth, and 10% in 80-120 cm depth, followed by AS-40 and BS-50, whereas AS-30 and BS-30 showed much less effects in increasing SWS across the 0-120 cm soil profile, compared to the CK. AS-50 significantly reduced soil water deficit (SWD, mm) by an average of123% during sowing to jointing, 318% during jointing to filling, and 221% during filling to maturity, compared to the CK, followed by AS-40 and BS-50. An integrated effect on increasing SWS and reducing SWD helped AS-50 boost grain yield by an average of 31% and biomass yield by 30%, compared to the CK. A power function for subsoiling depth and a negative linear function for SWD were used to fit the measured yields, showing the deepest subsoiling depth (50 cm) with the lowest SWD contributed to the highest yield. Systematic assessment showed that AS-50 received the highest evaluation index (0.69 out of 1.0) among all treatments. Conclusion Deepinter-row subsoilingwith annual repetition significantly boosts yield by alleviating SWD in critical growth period and increasing SWS in 20-80 cm soil depth. The results allow us to conclude that AS-50 can be adopted as an effective approach to increase crop productivity, alleviate water stress, and improve soil water availability for spring maize in northern China.	[Liu, Zhandong; Qin, Anzhen; Zhao, Ben; Xiao, Junfu; Sun, Jingsheng; Ning, Dongfeng; Liu, Zugui; Nan, Jiqin; Duan, Aiwang] Chinese Acad Agr Sci, Key Lab Crop Water Use & Regulat, Minist Agr, Farmland Irrigat Res Inst, Xinxiang, Peoples R China; [Ata-Ul-Karim, Syed Tahir] Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Duan, AW (corresponding author), Chinese Acad Agr Sci, Key Lab Crop Water Use & Regulat, Minist Agr, Farmland Irrigat Res Inst, Xinxiang, Peoples R China.	duanaiwang@aliyun.com	Ata-Ul-Karim, Syed Tahir/F-7468-2017; Ata-Ul-Karim, Syed Tahir/AAB-6257-2020; Qin, Anzhen/AAY-2027-2020	Ata-Ul-Karim, Syed Tahir/0000-0001-5233-4502; Ata-Ul-Karim, Syed Tahir/0000-0001-5233-4502; 	China Agriculture Research System [CARS-02]; National Natural Science Fund [51309226]; Agricultural Science and Technology Innovation Program (ASTIP); Special Fund for Agro-scientific Research in the Public Interest [201203077, 201503117]; Natural Science Foundation of Henan Province [162300410154]	China Agriculture Research System; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program (ASTIP); Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Henan Province	This research was jointly supported by the China Agriculture Research System (CARS-02), the National Natural Science Fund (51309226), the Agricultural Science and Technology Innovation Program (ASTIP), the Special Fund for Agro-scientific Research in the Public Interest (201203077 and 201503117), and the Natural Science Foundation of Henan Province (162300410154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci I, 2004, SOIL TILL RES, V77, P203, DOI 10.1016/j.still.2003.12.006; Allen R. G., 1998, FAO Irrigation and Drainage Paper; BUSSCHER WJ, 1988, SOIL SCI SOC AM J, V52, P804, DOI 10.2136/sssaj1988.03615995005200030037x; Cai HG, 2014, CROP J, V2, P297, DOI 10.1016/j.cj.2014.04.006; Castrignano A, 1997, SOIL TILL RES, V40, P227, DOI 10.1016/S0167-1987(96)01054-9; Chen HW, 2014, AGR RES, V3, P321, DOI 10.1007/s40003-014-0134-6; DeJonge KC, 2015, AGR WATER MANAGE, V156, P51, DOI 10.1016/j.agwat.2015.03.023; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; Gan YT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6012; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Guan DH, 2014, FIELD CROP RES, V157, P89, DOI 10.1016/j.fcr.2013.12.015; GUPTA RK, 2001, INDIGENOUS NUTR MANA; He J, 2007, SOIL TILL RES, V94, P493, DOI 10.1016/j.still.2006.10.005; He YB, 2015, GEODERMA, V245, P83, DOI 10.1016/j.geoderma.2015.01.020; Heatherly LG, 2001, AGRON J, V93, P511, DOI 10.2134/agronj2001.933511x; Hemmat A, 2004, FIELD CROP RES, V89, P123, DOI 10.1016/j.fcr.2004.01.019; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE, V103; Kong LA, 2014, AGRON SUSTAIN DEV, V34, P405, DOI 10.1007/s13593-013-0182-5; Li N, 2015, NUTR CYCL AGROECOSYS, V102, P397, DOI 10.1007/s10705-015-9713-6; Liu XJ, 2013, NAT HAZARDS, V65, P1393, DOI 10.1007/s11069-012-0416-x; Lopez-Fando C, 2009, SOIL TILL RES, V104, P278, DOI 10.1016/j.still.2009.03.005; Meng QF, 2013, FIELD CROP RES, V143, P91, DOI 10.1016/j.fcr.2012.09.023; Mohanty M, 2007, SOIL TILL RES, V93, P420, DOI 10.1016/j.still.2006.06.002; Mosaddeghi MR, 2009, SOIL TILL RES, V104, P173, DOI 10.1016/j.still.2008.10.011; Munkholm LJ, 2005, SOIL TILL RES, V80, P149, DOI 10.1016/j.still.2004.03.015; Patil SL, 2006, SOIL TILL RES, V89, P246, DOI 10.1016/j.still.2005.07.013; Qin AZ., 2013, THESIS GANSU AGR U L; Raper RL, 2007, SOIL TILL RES, V96, P174, DOI 10.1016/j.still.2007.05.004; Raper RL, 2005, T ASAE, V48, P2047, DOI 10.13031/2013.20081; Raper RL, 2005, APPL ENG AGRIC, V21, P337; TAYLOR HM, 1991, SOIL TILL RES, V19, P111, DOI 10.1016/0167-1987(91)90080-H; Verhulst N, 2011, PLANT SOIL, V344, P73, DOI 10.1007/s11104-011-0728-8; Wang QJ, 2014, SOIL TILL RES, V137, P43, DOI 10.1016/j.still.2013.11.006; Wang XB, 2006, CATENA, V66, P221, DOI 10.1016/j.catena.2006.02.006; Wang XB, 2012, FIELD CROP RES, V132, P106, DOI 10.1016/j.fcr.2011.09.012; Zhang YQ, 2004, AGR WATER MANAGE, V64, P107, DOI 10.1016/S0378-3774(03)00201-4; Zhao JF, 2015, AGR ECOSYST ENVIRON, V207, P79, DOI 10.1016/j.agee.2015.04.006; Zheng CY, 2014, J INTEGR AGR, V13, P2378, DOI 10.1016/S2095-3119(13)60733-9	38	9	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153809	10.1371/journal.pone.0153809	http://dx.doi.org/10.1371/journal.pone.0153809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101145	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500070
J	Schausberger, P; Patino-Ruiz, JD; Osakabe, M; Murata, Y; Sugimoto, N; Uesugi, R; Walzer, A				Schausberger, Peter; Patino-Ruiz, J. David; Osakabe, Masahiro; Murata, Yasumasa; Sugimoto, Naoya; Uesugi, Ryuji; Walzer, Andreas			Ultimate Drivers and Proximate Correlates of Polyandry in Predatory Mites	PLOS ONE			English	Article							GENETIC BENEFITS; MATING FREQUENCY; SEXUAL SELECTION; EVOLUTION; ACARI; LONGEVITY; FECUNDITY; BEHAVIOR; FEMALES; PLASTICITY	Polyandry is more widespread than anticipated from Bateman's principle but its ultimate (evolutionary) causes and proximate (mechanistic) correlates are more difficult to pinpoint than those of polygyny. Here, we combined mating experiments, quantification of reproductive traits and microsatellite genotyping to determine the fitness implications of polyandry in two predatory mite species, where males are highly polygynous (up to 45 fertilized females during life), whereas females range from monandry to various polyandry levels. The medium-level polyandrous (up to eight male mates possible) Neoseiulus californicus received clear direct and indirect benefits: multiply mated females produced more offspring with higher survival chances over longer times than singly mated females. In contrast, singly and multiply mated females of the low-level polyandrous (commonly two male mates at maximum) Phytoseiulus persimilis produced similar numbers of offspring having similar survival chances. In both species, multiple mating resulted in mixed offspring paternities, opening the chance for indirect fitness benefits such as enhanced genetic compatibility, complementarity and/or variability. However, the female re-mating likelihood and the paternity chance of non-first male mates were lower in P. persimilis than in N. californicus. Regarding proximate factors, in both species first mating duration and female re-mating likelihood were negatively correlated. Based on occasional fertilization failure of first male mates in P. persimilis, and mixed offspring paternities in both species, we argue that fertilization assurance and the chance to gain indirect fitness benefits are the ultimate drivers of polyandry in P. persimilis, whereas those of N. californicus are higher offspring numbers coupled with enhanced offspring viability and possibly other indirect fitness benefits. Overall, the adaptive significance and proximate events well reflected the polyandry levels. Our study provides a key example for linking behavioral experiments, quantification of reproductive traits and paternity analysis via offspring genotyping to explain the evolution of differing levels of polyandry.	[Schausberger, Peter; Patino-Ruiz, J. David; Walzer, Andreas] Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria; [Schausberger, Peter] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Osakabe, Masahiro; Murata, Yasumasa; Sugimoto, Naoya; Uesugi, Ryuji] Kyoto Univ, Lab Ecol Informat, Grad Sch Agr, Sakyo Ku, Oiwake Cho, Kyoto, Japan	University of Natural Resources & Life Sciences, Vienna; University of Vienna; Kyoto University	Schausberger, P (corresponding author), Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria.; Schausberger, P (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	peter.schausberger@univie.ac.at	Osakabe, Masahiro/H-8587-2019; Uesugi, Ryuji/HGC-2486-2022	Osakabe, Masahiro/0000-0002-2246-3431; Uesugi, Ryuji/0000-0003-4688-4975; Schausberger, Peter/0000-0002-1529-3198	Austrian Science Fund (FWF) [P 23504-B17]; Austrian Science Fund (FWF) [P 23504, P 25876] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financed by a grant from the Austrian Science Fund (FWF; P 23504-B17) to PS.	AMANO H, 1979, ACAROLOGIA, V20, P196; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Crean AJ, 2014, ECOL LETT, V17, P1545, DOI 10.1111/ele.12373; Crean AJ, 2013, ECOLOGY, V94, P2575, DOI 10.1890/13-0184.1; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Enigl M, 2004, ENTOMOL EXP APPL, V112, P21, DOI 10.1111/j.0013-8703.2004.00175.x; Firman RC, 2012, ECOL LETT, V15, P42, DOI 10.1111/j.1461-0248.2011.01706.x; Fisher DN, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-157; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; FOX CW, 1993, FUNCT ECOL, V7, P203, DOI 10.2307/2389888; Gotoh T, 2008, EXP APPL ACAROL, V44, P185, DOI 10.1007/s10493-008-9143-0; Gowaty PA, 2013, ANIM BEHAV, V86, P877, DOI 10.1016/j.anbehav.2013.08.015; Gowaty PA, 2012, FLY, V6, P3, DOI 10.4161/fly.18330; Gowaty PA, 2010, P NATL ACAD SCI USA, V107, P13771, DOI 10.1073/pnas.1006174107; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Ivy TM, 2005, EVOLUTION, V59, P152, DOI 10.1111/j.0014-3820.2005.tb00902.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Ji J, 2007, EXP APPL ACAROL, V43, P171, DOI 10.1007/s10493-007-9114-x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karlsson B, 1998, ECOLOGY, V79, P2931, DOI 10.1890/0012-9658(1998)079[2931:NGRBAR]2.0.CO;2; Kvarnemo C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0042; Pappas ML, 2007, EXP APPL ACAROL, V43, P161, DOI 10.1007/s10493-007-9112-z; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Perry JC, 2013, TRENDS ECOL EVOL, V28, P414, DOI 10.1016/j.tree.2013.03.005; POE SL, 1970, CAN ENTOMOL, V102, P1222, DOI 10.4039/Ent1021222-10; RIDLEY M, 1989, ANIM BEHAV, V37, P535, DOI 10.1016/0003-3472(89)90033-X; RIDLEY M, 1988, BIOL REV, V63, P509, DOI 10.1111/j.1469-185X.1988.tb00669.x; Sabelis M.W., 1985, P141; SABELIS MW, 1988, EXP APPL ACAROL, V4, P301, DOI 10.1007/BF01196192; Schausberger P, 2007, BEHAV ECOL SOCIOBIOL, V62, P119, DOI 10.1007/s00265-007-0444-9; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; Strodl MA, 2012, NATURWISSENSCHAFTEN, V99, P303, DOI 10.1007/s00114-012-0903-7; Thornhill N.W., 1993, NATURAL HIST INBREED; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tsunoda T, 2001, APPL ENTOMOL ZOOL, V36, P393, DOI 10.1303/aez.2001.393; Walzer A, 2015, ANIM BEHAV, V100, P96, DOI 10.1016/j.anbehav.2014.11.017; Walzer A, 2014, BIOL J LINN SOC, V111, P889, DOI 10.1111/bij.12235; Walzer A, 2011, BIOL J LINN SOC, V102, P650, DOI 10.1111/j.1095-8312.2010.01593.x; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4	45	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154355	10.1371/journal.pone.0154355	http://dx.doi.org/10.1371/journal.pone.0154355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100395	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500185
J	Soyka, RPW; Helgason, B; Marangalou, JH; van den Bergh, JP; van Rietbergen, B; Ferguson, SJ				Soyka, Rene P. Widmer; Helgason, Benedikt; Marangalou, Javad Hazrati; van den Bergh, Joop P.; van Rietbergen, Bert; Ferguson, Stephen J.			The Effectiveness of Percutaneous Vertebroplasty Is Determined by the Patient-Specific Bone Condition and the Treatment Strategy	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; VERTEBRAL BODY; CEMENT VOLUME; INTERVERTEBRAL DISC; RANDOMIZED-TRIAL; PROXIMAL FEMUR; FOLLOW-UP; FRACTURES; BIOMECHANICS; STIFFNESS	Purpose Vertebral fragility fractures are often treated by injecting bone cement into the collapsed vertebral bodies (vertebroplasty). The mechanisms by which vertebroplasty induces pain relief are not completely understood yet and recent debates cast doubt over the outcome of the procedure. The controversy is intensified by inconsistent results of randomized clinical trials and biomechanical studies that have investigated the effectiveness or the change in biomechanical response due to the reinforcement. The purpose of this study was to evaluate the effectiveness of vertebroplasty, by varying the relevant treatment parameters and (a) computationally predicting the improvement of the fracture risk depending on the chosen treatment strategy, and (b) identifying the determinants of a successful treatment. Methods A Finite Element model with a patient-specific failure criterion and direct simulation of PMMA infiltration in four lumbar vertebrae was used to assess the condition of the bone under compressive load before and after the virtual treatment, simulating in a total of 12000 virtual treatments. Results The results showed that vertebroplasty is capable of reducing the fracture risk by magnitudes, but can also have a detrimental effect. Effectiveness was strongly influenced by interactions between local bone quality, cement volume and injection location. However, only a moderate number of the investigated treatment strategies were able to achieve the necessary improvement for preventing a fracture. Conclusions We conclude that the effectiveness of vertebroplasty is sensitive to the patient's condition and the treatment strategy.	[Soyka, Rene P. Widmer; Helgason, Benedikt; Ferguson, Stephen J.] ETH, Inst Biomech, Zurich, Switzerland; [Marangalou, Javad Hazrati; van Rietbergen, Bert] Eindhoven Univ Technol, Orthopaed Biomech, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands; [van den Bergh, Joop P.] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [van den Bergh, Joop P.] Viecuri Med Ctr, Dept Internal Med, Venlo, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eindhoven University of Technology; Maastricht University; VieCuri Medical Center	Soyka, RPW (corresponding author), ETH, Inst Biomech, Zurich, Switzerland.	bhelgason@ethz.ch	Ferguson, Stephen J./A-4118-2012; Helgason, Benedikt/A-4386-2012	Ferguson, Stephen J./0000-0003-0650-5889; van den Bergh, Joop/0000-0003-3984-2232; Hazrati, Javad/0000-0002-1119-3587; Helgason, Benedikt/0000-0001-8324-2651	European Research Council [FP7-ICT-223865-VPHOP]	European Research Council(European Research Council (ERC)European Commission)	This work was funded by the European Research Council project FP7-ICT-223865-VPHOP.	Al-Ali F, 2009, AM J NEURORADIOL, V30, P1835, DOI 10.3174/ajnr.A1732; Andersson GBJ, 2009, NAT REV RHEUMATOL, V5, P662, DOI 10.1038/nrrheum.2009.233; Baerlocher MO, 2010, RADIOLOGY, V255, P669, DOI 10.1148/radiol.10092107; Baroud G, 2006, JOINT BONE SPINE, V73, P144, DOI 10.1016/j.jbspin.2005.02.004; Baroud G, 2003, RADIOLOGY, V229, P606, DOI 10.1148/radiol.2292030378; Baroud G, 2003, EUR SPINE J, V12, P421, DOI 10.1007/s00586-002-0512-9; Baroud G, 2003, MED ENG PHYS, V25, P283, DOI 10.1016/S1350-4533(02)00223-0; Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; Belkoff SM, 2001, SPINE, V26, P1537, DOI 10.1097/00007632-200107150-00007; Berlemann U, 2002, J BONE JOINT SURG BR, V84B, P748, DOI 10.1302/0301-620X.84B5.11841; Blasco J, 2012, J BONE MINER RES, V27, P1159, DOI 10.1002/jbmr.1564; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Chevalier Y, 2008, SPINE, V33, P1722, DOI 10.1097/BRS.0b013e31817c750b; Clark W, 2009, NEW ENGL J MED, V361, P2097, DOI 10.1056/NEJMc096289; Dall'Ara E, 2012, OSTEOPOROSIS INT, V23, P563, DOI 10.1007/s00198-011-1568-3; Dickey BT, 2012, J MECH BEHAV BIOMED, V5, P283, DOI 10.1016/j.jmbbm.2011.08.007; Dragomir-Daescu D, 2011, ANN BIOMED ENG, V39, P742, DOI 10.1007/s10439-010-0196-y; Edidin AA, 2013, OSTEOPOROSIS INT, V24, P451, DOI 10.1007/s00198-012-1965-2; Edidin AA, 2012, APPL HEALTH ECON HEA, V10, P273, DOI 10.2165/11633220-000000000-00000; Garcia D, 2009, BIOMECH MODEL MECHAN, V8, P149, DOI 10.1007/s10237-008-0125-2; Graham J, 2007, SPINE, V32, pE505, DOI 10.1097/BRS.0b013e318133fc73; Grassi L, 2011, MED ENG PHYS, V33, P112, DOI 10.1016/j.medengphy.2010.09.014; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; Heini PF, 2004, ORTHOPADE, P22; Helgason B, 2013, J BIOMED MATER RES B, V101B, P364, DOI 10.1002/jbm.b.32847; Helgason B, 2008, J BIOMECH, V41, P1675, DOI 10.1016/j.jbiomech.2008.03.007; Higgins KB, 2003, SPINE, V28, P1540, DOI 10.1097/00007632-200307150-00012; Hulme PA, 2006, SPINE, V31, P1983, DOI 10.1097/01.brs.0000229254.89952.6b; Jones AC, 2008, MED ENG PHYS, V30, P1287, DOI 10.1016/j.medengphy.2008.09.006; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P229, DOI 10.1007/s00198-004-1811-2; Kaufmann TJ, 2006, AM J NEURORADIOL, V27, P1933; Klazen CAH, 2010, AM J NEURORADIOL, V31, P1447, DOI 10.3174/ajnr.A2148; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Kopperdahl DL, 2014, J BONE MINER RES, V29, P570, DOI 10.1002/jbmr.2069; Lau E, 2008, J BONE JOINT SURG AM, V90A, P1479, DOI 10.2106/JBJS.G.00675; Liebschner MAK, 2001, SPINE, V26, P1547, DOI 10.1097/00007632-200107150-00009; Luo J, 2009, SPINE, V34, P2865, DOI 10.1097/BRS.0b013e3181b4ea1e; Marangalou JH, 2013, J BIOMECH, V46, P2356, DOI 10.1016/j.jbiomech.2013.07.042; Masala S, 2009, SKELETAL RADIOL, V38, P863, DOI 10.1007/s00256-009-0712-z; Masala S, 2009, EUR RADIOL, V19, P165, DOI 10.1007/s00330-008-1133-4; Mazzantini M, 2011, OSTEOPOROSIS INT, V22, P1599, DOI 10.1007/s00198-010-1341-z; Meijer GJM, 2010, J BIOMECH, V43, P1590, DOI 10.1016/j.jbiomech.2010.01.028; Molloy S, 2003, SPINE, V28, P1549, DOI 10.1097/00007632-200307150-00014; Polikeit A, 2003, SPINE, V28, P991, DOI 10.1097/00007632-200305150-00006; Race A, 2007, J BIOMECH, V40, P1002, DOI 10.1016/j.jbiomech.2006.04.003; Robinson Y, 2012, MATURITAS, V72, P42, DOI 10.1016/j.maturitas.2012.02.010; Rohlmann A, 2010, EUR SPINE J, V19, P1585, DOI 10.1007/s00586-010-1386-x; Sambrook P, 2009, IBMS BONEKEY, V5, P385; Soyka RPW, 2013, J MECH BEHAV BIOMED, V27, P43, DOI 10.1016/j.jmbbm.2013.06.007; Sun K, 2004, SPINE, V29, P1428, DOI 10.1097/01.BRS.0000128760.94173.90; Sun K, 2004, ANN BIOMED ENG, V32, P77, DOI 10.1023/B:ABME.0000007793.49771.6d; Svedbom A, 2013, OSTEOPOROSIS INT, V24, P355, DOI 10.1007/s00198-012-2102-y; Tohmeh AG, 1999, SPINE, V24, P1772, DOI 10.1097/00007632-199909010-00004; Truumees Eeric, 2004, Spine J, V4, P218, DOI 10.1016/j.spinee.2003.08.029; Tschirhart CE, 2005, J BIOMECH, V38, P1582, DOI 10.1016/j.jbiomech.2004.07.023; Wasnich RD, 1996, BONE, V18, pS179, DOI 10.1016/8756-3282(95)00499-8; Widmer RP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003735; Widmer RP, 2012, COMPUT METHODS BIOME; Wilcox RK, 2006, P I MECH ENG H, V220, P565, DOI 10.1243/09544119H00305; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Zysset PK, 1998, J BIOMECH ENG-T ASME, V120, P640, DOI 10.1115/1.2834756	63	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0151680	10.1371/journal.pone.0151680	http://dx.doi.org/10.1371/journal.pone.0151680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100630	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500006
J	Zhou, R; Kuang, Y; Zhou, J; Du, XW; Li, J; Shi, JF; Haburcak, R; Xu, B				Zhou, Rong; Kuang, Yi; Zhou, Jie; Du, Xuewen; Li, Jie; Shi, Junfeng; Haburcak, Richard; Xu, Bing			Nanonets Collect Cancer Secretome from Pericellular Space	PLOS ONE			English	Article							PROTEIN IDENTIFICATION DATA; CELL-LINES; TUMOR MICROENVIRONMENT; INTERSTITIAL FLUID; SMALL MOLECULES; HYDROGELATION; MECHANISMS; PROTEOMICS; PEPTIDES; EXOSOMES	Identifying novel cancer biomarkers is important for early cancer detection as it can reduce mortality rates. The cancer secretome, the collection of all macromolecules secreted by a tumor cell, alters its composition compared to normal tissue, and this change plays an important role in the observation of cancer progression. The collection and accurate analysis of cancer secretomes could lead to the discovery of novel biomarkers, thus improving outcomes of cancer treatment. We unexpectedly discovered that enzyme-instructed self-assembly (EISA) of a D-peptide hydrogelator results in nanonets/hydrogel around cancer cells that overexpress ectophosphatases. Here we show that these nanonets are able to rapidly collect proteins in the pericellular space (i.e., near the surface) of cancer cells. Because the secretory substances are at their highest concentration near the cell surface, the use of pericellular nanonets to collect the cancer secretome maximizes the yield and quality of samples, reduces pre-analytical variations, and allows the dynamic profiling of secretome samples. Thus, this new approach has great potential in identifying the heterotypic signaling in tumor microenvironments thereby improving the understanding of tumor microenvironments and accelerating the discovery of potential biomarkers in cancer biology. Data are available via ProteomeXchange with identifier PXD003924.	[Zhou, Rong; Kuang, Yi; Zhou, Jie; Du, Xuewen; Li, Jie; Shi, Junfeng; Haburcak, Richard; Xu, Bing] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA	Brandeis University	Xu, B (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02254 USA.	bxu@brandeis.edu	Li, Jie/ABD-8476-2021; XU, Bing/A-7828-2008	XU, Bing/0000-0002-4639-387X; Kuang, Yi/0000-0003-3643-2684; Haburcak, Richard/0000-0002-6591-8918	National Institutes of Health [R01CA142746]; Kenneth Rainin Foundation; National Science Foundation [DMR-1420382]; NATIONAL CANCER INSTITUTE [R01CA142746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kenneth Rainin Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is partially supported by National Institutes of Health (R01CA142746), Kenneth Rainin Foundation, and a National Science Foundation grant (DMR-1420382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BERNHARD A, 1953, SCIENCE, V118, P114, DOI 10.1126/science.118.3056.114; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Bradshaw RA, 2006, MOL CELL PROTEOMICS, V5, P787, DOI 10.1074/mcp.E600005-MCP200; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; ESTEBAN C, 1991, INT J CANCER, V49, P425, DOI 10.1002/ijc.2910490320; Gao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2040; Gromov P, 2013, BBA-PROTEINS PROTEOM, V1834, P2259, DOI 10.1016/j.bbapap.2013.01.013; Haslene-Hox H, 2013, BBA-PROTEINS PROTEOM, V1834, P2336, DOI 10.1016/j.bbapap.2013.01.028; Iguchi Haruhisa, 2010, Commun Integr Biol, V3, P478, DOI 10.4161/cib.3.5.12693; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iwata M, 2014, STEM CELLS DEV, V23, P729, DOI 10.1089/scd.2013.0300; Jeffries GDM, 2007, NANO LETT, V7, P415, DOI 10.1021/nl0626784; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kuang Y, 2014, ANGEW CHEM IN PRESS, V53; Lei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107746; Li JY, 2013, J AM CHEM SOC, V135, P542, DOI 10.1021/ja310019x; Lin QF, 2013, BBA-PROTEINS PROTEOM, V1834, P2360, DOI 10.1016/j.bbapap.2013.01.030; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Mbeunkui F, 2006, J PROTEOME RES, V5, P899, DOI 10.1021/pr050375p; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Polacek M, 2010, J ORTHOP RES, V28, P1040, DOI 10.1002/jor.21067; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Richards RI, 1997, TRENDS BIOCHEM SCI, V22, P432, DOI 10.1016/S0968-0004(97)01108-0; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Shin SJ, 2013, P NATL ACAD SCI USA, V110, P19414, DOI 10.1073/pnas.1309720110; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Tan HY, 2008, OPT COMMUN, V281, P3013, DOI 10.1016/j.optcom.2008.01.012; TANAKA T, 1967, J BIOCHEM-TOKYO, V62, P71, DOI 10.1093/oxfordjournals.jbchem.a128639; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang XW, 1998, LIFE SCI, V64, P17, DOI 10.1016/S0024-3205(98)00529-3; Whitaker RD, 2011, J BIOL CHEM, V286, P21623, DOI 10.1074/jbc.M111.239897; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52; Yang Z, 2008, ACCOUNTS CHEM RES, V41, P315, DOI 10.1021/ar7001914; Yang Z, 2007, ANGEW CHEM INT EDIT, V46, P8216, DOI 10.1002/anie.200701697; Yang ZM, 2007, ADV MATER, V19, P3152, DOI 10.1002/adma.200701971; Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y; Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340; Zhou J, 2014, J AM CHEM S IN PRESS	49	4	4	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154126	10.1371/journal.pone.0154126	http://dx.doi.org/10.1371/journal.pone.0154126			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100780	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500151
J	Chueca, N; Rivadulla, I; Lovatti, R; Reina, G; Blanco, A; Fernandez-Caballero, JA; Cardenoso, L; Rodriguez-Granjer, J; Fernandez-Alonso, M; Aguilera, A; Alvarez, M; Galan, JC; Garcia, F				Chueca, Natalia; Rivadulla, Isidro; Lovatti, Ruben; Reina, Gabriel; Blanco, Ana; Angel Fernandez-Caballero, Jose; Cardenoso, Laura; Rodriguez-Granjer, Javier; Fernandez-Alonso, Miriam; Aguilera, Antonio; Alvarez, Marta; Carlos Galan, Juan; Garcia, Federico			Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms	PLOS ONE			English	Article							ASSAY; PREVALENCE; INFECTION; LIPA	We aimed to evaluate the correct assignment of HCV genotypes by three commercial methods-Trugene HCV genotyping kit (Siemens), VERSANT HCV Genotype 2.0 assay (Siemens), and Real-Time HCV genotype II (Abbott)-compared to NS5B sequencing. We studied 327 clinical samples that carried representative HCV genotypes of the most frequent geno/subtypes in Spain. After commercial genotyping, the sequencing of a 367 bp fragment in the NS5B gene was used to assign genotypes. Major discrepancies were defined, e.g. differences in the assigned genotype by one of the three methods and NS5B sequencing, including misclassification of subtypes 1a and 1b. Minor discrepancies were considered when differences at subtype levels, other than 1a and 1b, were observed. The overall discordance with the reference method was 34% for Trugene and 15% for VERSANT HCV2.0. The Abbott assay correctly identified all 1a and 1b subtypes, but did not subtype all the 2, 3, 4 and 5 (34%) genotypes. Major discordances were found in 16% of cases for Trugene HCV, and the majority were 1b-to 1a-related discordances; major discordances were found for VERSANT HCV 2.0 in 6% of cases, which were all but one 1b to 1a cases. These results indicated that the Trugene assay especially, and to a lesser extent, Versant HCV 2.0, can fail to differentiate HCV subtypes 1a and 1b, and lead to critical errors in clinical practice for correctly using directly acting antiviral agents.	[Chueca, Natalia; Angel Fernandez-Caballero, Jose; Alvarez, Marta; Garcia, Federico] Complejo Hosp Univ Granada, Hosp San Cecilio, Inst Invest Biosanitaria IBS, Microbiol Serv, Granada, Spain; [Rivadulla, Isidro; Aguilera, Antonio] Hosp Conxo CHUS Santiago de Compostela, Microbiol Serv, Dept Microbiol & Parasitol USC, La Coruna, Spain; [Lovatti, Ruben; Carlos Galan, Juan] Hosp Ramon & Cajal, Microbiol Serv, IRYCIS, E-28034 Madrid, Spain; [Lovatti, Ruben; Carlos Galan, Juan] CIBERESP, Madrid, Spain; [Reina, Gabriel; Fernandez-Alonso, Miriam] Univ Navarra Clin, Navarra Inst Hlth Res IdiSNA, Microbiol Serv, Pamplona, Spain; [Blanco, Ana; Cardenoso, Laura] Hosp Princesa, Microbiol Serv, Madrid, Spain; [Rodriguez-Granjer, Javier] Complejo Hosp Univ Granada, Hosp Virgen Nieves, Microbiol Serv, Granada, Spain	Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Complejo Hospitalario Universitario A Coruna; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Navarra; Hospital de La Princesa; Hospital Universitario Virgen de las Nieves; University of Granada	Garcia, F (corresponding author), Complejo Hosp Univ Granada, Hosp San Cecilio, Inst Invest Biosanitaria IBS, Microbiol Serv, Granada, Spain.	fegarcia@ugr.es	Garcia, Federico/AAA-3175-2020; Reina, Gabriel/F-2709-2017; Fernández-Alonso, Mirian/Q-4471-2016; Aguilera, Antonio/L-6586-2018; Chueca, Natalia/T-9734-2019; Chueca, Natalia/K-5225-2014	Garcia, Federico/0000-0001-7611-781X; Reina, Gabriel/0000-0003-4079-9753; Fernández-Alonso, Mirian/0000-0001-8047-2734; Aguilera, Antonio/0000-0001-6940-241X; Chueca, Natalia/0000-0002-3420-3290; Chueca, Natalia/0000-0002-3420-3290; Blanco, Ana/0000-0002-3435-7919	Fondo de Investigacion Sanitaria [PI12/01053, PI15/00713]; Plan Nacional de I+D+I [RD12/0017/006]; Fundacion Progreso y salud, Junta de Andalucia [PI-0411-2014]; Programa de Intensificacion de la Actividad de Investigacion del Servicio Andaluz de Salud; Fondo Europeo de Desarrollo Regional-FEDER [RD12/0017/006]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Plan Nacional de I+D+I; Fundacion Progreso y salud, Junta de Andalucia(Junta de Andalucia); Programa de Intensificacion de la Actividad de Investigacion del Servicio Andaluz de Salud; Fondo Europeo de Desarrollo Regional-FEDER(European Commission)	This work was supported in part by grants from Fondo de Investigacion Sanitaria (PI12/01053, PI15/00713), RD12/0017/006 (Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER), and PI-0411-2014, Fundacion Progreso y salud, Junta de Andalucia. Federico Garcia has received a research extension grant from the Programa de Intensificacion de la Actividad de Investigacion del Servicio Andaluz de Salud.	[Anonymous], 2015, DOCUMENTO CONSENSO G; Avo AP, 2013, J MED VIROL, V85, P815, DOI 10.1002/jmv.23545; Belmonte P, 2019, SEGURO SALUD 5G; Benedet M, 2014, J CLIN VIROL, V60, P301, DOI 10.1016/j.jcv.2014.04.005; Berenguer Marina, 2014, Gastroenterol Hepatol, V37 Suppl 1, P23, DOI 10.1016/S0210-5705(15)30004-2; Buti M, 2015, J HEPATOL, V63, P1511, DOI 10.1016/j.jhep.2015.08.010; Cento V, 2013, ANTIVIR THER, V18, P645, DOI 10.3851/IMP2529; Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; Chevaliez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008209; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Garcia F, 2015, AIDS REV S1, V17, P8; Gonzalez V, 2013, J CLIN VIROL, V58, P249, DOI 10.1016/j.jcv.2013.05.005; Guelfo JR, 2014, J CLIN MICROBIOL, V52, P4027, DOI 10.1128/JCM.02209-14; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hedskog C, 2015, HEPATOLOGY, V61, P471, DOI 10.1002/hep.27361; Hngtyszyn HJ, 2005, ANTIVIR THER, V10, P1; Larrat S, 2013, J CLIN MICROBIOL, V51, P2815, DOI 10.1128/JCM.00586-13; Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934; McCormick AL, 2015, J CLIN VIROL, V66, P56, DOI 10.1016/j.jcv.2015.03.006; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Navarro D, 2015, AIDS REV S1, V17, P7; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006; Quer J, 2015, J CLIN MICROBIOL, V53, P219, DOI 10.1128/JCM.02093-14; Rein DB, 2015, CLIN INFECT DIS, V61, P157, DOI 10.1093/cid/civ220; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Sarrazin C, 2016, J HEPATOL, V64, P486, DOI 10.1016/j.jhep.2015.09.011; Sarrazin C, 2015, ANTIVIR RES, V116, P10, DOI 10.1016/j.antiviral.2015.01.003; Silberstein FC, 2016, HEPATOLOGY, V63, P1058, DOI 10.1002/hep.27895; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Soriano V, 2016, ANTIVIR THER, V21, P1, DOI 10.3851/IMP2975; Wyles D, 2015, HEPATOLOGY, V61, P1793, DOI 10.1002/hep.27814	33	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153754	10.1371/journal.pone.0153754	http://dx.doi.org/10.1371/journal.pone.0153754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097040	Green Published, gold			2022-12-26	WOS:000374543600052
J	Mitchell, BI; Byron, MM; Ng, RC; Chow, DC; Ndhlovu, LC; Shikuma, CM				Mitchell, Brooks I.; Byron, Mary Margaret; Ng, Roland C.; Chow, Dominic C.; Ndhlovu, Lishomwa C.; Shikuma, Cecilia M.			Elevation of Non-Classical (CD14(+/low)CD16(++)) Monocytes Is Associated with Increased Albuminuria and Urine TGF-beta(1) in HIV-Infected Individuals on Stable Antiretroviral Therapy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC KIDNEY-DISEASE; TGF-BETA; MICROALBUMINURIA; INFLAMMATION; EXPRESSION; HYPERTENSION; ACTIVATION; MARKERS; MONOCYTES/MACROPHAGES	Objective High rates of albuminuria are observed among HIV-infected individuals on stable antiretroviral therapy (ART). Though pro-inflammatory and pro-fibrotic responses are described as components of albuminuria in the general population, it is unclear how these responses are associated to albuminuria in ART-treated chronic HIV. We investigated the relationship of monocyte subsets and urine inflammatory and fibrotic biomarkers to albuminuria in ART-treated HIV-infected participants. Design and Methods Cross-sectional analyses were performed on Hawaii Aging with HIV-cardiovascular disease study cohort participants who were required at entry to be >= 40 years old and on ART >= 3 months. Monocyte subpopulations were determined in banked peripheral blood mononuclear cells (PBMC) using multi-parametric flow-cytometry. Entry random urine samples were assessed for albumin-to-creatinine ratios (UACR). Urine samples were measured for inflammatory and fibrotic biomarkers using Luminex technology. Results Among 96 HIV-infected subjects with measured UACR (87% male, 59% Caucasian, and 89% undetectable HIV RNA with median CD4 of 495.5 cells/mu L), 18 patients (19%) had albuminuria. Non-classical (CD14(low/+)CD16(++)) monocytes were significantly elevated in subjects with albuminuria (p = 0.034) and were correlated to UACR (r = 0.238, p = 0.019). Elevated non-classical monocyte counts were significant predictors of worsening albuminuria, independent of traditional-and ART-associated risk factors (beta = 0.539, p = 0.007). Urine TGF-beta 1 and collagen-IV were significantly higher in albuminuric compared to non-albuminuric participants (TGF-beta 1; p = 0.039 and collagen-IV; p = 0.042). Urine TGF-beta 1 was significantly correlated with non-classical monocyte counts (r = 0.464, p = 0.017). Conclusion Alterations in monocyte subpopulations and urine pro-fibrotic factors may play a role in kidney dysfunction during chronic HIV infection and warrants further study.	[Mitchell, Brooks I.; Byron, Mary Margaret; Ndhlovu, Lishomwa C.; Shikuma, Cecilia M.] Univ Hawaii, Dept Trop Med, Honolulu, HI 96822 USA; [Mitchell, Brooks I.; Chow, Dominic C.; Ndhlovu, Lishomwa C.; Shikuma, Cecilia M.] Univ Hawaii, Hawaii Ctr AIDS, Honolulu, HI 96822 USA; [Ng, Roland C.; Chow, Dominic C.; Shikuma, Cecilia M.] Univ Hawaii, Dept Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii System; University of Hawaii System	Mitchell, BI (corresponding author), Univ Hawaii, Dept Trop Med, Honolulu, HI 96822 USA.; Mitchell, BI (corresponding author), Univ Hawaii, Hawaii Ctr AIDS, Honolulu, HI 96822 USA.	brooksim@hawaii.edu	n, l/AAX-3992-2020	Ndhlovu, Lishomwa/0000-0001-5427-4187; Chow, Dominic/0000-0001-7395-038X	National Heart, Lung, and Blood Institute [R01HL095135]; National Institute on Minority Health and Health Disparities [8G12MD7601-27]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095135] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584, G12MD007601] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Grant Number R01HL095135 from the National Heart, Lung, and Blood Institute awarded to C.M.S. and Grant Number 8G12MD7601-27 from the National Institute on Minority Health and Health Disparities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JB, 1991, J CLIN INVEST, V87, P1773, DOI 10.1172/JCI115196; Ando M, 2012, CLIN EXP NEPHROL, V16, P363, DOI 10.1007/s10157-012-0585-7; Ando M, 2011, NEPHROL DIAL TRANSPL, V26, P3923, DOI 10.1093/ndt/gfr129; Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baekken M, 2008, NEPHROL DIAL TRANSPL, V23, P3130, DOI 10.1093/ndt/gfn236; Barbour JD, 2014, ATHEROSCLEROSIS, V232, P52, DOI 10.1016/j.atherosclerosis.2013.10.021; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Campbell LJ, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-85; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chang A, 2014, CURR OPIN NEPHROL HY, V23, P204, DOI 10.1097/01.mnh.0000444814.49755.90; Choi A, 2010, AM J KIDNEY DIS, V56, P872, DOI 10.1053/j.ajkd.2010.05.019; Choi AI, 2010, CIRCULATION, V121, P651, DOI 10.1161/CIRCULATIONAHA.109.898585; Comper WD, 2008, AM J PHYSIOL-RENAL, V295, pF1589, DOI 10.1152/ajprenal.00142.2008; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Frankenberger M, 1996, BLOOD, V87, P373; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gupta D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091569; Gupta SK, 2009, J INFECT DIS, V200, P614, DOI 10.1086/600890; Hadigan C, 2013, AM J NEPHROL, V37, P443, DOI 10.1159/000350384; Jalbert E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075500; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kim PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024610; Krishnan S, 2014, J INFECT DIS, V209, P931, DOI 10.1093/infdis/jit581; Kusao I, 2012, J NEUROPSYCH CLIN N, V24, P71, DOI 10.1176/appi.neuropsych.11050109; Lampropoulou IT, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/394206; LOTZ M, 1993, ANN NY ACAD SCI, V685, P501, DOI 10.1111/j.1749-6632.1993.tb35912.x; Ma J, 2014, INT J CLIN EXP PATHO, V7, P481; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Mizuno K, 2005, CLIN EXP IMMUNOL, V142, P461, DOI 10.1111/j.1365-2005.02932.x; Nadkarni GN, 2014, CURR OPIN HIV AIDS, V9, P340, DOI 10.1097/COH.0000000000000067; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; O-charoen P, 2014, AIDS RES HUM RETROV, V30, P1185, DOI [10.1089/aid.2014.0072, 10.1089/AID.2014.0072]; Patel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088934; Russo LM, 2007, DIABETES, V56, P380, DOI 10.2337/db06-1018; Russo LM, 2002, HYPERTENSION, V39, P281, DOI 10.1161/hy0202.104266; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shikuma CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090330; Shikuma CM, 2014, JAIDS-J ACQ IMM DEF, V65, P151, DOI 10.1097/01.qai.0000435599.27727.6c; Shikuma CM, 2012, AIDS RES HUM RETROV, V28, P793, DOI [10.1089/aid.2011.0086, 10.1089/AID.2011.0086]; SHUKLA RR, 1993, KIDNEY INT, V44, P1022, DOI 10.1038/ki.1993.344; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Szczech LA, 2010, HIV MED, V11, P419, DOI 10.1111/j.1468-1293.2009.00805.x; Szczech LA, 2004, KIDNEY INT, V66, P1145, DOI 10.1111/j.1523-1755.2004.00865.x; Szczech LA, 2007, AIDS, V21, P1003, DOI 10.1097/QAD.0b013e3280d3587f; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; Ucciferri C, 2012, EUR REV MED PHARMACO, V16, P491; WAHL SM, 1991, J EXP MED, V173, P981, DOI 10.1084/jem.173.4.981; Westhorpe CLV, 2014, IMMUNOL CELL BIOL, V92, P133, DOI 10.1038/icb.2013.84; Wilson EMP, 2014, J INFECT DIS, V210, P1396, DOI 10.1093/infdis/jiu275; Winston JA, 1999, KIDNEY INT, V55, P1036, DOI 10.1046/j.1523-1755.1999.0550031036.x; Yamamoto T, 1999, KIDNEY INT, V55, P579, DOI 10.1046/j.1523-1755.1999.00296.x; Yoshimoto S, 2007, AM J KIDNEY DIS, V50, P47, DOI 10.1053/j.ajkd.2007.04.012; Zidar DA, 2015, JAIDS-J ACQ IMM DEF, V69, P154, DOI 10.1097/QAI.0000000000000566; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048	69	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153758	10.1371/journal.pone.0153758	http://dx.doi.org/10.1371/journal.pone.0153758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097224	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600053
J	Manabe, K; Tsujikawa, A; Osaka, R; Nakano, Y; Fujita, T; Shiragami, C; Hirooka, K; Uji, A; Muraoka, Y				Manabe, Koichiro; Tsujikawa, Akitaka; Osaka, Rie; Nakano, Yuki; Fujita, Tomoyoshi; Shiragami, Chieko; Hirooka, Kazuyuki; Uji, Akihito; Muraoka, Yuki			Metamorphopsia Associated with Branch Retinal Vein Occlusion	PLOS ONE			English	Article							EPIRETINAL MEMBRANE SURGERY; CENTRAL SEROUS CHORIORETINOPATHY; MACULAR EDEMA; M-CHARTS; INTRAVITREAL BEVACIZUMAB; VISUAL-ACUITY; QUANTIFICATION; EYES; CONTRACTION; THICKNESS	Purpose To apply M-CHARTS for quantitative measurements of metamorphopsia in eyes with acute branch retinal vein occlusion (BRVO) and to elucidate the pathomorphology that causes metamorphopsia. Methods This prospective study consisted of 42 consecutive patients (42 eyes) with acute BRVO. Both at baseline and one month after treatment with ranibizumab, metamorphopsia was measured with M-CHARTS, and the retinal morphological changes were examined with optical coherence tomography. Results At baseline, metamorphopsia was detected in the vertical and/or horizontal directions in 29 (69.0%) eyes; the mean vertical and horizontal scores were 0.59 +/- 0.57 and 0.52 +/- 0.67, respectively. The maximum inner retinal thickness showed no association with the MCHARTS score, but the M-CHARTS score was correlated with the total foveal thickness (r = 0.43, p = 0.004), the height of serous retinal detachment (r = 0.31, p = 0.047), and the maximum outer retinal thickness (r = 0.36, p = 0.020). One month after treatment, both the inner and outer retinal thickness substantially decreased. However, metamorphopsia persisted in 26 (89.7%) of 29 eyes. The posttreatment M-CHARTS score was not correlated with any posttreatment morphological parameters. However, the posttreatment M-CHARTS score was weakly correlated with the baseline total foveal thickness (r = 0.35. p = 0.024) and closely correlated with the baseline M-CHARTS score (r = 0.78, p < 0.001). Conclusions Metamorphopsia associated with acute BRVO was quantified using M-CHARTS. Initial microstructural changes in the outer retina from acute BRVO may primarily account for the metamorphopsia.	[Manabe, Koichiro; Tsujikawa, Akitaka; Osaka, Rie; Nakano, Yuki; Fujita, Tomoyoshi; Shiragami, Chieko; Hirooka, Kazuyuki] Kagawa Univ, Dept Ophthalmol, Fac Med, Miki, Kagawa, Japan; [Uji, Akihito; Muraoka, Yuki] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kagawa University; Kyoto University	Tsujikawa, A (corresponding author), Kagawa Univ, Dept Ophthalmol, Fac Med, Miki, Kagawa, Japan.	tujikawa.kagawa@gmail.com		Tsujikawa, Akitaka/0000-0003-0779-7799	Japan Society for the Promotion of Science [15K10841]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (AT; 15K10841, https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2015, ACTA OPHTHALMOL, V93, pE649, DOI 10.1111/aos.12735; Akagi-Kurashige Y, 2014, AM J OPHTHALMOL, V157, P1239, DOI 10.1016/j.ajo.2014.02.026; Arimura E, 2005, INVEST OPHTH VIS SCI, V46, P2961, DOI 10.1167/iovs.04-1104; Arimura E, 2007, ACTA OPHTHALMOL SCAN, V85, P55, DOI 10.1111/j.1600-0420.2006.00729.x; Arimura E, 2011, INVEST OPHTH VIS SCI, V52, P128, DOI 10.1167/iovs.09-3535; Bae SW, 2013, INDIAN J OPHTHALMOL, V61, P172, DOI 10.4103/0301-4738.112162; Campochiaro PA, 2015, OPHTHALMOLOGY, V122, P538, DOI 10.1016/j.ophtha.2014.08.031; dell'Omo R, 2013, INVEST OPHTH VIS SCI, V54, P7803, DOI 10.1167/iovs.13-12817; Faes L, 2014, EYE, V28, P788, DOI 10.1038/eye.2014.104; Fujita K, 2014, RETINA-J RET VIT DIS, V34, P964, DOI 10.1097/IAE.0000000000000027; Fukuda S, 2009, BRIT J OPHTHALMOL, V93, P1595, DOI 10.1136/bjo.2008.155440; Hayreh SS, 2014, PROG RETIN EYE RES, V41, P1, DOI 10.1016/j.preteyeres.2014.04.001; Heier JS, 2012, OPHTHALMOLOGY, V119, P802, DOI 10.1016/j.ophtha.2011.12.005; Jonas J, 2010, DEV OPHTHALMOL, V47, P111, DOI 10.1159/000320076; Kim JW, 2016, ACTA OPHTHALMOL, V94, pE54, DOI 10.1111/aos.12795; Kinoshita T, 2016, GRAEF ARCH CLIN EXP, V254, P1041, DOI 10.1007/s00417-015-3147-3; Kinoshita T, 2015, CLIN OPHTHALMOL, V9, P225, DOI 10.2147/OPTH.S76847; Kinoshita T, 2012, INVEST OPHTH VIS SCI, V53, P3592, DOI 10.1167/iovs.12-9493; Krasnicki P, 2015, ADV MED SCI-POLAND, V60, P162, DOI 10.1016/j.advms.2015.01.006; Matsumoto C, 2003, INVEST OPHTH VIS SCI, V44, P4012, DOI 10.1167/iovs.03-0117; McGowan G, 2015, RETINA; Nakagawa Tomoya, 2007, Nippon Ganka Gakkai Zasshi, V111, P331; Nomoto H, 2013, EYE, V27, P924, DOI 10.1038/eye.2013.108; Nowomiejska K, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-13; Okamoto F, 2015, RETINA-J RET VIT DIS, V35, P2107, DOI 10.1097/IAE.0000000000000602; Okamoto F, 2014, AM J OPHTHALMOL, V157, P214, DOI 10.1016/j.ajo.2013.08.007; Okamoto F, 2012, INVEST OPHTH VIS SCI, V53, P6770, DOI 10.1167/iovs.12-9683; Okamoto Y, 2014, JPN J OPHTHALMOL, V58, P369, DOI 10.1007/s10384-014-0323-7; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Ota M, 2010, JPN J OPHTHALMOL, V54, P555, DOI 10.1007/s10384-010-0878-x; Simunovic MP, 2015, RETINA-J RET VIT DIS, V35, P1285, DOI 10.1097/IAE.0000000000000581; Stanga P. E., 2001, International Ophthalmology, V23, P191, DOI 10.1023/A:1014476430078; Tsujikawa A, 2010, AM J OPHTHALMOL, V149, P291, DOI 10.1016/j.ajo.2009.09.007; Uji A, 2014, AM J OPHTHALMOL, V157, P227, DOI 10.1016/j.ajo.2013.09.008; Vujosevic S, 2015, OPHTHALMIC RES, P26; Watanabe A, 2009, OPHTHALMOLOGY, V116, P1788, DOI 10.1016/j.ophtha.2009.04.046; Wiecek E, 2015, INVEST OPHTH VIS SCI, V56, P494, DOI 10.1167/iovs.14-15394; Yamaike N, 2008, OPHTHALMOLOGY, V115, P355, DOI 10.1016/j.ophtha.2007.04.052	38	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153817	10.1371/journal.pone.0153817	http://dx.doi.org/10.1371/journal.pone.0153817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123642	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700032
J	Ruiz-Gomez, G; Hawkins, JC; Philipp, J; Kunze, G; Wodtke, R; Loser, R; Fahmy, K; Pisabarro, MT				Ruiz-Gomez, Gloria; Hawkins, John C.; Philipp, Jenny; Kuenze, Georg; Wodtke, Robert; Loeser, Reik; Fahmy, Karim; Pisabarro, M. Teresa			Rational Structure-Based Rescaffolding Approach to De Novo Design of Interleukin 10 (IL-10) Receptor-1 Mimetics	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; PHAGE DISPLAY; CRYSTAL-STRUCTURE; ALPHA-HELICES; WATER; RECOGNITION; INHIBITION; TEMPLATES; BACTERIAL; ALGORITHM	Tackling protein interfaces with small molecules capable of modulating protein-protein interactions remains a challenge in structure-based ligand design. Particularly arduous are cases in which the epitopes involved in molecular recognition have a non-structured and discontinuous nature. Here, the basic strategy of translating continuous binding epitopes into mimetic scaffolds cannot be applied, and other innovative approaches are therefore required. We present a structure-based rational approach involving the use of a regular expression syntax inspired in the well established PROSITE to define minimal descriptors of geometric and functional constraints signifying relevant functionalities for recognition in protein interfaces of non-continuous and unstructured nature. These descriptors feed a search engine that explores the currently available three-dimensional chemical space of the Protein Data Bank (PDB) in order to identify in a straightforward manner regular architectures containing the desired functionalities, which could be used as templates to guide the rational design of small natural-like scaffolds mimicking the targeted recognition site. The application of this rescaffolding strategy to the discovery of natural scaffolds incorporating a selection of functionalities of interleukin-10 receptor-1 (IL-10R1), which are relevant for its interaction with interleukin-10 (IL-10) has resulted in the de novo design of a new class of potent IL-10 peptidomimetic ligands.	[Ruiz-Gomez, Gloria; Hawkins, John C.; Pisabarro, M. Teresa] BIOTEC TU Dresden, Struct Bioinformat, Dresden, Germany; [Philipp, Jenny; Fahmy, Karim] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, D-01314 Dresden, Germany; [Kuenze, Georg] Univ Leipzig, Inst Med Phys & Biophys, D-04109 Leipzig, Germany; [Wodtke, Robert; Loeser, Reik] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, D-01314 Dresden, Germany	Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Leipzig University; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR)	Ruiz-Gomez, G; Pisabarro, MT (corresponding author), BIOTEC TU Dresden, Struct Bioinformat, Dresden, Germany.	gloriaruizgomez@biotec.tu-dresden.de; mayte@biotec.tu-dresden.de	Fahmy, Karim/B-2708-2017; Löser, Reik/I-9469-2016; Pisabarro, M. Teresa/D-4270-2012	Fahmy, Karim/0000-0002-8752-5824; Löser, Reik/0000-0003-1531-7601; Wodtke, Robert/0000-0001-7462-7111	Alexander von Humboldt Foundation; German Research Foundation; TU Dresden	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation(German Research Foundation (DFG)); TU Dresden(European Commission)	GRG thanks the Alexander von Humboldt Foundation for a postdoctoral fellowship. The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Software Inc, 2009, DISC STUD MOD ENV RE; Albericio F, 2000, SOLID-PHASE SYNTHESIS, P275; Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239; [Anonymous], 2009, R LANG ENV STAT COMP; [Anonymous], 2012, MOL OP ENV MOE VERS; [Anonymous], 2004, ANGEW CHEM, V116, P2741; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Bahar I, 1996, FOLD DES, V1, P357, DOI 10.1016/S1359-0278(96)00051-X; Ball C, 2001, EUR CYTOKINE NETW, V12, P187; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Barker JA, 2003, BIOINFORMATICS, V19, P1644, DOI 10.1093/bioinformatics/btg226; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bradshaw RT, 2011, PROTEIN ENG DES SEL, V24, P197, DOI 10.1093/protein/gzq047; Case DA, 2012, AMBER 12; Chon JH, 2011, NEW BIOTECHNOL, V28, P458, DOI 10.1016/j.nbt.2011.03.015; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; de Araujo AD, 2014, ANGEW CHEM INT EDIT, V53, P6965, DOI 10.1002/anie.201310245; Debret G, 2009, NUCLEIC ACIDS RES, V37, pW459, DOI 10.1093/nar/gkp304; Delano WL., 2002, PYMOL MOL GRAPHICS S; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Gabrysova L, 2014, CURR TOP MICROBIOL, V380, P157, DOI 10.1007/978-3-662-43492-5_8; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Gude M, 2002, LETT PEPT SCI, V9, P203, DOI 10.1007/BF02538384; Harrison RS, 2010, P NATL ACAD SCI USA, V107, P11686, DOI 10.1073/pnas.1002498107; Hijnen M, 2007, VACCINE, V25, P6807, DOI 10.1016/j.vaccine.2007.06.027; Hill TA, 2014, ANGEW CHEM INT EDIT, V53, P13020, DOI 10.1002/anie.201401058; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IUPAC-IUB Commission on Biochemical Nomenclature, 1972, J BIOL CHEM, V247, P977; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kastenholz MA, 2000, J MED CHEM, V43, P3033, DOI 10.1021/jm000934y; Klebe G, 2015, NAT REV DRUG DISCOV, V14, P95, DOI 10.1038/nrd4486; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Kunze G, 2014, BIOMOL NMR ASSIGN, V8, P375, DOI 10.1007/s12104-013-9521-3; Kutchukian PS, 2009, J AM CHEM SOC, V131, P4622, DOI 10.1021/ja805037p; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Laskowski RA, 2005, J MOL BIOL, V351, P614, DOI 10.1016/j.jmb.2005.05.067; Martin ACR, 2000, PROTEIN ENG, V13, P829, DOI 10.1093/protein/13.12.829; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Milroy LG, 2014, CHEM REV, V114, P4695, DOI 10.1021/cr400698c; Mulder GE, 2012, CHEM COMMUN, V48, P10007, DOI 10.1039/c2cc35310e; Nadzirin N, 2013, NUCLEIC ACIDS RES, V41, pW432, DOI 10.1093/nar/gkt431; Nadzirin N, 2012, NUCLEIC ACIDS RES, V40, pW380, DOI 10.1093/nar/gks401; Nevola L, 2015, CHEM COMMUN, V51, P3302, DOI 10.1039/c4cc08565e; Omidfar K, 2015, EXPERT OPIN DRUG DIS, V10, P651, DOI 10.1517/17460441.2015.1037738; Papoian GA, 2003, J AM CHEM SOC, V125, P9170, DOI 10.1021/ja034729u; Pelay-Gimeno M, 2015, ANGEW CHEM INT EDIT, V54, P8896, DOI 10.1002/anie.201412070; Putnam WS, 2010, TRENDS BIOTECHNOL, V28, P509, DOI 10.1016/j.tibtech.2010.07.001; Rao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059415; Robinson JA, 2008, ACCOUNTS CHEM RES, V41, P1278, DOI 10.1021/ar700259k; Robinson JA, 2011, CURR OPIN CHEM BIOL, V15, P379, DOI 10.1016/j.cbpa.2011.02.015; Ross NT, 2010, PHILOS T R SOC A, V368, P989, DOI 10.1098/rsta.2009.0210; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Samsonov S, 2008, PROTEINS, V73, P515, DOI 10.1002/prot.22076; Shepherd NE, 2004, ANGEW CHEM INT EDIT, V43, P2687, DOI 10.1002/anie.200352659; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Teyra J, 2007, PROTEINS, V67, P1087, DOI 10.1002/prot.21394; Teyra J, 2011, PROTEINS, V79, P499, DOI 10.1002/prot.22897; Teyra J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-9; Thieriet N, 1997, TETRAHEDRON LETT, V38, P7275, DOI 10.1016/S0040-4039(97)01690-0; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; WINDSOR WT, 1993, BIOCHEMISTRY-US, V32, P8807, DOI 10.1021/bi00085a011; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395; Zdanov A, 1996, PROTEIN SCI, V5, P1955, DOI 10.1002/pro.5560051001	74	3	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154046	10.1371/journal.pone.0154046	http://dx.doi.org/10.1371/journal.pone.0154046			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123592	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700042
J	Alos, J; Palmer, M; Balle, S; Arlinghaus, R				Alos, Josep; Palmer, Miquel; Balle, Salvador; Arlinghaus, Robert			Bayesian State-Space Modelling of Conventional Acoustic Tracking Provides Accurate Descriptors of Home Range Behavior in a Small-Bodied Coastal Fish Species	PLOS ONE			English	Article							PEARLY RAZORFISH; TELEMETRY DATA; DIEL BEHAVIOR; MOVEMENT DATA; DESIGN; PERFORMANCE; NOVACULA; ATLANTIC; SYSTEM; SCALES	State-space models (SSM) are increasingly applied in studies involving biotelemetry-generated positional data because they are able to estimate movement parameters from positions that are unobserved or have been observed with non-negligible observational error. Popular telemetry systems in marine coastal fish consist of arrays of omnidirectional acoustic receivers, which generate a multivariate time-series of detection events across the tracking period. Here we report a novel Bayesian fitting of a SSM application that couples mechanistic movement properties within a home range (a specific case of random walk weighted by an Ornstein-Uhlenbeck process) with a model of observational error typical for data obtained from acoustic receiver arrays. We explored the performance and accuracy of the approach through simulation modelling and extensive sensitivity analyses of the effects of various configurations of movement properties and time-steps among positions. Model results show an accurate and unbiased estimation of the movement parameters, and in most cases the simulated movement parameters were properly retrieved. Only in extreme situations (when fast swimming speeds are combined with pooling the number of detections over long time-steps) the model produced some bias that needs to be accounted for in field applications. Our method was subsequently applied to real acoustic tracking data collected from a small marine coastal fish species, the pearly razorfish, Xyrichtys novacula. The Bayesian SSM we present here constitutes an alternative for those used to the Bayesian way of reasoning. Our Bayesian SSM can be easily adapted and generalized to any species, thereby allowing studies in freely roaming animals on the ecological and evolutionary consequences of home ranges and territory establishment, both in fishes and in other taxa.	[Alos, Josep; Arlinghaus, Robert] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Muggelseedamm 310, D-12587 Berlin, Germany; [Alos, Josep; Palmer, Miquel; Balle, Salvador] IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, C Miquel Marques 21, Esporles 07190, Illes Balears, Spain; [Arlinghaus, Robert] Humboldt Univ, Div Integrat Fisheries Management, Fac Life Sci, Invalidenstr 42, D-10155 Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Humboldt University of Berlin	Alos, J (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Muggelseedamm 310, D-12587 Berlin, Germany.; Alos, J (corresponding author), IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, C Miquel Marques 21, Esporles 07190, Illes Balears, Spain.	alos@imedea.uib-csic.es	Arlinghaus, Robert/J-6171-2019; Balle, Salvador/F-8575-2013; Arlinghaus, Robert/E-3340-2010; Palmer, Miquel/E-3561-2013	Balle, Salvador/0000-0002-7026-1391; Arlinghaus, Robert/0000-0003-2861-527X; Miquel, Palmer/0000-0002-7875-3673	Marie Curie Post-Doc grant (FP7-PEOPLE-IEF) [327160]; research project REC2 - Spanish Ministry of Economy and Competiveness [CTM2011-23835]; research project CONFLICT - Spanish Ministry of Economy and Competiveness [CGL2008-00958]; Juan de la Cierva Post-doc grant - Spanish Ministry of Economy and Competiveness [FJCI-2014-21239]; B-Types project through Leibniz Competition [SAW-2013-IGB-2]	Marie Curie Post-Doc grant (FP7-PEOPLE-IEF); research project REC2 - Spanish Ministry of Economy and Competiveness; research project CONFLICT - Spanish Ministry of Economy and Competiveness; Juan de la Cierva Post-doc grant - Spanish Ministry of Economy and Competiveness; B-Types project through Leibniz Competition	This study was funded through a Marie Curie Post-Doc grant (FP7-PEOPLE-2012-IEF, grant no. 327160). MP received additional funding from the research project REC2 (grant no. CTM2011-23835) and the research project CONFLICT (grant no. CGL2008-00958) and JA from a Juan de la Cierva Post-doc grant (grant no. FJCI-2014-21239), all of them funded by the Spanish Ministry of Economy and Competiveness. The project also received additional funding from the B-Types project funded through Leibniz Competition (grant no. SAW-2013-IGB-2) to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2015, MAR ECOL PROG SER, V518, P255, DOI 10.3354/meps11054; Albertsen CM, 2015, ECOLOGY, V96, P2598, DOI 10.1890/14-2101.1.sm; Alos J, 2012, MAR ECOL PROG SER, V460, P207, DOI 10.3354/meps09755; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Alos J, 2011, MAR ECOL PROG SER, V427, P173, DOI 10.3354/meps09042; Andrews KS, 2011, MAR BIOL, V158, P2377, DOI 10.1007/s00227-011-1724-5; Arlinghaus R, 2016, TRENDS ECOL EVOL, V31, P92, DOI 10.1016/j.tree.2015.11.008; Baktoft H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126534; Benhamou S, 2014, ECOL LETT, V17, P261, DOI 10.1111/ele.12225; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Botsford LW, 2003, ECOL APPL, V13, pS25; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Candi G, 2004, J FISH BIOL, V64, P1498, DOI 10.1111/j.0022-1112.2004.0404.x; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; D'Anna G, 2010, ITALIAN J ZOOLOGY, V78, P255; Donaldson MR, 2014, FRONT ECOL ENVIRON, V12, P565, DOI 10.1890/130283; DUNN JE, 1977, BIOMETRICS, V33, P85, DOI 10.2307/2529305; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Fagan W.F., 2014, B ECOL SOC AM, V95, P204, DOI DOI 10.1890/0012-9623-95.3.204; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Farmer NA, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-7; Gardiner C. W., 1990, HDB STOCHASTIC METHO; Gelman A., 2021, BAYESIAN DATA ANAL; Grothues TM, 2009, REV-METHODS TECHNOL, V9, P77, DOI 10.1007/978-1-4020-9640-2_5; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hedger RD, 2008, ICES J MAR SCI, V65, P1248, DOI 10.1093/icesjms/fsn109; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heupel MR, 2008, LIMNOL OCEANOGR-METH, V6, P327, DOI 10.4319/lom.2008.6.327; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; How J, 2012, MARINE FRESHWATER RE, V63, P321; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Katsanevakis S, 2005, SCI MAR, V69, P223, DOI 10.3989/scimar.2005.69n2223; Kessel ST, 2014, REV FISH BIOL FISHER, V24, P199, DOI 10.1007/s11160-013-9328-4; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Klimley AP, 1998, MAR TECHNOL SOC J, V32, P94; Koeck B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069303; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; MARCONATO A, 1995, J FISH BIOL, V47, P292, DOI 10.1006/jfbi.1995.0134; MARTINS EG, 2014, ANIMAL BIOTELEMETRY, V0002, P00013, DOI DOI 10.1186/2050-3385-2-13; Mathies NH, 2014, MAR ECOL PROG SER, V495, P27, DOI 10.3354/meps10582; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; Moorcroft PR, 2006, P ROY SOC B-BIOL SCI, V273, P1651, DOI 10.1098/rspb.2005.3439; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; Musyl M, 2001, ELECT TAGGING TRACKI, P343, DOI [10.1007/978-94-017-1402-0_19, DOI 10.3354/MEPS09899]; Palmer M, 2011, MAR ECOL PROG SER, V430, P87, DOI 10.3354/meps09109; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Payne NL, 2011, MARINE ECOLOGY PROGR, V419, P295; Pedersen MW, 2014, METHODS ECOL EVOL, V5, P1043, DOI 10.1111/2041-210X.12255; Pedersen MW, 2013, METHODS ECOL EVOL, V4, P920, DOI 10.1111/2041-210X.12086; Plummer M, 2006, R NEWS, V6, P5; Roy R., 2014, ANIM BIOTELEM, V2, P1, DOI DOI 10.1186/2050-3385-2-1; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Singh L, 2009, AFR J MAR SCI, V31, P355, DOI 10.2989/AJMS.2009.31.3.8.996; Smith GW, 1998, HYDROBIOLOGIA, V372, P9, DOI 10.1023/A:1017039325661; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Tolon V, 2009, CAN J ZOOL, V87, P1129, DOI 10.1139/Z09-101; Turchin Peter, 1998; Tuya F, 2005, MAR BIOL, V147, P1229, DOI 10.1007/s00227-005-0018-1; Van Moorter B, 2016, J ANIM ECOL, V85, P21, DOI 10.1111/1365-2656.12394; Villegas-Rios D, 2013, J SEA RES, V80, P61, DOI 10.1016/j.seares.2013.02.009; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1	78	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154089	10.1371/journal.pone.0154089	http://dx.doi.org/10.1371/journal.pone.0154089			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119718	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200044
J	Wong, DWC; Niu, WX; Wang, Y; Zhang, M				Wong, Duo Wai-Chi; Niu, Wenxin; Wang, Yan; Zhang, Ming			Finite Element Analysis of Foot and Ankle Impact Injury: Risk Evaluation of Calcaneus and Talus Fracture	PLOS ONE			English	Article							TRABECULAR BONE; BIOMECHANICS; MODEL; JOINT; TOLERANCE; LIGAMENTS; COMPLEX; WALKING; TRAUMA; SHEAR	Introduction Foot and ankle impact injury is common in geriatric trauma and often leads to fracture of rearfoot, including calcaneus and talus. The objective of this study was to assess the influence of foot impact on the risk of calcaneus and talus fracture via finite element analysis. Methods A three-dimensional finite element model of foot and ankle was constructed based on magnetic resonance images of a female aged 28. The foot sustained a 7-kg passive impact through a foot plate. The simulated impact velocities were from 2.0 to 7.0 m/s with 1.0 m/s interval. Results At 5.0 m/s impact velocity, the maximum von Mises stress of the trabecular calcaneus and talus were 3.21MPa and 2.41MPa respectively, while that of the Tresca stress were 3.46MPa and 2.55MPa. About 94% and 84% of the trabecular calcaneus and talus exceeded the shear yielding stress, while 21.7% and 18.3% yielded the compressive stress. The peak stresses were distributed around the talocalcaneal articulation and the calcaneal tuberosity inferiorly, which corresponded to the common fracture sites. Conclusions The prediction in this study showed that axial compressive impact at 5.0 m/s could produce considerable yielding of trabecular bone in both calcaneus and talus, dominantly by shear and compounded with compression that predispose the rearfoot in the risk of fracture. This study suggested the injury pattern and fracture mode of high energy trauma that provides insights in injury prevention and fracture management.	[Wong, Duo Wai-Chi; Niu, Wenxin; Wang, Yan; Zhang, Ming] Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Niu, Wenxin] Tongji Univ, Sch Med, Shanghai Yang Zhi Rehabil Hosp, Shanghai 200092, Peoples R China	Hong Kong Polytechnic University; Tongji University	Zhang, M (corresponding author), Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China.	ming.zhang@polyu.edu.hk	Zhang, Ming/F-8331-2011; Wong, Duo Wai-Chi/B-4127-2015; Wang, Yan/AAU-3194-2021	Zhang, Ming/0000-0002-6027-4594; Wong, Duo Wai-Chi/0000-0002-8805-1157; Wang, Yan/0000-0002-5404-4098; Niu, Wenxin/0000-0003-1349-4524	Research Grants Council of Hong Kong [PolyU5326/11E, PolyU152216/14E, PolyU15200215]; National Natural Science Foundation of China [11272273, 11120101001, 11302154]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Research Grants Council of Hong Kong (PolyU5326/11E, PolyU152216/14E, PolyU15200215), http://www.ugc.edu.hk/, and National Natural Science Foundation of China (11272273, 11120101001, 11302154), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou KA, 1998, CLIN ORTHOP RELAT R, P269; Bailey AM, 2015, TRAFFIC INJ PREV, V16, pS96, DOI 10.1080/15389588.2015.1061185; Banerjee R, 2014, MANNS SURG FOOT ANKL, V9th, P2101; Chang CY, 2008, STAPP CAR C, V52, P475; Chen WM, 2015, COMPUT METHOD BIOMEC, V18, P1582, DOI 10.1080/10255842.2014.930447; Cheung JTM, 2009, FOOTWEAR SCI, V1, P31, DOI 10.1080/19424280903002323; Cheung JTM, 2005, J BIOMECH, V38, P1045, DOI 10.1016/j.jbiomech.2004.05.035; Chi KJ, 2005, J BIOMECH, V38, P1387, DOI 10.1016/j.jbiomech.2004.06.020; Cho JR, 2009, J MECH SCI TECHNOL, V23, P2583, DOI 10.1007/s12206-009-0801-x; Crandall JR, BIOMECHANICAL RESPON; Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003; Farhang B, 2015, P I MECH ENG P-J SPO; Federal Aviation Administration, 1985, INJ CRIT HUM EXP IMP; Forman JL, 2015, ACCIDENT ANAL PREV, V80, P7, DOI 10.1016/j.aap.2015.03.004; Funk JR, 2002, J BIOMECH ENG-T ASME, V124, P750, DOI 10.1115/1.1514675; Gallenberger Kathryn, 2013, Ann Adv Automot Med, V57, P123; Garnier KB, 1999, MED ENG PHYS, V21, P641, DOI 10.1016/S1350-4533(99)00096-X; Gowing R, 2007, CAN J SURG, V50, P437; Gu YD, 2010, SKIN RES TECHNOL, V16, P291, DOI 10.1111/j.1600-0846.2010.00425.x; Herscovici D, 2012, GERIATR ORTHOP SURG, V3, P33, DOI 10.1177/2151458511436112; Hubbard M, 2009, SAFER SKI JUMP LANDI, P17; Kelly N, 2012, J MECH BEHAV BIOMED, V9, P184, DOI 10.1016/j.jmbbm.2011.11.013; Klopp G, 1997, P 1997 INT IRC C BIO; Lemmon D, 1997, J BIOMECH, V30, P615, DOI 10.1016/S0021-9290(97)00006-7; MCGEE A, 2004, TRAUMA, V6, P29, DOI DOI 10.1191/1460408604TA295OA; McKay BJ, 2009, STAPP CAR CRASH JO, V53, P229; Milz P, 1998, ACTA ORTHOP SCAND, V69, P51, DOI 10.3109/17453679809002357; Mittra E, 2008, J BIOMECH, V41, P368, DOI 10.1016/j.jbiomech.2007.09.003; Morales-Orcajo E., 2015, ARCH COMPUT METHODS, P1; Nakamura S, 1981, Bull Prosthet Res, V10-35, P27; Niu WX, 2011, HUM MOVEMENT SCI, V30, P614, DOI 10.1016/j.humov.2010.10.010; Parenteau CS, 1998, J BIOMECH ENG-T ASME, V120, P105, DOI 10.1115/1.2834289; Qian Z, 2013, DYNAMIC FINITE ELEME; Rammelt S, 2004, INJURY, V35, P443, DOI 10.1016/j.injury.2003.10.006; Sabry FF, 2000, FOOT ANKLE INT, V21, P114, DOI 10.1177/107110070002100204; Sanders RW, 2014, MANNS SURG FOOT ANKL, P2041; Sanyal A, 2012, J BIOMECH, V45, P2513, DOI 10.1016/j.jbiomech.2012.07.023; Schuenke M., 2007, THIEME ATLAS ANATOMY; SCHWAB CW, 1992, ARCH SURG-CHICAGO, V127, P701; Shin J, 2012, ANN BIOMED ENG, V40, P2519, DOI 10.1007/s10439-012-0607-3; SIEGLER S, 1988, FOOT ANKLE, V8, P234, DOI 10.1177/107110078800800502; Smith B R, 2005, Traffic Inj Prev, V6, P156, DOI 10.1080/15389580590931635; Telfer S, 2014, WHAT HAS FINITE ELEM; Wang Y, 2016, ANN BIOMED ENG, V44, P213, DOI 10.1007/s10439-015-1359-7; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134340; Wong DWC, 2015, J BIOMECH, V48, P3142, DOI 10.1016/j.jbiomech.2015.07.013; Wong DWC, 2014, MED ENG PHYS, V36, P1388, DOI 10.1016/j.medengphy.2014.03.004; Yoganandan N, 1997, J BIOMECH ENG-T ASME, V119, P433, DOI 10.1115/1.2798290; Zhang M, 1999, PROSTHET ORTHOT INT, V23, P135	49	46	47	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154435	10.1371/journal.pone.0154435	http://dx.doi.org/10.1371/journal.pone.0154435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119740	gold, Green Published, Green Submitted			2022-12-26	WOS:000374976200074
J	Javanbakht, T; Laurent, S; Stanicki, D; Wilkinson, KJ				Javanbakht, Taraneh; Laurent, Sophie; Stanicki, Dimitri; Wilkinson, Kevin J.			Relating the Surface Properties of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) to Their Bactericidal Effect towards a Biofilm of Streptococcus mutans	PLOS ONE			English	Article							DIFFUSION; CHARGE	This study was designed to determine the effects of superparamagnetic iron oxide nanoparticles (SPIONs) on the biological activity of a bacterial biofilm (Streptococcus mutans). Our hypothesis was that the diffusion of the SPIONs into biofilms would depend on their surface properties, which in turn would largely be determined by their surface functionality. Bare, positively charged and negatively charged SPIONs, with hydrodynamic diameters of 14.6 +/- 1.4 nm, 20.4 +/- 1.3 nm and 21.2 +/- 1.6 nm were evaluated. Time-of-flight secondary ion mass spectrometry (TOF-SIMS) and electrophoretic mobility (EPM) measurements were used to confirm that carboxylic functional groups predominated on the negatively charged SPIONS, whereas amine functional groups predominated on the positively charged particles. Transmission electron microscopy (TEM) showed the morphology and sizes of SPIONs. Scanning electron microscopy (SEM) and EPM measurements indicated that the surfaces of the SPIONs were covered with biomolecules following their incubation with the biofilm. Bare SPIONs killed bacteria less than the positively charged SPIONs at the highest exposure concentrations, but the toxicity of the bare and positively charged SPIONs was the same for lower SPION concentrations. The positively charged SPIONs were more effective in killing bacteria than the negatively charged ones. Nonetheless, electrophoretic mobilities of all three SPIONs (negative, bare and positively charged) became more negative following incubation with the (negatively-charged) biofilm. Therefore, while the surface charge of SPIONS was important in determining their biological activity, the initial surface charge was not constant in the presence of the biofilm, leading eventually to SPIONS with fairly similar surface charges in situ. The study nonetheless suggests that the surface characteristics of the SPIONS is an important parameter controlling the efficiency of antimicrobial agents. The analysis of the CFU/mL values shows that the SPIONs have the same toxicity on bacteria in solution in comparison with that on the biofilm.	[Javanbakht, Taraneh; Wilkinson, Kevin J.] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Laurent, Sophie; Stanicki, Dimitri] Univ Mons, Lab NMR & Mol Imaging, B-7000 Mons, Belgium; [Laurent, Sophie] CMMI, Gosselies, Belgium	Universite de Montreal	Javanbakht, T (corresponding author), Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada.	taraneh.javanbakht@umontreal.ca	Javanbakht, Taraneh/B-7775-2015; Wilkinson, Kevin J/I-4193-2012	Javanbakht, Taraneh/0000-0002-2658-330X; Wilkinson, Kevin J/0000-0002-7182-3624				Attila C, 2008, MICROB BIOTECHNOL, V1, P17, DOI 10.1111/j.1751-7915.2007.00002.x; Bridot JL, 2013, CONTRAST MEDIA MOL I, V8, P466, DOI 10.1002/cmmi.1552; Chen B, 2011, CURR CANCER DRUG TAR, V11, P184, DOI 10.2174/156800911794328475; Chen Yue, 2010, Chin J Cancer, V29, P125; Chew SC, 2014, MBIO, V5, DOI 10.1128/mBio.01536-14; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P7277, DOI 10.1021/es900249m; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Golmohamadi M, 2013, ENVIRON CHEM, V10, P34, DOI 10.1071/EN12106; Hong B, 2008, ADV EXP MED BIOL, V614, P265, DOI 10.1007/978-0-387-74911-2_30; Hu Y., 2012, THESIS TU DENMARK, P19; Issa B, 2013, INT J MOL SCI, V14, P21266, DOI 10.3390/ijms141121266; Javanbakht T, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3276-y; Jia F, 2013, J CONTROL RELEASE, V172, P1020, DOI 10.1016/j.jconrel.2013.10.012; Kazemzadeh Hamid, 2012, International Journal of Modern Physics: Conference Series, V5, P160, DOI 10.1142/S2010194512001973; Laurent S, 2012, PLOS ONE, V7, P306, DOI 10.1371/journal.pone.0029997; Leuba KD, 2013, INT J NANOMED, V8, P731, DOI 10.2147/IJN.S38256; Li XN, 2015, CHEM COMMUN, V51, P282, DOI 10.1039/c4cc07737g; Maurer-Jones MA, 2013, ANAL CHEM, V85, P3036, DOI 10.1021/ac303636s; Namanga J, 2013, J NANOMATER, V2013, DOI 10.1155/2013/137275; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Park H, 2011, J MICROBIOL METH, V84, P41, DOI 10.1016/j.mimet.2010.10.010; Peulen TO, 2011, ENVIRON SCI TECHNOL, V45, P3367, DOI 10.1021/es103450g; Sakulkhu U, 2014, SCI REP-UK, V4, DOI 10.1038/srep05020; Subbiandoss G, 2012, ACTA BIOMATER, V8, P2047, DOI 10.1016/j.actbio.2012.03.002; Taylor EN, 2012, SMALL, V8, P3016, DOI 10.1002/smll.201200575; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhang XF, 2011, J PHYS CHEM C, V115, P1436, DOI 10.1021/jp1075498; Zhang ZS, 2011, ANTIMICROB AGENTS CH, V55, P1075, DOI 10.1128/AAC.01329-10	28	29	29	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154445	10.1371/journal.pone.0154445	http://dx.doi.org/10.1371/journal.pone.0154445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115356	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600067
J	Yabe, S; Yamasaki, M; Ebana, K; Hayashi, T; Iwata, H				Yabe, Shiori; Yamasaki, Masanori; Ebana, Kaworu; Hayashi, Takeshi; Iwata, Hiroyoshi			Island-Model Genomic Selection for Long-Term Genetic Improvement of Autogamous Crops	PLOS ONE			English	Article								Acceleration of genetic improvement of autogamous crops such as wheat and rice is necessary to increase cereal production in response to the global food crisis. Population and pedigree methods of breeding, which are based on inbred line selection, are used commonly in the genetic improvement of autogamous crops. These methods, however, produce a few novel combinations of genes in a breeding population. Recurrent selection promotes recombination among genes and produces novel combinations of genes in a breeding population, but it requires inaccurate single-plant evaluation for selection. Genomic selection (GS), which can predict genetic potential of individuals based on their marker genotype, might have high reliability of single-plant evaluation and might be effective in recurrent selection. To evaluate the efficiency of recurrent selection with GS, we conducted simulations using real marker genotype data of rice cultivars. Additionally, we introduced the concept of an "island model" inspired by evolutionary algorithms that might be useful to maintain genetic variation through the breeding process. We conducted GS simulations using real marker genotype data of rice cultivars to evaluate the efficiency of recurrent selection and the island model in an autogamous species. Results demonstrated the importance of producing novel combinations of genes through recurrent selection. An initial population derived from admixture of multiple bi-parental crosses showed larger genetic gains than a population derived from a single bi-parental cross in whole cycles, suggesting the importance of genetic variation in an initial population. The island-model GS better maintained genetic improvement in later generations than the other GS methods, suggesting that the island-model GS can utilize genetic variation in breeding and can retain alleles with small effects in the breeding population. The island-model GS will become a new breeding method that enhances the potential of genomic selection in autogamous crops, especially bringing long-term improvement.	[Yabe, Shiori; Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo, Japan; [Yamasaki, Masanori] Kobe Univ, Food Resources Educ & Res Ctr, Grad Sch Agr Sci, Kasai, Hyogo, Japan; [Ebana, Kaworu] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan; [Yabe, Shiori; Hayashi, Takeshi] Natl Agr & Food Res Org, Agr Res Ctr, Tsukuba, Ibaraki, Japan	University of Tokyo; Kobe University; National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Iwata, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo, Japan.	aiwata@mail.ecc.u-tokyo.ac.jp	Yamasaki, Masanori/C-5193-2018	Yamasaki, Masanori/0000-0001-7759-3965	JSPS KAKENHI Grant [25_6921]; MEXT [25252002]; Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [NVR-0002]; JST/CREST; Grants-in-Aid for Scientific Research [25252002] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); JST/CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Number 25_6921, by a Grant-in-Aid for Scientific Research (A), MEXT, No. 25252002, by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, NVR-0002) and by JST/CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, 1203 ESA FAO UN AGR, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; Brown J., 2008, INTRO PLANT BREEDING; Cheng ZK, 2001, GENETICS, V157, P1749; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer D. S., 1996, Introduction to quantitative genetics.; FUJIMAKI H, 1979, JARQ-JPN AGR RES Q, V13, P153; HANSON WD, 1959, GENETICS, V44, P857; Hartl DL, 2007, PRINCIPLES POPULATIO; Harushima Y, 1998, GENETICS, V148, P479; Iwata H, 2011, TREE GENET GENOMES, V7, P747, DOI 10.1007/s11295-011-0371-9; Iwata H, 2010, CROP SCI, V50, P1269, DOI 10.2135/cropsci2009.08.0434; Jannink JL, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-35; Kurata N, 1997, PLANT MOL BIOL, V35, P101, DOI 10.1023/A:1005760717474; LANDE R, 1990, GENETICS, V124, P743; McClosky B, 2013, THEOR APPL GENET, V126, P2907, DOI 10.1007/s00122-013-2182-x; Meuwissen THE, 2001, GENETICS, V157, P1819; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagasaki H, 2010, BREEDING SCI, V60, P648, DOI 10.1270/jsbbs.60.648; O'Hagan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048862; R Core Team, 2021, R LANGUAGE ENV STAT; Rutkoski JE, 2011, EUPHYTICA, V179, P161, DOI 10.1007/s10681-010-0301-1; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thompson SR, 2008, 004408 AEDEWP OH STA; Ukai Y, 2003, PLANT BREEDING; Verhoeven KJF, 2006, HEREDITY, V96, P139, DOI 10.1038/sj.hdy.6800763; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Whitley D., 1999, Journal of Computing and Information Technology - CIT, V7, P33; Wright S, 1943, GENETICS, V28, P114; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Yabe S, 2014, CROP SCI, V54, P1448, DOI 10.2135/cropsci2013.05.0319; Yabe S, 2013, CROP SCI, V53, P95, DOI 10.2135/cropsci2012.03.0167; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yamasaki M, 2013, BREEDING SCI, V63, P49, DOI 10.1270/jsbbs.63.49	35	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153945	10.1371/journal.pone.0153945	http://dx.doi.org/10.1371/journal.pone.0153945			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115872	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600035
J	Tolstykh, EI; Degteva, MO; Bougrov, NG; Napier, BA				Tolstykh, Evgenia I.; Degteva, Marina O.; Bougrov, Nikolay G.; Napier, Bruce A.			Body Potassium Content and Radiation Dose from K-40 for the Urals Population (Russia)	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; AGE; SARCOPENIA; ETHNICITY; CHILDREN; SPAN; LIFE	Long-term whole-body monitoring of radionuclides in residents of the Urals Region has been performed at the Urals Research Center for Radiation Medicine (URCRM, Chelyabinsk). Quantification of K-40 was achieved by measuring the K-40 photopeak with four phoswich detectors in whole body counter SICH-9.1M. The current study presents the results of K-40 measurements in 3,651 women and 1,961 t-test; U-test men aged 11-90; measurements were performed in 2006-2014. The residents belonged to two ethnic groups, Turkic (Tatar, Bashkir) and Slavs (mainly Russian). The levels of K-40-body contents depend upon gender, age, and body mass. Significant ethnic-differences were not found in K-40-body contents and K-40 concentrations in terms of Bq per kg of body weight (in groups homogenous by age and gender). Both K-40-body contents and concentrations were significantly higher in men than in women in all age-groups; the difference was about 25%. The measured K-40-body content in men of 20-50 years was about 4200 Bq (134 g of K) and about 3000 Bq (95 g of K) in women. By the age of 80 these values decreased to 3200 Bq (102 g of K) in men and 2500 Bq (80 g of K) in women. Annual dose rates were maximal in the age group of 20-30 years-0.16 mGy/y for men and 0.13 mGy/y for women. Further, the dose-rates decreased with age and in the groups of 60-80 years were 0.13 mGy/y for men and 0.10 mGy/y for women. Within groups homogeneous by age and gender, individual dose rates are described by a normal statistical distribution. The coefficient of variation ranges from 9 to 14%, and on the average is 12.5%. Doses from naturally occurring K-40 accumulated over 70 years were found to be 9.9 mGy for men and 8.3 mGy for women; over 90 years - 12.5 and 10.4 mGy.	[Tolstykh, Evgenia I.; Degteva, Marina O.; Bougrov, Nikolay G.] Urals Res Ctr Radiat Med, Biophys Lab, Chelyabinsk, Russia; [Napier, Bruce A.] Pacific NW Natl Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Tolstykh, EI (corresponding author), Urals Res Ctr Radiat Med, Biophys Lab, Chelyabinsk, Russia.	evgnia@urcrm.ru	Degteva, Marina/AAV-9175-2020; Bugrov, Nikolay/G-8322-2016; Толстых, Евгения/A-7747-2016	Bugrov, Nikolay/0000-0002-3693-9218; Degteva, Marina/0000-0002-0248-9829	U.S. Department of Energy's, Office of International Health Programs; Federal Medical-Biological Agency [27.504.14.9]	U.S. Department of Energy's, Office of International Health Programs; Federal Medical-Biological Agency	The research was funded by the U.S. Department of Energy's, Office of International Health Programs (http://www.energy.gov/ehss/russian-health-studies-program-active-projects, Barret N. Fountos, Program Manager, to BN, MO); and by Federal Medical-Biological Agency (contract 27.504.14.9 http://fcp.economy.gov.ru/cgi-bin/cis/fcp.cgi/Fcp/ViewFcp/View/2012/368/, to ET, NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, REP GEN ASS SCI ANN, V1; Batsis JA, 2014, EUR J CLIN NUTR, V68, P1001, DOI 10.1038/ejcn.2014.117; Bougrov NG, 2008, MED EXTREME SITUATIO, V4, P78; Butte NF, 2000, PEDIATR RES, V47, P578, DOI 10.1203/00006450-200005000-00004; Degteva M., 2013, RAD HYG, V6, P5; Demontis F, 2013, DIS MODEL MECH, V6, P1339, DOI 10.1242/dmm.012559; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; FLYNN MA, 1989, AM J CLIN NUTR, V50, P713, DOI 10.1093/ajcn/50.4.713; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Gohary M. I., 2010, IRPS B, V24, P6; ICRP-23, 1975, ICRP23; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Khokhryakov VV, 2002, CONSEQUENCES ANTHROP, P8; Kovtun AN, 2000, RADIAT PROT DOSIM, V89, P239, DOI 10.1093/oxfordjournals.rpd.a033071; KOZHEUROV VP, 1994, SCI TOTAL ENVIRON, V142, P37, DOI 10.1016/0048-9697(94)90072-8; Lynch TP, 2004, RADIAT PROT DOSIM, V111, P319, DOI 10.1093/rpd/nch345; Murphy AJ, 2008, BRIT J NUTR, V100, P666, DOI 10.1017/S0007114507901269; Nikolic M, 2005, COLLEGIUM ANTROPOL, V29, P67; Siegel JA, 2007, J NUCL MED, V48, P253; Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956; Solomon AM, 2006, J ENDOCRINOL, V191, P349, DOI 10.1677/joe.1.06837; SPADY DW, 1986, J PEDIATR GASTR NUTR, V5, P750, DOI 10.1097/00005176-198609000-00015; Strom D. J., 2009, PNNL18240; Tolstykh EI, 2012, 4 UR RES CTR RAD MED; Wang ZM, 2007, J NUTR, V137, P1988, DOI 10.1093/jn/137.8.1988; Welle S, 2002, CAN J APPL PHYSIOL, V27, P19, DOI 10.1139/h02-002	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154266	10.1371/journal.pone.0154266	http://dx.doi.org/10.1371/journal.pone.0154266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111330	Green Submitted, Green Published, gold			2022-12-26	WOS:000374970600054
J	Apetri, MM; Harkes, R; Subramaniam, V; Canters, GW; Schmidt, T; Aartsma, TJ				Apetri, Mihaela M.; Harkes, Rolf; Subramaniam, Vinod; Canters, Gerard W.; Schmidt, Thomas; Aartsma, Thijs J.			Direct Observation of alpha-Synuclein Amyloid Aggregates in Endocytic Vesicles of Neuroblastoma Cells	PLOS ONE			English	Article							ENDOSOMAL-LYSOSOMAL SYSTEM; PARKINSONS-DISEASE; LEWY BODY; FIBRILS; INCLUSIONS; CLEARANCE; NEURONS; SEED	Aggregation of alpha-synuclein has been linked to both familial and sporadic Parkinson's disease. Recent studies suggest that alpha-synuclein aggregates may spread from cell to cell and raise questions about the propagation of neurodegeneration. While continuous progress has been made characterizing alpha-synuclein aggregates in vitro, there is a lack of information regarding the structure of these species inside the cells. Here, we use confocal fluorescence microscopy in combination with direct stochastic optical reconstruction microscopy, dSTORM, to investigate alpha-synuclein uptake when added exogenously to SH-SY5Y neuroblastoma cells, and to probe in situ morphological features of alpha-synuclein aggregates with near nanometer resolution. We demonstrate that using dSTORM, it is possible to follow noninvasively the uptake of extracellularly added alpha-synuclein aggregates by the cells. Once the aggregates are internalized, they move through the endosomal pathway and accumulate in lysosomes to be degraded. Our dSTORM data show that alpha-synuclein aggregates remain assembled after internalization and they are shortened as they move through the endosomal pathway. No further aggregation was observed inside the lysosomes as speculated in the literature, nor in the cytoplasm of the cells. Our study thus highlights the super-resolution capability of dSTORM to follow directly the endocytotic uptake of extracellularly added amyloid aggregates and to probe the morphology of in situ protein aggregates even when they accumulate in small vesicular compartments.	[Apetri, Mihaela M.; Harkes, Rolf; Canters, Gerard W.; Schmidt, Thomas; Aartsma, Thijs J.] Leiden Univ, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands; [Subramaniam, Vinod] FOM Inst AMOLF, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; AMOLF	Schmidt, T; Aartsma, TJ (corresponding author), Leiden Univ, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands.	schmidt@physics.leidenuniv.nl; aartsma@physics.leidenuniv.nl	Subramaniam, Vinod/B-4197-2010; Schmidt, Thomas/B-6296-2009	Subramaniam, Vinod/0000-0001-6712-7266; Schmidt, Thomas/0000-0002-0045-1851; Harkes, Rolf/0000-0001-6592-654X				Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Devic I, 2011, BRAIN, V134, DOI 10.1093/brain/awr015; Duim WC, 2011, CHEMPHYSCHEM, V12, P2386, DOI 10.1002/cphc.201100392; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Esbjorner EK, 2014, CHEM BIOL, V21, P732, DOI 10.1016/j.chembiol.2014.03.014; Freeman D, 2012, PLOS ONE, V8; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Roberti MJ, 2012, BIOPHYS J, V102, P1598, DOI 10.1016/j.bpj.2012.03.010; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; NIXON RA, 1995, TRENDS NEUROSCI, V18, P489, DOI 10.1016/0166-2236(95)92772-I; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Pinotsi D, 2014, NANO LETT, V14, P339, DOI 10.1021/nl4041093; Ries J, 2013, ACS CHEM NEUROSCI, V4, P1057, DOI 10.1021/cn400091m; Sahl SJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00895; Schierle GSK, 2011, J AM CHEM SOC, V133, P12902, DOI 10.1021/ja201651w; Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926; Sidhu A, 2014, BBA-PROTEINS PROTEOM, V1844, P2127, DOI 10.1016/j.bbapap.2014.09.007; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung JY, 2001, J BIOL CHEM, P276; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x	31	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153020	10.1371/journal.pone.0153020	http://dx.doi.org/10.1371/journal.pone.0153020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105068	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100007
J	Lindsay, T; Valdes, A				Lindsay, Tabitha; Valdes, Angel			The Model Organism Hermissenda crassicornis (Gastropoda: Heterobranchia) Is a Species Complex	PLOS ONE			English	Article							MOLLUSK; NUDIBRANCHIA; NETWORK; OPISTHOBRANCHIA; GLAUCIDAE; BEHAVIOR; GROWTH	Hermissenda crassicornis is a model organism used in various fields of research including neurology, ecology, pharmacology, and toxicology. In order to investigate the systematics of this species and the presence of cryptic species in H. crassicornis, we conducted a comprehensive molecular and morphological analysis of this species covering its entire range across the North Pacific Ocean. We determined that H. crassicornis constitutes a species complex of three distinct species. The name Hermissensa crassicornis is retained for the northeast Pacific species, occurring from Alaska to Northern California. The name H. opalescens is reinstated for a species occurring from the Sea of Cortez to Northern California. Finally, the name H. emurai is maintained for the northwestern species, found in Japan and in the Russian Far East. These three species have consistent morphological and color pattern differences that can be used for identification in the field.	[Lindsay, Tabitha; Valdes, Angel] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	Valdes, A (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	aavaldes@cpp.edu	Valdes, Angel/Q-1729-2018	Valdes, Angel/0000-0002-2347-4896	California State University Program for Education and Research in Biotechnology; Prete Foundation; Conchologists of America; California State Polytechnic University	California State University Program for Education and Research in Biotechnology; Prete Foundation; Conchologists of America; California State Polytechnic University	Funded by California State University Program for Education and Research in Biotechnology (http://www.calstate.edu/csuperb/) to AV, Prete Foundation to TL, Conchologists of America (http://www.conchologistsofamerica.org/home/) to TL, and the California State Polytechnic University (http://www.cpp.edu/) to TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Avila C, 1998, MAR FRESHW BEHAV PHY, V31, P1, DOI 10.1080/10236249809387059; Avila C, 1997, J EXP MAR BIOL ECOL, V218, P243, DOI 10.1016/S0022-0981(97)00077-4; AVILA C, 1994, BIOL BULL, V187, P252, DOI 10.1086/BBLv187n2p252; Baba K., 1937, J DEP AGR KYUSHU IMP, V5, P289; Behrens D.W., 2005, E PACIFIC NUDIBRANCH; Bergh R., 1878, VERH ZOOL BOT GES WI, V28, P553; Bergh R., 1879, P ACAD NAT SCI PHILA, V2, P71; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blackwell Kim T., 2006, Anatomical Record Part B:The New Anatomist, V289, P25, DOI 10.1002/ar.b.20090; Blackwell KT, 2000, J COMPUT NEUROSCI, V9, P149, DOI 10.1023/A:1008919924579; BUCHANAN J, 1986, J ULTRA MOL STRUCT R, V94, P52, DOI 10.1016/0889-1605(86)90051-0; Carmona L, 2014, ZOOL J LINN SOC-LOND, V170, P132, DOI 10.1111/zoj12098; Carmona L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063000; Churchill CKC, 2014, INVERTEBR SYST, V28, P174, DOI 10.1071/IS13038; Churchill CKC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1224; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cockerell T. D. A., 1905, Journal of Malacology, Vxii, P31; Cockerell TDA, 1901, J MALACOLOGY, V8, P121; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Cooper, 1863, P CALIFORNIA ACAD NA, V2, P202; Cooper J. G., 1863, P CALIFORNIA ACAD SC, V3, P56; Cooper JG, 1862, P CAL ACAD NAT SCI, V2, P207; Crow T, 2013, J NEUROPHYSIOL, V109, P640, DOI 10.1152/jn.00803.2012; CROW TJ, 1980, SCIENCE, V209, P412, DOI 10.1126/science.209.4454.412; CROW TJ, 1978, SCIENCE, V201, P1239, DOI 10.1126/science.694512; de Carvalho MR, 2005, SCIENCE, V307, P353; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; EAKIN RM, 1967, J CELL SCI, V2, P349; Epstein DA, 2000, BIOL BULL, V199, P182, DOI 10.2307/1542887; Eschscholtz JF, 1831, ZOOLOGISCHER ATLAS B; ETCHEBERRIGARAY R, 1992, P NATL ACAD SCI USA, V89, P7184, DOI 10.1073/pnas.89.15.7184; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; HODGE AJ, 1980, J ULTRA MOL STRUCT R, V70, P220, DOI 10.1016/S0022-5320(80)80007-4; Kasheverov IE, 2015, MAR DRUGS, V13, P1255, DOI 10.3390/md13031255; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; LEDERHENDLER II, 1986, J NEUROSCI, V6, P1325; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; MCDONALD GR, 1983, MALACOLOGIA, V24, P114; MILLER MC, 1974, ZOOL J LINN SOC-LOND, V54, P31, DOI 10.1111/j.1096-3642.1974.tb00792.x; O'Donoghue C. H., 1921, Transactions of the Canadian Institute, V13, P147; O'Donoghue C. H., 1922, Transactions of the Canadian Institute, V14, P123; O'Donoghue C. H., 1922, Nautilus Boston Mass, V35, P74; ODonoghue C. H., 1922, Transactions of the Canadian Institute, V14, P131; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Pola M, 2012, ZOOL J LINN SOC-LOND, V165, P311, DOI 10.1111/j.1096-3642.2012.00816.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; RAM JL, 1988, BEHAV NEURAL BIOL, V49, P97, DOI 10.1016/S0163-1047(88)91282-4; RICHARDS WG, 1987, BRAIN RES BULL, V19, P175, DOI 10.1016/0361-9230(87)90083-9; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Scotland Robert, 2003, Systematics and Biodiversity, V1, P139, DOI 10.1017/S1477200003001178; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAKEDA T, 1982, VISION RES, V22, P303, DOI 10.1016/0042-6989(82)90130-4; TAMSE CT, 1994, BIOL BULL, V187, P251, DOI 10.1086/BBLv187n2p251; WERNESS SA, 1992, BIOL CYBERN, V68, P125, DOI 10.1007/BF00201434; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Wollscheid E, 1999, MOL PHYLOGENET EVOL, V13, P215, DOI 10.1006/mpev.1999.0664; YAMOAH EN, 1994, J NEUROPHYSIOL, V72, P2196, DOI 10.1152/jn.1994.72.5.2196; ZACK S, 1975, BEHAVIOUR, V53, P238, DOI 10.1163/156853975X00218	64	38	43	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154265	10.1371/journal.pone.0154265	http://dx.doi.org/10.1371/journal.pone.0154265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105319	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100063
J	Dou, HL; Yang, HT; Feng, LM; Mou, P; Wang, TM; Ge, JP				Dou, Hailong; Yang, Haitao; Feng, Limin; Mou, Pu; Wang, Tianming; Ge, Jianping			Estimating the Population Size and Genetic Diversity of Amur Tigers in Northeast China	PLOS ONE			English	Article							PANTHERA-TIGRIS-ALTAICA; NATIONAL NATURE-RESERVE; SIBERIAN TIGER; CONSERVATION; LANDSCAPE; HUNCHUN; DENSITY; LEOPARD; PREY; IDENTIFICATION	Over the past century, the endangered Amur tiger (Panthera tigris altaica) has experienced a severe contraction in demography and geographic range because of habitat loss, poaching, and prey depletion. In its historical home in Northeast China, there appears to be a single tiger population that includes tigers in Southwest Primorye and Northeast China; however, the current demographic status of this population is uncertain. Information on the abundance, distribution and genetic diversity of this population for assessing the efficacy of conservation interventions are scarce. We used noninvasive genetic detection data from scats, capture-recapture models and an accumulation curve method to estimate the abundance of Amur tigers in Northeast China. We identified 11 individual tigers (6 females and 5 males) using 10 microsatellite loci in three nature reserves between April 2013 and May 2015. These tigers are confined primarily to a Hunchun Nature Reserve along the border with Russia, with an estimated population abundance of 9-11 tigers during the winter of 2014-2015. They showed a low level of genetic diversity. The mean number of alleles per locus was 2.60 and expected and observed heterozygosity were 0.42 and 0.49, respectively. We also documented long-distance dispersal (similar to 270 km) of a male Amur tiger to Huangnihe Nature Reserve from the border, suggesting that the expansion of neighboring Russian populations may eventually help sustain Chinese populations. However, the small and isolated population recorded by this study demonstrate that there is an urgent need for more intensive regional management to create a tiger-permeable landscape and increased genetic connectivity with other populations.	[Wang, Tianming] Beijing Normal Univ, Key Lab Biodivers Sci & Engn, Minist Educ, Beijing 100875, Peoples R China; Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Wang, TM (corresponding author), Beijing Normal Univ, Key Lab Biodivers Sci & Engn, Minist Educ, Beijing 100875, Peoples R China.	wangtianming@bnu.edu.cn	Feng, Limin/G-9539-2014	Feng, Limin/0000-0001-9526-1681	National Natural Science Foundation of China [31470566, 31270567, 31210103911, 31421063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31470566, 31270567, 31210103911and 31421063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasaad S, 2011, MAMM BIOL, V76, P722, DOI 10.1016/j.mambio.2011.01.011; Anuradha Reddy P, 2012, CONSERV GENET, V13, P779, DOI 10.1007/s10592-012-0326-1; Banks SC, 2003, ANIM CONSERV, V6, P101, DOI 10.1017/S1367943003003135; Caragiulo A, 2015, ORYX, V49, P632, DOI 10.1017/S0030605314000817; Chen Jiu-Yi, 2011, Chinese Journal of Zoology, V46, P46; Dunishenko, 2006, SURVEY AMUR SIBERIAN; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Gopalaswamy AM, 2012, ECOLOGY, V93, P1741, DOI 10.1890/11-2110.1; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hebblewhite M, 2012, ANIM CONSERV, V15, P579, DOI 10.1111/j.1469-1795.2012.00552.x; Henry P, 2009, MOL ECOL, V18, P3173, DOI 10.1111/j.1365-294X.2009.04266.x; Hernandez-Blanco JA, 2015, INTEGR ZOOL, V10, P365, DOI 10.1111/1749-4877.12140; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Kohn MH, 1999, P ROY SOC B-BIOL SCI, V266, P657, DOI 10.1098/rspb.1999.0686; Linkie M, 2008, BIOL CONSERV, V141, P2410, DOI 10.1016/j.biocon.2008.07.002; Liu D, 2013, CHINESE SCI BULL, V58, P2230, DOI 10.1007/s11434-013-5722-5; Luo SJ, 2010, INTEGR ZOOL, V5, P351, DOI 10.1111/j.1749-4877.2010.00222.x; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; McDonald T., 2015, MRA ANAL MARK RECAPT; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Miquelle DG, 2015, INTEGR ZOOL, V10, P389, DOI 10.1111/1749-4877.12146; Miquelle DG, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P403, DOI 10.1016/B978-0-8155-1570-8.00032-3; Miquelle Dale G., 2010, P325; Mondol S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000585; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Russello MA, 2004, CONSERV GENET, V5, P707, DOI 10.1007/s10592-004-1860-2; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Singh SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118846; Soh YH, 2014, BIOL CONSERV, V169, P117, DOI 10.1016/j.biocon.2013.10.011; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Sollmann R, 2013, BIOL CONSERV, V167, P242, DOI 10.1016/j.biocon.2013.08.003; Sorokin PA, 2016, INTEGR ZOOL, V11, P25, DOI 10.1111/1749-4877.12175; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Stephens PA, 2015, J APPL ECOL, V52, P1, DOI 10.1111/1365-2664.12383; Sugimoto T, 2006, CONSERV GENET, V7, P799, DOI 10.1007/s10592-005-9071-z; Sugimoto T, 2014, CONSERV GENET, V15, P521, DOI 10.1007/s10592-013-0558-8; Sugimoto T, 2012, J MAMMAL, V93, P93, DOI 10.1644/10-MAMM-A-368.1; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tian Y, 2011, ECOL MODEL, V222, P3166, DOI 10.1016/j.ecolmodel.2011.06.003; Tian Yu, 2009, Shengwu Duoyangxing, V17, P211; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Wang TM, 2016, LANDSCAPE ECOL, V31, P491, DOI 10.1007/s10980-015-0278-1; Wang TM, 2015, ORYX, V49, P578, DOI 10.1017/S0030605315000794; Wang Tianming, 2014, Cat News, V61, P18; Wu Z., 2013, REPORT SPECIFIC SURV; Xiao Wenhong, 2014, Biodiversity Science, V22, P717, DOI 10.3724/SP.J.1003.2014.14184; Xiao WH, 2014, THESIS BEIJING NORMA; Zhou Shaochun, 2008, Acta Theriologica Sinica, V28, P165	53	19	27	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154254	10.1371/journal.pone.0154254	http://dx.doi.org/10.1371/journal.pone.0154254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100387	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500173
J	Lee-Miller, T; Marneweck, M; Santello, M; Gordon, AM				Lee-Miller, Trevor; Marneweck, Michelle; Santello, Marco; Gordon, Andrew M.			Visual Cues of Object Properties Differentially Affect Anticipatory Planning of Digit Forces and Placement	PLOS ONE			English	Article							CENTER-OF-MASS; MEMORY REPRESENTATIONS; SENSORIMOTOR MEMORY; PRECISION GRIP; MANIPULATION; WEIGHT; INFORMATION; ADAPTATION; POSITIONS; REVEALS	Studies on anticipatory planning of object manipulation showed initial task failure (i.e., object roll) when visual object shape cues are incongruent with other visual cues, such as weight distribution/density (e.g., symmetrically shaped object with an asymmetrical density). This suggests that shape cues override density cues. However, these studies typically only measured forces, with digit placement constrained. Recent evidence suggests that when digit placement is unconstrained, subjects modulate digit forces and placement. Thus, unconstrained digit placement might be modulated on initial trials (since it is an explicit process), but not forces (since it is an implicit process). We tested whether shape and density cues would differentially influence anticipatory planning of digit placement and forces during initial trials of a two-digit object manipulation task. Furthermore, we tested whether shape cues would override density cues when cues are incongruent. Subjects grasped and lifted an object with the aim of preventing roll. In Experiment 1, the object was symmetrically shaped, but with asymmetrical density (incongruent cues). In Experiment 2, the object was asymmetrical in shape and density (congruent cues). In Experiment 3, the object was asymmetrically shaped, but with symmetrical density (incongruent cues). Results showed differential modulation of digit placement and forces (modulation of load force but not placement), but only when shape and density cues were congruent. When shape and density cues were incongruent, we found collinear digit placement and symmetrical force sharing. This suggests that congruent and incongruent shape and density cues differentially influence anticipatory planning of digit forces and placement. Furthermore, shape cues do not always override density cues. A continuum of visual cues, such as those alluding to shape and density, need to be integrated.	[Lee-Miller, Trevor; Marneweck, Michelle; Gordon, Andrew M.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA; [Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA	Columbia University; Columbia University Teachers College; Arizona State University; Arizona State University-Tempe	Gordon, AM (corresponding author), Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA.	ag275@columbia.edu		Marneweck, Michelle/0000-0002-3953-5956; Gordon, Andrew/0000-0003-1041-0479	National Science Foundation (NSF) [BCS-1153034, BCS 1152916]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research was supported by a Collaborative Research Grant BCS-1153034 (MS) and BCS 1152916 (AG) from the National Science Foundation (NSF; http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINGHAM GP, 1993, PERCEPT PSYCHOPHYS, V54, P617, DOI 10.3758/BF03211785; Buckingham G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054709; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Bursztyn LLCD, 2008, EXP BRAIN RES, V184, P127, DOI 10.1007/s00221-007-1173-z; Chouinard PA, 2009, NEUROIMAGE, V48, P696, DOI 10.1016/j.neuroimage.2009.07.020; Craje C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076855; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2007, J NEUROSCI, V27, P3974, DOI 10.1523/JNEUROSCI.0426-07.2007; Fu QS, 2012, J NEUROSCI, V32, P15086, DOI 10.1523/JNEUROSCI.2468-12.2012; Fu QS, 2011, J NEUROSCI, V31, P13576, DOI 10.1523/JNEUROSCI.1143-11.2011; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Gordon AM, 2004, IEMBS04, V2, P4641; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Ingram JN, 2010, CURR BIOL, V20, P618, DOI 10.1016/j.cub.2010.01.054; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Kroliczak G, 2008, J NEUROPHYSIOL, V100, P2627, DOI 10.1152/jn.01376.2007; Loh MN, 2010, J NEUROSCI, V30, P6984, DOI 10.1523/JNEUROSCI.6207-09.2010; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; Marneweck M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138258; Monaco S, 2014, CEREB CORTEX, V24, P1540, DOI 10.1093/cercor/bht006; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Salimi I, 2003, EXP BRAIN RES, V150, P9, DOI 10.1007/s00221-003-1394-8; Salimi I, 2000, J NEUROPHYSIOL, V84, P2390, DOI 10.1152/jn.2000.84.5.2390; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	28	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154033	10.1371/journal.pone.0154033	http://dx.doi.org/10.1371/journal.pone.0154033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100830	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500127
J	Shi, JJ; Chang, LW; Wang, J; Zhang, S; Yao, YH; Zhang, SX; Jiang, RF; Guo, LY; Guan, HX; Zhu, WZ				Shi, Jingjing; Chang, Liwen; Wang, Jian; Zhang, Shun; Yao, Yihao; Zhang, Shuixia; Jiang, Rifeng; Guo, Linying; Guan, Hanxiong; Zhu, Wenzhen			Initial Application of Diffusional Kurtosis Imaging in Evaluating Brain Development of Healthy Preterm Infants	PLOS ONE			English	Article							WHITE-MATTER DEVELOPMENT; LOW-BIRTH-WEIGHT; HUMAN FETAL; NERVOUS-SYSTEM; MATURATION; TRACTOGRAPHY; NEWBORNS; ABNORMALITIES; QUANTITATION; PARAMETERS	Objective To explore the parametric characteristics of diffusional kurtosis imaging (DKI) in the brain development of healthy preterm infants. Materials and Methods Conventional magnetic resonance imaging (MRI) and DKI were performed in 35 preterm (29 to 36 weeks gestational age [GA]; scanned at 33 to 44 weeks postmenstrual age [PMA]) and 10 term infants (37.4 to 40.7 weeks GA; scanned at 38.3 to 42.9 weeks PMA). Fractional anisotropy (FA), mean diffusivity (MD) and mean kurtosis (MK) values from 8 regions of interest, including both white matter (WM) and gray matter (GM), were obtained. Results MK and FA values were positively correlated with PMA in most selected WM regions, such as the posterior limbs of the internal capsule (PLIC) and the splenium of the corpus callosum (SCC). The positive correlation between MK value and PMA in the deep GM region was higher than that between FA and PMA. The MK value gradually decreased from the PLIC to the cerebral lobe. In addition, DKI parameters exhibited subtle differences in the parietal WM between the preterm and term control groups. Conclusions MK may serve as a more reliable imaging marker of the normal myelination process and provide a more robust characterization of deep GM maturation.	[Shi, Jingjing; Wang, Jian; Zhang, Shun; Yao, Yihao; Zhang, Shuixia; Jiang, Rifeng; Guo, Linying; Guan, Hanxiong; Zhu, Wenzhen] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chang, Liwen] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Ofneonatol, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Guan, HX; Zhu, WZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Tongji Med Coll, Wuhan 430074, Peoples R China.	hxguan@tjh.tjmu.edu.cn; zhuwenzhen@hotmail.com		Zhang, Shun/0000-0002-0001-1880	National Program of the Ministry of Science and Technology of China [2011BAI08B10]; National Natural Science Foundation of China [81171308]	National Program of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Program of the Ministry of Science and Technology of China during the "12th Five-Year Plan" (2011BAI08B10) (http://www.most.gov.cn/index.htm), and The National Natural Science Foundation of China (81171308) (http://www.nsfc.gov.cn/).	Ball G, 2013, P NATL ACAD SCI USA, V110, P9541, DOI 10.1073/pnas.1301652110; Benitez A, 2014, NEUROIMAGE-CLIN, V4, P64, DOI 10.1016/j.nicl.2013.11.001; Broekman BFP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115229; Chau V, 2009, PEDIATRICS, V123, P319, DOI 10.1542/peds.2008-0283; Chen YY, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/820847; de Vries LS, 2013, NEURORADIOLOGY, V55, P13, DOI 10.1007/s00234-013-1233-y; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Gao Y, 2012, NMR BIOMED, V25, P1369, DOI 10.1002/nbm.2809; Geng XJ, 2012, NEUROIMAGE, V61, P542, DOI 10.1016/j.neuroimage.2012.03.057; Gimenez M, 2008, NEUROIMAGE, V41, P728, DOI 10.1016/j.neuroimage.2008.02.029; Glenn GR, 2015, NMR BIOMED, V28, P1245, DOI 10.1002/nbm.3374; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Hui ES, 2015, NEUROIMAGE, V106, P391, DOI 10.1016/j.neuroimage.2014.11.015; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Hui ES, 2008, IEEE ENG MED BIO, P3941, DOI 10.1109/IEMBS.2008.4650072; Huppi PS, 1998, PEDIATR RES, V44, P584; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Kolasinski J, 2013, NEUROIMAGE, V79, P412, DOI 10.1016/j.neuroimage.2013.04.125; Ling XY, 2013, EUR J RADIOL, V82, pE476, DOI 10.1016/j.ejrad.2013.04.003; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; O'Rahilly R, 1999, TERATOLOGY, V60, P39, DOI 10.1002/(SICI)1096-9926(199907)60:1<39::AID-TERA11>3.0.CO;2-I; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Paydar A, 2014, AM J NEURORADIOL, V35, P808, DOI 10.3174/ajnr.A3764; Rodrigues K, 2011, NEUROIMAG CLIN N AM, V21, P127, DOI 10.1016/j.nic.2011.01.012; Rose SE, 2008, MAGN RESON MED, V60, P761, DOI 10.1002/mrm.21689; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Veraart J, 2011, MAGN RESON MED, V65, P138, DOI 10.1002/mrm.22603; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Xu G, 2014, CEREB CORTEX, V24, P579, DOI 10.1093/cercor/bhs330; Yoshida S, 2013, PEDIATR RADIOL, V43, P15, DOI 10.1007/s00247-012-2496-x	39	7	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154146	10.1371/journal.pone.0154146	http://dx.doi.org/10.1371/journal.pone.0154146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101246	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500155
J	Kim, DH; Choi, BH; Ku, SK; Park, JH; Oh, E; Kwak, MK				Kim, Dong-hyun; Choi, Bo-hyun; Ku, Sae-Kwang; Park, Jeong-hyeon; Oh, Euichaul; Kwak, Mi-Kyoung			Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ENDOTHELIAL GROWTH-FACTOR; DIABETIC-NEPHROPATHY; CARDIOVASCULAR-DISEASE; MOLECULAR-MECHANISMS; RECEPTOR ANTAGONIST; RENAL FIBROSIS; RISK-FACTOR; CYSTATIN-C	Chronic kidney disease (CKD) is a major complication of metabolic disorders such as diabetes mellitus, obesity, and hypertension. Comorbidity of these diseases is the factor exacerbating CKD progression. Statins are commonly used in patients with metabolic disorders to decrease the risk of cardiovascular complications. Sarpogrelate, a selective antagonist of 5-hydroxytryptamine (5-HT) 2A receptor, inhibits platelet aggregation and is used to improve peripheral circulation in diabetic patients. Here, we investigated the effects of sarpogrelate and rosuvastatin on CKD in mice that were subjected to a high fat diet (HFD) for 22 weeks and a single low dose of streptozotocin (STZ, 40 mg/kg). When mice were administrated sarpogrelate (50 mg/kg, p.o.) for 13 weeks, albuminuria and urinary cystatin C excretion were normalized and histopathological changes such as glomerular mesangial expansion, tubular damage, and accumulations in lipid droplets and collagen were significantly improved. Sarpogrelate treatment repressed the HFD/STZ-induced CD31 and vascular endothelial growth factor receptor-2 expressions, indicating the attenuation of glomerular endothelial proliferation. Additionally, sarpogrelate inhibited interstitial fibrosis by suppressing the increases in transforming growth factor-beta 1 (TGF-beta 1) and plasminogen activator inhibitor-1 (PAI-1). All of these functional and histological improvements were also seen in rosuvastatin (20 mg/kg) group and, notably, the combinatorial treatment with sarpogrelate and rosuvastatin showed additive beneficial effects on histopathological changes by HFD/STZ. Moreover, sarpogrelate reduced circulating levels of PAI-1 that were elevated in the HFD/STZ group. As supportive in vitro evidence, sarpogrelate incubation blocked TGF-beta 1/5-HT-inducible PAI-1 expression in murine glomerular mesangial cells. Taken together, sarpogrelate and rosuvastatin may be advantageous to control the progression of CKD in patients with comorbid metabolic disorders, and particularly, the use of sarpogrelate as adjunctive therapy with statins may provide additional benefits on CKD.	[Kim, Dong-hyun; Choi, Bo-hyun; Park, Jeong-hyeon; Oh, Euichaul; Kwak, Mi-Kyoung] Catholic Univ Korea, Coll Pharm, Bucheon 420743, Gyeonggi Do, South Korea; [Ku, Sae-Kwang] Daegu Haany Univ, Coll Korean Med, Gyongsan 712715, Gyeonsangbuk Do, South Korea	Catholic University of Korea; Daegu Haany University	Kwak, MK (corresponding author), Catholic Univ Korea, Coll Pharm, Bucheon 420743, Gyeonggi Do, South Korea.	mkwak@catholic.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2013M3A9B5075839, NRF-2013R1A2A2A01015497]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2013M3A9B5075839 and NRF-2013R1A2A2A01015497).	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Adly AAM, 2014, J DIABETES COMPLICAT, V28, P340, DOI 10.1016/j.jdiacomp.2014.01.011; Alessi MC, 2006, ARTERIOSCL THROM VAS, V26, P2200, DOI 10.1161/01.ATV.0000242905.41404.68; Athyrost VG, 2015, EXPERT OPIN PHARMACO, V16, P1449, DOI 10.1517/14656566.2015.1053464; BARRADAS MA, 1988, EUR J CLIN INVEST, V18, P399, DOI 10.1111/j.1365-2362.1988.tb01030.x; Bottinger EP, 2007, SEMINARS NEPHROLOGY; Braun L, 2012, INT J NEPHROL RENOV, V5, P151, DOI 10.2147/IJNRD.S37766; Campese VM, 2014, CLIN EXP NEPHROL, V18, P291, DOI 10.1007/s10157-014-0934-9; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P181, DOI 10.1016/S2213-8587(14)70246-3; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P865, DOI 10.1517/13543784.13.7.865; Doggreu SA, 2003, EXPERT OPIN INV DRUG, V12, P805, DOI 10.1517/eoid.12.5.805.22158; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Fraser SDS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0189-z; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Giunti S, 2010, AM J PHYSIOL-RENAL, V299, pF528, DOI 10.1152/ajprenal.00127.2010; Hamasaki Y, 2013, AM J PHYSIOL-RENAL, V305, pF1796, DOI 10.1152/ajprenal.00151.2013; HAMSTEN A, 1987, LANCET, V2, P3; Hasegawa Y, 2002, THROMB RES, V107, P319, DOI 10.1016/S0049-3848(02)00348-1; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Herget-Rosenthal S, 2004, ANN CLIN BIOCHEM, V41, P111, DOI 10.1258/000456304322879980; Hovind P, 2001, KIDNEY INT, V59, P702, DOI 10.1046/j.1523-1755.2001.059002702.x; Ito M, 2001, ENVIRON TOXICOL PHAR, V9, P71, DOI 10.1016/S1382-6689(00)00064-8; Jafar T, 2006, CHRONIC KIDNEY DIS D; Jagroop IA, 2001, J HUM HYPERTENS, V15, P203, DOI 10.1038/sj.jhh.1001146; Kasahara M, 2014, CLIN EXP NEPHROL, V18, P282, DOI 10.1007/s10157-013-0928-z; Kasho M, 1998, KIDNEY INT, V54, P1083, DOI 10.1046/j.1523-1755.1998.00114.x; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kobayashi S, 2008, CLIN EXP NEPHROL, V12, P119, DOI 10.1007/s10157-007-0011-8; Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406; Krag S, 2005, KIDNEY INT, V68, P2651, DOI 10.1111/j.1523-1755.2005.00737.x; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Landray MJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1793; Lee HS, 2008, J MED FOOD, V11, P294, DOI 10.1089/jmf.2007.578; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Malgorzewicz S, 2013, INT J MOL MED, V31, P503, DOI 10.3892/ijmm.2013.1234; MANTTARI M, 1995, HYPERTENSION, V26, P670, DOI 10.1161/01.HYP.26.4.670; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Ogawa S, 2008, CLIN J AM SOC NEPHRO, V3, P362, DOI 10.2215/CJN.03450807; Pakala R, 1997, CIRCULATION, V96, P2280; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Ryoo IG, 2015, ARCH PHARM RES, V38, P272, DOI 10.1007/s12272-014-0380-y; Saini HK, 2004, CARDIOVASC DRUG REV, V22, P27; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sirtori CR, 2014, PHARMACOL RES, V88, P3, DOI 10.1016/j.phrs.2014.03.002; Son JY, 2014, TOX RESEARCH, V30, P99, DOI 10.5487/TR.2014.30.2.099; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Suh DC, 2010, COMPLICATIONS, V24, P382, DOI DOI 10.1016/J.JDIAC0MP.2009.07.001; Takahashi T, 2002, DIABETES RES CLIN PR, V58, P123, DOI 10.1016/S0168-8227(02)00105-5; Tamura Y, 2011, INT J MOL MED, V28, P683, DOI 10.3892/ijmm.2011.769; Tsuchida K, 1999, DIABETOLOGIA, V42, P579, DOI 10.1007/s001250051198; Wasung ME, 2015, CLIN CHIM ACTA, V438, P350, DOI 10.1016/j.cca.2014.08.039	62	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153965	10.1371/journal.pone.0153965	http://dx.doi.org/10.1371/journal.pone.0153965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097221	Green Published, Green Submitted, gold			2022-12-26	WOS:000374543600076
J	Powley, IR; Hughes, MA; Cain, K; MacFarlane, M				Powley, I. R.; Hughes, M. A.; Cain, K.; MacFarlane, M.			Caspase-8 tyrosine-380 phosphorylation inhibits CD95 DISC function by preventing procaspase-8 maturation and cycling within the complex	ONCOGENE			English	Article							SIGNALING COMPLEX; CELL-DEATH; APOPTOSIS; MUTATIONS; RECONSTITUTION; ACTIVATION; MECHANISM; SURVIVAL; REVEALS; KINASES	Caspase-8 is a key initiator of apoptotic cell death where it functions as the apical protease in death receptor-mediated apoptosis triggered via the death-inducing signalling complex (DISC). However, the observation that caspase-8 is upregulated in many common tumour types led to the discovery of alternative non-apoptotic, pro-survival functions, many of which are contingent on phosphorylation of a tyrosine residue (Y380) found in the linker region between the two catalytic domains of the enzyme. Furthermore, Src-mediated Y380 phosphorylation leads to increased resistance to CD95-induced apoptosis; however, the mechanism underlying this impaired response to extrinsic apoptotic stimuli has not been identified. Consequently, we have employed a number of model systems to further dissect this protective mechanism. First, using an in vitro DISC model together with recombinant procaspase-8 variants, we show that Y380 phosphorylation inhibits procaspase-8 activation at the CD95 DISC, thereby preventing downstream activation of the caspase cascade. Second, we validated this finding in a cellular context using transfected neuroblastoma cell lines deficient in caspase-8. Reconstitution of these lines with phosphomimetic-caspase-8 results in increased resistance to CD95-mediated apoptosis and enhanced cell migration. When the in vitro DISC is assembled in the presence of cell lysate, caspase-8 Y380 phosphorylation attenuates DISC activity by inhibiting procaspase-8 autoproteolytic activity but not recruitment or homodimerization of caspase-8 within the complex. Once incorporated into the DISC, phosphorylated caspase-8 is unable to be released from the complex; this inhibits further cycling and release of active catalytic subunits into the cytoplasm, thus resulting in increased apoptotic resistance. Taken together, our novel findings expand our understanding of the key mechanisms underlying the anti-apoptotic functions of caspase-8 which may act as a critical block to existing antitumour therapies. Importantly, reversal or inhibition of caspase-8 phosphorylation may prove a valuable avenue to explore for sensitization of resistant tumours to extrinsic apoptotic stimuli.	[Powley, I. R.; Hughes, M. A.; Cain, K.; MacFarlane, M.] MRC, Toxicol Unit, Hodgkin Budding,POB 138,Lancaster Rd, Leicester LE1 9HN, Leics, England	University of Leicester	MacFarlane, M (corresponding author), MRC, Toxicol Unit, Hodgkin Budding,POB 138,Lancaster Rd, Leicester LE1 9HN, Leics, England.	mm21@le.ac.uk			UK Medical Research Council (MRC); Medical Research Council [MC_U132685863] Funding Source: researchfish; MRC [MC_U132685863] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Dr T Chernova for her valuable advice regarding qRT-PCR design and analysis. This work was supported by the UK Medical Research Council (MRC).	Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Ando M, 2013, CANCER SCI, V104, P1002, DOI 10.1111/cas.12191; Creedon Helen, 2012, Critical Reviews in Oncogenesis, V17, P145; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Dickens LS, 2012, EXP CELL RES, V318, P1269, DOI 10.1016/j.yexcr.2012.04.005; Frisch SM, 2008, CANCER RES, V68, P4491, DOI 10.1158/0008-5472.CAN-08-0952; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; Hughes MA, 2015, COLD SPRING HARB PRO, V12; Hughes MA, 2013, METHODS, V61, P98, DOI 10.1016/j.ymeth.2013.02.006; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Jia SH, 2008, J BIOL CHEM, V283, P5402, DOI 10.1074/jbc.M706462200; Keller N, 2010, CELL DEATH DIFFER, V17, P710, DOI 10.1038/cdd.2009.155; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Langlais C, 2015, COLD SPRING HARB PRO, V12; MacFarlane M, 1997, J CELL BIOL, V137, P469, DOI 10.1083/jcb.137.2.469; Mandal R, 2014, MOL ONCOL, V8, P232, DOI 10.1016/j.molonc.2013.11.003; Matthess Y, 2014, MOL ONCOL, V8, P596, DOI 10.1016/j.molonc.2013.12.013; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Parrish A.B., 2013, COLD SPRING HARB PER, V5, P5, DOI DOI 10.1101/CSHPERSPECT.A008672; Salvesen GS, 2014, SEMIN IMMUNOL, V26, P246, DOI 10.1016/j.smim.2014.03.005; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Soung YH, 2005, CANCER RES, V65, P815; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; Xu J, 2013, J BIOL CHEM, V288, P33263, DOI 10.1074/jbc.M113.508093; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002; Zonta F, 2014, BLOOD, V123, P875, DOI 10.1182/blood-2013-02-485540	30	23	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 27	2016	35	43					5629	5640		10.1038/onc.2016.99	http://dx.doi.org/10.1038/onc.2016.99			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XP	27109099	Green Published, hybrid			2022-12-26	WOS:000386998300006
J	Kuczynski, L; Rector, BG; Kiedrowicz, A; Lewandowski, M; Szydlo, W; Skoracka, A				Kuczynski, Lechoslaw; Rector, Brian G.; Kiedrowicz, Agnieszka; Lewandowski, Mariusz; Szydlo, Wiktoria; Skoracka, Anna			Thermal Niches of Two Invasive Genotypes of the Wheat Curl Mite Aceria tosichella: Congruence between Physiological and Geographical Distribution Data	PLOS ONE			English	Article							STREAK-MOSAIC-VIRUS; DIFFERENTIAL TRANSMISSION; ACARI ERIOPHYOIDEA; INFECTING WHEAT; 1ST REPORT; TEMPERATURE; COMPLEX; KEIFER; MODEL; ERIOPHYIDAE	The wheat curl mite (WCM), Aceria tosichella Keifer, is a major pest of cereals worldwide. It is also a complex of well-defined genetic lineages with divergent physiological traits, which has not been accounted for in applied contexts. The aims of the study were to model the thermal niches of the two most pestiferous WCM lineages, designated MT-1 and MT-8, and to assess the extent to which temperature determines the distribution of these lineages. WCM population dynamics were modeled based on thermal niche data from March to November on the area of Poland (>311,000 km(2)). The most suitable regions for population development were predicted and compared to empirical field abundance data. Congruence between modeled parameters and field data for mite presence were observed for both WCM lineages although congruence between modeled thermal suitability and mite field abundance was observed only for MT-8. Thermal niche data for MT-1 and MT-8 provide biological insights and aid monitoring and management of WCM and the plant viruses it vectors. The presented models accurately estimate distributions of WCM and can be incorporated into management strategies for both current and predicted climate scenarios.	[Kuczynski, Lechoslaw] Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Avian Biol & Ecol, Poznan, Poland; [Rector, Brian G.] USDA ARS, Great Basin Rangelands Res Unit, Reno, NV USA; [Kiedrowicz, Agnieszka; Szydlo, Wiktoria; Skoracka, Anna] Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Anim Taxon & Ecol, Poznan, Poland; [Lewandowski, Mariusz] Warsaw Univ Life Sci SGGW, Fac Hort Biotechnol & Landscape Architecture, Dept Appl Entomol, Warsaw, Poland	Adam Mickiewicz University; United States Department of Agriculture (USDA); Adam Mickiewicz University; Warsaw University of Life Sciences	Skoracka, A (corresponding author), Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Anim Taxon & Ecol, Poznan, Poland.	skoracka@amu.edu.pl	Kuczyński, Lechosław/E-5525-2011; Skoracka, Anna/E-6002-2011; Szydło, Wiktoria/GPX-7846-2022; Lewandowski, Mariusz/N-1142-2019; Lewandowski, Mariusz/H-2184-2011; Majer, Agnieszka/AGF-5472-2022; Majer, Agnieszka/K-5181-2016; Szydło, Wiktoria/ABF-7041-2020; Szydło, Wiktoria/L-4804-2016	Kuczyński, Lechosław/0000-0003-3498-5445; Skoracka, Anna/0000-0002-9485-532X; Lewandowski, Mariusz/0000-0001-5360-0382; Lewandowski, Mariusz/0000-0001-5360-0382; Majer, Agnieszka/0000-0002-2425-7885; Majer, Agnieszka/0000-0002-2425-7885; Szydło, Wiktoria/0000-0001-5990-5611; Rector, Brian/0000-0001-5356-8714	National Science Centre in Poland [2011/03/B/NZ8/00129]	National Science Centre in Poland(National Science Centre, Poland)	The study was funded by the National Science Centre in Poland, grant no. 2011/03/B/NZ8/00129. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JC, 1995, ENVIRON ENTOMOL, V24, P996, DOI 10.1093/ee/24.5.996; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Beaurepaire AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135103; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Calosi P, 2008, J BIOGEOGR, V35, P295, DOI 10.1111/j.1365-2699.2007.01787.x; Carew M, 2009, B ENTOMOL RES, V99, P479, DOI 10.1017/S0007485308006512; Courtin O, 2000, ANN APPL BIOL, V137, P207, DOI 10.1111/j.1744-7348.2000.tb00061.x; Coutts BA, 2014, PLANT DIS, V98, P285, DOI 10.1094/PDIS-03-13-0288-PDN; CRAGG JG, 1971, ECONOMETRICA, V39, P829, DOI 10.2307/1909582; Dabert Jacek, 2008, Zootaxa, V1719, P41; Delatte H, 2009, BIOL INVASIONS, V11, P1059, DOI 10.1007/s10530-008-9328-9; European Environment Agency, 172007 EEA; Fand BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124682; Fand BB, 2014, CROP PROT, V55, P98, DOI 10.1016/j.cropro.2013.10.020; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Gaston KJ, 1999, OIKOS, V86, P584, DOI 10.2307/3546663; Soares APG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133495; Greaves GJ, 2006, BIOL CONSERV, V132, P211, DOI 10.1016/j.biocon.2006.04.016; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haque MM, 2003, APPL ENTOMOL ZOOL, V38, P97, DOI 10.1303/aez.2003.97; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt CD, 2004, EOS T AGU, V85, P566, DOI DOI 10.1029/2004EO520005; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2015, RASTER GEOGRAPHIC DA; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Jacquot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088581; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Keifer HH, 1969, SPECIAL PUBLICATION; LIU SS, 1995, ANN ENTOMOL SOC AM, V88, P107, DOI 10.1093/aesa/88.2.107; Lu ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108428; Ma FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103279; McCarren KL, 2013, AUST J ENTOMOL, V52, P393, DOI 10.1111/aen.12041; McMechan AJ, 2014, PLANT DIS, V98, P806, DOI 10.1094/PDIS-06-13-0582-RE; Michalska K, 2010, EXP APPL ACAROL, V51, P31, DOI 10.1007/s10493-009-9319-2; Miller AD, 2013, MOL PHYLOGENET EVOL, V66, P928, DOI 10.1016/j.ympev.2012.11.021; Mooney Harold A., 2000, P425; Murray DAH, 2013, AUST J ENTOMOL, V52, P227, DOI 10.1111/aen.12017; Navia D, 2013, EXP APPL ACAROL, V59, P95, DOI 10.1007/s10493-012-9633-y; Oldfield G. N., 1996, ERIOPHYOID MITES THE, P259, DOI DOI 10.1016/S1572-4379(96)80017-0; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; R Core Team, 2021, R LANGUAGE ENV STAT; Ritz C, 2008, USE R, P1; Sabelis MW, 1996, ERIOPHYOID MITES THE, P329, DOI DOI 10.1016/S1572-4379(96)80020-0; Sanchez-Fernandez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048163; Schiffer M, 2009, ANN APPL BIOL, V155, P371, DOI 10.1111/j.1744-7348.2009.00349.x; Schmidt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132917; Schubert J, 2015, ARCH VIROL, V160, P1761, DOI 10.1007/s00705-015-2422-2; Seifers DL, 2009, PLANT DIS, V93, P25, DOI 10.1094/PDIS-93-1-0025; Skaug H, 2012, GLMMADMB GENERALIZED; Skoracka A, 2014, ANN APPL BIOL, V165, P222, DOI 10.1111/aab.12130; Skoracka A, 2010, B ENTOMOL RES, V100, P263, DOI 10.1017/S0007485309990216; Skoracka A, 2014, BIOL J LINN SOC, V111, P421, DOI 10.1111/bij.12213; Skoracka A, 2013, BIOL J LINN SOC, V109, P165, DOI 10.1111/bij.12024; Skoracka A, 2012, INVERTEBR SYST, V26, P417, DOI 10.1071/IS11037; Skoracka A, 2012, BIOLOGIA, V67, P546, DOI 10.2478/s11756-012-0025-x; SLYKHUIS JT, 1955, PHYTOPATHOLOGY, V45, P116; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Telleria JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146958; Thomas JA, 2003, EXP APPL ACAROL, V31, P253, DOI 10.1023/B:APPA.0000010384.12678.46; Tonnang HEZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135283; Truol G, 2004, AUSTRALAS PLANT PATH, V33, P137, DOI 10.1071/AP03092; Van Campenhout J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111889; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wosula EN, 2016, PLANT DIS, V100, P154, DOI 10.1094/PDIS-03-15-0342-RE; Wosula EN, 2015, J ECON ENTOMOL, V108, P1545, DOI 10.1093/jee/tov185; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806	70	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154600	10.1371/journal.pone.0154600	http://dx.doi.org/10.1371/journal.pone.0154600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123590	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700112
J	Esposito, F; Angileri, FF; Kruse, P; Cavallo, LM; Solari, D; Esposito, V; Tomasello, F; Cappabianca, P				Esposito, Felice; Angileri, Filippo Flavio; Kruse, Peter; Cavallo, Luigi Maria; Solari, Domenico; Esposito, Vincenzo; Tomasello, Francesco; Cappabianca, Paolo			Fibrin Sealants in Dura Sealing: A Systematic Literature Review	PLOS ONE			English	Review							CEREBROSPINAL-FLUID LEAK; COLLAGEN-ONLY BIOMATRIX; TRANSSPHENOIDAL SURGERY; ALLERGIC REACTION; MATER SUBSTITUTE; TISSUE ADHESIVE; SELLAR REPAIR; GLUE; PREVENTION; MANAGEMENT	Background Fibrin sealants are widely used in neurosurgery to seal the suture line, provide watertight closure, and prevent cerebrospinal fluid leaks. The aim of this systematic review is to summarize the current efficacy and safety literature of fibrin sealants in dura sealing and the prevention/treatment of cerebrospinal fluid leaks. Methods A comprehensive electronic literature search was run in the following databases: Cochrane Database of Systematic Reviews, Cochrane Central Resister of Controlled Trials, clinical-trials.gov, MEDLINE/PubMed, and EMBASE. Titles and abstracts of potential articles of interest were reviewed independently by 3 of the authors. Results A total of 1006 database records and additional records were identified. After screening for duplicates and relevance, a total of 78 articles were assessed by the investigators for eligibility. Thirty-eight were excluded and the full-text of 40 articles were included in the qualitative synthesis. Seven of these included only safety data and were included in the safety assessment. The remaining 33 articles included findings from 32 studies that enrolled a total of 2935 patients who were exposed to fibrin sealant. Among these 33 studies there were only 3 randomized controlled trials, with the remaining being prospective cohort analysis, case controlled studies, prospective or retrospective case series. One randomized controlled trial, with 89 patients exposed to fibrin sealant, found a greater rate of intraoperative watertight dura closure in the fibrin sealant group than the control group (92.1% versus 38.0%, p<0.001); however, post-operative cerebrospinal fluid leakage occurred in more fibrin sealant than control patients (6.7% versus 2.0%, p>0.05). Other clinical trials evaluated the effect of fibrin sealant in the postoperative prevention of cerebrospinal fluid leaks. These were generally lower level evidence studies (ie, not prospective, randomized, controlled trials) that were not designed or powered to demonstrate a significant advantage to fibrin sealant use. Two small case series studies evaluated the effect of fibrin sealants in persistent cerebrospinal fluid leak treatment, but did not establish firm efficacy conclusions. Specific adverse reports where fibrin sealants were used for dura sealing were limited, with only 8 cases reported in neurosurgical procedures since 1987 and most reporting only a speculative relationship/association with fibrin sealant exposure. Conclusions A major finding of this systematic literature review is that there is a paucity of randomized studies that have evaluated the effectiveness and safety of fibrin sealants in providing intraoperative watertight dura closure and post-operative cerebrospinal fluid leakage. Among the limited studies available, evidence from a single randomized, controlled trial indicates that fibrin sealants provide a higher rate of intraoperative watertight closure of the dura suture line than control, albeit with a higher rate of postoperative cerebrospinal fluid leakage. Evidence from non-randomized, controlled trials suggests that fibrin sealants may be effective in preventing cerebrospinal fluid leaks with an acceptable safety profile. There is a substantial need for randomized, controlled clinical trials or well-designed prospective observational trials where the conduct of a randomized trial is not feasible to fully assess the impact of fibrin sealant utilization on the rates of intraoperative dura closure, postoperative cerebrospinal leakage, and safety.	[Esposito, Felice; Angileri, Filippo Flavio; Tomasello, Francesco] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Div Neurosurg, Messina, Italy; [Cavallo, Luigi Maria; Solari, Domenico; Cappabianca, Paolo] Univ Naples Federico II, Dept Neurosci & Odontostomatol & Reprod Sci, Div Neurosurg, Naples, Italy; [Esposito, Vincenzo] Univ Roma La Sapienza, Div Neurosurg, Piazzale Aldo Moro 5, I-00185 Rome, Italy	University of Messina; University of Naples Federico II; Sapienza University Rome	Esposito, F (corresponding author), Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Div Neurosurg, Messina, Italy.	fesposito@unime.it	Angileri, Filippo/AAL-4851-2021; Esposito, Felice/F-4238-2012; Esposito, Felice/AAC-4646-2019; Angileri, Filippo Flavio/J-3533-2012; Esposito, Vincenzo/E-9994-2011; Angileri, Filippo/N-8556-2019	Esposito, Felice/0000-0003-1051-5924; Esposito, Felice/0000-0003-1051-5924; Angileri, Filippo Flavio/0000-0002-1107-4115; Esposito, Vincenzo/0000-0001-7316-5461; Angileri, Filippo/0000-0002-1107-4115; Esposito, Vincenzo/0000-0002-0647-5619	Baxter Italy	Baxter Italy	Dr. Felice Esposito received an unrestricted research grant from Baxter Italy and has given some didactic presentations on Dural Sealing methods. Dr. Paolo Cappabianca received an unrestricted research grant from Baxter Italy and has given some didactic presentations on Dural Sealing methods. Dr. Peter Kruse was paid for this structured literature review as an independent clinical consultant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Felice Esposito has given some didactic presentations on Dural Sealing methods. Paolo Cappabianca received an unrestricted research grant from Baxter Italy and has given some didactic presentations on Dural Sealing methods. Peter Kruse was paid for this structured literature review as an independent clinical consultant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KP, 2012, J NEUROL SURG PART B, V73, P401, DOI 10.1055/s-0032-1329618; Altomare DF, 2011, COLORECTAL DIS, V13, P82, DOI 10.1111/j.1463-1318.2009.02056.x; [Anonymous], 2013, TISSEEL PACKAGE INSE; [Anonymous], 2009, OXFORD CTR EVIDENCE; Becker SS, 2003, OTOL NEUROTOL, V24, P107, DOI 10.1097/00129492-200301000-00021; Beierlein W, 2000, TRANSFUSION, V40, P302, DOI 10.1046/j.1537-2995.2000.40030302.x; Biroli Francesco, 2008, Neurosurgery, V62, P273, DOI 10.1227/01.neu.0000317404.31336.69; Black P, 2002, J NEUROSURG, V96, P250, DOI 10.3171/spi.2002.96.2.0250; Cappabianca P, 2006, SURG NEUROL, V65, P144, DOI 10.1016/j.surneu.2005.08.023; Cappabianca P, 2004, SURG NEUROL, V62, P227, DOI 10.1016/j.surneu.2004.01.016; Cappabianca P, 2002, NEUROSURGERY, V51, P1365, DOI 10.1227/01.NEU.0000035904.77559.9F; Cappabianca P, 2010, ACTA NEUROCHIR, V152, P897, DOI 10.1007/s00701-009-0580-2; Carless PA, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004171; Cassano M, 2009, RHINOLOGY, V47, P362, DOI 10.4193/Rhin08.175; Cavallo LM, 2013, TRANSL MED UNISA, V7, P23; Cavallo LM, 2007, J NEUROSURG, V107, P713, DOI 10.3171/JNS-07/10/0713; Cho JM, 2011, NEUROSURGERY, V68, DOI 10.1227/NEU.0b013e318207b4ea; Czepko Ryszard, 2006, Polim Med, V36, P3; DANDREA AA, 1994, ITAL J GASTROENTEROL, V26, P283; Esposito F, 2008, CLIN NEUROL NEUROSUR, V110, P343, DOI 10.1016/j.clineuro.2007.12.016; Esposito F, 2013, CLIN NEUROL NEUROSUR, V115, P1735, DOI 10.1016/j.clineuro.2013.03.013; Felema GG, 2013, PEDIATR ANESTH, V23, P754, DOI 10.1111/pan.12180; Gazzeri R, 2011, WORLD NEUROSURG, V76, P173, DOI 10.1016/j.wneu.2010.09.029; Gazzeri R, 2009, ACTA NEUROCHIR, V151, P537, DOI 10.1007/s00701-009-0290-9; GILLMAN GS, 1995, J OTOLARYNGOL, V24, P191; Gonfiotti A, 2011, ANN THORAC SURG, V92, P1217, DOI 10.1016/j.athoracsur.2011.05.104; Gopal SC, 2008, J PEDIATR SURG, V43, P1869, DOI 10.1016/j.jpedsurg.2008.04.022; Green Alexander L, 2015, Br J Neurosurg, V29, P11, DOI 10.3109/02688697.2014.948808; Grimaud JC, 2010, GASTROENTEROLOGY, V138, P2275, DOI 10.1053/j.gastro.2010.02.013; Handa J, 1989, Nihon Geka Hokan, V58, P231; Hida K, 2006, SURG NEUROL, V65, P136, DOI 10.1016/j.surneu.2005.07.059; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hobbs CGL, 2011, J LARYNGOL OTOL, V125, P311, DOI 10.1017/S0022215110002483; Jankowitz BT, 2009, EUR SPINE J, V18, P1169, DOI 10.1007/s00586-009-0928-6; Kanazawa R, 2010, NEUROL MED-CHIR, V50, P608, DOI 10.2176/nmc.50.608; Kassam A, 2003, NEUROSURGERY, V52, P1102, DOI 10.1227/01.NEU.0000057699.37541.76; Kurschel S, 2007, CHILD NERV SYST, V23, P521, DOI 10.1007/s00381-006-0278-1; Lago Oliver J, 2010, CIR ESPAN, V90, P647; Lindsey I, 2002, DIS COLON RECTUM, V45, P1608, DOI 10.1007/s10350-004-7247-0; Mansouri A, 2016, J NEUROSURG, V124, P558, DOI 10.3171/2014.12.JNS142465; Merkus P, 2010, OTOL NEUROTOL, V31, P276, DOI 10.1097/MAO.0b013e3181cc06ad; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Murai Y, 2014, WORLD NEUROSURG, V81, P344, DOI 10.1016/j.wneu.2013.01.032; Nakamura H, 2005, SPINE, V30, pE347, DOI 10.1097/01.brs.0000167820.54413.8e; Nistor RF, 1997, SKULL BASE SURG, V7, P23, DOI 10.1055/s-2008-1058620; Parker SR, 2011, J NEUROSURG-PEDIATR, V8, P177, DOI 10.3171/2011.5.PEDS10362; Parlato C, 2011, ACTA NEUROCHIR, V153, P142, DOI 10.1007/s00701-010-0718-2; Reddy M, 2002, ACTA NEUROCHIR, V144, P265, DOI 10.1007/s007010200034; Reddy M, 2003, EUR SURG, V35, P278; Safan A, 2009, NEUROUROL URODYNAM, V28, P438, DOI 10.1002/nau.20754; SCHLENKER M, 1987, J NEUROL NEUROSUR PS, V50, P1715, DOI 10.1136/jnnp.50.12.1715; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Seda L, 2006, SURG NEUROL, V66, P46, DOI 10.1016/j.surneu.2005.10.021; Silecchia G, 2006, OBES SURG, V16, P125, DOI 10.1381/096089206775565249; Spotnitz WD, 2012, TRANSFUSION, V52, P2243, DOI 10.1111/j.1537-2995.2012.03707.x; SUZUKI Y, 1995, ARCH SURG-CHICAGO, V130, P952; Tamasauskas A, 2008, MEDICINA-LITHUANIA, V44, P302, DOI 10.3390/medicina44040039; Than KD, 2008, NEUROSURGERY, V63, P182, DOI 10.1227/01.NEU.0000313116.28200.67; Upadhyaya VD, 2007, WORLD J SURG, V31, P2412, DOI 10.1007/s00268-007-9244-7; VANVELTHOVEN V, 1991, ACTA NEUROCHIR, V109, P26, DOI 10.1007/BF01405692; Wakamoto H, 2002, NEUROL SURG TOKYO, V30, P1331; Weber R, 1996, ARCH OTOLARYNGOL, V122, P732; Yin Jian, 2005, Chinese Medical Sciences Journal, V20, P198; Yoshimoto Tetsuyuki, 1997, Neurologia Medico-Chirurgica, V37, P886, DOI 10.2176/nmc.37.886; Yu FB, 2015, J SPINAL DISORD TECH, V28, P389, DOI 10.1097/BSD.0000000000000031	65	49	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0151533	10.1371/journal.pone.0151533	http://dx.doi.org/10.1371/journal.pone.0151533			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119993	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200005
J	Howard, MG; McDonald, WJF; Forster, PI; Kress, WJ; Erickson, D; Faith, DP; Shapcott, A				Howard, Marion G.; McDonald, William J. F.; Forster, Paul I.; Kress, W. John; Erickson, David; Faith, Daniel P.; Shapcott, Alison			Patterns of Phylogenetic Diversity of Subtropical Rainforest of the Great Sandy Region, Australia Indicate Long Term Climatic Refugia	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FRASER ISLAND; DIVERSIFICATION; BIODIVERSITY; ENDEMISM; FRAGMENTATION; BIOGEOGRAPHY; COMMUNITIES; QUEENSLAND; EVOLUTION	Australia's Great Sandy Region is of international significance containing two World Heritage areas and patches of rainforest growing on white sand. Previous broad-scale analysis found the Great Sandy biogeographic subregion contained a significantly more phylogenetically even subset of species than expected by chance contrasting with rainforest on white sand in Peru. This study aimed to test the patterns of rainforest diversity and relatedness at a finer scale and to investigate why we may find different patterns of phylogenetic evenness compared with rainforests on white sands in other parts of the world. This study focussed on rainforest sites within the Great Sandy and surrounding areas in South East Queensland (SEQ), Australia. We undertook field collections, expanded our three-marker DNA barcode library of SEQ rainforest plants and updated the phylogeny to 95% of the SEQ rainforest flora. We sampled species composition of rainforest in fixed area plots from 100 sites. We calculated phylogenetic diversity (PD) measures as well as species richness (SR) for each rainforest community. These combined with site variables such as geology, were used to evaluate patterns and relatedness. We found that many rainforest communities in the Great Sandy area were significantly phylogenetically even at the individual site level consistent with a broader subregion analysis. Sites from adjacent areas were either not significant or were significantly phylogenetically clustered. Some results in the neighbouring areas were consistent with historic range expansions. In contrast with expectations, sites located on the oldest substrates had significantly lower phylogenetic diversity (PD). Fraser Island was once connected to mainland Australia, our results are consistent with a region geologically old enough to have continuously supported rainforest in refugia. The interface of tropical and temperate floras in part also explains the significant phylogenetic evenness and higher than expected phylogenetic diversity.	[Howard, Marion G.; Shapcott, Alison] Univ Sunshine Coast, Fac Sci Hlth Educ, Genecol Res Ctr, Maroochydore, Qld, Australia; [McDonald, William J. F.; Forster, Paul I.] Queensland Herbarium, Queensland Dept Sci Informat Technol & Innovat, Brisbane Bot Gardens, Toowong, Qld, Australia; [Kress, W. John; Erickson, David] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Faith, Daniel P.] Australian Museum, 6-8 Coll St, Sydney, NSW 2000, Australia	University of the Sunshine Coast; Smithsonian Institution; Smithsonian National Museum of Natural History; Australian Museum	Shapcott, A (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ, Genecol Res Ctr, Maroochydore, Qld, Australia.	ashapcot@usc.edu.au			Queensland Smithsonian Fellowship; Honours student Marion Howard	Queensland Smithsonian Fellowship; Honours student Marion Howard	This study was funded by student grant to Honours student Marion Howard; However it built on a previous larger project funded by Queensland Smithsonian Fellowship awarded to AS.	Accad A., 2013, REMNANT VEGETATION Q; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; BURBRIDGE NANCY T., 1960, AUSTRALIAN JOUR BOT, V8, P75, DOI 10.1071/BT9600075; Butler DW, 2007, J BIOGEOGR, V34, P1736, DOI 10.1111/j.1365-2699.2007.01734.x; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Clarke K.R., 2006, PRIMER V6 USER MANUA; Costion CM, 2014, DIVERS DISTRIB, V21, P1; Costion CM, 2015, DIVERS DISTRIB, V21, P279, DOI 10.1111/ddi.12266; Donders TH, 2006, PALAEOGEOGR PALAEOCL, V241, P417, DOI 10.1016/j.palaeo.2006.04.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erickson DL, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00358; ESRI, 2013, ARCGIS DESKT REL 10; Faith Daniel P., 2001, Pacific Conservation Biology, V6, P304; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fayolle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042381; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Fine PVA, 2005, EVOLUTION, V59, P1464; Geological Survey of Queensland, 2011, DIG GEOSC VECT DAT Q; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Harrold AG., 1987, STUDIES LANDSCAPE DY; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heads M, 2009, BIOL J LINN SOC, V96, P222, DOI 10.1111/j.1095-8312.2008.01118.x; IBM, 2013, SPSS STAT WIND VERS; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kooyman R, 2011, GLOBAL ECOL BIOGEOGR, V20, P707, DOI 10.1111/j.1466-8238.2010.00641.x; Kooyman RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080685; KRUCKEBERG AR, 1986, SYST BOT, V11, P455, DOI 10.2307/2419082; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawson Ben E., 2006, Pacific Conservation Biology, V12, P288; Lees BG, 2006, J COASTAL RES, V22, P78, DOI 10.2112/05A-0007.1; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Longmore ME, 1997, AUST J BOT, V45, P507, DOI 10.1071/BT96109; Maddison, 2018, MESQUITE MODULAR SYS; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Mayfield MM, 2009, AM NAT, V174, pE1, DOI 10.1086/599293; Mellick R, 2011, AUST J BOT, V59, P351, DOI 10.1071/BT10291; Miller M.A., 2010, P GAT COMP ENV WORKS; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Mwavu EN, 2015, BIOTROPICA, V47, P424, DOI 10.1111/btp.12223; NELDNER VJ, 2005, METHODOLOGY SURVEY M; Nichols WF, 1998, CONSERV BIOL, V12, P371, DOI 10.1046/j.1523-1739.1998.96237.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Queensland Herbarium, 2013, SURV MAPP 2011 VEG C; Saner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029642; Sattler P., 1999, CONSERVATION STATUS; Schnitzler J, 2011, SYST BIOL, V60, P343, DOI 10.1093/sysbio/syr006; Shapcott A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122164; Smith-Ramirez C, 2004, BIODIVERS CONSERV, V13, P373, DOI 10.1023/B:BIOC.0000006505.67560.9f; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Swenson Nathan G, 2012, Methods Mol Biol, V858, P409, DOI 10.1007/978-1-61779-591-6_20; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Waters JM, 2015, QUATERNARY SCI REV, V120, P47, DOI 10.1016/j.quascirev.2015.04.023; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEBB LJ, 1984, AUST J ECOL, V9, P169, DOI 10.1111/j.1442-9993.1984.tb01356.x; Weber LC, 2014, J BIOGEOGR, V41, P222, DOI 10.1111/jbi.12219; WHITEHEAD DR, 1969, EVOLUTION, V23, P171, DOI 10.1111/j.1558-5646.1969.tb03503.x; Yokoyama Y, 2001, QUATERN INT, V83-5, P9, DOI 10.1016/S1040-6182(01)00028-3	61	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153565	10.1371/journal.pone.0153565	http://dx.doi.org/10.1371/journal.pone.0153565			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119149	gold, Green Published, Green Submitted			2022-12-26	WOS:000374976200030
J	Kumar, N; Bera, BC; Greenbaum, BD; Bhatia, S; Sood, R; Selvaraj, P; Anand, T; Tripathi, BN; Virmani, N				Kumar, Naveen; Bera, Bidhan Chandra; Greenbaum, Benjamin D.; Bhatia, Sandeep; Sood, Richa; Selvaraj, Pavulraj; Anand, Taruna; Tripathi, Bhupendra Nath; Virmani, Nitin			Revelation of Influencing Factors in Overall Codon Usage Bias of Equine Influenza Viruses	PLOS ONE			English	Article							A VIRUS; RNASE-L; SYNONYMOUS MUTATIONS; ESCHERICHIA-COLI; EVOLUTION; SELECTION; GENOME; GENES; NUCLEOTIDE; ADAPTATION	Equine influenza viruses (EIVs) of H3N8 subtype are culprits of severe acute respiratory infections in horses, and are still responsible for significant outbreaks worldwide. Adaptability of influenza viruses to a particular host is significantly influenced by their codon usage preference, due to an absolute dependence on the host cellular machinery for their replication. In the present study, we analyzed genome-wide codon usage patterns in 92 EIV strains, including both H3N8 and H7N7 subtypes by computing several codon usage indices and applying multivariate statistical methods. Relative synonymous codon usage (RSCU) analysis disclosed bias of preferred synonymous codons towards A/U-ended codons. The overall codon usage bias in EIVs was slightly lower, and mainly affected by the nucleotide compositional constraints as inferred from the RSCU and effective number of codon (ENc) analysis. Our data suggested that codon usage pattern in EIVs is governed by the interplay of mutation pressure, natural selection from its hosts and undefined factors. The H7N7 subtype was found less fit to its host (horse) in comparison to H3N8, by possessing higher codon bias, lower mutation pressure and much less adaptation to tRNA pool of equine cells. To the best of our knowledge, this is the first report describing the codon usage analysis of the complete genomes of EIVs. The outcome of our study is likely to enhance our understanding of factors involved in viral adaptation, evolution, and fitness towards their hosts.	[Kumar, Naveen; Bhatia, Sandeep; Sood, Richa] NIHSAD, Immunol Lab, Bhopal, Madhya Pradesh, India; [Bera, Bidhan Chandra; Anand, Taruna] NRCE, Vet Type Culture Collect, Biotechnol Lab, Hisar, Haryana, India; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, New York, NY 10029 USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Hematol & Med Pathol, New York, NY 10029 USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pathol, New York, NY 10029 USA; [Selvaraj, Pavulraj; Tripathi, Bhupendra Nath; Virmani, Nitin] NRCE, Equine Pathol Lab, Hisar, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute of High Security Animal Diseases; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines	Virmani, N (corresponding author), NRCE, Equine Pathol Lab, Hisar, Haryana, India.	nvirmani@gmail.com	Kumar, Naveen/L-1588-2019; Kumar, Naveen/GZK-9881-2022; Kumar, Naveen/V-1009-2019; Selvaraj, Pavulraj/AAV-8266-2021	Kumar, Naveen/0000-0002-3326-5465; Kumar, Naveen/0000-0003-2529-8344; 	Indian Council of Agricultural Research, India	Indian Council of Agricultural Research, India(Indian Council of Agricultural Research (ICAR))	The Indian Council of Agricultural Research, India provided the necessary funding for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2004, ARCH VIROL, V149, P113, DOI 10.1007/s00705-003-0186-6; Agashe D, 2013, MOL BIOL EVOL, V30, P549, DOI 10.1093/molbev/mss273; Anhlan D, 2011, RNA, V17, P64, DOI 10.1261/rna.2395211; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Biro JC, 2008, THEOR BIOL MED MODEL, V5, P1; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; BULMER M, 1991, GENETICS, V129, P897; Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905; Carroll TD, 2014, J INFECT DIS, V209, P24, DOI 10.1093/infdis/jit540; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chen Y., 2014, JVIRUSES, V2014, DOI [DOI 10.1155/2014/329049, 10.1155/2014/329049]; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Cooper DA, 2015, J VIROL, V89, P2764, DOI 10.1128/JVI.02953-14; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; DESCHAVANNE P, 1995, NUCLEIC ACIDS RES, V23, P1350, DOI 10.1093/nar/23.8.1350; Dorn A, 2008, CURR OPIN MOL THER, V10, P10; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M., 2013, STRANGE SIMPLICITY C; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Feng KH, 2015, J VIROL, V89, P6860, DOI 10.1128/JVI.00521-15; Fu MH, 2010, ARCH VIROL, V155, P391, DOI 10.1007/s00705-010-0597-0; Gomez MM, 2011, INFECT GENET EVOL, V11, P580, DOI 10.1016/j.meegid.2011.01.006; Goni N, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-263; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Greenacre Michael, 1984, THEORY APPL CORRES A; Greenbaum BD, 2014, P NATL ACAD SCI USA, V111, P5054, DOI 10.1073/pnas.1402285111; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; GUO YJ, 1992, VIROLOGY, V188, P245, DOI 10.1016/0042-6822(92)90754-D; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Jimenez-Baranda S, 2011, J VIROL, V85, P3893, DOI 10.1128/JVI.01908-10; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Karlsson EA, 2012, EMERG INFECT DIS, V18, P1672, DOI 10.3201/eid1810.120214; Kitano M, 2010, VIROLOGY, V407, P178, DOI 10.1016/j.virol.2010.08.006; KURLAND CG, 1993, BIOCHEM SOC T, V21, P841, DOI 10.1042/bst0210841; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lu G, 2013, VIRUS GENES, V47, P250, DOI 10.1007/s11262-013-0935-x; Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001; Murcia PR, 2011, J VIROL, V85, P5312, DOI 10.1128/JVI.02619-10; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Peden JF, 1999, THESIS NOTTINGHAM U; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Rabadan R, 2006, J VIROL, V80, P11887, DOI 10.1128/JVI.01414-06; Romero H, 2003, GENE, V317, P141, DOI 10.1016/S0378-1119(03)00701-7; ROTHBERG PG, 1981, NUCLEIC ACIDS RES, V9, P6221, DOI 10.1093/nar/9.23.6221; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Skinner JA, 2014, CLIN VACCINE IMMUNOL, V21, P1668, DOI 10.1128/CVI.00547-14; Smith JM, 1996, GENETICS, V142, P1037; Solovyov A, 2010, PLOS CURRENTS, V2; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Supek F, 2004, BIOINFORMATICS, V20, P2329, DOI 10.1093/bioinformatics/bth238; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z; van Weringh A, 2011, MOL BIOL EVOL, V28, P1827, DOI 10.1093/molbev/msr005; Vetsigian K, 2009, P NATL ACAD SCI USA, V106, P215, DOI 10.1073/pnas.0810122106; Vider-Shalit T, 2007, J VIROL, V81, P9536, DOI 10.1128/JVI.02636-06; Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0; WEBSTER RG, 1993, EQUINE VET J, V25, P537, DOI 10.1111/j.2042-3306.1993.tb03009.x; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Yin X, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-356; Zhang YQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-174; Zhao KN, 2003, VIRUS RES, V98, P95, DOI 10.1016/j.virusres.2003.08.019; Zhong J, 2007, VIRUS GENES, V35, P767, DOI 10.1007/s11262-007-0159-z; Zhou T, 2005, BIOSYSTEMS, V81, P77, DOI 10.1016/j.biosystems.2005.03.002	83	62	70	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154376	10.1371/journal.pone.0154376	http://dx.doi.org/10.1371/journal.pone.0154376			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119730	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200064
J	Palik, DJ; Snow, AA; Stottlemyer, AL; Miriti, MN; Heaton, EA				Palik, D. J.; Snow, A. A.; Stottlemyer, A. L.; Miriti, M. N.; Heaton, E. A.			Relative Performance of Non-Local Cultivars and Local, Wild Populations of Switchgrass (Panicum virgatum) in Competition Experiments	PLOS ONE			English	Article							GENOTYPIC VARIATION; PROPAGULE PRESSURE; GENETIC DIVERSITY; SEED; ADAPTATION; BIOENERGY; DYNAMICS; INVASION; ECOTYPES; PATTERNS	The possibility of increased invasiveness in cultivated varieties of native perennial species is a question of interest in biofuel risk assessment. Competitive success is a key factor in the fitness and invasive potential of perennial plants, and thus the large-scale release of high-yielding biomass cultivars warrants empirical comparisons with local conspecifics in the presence of competitors. We evaluated the performance of non-local cultivars and local wild biotypes of the tallgrass species Panicum virgatum L. (switchgrass) in competition experiments during two growing seasons in Ohio and Iowa. At each location, we measured growth and reproductive traits (plant height, tiller number, flowering time, aboveground biomass, and seed production) of four non-locally sourced cultivars and two locally collected wild biotypes. Plants were grown in common garden experiments under three types of competition, referred to as none, moderate (with Schizachyrium scoparium), and high (with Bromus inermis). In both states, the two "lowland" cultivars grew taller, flowered later, and produced between 2x and 7.5x more biomass and between 3x and 34x more seeds per plant than local wild biotypes, while the other two cultivars were comparable to wild biotypes in these traits. Competition did not affect relative differences among biotypes, with the exception of shoot number, which was more similar among biotypes under high competition. Insights into functional differences between cultivars and wild biotypes are crucial for developing biomass crops while mitigating the potential for invasiveness. Here, two of the four cultivars generally performed better than wild biotypes, indicating that these biotypes may pose more of a risk in terms of their ability to establish vigorous feral populations in new regions outside of their area of origin. Our results support an ongoing assessment of switchgrass cultivars developed for large-scale planting for biofuels.	[Palik, D. J.; Snow, A. A.; Stottlemyer, A. L.; Miriti, M. N.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Heaton, E. A.] Iowa State Univ, Dept Agron, Ames, IA USA	University System of Ohio; Ohio State University; Iowa State University	Palik, DJ (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA.	palik.2@osu.edu			Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture [2010-33522-21703]	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture	This project was supported by Biotechnology Risk Assessment Grant Program, grant no. 2010-33522-21703, from the USDA National Institute of Food and Agriculture (recipient: Ohio State University, AA Snow) (http://www.reeis.usda.gov/web/crisprojectpages/0223354-gene-flow-and-fitness-studies-of-switchgrass-implications-for-new-biofuel-crops.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 2002, OIKOS, V96, P531, DOI 10.1034/j.1600-0706.2002.960314.x; Aspinwall MJ, 2013, NEW PHYTOL, V199, P966, DOI 10.1111/nph.12341; Baer SG, 2014, EVOL APPL, V7, P323, DOI 10.1111/eva.12124; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Barney JN, 2012, BIOMASS BIOENERG, V40, P143, DOI 10.1016/j.biombioe.2012.02.013; Barney JN, 2009, PLANT SCI, V177, P724, DOI 10.1016/j.plantsci.2009.09.003; BENGTSSON J, 1994, TRENDS ECOL EVOL, V9, P246, DOI 10.1016/0169-5347(94)90289-5; Benson EJ, 2006, PLANT ECOL, V187, P163, DOI 10.1007/s11258-005-0975-y; Bock J. H., 1998, GREAT PLAINS RES, V8, P213; Boe A, 1998, CROP SCI, V38, P540, DOI 10.2135/cropsci1998.0011183X003800020058x; Casler MD, 2007, CROP SCI, V47, P2249, DOI 10.2135/cropsci2006.12.0780; Casler MD, 2004, CROP SCI, V44, P293, DOI 10.2135/cropsci2004.2930; Casler MD, 2007, CROP SCI, V47, P2261, DOI 10.2135/cropsci2006.12.0797; Casler MD, 2014, CROP SCI, V54, P626, DOI 10.2135/cropsci2013.04.0239; Casler MD, 2011, PLANT GENOME-US, V4, P273, DOI 10.3835/plantgenome2011.10.0026; Cortese LM, 2010, BIOENERG RES, V3, P262, DOI 10.1007/s12155-010-9078-2; Dillemuth FP, 2009, BIOL INVASIONS, V11, P1381, DOI 10.1007/s10530-008-9346-7; DiTomaso JM, 2013, CALIF AGR, V67, P96, DOI 10.3733/ca.v067n02p96; Ecker G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130414; Gibson DJ, 2013, J VEG SCI, V24, P429, DOI 10.1111/j.1654-1103.2012.01475.x; Gibson DJ, 2012, OIKOS, V121, P496, DOI 10.1111/j.1600-0706.2011.19447.x; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; GROSS KL, 1991, OECOLOGIA, V87, P270, DOI 10.1007/BF00325266; Gustafson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091511; Gustafson DJ, 2004, FUNCT ECOL, V18, P451, DOI 10.1111/j.0269-8463.2004.00850.x; Gustafson DJ., 2001, P 17 N AM PRAIRIE C, P118; HARTNETT DC, 1993, AM J BOT, V80, P1114, DOI 10.2307/2445538; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Heaton EA, 2008, CURR OPIN BIOTECH, V19, P202, DOI 10.1016/j.copbio.2008.05.001; Herget ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119889; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Klopf RP, 2011, RESTOR ECOL, V19, P112, DOI 10.1111/j.1526-100X.2009.00539.x; Lambert AM, 2011, RESTOR ECOL, V19, P43, DOI 10.1111/j.1526-100X.2010.00673.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lowry DB, 2014, AM NAT, V183, P682, DOI 10.1086/675760; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Mutegi E., 2013, RESTORATION ECOLOGY, V22, P223; Nageswara-Rao M, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-77; Nageswara-Rao M, 2013, GENET RESOUR CROP EV, V60, P1057, DOI 10.1007/s10722-012-9903-x; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Polley HW, 2005, RESTOR ECOL, V13, P480, DOI 10.1111/j.1526-100X.2005.00060.x; R Core Team, 2021, R LANGUAGE ENV STAT; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schroder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071066; Simberloff D, 2008, WEED SCI, V56, P867, DOI 10.1614/WS-08-046.1; Sripathi R, 2013, EUPHYTICA, V191, P437, DOI 10.1007/s10681-013-0911-5; Stottlemyer AL, 2012, THESIS OHIO STATE U; USDA FSA, 2013, CONS RES PROGR; USDA/NRCS (U.S. Department of Agriculture/National Resources Conservation Service, 2013, THE PLANTS DAT; USDA-NRCS, 2011, REL BROCH BLACKW SWI; USDA-NRCS, 2011, REL BROCH KANL SWITC; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Wittmann MJ, 2014, OIKOS, V123, P441, DOI 10.1111/j.1600-0706.2013.01025.x; Wright L, 2010, BIOMASS BIOENERG, V34, P851, DOI 10.1016/j.biombioe.2010.01.030; WULFF RD, 1986, J ECOL, V74, P99, DOI 10.2307/2260351; Wullschleger SD, 2010, AGRON J, V102, P1158, DOI 10.2134/agronj2010.0087; Zalapa JE, 2011, THEOR APPL GENET, V122, P805, DOI 10.1007/s00122-010-1488-1; Zhang YW, 2011, GENETICA, V139, P933, DOI 10.1007/s10709-011-9597-6	61	11	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154444	10.1371/journal.pone.0154444	http://dx.doi.org/10.1371/journal.pone.0154444			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120201	Green Submitted, Green Published, gold			2022-12-26	WOS:000374976200077
J	Costa, A; Ianez, E; Ubeda, A; Hortal, E; Del-Ama, AJ; Gil-Agudo, A; Azorin, JM				Costa, Alvaro; Ianez, Eduardo; Ubeda, Andres; Hortal, Enrique; Del-Ama, Antonio J.; Gil-Agudo, Angel; Azorin, Jose M.			Decoding the Attentional Demands of Gait through EEG Gamma Band Features	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; MAXIMUM-ENTROPY METHOD; SPINAL-CORD-INJURY; MOTOR IMAGERY; BHATTACHARYYA DISTANCE; NEUROLOGICAL REHABILITATION; SELECTIVE ATTENTION; FREQUENCY-ANALYSIS; EXECUTIVE FUNCTION; TASK DEMANDS	Rehabilitation techniques are evolving focused on improving their performance in terms of duration and level of recovery. Current studies encourage the patient's involvement in their rehabilitation. Brain-Computer Interfaces are capable of decoding the cognitive state of users to provide feedback to an external device. On this paper, cortical information obtained from the scalp is acquired with the goal of studying the cognitive mechanisms related to the users' attention to the gait. Data from 10 healthy users and 3 incomplete Spinal Cord Injury patients are acquired during treadmill walking. During gait, users are asked to perform 4 attentional tasks. Data obtained are treated to reduce movement artifacts. Features from delta(1 - 4Hz), theta(4 -8Hz), alpha(8 - 12Hz), beta(12 -30Hz), gamma(low)(30 -50Hz), gamma(high)(50 - 90Hz) frequency bands are extracted and analyzed to find which ones provide more information related to attention. The selected bands are tested with 5 classifiers to distinguish between tasks. Classification results are also compared with chance levels to evaluate performance. Results show success rates of similar to 67% for healthy users and similar to 59% for patients. These values are obtained using features from. band suggesting that the attention mechanisms are related to selective attention mechanisms, meaning that, while the attention on gait decreases the level of attention on the environment and external visual information increases. Linear Discriminant Analysis, K-Nearest Neighbors and Support Vector Machine classifiers provide the best results for all users. Results from patients are slightly lower, but significantly different, than those obtained from healthy users supporting the idea that the patients pay more attention to gait during non-attentional tasks due to the inherent difficulties they have during normal gait. This study provides evidence of the existence of classifiable cortical information related to the attention level on the gait. This fact could allow the development of a real-time system that obtains the attention level during lower limb rehabilitation. This information could be used as feedback to adapt the rehabilitation strategy.	[Costa, Alvaro; Ianez, Eduardo; Ubeda, Andres; Hortal, Enrique; Azorin, Jose M.] Miguel Hernandez Univ, Brain Machine Interface Syst Lab, Ave Univ S-N, Elche 03202, Spain; [Del-Ama, Antonio J.; Gil-Agudo, Angel] Natl Hosp Spinal Cord Injury, Phys Med & Rehabil Dept, Biomech Unit, SESCAM, Finca Peraleda S-N, Toledo 45071, Spain; [Del-Ama, Antonio J.; Gil-Agudo, Angel] Natl Hosp Spinal Cord Injury, Phys Med & Rehabil Dept, Tech Aids Unit, SESCAM, Finca Peraleda S-N, Toledo 45071, Spain	Universidad Miguel Hernandez de Elche	Costa, A (corresponding author), Miguel Hernandez Univ, Brain Machine Interface Syst Lab, Ave Univ S-N, Elche 03202, Spain.	acosta@umh.es	del-Ama, Antonio J./G-3141-2016; Ubeda, Andres/E-9811-2018; Hortal, Enrique/R-9176-2018; Azorin, Jose M./M-8956-2019; Iáñez, Eduardo/J-9765-2014; Azorin, Jose M/G-2157-2011; Gil-Agudo, Ángel/ABD-3065-2021; Ubeda, Andres/K-4883-2015	del-Ama, Antonio J./0000-0001-6215-2593; Hortal, Enrique/0000-0003-2119-4169; Azorin, Jose M./0000-0001-5548-9657; Iáñez, Eduardo/0000-0001-8057-5952; Azorin, Jose M/0000-0001-5548-9657; Gil-Agudo, Ángel/0000-0001-5082-4225; Ubeda, Andres/0000-0003-3223-025X	Commission of the European Union under the BioMot project - Smart Wearable Robots with Bioinspired Sensory-Motor Skills [IFP7-ICT-2013-10-611695]	Commission of the European Union under the BioMot project - Smart Wearable Robots with Bioinspired Sensory-Motor Skills	This research has been funded by the Commission of the European Union under the BioMot project - Smart Wearable Robots with Bioinspired Sensory-Motor Skills ( Grant Agreement number IFP7-ICT-2013-10-611695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2009, IEEE ENG MED BIO, P5981, DOI 10.1109/IEMBS.2009.5335381; [Anonymous], IEEE REG 10 ANN INT; Antos A, 1999, IEEE T PATTERN ANAL, V21, P643, DOI 10.1109/34.777375; Bhattacharyya A, 1946, SANKHYA, V7, P401; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; CHAUDHURI G, 1991, COMMUN STAT THEORY, V20, P2195, DOI 10.1080/03610929108830627; Choi E, 2003, PATTERN RECOGN, V36, P1703, DOI 10.1016/S0031-3203(03)00035-9; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cunningham P., 2007, UCDCSI20074, DOI [10.1145/3459665, DOI 10.1145/3459665]; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Dobkin BH, 2007, J PHYSIOL-LONDON, V579, P637, DOI 10.1113/jphysiol.2006.123067; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Fell J, 2003, BRAIN RES REV, V42, P265, DOI 10.1016/S0165-0173(03)00178-4; Florez F, 2011, NCTA 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON NEURAL COMPUTATION THEORY AND APPLICATIONS, P415; Garipelli G, 2011, I IEEE EMBS C NEUR E, P408, DOI 10.1109/NER.2011.5910573; GASSER T, 1985, ELECTROEN CLIN NEURO, V61, P181, DOI 10.1016/0013-4694(85)91058-2; Genz A, 2000, J STAT COMPUT SIM, V68, P1, DOI 10.1080/00949650008812053; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Grosse P, 2002, CLIN NEUROPHYSIOL, V113, P1523, DOI 10.1016/S1388-2457(02)00223-7; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Heruti RJ, 2002, ARCH PHYS MED REHAB, V83, P742, DOI 10.1053/apmr.2002.32739; HOLSHEIMER J, 1977, ELECTROEN CLIN NEURO, V43, P52, DOI 10.1016/0013-4694(77)90194-8; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; KALRA L, 1993, STROKE, V24, P1462, DOI 10.1161/01.STR.24.10.1462; Kay E., 1994, PHYSIOTHERAPY, V80, P77, DOI [DOI 10.1016/S0031-9406(10)61012-7, https://doi.org/10.1016/S0031-9406(10)61012-7]; Killane I, 2013, IEEE ENG MED BIO, P6397, DOI 10.1109/EMBC.2013.6611018; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Kline JE, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046022; Koenig A, 2008, VIRTUAL ENV INCREASE; Lachaux JP, 1997, HUM BRAIN MAPP, V5, P26, DOI 10.1002/(SICI)1097-0193(1997)5:1<26::AID-HBM4>3.0.CO;2-P; Lansbergen MM, 2011, PROG NEURO-PSYCHOPH, V35, P47, DOI 10.1016/j.pnpbp.2010.08.004; Lotte Fabien, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3712, DOI 10.1109/ICPR.2010.904; Martin KL, 2013, J GERONTOL A-BIOL, V68, P726, DOI 10.1093/gerona/gls224; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Muller MM, 2000, INT J PSYCHOPHYSIOL, V38, P283, DOI 10.1016/s0167-8760(00)00171-9; Murphy Kevin P., 2006, NAIVE BAYES CLASSIFI; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; POLICH J, 1986, ELECTROEN CLIN NEURO, V63, P251, DOI 10.1016/0013-4694(86)90093-3; Porro CA, 1996, J NEUROSCI, V16, P7688; RAINFORD BD, 1994, HYPERFINE INTERACT, V87, P1129, DOI 10.1007/BF02068515; RAY WJ, 1985, INT J PSYCHOPHYSIOL, V3, P43, DOI 10.1016/0167-8760(85)90018-2; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Ryu K, 2005, INT J IND ERGONOM, V35, P991, DOI 10.1016/j.ergon.2005.04.005; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Samek W, 2013, IEEE T BIO-MED ENG, V60, P2289, DOI 10.1109/TBME.2013.2253608; Sanei S., 2013, EEG SIGNAL PROCESSIN; SCHELS HF, 1991, IEEE T BIO-MED ENG, V38, P821, DOI 10.1109/10.83601; Scholkopft B., 1999, NEURAL NETW SIGNAL P, V1, P1; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Stephenson R., 1993, PHYSIOTHERAPY, V79, P699, DOI [10.1016/s0031-9406(10)60008-9, DOI 10.1016/S0031-9406(10)60008-9]; Stevens JA, 2003, ARCH PHYS MED REHAB, V84, P1090, DOI 10.1016/S0003-9993(03)00042-X; Thome Antonio Carlos Gay, 2012, SVM CLASSIFIERS CONC; Ting-Yang Lin, 2013, Proceedings of the 2013 7th Asia Modelling Symposium (AMS 2013), P149, DOI 10.1109/AMS.2013.29; van Twillert S, 2009, CLIN REHABIL, V23, P938, DOI 10.1177/0269215509338125; Westgren N, 1998, ARCH PHYS MED REHAB, V79, P1433, DOI 10.1016/S0003-9993(98)90240-4; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Xuan Guorong, 1996, Proceedings of the 13th International Conference on Pattern Recognition, P195, DOI 10.1109/ICPR.1996.546751; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zimmerli L, 2009, 2009 VIRTUAL REHABILITATION INTERNATIONAL CONFERENCE, P150, DOI 10.1109/ICVR.2009.5174223	64	26	27	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154136	10.1371/journal.pone.0154136	http://dx.doi.org/10.1371/journal.pone.0154136			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115740	gold, Green Published, Green Submitted			2022-12-26	WOS:000374973600046
J	Faraji, A; Unlu, I; Crepeau, T; Healy, S; Crans, S; Lizarraga, G; Fonseca, D; Gaugler, R				Faraji, Ary; Unlu, Isik; Crepeau, Taryn; Healy, Sean; Crans, Scott; Lizarraga, Griffith; Fonseca, Dina; Gaugler, Randy			Droplet Characterization and Penetration of an Ultra-Low Volume Mosquito Adulticide Spray Targeting the Asian Tiger Mosquito, Aedes albopictus, within Urban and Suburban Environments of Northeastern USA	PLOS ONE			English	Article							COLD AEROSOL SPRAYER; DIPTERA-CULICIDAE; SPACE SPRAYS; INVASIVE MOSQUITOS; AEGYPTI L; MALATHION; EFFICACY; SIZE; INSECTICIDE; POPULATIONS	Adult control of Aedes albopictus via ultra-low volume is difficult because this species occurs primarily in peridomestic habitats where obstacles such as buildings and vegetation can disrupt spray plumes and droplet dispersion. We determined droplet penetration and characterization of a pyrethroid adulticide applied from the ground at mid (46.77 ml/ha) and maximum (93.53 ml/ha) label rates within cryptic habitats of urban and suburban environments. Droplets were collected from all habitats, with no significant differences detected between locations within the same application rate or collection method. No differences were detected in droplet densities (drops per mm(2)) between rates within urban environments, but more droplets were collected in urban (149.93 +/- 11.07 SE) than suburban sites (114.37 +/- 11.32) at the maximum label rate (P = 0.003). The excellent penetration of aerosols into cryptic habitats of an urban site was likely due to the shorter spray paths afforded by our network of roads and alleys. Mid label rates displayed similar droplet density values as maximum label rates in urban areas, indicating that lower rates may be used effectively to reduce costs, lessen non-target effects, and increase environmental stewardship. Advances in formulations and technology are driving changes in adulticide applications, leading to use of the minimum effective dose for maximum efficacy, precision, and accountability.	[Faraji, Ary; Unlu, Isik; Crans, Scott; Fonseca, Dina; Gaugler, Randy] Rutgers State Univ, Dept Entomol, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Faraji, Ary; Unlu, Isik] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA; [Crepeau, Taryn; Healy, Sean] Monmouth Cty Mosquito Exterminat Commiss, Eatontown, NJ USA; [Healy, Sean] Louisiana State Univ, Dept Entomol, Baton Rouge, LA 70803 USA; [Lizarraga, Griffith] Clarke Mosquito Control, Dept Environm Sci, Roselle, IL USA	Rutgers State University New Brunswick; Louisiana State University System; Louisiana State University	Faraji, A (corresponding author), Rutgers State Univ, Dept Entomol, Ctr Vector Biol, New Brunswick, NJ 08903 USA.; Faraji, A (corresponding author), Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA.	ary@slcmad.org	Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100	USDA [USDA-ARS-58-6615-8-105]; Rutgers University [USDA-ARS-58-6615-8-105]; Clarke Mosquito Control	USDA(United States Department of Agriculture (USDA)); Rutgers University; Clarke Mosquito Control	This work was funded by a cooperative Agreement between USDA and Rutgers University (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for the Asian Tiger Mosquito in New Jersey." Partial funding was provided by Clarke Mosquito Control through equipment and product support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache D.H., 1992, MICROCLIMATE SPRAY D; Barber JAS, 2007, J AM MOSQUITO CONTR, V23, P55, DOI 10.2987/8756-971X(2007)23[55:FTOMAP]2.0.CO;2; Bonds JAS, 2009, J AM MOSQUITO CONTR, V25, P474, DOI 10.2987/09-5882.1; Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x; Centers for Disease Control and Prevention, 2013, W NIL VIR US GUID SU; Clark GG, 2013, J MED ENTOMOL, V50, P1059, DOI 10.1603/ME12210; Clayson PJ, 2010, J AM MOSQUITO CONTR, V26, P229, DOI 10.2987/10-5999.1; Cooperband MF, 2010, J MED ENTOMOL, V47, P1099, DOI 10.1603/ME10021; CURTIS GA, 1988, J AM MOSQUITO CONTR, V4, P345; Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678; Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P304, DOI 10.2987/13-6334R.1; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; Farajollahi A, 2009, J MED ENTOMOL, V46, P1220, DOI 10.1603/033.046.0533; Farooq M, 2009, J AM MOSQUITO CONTR, V25, P521, DOI 10.2987/09-0009R.1; FOCKS DA, 1987, AM J TROP MED HYG, V36, P639, DOI 10.4269/ajtmh.1987.36.639; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Fritz BK, 2011, T ASABE, V54, P57; Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227; HAILE DG, 1982, MOSQ NEWS, V42, P576; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; LOFGREN CS, 1973, J ECON ENTOMOL, V66, P1085, DOI 10.1093/jee/66.5.1085; Matsunaga T., 1987, Japanese Journal of Sanitary Zoology, V38, P219; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; MOUNT GA, 1970, MOSQ NEWS, V30, P70; Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305; PANT CP, 1971, B WORLD HEALTH ORGAN, V45, P805; PERICH MJ, 1990, J AM MOSQUITO CONTR, V6, P1; PERICH MJ, 1992, J AM MOSQUITO CONTR, V8, P137; Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541; RATHBURN CB, 1989, J AM MOSQUITO CONTR, V5, P173; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; Reiter Paul, 1997, P425; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; [Rutgers University Center for Vector Biology], 2014, AR WID MAN AS TIG MO; Schleier JJ, 2010, J ENVIRON SCI HEAL B, V45, P621, DOI 10.1080/03601234.2010.502410; Suman DS, 2012, J AM MOSQUITO CONTR, V28, P338, DOI 10.2987/12-6289R.1; Unlu I, 2014, ACTA TROP, V137, P201, DOI 10.1016/j.actatropica.2014.05.009; Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999; Unlu I, 2012, J AM MOSQUITO CONTR, V28, P334, DOI 10.2987/12-6262R.1; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; WHO, 2006, PEST THEIR APPL	42	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0152069	10.1371/journal.pone.0152069	http://dx.doi.org/10.1371/journal.pone.0152069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116103	Green Published, gold, Green Submitted			2022-12-26	WOS:000374973600013
J	Tomasi, D; Shokri-Kojori, E; Volkow, ND				Tomasi, D.; Shokri-Kojori, E.; Volkow, N. D.			Temporal Changes in Local Functional Connectivity Density Reflect the Temporal Variability of the Amplitude of Low Frequency Fluctuations in Gray Matter	PLOS ONE			English	Article							GLOBAL SIGNAL REGRESSION; ANTI-CORRELATED NETWORKS; RESTING-STATE FMRI; HUMAN CONNECTOME; CORTICAL NETWORKS; BRAIN; PATTERNS; HUBS; ORGANIZATION; DYNAMICS	Data-driven functional connectivity density (FCD) mapping is being increasingly utilized to assess brain connectomics at rest in the healthy brain and its disruption in neuropsychiatric diseases with the underlying assumption that the spatiotemporal hub distribution is stationary. However, recent studies show that functional connectivity is highly dynamic. Here we study the temporal variability of the local FCD (lFCD) at high spatiotemporal resolution (2-mm isotropic; 0.72s) using a sliding-window approach and 'resting-state' datasets from 40 healthy subjects collected under the Human Connectome Project. Prominent functional connectivity hubs in visual and posterior parietal cortices had pronounced temporal changes in local FCD. These dynamic patterns in the strength of the lFCD hubs occurred in cortical gray matter with high sensitivity (up to 85%) and specificity (> 85%) and showed high reproducibility (up to 72%) across sessions and high test-retest reliability (ICC(3,1) > 0.5). The temporal changes in lFCD predominantly occurred in medial occipitoparietal regions and were proportional to the strength of the connectivity hubs. The temporal variability of the lFCD was associated with the amplitude of the low frequency fluctuations (ALFF). Pure randomness did not account for the probability distribution of lFCD. Shannon entropy increased in proportion to the strength of the lFCD hubs suggesting high average flow of information per unit of time in the lFCD hubs, particularly in medial occipitoparietal regions. Thus, the higher dynamic range of the lFCD hubs is consistent with their role in the complex orchestration of interacting brain networks.	[Tomasi, D.; Shokri-Kojori, E.; Volkow, N. D.] NIAAA, Bethesda, MD USA; [Volkow, N. D.] NIDA, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Tomasi, D (corresponding author), NIAAA, Bethesda, MD USA.	dardo.tomasi@nih.gov			NIH [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; National Institutes of Alcohol Abuse and Alcoholism [Y1AA-3009]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Systems Neuroscience at Washington University; National Institutes of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Data were provided by the Human Connectome Project, WU-Minn Consortium ( Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research and by the McDonnell Center for Systems Neuroscience at Washington University. This work was accomplished with support from the National Institutes of Alcohol Abuse and Alcoholism (Y1AA-3009).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Anteraper SA, 2013, BRAIN CONNECT, V3, P302, DOI 10.1089/brain.2012.0113; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blanken LME, 2015, AM J PSYCHIAT, V172, P479, DOI 10.1176/appi.ajp.2014.14040482; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Caeyenberghs K, 2014, BRAIN CONNECT; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chang C, 2013, NEUROIMAGE, V72, P227, DOI 10.1016/j.neuroimage.2013.01.049; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Ding JR, 2014, EPILEPSY RES, V108, P1184, DOI 10.1016/j.eplepsyres.2014.05.006; Doucet G, 2012, NEUROIMAGE, V59, P3194, DOI 10.1016/j.neuroimage.2011.11.059; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Kiviniemi V, 2011, BRAIN CONNECT, V1, P339, DOI 10.1089/brain.2011.0036; Konova A. B., 2015, BRAIN RES; Lang X, 2015, NEUROREPORT, V26, P17, DOI 10.1097/WNR.0000000000000294; Langbaum JBS, 2009, NEUROIMAGE, V45, P1107, DOI 10.1016/j.neuroimage.2008.12.072; Leonardi N, 2015, NEUROIMAGE, V104, P430, DOI 10.1016/j.neuroimage.2014.09.007; Liu B, 2015, BRAIN STRUCT FUNCT, V220, P91, DOI 10.1007/s00429-013-0640-5; Liu X, 2013, P NATL ACAD SCI USA, V110, P4392, DOI 10.1073/pnas.1216856110; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Magri C, 2012, J NEUROSCI, V32, P1395, DOI 10.1523/JNEUROSCI.3985-11.2012; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Press W. H., 1992, ART SCI COMPUTING; Qin W, 2014, CEREB CORTEX; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tagliazucchi E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00339; Tian T, 2013, J NEUROSCI, V33, P17519, DOI 10.1523/JNEUROSCI.2163-13.2013; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tomasi D., 2015, CEREB CORTEX; Tomasi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096176; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tomasi D, 2012, HUM BRAIN MAPP, V33, P849, DOI 10.1002/hbm.21252; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Wong CW, 2012, NEUROIMAGE, V63, P356, DOI 10.1016/j.neuroimage.2012.06.035; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yang Z, 2014, NEUROIMAGE, V93, P124, DOI 10.1016/j.neuroimage.2014.02.014; Yu QB, 2015, NEUROIMAGE, V107, P345, DOI 10.1016/j.neuroimage.2014.12.020; Zalesky A, 2015, NEUROIMAGE, V114, P466, DOI 10.1016/j.neuroimage.2015.03.047; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zhuo CJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00404	62	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154407	10.1371/journal.pone.0154407	http://dx.doi.org/10.1371/journal.pone.0154407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116610	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600065
J	Aissani, B; Wiener, HW; Zhang, K				Aissani, Brahim; Wiener, Howard W.; Zhang, Kui			Fine Mapping of the Body Fat QTL on Human Chromosome 1q43	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEVERE OBESITY; MICE LACKING; LINKAGE; ASSOCIATION; RECEPTOR; DOMAIN; RISK	Introduction Evidence for linkage and association of obesity-related quantitative traits to chromosome 1q43 has been reported in the Quebec Family Study (QFS) and in populations of Caribbean Hispanic ancestries yet no specific candidate locus has been replicated to date. Methods Using a set of 1,902 single nucleotide polymorphisms (SNPs) genotyped in 525 African American (AA) and 391 European American (EA) women enrolled in the NIEHS uterine fibroid study (NIEHS-UFS), we generated a fine association map for the body mass index (BMI) across a 2.3 megabase-long interval delimited by RGS7 (regulator of G-protein signaling 7) and PLD5 (Phospholipase D, member 5). Multivariable-adjusted linear regression models were fitted to the data to evaluate the association in race-stratified analyses and meta-analysis. Results The strongest associations were observed in a recessive genetic model and peaked in the 3' end of RGS7 at intronic rs261802 variant in the AA group (p = 1.0 x 10(-4)) and in meta-analysis of AA and EA samples (p = 9.0 x 10(-5)). In the EA group, moderate associations peaked at rs6429264 (p = 2.0 x 10(-3)) in the 2 Kb upstream sequence of RGS7. In the reference populations for the European ancestry in the 1,000 genomes project, rs6429264 occurs in strong linkage disequilibrium(D' = 0.94) with rs1341467, the strongest candidate SNP for total body fat in QFS that failed genotyping in the present study. Additionally we report moderate associations at the 3' end of PLD5 in meta-analysis (3.2 x 10(-4) <= p <= 5.8 x 10(-4)). Conclusion We report replication data suggesting that RGS7, a gene abundantly expressed in the brain, might be a putative body fat QTL on human chromosome 1q43. Future genetic and functional studies are required to substantiate our observations and to potentially link them to the neurobehavioral phenotypes associated with the RGS7 region.	[Aissani, Brahim; Wiener, Howard W.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Zhang, Kui] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA	University of Alabama System; University of Alabama Birmingham; Michigan Technological University	Aissani, B (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	baissani@uab.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD064398]; National Institute for Environmental Health Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064398] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant R01-HD064398 to BA from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov/Pages/index.aspx) and the National Institute for Environmental Health Science (http://www.niehs.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Aissani B., 2015, ENDOCR RELAT CANC; Aissani B, 2006, OBESITY, V14, P1605, DOI 10.1038/oby.2006.185; Aissani B, 2014, J HUM GENET, V59, P110, DOI 10.1038/jhg.2013.130; Aissani B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058399; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Baird DD, 2007, AM J EPIDEMIOL, V165, P157, DOI 10.1093/aje/kwj363; Benzing T, 2000, J BIOL CHEM, V275, P28167; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong CH, 2011, HUM GENET, V129, P209, DOI 10.1007/s00439-010-0916-2; Dong CH, 2010, STROKE, V41, P2750, DOI 10.1161/STROKEAHA.110.596981; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Gross KL, 2004, GENE CHROMOSOME CANC, V41, P183, DOI 10.1002/gcc.20079; Guo HY, 2014, ONCOTARGET, V5, P8625, DOI 10.18632/oncotarget.2349; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Holder JL, 2000, HUM MOL GENET, V9, P101; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lim GE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8671; Mustelin L, 2009, INT J OBESITY, V33, P29, DOI 10.1038/ijo.2008.258; Nelson RK, 2015, J LIPID RES, V56, P2229, DOI 10.1194/jlr.R059220; Paternoster L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003247; Pinhas-Hamiel O, 2006, ARCH PEDIAT ADOL MED, V160, P933, DOI 10.1001/archpedi.160.9.933; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Ukkola O, 2002, J CLIN ENDOCR METAB, V87, P3708, DOI 10.1210/jc.87.8.3708; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vogel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053025; Wang Q, 2011, FASEB J, V25, P3949, DOI 10.1096/fj.11-190157; Waugh JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027984; Wise LA, 2005, EPIDEMIOLOGY, V16, P346, DOI 10.1097/01.ede.0000158742.11877.99; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336	40	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153794	10.1371/journal.pone.0153794	http://dx.doi.org/10.1371/journal.pone.0153794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111224	Green Published, Green Submitted, gold			2022-12-26	WOS:000374970600021
J	Fitzpatrick, KE; Gray, R; Quigley, MA				Fitzpatrick, Kate E.; Gray, Ron; Quigley, Maria A.			Women's Longitudinal Patterns of Smoking during the Pre-Conception, Pregnancy and Postnatal Period: Evidence from the UK Infant Feeding Survey	PLOS ONE			English	Article							MODEL-SELECTION; CESSATION; RELAPSE; COHORT; EPIDEMIOLOGY; PREVALENCE; CRITERION; OUTCOMES	Background An understanding of women's longitudinal patterns of smoking during the pre-conception, pregnancy and postnatal period and the factors associated with these patterns could help better inform smoking cessation services and interventions. Methods Latent class analysis (LCA) was used to empirically identify women's smoking patterns in a sample of 10,768 mothers from the 2010 UK Infant Feeding Survey. Multinomial logistic regression was used to identify characteristics associated with these patterns. Results LCA identified five distinct smoking patterns during the pre-conception, pregnancy and postnatal period: "non-smokers" (74.1% of women); "pregnancy-inspired quitters" (10.2%); "persistent smokers" (10.1%); "temporary quitters" (4.4%); and postnatal quitters (1.1%). Smoking patterns varied markedly according to socio-demographic variables and parity. After adjusting for these variables, mothers who lived during pregnancy with a partner who smoked were more likely to be temporary quitters (aOR 2.64, 95% CI 1.74-3.99) or persistent smokers (aOR 3.32, 95% CI 2.34-4.72) than pregnancy-inspired quitters. Mothers who lived during pregnancy with someone else other than a partner who smoked were more likely to be persistent smokers (aOR 2.34, 95% CI 1.38-3.97) or postnatal quitters (aOR 2.97, 95% CI 1.078.24) than pregnancy-inspired quitters. Mothers given information on how their partner could stop smoking if they lived during pregnancy with a smoking partner were less likely to be persistent smokers (aOR 0.42, 95% CI 0.27-0.65) than pregnancy-inspired quitters. Conclusion Health professionals should ask about smoking at every opportunity, and refer women who self-report as current smokers to an evidence based smoking cessation service.	[Fitzpatrick, Kate E.; Gray, Ron; Quigley, Maria A.] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Policy Res Unit Maternal Hlth & Care, Oxford, England	University of Oxford	Quigley, MA (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Policy Res Unit Maternal Hlth & Care, Oxford, England.	maria.quigley@npeu.ox.ac.uk		Quigley, Maria/0000-0002-8058-6181	Policy Research Programme in the Department of Health	Policy Research Programme in the Department of Health	This paper reports on an independent study which is funded by the Policy Research Programme in the Department of Health. The views expressed are not necessarily those of the Department.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Chamberlain C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub4; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Colman GJ, 2003, AM J PREV MED, V24, P29, DOI 10.1016/S0749-3797(02)00574-3; Flemming K, 2015, J ADV NURS, V71, P1210, DOI 10.1111/jan.12580; Gray R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3754; Harmer C, 2013, NICOTINE TOB RES, V15, P904, DOI 10.1093/ntr/nts221; Hauge LJ, 2013, NICOTINE TOB RES, V15, P428, DOI 10.1093/ntr/nts147; Health and Social Care Information Centre, 2014, STAT WOM SMOK STAT T, V4; Health and Social Care Information Centre, 2012, STAT WOM SMOK STAT T; Hemsing N, 2009, NICE RAPID REV; Kahn RS, 2002, AM J PUBLIC HEALTH, V92, P1801, DOI 10.2105/AJPH.92.11.1801; Lanza ST, 2014, CA STATA PLUGIN USER; Lu Y, 2001, HEALTH PROMOT INT, V16, P355, DOI 10.1093/heapro/16.4.355; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; McAndrew F, 2012, INFANT FEEDING SURVE; Mumford EA, 2014, MATERN CHILD HLTH J, V18, P810, DOI 10.1007/s10995-013-1305-y; Munafo M, 2008, NICOTINE TOB RES, V10, P1609, DOI 10.1080/14622200802412895; Murphy DJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h297; Myers K., 2009, RAPID REV INTERVENTI; National Institute for Health & Clinical Excellence, 2010, NICE PUBL HLTH GUID; Prady SL, 2012, MATERN CHILD HLTH J, V16, P1364, DOI 10.1007/s10995-011-0899-1; Raisanen S, 2014, J EPIDEMIOL COMMUN H, V68, P159, DOI 10.1136/jech-2013-202991; *ROYAL COLL PHYS, 1992, SMOK YOUNG REP WORK; Royal College of Physicians, 2010, PASS SMOK CHILDR; Salihu HM, 2007, EARLY HUM DEV, V83, P713, DOI 10.1016/j.earlhumdev.2007.08.002; Schneider S, 2008, EUR J CONTRACEP REPR, V13, P138, DOI 10.1080/13625180802027993; Schneider S, 2010, DRUG ALCOHOL REV, V29, P81, DOI 10.1111/j.1465-3362.2009.00098.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Shipton D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4347; Solomon LJ, 2007, DRUG ALCOHOL DEPEN, V90, P224, DOI 10.1016/j.drugalcdep.2007.03.012	35	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153447	10.1371/journal.pone.0153447	http://dx.doi.org/10.1371/journal.pone.0153447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111661	gold, Green Published, Green Submitted			2022-12-26	WOS:000374970600014
J	Ye, H; Yan, ST; Jin, ZJ				Ye, Hao; Yan, Sunting; Jin, Zhijiang			Collapse of Corroded Pipelines under Combined Tension and External Pressure	PLOS ONE			English	Article							THICK-WALLED TUBES; HYDROSTATIC-PRESSURE; ASYMMETRIC COLLAPSE; CYLINDRICAL-SHELLS; OFFSHORE PIPELINES; NONUNIFORM; PIPES; LONG	In this work, collapse of corroded pipeline under combined external pressure and tension is investigated through numerical method. Axially uniform corrosion with symmetric imperfections is firstly considered. After verifying with existing experimental results, the finite element model is used to study the effect of tension on collapse pressure. An extensive parametric study is carried out using Python script and FORTRAN subroutine to investigate the influence of geometric parameters on the collapse behavior under combined loads. The results are used to develop an empirical equation for estimating the collapse pressure under tension. In addition, the effects of loading path, initial imperfection length, yielding anisotropy and corrosion defect length on the collapse behavior are also investigated. It is found that tension has a significant influence on collapse pressure of corroded pipelines. Loading path and anisotropic yielding are also important factors affecting the collapse behavior. For pipelines with relatively long corrosion defect, axially uniform corrosion models could be used to estimate the collapse pressure.	[Ye, Hao; Yan, Sunting; Jin, Zhijiang] Zhejiang Univ, Inst Proc Equipment, Coll Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Jin, ZJ (corresponding author), Zhejiang Univ, Inst Proc Equipment, Coll Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China.	jzj@zju.edu.cn		JIN, Zhi-jiang/0000-0002-8063-709X	National Natural Science Foundation of China [51175454]; Key Science-Technology Team of Zhejiang Province [2011R50005]; Zhejiang Science and Technology Plan Project [2012C11002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science-Technology Team of Zhejiang Province; Zhejiang Science and Technology Plan Project	This research was supported by the National Natural Science Foundation of China (51175454), Key Science-Technology Team of Zhejiang Province (2011R50005) and Zhejiang Science and Technology Plan Project (2012C11002). It is ZJ who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ABAQUS US MAN VERS 6; API Specification 5L, 2000, SPEC LIN PIP; BAI Y, 1995, J CONSTR STEEL RES, V32, P233, DOI 10.1016/0143-974X(95)93897-D; Corona E, 2000, J ENG MECH-ASCE, V126, P1232, DOI 10.1061/(ASCE)0733-9399(2000)126:12(1232); CORONA E, 1988, INT J SOLIDS STRUCT, V24, P505, DOI 10.1016/0020-7683(88)90005-4; CORONA E, 1987, J PRESS VESS-T ASME, V109, P302, DOI 10.1115/1.3264868; DYAU JY, 1993, INT J SOLIDS STRUCT, V30, P463, DOI 10.1016/0020-7683(93)90181-6; Fatt MSH, 1999, THIN WALL STRUCT, V35, P117, DOI 10.1016/S0263-8231(99)00021-X; Gere JM., 1961, THEORY ELASTIC STABI; Gong SF, 2013, SHIPS OFFSHORE STRUC, V8, P176, DOI 10.1080/17445302.2012.691273; Gong SF, 2011, J ZHEJIANG UNIV-SC A, V12, P627, DOI 10.1631/jzus.A1000489; He T, 2014, APPL OCEAN RES, V47, P199, DOI 10.1016/j.apor.2014.05.006; HILL R, 1948, PROC R SOC LON SER-A, V193, P281, DOI 10.1098/rspa.1948.0045; Kyriakides S., 2007, MECH OFFSHORE PIPELI; MADHAVAN R, 1993, J PRESS VESS-T ASME, V115, P15, DOI 10.1115/1.2929488; Netto TA, 2007, INT J SOLIDS STRUCT, V44, P7597, DOI 10.1016/j.ijsolstr.2007.04.028; Netto TA, 2010, APPL OCEAN RES, V32, P132, DOI 10.1016/j.apor.2009.12.007; Netto TA, 2009, APPL OCEAN RES, V31, P75, DOI 10.1016/j.apor.2009.07.004; Pinna R, 2000, J CONSTR STEEL RES, V56, P1, DOI 10.1016/S0143-974X(99)00104-2; Sakakibara N, 2008, INT J MECH SCI, V50, P1586, DOI 10.1016/j.ijmecsci.2008.10.006; Xue J, 2002, ENG STRUCT, V24, P1027, DOI 10.1016/S0141-0296(02)00029-9; Xue JH, 2008, J PRESS VESS-T ASME, V130, DOI 10.1115/1.2894293; Yan ST, 2015, ENG FAIL ANAL, V55, P39, DOI 10.1016/j.engfailanal.2015.05.005; Yan Sunting, 2014, Advanced Materials Research, V1008-1009, P1134, DOI 10.4028/www.scientific.net/AMR.1008-1009.1134; YEH MK, 1986, J ENERG RESOUR-ASME, V108, P35, DOI 10.1115/1.3231239	25	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154314	10.1371/journal.pone.0154314	http://dx.doi.org/10.1371/journal.pone.0154314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111544	Green Published, Green Submitted, gold			2022-12-26	WOS:000374970600056
J	Zhang, FP; Yang, QY; Zhang, SB				Zhang, Feng-Ping; Yang, Qiu-Yun; Zhang, Shi-Bao			Dual Effect of Phenolic Nectar on Three Floral Visitors of Elsholtzia rugulosa (Lamiaceae) in SW China	PLOS ONE			English	Article							4-HYDROXYBENZOIC ACID; TOXIC NECTAR; SALICYLIC-ACID; PLANT; HONEYS; COMPONENTS; MODULATE; FLOWERS; FILTER; BIRD	Some plants secrete toxic nectar to appeal to most effective pollinators and deter non-pollinators or nectar thieves; however available information about ecological function of toxic nectar remains scarce. Elsholtzia rugulosa stands out as a plant with toxic nectar recorded in SW China. We focused on the functional significance of the phenolic compound that imparts toxic to the nectar of E. rugulosa. The effects of phenolic nectar were studied in three visitors of the flowers of the winter-blooming E. rugulosa Hemsl. (Lamiaceae) in SW China. The pollinating species Apis cerana Fabricius (Apidae; Asian honey bee) and two occasional visitors, Vespa velutina Lepeletier (Vespidae; yellow-legged Asian hornet) and Bombus eximius Smith (Apidae; a bumble bee) were tested for their preferences for low and high concentrations of 4-hydroxybenzoic acid in hexose and sucrose solutions. The pollinator is important for the plant, which is dependent on pollinator visits to attain a higher seed production and it is most likely that the combination of phenolic toxic nectar and the adaptation to phenolic nectar by A. cerana delivers an evolutionary advantage to both actors. The low and high concentrations of the phenolic acid were nearly totally refused by both occasional visitors V. velutina and B. eximius and were preferred by the pollinator A. cerana. E. rugulosa gains by having a much higher seed production and the pollinating honey bee by having an exclusive and reliable food source during the winter season at high altitudes in SW China. We found that the function of the toxic phenolic compound has dual roles by appealing to legitimate pollinators and deterring non-pollinators of E. rugulosa.	[Zhang, Feng-Ping; Yang, Qiu-Yun; Zhang, Shi-Bao] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming 650201, Yunnan, Peoples R China; [Zhang, Feng-Ping; Yang, Qiu-Yun; Zhang, Shi-Bao] Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Res & Dev Wild Plant Resources, Kunming 650201, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhang, SB (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming 650201, Yunnan, Peoples R China.; Zhang, SB (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Res & Dev Wild Plant Resources, Kunming 650201, Yunnan, Peoples R China.	sbzhang@mail.kib.ac.cn			National Natural Science Foundation of China [31300200, 31170315, 31370362]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China (31300200, 31170315, 31370362).	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; BACH M, 1993, PLANT PHYSIOL, V103, P407, DOI 10.1104/pp.103.2.407; Baker H. G., 1975, Coevolution of animals and plants. Symposium 5 of the 1st International Congress of Systematic and Evolutionary Biology, Boulder, Colorado, USA. (Editors L. E. Gilbert and P. H. Raven)., P100; BAKER HG, 1977, APIDOLOGIE, V8, P349, DOI 10.1051/apido:19770405; BERNARDELLO LM, 1994, BIOTROPICA, V26, P113, DOI 10.2307/2389115; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Frankel S, 1998, J APICULT RES, V37, P27, DOI 10.1080/00218839.1998.11100951; Gheldof N, 2002, J AGR FOOD CHEM, V50, P5870, DOI 10.1021/jf0256135; Gronquist M, 2001, P NATL ACAD SCI USA, V98, P13745, DOI 10.1073/pnas.231471698; HAGLER JR, 1993, J KANSAS ENTOMOL SOC, V66, P223; HASLAM E, 1988, J CHEM ECOL, V14, P1789, DOI 10.1007/BF01013477; Horvath E, 2007, BIOL PLANTARUM, V51, P480, DOI 10.1007/s10535-007-0101-1; Ish-Am G, 1998, J HORTIC SCI BIOTECH, V73, P195, DOI 10.1080/14620316.1998.11510965; Janzen DH, 1977, BIOTROPICA, V9, P1252, DOI 10.2307/2388142; Johnson SD, 2006, ECOLOGY, V87, P2709, DOI 10.1890/0012-9658(2006)87[2709:DBNFAA]2.0.CO;2; Kevan P.G., 1995, P113; Liu F, 2007, FUNCT ECOL, V21, P96, DOI 10.1111/j.1365-2435.2006.01200.x; Liu FL, 2004, J APICULT RES, V43, P155; Liu FL, 2004, AM BEE J, V144, P707; Nagai T, 2001, FOOD CHEM, V75, P237, DOI 10.1016/S0308-8146(01)00193-5; Nicolson SW, 2015, EVOL ECOL, V29, P405, DOI 10.1007/s10682-014-9718-7; RHOADES DF, 1981, AM NAT, V117, P798, DOI 10.1086/283765; Rosenthal G.A., 1991, HERBIVORES THEIR INT, V1; Shi B, 2000, PLANT POLYPHENOLS, V280; Smith-Becker J, 1998, PLANT PHYSIOL, V116, P231, DOI 10.1104/pp.116.1.231; Tan K, 2012, ANIM BEHAV, V84, P1589, DOI 10.1016/j.anbehav.2012.09.037; Winston M.L., 1987, BIOL HONEY BEE, p[169, 46]	27	12	13	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154381	10.1371/journal.pone.0154381	http://dx.doi.org/10.1371/journal.pone.0154381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105024	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100070
J	Derraik, JGB; Lundgren, M; Cutfield, WS; Ahlsson, F				Derraik, Jose G. B.; Lundgren, Maria; Cutfield, Wayne S.; Ahlsson, Fredrik			Maternal Height and Preterm Birth: A Study on 192,432 Swedish Women	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; BODY-MASS INDEX; STATURE; LENGTH; LABOR; RISK; GESTATION; DELIVERY; AGE	Background There is increasing evidence that lower maternal stature is associated with shorter gestational length in the offspring. We examined the association between maternal height and the likelihood of delivering preterm babies in a large and homogeneous cohort of Swedish women. Methods This study covers antenatal data from the Swedish Medical Birth Register on 192,432 women (aged 26.0 years on average) born at term, from singleton pregnancies, and of Nordic ethnicity. Continuous associations between women's heights and the likelihood of preterm birth in the offspring were evaluated. Stratified analyses were also carried out, separating women into different height categories. Results Every cm decrease in maternal stature was associated with 0.2 days shortening of gestational age in the offspring (p<0.0001) and increasing odds of having a child born preterm (OR 1.03), very preterm (OR 1.03), or extremely preterm (OR 1.04). Besides, odds of all categories of preterm birth were highest among the shortest women but lowest among the tallest mothers. Specifically, women of short stature (<= 155 cm or <=-2.0 SDS below the population mean) had greater odds of having preterm (OR 1.65) or very preterm (OR 1.47) infants than women of average stature (-0.5 to 0.5 SDS). When compared to women of tall stature (>= 19 cm), mothers of short stature had even greater odds of giving birth to preterm (OR 2.07) or very preterm (OR 2.16) infants. Conclusions Among Swedish women, decreasing height was associated with a progressive increase in the odds of having an infant born preterm. Maternal short stature is a likely contributing factor to idiopathic preterm births worldwide, possibly due to maternal anatomical constraints.	[Derraik, Jose G. B.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Lundgren, Maria; Ahlsson, Fredrik] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	University of Auckland; Uppsala University	Derraik, JGB (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	j.derraik@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Ahlsson, Fredrik/0000-0002-8413-9274				Behrman RE, 2007, PRETERM BIRTH CAUSES; Beta J, 2011, PRENATAL DIAG, V31, P75, DOI 10.1002/pd.2662; Chan BCP, 2009, AUST NZ J OBSTET GYN, V49, P388, DOI 10.1111/j.1479-828X.2009.01006.x; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Dahl AK, 2010, AGE AGEING, V39, P445, DOI 10.1093/ageing/afq038; Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154; Derraik JGB, 2016, J OBSTET GYNAECOL, V36, P1, DOI 10.3109/01443615.2015.1006595; Gagel CK, 2010, AM J PERINAT, V27, P691, DOI 10.1055/s-0030-1253100; Han Z, 2012, J OBSTET GYNAECOL CA, V34, P721, DOI 10.1016/S1701-2163(16)35337-3; Kozuki N, 2015, J NUTR, V145, P2542, DOI 10.3945/jn.115.216374; KRAMER MS, 1995, OBSTET GYNECOL, V86, P744, DOI 10.1016/0029-7844(95)00267-U; March of Dimes PMNCH Save The Children WHO, 2012, GLOB ACT REP PRET BI, DOI DOI 10.1016/S0140-6736(12)61970-9; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Myklestad K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-33; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; Sharples H, 2012, NEW ZEAL MED J, V125, P60; Sorkin JD, 1999, AM J EPIDEMIOL, V150, P969, DOI 10.1093/oxfordjournals.aje.a010106; Subramanian SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018962; Zhang G, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001865; Zhang X, 2007, J PEDIATR-US, V150, P603, DOI 10.1016/j.jpeds.2007.01.048	22	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154304	10.1371/journal.pone.0154304	http://dx.doi.org/10.1371/journal.pone.0154304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100080	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500182
J	Pickles, K; Carter, SM; Rychetnik, L; McCaffery, K; Entwistle, VA				Pickles, Kristen; Carter, Stacy M.; Rychetnik, Lucie; McCaffery, Kirsten; Entwistle, Vikki A.			General Practitioners' Experiences of, and Responses to, Uncertainty in Prostate Cancer Screening: Insights from a Qualitative Study	PLOS ONE			English	Article							EXPRESSIONS; MEN	Background Prostate-specific antigen (PSA) testing for prostate cancer is controversial. There are unresolved tensions and disagreements amongst experts, and clinical guidelines conflict. This both reflects and generates significant uncertainty about the appropriateness of screening. Little is known about general practitioners' (GPs') perspectives and experiences in relation to PSA testing of asymptomatic men. In this paper we asked the following questions: (1) What are the primary sources of uncertainty as described by GPs in the context of PSA testing? (2) How do GPs experience and respond to different sources of uncertainty? Methods This was a qualitative study that explored general practitioners' current approaches to, and reasoning about, PSA testing of asymptomatic men. We draw on accounts generated from interviews with 69 general practitioners located in Australia (n = 40) and the United Kingdom (n = 29). The interviews were conducted in 2013-2014. Data were analysed using grounded theory methods. Uncertainty in PSA testing was identified as a core issue. Findings Australian GPs reported experiencing substantially more uncertainty than UK GPs. This seemed partly explainable by notable differences in conditions of practice between the two countries. Using Han et al's taxonomy of uncertainty as an initial framework, we first outline the different sources of uncertainty GPs (mostly Australian) described encountering in relation to prostate cancer screening and what the uncertainty was about. We then suggest an extension to Han et al's taxonomy based on our analysis of data relating to the varied ways that GPs manage uncertainties in the context of PSA testing. We outline three broad strategies: (1) taking charge of uncertainty; (2) engaging others in managing uncertainty; and (3) transferring the responsibility for reducing or managing some uncertainties to other parties. Conclusion Our analysis suggests some GPs experienced uncertainties associated with ambiguous guidance and the complexities of their situation as professionals with responsibilities to patients as considerably burdensome. This raises important questions about responsibility for uncertainty. In Australia in particular they feel insufficiently supported by the health care system to practice in ways that are recognisably consistent with 'evidence based' professional standards and appropriate for patients. More work is needed to clarify under what circumstances and how uncertainty should be communicated. Closer attention to different types and aspects of the uncertainty construct could be useful.	[Pickles, Kristen; Carter, Stacy M.] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Rychetnik, Lucie] Univ Notre Dame, Sch Med, Sydney, NSW, Australia; [McCaffery, Kirsten] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Entwistle, Vikki A.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB9 1FX, Scotland	University of Sydney; University of Notre Dame Australia; University of Sydney; University of Aberdeen	Pickles, K (corresponding author), Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia.	kristen.pickles@sydney.edu.au	Entwistle, Vikki Ann/I-9266-2019; McCaffery, Kirsten/K-7945-2019; Pickles, Kristen/AAE-8668-2021; Carter, Stacy/A-6544-2011	Entwistle, Vikki Ann/0000-0002-0856-4025; McCaffery, Kirsten/0000-0003-2696-5006; Pickles, Kristen/0000-0002-1621-3217; Carter, Stacy/0000-0003-2617-8694; Rychetnik, Lucie/0000-0001-6855-2897	National Health and Medical Research Council [1023197, 1032963]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The project was funded by a National Health and Medical Research Council grant 1023197 (https://www.nhmrc.gov.au/). SMC and LR obtained funding and are CIs on the NHMRC funded project grant. SMC is supported by NHMRC Career Development Fellowship 1032963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON P, 1984, SOC SCI MED, V19, P949, DOI 10.1016/0277-9536(84)90324-1; Burt RS, 2005, BROKERAGE CLOSURE IN; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Chapple A, 2008, QUAL HEALTH RES, V18, P56, DOI 10.1177/1049732307309000; Charmaz K, 2007, SAGE HDB GROUNDED TH, DOI DOI 10.4135/9781848607941; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Frosch DL, 2003, J GEN INTERN MED, V18, P781, DOI 10.1046/j.1525-1497.2003.20911.x; Germino BB, 1998, CANCER PRACT, V6, P107, DOI 10.1046/j.1523-5394.1998.1998006107.x; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gordon GH, 2000, PATIENT EDUC COUNS, V40, P59, DOI 10.1016/S0738-3991(99)00069-5; Griffiths F, 2006, SOC SCI MED, V62, P1078, DOI 10.1016/j.socscimed.2005.07.027; Hall KH, 2002, MED EDUC, V36, P216, DOI 10.1046/j.1365-2923.2002.01140.x; Han PKJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003226; Han PKJ, 2013, MED CARE RES REV, V70, p14S, DOI 10.1177/1077558712459361; Han PKJ, 2011, MED DECIS MAKING, V31, P828, DOI 10.1177/0272989X11393976; Hewson MG, 1996, J GEN INTERN MED, V11, P481, DOI 10.1007/BF02599044; Hoffman JR, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5702; JOHNSON BB, 1995, RISK ANAL, V15, P485, DOI 10.1111/j.1539-6924.1995.tb00341.x; KATZ J, 1984, HASTINGS CENT REP, V14, P35, DOI 10.2307/3560848; MANSON Neil, 2007, RETHINKING INFORM CO; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Ogden J, 2002, PATIENT EDUC COUNS, V48, P171, DOI 10.1016/S0738-3991(02)00020-4; Parascandola M, 2002, KENNEDY INST ETHIC J, V12, P245, DOI 10.1353/ken.2002.0018; Pickles K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006367; Politi MC, 2007, MED DECIS MAKING, V27, P681, DOI 10.1177/0272989x07307270; QUILL TE, 1993, HUM MED, V9, P109; RACGP, 2012, GUID PREV ACT GEN PR; RIZZO JA, 1993, SOC SCI MED, V37, P1451, DOI 10.1016/0277-9536(93)90179-8; Volk Robert J, 2003, Ann Fam Med, V1, P22, DOI 10.1370/afm.7	30	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153299	10.1371/journal.pone.0153299	http://dx.doi.org/10.1371/journal.pone.0153299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100402	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500029
J	Thompson, A; Stephens, JW; Bain, SC; Kanamarlapudi, V				Thompson, Aiysha; Stephens, Jeffrey W.; Bain, Stephen C.; Kanamarlapudi, Venkateswarlu			Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation	PLOS ONE			English	Article							ALLOSTERIC MODULATION; INSULIN-SECRETION; N-TERMINUS; CYTOPLASMIC DOMAIN; GLP-1 RECEPTOR; ACTIVATION; EXPRESSION; MEMBRANE; EXENDIN-(9-39); TRAFFICKING	The glucagon-like peptide receptor (GLP-1R), which is a G-protein coupled receptor (GPCR), signals through both G alpha s and G alpha q coupled pathways and ERK phosphorylation to stimulate insulin secretion. The aim of this study was to determine molecular details of the effect of small molecule agonists, compounds 2 and B, on GLP-1R mediated cAMP production, intracellular Ca2+ accumulation, ERK phosphorylation and its internalisation. In human GLP-1R (hGLP-1R) expressing cells, compounds 2 and B induced cAMP production but caused no intracellular Ca2+ accumulation, ERK phosphorylation or hGLP-1R internalisation. GLP-1 antagonists Ex(9-39) and JANT-4 and the orthosteric binding site mutation (V36A) in hGLP-1R failed to inhibit compounds 2 and B induced cAMP production, confirming that their binding site distinct from the GLP-1 binding site on GLP-1R. However, K334A mutation of hGLP-1R, which affects G alpha(s) coupling, inhibited GLP-1 as well as compounds 2 and B induced cAMP production, indicating that GLP-1, compounds 2 and B binding induce similar conformational changes in the GLP-1R for G alpha(s) coupling. Additionally, compound 2 or B binding to the hGLP-1R had significantly reduced GLP-1 induced intracellular Ca2+ accumulation, ERK phosphorylation and hGLP-1R internalisation. This study illustrates pharmacology of differential activation of GLP-1R by GLP-1 and compounds 2 and B.	[Thompson, Aiysha; Stephens, Jeffrey W.; Bain, Stephen C.; Kanamarlapudi, Venkateswarlu] Swansea Univ, Sch Med, Inst Life Sci 1, Singleton Pk, Swansea, W Glam, Wales	Swansea University	Kanamarlapudi, V (corresponding author), Swansea Univ, Sch Med, Inst Life Sci 1, Singleton Pk, Swansea, W Glam, Wales.	k.venkateswarlu@swansea.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483	Biotechnology and Biological Sciences Research Council UK [BB/C515455/2]; Medical Research Council UK [G0401232]; Biotechnology and Biological Sciences Research Council UK-Nova Nordisk studentship [BB/F017596/1]; MRC [G0401232] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C515455/2, 1095087] Funding Source: researchfish; Medical Research Council [G0401232] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council UK-Nova Nordisk studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council UK (BB/C515455/2) and Medical Research Council UK (G0401232) (VK). AT was recipient of a Biotechnology and Biological Sciences Research Council UK-Nova Nordisk studentship (BB/F017596/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond Aaron, 2006, Proc (Bayl Univ Med Cent), V19, P281; Bridges TM, 2008, ACS CHEM BIOL, V3, P530, DOI 10.1021/cb800116f; Cheong YH, 2012, BIOCHEM BIOPH RES CO, V417, P558, DOI 10.1016/j.bbrc.2011.12.004; Chung LTK, 2009, BIOCHEM BIOPH RES CO, V390, P613, DOI 10.1016/j.bbrc.2009.10.015; Coopman K, 2010, J PHARMACOL EXP THER, V334, P795, DOI 10.1124/jpet.110.166009; Davies JCB, 2014, BIOCHEM PHARMACOL, V92, P651, DOI 10.1016/j.bcp.2014.09.023; Davies JCB, 2014, BIOCHEM PHARMACOL, V90, P406, DOI 10.1016/j.bcp.2014.06.012; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Edavalath M, 2010, PATIENT PREFER ADHER, V4, P61; GOKE R, 1993, J BIOL CHEM, V268, P19650; Green BD, 2006, EUR J PHARMACOL, V547, P192, DOI 10.1016/j.ejphar.2006.07.043; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Irwin N, 2010, EUR J PHARMACOL, V628, P268, DOI 10.1016/j.ejphar.2009.11.022; Kanamarlapudi V, 2014, J BIOL CHEM, V289, P33378, DOI 10.1074/jbc.M113.534156; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Kuna RS, 2013, AM J PHYSIOL-ENDOC M, V305, pE161, DOI 10.1152/ajpendo.00551.2012; Li NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047936; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Mathi SK, 1997, MOL ENDOCRINOL, V11, P424, DOI 10.1210/me.11.4.424; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; ORSKOV C, 1993, DIABETES, V42, P658, DOI 10.2337/diabetes.42.5.658; Patterson JT, 2011, ACS CHEM BIOL, V6, P135, DOI 10.1021/cb1002015; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Roed SN, 2014, MOL CELL ENDOCRINOL, V382, P938, DOI 10.1016/j.mce.2013.11.010; Serre V, 1998, ENDOCRINOLOGY, V139, P4448, DOI 10.1210/en.139.11.4448; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Takhar S, 1996, ENDOCRINOLOGY, V137, P2175, DOI 10.1210/en.137.5.2175; Thomas RL, 2009, J PHARMACOL EXP THER, V331, P1086, DOI 10.1124/jpet.109.160242; Thompson A, 2013, CLIN EXP PHARMACOL P, V3, P2161, DOI [DOI 10.4172/2161-1459.1000138, 10.4172/2161-1459.1000138]; Thompson A, 2015, MOL CELL ENDOCRINOL, V413, P66, DOI 10.1016/j.mce.2015.06.012; Thompson A, 2015, BIOCHEM PHARMACOL, V93, P72, DOI 10.1016/j.bcp.2014.10.015; Thompson A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07410; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Vahl TP, 2003, J CLIN ENDOCR METAB, V88, P1772, DOI 10.1210/jc.2002-021479; Vazquez P, 2005, J ENDOCRINOL, V186, P221, DOI 10.1677/joe.1.06179; Venkateswarlu K, 2007, J CELL SCI, V120, P792, DOI 10.1242/jcs.03373; Willard Francis S, 2012, Exp Diabetes Res, V2012, P709893, DOI 10.1155/2012/709893; Wootten D, 2013, MOL PHARMACOL, V83, P822, DOI 10.1124/mol.112.084525; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319; Zahn K, 2002, J PHARMACOL EXP THER, V301, P720, DOI 10.1124/jpet.301.2.720	47	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154229	10.1371/journal.pone.0154229	http://dx.doi.org/10.1371/journal.pone.0154229			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100083	Green Submitted, gold, Green Published			2022-12-26	WOS:000374898500170
J	Zeyer, F; Mothes, B; Will, C; Carevic, M; Rottenberger, J; Nurnberg, B; Hartl, D; Handgretinger, R; Beer-Hammer, S; Kormann, MSD				Zeyer, Franziska; Mothes, Benedikt; Will, Clara; Carevic, Melanie; Rottenberger, Jennifer; Nuernberg, Bernd; Hartl, Dominik; Handgretinger, Rupert; Beer-Hammer, Sandra; Kormann, Michael S. D.			mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In Vivo	PLOS ONE			English	Article							AIRWAY HYPERRESPONSIVENESS; ALLERGIC-ASTHMA; POLYMORPHISM; EXPRESSION; DIAGNOSIS; EXPOSURE; HYGIENE; PSEUDOURIDINE; ASSOCIATION; POPULATION	Asthma is the most common chronic disease in childhood. Although several therapeutic options are currently available to control the symptoms, many drugs have significant side effects and asthma remains an incurable disease. Microbial exposure in early life reduces the risk of asthma and several studies have suggested protective effects of Toll-like receptor (TLR) activation. We showed previously that modified mRNA provides a safe and efficient therapeutic tool for in vivo gene supplementation. Since current asthma drugs do not take patient specific immune and TLR backgrounds into consideration, treatment with tailored mRNA could be an attractive approach to account for the patient's individual asthma phenotype. Therefore, we investigated the effect of a preventative treatment with combinations of Tlr1, Tlr2 and Tlr6 mRNA in a House Dust Mite-induced mouse model of asthma. We used chemically modified mRNA which is-in contrast to conventional viral vectors-non-integrating and highly efficient in gene transfer. In our study, we found that treatment with either Tlr1/2 mRNA or Tlr2/6 mRNA, but not Tlr2 mRNA alone, resulted in better lung function as well as reduced airway inflammation in vivo. The present results point to a potentially protective effect of TLR heterodimers in asthma pathogenesis.	[Zeyer, Franziska; Will, Clara; Carevic, Melanie; Rottenberger, Jennifer; Hartl, Dominik; Handgretinger, Rupert; Kormann, Michael S. D.] Univ Tubingen, Dept Pediat 1, Pediat Infectiol & Immunol, Translat Genom & Gene Therapy, Tubingen, Germany; [Mothes, Benedikt; Nuernberg, Bernd; Beer-Hammer, Sandra] Univ Tubingen, Dept Pharmacol & Expt Therapy, Tubingen, Germany; [Mothes, Benedikt; Nuernberg, Bernd; Beer-Hammer, Sandra] Univ Tubingen, ICePhA, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Kormann, MSD (corresponding author), Univ Tubingen, Dept Pediat 1, Pediat Infectiol & Immunol, Translat Genom & Gene Therapy, Tubingen, Germany.	michael.kormann@med.uni-tuebingen.de	Beer-Hammer, Sandra/AAK-4516-2020	Beer-Hammer, Sandra/0000-0001-6049-0257; Nurnberg, Bernd/0000-0002-5995-6555; Duckworth-Mothes, Benedikt/0000-0002-2352-2325	Deutsche Forschungsgemeinschaft (DFG) [DFG KO 4258/2-1]; University of Tubingen [2201-0-0]; European Respiratory Society (Maurizio Vignola Award); Gesellschaft fur Pulmonale Pneumologie (Klosterfrau grant); Interfaculty Center for Pharmacogenomics and Drug Research (ICEPHA Twinning Grant) [22-0-0]; DFG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Tubingen; European Respiratory Society (Maurizio Vignola Award); Gesellschaft fur Pulmonale Pneumologie (Klosterfrau grant); Interfaculty Center for Pharmacogenomics and Drug Research (ICEPHA Twinning Grant); DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de, DFG KO 4258/2-1, to MSDK), by the University of Tubingen with a fortune grant (no. 2201-0-0) and an IZKF graduate program grant (to FZ), by the European Respiratory Society (Maurizio Vignola Award, to MSDK), by the Gesellschaft fur Pulmonale Pneumologie (Klosterfrau grant, to MSDK), in part the Interfaculty Center for Pharmacogenomics and Drug Research (ICEPHA Twinning Grant 22-0-0, to SBH), and in part by the DFG (to BN and SBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aryan Z, 2015, CURR OPIN ALLERGY CL, V15, P568, DOI 10.1097/ACI.0000000000000212; Bezemer GFG, 2012, PHARMACOL REV, V64, P337, DOI 10.1124/pr.111.004622; Bottcher MF, 2004, J ALLERGY CLIN IMMUN, V114, P561, DOI 10.1016/j.jaci.2004.04.050; BOUSQUET J, 1992, ALLERGY, V47, P129, DOI 10.1111/j.1398-9995.1992.tb00952.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brown EM, 2013, SEMIN IMMUNOL, V25, P378, DOI 10.1016/j.smim.2013.09.003; Chen SZ, 2012, J ASTHMA, V49, P999, DOI 10.3109/02770903.2012.738270; Cohn L, 1998, J IMMUNOL, V161, P3813; Cui XY, 2015, OTOLARYNG HEAD NECK, V152, P233, DOI 10.1177/0194599814562173; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Ferreira DS, 2012, CLIN EXP ALLERGY, V42, P1459, DOI 10.1111/j.1365-2222.2012.04047.x; Fleming L, 2015, EUR RESPIR J, V46, P1322, DOI 10.1183/13993003.00780-2015; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; Guilbert TW, 2014, J ALLER CL IMM-PRACT, V2, P489, DOI 10.1016/j.jaip.2014.06.022; Hoffjan S, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-34; Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Kim DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125983; Koponen P, 2014, PEDIATR INFECT DIS J, V33, P463, DOI 10.1097/INF.0000000000000253; Kormann MSD, 2008, J ALLERGY CLIN IMMUN, V122, P86, DOI 10.1016/j.jaci.2008.04.039; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Kvarnhammar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068701; Li XD, 2014, ALLERGY ASTHMA PROC, V35, pE15, DOI 10.2500/aap.2014.35.3735; Liu CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075983; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Martinez FD, 1999, LANCET, V354, pS12, DOI 10.1016/S0140-6736(99)90437-3; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Mays LE, 2013, J CLIN INVEST, V123, P1216, DOI 10.1172/JCI65351; Moreira AP, 2011, J CLIN INVEST, V121, P4420, DOI 10.1172/JCI44999; Renkonen J, 2010, J ASTHMA ALLERGY, V3, P177, DOI 10.2147/JAA.S14459; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sahin F, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-20; SEARS MR, 1993, ALLERGY, V48, P12, DOI 10.1111/j.1398-9995.1993.tb04692.x; Sherriff A, 2002, ARCH DIS CHILD, V87, P26, DOI 10.1136/adc.87.1.26; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259	39	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154001	10.1371/journal.pone.0154001	http://dx.doi.org/10.1371/journal.pone.0154001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101288	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500119
J	Csosz, S; Fisher, BL				Csosz, Sandor; Fisher, Brian L.			Toward Objective, Morphology-Based Taxonomy: A Case Study on the Malagasy Nesomyrmex sikorai Species Group (Hymenoptera: Formicidae)	PLOS ONE			English	Article							CLUSTERS	Madagascar is one of the world's greatest biodiversity hotspots, meriting special attention from biodiversity scientists. It is an excellent testing ground for novel techniques in taxonomy that aim to increase classification objectivity and yield greater taxonomic resolving power. Here we reveal the diversity of a unique and largely unexplored fragment of the Malagasy ant fauna using an advanced combination of exploratory analyses on quantitative morphological data allowing for increased objectivity in taxonomic workflow. The diversity of the Nesomyrmex sikorai species-group was assessed via hypothesis-free nest-centroid-clustering combined with recursive partitioning to estimate the number of morphological clusters and determine the most probable boundaries between them. This combination of methods provides a highly automated and objective species delineation protocol based on continuous morphometric data. Delimitations of clusters recognized by these exploratory analyses were tested via confirmatory Linear Discriminant Analysis (LDA) and Multivariate Ratio Analysis (MRA). The final species hypotheses are corroborated by many qualitative characters, and the recognized species exhibit different spatial distributions and occupy different ecological regions. We describe and redescribe eight morphologically distinct species including six new species: Nesomyrmex excelsior sp. n., N. modestus sp. n., N. reticulatus sp. n., N. retusispinosus (Forel, 1892), N. rugosus sp. n., N. sikorai (Emery, 1896), N. striatus sp. n., and N. tamatavensis sp. n. An identification key for their worker castes using morphometric data is provided.	[Csosz, Sandor; Fisher, Brian L.] Calif Acad Sci, Dept Entomol, 55 Mus Concourse Dr, San Francisco, CA 94118 USA	California Academy of Sciences	Csosz, S (corresponding author), Calif Acad Sci, Dept Entomol, 55 Mus Concourse Dr, San Francisco, CA 94118 USA.	sandorcsosz2@gmail.com			National Science Foundation [DEB-0072713, DEB-0344731, DEB-0842395]; Schlinger Fellowship at the California Academy of Sciences; Museum of Comparative Zoology, Harvard University	National Science Foundation(National Science Foundation (NSF)); Schlinger Fellowship at the California Academy of Sciences; Museum of Comparative Zoology, Harvard University	This study was supported by the National Science Foundation under Grant No. DEB-0072713, DEB-0344731, and DEB-0842395 (http://www.nsf.gov/). SC was supported by the Schlinger Fellowship at the California Academy of Sciences and an Ernst Mayr Travel Grants (Museum of Comparative Zoology, Harvard University), http://www.mcz.harvard.edu/grants_and_funding/ernst-mayr-travel.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur H, 2014, SYST ENTOMOL, V39, P691, DOI 10.1111/syen.12081; Baur H, 2011, SYST BIOL, V60, P813, DOI 10.1093/sysbio/syr061; Beleites C, 2012, J STAT SOFTWAR UNPUB; Brown JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6046; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Cornet A., 1974, NOTICE EXPLICATIVE, V55; Csosz S, 2007, ZOOTAXA, P1; Csosz S, 2016, PEERJ, V4, DOI 10.7717/peerj.1796; Csosz S, 2014, ORG DIVERS EVOL, V14, P75, DOI 10.1007/s13127-013-0153-3; Csoz S, 2015, ZOOKEYS, P19, DOI 10.3897/zookeys.526.6037; Derkarabetian S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104982; Ezard THG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-175; Guillem RM, 2014, CURR ZOOL, V60, P62, DOI 10.1093/czoolo/60.1.62; Harris RA, 1979, OCC PAP ENT, V28, P1; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Maechler M, 2014, CLUSTER CLUSTER ANAL; Miko I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094056; Nilsen G., 2013, **DATA OBJECT**; Nilsen G, 2013, STAT APPL GENET MOL, V12, P637, DOI 10.1515/sagmb-2013-0016; R Core Team, R LANG ENV STAT COMP; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Richmond MP, 2012, ECOL EVOL, V2, P397, DOI 10.1002/ece3.93; Schatz GE., 2000, MEMOIRES SOC BIOGEOG, V1, P1, DOI DOI 10.1002/14356007; Seifert B, 2015, ZOOKEYS, P37, DOI 10.3897/zookeys.479.8510; Seifert B, 2014, MYRMECOL NEWS, V19, P1; Seltmann KC, 2012, J HYMENOPT RES, V27, P67, DOI 10.3897/JHR.27.2961; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Venables WN, 2002, RIPLEY BD MODERN APP; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Wachter GA, 2015, MOL ECOL, V24, P863, DOI 10.1111/mec.13077; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	32	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152454	10.1371/journal.pone.0152454	http://dx.doi.org/10.1371/journal.pone.0152454			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097219	Green Published, Green Submitted, gold			2022-12-26	WOS:000374543600012
J	Latronico, T; Depalo, N; Valente, G; Fanizza, E; Laquintana, V; Denora, N; Fasano, A; Striccoli, M; Colella, M; Agostiano, A; Curri, ML; Liuzzi, GM				Latronico, Tiziana; Depalo, Nicoletta; Valente, Gianpiero; Fanizza, Elisabetta; Laquintana, Valentino; Denora, Nunzio; Fasano, Anna; Striccoli, Marinella; Colella, Matilde; Agostiano, Angela; Curri, M. Lucia; Liuzzi, Grazia Maria			Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; QUANTUM DOTS; CELL-CULTURES; IN-VITRO; NANOPARTICLES; APOPTOSIS; NEURONS; CDSE; SURVIVAL; DELIVERY	Luminescent colloidal nanocrystals (NCs) are emerging as a new tool in neuroscience field, representing superior optical probes for cellular imaging and medical diagnosis of neurological disorders with respect to organic fluorophores. However, only a limited number of studies have, so far, explored NC applications in primary neurons, glia and related cells. Indeed astrocytes, as resident cells in the central nervous system (CNS), play an important pathogenic role in several neurodegenerative and neuroinflammatory diseases, therefore enhanced imaging tools for their thorough investigation are strongly amenable. Here, a comprehensive and systematic study on the in vitro toxicological effect of core-shell type luminescent CdSe@ZnS NCs incorporated in polyethylene glycol (PEG) terminated phospholipid micelles on primary cultures of rat astrocytes was carried out. Cytotoxicity response of empty micelles based on PEG modified phospholipids was compared to that of their NC containing counterpart, in order to investigate the effect on cell viability of both inorganic NCs and micelles protecting NC surface. Furthermore, since the surface charge and chemistry influence cell interaction and toxicity, effect of two different functional groups terminating PEG-modified phospholipid micelles, namely amine and carboxyl group, respectively, was evaluated against bare micelles, showing that carboxyl group was less toxic. The ability of PEG-lipid micelles to be internalized into the cells was qualitatively and quantitatively assessed by fluorescence microscopy and photoluminescence (PL) assay. The results of the experiments clearly demonstrate that, once incorporated into the micelles, a low, not toxic, concentration of NCs is sufficient to be distinctly detected within cells. The overall study provides essential indications to define the optimal experimental conditions to effectively and profitably use the proposed luminescent colloidal NCs as optical probe for future in vivo experiments.	[Latronico, Tiziana; Fasano, Anna; Colella, Matilde; Liuzzi, Grazia Maria] Univ Bari Aldo Moro, Dipartimento Biosci Biotecnol & Biofarmaceut, Bari, Italy; [Depalo, Nicoletta; Valente, Gianpiero; Striccoli, Marinella; Agostiano, Angela; Curri, M. Lucia] CNR, Ist Proc Chim Fis, I-70126 Bari, Italy; [Depalo, Nicoletta; Valente, Gianpiero; Striccoli, Marinella; Agostiano, Angela; Curri, M. Lucia] Univ Bari, Dipartimento Chim, Bari, Italy; [Valente, Gianpiero; Fanizza, Elisabetta; Agostiano, Angela] Univ Bari Aldo Moro, Dipartimento Chim, Bari, Italy; [Laquintana, Valentino; Denora, Nunzio] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Curri, ML (corresponding author), CNR, Ist Proc Chim Fis, I-70126 Bari, Italy.; Curri, ML (corresponding author), Univ Bari, Dipartimento Chim, Bari, Italy.	lucia.curri@ba.ipcf.cnr.it	Depalo, Nicoletta/AAD-9489-2020; Striccoli, Marinella/C-5456-2009; Curri, Maria Lucia/C-5360-2009; Liuzzi, Grazia Maria/GVR-7164-2022; Colella, Matilde/G-9246-2011; DENORA, Nunzio/J-6881-2018; agostiano, angela/E-2579-2015	Striccoli, Marinella/0000-0002-5366-691X; Colella, Matilde/0000-0002-9584-7030; DENORA, Nunzio/0000-0002-7756-7828; Valente, Gianpiero/0000-0002-6721-4180; agostiano, angela/0000-0003-1938-9944; Latronico, Tiziana/0000-0001-6971-5416; Liuzzi, Grazia Maria/0000-0001-5692-9335	PRIN [2010C4R8M8]; PON R&C MAAT-Molecular Nanotechnology for Health and Environment [PON02 00563 3316357]; FIRB Futuro in Ricerca [RBFR122HFZ]; Nanomax-integrable sensors for pathological biomarkers diagnosis (N-CHEM); National and Sens&Micro LAB (POFESR)	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); PON R&C MAAT-Molecular Nanotechnology for Health and Environment; FIRB Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Nanomax-integrable sensors for pathological biomarkers diagnosis (N-CHEM); National and Sens&Micro LAB (POFESR)	This work was supported by PRIN 2010-2011 (2010C4R8M8), PON R&C 2007-2013 MAAT-Molecular Nanotechnology for Health and Environment (Project number: PON02 00563 3316357), FIRB Futuro in Ricerca (RBFR122HFZ), Nanomax-integrable sensors for pathological biomarkers diagnosis (N-CHEM), National and Sens&Micro LAB (POFESR 2007-2013) projects.	Al-Ali A, 2015, TOXICOL RES-UK, V4, P623, DOI 10.1039/c4tx00175c; Arizono Misa, 2014, Curr Protoc Neurosci, V66, DOI 10.1002/0471142301.ns0221s66; Calvo P, 2002, EUR J NEUROSCI, V15, P1317, DOI 10.1046/j.1460-9568.2002.01967.x; Cardone A, 2012, BBA-BIOMEMBRANES, V1818, P2808, DOI 10.1016/j.bbamem.2012.06.011; Chan WH, 2006, TOXICOL LETT, V167, P191, DOI 10.1016/j.toxlet.2006.09.007; Chen N, 2012, BIOMATERIALS, V33, P1238, DOI 10.1016/j.biomaterials.2011.10.070; Damalakiene L, 2013, INT J NANOMED, V8, P555, DOI 10.2147/IJN.S39658; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Denora N, 2013, J CONTROL RELEASE, V172, P1111, DOI 10.1016/j.jconrel.2013.09.024; Depalo N, 2008, J COLLOID INTERF SCI, V325, P558, DOI 10.1016/j.jcis.2008.06.018; Depalo N, 2011, LANGMUIR, V27, P6962, DOI 10.1021/la200822b; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Fanizza E, 2010, LANGMUIR, V26, P14294, DOI 10.1021/la1023339; Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111; Gerbino A, 2012, CELL CALCIUM, V51, P393, DOI 10.1016/j.ceca.2012.01.002; Giancaspero TA, 2013, J BIOL CHEM, V288, P29069, DOI 10.1074/jbc.M113.500066; Gobe G, 2010, TOXICOL LETT, V198, P49, DOI 10.1016/j.toxlet.2010.04.013; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; Latronico T, 2013, TOXICOL SCI, V135, P218, DOI 10.1093/toxsci/kft146; Latronico T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049656; Li KG, 2009, TOXICOL IN VITRO, V23, P1007, DOI 10.1016/j.tiv.2009.06.020; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; Maysinger D, 2007, NANO LETT, V7, P2513, DOI 10.1021/nl071611t; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagy A, 2011, CHEM RES TOXICOL, V24, P2176, DOI 10.1021/tx2003195; Ni DL, 2014, ACS NANO, V8, P1231, DOI 10.1021/nn406197c; Pathak S, 2006, J NEUROSCI, V26, P1893, DOI 10.1523/JNEUROSCI.3847-05.2006; Pinkernelle J, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-32; Rivet CJ, 2012, CHEM RES TOXICOL, V25, P153, DOI 10.1021/tx200369s; Romoser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022079; Shilo M, 2014, NANOSCALE, V6, P2146, DOI 10.1039/c3nr04878k; Singh A V, 2012, THERANOSTIC IMPLICAT; Srikanth M, 2012, NAT REV NEUROL, V8, P307, DOI 10.1038/nrneurol.2012.76; Walters R, 2012, ASN NEURO, V4, DOI 10.1042/AN20120042; Wang J, 2012, ACS NANO, V6, P5018, DOI 10.1021/nn300571c; Wang J, 2012, J CONTROL RELEASE, V160, P637, DOI 10.1016/j.jconrel.2012.02.021; Xu G, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00140; Yan L, 2013, CHEM-ASIAN J, V8, P2342, DOI 10.1002/asia.201300542; Yong KT, 2010, INTEGR BIOL-UK, V2, P121, DOI 10.1039/b916663g; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zhao YL, 2015, TOXICOL RES-UK, V4, P399, DOI 10.1039/c4tx00207e	44	17	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153451	10.1371/journal.pone.0153451	http://dx.doi.org/10.1371/journal.pone.0153451			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097043	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600035
J	Stanger, SJ; Law, EA; Jamsai, D; O'Bryan, MK; Nixon, B; McLaughlin, EA; Aitken, RJ; Roman, SD				Stanger, Simone J.; Law, Estelle A.; Jamsai, Duangporn; O'Bryan, Moira K.; Nixon, Brett; McLaughlin, Eileen A.; Aitken, R. John; Roman, Shaun D.			A novel germ cell protein, SPIF (sperm PKA interacting factor), is essential for the formation of a PKA/TCP11 complex that undergoes conformational and phosphorylation changes upon capacitation	FASEB JOURNAL			English	Article						protein kinase A; tyrosine kinase; protein complex; sperm capacitation	MOUSE T-COMPLEX; SOLUBLE ADENYLYL-CYCLASE; FERTILIZATION PROMOTING PEPTIDE; TRANSMISSION RATIO DISTORTION; TYROSINE PHOSPHORYLATION; KINASE-A; CATALYTIC SUBUNIT; ACROSOME REACTION; MOLECULAR CHAPERONE; ESCHERICHIA-COLI	Spermatozoa require the process of capacitation to enable them to fertilize an egg. PKA is crucial to capacitation and the development of hyperactivated motility. Sperm PKA is activated by cAMP generated by the germ cell-enriched adenylyl cyclase encoded by Adcy10. Male mice lacking Adcy10 are sterile, because their spermatozoa are immotile. The current study was designed to identify binding partners of the sperm-specific (C alpha 2) catalytic subunit of PKA (PRKACA) by using it as the "bait" in a yeast 2-hybrid system. This approach was used to identify a novel germ cell-enriched protein, sperm PKA interacting factor (SPIF), in 25% of the positive clones. Homozygous Spif-null mice were embryonically lethal. SPIF was coexpressed and coregulated with PRKACA and with t-complex protein (TCP)-11, a protein associated with PKA signaling. We established that these 3 proteins form part of a novel complex in mouse spermatozoa. Upon capacitation, the SPIF protein becomes tyrosine phosphorylated in>95% of sperm. An apparent molecular rearrangement in the complex occurs, bringing PRKACA and TCP11 into proximity. Taken together, these results suggest a role for the novel complex of SPIF, PRKACA, and TCP11 during sperm capacitation, fertilization, and embryogenesis.	[Stanger, Simone J.; Nixon, Brett; McLaughlin, Eileen A.; Roman, Shaun D.] Univ Newcastle, Ctr Chem Biol, Callaghan, NSW, Australia; [Stanger, Simone J.; Nixon, Brett; McLaughlin, Eileen A.; Aitken, R. John; Roman, Shaun D.] Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia; [Stanger, Simone J.; Law, Estelle A.; Nixon, Brett; McLaughlin, Eileen A.; Roman, Shaun D.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Stanger, Simone J.; Jamsai, Duangporn; O'Bryan, Moira K.; Nixon, Brett; McLaughlin, Eileen A.; Aitken, R. John; Roman, Shaun D.] Univ Newcastle, Australian Res Council, Ctr Excellence Biotechnol & Dev, Callaghan, NSW, Australia; [Jamsai, Duangporn; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia	University of Newcastle; University of Newcastle; University of Newcastle; University of Newcastle; Monash University	Aitken, RJ; Roman, SD (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	john.aitken@newcastle.edu.au; shaun.roman@newcastle.edu.au	O'Bryan, Moira K/F-8256-2012; McLaughlin, Eileen A/G-7620-2013; McLaughlin, Eileen/AAF-5588-2021; Aitken, Robert John/AAY-8238-2020; Roman, Shaun/AFR-5087-2022; ROMAN, SHAUN/G-7047-2013; Nixon, Brett/B-5121-2012	O'Bryan, Moira K/0000-0001-7298-4940; Aitken, Robert John/0000-0002-9152-156X; McLaughlin, Eileen/0000-0002-5837-3876; ROMAN, SHAUN/0000-0002-7758-7757; Nixon, Brett/0000-0003-2745-8188	Australian Research Council Centre of Excellence in Biotechnology and Development	Australian Research Council Centre of Excellence in Biotechnology and Development(Australian Research Council)	The authors thank Amanda Anderson (Priority Research Centre for Reproductive Science and School of Environmental and Life Sciences, University of Newcastle) for providing samples for the PLAs. The study was supported by the Australian Research Council Centre of Excellence in Biotechnology and Development. The authors declare no conflicts of interest.	Aitken RJ, 1998, J CELL SCI, V111, P645; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Baker MA, 2009, DEV BIOL, V333, P57, DOI 10.1016/j.ydbio.2009.06.022; Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; Battistone MA, 2014, MOL HUM REPROD, V20, P1054, DOI 10.1093/molehr/gau073; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Breitbart H, 2003, CELL MOL BIOL, V49, P321; BROWN J, 1989, DEVELOPMENT, V106, P769; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Burton KA, 1999, J BIOL CHEM, V274, P24131, DOI 10.1074/jbc.274.34.24131; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Ecroyd HW, 2003, BIOL REPROD, V69, P347, DOI 10.1095/biolreprod.102.012716; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fraser LR, 1997, MOL REPROD DEV, V48, P375, DOI 10.1002/(SICI)1098-2795(199711)48:3&lt;375::AID-MRD11&gt;3.0.CO;2-V; Fraser LR, 1998, ANDROLOGIA, V30, P241; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Herrmann BG, 1999, NATURE, V402, P141, DOI 10.1038/45970; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; HOSSEINI R, 1994, MECH DEVELOP, V47, P73, DOI 10.1016/0925-4773(94)90097-3; Jamsai D, 2006, GENOMICS, V88, P309, DOI 10.1016/j.ygeno.2006.03.009; Kirschner LS, 2009, ENDOCR-RELAT CANCER, V16, P773, DOI 10.1677/ERC-09-0068; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lefievre L, 2002, J ANDROL, V23, P709; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu YY, 2011, TOHOKU J EXP MED, V224, P111, DOI 10.1620/tjem.224.111; Luconi M, 2005, BIOL REPROD, V72, P22, DOI 10.1095/biolreprod.104.032490; Luconi M, 2004, J CELL SCI, V117, P1235, DOI 10.1242/jcs.00931; LYON MF, 1986, CELL, V44, P357, DOI 10.1016/0092-8674(86)90770-1; Lyon MF, 2003, ANNU REV GENET, V37, P393, DOI 10.1146/annurev.genet.37.110801.143030; Ma YX, 2002, MOL HUM REPROD, V8, P24, DOI 10.1093/molehr/8.1.24; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MAZARAKIS ND, 1991, DEVELOPMENT, V111, P561; MORTIMER D, 1987, J REPROD FERTIL, V81, P127; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; OYEN O, 1990, BIOL REPROD, V43, P46, DOI 10.1095/biolreprod43.1.46; Redgrove KA, 2013, MOL HUM REPROD, V19, P120, DOI 10.1093/molehr/gas064; Reinton N, 2000, BIOL REPROD, V63, P607, DOI 10.1095/biolreprod63.2.607; San Agustin JT, 1998, J BIOL CHEM, V273, P24874, DOI 10.1074/jbc.273.38.24874; San Agustin JT, 2001, BIOL REPROD, V65, P151, DOI 10.1095/biolreprod65.1.151; San Agustin JT, 2000, MOL BIOL CELL, V11, P3031, DOI 10.1091/mbc.11.9.3031; SANAGUSTIN JT, 1994, CELL MOTIL CYTOSKEL, V27, P206, DOI 10.1002/cm.970270303; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; UHLER MD, 1986, J BIOL CHEM, V261, P5360; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Walsh A, 2008, BIOL REPROD, V78, P983, DOI 10.1095/biolreprod.107.066860; Zimmermann B, 1999, J BIOL CHEM, V274, P5370, DOI 10.1074/jbc.274.9.5370	54	7	8	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2777	2791		10.1096/fj.201500136R	http://dx.doi.org/10.1096/fj.201500136R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27105888				2022-12-26	WOS:000380994000014
J	Bolt, CC; Negi, S; Guimaraes-Camboa, N; Zhang, HM; Troy, JM; Lu, XC; Kispert, A; Evans, SM; Stubbs, L				Bolt, C. Chase; Negi, Soumya; Guimaraes-Camboa, Nuno; Zhang, Huimin; Troy, Joseph M.; Lu, Xiaochen; Kispert, Andreas; Evans, Sylvia M.; Stubbs, Lisa			Tbx18 Regulates the Differentiation of Periductal Smooth Muscle Stroma and the Maintenance of Epithelial Integrity in the Prostate	PLOS ONE			English	Article							UROGENITAL SINUS EPITHELIUM; ANDROGEN RECEPTOR; GENE-EXPRESSION; REACTIVE STROMA; MOUSE PROSTATE; MYOFIBROBLAST DIFFERENTIATION; BRANCHING MORPHOGENESIS; URETERAL MESENCHYME; REGIONAL-VARIATION; SEMINAL-VESICLE	The T-box transcription factor TBX18 is essential to mesenchymal cell differentiation in several tissues and Tbx18 loss-of-function results in dramatic organ malformations and perinatal lethality. Here we demonstrate for the first time that Tbx18 is required for the normal development of periductal smooth muscle stromal cells in prostate, particularly in the anterior lobe, with a clear impact on prostate health in adult mice. Prostate abnormalities are only subtly apparent in Tbx18 mutants at birth; to examine postnatal prostate development we utilized a relatively long-lived hypomorphic mutant and a novel conditional Tbx18 allele. Similar to the ureter, cells that fail to express Tbx18 do not condense normally into smooth muscle cells of the periductal prostatic stroma. However, in contrast to ureter, the periductal stromal cells in mutant prostate assume a hypertrophic, myofibroblastic state and the adjacent epithelium becomes grossly disorganized. To identify molecular events preceding the onset of this pathology, we compared gene expression in the urogenital sinus (UGS), from which the prostate develops, in Tbx18-null and wild type littermates at two embryonic stages. Genes that regulate cell proliferation, smooth muscle differentiation, prostate epithelium development, and inflammatory response were significantly dysregulated in the mutant urogenital sinus around the time that Tbx18 is first expressed in the wild type UGS, suggesting a direct role in regulating those genes. Together, these results argue that Tbx18 is essential to the differentiation and maintenance of the prostate periurethral mesenchyme and that it indirectly regulates epithelial differentiation through control of stromal-epithelial signaling.	[Bolt, C. Chase; Negi, Soumya; Zhang, Huimin; Lu, Xiaochen; Stubbs, Lisa] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Bolt, C. Chase; Negi, Soumya; Zhang, Huimin; Troy, Joseph M.; Lu, Xiaochen; Stubbs, Lisa] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Guimaraes-Camboa, Nuno; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, Skaggs Sch Pharm, La Jolla, CA 92037 USA; [Guimaraes-Camboa, Nuno; Evans, Sylvia M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92037 USA; [Troy, Joseph M.; Stubbs, Lisa] Univ Illinois, Illinois Informat Inst, Urbana, IL 61801 USA; [Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, OE5250,Carl Neuberg Str 1, D-30625 Hannover, Germany	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign; Hannover Medical School	Stubbs, L (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.; Stubbs, L (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.; Stubbs, L (corresponding author), Univ Illinois, Illinois Informat Inst, Urbana, IL 61801 USA.	ljstubbs@illinois.edu	Guimarães-Camboa, Nuno/K-5519-2016	Guimarães-Camboa, Nuno/0000-0001-5349-4604; Stubbs, Lisa/0000-0002-9556-1972; Bolt, Christopher Chase/0000-0002-3544-3552	U.S. National Institute of Diabetes and Digestive and Kidney Disorders [DK095685]; U.S. NIH National Heart, Lung, and Blood Institute R01 grants [HL123747, HL117649, HL074066]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074066, DP1HL117649, R01HL123747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095685] Funding Source: NIH RePORTER	U.S. National Institute of Diabetes and Digestive and Kidney Disorders; U.S. NIH National Heart, Lung, and Blood Institute R01 grants; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant number DK095685 from the U.S. National Institute of Diabetes and Digestive and Kidney Disorders (awarded to L.S.). The production of the Tbx18flox, Tbx18Cre, and Tbx18GFP alleles was supported by U.S. NIH National Heart, Lung, and Blood Institute R01 grants HL123747, HL117649, and HL074066 (awarded to S.M.E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Airik R, 2010, HUM MOL GENET, V19, P4918, DOI 10.1093/hmg/ddq426; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Bauman TM, 2014, AM J CLIN EXP UROL, V2, P313; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierhoff E, 1997, PROSTATE, V31, P234, DOI 10.1002/(SICI)1097-0045(19970601)31:4<234::AID-PROS4>3.0.CO;2-K; Blum R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013024; Bohnenpoll T, 2013, DEV BIOL, V380, P25, DOI 10.1016/j.ydbio.2013.04.036; Bolt CC, 2014, DEV BIOL, V392, P483, DOI 10.1016/j.ydbio.2014.05.010; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai Y, 2013, JOVE-J VIS EXP, DOI 10.3791/50327; Doles J, 2006, DEV BIOL, V295, P13, DOI 10.1016/j.ydbio.2005.12.002; DONJACOUR AA, 1995, DEVELOPMENT, V121, P2199; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Grabowska MM, 2014, CANCER METAST REV, V33, P377, DOI 10.1007/s10555-013-9487-8; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; Haraguchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042245; Hayward SW, 1996, ACTA ANAT, V155, P94; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZH, 2012, ONCOTARGET, V3, P651, DOI 10.18632/oncotarget.531; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lai KP, 2012, MOL ENDOCRINOL, V26, P52, DOI 10.1210/me.2011-1189; LEE C, 1990, BIOL REPROD, V43, P1079, DOI 10.1095/biolreprod43.6.1079; Mehta V, 2013, DEV BIOL, V376, P125, DOI 10.1016/j.ydbio.2013.01.034; Mehta V, 2011, DEV DYNAM, V240, P2548, DOI 10.1002/dvdy.22741; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Negmadjanov U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123046; Nemeth JA, 1996, PROSTATE, V28, P124; Nie XG, 2010, DEVELOPMENT, V137, P755, DOI 10.1242/dev.045757; Niu YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020202; Peng YC, 2013, P NATL ACADAY SCI; Peng YC, 2015, DEV BIOL, V400, P94, DOI 10.1016/j.ydbio.2015.01.019; Podlasek CA, 1997, DEV DYNAM, V208, P454; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; Schauer IG, 2011, DIFFERENTIATION, V82, P200, DOI 10.1016/j.diff.2011.05.007; Schweizer L, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-4; Shaw A, 2008, DIFFERENTIATION, V76, P599, DOI 10.1111/j.1432-0436.2008.00275.x; Simons BW, 2012, DEV BIOL, V371, P246, DOI 10.1016/j.ydbio.2012.08.016; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; Trowe MO, 2012, DEVELOPMENT, V139, P3099, DOI 10.1242/dev.077388; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wang YQ, 2009, GENESIS, V47, P409, DOI 10.1002/dvg.20515; Wu XY, 2011, DEV BIOL, V356, P337, DOI 10.1016/j.ydbio.2011.05.659; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yang XH, 2014, EUR J PHARMACOL, V734, P83, DOI 10.1016/j.ejphar.2014.04.007; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910; Zhu GD, 2007, PROSTATE, V67, P674, DOI 10.1002/pros.20563	61	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154413	10.1371/journal.pone.0154413	http://dx.doi.org/10.1371/journal.pone.0154413			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120339	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200068
J	Krull, AC; Cooper, VL; Coatney, JW; Shearer, JK; Gorden, PJ; Plummer, PJ				Krull, Adam C.; Cooper, Vickie L.; Coatney, John W.; Shearer, Jan K.; Gorden, Patrick J.; Plummer, Paul J.			A Highly Effective Protocol for the Rapid and Consistent Induction of Digital Dermatitis in Holstein Calves	PLOS ONE			English	Article							DAIRY-CATTLE; DICHELOBACTER-NODOSUS; INTERDIGITAL PAPILLOMATOSIS; CROSS-INFECTION; 1ST LACTATION; UK CATTLE; LESIONS; COWS; PREVALENCE; TREPONEMES	Bovine Digital Dermatitis (DD) is a leading cause of lameness in dairy cattle. DD is reportedly increasing in prevalence in beef cattle feedlots of the US. The exact etiologic agent(s) responsible for the disease have yet to be determined. Multiple studies have demonstrated the presence of a variety of Treponema spp. within lesions. Attempts to reproduce clinically relevant disease using pure cultures of these organisms has failed to result in lesions that mirror the morphology and severity of naturally occurring lesions. This manuscript details the systematic development of an experimental protocol that reliably induces digital dermatitis lesions on a large enough scale to allow experimental evaluation of treatment and prevention measures. In total, 21 protocols from five experiments were evaluated on their effectiveness in inducing DD lesions in 126 Holstein calves (504 feet). The protocols varied in the type and concentration of inoculum, frequency of inoculation, duration the feet were wrapped, and type of experimental controls need to validate a successful induction. Knowledge gained in the first four experiments resulted in a final protocol capable of inducing DD lesions in 42 of 44 (95%) feet over a 28 day period. All induced lesions were macroscopically and microscopically identified as clinical DD lesions by individuals blinded to protocols. Lesions were also located at the site of inoculation in the palmer aspect of the interdigital space, and induced clinically measurable lameness in a significant portion of the calves. Collectively these results validate the model and provide a rapid and reliable means of inducing DD in large groups of calves.	[Krull, Adam C.; Cooper, Vickie L.; Coatney, John W.; Shearer, Jan K.; Gorden, Patrick J.; Plummer, Paul J.] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Plummer, Paul J.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Preventat Med, Ames, IA USA	Iowa State University; Iowa State University	Plummer, PJ (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA.; Plummer, PJ (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Preventat Med, Ames, IA USA.	pplummer@iastate.edu	Gorden, Patrick/AAT-4403-2021	Gorden, Patrick/0000-0002-6096-0965	Boehringer Ingelheim Vetmedica Inc.; Iowa State University Faculty Startup-Funds	Boehringer Ingelheim Vetmedica Inc.(Boehringer Ingelheim); Iowa State University Faculty Startup-Funds	Boehringer Ingelheim Vetmedica Inc. provided funds for a portion of the research. Additional funds were provided by Iowa State University Faculty Startup-Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2009, J VET MED SCI, V71, P391, DOI 10.1292/jvms.71.391; Berry SL, 2004, 13 INT S RUM LAM 200; Berry SL, 2010, JAVMA-J AM VET MED A, V237, P555, DOI 10.2460/javma.237.5.555; BLOWEY RW, 1994, VET REC, V135, P577; BLOWEY RW, 1994, VET REC, V135, P115, DOI 10.1136/vr.135.5.115; BLOWEY RW, 1988, VET REC, V122, P505, DOI 10.1136/vr.122.21.505; Brandt S, 2011, VET MICROBIOL, V148, P161, DOI 10.1016/j.vetmic.2010.08.031; Brown CC, 2000, AM J VET RES, V61, P928, DOI 10.2460/ajvr.2000.61.928; Capion N, 2012, J DAIRY SCI, V95, P6457, DOI 10.3168/jds.2012-5335; Capion N, 2009, VET J, V182, P50, DOI 10.1016/j.tvjl.2008.05.026; Cheli R, 1974, 8 INT M DIS CATTL PI; Choi BK, 1997, INT J SYST BACTERIOL, V47, P175, DOI 10.1099/00207713-47-1-175; Clifford JR, 2014, 800200 USDA APHIS VE; Collighan RJ, 1997, FEMS MICROBIOL LETT, V156, P37, DOI 10.1016/S0378-1097(97)00399-6; Cornelisse JL, 1982, 4 INT S DIS RUM DIG; Cruz CEF, 2005, VET REC, V157, P834, DOI 10.1136/vr.157.26.834; Demirkan I, 2006, J APPL MICROBIOL, V101, P948, DOI 10.1111/j.1365-2672.2006.02976.x; Demirkan I, 1998, VET MICROBIOL, V60, P285, DOI 10.1016/S0378-1135(98)00146-1; Dopfer D, 1997, VET REC, V140, P620, DOI 10.1136/vr.140.24.620; Elliott MK, 2007, INFECT IMMUN, V75, P4400, DOI 10.1128/IAI.00019-07; Evans NJ, 2008, VET MICROBIOL, V130, P141, DOI 10.1016/j.vetmic.2007.12.019; Evans NJ, 2009, J CLIN MICROBIOL, V47, P689, DOI 10.1128/JCM.01914-08; Frankena K, 2009, PREV VET MED, V88, P150, DOI 10.1016/j.prevetmed.2008.08.004; Gilhuus M, 2013, VET MICROBIOL, V163, P142, DOI 10.1016/j.vetmic.2012.12.020; Gomez A, 2015, J DAIRY SCI, V98, P4487, DOI 10.3168/jds.2014-9041; Gomez A, 2012, J DAIRY SCI, V95, P1821, DOI 10.3168/jds.2011-4754; GRUND S, 1995, J VET MED B, V42, P533, DOI 10.1111/j.1439-0450.1995.tb00745.x; Klitgaard K, 2008, J CLIN MICROBIOL, V46, P3012, DOI 10.1128/JCM.00670-08; Knappe-Poindecker M, 2013, J DAIRY SCI, V96, P7617, DOI 10.3168/jds.2013-6717; Knappe-Poindecker M, 2014, VET MICROBIOL, V170, P375, DOI 10.1016/j.vetmic.2014.02.044; KONIAROVA I, 1993, VET MED-CZECH, V38, P589; Krull AC, 2014, INFECT IMMUN, V82, P3359, DOI 10.1128/IAI.02077-14; Laven RA, 2007, VET J, V174, P310, DOI 10.1016/j.tvjl.2006.07.008; Laven RA, 2006, VET REC, V159, P19, DOI 10.1136/vr.159.1.19; Laven RA, 2006, VET J, V171, P79, DOI 10.1016/j.tvjl.2004.08.009; Logue DN, 2005, VET J, V170, P12, DOI 10.1016/j.tvjl.2005.04.030; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Nishikawa A, 2008, VET REC, V163, P574, DOI 10.1136/vr.163.19.574; Nordhoff M, 2008, VET MICROBIOL, V131, P293, DOI 10.1016/j.vetmic.2008.04.019; Ohya T, 1999, VET REC, V145, P316, DOI 10.1136/vr.145.11.316; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; Read D. H., 1996, VET PATHOL, V33, P607; Read DH, 1998, J VET DIAGN INVEST, V10, P67, DOI 10.1177/104063879801000112; READ DH, 1992, VET REC, V130, P59, DOI 10.1136/vr.130.3.59; REBHUN WC, 1980, J AM VET MED ASSOC, V177, P437; Rogdo T, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-19; Santos TMA, 2012, FEMS MICROBIOL ECOL, V79, P518, DOI 10.1111/j.1574-6941.2011.01234.x; Schlafer S, 2008, VET MICROBIOL, V128, P118, DOI 10.1016/j.vetmic.2007.09.024; Schrank K, 1999, INT J SYST BACTERIOL, V49, P43, DOI 10.1099/00207713-49-1-43; Schroeder CM, 2003, ANAEROBE, V9, P151, DOI 10.1016/S1075-9964(03)00084-2; Silva LAF, 2005, CAN VET J, V46, P345; SKERMAN TM, 1975, J GEN MICROBIOL, V87, P107, DOI 10.1099/00221287-87-1-107; Sprecher DJ, 1997, THERIOGENOLOGY, V47, P1179, DOI 10.1016/S0093-691X(97)00098-8; Sullivan LE, 2013, VET REC, V173, P582, DOI 10.1136/vr.101802; Trott DJ, 2003, J CLIN MICROBIOL, V41, P2522, DOI 10.1128/JCM.41.6.2522-2529.2003; USDA, 2009, DAIR 2007 4; VANAMSTEL SR, 1995, J S AFR VET ASSOC, V66, P177; Walker RL, 1995, VET MICROBIOL, V47, P343, DOI 10.1016/0378-1135(95)00114-X; Yano T, 2010, VET MICROBIOL, V143, P352, DOI 10.1016/j.vetmic.2009.12.009	59	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154481	10.1371/journal.pone.0154481	http://dx.doi.org/10.1371/journal.pone.0154481			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119564	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200083
J	Bu, JD; Zhao, J; Liu, MJ				Bu, Jiaodi; Zhao, Jin; Liu, Mengjun			Expression Stabilities of Candidate Reference Genes for RT-qPCR in Chinese Jujube (Ziziphus jujuba Mill.) under a Variety of Conditions	PLOS ONE			English	Article							REAL-TIME PCR; INTERNAL CONTROL; SELECTION; NORMALIZATION; VALIDATION	Reverse transcription-quantitative real-time polymerase chain reaction (RT-qPCR) is a powerful method for evaluating patterns of gene expression. Jujube whole-genome sequencing has been completed, and analysis of gene function, an important part of any follow-up study, requires the appropriate selection of reference genes. Indeed, suitable reference gene selection for RT-qPCR is critical for accurate normalization of target gene expression. In this study, the software packages geNorm and NormFinder were employed to examine the expression stabilities of nine candidate reference genes under a variety of conditions. Actin-depolymerizing factor 1 (ACT1), Histone-H3 (His3), and Polyadenylate-binding protein-interacting protein (PAIP) were determined to be the most stably expressed genes during five stages of fruit development and ACT1, SiR-Fd, BTF3, and Tubulin alpha chain (TUA) across different tissues/organs. Whereas ACT1, Basic Transcription factor 3 (BTF3), Glyceraldehyde-3-phosphate dehydrogenase (GADPH), and PAIP were the most stable under dark conditions. ACT1, PAIP, BTF3, and Elongation factor 1-gamma (EF1 gamma) were the most stably expressed genes under phytoplasma infection. Among these genes, SiR-Fd and PAIP are here first reported as stable reference genes. When normalized using these most stable reference genes, the expression patterns of four target genes were found to be in accordance with physiological data, indicating that the reference genes selected in our study are suitable for use in such analyses. This study provides appropriate reference genes and corresponding primers for further RT-qPCR studies in Chinese jujube and emphasizes the importance of validating reference genes for gene expression analysis under variable experimental conditions.	[Bu, Jiaodi; Zhao, Jin] Agr Univ Hebei, Coll Life Sci, Baoding, Hebei, Peoples R China; [Liu, Mengjun] Agr Univ Hebei, Res Ctr Chinese Jujube, Baoding, Hebei, Peoples R China	Hebei Agricultural University; Hebei Agricultural University	Zhao, J (corresponding author), Agr Univ Hebei, Coll Life Sci, Baoding, Hebei, Peoples R China.; Liu, MJ (corresponding author), Agr Univ Hebei, Res Ctr Chinese Jujube, Baoding, Hebei, Peoples R China.	zhaojinbd@126.com; lmj1234567@aliyun.com			Funds for Hebei Distinguished Young Scholar [2016204145]; National Science and Technology Support Plan of China [2013BAD14B03]; Agricultural University of Hebei Foundation for Leaders of Disciplines in Science Technology	Funds for Hebei Distinguished Young Scholar; National Science and Technology Support Plan of China; Agricultural University of Hebei Foundation for Leaders of Disciplines in Science Technology	This study was supported by grants from Funds for Hebei Distinguished Young Scholar ( 2016204145), the National Science and Technology Support Plan of China ( 2013BAD14B03), and Agricultural University of Hebei Foundation for Leaders of Disciplines in Science Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Banda M, 2008, MUTAT RES-GEN TOX EN, V649, P126, DOI 10.1016/j.mrgentox.2007.08.005; Borges AF, 2014, PLOS ONE, V9, P1; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Feng H, 2012, PLANT PHYSIOL BIOCH, V51, P116, DOI 10.1016/j.plaphy.2011.10.010; Han X, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0050868; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Liu M., 2010, JUJUBE WITCHES BROOM; Liu M, 2009, CHINESE JUJUBE GERMS; Liu MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6315; Ma S, 2013, OXID MED CELL LONGEV, V2013, P1; Meng YL, 2013, SCI HORTIC-AMSTERDAM, V158, P16, DOI 10.1016/j.scienta.2013.04.019; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pinto F, 2012, PLOS ONE, V7, P1; Pinto F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034983; Sun HF, 2009, MOL BIOL REP, V36, P2183, DOI 10.1007/s11033-008-9433-y; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu JX, 2014, SCI HORTIC-AMSTERDAM, V176, P180, DOI 10.1016/j.scienta.2014.06.040; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Ye X, 2015, SCI HORTIC-AMSTERDAM, V181, P182, DOI 10.1016/j.scienta.2014.10.027; Zhang CM, 2015, SCI HORTIC-AMSTERDAM, V197, P166, DOI 10.1016/j.scienta.2015.09.026; [赵锦 ZHAO Jin], 2009, [植物遗传资源学报, Journal of Plant Genetic Resources], V10, P111; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8; Zhuang HH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00475	31	29	34	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154212	10.1371/journal.pone.0154212	http://dx.doi.org/10.1371/journal.pone.0154212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116123	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600049
J	Hammond, KR; O'Keefe, JM; Aldrich, SP; Loeb, SC				Hammond, Kristina R.; O'Keefe, Joy M.; Aldrich, Stephen P.; Loeb, Susan C.			A Presence-Only Model of Suitable Roosting Habitat for the Endangered Indiana Bat in the Southern Appalachians	PLOS ONE			English	Article							BLACK-HILLS; SELECTION; PERFORMANCE; CHIROPTERA; ECOLOGY; FORESTS; PINE; SPP.	We know little about how forest bats, which are cryptic and mobile, use roosts on a landscape scale. For widely distributed species like the endangered Indiana bat Myotis sodalis, identifying landscape-scale roost habitat associations will be important for managing the species in different regions where it occurs. For example, in the southern Appalachian Mountains, USA, M. sodalis roosts are scattered across a heavily forested landscape, which makes protecting individual roosts impractical during large-scale management activities. We created a predictive spatial model of summer roosting habitat to identify important predictors using the presence-only modeling program MaxEnt and an information theoretic approach for model comparison. Two of 26 candidate models together accounted for > 0.93 of AICc weights. Elevation and forest type were top predictors of presence; aspect north/south and distance-to-ridge were also important. The final average best model indicated that 5% of the study area was suitable habitat and 0.5% was optimal. This model matched our field observations that, in the southern Appalachian Mountains, optimal roosting habitat for M. sodalis is near the ridge top in south-facing mixed pine-hardwood forests at elevations from 260-575 m. Our findings, coupled with data from other studies, suggest M. sodalis is flexible in roost habitat selection across different ecoregions with varying topography and land use patterns. We caution that, while mature pine-hardwood forests are important now, specific areas of suitable and optimal habitat will change over time. Combining the information theoretic approach with presence-only models makes it possible to develop landscape-scale habitat suitability maps for forest bats.	[Hammond, Kristina R.; O'Keefe, Joy M.] Indiana State Univ, Ctr Bat Res Outreach & Conservat, Terre Haute, IN 47809 USA; [Aldrich, Stephen P.] Indiana State Univ, Dept Earth & Environm Syst, Terre Haute, IN 47809 USA; [Loeb, Susan C.] US Forest Serv, USDA, Southern Res Stn, Clemson, SC USA	Indiana State University; Indiana State University; United States Department of Agriculture (USDA); United States Forest Service	O'Keefe, JM (corresponding author), Indiana State Univ, Ctr Bat Res Outreach & Conservat, Terre Haute, IN 47809 USA.	joyokeefe@gmail.com	Aldrich, Stephen/AAD-6928-2019	Aldrich, Stephen/0000-0002-0492-2841	Joint Fire Science Program [09-1-08-2]; USDA Forest Service; Indiana Space Grant Consortium; Tallassee Fund; National Park Service; North Carolina Wildlife Resources Commission; Tennessee Wildlife Resources Agency; Eastern Band of Cherokee Indians	Joint Fire Science Program; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Indiana Space Grant Consortium; Tallassee Fund; National Park Service; North Carolina Wildlife Resources Commission; Tennessee Wildlife Resources Agency; Eastern Band of Cherokee Indians	Funding for this project was provided by the Joint Fire Science Program (09-1-08-2), USDA Forest Service, Indiana Space Grant Consortium, the Tallassee Fund, the National Park Service, the North Carolina Wildlife Resources Commission, Tennessee Wildlife Resources Agency, and the Eastern Band of Cherokee Indians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RA, 2008, J WILDLIFE MANAGE, V72, P1717, DOI 10.2193/2007-393; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barclay Robert M.R., 2007, P17; Bellamy C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128440; Bellamy C, 2013, J APPL ECOL, V50, P892, DOI 10.1111/1365-2664.12117; Britzke ER, 2003, SOUTHEAST NAT, V2, P235, DOI 10.1656/1528-7092(2003)002[0235:IBMSMR]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burns R.M., 1990, AGR HDB, V654; Carter TC, 2006, J WILDLIFE MANAGE, V70, P1185, DOI 10.2193/0022-541X(2006)70[1185:IBITMT]2.0.CO;2; Carter Timothy C., 2002, P160; Cryan PM, 2000, J MAMMAL, V81, P719, DOI 10.1644/1545-1542(2000)081<0719:EOEODO>2.3.CO;2; Cryan PM, 2001, ACTA CHIROPTEROL, V3, P43; DuChamp JE, 2007, BATS FORESTS CONSERV, P239; Dyer JM, 2006, BIOSCIENCE, V56, P341, DOI 10.1641/0006-3568(2006)56[341:RTDFOE]2.0.CO;2; Franzreb KE, 2005, PSWGTR1912005 USDA F; Gumbert Mark W., 2002, P143; Gumbert MW, 2001, THESIS E KENTUCKY U; Harvey Michael J., 2002, P29; Hein CD, 2008, J MAMMAL, V89, P964, DOI 10.1644/07-MAMM-A-335.1; HUMPHREY SR, 1977, J MAMMAL, V58, P334, DOI 10.2307/1379332; Iverson LR, 2002, FOREST ECOL MANAG, V155, P205, DOI 10.1016/S0378-1127(01)00559-X; Jaberg C, 2001, J APPL ECOL, V38, P1169, DOI 10.1046/j.0021-8901.2001.00668.x; Kalcounis-Ruppell MC, 2005, WILDLIFE SOC B, V33, P1123, DOI 10.2193/0091-7648(2005)33[1123:TRSBBA]2.0.CO;2; Krusac Dennis L., 2002, P55; Kurta Allen, 2002, P118; Lafon CW, 2007, RESTOR ECOL, V15, P400, DOI 10.1111/j.1526-100X.2007.00236.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loeb SC, 2013, ECOL EVOL, V3, P103, DOI 10.1002/ece3.440; Martinuzzi S, 2009, REMOTE SENS ENVIRON, V113, P2533, DOI 10.1016/j.rse.2009.07.002; Merckx B, 2011, ECOL MODEL, V222, P588, DOI 10.1016/j.ecolmodel.2010.11.016; Meyer ALS, 2014, AM J PRIMATOL, V76, P551, DOI 10.1002/ajp.22247; Miller DA, 2003, WILDLIFE SOC B, V31, P30; Miller Nancy E., 2002, P165; Moratelli R, 2011, MAMMALIA, V75, P227, DOI 10.1515/MAMM.2011.028; Neubaum DJ, 2006, J MAMMAL, V87, P470, DOI 10.1644/05-MAMM-A-252R1.1; Nowak J, 2008, J FOREST, V106, P261; Nuckolls AE, 2009, ECOSYSTEMS, V12, P179, DOI 10.1007/s10021-008-9215-3; O'Farrell MJ, 1999, J MAMMAL, V80, P24, DOI 10.2307/1383204; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Phillips A., 2010, ON BALANCE; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pie MR, 2013, ECOL MODEL, V250, P165, DOI 10.1016/j.ecolmodel.2012.10.019; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Russo D, 2015, J ZOOL, V297, P165, DOI 10.1111/jzo.12271; Schafale M.P., 2012, GUIDE NATURAL COMMUN; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Tessarolo G, 2014, DIVERS DISTRIB, V20, P1258, DOI 10.1111/ddi.12236; U. S. Fish & Wildlife Service (USFWS), 2011, SUPP DEC DOC RES WNS; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weller Theodore J., 2007, P263	55	16	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154464	10.1371/journal.pone.0154464	http://dx.doi.org/10.1371/journal.pone.0154464			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115605	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600069
J	Kirby, AE; Streby, A; Moe, CL				Kirby, Amy E.; Streby, Ashleigh; Moe, Christine L.			Vomiting as a Symptom and Transmission Risk in Norovirus Illness: Evidence from Human Challenge Studies	PLOS ONE			English	Article							NORWALK-LIKE VIRUS; AIRBORNE TRANSMISSION; UNITED-STATES; OUTBREAK; GASTROENTERITIS; PERSISTENCE; INFECTION; DISEASE	Background In the US, noroviruses are estimated to cause 21 million cases annually with economic losses reaching $2 billion. Outbreak investigations frequently implicate vomiting as a major transmission risk. However, little is known about the characteristics of vomiting as a symptom or the amount of virus present in emesis. Methodology and Principal Findings Emesis samples and symptomology data were obtained from previous norovirus human challenge studies with GI.1 Norwalk virus, GII.2 Snow Mountain virus, and a pilot study with GII.1 Hawaii virus. Viral titers in emesis were determined using strain-specific quantitative RT-PCR. In all four studies, vomiting was common with 40-100% of infected subjects vomiting at least once. However, only 45% of subjects with vomiting also had diarrhea. Most of the emesis samples had detectable virus and the mean viral titers were 8.0 x 10(5) and 3.9 x 10(4) genomic equivalent copies (GEC)/ml for GI and GII viruses, respectively (p = 0.02). Sample pH was correlated with GII.2 Snow Mountain virus detection. Conclusions and Significance Half of all subjects with symptomatic infection experienced vomiting and the average subject shed 1.7 x 10(8) GEC in emesis. Unlike shedding through stool, vomiting is more likely to result in significant environmental contamination, leading to transmission through fomites and airborne droplets. This quantitative data will be critical for risk assessment studies to further understand norovirus transmission and develop effective control measures. The correlation between sample pH and virus detection is consistent with a single site of virus replication in the small intestine and stomach contents becoming contaminated by intestinal reflux. Additionally, the frequency of vomiting without concurrent diarrhea suggests that epidemiology studies that enroll subjects based on the presence of diarrhea may be significantly underestimating the true burden of norovirus disease.	[Kirby, Amy E.; Streby, Ashleigh; Moe, Christine L.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Kirby, AE (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	aekirby@emory.edu		Kirby, Amy/0000-0002-6928-668X	Agriculture and Food Research Initiative Competitive grant from the US Department of Agriculture, National Institute of Food and Agriculture through the NoroCORE project [2011-68003-30395]	Agriculture and Food Research Initiative Competitive grant from the US Department of Agriculture, National Institute of Food and Agriculture through the NoroCORE project	This work was supported by the Agriculture and Food Research Initiative Competitive grant no. 2011-68003-30395 from the US Department of Agriculture, National Institute of Food and Agriculture through the NoroCORE project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong D, 2004, ALIMENT PHARM THERAP, V20, P19, DOI 10.1111/j.1365-2036.2004.02140.x; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Bernard H, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.8.20719; Bernstein DI, 2015, J INFECT DIS, V211, P870, DOI 10.1093/infdis/jiu497; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; Evans MR, 2002, EPIDEMIOL INFECT, V129, P355, DOI 10.1017/S0950268802007446; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hoefnagel J, 2012, EUROSURVEILLANCE, V17, P17; Karst SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004626; Kirby AE, 2014, J MED VIROL, V86, P2055, DOI 10.1002/jmv.23905; Leon JS, 2011, APPL ENVIRON MICROB, V77, P5476, DOI 10.1128/AEM.02801-10; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Liu PB, 2010, J MED VIROL, V82, P1612, DOI 10.1002/jmv.21851; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; Magill-Collins A, 2015, WILD ENVIRON MED, V26, P312, DOI 10.1016/j.wem.2015.02.007; Makison Booth Catherine, 2014, J Infect Prev, V15, P176, DOI 10.1177/1757177414545390; Marks PJ, 2000, EPIDEMIOL INFECT, V124, P481, DOI 10.1017/S0950268899003805; Marks PJ, 2003, EPIDEMIOL INFECT, V131, P727, DOI 10.1017/S0950268803008689; Morawska L, 2006, INDOOR AIR, V16, P335, DOI 10.1111/j.1600-0668.2006.00432.x; Muller L, 2015, EPIDEMIOL INFECT, V143, P2299, DOI 10.1017/S0950268814003409; Patterson W, 1997, Commun Dis Rep CDR Rev, V7, pR101; Petrignani M, 2015, J HOSP INFECT, V89, P163, DOI 10.1016/j.jhin.2014.11.015; Polkowska A, 2014, EPIDEMIOL INFECT, V142, P1877, DOI 10.1017/S0950268813002847; Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022; Repp KK, 2012, J INFECT DIS, V205, P1639, DOI 10.1093/infdis/jis250; Sartorius B, 2007, SCAND J INFECT DIS, V39, P323, DOI 10.1080/00365540601053006; Seitz SR, 2011, APPL ENVIRON MICROB, V77, P6884, DOI 10.1128/AEM.05806-11; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Thornley CN, 2011, CLIN INFECT DIS, V53, P515, DOI 10.1093/cid/cir465; Tung-Thompson G, 2015, FOOD ENVIRON VIROL, V7, P32, DOI 10.1007/s12560-014-9170-4; Wikswo M, 2014, AM J PUBLIC HEALTH, V104, pE13, DOI 10.2105/AJPH.2014.10411e13; Wikswo ME, 2011, CLIN INFECT DIS, V52, P1116, DOI 10.1093/cid/cir144; Zlot A, 2015, MMWR-MORBID MORTAL W, V64, P621	33	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0143759	10.1371/journal.pone.0143759	http://dx.doi.org/10.1371/journal.pone.0143759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116105	Green Published, gold, Green Submitted			2022-12-26	WOS:000374973600001
J	Sewe, MO; Ahlm, C; Rocklov, J				Sewe, Maquins Odhiambo; Ahlm, Clas; Rocklov, Joacim			Remotely Sensed Environmental Conditions and Malaria Mortality in Three Malaria Endemic Regions in Western Kenya	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; DEMOGRAPHIC SURVEILLANCE; LAND-COVER; ANOPHELES-GAMBIAE; HUMAN HEALTH; EAST-AFRICA; MODELS; RISK; ASSOCIATION; VARIABILITY	Background Malaria is an important cause of morbidity and mortality in malaria endemic countries. The malaria mosquito vectors depend on environmental conditions, such as temperature and rainfall, for reproduction and survival. To investigate the potential for weather driven early warning systems to prevent disease occurrence, the disease relationship to weather conditions need to be carefully investigated. Where meteorological observations are scarce, satellite derived products provide new opportunities to study the disease patterns depending on remotely sensed variables. In this study, we explored the lagged association of Normalized Difference Vegetation Index (NVDI), day Land Surface Temperature (LST) and precipitation on malaria mortality in three areas in Western Kenya. Methodology and Findings The lagged effect of each environmental variable on weekly malaria mortality was modeled using a Distributed Lag Non Linear Modeling approach. For each variable we constructed a natural spline basis with 3 degrees of freedom for both the lag dimension and the variable. Lag periods up to 12 weeks were considered. The effect of day LST varied between the areas with longer lags. In all the three areas, malaria mortality was associated with precipitation. The risk increased with increasing weekly total precipitation above 20 mm and peaking at 80 mm. The NDVI threshold for increased mortality risk was between 0.3 and 0.4 at shorter lags. Conclusion This study identified lag patterns and association of remote-sensing environmental factors and malaria mortality in three malaria endemic regions in Western Kenya. Our results show that rainfall has the most consistent predictive pattern to malaria transmission in the endemic study area. Results highlight a potential for development of locally based early warning forecasts that could potentially reduce the disease burden by enabling timely control actions.	[Sewe, Maquins Odhiambo] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Sewe, Maquins Odhiambo; Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden; [Ahlm, Clas] Umea Univ, Infect Dis, Dept Clin Microbiol, Umea, Sweden	Kenya Medical Research Institute; Umea University; Umea University	Sewe, MO (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.; Sewe, MO (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden.	sewemaquins@gmail.com		Rocklov, Joacim/0000-0003-4030-0449; sewe, maquins/0000-0003-1267-649X	President's Emergency Plan for AIDS Relief (PEPFAR) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA) and Division of Parasitic Diseases and Malaria (DPDM) [GH10-1001]; President's Malaria Initiative (PMI) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA) [GH10-1001]; HDSS; INDEPTH network; FAS, the Swedish Council for Working Life and Social Research [2006-1512]; President's Malaria Initiative (PMI) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Parasitic Diseases and Malaria (DPDM) [GH10-1001]	President's Emergency Plan for AIDS Relief (PEPFAR) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA) and Division of Parasitic Diseases and Malaria (DPDM); President's Malaria Initiative (PMI) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA); HDSS; INDEPTH network; FAS, the Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); President's Malaria Initiative (PMI) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Parasitic Diseases and Malaria (DPDM)	The KEMRI/CDC HDSS is funded by the President's Emergency Plan for AIDS Relief (PEPFAR) and the President's Malaria Initiative (PMI) through cooperative agreement No. GH10-1001 from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA) and Division of Parasitic Diseases and Malaria (DPDM). Funding has also been received through the studies nested in the HDSS and the INDEPTH network. This research was partly undertaken within the Umea Centre for Global Health Research at Umea University, with support from FAS, the Swedish Council for Working Life and Social Research ( grant no. 2006-1512). The funders had no role in design, analysis and writing of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amek N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-86; Amek N, 2011, SPAT SPATIO-TEMPORAL, V2, P283, DOI 10.1016/j.sste.2011.08.001; Amek NO, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25581; [Anonymous], 2014, R LANG ENV STAT COMP; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Bi Y, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-357; Brown ME, 2014, POPUL ENVIRON, V36, P48, DOI 10.1007/s11111-013-0201-0; Byass P, 2015, J GLOB HEALTH, V5, P65, DOI 10.7189/jogh.05.010402; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Ceccato P., 2005, Parassitologia (Rome), V47, P81; Christiansen-Jucht C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0489-3; Clennon JA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-58; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-328; Connor SJ, 2006, GEOSPATIAL HEALTH, V1, P17, DOI 10.4081/gh.2006.278; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Juri MJD, 2015, J VECTOR ECOL, V40, P36, DOI 10.1111/jvec.12130; Desai M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106197; Ehlkes L, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-35; Gasparrini A, 2014, STAT MED, V33, P881, DOI 10.1002/sim.5963; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Hallman J, TIS TIME INDEXES TIM; Haque U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014341; Hashemi S. A., 2011, World Applied Sciences Journal, V14, P1678; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Krefis AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017905; McCann RS, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-17; Midekisa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-165; Mutuku FM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-19; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Omumbo JA, 2002, PHOTOGRAMM ENG REM S, V68, P161; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Sewe M, 2015, INT J ENV RES PUB HE, V12, P1983, DOI 10.3390/ijerph120201983; Snow RW, 1998, T ROY SOC TROP MED H, V92, P601, DOI 10.1016/S0035-9203(98)90781-7; Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25369; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Thomson MC, 1997, PARASITOL TODAY, V13, P313, DOI 10.1016/S0169-4758(97)01097-1; Walker M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-311; WHO, WORLD MAL REP 2013; Zhao X, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-57	45	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154204	10.1371/journal.pone.0154204	http://dx.doi.org/10.1371/journal.pone.0154204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115874	gold, Green Published			2022-12-26	WOS:000374973600047
J	Pridmore, RW				Pridmore, Ralph W.			When Do Short-Wave Cones Signal Blue or Red? A Solution Introducing the Concept of Primary and Secondary Cone Outputs	PLOS ONE			English	Article							OPPONENT-COLORS THEORY; SPECTRAL SENSITIVITIES; COMPLEMENTARY COLORS; QUANTITATIVE ASPECTS; HUE; SATURATION	A recent paper by Oh and Sakata investigates the "incompletely solved mystery" of how the three cone responses map onto perceived hue, and particularly the S cone's well-known problematic contribution to blueness and redness. Citing previous workers, they argue the twentieth century traditional multistage model does not satisfactorily account for color appearance. In their experiment, increasing S cone excitation with shortening wavelength from about 480-460 nm increased perceived blueness up to the unique Blue point at 470 nm, when (a) it began decreasing and (b) redness perception began increasing. The authors asked, What mechanism can be responsible for such functions? I demonstrate a solution. First, it is shown the problem does not lie in the traditional opponent color chromatic responses yellow-blue, red-green (y-b, r-g, which accurately predict the above functions), but in the traditional multistage model of mapping cone responses to chromatic response functions. Arguably, this is due to the S cone's hypothetically signaling both blueness and redness by the same mechanism rather than by different, independent, mechanisms. Hence a new distinction or mechanism is proposed for a more accurate model, that introduces the new terms primary and secondary cone outputs. However, this distinction requires that the cones S, M, L each directly produce one of the three spectral chromatic responses b, g, y. Such a model was recently published, based on extremely high correlation of SML cone responsivities with the three spectral (bgy) chromatic responses. This model encodes the former directly onto the latter one-to-one as cone primary outputs, whilst S and L cones have a further or secondary function where each produces one of the two spectral lobes of r chromatic response. The proposed distinction between primary and secondary cone outputs is a new concept and useful tool in detailing cone outputs to chromatic channels, and provides a solution to the above "incompletely solved mystery." Thus the S cone has a primary output producing the total b chromatic response and a secondary output that shares with the L cone the production of r chromatic response, thus aligning with Oh and Sokata's results. The model similarly maps L cone to yellowness as primary output and to redness as secondary output.	[Pridmore, Ralph W.] Cent Houses Pty Ltd, 8c Rothwell Rd, Sydney, NSW 2074, Australia		Pridmore, RW (corresponding author), Cent Houses Pty Ltd, 8c Rothwell Rd, Sydney, NSW 2074, Australia.	rpridmo@bigpond.net.au		pridmore, ralph/0000-0001-7166-7249	Central Houses Pty Ltd	Central Houses Pty Ltd	The author is a director of Central Houses Pty Ltd, a private, small, family company, which only provided financial support in the form of research materials, and had no role in the study design or the preparation of the MS.	Abramov I, ANN REV PSYCHOL, V45, P451; BURNS SA, 1984, VISION RES, V24, P479, DOI 10.1016/0042-6989(84)90045-2; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P512, DOI 10.1073/pnas.97.1.512; Dowling J. E., 1987, RETINA APPROACHABLE; DRUM B, 1989, COLOR RES APPL, V14, P293, DOI 10.1002/col.5080140607; Estevez O., 1979, THESIS; Fairchild M. D., 2005, COLOR APPEARANCE MOD; FULD K, 1991, VISION RES, V31, P237, DOI 10.1016/0042-6989(91)90114-K; Hoyland H, 2009, SYSTEM RELIABILITY T; HURVICH LM, 1955, J OPT SOC AM, V45, P602, DOI 10.1364/JOSA.45.000602; Hurvich LM., 1981, COLOR VISION; INGLING CR, 1982, COLOR RES APPL, V7, P191, DOI 10.1002/col.5080070229; INGLING CR, 1977, VISION RES, V17, P1083, DOI 10.1016/0042-6989(77)90014-1; JAMESON D, 1955, J OPT SOC AM, V45, P546, DOI 10.1364/JOSA.45.000546; JAMESON D, 1968, J OPT SOC AM, V58, P429; Judd D. B., 1975, COLOR BUSINESS SCI I; Knoblauch K, 2001, VISUAL NEUROSCI, V18, P901, DOI 10.1017/S0952523801186062; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; KULP TD, 1995, VISION RES, V35, P2967, DOI 10.1016/0042-6989(95)00049-6; Mollon JD, 1987, COLOUR VISION DEFICI, P473; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Oh S, 2015, COLOR RES APPL, V40, P323, DOI 10.1002/col.21900; Pridmore RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077134; Pridmore RW, 2010, COLOR RES APPL, V35, P122, DOI 10.1002/col.20534; PRIDMORE RW, 1978, J OPT SOC AM, V68, P1490, DOI 10.1364/JOSA.68.001490; PRIDMORE RW, 1980, J OPT SOC AM, V70, P248, DOI 10.1364/JOSA.70.000248; Pridmore RW, 2007, EFFECT PURITY HUE AB; Romeskie MI., 1976, THESIS BROWN U; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; TAKAHASHI S, 1985, J OPT SOC AM A, V2, P705, DOI 10.1364/JOSAA.2.000705; VOS JJ, 1990, VISION RES, V30, P937, DOI 10.1016/0042-6989(90)90059-T; WERNER JS, 1979, J OPT SOC AM, V69, P422, DOI 10.1364/JOSA.69.000422; Wyszecki G, 1982, COLOR SCI, Vsecond	35	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154048	10.1371/journal.pone.0154048	http://dx.doi.org/10.1371/journal.pone.0154048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27110938	gold, Green Published			2022-12-26	WOS:000374565100038
J	Zeb, A; Zaman, G; Erturk, VS; Alzalg, B; Yousafzai, F; Khan, M				Zeb, Anwar; Zaman, Gul; Erturk, Vedat Suat; Alzalg, Baha; Yousafzai, Faisal; Khan, Madad			Approximating a Giving Up Smoking Dynamic on Adolescent Nicotine Dependence in Fractional Order	PLOS ONE			English	Article							DIFFERENTIAL TRANSFORM METHOD; EQUATIONS	In this work, we consider giving up smoking dynamic on adolescent nicotine dependence. First, we use the Caputo derivative to develop the model in fractional order. Then we apply two different numerical methods to compute accurate approximate solutions of this new model in fractional order and compare their results. In order to do this, we consider the generalized Euler method (GEM) and multi-step generalized differential transform method (MSGDTM). We also show the unique positive solution for this model and present numerical results graphically.	[Zeb, Anwar; Khan, Madad] COMSATS Inst Informat Technol, Dept Math, Abbottabad, Kpk, Pakistan; [Zaman, Gul] Univ Malakand, Dept Math, Chakdara Dir Lower, Khyber Pakhtunk, Pakistan; [Erturk, Vedat Suat] Ondokuz Mayis Univ, Fac Arts & Sci, Dept Math, Samsun, Turkey; [Alzalg, Baha] Buraimi Univ Coll, Dept Business Adm & Accounting, Al Buraimi, Oman; [Yousafzai, Faisal] COMSATS Inst Informat Technol Attack, Dept Math, Lahore, Pakistan	COMSATS University Islamabad (CUI); Ondokuz Mayis University; COMSATS University Islamabad (CUI)	Khan, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Abbottabad, Kpk, Pakistan.	madadmath@yahoo.com	Alzalg, Baha/Q-7575-2019; Alzalg, Baha/G-5775-2016; ERTURK, Vedat Suat/ABD-4512-2021	Alzalg, Baha/0000-0002-1839-8083; ERTURK, Vedat Suat/0000-0002-1322-8843; Khan, Madad/0000-0003-0044-961X				Alomari AK, 2011, COMPUT MATH APPL, V61, P2528, DOI 10.1016/j.camwa.2011.02.043; Brauer F., 2012, MATH MODELS POPULATI, V2; CAPUTO M, 1967, GEOPHYS J ROY ASTR S, V13, P529, DOI 10.1111/j.1365-246X.1967.tb02303.x; Choi H., 2011, KSIAM 2011 SPRING C; Das S., 2011, FUNCT FRACT CALC 2; Erturk VS, 2008, COMMUN NONLINEAR SCI, V13, P1642, DOI 10.1016/j.cnsns.2007.02.006; Gokdogan A, 2011, MATH COMPUT MODEL, V54, P2132, DOI 10.1016/j.mcm.2011.05.022; Jafari H, 2006, J COMPUT APPL MATH, V196, P644, DOI 10.1016/j.cam.2005.10.017; Kurulay M, 2010, COMMUN NONLINEAR SCI, V15, P1777, DOI 10.1016/j.cnsns.2009.07.014; Magin R.-L., 2006, FRACTIONAL CALCULUS; Momani S, 2008, J COMPUT APPL MATH, V220, P85, DOI 10.1016/j.cam.2007.07.033; Odibat Z, 2008, APPL MATH COMPUT, V197, P467, DOI 10.1016/j.amc.2007.07.068; Odibat Z, 2008, APPL MATH LETT, V21, P194, DOI 10.1016/j.aml.2007.02.022; Odibat ZM, 2007, APPL MATH COMPUT, V186, P286, DOI 10.1016/j.amc.2006.07.102; Odibat Zaid M., 2008, Journal of Applied Mathematics and Informatics, V26, P15; Podlubny I., 1999, FRACTIONAL DIFFERENT; SWARTZ JB, 1992, J EPIDEMIOL COMMUN H, V46, P311, DOI 10.1136/jech.46.3.311; Zeb A, 2013, APPL MATH MODEL, V37, P5326, DOI 10.1016/j.apm.2012.10.005	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0103617	10.1371/journal.pone.0103617	http://dx.doi.org/10.1371/journal.pone.0103617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105426	Green Published, gold			2022-12-26	WOS:000374565100001
J	Ali, AAA; Lee, YR; Chen, TC; Chen, CL; Lee, CC; Shiau, CY; Chiang, CH; Huang, HS				Ali, Ahmed Atef Ahmed; Lee, Yu-Ru; Chen, Tsung-Chih; Chen, Chun-Liang; Lee, Chia-Chung; Shiau, Chia-Yang; Chiang, Chiao-Hsi; Huang, Hsu-Shan			Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination	PLOS ONE			English	Article							NF-KAPPA-B; CACO-2 CELL-PERMEABILITY; DRUG-DELIVERY REVIEWS; IN-VITRO; MYCOBACTERIUM-TUBERCULOSIS; INFLAMMATORY RESPONSES; CANCER; ACTIVATION; RESISTANCE; TOXICITY	The novel compounds NSC745885 and NSC757963 developed at our laboratory were tested against a panel of 60 cancer cell lines at the National Cancer Institute, USA, and a panel of 39 cancer cell lines at the Japanese Foundation of Cancer Research. Both compounds demonstrated selective unique multi-log differential patterns of activity, with GI(50) values in the sub-micro molar range against cancer cells rather than normal cardiac cells. NSC757963 showed high selectivity towards the leukemia subpanel. Activities of both compounds strongly correlated to expression of NFKB1 and CSNK2B genes, implying that they may inhibit the NF-kappa B pathway. Immunocytochemical microscopy of OVCAR-3 cells showed clear cytosolic accumulation of the NF-kappa B p65 subunit following treatment. Western blotting showed dose dependent inhibition of the nuclear expression of the NF-kappa B p65 subunit with subsequent accumulation in the cytosol following treatment. Docking experiments showed binding of both compounds to the NF-kappa B activator IKK beta subunit preventing its translocation to the nucleus. Collectively, these results confirm the ability of our compounds to inhibit the constitutively active NF-kappa B pathway of OVCAR-3 cells. Furthermore, COMPARE analysis indicated that the activity of NSC757963 is similar to the antituberculosis agent rifamycin SV, this was confirmed by testing the antimycobacterial activity of NSC757963 against Mycobacterium tuberculosis, results revealed potent activity suitable for use in clinical practice. Molecular properties and Lipinski's parameters predicted acceptable bioavailability properties with no indication of mutagenicity, tumorigenicity, irritability and reproductive effects. Oral absorption experiments using the human Caco-2 model showed high intestinal absorption of NSC745885 by passive transport mechanism with no intestinal efflux or active transport mechanisms. The unique molecular characterization as well as the illustrated anticancer spectra of activity and bioavailability properties warrant further development of our compounds and present a foundation brick in the pre-clinical investigations to implement such compounds in clinical practice.	[Ali, Ahmed Atef Ahmed; Huang, Hsu-Shan] Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Mol & Cell Biol, Taipei, Taiwan; [Ali, Ahmed Atef Ahmed; Lee, Yu-Ru; Chiang, Chiao-Hsi; Huang, Hsu-Shan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Ali, Ahmed Atef Ahmed; Chen, Tsung-Chih; Chen, Chun-Liang; Lee, Chia-Chung; Huang, Hsu-Shan] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan; [Shiau, Chia-Yang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Taipei Medical University; National Defense Medical Center	Huang, HS (corresponding author), Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Mol & Cell Biol, Taipei, Taiwan.; Huang, HS (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Huang, HS (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan.	huanghs99@tmu.edu.tw	Chiang, Chiao-Hsi/AAS-9777-2021	Ali, Ahmed/0000-0002-0375-6511; CHEN, Tsung-Chih/0000-0001-8256-6240; Huang, Hsu-Shan/0000-0001-8162-5608	Taipei Medical University [TMU-NDMC-104-02]	Taipei Medical University	This work was supported by Taipei Medical University, TMU-NDMC-104-02, http://www.tmu.edu.tw/english/main.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AR, 2014, EUR J MED CHEM, V75, P492, DOI 10.1016/j.ejmech.2013.12.010; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Ataie-Kachoie P, 2013, MOL CANCER RES, V11, P1279, DOI 10.1158/1541-7786.MCR-13-0239; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Bhat-Nakshatri P, 2002, ONCOGENE, V21, P2066, DOI 10.1038/sj.onc.1205243; Blanchfield JT, 2003, J MED CHEM, V46, P1266, DOI 10.1021/jm020426j; Broeders JJW, 2012, CHEM RES TOXICOL, V25, P1442, DOI 10.1021/tx300221k; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Chang YL, 2011, INT J BIOCHEM CELL B, V43, P1720, DOI 10.1016/j.biocel.2011.08.006; Chen JE, 2015, BIOINFORMATICS, V31, P1484, DOI 10.1093/bioinformatics/btu841; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Fang XL, 2004, J CHEM INF COMP SCI, V44, P249, DOI 10.1021/ci034209i; Gills JJ, 2006, MOL CANCER THER, V5, P713, DOI 10.1158/1535-7163.MCT-05-0484; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hall L, 2011, JOVE-J VIS EXP, DOI 10.3791/3094; Hu CS, 2012, INT J NANOMED, V7, P4861, DOI 10.2147/IJN.S34770; Hu SQ, 2012, INT J MOL SCI, V13, P15653, DOI 10.3390/ijms131215653; Huang HS, 2009, BIOORGAN MED CHEM, V17, P7418, DOI 10.1016/j.bmc.2009.09.033; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Hwang JK, 2013, RHEUMATOLOGY, V52, P1583, DOI 10.1093/rheumatology/ket178; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Jhamb SS, 2014, BRAZ J INFECT DIS, V18, P336, DOI 10.1016/j.bjid.2013.12.004; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kratz JM, 2011, BRAZ J MED BIOL RES, V44, P531, DOI 10.1590/S0100-879X2011007500060; Lavon I, 2007, CANCER RES, V67, P8952, DOI 10.1158/0008-5472.CAN-06-3820; Lee YR, 2015, EUR J MED CHEM, V102, P661, DOI 10.1016/j.ejmech.2015.07.052; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu SP, 2013, J BIOL CHEM, V288, P22758, DOI 10.1074/jbc.M113.482596; Luzina EL, 2013, J FLUORINE CHEM, V148, P41, DOI 10.1016/j.jfluchem.2013.01.033; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Meng GQ, 2010, BRIT J PHARMACOL, V161, P1628, DOI 10.1111/j.1476-5381.2010.00993.x; Moreira AC, 2014, BBA-MOL BASIS DIS, V1842, P2468, DOI 10.1016/j.bbadis.2014.09.015; Naasani Imad, 2002, Methods Mol Biol, V191, P197; Narva S, 2016, EUR J MED CHEM, V114, P220, DOI 10.1016/j.ejmech.2016.02.059; Passagne I, 2006, TOXICOL APPL PHARM, V211, P97, DOI 10.1016/j.taap.2005.06.009; Rashidipour S, 2016, J BIOMOL STRUCT DYN, V34, P57, DOI 10.1080/07391102.2015.1009946; Ravi R, 2004, DRUG RESIST UPDATE, V7, P53, DOI 10.1016/j.drup.2004.01.003; Rostom SAF, 2006, BIOORGAN MED CHEM, V14, P6475, DOI 10.1016/j.bmc.2006.06.020; Sattar Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084045; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Tang SH, 2014, ONCOTARGET, V5, P10342, DOI 10.18632/oncotarget.1867; Torrea G, 2015, J ANTIMICROB CHEMOTH, V70, P2300, DOI 10.1093/jac/dkv117; Toungoussova OS, 2005, EUR J CLIN MICROBIOL, V24, P202, DOI 10.1007/s10096-005-1284-z; van Breemen Richard B, 2005, Expert Opin Drug Metab Toxicol, V1, P175, DOI 10.1517/17425255.1.2.175; Vavricka SR, 2002, HEPATOLOGY, V36, P164, DOI 10.1053/jhep.2002.34133; von Korff M, 2006, J CHEM INF MODEL, V46, P536, DOI 10.1021/ci050358k; Weaver KD, 2003, J NEURO-ONCOL, V61, P187, DOI 10.1023/A:1022554824129; Werngren J, 2014, ANTIMICROB AGENTS CH, V58, P4222, DOI 10.1128/AAC.02718-14; Wessling ST, 2007, BIOORGAN MED CHEM, V15, P4946, DOI 10.1016/j.bmc.2007.04.042; Xing MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133569; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	55	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154278	10.1371/journal.pone.0154278	http://dx.doi.org/10.1371/journal.pone.0154278			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100886	Green Submitted, gold, Green Published			2022-12-26	WOS:000374898500176
J	Cunningham, AL; Guentzel, MN; Yu, JJ; Hung, CY; Forsthuber, TG; Navara, CS; Yagita, H; Williams, IR; Klose, KE; Eaves-Pyles, TD; Arulanandam, BP				Cunningham, Aimee L.; Guentzel, M. Neal; Yu, Jieh-Juen; Hung, Chiung-Yu; Forsthuber, Thomas G.; Navara, Christopher S.; Yagita, Hideo; Williams, Ifor R.; Klose, Karl E.; Eaves-Pyles, Tonyia D.; Arulanandam, Bernard P.			M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensis	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; TRANSEPITHELIAL TRANSPORT; ANTIGEN; STRAIN; CHALLENGE; INFECTION; BACTERIA; MICE; DIFFERENTIATION; RESPONSES	M-cells (microfold cells) are thought to be a primary conduit of intestinal antigen trafficking. Using an established neutralizing anti-RANKL (Receptor Activator of NF-kappa B Ligand) antibody treatment to transiently deplete M-cells in vivo, we sought to determine whether intestinal M-cells were required for the effective induction of protective immunity following oral vaccination with Delta iglB (a defined live attenuated Francisella novicida mutant). M-cell depleted, Delta iglB-vaccinated mice exhibited increased (but not significant) morbidity and mortality following a subsequent homotypic or heterotypic pulmonary F. tularensis challenge. No significant differences in splenic IFN-gamma, IL-2, or IL-17 or serum antibody (IgG1, IgG2a, IgA) production were observed compared to non-depleted, Delta iglB-vaccinated animals suggesting complementary mechanisms for Delta iglB entry. Thus, we examined other possible routes of gastrointestinal antigen sampling following oral vaccination and found that Delta iglB co-localized to villus goblet cells and enterocytes. These results provide insight into the role of M-cells and complementary pathways in intestinal antigen trafficking that may be involved in the generation of optimal immunity following oral vaccination.	[Cunningham, Aimee L.; Guentzel, M. Neal; Yu, Jieh-Juen; Hung, Chiung-Yu; Forsthuber, Thomas G.; Navara, Christopher S.; Klose, Karl E.; Arulanandam, Bernard P.] Univ Texas San Antonio, Dept Biol, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Cunningham, Aimee L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Yagita, Hideo] Juntendo Univ, Dept Immunol, Tokyo, Japan; [Williams, Ifor R.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Eaves-Pyles, Tonyia D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio; Juntendo University; Emory University; University of Texas System; University of Texas Medical Branch Galveston	Arulanandam, BP (corresponding author), Univ Texas San Antonio, Dept Biol, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA.	bernard.arulanandam@utsa.edu	Navara, Christopher/C-2813-2011; Forsthuber, Thomas/AID-8080-2022; Williams, Ifor R/D-3648-2011	Williams, Ifor R/0000-0002-8810-2911; /0000-0003-0692-7125; Hung, Chiung Yu/0000-0003-1091-3420	UTHSCSA Department of Microbiology and Immunology Microbial Pathogenesis training grant (NIH) [T32AI007271]; UTSA Center for Excellence in Infection Genomics training grant (DOD) [W911NF-11-1-0136]; UTSA RCMI (Regional Centers in Minority Institutions) from the National Institute on Minority Health and Health Disparities [G12MD007591]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114762, T32AI007271] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	UTHSCSA Department of Microbiology and Immunology Microbial Pathogenesis training grant (NIH); UTSA Center for Excellence in Infection Genomics training grant (DOD); UTSA RCMI (Regional Centers in Minority Institutions) from the National Institute on Minority Health and Health Disparities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the UTHSCSA Department of Microbiology and Immunology Microbial Pathogenesis training grant (NIH #T32AI007271), the UTSA Center for Excellence in Infection Genomics training grant (DOD #W911NF-11-1-0136 for BPA), and a UTSA RCMI (Regional Centers in Minority Institutions) grant (#G12MD007591) from the National Institute on Minority Health and Health Disparities. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; AMERONGEN HM, 1991, J ACQ IMMUN DEF SYND, V4, P760; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brandtzaeg P, 2001, NAT IMMUNOL, V2, P1093, DOI 10.1038/ni1201-1093; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Dietrich G, 2003, VACCINE, V21, P678, DOI 10.1016/S0264-410X(02)00579-0; Donaldson DS, 2012, MUCOSAL IMMUNOL, V5, P216, DOI 10.1038/mi.2011.68; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fotopoulos G, 2002, P NATL ACAD SCI USA, V99, P9410, DOI 10.1073/pnas.142586899; Frey A, 1997, Behring Inst Mitt, P376; Geem D, 2012, JOVE-J VIS EXP, DOI 10.3791/4040; GODEFROY O, 1988, BIOL CELL, V63, P41, DOI 10.1016/0248-4900(88)90107-4; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; HUET C, 1987, J CELL BIOL, V105, P345, DOI 10.1083/jcb.105.1.345; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Kim SH, 2010, J IMMUNOL, V185, P5787, DOI 10.4049/jimmunol.0903184; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; KuoLee R, 2007, VACCINE, V25, P3781, DOI 10.1016/j.vaccine.2007.02.014; Levine MM, 2003, NAT MED, V9, P99, DOI 10.1038/nm0103-99; Li WD, 2013, VACCINE, V31, P5722, DOI 10.1016/j.vaccine.2013.09.036; Liu JR, 2007, BIOTECHNIQUES, V43, P487, DOI 10.2144/000112574; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Misumi S, 2009, J IMMUNOL, V182, P6061, DOI 10.4049/jimmunol.0802928; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Nikitas G, 2011, J EXP MED, V208, P2263, DOI 10.1084/jem.20110560; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Roth-Walter F, 2005, IMMUNOL LETT, V100, P182, DOI 10.1016/j.imlet.2005.03.020; Signarovitz AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047639; Skyberg JA, 2013, INFECT IMMUN, V81, P3099, DOI 10.1128/IAI.00203-13; SURCEL HM, 1991, INFECT IMMUN, V59, P1948, DOI 10.1128/IAI.59.6.1948-1953.1991; Tsai YH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003381; Westphal S, 2008, AM J PATHOL, V172, P671, DOI 10.2353/ajpath.2008.070393	44	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153402	10.1371/journal.pone.0153402	http://dx.doi.org/10.1371/journal.pone.0153402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100824	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500031
J	Liao, YL; Zhang, Y; He, L; Wang, JF; Liu, X; Zhang, NX; Xu, B				Liao, Yilan; Zhang, Yan; He, Lei; Wang, Jinfeng; Liu, Xin; Zhang, Ningxu; Xu, Bing			Temporal and Spatial Analysis of Neural Tube Defects and Detection of Geographical Factors in Shanxi Province, China	PLOS ONE			English	Article							HIGH PREVALENCE; TRACE-ELEMENTS; FOLIC-ACID; RISK; AREA; POPULATION; EXPOSURE; RATES; SOIL	Background Neural tube defects (NTDs) are congenital birth defects that occur in the central nervous system, and they have the highest incidence among all birth defects. Shanxi Province in China has the world's highest rate of NTDs. Since the 1990s, China's government has worked on many birth defect prevention programs to reduce the occurrence of NTDs, such as pregnancy planning, health education, genetic counseling, antenatal ultrasonography and serological screening. However, the rate of NTDs in Shanxi Province is still higher than the world's average morbidity rate after intervention. In addition, Shanxi Province has abundant coal reserves, and is the largest coal production province in China. The objectives of this study are to determine the temporal and spatial variation of the NTD rate in rural areas of Shanxi Province, China, and identify geographical environmental factors that were associated with NTDs in the risk area. Methods In this study, Heshun County and Yuanping County in Shanxi Province, which have high incidence of NTDs, were selected as the study areas. Two paired sample T test was used to analyze the changes in the risk of NTDs from the time dimension. Ripley's k function and spatial filtering were combined with geographic information system (GIS) software to study the changes in the risk of NTDs from the spatial dimension. In addition, geographical detectors were used to identify the risk geographical environmental factors of NTDs in the study areas, especially the areas close to the coal sites and main roads. Results In both Heshun County and Yuanping County, the incidence of NTDs was significantly (P<0.05) reduced after intervention. The results from spatial analysis showed that significant spatial heterogeneity existed in both counties. NTD clusters were still identified in areas close to coal sites and main roads after interventions. This study also revealed that the elevation, fault and soil types always had a larger influence on the incidence of NTDs in our study areas. In addition, distance to the river was a risk factor of NTDs in areas close to the coal sites and main roads. Conclusion The existing interventions may have played an important role to reduce the incidence of NTDs. However, there is still spatial heterogeneity in both counties after using the traditional intervention methods. The government needs to take more measures to strengthen the environmental restoration to prevent the occurrence of NTDs, especially those areas close to coal sites and main roads. The outcome of this research provides an important theoretical basis and technical support for the government to prevent the occurrence of NTDs.	[Liao, Yilan; Wang, Jinfeng; Zhang, Ningxu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing 100101, Peoples R China; [Liao, Yilan; Wang, Jinfeng; Zhang, Ningxu] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing 102206, Peoples R China; [Zhang, Yan] Henan Acad Agr Sci, Inst Agr Econ & Informat, Zhengzhou 450002, Peoples R China; [He, Lei] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Liu, Xin] Curtin Univ, Dept Spatial Sci, Bentley, WA 6845, Australia; [Xu, Bing] Changan Univ, Xian 710054, Peoples R China; [Xu, Bing] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Center for Disease Control & Prevention; Henan Academy of Agricultural Sciences; University of California System; University of California Berkeley; Curtin University; Chang'an University	Liao, YL; Wang, JF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing 100101, Peoples R China.; Liao, YL; Wang, JF (corresponding author), Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing 102206, Peoples R China.	liaoyl@lreis.ac.cn; wangjf@lreis.ac.cn	Liu, Xin/AGH-0829-2022	Liu, Xin/0000-0003-4513-3395; Wang, Jinfeng/0000-0002-6687-9420	National Natural Science Foundation of China [41471377, 41101431]; Young Talent Fund of the Institute of Geographic Sciences and Natural Resources Research, CAS [2012RC201]; Youth Innovation Promotion Association of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talent Fund of the Institute of Geographic Sciences and Natural Resources Research, CAS; Youth Innovation Promotion Association of the Chinese Academy of Sciences	This study was supported by the National Natural Science Foundation of China, http://www.nsfc.gov.cn/publish/portal1/ (Nos. 41471377, 41101431), and the Young Talent Fund of the Institute of Geographic Sciences and Natural Resources Research, CAS, http://english.igsnrr.cas.cn/ (2012RC201).; This study was supported by the National Natural Science Foundation of China http://www.nsfc.gov.cn/publish/portal1/ (Nos. 41471377, 41101431), and the Yong Talent Fund of the Institute of Geographic Sciences and Natural Resources Research, CAS http://english.igsnrr.cas.cn/ (2012RC201). We would like to thank all the staff enrolled in this study for their excellent cooperation. We also thank the Youth Innovation Promotion Association of the Chinese Academy of Sciences for their support.	An HX, 2010, J SHANXI MED U, V41, P1090; Araneta MRG, 2000, TERATOLOGY, V62, P195, DOI 10.1002/1096-9926(200010)62:4<195::AID-TERA5>3.0.CO;2-5; Box J. F., 1987, STAT SCI, V2, P45, DOI [10.1214/ss/1177013437, DOI 10.1214/SS/1177013437]; Brender JD, 2006, ENVIRON RES, V101, P132, DOI 10.1016/j.envres.2005.08.003; Castilla EE, 1999, AM J MED GENET, V86, P9, DOI 10.1002/(SICI)1096-8628(19990903)86:1<9::AID-AJMG3>3.0.CO;2-X; Dai Li, 2002, Zhonghua Yufang Yixue Zazhi, V36, P402; Durbeck H, 2002, CLUSTERSEER SOFTWARE; Frey L, 2003, EPILEPSIA, V44, P4, DOI 10.1046/j.1528-1157.44.s3.2.x; Gu X, 2007, BIRTH DEFECTS RES A, V79, P702, DOI 10.1002/bdra.20397; Hu Y, 2011, PLOS ONE, V6, P214; Huang J, 2011, BIOMED ENVIRON SCI, V24, P94, DOI 10.3967/0895-3988.2011.02.002; Kafadar K, 1996, STAT MED, V15, P2539, DOI 10.1002/(SICI)1097-0258(19961215)15:23<2539::AID-SIM379>3.0.CO;2-B; Li XinHu, 2007, Research of Environmental Sciences, V20, P21; Li Xinhu, 2006, Toxicological and Environmental Chemistry, V88, P551, DOI 10.1080/00222930600803282; Li ZW, 2011, AM J EPIDEMIOL, V174, P451, DOI 10.1093/aje/kwr108; Li ZW, 2006, BIRTH DEFECTS RES A, V76, P237, DOI 10.1002/bdra.20248; Liao YL, 2010, INT J ENVIRON HEAL R, V20, P439, DOI 10.1080/09603123.2010.491854; Liao YL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-391; Liu XX, SHANXI PROVINCE HAD; Milunsky A., 2010, GENETIC DISORDERS FE; Ozdenerol Esra, 2005, Int J Health Geogr, V4, P19, DOI 10.1186/1476-072X-4-19; Ren Y, 2014, LANDSCAPE ECOL; Ren ZP, 2013, STOCH ENV RES RISK A, V27, P1695, DOI 10.1007/s00477-013-0707-0; Rushton G, 1996, STAT MED, V15, P717, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<717::AID-SIM243>3.0.CO;2-0; Rushton G, 1989, SPATIAL ANAL INFANT; Talbot TO, 2000, STAT MED, V19, P2399, DOI 10.1002/1097-0258(20000915/30)19:17/18<2399::AID-SIM577>3.3.CO;2-I; Wang GH, 2009, WORK PROGRAM FULL IM; Wang JF, 2012, ENVIRON MODELL SOFTW, V33, P114, DOI 10.1016/j.envsoft.2012.01.015; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang JF, 2010, INT J GEOGR INF SCI, V24, P523, DOI 10.1080/13658810902873512; Wu JL, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-23; Yi YN, 2011, EUR J PEDIATR, V170, P1391, DOI 10.1007/s00431-011-1492-8; Zhang BG, 2001, SHANXI SCI TECH COMM, V143, P60; Zhang JY, 2004, FUEL, V83, P129, DOI 10.1016/S0016-2361(03)00221-7; Zhang L, 2004, CHIN J REPROD HLTH, V15, P293; Zhang SL, 2012, SHANXI COAL, V32, P41	36	27	32	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0150332	10.1371/journal.pone.0150332	http://dx.doi.org/10.1371/journal.pone.0150332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100082	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500002
J	Ostrowski, MF; Prosperi, JM; David, J				Ostrowski, Marie-France; Prosperi, Jean-Marie; David, Jacques			Potential Implications of Climate Change on Aegilops Species Distribution: Sympatry of These Crop Wild Relatives with the Major European Crop Triticum aestivum and Conservation Issues	PLOS ONE			English	Article							GENE FLOW; MALE-STERILITY; HEAT-STRESS; BREAD WHEAT; D-GENOME; LAND-USE; CYLINDRICA; DIVERSITY; L.; GENICULATA	Gene flow from crop to wild relatives is a common phenomenon which can lead to reduced adaptation of the wild relatives to natural ecosystems and/or increased adaptation to agro-systems (weediness). With global warming, wild relative distributions will likely change, thus modifying the width and/ or location of co-occurrence zones where crop-wild hybridization events could occur (sympatry). This study investigates current and 2050 projected changes in sympatry levels between cultivated wheat and six of the most common Aegilops species in Europe. Projections were generated using MaxEnt on presence-only data, bioclimatic variables, and considering two migration hypotheses and two 2050 climate scenarios (RCP4.5 and RCP8.5). Overall, a general decline in suitable climatic conditions for Aegilops species outside the European zone and a parallel increase in Europe were predicted. If no migration could occur, the decline was predicted to be more acute outside than within the European zone. The potential sympatry level in Europe by 2050 was predicted to increase at a higher rate than species richness, and most expansions were predicted to occur in three countries, which are currently among the top four wheat producers in Europe: Russia, France and Ukraine. The results are also discussed with regard to conservation issues of these crop wild relatives.	[Ostrowski, Marie-France; Prosperi, Jean-Marie] Montpellier Supagro, Inst Natl Rech Agron, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France; [Ostrowski, Marie-France; David, Jacques] Montpellier Supagro, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; Institut Agro; Montpellier SupAgro	Ostrowski, MF; Prosperi, JM (corresponding author), Montpellier Supagro, Inst Natl Rech Agron, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France.; Ostrowski, MF; David, J (corresponding author), Montpellier Supagro, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France.	marie-france.ostrowski@orange.fr; jean-marie.prosperi@supagro.inra.fr; jacques.david@supagro.inra.fr	PROSPERI, Jean-Marie/B-9036-2008		Institut National de la Recherche Agronomique (INRA); Ministere de l'Enseignement et de la Recherche; Ministere de l'Agriculture, France	Institut National de la Recherche Agronomique (INRA); Ministere de l'Enseignement et de la Recherche; Ministere de l'Agriculture, France	This work was a part of a project supported by the Institut National de la Recherche Agronomique (INRA:http://www.montpellier.inra.fr/), Ministere de l'Enseignement et de la Recherche (http://www.enseignementsup-recherche.gouv.fr/) and Ministere de l'Agriculture (http://agriculture.gouv.fr/), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; Arrigo N, 2011, EVOL APPL, V4, P685, DOI 10.1111/j.1752-4571.2011.00191.x; Arrigo N, 2010, NEW PHYTOL, V187, P1170, DOI 10.1111/j.1469-8137.2010.03328.x; Audsley E, 2015, CLIMATIC CHANGE, V128, P215, DOI 10.1007/s10584-014-1164-6; Badaeva ED, 2002, PLANT SYST EVOL, V231, P163, DOI 10.1007/s006060200018; Beauregard F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092642; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cicero C, 2004, EVOLUTION, V58, P1573; Cifuentes M, 2010, CYTOGENET GENOME RES, V129, P124, DOI 10.1159/000313593; DATTA SC, 1972, PLANTA, V105, P155, DOI 10.1007/BF00385574; David JL, 2004, BIOL J LINN SOC, V82, P503, DOI 10.1111/j.1095-8312.2004.00336.x; DAVID JL, 1993, J EVOLUTION BIOL, V6, P659, DOI 10.1046/j.1420-9101.1993.6050659.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Davy JS, 2008, U CALIFORNIA PUBLICA; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; DiTomaso J.M., 2007, WEEDS CALIFORNIA OTH, V3488; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; DONALD WW, 1991, WEED TECHNOL, V5, P3, DOI 10.1017/S0890037X00033170; DONALD WW, 1984, WEED SCI, V32, P631, DOI 10.1017/S0043174500059701; Dyer AR, 2010, EVOL APPL, V3, P179, DOI 10.1111/j.1752-4571.2010.00118.x; Econopouly BF, 2013, AGR ECOSYST ENVIRON, V164, P244, DOI 10.1016/j.agee.2012.10.005; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; Fandrich L, 2006, WEED SCI, V54, P443, DOI 10.1614/WS-05-103R.1; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Gandhi HT, 2009, THEOR APPL GENET, V119, P1013, DOI 10.1007/s00122-009-1105-3; Guadagnuolo R, 2001, THEOR APPL GENET, V103, P1, DOI 10.1007/s001220100636; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HAMMER K, 1980, Kulturpflanze, V28, P33; Harfoot M, 2014, GLOBAL ECOL BIOGEOGR, V23, P124, DOI 10.1111/geb.12100; Haygood R, 2003, P ROY SOC B-BIOL SCI, V270, P1879, DOI 10.1098/rspb.2003.2426; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hufbauer RA, 2013, J EVOLUTION BIOL, V26, P1691, DOI 10.1111/jeb.12167; Hufford MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047659; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; International Union for Conservation of Nature Natural Resources. Species Survival Commission IUCN Species Survival Commission, 2001, IUCN RED LIST CAT CR; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee.2008.01.013; Jenczewski Eric, 2003, Environmental Biosafety Research, V2, P9, DOI 10.1051/ebr:2003001; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kilian B, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P1, DOI 10.1007/978-3-642-14228-4_1; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loureiro I, 2008, WEED RES, V48, P561, DOI 10.1111/j.1365-3180.2008.00659.x; Loureiro I, 2009, SPAN J AGRIC RES, V7, P614; Lukac M, 2012, ANN BOT-LONDON, V109, P843, DOI 10.1093/aob/mcr308; LYON DJ, 1992, J PROD AGRIC, V5, P282, DOI 10.2134/jpa1992.0282; Lyons KG, 2010, INVAS PLANT SCI MANA, V3, P376, DOI 10.1614/IPSM-09-036.1; Mahjoub A., 2008, World Journal of Agricultural Sciences, V4, P737; Maillet J, 2000, WEED RES, V40, P11, DOI 10.1046/j.1365-3180.2000.00171.x; MARANON T, 1989, SEED SCI TECHNOL, V17, P583; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Maxted N., 2008, Plant Genetic Resources Characterization and Utilization, V6, P126, DOI 10.1017/S147926210899314X; Maxted N, 2009, ESTABLISHMENT GLOBAL, V266; Meesean A, 2012, SIGMEA SUSTAINABLE I; Meimberg H, 2010, MOL ECOL, V19, P5308, DOI 10.1111/j.1365-294X.2010.04875.x; Meimberg H, 2009, AM J BOT, V96, P1262, DOI 10.3732/ajb.0800345; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morrison LA, 2002, CROP SCI, V42, P1863, DOI 10.2135/cropsci2002.1863; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Pajkovic M, 2014, MOL ECOL, V23, P5089, DOI 10.1111/mec.12918; Parisod C, 2013, J EVOLUTION BIOL, V26, P223, DOI 10.1111/jeb.12040; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perrino EV, 2014, SYST BIODIVERS, V12, P331, DOI 10.1080/14772000.2014.909543; Peters A., 1996, Rangelands, V18, P8; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Phillips S., 2011, BRIEF TUTORIAL MAXEN; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Qin D, 2014, CLIMATE CHANGE 2013; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Rice KJ, 2013, BIOL INVASIONS, V15, P2531, DOI 10.1007/s10530-013-0471-6; Rounsevell MDA, 2005, AGR ECOSYST ENVIRON, V107, P117, DOI 10.1016/j.agee.2004.12.002; SAINI HS, 1984, AUST J PLANT PHYSIOL, V11, P243, DOI 10.1071/PP9840243; Sakata T, 2000, J PLANT RES, V113, P395, DOI 10.1007/PL00013947; Sakata T., 2008, INT J PLANT DEV BIOL, V2, P42; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; Schoenenberger N, 2005, THEOR APPL GENET, V111, P1338, DOI 10.1007/s00122-005-0063-7; Snyder JR, 2000, WEED SCI, V48, P588, DOI 10.1614/0043-1745(2000)048[0588:SPOTAB]2.0.CO;2; Swenson NG, 2006, J EVOLUTION BIOL, V19, P717, DOI 10.1111/j.1420-9101.2005.01066.x; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomson DM, 2007, ECOLOGY, V88, P3126, DOI 10.1890/06-1463.1; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Van Slageren M.W., 1994, ICARDA WAGENINGEN AG; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Wang AB, 2010, ANN BOT-LONDON, V106, P95, DOI 10.1093/aob/mcq089; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Weissmann S, 2005, MOL BIOL EVOL, V22, P2055, DOI 10.1093/molbev/msi196; Westbrooks R, 1998, 490 FED INT COMM MAN; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475; Zaharieva M, 2006, CROP SCI, V46, P512, DOI 10.2135/cropsci2005.0023; Zaharieva M, 2004, BIODIVERS CONSERV, V13, P2319, DOI 10.1023/B:BIOC.0000047917.11509.a2; Zaharieva M, 2003, GENET RESOUR CROP EV, V50, P507, DOI 10.1023/A:1023938621936; Zaharieva M, 2001, CROP SCI, V41, P1321, DOI 10.2135/cropsci2001.4141321x; ZOHARY D, 1969, EUPHYTICA, V18, P58; ZOHARY D, 1962, EVOLUTION, V16, P44, DOI 10.2307/2406265; ZOHARY D., 1965, The genetics of colonizing species: Proc. 1st Internat. Union. biol. Sci., Asilomar, California., P403	110	10	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153974	10.1371/journal.pone.0153974	http://dx.doi.org/10.1371/journal.pone.0153974			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100790	gold, Green Submitted, Green Published			2022-12-26	WOS:000374898500115
J	Rebolleda, N; Losada-Fernandez, I; Perez-Chacon, G; Castejon, R; Rosado, S; Morado, M; Vallejo-Cremades, MT; Martinez, A; Vargas-Nunez, JA; Perez-Aciego, P				Rebolleda, Nerea; Losada-Fernandez, Ignacio; Perez-Chacon, Gema; Castejon, Raquel; Rosado, Silvia; Morado, Marta; Teresa Vallejo-Cremades, Maria; Martinez, Andrea; Vargas-Nunez, Juan A.; Perez-Aciego, Paloma			Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model	PLOS ONE			English	Article							INDUCED LUNG TUMORIGENESIS; HSP90 INHIBITOR SNX-7081; COLON-CANCER CELLS; PRIMARY CLL CELLS; HEAT-SHOCK-PROTEIN-90 HSP90; AKT INHIBITOR; IN-VIVO; B-CELLS; APOPTOSIS; MICE	B-cell chronic lymphocytic leukemia (CLL) remains an incurable disease, and despite the improvement achieved by therapeutic regimes developed over the last years still a subset of patients face a rather poor prognosis and will eventually relapse and become refractory to therapy. The natural rotenoid deguelin has been shown to induce apoptosis in several cancer cells and cell lines, including primary human CLL cells, and to act as a chemo-preventive agent in animal models of induced carcinogenesis. In this work, we show that deguelin induces apoptosis in vitro in primary human CLL cells and in CLL-like cells from the New Zealand Black (NZB) mouse strain. In both of them, deguelin dowregulates AKT, NF kappa B and several downstream antiapoptotic proteins (XIAP, cIAP, BCL2, BCL-XL and survivin), activating the mitochondrial pathway of apoptosis. Moreover, deguelin inhibits stromal cell-mediated c-Myc upregulation and resistance to fludarabine, increasing fludarabine induced DNA damage. We further show that deguelin has activity in vivo against NZB CLL-like cells in an experimental model of CLL in young NZB mice transplanted with spleen cells from aged NZB mice with lymphoproliferation. Moreover, the combination of deguelin and fludarabine in this model prolonged the survival of transplanted mice at doses of both compounds that were ineffective when administered individually. These results suggest deguelin could have potential for the treatment of human CLL.	[Rebolleda, Nerea; Losada-Fernandez, Ignacio; Martinez, Andrea; Perez-Aciego, Paloma] Fdn LAIR, Madrid, Spain; [Perez-Chacon, Gema] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Castejon, Raquel; Rosado, Silvia; Vargas-Nunez, Juan A.] Univ Autonoma Madrid, Med Interna Serv, Hosp Univ Puerta Hierro Majadahonda, IDIPHIM, Madrid, Spain; [Morado, Marta] Hosp Univ La Paz, Serv Hematol & Hemoterapia, Madrid, Spain; [Teresa Vallejo-Cremades, Maria] Hosp Univ La Paz, IdiPaz, Lab Imagen Plataforma Apoyo & Invest, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario La Paz; Hospital Universitario La Paz	Perez-Aciego, P (corresponding author), Fdn LAIR, Madrid, Spain.	paloma_perez@cilsp.com	Vargas, Juan Antonion/H-8933-2017; García, Silvia Rosado/H-7461-2017; Perez-Chacon, Gema/H-5954-2015	Vargas, Juan Antonion/0000-0002-2221-4304; García, Silvia Rosado/0000-0001-8131-819X; Perez-Chacon, Gema/0000-0002-2081-0882; Perez-Aciego, Paloma/0000-0003-4819-5890	Fondo de Investigaciones Sanitarias, Ministerio de Sanidad [PI08/1099, PI13/01607]; La Caixa [P22664]; Fundacion LAIR [P160105]	Fondo de Investigaciones Sanitarias, Ministerio de Sanidad(Spanish GovernmentInstituto de Salud Carlos III); La Caixa(La Caixa Foundation); Fundacion LAIR	This work was supported by Fondo de Investigaciones Sanitarias, Ministerio de Sanidad, (http://www.isciii.es/ISCIII/es/general/index.shtml): PI08/1099, JAV-N; Fondo de Investigaciones Sanitarias, Ministerio de Sanidad (http://www.isciii.es/ISCIII/es/general/index.shtml): PI13/01607, JAV-N; La Caixa (http://obrasocial.lacaixa.es/): P22664, PP-A; and Fundacion LAIR (http://www.fundacionlair.org): P160105, NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banz VM, 2009, BBA-MOL CELL RES, V1793, P1597, DOI 10.1016/j.bbamcr.2009.08.002; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Best OG, 2010, BRIT J HAEMATOL, V151, P185, DOI 10.1111/j.1365-2141.2010.08348.x; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Burger JA, 2014, SEMIN CANCER BIOL, V24, P71, DOI 10.1016/j.semcancer.2013.08.011; Castro JE, 2005, BLOOD, V106, P2506, DOI 10.1182/blood-2005-03-1099; Chang DJ, 2012, J MED CHEM, V55, P10863, DOI 10.1021/jm301488q; Che YP, 2013, J PROTEOME RES, V12, P1710, DOI 10.1021/pr301055y; Chen Y, 2009, INT J HEMATOL, V89, P618, DOI 10.1007/s12185-009-0307-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chun KH, 2003, JNCI-J NATL CANCER I, V95, P291, DOI 10.1093/jnci/95.4.291; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Duerfeldt AS, 2010, BIOORG MED CHEM LETT, V20, P4983, DOI 10.1016/j.bmcl.2010.06.108; EAST J, 1969, CLIN EXP IMMUNOL, V4, P621; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FESTING M F W, 1971, Laboratory Animals (London), V5, P179, DOI 10.1258/002367771781006564; Fiorcari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083830; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Geeraerts B, 2007, LEUKEMIA, V21, P1610, DOI 10.1038/sj.leu.2404788; Granziero L, 2001, BLOOD, V97, P2777, DOI 10.1182/blood.V97.9.2777; Hail N, 2004, APOPTOSIS, V9, P437; Hallek M, 2015, AM J HEMATOL, V90, P446, DOI 10.1002/ajh.23979; Hallek M, 2010, ANN ONCOL, V21, P154, DOI 10.1093/annonc/mdq373; Herishanu Y, 2013, HEMATOL ONCOL CLIN N, V27, P173, DOI 10.1016/j.hoc.2013.01.002; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Horie R, 2006, LEUKEMIA, V20, P800, DOI 10.1038/sj.leu.2404167; HUANG P, 1990, J BIOL CHEM, V265, P16617; Jitschin R, 2015, BLOOD, V125, P3432, DOI 10.1182/blood-2014-10-607036; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kaufman KL, 2015, ONCOTARGET, V6, P40981, DOI 10.18632/oncotarget.5715; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Lefranc Marie-Paule, 2004, In Silico Biology, V4, P17; Li R, 2009, INT J HEMATOL, V89, P628, DOI 10.1007/s12185-009-0311-8; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Matthews C, 2004, LEUKEMIA LYMPHOMA, V45, P1899, DOI 10.1080/10428190410001710812; Mehta R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065113; Moreno C, 2010, BLOOD, V116, P4771, DOI 10.1182/blood-2010-05-286500; Moussay E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-115; Munzert G, 2002, BLOOD, V100, P3749, DOI 10.1182/blood.V100.10.3749; Murillo G, 2003, INT J CANCER, V104, P7, DOI 10.1002/ijc.10901; Murillo G, 2002, EUR J CANCER, V38, P2446, DOI 10.1016/S0959-8049(02)00192-2; Nair AS, 2006, J IMMUNOL, V177, P5612, DOI 10.4049/jimmunol.177.8.5612; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Neffendorf JE, 2013, NEW ENGL J MED, V369, P1277, DOI 10.1056/NEJMc1309710; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Perez-Chacon G, 2009, INT J LAB HEMATOL, V31, P327, DOI 10.1111/j.1751-553X.2008.01030.x; Perez-Chacon G, 2007, LEUKEMIA RES, V31, P183, DOI 10.1016/j.leukres.2006.03.021; Perez-Chacon G, 2012, J IMMUNOL, V189, P1053, DOI 10.4049/jimmunol.1200814; Purroy N, 2014, LEUKEMIA, V28, P1993, DOI 10.1038/leu.2014.96; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; RAVECHE ES, 1988, J IMMUNOL, V141, P4133; Regan PL, 2011, INT J ONCOL, V38, P105, DOI 10.3892/ijo_00000829; Salerno E, 2010, CYTOM PART B-CLIN CY, V78B, pS98, DOI 10.1002/cyto.b.20544; Scaglione BJ, 2007, BRIT J HAEMATOL, V139, P645, DOI 10.1111/j.1365-2141.2007.06851.x; SHIRAI T, 1992, ANN NY ACAD SCI, V651, P509; STALL AM, 1988, P NATL ACAD SCI USA, V85, P7312, DOI 10.1073/pnas.85.19.7312; Tillotson B, 2010, J BIOL CHEM, V285, P39835, DOI 10.1074/jbc.M110.141580; Tsimberidou AM, 2009, CANCER-AM CANCER SOC, V115, P2824, DOI 10.1002/cncr.24329; URASHIMA M, 1995, BLOOD, V85, P1903, DOI 10.1182/blood.V85.7.1903.bloodjournal8571903; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Walsby E, 2012, ONCOTARGET, V3, P525; Woo JK, 2009, CANCER PREV RES, V2, P361, DOI 10.1158/1940-6207.CAPR-08-0237; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674	69	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154159	10.1371/journal.pone.0154159	http://dx.doi.org/10.1371/journal.pone.0154159			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101369	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500156
J	Zou, HT; Ye, XH; Li, JQ; Lu, J; Fan, QF; Yu, N; Zhang, YL; Dang, XL; Zhang, YL				Zou, Hongtao; Ye, Xuhong; Li, Jiaqi; Lu, Jia; Fan, Qingfeng; Yu, Na; Zhang, Yuling; Dang, Xiuli; Zhang, Yulong			Effects of Straw Return in Deep Soils with Urea Addition on the Soil Organic Carbon Fractions in a Semi-Arid Temperate Cornfield	PLOS ONE			English	Article							CROP RESIDUES; NITROGEN MINERALIZATION; MICROBIAL BIOMASS; DIFFERENT TILLAGE; ENZYME-ACTIVITIES; WATER ADDITION; MANAGEMENT; QUALITY; MATTER; SEQUESTRATION	Returning straw to deep soil layers by using a deep-ditching-ridge-ploughing method is an innovative management practice that improves soil quality by increasing the soil organic carbon (SOC) content. However, the optimum quantity of straw return has not been determined. To solve this practical production problem, the following treatments with different amounts of corn straw were investigated: no straw return, CK; 400 kg ha(-1) straw, S-400; 800 kg ha-1 straw, S-800; 1200 kg ha(-1) straw, S-1200; and 1600 kg ha(-1) straw, S-1600. After straw was returned to the soil for two years, the microbial biomass C (MBC), easily oxidized organic C (EOC), dissolved organic C (DOC) and light fraction organic C (LFOC) content were measured at three soil depths (0-10, 10-20, and 20-40 cm). The results showed that the combined application of 800 kg ha(-1) straw significantly increased the EOC, MBC, and LFOC contents and was a suitable agricultural practice for this region. Moreover, our results demonstrated that returning straw to deep soil layers was effective for increasing the SOC content.	[Zhang, Yulong] Shenyang Agr Univ, Coll Land & Environm, Shenyang 110161, Peoples R China; Minist Agr, Key Lab Cultivated Land Conservat, Shenyang, Peoples R China	Shenyang Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, YL (corresponding author), Shenyang Agr Univ, Coll Land & Environm, Shenyang 110161, Peoples R China.	yexuhong1980@163.com	dang, xiuli/ABG-4716-2021	dang, xiuli/0000-0002-1702-9745; /0000-0001-6772-5338	National Science and Technology Support Program [2012BAD05B01, 2015BAD23B0203]; Research Projects of Agricultural Public Welfare Industry of China [201303125]; National Natural Science Foundation of China [31572206, 41301255]; Liaoning Agricultural Science and Technology Innovation Talents Training Program [2015051]	National Science and Technology Support Program; Research Projects of Agricultural Public Welfare Industry of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Agricultural Science and Technology Innovation Talents Training Program	The work was supported by the National Science and Technology Support Program (grant no: 2012BAD05B01, 2015BAD23B0203), Research Projects of Agricultural Public Welfare Industry of China (grant no: 201303125), the National Natural Science Foundation of China (grant no: 31572206, 41301255) and Liaoning Agricultural Science and Technology Innovation Talents Training Program (grant no: 2015051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by the National Science and Technology Support Program (Grant No: 2012BAD05B01, 2015BAD23B0203), Research Projects of Agricultural Public Welfare Industry of China (Grant No: 201303125), the National Natural Science Foundation of China (Grant No: 31572206, 41301255) and Liaoning Agricultural Science and Technology Innovation Talents Training Program (Grant No: 2015051).	Andruschkewitsch R, 2013, GEODERMA, V192, P368, DOI 10.1016/j.geoderma.2012.07.005; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Cao ZhiHong, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P179; Chen HL, 2010, J SOIL SEDIMENT, V10, P915, DOI 10.1007/s11368-010-0210-x; COLEMAN DC, 1983, ADV ECOL RES, V13, P1, DOI 10.1016/S0065-2504(08)60107-5; Gaind S, 2005, J BASIC MICROB, V45, P301, DOI 10.1002/jobm.200410483; Ge Li-li, 2013, Zhongguo Shuidao Kexue, V27, P153, DOI 10.3969/j.issn.1001-7216.2013.02.007; Hai-bo W., 2008, TERRITORY NAT RES ST, V2, P92; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Ji BY, 2014, SCI WORLD J, DOI 10.1155/2014/451493; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kandeler E, 1999, BIOL FERT SOILS, V28, P343, DOI 10.1007/s003740050502; Laird DA, 2013, SOIL TILL RES, V134, P33, DOI 10.1016/j.still.2013.07.001; Li S, 2016, SOIL TILL RES, V157, P43, DOI 10.1016/j.still.2015.11.002; [刘芳 Liu Fang], 2012, [作物杂志, Crops], P18; LuMeiRong, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P41; MOORE TR, 1992, SOIL SCI, V154, P120, DOI 10.1097/00010694-199208000-00005; Moreno-Cornejo J, 2014, GEODERMA, V230, P58, DOI 10.1016/j.geoderma.2014.03.024; Neff JC, 2001, ECOSYSTEMS, V4, P29, DOI 10.1007/s100210000058; [邱学礼 Qiu Xueli], 2012, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V21, P125; Riestra D, 2012, SOIL SCI, V177, P279, DOI 10.1097/SS.0b013e318245d0fe; Spedding TA, 2004, SOIL BIOL BIOCHEM, V36, P499, DOI 10.1016/j.soilbio.2003.10.026; Thorburn PJ, 2012, SOIL TILL RES, V120, P99, DOI 10.1016/j.still.2011.11.009; Tiao SZ, 2010, J APPL ECOL, V21, P373; Trinsoutrot I, 2000, SOIL SCI SOC AM J, V64, P918, DOI 10.2136/sssaj2000.643918x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P697, DOI 10.1016/0038-0717(87)90051-4; WANDER MM, 1994, SOIL SCI SOC AM J, V58, P1130, DOI 10.2136/sssaj1994.03615995005800040018x; Wang LY, 2010, AGR MECH RES, V3, P1; Wang RZ, 2015, SOIL BIOL BIOCHEM, V81, P159, DOI 10.1016/j.soilbio.2014.11.015; Wang RZ, 2014, PLANT SOIL, V381, P323, DOI 10.1007/s11104-014-2129-2; [王胜楠 Wang Shengnan], 2015, [水土保持学报, Journal of Soil and Water Conservation], V29, P154; Wang SN, 2015, EFFECTS STRAW RETURN; Wang X.B., 2000, AGR SCI CHINA, V33, P54; Xie WenYan, 2011, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V42, P60; Zhang GS, 2008, SOIL TILL RES, V98, P113, DOI 10.1016/j.still.2007.09.001; Zhang YaLi, 1998, Journal of Nanjing Agricultural University, V21, P59; Zhao Peng, 2008, Acta Agronomica Sinica, V34, P1014, DOI 10.3724/SP.J.1006.2008.01014; Zhou L., 2012, J ANHUI AGR SCI, V40, P15853; Zhu Liucun, 2014, Biomed Res Int, V2014, P750961, DOI 10.1155/2014/750961; Zou CongMing, 2010, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V18, P496, DOI 10.3724/SP.J.1011.2010.00496; [邹洪涛 Zou Hongtao], 2013, [土壤通报, Journal of Soil Science], V44, P1398; Zou HT, 2012, SHENYANG AGR U, V43, P494	44	18	18	16	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153214	10.1371/journal.pone.0153214	http://dx.doi.org/10.1371/journal.pone.0153214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123594	Green Published, gold			2022-12-26	WOS:000375211700012
J	Davern, SM; McKnight, TE; Standaert, RF; Morrell-Falvey, JL; Shpak, ED; Kalluri, UC; Jelenska, J; Greenberg, JT; Mirzadeh, S				Davern, Sandra M.; McKnight, Timothy E.; Standaert, Robert F.; Morrell-Falvey, Jennifer L.; Shpak, Elena D.; Kalluri, Udaya C.; Jelenska, Joanna; Greenberg, Jean T.; Mirzadeh, Saed			Carbon Nanofiber Arrays: A Novel Tool for Microdelivery of Biomolecules to Plants	PLOS ONE			English	Article							POST-PHLOEM TRANSPORT; FLUORESCENT TRACERS; MOVEMENT PROTEIN; LUCIFER YELLOW; MOSAIC-VIRUS; MINOR VEINS; SIEVE TUBE; TRANSIENT TRANSFORMATION; SYMPLASTIC TRANSPORT; HYDRODYNAMIC RADII	Effective methods for delivering bioprobes into the cells of intact plants are essential for investigating diverse biological processes. Increasing research on trees, such as Populus spp., for bioenergy applications is driving the need for techniques that work well with tree species. This report introduces vertically aligned carbon nanofiber (VACNF) arrays as a new tool for microdelivery of labeled molecules to Populus leaf tissue and whole plants. We demonstrated that VACNFs penetrate the leaf surface to deliver sub-microliter quantities of solution containing fluorescent or radiolabeled molecules into Populus leaf cells. Importantly, VACNFs proved to be gentler than abrasion with carborundum, a common way to introduce material into leaves. Unlike carborundum, VACNFs did not disrupt cell or tissue integrity, nor did they induce production of hydrogen peroxide, a typical wound response. We show that femtomole to picomole quantities of labeled molecules (fluorescent dyes, small proteins and dextran), ranging from 0.5-500 kDa, can be introduced by VACNFs, and we demonstrate the use of the approach to track delivered probes from their site of introduction on the leaf to distal plant regions. VACNF arrays thus offer an attractive microdelivery method for the introduction of biomolecules and other probes into trees and potentially other types of plants.	[Davern, Sandra M.; Standaert, Robert F.; Morrell-Falvey, Jennifer L.; Kalluri, Udaya C.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [McKnight, Timothy E.] Oak Ridge Natl Lab, Elect & Elect Syst Res Div, Oak Ridge, TN USA; [Standaert, Robert F.] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN USA; [Mirzadeh, Saed] Oak Ridge Natl Lab, Nucl Secur & Isotope Technol Div, Oak Ridge, TN USA; [Standaert, Robert F.; Morrell-Falvey, Jennifer L.; Shpak, Elena D.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA; [Jelenska, Joanna; Greenberg, Jean T.] Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Chicago	Standaert, RF (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA.; Standaert, RF (corresponding author), Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN USA.; Standaert, RF (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA.	standaertrf@ornl.gov	Standaert, Robert F/D-9467-2013; Standaert, Robert F./AAI-1532-2021; Morrell-Falvey, Jennifer L/A-6615-2011	Standaert, Robert F/0000-0002-5684-1322; Morrell-Falvey, Jennifer L/0000-0002-9362-7528; Greenberg, Jean/0000-0002-7213-7618; KALLURI, UDAYA/0000-0002-5963-8370	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research [ERKP-417]; U.S. Department of Energy [DE-AC05-00OR22725]	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research, ERKP-417, http://science.energy.gov/ber/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. David Weston and Dr. Abhijit Karve for the CmPP16-1 DNA. We acknowledge Dr. Tim Tschaplinski and Dr. Mitch Doktycz for critical review of the manuscript. We thank Trish Lankford for technical assistance, and Zackary Moore for assistance with plant growth and maintenance. Nanofiber arrays were produced at the Center for Nanophase Materials Sciences (CNMS), which is a DOE Office of Science User Facility. We thank Dale Hensley and the CNMS for assistance with the production of nanofiber arrays. This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).	Aciksoz SB, 2011, PLANT SOIL, V349, P215, DOI 10.1007/s11104-011-0863-2; Aoki K, 2005, PLANT CELL, V17, P1801, DOI 10.1105/tpc.105.031419; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Ascencio-Ibanez JT, 2007, J VIROL METHODS, V142, P198, DOI 10.1016/j.jviromet.2007.01.031; Balachandran S, 1997, P NATL ACAD SCI USA, V94, P14150, DOI 10.1073/pnas.94.25.14150; Bishopp A, 2011, CURR BIOL, V21, P927, DOI 10.1016/j.cub.2011.04.049; Brown PH, 1999, PLANT PHYSIOL, V119, P17, DOI 10.1104/pp.119.1.17; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Cheng YH, 1996, PLANT CELL REP, V16, P127, DOI 10.1007/BF01890852; Coleman JS, 1986, TREE PHYSIOL, V2, P289, DOI 10.1093/treephys/2.1-2-3.289; Curuk S, 2005, ENG LIFE SCI, V5, P169, DOI 10.1002/elsc.200520069; DERRICK PM, 1990, PLANTA, V181, P555, DOI 10.1007/BF00193010; ERWEE MG, 1983, PLANTA, V158, P320, DOI 10.1007/BF00397334; Etxeberria E, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1500106; Fisher DB, 2000, PLANT PHYSIOL, V123, P125, DOI 10.1104/pp.123.1.125; FISHER DG, 1988, PLANT CELL ENVIRON, V11, P639, DOI 10.1111/j.1365-3040.1988.tb01806.x; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Fujimaki S, 2000, PLANT CELL PHYSIOL, V41, P124, DOI 10.1093/pcp/41.1.124; GEIGER DR, 1974, PLANT PHYSIOL, V54, P892, DOI 10.1104/pp.54.6.892; GOODWIN PB, 1983, PLANTA, V157, P124, DOI 10.1007/BF00393645; IFletcher BL, 2006, ADV MATER, V18, P1689, DOI [10.1002/adma.200502688, DOI 10.1002/ADMA.200502688]; Jones Huw D., 2009, V513, P131, DOI 10.1007/978-1-59745-427-8_8; Jones Huw D., 2009, V513, P111, DOI 10.1007/978-1-59745-427-8_7; Kaplan M, 2010, J FOOD AGRIC ENVIRON, V8, P728; Kempers R, 1999, PLANT BIOLOGY, V1, P61, DOI 10.1055/s-2007-978489; Kim I, 2005, P NATL ACAD SCI USA, V102, P11945, DOI 10.1073/pnas.0505622102; Kim I, 2005, P NATL ACAD SCI USA, V102, P2227, DOI 10.1073/pnas.0409193102; Knoblauch M, 1998, PLANT CELL, V10, P35, DOI 10.1105/tpc.10.1.35; Lin YH, 2011, NAT PROTOC, V6, P36, DOI 10.1038/nprot.2010.171; MADORE MA, 1986, PLANT PHYSIOL, V82, P432, DOI 10.1104/pp.82.2.432; Mandal B, 2001, PLANT DIS, V85, P1259, DOI 10.1094/PDIS.2001.85.12.1259; Mann DGJ, 2008, ACS NANO, V2, P69, DOI 10.1021/nn700198y; MCCONAHEY PJ, 1966, INT ARCH ALLER A IMM, V29, P185, DOI 10.1159/000229699; McKnight TE, 2005, METH MOL B, V303, P191; McKnight TE, 2004, NANO LETT, V4, P1213, DOI 10.1021/nl049504b; Melechko AV, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/19/193001; Melechko AV, 2005, J APPL PHYS, V97, DOI 10.1063/1.1857591; Melechko AV, 2002, J VAC SCI TECHNOL B, V20, P2730, DOI 10.1116/1.1515306; Neumann PM, 2010, J EXP BOT, V61, P1711, DOI 10.1093/jxb/erq037; NEUMANN PM, 1987, PLANT PHYSIOL, V83, P941, DOI 10.1104/pp.83.4.941; OPARKA KJ, 1988, PLANTA, V176, P533, DOI 10.1007/BF00397661; OPARKA KJ, 1991, J EXP BOT, V42, P565, DOI 10.1093/jxb/42.5.565; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; PALEVITZ BA, 1985, PLANTA, V164, P473, DOI 10.1007/BF00395962; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Picard K, 2013, METHODS MOL BIOL, V1069, P215, DOI 10.1007/978-1-62703-613-9_15; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Rasmussen J, 2015, J PLANT BIOL, V58, P1, DOI 10.1007/s12374-014-0258-z; RUSSIN WA, 1985, AM J BOT, V72, P1232, DOI 10.2307/2443404; SEEAR J, 1968, PHYSIOL PLANTARUM, V21, P979, DOI 10.1111/j.1399-3054.1968.tb07325.x; Siuti P, 2011, LAB CHIP, V11, P3523, DOI 10.1039/c1lc20462a; SRISINK S, 1994, AUST J AGR RES, V45, P625, DOI 10.1071/AR9940625; Takata N, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-30; TERRY BR, 1987, PLANTA, V171, P145, DOI 10.1007/BF00391090; Tsuda K, 2012, PLANT J, V69, P713, DOI 10.1111/j.1365-313X.2011.04819.x; TUCKER EB, 1982, PROTOPLASMA, V113, P193, DOI 10.1007/BF01280907; TURGEON R, 1989, PLANTA, V179, P24, DOI 10.1007/BF00395767; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; ULRICH JM, 1965, AM J BOT, V52, P120, DOI 10.2307/2440226; VANALFEN NK, 1979, PLANT PHYSIOL, V63, P1072, DOI 10.1104/pp.63.6.1072; VANKESTEREN WJP, 1988, PLANT PHYSIOL, V88, P667, DOI 10.1104/pp.88.3.667; WAIGMANN E, 1994, P NATL ACAD SCI USA, V91, P1433, DOI 10.1073/pnas.91.4.1433; WANG N, 1994, PLANT PHYSIOL, V104, P17, DOI 10.1104/pp.104.1.17; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94; Yang XH, 2011, GENOME RES, V21, P634, DOI 10.1101/gr.109280.110; Zhang CK, 2014, PLANT PHYSIOL, V166, P306, DOI 10.1104/pp.114.245845	70	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153621	10.1371/journal.pone.0153621	http://dx.doi.org/10.1371/journal.pone.0153621			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119338	gold, Green Submitted, Green Published			2022-12-26	WOS:000374976200031
J	Delroisse, J; Mallefet, J; Flammang, P				Delroisse, Jerome; Mallefet, Jerome; Flammang, Patrick			De Novo Adult Transcriptomes of Two European Brittle Stars: Spotlight on Opsin-Based Photoreception	PLOS ONE			English	Article							CUCUMBER APOSTICHOPUS-JAPONICUS; RNA-SEQ; AMPHIURA-FILIFORMIS; SEQUENCE ALIGNMENT; GENE-EXPRESSION; EVOLUTION; PHOTOTRANSDUCTION; RHODOPSIN; PROTEIN; SYSTEM	Next generation sequencing (NGS) technology allows to obtain a deeper and more complete view of transcriptomes. For non-model or emerging model marine organisms, NGS technologies offer a great opportunity for rapid access to genetic information. In this study, paired-end Illumina HiSeq (TM) technology has been employed to analyse transcriptomes from the arm tissues of two European brittle star species, Amphiura filiformis and Ophiopsila aranea. About 48 million Illumina reads were generated and 136,387 total unigenes were predicted from A. filiformis arm tissues. For O. aranea arm tissues, about 47 million reads were generated and 123,324 total unigenes were obtained. Twenty-four percent of the total unigenes from A. filiformis show significant matches with sequences present in reference online databases, whereas, for O. aranea, this percentage amounts to 23%. In both species, around 50% of the predicted annotated unigenes were significantly similar to transcripts from the purple sea urchin, the closest species to date that has undergone complete genome sequencing and annotation. GO, COG and KEGG analyses were performed on predicted brittle star unigenes. We focused our analyses on the phototransduction actors involved in light perception. Firstly, two new echinoderm opsins were identified in O. aranea: one rhabdomeric opsin (homologous to vertebrate melanopsin) and one RGR opsin. The RGR-opsin is supposed to be involved in retinal regeneration while the r-opsin is suspected to play a role in visual-like behaviour. Secondly, potential phototransduction actors were identified in both transcriptomes using the fly (rhabdomeric) and mammal (ciliary) classical phototransduction pathways as references. Finally, the sensitivity of O. aranea to monochromatic light was investigated to complement data available for A. filiformis. The presence of microlens-like structures at the surface of dorsal arm plate of O. aranea could potentially explain phototactic behaviour differences between the two species. The results confirm (i) the ability of these brittle stars to perceive light using opsin-based photoreception, (ii) suggest the co-occurrence of both rhabdomeric and ciliary photoreceptors, and (iii) emphasise the complexity of light perception in this echinoderm class.	[Delroisse, Jerome; Flammang, Patrick] Univ Mons UMONS, Res Inst Biosci Biol Marine Organisms & Biomimet, Mons, Belgium; [Delroisse, Jerome] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Mallefet, Jerome] Catholic Univ Louvain La Neuve, Marine Biol Lab, Louvain, Belgium	University of Mons; University of London; Queen Mary University London; Universite Catholique Louvain	Delroisse, J (corresponding author), Univ Mons UMONS, Res Inst Biosci Biol Marine Organisms & Biomimet, Mons, Belgium.	jerome.delroisse@umons.ac.be	Flammang, Patrick/H-9465-2019; Delroisse, Jérôme/G-1274-2014; Delroisse, Jerome/H-3658-2019	Flammang, Patrick/0000-0001-9938-1154; Delroisse, Jérôme/0000-0002-9233-6470; Delroisse, Jerome/0000-0002-9233-6470; mallefet, jerome/0000-0003-0918-3491	FRFC [2.4590.11]	FRFC(Fonds de la Recherche Scientifique - FNRS)	JD, JM and PF are respectively Research Fellow, Research Associate, and Research Director of the Fund for Scientific Research of Belgium (F.R. S.-FNRS). Work supported in part by a FRFC Grant no 2.4590.11. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Alice Jones for O. aranea collections. We thank BGI for cDNA library preparation, sequencing and preliminary data analysis. J.D., J.M. and P.F. are respectively Research Fellow, Research Associate, and Research Director of the Fund for Scientific Research of Belgium (F.R. S.-FNRS). Work supported in part by a FRFC Grant no 2.4590.11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study is a contribution from the "Centre Interuniversitaire de Biologie Marine" (CIBIM).	Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; Arendt D, 2003, INT J DEV BIOL, V47, P563; Astley HC, 2012, J EXP BIOL, V215, P1923, DOI 10.1242/jeb.068460; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Burns G, 2013, MAR GENOM, V9, P9, DOI 10.1016/j.margen.2012.05.003; Byrne Maria, 1994, P247; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Cao PX, 2012, FASEB J, V26, P480, DOI 10.1096/fj.11-197798; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cronin TW, 2014, EVOLUTION VISUAL NON, P105, DOI DOI 10.1007/978-1-4614-4355-1_4; D'Aniello S, 2015, MAR GENOM, V24, P177, DOI 10.1016/j.margen.2015.10.001; Delroisse J, 2015, MAR GENOM, V23, P109, DOI 10.1016/j.margen.2015.05.014; Delroisse J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1035; Delroisse J, 2013, CAH BIOL MAR, V54, P721; Dilly GF, 2015, MOL ECOL RESOUR, V15, P425, DOI 10.1111/1755-0998.12316; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elphick MR, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00002; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Falkner I, 2006, J MAR BIOL ASSOC UK, V86, P1199, DOI 10.1017/S0025315406014196; Feuda R, 2014, GENOME BIOL EVOL, V6, P1964, DOI 10.1093/gbe/evu154; Feuda R, 2012, P NATL ACAD SCI USA, V109, P18868, DOI 10.1073/pnas.1204609109; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gehring WJ, 2014, WIRES DEV BIOL, V3, P1, DOI 10.1002/wdev.96; Gillard GB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-45; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; Heinzeller T, 2005, MUNCH P 11 INT ECH C; Hemandezl V, 2006, CHALL OPP HEALTHGR P; HENDLER G, 1988, BIOL BULL, V174, P20, DOI 10.2307/1541755; HENDLER G, 1984, PSZNI MAR ECOL, V5, P379, DOI 10.1111/j.1439-0485.1984.tb00131.x; HENDLER G, 1987, ZOOMORPHOLOGY, V107, P261, DOI 10.1007/BF00312172; Hennebert E, 2014, P NATL ACAD SCI USA, V111, P6317, DOI 10.1073/pnas.1400089111; Hodkinson BP, 2015, ADV WOUND CARE, V4, P50, DOI 10.1089/wound.2014.0542; Iseli C, 1999, ESTSCAN PROGRAM DETE; Johnsen S, 1997, BIOL BULL, V193, P97, DOI 10.2307/1542739; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lawrence J. M., 1987, FUNCTIONAL BIOL ECHI, DOI 10.1002/iroh.19890740316; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Ma DY, 2014, J OCEAN U CHINA, V13, P1033, DOI 10.1007/s11802-014-2297-y; Ma DY, 2014, ACTA OCEANOL SIN, V33, P55, DOI 10.1007/s13131-014-0464-z; Ma DY, 2014, CHIN J OCEANOL LIMN, V32, P34, DOI 10.1007/s00343-014-3041-6; MARKEL K, 1985, ZOOMORPHOLOGY, V105, P197, DOI 10.1007/BF00312157; Mashanov VS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-357; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oppenheim SJ, 2015, INSECT MOL BIOL, V24, P139, DOI 10.1111/imb.12154; Pairett AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069852; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Plachetzki DC, 2010, P ROY SOC B-BIOL SCI, V277, P1963, DOI 10.1098/rspb.2009.1797; Purushothaman S, 2015, J PROTEOMICS, V112, P113, DOI 10.1016/j.jprot.2014.08.011; Raible F, 2006, DEV BIOL, V300, P461, DOI 10.1016/j.ydbio.2006.08.070; Reich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119627; Rosenberg R, 2004, MAR BIOL, V145, P651, DOI 10.1007/s00227-004-1365-z; Schnitzler CE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-107; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Tamura K., 2013, MOL BIOL EVOL; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2012, WIRES MEMBR TRANSP S, V1, P104, DOI [10.1002/wmts.6, DOI 10.1002/WMTS.6]; Tong D, 2009, P NATL ACAD SCI USA, V106, P9836, DOI 10.1073/pnas.0904571106; Tu Q, 2014, DEV BIOL, V385, P160, DOI 10.1016/j.ydbio.2013.11.019; Ullrich-Luter EM, 2013, INTEGR COMP BIOL, V53, P27, DOI 10.1093/icb/ict050; Ullrich-Luter EM, 2011, P NATL ACAD SCI USA, V108, P8367, DOI 10.1073/pnas.1018495108; Vaughn R, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-19; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wygoda JA, 2014, GENOME BIOL EVOL, V6, P964, DOI 10.1093/gbe/evu070; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yewers MS, 2015, J EXP BIOL, V218, P1556, DOI 10.1242/jeb.119404; Zhao Y, 2014, COMP BIOCHEM PHYS D, V10, P30, DOI 10.1016/j.cbd.2014.02.002; Zhao Yunde, 2014, Arabidopsis Book, V12, pe0173, DOI 10.1199/tab.0173; Zhou ZC, 2014, MOL ECOL RESOUR, V14, P127, DOI 10.1111/1755-0998.12147	96	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152988	10.1371/journal.pone.0152988	http://dx.doi.org/10.1371/journal.pone.0152988			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119739	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200014
J	Ojeda, B; Salazar, A; Duenas, M; Torres, LM; Mico, JA; Failde, I				Ojeda, B.; Salazar, A.; Duenas, M.; Torres, L. M.; Mico, J. A.; Failde, I.			Assessing the Construct Validity and Internal Reliability of the Screening Tool Test Your Memory in Patients with Chronic Pain	PLOS ONE			English	Article							MINI-MENTAL-STATE; LOW-BACK-PAIN; COGNITIVE FUNCTION; PSYCHOMETRIC PROPERTIES; FIBROMYALGIA SYNDROME; MEDICAL OUTCOMES; SPANISH VERSION; IMPAIRMENT; ATTENTION; SLEEP	Patients with chronic pain often complain about cognitive difficulties, and since these symptoms represent an additional source of suffering and distress, evaluating the cognitive status of these patients with valid and reliable tests should be an important part of their overall assessment. Although cognitive impairment is a critical characteristic of pain, there is no specific measure designed to detect these effects in this population. The objective was to analyze the psychometric properties of the "Test Your Memory" (TYM) test in patients with chronic pain of three different origins. A cross-sectional study was carried out on 72 subjects free of pain and 254 patients suffering from different types of chronic pain: neuropathic pain (104), musculoskeletal pain (99) and fibromyalgia (51). The construct validity of the TYM was assessed using the Mini-Mental State Examination (MMSE), Hospital Anxiety and Depression Scale (HADs), Index-9 from MOS-sleep, SF-12, and through the intensity (Visual Analogical Scale) and duration of pain. An exploratory factor analysis was also performed and internal reliability was assessed using Cronbach's alpha. After adjusting for potential confounders the TYM could distinguish between pain and pain-free patients, and it was correlated with the: MMSE (0.89, p<0.001); HAD-anxiety (-0.50, p<0.001) and HAD-depression scales (-0.52, p<0.001); MOS-sleep Index-9 (-0.49, p<0.001); and the physical (0.49, p<.001) and mental components (0.55, p<.001) of SF-12. The exploratory structure of the TYM showed an 8-factor solution that explained 53% of the variance, and Cronbach's alpha was 0.66. The TYM is a valid and reliable screening instrument to assess cognitive function in chronic pain patients that will be of particular value in clinical situations.	[Ojeda, B.; Salazar, A.; Failde, I.] Univ Cadiz, Prevent Med & Publ Hlth Area, Observ Pain External Chair Pain, Cadiz, Spain; [Duenas, M.] Univ Cadiz, Salus Infirmorum Fac Nursing, Cadiz, Spain; [Torres, L. M.] Univ Hosp Puerta del Mar, Dept Anesthesiol Crit Care & Pain Management, Cadiz, Spain; [Mico, J. A.] Univ Cadiz, Inst Salud Carlos III, Dept Neurosci Pharmacol & Psychiat, CIBER Mental Hlth,CIBERSAM, Cadiz, Spain	Universidad de Cadiz; Universidad de Cadiz; Universidad de Cadiz; Hospital Universitario Puerta del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Universidad de Cadiz	Ojeda, B (corresponding author), Univ Cadiz, Prevent Med & Publ Hlth Area, Observ Pain External Chair Pain, Cadiz, Spain.	begona.ojeda@uca.es	MICO, JUAN ANTONIO/E-1527-2013; Failde, Immaculada/AAL-8563-2020; Salazar, Alejandro/K-9183-2014; Torres, Luis M/Q-6983-2019; Dueñas, María/AAT-1354-2020; Torres, Luis Miguel/O-1720-2015	MICO, JUAN ANTONIO/0000-0001-8905-8484; Failde, Immaculada/0000-0002-6603-3054; Salazar, Alejandro/0000-0001-9567-462X; Duenas, Maria/0000-0003-4822-7258; Ojeda, Begona/0000-0002-7844-8986; Torres, Luis Miguel/0000-0002-0194-7875	Grunenthal Foundation; External Chair of Pain	Grunenthal Foundation; External Chair of Pain	This study was funded by the Grunenthal Foundation with an unrestricted grant for data collection and analysis. The authors are also grateful to the External Chair of Pain for the funding that allowed them to carry out this research, collaboration between the University of Cadiz and the Grunenthal Foundation. No member of Grunenthal Foundation staff had any role in the interpretation of data, in the writing of the report or in the decision to submit the paper for publication to the journal.	ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Beblo T, 2011, NEUROPSYCHOL REV, V21, P337, DOI 10.1007/s11065-011-9171-0; Brown J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2030; Brown SC, 2002, PAIN, V96, P279, DOI 10.1016/S0304-3959(01)00457-2; Castel A., 2008, Rev. Soc. Esp. Dolor, V15, P358; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Dick BD, 2007, ANESTH ANALG, V104, P1223, DOI 10.1213/01.ane.0000263280.49786.f5; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Eccleston C, 1997, PAIN, V72, P209, DOI 10.1016/S0304-3959(97)00030-4; Fernandez E, 2012, PAIN COMORBIDITIES U, P279; Ferrero-Arias J, 2016, NEUROLOGIA, V31, P33, DOI 10.1016/j.nrl.2013.12.009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Gustin SM, 2015, PAIN PRACT; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hays RD, 2005, SLEEP MED, V6, P41, DOI 10.1016/j.sleep.2004.07.006; Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4; Huh J, 2006, J CONSUM AFF, V40, P90; Iezzi T, 1999, J BEHAV MED, V22, P205, DOI 10.1023/A:1018791622441; Joliffe IT., 1996, PRINCIPAL COMPONENTS; Jorge LL, 2009, EUR J PHYS REHAB MED, V45, P469; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kendall M. G, 1979, ADV THEORY STAT, V4th; Koekkoek PS, 2013, J NEUROL SCI, V328, P92, DOI 10.1016/j.jns.2013.02.028; Kurita GP, 2012, ACTA ANAESTH SCAND, V56, P1257, DOI 10.1111/j.1399-6576.2012.02760.x; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Lezak MD, 2012, VERBAL FUNCTIONS LEN, P542; Lobo A, 1999, MED CLIN-BARCELONA, V112, P767; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; Melkumova KA, 2011, NEUROSCIENCE BEHAV P, V41, P20, DOI DOI 10.1007/S11055-010-9376-3; Meyer JS, 2000, HEADACHE, V40, P638, DOI 10.1046/j.1526-4610.2000.040008638.x; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Munoz M, 2005, CLIN J PAIN, V21, P287; Ojeda B, 2012, MED CLIN-BARCELONA, V138, P429, DOI 10.1016/j.medcli.2011.08.007; Oosterman JM, 2011, CLIN J PAIN, V27, P70, DOI 10.1097/AJP.0b013e3181f15cf5; Pincus T, 1998, BRIT J CLIN PSYCHOL, V37, P49, DOI 10.1111/j.2044-8260.1998.tb01278.x; PITMAN E., 1949, LECT NOTES NONPARAME; Povedano M, 2007, J PAIN SYMPTOM MANAG, V33, P78, DOI 10.1016/j.jpainsymman.2006.07.012; Rami L, 2010, ARCH GERONTOL GERIAT, V50, P171, DOI 10.1016/j.archger.2009.03.005; Rejas J, 2007, EUR J PAIN, V11, P329, DOI 10.1016/j.ejpain.2006.05.002; del Paso GAR, 2012, EUR J PAIN, V16, P421, DOI 10.1002/j.1532-2149.2011.00032.x; Rodriguez-Andreu J, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-162; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Sjogren P, 2005, EUR J PAIN, V9, P453, DOI 10.1016/j.ejpain.2004.10.005; Soderfjell S, 2006, SCAND J PSYCHOL, V47, P349, DOI 10.1111/j.1467-9450.2006.00540.x; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Tejero A., 1986, REV DEP PSIQUIATRIA, V13, P233; van Schalkwyk G, 2012, J GERIATR PSYCH NEUR, V25, P85, DOI 10.1177/0891988712447895; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Weiner DK, 2006, PAIN MED, V7, P60, DOI 10.1111/j.1526-4637.2006.00091.x; Williams DA, 2011, J MUSCULOSKELET PAIN, V19, P66, DOI 10.3109/10582452.2011.558989; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154240	10.1371/journal.pone.0154240	http://dx.doi.org/10.1371/journal.pone.0154240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119165	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200050
J	Thibodeau, PH				Thibodeau, Paul H.			A Moist Crevice for Word Aversion: In Semantics Not Sounds	PLOS ONE			English	Article							FACIAL EFFERENCE; EMOTIONAL WORDS; DISGUST; DOMAINS; CONSEQUENCES; ORGANIZATION; ASSOCIATION; SENSITIVITY; HYPOTHESIS; RESPONSES	Why do people self-report an aversion to words like "moist"? The present studies represent an initial scientific exploration into the phenomenon of word aversion by investigating its prevalence and cause. Results of five experiments indicate that about 10-20% of the population is averse to the word "moist." This population often speculates that phonological properties of the word are the cause of their displeasure. However, data from the current studies point to semantic features of the word-namely, associations with disgusting bodily functions-as a more prominent source of peoples' unpleasant experience. "Moist," for averse participants, was notable for its valence and personal use, rather than imagery or arousal-a finding that was confirmed by an experiment designed to induce an aversion to the word. Analyses of individual difference measures suggest that word aversion is more prevalent among younger, more educated, and more neurotic people, and is more commonly reported by females than males.	[Thibodeau, Paul H.] Oberlin Coll, Dept Psychol, Oberlin, OH 44074 USA	Oberlin College	Thibodeau, PH (corresponding author), Oberlin Coll, Dept Psychol, Oberlin, OH 44074 USA.	paul.thibodeau@oberlin.edu	Thibodeau, Paul/AAY-7259-2021					Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; [Anonymous], 2013, PEOPLE MAGAZINE 0211; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barsalou L.W., 2012, CAMBRIDGE HDB PSYCHO, P239, DOI [10.1017/CBO9781139029377.017, DOI 10.1017/CBO9781139029377.017]; Bates D., 2015, LINEAR MIXED EFFECTS; BUCK R, 1980, J PERS SOC PSYCHOL, V38, P811, DOI 10.1037/0022-3514.38.5.811; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Corkin S., 2003, PNAS, V101, P310; Cox TJ, 2008, APPL ACOUST, V69, P1195, DOI 10.1016/j.apacoust.2007.11.004; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Druschel BA, 1999, PERS INDIV DIFFER, V26, P739, DOI 10.1016/S0191-8869(98)00196-2; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; ELY DJ, 1975, B PSYCHONOMIC SOC, V6, P295, DOI 10.3758/BF03336667; Friedrich Paul, 1979, LANGUAGE CONTEXT IMA, P1; GAZZANIGA MS, 1995, NEURON, V14, P217, DOI 10.1016/0896-6273(95)90280-5; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Greenman B., 2012, NEW YORKER; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2000, MORAL DUMBFOUN UNPUB; HALPERN DL, 1986, PERCEPT PSYCHOPHYS, V39, P77, DOI 10.3758/BF03211488; HERR PM, 1983, J EXP SOC PSYCHOL, V19, P323, DOI 10.1016/0022-1031(83)90026-4; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; Hutchison KA, 2008, Q J EXP PSYCHOL, V61, P1036, DOI 10.1080/17470210701438111; Janschewitz K, 2008, BEHAV RES METHODS, V40, P1065, DOI 10.3758/BRM.40.4.1065; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lockwood G., 2015, FRONT PSYCHOL, V6, P1, DOI DOI 10.3389/fpsyg.2015.01246; Malady J. X. M., 2013, SLATE; McCabe G.., 1999, PRACTICE STAT; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Nelson DL, 2000, MEM COGNITION, V28, P887, DOI 10.3758/BF03209337; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Nisita L, 2013, REFINERY 29     1121; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Oehler M., 2011, THE J, V130, DOI [10.1121/1.3655174, DOI 10.1121/1.3655174]; Perniss P, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00227; Pinker S., 2007, STUFF THOUGHT LANGUA; Preston JL, 2012, J EXP SOC PSYCHOL, V48, P1365, DOI 10.1016/j.jesp.2012.05.015; Ripley B, 2014, SUPPORT FUNCTIONS DA; ROZIN P, 1986, J PERS SOC PSYCHOL, V50, P703, DOI 10.1037/0022-3514.50.4.703; Rozin P, 2013, TRENDS COGN SCI, V17, P367, DOI 10.1016/j.tics.2013.06.001; Shah Y., 2015, HUFFINGTON POST; Strack F., 1988, J PERS SOC PSYCHOL, V54, P768; Strawbridge WJ, 1998, J GERONTOL B-PSYCHOL, V53, pS118, DOI 10.1093/geronb/53B.3.S118; Swann WB, 2001, J PERS SOC PSYCHOL, V81, P1160, DOI 10.1037/0022-3514.81.6.1160; Talmi D, 2004, MEM COGNITION, V32, P742, DOI 10.3758/BF03195864; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; UNDERWOOD BJ, 1965, J EXP PSYCHOL, V70, P122, DOI 10.1037/h0022014; Venables WN., 2002, MODERN APPL STAT S 4; Ward R., 2009, MISSISSIPPI STA 0409; ZAJONC RB, 1985, SCIENCE, V228, P15, DOI 10.1126/science.3883492; ZAJONC RB, 1989, PSYCHOL REV, V96, P395, DOI 10.1037/0033-295X.96.3.395	57	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153686	10.1371/journal.pone.0153686	http://dx.doi.org/10.1371/journal.pone.0153686			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119522	gold, Green Published, Green Submitted			2022-12-26	WOS:000374976200033
J	Yan, J; Liu, J; Su, B; Pan, XH; Wang, Z; Wu, JJ; Zhang, JF; Ruan, YH; Hsi, J; Liao, LJ; Shao, YM; Xing, H				Yan, Jing; Liu, Jia; Su, Bin; Pan, Xiaohong; Wang, Zhe; Wu, Jianjun; Zhang, Jiafeng; Ruan, Yuhua; Hsi, Jenny; Liao, Lingjie; Shao, Yiming; Xing, Hui			Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ANTIRETROVIRAL THERAPY; SELF-REPORT; INFECTED PATIENTS; CLINICAL-TRIALS; ADHERENCE; OUTCOMES; PLASMA; HAART; PHARMACOKINETICS	Background The assessment of adherence to antiretroviral therapy (ART) is important in order to predict treatment outcomes. Lamivudine (3TC) is one of the most widely used NRTIs in China, but its concentrations in hair and association with virologic failure and drug resistance have not been studied. Methods We conducted a cross-sectional survey to investigate 3TC concentrations in hair as a predictor of virologic failure and drug resistance among HIV patients receiving free ART. We also compared the capacity of hair 3TC concentrations with self-reported adherence in predicting virologic responses. Hair 3TC concentrations were detected through the LC-MS/MS system. Results In patients without HIV drug resistance (HIVDR), with a threshold hair 3TC concentration of 260 ng/g, the sensitivity and specificity in predicting virologic suppression were 76.9% and 89.9%, respectively. Some factors, including CD4(+) cell counts, initial treatment regimens with 3TC, and current regimens with second-line drugs, influenced the association between hair 3TC concentrations and virologic suppression. In patients who experienced virologic failure with HIVDR, with a threshold of 180 ng/g, the sensitivity and specificity were 70.0% and 74.4%, respectively. Hair 3TC concentrations had higher sensitivity and specificity in predicting virologic failure and drug resistance than self-reported adherence. Conclusions The hair 3TC concentration was a stronger indicator than self-reported adherence in predicting virologic failure and drug resistance in HIV patients receiving free ART.	[Yan, Jing; Ruan, Yuhua; Hsi, Jenny; Liao, Lingjie; Shao, Yiming; Xing, Hui] Collaborat Innovat Ctr Diag & Treatment Infect Di, Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control NCAIDS & Prevent, State Key Lab Infect Dis Prevent & Control SKLID, Beijing, Peoples R China; [Liu, Jia; Wang, Zhe] Henan Ctr Dis Control & Prevent, Zhenzhou, Henan Province, Peoples R China; [Su, Bin; Wu, Jianjun] Anhui Ctr Dis Control & Prevent, Hefei, Anhui, Peoples R China; [Pan, Xiaohong; Zhang, Jiafeng] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Xing, H (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control NCAIDS & Prevent, State Key Lab Infect Dis Prevent & Control SKLID, Beijing, Peoples R China.	xingh@chinaaids.cn	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Ministry of Science and Technology of China [2012ZX10001-002, 2009DFB30420]; Chinese State Key Laboratory of Infectious Disease Develop Grant; International Development Research Center of Canada [104519-010]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese State Key Laboratory of Infectious Disease Develop Grant; International Development Research Center of Canada	This study was supported by grants from the Ministry of Science and Technology of China (2012ZX10001-002 and 2009DFB30420), the Chinese State Key Laboratory of Infectious Disease Develop Grant, and the International Development Research Center of Canada (grant #104519-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2006, JAIDS-J ACQ IMM DEF, V42, P455, DOI 10.1097/01.qai.0000225020.73760.c2; [Anonymous], 2005, CHINA FREE ART MANUA; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Back D, 2002, AIDS, V16, pS5, DOI 10.1097/00002030-200203001-00002; Baxi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129100; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Bernard L, 2002, ANN INTERN MED, V137, P656, DOI 10.7326/0003-4819-137-8-200210150-00009; Condra JH, 1998, ANN INTERN MED, V128, P951, DOI 10.7326/0003-4819-128-11-199806010-00017; Duong M, 2001, CLIN INFECT DIS, V33, P386, DOI 10.1086/321876; Fletcher CV, 1999, ANN PHARMACOTHER, V33, P989, DOI 10.1345/aph.19075; Friedland GH, 1999, AIDS, V13, pS61; Gandhi M, 2002, ANN INTERN MED, V137, P696, DOI 10.7326/0003-4819-137-8-200210150-00016; Gandhi M, 2014, AIDS RES HUM RETROV, V30, P25, DOI [10.1089/aid.2013.0239, 10.1089/AID.2013.0239]; Gandhi M, 2011, CLIN INFECT DIS, V52, P1267, DOI 10.1093/cid/cir131; Gandhi M, 2009, AIDS, V23, P471, DOI 10.1097/QAD.0b013e328325a4a9; GRAHAM K, 1989, JAMA-J AM MED ASSOC, V262, P3328, DOI 10.1001/jama.262.23.3328; Huang Y, 2008, RAPID COMMUN MASS SP, V22, P3401, DOI 10.1002/rcm.3750; Huang Y, 2011, ANAL BIOANAL CHEM, V401, P1923, DOI 10.1007/s00216-011-5278-7; KINTZ P, 1993, INT J LEGAL MED, V105, P283, DOI 10.1007/BF01370386; Kumar AKH, 2009, INDIAN J MED RES, V130, P451; Kumar Agibothu K Hemanth, 2006, MedGenMed, V8, P53; LeBeau MA, 2011, FORENSIC SCI INT, V210, P110, DOI 10.1016/j.forsciint.2011.02.015; Leng XB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005886; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Marcellin F, 2013, EXPERT REV ANTI-INFE, V11, P239, DOI [10.1586/ERI.13.8, 10.1586/eri.13.8]; Minzi OM, 2011, THER CLIN RISK MANAG, V7, P441, DOI 10.2147/TCRM.S23625; Nakahara Y, 1999, J CHROMATOGR B, V733, P161, DOI 10.1016/S0378-4347(99)00059-6; Panhard X, 2007, EUR J CLIN PHARMACOL, V63, P1019, DOI 10.1007/s00228-007-0337-x; Ruan YH, 2010, TROP MED INT HEALTH, V15, P1357, DOI 10.1111/j.1365-3156.2010.02621.x; van Zyl GU, 2011, JAIDS-J ACQ IMM DEF, V56, P333, DOI 10.1097/QAI.0b013e31820dc0cc; Wang X, 2011, CURR HIV RES, V9, P103, DOI 10.2174/157016211795569122; Xing H, 2015, J ANTIMICROB CHEMOTH, V70, P2097, DOI 10.1093/jac/dkv078; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054917; Yuen GJ, 2004, ANTIMICROB AGENTS CH, V48, P176, DOI 10.1128/AAC.48.1.176-182.2004; Zhang F, 2008, CHINA FREE ART MANUA	36	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154421	10.1371/journal.pone.0154421	http://dx.doi.org/10.1371/journal.pone.0154421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119346	gold, Green Submitted, Green Published			2022-12-26	WOS:000374976200071
J	Gillen, JB; Martin, BJ; MacInnis, MJ; Skelly, LE; Tarnopolsky, MA; Gibala, MJ				Gillen, Jenna B.; Martin, Brian J.; MacInnis, Martin J.; Skelly, Lauren E.; Tarnopolsky, Mark A.; Gibala, Martin J.			Twelve Weeks of Sprint Interval Training Improves Indices of Cardiometabolic Health Similar to Traditional Endurance Training despite a Five-Fold Lower Exercise Volume and Time Commitment	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SKELETAL-MUSCLE; CARDIORESPIRATORY FITNESS; GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY; INSULIN SENSITIVITY; INTENSITY; ADAPTATIONS; CAPACITY; ADULTS	Aims We investigated whether sprint interval training (SIT) was a time-efficient exercise strategy to improve insulin sensitivity and other indices of cardiometabolic health to the same extent as traditional moderate-intensity continuous training (MICT). SIT involved 1 minute of intense exercise within a 10-minute time commitment, whereas MICT involved 50 minutes of continuous exercise per session. Methods Sedentary men (27 +/- 8y; BMI = 26 +/- 6kg/m(2)) performed three weekly sessions of SIT (n = 9) or MICT (n = 10) for 12 weeks or served as non-training controls (n = 6). SIT involved 3x20second 'all-out' cycle sprints (similar to 500W) interspersed with 2 minutes of cycling at 50W, whereas MICT involved 45 minutes of continuous cycling at similar to 70% maximal heart rate (similar to 110W). Both protocols involved a 2-minute warm-up and 3-minute cool-down at 50W. Results Peak oxygen uptake increased after training by 19% in both groups (SIT: 32 +/- 7 to 38 +/- 8; MICT: 34 +/- 6 to 40 +/- 8ml/kg/min; p< 0.001 for both). Insulin sensitivity index (CSI), determined by intravenous glucose tolerance tests performed before and 72 hours after training, increased similarly after SIT (4.9 +/- 2.5 to 7.5 +/- 4.7, p = 0.002) and MICT (5.0 +/- 3.3 to 6.7 +/- 5.0 x 10(-4) min(-1) [mu/mL](-1), p = 0.013) (p< 0.05). Skeletal muscle mitochondrial content also increased similarly after SIT and MICT, as primarily reflected by the maximal activity of citrate synthase (CS; P< 0.001). The corresponding changes in the control group were small for VO(2)peak (p = 0.99), CSI (p = 0.63) and CS (p = 0.97). Conclusions Twelve weeks of brief intense interval exercise improved indices of cardiometabolic health to the same extent as traditional endurance training in sedentary men, despite a five-fold lower exercise volume and time commitment.	[Gillen, Jenna B.; Martin, Brian J.; MacInnis, Martin J.; Skelly, Lauren E.; Tarnopolsky, Mark A.; Gibala, Martin J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada	McMaster University; McMaster University	Gibala, MJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	gibalam@mcmaster.ca		MacInnis, Martin/0000-0002-0377-5800	Natural Sciences and Engineering Research Council (NSERC) [RGPIN/227858-2010]; McMaster University	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster University	This project was supported by an operating grant from the Natural Sciences and Engineering Research Council (NSERC; grant number RGPIN/227858-2010) and an internally-sponsored research grant from McMaster University to MJG. JBG held a NSERC Vanier Canada Graduate Scholarship. MJM held an NSERC Postdoctoral Fellowship. LES held an NSERC Canada Graduate Scholarship (Masters).	Akerstrom T, 2014, AM J PHYSIOL-ENDOC M, V307, pE1105, DOI 10.1152/ajpendo.00020.2014; [Anonymous], 2013, OPEN J MOL INTEGR PH, V03, P202, DOI [10.4236/ojmip.2013.34027, DOI 10.4236/OJMIP.2013.34027]; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Barry VW, 2014, PROG CARDIOVASC DIS, V56, P382, DOI 10.1016/j.pcad.2013.09.002; Biddle SJH, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0254-9; Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012; BLOMQVIST CG, 1983, ANNU REV PHYSIOL, V45, P169, DOI 10.1146/annurev.ph.45.030183.001125; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386; Cocks M, 2016, J PHYSIOL-LONDON, V594, P2307, DOI 10.1113/jphysiol.2014.285254; Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566; Colley RC, 2011, HLTH REP, V22, P7; Egan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074098; Ekkekakis P, 2009, SPORTS MED, V39, P857, DOI 10.2165/11315210-000000000-00000; Ortega JF, 2014, APPL PHYSIOL NUTR ME, V39, P787, DOI 10.1139/apnm-2013-0507; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gillen JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111489; Gillen JB, 2014, APPL PHYSIOL NUTR ME, V39, P409, DOI 10.1139/apnm-2013-0187; Gormley SE, 2008, MED SCI SPORT EXER, V40, P1336, DOI 10.1249/MSS.0b013e31816c4839; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Houmard JA, 2004, J APPL PHYSIOL, V96, P101, DOI 10.1152/japplphysiol.00707.2003; Jung ME, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/191595; Jung ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114541; Karstoft K, 2013, DIABETES CARE, V36, P228, DOI 10.2337/dc12-0658; KNUTTGEN HG, 1973, MED SCI SPORT EXER, V5, P220; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matsuo T, 2014, MED SCI SPORT EXER, V46, P42, DOI 10.1249/MSS.0b013e3182a38da8; Metcalfe RS, 2012, EUR J APPL PHYSIOL, V112, P2767, DOI 10.1007/s00421-011-2254-z; Murias JM, 2010, J APPL PHYSIOL, V108, P621, DOI 10.1152/japplphysiol.01152.2009; Ortega JF, 2015, INT J SPORTS MED, V36, P209, DOI 10.1055/s-0034-1389942; Parfitt G, 2009, J EXERC SCI FIT, V7, pS34, DOI 10.1016/S1728-869X(09)60021-6; Richards JC, 2010, J PHYSIOL-LONDON, V588, P2961, DOI 10.1113/jphysiol.2010.189886; Ross R, 2015, MAYO CLIN PROC, V90, P1506, DOI 10.1016/j.mayocp.2015.07.024; Ross R, 2015, ANN INTERN MED, V162, P325, DOI 10.7326/M14-1189; Samjoo IA, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.30; Shepherd SO, 2013, J PHYSIOL-LONDON, V591, P657, DOI 10.1113/jphysiol.2012.240952; Sloth M, 2013, SCAND J MED SCI SPOR, V23, pE341, DOI 10.1111/sms.12092; Stephenson EJ, 2014, BBA-GEN SUBJECTS, V1840, P1285, DOI 10.1016/j.bbagen.2013.12.004; Tabata I, 1996, MED SCI SPORT EXER, V28, P1327, DOI 10.1097/00005768-199610000-00018; Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Trilk JL, 2011, EUR J APPL PHYSIOL, V111, P1591, DOI 10.1007/s00421-010-1777-z; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Tura A, 2010, DIABETOLOGIA, V53, P144, DOI 10.1007/s00125-009-1547-9; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	57	178	181	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154075	10.1371/journal.pone.0154075	http://dx.doi.org/10.1371/journal.pone.0154075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115137	Green Published, gold, Green Submitted			2022-12-26	WOS:000374973600042
J	Grytdal, SP; DeBess, E; Lee, LE; Blythe, D; Ryan, P; Biggs, C; Cameron, M; Schmidt, M; Parashar, UD; Hall, AJ				Grytdal, Scott P.; DeBess, Emilio; Lee, Lore E.; Blythe, David; Ryan, Patricia; Biggs, Christianne; Cameron, Miriam; Schmidt, Mark; Parashar, Umesh D.; Hall, Aron J.			Incidence of Norovirus and Other Viral Pathogens That Cause Acute Gastroenteritis (AGE) among Kaiser Permanente Member Populations in the United States, 2012-2013	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; FOODBORNE ILLNESS; UNSPECIFIED AGENTS; ROTAVIRUS VACCINE; BURDEN; COMMUNITY; OUTBREAKS; CHILDREN	Noroviruses and other viral pathogens are increasingly recognized as frequent causes of acute gastroenteritis (AGE). However, few laboratory-based data are available on the incidence of AGE caused by viral pathogens in the U.S. This study examined stool specimens submitted for routine clinical diagnostics from patients enrolled in Kaiser Permanente (KP) health plans in metro Portland, OR, and the Maryland, District of Columbia, and northern Virginia geographic areas to estimate the incidence of viral enteropathogens in these populations. Over a one-year study period, participating laboratories randomly selected stools submitted for routine clinical diagnostics for inclusion in the study along with accompanying demographic and clinical data. Selected stools were tested for norovirus, rotavirus, sapovirus, and astrovirus using standardized real-time RT-PCR protocols. Each KP site provided administrative data which were used in conjunction with previously published data on healthcare utilization to extrapolate pathogen detection rates into population-based incidence rates. A total of 1,099 specimens collected during August 2012 to September 2013 were included. Mean age of patients providing stool specimens was 46 years (range: 0-98 years). Noroviruses were the most common viral pathogen identified among patients with AGE (n = 63 specimens, 6% of specimens tested). In addition, 22 (2%) of specimens were positive for rotavirus; 19 (2%) were positive for sapovirus; and 7 (1%) were positive for astrovirus. Incidence of norovirus-associated outpatient visits was 5.6 per 1,000 person-years; incidence of norovirus disease in the community was estimated to be 69.5 per 1,000 person-years. Norovirus incidence was highest among children < 5 years of age (outpatient incidence = 25.6 per 1,000 person-years; community incidence = 152.2 per 1,000 personyears), followed by older adults aged > 65 years (outpatient incidence = 7.8 per 1,000 person-years; community incidence = 75.8 per 1,000 person-years). Outpatient incidence rates of rotavirus, sapovirus, and astrovirus were 2.0, 1.6, 0.6 per 1,000 person-years, respectively; community incidence rates for these viruses were 23.4, 22.5, and 8.5 per 1,000 person-years, respectively. This study provides the first age-group specific laboratory-based community and outpatient incidence rates for norovirus AGE in the U.S. Norovirus was the most frequently detected viral enteropathogen across the age spectrum with the highest rates of norovirus disease observed among young children and, to a lesser extent, the elderly. These data provide a better understanding of the norovirus disease burden in the United States, including variations within different age groups, which can help inform the development, targeting, and future impacts of interventions, including vaccines.	[Grytdal, Scott P.; Parashar, Umesh D.; Hall, Aron J.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [DeBess, Emilio; Lee, Lore E.] Oregon Hlth Author, Publ Hlth Div, Dept Human Serv, Portland, OR USA; [Blythe, David; Ryan, Patricia; Biggs, Christianne] Maryland Dept Hlth & Mental Hyg, Off Infect Dis & Epidemiol, Baltimore, MD USA; [Cameron, Miriam] Kaiser Permanente Mid Atlantic States, Rockville, MD USA; [Schmidt, Mark] Kaiser Permanente Ctr Hlth Res, Portland, OR USA	Centers for Disease Control & Prevention - USA; Maryland Department of Health & Mental Hygiene; Kaiser Permanente; Kaiser Permanente	Grytdal, SP (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.	spgrytdal@cdc.gov			National Institute of Food and Agriculture, U.S. Department of Agriculture, [2011-68003-30395]	National Institute of Food and Agriculture, U.S. Department of Agriculture,(United States Department of Agriculture (USDA))	This study was supported in part by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2011-68003-30395.	Ahmed SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075922; Belliot G, 1997, ARCH VIROL, V142, P1323, DOI 10.1007/s007050050163; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Freeman MM, 2008, J MED VIROL, V80, P1489, DOI 10.1002/jmv.21228; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Grytdal SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126733; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Jones TF, 2007, EPIDEMIOL INFECT, V135, P293, DOI 10.1017/S0950268806006765; Karsten C, 2009, EUR J CLIN MICROBIOL, V28, P935, DOI 10.1007/s10096-009-0729-1; Leshem E, 2015, JAMA-J AM MED ASSOC, V313, P2282, DOI 10.1001/jama.2015.5571; Leshem E, 2014, PEDIATRICS, V134, P15, DOI 10.1542/peds.2013-3849; Leshem E, 2013, EMERG INFECT DIS, V19, P1231, DOI 10.3201/eid1908.130458; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Okada M, 2006, ARCH VIROL, V151, P2503, DOI 10.1007/s00705-006-0820-1; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Pringle K, 2015, FUTURE MICROBIOL, V10, P53, DOI 10.2217/fmb.14.102; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Verhoef L., 2012, EPIDEMIOLOGY INFECT, P1, DOI DOI 10.1017/S0950268812000799.[EPUB	27	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0148395	10.1371/journal.pone.0148395	http://dx.doi.org/10.1371/journal.pone.0148395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115485	gold, Green Submitted, Green Published			2022-12-26	WOS:000374973600008
J	Rha, B; Lopman, BA; Alcala, AN; Riddle, MS; Porter, CK				Rha, Brian; Lopman, Benjamin A.; Alcala, Ashley N.; Riddle, Mark S.; Porter, Chad K.			Incidence of Norovirus-Associated Medical Encounters among Active Duty United States Military Personnel and Their Dependents	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; ACUTE GASTROENTERITIS; ENGLAND; BURDEN; ADULTS; WALES; SURVEILLANCE; COMMUNITY; OUTBREAKS; ILLNESS	Background Norovirus is a leading cause of gastroenteritis episodes and outbreaks in US military deployments, but estimates of endemic disease burden among military personnel in garrison are lacking. Methods Diagnostic codes from gastroenteritis-associated medical encounters of active duty military personnel and their beneficiaries from July 1998-June 2011 were obtained from the Armed Forces Health Surveillance Center. Using time-series regression models, cause-unspecified encounters were modeled as a function of encounters for specific enteropathogens. Model residuals (representing unexplained encounters) were used to estimate norovirus-attributable medical encounters. Incidence rates were calculated using population data for both active duty and beneficiary populations. Results The estimated annual mean rate of norovirus-associated medically-attended visits among active duty personnel and their beneficiaries was 292 (95% CI: 258 to 326) and 93 (95% CI: 80 to 105) encounters per 10,000 persons, respectively. Rates were highest among beneficiaries < 5 years of age with a median annual rate of 435 (range: 318 to 646) encounters per 10,000 children. Norovirus was estimated to cause 31% and 27% of all-cause gastroenteritis encounters in the active duty and beneficiary populations, respectively, with over 60% occurring between November and April. There was no evidence of any lag effect where norovirus disease occurred in one population before the other, or in one beneficiary age group before the others. Conclusions Norovirus is a major cause of medically-attended gastroenteritis among non-deployed US military active duty members as well as in their beneficiaries.	[Rha, Brian; Lopman, Benjamin A.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Rha, Brian] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Alcala, Ashley N.; Riddle, Mark S.; Porter, Chad K.] Naval Med Res Ctr, Silver Spring, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Naval Medical Research Center (NMRC)	Rha, B; Lopman, BA (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.; Rha, B (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.	wif8@cdc.gov; blopman@cdc.gov	Riddle, Mark/R-8788-2019	Riddle, Mark/0000-0002-0607-7880	Military Infectious Disease Research Program	Military Infectious Disease Research Program	This work was supported/funded by the Military Infectious Disease Research Program, but without specific funding for this project.	[Anonymous], 2011, MSMR, V18, P7; Armed Forces Health Surveillance C, 2013, MSMR, V20, P7; Armed Forces Health Surveillance C, 2013, MSMR, V20; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Bartsch SM, 2012, VACCINE, V30, P7097, DOI 10.1016/j.vaccine.2012.09.040; Bentham G, 2001, INT J BIOMETEOROL, V45, P22, DOI 10.1007/s004840000083; Blankson KL, 2014, PEDIATRICS, V133, P627, DOI 10.1542/peds.2013-1630; Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Haustein T, 2009, CLIN INFECT DIS, V49, P1890, DOI 10.1086/648440; Karsten C, 2009, EUR J CLIN MICROBIOL, V28, P935, DOI 10.1007/s10096-009-0729-1; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Markov PV, 2007, EPIDEMIOL INFECT, V135, P17, DOI 10.1017/S0950268806006625; Moore M., 2010, HARNESSING FULL VALU; Mounts AW, 2000, J INFECT DIS, V181, pS284, DOI 10.1086/315586; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Porter CK, 2012, CLIN INFECT DIS, V55, P915, DOI 10.1093/cid/cis576; Reaves Erik J, 2012, MSMR, V19, P17; Richardson C, 2013, EXPERT REV VACCINES, V12, P155, DOI [10.1586/erv.12.145, 10.1586/ERV.12.145]; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Verhoef L, 2013, EPIDEMIOL INFECT, V141, P496, DOI 10.1017/S0950268812000799; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zanini B, 2012, AM J GASTROENTEROL, V107, P891, DOI 10.1038/ajg.2012.102	35	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0148505	10.1371/journal.pone.0148505	http://dx.doi.org/10.1371/journal.pone.0148505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115602	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600009
J	Center, KE; Gunn, JKL; Asaolu, IO; Gibson, SJ; Ehiri, JE				Center, Katherine E.; Gunn, Jayleen K. L.; Asaolu, Ibitola O.; Gibson, Steven J.; Ehiri, John E.			Contraceptive Use and Uptake of HIV-Testing among Sub-Saharan African Women	PLOS ONE			English	Article							PREVENTION; INFECTION; ABC	Despite improved availability of simple, relatively inexpensive, and highly effective antiretroviral treatment for HIV/AIDS, the disease remains a major public health challenge for women in sub-Saharan Africa (SSA). Given the numerous barriers in access to care for women in this region, every health issue that brings them into contact with the health system should be optimized as an opportunity to integrate HIV/AIDS prevention. Because most non-condom forms of modern contraception require a clinical appointment for use, contraception appointments could provide a confidential opportunity for access to HIV counseling, testing, and referral to care. This study sought to investigate the relationship between contraceptive methods and HIV testing among women in SSA. Data from the Demographic and Health Survey from four African countries-Congo, Mozambique, Nigeria, and Uganda-was used to examine whether modern (e.g., pills, condom) or traditional (e.g., periodic abstinence, withdrawal) forms of contraception were associated with uptake of HIV testing. Data for the current analyses were restricted to 35,748 women with complete information on the variables of interest. Chi-square tests and logistic regression models were used to assess the relationship between uptake of HIV testing and respondents' baseline characteristics and contraceptive methods. In the total sample and in Mozambique, women who used modern forms of contraception were more likely to be tested for HIV compared to those who did not use contraception. This positive association was not demonstrated in Congo, Nigeria, or Uganda. That many women who access modern contraception are not tested for HIV in high HIV burden areas highlights a missed opportunity to deliver an important intervention to promote maternal and child health. Given the increasing popularity of hormonal contraception methods in low-income countries, there is an urgent need to integrate HIV counseling, testing, and treatment into family planning programs. Women on hormonal contraceptives should be encouraged to continue to use condoms for HIV-prevention.	[Center, Katherine E.] Univ Arizona, Dept Obstet & Gynecol, Tucson, AZ USA; [Center, Katherine E.] Biomed Res & Educ Fdn Southern Arizona, Tucson, AZ USA; [Gunn, Jayleen K. L.] Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Asaolu, Ibitola O.; Ehiri, John E.] Univ Arizona, Dept Hlth Promot Sci, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Gibson, Steven J.] Univ Arizona, Ctr Canc, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Ehiri, JE (corresponding author), Univ Arizona, Dept Hlth Promot Sci, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA.	jehiri@email.arizona.edu						[Anonymous], 2007, COCHRANE LIB, DOI DOI 10.1002/14651858; [Anonymous], 2013, WORLD CONTR PATT 201; [Anonymous], 2015, PREV MOTH TO CHILD T; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Chiao C, 2009, HEALTH PLACE, V15, P742, DOI 10.1016/j.healthplace.2008.12.001; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; Collins L., 2013, SEXUAL HLTH EXCHANGE, P4; Dworkin SL, 2007, AM J PUBLIC HEALTH, V97, P13, DOI 10.2105/AJPH.2005.074591; Emina JBO, 2014, CONTRACEPTION, V90, P154, DOI 10.1016/j.contraception.2014.02.001; Gage AJ, 1998, STUD FAMILY PLANN, V29, P154, DOI 10.2307/172156; Heikinheimo O, 2009, HUM REPROD UPDATE, V15, P165, DOI 10.1093/humupd/dmn049; Korra A., 2002, ATTITUDES FAMILY PLA; Madsen EL, 2015, J BIOSOC SCI, V47, P329, DOI 10.1017/S0021932014000108; Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778; Pacque-Margolis S, 2013, EXPLORING CONTRACEPT; Reid-Hresko J, 2014, CULT HEALTH SEX, V16, P765, DOI 10.1080/13691058.2014.911959; Sambisa W, 2010, AIDS CARE, V22, P170, DOI 10.1080/09540120903038374; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Staveteig S, 2013, DHS COMPARATIVE REPO; Survey TDaH, 2015, SURVEY TDAH DATA COL; The Demographic and Health Surveys, 2015, US DAT AN; UNAIDS, 2014, GAP REP; UNICEF, HIV AIDS DEF IND; USAID website, TECHN BRIEF HORM CON; Wang CC, 1999, J ACQ IMMUN DEF SYND, V21, P51, DOI 10.1097/00126334-199905010-00007; WELLER SC, 1993, SOC SCI MED, V36, P1635, DOI 10.1016/0277-9536(93)90352-5; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; World Health Organization, 2012, PROGR RES CONS HORM; World Health Organization, 2015, FAM PLANN CONTR	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154213	10.1371/journal.pone.0154213	http://dx.doi.org/10.1371/journal.pone.0154213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111915	Green Submitted, Green Published, gold			2022-12-26	WOS:000374970600049
J	Hornig, NC; de Beaufort, C; Denzer, F; Cools, M; Wabitsch, M; Ukat, M; Kulle, AE; Schweikert, HU; Werner, R; Hiort, O; Audi, L; Siebert, R; Ammerpohl, O; Holterhus, PM				Hornig, Nadine C.; de Beaufort, Carine; Denzer, Friederike; Cools, Martine; Wabitsch, Martin; Ukat, Martin; Kulle, Alexandra E.; Schweikert, Hans-Udo; Werner, Ralf; Hiort, Olaf; Audi, Laura; Siebert, Reiner; Ammerpohl, Ole; Holterhus, Paul-Martin			A Recurrent Germline Mutation in the 5'UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation	PLOS ONE			English	Article							GENITAL SKIN FIBROBLASTS; OPEN READING FRAMES; SEX DEVELOPMENT; GENE-MUTATIONS; MESSENGER-RNA; IDENTIFICATION; TRANSCRIPTION; INITIATION; PHENOTYPE; CANCER	A subset of patients with monogenic disorders lacks disease causing mutations in the protein coding region of the corresponding gene. Here we describe a recurrent germline mutation found in two unrelated patients with complete androgen insensitivity syndrome (CAIS) generating an upstream open reading frame (uORF) in the 5' untranslated region (5'-UTR) of the androgen receptor (AR) gene. We show in patient derived primary genital skin fibroblasts as well as in cell-based reporter assays that this mutation severely impacts AR function by reducing AR protein levels without affecting AR mRNA levels. Importantly, the newly generated uORF translates into a polypeptide and the expression level of this polypeptide inversely correlates with protein translation from the primary ORF of the AR thereby providing a model for AR-5'UTR mediated translational repression. Our findings not only add a hitherto unrecognized genetic cause to complete androgen insensitivity but also underline the importance of 5'UTR mutations affecting uORFs for the pathogenesis of monogenic disorders in general.	[Hornig, Nadine C.; Ukat, Martin; Kulle, Alexandra E.; Holterhus, Paul-Martin] Univ Kiel, Dept Pediat, Div Pediat Endocrinol & Diabet, Campus Kiel, Kiel, Germany; [Hornig, Nadine C.; Ukat, Martin; Kulle, Alexandra E.; Siebert, Reiner; Ammerpohl, Ole; Holterhus, Paul-Martin] Univ Hosp Schleswig Holstein, Campus Kiel, Kiel, Germany; [de Beaufort, Carine] CH Luxembourg, Pediat Clin, Luxembourg, Luxembourg; [Denzer, Friederike; Wabitsch, Martin] Univ Ulm, Dept Pediat, Div Pediat Endocrinol & Diabetol, D-89069 Ulm, Germany; [Cools, Martine] Ghent Univ Hosp, Dept Pediat, Div Pediat Endocrinol, Ghent, Belgium; [Cools, Martine] Univ Ghent, B-9000 Ghent, Belgium; [Schweikert, Hans-Udo] Univ Bonn, Dept Med 3, Bonn, Germany; [Werner, Ralf; Hiort, Olaf] Med Univ Lubeck, Dept Pediat, Div Expt Pediat Endocrinol, D-23538 Lubeck, Germany; [Audi, Laura] Hosp Valle De Hebron, Vall dHebron Res Inst VHIR, Barcelona, Spain; [Audi, Laura] Ctr Biomed Res Network Rare Dis CIBERER, Barcelona, Spain; [Hornig, Nadine C.; Siebert, Reiner; Ammerpohl, Ole] Univ Kiel, Inst Human Genet, Campus Kiel, Kiel, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Ulm University; Ghent University; Ghent University Hospital; Ghent University; University of Bonn; University of Lubeck; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Kiel	Hornig, NC; Holterhus, PM (corresponding author), Univ Kiel, Dept Pediat, Div Pediat Endocrinol & Diabet, Campus Kiel, Kiel, Germany.; Hornig, NC; Holterhus, PM (corresponding author), Univ Hosp Schleswig Holstein, Campus Kiel, Kiel, Germany.; Hornig, NC (corresponding author), Univ Kiel, Inst Human Genet, Campus Kiel, Kiel, Germany.	nhornig@medgen.uni-kiel.de; holterhus@pediatrics.uni-kiel.de	Siebert, Reiner/A-8049-2010; de Beaufort, Carine/AAJ-8063-2021; Cools, Martine/J-4580-2012; Ammerpohl, Ole/G-2691-2010; Hornig, Nadine/AAO-2648-2021	de Beaufort, Carine/0000-0003-4310-6799; Cools, Martine/0000-0002-9552-4899; Werner, Ralf/0000-0003-3718-3595	Medical Faculty of the Christian-Albrechts-University, CAU, Kiel, Germany (Forschungsforderung - Anschub); German Research Council (Deutsche Forschungsgemeinschaft, DFG) [Ho2073/7-1/7-3, AM 343/2-1/2-3]	Medical Faculty of the Christian-Albrechts-University, CAU, Kiel, Germany (Forschungsforderung - Anschub); German Research Council (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	The study has been funded by the Medical Faculty of the Christian-Albrechts-University, CAU, Kiel, Germany (Forschungsforderung 2015 - Anschub to NH) and the German Research Council (Deutsche Forschungsgemeinschaft, DFG) (Ho2073/7-1/7-3 to PMH and AM 343/2-1/2-3 to OA). The authors thank the KinderKrebsInitiative Buchholz/Holm-Seppensen for providing infrastructure.	Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Appari M, 2009, J MOL MED, V87, P623, DOI 10.1007/s00109-009-0462-3; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Audi L, 2010, J CLIN ENDOCR METAB, V95, P1876, DOI 10.1210/jc.2009-2146; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Crocitto LE, 1997, J UROLOGY, V158, P1599, DOI 10.1016/S0022-5347(01)64287-3; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Deeb A, 2005, CLIN ENDOCRINOL, V63, P56, DOI 10.1111/j.1365-2265.2005.02298.x; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Hiort O, 2014, NAT REV ENDOCRINOL, V10, P520, DOI 10.1038/nrendo.2014.108; Holterhus PM, 1997, J CLIN ENDOCR METAB, V82, P3584, DOI 10.1210/jc.82.11.3584; Jaaskelainen J, 2012, MOL CELL ENDOCRINOL, V352, P4, DOI 10.1016/j.mce.2011.08.006; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Liegibel UM, 2003, STEROIDS, V68, P1179, DOI 10.1016/j.steroids.2003.08.016; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; MIZOKAMI A, 1994, J BIOL CHEM, V269, P25655; Mongan NP, 2015, BEST PRACT RES CL EN, V29, P569, DOI 10.1016/j.beem.2015.04.005; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Peters KM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-132; Ramalingam P, 2014, RNA, V20, P76, DOI 10.1261/rna.041814.113; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Werner R, 2014, ENDOCR DEV, V27, P28, DOI 10.1159/000363610; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; WILSON CM, 1994, P NATL ACAD SCI USA, V91, P1234, DOI 10.1073/pnas.91.4.1234; ZOPPI S, 1993, J CLIN INVEST, V91, P1105, DOI 10.1172/JCI116269	29	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154158	10.1371/journal.pone.0154158	http://dx.doi.org/10.1371/journal.pone.0154158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110943	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600040
J	Zhang, XM; Zhou, YF; Xu, MM; Chen, G				Zhang, Xiaoming; Zhou, Youfa; Xu, Mingmin; Chen, Gang			Autophagy Is Involved in the Sevoflurane Anesthesia-Induced Cognitive Dysfunction of Aged Rats	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES	Autophagy is associated with regulation of both the survival and death of neurons, and has been linked to many neurodegenerative diseases. Postoperative cognitive dysfunction is commonly observed in elderly patients following anesthesia, but the pathophysiological mechanisms are largely unexplored. Similar effects have been found in aged rats under sevoflurane anesthesia; however, the role of autophagy in sevoflurane anesthesia-induced hippocampal neuron apoptosis of older rats remains elusive. The present study was designed to investigate the effects of autophagy on the sevoflurane-induced cognitive dysfunction in aged rats, and to identify the role of autophagy in sevoflurane-induced neuron apoptosis. We used 20-month-old rats under sevoflurane anesthesia to study memory performance, neuron apoptosis, and autophagy. The results demonstrated that sevoflurane anesthesia significantly impaired memory performance and induced hippocampal neuron apoptosis. Interestingly, treatment of rapamycin, an autophagy inducer, improved the cognitive deficit observed in the aged rats under sevoflurane anesthesia by improving autophagic flux. Rapamycin treatment led to the rapid accumulation of autophagic bodies and autophagy lysosomes, decreased p62 protein levels, and increased the ratio of microtubule-associated protein light chain 3 II (LC3-II) to LC3-I in hippocampal neurons through the mTOR signaling pathway. However, administration of an autophagy inhibitor (chloroquine) attenuated the autophagic flux and increased the severity of sevoflurane anesthesia-induced neuronal apoptosis and memory impairment. These findings suggest that impaired autophagy in the hippocampal neurons of aged rats after sevoflurane anesthesia may contribute to cognitive impairment. Therefore, our findings represent a potential novel target for proautophagy treatments in patients with sevoflurane anesthesia-induced neurodegeneration.	[Zhang, Xiaoming; Xu, Mingmin] Zhejiang Univ, Sch Med, Dept Anat & Cell Biol, Hangzhou, Peoples R China; [Zhou, Youfa; Chen, Gang] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Mingmin] First Hosp Jiaxing City, Dept Anesthesiol, Jiaxing, Peoples R China	Zhejiang University; Zhejiang University	Chen, G (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China.	dctor_gangchen@163.com			National Natural Science Foundation of China [81371214]; Zhejiang Provincial Natural Science Foundation of China [LY12H09005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The paper was supported by grants from the National Natural Science Foundation of China (No. 81371214) and Zhejiang Provincial Natural Science Foundation of China (No. LY12H09005).	Booth LA, 2014, CELL SIGNAL, V26, P549, DOI 10.1016/j.cellsig.2013.11.028; Cai N, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-28; Carroll B, 2015, AMINO ACIDS, V47, P2065, DOI 10.1007/s00726-014-1775-2; Castets P, 2013, AUTOPHAGY, V9, P1435, DOI 10.4161/auto.25722; Chang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081095; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057870; Coburn M, 2010, ANAESTHESIST, V59, P177, DOI 10.1007/s00101-009-1657-2; Fernandez AF, 2015, J CLIN INVEST, V125, P33, DOI 10.1172/JCI73940; Hu FL, 2014, APOPTOSIS, V19, P210, DOI 10.1007/s10495-013-0914-7; Kiriyama Y, 2015, INT J MOL SCI, V16, P26797, DOI 10.3390/ijms161125990; Liu YZ, 2013, AM J MED SCI, V345, P355, DOI 10.1097/MAJ.0b013e31825a674d; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mufson EJ, 2015, NEUROSCIENCE, V309, P51, DOI 10.1016/j.neuroscience.2015.03.006; Nah J, 2015, MOL CELLS, V38, P381, DOI 10.14348/molcells.2015.0034; Newton PT, 2015, AUTOPHAGY, V11, P1594, DOI 10.1080/15548627.2015.1068489; Nijholt DAT, 2011, CELL DEATH DIFFER, V18, P1071, DOI 10.1038/cdd.2010.176; Papackova Z, 2014, PHYSIOL RES, V63, P409, DOI 10.33549/physiolres.932684; Passot JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032560; Qiao Y, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0130-9; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Shoair Osama A, 2015, J Anaesthesiol Clin Pharmacol, V31, P30, DOI 10.4103/0970-9185.150530; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tao H, 2014, MED SCI MONITOR, V20, P1902, DOI [10.12659/MSM.892271, 10.12659/MSM.892485]; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Xiong WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079408; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	26	32	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153505	10.1371/journal.pone.0153505	http://dx.doi.org/10.1371/journal.pone.0153505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111854	gold, Green Published, Green Submitted			2022-12-26	WOS:000374970600016
J	Liang, CT; Huang, HB; Wang, CC; Chen, YR; Chang, CF; Shiao, MS; Chen, YC; Lin, TH				Liang, Chu-Ting; Huang, Hsien-Bin; Wang, Chih-Ching; Chen, Yi-Ru; Chang, Chi-Fon; Shiao, Ming-Shi; Chen, Yi-Cheng; Lin, Ta-Hsien			L17A/F19A Substitutions Augment the alpha-Helicity of beta-Amyloid Peptide Discordant Segment	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; FIBRIL-FORMING PROTEINS; SOLID-STATE NMR; ALZHEIMERS-DISEASE; CHEMICAL-SHIFTS; AGGREGATION; NEUROTOXICITY; DOMAIN	beta-amyloid peptide (A beta) aggregation has been thought to be associated with the pathogenesis of Alzheimer's disease. Recently, we showed that L17A/F19A substitutions may increase the structural stability of wild-type and Arctic-type A beta(40) and decrease the rates of structural conversion and fibril formation. However, the underlying mechanism for the increase of structural stability as a result of the alanine substitutions remained elusive. In this study, we apply nuclear magnetic resonance and circular dichroism spectroscopies to characterize the A beta(40) structure, demonstrating that L17A/F19A substitutions can augment the alpha-helicity of the residues located in the alpha/beta-discordant segment (resides 15 to 23) of both wild-type and Arctic-type A beta(40). These results provide a structural basis to link the alpha-helicity of the alpha/beta-discordant/beta-discordant segment with the conformational conversion propensity of A beta.	[Liang, Chu-Ting; Lin, Ta-Hsien] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Liang, Chu-Ting; Lin, Ta-Hsien] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Liang, Chu-Ting; Lin, Ta-Hsien] Taipei Vet Gen Hosp, Basic Res Div, Dept Med Res, Taipei, Taiwan; [Huang, Hsien-Bin] Natl Chung Cheng Univ, Dept Life Sci, Chiayi 621, Taiwan; [Huang, Hsien-Bin] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi 621, Taiwan; [Wang, Chih-Ching; Chen, Yi-Ru; Lin, Ta-Hsien] Natl Yang Ming Univ, Struct Biol Program, Taipei 112, Taiwan; [Wang, Chih-Ching; Lin, Ta-Hsien] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chen, Yi-Ru] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Chang, Chi-Fon] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Shiao, Ming-Shi] Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan; [Chen, Yi-Cheng] Mackay Med Coll, Dept Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Chung Cheng University; National Chung Cheng University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Chang Gung University; Mackay Medical College	Lin, TH (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.; Lin, TH (corresponding author), Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan.; Lin, TH (corresponding author), Taipei Vet Gen Hosp, Basic Res Div, Dept Med Res, Taipei, Taiwan.; Lin, TH (corresponding author), Natl Yang Ming Univ, Struct Biol Program, Taipei 112, Taiwan.; Lin, TH (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.; Chen, YC (corresponding author), Mackay Med Coll, Dept Med, Taipei, Taiwan.	chen15@mmc.edu.tw; thlin@vghtpe.gov.tw		Chang, Chi-Fon/0000-0002-2961-0748	National Science Council of the Republic of China [NSC99-2320-B-194-003-MY3, NSC101-2113-M-010-003-MY2, MOST103-2113-M-010-002]; Taipei Veterans General Hospital, Taiwan, ROC [V100C-180, V101C-003, V102C-037]; Ministry of Education, Aiming for the Top University Plan	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan, ROC(Taipei Veterans General Hospital); Ministry of Education, Aiming for the Top University Plan	This work was supported by grants from the National Science Council of the Republic of China (NSC99-2320-B-194-003-MY3, NSC101-2113-M-010-003-MY2 and MOST103-2113-M-010-002), Taipei Veterans General Hospital, Taiwan, ROC (V100C-180, V101C-003 and V102C-037) and a grant from Ministry of Education, Aiming for the Top University Plan.	Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Carter MD, 2010, CLIN PHARMACOL THER, V88, P475, DOI 10.1038/clpt.2010.165; Chen YR, 2011, BIOCHEM BIOPH RES CO, V405, P91, DOI 10.1016/j.bbrc.2010.12.133; [陈颖 Chen Ying], 2013, [广东农业科学, Guangdong Agricultural Sciences], V40, P8; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Dyson HJ, 1998, NAT STRUCT BIOL, V5, P499, DOI 10.1038/739; Esler WP, 1996, BIOCHEMISTRY-US, V35, P13914, DOI 10.1021/bi961302+; Findeis MA, 2000, BBA-MOL BASIS DIS, V1502, P76, DOI 10.1016/S0925-4439(00)00034-X; Funke SA, 2012, CURR PHARM DESIGN, V18, P755; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Jana AK, 2013, PHYS CHEM CHEM PHYS, V15, P837, DOI 10.1039/c2cp42933k; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kumar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129087; Kumar J, 2014, PRION, V8, P118, DOI 10.4161/pri.28220; Lee EK, 2005, PROTEIN EXPRES PURIF, V40, P183, DOI 10.1016/j.pep.2004.12.014; Lo CJ, 2015, AMYLOID, V22, P8, DOI 10.3109/13506129.2014.980943; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Morimoto A, 2002, BIOCHEM BIOPH RES CO, V295, P306, DOI 10.1016/S0006-291X(02)00670-8; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Parthasarathy S, 2015, J AM CHEM SOC, V137, P6480, DOI 10.1021/jacs.5b03373; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Song YL, 2014, J AM CHEM SOC, V136, P4093, DOI 10.1021/ja4114374; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Wang CC, 2012, J BIOMOL STRUCT DYN, V30, P160, DOI 10.1080/07391102.2012.677767; Weinstock DS, 2008, PROTEIN SCI, V17, P950, DOI 10.1110/ps.073365408; WISHART DS, 1994, J BIOMOL NMR, V4, P171	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154327	10.1371/journal.pone.0154327	http://dx.doi.org/10.1371/journal.pone.0154327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104649	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100067
J	Cao, B; Christophersen, L; Kolpen, M; Jensen, PO; Sneppen, K; Hoiby, N; Moser, C; Sams, T				Cao, Bao; Christophersen, Lars; Kolpen, Mette; Jensen, Peter Ostrup; Sneppen, Kim; Hoiby, Niels; Moser, Claus; Sams, Thomas			Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; INFLAMMATORY RESPONSE; LUNG INFECTION; BACTERIAL; GELS; EXOPOLYSACCHARIDE; PHARMACOKINETICS; PENETRATION; STRATEGIES	Microbial cells embedded in a self-produced extracellular biofilm matrix cause chronic infections, e. g. by Pseudomonas aeruginosa in the lungs of cystic fibrosis patients. The antibiotic killing of bacteria in biofilms is generally known to be reduced by 100-1000 times relative to planktonic bacteria. This makes such infections difficult to treat. We have therefore proposed that biofilms can be regarded as an independent compartment with distinct pharmacokinetics. To elucidate this pharmacokinetics we have measured the penetration of the tobramycin into seaweed alginate beads which serve as a model of the extracellular polysaccharide matrix in P. aeruginosa biofilm. We find that, rather than a normal first order saturation curve, the concentration of tobramycin in the alginate beads follows a power-law as a function of the external concentration. Further, the tobramycin is observed to be uniformly distributed throughout the volume of the alginate bead. The power-law appears to be a consequence of binding to a multitude of different binding sites. In a diffusion model these results are shown to produce pronounced retardation of the penetration of tobramycin into the biofilm. This filtering of the free tobramycin concentration inside biofilm beads is expected to aid in augmenting the survival probability of bacteria residing in the biofilm.	[Cao, Bao; Christophersen, Lars; Kolpen, Mette; Jensen, Peter Ostrup; Hoiby, Niels; Moser, Claus] Rigshosp, Copenhagen Univ Hosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Kolpen, Mette; Hoiby, Niels] Univ Copenhagen, Dept Immunol & Microbiol, UC CARE, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Sneppen, Kim] Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark; [Sams, Thomas] Tech Univ Denmark, Dept Elect Engn, Biomed Engn, DK-2800 Lyngby, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Technical University of Denmark	Sams, T (corresponding author), Tech Univ Denmark, Dept Elect Engn, Biomed Engn, DK-2800 Lyngby, Denmark.	tsams@dtu.dk	Jensen, Peter Ostrup/HGD-7725-2022; Sams, Thomas/A-9781-2014; Moser, Claus Ernst/GPK-5546-2022; Moser, Claus Ernst/N-5951-2017	Sams, Thomas/0000-0002-6316-2539; Moser, Claus Ernst/0000-0002-7664-8570; Moser, Claus Ernst/0000-0002-7664-8570; Jensen, Peter Ostrup/0000-0003-1648-7186; Sneppen, Kim/0000-0001-9820-3567; Hoiby, Niels/0000-0002-1347-725X; Kolpen, Mette/0000-0001-5575-0384				[Anonymous], 2015, MATLAB VERSION 8 6 0; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; BROWN W, 1981, POLYMER, V22, P185, DOI 10.1016/0032-3861(81)90196-8; Cao B, 2015, J ANTIMICROB CHEMOTH, V70, P2057, DOI 10.1093/jac/dkv058; Christophersen LJ, 2012, CLIN EXP IMMUNOL, V170, P222, DOI 10.1111/j.1365-2249.2012.04652.x; Demczar DJ, 1997, ANTIMICROB AGENTS CH, V41, P1115, DOI 10.1128/AAC.41.5.1115; Ferkinghoff-Borg J, 2014, MOL BIOSYST, V10, P103, DOI 10.1039/c3mb70230h; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; GORDON CA, 1988, J ANTIMICROB CHEMOTH, V22, P667, DOI 10.1093/jac/22.5.667; Hennig S, 2013, CLIN PHARMACOKINET, V52, P289, DOI 10.1007/s40262-013-0036-y; Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1128/AAC.49.6.2467-2473.2005; Lorain Victor, 2005, ANTIBIOTICS LAB MED; MACKIE JS, 1955, PROC R SOC LON SER-A, V232, P498, DOI 10.1098/rspa.1955.0234; MUHR AH, 1982, POLYMER, V23, P1012, DOI 10.1016/0032-3861(82)90402-5; NICHOLS WW, 1988, ANTIMICROB AGENTS CH, V32, P518, DOI 10.1128/AAC.32.4.518; PEDERSEN SS, 1990, INFECT IMMUN, V58, P3363, DOI 10.1128/IAI.58.10.3363-3368.1990; PEDERSEN SS, 1990, APMIS, V98, P203, DOI 10.1111/j.1699-0463.1990.tb01023.x; SKEEL RD, 1990, SIAM J SCI STAT COMP, V11, P1, DOI 10.1137/0911001; Sneppen K., 2014, MODELS OF LIFE; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; STEWART PS, 1993, APPL ENVIRON MICROB, V59, P327, DOI 10.1128/AEM.59.1.327-329.1993; Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B; Sun FJ, 2013, FUTURE MICROBIOL, V8, P877, DOI 10.2217/fmb.13.58; Szomolay B, 2005, ENVIRON MICROBIOL, V7, P1186, DOI 10.1111/j.1462-2920.2005.00797.x; TANNENBAUM CS, 1984, ANTIMICROB AGENTS CH, V25, P673, DOI 10.1128/AAC.25.6.673; Tseng BS, 2013, ENVIRON MICROBIOL, V15, P2865, DOI 10.1111/1462-2920.12155; Van Acker H, 2014, TRENDS MICROBIOL, V22, P326, DOI 10.1016/j.tim.2014.02.001; WESTRIN BA, 1991, BIOTECHNOL BIOENG, V38, P439, DOI 10.1002/bit.260380502	28	33	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153616	10.1371/journal.pone.0153616	http://dx.doi.org/10.1371/journal.pone.0153616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100887	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500044
J	Depardieu, C; Premont, V; Boily, C; Caron, J				Depardieu, Claire; Premont, Valerie; Boily, Carole; Caron, Jean			Sawdust and Bark-Based Substrates for Soilless Strawberry Production: Irrigation and Electrical Conductivity Management	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY; CHEMICAL-PROPERTIES; GROWING MEDIA; PEAT MOSS; COIR; GROWTH; YIELD; AERATION; ELSANTA; QUALITY	The objective of this work was to optimize a soilless growing system for producing bare-root strawberry transplants in three organic substrates. Three trials were conducted in the Quebec City area to determine the productivity potential of a peat-sawdust mixture (PS25) and an aged bark (AB) material compared to conventional coconut fiber (CF) substrate. A first experiment was carried out to define appropriate irrigation set points for each substrate that allowed optimal plant growth and fruit yields. For all substrates, wetter conditions (irrigation started at -1.0 kPa for CF; -1.5 kPa for AB and PS25, relative to -1.5 kPa for CF; -2.5 kPa for AB and PS25) enhanced plant growth and fruit production. The second trial was carried out to test the productivity potential for commercial production of the three substrates using high-tunnels. After the addition of an initial fertilizer application to PS25, we successfully established bare-root plants that gave similar fruit yields than those in CF and AB. The productivity potential of PS25 and AB were further confirmed during a third trial under greenhouse conditions. The critical factor for plant establishment in PS25 was attributed to consistent N, P and S immobilization by microorganisms, as well as the retention of other elements (Mg2+, K+) in the growth media. Taken together, our results showed that PS25 and AB are promising alternative substrates to coconut coir dust for strawberry cultivation. This paper also provides a useful guide for strawberry cultivation in Quebec, and suggests future research that might be conducted to optimize soilless systems for cold-climate strawberry production in Northern America.	[Depardieu, Claire; Premont, Valerie; Boily, Carole; Caron, Jean] Univ Laval, Dept Sols & Genie Agroalimentaire, 2480 Blvd Hochelaga, Quebec City, PQ G1V 0A6, Canada	Laval University	Depardieu, C (corresponding author), Univ Laval, Dept Sols & Genie Agroalimentaire, 2480 Blvd Hochelaga, Quebec City, PQ G1V 0A6, Canada.	calima45@hotmail.fr			Natural Sciences and Engineering Research Council of Canada (NSERC); Ferme Onesime Pouliot; Hortau	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ferme Onesime Pouliot; Hortau	The authors acknowledge the financial and collaboration of the Natural Sciences and Engineering Research Council of Canada (NSERC), Ferme Onesime Pouliot and Hortau to have funded and collaborated in this study. NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2002, BIORESOURCE TECHNOL, V82, P241, DOI 10.1016/S0960-8524(01)00189-4; Abu-Hamdeh NH, 1999, SOIL TILL RES, V52, P113, DOI 10.1016/S0167-1987(99)00064-1; Allaire SE, 2005, CAN J SOIL SCI, V85, P67, DOI 10.4141/S04-026; Andriolo JL, 2011, HORTIC BRAS, V29, P516, DOI 10.1590/S0102-05362011000400012; Arenas M, 2002, HORTSCIENCE, V37, P309, DOI 10.21273/HORTSCI.37.2.309; Ballington JR, 2008, HORTSCIENCE, V43, P1982, DOI 10.21273/HORTSCI.43.7.1982; Bradley D., 2007, CANADA SUSTAINABLE F; Cantliffe DJ, 2007, PROC FL STATE HORTIC, V120, P157; Caron J, 2005, SOIL SCI SOC AM J, V69, P783, DOI 10.2136/sssaj2004.0107; Caron J, 2015, VADOSE ZONE J, V14, DOI 10.2136/vzj2014.10.0146; Caron J, 2002, SOIL SCI SOC AM J, V66, P373, DOI 10.2136/sssaj2002.0373; Caron J, 2010, CAN J SOIL SCI, V90, P481, DOI 10.4141/CJSS09015; Clark GA, 1993, FINAL REPORT TO THE; Collette L, 2011, SAVE AND GROW A POLI; Conseil des productions vegetales du Quebec, 1997, PLANTES FOURRAGERES; Conseil des Productions Vegetales du Quebec (CPVQ), 1988, METHODES DANALYSE DE; CTIFL, 1990, CER, P361; D'Anna F, 2003, ACTA HORTIC, P355, DOI 10.17660/ActaHortic.2003.609.53; Darnell RL, 2001, J AM SOC HORTIC SCI, V126, P560, DOI 10.21273/JASHS.126.5.560; Davis AS, 2009, EVALUATION OF THREE, P58; Di Benedetto A., 2012, PEAT FORMATION USES, P1; Domeno I, 2009, SCI HORTIC-AMSTERDAM, V122, P269, DOI 10.1016/j.scienta.2009.05.006; Dorais M, 2007, ACTA HORTIC, P589, DOI 10.17660/ActaHortic.2007.761.82; Fennimore SA, 2013, CALIF AGR, V67, P139, DOI 10.3733/ca.v067n03p139; Morillo JG, 2015, AGR WATER MANAGE, V151, P43, DOI 10.1016/j.agwat.2014.09.021; Grattan J, 2002, PUBLICATION, V8066; Hartz T. K., 1996, HortTechnology, V6, P168; Hochmuth G, 2006, HORTTECHNOLOGY, V16, P205, DOI 10.21273/HORTTECH.16.2.0205; Hoffman GJ, 2007, DEV AGR ENG, V13, P131, DOI 10.1016/S0167-4137(07)80007-2; Hoppula KI, 2007, IRRIGATION SCI, V25, P401, DOI 10.1007/s00271-006-0055-7; Jackson BE, 2009, HORTSCIENCE, V44, P1983, DOI 10.21273/HORTSCI.44.7.1983; Jarosz Z, 2010, ACTA SCI POL-HORTORU, V9, P87; Jensen MH, 1997, HORTSCIENCE, V32, P1018, DOI 10.21273/HORTSCI.32.6.1018; Jung JiYoung, 2014, African Journal of Biotechnology, V13, P1541; Kadir S, 2006, HORTSCIENCE, V41, P329, DOI 10.21273/HORTSCI.41.2.329; Kruistum G van, 2014, PROCEEDINGS OF THE 2; Landis TD, 2009, NAT P FOR CONS NURS, P26; Lemay I, 2012, HORTSCIENCE, V47, P1141, DOI 10.21273/HORTSCI.47.8.1141; Letourneau G, 2009, THESIS; Lieten P, 2013, INT J FRUIT SCI, V13, P84, DOI 10.1080/15538362.2012.697024; Marinou E, 2013, PLANT SOIL ENVIRON, V59, P452, DOI 10.17221/297/2013-PSE; Mattner SW, 2014, ISHS ACTA HORTICULTU, V1044; Medina Y, 2009, ISHS ACTA HORTIC 893, V893; Morgan L, 2005, THE BEST OF THE GROW, P23; Naasz R, 2009, SOIL SCI SOC AM J, V73, P780, DOI 10.2136/sssaj2008.0058; Noguera P, 2003, COMMUN SOIL SCI PLAN, V34, P593, DOI 10.1081/CSS-120017842; Noguera P, 2000, ACTA HORTIC, P279, DOI 10.17660/ActaHortic.2000.517.34; Poling EB, 2000, ACTA HORTIC, P393; Raviv M., 2002, HYDROPONIC PRODUCTIO, P25; Raynal-Lacroix C, 2005, FERTIRRIGATION DES V; Rowley D, 2011, HORTSCIENCE, V46, P1480, DOI 10.21273/HORTSCI.46.11.1480; Saied AS, 2005, SCI HORTIC-AMSTERDAM, V103, P289, DOI 10.1016/j.scienta.2004.06.015; Sawan OMM, 1996, ACTA HORTIC, P127, DOI 10.17660/ActaHortic.1996.434.14; Smith R., 2009, PROC 2009 IRRIGATION, P1; Statistics Canada, 2012, FRUIT AND VEGETABLE; Takeda F, 2003, PROC XXVI IHC BERRY, P626; Thomas GV, 2013, CURR SCI INDIA, V104, P245; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vano I, 2011, SOIL SCI PLANT NUTR, V57, P348, DOI 10.1080/00380768.2011.574596; Wilkinson K, 2014, AGR HDB, V732, P376; Yuan BZ, 2004, BIOSYST ENG, V87, P237, DOI 10.1016/j.biosystemseng.2003.10.014	61	17	17	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154104	10.1371/journal.pone.0154104	http://dx.doi.org/10.1371/journal.pone.0154104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099949	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500145
J	Eriksson, J; Langel, U				Eriksson, Jonas; Langel, Ulo			Quantitative Microplate Assay for Real-Time Nuclease Kinetics	PLOS ONE			English	Article							INORGANIC-PHOSPHATE; EXONUCLEASE-III; RNA; ENZYME	Utilizing the phenomenon of nucleases exposing oligonucleotide phosphate backbones to phosphatases we present a novel quantitative method for kinetics of nuclease catalysis. Inorganic phosphate released from nuclease products by phosphatases could be quantified in real-time by a fluorescent sensor of inorganic phosphate. Two different nucleases were employed, showing the versatility of this assay for multiple turnover label-free nuclease studies.	[Eriksson, Jonas; Langel, Ulo] Stockholm Univ, Dept Neurochem, S-10691 Stockholm, Sweden	Stockholm University	Eriksson, J (corresponding author), Stockholm Univ, Dept Neurochem, S-10691 Stockholm, Sweden.	jonas.eriksson@neurochem.su.se	Langel, Ulo/K-9773-2018	Eriksson, Jonas/0000-0001-8813-1096; Langel, Ulo/0000-0001-6107-0844	Swedish Research Council for Natural Sciences [621-2011-5902]; Swedish Research Council for Medical Research [K2012-66X-21148-04-5]; Swedish Cancer Society [CAN 2012/251]	Swedish Research Council for Natural Sciences; Swedish Research Council for Medical Research; Swedish Cancer Society(Swedish Cancer Society)	This work was supported by grants to UL from the Swedish Research Council for Natural Sciences (621-2011-5902), the Swedish Research Council for Medical Research (K2012-66X-21148-04-5) and the Swedish Cancer Society (CAN 2012/251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CHOU KC, 1994, ANAL BIOCHEM, V221, P217, DOI 10.1006/abio.1994.1405; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; Das U, 2013, NUCLEIC ACIDS RES, V41, P355, DOI 10.1093/nar/gks977; DUSSOIX D, 1962, J MOL BIOL, V5, P37, DOI 10.1016/S0022-2836(62)80059-X; Eriksson J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135984; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kay HD, 1929, BRIT J EXP PATHOL, V10, P253; Lee J, 2012, ANALYST, V137, P2024, DOI 10.1039/c2an16214h; Li J J, 2000, Nucleic Acids Res, V28, pE52, DOI 10.1093/nar/28.11.e52; LINXWEILER W, 1982, NUCLEIC ACIDS RES, V10, P4845, DOI 10.1093/nar/10.16.4845; Liu L, 2013, TALANTA, V115, P819, DOI 10.1016/j.talanta.2013.06.062; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Mei SHJ, 2003, J AM CHEM SOC, V125, P412, DOI 10.1021/ja0281232; Michaelis L, 1913, BIOCHEM Z, V49, P333; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Morse DP, 1997, BIOCHEMISTRY-US, V36, P8429, DOI 10.1021/bi9709607; Mouratou B, 2002, ANAL BIOCHEM, V309, P40, DOI 10.1016/S0003-2697(02)00272-5; Nixon AE, 1998, ANAL BIOCHEM, V265, P299, DOI 10.1006/abio.1998.2916; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; THOMAS KR, 1978, J BIOL CHEM, V253, P424; Wang LH, 2015, ANAL BIOCHEM, V468, P34, DOI 10.1016/j.ab.2014.09.011; Xu QF, 2012, ANAL CHEM, V84, P10845, DOI 10.1021/ac303095z	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154099	10.1371/journal.pone.0154099	http://dx.doi.org/10.1371/journal.pone.0154099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101307	Green Published, gold			2022-12-26	WOS:000374898500143
J	Herry, CL; Cortes, M; Wu, HT; Durosier, LD; Cao, MJ; Burns, P; Desrochers, A; Fecteau, G; Seely, AJE; Frasch, MG				Herry, Christophe L.; Cortes, Marina; Wu, Hau-Tieng; Durosier, Lucien D.; Cao, Mingju; Burns, Patrick; Desrochers, Andre; Fecteau, Gilles; Seely, Andrew J. E.; Frasch, Martin G.			Temporal Patterns in Sheep Fetal Heart Rate Variability Correlate to Systemic Cytokine Inflammatory Response: A Methodological Exploration of Monitoring Potential Using Complex Signals Bioinformatics	PLOS ONE			English	Article							NEAR-TERM; WEIGHT; BIRTH	Fetal inflammation is associated with increased risk for postnatal organ injuries. No means of early detection exist. We hypothesized that systemic fetal inflammation leads to distinct alterations of fetal heart rate variability (fHRV). We tested this hypothesis deploying a novel series of approaches from complex signals bioinformatics. In chronically instrumented near-term fetal sheep, we induced an inflammatory response with lipopolysaccharide (LPS) injected intravenously (n = 10) observing it over 54 hours; seven additional fetuses served as controls. Fifty-one fHRV measures were determined continuously every 5minutes using Continuous Individualized Multi-organ Variability Analysis (CIMVA). CIMVA creates an fHRV measures matrix across five signal-analytical domains, thus describing complementary properties of fHRV. We implemented, validated and tested methodology to obtain a subset of CIMVA fHRV measures that matched best the temporal profile of the inflammatory cytokine IL-6. In the LPS group, IL-6 peaked at 3 hours. For the LPS, but not control group, a sharp increase in standardized difference in variability with respect to baseline levels was observed between 3 h and 6 h abating to baseline levels, thus tracking closely the IL-6 inflammatory profile. We derived fHRV inflammatory index (FII) consisting of 15 fHRV measures reflecting the fetal inflammatory response with prediction accuracy of 90%. Hierarchical clustering validated the selection of 14 out of 15 fHRV measures comprising FII. We developed methodology to identify a distinctive subset of fHRV measures that tracks inflammation over time. The broader potential of this bioinformatics approach is discussed to detect physiological responses encoded in HRV measures.	[Herry, Christophe L.; Seely, Andrew J. E.] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Durosier, Lucien D.; Cao, Mingju; Frasch, Martin G.] Univ Montreal, Dept OBGYN, CHU Ste Justine Res Ctr, Montreal, PQ, Canada; [Durosier, Lucien D.; Cao, Mingju; Frasch, Martin G.] Univ Montreal, Dept Neurosci, CHU Ste Justine Res Ctr, Montreal, PQ, Canada; [Burns, Patrick; Desrochers, Andre; Fecteau, Gilles] Univ Montreal, CHUV, Clin Sci, St Hyacinthe, PQ, Canada; [Seely, Andrew J. E.] Univ Ottawa, Div Thorac Surg, Ottawa, ON, Canada; [Seely, Andrew J. E.] Univ Ottawa, Div Crit Care Med, Ottawa, ON, Canada; [Cortes, Marina; Frasch, Martin G.] Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada; [Wu, Hau-Tieng] Univ Toronto, Dept Math, Toronto, ON M5S 1A1, Canada	University of Ottawa; Ottawa Hospital Research Institute; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Ottawa; University of Ottawa; Universite de Montreal; University of Toronto	Frasch, MG (corresponding author), Univ Montreal, Dept OBGYN, CHU Ste Justine Res Ctr, Montreal, PQ, Canada.; Frasch, MG (corresponding author), Univ Montreal, Dept Neurosci, CHU Ste Justine Res Ctr, Montreal, PQ, Canada.; Frasch, MG (corresponding author), Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada.	mfrasch@uw.edu	Cortes, Marina/O-3291-2013; Desrochers, Andre/E-7634-2019; Burns, Patrick/C-5943-2013; Frasch, Martin/AAN-8507-2020; Herry, Christophe/AAF-2086-2020	Cortes, Marina/0000-0002-4710-6334; Burns, Patrick/0000-0001-5229-3886; Frasch, Martin/0000-0003-3159-6321; Herry, Christophe/0000-0003-1863-5920; Wu, Hau-Tieng/0000-0002-0253-3156; Cao, Mingju/0000-0003-3380-7620	Canadian Institutes of Health Research, CIHR; fonds de recherche du Quebec en sante, FRQS; MATHEMATICS OF INFORMATION TECHNOLOGY AND COMPLEX SYSTEMS, MITACS/NeuroDevNet; Molly Towell Perinatal Research Foundation; CHU Ste-Justine Research Center; CIHR; NeuroDevNet/MITACS	Canadian Institutes of Health Research, CIHR(Canadian Institutes of Health Research (CIHR)); fonds de recherche du Quebec en sante, FRQS; MATHEMATICS OF INFORMATION TECHNOLOGY AND COMPLEX SYSTEMS, MITACS/NeuroDevNet; Molly Towell Perinatal Research Foundation; CHU Ste-Justine Research Center; CIHR(Canadian Institutes of Health Research (CIHR)); NeuroDevNet/MITACS	Funding was provided by the Canadian Institutes of Health Research, CIHR (to MGF and AJES); fonds de recherche du Quebec en sante, FRQS, MATHEMATICS OF INFORMATION TECHNOLOGY AND COMPLEX SYSTEMS, MITACS/NeuroDevNet, Molly Towell Perinatal Research Foundation and CHU Ste-Justine Research Center (to MGF); CIHR-funded Quebec Training Network in Perinatal Research, QTNPR and NeuroDevNet/MITACS (to LDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuchee A, 2012, SLEEP, V35, P1541, DOI 10.5665/sleep.2206; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Durosier LD, 2015, PHYSIOL MEAS, V36, DOI 10.1088/0967-3334/36/10/2089; Frasch MG, 2007, J PHYSIOL-LONDON, V579, P893, DOI 10.1113/jphysiol.2006.124800; Frasch MG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00378; Frasch MG, 2014, PHYSIOL MEAS, V35, pL1, DOI 10.1088/0967-3334/35/12/L1; Frasch MG, 2008, REPROD SCI, V15, P863, DOI 10.1177/1933719108324894; Frasch MG, 2009, AM J PHYSIOL-REG I, V296, pR702, DOI 10.1152/ajpregu.90474.2008; Garite TJ, 2001, CLIN PERINATOL, V28, P837, DOI 10.1016/S0095-5108(03)00081-2; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Johnstone IM, 2009, PHILOS T R SOC A, V367, P4237, DOI 10.1098/rsta.2009.0159; Liu HL, 2016, PEDIATR CRIT CARE ME, V17, pE165, DOI 10.1097/PCC.0000000000000643; Ratcliffe SJ, 2008, J STAT SOFTW, V25, P1; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566	17	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153515	10.1371/journal.pone.0153515	http://dx.doi.org/10.1371/journal.pone.0153515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100089	gold, Green Submitted, Green Published			2022-12-26	WOS:000374898500038
J	Nonnemacher, MR; Pirrone, V; Feng, R; Moldover, B; Passic, S; Aiamkitsumrit, B; Dampier, W; Wojno, A; Kilareski, E; Blakey, B; Ku, TSJ; Shah, S; Sullivan, NT; Jacobson, JM; Wigdahl, B				Nonnemacher, Michael R.; Pirrone, Vanessa; Feng, Rui; Moldover, Brian; Passic, Shendra; Aiamkitsumrit, Benjamas; Dampier, Will; Wojno, Adam; Kilareski, Evelyn; Blakey, Brandon; Ku, Tse-Sheun Jade; Shah, Sonia; Sullivan, Neil T.; Jacobson, Jeffrey M.; Wigdahl, Brian			HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; NEGATIVE REGULATORY ELEMENT; CENTRAL-NERVOUS-SYSTEM; SEQUENCE CONFIGURATIONS; BIOLOGICAL PHENOTYPE; MICROGLIAL CELLS; WIDE-RANGE; TYPE-1; INFECTION	The large majority of human immunodeficiency virus type 1 (HIV-1) markers of disease progression/severity previously identified have been associated with alterations in host genetic and immune responses, with few studies focused on viral genetic markers correlate with changes in disease severity. This study presents a cross-sectional/longitudinal study of HIV-1 single nucleotide polymorphisms (SNPs) contained within the viral promoter or long terminal repeat (LTR)in patients within the Drexel Medicine CNS AIDS Research and Eradication Study (CARES) Cohort. HIV-1 LTR SNPs were found to associate with the classical clinical disease parameters CD4(+) T-cell count and log viral load. They were found in both defined and undefined transcription factor binding sites of the LTR. A novel SNP identified at position 108 in a known COUP (chicken ovalbumin upstream promoter)/AP1 transcription factor binding site was significantly correlated with binding phenotypes that are potentially the underlying cause of the associated clinical outcome (increase in viral load and decrease in CD4(+) T-cell count).	[Nonnemacher, Michael R.; Pirrone, Vanessa; Passic, Shendra; Aiamkitsumrit, Benjamas; Dampier, Will; Wojno, Adam; Kilareski, Evelyn; Blakey, Brandon; Ku, Tse-Sheun Jade; Shah, Sonia; Sullivan, Neil T.; Jacobson, Jeffrey M.; Wigdahl, Brian] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Nonnemacher, Michael R.; Pirrone, Vanessa; Passic, Shendra; Aiamkitsumrit, Benjamas; Dampier, Will; Wojno, Adam; Kilareski, Evelyn; Blakey, Brandon; Ku, Tse-Sheun Jade; Shah, Sonia; Sullivan, Neil T.; Jacobson, Jeffrey M.; Wigdahl, Brian] Drexel Univ, Coll Med, Ctr Mol Virol & Translat Neurosci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA; [Feng, Rui] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Moldover, Brian] B Tech Consulting Ltd, Philadelphia, PA USA; [Jacobson, Jeffrey M.; Wigdahl, Brian] Drexel Univ, Ctr Clin & Translat Med, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA; [Jacobson, Jeffrey M.] Drexel Univ, Div Infect Dis & HIV Med, Dept Med, Coll Med, Philadelphia, PA 19104 USA	Drexel University; Drexel University; University of Pennsylvania; Pennsylvania Medicine; Drexel University; Drexel University	Wigdahl, B (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.; Wigdahl, B (corresponding author), Drexel Univ, Coll Med, Ctr Mol Virol & Translat Neurosci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA.; Wigdahl, B (corresponding author), Drexel Univ, Ctr Clin & Translat Med, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA.	bwigdahl@drexelmed.edu		Sullivan, Neil/0000-0002-4589-9182	Public Health Service; National Institutes of Health through the National Institute of Neurological Disorders and Stroke [NS32092, NS46263]; National Institute of Drug Abuse [DA19807]; National Institute for Mental Health under the Ruth L. Kirschstein National Research Service [5T32MH079785]; B-Tech Consulting; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH079785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046263, R01NS032092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019807] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health through the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute for Mental Health under the Ruth L. Kirschstein National Research Service; B-Tech Consulting; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded in part by the Public Health Service, National Institutes of Health through grants from the National Institute of Neurological Disorders and Stroke, NS32092 and NS46263, the National Institute of Drug Abuse, DA19807 (Dr. Brian Wigdahl, Principal Investigator), and from the National Institute for Mental Health under the Ruth L. Kirschstein National Research Service Award 5T32MH079785. Brian Moldover receives a salary from B-Tech Consulting; the specific role of this author is articulated in the Author Contributions section. These contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKHALED M, 1995, AIDS, V9, P675, DOI 10.1097/00002030-199507000-00002; AITKHALED M, 1994, J GEN VIROL, V75, P1615, DOI 10.1099/0022-1317-75-7-1615; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bartlett JG, 2005, CHARGE TRANSFER DNA, P1; Bhatia R, 2005, GUIDELINES HIV DIAGN; BOZZETTE SA, 1993, J INFECT DIS, V168, P1374, DOI 10.1093/infdis/168.6.1374; Bracho MA, 1998, J GEN VIROL, V79, P2921, DOI 10.1099/0022-1317-79-12-2921; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Burdo TH, 2004, J NEUROVIROL, V10, P7, DOI [10.1080/753312746, 10.1080/13550280490270789]; Burdo TH, 2004, DNA CELL BIOL, V23, P261, DOI 10.1089/104454904773819842; CANONNEHERGAUX F, 1995, J VIROL, V69, P6634, DOI 10.1128/JVI.69.11.6634-6642.1995; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; CONNOR RI, 1993, J VIROL, V67, P1772, DOI 10.1128/JVI.67.4.1772-1777.1993; COONEY AJ, 1991, J VIROL, V65, P2853, DOI 10.1128/JVI.65.6.2853-2860.1991; CORBOY JR, 1992, SCIENCE, V258, P1804, DOI 10.1126/science.1465618; CULLEN BR, 1991, ANNU REV MICROBIOL, V45, P219; Dahiya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088116; DELASSUS S, 1991, J VIROL, V65, P225, DOI 10.1128/JVI.65.1.225-231.1991; Dunfee RL, 2006, P NATL ACAD SCI USA, V103, P15160, DOI 10.1073/pnas.0605513103; Estable MC, 1996, J VIROL, V70, P4053, DOI 10.1128/JVI.70.6.4053-4062.1996; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2011, J INFECT DIS, V203, P773, DOI 10.1093/infdis/jiq125; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Hogan TH, 2003, J NEUROVIROL, V9, P55, DOI 10.1080/13550280390173292; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Kingsman SM, 1996, EUR J BIOCHEM, V240, P491, DOI 10.1111/j.1432-1033.1996.0491h.x; Kirchhoff F, 1997, VIROLOGY, V232, P319, DOI 10.1006/viro.1997.8586; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; KOOT M, 1992, AIDS, V6, P49, DOI 10.1097/00002030-199201000-00006; LADIAS JAA, 1994, J BIOL CHEM, V269, P5944; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li LN, 2011, J NEUROVIROL, V17, P92, DOI 10.1007/s13365-010-0014-1; Lingappa JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028632; LU YC, 1990, J VIROL, V64, P5226, DOI 10.1128/JVI.64.10.5226-5229.1990; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; MICHAEL NL, 1994, J VIROL, V68, P3163, DOI 10.1128/JVI.68.5.3163-3174.1994; Naggie S, 2012, J INFECT DIS, V205, P376, DOI 10.1093/infdis/jir754; NIELSEN C, 1993, AIDS, V7, P1035, DOI 10.1097/00002030-199308000-00002; Nonnemacher MR, 2004, J NEUROIMMUNOL, V157, P39, DOI 10.1016/j.jneuroim.2004.08.021; ORCHARD K, 1992, NUCLEIC ACIDS RES, V20, P5429, DOI 10.1093/nar/20.20.5429; ORCHARD K, 1990, J VIROL, V64, P3234, DOI 10.1128/JVI.64.7.3234-3239.1990; PANG S, 1992, AIDS, V6, P453, DOI 10.1097/00002030-199205000-00003; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pelak K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001208; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Pirrone V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/548749; Poon AFY, 2010, MOL BIOL EVOL, V27, P819, DOI 10.1093/molbev/msp289; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rallon NI, 2011, AIDS, V25, P269, DOI 10.1097/QAD.0b013e328341b84e; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; Ross HL, 2001, J NEUROVIROL, V7, P235; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schwartz GW, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/3/035005; Shah S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/320642; Shea PR, 2013, ANNU REV MED, V64, P203, DOI 10.1146/annurev-med-052511-135400; Shi J, 2015, J VIROL, V89, P208, DOI 10.1128/JVI.01411-14; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; van Manen D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-70; Verbeke G, 2000, LINEAR MIXED MODELS; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	65	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0150835	10.1371/journal.pone.0150835	http://dx.doi.org/10.1371/journal.pone.0150835			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100290	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500004
J	Rizk, HH; Hamdy, NM; Al-Ansari, NL; El-Mesallamy, HO				Rizk, Hanan H.; Hamdy, Nadia M.; Al-Ansari, Nadia L.; El-Mesallamy, Hala O.			Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; RIBAVIRIN TREATMENT; INSULIN-RESISTANCE; EXPRESSION LEVELS; PLUS RIBAVIRIN; VIRUS; IL28B; PD-1; INFECTION; CTLA-4	Background Egypt has the highest prevalence of a difficult to treat chronic hepatitis C virus (HCV), genotype 4. Pretreatment factors could guide individualization of therapy which aids in treatment optimization and interleukin IL28B gene polymorphism has been shown to closely relate to HCV treatment response. Polymorphisms in genes encoding inhibitors of T-cell response, which have role in disease progression as Programmed Cell Death 1 (PD-1), and Cytotoxic T-Lymphocytes Antigen-4 (CTLA-4), could be candidate markers predicting treatment response. Methods This cohort study consisted of 200 chronic HCV genotype 4 infected patients treated with PegIFN alpha-2a and RBV in 2 hepatology centers. Genotyping of the polymorphisms in the IL28B gene region (rs12979860), PD1.3 (rs11568821) and CTLA-4 (rs231775) was performed on DNA collected from each patient using TaqMan (R) genotyping assay. Groups were classified according to response into sustained virological responders (SVR), or non-responders (NR). A multivariate logistic regression analysis was used to identify potential markers, host pretreatment clinical and viral predictive factors including viral load, insulin resistance, and alpha fetoprotein (AFP) related to treatment response. Results Our results showed that in a multivariate analyses IL28B C/C genotype was the most significant predictor for SVR (OR = 10.86; p<0.0001) followed by AFP (OR = 0.915; p = 0.001) then CTLA-4/G genotypes (OR = 1.948; p = 0.022). However, PD-1.3/A genotypes and platelets count were significantly related to response in univariate analysis only (OR = 1.973; p = 0.023; OR = 1.007; p = 0.009 respectively). Conclusion IL28B SNP, AFP level, and CTLA-4 SNP could be used in conjunction to predict treatment response in HCV genotype 4 infected Egyptian patients.	[Rizk, Hanan H.; Hamdy, Nadia M.; El-Mesallamy, Hala O.] Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Al-Ansari, Nadia L.] Ain Shams Univ, Fac Med, Endem Med Dept & Hepatol Unit, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University	El-Mesallamy, HO (corresponding author), Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	hala.elmesallamy@hotmail.com	Hamdy, Nadia/AAB-6087-2021	Hamdy, Nadia/0000-0003-2105-107X				Abdoul H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002391; Aggour S., 2015, DAILY NEWS EGYPT; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Barth H, 2015, WORLD J HEPATOL, V7, P725, DOI 10.4254/wjh.v7.i5.725; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Danilovic DLS, 2012, LIVER INT, V32, P803, DOI 10.1111/j.1478-3231.2011.02694.x; De Nicola S, 2012, HEPATOLOGY, V55, P336, DOI 10.1002/hep.24683; Sabaawy D, 2015, APMIS, V123, P482, DOI 10.1111/apm.12377; El Sayed Nasr, 2012, Morbidity and Mortality Weekly Report, V61, P545; Estrabaud E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121395; Feeney ER, 2014, BMJ-BRIT MED J, V348, P3308; Ford N, 2012, B WORLD HEALTH ORGAN, V90, P540, DOI 10.2471/BLT.11.097147; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hayes CN, 2012, NAT REV GASTRO HEPAT, V9, P406, DOI 10.1038/nrgastro.2012.101; Intlekofer AM, 2013, J LEUKOCYTE BIOL, V94, P25, DOI 10.1189/jlb.1212621; Kamal-Yanni M, 2015, LANCET GLOB HEALTH, V3, pE73, DOI 10.1016/S2214-109X(14)70365-1; Kanda T, 2013, WORLD J HEPATOL, V5, P182, DOI 10.4254/wjh.v5.i4.182; Khairy M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10509; Khudayberganova D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093011; Kristjansdottir H, 2010, ARTHRITIS RHEUM-US, V62, P1702, DOI 10.1002/art.27417; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; LEE YH, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1039/C4CC06435F); Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Matas M, 2014, INT MICROBIOL, V17, P11, DOI 10.2436/20.1501.01.203; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Newby PR, 2007, CLIN ENDOCRINOL, V67, P125, DOI 10.1111/j.1365-2265.2007.02848.x; O'Brien TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020904; Ogawa E, 2012, J HEPATOL, V56, pS474, DOI 10.1016/S0168-8278(12)61209-4; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pawlotsky JM, 2014, J HEPATOL, V61, P373, DOI 10.1016/j.jhep.2014.05.001; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Vidal-Castineira JR, 2012, J HEPATOL, V56, P1230, DOI 10.1016/j.jhep.2012.01.011; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Saleh HM, 2009, IRAN J PUBLIC HEALTH, V38, P56; Shehab H, 2014, J INTERF CYTOK RES, V34, P727, DOI 10.1089/jir.2013.0127; Smith KR, 2011, GENOME MED, P3; Strahotin CS, 2012, ADV VIROL, V2012, DOI 10.1155/2012/267483; Tachi Y, 2016, J GASTROEN HEPATOL, V31, P1001, DOI 10.1111/jgh.13245; Tipu I, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.15076; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Wang L, 2014, BIOMED REP, V2, P270, DOI 10.3892/br.2014.217; Wang XB, 2008, J INTERN MED, V263, P61, DOI 10.1111/j.1365-2796.2007.01879.x; World Health Organization, 2015, HEP C; Yee LJ, 2003, J INFECT DIS, V187, P1264, DOI 10.1086/374561; Younossi ZM, 2012, J TRANSL MED, V7, P10; Youssef SS, 2014, J INTERF CYTOK RES, V34, P505, DOI 10.1089/jir.2013.0115	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153895	10.1371/journal.pone.0153895	http://dx.doi.org/10.1371/journal.pone.0153895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100663	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500090
J	Rutkis, R; Strazdina, I; Balodite, E; Lasa, Z; Galinina, N; Kalnenieks, U				Rutkis, Reinis; Strazdina, Inese; Balodite, Elina; Lasa, Zane; Galinina, Nina; Kalnenieks, Uldis			The Low Energy-Coupling Respiration in Zymomonas mobilis Accelerates Flux in the Entner-Doudoroff Pathway	PLOS ONE			English	Article							ALCOHOL-DEHYDROGENASE-II; ETHANOL-PRODUCTION; GENOME SEQUENCE; ELECTRON-TRANSPORT; AEROBIC GROWTH; CHAIN; METABOLISM; OXIDASE; CYANIDE; OXYGEN	Performing oxidative phosphorylation is the primary role of respiratory chain both in bacteria and eukaryotes. Yet, the branched respiratory chains of prokaryotes contain alternative, low energy-coupling electron pathways, which serve for functions other than oxidative ATP generation (like those of respiratory protection, adaptation to low-oxygen media, redox balancing, etc.), some of which are still poorly understood. We here demonstrate that withdrawal of reducing equivalents by the energetically uncoupled respiratory chain of the bacterium Zymomonas mobilis accelerates its fermentative catabolism, increasing the glucose consumption rate. This is in contrast to what has been observed in other respiring bacteria and yeast. This effect takes place after air is introduced to glucose-consuming anaerobic cell suspension, and can be simulated using a kinetic model of the Entner-Doudoroff pathway in combination with a simple net reaction of NADH oxidation that does not involve oxidative phosphorylation. Although aeration hampers batch growth of respiring Z. mobilis culture due to accumulation of toxic byproducts, nevertheless under non-growing conditions respiration is shown to confer an adaptive advantage for the wild type over the non-respiring Ndh knock-out mutant. If cells get occasional access to limited amount of glucose for short periods of time, the elevated glucose uptake rate selectively improves survival of the respiring Z. mobilis phenotype.	[Rutkis, Reinis; Strazdina, Inese; Balodite, Elina; Lasa, Zane; Galinina, Nina; Kalnenieks, Uldis] Univ Latvia, Inst Microbiol & Biotechnol, Jelgavas St 1, LV-1004 Riga, Latvia	Riga Stradins University; University of Latvia	Kalnenieks, U (corresponding author), Univ Latvia, Inst Microbiol & Biotechnol, Jelgavas St 1, LV-1004 Riga, Latvia.	kalnen@lanet.lv			Latvian Council of Science [536/2012]	Latvian Council of Science(Latvian Ministry of Education and Science)	All authors received funding from grant No. 536/2012 of the Latvian Council of Science (http://www.lzp.lv/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN HJ, 1991, J BACTERIOL, V173, P5975, DOI 10.1128/jb.173.19.5975-5982.1991; Balodite E, 2014, MICROBIOL-SGM, V160, P2045, DOI 10.1099/mic.0.081612-0; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, V1; BRINGER S, 1984, ARCH MICROBIOL, V139, P376, DOI 10.1007/BF00408383; BRINGERMEYER S, 1989, APPL MICROBIOL BIOT, V31, P529, DOI 10.1007/BF00270789; CHANCE B, 1959, NATURE, V184, P931, DOI 10.1038/184931a0; DAWES EA, 1970, J GEN MICROBIOL, V60, P31, DOI 10.1099/00221287-60-1-31; Desiniotis A, 2012, J BACTERIOL, V194, P5966, DOI 10.1128/JB.01398-12; DIMARCO AA, 1985, APPL ENVIRON MICROB, V49, P151, DOI 10.1128/AEM.49.1.151-157.1985; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Hayashi T, 2015, MICROBIOL-SGM, V161, P2384, DOI 10.1099/mic.0.000195; Hayashi T, 2012, APPL ENVIRON MICROB, V78, P5622, DOI 10.1128/AEM.00733-12; Hayashi T, 2011, J BIOSCI BIOENG, V111, P414, DOI 10.1016/j.jbiosc.2010.12.009; KALNENIEKS U, 1993, ARCH MICROBIOL, V160, P74, DOI 10.1007/BF00258148; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Kalnenieks U, 2000, MICROBIOL-UK, V146, P1259, DOI 10.1099/00221287-146-6-1259; Kalnenieks U, 2005, ARCH MICROBIOL, V183, P450, DOI 10.1007/s00203-005-0023-2; Kalnenieks U, 2008, MICROBIOL-SGM, V154, P989, DOI 10.1099/mic.0.2007/012682-0; Kalnenieks U, 2006, ADV MICROB PHYSIOL, V51, P73, DOI 10.1016/S0065-2911(06)51002-1; KIM YJ, 1995, J BACTERIOL, V177, P5176, DOI 10.1128/jb.177.17.5176-5178.1995; Kouvelis VN, 2011, J BACTERIOL, V193, P5049, DOI 10.1128/JB.05273-11; Kouvelis VN, 2009, J BACTERIOL, V191, P7140, DOI 10.1128/JB.01084-09; KREBS EG, 1955, METHOD ENZYMOL, V1, P407, DOI 10.1016/0076-6879(55)01066-5; Kremer TA, 2015, P NATL ACAD SCI USA, V112, P2222, DOI 10.1073/pnas.1420663112; OHTA K, 1991, APPL ENVIRON MICROB, V57, P893, DOI 10.1128/AEM.57.4.893-900.1991; PANKOVA LM, 1988, APPL MICROBIOL BIOT, V28, P583; Pentjuss A, 2013, J BIOTECHNOL, V165, P1, DOI 10.1016/j.jbiotec.2013.02.014; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; Rogers PL, 2007, ADV BIOCHEM ENG BIOT, V108, P263, DOI 10.1007/10_2007_060; Rogers P. L., 1982, MICROB REACT, V23, P37; Rutkis R., 2014, J BASIC MICROB, V54, P1; Rutkis R, 2013, MICROBIOL-SGM, V159, P2674, DOI 10.1099/mic.0.071340-0; SAHM H, 1987, ACTA BIOTECHNOL, V7, P307, DOI 10.1002/abio.370070405; Scopes RK, 1997, BIOCHEM J, V326, P731, DOI 10.1042/bj3260731; Seo JS, 2005, NAT BIOTECHNOL, V23, P63, DOI 10.1038/nbt1045; Sootsuwan K, 2008, J MOL MICROB BIOTECH, V14, P163, DOI 10.1159/000112598; Sootsuwan K, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-180; STANLEY GA, 1993, BIOTECHNOL BIOENG, V42, P24, DOI 10.1002/bit.260420104; Strazdina I, 2012, ARCH MICROBIOL, V194, P461, DOI 10.1007/s00203-011-0785-7; STROHDEICHER M, 1990, ARCH MICROBIOL, V154, P536; Toh H, 1997, ARCH MICROBIOL, V168, P46, DOI 10.1007/s002030050468; Widiastuti H, 2011, BIOTECHNOL BIOENG, V108, P655, DOI 10.1002/bit.22965; Yang SH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00246; ZHANG M, 1995, SCIENCE, V267, P240, DOI 10.1126/science.267.5195.240; [No title captured]	45	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153866	10.1371/journal.pone.0153866	http://dx.doi.org/10.1371/journal.pone.0153866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100889	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500080
J	Sato, K; Suda, K; Shimizu, S; Sakai, K; Mizuuchi, H; Tomizawa, K; Takemoto, T; Nishio, K; Mitsudomi, T				Sato, Katsuaki; Suda, Kenichi; Shimizu, Shigeki; Sakai, Kazuko; Mizuuchi, Hiroshi; Tomizawa, Kenji; Takemoto, Toshiki; Nishio, Kazuto; Mitsudomi, Tetsuya			Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; TYROSINE KINASE AXL; ACQUIRED-RESISTANCE; CELL CARCINOMA; OVARIAN-CANCER; SURVIVAL; CLASSIFICATION; AMPLIFICATION; ACTIVATION; INHIBITORS	The receptor tyrosine kinase AXL is a member of the Tyro3-Axl-Mer receptor tyrosine kinase subfamily. AXL affects several cellular functions, including growth and migration. AXL aberration is reportedly a marker for poor prognosis and treatment resistance in various cancers. In this study, we analyzed clinical, pathological, and molecular features of AXL expression in lung adenocarcinomas (LADs). We examined 161 LAD specimens from patients who underwent pulmonary resections. When AXL protein expression was quantified (0, 1+, 2+, 3+) according to immunohistochemical staining intensity, results were 0: 35%; 1+: 20%; 2+: 37%; and 3+: 7% for the 161 samples. AXL expression status did not correlate with clinical features, including smoking status and pathological stage. However, patients whose specimens showed strong AXL expression (3+) had markedly poorer prognoses than other groups (P = 0.0033). Strong AXL expression was also significantly associated with downregulation of E-cadherin (P = 0.025) and CD44 (P = 0.0010). In addition, 9 of 12 specimens with strong AXL expression had driver gene mutations (6 with EGFR, 2 with KRAS, 1 with ALK). In conclusion, we found that strong AXL expression in surgically resected LADs was a predictor of poor prognosis. LADs with strong AXL expression were characterized by mesenchymal status, higher expression of stem-cell-like markers, and frequent driver gene mutations.	[Sato, Katsuaki; Suda, Kenichi; Mizuuchi, Hiroshi; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya] Kinki Univ, Div Thorac Surg, Dept Surg, Fac Med, Osaka, Japan; [Shimizu, Shigeki] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo, Japan; [Sakai, Kazuko; Nishio, Kazuto] Kinki Univ, Dept Genome Biol, Fac Med, Osaka, Japan	Kindai University (Kinki University); Hyogo College of Medicine; Kindai University (Kinki University)	Mitsudomi, T (corresponding author), Kinki Univ, Div Thorac Surg, Dept Surg, Fac Med, Osaka, Japan.	mitsudom@surg.med.kindai.ac.jp		Mitsudomi, Tetsuya/0000-0001-9860-8505; Suda, Kenichi/0000-0002-0842-8832; Sato, Katsuaki/0000-0003-4045-7796	Ministry of Education, Science, Sports, and Culture of Japan [15K18450]; Uehara Memorial Foundation; Takeda Science Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	The present study is partly supported by Grants-in-Aid of Cancer Research from the Ministry of Education, Science, Sports, and Culture of Japan (K. Suda, 15K18450); the Uehara Memorial Foundation (T. Mitsudomi); and the Takeda Science Foundation (T. Mitsudomi).; The authors are grateful to Ms. Tomoko Hashimoto for her technical assistance. The present study is partly supported by Grants-in-Aid of Cancer Research from the Ministry of Education, Science, Sports, and Culture of Japan (K. Suda, 15K18450), the Uehara Memorial Foundation (T. Mitsudomi), and the Takeda Science Foundation (T. Mitsudomi).	Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Bae SY, 2015, ONCOTARGET; Brand TM, 2014, AXL MEDIATES RESISTA, DOI [10.1158/0008-5472.CAN-14-0294, DOI 10.1158/0008-5472.CAN-14-0294]; Cheng P, 2015, STEM CELL REP, V4, P899, DOI 10.1016/j.stemcr.2015.03.005; Cichon MA, 2014, ONCOGENE, V33, P4185, DOI 10.1038/onc.2013.388; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Hong J, 2013, CANCER RES, V73, P331, DOI 10.1158/0008-5472.CAN-12-3151; Ishikawa M, 2013, ANN SURG ONCOL, V20, pS467, DOI 10.1245/s10434-012-2795-3; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Macleod K, 2005, CANCER RES, V65, P6789, DOI 10.1158/0008-5472.CAN-04-2684; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924; Paccez JD, 2014, INT J CANCER, V134, P1024, DOI 10.1002/ijc.28246; Postel-Vinay S, 2012, NAT GENET, V44, P835, DOI 10.1038/ng.2362; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Rho JK, 2014, CANCER RES, V74, P253, DOI 10.1158/0008-5472.CAN-13-1103; Sakai K, 2014, ONCOTARGET, V5, P9641, DOI 10.18632/oncotarget.2438; Sica G, 2010, AM J SURG PATHOL, V34, P1155, DOI 10.1097/PAS.0b013e3181e4ee32; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Suda K, 2011, INT J CLIN ONCOL, V16, P294, DOI 10.1007/s10147-011-0262-y; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Sung WJ, 2015, INT J CLIN EXP PATHO, V8, P8997; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wu F, 2014, INT J CLIN EXP PATHO, V7, P6653; Yang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099763; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	32	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154186	10.1371/journal.pone.0154186	http://dx.doi.org/10.1371/journal.pone.0154186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100677	Green Published, gold			2022-12-26	WOS:000374898500162
J	Seim, A; Omurova, G; Azisov, E; Musuraliev, K; Aliev, K; Tulyaganov, T; Nikolyai, L; Botman, E; Helle, G; Linan, ID; Jivcov, S; Linderholm, HW				Seim, Andrea; Omurova, Gulzar; Azisov, Erlan; Musuraliev, Kanaat; Aliev, Kumar; Tulyaganov, Timur; Nikolyai, Lyutsian; Botman, Evgeniy; Helle, Gerd; Dorado Linan, Isabel; Jivcov, Sandra; Linderholm, Hans W.			Climate Change Increases Drought Stress of Juniper Trees in the Mountains of Central Asia	PLOS ONE			English	Article							WATER-USE EFFICIENCY; TIEN-SHAN; GROWTH; RESPONSES; TEMPERATURES; IMPACTS; REGION; SPRUCE; SHIFT; RIVER	Assessments of climate change impacts on forests and their vitality are essential for semi-arid environments such as Central Asia, where the mountain regions belong to the globally important biodiversity hotspots. Alterations in species distribution or drought-induced tree mortality might not only result in a loss of biodiversity but also in a loss of other ecosystem services. Here, we evaluate spatial trends and patterns of the growth-climate relationship in a tree-ring network comprising 33 juniper sites from the northern Pamir-Alay and Tien Shan mountain ranges in eastern Uzbekistan and across Kyrgyzstan for the common period 1935-2011. Junipers growing at lower elevations are sensitive to summer drought, which has increased in intensity during the studied period. At higher elevations, juniper growth, previously favored by warm summer temperatures, has in the recent few decades become negatively affected by increasing summer aridity. Moreover, response shifts are observed during all seasons. Rising temperatures and alterations in precipitation patterns during the past eight decades can account for the observed increase in drought stress of junipers at all altitudes. The implications of our findings are vital for the application of adequate long-term measures of ecosystem conservation, but also for paleo-climatic approaches and coupled climate-vegetation model simulations for Central Asia.	[Seim, Andrea; Linderholm, Hans W.] Univ Gothenburg, Dept Earth Sci, Reg Climate Grp, Gothenburg, Sweden; [Omurova, Gulzar; Azisov, Erlan] CAIAG, Bishkek, Kyrgyzstan; [Omurova, Gulzar; Musuraliev, Kanaat] KNAU, Bishkek, Kyrgyzstan; [Musuraliev, Kanaat] Natl Acad Sci Republ Kyrgyzstan, Innovat Ctr Phytotechnol, Bishkek, Kyrgyzstan; [Aliev, Kumar] Univ Cent Asia, Bishkek, Kyrgyzstan; [Tulyaganov, Timur; Nikolyai, Lyutsian; Botman, Evgeniy] RSPCDGF, Tashkent, Uzbekistan; [Helle, Gerd] Helmholtz Ctr Potsdam, German Ctr Geosci Climate Dynam & Landscape Evolu, Potsdam, Germany; [Dorado Linan, Isabel] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Forest Res Ctr, Madrid, Spain; [Jivcov, Sandra] Univ Cologne, Inst Geol & Mineral, D-50931 Cologne, Germany	University of Gothenburg; Central-Asian Institute for Applied Geosciences (CAIAG); Kyrgyz National Agrarian University; National Academy of Sciences of the Kyrgyz Republic (NAS KR); American University of Central Asia; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); University of Cologne	Seim, A (corresponding author), Univ Gothenburg, Dept Earth Sci, Reg Climate Grp, Gothenburg, Sweden.	andrea.seim@gvc.gu.se	Linderholm, Hans W/N-1020-2013; Botman, Evgeniy/AAC-3857-2021; Dorado Liñán, Isabel/B-4393-2017; Liñán, Isabel Dorado/AAR-1539-2020	Linderholm, Hans W/0000-0002-1522-8919; Dorado Liñán, Isabel/0000-0002-8913-0420; Liñán, Isabel Dorado/0000-0002-8913-0420; Seim, Andrea/0000-0002-7201-8010; Helle, Gerhard/0000-0001-9988-6638; Omurova, Gulzar/0000-0002-9951-3628	Kungliga Vetenskapsakademien (KVA, Margit Althins Stipendiefond); Svenska Sallskapet for Antropologi och Geografi (SSAG); Wilhelm och Martina Lundgrens Vetenskapsfond; Swedish International Development Cooperation Agency SIDA [SWE-2009-245]	Kungliga Vetenskapsakademien (KVA, Margit Althins Stipendiefond); Svenska Sallskapet for Antropologi och Geografi (SSAG); Wilhelm och Martina Lundgrens Vetenskapsfond; Swedish International Development Cooperation Agency SIDA	The study was partially funded by Kungliga Vetenskapsakademien (KVA, including the Margit Althins Stipendiefond), Svenska Sallskapet for Antropologi och Geografi (SSAG), Wilhelm och Martina Lundgrens Vetenskapsfond and Swedish International Development Cooperation Agency SIDA (project SWE-2009-245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen VB, 1997, J CLIMATE, V10, P1393, DOI 10.1175/1520-0442(1997)010<1393:CAHCIT>2.0.CO;2; Aizen VB, 2007, GLOBAL PLANET CHANGE, V56, P328, DOI 10.1016/j.gloplacha.2006.07.016; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andreu-Hayles L, 2011, GLOBAL CHANGE BIOL, V17, P2095, DOI 10.1111/j.1365-2486.2010.02373.x; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; Botman E., 2008, CLIMATE CHANGE CONSE; Brauning A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020793; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Buntgen U, 2006, TREES-STRUCT FUNCT, V20, P99, DOI 10.1007/s00468-005-0017-3; Buntgen U, 2005, CLIM DYNAM, V25, P141, DOI 10.1007/s00382-005-0028-1; Buntgen U, 2006, J CLIMATE, V19, P5606, DOI 10.1175/JCLI3917.1; Burrough PA, 2011, PRINCIPLES GEOGRAPHI; Linares JC, 2012, GLOBAL CHANGE BIOL, V18, P1000, DOI 10.1111/j.1365-2486.2011.02566.x; Carrer M, 2006, NEW PHYTOL, V170, P861, DOI 10.1111/j.1469-8137.2006.01703.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cook E.R., 2005, PROGRAM ARSTAN TREE; Cook ER, 1997, HOLOCENE, V7, P361, DOI 10.1177/095968369700700314; Edenhofer O., 2014, CONTRIBUTION WORKING; Esper J, 2003, CLIM DYNAM, V21, P699, DOI 10.1007/s00382-003-0356-y; Esper J, 2002, HOLOCENE, V12, P267, DOI 10.1191/0959683602hl543rp; ESRI, 2011, ARCGIS DESKT REL 10; Fisher M, 1997, GLOBAL ECOL BIOGEOGR, V6, P379, DOI 10.2307/2997338; Fritts H.C, 1976, TREE RINGS CLIMATE; Galvan JD, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084001; Glazirin GE, 2005, NIGMI P, V5, P24; Granda E, 2014, OECOLOGIA, V174, P307, DOI 10.1007/s00442-013-2742-4; Graybill D, 1992, RECENT DENDROCHRONOL; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hessl A, 2007, PROF GEOGR, V59, P87, DOI 10.1111/j.1467-9272.2007.00593.x; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Horton DE, 2015, NATURE, V522, P465, DOI 10.1038/nature14550; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kyrgyzstan N., 2009, 2 NATL COMMUNICATION; Levesque M, 2014, NEW PHYTOL, V203, P94, DOI 10.1111/nph.12772; Liang EY, 2008, GLOBAL PLANET CHANGE, V61, P313, DOI 10.1016/j.gloplacha.2007.10.008; Liang E, 2016, CLIMATIC CHANGE, V134, P163, DOI 10.1007/s10584-015-1531-y; Lioubimtseva E, 2009, J ARID ENVIRON, V73, P963, DOI 10.1016/j.jaridenv.2009.04.022; Liu HY, 2013, GLOBAL CHANGE BIOL, V19, P2500, DOI 10.1111/gcb.12217; Liu Y, 2009, SCI CHINA SER D, V52, P348, DOI 10.1007/s11430-009-0025-z; Lutgens F.K., 2001, ATMOSPHERE INTRO MET; Melvin Thomas M., 2007, Dendrochronologia, V25, P65, DOI 10.1016/j.dendro.2007.01.004; Merzlyakova I., 2002, MOUNTAINS CENTRAL AS, P377; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Mosello B, 2008, J PUBLIC INT AFFAIRS, V19; Mukhamedshin KD, 1977, TIEN SHAN JUNIPER FO; Osborn T, 1997, DENDROCHRONOLOGIA, V15, pe99; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Saiko TA, 2000, APPL GEOGR, V20, P349, DOI 10.1016/S0143-6228(00)00014-X; Salzer MW, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/114007; Savitskiy AG, 2008, ADAPTIVE AND INTEGRATED WATER MANAGEMENT: COPING WITH COMPLEXITY AND UNCERTAINTY, P323, DOI 10.1007/978-3-540-75941-6_17; Seim A, 2015, TREES-STRUCT FUNCT, P1, DOI [10.1007/s00468-015-1316-y, DOI 10.1007/S00468-015-1316-Y]; Solomina Olga, 2014, [Geography, Environment, Sustainability, Geography, Environment, Sustainability], V7, P66; Sorg A, 2014, ENVIRON SCI POLICY, V43, P68, DOI 10.1016/j.envsci.2013.11.003; Spaargaren OC, 1998, WORLD REFERENCE BASE; Stokes M.A., 1996, INTRO TREE RING DATI; Uzbekistan N., 2009, 2 NATL COMMUNICATION; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Williams M.W., 2008, CENTRAL ASIA TEMPERA, DOI [10.7265/N5NK3BZ8, DOI 10.7265/N5NK3BZ8]; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Winter MB, 2009, EUR J FOREST RES, V128, P531, DOI 10.1007/s10342-009-0295-1; Zhang TW, 2014, DENDROCHRONOLOGIA, V32, P230, DOI 10.1016/j.dendro.2014.03.002	66	21	22	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153888	10.1371/journal.pone.0153888	http://dx.doi.org/10.1371/journal.pone.0153888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100092	Green Published, gold			2022-12-26	WOS:000374898500086
J	Weikl, F; Tischer, C; Probst, AJ; Heinrich, J; Markevych, I; Jochner, S; Pritsch, K				Weikl, Fabian; Tischer, Christina; Probst, Alexander J.; Heinrich, Joachim; Markevych, Iana; Jochner, Susanne; Pritsch, Karin			Fungal and Bacterial Communities in Indoor Dust Follow Different Environmental Determinants	PLOS ONE			English	Article							AIRBORNE BACTERIAL; TEMPORAL VARIABILITY; ATOPIC SENSITIZATION; SEASONAL VARIABILITY; MICROBIAL DIVERSITY; PARTICULATE MATTER; OUTDOOR AIR; ENDOTOXIN; ALLERGENS; PRIMERS	People spend most of their time inside buildings and the indoor microbiome is a major part of our everyday environment. It affects humans' wellbeing and therefore its composition is important for use in inferring human health impacts. It is still not well understood how environmental conditions affect indoor microbial communities. Existing studies have mostly focussed on the local (e.g., building units) or continental scale and rarely on the regional scale, e.g. a specific metropolitan area. Therefore, we wanted to identify key environmental determinants for the house dust microbiome from an existing collection of spatially (area of Munich, Germany) and temporally (301 days) distributed samples and to determine changes in the community as a function of time. To that end, dust samples that had been collected once from the living room floors of 286 individual households, were profiled for fungal and bacterial community variation and diversity using microbial fingerprinting techniques. The profiles were tested for their association with occupant behaviour, building characteristics, outdoor pollution, vegetation, and urbanization. Our results showed that more environmental and particularly outdoor factors (vegetation, urbanization, airborne particulate matter) affected the community composition of indoor fungi than of bacteria. The passage of time affected fungi and, surprisingly, also strongly affected bacteria. We inferred that fungal communities in indoor dust changed semi-annually, whereas bacterial communities paralleled outdoor plant phenological periods. These differences in temporal dynamics cannot be fully explained and should be further investigated in future studies on indoor microbiomes.	[Weikl, Fabian; Pritsch, Karin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Neuherberg, Germany; [Tischer, Christina; Heinrich, Joachim; Markevych, Iana] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Tischer, Christina] Ctr Res Environm Epidemiol, Barcelona, Spain; [Probst, Alexander J.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Heinrich, Joachim] Univ Munich, Univ Hosp Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Markevych, Iana] Univ Munich, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Munich, Germany; [Jochner, Susanne] Catholic Univ Eichstatt Ingolstadt, Phys Geog Landscape Ecol & Sustainable Ecosyst De, Eichstatt, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Berkeley; University of Munich; University of Munich	Weikl, F (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Neuherberg, Germany.	fabian.weikl@helmholtz-muenchen.de	Heinrich, Joachim/N-1720-2013; Probst, Alexander J/K-2813-2016; Jochner-Oette, Susanne/D-4201-2017; Markevych, Iana/AAQ-3332-2020	Heinrich, Joachim/0000-0002-9620-1629; Markevych, Iana/0000-0002-5214-0748; Weikl, Fabian Christopher/0000-0003-3973-6341; Probst, Alexander/0000-0002-9392-6544; Jochner-Oette, Susanne/0000-0002-5371-9516				Adams RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091283; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Adhikari A, 2006, ENVIRON POLLUT, V140, P16, DOI 10.1016/j.envpol.2005.07.004; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Barberan A, 2015, P ROY SOC B-BIOL SCI, V282, P212, DOI 10.1098/rspb.2015.1139; Barberan A, 2015, P NATL ACAD SCI USA, V112, P5756, DOI 10.1073/pnas.1420815112; Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0; Bowers RM, 2013, ENVIRON SCI TECHNOL, V47, P12097, DOI 10.1021/es402970s; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Burge HA, 2002, J ALLERGY CLIN IMMUN, V110, P544, DOI 10.1067/mai.2002.128674; Casas L, 2013, INDOOR AIR, V23, P208, DOI 10.1111/ina.12017; Chen J, GUNIFRAC GENERALIZED; Collins RE, 2007, NUCLEIC ACIDS RES, V35, pW58, DOI 10.1093/nar/gkm384; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Fernandez-Rodriguez S, 2014, FUNGAL ECOL, V7, P16, DOI 10.1016/j.funeco.2013.11.004; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Heald CL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037493; Heinrich J, 2003, J EXPO ANAL ENV EPID, V13, P152, DOI 10.1038/sj.jea.7500267; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Heseltine E, 2009, WHO GUIDELINES FOR I; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Kelley ST, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-202; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Kettleson EM, 2015, ENVIRON RES, V138, P130, DOI 10.1016/j.envres.2015.02.003; Koch A, 2000, ALLERGY, V55, P176, DOI 10.1034/j.1398-9995.2000.00233.x; Kopperud RJ, 2004, J AIR WASTE MANAGE, V54, P1188, DOI 10.1080/10473289.2004.10470983; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Li KJ, 2010, AEROBIOLOGIA, V26, P233, DOI 10.1007/s10453-010-9159-x; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Maron PA, 2005, ATMOS ENVIRON, V39, P3687, DOI 10.1016/j.atmosenv.2005.03.002; Martin LJ, 2015, TRENDS ECOL EVOL, V30, P223, DOI 10.1016/j.tree.2015.02.001; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Mitakakis T., 1997, AEROBIOLOGIA, V13, P83, DOI [10.1007/BF02694423, DOI 10.1007/BF02694423]; Moschandreas DJ, 2003, AEROSOL SCI TECH, V37, P899, DOI 10.1080/02786820300935; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Nevalainen A, 2005, INDOOR AIR, V15, P58, DOI 10.1111/j.1600-0668.2005.00344.x; Nevalainen A, 2015, INDOOR AIR, V25, P125, DOI 10.1111/ina.12182; Oksanen J., **DATA OBJECT**; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; Polymenakou PN, 2013, AEROBIOLOGIA, V29, P429, DOI 10.1007/s10453-013-9295-1; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Ruokolainen L, 2015, ALLERGY, V70, P195, DOI 10.1111/all.12545; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; Team RC., 2013, R A LANGUAGE AND ENV; Valkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131594; Vesper S, 2007, J OCCUP ENVIRON MED, V49, P829, DOI 10.1097/JOM.0b013e3181255e98; White T.J., 1990, INFECT GENET EVOL, V3, P315; Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30; Zhang T, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024010; Zutavern A, 2006, PEDIATRICS, V117, P401, DOI 10.1542/peds.2004-2521	60	54	55	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154131	10.1371/journal.pone.0154131	http://dx.doi.org/10.1371/journal.pone.0154131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100967	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500153
J	Green, BB; Houseman, EA; Johnson, KC; Guerin, DJ; Armstrong, DA; Christensen, BC; Marsit, CJ				Green, Benjamin B.; Houseman, E. Andres; Johnson, Kevin C.; Guerin, Dylan J.; Armstrong, David A.; Christensen, Brock C.; Marsit, Carmen J.			Hydroxymethylation is uniquely distributed within term placenta, and is associated with gene expression	FASEB JOURNAL			English	Article						5-hydroxymethylcytosine; RNA-seq; DOHaD	EMBRYONIC STEM-CELLS; GENOME-WIDE ANALYSIS; DNA METHYLATION; BASE-RESOLUTION; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; REVEALS; BRAIN; 5-FORMYLCYTOSINE; BLOOD	The conversion of cytosine to 5-methylcystosine (5mC) is an important regulator of gene expression. 5mC may be enzymatically converted to 5-hydroxymethylcytosine (5hmC), with a potentially distinct regulatory function. We sought to investigate these cytosine modifications and their effect on gene expression by parallel processing of genomic DNA using bisulfite and oxidative bisulfite conversion in conjunction with RNA sequencing. Although values of 5hmC across the placental genome were generally low, we identified similar to 21,000 loci with consistently elevated levels of 5-hydroxymethycytosine. Absence of 5hmC was observed in CpG islands and, to a greater extent, in non-CpG island-associated regions. 5hmC was enriched within poised enhancers, and depleted within active enhancers, as defined by H3K27ac and H3K4me1 measurements. 5hmC and 5mC were significantly elevated in transcriptionally silent genes when compared with actively transcribed genes. 5hmC was positively associated with transcription in actively transcribed genes only. Our data suggest that dynamic cytosine regulation, associated with transcription, provides the most complete epigenomic landscape of the humanplacenta, and will be useful for future studies of the placental epigenome.	[Green, Benjamin B.; Johnson, Kevin C.; Guerin, Dylan J.; Armstrong, David A.; Christensen, Brock C.; Marsit, Carmen J.] Dartmouth Coll, Geisel Sch Med, Dept Epidemiol, Hanover, NH USA; [Green, Benjamin B.; Johnson, Kevin C.; Guerin, Dylan J.; Armstrong, David A.; Christensen, Brock C.; Marsit, Carmen J.] Dartmouth Coll, Geisel Sch Med, Dept Pharmacol & Toxicol, Hanover, NH USA; [Houseman, E. Andres] Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Corvallis, OR USA	Dartmouth College; Dartmouth College; Oregon State University	Green, BB (corresponding author), Geisel Sch Med, 7650 Williamson, Lebanon, NH 03756 USA.	benjamin.b.green@dartmouth.edu		Marsit, Carmen/0000-0003-4566-150X	U.S. National Institutes of Health (NIH), National Institute of Mental Illness [R01MH094609]; NIH National Institute of Environmental Health Sciences [R01ES022223, P01 ES022832]; U.S. Environmental Protection Agency (EPA) [RD83544201]; NATIONAL CANCER INSTITUTE [R25CA134286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES022832, R01ES022223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094609] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Mental Illness; NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the U.S. National Institutes of Health (NIH), National Institute of Mental Illness (Grant R01MH094609), the NIH National Institute of Environmental Health Sciences (Grants R01ES022223 and P01 ES022832), and by the U.S. Environmental Protection Agency (EPA; Grant RD83544201). This article's contents are solely the responsibility of the grantee, and do not necessarily represent the official views of the EPA. Furthermore, the EPA does not endorse the purchase of any commercial products or services mentioned in the presentation. B.B.G. contributed to the concept and design of the experiment, performed statistical analyses, interpreted the results, and wrote and revised the manuscript. E.A.H. generated the statistical models, performed statistical analyses, interpreted the results, and revised the manuscript. K.C.J. performed statistical analyses, interpreted the results, and revised the manuscript. D.J.G. collected the data and revised the manuscript. D.A.A. collected data and revised the manuscript. B.C.C. contributed to the concept and design of the experiment, interpreted the results, and revised the manuscript. C.J.M. contributed to the concept and design of the experiment, interpreted the results, and revised the manuscript. All authors have read and approved the final manuscript. The authors declare no conflicts of interest.	Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Binder AM, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0116-y; Chapman CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17568; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Field SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118202; Finer S, 2015, HUM MOL GENET, V24, P3021, DOI 10.1093/hmg/ddv013; Gelmann EP, 2003, PROSTATE, V55, P111, DOI 10.1002/pros.10210; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Green Benjamin B, 2015, Curr Environ Health Rep, V2, P126, DOI 10.1007/s40572-015-0045-0; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Maccani JZJ, 2015, REPROD TOXICOL, V57, P43, DOI 10.1016/j.reprotox.2015.05.002; Maccani JZJ, 2015, ENVIRON HEALTH PERSP, V123, P723, DOI 10.1289/ehp.1408561; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; Nestor C, 2010, BIOTECHNIQUES, V48, P317, DOI 10.2144/000113403; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Peffers MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4278; Piyasena C, 2015, EPIGENETICS-US, V10, P692, DOI 10.1080/15592294.2015.1062963; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson WP, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023044; Ruchat SM, 2013, EPIGENETICS-US, V8, P935, DOI 10.4161/epi.25578; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stewart SK, 2015, METHODS, V72, P9, DOI 10.1016/j.ymeth.2014.08.009; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Sui WG, 2015, INT J MOL MED, V35, P1467, DOI 10.3892/ijmm.2015.2149; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Taylor SEB, 2015, ARTHRITIS RHEUMATOL, V67, P2129, DOI 10.1002/art.39179; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wen L, 2014, GENOMICS, V104, P341, DOI 10.1016/j.ygeno.2014.08.020; Wen L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r49; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	44	26	26	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2874	2884		10.1096/fj.201600310R	http://dx.doi.org/10.1096/fj.201600310R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27118675	Green Published			2022-12-26	WOS:000380994000022
J	Bieri, T; Onishi, M; Xiang, TT; Grossman, AR; Pringle, JR				Bieri, Tamaki; Onishi, Masayuki; Xiang, Tingting; Grossman, Arthur R.; Pringle, John R.			Relative Contributions of Various Cellular Mechanisms to Loss of Algae during Cnidarian Bleaching	PLOS ONE			English	Article							SYMBIOTIC SEA-ANEMONE; DINOFLAGELLATE SYMBIOSIS; SCLERACTINIAN CORALS; AIPTASIA-PALLIDA; MODEL SYSTEM; ENDOSYMBIOTIC ALGAE; OXIDATIVE STRESS; LIGHT-INTENSITY; THERMAL-STRESS; HEAT-STRESS	When exposed to stress such as high seawater temperature, corals and other cnidarians can bleach due to loss of symbiotic algae from the host tissue and/or loss of pigments from the algae. Although the environmental conditions that trigger bleaching are reasonably well known, its cellular and molecular mechanisms are not well understood. Previous studies have reported the occurrence of at least four different cellular mechanisms for the loss of symbiotic algae from the host tissue: in situ degradation of algae, exocytic release of algae from the host, detachment of host cells containing algae, and death of host cells containing algae. The relative contributions of these several mechanisms to bleaching remain unclear, and it is also not known whether these relative contributions change in animals subjected to different types and/or durations of stresses. In this study, we used a clonal population of the small sea anemone Aiptasia, exposed individuals to various precisely controlled stress conditions, and quantitatively assessed the several possible bleaching mechanisms in parallel. Under all stress conditions tested, except for acute cold shock at 4 degrees C, expulsion of intact algae from the host cells appeared to be by far the predominant mechanism of bleaching. During acute cold shock, in situ degradation of algae and host-cell detachment also became quantitatively significant, and the algae released under these conditions appeared to be severely damaged.	[Bieri, Tamaki; Onishi, Masayuki; Pringle, John R.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Bieri, Tamaki; Grossman, Arthur R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA	Stanford University; Stanford University; Carnegie Institution for Science	Pringle, JR (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	jpringle@stanford.edu	Xiang, Tingting/H-9352-2019	Xiang, Tingting/0000-0001-9062-2273; Onishi, Masayuki/0000-0002-9799-4501	Gordon and Betty Moore Foundation [2629]; International Fulbright Science and Technology Program; National Institutes of Health Instrumentation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026780] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); International Fulbright Science and Technology Program; National Institutes of Health Instrumentation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Gordon and Betty Moore Foundation (www.moore.org) Grant 2629 to JRP and ARG, International Fulbright Science and Technology Program to TB, and National Institutes of Health Instrumentation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, CORAL REEFS, V27, P593, DOI 10.1007/s00338-008-0355-x; Baumgarten S, 2015, P NATL ACAD SCI USA, V112, P11893, DOI 10.1073/pnas.1513318112; BROWN BE, 1995, MAR BIOL, V122, P655, DOI 10.1007/BF00350687; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Downs CA, 2009, AUTOPHAGY, V5, P211, DOI 10.4161/auto.5.2.7405; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2006, J MOL EVOL, V63, P95, DOI 10.1007/s00239-005-0236-7; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039024; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Dunn SR, 2002, J EXP MAR BIOL ECOL, V272, P29, DOI 10.1016/S0022-0981(02)00036-9; DYKENS JA, 1992, J EXP BIOL, V168, P219; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Fujise Lisa, 2013, Galaxea - Tokyo, V15, P29; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; GLYNN PW, 1985, DIS AQUAT ORGAN, V1, P29, DOI 10.3354/dao001029; Hambleton EA, 2014, J EXP BIOL, V217, P1613, DOI 10.1242/jeb.095679; Hanes SD, 2013, INVERTEBR BIOL, V132, P95, DOI 10.1111/ivb.12018; Hawkins TD, 2013, FASEB J, V27, P4790, DOI 10.1096/fj.13-235051; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOEGHGULDBERG O, 1987, CORAL REEFS, V5, P201, DOI 10.1007/BF00300964; Krediet CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135725; Kvitt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028665; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; Leal MC, 2015, J EXP BIOL, V218, P858, DOI 10.1242/jeb.115519; Lehnert EM, 2014, G3-GENES GENOM GENET, V4, P277, DOI 10.1534/g3.113.009084; Lehnert EM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-271; LeTissier MDA, 1996, MAR ECOL PROG SER, V136, P235, DOI 10.3354/meps136235; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; National Oceanic and Athmospheric Administration, 2011, VAL COR EC; Nii CM, 1997, BIOL BULL, V192, P444, DOI 10.2307/1542753; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Paxton CW, 2013, J EXP BIOL, V216, P2813, DOI 10.1242/jeb.087858; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Pochon X, 2014, PEERJ, V2, DOI 10.7717/peerj.394; Poreba M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008680; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Sawyer SJ, 2001, J EXP BIOL, V204, P3443; SCHOENBERG DA, 1980, PROC R SOC SER B-BIO, V207, P445, DOI 10.1098/rspb.1980.0033; STEELE RD, 1976, J ZOOL, V179, P387; STEEN RG, 1987, BIOL BULL, V172, P246, DOI 10.2307/1541797; Strychar KB, 2004, PHYCOLOGIA, V43, P768, DOI 10.2216/i0031-8884-43-6-768.1; Strychar KB, 2004, MAR FRESHWATER RES, V55, P135, DOI 10.1071/MF03080; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; Titlyanov EA, 1996, MAR ECOL PROG SER, V139, P167, DOI 10.3354/meps139167; Tolleter D, 2013, CURR BIOL, V23, P1782, DOI 10.1016/j.cub.2013.07.041; Voolstra CR, 2013, MOL ECOL, V22, P4366, DOI 10.1111/mec.12464; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Xiang TT, 2015, PLANT J, V82, P67, DOI 10.1111/tpj.12789; Xiang TT, 2013, J PHYCOL, V49, P447, DOI 10.1111/jpy.12055; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	59	54	56	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152693	10.1371/journal.pone.0152693	http://dx.doi.org/10.1371/journal.pone.0152693			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119147	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200010
J	Daujeard, C; Geraads, D; Gallotti, R; Lefevre, D; Mohib, A; Raynal, JP; Hublin, JJ				Daujeard, Camille; Geraads, Denis; Gallotti, Rosalia; Lefevre, David; Mohib, Abderrahim; Raynal, Jean-Paul; Hublin, Jean-Jacques			Pleistocene Hominins as a Resource for Carnivores: A c. 500,000-Year-Old Human Femur Bearing Tooth-Marks in North Africa (Thomas Quarry I, Morocco)	PLOS ONE			English	Article							GRAN DOLINA SIERRA; MIDDLE PLEISTOCENE; HUMAN REMAINS; LONG BONES; LOS HUESOS; EARLIEST OCCUPATION; NEANDERTHAL REMAINS; HOMO; CAVE; CONSUMPTION	In many Middle Pleistocene sites, the co-occurrence of hominins with carnivores, who both contributed to faunal accumulations, suggests competition for resources as well as for living spaces. Despite this, there is very little evidence of direct interaction between them to-date. Recently, a human femoral diaphysis has been recognized in South-West of Casablanca (Morocco), in the locality called Thomas Quarry I. This site is famous for its Middle Pleistocene fossil hominins considered representatives of Homo rhodesiensis. The bone was discovered in Unit 4 of the Grotte a Hominides (GH), dated to c.500 ky and was associated with Acheulean artefacts and a rich mammalian fauna. Anatomically, it fits well within the group of known early Middle Pleistocene Homo, but its chief point of interest is that the diaphyseal ends display numerous tooth marks showing that it had been consumed shortly after death by a large carnivore, probably a hyena. This bone represents the first evidence of consumption of human remains by carnivores in the cave. Whether predated or scavenged, this chewed femur indicates that humans were a resource for carnivores, underlining their close relationships during the Middle Pleistocene in Atlantic Morocco.	[Daujeard, Camille] UPVD, UPMC, Univ Paris 04, CNRS,HNHP,MNHN,UMR 7194, Paris, France; [Geraads, Denis] UPMC, Univ Paris 04, CNRS, CR2P,MNHN,UMR 7207, Paris, France; [Geraads, Denis; Raynal, Jean-Paul; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Gallotti, Rosalia] Univ Roma La Sapienza, Dipartimento Sci Antichita, Via Volsci 122, I-00185 Rome, Italy; [Gallotti, Rosalia; Raynal, Jean-Paul] Univ Bordeaux, PACEA, CNRS, UMR 5199, Pessac, France; [Lefevre, David] Univ Montpellier 3, CNRS, UMR 5140, Archeol Soc Mediterraneennes, F-34032 Montpellier, France; [Mohib, Abderrahim] Inst Natl Sci Archeol Patrimoine, Rabat, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Montpellier; Universite Paul-Valery	Hublin, JJ (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	hublin@eva.mpg.de	Daujeard, Camille/AAQ-4952-2020; Gallotti, Rosalia/AAP-4599-2020; Geraads, Denis/AAY-6051-2020; GERAADS, Denis/AAC-7241-2021	Daujeard, Camille/0000-0001-7489-8691; Gallotti, Rosalia/0000-0001-7308-7715; GERAADS, Denis/0000-0003-2475-8011; LEFEVRE, David/0000-0002-9086-4093	Ministere de la Culture of the Kingdom of Morocco (Institut National des Sciences de l'Archeologie et du Patrimoine - INSAP); Ministere des Affaires etrangeres et du Developpement International of France; Region Aquitaine for project Origines III [20101401006]; Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany	Ministere de la Culture of the Kingdom of Morocco (Institut National des Sciences de l'Archeologie et du Patrimoine - INSAP); Ministere des Affaires etrangeres et du Developpement International of France; Region Aquitaine for project Origines III; Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany	The Morocco-France Casablanca Project was jointly funded by the Ministere de la Culture of the Kingdom of Morocco (Institut National des Sciences de l'Archeologie et du Patrimoine - INSAP), the Ministere des Affaires etrangeres et du Developpement International of France, the Funding Region Aquitaine for project Origines III (contract 20101401006) and the Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany.	Andres M, 2003, ARCHAEOL ANTHROP SCI, V4, P209; Andrews P, 1997, J HUM EVOL, V33, P191, DOI 10.1006/jhev.1997.0137; Arilla M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102457; Arribas A, 1999, J ARCHAEOL SCI, V26, P571, DOI 10.1006/jasc.1998.0346; Arribas A., 1997, CUATERNARIO GEOMORFO, V11, P55; Arsuaga JL, 2007, J HUM EVOL, V52, P31, DOI 10.1016/j.jhevol.2006.07.011; Auguste P., 1995, B SOC PREHISTORIQUE, V92, P155; Barba R, 2007, VERTEBR PALEOBIOL PA, P217; Baynes-Rock M, 2008, THESIS J COOK U; Beauval C, 2005, P NATL ACAD SCI USA, V102, P7085, DOI 10.1073/pnas.0502656102; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Bernoussi R, 1997, THESIS U BORDEAUX 1; Biberson P, 1956, B ARCHEOLOGIE MAROCA, V1, P39; Biberson P., 1961, PUBLICATIONS SERVICE, V17; Binford L.R., 1981, BONES ANCIENT MEN MO; Blasco R, 2011, J ARCHAEOL SCI, V38, P3373, DOI 10.1016/j.jas.2011.07.023; Blasco R, 2010, J ARCHAEOL SCI, V37, P2051, DOI 10.1016/j.jas.2010.03.010; Blasco R, 2009, CR PALEVOL, V8, P579, DOI 10.1016/j.crpv.2009.06.003; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Blumenschine RJ, 1986, OXFORD BAR INT SERIE, V283; Boaz NT, 2004, J HUM EVOL, V46, P519, DOI 10.1016/j.jhevol.2004.01.007; Boaz NT., 2000, ACTA ANTHR SINICA, V19, P224; Brain CK, 1981, HUNTERS HUNTED; Brantingham PJ, 1998, J ANTHROPOL ARCHAEOL, V17, P327, DOI 10.1006/jaar.1998.0326; Brugal Jean-Philip, 2004, Revue de Paleobiologie, V23, P575; Camaros E, 2015, ARCHAEOL AN IN PRESS; Campmas E, 2008, ANN PALEONTOL, V94, P167, DOI 10.1016/j.annpal.2008.06.001; Carretero JM, 2012, J HUM EVOL, V62, P242, DOI 10.1016/j.jhevol.2011.11.004; Coard R, 2007, J ARCHAEOL SCI, V34, P1677, DOI 10.1016/j.jas.2006.12.006; Daujeard Camille, 2012, Journal of Taphonomy, V10, P349; David F, 2009, J HUM EVOL, V57, P805, DOI 10.1016/j.jhevol.2009.03.006; Delaney-Rivera C, 2009, J ARCHAEOL SCI, V36, P2597, DOI 10.1016/j.jas.2009.08.001; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P1385, DOI 10.1016/S0305-4403(03)00027-X; Dominguez-Rodrigo M, 1999, PALAEOGEOGR PALAEOCL, V149, P373, DOI 10.1016/S0031-0182(98)00213-2; Dominguez-Rodrigo M, 2015, QUATERNARY SCI REV, V126, P67, DOI 10.1016/j.quascirev.2015.08.020; Dominguez-Rodrigo Manuel, 2012, Journal of Taphonomy, V10, P147; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Eng CM, 2013, AM J PHYS ANTHROPOL, V151, P544, DOI 10.1002/ajpa.22296; ENNOUCHI E, 1969, CR ACAD SCI D NAT, V269, P763; Fosse P., 1997, PALEO, V9, P15, DOI [10.3406/pal.1997.1227, DOI 10.3406/PAL.1997.1227]; Fourvel Jean-Baptiste, 2012, Journal of Taphonomy, V10, P239; GERAADS D, 1980, CR ACAD SCI D NAT, V291, P195; Geraads D., 1980, Quaternaria, V22, P65; GERAADS D, 1983, ANTHROPOLOGIE, V87, P138; GERAADS D, 1986, QUATERNARY RES, V25, P380, DOI 10.1016/0033-5894(86)90008-6; Geraads D., 2010, ANTHROPOLOGIE, V114, P324; Geraads Denis, 2002, Quaternaire, V13, P43; Geraads D, 2011, PALAEONTOLOGY, V54, P429, DOI 10.1111/j.1475-4983.2011.01039.x; Geraads D, 2008, CR PALEVOL, V7, P591, DOI 10.1016/j.crpv.2008.09.008; Giacobini G, 1991, QUATERN NOVA, V1, P593; Gidna A, 2013, J ARCHAEOL SCI, V40, P1903, DOI 10.1016/j.jas.2012.11.023; Gidna AO, 2014, QUATERN INT, V322, P167, DOI 10.1016/j.quaint.2013.08.059; Gilbert WH, 2008, HOMOERECTUS PLEISTOC, P376; Grayson DK, 2003, J ARCHAEOL SCI, V30, P585, DOI 10.1016/S0305-4403(02)00205-4; GRIMAUDHERVE D, 1994, CR ACAD SCI II, V318, P1139; GRINE FE, 1995, AM J PHYS ANTHROPOL, V97, P151, DOI 10.1002/ajpa.1330970207; HAYNES G, 1983, PALEOBIOLOGY, V9, P164, DOI 10.1017/S0094837300007545; HAYNES G, 1980, PALEOBIOLOGY, V6, P341, DOI 10.1017/S0094837300006849; Hossini S, 2002, THESIS U MOULAY ISMA; Hublin J.J., 2001, HUMAN ROOTS AFRICA A, P99; Hublin JJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0062; HUBLIN JJ, 1992, CR ACAD SCI II, V314, P975; Janssens L, 2015, LATE GLACIAL BURIAL, P253; KENNEDY GE, 1983, J HUM EVOL, V12, P587, DOI 10.1016/S0047-2484(83)80001-3; Kitagawa Keiko, 2012, Journal of Taphonomy, V10, P439; Lefevre D., 2002, PALEORIVAGES CASABLA, V13, P9, DOI DOI 10.3406/quate.2002.1700; Lefevre D, 2000, THESIS U P VALERY MO; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Arsuaga JL, 2015, P NATL ACAD SCI USA, V112, P11524, DOI 10.1073/pnas.1514828112; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Mann AE, 2005, PALEOANTHROPOLOGY A, V28; Martinez-Moreno J., 2010, ZONA ARQUEOLOGICA, V13, P230; McCown TD., 1939, FOSSIL HUMAN REMAINS; Moncel MH, 2012, J HUM EVOL, V63, P653, DOI 10.1016/j.jhevol.2012.08.001; Moncel MH, 2008, MEMOIRE SOC PREHISTO, V46; Moncel MH, 2015, QUATERN INT IN PRESS; Munzel SC, 2004, INT J OSTEOARCHAEOL, V14, P225, DOI 10.1002/oa.758; Njau JK, 2012, J HUM EVOL, V63, P408, DOI 10.1016/j.jhevol.2011.05.008; Oakley K.P., 1977, P PREHIST SOC, V43, P13, DOI [10.1017/S0079497X00010343, DOI 10.1017/S0079497X00010343]; Palombo MR, 2008, QUATERN INT, V179, P176, DOI 10.1016/j.quaint.2007.08.029; Palombo MR, 2006, QUATERN INT, V149, P94, DOI 10.1016/j.quaint.2005.11.022; Palombo MR, 2010, QUATERN INT, V223, P179, DOI 10.1016/j.quaint.2009.11.016; Parkinson JA, 2015, J HUM EVOL, V80, P114, DOI 10.1016/j.jhevol.2014.10.011; Pickering TR, 2004, J HUM EVOL, V46, P595, DOI 10.1016/j.jhevol.2004.03.002; Pickering TR, 2002, INT J OSTEOARCHAEOL, V12, P127, DOI 10.1002/oa.594; Puymerail L., 2011, THESIS MUSEUM NATL H; Puymerail L, 2012, CR PALEVOL, V11, P581, DOI 10.1016/j.crpv.2012.07.001; Quam RM, 2001, J HUM EVOL, V41, P385, DOI 10.1006/jhev.2001.0486; Raynal J.-P., 2002, QUATERNAIRE, V13, P65, DOI DOI 10.3406/QUATE.2002.1704]; Raynal JP, 2010, QUATERN INT, V223, P369, DOI 10.1016/j.quaint.2010.03.011; Raynal JP, 2001, QUATERN INT, V75, P65, DOI 10.1016/S1040-6182(00)00078-1; Raynal JP, 1995, EARLIEST OCCUPATION, P255; Raynal JP, 2011, B SOC PREHISTORIQUE, V108, P1; Rhodes EJ, 2006, QUATERNARY SCI REV, V25, P2569, DOI 10.1016/j.quascirev.2005.09.010; Roebroeks W, 2001, J HUM EVOL, V41, P437, DOI 10.1006/jhev.2001.0499; Rolland N, 2010, QUATERN INT, V223, P54, DOI 10.1016/j.quaint.2010.02.011; Rosell Jordi, 2012, Journal of Taphonomy, V10, P125; Rosell Jordi, 2009, Journal of Taphonomy, V7, P305; Ruff CB, 1983, AM J PHYS ANTHROPOL, V60, P259; Sahnouni M, 2013, J HUM EVOL, V64, P137, DOI 10.1016/j.jhevol.2012.10.007; Saladie P, 2013, INT J OSTEOARCHAEOL, V23, P13, DOI 10.1002/oa.1237; Saladie P, 2014, QUATERNARY SCI REV, V93, P47, DOI 10.1016/j.quascirev.2014.04.001; Sam Y, 2011, ACT 30 RENC INT ARCH, P65; Schulting RJ, 2005, J HUM EVOL, V48, P493, DOI 10.1016/j.jhevol.2005.02.001; Selvaggio MM, 2001, J ARCHAEOL SCI, V28, P465, DOI 10.1006/jasc.2000.0557; Serangeli J, 2015, J HUM EVOL, V89, P172, DOI 10.1016/j.jhevol.2015.08.005; SHIPMAN P, 1984, CURR ANTHROPOL, V25, P116, DOI 10.1086/203091; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Stiner Mary C., 2012, Journal of Taphonomy, V10, P129; Stiner MC, 2002, J ARCHAEOL RES, V10, P1, DOI 10.1023/A:1014588307174; Texier JP, 2002, PALEORIVAGES CASABLA, V13, P23; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Tournepiche J.-F., 1994, PALEO, V6, P319; Tournepiche JF, 1996, CR ACAD SCI II A, V322, P429; Trinkaus E, 2008, AM J PHYS ANTHROPOL, V135, P371, DOI 10.1002/ajpa.20753; Trinkaus E, 2007, AM J PHYS ANTHROPOL, V134, P263, DOI 10.1002/ajpa.20669; Trinkaus Erik, 2012, Paleoanthropology, V2012, P13; TURNER A, 1992, J HUM EVOL, V22, P109, DOI 10.1016/0047-2484(92)90033-6; Valensi P, 2004, INT J OSTEOARCHAEOL, V14, P256, DOI 10.1002/oa.760; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Werdelin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057944; WHITE TD, 1991, CURR ANTHROPOL, V32, P118, DOI 10.1086/203931	122	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152284	10.1371/journal.pone.0152284	http://dx.doi.org/10.1371/journal.pone.0152284			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120202	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200007
J	Fujiwara, M; Kawasaki, Y; Yamada, H				Fujiwara, Masakazu; Kawasaki, Yohei; Yamada, Hiroshi			A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association Analysis	PLOS ONE			English	Article							RISK	Background Rapid dissemination of information regarding adverse drug reactions is a key aspect for improving pharmacovigilance. There is a possibility that unknown adverse drug reactions will become apparent through post-marketing administration. Currently, although there have been studies evaluating the relationships between a drug and adverse drug reactions using the JADER database which collects reported spontaneous adverse drug reactions, an efficient approach to assess the association between adverse drug reactions of drugs with the same indications as well as the influence of demographics (e.g. gender) has not been proposed. Methods and Findings We utilized the REAC and DEMO tables from the May 2015 version of JADER for patients taking antidepressant drugs (SSRI, SNRI, and NaSSA). We evaluated the associations using association analyses with an apriori algorithm. Support, confidence, lift, and conviction were used as indicators for associations. The highest score in adverse drug reactions for SSRI was obtained for "aspartate aminotransferase increased", "alanine aminotransferase increased", with values of 0.0059, 0.93, 135.5, and 13.9 for support, confidence, lift and conviction, respectively. For SNRI, "international normalized ratio increased", "drug interaction" were observed with 0.0064, 1.00, 71.9, and NA. For NaSSA, "anxiety", "irritability" were observed with 0.0058, 0.80, 49.9, and 4.9. For female taking SSRI, the highest support scores were observed in "twenties", "suicide attempt", whereas "thirties", "neuroleptic malignant syndrome" were observed for male. Second, for SNRI, "eighties", "inappropriate antidiuretic hormone secretion" were observed for female, whereas "interstitial lung disease" and "hepatitis fulminant" were for male. Finally, for NaSSA, "suicidal ideation" was for female, and "rhabdomyolysis" was for male. Conclusions Different combinations of adverse drug reactions were noted between the antidepressants. In addition, the reported adverse drug reactions differed by gender. This approach using a large database for examining the associations can improve safety monitoring during the post-marketing phase.	[Fujiwara, Masakazu; Kawasaki, Yohei; Yamada, Hiroshi] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka 4228526, Japan; [Fujiwara, Masakazu] Shionogi Pharmaceut Co, Dept Biostat, Osaka, Japan	University of Shizuoka; Shionogi & Company Limited	Fujiwara, M (corresponding author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka 4228526, Japan.; Fujiwara, M (corresponding author), Shionogi Pharmaceut Co, Dept Biostat, Osaka, Japan.	masakazu.fujiwara@shionogi.co.jp		Kawasaki, Yohei/0000-0002-7474-7647	Japanese Ministry of Health, Labor and Welfare [24220501]; Shionogi Pharmaceutical Company	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Shionogi Pharmaceutical Company	This work was supported in part by a grant from the Japanese Ministry of Health, Labor and Welfare (No. 24220501) to HY. No additional external funding was received for this study. Shionogi Pharmaceutical Company provided support in the form of salaries for author MF but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Agrawal R., 1994, P 20 INT C VER LARG, P487; [Anonymous], 2005, GUID IND GOOD PHARM; [Anonymous], 2004, PHARM PLANN; Dodd S, 2011, AUST NZ J PSYCHIAT, V45, P712, DOI 10.3109/00048674.2011.595686; Food and Drug Administration, 2005, GUID IND PREM RISK A; Grigoriadis Sophie, 2007, Ann Clin Psychiatry, V19, P247, DOI 10.1080/10401230701653294; Hahsler M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I15; Hahsler M., 2014, PACKAGE ARULES; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Lenca P, 2008, EUR J OPER RES, V184, P610, DOI 10.1016/j.ejor.2006.10.059; Mizutani S, 2014, COMPUT BIOL CHEM, V50, P50, DOI 10.1016/j.compbiolchem.2014.01.006; Nomura K, 2015, DRUG DES DEV THER, V9, P3031, DOI 10.2147/DDDT.S81998; Pharmaceutical and Medical Devices Agency, 2012, RISK MAN PLAN GUID; Takarabe M, 2012, BIOINFORMATICS, V28, pI611, DOI 10.1093/bioinformatics/bts413; Takarabe M, 2011, J CHEM INF MODEL, V51, P2977, DOI 10.1021/ci200367w; Takarabe Masataka, 2010, V22, P167; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; Umetsu R, 2014, YAKUGAKU ZASSHI, V134, P299, DOI 10.1248/yakushi.13-00225; Voican CS, 2014, AM J PSYCHIAT, V171, P404, DOI 10.1176/appi.ajp.2013.13050709; Weeke P, 2012, CLIN PHARMACOL THER, V92, P72, DOI 10.1038/clpt.2011.368; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Yukio T., 2014, JPN J PHARMACOEPIDEM, V19, P14	23	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154425	10.1371/journal.pone.0154425	http://dx.doi.org/10.1371/journal.pone.0154425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119382	Green Submitted, gold, Green Published			2022-12-26	WOS:000374976200072
J	Tawada, M; Ito, Y; Hamada, C; Honda, K; Mizuno, M; Suzuki, Y; Sakata, F; Terabayashi, T; Matsukawa, Y; Maruyama, S; Imai, E; Matsuo, S; Takei, Y				Tawada, Mitsuhiro; Ito, Yasuhiko; Hamada, Chieko; Honda, Kazuho; Mizuno, Masashi; Suzuki, Yasuhiro; Sakata, Fumiko; Terabayashi, Takeshi; Matsukawa, Yoshihisa; Maruyama, Shoichi; Imai, Enyu; Matsuo, Seiichi; Takei, Yoshifumi			Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients	PLOS ONE			English	Article							RISK-FACTORS; MEMBRANE; FIBROSIS; MODEL; DIAGNOSIS; TRANSPORT; EPS; LYMPHANGIOGENESIS; RECOMMENDATIONS; PERMEABILITY	Background and Objectives Encapsulating peritoneal sclerosis (EPS) is a rare but serious and life-threatening complication of peritoneal dialysis (PD). However, the precise pathogenesis remains unclear; in addition, predictors and early diagnostic biomarkers for EPS have not yet to be established. Methods Eighty-three peritoneal membrane samples taken at catheter removal were examined to identify pathological characteristics of chronic peritoneal deterioration, which promotes EPS in patients undergoing long-term PD treatment with low occurrence of peritonitis. Results According to univariable logistic regression analysis of the pathological findings, thickness of the peritoneal membrane (P = 0.045), new membrane formation score (P = 0.006), ratio of luminal diameter to vessel diameter (L/V ratio, P<0.001), presence of CD31-negative vessels (P = 0.021), fibrin deposition (P<0.001), and collagen volume fraction (P = 0.018) were associated with EPS development. In analyses of samples with and without EPS matched for PD treatment period, non-diabetes, and PD solution, univariable analysis identified L/V ratio (per 0.1 increase: odds ratio (OR) 0.44, P = 0.003) and fibrin deposition (OR 6.35, P = 0.027) as the factors associated with EPS. L/V ratio was lower in patients with fibrin exudation than in patients without fibrin exudation. Conclusions These findings suggest that damage to vascular endothelial cells, as represented by low L/V ratio, could be a predictive finding for the development of EPS, particularly in long-term PD patients unaffected by peritonitis.	[Tawada, Mitsuhiro; Ito, Yasuhiko; Mizuno, Masashi; Suzuki, Yasuhiro; Sakata, Fumiko; Terabayashi, Takeshi; Maruyama, Shoichi; Imai, Enyu; Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Nephrol & Renal Replacement Therapy, Nagoya, Aichi 4648601, Japan; [Hamada, Chieko] Juntendo Univ, Dept Nephrol, Tokyo, Japan; [Honda, Kazuho] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan; [Matsukawa, Yoshihisa] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan; [Takei, Yoshifumi] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan	Nagoya University; Juntendo University; Tokyo Women's Medical University; Nagoya University; Nagoya University	Ito, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol & Renal Replacement Therapy, Nagoya, Aichi 4648601, Japan.	yasuito@med.nagoya-u.ac.jp	Mizuno, Masashi/I-7347-2014		Ministry of Education, Science, and Culture, Japan [20590972]; Aichi Kidney Foundation; Grants-in-Aid for Scientific Research [15K15063] Funding Source: KAKEN	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Aichi Kidney Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture, Japan (YI, #20590972), and a 2014 research grant from the Aichi Kidney Foundation (MT and YI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramaniam G, 2009, NEPHROL DIAL TRANSPL, V24, P3209, DOI 10.1093/ndt/gfp008; Braun N, 2011, NEPHROL DIAL TRANSPL, V26, P1033, DOI 10.1093/ndt/gfq488; Brown EA, 2009, PERITON DIALYSIS INT, V29, P595; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Devuyst O, 2010, J AM SOC NEPHROL, V21, P1077, DOI 10.1681/ASN.2009070694; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Flessner MF, 2008, PERITON DIALYSIS INT, V28, P6; Goodlad C, 2011, NEPHROL DIAL TRANSPL, V26, P1374, DOI 10.1093/ndt/gfq533; Gupta S, 2007, CLIN NEPHROL, V68, P125; Habib AM, 2010, NEPHROL DIAL TRANSPL, V25, P1633, DOI 10.1093/ndt/gfp677; Habib SM, 2013, AM J NEPHROL, V37, P223, DOI 10.1159/000348267; Hamada C, 2015, J ARTIF ORGANS, V18, P243, DOI 10.1007/s10047-015-0822-4; Honda K, 2005, PERITON DIALYSIS INT, V25, pS19; Honda K, 2008, CLIN J AM SOC NEPHRO, V3, P720, DOI 10.2215/CJN.03630807; Johnson DW, 2010, KIDNEY INT, V77, P904, DOI 10.1038/ki.2010.16; Kato H, 2012, NEPHROL DIAL TRANSPL, V27, P526, DOI 10.1093/ndt/gfr302; Kawaguchi Y, 2005, PERITON DIALYSIS INT, V25, pS83; Kawanishi K, 2013, PERITON DIALYSIS INT, V33, P242, DOI 10.3747/pdi.2011.00270; Kim YL, 1999, PERITON DIALYSIS INT, V19, pS384; Kinashi H, 2013, J AM SOC NEPHROL, V24, P1627, DOI 10.1681/ASN.2012030226; Kojima H, 2013, AM J PATHOL, V182, P410, DOI 10.1016/j.ajpath.2012.10.016; Korte MR, 2007, NEPHROL DIAL TRANSPL, V22, P2412, DOI 10.1093/ndt/gfm171; Korte MR, 2011, NAT REV NEPHROL, V7, P528, DOI 10.1038/nrneph.2011.93; Korte MR, 2011, PERITON DIALYSIS INT, V31, P269, DOI 10.3747/pdi.2010.00167; Lambie ML, 2010, KIDNEY INT, V78, P611, DOI 10.1038/ki.2010.186; Lee HY, 2003, NEPHROLOGY, V8, pS33, DOI 10.1046/j.1440-1797.8.s.11.x; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Mizuno M, 2012, AM J PHYSIOL-RENAL, V302, pF1245, DOI 10.1152/ajprenal.00652.2011; Mizuno M, 2009, J IMMUNOL, V183, P1403, DOI 10.4049/jimmunol.0804245; Moberly JB, 2002, KIDNEY INT, V62, pS23, DOI 10.1046/j.1523-1755.62.s81.5.x; Morelle J, 2015, J AM SOC NEPHROL, V26, P2521, DOI 10.1681/ASN.2014090939; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Nakayama M, 2005, PERITON DIALYSIS INT, V25, pS71; Nishimura H, 2008, AM J PHYSIOL-RENAL, V294, pF1084, DOI 10.1152/ajprenal.00565.2007; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Rigby RJ, 1998, NEPHROL DIAL TRANSPL, V13, P154, DOI 10.1093/ndt/13.1.154; Sakamoto I, 2009, KIDNEY INT, V75, P828, DOI 10.1038/ki.2008.661; Sampimon DE, 2010, PERITON DIALYSIS INT, V30, P163, DOI 10.3747/pdi.2009.00022; Sawai A, 2011, NEPHROL DIAL TRANSPL, V26, P2322, DOI 10.1093/ndt/gfq702; Sherif AM, 2008, THER APHER DIAL, V12, P33, DOI 10.1111/j.1744-9987.2007.00538.x; Summers AM, 2010, PERITON DIALYSIS INT, V30, P158, DOI 10.3747/pdi.2009.00267; Suzuki Y, 2012, KIDNEY INT, V81, P865, DOI 10.1038/ki.2011.464; Tarzi RM, 2008, CLIN J AM SOC NEPHRO, V3, P1702, DOI 10.2215/CJN.01820408; Terabayashi T, 2015, LAB INVEST, V95, P1029, DOI 10.1038/labinvest.2015.87; Trigka K, 2011, INT UROL NEPHROL, V43, P519, DOI 10.1007/s11255-010-9848-y; Troidle Laura, 2005, Adv Perit Dial, V21, P98; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Yamamoto Ryo, 2005, Clin Exp Nephrol, V9, P148, DOI 10.1007/s10157-005-0349-8; Yamamoto T, 2010, PERITON DIALYSIS INT, V30, P343, DOI 10.3747/pdi.2008.00273	49	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154644	10.1371/journal.pone.0154644	http://dx.doi.org/10.1371/journal.pone.0154644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119341	Green Submitted, gold, Green Published			2022-12-26	WOS:000374976200091
J	Prays, N; Kaupenjohann, M				Prays, Nadia; Kaupenjohann, Martin			Initial Effects of Differently Treated Biogas Residues from Municipal and Industrial Wastes on Spring Barley Yield Formation	PLOS ONE			English	Article							SEPARATED HOUSEHOLD WASTE; ANAEROBIC-DIGESTION; NITROGEN-FERTILIZER; CURRENT STATE; CROP GROWTH; SOIL; MANURE; QUALITY; AVAILABILITY; AMENDMENT	Soil application of biogas residues (BGRs) is important for closing nutrient cycles. This study examined the efficiency and impact on yields and yield formation of solid-liquid separated residues from biodegradable municipal and industrial wastes (bio-waste) in comparison to complete BGRs, nitrification inhibitor, agricultural BGRs, mineral fertilizer and unfertilized plots as control. The experiment was set up as a randomized block design on silt loam Cambisol. Biogas residues from four biogas plants were evaluated. Plants per m(2), ears per plant, grains per ear and thousand grain weight (TGW) were measured at harvest. Fertilization with BGRs resulted in similar biomass yields compared with mineral fertilizer. Mineral fertilizer (71 dt/ha) and plots fertilized with liquid fraction (59-62 dt/ha) indicated a trend to higher yields than solid fraction or complete BGR due to its high ammonia content. Liquid fractions and fraction with nitrification inhibitor induced fewer plants per m(2) than corresponding solid and complete variants due to a potential phytotoxicity of high NH4-N concentration during germination. However, barley on plots fertilized with liquid fraction compensated the disadvantages at the beginning during the vegetation period and induced higher grain yields than solid fraction. This was attributable to a higher number of ears per plant and grains per ear. In conclusion, BGRs from biodegradable municipal and industrial wastes can be used for soil fertilization and replace considerable amounts of mineral fertilizer. Our study showed that direct application of the liquid fraction of BGR is the most suitable strategy to achieve highest grain yields. Nevertheless potential phytotoxicity of the high NH4-N concentration in the liquid fraction should be considered.	[Prays, Nadia] UFZ Helmholtz Ctr Environm Res, Dept Bioenergy, Halle, Germany; [Kaupenjohann, Martin] Tech Univ Berlin, Dept Soil Sci, Berlin, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Berlin	Prays, N (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Bioenergy, Halle, Germany.	nadia.prays@ufz.de		Prays, Nadia/0000-0003-3134-7704	Helmholtz Association of German Research Centres within the Initiative and Networking Fund for the Department of Bioenergy (UFZ)	Helmholtz Association of German Research Centres within the Initiative and Networking Fund for the Department of Bioenergy (UFZ)	The present study was supported by the Helmholtz Association of German Research Centres within the Initiative and Networking Fund for the Department of Bioenergy (UFZ).	Abdullahi YA, 2008, BIORESOURCE TECHNOL, V99, P8631, DOI 10.1016/j.biortech.2008.04.027; Abubaker J, 2012, APPL ENERG, V99, P126, DOI 10.1016/j.apenergy.2012.04.050; Al-Juhaimi FY, 2014, PAK J BOT, V46, P471; [Anonymous], 2001, 12879 DIN EN; [Anonymous], 2014, AGRON SUSTAIN DEV, V34, P473, DOI [10.1007/s13593-013-0196-z, DOI 10.1007/S13593-013-0196-Z]; [Anonymous], 2014, WORLD SOIL RESOURCES; [Anonymous], 2001, 12880 DIN EN; [Anonymous], 1993, 25663 DIN EN; Alburquerque JA, 2012, AGR ECOSYST ENVIRON, V160, P15, DOI 10.1016/j.agee.2011.03.007; Alburquerque JA, 2012, BIOMASS BIOENERG, V40, P181, DOI 10.1016/j.biombioe.2012.02.018; Bachmann S, 2014, BIOMASS BIOENERG, V70, P429, DOI 10.1016/j.biombioe.2014.08.004; BAETHGEN WE, 1995, FIELD CROP RES, V43, P87, DOI 10.1016/0378-4290(95)00034-N; Bath B, 1999, ACTA AGR SCAND B-S P, V49, P201, DOI 10.1080/713782027; Chen RR, 2012, BIOMASS BIOENERG, V45, P221, DOI 10.1016/j.biombioe.2012.06.014; de la Fuente C, 2013, BIOL FERT SOILS, V49, P313, DOI 10.1007/s00374-012-0719-9; Diepenbrock W., 1999, SPEZIELLER PFLANZENB; DIN, 2002, 11277 DIN ISO; DIN (Deutsches Institut fur Normung e. V.) 38406-5, 1983, 384065 DIN; Fachagentur fur nachwachsende Rohstoffe e. V, 2014, BAS BIOEN DEUTSCHL 2; Federal Ministry for Economic Affairs and Energy, 2014, 2 FED MIN EC AFF EN; German National Academy of Sciences Leopoldina, 2012, BIOEN CHANC LIM; Haraldsen TK, 2011, WASTE MANAGE RES, V29, P1271, DOI 10.1177/0734242X11411975; Herrmann A, 2013, J AGR SCI-CAMBRIDGE, V151, P449, DOI 10.1017/S0021859612000548; Herrmann A, 2013, BIOENERG RES, V6, P372, DOI 10.1007/s12155-012-9227-x; Holm-Nielsen JB, 2009, BIORESOURCE TECHNOL, V100, P5478, DOI 10.1016/j.biortech.2008.12.046; Insam H, 2015, SOIL BIOL BIOCHEM, V84, P1, DOI 10.1016/j.soilbio.2015.02.006; Jorgensen K, 2009, BIORESOURCE TECHNOL, V100, P3088, DOI 10.1016/j.biortech.2009.01.065; Koutna K, 2003, PLANT SOIL ENVIRON, V49, P457, DOI 10.17221/4157-PSE; Loria ER, 2007, AGRON J, V99, P1119, DOI 10.2134/agronj2006.0251; MA BL, 1992, J AGRON CROP SCI, V169, P151, DOI 10.1111/j.1439-037X.1992.tb01021.x; Moller K, 2008, NUTR CYCL AGROECOSYS, V82, P209, DOI 10.1007/s10705-008-9196-9; Moller K, 2015, AGRON SUSTAIN DEV, V35, P1021, DOI 10.1007/s13593-015-0284-3; Moller K, 2012, ENG LIFE SCI, V12, P242, DOI 10.1002/elsc.201100085; Moeller K, 2009, EUR J AGRON, V30, P1, DOI 10.1016/j.eja.2008.06.003; Moller HB, 2007, T ASABE, V50, P193, DOI 10.13031/2013.22400; Moller HB, 2002, BIORESOURCE TECHNOL, V85, P189, DOI 10.1016/S0960-8524(02)00047-0; Nicoletto C, 2014, SCI HORTIC-AMSTERDAM, V180, P207, DOI 10.1016/j.scienta.2014.10.028; Odlare M, 2008, WASTE MANAGE, V28, P1246, DOI 10.1016/j.wasman.2007.06.005; Odlare M, 2014, J AGR SCI, V152, P134, DOI 10.1017/S0021859612001050; Odlare M, 2011, APPL ENERG, V88, P2210, DOI 10.1016/j.apenergy.2010.12.043; Petr J, 1988, YIELD FORMATION MAIN, P1; Sanger A, 2010, J PLANT NUTR SOIL SC, V173, P692, DOI 10.1002/jpln.200900254; Schittenhelm S, 2006, J AGRON CROP SCI, V192, P434, DOI 10.1111/j.1439-037X.2006.00226.x; Statistisches Landesamt, 2012, STATISTISCHER BERICH; Svensson K, 2004, J AGR SCI-CAMBRIDGE, V142, P461, DOI 10.1017/S0021859604004514; Tambone F, 2010, CHEMOSPHERE, V81, P577, DOI 10.1016/j.chemosphere.2010.08.034; Teglia C, 2011, WASTE BIOMASS VALORI, V2, P113, DOI 10.1007/s12649-010-9059-x; Thran D, 2015, SCHRIFTENREIHE BMWI; Thran D., 2015, IEA BIOENERGY TASK 4; Weiland P, 2003, APPL BIOCHEM BIOTECH, V109, P263, DOI 10.1385/ABAB:109:1-3:263; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Zirkler D, 2014, BIOMASS BIOENERG, V67, P89, DOI 10.1016/j.biombioe.2014.04.021	52	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154232	10.1371/journal.pone.0154232	http://dx.doi.org/10.1371/journal.pone.0154232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116355	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600051
J	Ferreira, HR; Ferreira, PG; Loures, JP; Fernandes, J; Fernandes, LC; Buck, HS; Montor, WR				Ferreira, Heros Ribeiro; Ferreira, Pamela Gill; Loures, Joao Paulo; Fernandes Filho, Jose; Fernandes, Luiz Claudio; Buck, Hudson Sousa; Montor, Wagner Ricardo			Acute Oxidative Effect and Muscle Damage after a Maximum 4 Min Test in High Performance Athletes	PLOS ONE			English	Article							KAYAK ERGOMETER PERFORMANCE; ANTIOXIDANT STATUS; ALPHA-TOCOPHEROL; EXERCISE; STRESS; RESPONSES; PADDLERS; INTENSITY; STRENGTH; SWIMMERS	The purpose of this investigation was to determine lipid peroxidation markers, physiological stress and muscle damage in elite kayakers in response to a maximum 4-min kayak ergometer test (KE test), and possible correlations with individual 1000m kayaking performances. The sample consisted of twenty-three adult male and nine adult female elite kayakers, with more than three years' experience in international events, who voluntarily took part in this study. The subjects performed a 10-min warm-up, followed by a 2-min passive interval, before starting the test itself, which consisted of a maximum 4-min work paddling on an ergometer; right after the end of the test, an 8 ml blood sample was collected for analysis. 72 hours after the test, all athletes took part in an official race, when then it was possible to check their performance in the on site K1 1000m test (P1000m). The results showed that all lipoproteins and hematological parameters tested presented a significant difference (p less than or similar to 0.05) after exercise for both genders. In addition, parameters related to muscle damage such as lactate dehydrogenase (LDH) and creatine kinase (CK) presented significant differences after stress. Uric acid presented an inverse correlation with the performance (r = -0.76), while CK presented a positive correlation (r = 0.46) with it. Based on these results, it was possible to verify muscle damage and the level of oxidative stress caused by indoor training with specific ergometers for speed kayaking, highlighting the importance of analyzing and getting to know the physiological responses to this type of training, in order to provide information to coaches and optimize athletic performance.	[Ferreira, Heros Ribeiro; Buck, Hudson Sousa; Montor, Wagner Ricardo] Santa Casa Sao Paulo Sch Med Sci, Sao Paulo, SP, Brazil; [Ferreira, Pamela Gill; Fernandes, Luiz Claudio] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil; [Loures, Joao Paulo] Univ Sao Paulo, Sao Paulo, SP, Brazil; [Fernandes Filho, Jose] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Ferreira, Heros Ribeiro] Santa Casa Sao Paulo Sch Med Sci, Dept Physiol Sci, Sao Paulo, SP, Brazil	Universidade Federal do Parana; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Ferreira, HR (corresponding author), Santa Casa Sao Paulo Sch Med Sci, Sao Paulo, SP, Brazil.; Ferreira, HR (corresponding author), Santa Casa Sao Paulo Sch Med Sci, Dept Physiol Sci, Sao Paulo, SP, Brazil.	heros.esporte@gmail.com	Fernandes, Luiz C/I-4907-2014; Loures, Joao Paulo/N-1997-2019; Buck, Hudson/E-7664-2013; Montor, Wagner/J-2568-2012; Montor, Wagner/AAF-2538-2021	Loures, Joao Paulo/0000-0002-6778-3877; Buck, Hudson/0000-0002-1867-2441; Montor, Wagner/0000-0003-3746-9366; 	CAPES (Coordination of Improvement of Higher Education Personnel-Improvement Coordination of Higher Education Personnel); FAP (Research Support Fund-FCMSCSP-Santa Casa de Sao Paulo School of Medical Sciences-Research support fund-Santa Casa de Sao Paulo School of Medical Sciences)	CAPES (Coordination of Improvement of Higher Education Personnel-Improvement Coordination of Higher Education Personnel); FAP (Research Support Fund-FCMSCSP-Santa Casa de Sao Paulo School of Medical Sciences-Research support fund-Santa Casa de Sao Paulo School of Medical Sciences)	This work was supported by CAPES (Coordination of Improvement of Higher Education Personnel-Improvement Coordination of Higher Education Personnel) and FAP (Research Support Fund-FCMSCSP-Santa Casa de Sao Paulo School of Medical Sciences-Research support fund-Santa Casa de Sao Paulo School of Medical Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland TR, 2003, J SCI MED SPORT, V6, P285, DOI 10.1016/S1440-2440(03)80022-1; Aguilo A, 2005, PHYSIOL BEHAV, V84, P1, DOI 10.1016/j.physbeh.2004.07.034; ARMSTRONG RB, 1984, MED SCI SPORT EXER, V16, P529; Billat V, 1996, ERGONOMICS, V39, P267, DOI 10.1080/00140139608964457; Bishop D, 2000, EUR J APPL PHYSIOL, V82, P91, DOI 10.1007/s004210050656; Bishop D, 2004, INT J SPORTS MED, V25, P68; Bishop D, 2003, J SPORT SCI, V21, P13, DOI 10.1080/0264041031000070912; Bishop D, 2002, MED SCI SPORT EXER, V34, P1041, DOI 10.1097/00005768-200206000-00022; Bjerkefors A, 2006, EUR J APPL PHYSIOL, V97, P613, DOI 10.1007/s00421-006-0231-8; Bouzid MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090420; Crewther BT, 2011, SPORTS MED, V41, P103, DOI 10.2165/11539170-000000000-00000; Davranche K, 2009, J SPORT EXERCISE PSY, V31, P554, DOI 10.1123/jsep.31.4.554; Ferreira HF, 2015, J ANDALUZA SPORT MED, V12, P120; Ferreira HF, 2014, J EXERCISE PHYSL, V17, P34; Ferreira HF, 2012, FIEP B, V1, P12; Ferreira HF, 2015, J ANDALUZA SPORT MED, V2, P1; Ferreira HF, 2008, EF DEPORTES J, V13, P1; FERREIRA HF, 2015, J EXERCISE PHYSL, V18, P84; FLYNN MG, 1994, INT J SPORTS MED, V15, P21, DOI 10.1055/s-2007-1021014; Janssen I, 2010, SPORT BIOMECH, V9, P47, DOI 10.1080/14763141003690229; Meyer T, 2001, MED SCI SPORT EXER, V33, P549; Minematsu T, 2013, WOUND REPAIR REGEN, V21, P329, DOI 10.1111/wrr.12017; Mujika I, 1996, MED SCI SPORT EXER, V28, P251, DOI 10.1097/00005768-199602000-00015; Paschalis V, 2005, INT J SPORTS MED, V26, P827, DOI 10.1055/s-2005-837461; RIDGE BR, 1976, MED SCI SPORT EXER, V8, P18; Santhiago V, 2011, J STRENGTH COND RES, V25, P825, DOI 10.1519/JSC.0b013e3181c69996; Schroder H, 2001, EUR J NUTR, V40, P178, DOI 10.1007/s003940170006; SHEPHARD RJ, 1987, SPORTS MED, V4, P19, DOI 10.2165/00007256-198704010-00003; Sondergaard E, 2014, METABOLISM, V63, P61, DOI 10.1016/j.metabol.2013.08.011; Subudhi AW, 2001, INT J SPORT NUTR EXE, V11, P32, DOI 10.1123/ijsnem.11.1.32; Tanhoffer R., 2013, J EXER PHYS ONLINE, V16, P53; Teixeira VH, 2013, J SPORT MED PHYS FIT, V53, P71; Teixeira V, 2009, INT J SPORT NUTR EXE, V19, P443, DOI 10.1123/ijsnem.19.5.443; TESCH PA, 1984, EUR J APPL PHYSIOL O, V52, P441, DOI 10.1007/BF00943377; van Someren KA, 2000, INT J SPORTS MED, V21, P200; van Someren KA, 2002, INT J SPORTS MED, V23, P28, DOI 10.1055/s-2002-19268; van Someren KA, 2008, INTJ SPORT PHYSIOL, V3, P207, DOI 10.1123/ijspp.3.2.207; Vollaard NBJ, 2006, MED SCI SPORT EXER, V38, P1335, DOI 10.1249/01.mss.0000227320.23847.80; Wozniak A, 2007, EUR J APPL PHYSIOL, V100, P137, DOI 10.1007/s00421-007-0404-0; You ZS, 2002, GENE DEV, V16, P1182, DOI 10.1101/gad.985302; Zeni AI, 1996, JAMA-J AM MED ASSOC, V275, P1424, DOI 10.1001/jama.275.18.1424; Ziolkowski W, 2015, FREE RADICAL RES, V49, P7, DOI 10.3109/10715762.2014.968147; Ziouzenkova O, 1996, J LIPID RES, V37, P1936	43	4	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153709	10.1371/journal.pone.0153709	http://dx.doi.org/10.1371/journal.pone.0153709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111088	gold, Green Published			2022-12-26	WOS:000374970600020
J	Meyers, DJ; Ozonoff, A; Baruwal, A; Pande, S; Harsha, A; Sharma, R; Schwarz, D; Schwarz, RK; Bista, D; Halliday, S; Maru, DSR				Meyers, David J.; Ozonoff, Al; Baruwal, Ashma; Pande, Sami; Harsha, Alex; Sharma, Ranju; Schwarz, Dan; Schwarz, Ryan K.; Bista, Deepak; Halliday, Scott; Maru, Duncan S. R.			Combining Healthcare-Based and Participatory Approaches to Surveillance: Trends in Diarrheal and Respiratory Conditions Collected by a Mobile Phone System by Community Health Workers in Rural Nepal	PLOS ONE			English	Article							INFLUENZA-LIKE ILLNESS; GENERAL-POPULATION; DISEASE; BANGLADESH; COVERAGE; WEB	Background Surveillance systems are increasingly relying upon community-based or crowd-sourced data to complement traditional facilities-based data sources. Data collected by community health workers during the routine course of care could combine the early warning power of community-based data collection with the predictability and diagnostic regularity of facility data. These data could inform public health responses to epidemics and spatially-clustered endemic diseases. Here, we analyze data collected on a daily basis by community health workers during the routine course of clinical care in rural Nepal. We evaluate if such community-based surveillance systems can capture temporal trends in diarrheal diseases and acute respiratory infections. Methods During the course of their clinical activities from January to December 2013, community health workers recorded healthcare encounters using mobile phones. In parallel, we accessed condition-specific admissions from 2011-2013 in the hospital from which the community health program was based. We compared diarrhea and acute respiratory infection rates from both the hospital and the community, and assigned three categories of local disease activity (low, medium, and high) to each week in each village cluster with categories determined by tertiles. We compared condition-specific mean hospital rates across categories using ANOVA to assess concordance between hospital and community-collected data. Results There were 2,710 cases of diarrhea and 373 cases of acute respiratory infection reported by community health workers during the one-year study period. At the hospital, the average weekly incidence of diarrhea and acute respiratory infections over the three-year period was 1.8 and 3.9 cases respectively per 1,000 people in each village cluster. In the community, the average weekly rate of diarrhea and acute respiratory infections was 2.7 and 0.5 cases respectively per 1,000 people. Both diarrhea and acute respiratory infections exhibited significant differences between the three categories of disease rate burden (diarrhea p = 0.009, acute respiratory infection p = 0.001) when comparing community health worker-collected rates to hospital rates. Conclusion Community-level data on diarrhea and acute respiratory infections modestly correlated with hospital data for the same condition in each village each week. Our experience suggests that community health worker-collected data on mobile phones may be a feasible adjunct to other community-and healthcare-related data sources for surveillance of such conditions. Such systems are vitally needed in resource-limited settings like rural Nepal.	[Meyers, David J.; Baruwal, Ashma; Harsha, Alex; Schwarz, Dan; Schwarz, Ryan K.; Bista, Deepak; Halliday, Scott; Maru, Duncan S. R.] Bayalpata Hosp, Possible, Sanfebagar 10, Achham, Nepal; [Meyers, David J.] Harvard Univ, Dept Hlth Policy & Management, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Ozonoff, Al] Boston Childrens Hosp, Ctr Patient Safety & Qual Res, Boston, MA USA; [Ozonoff, Al; Harsha, Alex] Harvard Univ, Sch Med, Boston, MA USA; [Pande, Sami] United Nations Populat Fund, Kathmandu, Nepal; [Sharma, Ranju] Medic Mobile, San Francisco, CA USA; [Schwarz, Dan; Schwarz, Ryan K.; Halliday, Scott; Maru, Duncan S. R.] Brigham & Womens Hosp, Dept Med, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Schwarz, Dan; Schwarz, Ryan K.; Maru, Duncan S. R.] Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA; [Halliday, Scott] Univ Washington, Henry M Jackson Sch Int Studies, Seattle, WA 98195 USA; [Maru, Duncan S. R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; United Nations Population Fund; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School	Maru, DSR (corresponding author), Bayalpata Hosp, Possible, Sanfebagar 10, Achham, Nepal.; Maru, DSR (corresponding author), Brigham & Womens Hosp, Dept Med, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Maru, DSR (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA.; Maru, DSR (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA USA.	duncan@possiblehealth.org	Meyers, David J/AFI-1703-2022; Urzua, Andrea Silva/AAS-7284-2020	Meyers, David J/0000-0002-4081-1751; Halliday, Scott/0000-0003-1178-6937; Maru, Duncan/0000-0002-5923-6910	Grand Challenges Canada; Government of Canada; Thrasher Research Fund	Grand Challenges Canada(CGIAR); Government of Canada(CGIAR); Thrasher Research Fund	This work was supported by a "Stars in Global Health" grant from Grand Challenges Canada. Grand Challenges Canada is funded by the Government of Canada and is dedicated to supporting Bold Ideas with Big Impact in global health. This work was also supported by an "Early Career Award" from the Thrasher Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouzou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088939; Aryal Umesh Raj, 2012, BMC Res Notes, V5, P489, DOI 10.1186/1756-0500-5-489; Bodnar T, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P651, DOI 10.1145/2567948.2579272; Bodnar T, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P699; Breiman RF, 2004, LANCET, V364, P2204, DOI 10.1016/S0140-6736(04)17593-4; Brinkel J, 2014, INT J ENV RES PUB HE, V11, P11559, DOI 10.3390/ijerph111111559; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Central Bureau of Statistics, 2012, NAT POP HOUS CENS 20; Chang AY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-49; Chretien JP, 2008, PLOS MED, V5, P367, DOI 10.1371/journal.pmed.0050072; Darmstadt GL, 2010, HEALTH POLICY PLANN, V25, P112, DOI 10.1093/heapol/czp048; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; Goutard FL, 2015, PREV VET MED, V120, P12, DOI 10.1016/j.prevetmed.2015.02.014; Government of Nepal National Planning Commission, 2014, NEP HUM DEV REP 2014; Huaman MA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-16; Huang CY, 2011, TECHNOL FORECAST SOC, V78, P703, DOI 10.1016/j.techfore.2010.10.009; Johansson M, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P695; Kasolo F, 2013, BIOSECUR BIOTERROR, V11, P163, DOI 10.1089/bsp.2013.0032; Kostkova P., 2013, P 22 INT C WORLD WID, P687; Kostkova P, 2013, J MED INTERNET RES, V15, P167, DOI 10.2196/jmir.2146; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Lazarus R, 2002, EMERG INFECT DIS, V8, P753, DOI 10.3201/eid0808.020239; Lewis MD, 2002, AM J PREV MED, V23, P180, DOI 10.1016/S0749-3797(02)00490-7; Mallat SG, 2014, BMC PUBLIC HEALTH, V14, P1; Marquet RL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-242; McNeill A, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P673, DOI 10.1145/2567948.2579280; Ministry of Health and Population (MOHP), 2012, NEP DEM HLTH SURV 20; Otieno CF, 2012, J COMMUN HEALTH, V37, P48, DOI 10.1007/s10900-011-9414-2; Paolotti D, 2014, CLIN MICROBIOL INFEC, V20, P17, DOI 10.1111/1469-0691.12477; Rajput ZA, 2012, J AM MED INFORM ASSN, V19, P655, DOI 10.1136/amiajnl-2011-000476; Rosenthal EL, 2011, J AMBUL CARE MANAG, V34, P247, DOI 10.1097/JAC.0b013e31821c64d7; Seddon D, 2002, CRIT ASIAN STUD, V34, P19, DOI 10.1080/146727102760166581; Shears P, 2000, ACTA TROP, V76, P3, DOI 10.1016/S0001-706X(00)00081-4; Susumpow P, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P663, DOI 10.1145/2567948.2579273; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; van der Goot E, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P703; World Health Organization, 2014, TOP 10 CAUS DEATH; Yom-Tov E., 2015, P 5 INT C DIG HLTH 2, P115, DOI DOI 10.1145/2750511.2750512; Zaidi SMA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002574	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152738	10.1371/journal.pone.0152738	http://dx.doi.org/10.1371/journal.pone.0152738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111734	Green Submitted, Green Published, gold			2022-12-26	WOS:000374970600004
J	Gallay, PA; Chatterji, U; Bobardt, MD; Long, ZY; Zhang, SL; Su, Z				Gallay, Philippe A.; Chatterji, Udayan; Bobardt, Michael D.; Long, Zhengyu; Zhang, Shengli; Su, Zhuang			Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; GENOTYPE 1 INFECTION; NS5A DOMAIN-II; CYCLOSPORINE-A; ISOMERASE ACTIVITY; ALISPORIVIR PLUS; BINDING-SITE; REPLICATION; RESISTANCE; INTERFERON	Shortened current direct-acting antiviral (DAA) therapies while less expensive, have not provided satisfactory efficacy in naive cirrhotics, treatment experienced non-cirrhotics or even genotype-3 (GT3)-infected patients. Since DAA regimens consist of the same classes of inhibitors-NS5A (NS5Ai) and NS5B (NS5Bi) +/- NS3 (NS3i) inhibitors-it is likely that their costs will be high and will provide similar degrees of protection. Integrating drugs with distinct mechanisms of action (MoA) into DAA regimens could provide the solution for shortening the period of treatment. One such class of agents is the cyclophilin inhibitors (CypI), which has shown efficacy in patients. Resistance-associated variants persist for years post-treatment in patients exposed to NS5Ai or NS5Bi who fail to achieve a sustained virologic response, impairing their chance for cure on retreatment with existing DAA combinations. Because of their high barrier to resistance, CypI may be particularly useful as a rescue therapy for patients who have relapsed with DAA resistance-associated variants. In this study, we analyzed the anti-HCV properties of the novel cyclosporine A (CsA) derivate-STG-175. The non-immunosuppressive STG-175 possesses a high (EC50 11.5-38.9 nM) multi-genotypic (GT1a to 4a) anti-HCV activity. STG-175 clears cells from HCV since no viral replication rebound was observed after cessation of drug treatment. It presents a higher barrier to resistance than other CypI or selected DAAs. HCV variants, which emerged under STG-175 pressure, are only similar to 2-fold resistant to the drug. No cross-resistance was observed with DAAs STG-175 was efficacious against DAA-resistant HCV variants. Drug combination studies revealed that STG-175 provides additive and synergistic effects against GT1a to 4a. STG-175 inhibits the infection of HCV, HIV-1 and HBV in mono-, dual-and triple-infection settings. Altogether these results suggest that the new CypI STG-175 represents an attractive drug partner for IFN-free DAA regimens for the treatment of HCV and co-infections.	[Gallay, Philippe A.; Chatterji, Udayan; Bobardt, Michael D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Long, Zhengyu; Zhang, Shengli; Su, Zhuang] S&T Global Inc, 470 Wildwood Ave,Unit 3, Woburn, MA 01801 USA	Scripps Research Institute	Gallay, PA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Su, Z (corresponding author), S&T Global Inc, 470 Wildwood Ave,Unit 3, Woburn, MA 01801 USA.	gallay@scripps.edu; zhuang.su@stglobalinc.com			U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases (NIAID) [AI087746]; ST Global [2179]; S T Global, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087746, R01AI105007] Funding Source: NIH RePORTER	U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases (NIAID); ST Global; S T Global, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. Public Health Service grant no. Grant no. AI087746 (P.A.G.) from the National Institute of Allergy and Infectious Diseases (NIAID) (https://www.niaid.nih.gov) and a Special Funding Project 2179 from S&T Global (http://www.stglobalinc.com). S & T Global, Inc. provided support in the form of salaries for authors ZL, SZ and ZS, and also play additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Ansari IUH, 2013, VIROLOGY, V436, P268, DOI 10.1016/j.virol.2012.11.018; Ansari IUH, 2012, VIRUSES-BASEL, V4, P3303, DOI 10.3390/v4123303; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; BAUMANN G, 1992, TRANSPLANT P, V24, P43; Berger C, 2014, GASTROENTEROLOGY, V147, P1094, DOI 10.1053/j.gastro.2014.07.019; Bobardt MD, 2008, P NATL ACAD SCI USA, V105, P5525, DOI 10.1073/pnas.0801388105; Buti M, 2015, J VIRAL HEPATITIS, V22, P596, DOI 10.1111/jvh.12360; Chatterji U, 2015, ANTIMICROB AGENTS CH; Chatterji U, 2014, ANTIMICROB AGENTS CH, V58, P3327, DOI 10.1128/AAC.00016-14; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; Cross TJS, 2008, POSTGRAD MED J, V84, DOI 10.1136/pgmj.2008.068205; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P231, DOI 10.1053/j.gastro.2005.11.010; Dorner M, 2013, NATURE, V501, P237, DOI 10.1038/nature12427; Dvory-Sobol H, 2015, J HEPATOL, V62, pS221, DOI 10.1016/S0168-8278(15)30073-8; Eyre Nicholas S, 2014, Gastroenterology, V147, P959, DOI 10.1053/j.gastro.2014.09.024; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; FISCHER G, 1984, BIOCHIM BIOPHYS ACTA, V791, P87, DOI 10.1016/0167-4838(84)90285-1; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Gaither LA, 2010, VIROLOGY, V397, P43, DOI 10.1016/j.virol.2009.10.043; Gallay PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134707; Garcia-Rivera JA, 2012, ANTIMICROB AGENTS CH, V56, P5113, DOI 10.1128/AAC.00919-12; Gawlik K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088866; Grise H, 2012, J VIROL, V86, P4811, DOI 10.1128/JVI.06641-11; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hansson MJ, 2015, CHEM BIOL, V22, P285, DOI 10.1016/j.chembiol.2014.10.023; Hopkins S, 2012, ANTIMICROB AGENTS CH, V56, P3888, DOI 10.1128/AAC.00693-12; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krishnan P, 2015, J HEPATOL, V62, pS220, DOI 10.1016/S0168-8278(15)30071-4; Liu SK, 2004, NUCLEIC ACIDS RES, V32, P3752, DOI 10.1093/nar/gkh715; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Pawlotsky JM, 2015, NAT REV GASTRO HEPAT, V12, P673, DOI 10.1038/nrgastro.2015.184; Pawlotsky JM, 2015, HEPATOLOGY, V62, P1013, DOI 10.1002/hep.27960; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P22, DOI 10.1055/s-0034-1371007; Phillips S, 2015, GASTROENTEROLOGY, V148, P403, DOI 10.1053/j.gastro.2014.10.004; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Robinson M, 2010, ANTIMICROB AGENTS CH, V54, P3099, DOI 10.1128/AAC.00289-10; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rosnoblet C, 2012, J BIOL CHEM, V287, P44249, DOI 10.1074/jbc.M112.392209; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; Soriano V, 2008, EXPERT OPIN EMERG DR, V13, P1, DOI 10.1517/14728214.13.1.1 ; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tiongyip C, 2011, 6 INT WORKSH HEP C R; Tong MJ, 1997, HEPATOLOGY, V26, P747, DOI 10.1002/hep.510260330; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; U.S. Food and Drug Administration, 2014, SOVALDITM SOFOSBUVIR; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Zeuzem S, 2015, ALIMENT PHARM THER, V42, P829, DOI 10.1111/apt.13342; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	68	5	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0152036	10.1371/journal.pone.0152036	http://dx.doi.org/10.1371/journal.pone.0152036			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104614	Green Published, gold			2022-12-26	WOS:000374565100003
J	Hou, X; Xiao, M; Chen, SCA; Wang, H; Zhang, L; Fan, X; Xu, ZP; Cheng, JW; Kong, FR; Zhao, YP; Xu, YC				Hou, Xin; Xiao, Meng; Chen, Sharon C-A; Wang, He; Zhang, Li; Fan, Xin; Xu, Zhi-Peng; Cheng, Jing-Wei; Kong, Fanrong; Zhao, Yu-Pei; Xu, Ying-Chun			Sequencer-Based Capillary Gel Electrophoresis (SCGE) Targeting the rDNA Internal Transcribed Spacer (ITS) Regions for Accurate Identification of Clinically Important Yeast Species	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; ROLLING-CIRCLE AMPLIFICATION; MULTIPLEX PCR ASSAY; MEDICALLY IMPORTANT; CANDIDA-GLABRATA; PATHOGENIC YEASTS; GROUP-II; CHINA; SURVEILLANCE; FUNGAL	Accurate species identification of Candida, Cryptococcus, Trichosporon and other yeast pathogens is important for clinical management. In the present study, we developed and evaluated a yeast species identification scheme by determining the rDNA internal transcribed spacer (ITS) region length types (LTs) using a sequencer-based capillary gel electrophoresis (SCGE) approach. A total of 156 yeast isolates encompassing 32 species were first used to establish a reference SCGE ITS LT database. Evaluation of the ITS LT database was then performed on (i) a separate set of (n = 97) clinical isolates by SCGE, and (ii) 41 isolates of 41 additional yeast species from GenBank by in silico analysis. Of 156 isolates used to build the reference database, 41 ITS LTs were identified, which correctly identified 29 of the 32 (90.6%) species, with the exception of Trichosporon asahii, Trichosporon japonicum and Trichosporon asteroides. In addition, eight of the 32 species revealed different electropherograms and were subtyped into 2-3 different ITS LTs each. Of the 97 test isolates used to evaluate the ITS LT scheme, 96 (99.0%) were correctly identified to species level, with the remaining isolate having a novel ITS LT. Of the additional 41 isolates for in silico analysis, none was misidentified by the ITS LT database except for Trichosporon mucoides whose ITS LT profile was identical to that of Trichosporon dermatis. In conclusion, yeast identification by the present SCGE ITS LT assay is a fast, reproducible and accurate alternative for the identification of clinically important yeasts with the exception of Trichosporon species.	[Hou, Xin; Xiao, Meng; Wang, He; Zhang, Li; Fan, Xin; Xu, Zhi-Peng; Cheng, Jing-Wei; Xu, Ying-Chun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China; [Hou, Xin; Xiao, Meng; Wang, He; Zhang, Li; Fan, Xin; Xu, Zhi-Peng; Cheng, Jing-Wei] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing 100730, Peoples R China; [Chen, Sharon C-A; Kong, Fanrong] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Lab Serv,ICPMR Pathol West, Darcy Rd, Westmead, NSW 2145, Australia; [Zhao, Yu-Pei] Chinese Acad Med Sci, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Sydney; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Xu, YC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	National Research Special Fund for Public Welfare Industry of Health of China [201402001]	National Research Special Fund for Public Welfare Industry of Health of China	This work was funded by the National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001), http://www.nhfpc.gov.cn/zwgkzt/pkjjy1/201302/9cb220c8a5704c0a9ebf5ef65a337544.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Borman AM, 2010, J CLIN MICROBIOL, V48, P3648, DOI 10.1128/JCM.01071-10; Bougnoux ME, 2004, INFECT GENET EVOL, V4, P243, DOI 10.1016/j.meegid.2004.06.002; Capoor MR, 2014, INDIAN J MED MICROBI, V32, P304, DOI 10.4103/0255-0857.136576; Cendejas-Bueno E, 2012, J CLIN MICROBIOL, V50, P3641, DOI 10.1128/JCM.02248-12; Chagas-Neto TC, 2009, J CLIN MICROBIOL, V47, P1074, DOI 10.1128/JCM.01614-08; Chitasombat MN, 2012, J INFECTION, V64, P68, DOI 10.1016/j.jinf.2011.11.002; Roman ADE, 2014, INT J STD AIDS, V25, P70, DOI 10.1177/0956462413487716; Dignani Maria Cecilia, 2014, F1000Prime Rep, V6, P81, DOI 10.12703/P6-81; Fan X, 2014, CHINESE MED J-PEKING, V127, P4226, DOI 10.3760/cma.j.issn.0366-6999.20142048; Fan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106949; Gil-Alonso S, 2015, ANTIMICROB AGENTS CH, V59, P3615, DOI 10.1128/AAC.04474-14; Gray TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102290; Guo LN, 2011, J CLIN MICROBIOL, V49, P3805, DOI 10.1128/JCM.00937-11; Katsu M, 2004, FEMS YEAST RES, V4, P377, DOI 10.1016/S1567-1356(03)00176-4; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; Mallus F, 2013, J MICROBIOL METH, V92, P150, DOI 10.1016/j.mimet.2012.11.022; Merseguel KB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0793-3; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Monstein HJ, 2014, J MICROBIOL METH, V96, P81, DOI 10.1016/j.mimet.2013.11.004; Nilsson RH, 2015, MICROBES ENVIRON, V30, P145, DOI 10.1264/jsme2.ME14121; Pannanusorn S, 2012, MYCOSES, V55, P172, DOI 10.1111/j.1439-0507.2011.02064.x; Playford EG, 2006, J CLIN MICROBIOL, V44, P876, DOI 10.1128/JCM.44.3.876-880.2006; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sugita T, 2004, J CLIN MICROBIOL, V42, P5467, DOI 10.1128/JCM.42.12.5467-5471.2004; Swoboda-Kopec E, 2014, MYCOSES, V57, P747, DOI 10.1111/myc.12264; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Wang H, 2012, J CLIN MICROBIOL, V50, P3952, DOI 10.1128/JCM.01130-12; Wehrhahn MC, 2012, J CLIN MICROBIOL, V50, P3478, DOI 10.1128/JCM.01311-12; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xiao M, 2016, J CLIN MICROBIOL, V54, P226, DOI 10.1128/JCM.02830-15; Xiao M, 2014, J CLIN MICROBIOL, V52, P3044, DOI 10.1128/JCM.00246-14; Xiao M, 2013, MED MYCOL, V51, P300, DOI 10.3109/13693786.2012.723223; Xiao M, 2012, J CLIN MICROBIOL, V50, P2755, DOI 10.1128/JCM.00777-12; Zhang L, 2014, J CLIN MICROBIOL, V52, P572, DOI 10.1128/JCM.02543-13; Zhao Y, 2015, INT J MOL SCI, V16, P25067, DOI 10.3390/ijms161025067; Zhou XY, 2008, J CLIN MICROBIOL, V46, P2423, DOI 10.1128/JCM.00420-08	38	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154385	10.1371/journal.pone.0154385	http://dx.doi.org/10.1371/journal.pone.0154385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105313	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100072
J	Maranda, L; Gupta, OT				Maranda, Louise; Gupta, Olga T.			Association between Responsible Pet Ownership and Glycemic Control in Youths with Type 1 Diabetes	PLOS ONE			English	Article							HUMAN HEALTH; METABOLIC-CONTROL; SELF-MANAGEMENT; ADOLESCENTS; ADHERENCE; CHILDREN; ANIMALS; CARE	Type 1 diabetes mellitus (T1DM) a chronic characterized by an absolute insulin deficiency requires conscientious patient self-management to maintain glucose control within a normal range. Family cohesion and adaptability, positive coping strategies, social support and adequate self-regulatory behavior are found to favorably influence glycemic control. Our hypothesis was that the responsible care of a companion animal is associated with these positive attributes and correlated with the successful management of a chronic illness such as type 1 diabetes. We recruited 223 youths between 9 and 19 years of age from the Pediatric Diabetes clinic at the University of Massachusetts Medical School, reviewed the status of their glycemic control (using three consecutive A1c values) and asked them questions about the presence of a pet at home, and their level of involvement with its care. Multivariate analyses show that children who care actively for one or more pets at home are 2.5 times more likely to have control over their glycemic levels than children who do not care for a pet, adjusting for duration of disease, socio-economic status, age and self-management [1.1 to 5.8], p(Wald) = 0.032. A separate model involving the care of a petdog only yielded comparable results (ORa = 2.6 [1.1 to 5.9], p(Wald) = 0.023).	[Maranda, Louise] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Gupta, Olga T.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Endocrinol, Dallas, TX 75390 USA; [Maranda, Louise] UMass Med Sch, Dept Quantitat Hlth Sci, Albert Sherman Ctr, AS6-1063,55 Lave Ave North, Worcester, MA 01655 USA; [Gupta, Olga T.] Univ Texas SW Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas Southwestern Medical Center Dallas	Maranda, L (corresponding author), Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA.; Maranda, L (corresponding author), UMass Med Sch, Dept Quantitat Hlth Sci, Albert Sherman Ctr, AS6-1063,55 Lave Ave North, Worcester, MA 01655 USA.	louise.maranda@umassmed.edu	Maranda, Louise/C-7304-2017	Maranda, Louise/0000-0003-2913-2552	Eunice Kennedy Shriver National Institute of Child Health & Human Development; WALTHAM Centre for Pet Nutrition, a division of Mars, Incorporated;  [R03-HD071263-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD071263] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); WALTHAM Centre for Pet Nutrition, a division of Mars, Incorporated; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project described was supported by Grant Number R03-HD071263-01, co-funded by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (www.nichd.nih.gov) and WALTHAM Centre for Pet Nutrition (www.mars.com), a division of Mars, Incorporated. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, or Mars-Waltham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, DIABETES CARE, V28, pS4; Barker SB, 2003, AM BEHAV SCI, V47, P94, DOI 10.1177/0002764203255215; Downs TJ, ENV HLTH PERSPEC, V118, P1318; Greening L, 2007, J PEDIATR PSYCHOL, V32, P437, DOI 10.1093/jpepsy/jsl029; Hanna KM, 2005, J PEDIATR PSYCHOL, V30, P257, DOI 10.1093/jpepsy/jsi036; Hermanns N, 2007, DIABETOLOGIA, V50, P930, DOI 10.1007/s00125-007-0643-y; Iannotti RJ, 2006, J DEV BEHAV PEDIATR, V27, P98, DOI 10.1097/00004703-200604000-00003; King PS, 2012, J ADOLESCENT HEALTH, V50, P491, DOI 10.1016/j.jadohealth.2011.09.007; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Mortensen HB, 1998, DIABETIC MED, V15, P752, DOI 10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; Ohmann S, 2010, PSYCHOL MED, V40, P95, DOI 10.1017/S0033291709005777; Peel E, 2010, BRIT J GEN PRACT, V60, P570, DOI 10.3399/bjgp10X515061; Rausch JR, 2012, DIABETES CARE, V35, P1219, DOI 10.2337/dc11-2163; Schilling LS, 2009, NURS RES, V58, P228, DOI 10.1097/NNR.0b013e3181ac142a; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186; Wells DL, 2007, BRIT J HEALTH PSYCH, V12, P145, DOI 10.1348/135910706X103284; Wells DL, 2009, J SOC ISSUES, V65, P523, DOI 10.1111/j.1540-4560.2009.01612.x; Wells DL, 2008, J ALTERN COMPLEM MED, V14, P1235, DOI 10.1089/acm.2008.0288; Yi-Frazier JP, 2012, PSYCHOLOGY, V03, P1116	20	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0152332	10.1371/journal.pone.0152332	http://dx.doi.org/10.1371/journal.pone.0152332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27104736	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100004
J	Di Mattei, VE; Carnelli, L; Mazzetti, M; Bernardi, M; Di Pierro, R; Bergamini, A; Mangili, G; Candiani, M; Sarno, L				Di Mattei, Valentina E.; Carnelli, Letizia; Mazzetti, Martina; Bernardi, Martina; Di Pierro, Rossella; Bergamini, Alice; Mangili, Giorgia; Candiani, Massimo; Sarno, Lucio			Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition?	PLOS ONE			English	Article							COMMON-SENSE MODEL; CANCER-PATIENTS; PERCEPTION QUESTIONNAIRE; PSYCHOLOGICAL DISTRESS; MOLAR PREGNANCY; DIAGNOSIS; SURVIVORS; ADJUSTMENT; OUTCOMES; HEALTH	Background Gestational Trophoblastic Disease comprises a group of benign and malignant disorders that derive from the placenta. Using Leventhal's Common-Sense Model as a theoretical framework, this paper examines illness perception in women who have been diagnosed with this disease. Methods Thirty-one women diagnosed with Gestational Trophoblastic Disease in a hospital in Italy were asked to complete the Illness Perception Questionnaire-Revised to measure the following: illness Identity, illness opinions and causes of Gestational Trophoblastic Disease. Results High mean scores were observed in the Emotional representations and Treatment control subscales. A significant difference emerged between hydatidiform mole patients and those with gestational trophoblastic neoplasia on the Identity subscale. A significant correlation emerged between "time since diagnosis" and the Treatment control subscale. Discussion This study is the first to investigate illness perception in Gestational Trophoblastic Disease. From a clinical perspective the results highlight the need for multidisciplinary support programs to promote a more realistic illness perception.	[Di Mattei, Valentina E.; Carnelli, Letizia; Mazzetti, Martina; Bernardi, Martina; Candiani, Massimo; Sarno, Lucio] Univ Vita Salute San Raffaele, Milan, Italy; [Di Mattei, Valentina E.; Carnelli, Letizia; Sarno, Lucio] IRCCS San Raffaele Hosp, Clin & Hlth Psychol Unit, Milan, Italy; [Di Pierro, Rossella] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Bergamini, Alice; Mangili, Giorgia; Candiani, Massimo] IRCCS San Raffaele Hosp, Obstet & Gynecol Unit, Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Carnelli, L (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.; Carnelli, L (corresponding author), IRCCS San Raffaele Hosp, Clin & Hlth Psychol Unit, Milan, Italy.	carnelli.letizia@hsr.it	BERGAMINI, ALICE/AAN-2060-2020; mangili, giorgia/Y-9673-2019; Di Mattei, Valentina/AAC-4634-2022; Candiani, Massimo/ABG-9811-2020	BERGAMINI, ALICE/0000-0002-1915-8313; mangili, giorgia/0000-0002-8451-429X; DI PIERRO, ROSSELLA/0000-0001-7930-1559; CANDIANI, Massimo/0000-0002-2129-2626				Allen JE, 2003, AM J OBSTET GYNECOL, V188, P1151, DOI 10.1067/mob.2003.297; Bess Karen A, 2006, AWHONN Lifelines, V10, P320; Dempster M, 2012, DIS ESOPHAGUS, V25, P222, DOI 10.1111/j.1442-2050.2011.01233.x; Di Mattei VE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128354; Di Mattei VE, 2014, J REPROD MED, V59, P488; Fischer MJ, 2013, BRIT J HEALTH PSYCH, V18, P526, DOI 10.1111/j.2044-8287.2012.02100.x; FLAM F, 1993, J PSYCHOSOM OBST GYN, V14, P241, DOI 10.3109/01674829309084447; Foster NE, 2008, PAIN, V136, P177, DOI 10.1016/j.pain.2007.12.007; Garner E, 2003, BEST PRACT RES CL OB, V17, P959, DOI 10.1016/S1521-6934(03)00093-2; Giardini A, 2007, G Ital Med Lav Ergon, V29, pA64; Gould RV, 2010, PSYCHOL HEALTH, V25, P633, DOI 10.1080/08870440902811163; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hale ED, 2007, RHEUMATOLOGY, V46, P904, DOI 10.1093/rheumatology/kem060; Hopman P, 2015, PSYCHO-ONCOLOGY, V24, P11, DOI 10.1002/pon.3591; Horowitz NS, 2009, GESTATIONAL TROPHOBL, Vthird, P460; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Ireson J, 2014, J REPROD MED, V59, P195; Jorgensen IL, 2009, ACTA ONCOL, V48, P1119, DOI 10.3109/02841860903033922; Keeling M, 2013, PSYCHO-ONCOLOGY, V22, P1421, DOI 10.1002/pon.3158; Lau R. R., 1983, HEALTH PSYCHOL, V2, P167, DOI [10.1037/0278-6133.2.2.167, DOI 10.1037/0278-6133.2.2.167]; Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219; Leventhal H., 1982, 20 INT C APPL PSYCH; Leventhal H, 1980, CONTRIBUTIONS MED PS, P17; Llewellyn CD, 2007, J PSYCHOSOM RES, V63, P17, DOI 10.1016/j.jpsychores.2007.01.013; Lurain JR, 2010, AM J OBSTET GYNECOL, V203, P531, DOI 10.1016/j.ajog.2010.06.073; Mangili G, 2014, INT J GYNECOL CANCER, V24, pS109, DOI 10.1097/IGC.0000000000000294; Mangili G, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.036; McCorry NK, 2013, PSYCHO-ONCOLOGY, V22, P692, DOI 10.1002/pon.3054; MEYER D, 1985, HEALTH PSYCHOL, V4, P115, DOI 10.1037/0278-6133.4.2.115; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; NGAN HYS, 1986, J REPROD MED, V31, P173; Parazzini F, 2012, INT J GYNECOL CANCER, V22, P318, DOI 10.1097/IGC.0b013e31823b3504; Paschali AA, 2015, PSYCHO-ONCOLOGY, V24, P901, DOI 10.1002/pon.3741; Petersen RW, 2005, GYNECOL ONCOL, V97, P535, DOI 10.1016/j.ygyno.2005.01.015; Razavi D, 2002, BRIT J CANCER, V87, P1, DOI 10.1038/sj.bjc.6600412; Rozema H, 2009, PSYCHO-ONCOLOGY, V18, P849, DOI 10.1002/pon.1488; Savage PM, 2013, J OBSTET GYNAECOL, V33, P406, DOI 10.3109/01443615.2013.771159; Seckl MJ, 2013, ANN ONCOL, V24, P39, DOI 10.1093/annonc/mdt345; Soper JT, 2006, OBSTET GYNECOL, V108, P176, DOI 10.1097/01.AOG.0000224697.31138.a1; Stafford L, 2011, INT J GYNECOL CANCER, V21, P1256, DOI 10.1097/IGC.0b013e3182259c04; Stafford L, 2011, INT J GYNECOL CANCER, V21, P161, DOI 10.1097/IGC.0b013e31820156d8; Tse KY, 2012, BEST PRACT RES CL OB, V26, P357, DOI 10.1016/j.bpobgyn.2011.11.009; Vaughan R, 2003, BRIT J HEALTH PSYCH, V8, P287, DOI 10.1348/135910703322370860; Ferreira EGV, 2009, J REPROD MED, V54, P239; Walsh JC, 2004, J PSYCHOSOM RES, V56, P67, DOI 10.1016/S0022-3999(03)00082-5; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; WENZEL L, 1992, GYNECOL ONCOL, V46, P74, DOI 10.1016/0090-8258(92)90200-3; Wenzel L, 2004, J REPROD MED, V49, P589; Wenzel L, 2002, J REPROD MED, V47, P387; WENZEL LB, 1994, J REPROD MED, V39, P163	50	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153869	10.1371/journal.pone.0153869	http://dx.doi.org/10.1371/journal.pone.0153869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101144	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500082
J	Gigli, CC; Scaramuzza, L; Gandaglia, A; Bellini, E; Gabaglio, M; Parolaro, D; Kilstrup-Nielsen, C; Landsberger, N; Bedogni, F				Gigli, Clementina Cobolli; Scaramuzza, Linda; Gandaglia, Anna; Bellini, Elisa; Gabaglio, Marina; Parolaro, Daniela; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta; Bedogni, Francesco			MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background	PLOS ONE			English	Article							RETT-SYNDROME; MOUSE MODEL; MUTANT MICE; SOCIAL INTERACTIONS; DEFICIENCY; EXPRESSION; NEURONS; ABNORMALITIES; MORPHOLOGY; DELIVERY	MECP2 mutations cause a number of neurological disorders of which Rett syndrome (RTT) represents the most thoroughly analysed condition. Many Mecp2 mouse models have been generated through the years; their validity is demonstrated by the presence of a broad spectrum of phenotypes largely mimicking those manifested by RTT patients. These mouse models, between which the C57BL/6 Mecp2(tm1.1Bird) strain probably represents the most used, enabled to disclose much of the roles of Mecp2. However, small litters with little viability and poor maternal care hamper the maintenance of the colony, thus limiting research on such animals. For this reason, past studies often used Mecp2 mouse models on mixed genetic backgrounds, thus opening questions on whether modifier genes could be responsible for at least part of the described effects. To verify this possibility, and facilitate the maintenance of the Mecp2 colony, we transferred the Mecp2(tm1.1Bird) allele on the stronger CD1 background. The CD1 strain is easier to maintain and largely recapitulates the phenotypes already described in Mecp2-null mice. We believe that this mouse model will foster the research on RTT.	[Gigli, Clementina Cobolli; Scaramuzza, Linda; Gandaglia, Anna; Bellini, Elisa; Landsberger, Nicoletta; Bedogni, Francesco] Ist Sci San Raffaele, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy; [Bellini, Elisa] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Gabaglio, Marina; Parolaro, Daniela; Kilstrup-Nielsen, Charlotte] Univ Insubria, Dept Biotechnol & Life Sci, Busto Arsizio, Italy; [Parolaro, Daniela] ZardiGori Fdn, Milan, Italy; [Landsberger, Nicoletta] Univ Milan, Dept Med Biotechnol & Translat Med, LITA, Segrate, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Zurich; University Zurich Hospital; University of Insubria; University of Milan	Landsberger, N; Bedogni, F (corresponding author), Ist Sci San Raffaele, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy.; Landsberger, N (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, LITA, Segrate, Italy.	nicoletta.landsberger@unimi.it; bedogni.francesco@hsr.it		Landsberger, Nicoletta/0000-0003-0820-3155; bedogni, francesco/0000-0002-6651-0041; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077	Jerome Lejeune Foundation; proRETT Ricerca	Jerome Lejeune Foundation; proRETT Ricerca	This work was supported by Jerome Lejeune Foundation to Francesco Bedogni, Jerome Lejeune Foundation to Nicoletta Landsberger, and proRETT Ricerca to Nicoletta Landsberger.	Aldinger KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004729; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Armstrong DD, 1999, PEDIATR NEUROL, V20, P125, DOI 10.1016/S0887-8994(98)00124-6; Bedogni F, 2016, CEREB CORTEX, V26, P2517, DOI 10.1093/cercor/bhv078; Bedogni F, 2014, NEUROSCI BIOBEHAV R, V46, P187, DOI 10.1016/j.neubiorev.2014.01.011; Belichenko NP, 2008, J COMP NEUROL, V508, P184, DOI 10.1002/cne.21673; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Conti V, 2015, PLOS ONE IN PRESS; Fischer M, 2009, J NEUROPHYSIOL, V101, P1016, DOI 10.1152/jn.91124.2008; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Jugloff DGM, 2008, HUM MOL GENET, V17, P1386, DOI 10.1093/hmg/ddn026; Jugloff DGM, 2006, J NEUROSCI METH, V154, P89, DOI 10.1016/j.jneumeth.2005.12.002; Justice MJ, 2013, RARE DIS, V1, DOI 10.4161/rdis.27265; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kerr B, 2008, HUM MOL GENET, V17, P1707, DOI 10.1093/hmg/ddn061; Kilstrup-Nielsen C, 2015, NEUROBIOLOGY OF BRAIN DISORDERS: BIOLOGICAL BASIS OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, P98, DOI 10.1016/B978-0-12-398270-4.00007-0; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Panighini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064863; Park MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109527; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Pitcher MR, 2013, HUM MOL GENET, V22, P2626, DOI 10.1093/hmg/ddt111; Ricceri L, 2008, BEHAV PHARMACOL, V19, P501, DOI 10.1097/FBP.0b013e32830c3645; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Rietveld L, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00145, 10.3389/fnel.2015.00145]; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; Roceri M, 2002, MOL PSYCHIATR, V7, P609, DOI 10.1038/sj.mp.4001036; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Schaevitz LR, 2013, GENES BRAIN BEHAV, V12, P732, DOI 10.1111/gbb.12070; Segatto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104834; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009	42	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153473	10.1371/journal.pone.0153473	http://dx.doi.org/10.1371/journal.pone.0153473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097329	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000374543600037
J	Chiu, TCR; Ngo, HC; Lau, LW; Leung, KW; Lo, MH; Yu, HF; Ying, M				Chiu, Tsz-chun Roxy; Ngo, Hiu-ching; Lau, Lai-wa; Leung, King-wah; Lo, Man-him; Yu, Ho-fai; Ying, Michael			An Investigation of the Immediate Effect of Static Stretching on the Morphology and Stiffness of Achilles Tendon in Dominant and Non-Dominant Legs	PLOS ONE			English	Article							IN-VIVO; BIOMECHANICAL PROPERTIES; GASTROCNEMIUS-MUSCLE; CALCANEAL TENDON; ANKLE; TENDINOPATHY; ELASTOGRAPHY; ASYMMETRY; RESPONSES; EXERCISE	Aims This study was undertaken to investigate the immediate effect of static stretching on normal Achilles tendon morphology and stiffness, and the different effect on dominant and non-dominant legs; and to evaluate inter-operator and intra-operator reliability of using shear-wave elastography in measuring Achilles tendon stiffness. Methods 20 healthy subjects (13 males, 7 females) were included in the study. Thickness, cross-sectional area and stiffness of Achilles tendons in both legs were measured before and after 5-min static stretching using grey-scale ultrasound and shear-wave elastography. Inter-operator and intra-operator reliability of tendon stiffness measurements of six operators were evaluated. Results Result showed that there was no significant change in the thickness and cross-sectional area of Achilles tendon after static stretching in both dominant and non-dominant legs (p > 0.05). Tendon stiffness showed a significant increase in non-dominant leg (p < 0.05) but not in dominant leg (p > 0.05). The inter-operator reliability of shear-wave elastography measurements was 0.749 and the intra-operator reliability ranged from 0.751 to 0.941. Conclusion Shear-wave elastography is a useful and non-invasive imaging tool to assess the immediate stiffness change of Achilles tendon in response to static stretching with high intra-operator and inter-operator reliability.	[Chiu, Tsz-chun Roxy; Ngo, Hiu-ching; Lau, Lai-wa; Leung, King-wah; Lo, Man-him; Yu, Ho-fai; Ying, Michael] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Ying, M (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.	htmying@polyu.edu.hk		Ying, Michael/0000-0001-5979-6072				Arampatzis A, 2007, J EXP BIOL, V210, P2743, DOI 10.1242/jeb.003814; Aubry S, 2013, SKELETAL RADIOL, V42, P1143, DOI 10.1007/s00256-013-1649-9; Avela J, 2004, J APPL PHYSIOL, V96, P2325, DOI 10.1152/japplphysiol.01010.2003; Bohm S, 2015, SCAND J MED SCI SPOR, V25, pE124, DOI 10.1111/sms.12242; Brum J, 2014, PHYS MED BIOL, V59, P505, DOI 10.1088/0031-9155/59/3/505; Burgess KE, 2009, J ORTHOP RES, V27, P510, DOI 10.1002/jor.20768; Chen XM, 2013, J ULTRAS MED, V32, P449, DOI 10.7863/jum.2013.32.3.449; de Almeida FM, 2009, CONNECT TISSUE RES, V50, P279, DOI 10.3109/03008200802697435; Kato E, 2010, EUR J SPORT SCI, V10, P111, DOI 10.1080/17461390903307834; Kubo K, 2002, ACTA PHYSIOL SCAND, V175, P157, DOI 10.1046/j.1365-201X.2002.00976.x; Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445; Obst SJ, 2013, MED SCI SPORT EXER, V45, P1534, DOI 10.1249/MSS.0b013e318289d821; Pang BSF, 2006, J ULTRAS MED, V25, P1291, DOI 10.7863/jum.2006.25.10.1291; Park DY, 2006, FOOT ANKLE INT, V27, P1086, DOI 10.1177/107110070602701215; Peltz CD, 2013, SKELETAL RADIOL, V42, P1151, DOI 10.1007/s00256-013-1629-0; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Simmons JG, 2002, AM J PHYSIOL-GASTR L, V283, pG809, DOI 10.1152/ajpgi.00057.2002; Valderrabano V, 2007, FOOT ANKLE INT, V28, P242, DOI 10.3113/FAI.2007.0242; Velotta J, 2011, PORTUGESE J SPORT SC, V11, P1035; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang JHC, 2006, CLIN ORTHOP RELAT R, P320, DOI 10.1097/01.blo.0000195927.81845.46; Wang Y, 2012, J APPL BIOMECH, V28, P473, DOI 10.1123/jab.28.4.473; Ying M, 2003, ULTRASOUND MED BIOL, V29, P637, DOI 10.1016/S0301-5629(03)00008-5	23	18	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154443	10.1371/journal.pone.0154443	http://dx.doi.org/10.1371/journal.pone.0154443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120097	gold, Green Published, Green Submitted			2022-12-26	WOS:000374976200076
J	dos Reis, VM; Karez, CS; Mariath, R; de Moraes, FC; de Carvalho, RT; Brasileiro, PS; Bahia, RD; Lotufo, TMD; Ramalho, LV; de Moura, RL; Francini, RB; Pereira, GH; Thompson, FL; Bastos, AC; Salgado, LT; Amado, GM				dos Reis, Vanessa Moura; Karez, Claudia Santiago; Mariath, Rodrigo; de Moraes, Fernando Coreixas; de Carvalho, Rodrigo Tomazetto; Brasileiro, Poliana Silva; Bahia, Ricardo da Gama; da Cruz Lotufo, Tito Monteiro; Ramalho, Lais Vieira; de Moura, Rodrigo Leao; Francini-Filho, Ronaldo Bastos; Pereira-Filho, Guilherme Henrique; Thompson, Fabiano Lopes; Bastos, Alex Cardoso; Salgado, Leonardo Tavares; Amado-Filho, Gilberto Menezes			Carbonate Production by Benthic Communities on Shallow Coralgal Reefs of Abrolhos Bank, Brazil	PLOS ONE			English	Article							CRUSTOSE CORALLINE ALGAE; CLIMATE-CHANGE; ENCRUSTER COMMUNITIES; ARTIFICIAL REEF; SOUTH ATLANTIC; SEDIMENTATION; RHODOPHYTA; DECLINE; GROWTH; RATES	The abundance of reef builders, non-builders and the calcium carbonate produced by communities established in Calcification Accretion Units (CAUs) were determined in three Abrolhos Bank shallow reefs during the period from 2012 to 2014. In addition, the seawater temperature, the irradiance, and the amount and composition of the sediments were determined. The inner and outer reef arcs were compared. CAUs located on the inner reef shelf were under the influence of terrigenous sediments. On the outer reefs, the sediments were composed primarily of marine biogenic carbonates. The mean carbonate production in shallow reefs of Abrolhos was 579 +/- 98 g m(-2) y(-1). The builder community was dominated by crustose coralline algae, while the non-builder community was dominated by turf. A marine heat wave was detected during the summer of 2013-2014, and the number of consecutive days with a temperature above or below the summer mean was positively correlated with the turf cover increase. The mean carbonate production of the shallow reefs of Abrolhos Bank was greater than the estimated carbonate production measured for artificial structures on several other shallow reefs of the world. The calcimass was higher than the non-calcareous mass, suggesting that the Abrolhos reefs are still in a positive carbonate production balance. Given that marine heat waves produce an increase of turf cover on the shallow reefs of the Abrolhos, a decrease in the cover represented by reef builders and shifting carbonate production are expected in the near future.	[dos Reis, Vanessa Moura; Karez, Claudia Santiago; Mariath, Rodrigo; de Moraes, Fernando Coreixas; de Carvalho, Rodrigo Tomazetto; Brasileiro, Poliana Silva; Bahia, Ricardo da Gama; Salgado, Leonardo Tavares; Amado-Filho, Gilberto Menezes] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Rio De Janeiro, Brazil; [da Cruz Lotufo, Tito Monteiro] Univ Sao Paulo, Inst Oceanog, Sao Paulo, SP, Brazil; [Ramalho, Lais Vieira] Museu Nacl Rio de Janeiro, Dept Invertebrados, Rio De Janeiro, Rio De Janeiro, Brazil; [de Moura, Rodrigo Leao; Thompson, Fabiano Lopes] Univ Fed Rio de Janeiro, Dept Biol Marinha, Rio De Janeiro, Rio De Janeiro, Brazil; [Francini-Filho, Ronaldo Bastos] Univ Fed Paraiba, Dept Engn & Meio Ambiente, Rio Tinto, Paraiba, Brazil; [Pereira-Filho, Guilherme Henrique] Univ Fed Sao Paulo, Inst Mar, Sao Paulo, Brazil; [Bastos, Alex Cardoso] Univ Fed Espirito Santo, Dept Oceanog, Vitoria, ES, Brazil	Jardim Botanico do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade Federal da Paraiba; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Espirito Santo	Amado, GM (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Rio De Janeiro, Brazil.	gfilho@jbrj.gov.br	Salgado, Leonardo T/F-1123-2013; Francini-Filho, Ronaldo/I-5708-2012; Ramalho, Lais Vieira/AAH-1596-2019; Karez, Claudia S/N-6656-2015; Pereira-Filho, Guilherme-Henrique/I-2946-2013; Carvalho, Rodrigo/GLU-1952-2022; de Moura, Rodrigo Leao/AAL-5781-2020; Lotufo, Tito M. C./E-7836-2011	Francini-Filho, Ronaldo/0000-0002-7678-6797; Ramalho, Lais Vieira/0000-0003-1459-3954; Karez, Claudia S/0000-0003-0820-4166; Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241; Carvalho, Rodrigo/0000-0002-2613-0001; de Moura, Rodrigo Leao/0000-0002-5597-6196; Lotufo, Tito M. C./0000-0003-3630-1342; Thompson, Fabiano/0000-0002-7562-1683	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Pesquisa Ecologica de Longa Duracao-PELD [34/2012]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Amparo a Pesquisa do Estado do Espirito Santo; Rede Abrolhos/SISBIOTA (MCT/CNPq/CAPES/FAPES); Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis/BRASOIL-Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Pesquisa Ecologica de Longa Duracao-PELD; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo; Rede Abrolhos/SISBIOTA (MCT/CNPq/CAPES/FAPES); Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis/BRASOIL-Brazil	Financial support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Pesquisa Ecologica de Longa Duracao-PELD (#34/2012), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Fundacao de Amparo a Pesquisa do Estado do Espirito Santo, Rede Abrolhos/SISBIOTA (MCT/CNPq/CAPES/FAPES) and Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis/BRASOIL-Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEY W H, 1975, Phycologia, V14, P55, DOI 10.2216/i0031-8884-14-2-55.1; AIROLDI L, 1995, BOT MAR, V38, P227, DOI 10.1515/botm.1995.38.1-6.227; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; Almeida VES, 2011, THESIS U FEDERAL BAH; Alves N, 2010, ENV MICROBIOL REP, V2, P90, DOI 10.1111/j.1758-2229.2009.00101.x; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Antunes P, 1999, ECOL ECON, V31, P215, DOI 10.1016/S0921-8009(99)00080-4; Azevedo FBB, 2006, BRAZ ARCH BIOL TECHN, V49, P263, DOI 10.1590/S1516-89132006000300012; BAILEYBROCK JH, 1989, B MAR SCI, V44, P580; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Basso D, 2012, GEODIVERSITAS, V34, P13, DOI 10.5252/g2012n1a2; BENAYAHU Y, 1981, B MAR SCI, V31, P514; Benzoni F, 2011, MAR BIOL, V158, P2419, DOI 10.1007/s00227-011-1743-2; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Castro Clovis B., 1999, Revista Brasileira de Oceanografia, V47, P87; Cetz-Navarro NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054810; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Costa OS, 2002, P 9 INT COR REEF S, P507; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Field SN, 2007, CORAL REEFS, V26, P279, DOI 10.1007/s00338-006-0191-9; Figueiredo MAO, 2002, P 9 INT COR REEF S, P498; Figueiredo MAO, 2006, RAP B BIOL ASSESS, V38, P67; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Francini-Filho RB, 2008, FISH RES, V93, P346, DOI 10.1016/j.fishres.2008.06.011; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; Gherardi DFM, 2001, CORAL REEFS, V19, P205, DOI 10.1007/s003380000100; Ginsburg RN, 1994, PROCEEDINGS OF THE C; Glasby TM, 2000, J EXP MAR BIOL ECOL, V248, P177, DOI 10.1016/S0022-0981(00)00169-6; GROSBERG RK, 1981, NATURE, V290, P700, DOI 10.1038/290700a0; Haas A, 2010, CORAL REEFS, V29, P93, DOI 10.1007/s00338-009-0556-y; HAY ME, 1981, ECOLOGY, V62, P739, DOI 10.2307/1937742; Hepburn LJ, 2015, CORAL REEFS, V34, P189, DOI 10.1007/s00338-014-1227-1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Instituto Nacional de Pesquisas Espaciais, 2015, TEMP VER VAO SUP 201; Jameson S. C, 1995, STATE REEFS REGIONAL; Kamenos NA, 2010, J PHYCOL, V46, P331, DOI 10.1111/j.1529-8817.2009.00780.x; Kuffner IB, 2013, CORAL REEFS, V32, P987, DOI 10.1007/s00338-013-1047-8; Leao Z, 1997, P 8 INT COR REEF S, V2, P1767; Leao Z. M. A. N., 2002, DNPM CPRM COMISSAO B, V1, P345; Leão Zelinda Margarida Andrade Nery, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000300006; LITTLER MM, 1980, AM NAT, V116, P25, DOI 10.1086/283610; Mallela J, 2007, CORAL REEFS, V26, P775, DOI 10.1007/s00338-007-0260-8; Mallela J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060010; Mariath R, 2013, HELGOLAND MAR RES, V67, P687, DOI 10.1007/s10152-013-0354-3; MATSUDA S, 1989, CORAL REEFS, V7, P185, DOI 10.1007/BF00301597; Maughan BC, 2001, J EXP MAR BIOL ECOL, V256, P59, DOI 10.1016/S0022-0981(00)00304-X; Monniot C, 1991, CORAL REEF ASCIDIANS; Morgan KM, 2014, MAR FRESHWATER RES, V65, P720, DOI 10.1071/MF13155; Moura R. L., 2007, AQUATIC PROTECTED AR, P175; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Newman SP, 2015, J ANIM ECOL, V84, P1678, DOI 10.1111/1365-2656.12429; Pari N, 1998, MAR ECOL PROG SER, V166, P119, DOI 10.3354/meps166119; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; QUINN JF, 1982, OECOLOGIA, V54, P129, DOI 10.1007/BF00541119; Schroeder PA, 2014, ELEMENTS, V10, P177, DOI 10.2113/gselements.10.3.177; SCHUHMACHER H, 1977, HELGOLAND WISS MEER, V30, P400, DOI 10.1007/BF02207850; Segal B, 2011, BRAZ J OCEANOGR, V59, P119, DOI 10.1590/S1679-87592011000200001; Shenkar N, 2012, MAR BIODIVERS, V42, P459, DOI 10.1007/s12526-012-0124-5; Short J, 2015, CONT SHELF RES, V106, P38, DOI 10.1016/j.csr.2015.07.003; Silva AS, 2013, CONT SHELF RES, V70, P159, DOI 10.1016/j.csr.2013.06.002; SOUSA WP, 1981, OECOLOGIA, V48, P297, DOI 10.1007/BF00346486; SOUSA WP, 1980, OECOLOGIA, V45, P72, DOI 10.1007/BF00346709; Spieler RE, 2001, B MAR SCI, V69, P1013; Steneck R.S., 1997, P 8 INT CORAL REEF S, P6; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; STEWART JG, 1989, J PHYCOL, V25, P436, DOI 10.1111/j.1529-8817.1989.tb00248.x; Stocker T.F., 2013, CLIMATE CHANGE 2013; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Tâmega Frederico Tapajós de Souza, 2007, Rodriguésia, V58, P941, DOI 10.1590/2175-7860200758413; Taylor Paul D., 2000, P195, DOI 10.1017/CBO9780511535505.015; Titschack J, 2011, AM MINERAL, V96, P1028, DOI 10.2138/am.2011.3665; Vargas-Angel B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142196; Villaca Roberto, 1997, Revista Brasileira de Oceanografia, V45, P35; Villas Bôas Alexandre Bigio, 2005, Braz. j. oceanogr., V53, P147, DOI 10.1590/S1679-87592005000200005; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361	86	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154417	10.1371/journal.pone.0154417	http://dx.doi.org/10.1371/journal.pone.0154417			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119151	Green Published, gold, Green Submitted			2022-12-26	WOS:000374976200070
J	Furukawa, H; Oka, S; Kawasaki, A; Shimada, K; Sugii, S; Matsushita, T; Hashimoto, A; Komiya, A; Fukui, N; Kobayashi, K; Osada, A; Ihata, A; Kondo, Y; Nagai, T; Setoguchi, K; Okamoto, A; Okamoto, A; Chiba, N; Suematsu, E; Kono, H; Katayama, M; Hirohata, S; Sumida, T; Migita, K; Hasegawa, M; Fujimoto, M; Sato, S; Nagaoka, S; Takehara, K; Tohma, S; Tsuchiya, N				Furukawa, Hiroshi; Oka, Shomi; Kawasaki, Aya; Shimada, Kota; Sugii, Shoji; Matsushita, Takashi; Hashimoto, Atsushi; Komiya, Akiko; Fukui, Naoshi; Kobayashi, Kouji; Osada, Atsumu; Ihata, Atsushi; Kondo, Yuya; Nagai, Tatsuo; Setoguchi, Keigo; Okamoto, Akiko; Okamoto, Akira; Chiba, Noriyuki; Suematsu, Eiichi; Kono, Hajime; Katayama, Masao; Hirohata, Shunsei; Sumida, Takayuki; Migita, Kiyoshi; Hasegawa, Minoru; Fujimoto, Manabu; Sato, Shinichi; Nagaoka, Shouhei; Takehara, Kazuhiko; Tohma, Shigeto; Tsuchiya, Naoyuki			Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01	PLOS ONE			English	Article							CLASS-II GENES; SCLERODERMA; SUSCEPTIBILITY; ASSOCIATION; AUTOANTIBODY; GENETICS; DISEASE	Objective Several studies on associations between human leukocyte antigen (HLA) allele frequencies and susceptibility to systemic sclerosis (SSc) have been reported. Anti-centromere antibodies (ACA) and anti-topoisomerase I antibodies (ATA) are found in SSc patients. Here, we sought to identify HLA alleles associated with SSc in Japanese, and explored their associations with SSc phenotypes including the presence of autoantibodies. Methods Associations of HLA-DRB1, DQB1, and DPB1 were analyzed in 463 Japanese SSc patients and 413 controls. Results We found that DRB1* 13: 02 (P = 0.0011, Pc = 0.0319, odds ratio [OR] 0.46, 95% confidence interval [CI] 0.29-0.73), DRB1* 14: 06 (P = 6.60X10(-5), Pc = 0.0020, OR 0.05, 95% CI 0.01-0.41), DQB1* 03: 01 (P = 0.0009, Pc = 0.0150, OR 0.56, 95% CI 0.40-0.79), and DPB1* 02: 01 (P = 5.16X10(-6), Pc = 8.77X10(-5), OR 0.52, 95% CI 0.39-0.69) were protectively associated with SSc. In addition, these four alleles seemed to be independently associated with the protection against the susceptibility of SSc. On the other hand, we could not find predisposing alleles for overall SSc. With respect to SSc subsets, a tendency for these four alleles to be protectively associated was observed. However, there was a significant association between DRB1* 01: 01, DRB1* 10: 01, DQB1* 05: 01, and DPB1* 04: 02 and the susceptibility to SSc with ACA. On the other hand, the presence of DRB1* 15: 02, DQB1* 06: 01, DPB1* 03: 01, and DPB1* 09: 01 was associated with SSc with ATA. Conclusion Thus, the present study has identified protective associations of the four HLA class II alleles with overall Japanese SSc and predisposing associations of HLA class II alleles with Japanese SSc subsets.	[Furukawa, Hiroshi; Oka, Shomi; Kawasaki, Aya; Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Furukawa, Hiroshi; Oka, Shomi; Komiya, Akiko; Fukui, Naoshi; Tohma, Shigeto] Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Hashimoto, Atsushi] Natl Hosp Org, Sagamihara Hosp, Dept Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Sugii, Shoji] Tokyo Metropolitan Tama Med Ctr, Dept Rheumat Dis, 2-8-29 Musashi Dai, Fuchu, Tokyo, Japan; [Matsushita, Takashi; Takehara, Kazuhiko] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Dermatol, Fac Med, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan; [Kobayashi, Kouji; Osada, Atsumu; Ihata, Atsushi; Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Kanazawa Ku, 1-21-1 Rokuura Higashi, Yokohama, Kanagawa, Japan; [Kondo, Yuya; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Nagai, Tatsuo; Hirohata, Shunsei] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 228, Japan; [Setoguchi, Keigo] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Allergy & Immunol Dis, Bunkyo Ku, 3-18-22 Hon Komagome, Tokyo, Japan; [Okamoto, Akiko; Kono, Hajime] Teikyo Univ, Dept Internal Med, Itabashi Ku, 2-11-1 Kaga, Tokyo, Japan; [Okamoto, Akira] Natl Hosp Org, Himeji Med Ctr, Dept Rheumatol, 68 Hon Machi, Himeji, Hyogo, Japan; [Chiba, Noriyuki] Natl Hosp Org, Morioka Hosp, Dept Rheumatol, 1-25-1 Aoyama, Morioka, Iwate, Japan; [Suematsu, Eiichi] Natl Hosp Org, Dept Internal Med & Rheumatol, Kyushu Med Ctr, Clin Res Inst,Chuo Ku, 1-8-1 Jigyohama, Fukuoka, Japan; [Katayama, Masao] Natl Hosp Org, Nagoya Med Ctr, Dept Internal Med, Naka Ku, 4-1-1 Sannomaru, Nagoya, Aichi, Japan; [Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, 2-1001-1 Kubara, Omura, Japan; [Hasegawa, Minoru] Univ Fukui, Sch Med, Dept Dermatol, Fac Med Sci, 23-3 Matsuokashimoaizuki, Eiheiji, Japan; [Fujimoto, Manabu] Univ Tsukuba, Dept Dermatol, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Sato, Shinichi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan	University of Tsukuba; Kanazawa University; University of Tsukuba; Kitasato University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Teikyo University; Nagoya Medical Center; University of Fukui; University of Tsukuba; University of Tokyo	Furukawa, H (corresponding author), Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.; Furukawa, H (corresponding author), Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan.	furukawa-tky@umin.org	Matsushita, Takashi/C-4750-2015; Tsuchiya, Naoyuki/CAA-4545-2022	Matsushita, Takashi/0000-0002-1617-086X; Tsuchiya, Naoyuki/0000-0002-6776-5580; Fujimoto, Manabu/0000-0002-3062-4872; Kono, Hajime/0000-0002-4578-8677; Hasegawa, Minoru/0000-0003-3738-2682	Japan Society for the Promotion of Science [26293123, 22591090, 24791018]; Ministry of Health, Labour, and Welfare of Japan; National Hospital Organization; Daiwa Securities Health Foundation; Japan Research Foundation for Clinical Pharmacology; Nakatomi Foundation; Takeda Science Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Kato Memorial Trust for Nambyo Research; Abbott Japan Co., Ltd.; Astellas Pharma Inc.; Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.; Mitsuibishi Tanabe Pharma Corporation; Merck Sharp and Dohme Inc.; Pfizer Japan Inc.; Takeda Pharmaceutical Company Limited; Teijin Pharma Limited	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Hospital Organization; Daiwa Securities Health Foundation; Japan Research Foundation for Clinical Pharmacology; Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Kato Memorial Trust for Nambyo Research(Kato Memorial Trust for Nambyo Research); Abbott Japan Co., Ltd.(Abbott Laboratories); Astellas Pharma Inc.(Astellas Pharmaceuticals); Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.(Eisai Co Ltd); Mitsuibishi Tanabe Pharma Corporation; Merck Sharp and Dohme Inc.(Merck & Company); Pfizer Japan Inc.(Pfizer); Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); Teijin Pharma Limited(Teijin Pharma Limited)	The study was supported by Grants-in-Aid for Scientific Research ( B, C) ( 26293123, 22591090) and for Young Scientists ( B) ( 24791018) from the Japan Society for the Promotion of Science, Health and Labour Science Research Grants from the Ministry of Health, Labour, and Welfare of Japan, Grants-in-Aid for Clinical Research from National Hospital Organization, Research Grants from Daiwa Securities Health Foundation, Research Grants from Japan Research Foundation for Clinical Pharmacology, Research Grants from The Nakatomi Foundation, Research Grants from Takeda Science Foundation, Research Grants from Mitsui Sumitomo Insurance Welfare Foundation, Research Grants from Kato Memorial Trust for Nambyo Research, and research grants from the following pharmaceutical companies: Abbott Japan Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsuibishi Tanabe Pharma Corporation, Merck Sharp and Dohme Inc., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparing the manuscript.	Agarwal SK, 2010, DISCOV MED, V10, P134; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Assassi S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-9; Beretta L, 2012, RHEUMATOLOGY, V51, P52, DOI 10.1093/rheumatology/ker335; DOUVAS AS, 1979, J BIOL CHEM, V254, P10514; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Furukawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087792; Furukawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033133; He DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106939; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kamatani N, 2004, TISSUE CULTURE RES C, V23, P71; Kuwana M, 1999, INTERNAL MED, V38, P336, DOI 10.2169/internalmedicine.38.336; KUWANA M, 1995, ANN RHEUM DIS, V54, P983, DOI 10.1136/ard.54.12.983; LEROY EC, 1988, J RHEUMATOL, V15, P202; Louthrenoo W, 2013, RHEUMATOL INT, V33, P2069, DOI 10.1007/s00296-013-2686-3; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; Migita K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078699; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; Nakajima F, 2001, MHC, V8, P1; Oka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099453; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ueki A, 2001, IMMUNOBIOLOGY, V204, P458, DOI 10.1078/0171-2985-00055; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Zhou XD, 2013, INT J IMMUNOPATH PH, V26, P747, DOI 10.1177/039463201302600318	28	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154255	10.1371/journal.pone.0154255	http://dx.doi.org/10.1371/journal.pone.0154255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116456	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600052
J	Martinez, RDF; Lamanna, MC; Novas, FE; Ridgely, RC; Casal, GA; Martinez, JE; Vita, JR; Witmer, LM				Martinez, Ruben D. F.; Lamanna, Matthew C.; Novas, Fernando E.; Ridgely, Ryan C.; Casal, Gabriel A.; Martinez, Javier E.; Vita, Javier R.; Witmer, Lawrence M.			A Basal Lithostrotian Titanosaur (Dinosauria: Sauropoda) with a Complete Skull: Implications for the Evolution and Paleobiology of Titanosauria	PLOS ONE			English	Article							BAJO BARREAL FORMATION; SAN-JORGE BASIN; RIO NEGRO PROVINCE; RAPETOSAURUS-KRAUSEI SAUROPODA; SP-NOV.; CENTRAL PATAGONIA; KATEPENSAURUS-GOICOECHEAI; REBBACHISAURID SAUROPODA; FEEDING STRATEGIES; DENTAL MICROWEAR	We describe Sarmientosaurus musacchioi gen. et sp. nov., a titanosaurian sauropod dinosaur from the Upper Cretaceous (Cenomanian-Turonian) Lower Member of the Bajo Barreal Formation of southern Chubut Province in central Patagonia, Argentina. The holotypic and only known specimen consists of an articulated, virtually complete skull and part of the cranial and middle cervical series. Sarmientosaurus exhibits the following distinctive features that we interpret as autapomorphies: (1) maximum diameter of orbit nearly 40% rostrocaudal length of cranium; (2) complex maxilla-lacrimal articulation, in which the lacrimal clasps the ascending ramus of the maxilla; (3) medial edge of caudal sector of maxillary ascending ramus bordering bony nasal aperture with low but distinct ridge; (4) 'tongue-like' ventral process of quadratojugal that overlaps quadrate caudally; (5) separate foramina for all three branches of the trigeminal nerve; (6) absence of median venous canal connecting infundibular region to ventral part of brainstem; (7) subvertical premaxillary, procumbent maxillary, and recumbent dentary teeth; (8) cervical vertebrae with 'strut-like' centroprezy-gapophyseal laminae; (9) extremely elongate and slender ossified tendon positioned ventrolateral to cervical vertebrae and ribs. The cranial endocast of Sarmientosaurus preserves some of the most complete information obtained to date regarding the brain and sensory systems of sauropods. Phylogenetic analysis recovers the new taxon as a basal member of Lithostrotia, as the most plesiomorphic titanosaurian to be preserved with a complete skull. Sarmientosaurus provides a wealth of new cranial evidence that reaffirms the close relationship of titanosaurs to Brachiosauridae. Moreover, the presence of the relatively derived lithostrotian Tapuiasaurus in Aptian deposits indicates that the new Patagonian genus represents a 'ghost lineage' with a comparatively plesiomorphic craniodental form, the evolutionary history of which is missing for at least 13 million years of the Cretaceous. The skull anatomy of Sarmientosaurus suggests that multiple titanosaurian species with dissimilar cranial structures coexisted in the early Late Cretaceous of southern South America. Furthermore, the new taxon possesses a number of distinctive morphologies-such as the ossified cervical tendon, extremely pneumatized cervical vertebrae, and a habitually downward-facing snout-that have rarely, if ever, been documented in other titanosaurs, thus broadening our understanding of the anatomical diversity of this remarkable sauropod clade. The latter two features were convergently acquired by at least one penecontemporaneous diplodocoid, and may represent mutual specializations for consuming low-growing vegetation.	[Martinez, Ruben D. F.; Casal, Gabriel A.] Univ Nacl Patagonia San Juan Bosco, Lab Paleovertebrados, Rivadavia, Chubut, Argentina; [Lamanna, Matthew C.] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA USA; [Novas, Fernando E.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Anat Comparada & Evoluc Vertebrados, Buenos Aires, DF, Argentina; [Ridgely, Ryan C.; Witmer, Lawrence M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Martinez, Javier E.] Hosp Reg Comodoro Rivadavia, Comodoro Rivadavia, Chubut, Argentina; [Vita, Javier R.] Resonancia Magnet Borelli, Comodoro Rivadavia, Chubut, Argentina	Universidad Nacional de la Patagonia San Juan Bosco; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University System of Ohio; Ohio University	Martinez, RDF (corresponding author), Univ Nacl Patagonia San Juan Bosco, Lab Paleovertebrados, Rivadavia, Chubut, Argentina.	rudaframartinez@gmail.com		Witmer, Lawrence/0000-0002-7610-0118	Facultad de Ciencias Naturales of the Universidad Nacional de la Patagonia San Juan Bosco; National Geographic Society [6646-99]; Ohio University Heritage College of Osteopathic Medicine; National Science Foundation [IBN-0343744, IOB-0517257, IOS-1050154]; Ohio Supercomputing Center; Division Of Integrative Organismal Systems [1456503, 1050154] Funding Source: National Science Foundation	Facultad de Ciencias Naturales of the Universidad Nacional de la Patagonia San Juan Bosco; National Geographic Society(National Geographic Society); Ohio University Heritage College of Osteopathic Medicine; National Science Foundation(National Science Foundation (NSF)); Ohio Supercomputing Center; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	R.D. F.M. and G.A.C. were supported by the Facultad de Ciencias Naturales of the Universidad Nacional de la Patagonia San Juan Bosco (http://www.fcn.unp.edu.ar/). M.C.L.'s participation in the research was supported by Carnegie Museum of Natural History (http://www.carnegiemnh.org/), the University of Pennsylvania (http://www.upenn.edu/), the National Geographic Society (Grant 6646-99) (http://www.nationalgeographic.com/), the Jurassic Foundation (http://jurassicfoundation.org/), the Evolving Earth Foundation (http://www.evolvingearth.org/), the Delaware Valley Paleontological Society (http://dvps.essentrix.net/), and the Paleontological Society (http://www.paleosoc.org/). L.M.W. and R.C.R. acknowledge funding support from the Ohio University Heritage College of Osteopathic Medicine (http://www.oucom.ohiou.edu/) and the National Science Foundation (IBN-0343744, IOB-0517257, IOS-1050154) (http://www.nsf.gov/). The Ohio Supercomputing Center (https://www.osc.edu/) provided additional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerda IA, 2009, AMEGHINIANA, V46, P193; Allain R, 1998, DESCRIPTION SYSTEMAT, P79; Apesteguia S, 2004, NATURWISSENSCHAFTEN, V91, P493, DOI 10.1007/s00114-004-0560-6; Apesteguia S., 2006, REV MUSEO ARGENTINO, V7, P153; ARCHANGELSKY S, 1994, CRETACEOUS RES, V15, P127, DOI 10.1006/cres.1994.1006; ARCHANGELSKY S, 2001, PUBLICACION ESPECIAL, V7, P15; Archangelsky S, 2009, CRETACEOUS RES, V30, P1073, DOI 10.1016/j.cretres.2009.03.001; BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Barrett Paul M., 1994, Gaia, V10, P195; Barrett PM, 2002, PALAEONTOLOGY, V45, P1197, DOI 10.1111/1475-4983.00282; BERMAN D S, 1982, Annals of Carnegie Museum, V51, P405; Bonaparte J. F., 1979, ACTAS, V2, P393; Bonaparte JF., 1993, AMEGHINIANA, V30, P217; Bonaparte JF, 2006, CRETACEOUS RES, V27, P364, DOI 10.1016/j.cretres.2005.07.004; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Bridge JS, 2000, J SEDIMENT RES, V70, P341, DOI 10.1306/2DC40915-0E47-11D7-8643000102C1865D; Britt BB, 1993, THESIS; Bruner HL, 1907, AM J ANAT, V7, P1, DOI 10.1002/aja.1000070102; Button DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2114; Calvo JO, 2006, AN ACAD BRAS CIENC, V78, P175, DOI 10.1590/S0001-37652006000100015; Calvo JO, 2003, REV GEOL CHILE, V30, P333; Calvo JO, 1996, AMEGHINIANA, V33, P461; Calvo Jorge O., 1994, Gaia, V10, P183; Calvo Jorge O., 1995, Gaia, V11, P13; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P485; CANUDO JI., 2002, ASOCIACION PALEONTOL, V32, P12; Carabajal AP, 2008, CRETACEOUS RES, V29, P643, DOI 10.1016/j.cretres.2008.01.011; Carabajal AP, 2014, J VERTEBR PALEONTOL, V34, P870, DOI 10.1080/02724634.2014.838174; Carabajal AP, 2012, ANAT REC, V295, P2141, DOI 10.1002/ar.22572; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Carpenter K, 2005, LIFE O PAST, P78; Carpenter Kenneth, 1998, Modern Geology, V23, P69; Casal G, 2010, REV BRAS PALEONTOLOG, V13, P247, DOI 10.4072/rbp.2010.3.08; Casal G, 2009, GEOBIOS-LYON, V42, P553, DOI 10.1016/j.geobios.2009.03.002; Casal Gabriel A, 2015, Rev. Asoc. Geol. Argent., V72, P77; Casal GA, 2013, AMEGHINIANA, V50, P571, DOI 10.5710/AMGH.23.08.2013.617; Cerda IA, 2012, PALAEONTOL Z, V86, P441, DOI 10.1007/s12542-012-0140-6; Cerda IA, 2012, NATURWISSENSCHAFTEN, V99, P83, DOI 10.1007/s00114-011-0869-x; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Chatterjee Sankar, 1996, Memoirs of the Queensland Museum, V39, P489; Chiappe LM, 2001, SCIENCE, V293, P2444, DOI 10.1126/science.1063723; Christiansen Per, 2000, Historical Biology, V14, P137; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Clyde WC, 2014, GEOL SOC AM BULL, V126, P289, DOI 10.1130/B30915.1; COLBERT EH, 1993, AM J SCI, V293A, P1, DOI 10.2475/ajs.293.A.1; COOMBS WP, 1975, PALAEOGEOGR PALAEOCL, V17, P1, DOI 10.1016/0031-0182(75)90027-9; Coria RA, 2001, AMEGHINIANA, V38, P463; Coria RA, 2005, LIFE O PAST, P153; Coria RA, 1999, AMEGHINIANA, V36, P98; Curry KA, 2001, THESIS; D'Emic MD, 2013, J SYST PALAEONTOL, V11, P707, DOI 10.1080/14772019.2012.667446; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; D'Emic MD, 2012, J VERTEBR PALEONTOL, V32, P883, DOI 10.1080/02724634.2012.671204; Dalla Vecchia Fabio M., 1999, Natura Nascosta, V18, P6; De Almeida Campos Diogenes, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P565; de Broin FD, 2001, CR ACAD SCI II A, V333, P463; Diaz VD, 2012, P GEOLOGIST ASSOC, V123, P626, DOI 10.1016/j.pgeola.2012.04.002; Diaz VD, 2011, ACTA PALAEONTOL POL, V56, P521, DOI 10.4202/app.2010.0043; FARLOW JO, 1987, PALEOBIOLOGY, V13, P60; Figari E., 1990, 3 REUN ARGENTINA SED, V1, P130; Filippi LS, 2011, GEOL ACTA, V9, P1, DOI 10.1344/105.000001648; Filippi LS, 2008, AMEGHINIANA, V45, P575; Filippi LS, 2011, ACTA PALAEONTOL POL, V56, P505, DOI 10.4202/app.2010.0019; Franzosa J.W., 2004, THESIS; Gallina PA, 2011, ACTA PALAEONTOL POL, V56, P45, DOI 10.4202/app.2010.0011; Galton P.M., 1985, Geologica et Palaeontologica, V19, P119; Garcia G, 2010, B SOC GEOL FR, V181, P269, DOI 10.2113/gssgfbull.181.3.269; Garcia RA, 2008, GEOBIOS-LYON, V41, P625, DOI 10.1016/j.geobios.2007.11.005; Garcia RA, 2015, AMEGHINIANA, V52, P29, DOI 10.5710/AMGH.16.07.2014.829; Garcia RA, 2010, AMEGHINIANA, V47, P409, DOI 10.5710/AMGH.v47i4.4; Garcia RA, 2010, AMEGHINIANA, V47, P45, DOI 10.5710/AMGH.v47i1.6; Garrido Alberto C., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P121; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gee Carole T., 2011, P34; Gilmore C. W., 1933, American Museum Novitates, V679, P1; Gimenez O., 2008, NATURALIA PATAGONICA, V4, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gomani Elizabeth M., 2005, Palaeontologia Electronica, V8, P1; Gomani EM, 1999, THESIS; Riga BJG, 2014, AMEGHINIANA, V51, P3, DOI 10.5710/AMEGH.26.12.1013.1889; Riga BJG, 2009, CRETACEOUS RES, V30, P135, DOI 10.1016/j.cretres.2008.06.006; Gonzalez Riga BJ., 2011, PALEONTOLOG A DINOSA, P125; Goswami A, 2005, J VERTEBR PALEONTOL, V25, P320, DOI 10.1671/0272-4634(2005)025[0320:DMITAI]2.0.CO;2; Harris JD, 2006, J VERTEBR PALEONTOL, V26, P88, DOI 10.1671/0272-4634(2006)26[88:COOSES]2.0.CO;2; Harris JD, 2006, J SYST PALAEONTOL, V4, P185, DOI 10.1017/S1477201906001805; Holland W. J., 1924, Memoirs of the Carnegie Museum, V9, P379; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Hopson J.A., 1979, P39; Huene F.V., 1933, MEMOIRS GEOLOGICAL S, V21, P1; Huene F. von, 1929, Anales del Museo de La Plata, V3, P1; Huene F. von, 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Hutchinson JR, 2002, COMP BIOCHEM PHYS A, V133, P1051, DOI 10.1016/S1095-6433(02)00158-7; Ibiricu L.M., 2011, BRAZILIAN GEOGR J GE, V2, P337; Ibiricu LM, 2015, AMEGHINIANA, V52, P430, DOI 10.5710/AMGH.24.04.2015.2830; Ibiricu LM, 2014, ZOOTAXA, V3786, P401, DOI 10.11646/zootaxa.3786.4.1; Ibiricu LM, 2013, J VERTEBR PALEONTOL, V33, P1351, DOI 10.1080/02724634.2013.776562; Ibiricu LM, 2012, AMEGHINIANA, V49, P657, DOI 10.5710/AMGH.28.4.2011.520; Ibiricu LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064253; Ibiricu LM, 2012, CRETACEOUS RES, V34, P220, DOI 10.1016/j.cretres.2011.11.003; Iglesias A, 2007, PALAEONTOLOGY, V50, P445, DOI 10.1111/j.1475-4983.2007.00639.x; JACOBS LL, 1993, PALAEONTOLOGY, V36, P523; Jain SL, 1997, J VERTEBR PALEONTOL, V17, P114, DOI 10.1080/02724634.1997.10010958; JANENSCH W., 1950, PALAEONTOGRAPHICA SUPPL, V7, P31; Janensch W., 1936, Palaeontologische Zeitschrift, V18, P181; Janensch W, 1935, PALAEONTOGRAPHICA S, V7, P145; Kellner A. W. A, 2006, GEOLOGIA, V74, P1; Kellner Alexander W.A., 1999, National Science Museum Monographs, V15, P111; Klein N., 2011, BIOL SAUROPOD DINOSA; Klein N, 2012, BIOL LETT, V2012; Knoll F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054991; Knoll F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030060; Knoll F, 2009, ANN PALEONTOL, V95, P165, DOI 10.1016/j.annpal.2009.06.001; Ksepka DT, 2010, AM MUS NOVIT, P1, DOI 10.1206/3700.2; Ksepka DT, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3508[1:EEALSF]2.0.CO;2; KURZANOV SM, 1983, PALEONTOL ZH, P90; Lacovara KJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06196; Lamanna M. C., 2004, THESIS; Lamanna MC, 2012, J VERTEBR PALEONTOL, V32, P124; Lamanna MC, 2002, J VERTEBR PALEONTOL, V22, P58, DOI 10.1671/0272-4634(2002)022[0058:ADATDF]2.0.CO;2; Le Loeuff J, 2005, LIFE O PAST, P115; LELOEUFF J, 1989, CR ACAD SCI II, V309, P851; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; Carballido JL, 2012, HIST BIOL, V24, P631, DOI 10.1080/08912963.2012.672416; Machado EB, 2013, ZOOTAXA, V3701, P301, DOI 10.11646/zootaxa.3701.3.1; Madsen James H. Jr, 1995, Bulletin of Carnegie Museum of Natural History, V31, P1; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Mannion PD, 2012, J VERTEBR PALEONTOL, V32, P614, DOI 10.1080/02724634.2012.660898; Mannion PD, 2011, J SYST PALAEONTOL, V9, P355, DOI 10.1080/14772019.2010.527379; Marpmann JS, 2015, J SYST PALAEONTOL, V13, P221, DOI 10.1080/14772019.2013.875074; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Martin Valerie, 1999, Oryctos, V2, P39; Martin Valerie, 1994, Gaia, V10, P147; Martinelli AG, 2015, J S AM EARTH SCI, V61, P164, DOI 10.1016/j.jsames.2015.02.009; Martinelli Agustin G., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P257; Martinez R, 2004, AMEGHINIANA, V41, P577; Martinez R., 1986, 4 C ARG PAL BIOESTR, V2, P23; Martinez R, 1998, 3 ANN C SAMC PROJ, V381, P20; Martinez R, 2009, AMEGHINIANA, V46, p36R; Martinez RD, 2004, J VERTEBR PALEONTOL, V24, P107, DOI 10.1671/9.1; Martinez RD, 1998, ACTA GEOLOGICA LEOPO, VXXI, P119; Martinez Ruben, 1998, Journal of Vertebrate Paleontology, V18, p61A; Martinez Ruben D., 2006, Revista del Museo Argentino de Ciencias Naturales, V8, P243; Mateer N.J., 1985, Bulletin of the Geological Institutions of the University of Uppsala, P125; McIntosh J.S., 1990, P345; MCINTOSH JS, 1975, J PALEONTOL, V49, P187; Miyashita T, 2011, J ANAT, V219, P661, DOI 10.1111/j.1469-7580.2011.01427.x; Mohabey DM, 2005, GONDWANA GEOLOGICAL, P101; Navarrete C, 2011, REV BRAS PALEONTOLOG, V14, P1, DOI 10.4072/rbp.2011.1.01; Novas F. E., 2009, AGE DINOSAURS S AM; Nowinski A., 1971, Palaeontologia Polonica, VNo. 25, P57; O'Donoghue CH, 1921, PHILOS T R SOC LON B, V210, P175, DOI 10.1098/rstb.1921.0006; OELRICH THOMAS M., 1956, MISC PUBL MUS ZOOL U MICHIGAN, V94, P9; Organ CL, 2005, J VERTEBR PALEONTOL, V25, P602, DOI 10.1671/0272-4634(2005)025[0602:THOOTI]2.0.CO;2; Osborn H. F., 1924, American Museum Novitates, VNo. 128, P1; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Otero A, 2011, AMEGHINIANA, V48, P655, DOI 10.5710/AMGH.v48i4(482); Parrish JM, 2003, J VERTEBR PALEONTOL, V23, p85A; Paulina Carabajal A, 2007, AMEGHINIANA, V44, P109; Poropat SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079932; Porter WR., 2015, THESIS; Powell J., 1989, AN 11 C BRAS PAL, V89, P165, DOI [10.35537/10915/4308, DOI 10.35537/10915/4308]; POWELL J E, 1979, Ameghiniana, V16, P191; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; Powell J.E., 1987, ANAIS X C BRAS PAL C, V1, P155; Powell J.E., 1990, ACT 5 C ARG PAL BIOE, V1, P123, DOI DOI 10.1016/J.GEOBIOS.2005.06.001; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Pujana Roberto R., 2007, Revista del Museo Argentino de Ciencias Naturales, V9, P161; Riga BJG, 2003, AMEGHINIANA, V40, P155; Rodriguez J.F.R., 1993, 2 C GEOL ARG 12 C EX, V1, P194; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers KC, 2014, J VERTEBR PALEONTOL, V34, P606, DOI 10.1080/02724634.2013.822874; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Rose Peter J., 2007, Palaeontologia Electronica, V10, P1; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2082, DOI 10.1139/e93-180; Ryan M.J., 1997, ENCY DINOSAURS, P169; Saegusa H, 2014, ZOOTAXA, V3848, P1, DOI 10.11646/zootaxa.3848.1.1; Salgado L, 2005, ACTA PALAEONTOL POL, V50, P79; Salgado L, 2015, HIST BIOL, V27, P525, DOI 10.1080/08912963.2014.894038; Salgado L, 1999, AMEGHINIANA, V36, P203; Salgado Leonardo, 1997, Ameghiniana, V34, P33; Salgado Leonardo, 2007, P188; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Sampson S.D., 2007, SOC VERTEBRATE PALEO, V8, P32, DOI DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO; SANDER P.M., 2010, PLANTS MESOZOIC TIME, P330; Sander PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078573; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2013, PLOS ONE COLLECTIONS; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Schwarz D, 2006, ECLOGAE GEOL HELV, V99, P65, DOI 10.1007/s00015-006-1177-x; Sciutto JC., 1994, NATURALIA PATAG NICA, V2, P27; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Snively E, 2007, ANAT REC, V290, P934, DOI 10.1002/ar.20563; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; STOKES WL, 1987, J PALEONTOL, V61, P1242, DOI 10.1017/S0022336000029619; Suarez M, 2014, J S AM EARTH SCI, V50, P67, DOI 10.1016/j.jsames.2013.10.008; Sues HD, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.889145; Suteethorn S, 2009, GEOL SOC SPEC PUBL, V315, P189, DOI 10.1144/SP315.14; Taggart Ralph E., 1997, P403; Tidwell V, 2003, J VERTEBR PALEONTOL, V23, P176, DOI 10.1671/0272-4634(2003)23[176:BOAECT]2.0.CO;2; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Vakhrameev V.A., 1988, JURASSIC CRETACEOUS; Walker JD, 2013, GEOL SOC AM BULL, V125, P259, DOI 10.1130/B30712.1; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Wedel MJ, 2000, J VERTEBR PALEONTOL, V20, P109, DOI 10.1671/0272-4634(2000)020[0109:SPANSF]2.0.CO;2; Wedel MJ, 2007, THESIS; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; WEISHAMPEL DB, 1991, RES EXPLOR, V7, P196; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Williams VS, 2009, P NATL ACAD SCI USA, V106, P11194, DOI 10.1073/pnas.0812631106; WILSON J., 2006, ACT 3 JORN DIN ENT B, P169; Wilson J. A., 2009, Contributions from the Museum of Paleontology University of Michigan, V32, P17; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P471, DOI 10.1671/0272-4634(2006)26[471:ATDSAF]2.0.CO;2; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Wiman C, 1929, PALAEONTOLOGIA SINIC, V6, P1; Wings O, 2007, P ROY SOC B-BIOL SCI, V274, P635, DOI 10.1098/rspb.2006.3763; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witmer Lawrence M., 2008, P117; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Witmer LM, 2001, SCIENCE, V293, P850, DOI 10.1126/science.1062681; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Young C.C., 1972, I VERTEBRATE PALEO A, V8, P1; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663; Zheng Z., 1996, THESIS	243	57	58	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0151661	10.1371/journal.pone.0151661	http://dx.doi.org/10.1371/journal.pone.0151661			82	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115989	Green Published, gold			2022-12-26	WOS:000374973600012
J	Wang, PQ; Cao, JB; Liu, N; Ma, L; Zhou, XY; Zhang, H; Wang, YG				Wang, Peiqi; Cao, Jiangbei; Liu, Na; Ma, Li; Zhou, Xueyue; Zhang, Hong; Wang, Yongan			Protective Effects of Edaravone in Adult Rats with Surgery and Lipopolysaccharide Administration-Induced Cognitive Function Impairment	PLOS ONE			English	Article							MORRIS WATER MAZE; BLOOD-BRAIN-BARRIER; OXIDATIVE STRESS; PARKINSONS-DISEASE; RADICAL SCAVENGER; AGED MICE; MEMORY; DYSFUNCTION; NEUROINFLAMMATION; ACTIVATION	Postoperative cognitive dysfunction (POCD) is a clinical syndrome characterized by cognitive declines in patients after surgery. Previous studies have suggested that surgery contributed to such impairment. It has been proven that neuroinflammation may exacerbate surgery-induced cognitive impairment in aged rats. The free radical scavenger edaravone has high blood brain barrier permeability, and was demonstrated to effectively remove free radicals from the brain and alleviate the development of POCD in patients undergoing carotid endarterectomy, suggesting its potential role in preventing POCD. For this reason, this study was designed to determine whether edaravone is protective against POCD through its inhibitory effects on inflammatory cytokines and oxidative stress. First, Sprague Dawley adult male rats were administered 3 mg/ kg edaravone intraperitoneally after undergoing a unilateral nephrectomy combined with lipopolysaccharide injection. Second, behavioral parameters related to cognitive function were recorded by fear conditioning and Morris Water Maze tests. Last, superoxide dismutase activities and malondialdehyde levels were measured in the hippocampi and prefrontal cortex on postoperative days 3 and 7, and microglial (Iba1) activation, p-Akt and p-mTOR protein expression, and synaptic function (synapsin 1) were also examined 3 and 7 days after surgery. Rats that underwent surgery plus lipopolysaccharide administration showed significant impairments in spatial and working memory, accompanied by significant reductions in hippocampal-dependent and independent fear responses. All impairments were attenuated by treatment with edaravone. Moreover, an abnormal decrease in superoxide dismutase activation, abnormal increase in malondialdehyde levels, significant increase in microglial reactivity, downregulation of p-Akt and p-mTOR protein expression, and a statistically significant decrease in synapsin-1 were observed in the hippocampi and prefrontal cortices of rats at different time points after surgery. All mentioned abnormal changes were totally or partially reversed by edaravone. To our knowledge, few reports have shown greater protective effects of edaravone on POCD induced by surgery plus lipopolysaccharide administration from its anti-oxidative stress and anti-inflammatory effects, as well as maintenance of Akt/mTOR signal pathway activation; these might be closely related to the therapeutic effects of edaravone. Our research demonstrates the potential use of edaravone in the treatment of POCD.	[Wang, Peiqi; Cao, Jiangbei; Liu, Na; Ma, Li; Zhou, Xueyue; Zhang, Hong] Chinese PLA, Gen Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Wang, Peiqi; Cao, Jiangbei; Liu, Na; Ma, Li; Zhou, Xueyue; Zhang, Hong] Chinese PLA, Gen Hosp, Operat Ctr, Beijing, Peoples R China; [Liu, Na] Chengde Med Univ, Affiliated Hosp, Dept Anesthesiol, Chengde, Peoples R China; [Ma, Li] Chinese Peoples Liberat Army, Dept Anesthesiol, Beijing Mil Gen Hosp, Beijing, Peoples R China; [Wang, Yongan] Acad Mil Med Sci, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China	Chengde Medical University; Academy of Military Medical Sciences - China	Zhang, H (corresponding author), Chinese PLA, Gen Hosp, Dept Anesthesiol, Beijing, Peoples R China.; Zhang, H (corresponding author), Chinese PLA, Gen Hosp, Operat Ctr, Beijing, Peoples R China.; Wang, YG (corresponding author), Acad Mil Med Sci, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China.	mazuima301@163.com; yonganw@sina.com	Cao, Jiangbei/ADE-0079-2022; Cao, jiangbei/AFS-3772-2022	Cao, Jiangbei/0000-0003-1218-4639; 	General Logistics Department [13BJZ38]; Military Medical Scientific and Technological Project for the "Twelfth Five-year Plan" [AWS15J007, BWS12J042]	General Logistics Department; Military Medical Scientific and Technological Project for the "Twelfth Five-year Plan"	This study was supported by a grant in the special subject of health care from the General Logistics Department (13BJZ38) and a Military Medical Scientific and Technological Project for the "Twelfth Five-year Plan" (AWS15J007, BWS12J042).	Al Banchaabouchi M, 2001, NEPHRON, V89, P90, DOI 10.1159/000046049; Banoub JH, 2010, MASS SPECTROM REV, V29, P606, DOI 10.1002/mas.20258; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Cain DP, 1996, REV NEUROSCIENCE, V7, P215; Calvino E, 2011, BIOCHEM PHARMACOL, V82, P1619, DOI 10.1016/j.bcp.2011.08.017; Chen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134307; Choopankareh S, 2015, TURK J MED SCI, V45, P842, DOI 10.3906/sag-1406-35; Chung E, 2015, CARDIOVASC PSYCHIAT, V2015, P1, DOI 10.1155/2015/370612; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Di Vita G, 2006, WOUND REPAIR REGEN, V14, P259, DOI 10.1111/j.1743-6109.2006.00120.x; Diana G, 2007, P NATL ACAD SCI USA, V104, P636, DOI 10.1073/pnas.0610059104; Dohare P, 2014, FREE RADICAL BIO MED, V77, P168, DOI 10.1016/j.freeradbiomed.2014.08.029; Dong HQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0140-4; Dong ZF, 2013, NEUROPHARMACOLOGY, V64, P65, DOI 10.1016/j.neuropharm.2012.06.027; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fidalgo AR, 2011, NEUROSCI LETT, V498, P63, DOI 10.1016/j.neulet.2011.04.063; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Hara N, 2015, SHOCK, V44, P578, DOI 10.1097/SHK.0000000000000465; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hovens IB, 2012, BRAIN BEHAV IMMUN, V26, P1169, DOI 10.1016/j.bbi.2012.06.004; Huang CS, 2015, BIOCHEM PHARMACOL, V93, P352, DOI 10.1016/j.bcp.2014.12.005; INOUE T, 1994, PHARMACOL BIOCHEM BE, V49, P911, DOI 10.1016/0091-3057(94)90243-7; Jiao SS, 2015, P NATL ACAD SCI USA, V112, P5225, DOI 10.1073/pnas.1422998112; Kalb A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062679; Kempermann G., 2015, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPE; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kobbe P, 2008, SHOCK, V30, P43, DOI [10.1097/SHK.0b013e318d190b, 10.1097/SHK.0b013e31815d190b]; Krenk L, 2010, ACTA ANAESTH SCAND, V54, P951, DOI 10.1111/j.1399-6576.2010.02268.x; Lee J, 2016, REPRODUCTION, V151, P187, DOI 10.1530/REP-15-0302; Li L, 2015, EXP NEUROL, V272, P135, DOI 10.1016/j.expneurol.2014.12.020; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; O' Neill C, 2013, EXP GERONTOL, V48, P647, DOI 10.1016/j.exger.2013.02.025; Oddo Salvatore, 2012, Front Biosci (Schol Ed), V4, P941; Ogasawara K, 2005, SURG NEUROL, V64, P309, DOI 10.1016/j.surneu.2005.01.008; Pasechnik I. N., 2009, Anesteziologiya i Reanimatologiya, P50; Peng SY, 2015, J NEUROSCI, V35, P1250, DOI 10.1523/JNEUROSCI.2444-14.2015; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Qiao Y, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0130-9; Ramirez-Sanchez J, 2015, NEUROCHEM INT, V90, P215, DOI 10.1016/j.neuint.2015.09.003; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Sun J, 2016, NEUROSCI LETT, V613, P30, DOI 10.1016/j.neulet.2015.12.047; Sun YY, 2015, STROKE, V46, P1947, DOI 10.1161/STROKEAHA.115.009162; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tarassishin L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-187; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wang YR, 2015, INT IMMUNOPHARMACOL, V28, P136, DOI 10.1016/j.intimp.2015.05.044; Xia SF, 2015, PHYSIOL BEHAV, V138, P325, DOI 10.1016/j.physbeh.2014.09.008; Yang R, 2015, NEUROL SCI; Zhang XQ, 2013, J NEUROSCI, V33, P17737, DOI 10.1523/JNEUROSCI.2049-13.2013	60	22	23	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153708	10.1371/journal.pone.0153708	http://dx.doi.org/10.1371/journal.pone.0153708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116382	gold, Green Published, Green Submitted			2022-12-26	WOS:000374973600027
J	Ting, WH; Chien, MN; Lo, FS; Wang, CH; Huang, CY; Lin, CL; Lin, WS; Chang, TY; Yang, HW; Chen, WF; Lien, YP; Cheng, BW; Lin, CH; Chen, CC; Wu, YL; Hung, CM; Li, HJ; Chan, CI; Lee, YJ				Ting, Wei-Hsin; Chien, Ming-Nan; Lo, Fu-Sung; Wang, Chao-Hung; Huang, Chi-Yu; Lin, Chiung-Ling; Lin, Wen-Shan; Chang, Tzu-Yang; Yang, Horng-Woei; Chen, Wei-Fang; Lien, Ya-Ping; Cheng, Bi-Wen; Lin, Chao-Hsu; Chen, Chia-Ching; Wu, Yi-Lei; Hung, Chen-Mei; Li, Hsin-Jung; Chan, Chon-In; Lee, Yann-Jinn			Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study	PLOS ONE			English	Article							GRAVES-DISEASE; HASHIMOTOS-THYROIDITIS; CHROMOSOME 2Q33; SOLUBLE CTLA-4; STOP-SIGNAL; SUSCEPTIBILITY; POPULATION; METAANALYSIS; PROMOTER; JAPANESE	Autoimmune thyroid disease (AITD), including Graves disease (GD) and Hashimoto disease (HD), is an organ-specific autoimmune disease with a strong genetic component. Although the cytotoxic T-lymphocyte-associated protein 4 (CTLA4) polymorphism has been reported to be associated with AITD in adults, few studies have focused on children. The aim of our study was to investigate whether the CTLA4 polymorphisms, including -318C/T (rs5742909), + 49A/G (rs231775), and CT60 (rs3087243), were associated with GD and HD in Han Chinese adults and children. We studied 289 adult GD, 265 pediatric GD, 229 pediatric HD patients, and 1058 healthy controls and then compared genotype, allele, carrier, and haplotype frequencies between patients and controls. We found that CTLA4 SNPs + 49A/G and CT60 were associated with GD in adults and children. Allele G of + 49A/G was significantly associated with GD in adults (odds ratio [OR], 1.50; 95% confidence interval [CI], 1.21-1.84; corrected P value [Pc] < 0.001) and children (OR, 1.42; 95% CI, 1.15-1.77; Pc = 0.002). Allele G of CT60 also significantly increased risk of GD in adults (OR, 1.63; 95% CI, 1.27-2.09; Pc < 0.001) and GD in children (OR, 1.58; 95% CI, 1.22-2.04; Pc < 0.001). Significant linkage disequilibrium was found between +49A/G and CT60 in GD and control subjects (D' = 0.92). Our results showed that CTLA4 was associated with both GD and HD and played an equivalent role in both adult and pediatric GD in Han Chinese population.	[Ting, Wei-Hsin; Huang, Chi-Yu; Chan, Chon-In; Lee, Yann-Jinn] MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan; [Chien, Ming-Nan; Wang, Chao-Hung] MacKay Mem Hosp, Dept Endocrinol & Metab, Taipei, Taiwan; [Ting, Wei-Hsin; Chien, Ming-Nan; Huang, Chi-Yu; Lee, Yann-Jinn] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Chien, Ming-Nan] Natl Taipei Univ Technol, Inst Mechatron Engn, Taipei 106, Taiwan; [Ting, Wei-Hsin; Chien, Ming-Nan] MacKay Jr Coll Med Nursing & Management, New Taipei, Taiwan; [Lo, Fu-Sung] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Lo, Fu-Sung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lin, Chiung-Ling; Lin, Wen-Shan; Chang, Tzu-Yang; Yang, Horng-Woei; Chen, Wei-Fang; Lien, Ya-Ping; Lee, Yann-Jinn] MacKay Mem Hosp Tamsui, Dept Med Res, New Taipei, Taiwan; [Cheng, Bi-Wen; Lin, Chao-Hsu] MacKay Mem Hosp HsinChu, Dept Pediat, Hsinchu, Taiwan; [Chen, Chia-Ching] Chiayi Christian Hosp, Dept Pediat, Chiayi, Taiwan; [Wu, Yi-Lei] Changhua Christian Hosp, Dept Pediat, Changhua, Taiwan; [Hung, Chen-Mei] Hsinchu Cathay Gen Hosp, Dept Pediat, Hsinchu, Taiwan; [Li, Hsin-Jung] St Martin De Porres Hosp, Dept Pediat, Chiayi, Taiwan; [Lee, Yann-Jinn] Taipei Med Univ, Sch Med, Dept Pediat, Coll Med, Taipei, Taiwan; [Lee, Yann-Jinn] MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; National Taipei University of Technology; Mackay Junior College of Medicine, Nursing & Management; Chang Gung Memorial Hospital; Chang Gung University; Mackay Memorial Hospital; Chia-Yi Christian Hospital; Changhua Christian Hospital; Cathay General Hospital; Taipei Medical University; Mackay Medical College	Lee, YJ (corresponding author), MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan.; Lee, YJ (corresponding author), MacKay Med Coll, Dept Med, New Taipei, Taiwan.; Lee, YJ (corresponding author), MacKay Mem Hosp Tamsui, Dept Med Res, New Taipei, Taiwan.; Lee, YJ (corresponding author), Taipei Med Univ, Sch Med, Dept Pediat, Coll Med, Taipei, Taiwan.; Lee, YJ (corresponding author), MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan.	yannlee@mmh.org.tw	Wang, Chao/GXF-8353-2022		Ministry of Science and Technology, Executive Yuan [NSC 101-2314-B-715-002-MY3]; MacKay Memorial Hospital, Taipei [MMH E-102-07]; MacKay Medical College, New Taipei City, Taiwan [MMC RD1010045]	Ministry of Science and Technology, Executive Yuan; MacKay Memorial Hospital, Taipei; MacKay Medical College, New Taipei City, Taiwan	This study was supported by grants NSC 101-2314-B-715-002-MY3 from the Ministry of Science and Technology, Executive Yuan; MMH E-102-07 from MacKay Memorial Hospital, Taipei; and MMC RD1010045 from MacKay Medical College, New Taipei City, Taiwan.	Anjos S, 2002, J BIOL CHEM, V277, P46478, DOI 10.1074/jbc.M206894200; Antonelli A, 2015, AUTOIMMUN REV, V14, P174, DOI 10.1016/j.autrev.2014.10.016; Ban Y, 2004, J CLIN ENDOCR METAB, V89, P4562, DOI 10.1210/jc.2003-031693; Ban Y, 2003, GENES IMMUN, V4, P586, DOI 10.1038/sj.gene.6364018; Barlow ABT, 1996, CLIN ENDOCRINOL, V44, P73, DOI 10.1046/j.1365-2265.1996.634454.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bicek A, 2009, HUM IMMUNOL, V70, P820, DOI 10.1016/j.humimm.2009.06.016; Brandstaetter A, 2010, PLOS ONE, V5, pe9821, DOI [10.1371/journal.pone.0009821, DOI 10.1371/JOURNAL.PONE.0009821]; Braun J, 1998, TISSUE ANTIGENS, V51, P563, DOI 10.1111/j.1399-0039.1998.tb02993.x; Brix TH, 2011, ANN ENDOCRINOL-PARIS, V72, P103, DOI 10.1016/j.ando.2011.03.013; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; Brown RS, 2009, BROOKS CLIN PEDIAT E, P250; Butty V, 2007, P NATL ACAD SCI USA, V104, P570, DOI 10.1073/pnas.0610124104; Chong KKL, 2008, INVEST OPHTH VIS SCI, V49, P2409, DOI 10.1167/iovs.07-1433; Cury AN, 2008, HORM RES, V70, P36, DOI 10.1159/000129676; DARIAVACH P, 1988, EUR J IMMUNOL, V18, P1901, DOI 10.1002/eji.1830181206; Daroszewski J, 2009, EUR J ENDOCRINOL, V161, P787, DOI 10.1530/EJE-09-0600; Deichmann K, 1996, BIOCHEM BIOPH RES CO, V225, P817, DOI 10.1006/bbrc.1996.1256; Donner H, 1997, J CLIN ENDOCR METAB, V82, P4130, DOI 10.1210/jc.82.12.4130; Du L, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-46; Feng M, 2013, ENDOCRINE, V44, P350, DOI 10.1007/s12020-013-0014-z; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Furugaki K, 2004, J HUM GENET, V49, P166, DOI 10.1007/s10038-003-0120-5; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Han SZ, 2006, HUM IMMUNOL, V67, P618, DOI 10.1016/j.humimm.2006.05.003; HARPER K, 1991, J IMMUNOL, V147, P1037; Heward JM, 1999, J CLIN ENDOCR METAB, V84, P2398, DOI 10.1210/jc.84.7.2398; Huang CY, 2013, HUM IMMUNOL, V74, P120, DOI 10.1016/j.humimm.2012.10.005; Iwama S, 2005, HORM RES, V63, P55, DOI 10.1159/000083137; JAKSIC J, 1994, ARCH DIS CHILD, V70, P103, DOI 10.1136/adc.70.2.103; Kavvoura FK, 2007, J CLIN ENDOCR METAB, V92, P3162, DOI 10.1210/jc.2007-0147; Kliegman RM, 2011, NELSON TXB PEDIAT, P1895; Kolar P, 2009, ARTHRITIS RHEUM-US, V60, P123, DOI 10.1002/art.24181; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kucharska AM, 2012, HORM RES PAEDIAT, V78, P67, DOI 10.1159/000338997; Lee HJ, 2015, J AUTOIMMUN, V64, P82, DOI 10.1016/j.jaut.2015.07.009; Lee YJ, 1998, M D COMPUT, V15, P327; Ligers A, 2001, GENES IMMUN, V2, P145, DOI 10.1038/sj.gene.6363752; Mandel SJ, 2011, WILLIAMS TXB ENDOCRI, P362; McGrogan A, 2008, CLIN ENDOCRINOL, V69, P687, DOI 10.1111/j.1365-2265.2008.03338.x; Ni J, 2014, ENDOCR RES, V39, P180, DOI 10.3109/07435800.2013.879167; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Nyholt DR, 2001, HUM GENET, V109, P564, DOI 10.1007/s00439-001-0611-4; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Ohashi J, 2001, ANN HUM GENET, V65, P197, DOI 10.1017/S000348000100851X; Orozco G, 2004, TISSUE ANTIGENS, V64, P667, DOI 10.1111/j.1399-0039.2004.00318.x; Pastuszak-Lewandoska D, 2012, ARCH MED SCI, V8, P415, DOI 10.5114/aoms.2012.28593; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purohit Sharad, 2005, J Autoimmune Dis, V2, P8, DOI 10.1186/1740-2557-2-8; Qiu H, 2014, ENDOCRINE, V45, P198, DOI 10.1007/s12020-013-9985-z; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Si XY, 2012, EXP THER MED, V4, P538, DOI 10.3892/etm.2012.618; STENSZKY V, 1985, J CLIN ENDOCR METAB, V61, P735, DOI 10.1210/jcem-61-4-735; Su TH, 2007, CARCINOGENESIS, V28, P1237, DOI 10.1093/carcin/bgm043; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; Tanda ML, 2009, HORM METAB RES, V41, P436, DOI 10.1055/s-0029-1215568; Terauchi M, 2003, J ENDOCRINOL INVEST, V26, P1208, DOI 10.1007/BF03349159; Tomer Y, 2001, J CLIN ENDOCR METAB, V86, P1687, DOI 10.1210/jc.86.4.1687; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Tomer Y, 2009, J AUTOIMMUN, V32, P231, DOI 10.1016/j.jaut.2009.02.007; Tomoyose T, 2002, THYROID, V12, P673, DOI 10.1089/105072502760258640; Torres B, 2004, ARTHRITIS RHEUM-US, V50, P2211, DOI 10.1002/art.20347; Tsai ST, 2008, J PEDIATR ENDOCR MET, V21, P665; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vaidya B, 2004, EUR J ENDOCRINOL, V150, P619, DOI 10.1530/eje.0.1500619; Vaidya B, 2003, CLIN ENDOCRINOL, V58, P732, DOI 10.1046/j.1365-2265.2003.01778.x; Wang PW, 2004, J CLIN ENDOCR METAB, V89, P169, DOI 10.1210/jc.2003-030854; Wang XB, 2002, GENES IMMUN, V3, P233, DOI 10.1038/sj.gene.6363869; Weng YC, 2005, ANN CLIN LAB SCI, V35, P259; Yesilkaya E, 2008, GENET TEST, V12, P461, DOI 10.1089/gte.2008.0053; Yung E, 2002, CLIN ENDOCRINOL, V56, P649, DOI 10.1046/j.1365-2265.2002.01234.x; Zhang Qin, 2006, J Zhejiang Univ Sci B, V7, P887, DOI 10.1631/jzus.2006.B0887	74	45	53	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154394	10.1371/journal.pone.0154394	http://dx.doi.org/10.1371/journal.pone.0154394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111218	Green Published, Green Submitted, gold			2022-12-26	WOS:000374970600064
J	Belote, RT; Dietz, MS; McRae, BH; Theobald, DM; McClure, ML; Irwin, GH; McKinley, PS; Gage, JA; Aplet, GH				Belote, R. Travis; Dietz, Matthew S.; McRae, Brad H.; Theobald, David M.; McClure, Meredith L.; Irwin, G. Hugh; McKinley, Peter S.; Gage, Josh A.; Aplet, Gregory H.			Identifying Corridors among Large Protected Areas in the United States	PLOS ONE			English	Article							CONSERVING BIODIVERSITY; CLIMATE-CHANGE; CONSERVATION; CONNECTIVITY; MANAGEMENT; NETWORK; MODEL; WILDERNESS; MAMMALS	Conservation scientists emphasize the importance of maintaining a connected network of protected areas to prevent ecosystems and populations from becoming isolated, reduce the risk of extinction, and ultimately sustain biodiversity. Keeping protected areas connected in a network is increasingly recognized as a conservation priority in the current era of rapid climate change. Models that identify suitable linkages between core areas have been used to prioritize potentially important corridors for maintaining functional connectivity. Here, we identify the most "natural" (i.e., least human-modified) corridors between large protected areas in the contiguous Unites States. We aggregated results from multiple connectivity models to develop a composite map of corridors reflecting agreement of models run under different assumptions about how human modification of land may influence connectivity. To identify which land units are most important for sustaining structural connectivity, we used the composite map of corridors to evaluate connectivity priorities in two ways: (1) among land units outside of our pool of large core protected areas and (2) among units administratively protected as Inventoried Roadless (IRAs) or Wilderness Study Areas (WSAs). Corridor values varied substantially among classes of "unprotected" non-core land units, and land units of high connectivity value and priority represent diverse ownerships and existing levels of protections. We provide a ranking of IRAs and WSAs that should be prioritized for additional protection to maintain minimal human modification. Our results provide a coarsescale assessment of connectivity priorities for maintaining a connected network of protected areas.	[Belote, R. Travis] Wilderness Soc, Bozeman, MT USA; [Dietz, Matthew S.] Wilderness Soc, San Francisco, CA USA; [McRae, Brad H.] Nature Conservancy, Seattle, WA USA; [Theobald, David M.] Conservat Sci Partners Inc, Ft Collins, CO USA; [McClure, Meredith L.] Ctr Large Landscape Conservat, Bozeman, MT USA; [Irwin, G. Hugh] Wilderness Soc, Black Mt, NC USA; [McKinley, Peter S.] Wilderness Soc, Hallowell, ME USA; [Gage, Josh A.] Gage Cartograph, Bozeman, MT USA; [Aplet, Gregory H.] Wilderness Soc, Denver, CO USA	Nature Conservancy	Belote, RT (corresponding author), Wilderness Soc, Bozeman, MT USA.	travis_belote@tws.org			Wilderness Society	Wilderness Society	The Wilderness Society funded this work. The funder provided support in the form of salaries for author JAG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Ament R, 2014, WILDLIFE CONNECTIVIT; Aplet G, 2000, US FOR SERV RMRS-P, V2, P89; Aplet GH, 1999, DENVER U LAW REV, V76, P347; Aycrigg JL, 2015, J-FOR, V114, P1, DOI DOI 10.5849/JOF.15-050; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier Paul, 2012, Ecological Restoration, V30, P312, DOI 10.3368/er.30.4.312; Beier P, 2011, CONSERV BIOL, V25, P879, DOI 10.1111/j.1523-1739.2011.01716.x; Bowman J, 2002, ECOLOGY, V83, P2049, DOI 10.2307/3071786; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Dickson BG, 2014, BIOL CONSERV, V178, P117, DOI 10.1016/j.biocon.2014.08.001; Dietz MS, 2015, BIOL CONSERV, V184, P431, DOI 10.1016/j.biocon.2015.02.024; Fremier AK, 2015, BIOL CONSERV, V191, P29, DOI 10.1016/j.biocon.2015.06.029; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gergely KJ, 2013, PAD US NATL INVENTOR; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hagerman SM, 2014, ECOL APPL, V24, P548, DOI 10.1890/13-0400.1; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Hoctor T, 2008, J CONSERVATION PLANN, V4, P90; Keeley ATK, 2015, COMP ESTIMATES LANDS; Keeley ATK, LANDSC ECOL IN PRESS; Krosby M, 2015, LANDSCAPE ECOL, V30, P2121, DOI 10.1007/s10980-015-0235-z; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; McRae, 2014, RIPARIAN CLIMATE COR; McRae B, 2012, LINKAGE MAPPER USER, P1; McRae B., 2009, CIRCUITSCAPE USER GU; Minor ES, 2010, CONSERV BIOL, V24, P1549, DOI 10.1111/j.1523-1739.2010.01558.x; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Ordonez A, 2014, NAT CLIM CHANGE, V4, P811, DOI [10.1038/nclimate2337, 10.1038/NCLIMATE2337]; Pachauri R.K., 2014, CONTRIBUTION WORKING; QUAMMEN D, 1996, SONG DODO ISLAND BIO; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Rudnick D.A., 2012, ISSUES ECOLOGY, V11, P28; Schmitz OJ, 2015, NAT AREA J, V35, P190, DOI 10.3375/043.035.0120; Shah VB, 2007, ECOLOGY, V89, P2712; SIMBERLOFF D, 1992, CONSERV BIOL, V6, P493, DOI 10.1046/j.1523-1739.1992.06040493.x; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Theobald DM, 2013, LANDSCAPE ECOL, V28, P1859, DOI 10.1007/s10980-013-9941-6; Theobald DM, 2012, CONSERV LETT, V5, P123, DOI 10.1111/j.1755-263X.2011.00218.x; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	48	76	79	17	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154223	10.1371/journal.pone.0154223	http://dx.doi.org/10.1371/journal.pone.0154223			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104683	Green Submitted, Green Published, gold			2022-12-26	WOS:000374565100058
J	Ackema, KB; Prescianotto-Baschong, C; Hench, J; Wang, SC; Chia, ZH; Mergentaler, H; Bard, F; Frank, S; Spang, A				Ackema, Karin B.; Prescianotto-Baschong, Cristina; Hench, Jurgen; Wang, Shyi Chyi; Chia, Zhi Hui; Mergentaler, Heidi; Bard, Frederic; Frank, Stephan; Spang, Anne			Sar1, a Novel Regulator of ER-Mitochondrial Contact Sites	PLOS ONE			English	Article							EARLY SECRETORY PATHWAY; OUTER-MEMBRANE PROTEIN; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; C-ELEGANS; CAENORHABDITIS-ELEGANS; COPII VESICLE; YEAST; COMPLEX; GTPASE	Endoplasmic reticulum (ER)-mitochondrial contact sites play a pivotal role in exchange of lipids and ions between the two organelles. How size and function of these contact sites are regulated remains elusive. Here we report a previously unanticipated, but conserved role of the small GTPase Sar1 in the regulation of ER-mitochondrial contact site size. Activated Sar1 introduces membrane curvature through its N-terminal amphiphatic helix at the ER-mitochondria interphase and thereby reducing contact size. Conversely, the S. cerevisiae N3-Sar1 mutant, in which curvature induction is decreased, caused an increase in ER-mitochondrial contacts. As a consequence, ER tubules are no longer able to mark the prospective scission site on mitochondria, thereby impairing mitochondrial dynamics. Consistently, blocking mitochondrial fusion partially rescued, whereas deletion of the dynamin-like protein enhanced the phenotype in the sar1D32G mutant. We conclude that Sar1 regulates the size of ER-mitochondria contact sites through its effects on membrane curvature.	[Ackema, Karin B.; Prescianotto-Baschong, Cristina; Mergentaler, Heidi; Spang, Anne] Univ Basel, Growth & Dev, Biozentrum, CH-4056 Basel, Switzerland; [Hench, Jurgen; Frank, Stephan] Univ Basel Hosp, Inst Pathol, Div Neuropathol, CH-4031 Basel, Switzerland; [Wang, Shyi Chyi; Chia, Zhi Hui; Bard, Frederic] Inst Mol & Cell Biol, Singapore 138673, Singapore	University of Basel; University of Basel; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Spang, A (corresponding author), Univ Basel, Growth & Dev, Biozentrum, CH-4056 Basel, Switzerland.	anne.spang@unibas.ch	Spang, Anne/M-7223-2019	Spang, Anne/0000-0002-2387-6203	University of Basel: unibas.ch; Swiss National Science Foundation [31003A_141207]; University of Basel	University of Basel: unibas.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	This work was supported by the University of Basel: unibas.ch, and Swiss National Science Foundation: 31003A_141207, snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank M. Lee, E. Miller, R. Schekman, B. Westermann, K. Sato, A. van der Bliek, J. Shaw and the Caenorhabditis Genetics Center for reagents, S. Ipsen for technical support, and I. G. Macara for critical comments on the manuscript. We thank B. Westermann for helpful discussions on mitochondrial phenotypes. The Biozentrum Imaging Core Facility is acknowledged for technical support. This research was supported by the Swiss National Science Foundation (31003A_141207) and the University of Basel.	Ackema KB, 2014, EMBO J, DOI 10.15252/embj.201489039; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; BRENNER S, 1974, GENETICS, V77, P71; Elbaz-Alon Y, 2015, CELL REP, V12, P7, DOI 10.1016/j.celrep.2015.06.022; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Fernandez-Busnadiego R, 2015, P NATL ACAD SCI USA, V112, pE2004, DOI 10.1073/pnas.1503191112; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Hariri H, 2014, J MOL BIOL, V426, P3811, DOI 10.1016/j.jmb.2014.08.023; Hench J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028417; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Itoh K, 2013, MOL BIOL CELL, V24, P1842, DOI 10.1091/mbc.E13-03-0125; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kodera C, 2014, J BIOL CHEM, V289, P21423, DOI 10.1074/jbc.M114.553917; Kondo-Okamoto N, 2008, EMBO REP, V9, P63, DOI 10.1038/sj.embor.7401113; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prescianotto-Baschong C, 2002, TRAFFIC, V3, P37, DOI 10.1034/j.1600-0854.2002.30106.x; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Saito K, 2014, J CELL BIOL, V206, P751, DOI 10.1083/jcb.201312062; Saito Y, 1999, J BIOCHEM-TOKYO, V125, P130, DOI 10.1093/oxfordjournals.jbchem.a022249; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Settles EI, 2010, BIOPHYS J, V99, P1539, DOI 10.1016/j.bpj.2010.06.059; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Voss C, 2012, J CELL SCI, V125, P4791, DOI 10.1242/jcs.105635; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L	46	15	15	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154280	10.1371/journal.pone.0154280	http://dx.doi.org/10.1371/journal.pone.0154280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101143	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000374898500178
J	Janmaat, VT; Bruno, MJ; Polinder, S; Lorenzen, S; Lordick, F; Peppelenbosch, MP; Spaander, MCW				Janmaat, Vincent T.; Bruno, Marco J.; Polinder, Suzanne; Lorenzen, Sylvie; Lordick, Florian; Peppelenbosch, Maikel P.; Spaander, Manon C. W.			Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; GROWTH-FACTOR-RECEPTOR; CLINICAL-TRIAL; PHASE-II; SURVIVAL; POLYMORPHISMS; OVEREXPRESSION; AMPLIFICATION; SURVEILLANCE; PANITUMUMAB	Background Costly biologicals in palliative oncology are emerging at a rapid pace. For example, in patients with advanced esophageal squamous cell carcinoma addition of cetuximab to a palliative chemotherapy regimen appears to improve survival. However, it simultaneously results in higher costs. We aimed to determine the incremental cost-effectiveness ratio of adding cetuximab to first-line chemotherapeutic treatment of patients with advanced esophageal squamous cell carcinoma, based on data from a randomized controlled phase II trial. Methods A cost effectiveness analysis model was applied based on individual patient data. It included only direct medical costs from the health-care perspective. Quality-adjusted life-years and incremental cost-effectiveness ratios were calculated. Sensitivity analysis was performed by a Monte Carlo analysis. Results Adding cetuximab to a cisplatin-5-fluorouracil first-line regimen for advanced esophageal squamous cell carcinoma resulted in an the incremental cost-effectiveness ratio of (sic)252,203 per quality-adjusted life-year. Sensitivity analysis shows that there is a chance of less than 0.001 that the incremental cost-effectiveness ratio will be less than a maximum willingness to pay threshold of (sic)40,000 per quality-adjusted life-year, which is representative for the threshold used in The Netherlands and other developed countries. Conclusions Addition of cetuximab to a cisplatin-5-fluorouracil first-line regimen for advanced esophageal squamous cell carcinoma is not cost-effective when appraised according to currently accepted criteria. Cost-effectiveness analyses using outcome data from early clinical trials (i.c. a phase II trial) enable pharmaceutical companies and policy makers to gain early insight into whether a new drug meets the current eligibility standards for reimbursement and thereby potential admittance for use in regular clinical practice.	[Janmaat, Vincent T.; Bruno, Marco J.; Peppelenbosch, Maikel P.; Spaander, Manon C. W.] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Polinder, Suzanne] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Lorenzen, Sylvie] Tech Univ Munich, Dept Internal Med Hematol Med Oncol 3, D-80290 Munich, Germany; [Lordick, Florian] Univ Leipzig, UCCL, D-04109 Leipzig, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Technical University of Munich; Leipzig University	Spaander, MCW (corresponding author), Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	v.spaander@erasmusmc.nl	Peppelenbosch, Maikel P./U-5304-2019	Janmaat, Vincent/0000-0002-8279-1816; Peppelenbosch, Maikel/0000-0001-9112-6028	Merck Serono	Merck Serono(Merck & Company)	One of the authors F. Lordick received research support, travel support and lecture honoraria from Merck Serono. This did not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Appleby J, 2009, HEALTH POLICY, V91, P239, DOI 10.1016/j.healthpol.2008.12.010; Council for Public Health and Health Care to the Minister of Health, 2006, WELF SPORT SENS SUST; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Garside R, 2006, HEALTH TECHNOL ASSES, V10, P1; Gibault L, 2005, BRIT J CANCER, V93, P107, DOI 10.1038/sj.bjc.6602625; Graziano F, 2008, J CLIN ONCOL, V26, P1427, DOI 10.1200/JCO.2007.12.4602; Greenhalgh J, 2009, HEALTH TECHNOL ASSES, V13, P49, DOI 10.3310/hta13suppl3/08; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Hanawa M, 2006, INT J CANCER, V118, P1173, DOI 10.1002/ijc.21454; Higginson IJ, 2009, J PAIN SYMPTOM MANAG, V38, P816, DOI 10.1016/j.jpainsymman.2009.07.002; Hill S, 2003, PHARMACOECONOMICS, V21, P761, DOI 10.2165/00019053-200321110-00001; Hoyle M, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17140; Hughes DA, 2001, PHARMACOECONOMICS, V19, P1069, DOI 10.2165/00019053-200119110-00001; Hulp CF, 2007, FARMACOTHERAPEUTISCH; Hurt CN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-466; ITAKURA Y, 1994, CANCER, V74, P795, DOI 10.1002/1097-0142(19940801)74:3<795::AID-CNCR2820740303>3.0.CO;2-I; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lorenzen S, 2009, ANN ONCOL, V20, P1667, DOI 10.1093/annonc/mdp069; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Martin S, 2012, HEALTH ECON, V21, P316, DOI 10.1002/hec.1716; Mittmann N, 2009, J NATL CANCER I, V101, P1182, DOI 10.1093/jnci/djp232; National Institute for Care and health Excellence (NICE), 2009, CET TREATM REC MET S; National Institute for Health and Clinical Excellence, 2010, BARR OES ABL THER TR; Pander J, 2010, EUR J CANCER, V46, P1829, DOI 10.1016/j.ejca.2010.03.017; Polednak AP, 2003, INT J CANCER, V105, P98, DOI 10.1002/ijc.11029; Rickwood S, 2017, GLOBAL USE MED OUTLO; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Simoens S, 2011, CLINICOECONOMIC OUTC, V3, P29, DOI 10.2147/CEOR.S12494; Smulders Y M, 2006, Ned Tijdschr Geneeskd, V150, P2467; Thijssen J, 2014, PACE, V37, P25, DOI 10.1111/pace.12238; Zhang W, 2006, PHARMACOGENET GENOM, V16, P475, DOI 10.1097/01.fpc.0000220562.67595.a5	35	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153943	10.1371/journal.pone.0153943	http://dx.doi.org/10.1371/journal.pone.0153943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100871	gold, Green Submitted, Green Published			2022-12-26	WOS:000374898500104
J	Lee, AH; Fidock, DA				Lee, Andrew H.; Fidock, David A.			Evidence of a Mild Mutator Phenotype in Cambodian Plasmodium falciparum Malaria Parasites	PLOS ONE			English	Article							CATION ATPASE PFATP4; DRUG-RESISTANCE; SACCHAROMYCES-CEREVISIAE; SPIROINDOLONE KAE609; WEAK MUTATORS; MUTATIONS; FREQUENCIES; EVOLUTION; ANTIMALARIALS; SENSITIVITY	Malaria control efforts have been continuously stymied by drug-resistant strains of Plasmodium falciparum, which typically originate in Southeast Asia prior to spreading into high-transmission settings in Africa. One earlier proposed explanation for Southeast Asia being a hotbed of resistance has been the hypermutability or "Accelerated Resistance to Multiple Drugs" (ARMD) phenotype, whereby multidrug-resistant Southeast Asian parasites were reported to exhibit 1,000-fold higher rates of resistance to unrelated antimalarial agents when compared to drug-sensitive parasites. However, three recent studies do not recapitulate this hypermutability phenotype. Intriguingly, genome sequencing of recently derived multidrug-resistant Cambodian isolates has identified a high proportion of DNA repair gene mutations in multidrug-resistant parasites, suggesting their potential role in shaping local parasite evolution. By adapting fluctuation assays for use in P. falciparum, we have examined the in vitro mutation rates of five recent Cambodian isolates and three reference laboratory strains. For these studies we also generated a knockout parasite line lacking the DNA repair factor Exonuclease I. In these assays, parasites were typed for their ability to acquire resistance to KAE609, currently in advanced clinical trials, yielding 13 novel mutations in the Na+/H+-ATPase PfATP4, the primary resistance determinant. We observed no evidence of hypermutability. Instead, we found evidence of a mild mutator (up to a 3.4-fold increase in mutation rate) phenotype in two artemisinin-resistant Cambodian isolates, which carry DNA repair gene mutations. We observed that one such mutation in the Mismatch Repair protein Mlh1 contributes to the mild mutator phenotype when modeled in yeast (scmlh1-P157S). Compared to basal rates of mutation, a mild mutator phenotype may provide a greater overall benefit for parasites in Southeast Asia in terms of generating drug resistance without incurring detrimental fitness costs.	[Lee, Andrew H.; Fidock, David A.] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA; [Fidock, David A.] Columbia Univ, Dept Med, Div Infect Dis, New York, NY USA	Columbia University; Columbia University	Fidock, DA (corresponding author), Columbia Univ, Dept Microbiol & Immunol, New York, NY USA.; Fidock, DA (corresponding author), Columbia Univ, Dept Med, Div Infect Dis, New York, NY USA.	df2260@cumc.columbia.edu		Fidock, David/0000-0001-6753-8938	National Institutes of Health [R01 AI109023, R01 AI50234, T32 AI106711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050234, R37AI050234, T32AI106711, R01AI109023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (https://www.nih.gov/) R01 AI109023, R01 AI50234, T32 AI106711 to DAF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Baquero MR, 2004, J BACTERIOL, V186, P5538, DOI 10.1128/JB.186.16.5538-5542.2004; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Boiteux S, 2013, GENETICS, V193, P1025, DOI 10.1534/genetics.112.145219; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Brown TS, 2015, INFECT GENET EVOL, V30, P318, DOI 10.1016/j.meegid.2014.12.010; Claessens A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004812; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000103; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Denamur E, 2005, GENETICS, V171, P825, DOI 10.1534/genetics.105.045526; Diagana TT, 2015, DRUG DISCOV TODAY, V20, P1265, DOI 10.1016/j.drudis.2015.06.009; Dondorp Arjen M, 2011, N Engl J Med, V365, P1073, DOI 10.1056/NEJMp1108322; Ekland EH, 2011, FASEB J, V25, P3583, DOI 10.1096/fj.11-187401; Fidock DA, 1998, MOL PHARMACOL, V54, P1140, DOI 10.1124/mol.54.6.1140; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; Gabryszewski SJ, 2016, MOL BIOL EVOL IN PRE; Goodyer ID, 1997, EXP PARASITOL, V86, P158, DOI 10.1006/expr.1997.4156; Greene CN, 2001, GENETICS, V159, P65; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Gustafsson I, 2003, J ANTIMICROB CHEMOTH, V52, P645, DOI 10.1093/jac/dkg427; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Lehane AM, 2014, MOL MICROBIOL, V94, P327, DOI 10.1111/mmi.12765; Leong FJ, 2014, ANTIMICROB AGENTS CH, V58, P6209, DOI 10.1128/AAC.03393-14; Luria SE, 1943, GENETICS, V28, P491; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; ODUOLA AMJ, 1988, EXP PARASITOL, V67, P354, DOI 10.1016/0014-4894(88)90082-3; Orlen H, 2006, ANTIMICROB AGENTS CH, V50, P3454, DOI 10.1128/AAC.00783-06; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sa JM, 2011, ESSAYS BIOCHEM, V51, P137, DOI [10.1042/BSE0510137, 10.1042/bse0510137]; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sokolsky T, 2000, GENETICS, V155, P589; Spillman NJ, 2013, CELL HOST MICROBE, V13, P227, DOI 10.1016/j.chom.2012.12.006; Spillman NJ, 2015, INT J PARASITOL-DRUG, V5, P149, DOI 10.1016/j.ijpddr.2015.07.001; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Takahashi M, 2007, CANCER RES, V67, P4595, DOI 10.1158/0008-5472.CAN-06-3509; Takala-Harrison S, 2015, ANN NY ACAD SCI, V1342, P62, DOI 10.1111/nyas.12766; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; UDEINYA IJ, 1983, EXP PARASITOL, V56, P207, DOI 10.1016/0014-4894(83)90064-4; Vaidya AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6521; Venkatesan M, 2013, TRENDS PARASITOL, V29, P497, DOI 10.1016/j.pt.2013.07.008; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; White NJ, 2014, NEW ENGL J MED, V371, P403, DOI 10.1056/NEJMoa1315860; WHO, 2012, GLOB PLAN INSECTICID; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yuthavong Y, 2012, P NATL ACAD SCI USA, V109, P16823, DOI 10.1073/pnas.1204556109; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023	58	26	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154166	10.1371/journal.pone.0154166	http://dx.doi.org/10.1371/journal.pone.0154166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100094	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500158
J	Nicotra, A; Newman, C; Johnson, M; Eremin, O; Friede, T; Malik, O; Nicholas, R				Nicotra, Alessia; Newman, Claus; Johnson, Martin; Eremin, Oleg; Friede, Tim; Malik, Omar; Nicholas, Richard			Peripheral Nerve Dysfunction in Middle-Aged Subjects Born with Thalidomide Embryopathy	PLOS ONE			English	Article							NEUROPATHY	Background Phocomelia is an extremely rare congenital malformation that emerged as one extreme of a range of defects resulting from in utero exposure to thalidomide. Individuals with thalidomide embryopathy (TE) have reported developing symptoms suggestive of peripheral nervous system dysfunction in the mal-developed limbs in later life. Methods Case control study comparing TE subjects with upper limb anomalies and neuropathic symptoms with healthy controls using standard neurophysiological testing. Other causes of a peripheral neuropathy were excluded prior to assessment. Results Clinical examination of 17 subjects with TE (aged 50.4 +/- 1.3 [mean +/- standard deviation] years, 10 females) and 17 controls (37.9 +/- 9.0 years; 8 females) demonstrated features of upper limb compressive neuropathy in three-quarters of subjects. Additionally there were examination findings suggestive of mild sensory neuropathy in the lower limbs (n = 1), L5 radiculopathic sensory impairment (n = 1) and cervical myelopathy (n = 1). In TE there were electrophysiological changes consistent with a median large fibre neuropathic abnormality (mean compound muscle action potential difference -6.3 mV ([-9.3, -3.3], p = 0.0002) ([95% CI], p-value)) and reduced sympathetic skin response amplitudes (-0.8 mV ([-1.5, -0.2], p = 0.0089)) in the affected upper limbs. In the lower limbs there was evidence of sural nerve dysfunction (sensory nerve action potential -5.8 mu V ([-10.7, -0.8], p = 0.0232)) and impaired warm perception thresholds (+3.0 degrees C ([0.6, 5.4], p = 0.0169)). Conclusions We found a range of clinical features relevant to individuals with TE beyond upper limb compressive neuropathies supporting the need for a detailed neurological examination to exclude other treatable pathologies. The electrophysiological evidence of large and small fibre axonal nerve dysfunction in symptomatic and asymptomatic limbs may be a result of the original insult and merits further investigation.	[Nicotra, Alessia; Malik, Omar; Nicholas, Richard] Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Neurosci, Fulham Palace Rd, London W6 8RF, England; [Newman, Claus; Johnson, Martin] Thalidomide Trust, 1 Eaton Court Rd,Colmworth Business Pk, St Neots PE19 8ER, Cambs, England; [Eremin, Oleg] Lincoln Cty Hosp, United Lincolnshire Hosp NHS Trust, Greetwell Rd, Lincoln LN2 5QY, England; [Friede, Tim] Univ Med Ctr Gottingen, Dept Med Stat, D-37073 Gottingen, Germany; [Nicholas, Richard] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Expt Med, Ctr Neurosci,Wolfson Neurosci Labs, London, England	Imperial College London; University of Gottingen; Imperial College London	Nicholas, R (corresponding author), Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Neurosci, Fulham Palace Rd, London W6 8RF, England.; Nicholas, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Expt Med, Ctr Neurosci,Wolfson Neurosci Labs, London, England.	r.nicholas@imperial.ac.uk	Friede, Tim/ABF-1132-2021	Friede, Tim/0000-0001-5347-7441	Thalidomide Trust	Thalidomide Trust	Grant from the Thalidomide Trust, who had no role in the design and analysis of the study.	[Anonymous], 1964, MINISTRY HLTH REPORT, V112; Bastuji-Garin S, 2002, J INVEST DERMATOL, V119, P1020, DOI 10.1046/j.1523-1747.2002.19502.x; Cohen S, 1962, NEW ENGL J MED, V266, P1208; Cortes-Hernandez J, 2012, BRIT J DERMATOL, V166, P616, DOI 10.1111/j.1365-2133.2011.10693.x; FULLERTON P, 1961, BMJ-BRIT MED J, V2, P855, DOI 10.1136/bmj.2.5256.855; Jankelowitz SK, 2013, EUR J NEUROL, V20, P509, DOI 10.1111/ene.12005; KIDA M, 1987, THALIDOMIDE EMBRYOPA; LAGUENY A, 1986, MUSCLE NERVE, V9, P837, DOI 10.1002/mus.880090907; LENZ W, 1962, LANCET, V1, P45; McCredie J., 2007, THALIDOMIDE BIRTH DE; MELLIN GW, 1962, NEW ENGL J MED, V267, P1238, DOI 10.1056/NEJM196212132672407; NEWMAN CGH, 1986, CLIN PERINATOL, V13, P555, DOI 10.1016/S0095-5108(18)30810-8; OCHONISKY S, 1994, ARCH DERMATOL, V130, P66, DOI 10.1001/archderm.130.1.66; Spiers AL, 1962, LANCET, V279, P303; WULFF CH, 1985, BRIT J DERMATOL, V112, P475, DOI 10.1111/j.1365-2133.1985.tb02323.x	15	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152902	10.1371/journal.pone.0152902	http://dx.doi.org/10.1371/journal.pone.0152902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100829	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500019
J	Marzolf, G; Sabou, M; Lannes, B; Cotton, F; Meyronet, D; Galanaud, D; Cottier, JP; Grand, S; Desal, H; Kreutz, J; Schenck, M; Meyer, N; Schneider, F; Dietemann, JL; Koob, M; Herbrecht, R; Kremer, S				Marzolf, Guillaume; Sabou, Marcela; Lannes, Beatrice; Cotton, Francois; Meyronet, David; Galanaud, Damien; Cottier, Jean-Philippe; Grand, Sylvie; Desal, Hubert; Kreutz, Julie; Schenck, Maleka; Meyer, Nicolas; Schneider, Francis; Dietemann, Jean-Louis; Koob, Meriam; Herbrecht, Raoul; Kremer, Stephane			Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BONE-MARROW-TRANSPLANTATION; INVASIVE ASPERGILLOSIS; FUNGAL-INFECTIONS; INTRACRANIAL ASPERGILLOSIS; IMMUNOCOMPROMISED PATIENTS; BRAIN ASPERGILLOSIS; MYCOTIC-ANEURYSM; ACUTE-LEUKEMIA; MR	Cerebral aspergillosis is associated with a significant morbidity and mortality rate. The imaging data present different patterns and no full consensus exists on typical imaging characteristics of the cerebral lesions. We reviewed MRI findings in 21 patients with cerebral aspergillosis and correlated them to the immune status of the patients and to neuropathological findings when tissue was available. The lesions were characterized by their number, topography, and MRI signal. Dissemination to the brain resulted from direct spread from paranasal sinuses in 8 patients, 6 of them being immunocompetent. Hematogenous dissemination was observed in 13 patients, all were immunosuppressed. In this later group we identified a total of 329 parenchymal abscesses involving the whole brain with a predilection for the corticomedullary junction. More than half the patients had a corpus callosum lesion. Hemorrhagic lesions accounted for 13% and contrast enhancement was observed in 61% of the lesions. Patients with hematogenous dissemination were younger (p = 0.003), had more intracranial lesions (p = 0.0004) and had a higher 12-week mortality rate (p = 0.046) than patients with direct spread from paranasal sinuses. Analysis of 12 aneurysms allowed us to highlight two distinct situations. In case of direct spread from the paranasal sinuses, aneurysms are saccular and located on the proximal artery portions, while the hematogenous dissemination in immunocompromised patients is more frequently associated with distal and fusiform aneurysms. MRI is the exam of choice for cerebral aspergillosis. Number and type of lesions are different according to the mode of dissemination of the infection.	[Marzolf, Guillaume; Dietemann, Jean-Louis; Koob, Meriam; Kremer, Stephane] Hop Univ Strasbourg, Dept Neuroradiol, Strasbourg, France; [Sabou, Marcela] Hop Univ Strasbourg, Lab Parasitol & Mycol Med, Strasbourg, France; [Lannes, Beatrice] Hop Univ Strasbourg, Serv Pathol, Strasbourg, France; [Cotton, Francois] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Neuroradiol, Lyon, France; [Meyronet, David] Hosp Civils Lyon, Dept Neuropathol, Lyon, France; [Galanaud, Damien] Hop Paris, Hop La Pitie Salpetriere, Dept Neuroradiol, Paris, France; [Cottier, Jean-Philippe] CHU Tours, Dept Neuroradiol, Tours, France; [Grand, Sylvie] CHU Grenoble, Dept Neuroradiol, F-38043 Grenoble, France; [Desal, Hubert] CHU Nantes, Hop Nord Laennec, Dept Neuroradiol, F-44035 Nantes 01, France; [Kreutz, Julie] Ctr Hosp Univ Liege, Dept Radiol, Liege, Belgium; [Schenck, Maleka; Schneider, Francis] Hop Univ Strasbourg, Serv Reanimat Med, Strasbourg, France; [Meyer, Nicolas] Fac Med Strasbourg, Lab Biostat, Strasbourg, France; [Herbrecht, Raoul] Hop Univ Strasbourg, Dept Hematol & Oncol, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Lyon; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Tours; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Nantes Universite; CHU de Nantes; University of Liege; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Marzolf, G (corresponding author), Hop Univ Strasbourg, Dept Neuroradiol, Strasbourg, France.	guillaume.marzolf@chru-strasbourg.fr	Cottier, Jean-Philippe/AAZ-6005-2021; Herbrecht, Raoul/AAT-1763-2021; cotton, francois/F-4762-2013; Herbrecht, Raoul/GVU-1333-2022; Desal, Hubert/T-2089-2019	Herbrecht, Raoul/0000-0002-9381-4876; cotton, francois/0000-0003-0046-2478; Cottier, Jean-Philippe/0000-0001-9166-212X	Pfizer; Basilea; Gilead; Merck; Schering-Plough	Pfizer(Pfizer); Basilea; Gilead(Gilead Sciences); Merck(Merck & Company); Schering-Plough(Merck & CompanySchering Plough Corporation)	Raoul Herbrecht, M.D., PhD, holds a consultancy with Pfizer including a grant from Pfizer; payment for lectures at Basilea, Gilead, Merck, Schering-Plough; travel/accomodation/meetings at Gilead, Pfizer, Merck. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ADLER CH, 1989, MOVEMENT DISORD, V4, P333, DOI 10.1002/mds.870040407; Almutairi BM, 2009, RADIOGRAPHICS, V29, P375, DOI 10.1148/rg.292075143; ASHDOWN BC, 1994, AM J ROENTGENOL, V162, P155, DOI 10.2214/ajr.162.1.8273655; Boes B, 1994, J Neuroimaging, V4, P123; Charlot M, 2007, EUR J NEUROL, V14, P912, DOI 10.1111/j.1468-1331.2007.01874.x; COX J, 1992, AM J NEURORADIOL, V13, P1489; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; DeLone DR, 1999, AM J NEURORADIOL, V20, P1597; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Dietrich U, 2001, EUR RADIOL, V11, P1242, DOI 10.1007/s003300000756; Finelli PF, 2014, NEURORADIOL J, V27, P280, DOI 10.15274/NRJ-2014-10036; Gabelmann A, 2007, EUR J NEUROL, V14, P548, DOI 10.1111/j.1468-1331.2007.01755.x; Gaviani P, 2005, AM J NEURORADIOL, V26, P1115; Guermazi A, 2003, EUR RADIOL, V13, P377, DOI 10.1007/s00330-002-1480-5; Harris DE, 1997, NEUROIMAG CLIN N AM, V7, P187; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Hirschi S, 2012, J CLIN MICROBIOL, V50, P4168, DOI 10.1128/JCM.01928-12; Hurst RW, 2001, AM J NEURORADIOL, V22, P858; Kami M, 1999, INTERNAL MED, V38, P45, DOI 10.2169/internalmedicine.38.45; Kornienko VN., 2008, DIAGNOSTIC NEURORADI; Lee GJ, 2013, J KOREAN NEUROSURG S, V53, P312, DOI 10.3340/jkns.2013.53.5.312; MIAUX Y, 1995, AM J NEURORADIOL, V16, P555; Negoro E, 2013, INT J HEMATOL, V98, P4, DOI 10.1007/s12185-013-1369-x; Okafuji T, 2003, COMPUT MED IMAG GRAP, V27, P489, DOI 10.1016/S0895-6111(03)00033-8; Osborn AG., 1999, DIAGNOSTIC CEREBRAL, V2nd ed; Pagano L, 1996, CLIN INFECT DIS, V23, P628, DOI 10.1093/clinids/23.3.628; Pollack E, 2007, J NEUROIMAGING, V17, P361, DOI 10.1111/j.1552-6569.2007.00105.x; Schwartz S, 2005, BLOOD, V106, P2641, DOI 10.1182/blood-2005-02-0733; SPARANO JA, 1992, J NEURO-ONCOL, V13, P91; Starkey J, 2014, CLIN NEURORADIOL, V24, P217, DOI 10.1007/s00062-014-0305-7; Tempkin AD, 2006, RADIOGRAPHICS, V26, P1239, DOI 10.1148/rg.264055152; Yamada K, 2002, ACAD RADIOL, V9, P163, DOI 10.1016/S1076-6332(03)80166-6; YOUNG RC, 1970, MEDICINE, V49, P147, DOI 10.1097/00005792-197003000-00002; ZINREICH SJ, 1988, RADIOLOGY, V169, P439, DOI 10.1148/radiology.169.2.3174990	34	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152475	10.1371/journal.pone.0152475	http://dx.doi.org/10.1371/journal.pone.0152475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097323	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600013
J	Nie, XQ; Yang, YH; Yang, LC; Zhou, GY				Nie, Xiuqing; Yang, Yuanhe; Yang, Lucun; Zhou, Guoying			Above- and Belowground Biomass Allocation in Shrub Biomes across the Northeast Tibetan Plateau	PLOS ONE			English	Article							GLOBAL PATTERNS; GROWTH; PLANTS; LAND	Biomass partitioning has been explored across various biomes. However, the strategies of allocation in plants still remain contentious. This study investigated allocation patterns of above-and belowground biomass at the community level, using biomass survey from the Tibetan Plateau. We explored above-and belowground biomass by conducting three consecutive sampling campaigns across shrub biomes on the northeast Tibetan Plateau during 2011-2013. We then documented the above-ground biomass (AGB), below-ground biomass (BGB) and root: shoot ratio (R/S) and the relationships between R/S and environment factors using data from 201 plots surveyed from 67 sites. We further examined relationships between above-ground and below-ground biomass across various shrub types. Our results indicated that the median values of AGB, BGB, and R/S in Tibetan shrub were 1102.55, 874.91 g m(-2), and 0.85, respectively. R/S showed significant trend with mean annual precipitation (MAP), while decreased with mean annual temperature (MAT). Reduced major axis analysis indicated that the slope of the log-log relationship between above-and belowground biomass revealed a significant difference from 1.0 over space, supporting the optimal hypothesis. Interestingly, the slopes of the allometric relationship between log AGB and log BGB differed significantly between alpine and desert shrub. Our findings supported the optimal theory of above-and belowground biomass partitioning in Tibetan shrub, while the isometric hypothesis for alpine shrub at the community level.	[Nie, Xiuqing; Yang, Lucun; Zhou, Guoying] Chinese Acad Sci, Northwest Inst Plateau Biol, Xining 810008, Peoples R China; [Nie, Xiuqing; Yang, Lucun; Zhou, Guoying] Chinese Acad Sci, Key Lab Tibetan Med Res, Xining 810008, Peoples R China; [Yang, Yuanhe] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Nie, Xiuqing] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, GY (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Xining 810008, Peoples R China.; Zhou, GY (corresponding author), Chinese Acad Sci, Key Lab Tibetan Med Res, Xining 810008, Peoples R China.	zhougy@nwipb.cas.cn	Zhou, Guoying/AAE-5590-2020; Yang, Yuanhe/D-1448-2011		National Program on Key Basic Research Project [2012CB026105]; National Science and Technology Support Project [2014BAC05B01]; "Strategic Priority Research Program" of CAS [XDA05050303]; National Natural Science Foundation of China [40801076]	National Program on Key Basic Research Project(National Basic Research Program of China); National Science and Technology Support Project; "Strategic Priority Research Program" of CAS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the "National Program on Key Basic Research Project" (grant number 2012CB026105), "National Science and Technology Support Project" (grant number 2014BAC05B01; http://168.160.10.98/sbksdy/#), "Strategic Priority Research Program" of CAS (grant number XDA05050303) and "National Natural Science Foundation of China" (grant number 40801076; http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). All funding was received by Guoying Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; DAVIDSON RL, 1969, ANN BOT-LONDON, V33, P561, DOI 10.1093/oxfordjournals.aob.a084308; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Fan JW, 2009, J ARID ENVIRON, V73, P521, DOI 10.1016/j.jaridenv.2008.12.004; Fang JingYun, 2009, Biodiversity Science, V17, P533, DOI 10.3724/SP.J.1003.2009.09253; GALE J, 1972, ECOLOGY, V53, P494, DOI 10.2307/1934239; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Gilmanov TG, 1997, ECOL MODEL, V96, P191, DOI 10.1016/S0304-3800(96)00067-1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hui D., 2005, NEW PHYTOL, V169, P85; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; [马文红 Ma Wenhong], 2006, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V42, P774; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Niklas KJ, 2005, ANN BOT-LONDON, V95, P315, DOI 10.1093/aob/mci028; Niu Cun-yang, 2013, Shengtaixue Zazhi, V32, P1980; Paruelo JM, 1999, ECOSYSTEMS, V2, P64, DOI 10.1007/s100219900058; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Titlyanova AA, 1999, J VEG SCI, V10, P307, DOI 10.2307/3237060; Vogt K., 1991, TECHNIQUES APPROACHE, P477; WOODWARD FI, 1986, OECOLOGIA, V70, P580, DOI 10.1007/BF00379908; WOODWARD FI, 1975, NEW PHYTOL, V74, P335, DOI 10.1111/j.1469-8137.1975.tb02621.x; Wright I.J., 2003, S MATR STANDARDIZED; Wu, 1980, VEGETATION CHINA, P430; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; [杨昊天 Yang Haotian], 2013, [中国沙漠, Journal of Desert Research], V33, P1340; Yang X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05448; Yang YH, 2011, J ECOL, V99, P431, DOI 10.1111/j.1365-2745.2010.01774.x; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; ZHANG Z, 2009, GEOGRAPHY QINGHAI PL, P25; Zhao Can, 2014, Journal of Beijing Forestry University, V36, P62; ZHOU X, 1987, VEGETATION QINGHAI P, P53; 王亮, 2010, [中国科学：生命科学, Scientia Sinica Vitae], V40, P642	42	24	29	5	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154251	10.1371/journal.pone.0154251	http://dx.doi.org/10.1371/journal.pone.0154251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119379	Green Submitted, Green Published, gold			2022-12-26	WOS:000374976200052
J	Zhao, L; Mahony, D; Cavallro, AS; Zhang, B; Zhang, J; Deringer, JR; Zhao, CX; Brown, WC; Yu, CZ; Mitter, N; Middelberg, APJ				Zhao, Liang; Mahony, Donna; Cavallro, Antonino S.; Zhang, Bing; Zhang, Jun; Deringer, James R.; Zhao, Chun-Xia; Brown, Wendy C.; Yu, Chengzhong; Mitter, Neena; Middelberg, Anton P. J.			Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale	PLOS ONE			English	Article							IV SECRETION SYSTEM; MESOPOROUS SILICA NANOPARTICLES; VIRUS E2 PROTEIN; VACCINE; ADJUVANTS; PURIFICATION; INFECTION; RESPONSES; DELIVERY; COMPLEX	Anaplasma marginale is the most prevalent tick-borne livestock pathogen and poses a significant threat to cattle industry. In contrast to currently available live blood-derived vaccines against A. marginale, alternative safer and better-defined subunit vaccines will be of great significance. Two proteins (VirB9-1 and VirB9-2) from the Type IV secretion system of A. marginale have been shown to induce humoral and cellular immunity. In this study, Escherichia coli were used to express VirB9-1 and VirB9-2 proteins. Silica vesicles having a thin wall of 6 nm and pore size of 5.8 nm were used as the carrier and adjuvant to deliver these two antigens both as individual or mixed nano-formulations. High loading capacity was achieved for both proteins, and the mouse immunisation trial with individual as well as mixed nano-formulations showed high levels of antibody titres over 107 and strong T-cell responses. The mixed nano-formulation also stimulated high-level recall responses in bovine T-cell proliferation assays. These results open a promising path towards the development of efficient A. marginale vaccines and provide better understanding on the role of silica vesicles to deliver multivalent vaccines as mixed nano-formulations able to activate both B-cell and T-cell immunity, for improved animal health.	[Zhao, Liang; Zhang, Jun; Zhao, Chun-Xia; Yu, Chengzhong; Middelberg, Anton P. J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia; [Mahony, Donna; Cavallro, Antonino S.; Mitter, Neena] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld 4072, Australia; [Zhang, Bing] Queensland Dept Agr Fisheries & Forestry, Anim Sci, St Lucia, Qld 4072, Australia; [Deringer, James R.; Brown, Wendy C.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, POB 647040, Pullman, WA 99164 USA	University of Queensland; University of Queensland; Queensland Department of Agriculture & Fisheries; Washington State University	Middelberg, APJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.; Mitter, N (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld 4072, Australia.	n.mitter@uq.edu.au; a.middelberg@uq.edu.au	Zhao, Chun-Xia Rosie/I-4224-2012; Yu, Chengzhong/I-8663-2012; Zhao, Chun-Xia/AAT-2168-2020; mitter, neena/D-1862-2013	Zhao, Chun-Xia Rosie/0000-0002-3365-3759; Yu, Chengzhong/0000-0003-3707-0785; Zhao, Chun-Xia/0000-0002-3365-3759; mitter, neena/0000-0001-6146-6179; Cavallaro, Tony/0000-0002-3601-3386; Middelberg, Anton/0000-0001-5922-5704; Zhang, Jun/0000-0001-7030-2686	Queensland Government Research Partnerships grant [013936_471]	Queensland Government Research Partnerships grant	This work was supported by the Queensland Government Research Partnerships grant ( Project 013936_471), https://www.business.qld.gov.au/industry/science/grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brown WC, 1998, INFECT IMMUN, V66, P5406, DOI 10.1128/IAI.66.11.5406-5413.1998; Cavallaro AS, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-57; Chuan YP, 2008, J BIOTECHNOL, V134, P64, DOI 10.1016/j.jbiotec.2007.12.004; Cohen S, 1994, Int J Technol Assess Health Care, V10, P121; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Heath DD, 2012, VACCINE, V30, P3076, DOI 10.1016/j.vaccine.2012.02.073; KENSIL CR, 1991, J IMMUNOL, V146, P431; Kocan KM, 2003, CLIN MICROBIOL REV, V16, P698, DOI 10.1128/CMR.16.4.698-712.2003; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; Lopez JE, 2007, INFECT IMMUN, V75, P2333, DOI 10.1128/IAI.00061-07; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; Mahony D, 2014, NANOSCALE, V6, P6617, DOI 10.1039/c4nr01202j; Mahony D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141870; Mahony D, 2013, SMALL, V9, P3138, DOI 10.1002/smll.201300012; Marcelino I, 2012, J PROTEOMICS, V75, P4232, DOI 10.1016/j.jprot.2012.03.026; Mody KT, 2014, BIOMATERIALS, V35, P9972, DOI 10.1016/j.biomaterials.2014.08.044; Morse K, 2012, IMMUNOGENETICS, V64, P507, DOI 10.1007/s00251-012-0606-4; Morse K, 2012, INFECT IMMUN, V80, P215, DOI 10.1128/IAI.05798-11; Palmer GH, 1999, PARASITOL TODAY, V15, P281, DOI 10.1016/S0169-4758(99)01469-6; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Rice-Ficht AC, 2010, CURR OPIN MICROBIOL, V13, P106, DOI 10.1016/j.mib.2009.12.001; Schadlicha L, 2009, VACCINE, V27, P1511, DOI 10.1016/j.vaccine.2009.01.014; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; Spickler AR, 2003, J VET INTERN MED, V17, P273, DOI 10.1892/0891-6640(2003)017&lt;0273:AIVVMO&gt;2.3.CO;2; Sutten EL, 2010, INFECT IMMUN, V78, P1314, DOI 10.1128/IAI.01207-09; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; [Tick Fever Centre Queensland Australia Department of Agriculture Fisheries and Forestry], 2007, COMB 3 1 LIV TICK FE; Yuan H, 2001, J VIROL, V75, P7848, DOI 10.1128/JVI.75.17.7848-7853.2001; Zhang J, 2014, SMALL, V10, P5068, DOI 10.1002/smll.201401538; Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069	32	16	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154295	10.1371/journal.pone.0154295	http://dx.doi.org/10.1371/journal.pone.0154295			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115492	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600056
J	Marini, G; Poletti, P; Giacobini, M; Pugliese, A; Merler, S; Rosa, R				Marini, Giovanni; Poletti, Piero; Giacobini, Mario; Pugliese, Andrea; Merler, Stefano; Rosa, Roberto			The Role of Climatic and Density Dependent Factors in Shaping Mosquito Population Dynamics: The Case of Culex pipiens in Northwestern Italy	PLOS ONE			English	Article							WEST-NILE-VIRUS; DRIVEN ABUNDANCE MODEL; AEDES-ALBOPICTUS; HUMAN-DISEASE; TEMPERATURE; TRANSMISSION; SURVIVAL; COMPLEX; EUROPE; REGION	Culex pipiens mosquito is a species widely spread across Europe and represents a competent vector for many arboviruses such as West Nile virus (WNV), which has been recently circulating in many European countries, causing hundreds of human cases. In order to identify the main determinants of the high heterogeneity in Cx. pipiens abundance observed in Piedmont region (Northwestern Italy) among different seasons, we developed a density-dependent stochastic model that takes explicitly into account the role played by temperature, which affects both developmental and mortality rates of different life stages. The model was calibrated with a Markov chain Monte Carlo approach exploring the likelihood of recorded capture data gathered in the study area from 2000 to 2011; in this way, we disentangled the role played by different seasonal eco-climatic factors in shaping the vector abundance. Illustrative simulations have been performed to forecast likely changes if temperature or density-dependent inputs would change. Our analysis suggests that inter-seasonal differences in the mosquito dynamics are largely driven by different temporal patterns of temperature and seasonal-specific larval carrying capacities. Specifically, high temperatures during early spring hasten the onset of the breeding season and increase population abundance in that period, while, high temperatures during the summer can decrease population size by increasing adult mortality. Higher densities of adult mosquitoes are associated with higher larval carrying capacities, which are positively correlated with spring precipitations. Finally, an increase in larval carrying capacity is expected to proportionally increase adult mosquito abundance.	[Marini, Giovanni; Pugliese, Andrea] Univ Trento, Dept Math, Trento, Italy; [Marini, Giovanni; Rosa, Roberto] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, TN, Italy; [Poletti, Piero; Merler, Stefano] Bruno Kessler Fdn, Trento, Italy; [Poletti, Piero] Univ Commerciale L Bocconi, Dondena Ctr Res Social Dynam & Publ Policy, Dept Policy Anal & Publ Management, Milan, Italy; [Giacobini, Mario] Univ Turin, Dept Vet Sci, Turin, Italy	University of Trento; Fondazione Edmund Mach; Fondazione Bruno Kessler; Bocconi University; University of Turin	Marini, G (corresponding author), Univ Trento, Dept Math, Trento, Italy.; Marini, G (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, TN, Italy.	giovanni.marini@fmach.it	merler, stefano/I-3557-2017; Marini, Giovanni/C-3808-2018; Rosa, Roberto/B-8562-2011; Pugliese, Andrea/E-1905-2011; Rosà, Roberto/AAB-4479-2021	merler, stefano/0000-0002-5117-0611; Marini, Giovanni/0000-0001-9721-7211; Rosa, Roberto/0000-0002-8655-2230; Pugliese, Andrea/0000-0002-3512-8560; Rosà, Roberto/0000-0002-8655-2230; Poletti, Piero/0000-0001-5453-5199	Regione Piemonte; Autonomous Province of Trento (Italy) [319292-S116-2013]; Project LExEM (Laboratory of excellence for epidemiology and modelling)	Regione Piemonte(Regione Piemonte); Autonomous Province of Trento (Italy)(Autonomous Province of Trento); Project LExEM (Laboratory of excellence for epidemiology and modelling)	The field work was supported by Regione Piemonte, according the regional law 75/95. This work was funded by the Autonomous Province of Trento (Italy), Research funds for Grandi Progetti (Prot. n. 319292-S116-2013), Project LExEM (Laboratory of excellence for epidemiology and modelling, http://www.lexem.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifin SMN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-424; Arpa Piemonte, 2015, DAT AMB; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Bisanzio D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-230; Bolker B, 2008, ECOLOGICAL MODELS DA; Cailly P, 2012, ECOL MODEL, V227, P7, DOI 10.1016/j.ecolmodel.2011.10.027; Calistri P, 2010, ZOONOSES PUBLIC HLTH, V57, P211, DOI 10.1111/j.1863-2378.2009.01303.x; Centers for Disease Control and Prevention, 2015, FIN MAPS DAT 1999 20; Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011; Ciota AT, 2014, J MED ENTOMOL, V51, P55, DOI 10.1603/ME13003; Colborn JM, 2013, J AM MOSQUITO CONTR, V29, P123, DOI 10.2987/13-6326r.1; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; EIRAYAH E, 1983, ENTOMOL EXP APPL, V33, P349, DOI 10.1111/j.1570-7458.1983.tb03281.x; Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 EM V; Faraj C., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P119; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Gaibani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064761; Gilks W.R., 1996, MARKOV CHAIN MONTE C; Gong HF, 2011, INT J BIOMETEOROL, V55, P435, DOI 10.1007/s00484-010-0354-9; Kilpatrick AM, 2013, AM J EPIDEMIOL, V178, P829, DOI 10.1093/aje/kwt046; Loetti V., 2011, Journal of Natural History, V45, P2203, DOI 10.1080/00222933.2011.590946; Loncaric Z, 2013, THEOR POPUL BIOL, V83, P82, DOI 10.1016/j.tpb.2012.08.002; Lundstrom JO, 2001, J MED ENTOMOL, V38, P289, DOI 10.1603/0022-2585-38.2.289; Monaco F, 2010, ZOONOSES PUBLIC HLTH, V57, P476, DOI 10.1111/j.1863-2378.2009.01245.x; Morin CW, 2010, INT J BIOMETEOROL, V54, P517, DOI 10.1007/s00484-010-0349-6; Mulatti P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-26; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Pawelek KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108452; Pecorari M, 2009, EUROSURVEILLANCE, V14, P15; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Reisen WK, 2008, J MED ENTOMOL, V45, P494, DOI 10.1603/0022-2585(2008)45[494:PWNVTA]2.0.CO;2; Rizzoli A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0831-4; Rosa R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-269; Simpson JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007861; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SPIELMAN A, 1973, ANN ENTOMOL SOC AM, V66, P905, DOI 10.1093/aesa/66.4.905; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Turell MJ, 2014, J AM MOSQUITO CONTR, V30, P253, DOI 10.2987/14-6441R.1; United States Naval Meteorology and Oceanography Command, 2015, NAV OC PORT DAT SERV; Vinogradova EB, 2011, ENTMOL REV, V91, P729; Yamana TK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-235; Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1	46	26	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154018	10.1371/journal.pone.0154018	http://dx.doi.org/10.1371/journal.pone.0154018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105065	Green Published, gold, Green Submitted			2022-12-26	WOS:000374565100034
J	Wang, JR; Carrillo, JJ; Lin, HV				Wang, Jingru; Carrillo, Juan J.; Lin, Hua V.			GPR142 Agonists Stimulate Glucose-Dependent Insulin Secretion via Gq-Dependent Signaling	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CELLS; SYSTEM	GPR142 is an islet-enriched G protein-coupled receptor that has been investigated as a novel therapeutic target for the treatment of type 2 diabetes by virtue of its insulin secretagogue activity. However, the signaling pathways downstream of GPR142 and whether its stimulation of insulin release is glucose-dependent remain poorly characterized. In this study, we show that both native and synthetic GPR142 agonists can activate Gq as well as Gi signaling when GPR142 is recombinantly expressed in HEK293 cells. However, in primary pancreatic islets, a native cellular system, the insulin secretagogue activity of GPR142 agonists only requires Gq activation. In addition, our results show that stimulation of insulin secretion by GPR142 in pancreatic islets is strictly glucose-dependent.	[Wang, Jingru; Lin, Hua V.] Eli Lilly & Co, LCRDC, Shanghai, Peoples R China; [Carrillo, Juan J.] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly	Lin, HV (corresponding author), Eli Lilly & Co, LCRDC, Shanghai, Peoples R China.	lin_hua@lilly.com		Lin, Hua/0000-0001-5001-5567	Eli Lilly Co.	Eli Lilly Co.(Eli Lilly)	All authors are employees of Eli Lilly & Co. Eli Lilly & Co. provided support in the form of salaries for authors (JW, JJC, HVL) and funding for research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each author are articulated in the 'author contributions' section.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Bandholtz S, 2015, DIABETES S1, V64, pA341; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Campbell JE, 2016, NAT MED, V22, P84, DOI 10.1038/nm.3997; Cryer PE, 2014, DIABETES, V63, P2188, DOI 10.2337/db14-0059; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Eishingdrelo Haifeng, 2013, Curr Chem Genom Transl Med, V7, P9, DOI 10.2174/2213988501307010009; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; Farrell SR, 2014, CHANNELS, V8, P519, DOI 10.4161/19336950.2014.967623; Inamdar V, 2015, PLATELETS, V26, P771, DOI 10.3109/09537104.2014.998993; Jacobson KA, 2015, MOL PHARMACOL, V88, P220, DOI 10.1124/mol.114.095711; Kenakin T, 1997, TRENDS PHARMACOL SCI, V18, P456, DOI 10.1016/S0165-6147(97)90683-0; Koyama H, 2016, ENDOCRINOLOGY, V157, P692, DOI 10.1210/en.2015-1784; Lizarzaburu M, 2012, BIOORG MED CHEM LETT, V22, P5942, DOI 10.1016/j.bmcl.2012.07.063; Matsuo A, 2005, BIOCHEM BIOPH RES CO, V331, P363, DOI 10.1016/j.bbrc.2005.03.174; Ogawa Y., 2008, International patent, Patent No. [WO 2008/045484 A1, 2008045484]; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Toda N, 2013, ACS MED CHEM LETT, V4, P790, DOI 10.1021/ml400186z; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yang SK, 2007, AM J PHYSIOL-ENDOC M, V292, pE1863, DOI 10.1152/ajpendo.00047.2007; Zhang XY, 2015, P NATL ACAD SCI USA, V112, P13651, DOI 10.1073/pnas.1518540112	25	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154452	10.1371/journal.pone.0154452	http://dx.doi.org/10.1371/journal.pone.0154452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104960	Green Submitted, Green Published, gold			2022-12-26	WOS:000374565100078
J	Kitaoka, K; Kawata, S; Yoshida, T; Kadoriku, F; Kitamura, M				Kitaoka, Kazuyoshi; Kawata, Shiyori; Yoshida, Tomohiro; Kadoriku, Fumiya; Kitamura, Mitsuo			Exposure to an Extremely-Low-Frequency Magnetic Field Stimulates Adrenal Steroidogenesis via Inhibition of Phosphodiesterase Activity in a Mouse Adrenal Cell Line	PLOS ONE			English	Article							ELECTROMAGNETIC-FIELD; INTENSITY; PATHWAYS; CAMP	Extremely low-frequency magnetic fields (ELF-MFs) are generated by power lines and household electrical devices. In the last several decades, some evidence has shown an association between ELF-MF exposure and depression and/or anxiety in epidemiological and animal studies. The mechanism underlying ELF-MF-induced depression is considered to involve adrenal steroidogenesis, which is triggered by ELF-MF exposure. However, how ELF-MFs stimulate adrenal steroidogenesis is controversial. In the current study, we investigated the effect of ELF-MF exposure on the mouse adrenal cortex-derived Y-1 cell line and the human adrenal cortex-derived H295R cell line to clarify whether the ELF-MF stimulates adrenal steroidogenesis directly. ELF-MF exposure was found to significantly stimulate adrenal steroidogenesis (p < 0.01-0.05) and the expression of adrenal steroid synthetic enzymes (p < 0.05) in Y-1 cells, but the effect was weak in H295R cells. Y-1 cells exposed to an ELF-MF showed significant decreases in phosphodiesterase activity (p < 0.05) and intracellular Ca2+ concentration (p < 0.01) and significant increases in intracellular cyclic adenosine monophosphate (cAMP) concentration (p < 0.001-0.05) and cAMP response element-binding protein phosphorylation (p < 0.05). The increase in cAMP was not inhibited by treatment with NF449, an inhibitor of the Gs alpha subunit of G protein. Our results suggest that ELF-MF exposure stimulates adrenal steroidogenesis via an increase in intracellular cAMP caused by the inhibition of phosphodiesterase activity in Y-1 cells. The same mechanism may trigger the increase in adrenal steroid secretion in mice observed in our previous study.	[Kitaoka, Kazuyoshi] Univ Tokushima, Inst Liberal Arts & Sci, Tokushima 770, Japan; [Kawata, Shiyori; Yoshida, Tomohiro; Kadoriku, Fumiya] Univ Tokushima, Student Lab, Fac Med, Tokushima 770, Japan; [Kitamura, Mitsuo] Univ Tokushima, Grad Sch, Inst Biomed Sci, Support Ctr Adv Med Sci, Tokushima 770, Japan	Tokushima University; Tokushima University; Tokushima University	Kitaoka, K (corresponding author), Univ Tokushima, Inst Liberal Arts & Sci, Tokushima 770, Japan.	kitaoka@tokushima-u.ac.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI Grant [25870475]	JSPS (Japan Society for the Promotion of Science) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by 25870475 JSPS (Japan Society for the Promotion of Science) KAKENHI Grant (https://www.jsps.go.jp/j-grantsinaid/).	Afework M, 1999, CELL TISSUE RES, V298, P449, DOI 10.1007/s004419900103; Martinez MA, 2012, CELL PHYSIOL BIOCHEM, V29, P675, DOI 10.1159/000178457; Chen CC, 2000, LIFE SCI, V67, P2045, DOI 10.1016/S0024-3205(00)00790-6; Chen L, 2015, EUR UROL, V68, P674, DOI 10.1016/j.eururo.2015.03.031; Cook CM, 2006, BIOELECTROMAGNETICS, V27, P613, DOI 10.1002/bem.20247; Di Lazzaro V, 2013, BRAIN STIMUL, V6, P469, DOI 10.1016/j.brs.2013.01.004; Fan WX, 2015, INT J CLIN EXP MED, V8, P7394; Gallo-Payet N, 2014, COMPR PHYSIOL, V4, P889, DOI 10.1002/cphy.c130050; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Goodman R, 2009, INT J RADIAT BIOL, V85, P851, DOI [10.3109/09553000903072488, 10.1080/09553000903072488]; Nguyen H, 2014, REV CARDIOVASC MED, V15, P158, DOI 10.3909/ricm0679; Hulsmann M, 2003, EUR J PHARMACOL, V470, P1, DOI 10.1016/S0014-2999(03)01761-8; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Kaneda T, 1997, JPN J PHARMACOL, V75, P77, DOI 10.1254/jjp.75.77; Kitaoka K, 2013, NEUROPHARMACOLOGY, V72, P58, DOI 10.1016/j.neuropharm.2013.04.009; Kitaoka K, 2013, BIOELECTROMAGNETICS, V34, P43, DOI 10.1002/bem.21743; Liu TT, 2008, NEUROSCI LETT, V434, P12, DOI 10.1016/j.neulet.2008.01.019; Mattsson MO, 2012, TOXICOLOGY, V301, P1, DOI 10.1016/j.tox.2012.06.011; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Mostafa RM, 2002, PHYSIOL BEHAV, V76, P589, DOI 10.1016/S0031-9384(02)00730-8; Okamoto M, 2005, BIOCHEM BIOPH RES CO, V338, P325, DOI 10.1016/j.bbrc.2005.07.187; POOLE C, 1993, AM J EPIDEMIOL, V137, P318, DOI 10.1093/oxfordjournals.aje.a116679; Razavi Shahnaz, 2014, Adv Biomed Res, V3, P25, DOI 10.4103/2277-9175.124668; Soda A, 2008, J MED INVESTIG, V55, P267, DOI 10.2152/jmi.55.267; Spiga F, 2011, J NEUROENDOCRINOL, V23, P136, DOI 10.1111/j.1365-2826.2010.02096.x; Szemerszky R, 2010, BRAIN RES BULL, V81, P92, DOI 10.1016/j.brainresbull.2009.10.015; Tsai LCL, 2012, HORM METAB RES, V44, P790, DOI 10.1055/s-0032-1321861; Tsai LCL, 2011, CURR OPIN PHARMACOL, V11, P670, DOI 10.1016/j.coph.2011.09.003; Tsai LCL, 2011, MOL PHARMACOL, V79, P639, DOI 10.1124/mol.110.069104; WILSON BW, 1988, BIOELECTROMAGNETICS, V9, P195, DOI 10.1002/bem.2250090211	30	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154167	10.1371/journal.pone.0154167	http://dx.doi.org/10.1371/journal.pone.0154167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100201	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500159
J	Kugino, K; Tamaru, S; Hisatomi, Y; Sakaguchi, T				Kugino, Kenji; Tamaru, Shizuka; Hisatomi, Yuko; Sakaguchi, Tadashi			Long-Duration Carbon Dioxide Anesthesia of Fish Using Ultra Fine (Nano-Scale) Bubbles	PLOS ONE			English	Article							TRANSPORTATION; CARP	Introduction: We investigated whether adding ultrafine (nano-scale) oxygen-carrying bubbles to water concurrently with dissolved carbon-dioxide (CO2) could result in safe, long-duration anesthesia for fish. Results: To confirm the lethal effects of CO2 alone, fishes were anesthetized with dissolved CO2 in 20 degrees C seawater. Within 30 minutes, all fishes, regardless of species, died suddenly due to CO2-induced narcosis, even when the water was saturated with oxygen. Death was attributed to respiration failure caused by hypoxemia. When ultrafine oxygen-carrying bubbles were supplied along with dissolved CO2, five chicken grunts were able to remain anesthetized for 22 hours and awoke normally within 2-3 hours after cessation of anesthesia. Conclusions: The high internal pressures and oxygen levels of the ultrafine bubbles enabled efficient oxygen diffusion across the branchia and permitted the organismal oxygen demands of individual anesthetized fish to be met. Thus, we demonstrated a method for safe, long-duration carbon dioxide anesthesia in living fish under normal water temperatures.	[Kugino, Kenji; Tamaru, Shizuka] Nagasaki Univ, Grad Sch Human Hlth Sci, Div Nutrit Sci, Nagasaki 8512195, Japan; [Hisatomi, Yuko] Nishikyushu Univ, Dept Hlth & Nutr Sci, Fac Hlth & Social Welf Sci, Saga 8420015, Japan; [Sakaguchi, Tadashi] Marine Biotechnol Inc, Inst Marine Sci & Technol, Fukuoka 8113501, Japan	Nagasaki University	Tamaru, S (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, Div Nutrit Sci, Nagasaki 8512195, Japan.	tamaru@sun.ac.jp			Institute of Marine Sciences and Technologies, Marine Biotechnology Inc.	Institute of Marine Sciences and Technologies, Marine Biotechnology Inc.	The authors received no specific funding for this paper. The Institute of Marine Sciences and Technologies, Marine Biotechnology Inc. provided support in the form of laboratory facilities for this for study. TS was employed by the Institute of Marine Sciences and Technologies, Marine Biotechnology Inc. at the time this research was conducted but participated in this study using holiday time.	Blessing JJ, 2010, J FISH BIOL, V76, P2571, DOI 10.1111/j.1095-8649.2010.02633.x; CHALON J, 1983, ACTA ANAESTH SCAND, V27, P361, DOI 10.1111/j.1399-6576.1983.tb01968.x; Chen K, 2014, ZEBRAFISH, V11, P71, DOI 10.1089/zeb.2012.0858; Collymore C, 2014, J AM ASSOC LAB ANIM, V53, P198; Gomes L. C., 2006, Braz. J. Biol., V66, P493, DOI 10.1590/S1519-69842006000300015; Grottum JA, 1996, COMP BIOCHEM PHYS A, V115, P323, DOI 10.1016/S0300-9629(96)00100-4; Kugino K, 2014, International Applications under the Patent Cooperation Treaty Patent, Patent No. [PCT/JP2014/053673, 2014053673]; Laplace P. S., 1805, TRAITE MECH CELESTE, V10, P349; Mi HB, 2012, FISH PHYSIOL BIOCHEM, V38, P1721, DOI 10.1007/s10695-012-9669-2; MITSUDA H, 1982, J NUTR SCI VITAMINOL, V28, P35, DOI 10.3177/jnsv.28.35; Mitsuda H, 1991, JPN J FREEZING DRYIN, V37, P54; Stokes G.G., 1845, T CAMBRIDGE PHILOS S, V8, P287; TAKEDA T, 1983, B JPN SOC SCI FISH, V49, P725; Talley L., 2006, OCEANOGR, V19, P32, DOI [10.5670/oceanog.2006.42, DOI 10.5670/OCEANOG.2006.42]; Watanabe K., 2006, AQUACULTURE SCI, V54, P255, DOI [10.11233/aquaculturesci1953.54.255, DOI 10.11233/AQUACULTURESCI1953.54.255]; Watanabe K, 2007, NIPPON SUISAN GAKK, V73, P287, DOI 10.2331/suisan.73.287; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]	17	13	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153542	10.1371/journal.pone.0153542	http://dx.doi.org/10.1371/journal.pone.0153542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100285	gold, Green Submitted, Green Published			2022-12-26	WOS:000374898500040
J	Liu, BJ; Zhang, BD; Xue, DX; Gao, TX; Liu, JX				Liu, Bing-Jian; Zhang, Bai-Dong; Xue, Dong-Xiu; Gao, Tian-Xiang; Liu, Jin-Xian			Population Structure and Adaptive Divergence in a High Gene Flow Marine Fish: The Small Yellow Croaker (Larimichthys polyactis)	PLOS ONE			English	Article							DEMOGRAPHIC HISTORY; LOCAL SELECTION; DIVERSITY; SOFTWARE; SEA; DIFFERENTIATION; ADAPTATION; MICROSATELLITES; CONSERVATION; CONNECTIVITY	The spatial distribution of genetic diversity has been long considered as a key component of policy development for management and conservation of marine fishes. However, unraveling the population genetic structure of migratory fish species is challenging due to high potential for gene flow. Despite the shallow population differentiation revealed by putatively neutral loci, the higher genetic differentiation with panels of putatively adaptive loci could provide greater resolution for stock identification. Here, patterns of population differentiation of small yellow croaker (Larimichthys polyactis) were investigated by genotyping 15 highly polymorphic microsatellites in 337 individuals of 15 geographic populations collected from both spawning and overwintering grounds. Outlier analyses indicated that the locus Lpol03 might be under directional selection, which showed a strong homology with Grid2 gene encoding the glutamate receptor delta 2 protein (GluR delta 2). Based on Lpol03, two distinct clusters were identified by both STRUCTURE and PCoA analyses, suggesting that there were two overwintering aggregations of L. polyactis. A novel migration pattern was suggested for L. polyactis, which was inconsistent with results of previous studies based on historical fishing yield statistics. These results provided new perspectives on the population genetic structure and migratory routes of L. polyactis, which could have significant implications for sustainable management and utilization of this important fishery resource.	[Liu, Bing-Jian; Zhang, Bai-Dong; Xue, Dong-Xiu; Liu, Jin-Xian] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Shandong, Peoples R China; [Liu, Bing-Jian; Zhang, Bai-Dong; Xue, Dong-Xiu; Liu, Jin-Xian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Liu, Bing-Jian; Zhang, Bai-Dong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Tian-Xiang] Zhejiang Ocean Univ, Sch Fisheries, Zhoushan, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang Ocean University	Liu, JX (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Shandong, Peoples R China.; Liu, JX (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	jinxianliu@gmail.com	Zhang, Baidong/AAA-9633-2022		Joint Project of the National Natural Science Foundation of China and Shandong Province: Marine Ecology and Environmental Sciences [U1406403]; National Natural Science Foundation of China [30471329]; 100 Talents Program of the Chinese Academy of Sciences; Strategic Priority Research Program of Chinese Academy of Sciences [XDA11020704]	Joint Project of the National Natural Science Foundation of China and Shandong Province: Marine Ecology and Environmental Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by the Joint Project of the National Natural Science Foundation of China and Shandong Province: Marine Ecology and Environmental Sciences (U1406403) to JXL, the National Natural Science Foundation of China (No. 30471329) to TXG, and 100 Talents Program of the Chinese Academy of Sciences to JXL; and the Strategic Priority Research Program of Chinese Academy of Sciences (No. XDA11020704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HS, 2013, MOL BIOL REP, V40, P3445, DOI 10.1007/s11033-012-2044-7; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Banks MA, 1999, J HERED, V90, P281, DOI 10.1093/jhered/90.2.281; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bekkevold D, 2005, EVOLUTION, V59, P2656; Chu YT, 1963, MONOGRAPHS FISHES CH, p[i, 1]; Cunningham KM, 2009, CAN J FISH AQUAT SCI, V66, P153, DOI 10.1139/F08-199; DeFaveri J, 2013, EVOLUTION, V67, P2530, DOI 10.1111/evo.12097; [丁峰元 DING Fengyuan], 2007, [自然资源学报, Journal of Natural Resources], V22, P1013; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Florin AB, 2010, FISH RES, V102, P207, DOI 10.1016/j.fishres.2009.12.002; Fourcade Y, 2013, MOL ECOL, V22, P2065, DOI 10.1111/mec.12158; Froese R, 2003, GLOBAL CAPTURE PRODU; Gagnaire PA, 2012, GENETICS, V190, P725, DOI 10.1534/genetics.111.134825; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Galindo HM, 2010, MOL ECOL, V19, P3692, DOI 10.1111/j.1365-294X.2010.04694.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Han ZQ, 2009, AFR J AGR RES, V4, P605; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jin XS, 2004, ESTUAR COAST SHELF S, V59, P163, DOI 10.1016/j.ecss.2003.08.005; Karlsson S, 2005, ICES J MAR SCI, V62, P1588, DOI 10.1016/j.icesjms.2005.05.009; Kim JK, 2010, ANIM CELLS SYST, V14, P45, DOI 10.1080/19768351003764973; Kim MJ, 2010, FISHERIES SCI, V76, P595, DOI 10.1007/s12562-010-0249-z; KIMURA M, 1964, GENETICS, V49, P725; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamichhaney S, 2012, P NATL ACAD SCI USA, V109, P19345, DOI 10.1073/pnas.1216128109; Larmuseau MHD, 2009, MOL ECOL, V18, P4227, DOI 10.1111/j.1365-294X.2009.04331.x; [李建生 LI Jian-sheng], 2009, [中国水产科学, Journal of Fishery Sciences of China], V16, P348; [李峣 LI Yao], 2007, [海洋水产研究, Marine Fisheries Research], V28, P104; Li Y, 2013, BIOCHEM SYST ECOL, V50, P331, DOI 10.1016/j.bse.2013.05.003; Lie HJ, 2001, J GEOPHYS RES-OCEANS, V106, P22199, DOI 10.1029/2000JC000629; Lin LS, 2009, AFR J BIOTECHNOL, V8, P2700; Lin Long-shan, 2008, Marine Fisheries, V30, P126; [林龙山 Lin Longshan], 2004, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V34, P565; Liu BJ, 2014, CONSERV GENET RESOUR, V6, P397, DOI 10.1007/s12686-013-0102-7; Liu JX, 2006, MOL PHYLOGENET EVOL, V39, P799, DOI 10.1016/j.ympev.2006.01.009; Liu JX, 2011, MAR BIOL, V158, P893, DOI 10.1007/s00227-010-1616-0; Liu QA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000097; Liu X., 1962, RES SMALL YELLOW CRO, P35; Marchant S, 2009, AQUAC RES, V40, P298, DOI 10.1111/j.1365-2109.2008.02089.x; Meng Zi-Ning, 2003, Shengwu Duoyangxing, V11, P197; Mikami Y, 2004, BIOCHEM BIOPH RES CO, V322, P168, DOI 10.1016/j.bbrc.2004.07.095; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nielsen EE, 2004, MOL ECOL, V13, P585, DOI 10.1046/j.1365-294X.2004.02097.x; Park SDE, 2001, THESIS; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard J. K., 2009, DOCUMENTATION STRUCT, P1; Pujolar JM, 2014, MOL ECOL, V23, P2514, DOI 10.1111/mec.12753; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Russello MA, 2012, EVOL APPL, V5, P39, DOI 10.1111/j.1752-4571.2011.00206.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shepherd TD, 2004, FISH FISH, V5, P141, DOI 10.1111/j.1467-2979.2004.00143.x; Shikano T, 2010, MOL ECOL, V19, P1147, DOI 10.1111/j.1365-294X.2010.04553.x; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Strasburg JL, 2009, MOL BIOL EVOL, V26, P1341, DOI 10.1093/molbev/msp043; Tang Yan-Cheng, 2000, Acta Botanica Yunnanica, V22, P1; Teacher AGF, 2013, EVOL APPL, V6, P549, DOI 10.1111/eva.12042; Turner TL, 2010, MOL ECOL, V19, P848, DOI 10.1111/j.1365-294X.2010.04532.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandamme SG, 2014, MOL ECOL, V23, P618, DOI 10.1111/mec.12628; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wang L, 2015, FISH RES, V161, P86, DOI 10.1016/j.fishres.2014.06.006; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083493; Was A, 2008, ICES J MAR SCI, V65, P216, DOI 10.1093/icesjms/fsm187; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Xiao YS, 2015, MITOCHONDR DNA, V26, P409, DOI 10.3109/19401736.2013.843076; Xiao YS, 2009, ENVIRON BIOL FISH, V85, P303, DOI 10.1007/s10641-009-9497-0; Xu Zhao-li, 2010, Yingyong Shengtai Xuebao, V21, P2856; [徐兆礼 XU Zhao-li], 2009, [中国水产科学, Journal of Fishery Sciences of China], V16, P931; [于非 YU Fei], 2006, [海洋学报, Acta Oceanologica Sinica], V28, P26	79	16	17	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154020	10.1371/journal.pone.0154020	http://dx.doi.org/10.1371/journal.pone.0154020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100462	Green Submitted, gold, Green Published			2022-12-26	WOS:000374898500125
J	Liu, LL; Cheng, JH; Liu, YH; Sheng, JD				Liu, Lili; Cheng, Junhui; Liu, Yunhua; Sheng, Jiandong			Relationship of Productivity to Species Richness in the Xinjiang Temperate Grassland	PLOS ONE			English	Article							BETA DIVERSITY; ECOSYSTEM STABILITY; BIODIVERSITY; PRECIPITATION; VARIABILITY; COEXISTENCE; RESOURCE	The relationship between species richness (SR) and above ground net primary productivity (ANPP) is still a central and debated issue in community ecology. Previous studies have often emphasized the relationship of alpha diversity (number of species identity) to the mean ANPP with respect to the SR-ANPP relationship while neglecting the contribution of beta diversity (dissimilarity in species composition) to the mean ANPP and to the stability of ANPP (coefficient of ANPP: CV of ANPP). In this study, we used alpha and beta diversity, mean ANPP and the CV of ANPP collected from 159 sites and belonging to three vegetation types in the Xinjiang temperate grassland to first examine their trends along climatic factors and among different vegetation types and then test the relationship among alpha (beta) diversity and mean ANPP and the CV of ANPP. Our results showed that in the Xinjiang temperate grasslands, alpha diversity was positively and linearly correlated with MAP but unimodally correlated with MAT. Meanwhile, beta diversity was unimodally correlated with MAP but linearly correlated with MAT. Relative to desert steppe, meadow steppe and typical steppe had the highest alpha and beta diversity, respectively. Except for ANPP exhibiting a quadratic relationship with MAP, no significant relationship was found among ANPP, the CV of ANPP and climatic factors. ANPP and the CV of ANPP also exhibited no apparent patterns in variation among different vegetation types. Our results further showed that mean ANPP was closely associated with alpha diversity. Both linear and unimodal relationships were detected between alpha diversity and mean ANPP, but their particular form was texture-dependent. Meanwhile, the CV of ANPP was positively correlated with beta diversity. Our results indicated that in addition to incorporating alpha diversity and mean ANPP, incorporating beta diversity and the CV of ANPP could expand our understanding of the SR-ANPP relationship.	[Liu, Lili; Cheng, Junhui; Liu, Yunhua; Sheng, Jiandong] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Soil & Plant Ecol Proc, Urumqi, Peoples R China	Xinjiang Agricultural University	Sheng, JD (corresponding author), Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Soil & Plant Ecol Proc, Urumqi, Peoples R China.	sjd_2004@126.com			Strategic Priority Research Program of Chinese Academy of Sciences [XDA05050405]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was financially supported by Strategic Priority Research Program of Chinese Academy of Sciences (XDA05050405). JD S received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson TM, 2004, OECOLOGIA, V139, P277, DOI 10.1007/s00442-004-1499-1; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Department of Animal Husbandry of Xinjiang Uygur Autonomous Region, 1993, RES ULT XINJ GRASSL; Fan Lian-Lian, 2012, Chinese Journal of Plant Ecology, V36, P126, DOI 10.3724/SP.J.1258.2012.00126; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Grime J. P., 2001, PLANT STRATEGIES VEG; Gross KL, 2000, OIKOS, V89, P417, DOI 10.1034/j.1600-0706.2000.890301.x; Guo QF, 1998, ECOLOGY, V79, P2555, DOI 10.1890/0012-9658(1998)079[2555:SRABDO]2.0.CO;2; Harrison S, 2006, J ECOL, V94, P110, DOI 10.1111/j.1365-2745.2005.01078.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; [胡列群 Hu Liequn], 2013, [冰川冻土, Journal of Glaciology and Geocryology], V35, P793; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; Johnson KH, 1996, TRENDS ECOL EVOL, V11, P372, DOI 10.1016/0169-5347(96)10040-9; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Li JF, 1991, CLIMATE IN XINJIANG; Li LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066450; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Ninyerola M, 2000, INT J CLIMATOL, V20, P1823, DOI 10.1002/1097-0088(20001130)20:14<1823::AID-JOC566>3.0.CO;2-B; R Development Core Team, 2012, R LANG ENV STAT COMP; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Trumbore S, 2009, ANNU REV EARTH PL SC, V37, P47, DOI 10.1146/annurev.earth.36.031207.124300; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5799; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x	36	5	6	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154026	10.1371/journal.pone.0154026	http://dx.doi.org/10.1371/journal.pone.0154026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100676	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500126
J	Marrazzo, P; Maccari, S; Taddei, A; Bevan, L; Telford, J; Soriani, M; Pezzicoli, A				Marrazzo, Pasquale; Maccari, Silvia; Taddei, Annarita; Bevan, Luke; Telford, John; Soriani, Marco; Pezzicoli, Alfredo			3D Reconstruction of the Human Airway Mucosa In Vitro as an Experimental Model to Study NTHi Infections	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; MESENCHYMAL STEM-CELLS; RESPIRATORY-TRACT; EPITHELIAL-CELLS; REGENERATION; TISSUE; MECHANISMS; COCULTURE; EXPLANTS; DISEASE	We have established an in vitro 3D system which recapitulates the human tracheo-bronchial mucosa comprehensive of the pseudostratified epithelium and the underlying stromal tissue. In particular, we reported that the mature model, entirely constituted of primary cells of human origin, develops key markers proper of the native tissue such as the mucociliary differentiation of the epithelial sheet and the formation of the basement membrane. The infection of the pseudo-tissue with a strain of NonTypeable Haemophilus influenzae results in bacteria association and crossing of the mucus layer leading to an apparent targeting of the stromal space where they release large amounts of vesicles and form macro-structures. In summary, we propose our in vitro model as a reliable and potentially customizable system to study mid/long term host-pathogen processes.	[Marrazzo, Pasquale; Maccari, Silvia; Telford, John; Soriani, Marco; Pezzicoli, Alfredo] GSK Vaccines Srl, Via Fiorentina 1, I-53100 Siena, Italy; [Taddei, Annarita] Univ Tuscia, Interdept Ctr Electron Microscopy, Viterbo, Italy; [Bevan, Luke] Novartis Inst BioMed Res, Resp Dis Area, Horsham RH12 5AB, W Sussex, England	GlaxoSmithKline; Tuscia University; Novartis	Soriani, M; Pezzicoli, A (corresponding author), GSK Vaccines Srl, Via Fiorentina 1, I-53100 Siena, Italy.	marco.x.soriani@gsk.com; alfredo.x.pezzicoli@gsk.com	Marrazzo, Pasquale/G-9857-2016; Telford, John Laird/ABG-8144-2020	Marrazzo, Pasquale/0000-0001-6644-5828; SORIANI, Marco/0000-0002-9752-5844	GSK Vaccines	GSK Vaccines	This work was supported by internal funding from GSK Vaccines. The funder provided support in the form of salaries for authors PM, SM, JT, MS and AP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Akram KM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-9; Anh TNH, 2012, AM J PHYSIOL-LUNG C, V302, pL226, DOI 10.1152/ajplung.00059.2011; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Bandi V, 2001, AM J RESP CRIT CARE, V164, P2114, DOI 10.1164/ajrccm.164.11.2104093; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Bouhout S., 2014, PRODUCTION TISSUE EN; Brand-Saberi BEM, 2014, THORAC SURG CLIN, V24, P1, DOI 10.1016/j.thorsurg.2013.09.004; Choe MM, 2006, NAT PROTOC, V1, P357, DOI 10.1038/nprot.2006.54; Clementi CF, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00001; De Chiara M, 2014, P NATL ACAD SCI USA, V111, P5439, DOI 10.1073/pnas.1403353111; Dromann D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-67; Duell BL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852419; ECAY TW, 1992, EXP CELL RES, V203, P32, DOI 10.1016/0014-4827(92)90036-8; FORSGREN J, 1994, INFECT IMMUN, V62, P673, DOI 10.1128/IAI.62.2.673-679.1994; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Harrington H, 2014, MOL PHARMACEUT, V11, P2082, DOI 10.1021/mp5000295; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07; Kobayashi K, 2006, TISSUE ENG, V12, P2619, DOI 10.1089/ten.2006.12.2619; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Le Visage C, 2004, TISSUE ENG, V10, P1426, DOI 10.1089/ten.2004.10.1426; Liu YY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00342; Mazzoleni G, 2009, GENES NUTR, V4, P13, DOI 10.1007/s12263-008-0107-0; Moller LVM, 1998, AM J RESP CRIT CARE, V157, P950; Nistico L, 2011, J CLIN MICROBIOL, V49, P1411, DOI 10.1128/JCM.00756-10; Pageau SC, 2011, BIOMATERIALS, V32, P7169, DOI 10.1016/j.biomaterials.2011.06.017; Paquette JS, 2003, IN VITRO CELL DEV-AN, V39, P213; Pohl C, 2009, EUR J PHARM BIOPHARM, V72, P339, DOI 10.1016/j.ejpb.2008.07.012; Power PM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-273; Ren DB, 2012, EXP BIOL MED, V237, P540, DOI 10.1258/ebm.2012.011377; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rothen-Rutishauser BM, 2005, AM J RESP CELL MOL, V32, P281, DOI 10.1165/rcmb.2004-0187OC; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11; Steinke M, 2014, BIOMATERIALS, V35, P7355, DOI 10.1016/j.biomaterials.2014.05.031; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Van Eldere J, 2014, LANCET INFECT DIS, V14, P1281, DOI 10.1016/S1473-3099(14)70734-0; van Schilfgaarde M, 1999, MICROB PATHOGENESIS, V26, P249, DOI 10.1006/mpat.1998.0269; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045	40	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153985	10.1371/journal.pone.0153985	http://dx.doi.org/10.1371/journal.pone.0153985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101006	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500117
J	Munoz, R; Borobia, AM; Quintana, M; Martinez, A; Ramirez, E; Munoz, M; Frias, J; Carcas, AJ				Munoz, Ral; Borobia, Alberto M.; Quintana, Manuel; Martinez, Ana; Ramirez, Elena; Munoz, Mario; Frias, Jesus; Carcas, Antonio J.			Outcomes and Costs of Poisoned Patients Admitted to an Adult Emergency Department of a Spanish Tertiary Hospital: Evaluation through a Toxicovigilance Program	PLOS ONE			English	Article							TRENDS; REPETITION; MORTALITY; STAY	The Abstract Toxicovigilance is the active process of identifying and evaluating the toxic risks existing in a community, and evaluating the measures taken to reduce or eliminate them. Objective Through a validated toxicovigilance program (SAT-HULP) we examined the characteristics of acute poisoning cases (APC) attended in the Emergency Department (ED) of La Paz Hospital (Madrid, Spain) and assessed their economic impact on the health system. Material and Methods The active poisoning surveillance system performs a daily search for cases in the hospital's computerized case records. Found cases are entered into a database for recording of type of poisoning episode, reasons for exposure, causative agent, signs and symptoms and treatment. We carried out a cross-sectional epidemiological study with analytical projection, based on an impact study on cost per survivor. The data for the costs attributable to cases of APC observed at HULP (outpatients and inpatients) was obtained from the based on the information provided by the diagnosis-related groups (DRG) through the corresponding hospital discharge reports (available through SAT-HULP). Results During the first 30 month of SAT-HULP operation we found a total of 3,195 APC, a cumulative incidence rate of 1.75% of patients attended in the ED. The mean (SD) patient age was 40.9 (17.8) years and 51.2% were men. Drug abuse accounted for 47.5% of the cases. Suicide attempt was the second most frequent category (38.1%) and other causes accounted for 14.5% of APC. The total cost of hospital care for our hospital rose to (sic)1,825,263.24 (approximately (sic)730,105.30/year) resulting in a permanent occupation of 4 beds/year. Conclusions SAT-HULP constitutes a validated toxicovigilance tool, which continuously integrates available data in real-time and helps health services manage APC data flexibly, including the consumption of resources from the health system.	[Munoz, Ral; Borobia, Alberto M.; Ramirez, Elena; Munoz, Mario; Frias, Jesus; Carcas, Antonio J.] Univ Autonoma Madrid, Clin Pharmacol Deparment, Hosp Univ La Paz, IdiPaz,Sch Med, Madrid, Spain; [Borobia, Alberto M.; Quintana, Manuel; Martinez, Ana] Univ Autonoma Madrid, Dept Accid & Emergency, Hosp Univ La Paz, Crit Care Dept,Sch Med,IdiPaz, Madrid, Spain; [Munoz, Ral; Borobia, Alberto M.; Quintana, Manuel; Martinez, Ana; Munoz, Mario; Frias, Jesus; Carcas, Antonio J.] Hosp Univ La Paz, Clin Toxicol Unit, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario La Paz	Munoz, R; Carcas, AJ (corresponding author), Univ Autonoma Madrid, Clin Pharmacol Deparment, Hosp Univ La Paz, IdiPaz,Sch Med, Madrid, Spain.; Munoz, R; Carcas, AJ (corresponding author), Hosp Univ La Paz, Clin Toxicol Unit, Madrid, Spain.	rmunozromo@gmail.com; antonio.carcas@uam.es	Ramírez, Elena/S-5600-2018; Quintana-Díaz, Manuel/M-2313-2017; Quintana-Diaz, Manuel/AAE-2265-2022; Ramírez, Elena/AGX-8858-2022; Carcas, Antonio J/E-1149-2012; Borobia, Alberto M./H-6887-2013	Ramírez, Elena/0000-0002-4052-8876; Quintana-Díaz, Manuel/0000-0003-4852-4148; Quintana-Diaz, Manuel/0000-0003-4852-4148; Ramírez, Elena/0000-0002-4052-8876; Carcas, Antonio J/0000-0003-1823-4174; Borobia, Alberto M./0000-0002-8584-3263				Abad-Santos F, 2000, THER DRUG MONIT, V22, P163, DOI 10.1097/00007691-200004000-00004; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 2009, INF AN 2009; [Anonymous], 2009, B OFICIAL COMUNIDAD, V215, P15; Barrientos R, 1996, REV CALIDAD ASISTENC, V11, P37; Barrientos R, 2003, MED INTENSIVA, V27, P391; Buehler W, 2004, MMWR-MORBID MORTAL W, V53, P1; Putze GB, 2008, EMERGENCIAS, V20, P15; Camidge DR, 2003, BRIT J CLIN PHARMACO, V56, P613, DOI 10.1046/j.1365-2125.2003.01910.x; Carlsten A, 1996, ACTA PSYCHIAT SCAND, V94, P94, DOI 10.1111/j.1600-0447.1996.tb09831.x; Ferrer A, 2000, MED CLIN-BARCELONA, V115, P238, DOI 10.1016/S0025-7753(00)71518-1; Friedman LS, 2014, CLIN TOXICOL, V52, P198, DOI 10.3109/15563650.2014.892125; Andres MCG, 2011, EMERGENCIAS, V23, P193; Hawton K, 1997, DRUG ALCOHOL REV, V16, P123, DOI 10.1080/09595239700186411; Heyerdahl F, 2009, BRIT J PSYCHIAT, V194, P73, DOI 10.1192/bjp.bp.107.048322; Hoyt BT, 1999, ACAD EMERG MED, V6, P851, DOI 10.1111/j.1553-2712.1999.tb01220.x; Hu YH, 2010, J CHIN MED ASSOC, V73, P78, DOI 10.1016/S1726-4901(10)70006-X; Johnsson E, 1997, ACTA PSYCHIAT SCAND, V96, P362, DOI 10.1111/j.1600-0447.1997.tb09930.x; Kapur N, 1999, BRIT J GEN PRACT, V49, P733; Kapur N, 1998, BRIT MED J, V316, P831, DOI 10.1136/bmj.316.7134.831; Krajewski AK, 2015, CLIN TOXICOL, V53, P433, DOI 10.3109/15563650.2015.1030677; Librero J, 1999, J CLIN EPIDEMIOL, V52, P171, DOI 10.1016/S0895-4356(98)00160-7; Liisanantti JH, 2011, J CRIT CARE, V26, P160, DOI 10.1016/j.jcrc.2010.08.009; Litovitz T, 1998, DRUG SAFETY, V18, P9, DOI 10.2165/00002018-199818010-00002; McKenzie MS, 2007, PHARMACOEPIDEM DR S, V16, P513, DOI 10.1002/pds.1355; Moran JL, 2008, CRIT CARE MED, V36, P46, DOI 10.1097/01.CCM.0000295313.08084.58; Munoz R, 2013, EMERGENCIAS, V25, P423; Okumura Y, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001857; Okumura Y, 2012, GEN HOSP PSYCHIAT, V34, P681, DOI 10.1016/j.genhosppsych.2012.07.009; Prescott K, 2009, BRIT J CLIN PHARMACO, V68, P260, DOI 10.1111/j.1365-2125.2009.03458.x; Rafnsson SB, 2007, HUM EXP TOXICOL, V26, P49, DOI 10.1177/0960327107071855; Ruse M, 2000, ANN EMERG MED, V35, P512, DOI 10.1016/S0196-0644(00)70016-3; Satar S, 2005, ADV THER, V22, P137, DOI 10.1007/BF02849884; Strassels SA, 2009, J MANAGE CARE PHARM, V15, P556, DOI 10.18553/jmcp.2009.15.7.556; Townsend E, 2001, SOC PSYCH PSYCH EPID, V36, P228, DOI 10.1007/s001270170053; Watson AW, 2005, TOXICOL APPL PHARM, V207, pS604; Watson WA, 2005, AM J EMERG MED, V23, P589, DOI 10.1016/j.ajem.2005.05.001; White AM, 2011, J STUD ALCOHOL DRUGS, V72, P774, DOI 10.15288/jsad.2011.72.774; World Health Organisation, 2011, POIS PREV MAN 2011; Wu AHB, 2010, CLIN PHARMACOL THER, V88, P295, DOI 10.1038/clpt.2010.45; Yang ChM, 2006, HEALTH SERV RES, V125, P1	41	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152876	10.1371/journal.pone.0152876	http://dx.doi.org/10.1371/journal.pone.0152876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100460	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500017
J	Suwarnalata, G; Tan, AH; Isa, H; Gudimella, R; Anwar, A; Loke, MF; Mahadeva, S; Lim, SY; Vadivelu, J				Suwarnalata, Gunasekaran; Tan, Ai Huey; Isa, Hidayah; Gudimella, Ranganath; Anwar, Arif; Loke, Mun Fai; Mahadeva, Sanjiv; Lim, Shen-Yang; Vadivelu, Jamuna			Augmentation of Autoantibodies by Helicobacter pylori in Parkinson's Disease Patients May Be Linked to Greater Severity	PLOS ONE			English	Article							IDIOPATHIC PARKINSONISM; GROWTH-FACTOR; DOPAMINERGIC-NEURONS; GASTROINTESTINAL-TRACT; INFECTION; GASTRITIS; RAT; ERADICATION; PROTEIN; BRAIN	Parkinson's disease (PD) is the second most common chronic and progressive neuro-degenerative disorder. Its etiology remains elusive and at present only symptomatic treatments exists. Helicobacter pylori chronically colonizes the gastric mucosa of more than half of the global human population. Interestingly, H. pylori positivity has been found to be associated with greater of PD motor severity. In order to investigate the underlying cause of this association, the Sengenics Immunome protein array, which enables simultaneous screening for autoantibodies against 1636 human proteins, was used to screen the serum of 30 H. pylori-seropositive PD patients (case) and 30 age-and gender-matched H. pylori-seronegative PD patients (control) in this study. In total, 13 significant autoantibodies were identified and ranked, with 8 up-regulated and 5 down-regulated in the case group. Among autoantibodies found to be elevated in H. pylori-seropositive PD were included antibodies that recognize Nuclear factor I subtype A (NFIA), Platelet-derived growth factor B (PDGFB) and Eukaryotic translation initiation factor 4A3 (eIFA3). The presence of elevated autoantibodies against proteins essential for normal neurological functions suggest that immunomodulatory properties of H. pylori may explain the association between H. pylori positivity and greater PD motor severity.	[Suwarnalata, Gunasekaran; Isa, Hidayah; Loke, Mun Fai; Vadivelu, Jamuna] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Tan, Ai Huey; Lim, Shen-Yang] Univ Malaya, Div Neurol, Kuala Lumpur, Malaysia; [Tan, Ai Huey; Lim, Shen-Yang] Univ Malaya, Mah Pooi Soo & Tan Chin Nam Ctr Parkinsons & Rela, Kuala Lumpur, Malaysia; [Gudimella, Ranganath; Anwar, Arif] Univ Malaya, Sengen Sdn Bhd, Kuala Lumpur, Malaysia; [Mahadeva, Sanjiv] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Loke, Mun Fai/B-1060-2011; Lim, Shen-Yang/E-5099-2010; Tan, Ai Huey/G-5264-2016; Mahadeva, Sanjiv/E-1711-2011; VADIVELU, JAMUNARANI S/B-8696-2010	Loke, Mun Fai/0000-0002-3554-5313; Mahadeva, Sanjiv/0000-0001-5824-0590; VADIVELU, JAMUNARANI S/0000-0001-7322-3676	University of Malaya-Ministry of Education (UM-MoE) High Impact Research (HIR) Grant [UM.C/625/1/HIR/MOE/CHAN/13/4, H-50001-00-A000029]	University of Malaya-Ministry of Education (UM-MoE) High Impact Research (HIR) Grant	This study was supported by the University of Malaya-Ministry of Education (UM-MoE) High Impact Research (HIR) Grant UM.C/625/1/HIR/MOE/CHAN/13/4 (Account No. H-50001-00-A000029). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arai H, 2006, HISTOL HISTOPATHOL, V21, P673, DOI 10.14670/HH-21.673; Ayada K, 2009, LUPUS, V18, P1154, DOI 10.1177/0961203309106600; Barker-Haliski ML, 2012, NEUROSCIENCE, V226, P51, DOI 10.1016/j.neuroscience.2012.09.003; Baudron CR, 2013, HELICOBACTER, V18, P44, DOI 10.1111/hel.12077; Bauer B., 2011, ULCERS, V2011, DOI [DOI 10.1155/2011/340157, 10.1155/2011/340157]; Boutell JM, 2004, PROTEOMICS, V4, P1950, DOI 10.1002/pmic.200300722; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Cersosimo MG, 2008, MOVEMENT DISORD, V23, P1065, DOI 10.1002/mds.22051; Contreras M, 2008, AM J TROP MED HYG, V78, P574, DOI 10.4269/ajtmh.2008.78.574; Deretzi G, 2011, CURR MOL MED, V11, P696, DOI 10.2174/156652411797536660; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Dobbs RJ, 2008, HELICOBACTER, V13, P309, DOI 10.1111/j.1523-5378.2008.00622.x; Dobbs RJ, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-12; Dobbs RJ, 2012, NEURODEGENER DIS, V10, P183, DOI 10.1159/000332807; Dobbs SM, 2000, MED HYPOTHESES, V55, P93, DOI 10.1054/mehy.2000.1110; Dobbs SM, 2016, J NEUROVIROL, V22, P22, DOI 10.1007/s13365-015-0357-8; Dobbs SM, 2013, HELICOBACTER, V18, P187, DOI 10.1111/hel.12035; Dobbs SM, 2010, HELICOBACTER, V15, P279, DOI 10.1111/j.1523-5378.2010.00768.x; Everhart JE, 2002, CLIN DIAGN LAB IMMUN, V9, P412, DOI 10.1128/CDLI.9.2.412-416.2002; Funa K, 1996, NEUROSCIENCE, V74, P825, DOI 10.1016/0306-4522(96)00152-2; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Liu B, 2003, ENVIRON HEALTH PERSP, V111, P1065, DOI 10.1289/ehp.6361; NEGRINI R, 1993, EUR J GASTROEN HEPAT, V5, pS27; NEGRINI R, 1992, SCAND J GASTROENTERO, V27, P599, DOI 10.3109/00365529209000125; NEGRINI R, 1991, GASTROENTEROLOGY, V101, P437, DOI 10.1016/0016-5085(91)90023-E; Nielsen HH, 2012, EUR J NEUROL, V19, P864, DOI 10.1111/j.1468-1331.2011.03643.x; NIKKHAH G, 1993, EXP BRAIN RES, V92, P516; OTHBERG A, 1995, EXP BRAIN RES, V105, P111; Paul G, 2015, J CLIN INVEST, V125, P1339, DOI 10.1172/JCI79635; Peleteiro B, 2014, DIGEST DIS SCI, V59, P1698, DOI 10.1007/s10620-014-3063-0; Pierantozzi M, 2006, NEUROLOGY, V66, P1824, DOI 10.1212/01.wnl.0000221672.01272.ba; Pietz K, 1996, NEUROSCI LETT, V204, P101, DOI 10.1016/0304-3940(96)12326-0; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Ram M, 2013, CLIN CHEM LAB MED, V51, P1075, DOI 10.1515/cclm-2012-0477; Rees K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008535.pub2; Robinson WH, 2003, PROTEOMICS, V3, P2077, DOI 10.1002/pmic.200300583; Romero-Gallo J, 2002, CLIN DIAGN LAB IMMUN, V9, P1313, DOI 10.1128/CDLI.9.6.1313-1317.2002; Sakagami T, 1996, GUT, V39, P639, DOI 10.1136/gut.39.5.639; Solari N, 2013, LEARN MEMORY, V20, P592, DOI 10.1101/lm.032029.113; STRANG R R, 1965, Med J Aust, V1, P842; STRANG RR, 1966, ACTA NEUROL SCAND, V42, P124, DOI 10.1111/j.1600-0404.1966.tb05991.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Supajatura V, 2002, J IMMUNOL, V168, P2603, DOI 10.4049/jimmunol.168.6.2603; Takahashi T, 2004, BRIT J HAEMATOL, V124, P91, DOI 10.1046/j.1365-2141.2003.04735.x; Tan AH, 2015, PARKINSONISM RELAT D, V21, P221, DOI 10.1016/j.parkreldis.2014.12.009; Toh BH, 2014, AUTOIMMUN REV, V13, P459, DOI 10.1016/j.autrev.2014.01.048; Weller C, 2005, HELICOBACTER, V10, P288, DOI 10.1111/j.1523-5378.2005.00329.x; Zachrisson O, 2011, J PARKINSON DIS, V1, P49, DOI 10.3233/JPD-2011-0003; Zheng S, 2010, J CLIN INVEST, V120, P2446, DOI 10.1172/JCI33144	49	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153725	10.1371/journal.pone.0153725	http://dx.doi.org/10.1371/journal.pone.0153725			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100827	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500055
J	Zhang, YP; Li, J; Song, S; Tardif, T; Burmeister, M; Villafuerte, SM; Su, MM; McBride, C; Shu, H				Zhang, Yuping; Li, Jun; Song, Shuang; Tardif, Twila; Burmeister, Margit; Villafuerte, Sandra M.; Su, Mengmeng; McBride, Catherine; Shu, Hua			Association of DCDC2 Polymorphisms with Normal Variations in Reading Abilities in a Chinese Population	PLOS ONE			English	Article							DYSLEXIA SUSCEPTIBILITY GENE; DEVELOPMENTAL DYSLEXIA; ENVIRONMENTAL-INFLUENCES; PHONOLOGICAL SKILLS; KIAA0319; CHILDREN; LINKAGE; DISABILITIES; AWARENESS; LANGUAGE	The doublecortin domain-containing 2 (DCDC2) gene, which is located on chromosome 6p22.1, has been widely suggested to be a candidate gene for dyslexia, but its role in typical reading development over time remains to be clarified. In the present study, we explored the role of DCDC2 in contributing to the individual differences in reading development from ages 6 to 11 years by analysing data from 284 unrelated children who were participating in the Chinese Longitudinal Study of Reading Development (CLSRD). The associations of eight single nucleotide polymorphisms (SNPs) in DCDC2 with the latent intercept and slope of children's reading scores were examined in the first step. There was significant support for an association of rs807724 with the intercept for the reading comprehension measure of reading fluency, and the minor "G" allele was associated with poor reading performance. Next, we further tested the rs807724 SNP in association with the reading ability at each tested time and revealed that, in addition to significant associations with the two main reading measures (reading fluency and Chinese character reading) over multiple testing occasions, this SNP also showed associations with reading-related cognitive skills, including morphological production, orthographic judgment and phonological processing skills (rapid number naming, phoneme deletion, and tone detection). This study provides support for DCDC2 as a risk gene for reading disability and suggests that this gene is also operative for typical reading development in the Han population.	[Zhang, Yuping] Chengdu Med Coll, Dept Psychol, Chengdu, Peoples R China; [Zhang, Yuping] Chengdu Med Coll, ResearchCtr Appl Psychol Sichuan, Chengdu, Peoples R China; [Zhang, Yuping; Li, Jun; Song, Shuang; Su, Mengmeng; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Tardif, Twila] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Burmeister, Margit; Villafuerte, Sandra M.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Burmeister, Margit; Villafuerte, Sandra M.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Burmeister, Margit] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [McBride, Catherine] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Shu, Hua] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China	Chengdu Medical College; Chengdu Medical College; Beijing Normal University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese University of Hong Kong; Beijing Normal University; Beijing Normal University	Zhang, YP (corresponding author), Chengdu Med Coll, Dept Psychol, Chengdu, Peoples R China.; Zhang, YP (corresponding author), Chengdu Med Coll, ResearchCtr Appl Psychol Sichuan, Chengdu, Peoples R China.; Zhang, YP; Shu, H (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.; Shu, H (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.; Shu, H (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China.	michelle1368@126.com; shuh@bnu.edu.cn		Tardif, Twila Z/0000-0001-8739-9090	National Key Basic Research Program of China [2014CB846103]; Major Project of Philosophy and Social Science Foundation by Ministry of Education [11JZD041]; National Natural Science Foundation of China [31271082, 31500910, 81461130018]; National Institute of Child Health and Human Development [P01 HD001994]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning [CNLZD1202]; Humanities and Social Science Project of Sichuan Educational Committee [CSXL-131001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD001994] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); Major Project of Philosophy and Social Science Foundation by Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; Humanities and Social Science Project of Sichuan Educational Committee; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by National Key Basic Research Program of China (2014CB846103), by Major Project of Philosophy and Social Science Foundation by Ministry of Education (11JZD041), by the National Natural Science Foundation of China (31271082, 31500910, 81461130018), by the National Institute of Child Health and Human Development (P01 HD001994) to Haskins Laboratories, and by a grant from the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (CNLZD1202), as well as CSXL-131001 from the Humanities and Social Science Project of Sichuan Educational Committee.	Anthoni H, 2007, HUM MOL GENET, V16, P667, DOI 10.1093/hmg/ddm009; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Chow BW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047872, DOI 10.1371/JOURNAL.PONE.0047872]; Christopher ME, 2013, SCI STUD READ, V17, P350, DOI 10.1080/10888438.2012.729119; Christopher ME, 2013, J EXP CHILD PSYCHOL, V115, P453, DOI 10.1016/j.jecp.2013.03.008; Chun D., 2015, J 2 LANG PRONUNCIATI, V1, P86, DOI [10.1075/jslp.1.1.04chu, DOI 10.1075/JSLP.1.1.04CHU]; Couto JM, 2010, AM J MED GENET B, V153B, P447, DOI 10.1002/ajmg.b.30999; Deffenbacher KE, 2004, HUM GENET, V115, P128, DOI 10.1007/s00439-004-1126-6; Duncan T, 2006, INTRO LATENT VARIABL; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; Harold D, 2006, MOL PSYCHIATR, V11, P1085, DOI 10.1038/sj.mp.4001904; Ho CSH, 1997, DEV PSYCHOL, V33, P946, DOI 10.1037/0012-1649.33.6.946; Ho CSH, 2004, COGNITION, V91, P43, DOI 10.1016/S0010-0277(03)00163-X; Kere J, 2011, WIRES COGN SCI, V2, P441, DOI 10.1002/wcs.138; Lei L, 2011, J CHILD PSYCHOL PSYC, V52, P212, DOI 10.1111/j.1469-7610.2010.02311.x; Leong CK, 2008, READ WRIT, V21, P559, DOI 10.1007/s11145-007-9113-7; Li H, 2012, J RES READ, V35, P287, DOI 10.1111/j.1467-9817.2010.01460.x; Lind PA, 2010, EUR J HUM GENET, V18, P668, DOI 10.1038/ejhg.2009.237; Logan JAR, 2013, CHILD DEV, V84, P2131, DOI 10.1111/cdev.12104; Ludwig KU, 2008, J NEURAL TRANSM, V115, P1587, DOI 10.1007/s00702-008-0124-6; Marino C, 2011, BEHAV GENET, V41, P67, DOI 10.1007/s10519-010-9412-7; McBride-Chang Catherine., 2005, READ WRIT, V18, P99, DOI [10.1007/s11145-004-7343-5, DOI 10.1007/S11145-004-7343-5]; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Moll K, 2009, SCI STUD READ, V13, P1, DOI 10.1080/10888430802631684; Muthen L.K., MPLUS USERS GUIDE, V8th; Newbury DF, 2011, BEHAV GENET, V41, P90, DOI 10.1007/s10519-010-9424-3; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Paracchini S, 2008, AM J PSYCHIAT, V165, P1576, DOI 10.1176/appi.ajp.2008.07121872; Petrill SA, 2007, READ WRIT, V20, P127, DOI 10.1007/s11145-006-9021-2; Petrill SA, 2010, J CHILD PSYCHOL PSYC, V51, P660, DOI 10.1111/j.1469-7610.2009.02204.x; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scerri TS, 2011, BIOL PSYCHIAT, V70, P237, DOI 10.1016/j.biopsych.2011.02.005; Schumacher J, 2006, AM J HUM GENET, V78, P52, DOI 10.1086/498992; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Shu H, 2003, CHILD DEV, V74, P27, DOI 10.1111/1467-8624.00519; Shu H, 2008, DEVELOPMENTAL SCI, V11, P171, DOI 10.1111/j.1467-7687.2007.00654.x; Sun YM, 2014, AM J MED GENET B, V165, P627, DOI 10.1002/ajmg.b.32267; Wilcke A, 2009, ANN DYSLEXIA, V59, P1, DOI 10.1007/s11881-008-0020-7; Wolf M., 2002, READING WRITING INTE, V15, P43, DOI [10.1023/A:1013816320290, DOI 10.1023/A:1013816320290]; Ziegler JC, 2010, PSYCHOL SCI, V21, P551, DOI 10.1177/0956797610363406	44	11	12	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153603	10.1371/journal.pone.0153603	http://dx.doi.org/10.1371/journal.pone.0153603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100778	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500043
J	Salas-Gismondi, R; Flynn, JJ; Baby, P; Tejada-Lara, JV; Claude, J; Antoine, PO				Salas-Gismondi, Rodolfo; Flynn, John J.; Baby, Patrice; Tejada-Lara, Julia V.; Claude, Julien; Antoine, Pierre-Olivier			A New 13 Million Year Old Gavialoid Crocodylian from Proto-Amazonian Mega-Wetlands Reveals Parallel Evolutionary Trends in Skull Shape Linked to Longirostry	PLOS ONE			English	Article							MIOCENE; PALEOCENE; BASIN; CONNECTIONS; DIVERSITY; OLIGOCENE; GHARIAL; URUMACO	Gavialoid crocodylians are the archetypal longirostrine archosaurs and, as such, understanding their patterns of evolution is fundamental to recognizing cranial rearrangements and reconstructing adaptive pathways associated with elongation of the rostrum (longirostry). The living Indian gharial Gavialis gangeticus is the sole survivor of the group, thus providing unique evidence on the distinctive biology of its fossil kin. Yet phylogenetic relationships and evolutionary ecology spanning similar to 70 million-years of longirostrine crocodylian diversification remain unclear. Analysis of cranial anatomy of a new proto-Amazonian gavialoid, Gryposuchus pachakamue sp. nov., from the Miocene lakes and swamps of the Pebas Mega-Wetland System reveals that acquisition of both widely separated and protruding eyes (telescoped orbits) and riverine ecology within South American and Indian gavialoids is the result of parallel evolution. Phylogenetic and morphometric analyses show that, in association with longirostry, circumorbital bone configuration can evolve rapidly for coping with trends in environmental conditions and may reflect shifts in feeding strategy. Our results support a long-term radiation of the South American forms, with taxa occupying either extreme of the gavialoid morphospace showing preferences for coastal marine versus fluvial environments. The early biogeographic history of South American gavialoids was strongly linked to the northward drainage system connecting proto-Amazonian wetlands to the Caribbean region.	[Salas-Gismondi, Rodolfo; Claude, Julien; Antoine, Pierre-Olivier] Univ Montpellier, Inst Sci eVOLUT, CNRS, IRD,EPHE, F-34095 Montpellier, France; [Salas-Gismondi, Rodolfo; Tejada-Lara, Julia V.] Univ Nacl Mayor San Marcos, Dept Paleontol Vertebrados, Museo Hist Nat, Ave Arenales 1256, Lima 14, Peru; [Flynn, John J.; Tejada-Lara, Julia V.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Baby, Patrice] Univ Toulouse, Geoscie Environm Toulouse, UPS SVT OMP, CNRS,IRD, 14 Ave Edouard Belin, F-31400 Toulouse, France; [Baby, Patrice] Convenio IRD PeruPetro, Ave Luis Aldana 320, Lima, Peru; [Tejada-Lara, Julia V.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universidad Nacional Mayor de San Marcos; American Museum of Natural History (AMNH); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Columbia University	Salas-Gismondi, R (corresponding author), Univ Montpellier, Inst Sci eVOLUT, CNRS, IRD,EPHE, F-34095 Montpellier, France.; Salas-Gismondi, R (corresponding author), Univ Nacl Mayor San Marcos, Dept Paleontol Vertebrados, Museo Hist Nat, Ave Arenales 1256, Lima 14, Peru.	rodolfo.salas-gismondi@univ-montp2.fr	Baby, Patrice/D-2936-2009; Baby, Patrice/AAL-6640-2021; claude, julien/G-7411-2016	Baby, Patrice/0000-0001-6142-5174; Baby, Patrice/0000-0001-6142-5174; claude, julien/0000-0002-9267-1228; Salas-Gismondi, Rodolfo/0000-0001-9990-8841	Frick Fund, Division of Paleontology, American Museum of Natural History; Escuela Doctoral Franco-Peruana en Ciencias de la Vida; Frick Fund (American Museum of Natural History)	Frick Fund, Division of Paleontology, American Museum of Natural History; Escuela Doctoral Franco-Peruana en Ciencias de la Vida; Frick Fund (American Museum of Natural History)	The study was financially supported by the Frick Fund, Division of Paleontology, American Museum of Natural History. RS-G benefitted from a Doctoral grant of the Escuela Doctoral Franco-Peruana en Ciencias de la Vida, and from financial support of the Frick Fund (American Museum of Natural History) and the Projects-Sud of the ISEM for visiting collections, Institut de Recherche pour le Developpement, and from CampusFrance.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Aguilera O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076202; Blakey RC, 2008, GEOL SOC AM SPEC PAP, V441, P1, DOI 10.1130/2008.2441(01); Bocquentin Villanueva J., 1981, Geobios (Villeurbanne), V14, P415; Boonstra M, 2015, PALAEOGEOGR PALAEOCL, V417, P176, DOI 10.1016/j.palaeo.2014.10.032; Brochu CA, 2004, J VERTEBR PALEONTOL, V24, P610, DOI 10.1671/0272-4634(2004)024[0610:ANLCGC]2.0.CO;2; Brochu CA, 2006, J PALEONTOL, V80, P162, DOI 10.1666/0022-3360(2006)080[0162:OAPSOE]2.0.CO;2; Brochu CA, 2004, SPEC PAP PALAEONTOL, P61; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brochu CA, 2011, ZOOL J LINN SOC-LOND, V163, pS228, DOI 10.1111/j.1096-3642.2011.00716.x; Buffetaut E, 1982, GEOBIOS MEMOIRE SPEC, V15, P127, DOI DOI 10.1016/S0016-6995(82)80107-1; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; Claude J, 2008, MORPHOMETRICS R; Cozzuol MA, 2006, J S AM EARTH SCI, V21, P185, DOI 10.1016/j.jsames.2006.03.005; Gasparini Z, 1968, AMEGHINIANA, V8, P299; Gatesy J, 2003, SYST BIOL, V52, P403, DOI 10.1080/10635150390197037; Gingras MK, 2002, J SEDIMENT RES, V72, P871, DOI 10.1306/052002720871; Gmelin J., 1789, LINNEI SYSTEMA NATUR; Goloboff P, 2008, CLADISTICS, V24, P91; Gurich GJE, 1912, JB HAMBURG WISE ANAT, VXXIX, P59; Harshman J, 2003, SYST BIOL, V52, P386, DOI 10.1080/10635150390197028; Hass CA, 1992, MOL PHYLOGENET EVOL, V1, P193, DOI 10.1016/1055-7903(92)90015-9; Hay O.P., 1930, CARNEGIE I WASHINGTO, V390, P1; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V112, P187, DOI 10.1016/0031-0182(94)90074-4; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P123; Hovikoski J, 2001, THESIS U TURKU FINLA; Hua S, 2004, J VERTEBR PALEONTOL, V24, P341, DOI 10.1671/1104; Huxley T.H., 1875, Q J GEOLOGICAL SOC, V41, P423, DOI DOI 10.1144/GSL.JGS.1875.031.01-04.29; Jouve S, 2008, J VERTEBR PALEONTOL, V28, P409, DOI 10.1671/0272-4634(2008)28[409:TOACPP]2.0.CO;2; Jouve S, 2006, GEOBIOS-LYON, V39, P817, DOI 10.1016/j.geobios.2005.07.003; KALIN JOSEF ALOIS, 1933, ZOOL JAHRB ABT ANAT U ONT, V57, P535; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kraus R., 1998, PALAONTOLOGISCHE Z, V72, P389, DOI DOI 10.1007/BF02988368; Langston W., 1965, U CALIFORNIA PUBLICA, V52, P1; Langston Wann Jr., 1997, P113; Lovejoy NR, 1998, NATURE, V396, P421, DOI 10.1038/24757; Lundberg John G., 1998, P13; Martin JE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5658; Martin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044541; Mook CC, 1921, B AM MUS NAT HIST, V44, P51; Moraes-Santos H, 2011, ZOOL J LINN SOC-LOND, V163, pS132, DOI 10.1111/j.1096-3642.2011.00710.x; Moreno F, 2015, SWISS J PALAEONTOL, V134, P5, DOI 10.1007/s13358-015-0071-4; Munoz-Torres FA, 2006, J S AM EARTH SCI, V21, P75, DOI 10.1016/j.jsames.2005.08.005; NORELL MA, 1989, J HERPETOL, V23, P325, DOI 10.2307/1564042; Nuttall C.P., 1990, Bulletin of the British Museum (Natural History) Geology, V45, P165; Oaks JR, 2011, EVOLUTION, V65, P3285, DOI 10.1111/j.1558-5646.2011.01373.x; Quiroz L, 2010, URUMACO VENEZUELAN P, P153; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rebata LA, 2006, J S AM EARTH SCI, V21, P116, DOI [10.10116/ jsames.2005.07.011, DOI 10.10116/JSAMES.2005.07]; Riff D, 2008, PALAEONTOL Z, V82, P178, DOI 10.1007/BF02988408; Roddaz M, 2005, TECTONOPHYSICS, V399, P87, DOI 10.1016/j.tecto.2004.12.017; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Salas-Gismondi R., 2007, Cuadernos del Museo Geominero, V8, P355; Salas-Gismondi R, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2490; Sanchez-Villagra MR, 2006, J SYST PALAEONTOL, V4, P213, DOI 10.1017/S1477201906001829; Scheyer TM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2940; SILL W D, 1970, Ameghiniana, V7, P151; Tejada-Lara JV, 2015, PALAEONTOLOGY, V58, P341, DOI 10.1111/pala.12147; THORBJARNARSON JB, 1990, J HERPETOL, V24, P99, DOI 10.2307/1564301; Vargas-Llosa M, 1987, EL HABLADOR; Velez-Juarbe J, 2007, P ROY SOC B-BIOL SCI, V274, P1245, DOI 10.1098/rspb.2006.0455; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P291; Wesselingh FP, 2006, J S AM EARTH SCI, V21, P49, DOI 10.1016/j.jsames.2005.07.013; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35; Whitaker R., 1983, J BOMBAY NAT HIST SO, V79, P531; Wilberg EW, 2015, SYST BIOL, V64, P621, DOI 10.1093/sysbio/syv020	69	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152453	10.1371/journal.pone.0152453	http://dx.doi.org/10.1371/journal.pone.0152453			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097031	Green Published, Green Accepted, gold			2022-12-26	WOS:000374543600011
J	Cheng, J; Su, XO; Yao, Y; Han, CQ; Wang, S; Zhao, YP				Cheng, Jie; Su, Xiao-Ou; Yao, Yue; Han, Caiqin; Wang, Shi; Zhao, Yiping			Highly Sensitive Detection of Melamine Using a One-Step Sample Treatment Combined with a Portable Ag Nanostructure Array SERS Sensor	PLOS ONE			English	Article							ENHANCED RAMAN-SPECTROSCOPY; NANOPARTICLES; TOXICITY; FORMULA; POWDER; CATS; MILK	There is an urgent need for rapid and reliable methods able to detect melamine in animal feed. In this study, a quick, simple, and sensitive method for the determination of melamine content in animal feed was developed using surface-enhanced Raman spectroscopy on fabricated Ag nanorod (AgNR) array substrates with a one-step sample extraction procedure. The AgNR array substrates washed by HNO3 solvent (10(-7) M) and methanol and showed the good stability within 6 months. The Raman shift at Delta v = 682 cm(-1) was used as the characteristic melamine peak in the calculations. Sufficient linearity was obtained in the 2-200 mu g.g(-1) range (R-2 = 0.926). The limits of detection and quantification were 0.9 and 2 mu g.g(-1), respectively. The recovery rates were 89.7-93.3%, with coefficients of variation below 2.02%. The method showed good accuracy compared with the tradition GC-MS analysis. This new protocol only need 2 min to fininsh the detection which could be developed for rapid onsite screening of melamine contamination in quality control and market surveillance applications.	[Cheng, Jie; Su, Xiao-Ou; Wang, Shi] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China; [Yao, Yue; Han, Caiqin] Jiangsu Normal Univ, Sch Phys & Elect Engn, Nanjing, Jiangsu, Peoples R China; [Zhao, Yiping] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; Jiangsu Normal University; University System of Georgia; University of Georgia	Su, XO (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China.	suxiaoou@caas.cn	Cheng, Jie/ABG-3067-2021; Li, Xiaomin/ABI-2638-2020; Zhao, Yiping/A-4968-2008	Zhao, Yiping/0000-0002-3710-4159	innovation project for the Chinese Academy of Agricultural Sciences; Div Of Chem, Bioeng, Env, & Transp Sys [1064228] Funding Source: National Science Foundation	innovation project for the Chinese Academy of Agricultural Sciences; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the innovation project for the Chinese Academy of Agricultural Sciences (http://www.caas.cn/kjcxgczl/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, BULLET 1372 2007 CHI, P6; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Brown CA, 2007, J VET DIAGN INVEST, V19, P525, DOI 10.1177/104063870701900510; Chen J, 2015, J RAMAN SPECTROSC, V46, P64, DOI 10.1002/jrs.4612; Cheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107770; Dobson RLM, 2008, TOXICOL SCI, V106, P251, DOI 10.1093/toxsci/kfn160; Driskell JD, 2008, J PHYS CHEM C, V112, P895, DOI 10.1021/jp075288u; Du XB, 2010, APPL SPECTROSC, V64, P781, DOI 10.1366/000370210791666426; Eric LR, 2009, PRINCIPLES SURFACE E; Fu JX, 2008, J PHYS CHEM C, V112, P16784, DOI 10.1021/jp802909g; Garber EAE, 2008, J FOOD PROTECT, V71, P590, DOI 10.4315/0362-028X-71.3.590; Han CQ, 2014, TALANTA, V128, P293, DOI 10.1016/j.talanta.2014.04.083; Hau AKC, 2009, J AM SOC NEPHROL, V20, P245, DOI 10.1681/ASN.2008101065; Haughey SA, 2013, FOOD CHEM, V136, P1557, DOI 10.1016/j.foodchem.2012.01.068; Haynes CL, 2005, ANAL CHEM, V77, p338A, DOI 10.1021/ac053456d; Kneipp K, 2002, APPL SPECTROSC, V56, P150, DOI 10.1366/0003702021954557; Lam CW, 2009, CLIN CHIM ACTA, V402, P150, DOI 10.1016/j.cca.2008.12.035; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lin M, 2008, J FOOD SCI, V73, pT129, DOI 10.1111/j.1750-3841.2008.00901.x; Liu YJ, 2010, J PHYS CHEM C, V114, P8176, DOI 10.1021/jp1001644; Mauer LJ, 2009, J AGR FOOD CHEM, V57, P3974, DOI 10.1021/jf900587m; Mecker LC, 2012, ANAL CHIM ACTA, V733, P48, DOI 10.1016/j.aca.2012.05.001; Moskovits M, 2005, J RAMAN SPECTROSC, V36, P485, DOI 10.1002/jrs.1362; Muniz-Valencia R, 2008, ANAL BIOANAL CHEM, V392, P523, DOI 10.1007/s00216-008-2294-3; Negri P, 2011, APPL SPECTROSC, V65, P66, DOI 10.1366/10-06037; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Vivo-Truyols G, 2006, ANAL CHEM, V78, P4598, DOI 10.1021/ac0600196; Wu XM, 2013, ANALYST, V138, P3005, DOI 10.1039/c3an00186e; Wu XM, 2012, ANALYST, V137, P4226, DOI 10.1039/c2an35378d; Xu WG, 2012, P NATL ACAD SCI USA, V109, P9281, DOI 10.1073/pnas.1205478109; Xu XM, 2009, ANAL CHIM ACTA, V650, P39, DOI 10.1016/j.aca.2009.04.026; Xu XW, 2009, BIOSENS BIOELECTRON, V24, P3153, DOI 10.1016/j.bios.2009.03.025; Yazgan NN, 2012, ANAL BIOANAL CHEM, V403, P2009, DOI 10.1007/s00216-012-5971-1; Yin WW, 2010, J AGR FOOD CHEM, V58, P8152, DOI 10.1021/jf1006209	34	18	18	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154402	10.1371/journal.pone.0154402	http://dx.doi.org/10.1371/journal.pone.0154402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120183	Green Published, gold			2022-12-26	WOS:000374976200067
J	Hinder, M; Perdomo, A; Tracy, M				Hinder, Murray; Perdomo, Aldo; Tracy, Mark			Dangerous Pressurization and Inappropriate Alarms during Water Occlusion of the Expiratory Circuit of Commonly Used Infant Ventilators	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; MECHANICAL VENTILATION; PRETERM INFANTS; NASAL CPAP; PERFORMANCE; HUMIDIFIERS; LIMB	Background Non-invasive continuous positive airways pressure is commonly a primary respiratory therapy delivered via multi-purpose ventilators in premature newborns. Expiratory limb occlusion due to water accumulation or 'rainout' from gas humidification is a frequent issue. A case of expiratory limb occlusion due to rainout causing unexpected and excessive repetitive airway pressurisation in a Draeger VN500 prompted a systematic bench test examination of currently available ventilators. Objective To assess neonatal ventilator response to partial or complete expiratory limb occlusion when set to non-invasive continuous positive airway pressure mode. Design Seven commercially available neonatal ventilators connected to a test lung using a standard infant humidifier circuit with partial and/or complete expiratory limb occlusion were examined in a bench test study. Each ventilator was set to deliver 6 cmH(2)O in non-invasive mode and respiratory mechanics data for 75%, 80% and 100% occlusion were collected. Results Several ventilators responded inappropriately with complete occlusion by cyclical pressurisation/depressurisation to peak pressures of between 19.4 and 64.6 cmH(2)O at rates varying between 2 to 77 inflations per minute. Tidal volumes varied between 10.1 and 24.3mL. Alarm responses varied from 'specific' (tube occluded) to 'ambiguous' (Safety valve open). Carefusion Avea responded by continuing to provide the set distending pressure and displaying an appropriate alarm message. Draeger Babylog 8000 did not alarm with partial occlusions and incorrectly displayed airways pressure at 6.1cmH(2)O compared to the measured values of 13cmH(2)O. Conclusions This study found a potential for significant adverse ventilator response due to complete or near complete expiratory limb occlusion in CPAP mode.	[Hinder, Murray; Perdomo, Aldo; Tracy, Mark] Westmead Hosp, Neonatal Intens Care Unit, Sydney, NSW, Australia; [Hinder, Murray] Univ Sydney, Sydney, NSW 2006, Australia; [Tracy, Mark] Univ Sydney, Dept Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Tracy, M (corresponding author), Westmead Hosp, Neonatal Intens Care Unit, Sydney, NSW, Australia.; Tracy, M (corresponding author), Univ Sydney, Dept Paediat & Child Hlth, Sydney, NSW 2006, Australia.	mark.tracy@health.nsw.gov.au		Hinder, Murray/0000-0002-9179-316X; Perdomo, Aldo/0000-0002-4103-5109; Tracy, Mark/0000-0001-5648-468X				Chatburn RL, 2014, RESP CARE, V59, P1747, DOI 10.4187/respcare.03057; Chatburn RL, 2011, RESP CARE, V56, P85, DOI 10.4187/respcare.00967; CHILTON HW, 1979, J PEDIATR-US, V94, P808, DOI 10.1016/S0022-3476(79)80163-8; Claure N, 2007, ARCH DIS CHILD-FETAL, V92, P508, DOI 10.1136/adc.2006.108852; De Paoli AG, 2005, ARCH DIS CHILD-FETAL, V90, pF79, DOI 10.1136/adc.2004.052274; Fisher & Paykel Healthcare, 2012, RT265 INF CIRC KIT P; Fisher & Paykel Healthcare, 2003, WHAT IS OPT CIRC CON; Fisher & Paykel Healthcare, 2005, NEON CIRC SETU 18504; HALL MW, 1983, CRIT CARE MED, V11, P26, DOI 10.1097/00003246-198301000-00008; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; International Organization for Standardization, 2004, 1065112004 ISO; Lellouche F, 2004, AM J RESP CRIT CARE, V170, P1073, DOI 10.1164/rccm.200309-1245OC; Makhoul IR, 2002, ASAIO J, V48, P476, DOI 10.1097/00002480-200209000-00006; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Pillow JJ, 2012, CLIN PERINATOL, V39, P483, DOI 10.1016/j.clp.2012.06.007; Schena E, 2013, PHYSIOL MEAS, V34, P813, DOI 10.1088/0967-3334/34/7/813; Todd DA, 2001, J PAEDIATR CHILD H, V37, P489, DOI 10.1046/j.1440-1754.2001.00750.x; Youngquist TM, 2013, RESP CARE, V58, P1840, DOI 10.4187/respcare.02322	18	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154034	10.1371/journal.pone.0154034	http://dx.doi.org/10.1371/journal.pone.0154034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116224	gold, Green Published, Green Submitted			2022-12-26	WOS:000374973600038
J	Matsuba, R; Imamura, M; Tanaka, Y; Iwata, M; Hirose, H; Kaku, K; Maegawa, H; Watada, H; Tobe, K; Kashiwagi, A; Kawamori, R; Maeda, S				Matsuba, Ren; Imamura, Minako; Tanaka, Yasushi; Iwata, Minoru; Hirose, Hiroshi; Kaku, Kohei; Maegawa, Hiroshi; Watada, Hirotaka; Tobe, Kazuyuki; Kashiwagi, Atsunori; Kawamori, Ryuzo; Maeda, Shiro			Replication Study in a Japanese Population of Six Susceptibility Loci for Type 2 Diabetes Originally Identified by a Transethnic Meta-Analysis of Genome-Wide Association Studies	PLOS ONE			English	Article							GENETIC ARCHITECTURE; RISK LOCI; VARIANTS; HOMEOSTASIS; GLUCOSE; TCF7L2; KCNQ1	Aim We performed a replication study in a Japanese population to evaluate the association between type 2 diabetes and six susceptibility loci (TMEM154, SSR1, FAF1, POU5F1, ARL15, and MPHOSPH9) originally identified by a transethnic meta-analysis of genome-wide association studies (GWAS) in 2014. Methods We genotyped 7,620 Japanese participants (5,817 type 2 diabetes patients and 1,803 controls) for each of the single nucleotide polymorphisms (SNPs) using a multiplex polymerase chain reaction invader assay. The association of each SNP locus with the disease was evaluated using logistic regression analysis. Results Of the six SNPs examined in this study, four (rs6813195 near TMEM154, rs17106184 in FAF1, rs3130501 in POU5F1 and rs4275659 near MPHOSPH9) had the same direction of effect as in the original reports, but two (rs9505118 in SSR1 and rs702634 in ARL15) had the opposite direction of effect. Among these loci, rs3130501 and rs4275659 were nominally associated with type 2 diabetes (rs3130501; p = 0.017, odds ratio [OR] = 1.113, 95% confidence interval [CI] 1.019-1.215, rs4275659; p = 0.012, OR = 1.127, 95% CI 1.026-1.238, adjusted for sex, age and body mass index), but we did not observe a significant association with type 2 diabetes for any of the six evaluated SNP loci in our Japanese population. Conclusions Our results indicate that effects of the six SNP loci identified in the transethnic GWAS meta-analysis are not major among the Japanese, although SNPs in POU5F1 and MPHOSPH9 loci may have some effect on susceptibility to type 2 diabetes in this population.	[Matsuba, Ren; Imamura, Minako; Maeda, Shiro] RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan; [Matsuba, Ren; Tanaka, Yasushi] St Marianna Univ, Sch Med, Div Endocrinol & Metab, Dept Internal Med, Kawasaki, Kanagawa, Japan; [Iwata, Minoru; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 930, Japan; [Iwata, Minoru] Toyama Univ, Hlth Adm Ctr, Toyama 930, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo, Japan; [Kaku, Kohei] Kawasaki Med Sch, Dept Internal Med, Kurashiki, Okayama, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Tokyo, Japan; [Watada, Hirotaka; Kawamori, Ryuzo] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan; [Maeda, Shiro] Univ Ryukyus, Grad Sch Med, Dept Adv Genom & Lab Med, Nishihara, Okinawa 90301, Japan; [Maeda, Shiro] Univ Ryukyus Hosp, Div Clin Lab & Blood Transfus, Nishihara, Okinawa, Japan	RIKEN; Saint Marianna University; University of Toyama; University of Toyama; Keio University; Kawasaki Medical School; Shiga University of Medical Science; Juntendo University; Juntendo University; University of the Ryukyus; University of the Ryukyus	Imamura, M (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan.	minako.imamura@riken.jp	Kashiwagi, Atsunori/H-8712-2019; Hirose, Hiroshi/F-8556-2014	Maegawa, Hiroshi/0000-0002-4611-8149; Watada, Hirotaka/0000-0001-5961-1816; Matsuba, Ren/0000-0001-5041-6344	Novo Nordisk Pharma; Eli Lilly Japan; Sanofi; Dainippon Sumitomo Pharma; Fujifilm; Bayer; Kissei Phamaceutical Co.; Mochida Pharmaceutical Co; MSD; Takeda Pharmaceutical Co; Boehringer Ingelheim; Daiichi Sankyo, Inc; Ono Pharmaceutical Co.; Novartis Pharmaceuticals; Mitsubishi-Tanabe Pharma; AstraZeneca; Kyowa Hokko Kirin Co; Sanwa Kagaku Kenkyusho Co; Kowa Co.; Astellas Pharma Inc.; Pfizer Inc.; Johnson Johnson; Kyowa Hokko Kirin Co.; Bristol-Myers Squibb; Dainippon Sumitomo Pharma.; Teijin Pharma; Mochida Pharmaceutical Co.; Sanwa Kagaku Kenkyusho Co.; Takeda Pharmaceutical Co.; Taisho Toyama Pharmaceutical Co	Novo Nordisk Pharma(Novo Nordisk); Eli Lilly Japan(Eli Lilly); Sanofi; Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Fujifilm; Bayer(Bayer AG); Kissei Phamaceutical Co.(Kissei Pharmaceutical Co LtdInoue Research Award for Young ScientistsMukai Science and Technology Foundation); Mochida Pharmaceutical Co; MSD; Takeda Pharmaceutical Co(Takeda Pharmaceutical Company Ltd); Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo, Inc(Daiichi Sankyo Company Limited); Ono Pharmaceutical Co.; Novartis Pharmaceuticals(Novartis); Mitsubishi-Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); AstraZeneca(AstraZeneca); Kyowa Hokko Kirin Co; Sanwa Kagaku Kenkyusho Co; Kowa Co.; Astellas Pharma Inc.(Astellas Pharmaceuticals); Pfizer Inc.(Pfizer); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Kyowa Hokko Kirin Co.; Bristol-Myers Squibb(Bristol-Myers Squibb); Dainippon Sumitomo Pharma.(Dainippon Sumitomo Pharma Co., Ltd.); Teijin Pharma; Mochida Pharmaceutical Co.; Sanwa Kagaku Kenkyusho Co.; Takeda Pharmaceutical Co.(Takeda Pharmaceutical Company Ltd); Taisho Toyama Pharmaceutical Co	The authors have read the journal's policy and the authors of this manuscript have the following competing interests. HW is a member of advisory panel of Novo Nordisk Pharma, Sanofi, Dainippon Sumitomo Pharma, Mochida Pharmaceutical Co, MSD, Takeda Pharmaceutical Co, Boehringer Ingelheim, Ono Pharmaceutical Co., Novartis Pharmaceuticals, Mitsubishi-Tanabe Pharma, AstraZeneca, Kowa Co. Astellas Pharma Inc., Pfizer Inc., has received lecture fees from Novo Nordisk Pharma, Eli Lilly Japan, Sanofi, Dainippon Sumitomo Pharma, Fujifilm, Bayer, Kissei Phamaceutical Co., Mochida Pharmaceutical Co, MSD, Takeda Pharmaceutical Co, Boehringer Ingelheim, Daiichi Sankyo, Inc, Ono Pharmaceutical Co. Novartis Pharmaceuticals, Boehringer Ingelheim, Mitsubishi-Tanabe Pharma, AstraZeneca, Kyowa Hokko Kirin Co, Sanwa Kagaku Kenkyusho Co, Kowa Co. Astellas Pharma Inc., Pfizer Inc., and received research funds from Johnson & Johnson, Kyowa Hokko Kirin Co., Kissei Phamaceutical Co., Bristol-Myers Squibb, Novo Nordisk Pharma, Astellas Pharma Inc., MSD, Dainippon Sumitomo Pharma., AstraZeneca, Teijin Pharma, Mochida Pharmaceutical Co., Sanofi, Sanwa Kagaku Kenkyusho Co., Boehringer Ingelheim, Pfizer Inc., Novartis Pharmaceuticals, Ono Pharmaceutical Co., Mitsubishi-Tanabe Pharma, Daiichi Sankyo, Inc, Takeda Pharmaceutical Co., Eli Lilly Japan, Taisho Toyama Pharmaceutical Co. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2013, DIABETES ATLAS; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fukuda H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046263; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Imamura M, 2011, DIABETOLOGIA, V54, P3071, DOI 10.1007/s00125-011-2293-3; Imamura M, 2013, J DIABETES INVEST, V4, P168, DOI 10.1111/jdi.12017; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Omori S, 2009, DIABETOLOGIA, V52, P1554, DOI 10.1007/s00125-009-1397-5; Sakai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076317; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154093	10.1371/journal.pone.0154093	http://dx.doi.org/10.1371/journal.pone.0154093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115357	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600043
J	Ramanathan, A; Gusarova, V; Stahl, N; Gurnett-Bander, A; Kyratsous, CA				Ramanathan, Aarti; Gusarova, Viktoria; Stahl, Neil; Gurnett-Bander, Anne; Kyratsous, Christos A.			Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; CARDIOVASCULAR RISK PATIENTS; MONOCLONAL-ANTIBODY; LDL CHOLESTEROL; CELL ENTRY; INHIBITOR ALIROCUMAB; HYPERCHOLESTEROLEMIA; EFFICACY; BINDING; SAFETY	Background Proprotein convertase subtilisin/kexin type 9 (PSCK9) is secreted mainly from the liver and binds to the low-density lipoprotein receptor (LDLR), reducing LDLR availability and thus resulting in an increase in LDL-cholesterol. While the LDLR has been implicated in the cell entry process of the hepatitis C virus (HCV), overexpression of an artificial non-secreted, cell membrane-bound form of PCSK9 has also been shown to reduce surface expression of CD81, a major component of the HCV entry complex, leading to concerns that pharmacological inhibition of PCSK9 may increase susceptibility to HCV infection by increasing either CD81 or LDLR availability. Here, we evaluated effects of PCSK9 and PCSK9 blockade on CD81 levels and HCV entry with a physiologically relevant model using native secreted PCSK9 and a monoclonal antibody to PCSK9, alirocumab. Methods and Results Flow cytometry and Western blotting of human hepatocyte Huh-7 cells showed that, although LDLR levels were reduced when cells were exposed to increasing PCSK9 concentrations, there was no correlation between total or surface CD81 levels and the presence and amount of soluble PCSK9. Moreover, inhibiting PCSK9 with the monoclonal antibody alirocumab did not affect expression levels of CD81. In an in vitro model of HCV entry, addition of soluble PCSK9 or treatment with alirocumab had no effect on the ability of either lentiviral particles bearing the HCV glycoproteins or JFH-1 based cell culture virus to enter hepatocytes. Consistent with these in vitro findings, no differences were observed in hepatic CD81 levels using in vivo mouse models, including Pcsk9(-/-) mice compared with wild-type controls and hyperlipidemic mice homozygous for human Pcsk9 and heterozygous for Ldlr deletion, treated with either alirocumab or isotype control antibody. Conclusion These results suggest that inhibition of PCSK9 with alirocumab has no effect on CD81 and does not result in increased susceptibility to HCV entry.	[Ramanathan, Aarti; Gusarova, Viktoria; Stahl, Neil; Gurnett-Bander, Anne; Kyratsous, Christos A.] Regeneron Pharmaceut Inc, Tarrytown, NY USA; [Ramanathan, Aarti] Drexel Coll Med, Dept Microbiol & Immunol, Philadelphia, PA USA	Regeneron; Drexel University	Kyratsous, CA (corresponding author), Regeneron Pharmaceut Inc, Tarrytown, NY USA.	christos.kyratsous@regeneron.com			Sanofi; Regeneron Pharmaceuticals, Inc.; Regeneron Pharmaceuticals Inc.	Sanofi(Sanofi-Aventis); Regeneron Pharmaceuticals, Inc.(Regeneron); Regeneron Pharmaceuticals Inc.(Regeneron)	This study was funded by Sanofi and Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals Inc. provided support in the form of salaries, stock option and/or stock for authors [ AR, VG, NS, AGB, CAK]. The specific roles of these authors are articulated in the "author contributions" section. Sanofi and Regeneron Pharmaceuticals, Inc. funded materials for conduct of the study, and were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch Birke, 2009, V510, P279, DOI 10.1007/978-1-59745-394-3_21; Bays H, 2015, J CLIN ENDOCR METAB, V100, P3140, DOI 10.1210/jc.2015-1520; Cannon CP, 2015, EUR HEART J, V36, P1186, DOI 10.1093/eurheartj/ehv028; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Gusarova V, 2012, CLIN LIPIDOL, V7, P737, DOI 10.2217/CLP.12.70; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Kastelein JJP, 2015, EUR HEART J, V36, P2996, DOI 10.1093/eurheartj/ehv370; Kereiakes DJ, 2015, AM HEART J, V169, P906, DOI 10.1016/j.ahj.2015.03.004; Labonte P, 2009, HEPATOLOGY, V50, P17, DOI 10.1002/hep.22911; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Le QT, 2015, J BIOL CHEM, V290, P23385, DOI 10.1074/jbc.M115.642991; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Milazzo L, 2012, NEW ENGL J MED, V366, P2425, DOI 10.1056/NEJMc1204929; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2012, CURR OPIN VIROL, V2, P14, DOI 10.1016/j.coviro.2011.12.007; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Roth EM, 2014, INT J CARDIOL, V176, P55, DOI 10.1016/j.ijcard.2014.06.049; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Swergold GD, 2012, NEW ENGL J MED, V366, P2426; Vieyres G, 2013, METHODS, V59, P233, DOI 10.1016/j.ymeth.2012.09.005; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	31	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154498	10.1371/journal.pone.0154498	http://dx.doi.org/10.1371/journal.pone.0154498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115873	gold, Green Published			2022-12-26	WOS:000374973600071
J	Shah, B; Lutter, D; Bochenek, ML; Kato, K; Tsytsyura, Y; Glyvuk, N; Sakakibara, A; Klingauf, J; Adams, RH; Puschel, AW				Shah, Bhavin; Lutter, Daniela; Bochenek, Magdalena L.; Kato, Katsuhiro; Tsytsyura, Yaroslav; Glyvuk, Natalia; Sakakibara, Akira; Klingauf, Juergen; Adams, Ralf H.; Pueschel, Andreas W.			C3G/Rapgef1 Is Required in Multipolar Neurons for the Transition to a Bipolar Morphology during Cortical Development	PLOS ONE			English	Article							DEVELOPING CEREBRAL-CORTEX; NUCLEOTIDE EXCHANGE FACTOR; PYRAMIDAL NEURONS; RADIAL GLIA; MIGRATION; REELIN; POLARITY; ACTIVATION; RAP1; NEOCORTEX	The establishment of a polarized morphology is essential for the development and function of neurons. During the development of the mammalian neocortex, neurons arise in the ventricular zone (VZ) from radial glia cells (RGCs) and leave the VZ to generate the cortical plate (CP). During their migration, newborn neurons first assume a multipolar morphology in the subventricular zone (SVZ) and lower intermediate zone (IZ). Subsequently, they undergo a multi-to-bipolar (MTB) transition to become bipolar in the upper IZ by developing a leading process and a trailing axon. The small GTPases Rap1A and Rap1B act as master regulators of neural cell polarity in the developing mouse neocortex. They are required for maintaining the polarity of RGCs and directing the MTB transition of multipolar neurons. Here we show that the Rap1 guanine nucleotide exchange factor (GEF) C3G (encoded by the Rapgef1 gene) is a crucial regulator of the MTB transition in vivo by conditionally inactivating the Rapgef1 gene in the developing mouse cortex at different time points during neuronal development. Inactivation of C3G results in defects in neuronal migration, axon formation and cortical lamination. Live cell imaging shows that C3G is required in cortical neurons for both the specification of an axon and the initiation of radial migration by forming a leading process.	[Shah, Bhavin; Lutter, Daniela; Pueschel, Andreas W.] Univ Munster, Inst Mol Zellbiol, Schlosspl 5, D-48149 Munster, Germany; [Bochenek, Magdalena L.; Kato, Katsuhiro; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Bochenek, Magdalena L.; Kato, Katsuhiro; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Tsytsyura, Yaroslav; Glyvuk, Natalia; Klingauf, Juergen] Inst Med Phys & Biophys, Robert Koch Str 31, D-48149 Munster, Germany; [Shah, Bhavin; Pueschel, Andreas W.] Univ Munster, Cells In Mot Cluster Excellence, D-48149 Munster, Germany; [Sakakibara, Akira] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan; [Bochenek, Magdalena L.] Univ Med Ctr Mainz, Div Cardiol, Ctr Thrombosis & Hemostasis, Mainz, Germany	University of Munster; Max Planck Society; University of Munster; University of Munster; Chubu University; Johannes Gutenberg University of Mainz	Puschel, AW (corresponding author), Univ Munster, Inst Mol Zellbiol, Schlosspl 5, D-48149 Munster, Germany.; Puschel, AW (corresponding author), Univ Munster, Cells In Mot Cluster Excellence, D-48149 Munster, Germany.	apuschel@uni-muenster.de	Kato, Katsuhiro/AAV-8356-2020; Adams, Ralf H/AAE-9274-2019		Deutsche Forschungsgemeinschaft (AWP) [SFB 629 TP A15, EXC 1003-CiM]	Deutsche Forschungsgemeinschaft (AWP)	Support from the Deutsche Forschungsgemeinschaft (AWP: SFB 629 TP A15 and EXC 1003-CiM) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Bilasy SE, 2009, EUR J NEUROSCI, V29, P1994, DOI 10.1111/j.1460-9568.2009.06754.x; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Cooper JA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00386; Del Rio JA, 2000, CEREB CORTEX, V10, P784, DOI 10.1093/cercor/10.8.784; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Gloerich M, 2011, TRENDS CELL BIOL, V21, P615, DOI 10.1016/j.tcb.2011.07.001; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo HL, 2000, BIOCHEM BIOPH RES CO, V273, P661, DOI 10.1006/bbrc.2000.2870; Hatanaka Y, 2013, CEREB CORTEX, V23, P105, DOI 10.1093/cercor/bhr383; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kitazawa A, 2014, J NEUROSCI, V34, P1115, DOI 10.1523/JNEUROSCI.2254-13.2014; Kuo G, 2005, J NEUROSCI, V25, P8578, DOI 10.1523/JNEUROSCI.1656-05.2005; Lakoma J, 2011, DEVELOPMENT, V138, P5223, DOI 10.1242/dev.063776; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Namba T, 2014, NEURON, V81, P814, DOI 10.1016/j.neuron.2013.12.015; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Okamoto M, 2013, NAT NEUROSCI, V16, P1556, DOI 10.1038/nn.3525; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; Sakakibara A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00116; Sakakibara A, 2014, CEREB CORTEX, V24, P1301, DOI 10.1093/cercor/bhs411; Schmid MT, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00215; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sekine K, 2012, NEURON, V76, P353, DOI 10.1016/j.neuron.2012.07.020; Shah B, 2017, CEREB CORTEX, V27, P1253, DOI 10.1093/cercor/bhv341; Tabata H, 2003, J NEUROSCI, V23, P9996; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Voss AK, 2003, DEVELOPMENT, V130, P355, DOI 10.1242/dev.00217; Voss AK, 2008, DEVELOPMENT, V135, P2139, DOI 10.1242/dev.016725; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Ye T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5826	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154174	10.1371/journal.pone.0154174	http://dx.doi.org/10.1371/journal.pone.0154174			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111087	Green Published, gold			2022-12-26	WOS:000374970600041
J	Annarapu, GK; Singhal, R; Peng, YD; Guchhait, P				Annarapu, Gowtham K.; Singhal, Rashi; Peng, Yuandong; Guchhait, Prasenjit			Inhibition of Hb Binding to GP1b alpha Abrogates Hb-Mediated Thrombus Formation on Immobilized VWF and Collagen under Physiological Shear Stress	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; VON-WILLEBRAND-FACTOR; INTRAVASCULAR HEMOLYSIS; PLATELET ACTIVATION; MECHANISM; ADHESION; DISEASE	Background Reports including our own describe that intravascular hemolysis increases the risk of thrombosis in hemolytic disorders. Our recent study shows that plasma Hb concentrations correlate directly with platelet activation in patients with paroxysmal nocturnal hemoglobinuria (PNH). The binding of Hb to glycoprotein1ba (GP1b alpha) increases platelet activation. A peptide AA1-50, designed from N-terminal amino acid sequence of GP1b alpha significantly inhibits the Hb binding to GP1b alpha as well as Hb-induced platelet activation. This study further examined if the Hb-mediated platelet activation plays any significant role in thrombus formation on subendothelium matrix under physiological flow shear stresses and the inhibition of Hbplatelet interaction can abrogate the above effects of Hb. Methods and Results Study performed thrombus formation assay in vitro by perfusing whole blood over immobilized VWF or collagen type I in presence of Hb under shear stresses simulating arterial or venous flow. The Hb concentrations ranging from 5 to 10 mu M, commonly observed level in plasma of the hemolytic patients including PNH, dose-dependently increased thrombus formation on immobilized VWF under higher shear stress of 25 dyne/cm(2), but not at 5 dyne/cm(2). The above Hb concentrations also increased thrombus formation on immobilized collagen under both shear stresses of 5 and 25 dyne/cm(2). The peptide AA1-50 abrogated invariably the above effects of Hb on thrombus formation. Conclusions and Significance This study therefore indicates that the Hb-induced platelet activation plays a crucial role in thrombus formation on immobilized VWF or collagen under physiological flow shear stresses. Thus suggesting a probable role of this mechanism in facilitating thrombosis under hemolytic conditions.	[Annarapu, Gowtham K.; Singhal, Rashi; Guchhait, Prasenjit] Natl Capital Reg Biotech Sci Cluster, Reg Ctr Biotechnol, Dis Biol Lab, Faridabad, India; [Annarapu, Gowtham K.; Singhal, Rashi] Manipal Univ, Dept Biotechnol, Manipal, Karnataka, India; [Peng, Yuandong] Baylor Coll Med, Dept Med, Cardiovasc Res Sect, Houston, TX 77030 USA	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Manipal Academy of Higher Education (MAHE); Baylor College of Medicine	Guchhait, P (corresponding author), Natl Capital Reg Biotech Sci Cluster, Reg Ctr Biotechnol, Dis Biol Lab, Faridabad, India.	prasenjit@rcb.res.in	Annarapu, Gowtham K/N-5829-2017	Annarapu, Gowtham K/0000-0002-6761-0976	Department of Biotechnology, Govt. of India [BTPR8501, BTPR9389]; American Heart Association [SDG 0635155N]; National Institute of Health USA [HL095676]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095676] Funding Source: NIH RePORTER	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); American Heart Association(American Heart Association); National Institute of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was financially supported by grants (BTPR8501 and BTPR9389) from the Department of Biotechnology, Govt. of India to PG, and grants from the American Heart Association (SDG 0635155N) and the National Institute of Health USA (HL095676) to YP.	ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Audebert HJ, 2005, J NEUROL, V252, P1379, DOI 10.1007/s00415-005-0871-3; Cappellini Maria Domenica, 2007, Hematology Am Soc Hematol Educ Program, P74; DIXON RH, 1977, J CLIN INVEST, V59, P360, DOI 10.1172/JCI108648; Fu XY, 2011, BLOOD, V118, P5283, DOI 10.1182/blood-2011-01-331074; GRALNICK HR, 1995, BRIT J HAEMATOL, V91, P697, DOI 10.1111/j.1365-2141.1995.tb05371.x; Helms CC, 2013, J THROMB HAEMOST, V11, P2148, DOI 10.1111/jth.12422; Hill A, 2013, BLOOD, V121, P4985, DOI 10.1182/blood-2012-09-311381; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Poulou LS, 2008, THROMB HAEMOSTASIS, V99, P642, DOI 10.1160/TH07-11-0664; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Singhal R, 2015, HAEMATOLOGICA, V100, P1526, DOI 10.3324/haematol.2015.132183; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhou Z, 2009, THROMB HAEMOSTASIS, V101, P1070, DOI 10.1160/TH08-10-0677; Ziakas PD, 2007, J THROMB HAEMOST, V5, P642, DOI 10.1111/j.1538-7836.2007.02379.x	17	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154276	10.1371/journal.pone.0154276	http://dx.doi.org/10.1371/journal.pone.0154276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105433	Green Submitted, Green Published, gold			2022-12-26	WOS:000374565100064
J	Xu, Y; Ding, J; Wu, LY				Xu, Yan; Ding, Jun; Wu, Ling-Yun			iSulf-Cys: Prediction of S-sulfenylation Sites in Proteins with Physicochemical Properties of Amino Acids	PLOS ONE			English	Article							IDENTIFICATION; LOGO; TOOL	Cysteine S-sulfenylation is an important post-translational modification (PTM) in proteins, and provides redox regulation of protein functions. Bioinformatics and structural analyses indicated that S-sulfenylation could impact many biological and functional categories and had distinct structural features. However, major limitations for identifying cysteine S-sulfenylation were expensive and low-throughout. In view of this situation, the establishment of a useful computational method and the development of an efficient predictor are highly desired. In this study, a predictor iSulf-Cys which incorporated 14 kinds of physicochemical properties of amino acids was proposed. With the 10-fold cross-validation, the value of area under the curve (AUC) was 0.7155 +/- 0.0085, MCC 0.3122 +/- 0.0144 on the training dataset for 20 times. iSulf-Cys also showed satisfying performance in the independent testing dataset with AUC 0.7343 and MCC 0.3315. Features which were constructed from physicochemical properties and position were carefully analyzed. Meanwhile, a user-friendly webserver for iSulf-Cys is accessible at http://app.aporc.org/iSulf-Cys/.	[Xu, Yan; Ding, Jun] Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China; [Wu, Ling-Yun] Chinese Acad Sci, Inst Appl Math, Acad Math & Syst Sci, Beijing 100190, Peoples R China	University of Science & Technology Beijing; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Xu, Y (corresponding author), Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China.	xuyan@ustb.edu.cn		Xu, Yan/0000-0001-9462-580X	Natural Science Foundation of China [11301024, 31171263, 81272578, J1103514]; Fundamental Research Funds for the Central Universities [FRF-BR-15-075A]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the Natural Science Foundation of China (11301024, 31171263, 81272578, and J1103514) and the Fundamental Research Funds for the Central Universities (No. FRF-BR-15-075A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; Jahandideh S, 2012, J THEOR BIOL, V312, P65, DOI 10.1016/j.jtbi.2012.07.013; Japkowicz N, 2000, IC-AI'2000: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOL 1-III, P111; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Li FY, 2015, BIOINFORMATICS, V31, P1411, DOI 10.1093/bioinformatics/btu852; Li SL, 2009, PROTEIN PEPTIDE LETT, V16, P977, DOI 10.2174/092986609788923338; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Liu XY, 2006, IEEE DATA MINING, P970; Nanni L, 2012, AMINO ACIDS, V43, P657, DOI 10.1007/s00726-011-1114-9; Pan ZC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07331; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Simon GM, 2013, NAT CHEM BIOL, V9, P200, DOI 10.1038/nchembio.1211; Szychowski J, 2010, J AM CHEM SOC, V132, P18351, DOI 10.1021/ja1083909; Tang YR, 2007, PROTEIN ENG DES SEL, V20, P405, DOI 10.1093/protein/gzm035; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Bui VM, 2016, BIOINFORMATICS, V32, P165, DOI 10.1093/bioinformatics/btv558; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xu HD, 2015, BIOINFORMATICS, V31, P3748, DOI 10.1093/bioinformatics/btv439; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5776; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383; Zhao XW, 2015, J THEOR BIOL, V374, P60, DOI 10.1016/j.jtbi.2015.03.029; Zhao XW, 2015, MOL BIOSYST, V11, P923, DOI 10.1039/c4mb00680a; Zhao XW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/109549; Zheng LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028221	30	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154237	10.1371/journal.pone.0154237	http://dx.doi.org/10.1371/journal.pone.0154237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104833	gold, Green Published, Green Submitted			2022-12-26	WOS:000374565100059
J	Kumwenda, M; Desmond, N; Hart, G; Choko, A; Chipungu, GA; Nyirenda, D; Shand, T; Corbett, EL; Chikovore, J				Kumwenda, Moses; Desmond, Nicola; Hart, Graham; Choko, Augustine; Chipungu, Geoffrey A.; Nyirenda, Deborah; Shand, Tim; Corbett, Elizabeth L.; Chikovore, Jeremiah			Treatment-Seeking for Tuberculosis-Suggestive Symptoms: A Reflection on the Role of Human Agency in the Context of Universal Health Coverage in Malawi	PLOS ONE			English	Article							CARE-SEEKING; CHRONIC COUGH; PULMONARY TUBERCULOSIS; URBAN ZAMBIA; DIAGNOSIS; SERVICES; GENDER; HIV; BARRIERS; BEHAVIOR	Tuberculosis (TB) is highly infectious and one of the leading killers globally. Several studies from sub-Saharan Africa highlight health systems challenges that affect ability to cope with existing disease burden, including TB, although most of these employ survey-type approaches. Consequently, few address community or patient perspectives and experiences. At the same time, understanding of the mechanisms by which the health systems challenges translate into seeking or avoidance of formal health care remains limited. This paper applies the notion of human agency to examine the ways people who have symptoms suggestive of TB respond to and deal with the symptoms vis-a-vis major challenges inherent within health delivery systems. Empirical data were drawn from a qualitative study exploring the ways in which notions of masculinity affect engagement with care, including men's well-documented tendency to delay in seeking care for TB symptoms. The study was carried out in three high-density locales of urban Blantyre, Malawi. Data were collected in March 2011 -March 2012 using focus group discussions, of which eight (mixed sex = two; female only = three; male only = three) were with 74 ordinary community members, and two (both mixed sex) were with 20 health workers; and in-depth interviews with 20 TB patients (female = 14) and 20 un-investigated chronic coughers (female = eight). The research process employed a modified version of grounded theory. Data were coded using a coding scheme that was initially generated from the study aims and subsequently progressively amended to incorporate concepts emerging during the analysis. Coded data were retrieved, re-read, and broken down and reconnected iteratively to generate themes. A myriad of problems were described for health systems at the primary health care level, centring largely on shortages of resources (human, equipment, and drugs) and unprofessional conduct by health care providers. Participants consistently pointed out how the problems could drive patients from promptly reporting symptoms at primary healthcare centres. The accounts suggest that in responding to illness symptoms including those suggestive of TB, patients navigate their options taking into cognisance past and current experiences with formal health systems. Understanding and factoring in the mediating role of such 'agency' is critical when implementing efforts to promote timely response to TB-suggestive symptoms.	[Kumwenda, Moses; Desmond, Nicola; Choko, Augustine; Corbett, Elizabeth L.] Malawi Liverpool Wellcome Res Programme, Blantyre, Malawi; [Kumwenda, Moses; Chipungu, Geoffrey A.] Coll Med, Helse Nord TB Initiat, Blantyre, Malawi; [Desmond, Nicola; Nyirenda, Deborah] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Hart, Graham] UCL, Sch Life & Med Sci, London, England; [Choko, Augustine; Corbett, Elizabeth L.] London Sch Hyg & Trop Med, London WC1, England; [Nyirenda, Deborah] Coll Med, Sch Publ Hlth & Family Med, Blantyre, Malawi; [Shand, Tim] UCL, Inst Global Hlth, London, England; [Shand, Tim] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Chikovore, Jeremiah] Human Sci Res Council, HIV AIDS Sexually Transmitted Infect & TB, Durban, South Africa	University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Malawi; University of London; University College London; University of Cape Town; Human Sciences Research Council-South Africa	Chikovore, J (corresponding author), Human Sci Res Council, HIV AIDS Sexually Transmitted Infect & TB, Durban, South Africa.	jchikovore@hsrc.ac.za	Desmond, Nicola/ABA-6504-2020; Desmond, Nicola/GYQ-8574-2022	Desmond, Nicola/0000-0002-2874-8569; Kumwenda, Moses Kelly/0000-0003-3091-7330; Nyirenda, Deborah/0000-0002-5867-4687; Corbett, Elizabeth/0000-0002-3552-3181; Chikovore, Jeremiah/0000-0002-4910-6952	Wellcome Trust; Helse-Noord Initiative grant; National Institute for Health Research [NF-SI-0611-10255] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Helse-Noord Initiative grant; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was mainly supported via a Wellcome Trust Training Fellowship award to Jeremiah Chikovore, with additional support coming from a Wellcome Trust Senior Research Fellowship award to Professor Liz Corbett, and a Helse-Noord Initiative grant to Moses Kumwenda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayisi JG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-515; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Baltussen RMPM, 2002, HEALTH POLICY PLANN, V17, P42, DOI 10.1093/heapol/17.1.42; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Bedell RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039347; Beyers N, 2003, PREVALENCE TUBERCULO; Boon H, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-15; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Chikovore J, 2015, GLOBAL HLTH ACTION, V8; Chikovore J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1053; Corbett E, 2012, INTENSIFIED HIV TB P, V10; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Crampin AC, 2009, INT J TUBERC LUNG D, V13, P153; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Dimitrova B, 2006, HEALTH POLICY PLANN, V21, P265, DOI 10.1093/heapol/czl014; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; Emirbayer M, 1998, AM J SOCIOL, V103, P962, DOI 10.1086/231294; Emslie C, 2006, SOC SCI MED, V62, P2246, DOI 10.1016/j.socscimed.2005.10.017; Godfrey-Faussett R, 2002, INT J TUBERC LUNG D, V6, P796; Houben RMGJ, 2009, T ROY SOC TROP MED H, V103, P1187, DOI 10.1016/j.trstmh.2009.03.013; Hu A, 2012, HEALTH CARE WOMEN IN, V33, P29, DOI 10.1080/07399332.2011.630495; Jonsen K, 2009, QUAL RES ORGAN MANAG, V4, P123, DOI 10.1108/17465640910978391; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Kumwenda M, 2011, INT J TUBERC LUNG D, V15, P1663, DOI 10.5588/ijtld.10.0741; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; MacPherson P, 2013, AM J EPIDEMIOL, V177, P1143, DOI 10.1093/aje/kws376; Malcher G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7054; Mavhu W, 2010, TROP MED INT HEALTH, V15, P574, DOI 10.1111/j.1365-3156.2010.02493.x; Moynihan C, 1998, BRIT MED J, V317, P1072; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Needham DM, 2001, TROP MED INT HEALTH, V6, P256, DOI 10.1046/j.1365-3156.2001.00709.x; Nliwasa M, 2016, INT J TUBERC LUNG D, V20, P202, DOI 10.5588/ijtld.15.0388; Phetlhu DR., 2011, J SOC SCI, V29, P23; Priest Helena, 2002, Nurse Res, V10, P30; Ridde V, 2011, HEALTH POLICY PLANN, V26, P1, DOI 10.1093/heapol/czq021; Salaniponi FML, 2000, INT J TUBERC LUNG D, V4, P327; Sandelowski M, 2000, RES NURS HEALTH, V23, P246, DOI 10.1002/1098-240X(200006)23:3<246::AID-NUR9>3.0.CO;2-H; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Simwaka Bertha Nhlema, 2007, Int J Equity Health, V6, P24, DOI 10.1186/1475-9276-6-24; Siu GE, 2013, SOC SCI MED, V89, P45, DOI 10.1016/j.socscimed.2013.04.025; Steen TW, 1998, INT J TUBERC LUNG D, V2, P627; Thorson A, 2001, Curr Opin Pulm Med, V7, P165, DOI 10.1097/00063198-200105000-00009; White A., 2003, REPORT STATE MENS HL; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2015, GLOB TUB REP 2015; Yamasaki-Nakagawa M, 2001, INT J TUBERC LUNG D, V5, P24; Zhang TH, 2007, HEALTH POLICY, V81, P155, DOI 10.1016/j.healthpol.2005.12.009	53	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154103	10.1371/journal.pone.0154103	http://dx.doi.org/10.1371/journal.pone.0154103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101407	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500144
J	van der Valk, ME; Mangen, MJJ; Severs, M; van der Have, M; Dijkstra, G; van Bodegraven, AA; Fidder, HH; de Jong, DJ; van der Woude, CJ; Romberg-Camps, MJL; Clemens, CHM; Jansen, JM; de Meeberg, PCV; Mahmmod, N; van der Meulen-de Jong, AE; Ponsioen, CY; Bolwerk, C; Vermeijden, JR; Siersema, PD; Leenders, M; Oldenburg, B				van der Valk, Mirthe E.; Mangen, Marie-Josee J.; Severs, Mirjam; van der Have, Mike; Dijkstra, Gerard; van Bodegraven, Ad A.; Fidder, Herma H.; de Jong, Dirk J.; van der Woude, C. Janneke; Romberg-Camps, Marielle J. L.; Clemens, Cees H. M.; Jansen, Jeroen M.; de Meeberg, Paul C. van; Mahmmod, Nofel; van der Meulen-de Jong, Andrea E.; Ponsioen, Cyriel Y.; Bolwerk, Clemens; Vermeijden, J. Reinoud; Siersema, Peter D.; Leenders, Max; Oldenburg, Bas		COIN Study Grp; Dutch Initiative Crohn Colitis	Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up	PLOS ONE			English	Article							POPULATION-BASED COHORT; HEALTH-CARE COSTS; CROHNS-DISEASE; ULCERATIVE-COLITIS; RHEUMATOID-ARTHRITIS; INCEPTION COHORT; CLINICAL-COURSE; ILLNESS; PREDICTORS; SWEDEN	Background With the increasing use of anti-TNF therapy in inflammatory bowel disease (IBD), a shift of costs has been observed with medication costs replacing hospitalization and surgery as major cost driver. We aimed to explore the evolution of IBD-related costs over two years of follow-up. Methods and Findings In total 1,307 Crohn's disease (CD) patients and 915 ulcerative colitis (UC) patients were prospectively followed for two years by three-monthly web-based questionnaires. Changes of healthcare costs, productivity costs and out-of-pocket costs over time were assessed using mixed model analysis. Multivariable logistic regression analysis was used to identify costs drivers. In total 737 CD patients and 566 UC were included. Total costs were stable over two years of follow-up, with annual total costs of (sic)7,835 in CD and (sic)3,600 in UC. However, within healthcare costs, the proportion of anti-TNF therapy-related costs increased from 64% to 72% in CD (p<0.01) and from 31% to 39% in UC (p < 0.01). In contrast, the proportion of hospitalization costs decreased from 19% to 13% in CD (p<0.01), and 22% to 15% in UC (p < 0.01). Penetrating disease course predicted an increase of healthcare costs (adjusted odds ratio (adj. OR) 1.95 (95% CI 1.02-3.37) in CD and age <40 years in UC (adj. OR 4.72 (95% CI 1.61-13.86)). Conclusions BD-related costs remained stable over two years. However, the proportion of anti-TNF-related healthcare costs increased, while hospitalization costs decreased. Factors associated with increased costs were penetrating disease course in CD and age <40 in UC.	[van der Valk, Mirthe E.; Severs, Mirjam; van der Have, Mike; Fidder, Herma H.; Siersema, Peter D.; Leenders, Max; Oldenburg, Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Mangen, Marie-Josee J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Dijkstra, Gerard] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9713 AV Groningen, Netherlands; [van Bodegraven, Ad A.] Vrije Univ Amsterdam, Dept Gastroenterol & Hepatol, Med Ctr, Amsterdam, Netherlands; [van Bodegraven, Ad A.; Romberg-Camps, Marielle J. L.] Atrium Orbis Med Ctr, Dept Internal Med Gastroenterol & Geriatr, Heerlen Sittard Geleen, Netherlands; [de Jong, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [van der Woude, C. Janneke] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Clemens, Cees H. M.] Diaconessenhuis, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Jansen, Jeroen M.] Onze Lieve Vrouw Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [de Meeberg, Paul C. van] Slingeland Hosp, Dept Gastroenterol & Hepatol, Doetinchem, Netherlands; [Mahmmod, Nofel] Antonius Hosp, Dept Gastroenterol & Hepatol, Nieuwegein, Netherlands; [van der Meulen-de Jong, Andrea E.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Ponsioen, Cyriel Y.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Bolwerk, Clemens] Reinier de Graaf Grp, Dept Gastroenterol & Hepatol, Delft, Netherlands; [Vermeijden, J. Reinoud] Meander Med Ctr, Dept Gastroenterol & Hepatol, Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; Vrije Universiteit Amsterdam; Atrium Medical Center; Orbis Medical Center; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Onze Lieve Vrouwe Gasthuis Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Reinier de Graaf Hospital; Meander Medisch Centrum	Oldenburg, B (corresponding author), Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands.	boldenbu@umcutrecht.nl	van Bodegraven, Ad/ABG-4367-2020; van Bodegraven, Ad A/L-3180-2013; van der Meulen, Andrea/AAU-9430-2020; Siersema, Peter/V-1636-2019	van der Meulen, Andrea/0000-0001-9353-5431; van der Woude, C.Janneke/0000-0003-3875-6957; Mangen, Marie-Josee J./0000-0001-8914-2045; /0000-0003-4563-7462	Abbvie	Abbvie(AbbVie)	This study was funded by an unrestricted grant of Abbvie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi A, 2004, GUT, V53, P1471, DOI 10.1136/gut.2004.041616; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Bernstein CN, 2012, GUT, V61, P622, DOI 10.1136/gutjnl-2011-301397; Bitton A, 2001, GASTROENTEROLOGY, V120, P13, DOI 10.1053/gast.2001.20912; Blomqvist P, 1997, SCAND J GASTROENTERO, V32, P1134, DOI 10.3109/00365529709002993; Bodger K, 2002, PHARMACOECONOMICS, V20, P639, DOI 10.2165/00019053-200220100-00001; Burisch J, 2015, INFLAMM BOWEL DIS, V21, P121, DOI 10.1097/MIB.0000000000000250; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Gibson TB, 2008, J OCCUP ENVIRON MED, V50, P1261, DOI 10.1097/JOM.0b013e318181b8ca; Hoie O, 2007, AM J GASTROENTEROL, V102, P1692, DOI 10.1111/j.1572-0241.2007.01265.x; Huscher D, 2015, ANN RHEUM DIS, V74, P738, DOI 10.1136/annrheumdis-2013-204311; Etchevers MJ, 2009, INFLAMM BOWEL DIS, V15, P1320, DOI 10.1002/ibd.20897; Juan J, 2003, DIGEST LIVER DIS, V35, P853, DOI 10.1016/j.dld.2003.07.002; Kalkan A, 2014, RHEUMATOLOGY, V53, P153, DOI 10.1093/rheumatology/ket290; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Loly C, 2008, SCAND J GASTROENTERO, V43, P948, DOI 10.1080/00365520801957149; Mesterton J, 2009, INFLAMM BOWEL DIS, V15, P1882, DOI 10.1002/ibd.20939; Moum B, 1997, SCAND J GASTROENTERO, V32, P1005, DOI 10.3109/00365529709011217; Odes S, 2006, GASTROENTEROLOGY, V131, P719, DOI 10.1053/j.gastro.2006.05.052; Prenzler A, 2011, EUR J HEALTH ECON, V12, P273, DOI 10.1007/s10198-010-0281-z; Solberg IC, 2007, CLIN GASTROENTEROL H, V5, P1430, DOI 10.1016/j.cgh.2007.09.002; Stark R, 2006, PHARMACOECONOMICS, V24, P797, DOI 10.2165/00019053-200624080-00006; Targownik LE, 2012, AM J GASTROENTEROL, V107, P1228, DOI 10.1038/ajg.2012.127; van der Have M, 2014, INFLAMM BOWEL DIS, V20, P637, DOI 10.1097/01.MIB.0000442677.55051.03; van der Valk ME, 2014, GUT, V63, P72, DOI 10.1136/gutjnl-2012-303376	25	74	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0142481	10.1371/journal.pone.0142481	http://dx.doi.org/10.1371/journal.pone.0142481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099937	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500001
J	Yang, LC; Zhang, YH; Wang, J; Huang, ZW; Gou, LY; Wang, ZL; Ren, TX; Piao, JH; Yang, XG				Yang, Lichen; Zhang, Yuhui; Wang, Jun; Huang, Zhengwu; Gou, Lingyan; Wang, Zhilin; Ren, Tongxiang; Piao, Jianhua; Yang, Xiaoguang			Non-Heme Iron Absorption and Utilization from Typical Whole Chinese Diets in Young Chinese Urban Men Measured by a Double-Labeled Stable Isotope Technique	PLOS ONE			English	Article							ERYTHROCYTE INCORPORATION; FERRITIN CONCENTRATIONS; REFERENCE VALUES; HAN POPULATION; BIOAVAILABILITY; WOMEN; MEAL; ZINC; VITAMIN; C282Y	Background This study was to observe the non-heme iron absorption and biological utilization from typical whole Chinese diets in young Chinese healthy urban men, and to observe if the iron absorption and utilization could be affected by the staple food patterns of Southern and Northern China. Materials and Methods Twenty-two young urban men aged 18-24 years were recruited and randomly assigned to two groups in which the staple food was rice and steamed buns, respectively. Each subject received 3 meals containing approximately 3.25 mg stable (FeSO4)-Fe-57 (the ratio of Fe-57 content in breakfast, lunch and dinner was 1: 2: 2) daily for 2 consecutive days. In addition, approximately 2.4 mg (FeSO4)-Fe-58 was administered intravenously to each subject at 30-60 min after dinner each day. Blood samples were collected from each subject to measure the enrichment of the Fe-57 and Fe-58. Fourteen days after the experimental diet, non-heme iron absorption was assessed by measuring Fe-57 incorporation into red blood cells, and absorbed iron utilization was determined according to the red blood cell incorporation of intravenously infused Fe-58 SO4. Results Non-heme iron intake values overall, and in the rice and steamed buns groups were 12.8 +/- 2.1, 11.3 +/- 1.3 and 14.3 +/- 1.5 mg, respectively; the mean Fe-57 absorption rates were 11 +/- 7%, 13 +/- 7%, and 8 +/- 4%, respectively; and the mean infused Fe-58 utilization rates were 85 +/- 8%, 84 +/- 6%, and 85 +/- 10%, respectively. There was no significantly difference in the iron intakes, and Fe-57 absorption and infused Fe-58 utilization rates between rice and steamed buns groups (all P>0.05). Conclusion We present the non-heme iron absorption and utilization rates from typical whole Chinese diets among young Chinese healthy urban men, which was not affected by the representative staple food patterns of Southern and Northern China. This study will provide a basis for the setting of Chinese iron DRIs.	[Yang, Lichen; Huang, Zhengwu; Piao, Jianhua; Yang, Xiaoguang] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr Hlth, Minist Hlth, Key Lab Trace Element Nutr, Beijing 100050, Peoples R China; [Zhang, Yuhui; Gou, Lingyan; Wang, Zhilin] Bethune Mil Med Coll, Shijiazhuang 050081, Hebei, Peoples R China; [Wang, Jun; Ren, Tongxiang] Natl Res Ctr Certified Reference Mat, Natl Inst Metrol, Beijing 100029, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Metrology China	Yang, XG (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr Hlth, Minist Hlth, Key Lab Trace Element Nutr, Beijing 100050, Peoples R China.	xyangcdc@sina.com	ren, tongxiang/AAB-9919-2019		National Science & Technology Pillar Program [2008BA158B02]	National Science & Technology Pillar Program	This project was supported by the Key Projects in the National Science & Technology Pillar Program during the Eleventh Five-Year Plan Period (www.nsfc.gov.cn, grant no.: 2008BA158B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizari AR, 2012, J NUTR, V142, P1950, DOI 10.3945/jn.112.164095; ACOSTA A, 1984, AM J CLIN NUTR, V39, P953, DOI 10.1093/ajcn/39.6.953; [Anonymous], 2012, 2 NAT REP BIOCH IND; Ashmore JH, 2013, EUR J CANCER PREV, V22, P506, DOI 10.1097/CEJ.0b013e32836056f8; Atkinson SA, 2011, AM J CLIN NUTR, V94, p655S, DOI 10.3945/ajcn.110.005728; BARRETT JFR, 1992, CLIN SCI, V83, P213, DOI 10.1042/cs0830213; Bavbek N, 2014, RENAL FAILURE, V36, P187, DOI 10.3109/0886022X.2013.836750; CARLSEN O, 1990, SCAND J CLIN LAB INV, V50, P63, DOI 10.3109/00365519009091566; Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051; Cheung CL, 2013, CLIN NUTR, V32, P1055, DOI 10.1016/j.clnu.2012.11.024; Chinese Nutrition Society, 2013, CHIN DIET REF INT; Cockell KA, 2009, AM J CLIN NUTR, V90, P1023, DOI 10.3945/ajcn.2009.27561; Collings R, 2013, AM J CLIN NUTR, V98, P65, DOI 10.3945/ajcn.112.050609; Cook JD, 2001, AM J CLIN NUTR, V73, P93; Dainty JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111824; Davidsson L, 2000, BRIT J NUTR, V84, P847; DellaValle DM, 2015, J NUTR, V145, P2253, DOI 10.3945/jn.115.217273; Diaz M, 2003, AM J CLIN NUTR, V78, P436, DOI 10.1093/ajcn/78.3.436; Etcheverry P, 2006, J AM COLL NUTR, V25, P34, DOI 10.1080/07315724.2006.10719512; Fairweather-Tait SJ, 2010, INT J VITAM NUTR RES, V80, P249, DOI 10.1024/0300-9831/a000031; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gropper S., 2005, ADV NUTR HUMAN METAB; Harvey LJ, 2013, CRIT REV FOOD SCI, V53, P1064, DOI 10.1080/10408398.2012.742860; Hunt JR, 2004, AM J CLIN NUTR, V80, P924, DOI 10.1093/ajcn/80.4.924; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Institute of Medicine (US) Subcommittee on Interpretation and Uses of Dietary Reference Intakes; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2000, DRI DIET REF INT APP; Kalasuramath S, 2013, INDIAN J MED RES, V137, P324; Kristensen MB, 2005, BRIT J NUTR, V94, P78, DOI 10.1079/BJN20051417; Lin A, 2007, TISSUE ANTIGENS, V70, P252, DOI 10.1111/j.1399-0039.2007.00877.x; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Moretti D, 2006, AM J CLIN NUTR, V83, P632, DOI 10.1093/ajcn.83.3.632; Nair KM, 2013, J NUTR, V143, P852, DOI 10.3945/jn.112.171702; National Health and Family Planning Commission of the People' Republic of China, 2012, STAND US NUTR FORT S; Navas-Carretero S, 2008, J AM COLL NUTR, V27, P96, DOI 10.1080/07315724.2008.10719680; NELSON R, 1978, SOUTHERN MED J, V71, P1482, DOI 10.1097/00007611-197812000-00011; Nie L, 2010, ANN HEMATOL, V89, P1249, DOI 10.1007/s00277-010-1016-z; Paik HY, 2008, ASIA PAC J CLIN NUTR, V17, P416; Patterson KY, 2001, EXP BIOL MED, V226, P271, DOI 10.1177/153537020122600403; Petry N, 2014, J NUTR, V144, P1681, DOI 10.3945/jn.114.192989; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Pizarro F, 2006, AM J CLIN NUTR, V84, P830, DOI 10.1093/ajcn/84.4.830; Reddy MB, 2006, J NUTR, V136, P576, DOI 10.1093/jn/136.3.576; Reddy MB, 2000, AM J CLIN NUTR, V71, P937; Roe MA, 2005, AM J CLIN NUTR, V81, P814, DOI 10.1093/ajcn/81.4.814; Sasaki S, 2008, ASIA PAC J CLIN NUTR, V17, P420; SHARMA JC, 1984, AGE AGEING, V13, P248, DOI 10.1093/ageing/13.4.248; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Thankachan P, 2012, EUR J CLIN NUTR, V66, P481, DOI 10.1038/ejcn.2011.169; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; Turin TC, 2010, J EPIDEMIOL, V20, pS557, DOI 10.2188/jea.JE20090225; TURNLUND JR, 1991, CRIT REV FOOD SCI, V30, P387, DOI 10.1080/10408399109527549; van den Heuvel EGHM, 1998, CLIN CHEM, V44, P649; Whittaker PG, 2001, BRIT J NUTR, V86, P323, DOI 10.1079/BJN2001390; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; Yang LC, 2005, J TRACE ELEM MED BIO, V19, P159, DOI 10.1016/j.jtemb.2005.09.001; Yu Dan, 2013, Wei Sheng Yan Jiu, V42, P228; Yu XY, 2012, ASIAN J ANDROL, V14, P599, DOI 10.1038/aja.2012.1; Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119; Zhou Ji-Chang, 2006, Wei Sheng Yan Jiu, V35, P66; Zhou T, 2008, RAPID COMMUN MASS SP, V22, P717, DOI 10.1002/rcm.3406	60	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153885	10.1371/journal.pone.0153885	http://dx.doi.org/10.1371/journal.pone.0153885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099954	gold, Green Published, Green Submitted			2022-12-26	WOS:000374898500085
J	Reuter, KE; Wills, AR; Lee, RW; Cordes, EE; Sewall, BJ				Reuter, Kim E.; Wills, Abigail R.; Lee, Raymond W.; Cordes, Erik E.; Sewall, Brent J.			Using Stable Isotopes to Infer the Impacts of Habitat Change on the Diets and Vertical Stratification of Frugivorous Bats in Madagascar	PLOS ONE			English	Article							FEEDING ECOLOGY; PTEROPUS-RUFUS; SEED DISPERSAL; FLYING-FOXES; NECTARIVOROUS BATS; FRUIT BATS; FOREST; CONSERVATION; PTEROPODIDAE; SELECTION	Human-modified habitats are expanding rapidly; many tropical countries have highly fragmented and degraded forests. Preserving biodiversity in these areas involves protecting species-like frugivorous bats-that are important to forest regeneration. Fruit bats provide critical ecosystem services including seed dispersal, but studies of how their diets are affected by habitat change have often been rather localized. This study used stable isotope analyses (delta N-15 and delta C-13 measurement) to examine how two fruit bat species in Madagascar, Pteropus rufus (n = 138) and Eidolon dupreanum (n = 52) are impacted by habitat change across a large spatial scale. Limited data for Rousettus madagascariensis are also presented. Our results indicated that the three species had broadly overlapping diets. Differences in diet were nonetheless detectable between P. rufus and E. dupreanum, and these diets shifted when they co-occurred, suggesting resource partitioning across habitats and vertical strata within the canopy to avoid competition. Changes in diet were correlated with a decrease in forest cover, though at a larger spatial scale in P. rufus than in E. dupreanum. These results suggest fruit bat species exhibit differing responses to habitat change, highlight the threats fruit bats face from habitat change, and clarify the spatial scales at which conservation efforts could be implemented.	[Reuter, Kim E.; Cordes, Erik E.; Sewall, Brent J.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Wills, Abigail R.] Mpingo Conservat & Dev Initiat, Kilwa Masoko, Tanzania; [Lee, Raymond W.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Washington State University	Reuter, KE (corresponding author), Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.	kimeleanorreuter@gmail.com	Cordes, Erik E/B-3293-2009	Cordes, Erik E/0000-0002-6989-2348	National Science Foundation Graduate Research Fellowship [DGE-1144462]; National Science Foundation [DEB-1257916]; Explorers Club Grant; Temple University Faculty Senate grant; Division Of Environmental Biology [1257916] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Explorers Club Grant; Temple University Faculty Senate grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (https://www.nsfgrfp.org/) under Grant No. (DGE-1144462) to KER, a National Science Foundation grant (DEB-1257916) to BJS (http://www.nsf.gov/div/index.jsp?div=DEB), an Explorers Club Grant to KER (https://explorers.org/expeditions/funding/expedition_grants), and a Temple University Faculty Senate grant to BJS (https://www.temple.edu/research/facinitiatives/facini_int_funding.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andriafidison D, 2006, BIOTROPICA, V38, P85, DOI 10.1111/j.1744-7429.2006.00112.x; Andrianaivoarivelo RA, 2011, MAMMALIA, V75, P69, DOI 10.1515/MAMM.2010.071; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; BAUM DA, 1995, ANN MO BOT GARD, V82, P322, DOI 10.2307/2399883; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bollen A, 2002, ACTA CHIROPTEROL, V4, P33, DOI 10.3161/001.004.0105; Bravo A, 2010, BIOTROPICA, V42, P276, DOI 10.1111/j.1744-7429.2010.00639.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cabanellas-Reboredo M, 2009, J MOLLUS STUD, V75, P343, DOI 10.1093/mollus/eyp021; Cardiff SG, 2009, AFR J ECOL, V47, P640, DOI 10.1111/j.1365-2028.2008.01015.x; Cosson JF, 1999, J TROP ECOL, V15, P515, DOI 10.1017/S026646749900098X; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Crowley BE, 2011, J BIOGEOGR, V38, P2106, DOI 10.1111/j.1365-2699.2011.02551.x; Dammhahn M, 2014, J TROP ECOL, V30, P97, DOI 10.1017/S0266467413000825; Dethier MN, 2013, MAR ECOL PROG SER, V478, P1, DOI 10.3354/meps10310; Deudero S, 2009, J EXP MAR BIOL ECOL, V368, P181, DOI 10.1016/j.jembe.2008.10.008; ESRI, 2011, ARCGIS DESKT REL 10; Fisher R. A., 1946, Statistical methods for research workers.; Fraser EE, 2013, CAN J ZOOL, V91, P533, DOI 10.1139/cjz-2013-0072; Garbutt N, 2007, MAMMALS MADAGASCAR C; Goodman SM, 2005, ANIM CONSERV, V8, P153, DOI 10.1017/S136794300500199X; GORCHOV DL, 1993, VEGETATIO, V108, P339; Herrera LG, 2008, J MAMMAL, V89, P1184, DOI 10.1644/07-MAMM-A-263.1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; IUCN Red List of Threatened Species, 2013, IUCN RED LIST THREAT; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jenkins RKB, 2007, ORYX, V41, P263, DOI 10.1017/S0030605307001883; Jenkins Richard K.B., 2008, Madagascar Conservation & Development, V3, P22; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; llo Program, 2003, REC COMM 2001; Long E, 2007, J TROP ECOL, V23, P397, DOI 10.1017/S0266467407004178; Luskin MS, 2010, BIOTROPICA, V42, P246, DOI 10.1111/j.1744-7429.2009.00577.x; MacKinnon J., 2003, NATURAL HIST MADAGAS, P1299; MARSHALL AG, 1985, ZOOL J LINN SOC-LOND, V83, P351, DOI 10.1111/j.1096-3642.1985.tb01181.x; Medellin RA, 1999, BIOTROPICA, V31, P478, DOI 10.1111/j.1744-7429.1999.tb00390.x; Mildenstein TL, 2005, BIOL CONSERV, V126, P93, DOI 10.1016/j.biocon.2005.05.001; Moat J., 2007, ATLAS VEGETATION MAD; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oleksy R, 2015, GLOB ECOL CONSERV, V3, P678, DOI 10.1016/j.gecco.2015.02.012; Ossa G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045729; Owens J. R., 2013, THESIS DREXEL U; Picot M, 2007, AFR J ECOL, V45, P645, DOI 10.1111/j.1365-2028.2007.00788.x; Reuter KE, 2015, THESIS TEMPLE U; Reuter KE, 2015, ORYX, V1; Rex K, 2011, J TROP ECOL, V27, P211, DOI 10.1017/S0266467411000022; Scanlon AT, 2013, AUST J ZOOL, V61, P342, DOI 10.1071/ZO13047; Sewall BJ, 2003, ORYX, V37, P344, DOI 10.1017/S0030605303000607; Sewall BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068657; Soto-Centeno JA, 2006, J MAMMAL, V87, P19, DOI 10.1644/05-MAMM-041R1.1; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; U.S. Department of the Interior, 2014, USGS EARTH EXPL; Voigt CC, 2004, J EXP BIOL, V207, P1741, DOI 10.1242/jeb.00929; Voigt CC, 2012, J TROP ECOL, V28, P181, DOI 10.1017/S0266467411000666; WINTER K, 1979, OECOLOGIA, V40, P103, DOI 10.1007/BF00388814; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Yohannes E, 2008, OECOLOGIA, V158, P299, DOI 10.1007/s00442-008-1138-3	62	10	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153192	10.1371/journal.pone.0153192	http://dx.doi.org/10.1371/journal.pone.0153192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097316	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600029
J	Ramondt, S; Tiemensma, J; Cameron, LD; Broadbent, E; Kaptein, AA				Ramondt, Steven; Tiemensma, Jitske; Cameron, Linda D.; Broadbent, Elizabeth; Kaptein, Adrian A.			Drawings of Blood Cells Reveal People's Perception of Their Blood Disorder: A Pilot Study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; QUALITY-OF-LIFE; ILLNESS PERCEPTIONS; VESTIBULAR SCHWANNOMA; MYOCARDIAL-INFARCTION; PATIENT DRAWINGS; DISEASE; QUESTIONNAIRE; CHILDREN; THALASSEMIA	Context Sickle cell disease (SCD) and thalassemia are rare but chronic blood disorders. Recent literature showed impaired quality of life (QOL) in people with these blood disorders. Assessing one of the determinants of QOL (i.e. illness perceptions) therefore, is an important next research area. Objective We aimed to explore illness perceptions of people with a blood disorder with drawings in addition to the Brief Illness Perception Questionnaire (Brief IPQ). Drawings are a novel method to assess illness perceptions and the free-range answers drawings offer can add additional insight into how people perceive their illness. Method We conducted a cross-sectional study including 17 participants with a blood disorder. Participants' illness perceptions were assessed by the Brief IPQ and drawings. Brief IPQ scores were compared with reference groups from the literature (i.e. people with asthma or lupus erythematosus). Results Participants with SCD or thalassemia perceived their blood disorder as being more chronic and reported more severe symptoms than people with either asthma or lupus erythematosus. In the drawings of these participants with a blood disorder, a greater number of blood cells drawn was negatively correlated with perceived personal control (P<0.05), indicating that a greater quantity in the drawing is associated with more negative or distressing beliefs. Conclusion Participants with a blood disorder perceive their disease as fairly threatening compared with people with other chronic illnesses. Drawings can add additional insight into how people perceive their illness by offering free-range answers.	[Ramondt, Steven; Kaptein, Adrian A.] Leiden Univ, Med Ctr, Dept Med Psychol, Leiden, Netherlands; [Ramondt, Steven; Tiemensma, Jitske; Cameron, Linda D.] Univ Calif Merced, Psychol Sci, Merced, CA USA; [Broadbent, Elizabeth] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Merced; University of Auckland	Tiemensma, J (corresponding author), Univ Calif Merced, Psychol Sci, Merced, CA USA.	jtiemensma@ucmerced.edu		Broadbent, Elizabeth/0000-0003-3626-9100; Ramondt, Steven/0000-0001-6794-6894; Tiemensma, Jitske/0000-0003-4420-8711				Angstroem-Braennstroem, 2014, J PEDIATR ONCOL NURS, V31, P135, DOI 10.1177/1043454214521693; Ataga KI, 2007, BRIT J HAEMATOL, V139, P3, DOI 10.1111/j.1365-2141.2007.06740.x; Broadbent E, 2004, J PSYCHOSOM RES, V57, P583, DOI 10.1016/j.jpsychores.2004.03.014; Broadbent E, 2006, PSYCHOSOM MED, V68, P910, DOI 10.1097/01.psy.0000242121.02571.10; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Broadbent E, 2009, J PSYCHOSOM RES, V66, P465, DOI 10.1016/j.jpsychores.2008.09.006; Chong J, 2013, HEALTH PSYCHOL, V32, P710, DOI 10.1037/a0027353; CRADDICK R A, 1963, Percept Mot Skills, V17, P335; Daleboudt GMN, 2011, LUPUS, V20, P290, DOI 10.1177/0961203310385552; Daleboudt GMN, 2013, J PSYCHOSOM RES, V74, P260, DOI 10.1016/j.jpsychores.2012.11.004; de Raaij EJ, 2012, MANUAL THER, V17, P330, DOI 10.1016/j.math.2012.03.001; GABUTTI V, 1994, BAIL CL HAE, V7, P919, DOI 10.1016/S0950-3536(05)80131-3; Giordano PC, 2004, HEMOGLOBIN, V28, P287, DOI 10.1081/HEM-200037735; Guillemin M, 2004, QUAL HEALTH RES, V14, P272, DOI 10.1177/1049732303260445; Leventhal H., 2003, SELF REGULATION HLTH, P42, DOI DOI 10.4324/9780203553220; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nowicka-Sauer K, 2007, CLIN RHEUMATOL, V26, P1523, DOI 10.1007/s10067-007-0619-9; Petrie KJ, 2007, CURR OPIN PSYCHIATR, V20, P163, DOI 10.1097/YCO.0b013e328014a871; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Reynolds L, 2007, J PSYCHOSOM RES, V63, P525, DOI 10.1016/j.jpsychores.2007.03.007; Salmon P L, 1993, J Holist Nurs, V11, P21, DOI 10.1177/089801019301100104; Scharloo M, 1998, J PSYCHOSOM RES, V44, P573, DOI 10.1016/S0022-3999(97)00254-7; Schreurs P, 1993, UTRECHTSE COPING LIJ; Scott SE, 2015, PSYCHOL HEALTH, V30, P1035, DOI 10.1080/08870446.2015.1016943; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; Tiemensma J, 2012, J CLIN ENDOCR METAB, V97, P3123, DOI 10.1210/jc.2012-1235; van den Tweel XW, 2008, HAEMATOLOGICA, V93, P588, DOI 10.3324/haematol.11610; van Leeuwen BM, 2015, LARYNGOSCOPE, V125, P2660, DOI 10.1002/lary.25386; Vogel JJ, 2008, OTOL NEUROTOL, V29, P839, DOI 10.1097/MAO.0b013e3181820246; Weatherall DJ, 1997, BRIT MED J, V314, P1675, DOI 10.1136/bmj.314.7095.1675; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Woodgate RL, 2014, CANCER NURS, V37, P146, DOI 10.1097/NCC.0b013e31829ded29	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154348	10.1371/journal.pone.0154348	http://dx.doi.org/10.1371/journal.pone.0154348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK8XE	27123580	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700072
J	McFadden-Hiller, JE; Beyer, DE; Belant, JL				McFadden-Hiller, Jamie E.; Beyer, Dean E., Jr.; Belant, Jerrold L.			Spatial Distribution of Black Bear Incident Reports in Michigan	PLOS ONE			English	Article							CARNIVORE CONSERVATION; CONFLICTS; SELECTION; BEHAVIOR; ROADS; MANAGEMENT; PATTERNS; PROGRAMS; SPACE	Interactions between humans and carnivores have existed for centuries due to competition for food and space. American black bears are increasing in abundance and populations are expanding geographically in many portions of its range, including areas that are also increasing in human density, often resulting in associated increases in human-bear conflict (hereafter, bear incidents). We used public reports of bear incidents in Michigan, USA, from 2003-2011 to assess the relative contributions of ecological and anthropogenic variables in explaining the spatial distribution of bear incidents and estimated the potential risk of bear incidents. We used weighted Normalized Difference Vegetation Index mean as an index of primary productivity, region (i.e., Upper Peninsula or Lower Peninsula), primary and secondary road densities, and percentage land cover type within 6.5-km(2) circular buffers around bear incidents and random points. We developed 22 a priori models and used generalized linear models and Akaike's Information Criterion (AIC) to rank models. The global model was the best compromise between model complexity and model fit (w = 0.99), with a Delta AIC 8.99 units from the second best performing model. We found that as deciduous forest cover increased, the probability of bear incident occurrence increased. Among the measured anthropogenic variables, cultivated crops and primary roads were the most important in our AIC-best model and were both positively related to the probability of bear incident occurrence. The spatial distribution of relative bear incident risk varied markedly throughout Michigan. Forest cover fragmented with agriculture and other anthropogenic activities presents an environment that likely facilitates bear incidents. Our map can help wildlife managers identify areas of bear incident occurrence, which in turn can be used to help develop strategies aimed at reducing incidents. Researchers and wildlife managers can use similar mapping techniques to assess locations of specific conflict types or to address human impacts on endangered species.	[McFadden-Hiller, Jamie E.; Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Starkville, MS USA; [Beyer, Dean E., Jr.] Michigan Dept Nat Resources, Wildlife Div, Marquette, MI USA	Mississippi State University	McFadden-Hiller, JE; Belant, JL (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Starkville, MS USA.	jem739@msstate.edu; j.belant@msstate.edu	Belant, Jerrold/HDM-7749-2022		Mississippi State University; Michigan Department of Natural Resources	Mississippi State University; Michigan Department of Natural Resources	This study was supported by Mississippi State University and Michigan Department of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DA, 1995, 178 GTRNC US FOR SER; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baruch-Mordo S, 2008, J WILDLIFE MANAGE, V72, P1853, DOI 10.2193/2007-442; Baruch-Mordo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085122; Beckmann Jon P., 2008, Human-Wildlife Conflicts, V2, P168; Beckmann JP, 2004, WILDLIFE SOC B, V32, P1141, DOI 10.2193/0091-7648(2004)032[1141:EODTAD]2.0.CO;2; Belant JL, 2011, URSUS, V22, P9, DOI 10.2192/URSUS-D-10-00011.1; BELANT JL, 2011, HUM WILDLIFE CONFLIC, V0001, P00001; Beyer H. L, 2012, GEOSPATIAL MODELLING; Boitani L, 2000, 113 COUNC EUR; Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carter N., 2007, THESIS U MICHIGAN; Carter NH, 2010, URSUS, V21, P57, DOI 10.2192/09GR011.1; City and County of Denver Technology Service/G.I.S. Data, 2011, CENS BLOCKS 2010 VEC; Conover M., 2002, RESOLVING HUMAN WILD; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Ditmer MA, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00199.1; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Dreher BP, 2007, J WILDLIFE MANAGE, V71, P2684, DOI 10.2193/2006-398; Elfstrom M, 2014, MAMMAL REV, V44, P5, DOI 10.1111/j.1365-2907.2012.00223.x; Ellis RD, 2012, LANDSCAPE ECOL, V27, P1, DOI 10.1007/s10980-011-9671-6; Environmental Systems Research Institute Inc., 2014, ARCGIS VERS 10 2; Etter DR, 2003, 17 E BLACK BEAR WORK, P41; Etter DR, 2002, W127R20 MICH DEP NAT; Evans MJ, 2014, J WILDLIFE MANAGE, V78, P1477, DOI 10.1002/jwmg.796; Fecske DM, 2002, SOUTHEAST NAT, V1, P77, DOI 10.1656/1528-7092(2002)001[0077:HUBFBB]2.0.CO;2; FHWA, 2013, HIGHW FUNCT CLASS CO; Gompper ME, 2015, SCIENCE, V347, P381, DOI 10.1126/science.347.6220.382-b; Gore ML, 2006, WILDLIFE SOC B, V34, P36, DOI 10.2193/0091-7648(2006)34[36:SPORAW]2.0.CO;2; Gore ML, 2006, URSUS, V17, P75, DOI 10.2192/1537-6176(2006)17[75:EPFRAB]2.0.CO;2; Gray RM, 2004, URSUS, V15, P188, DOI 10.2192/1537-6176(2004)015<0188:FWABBI>2.0.CO;2; HELLGREN E.C., 1992, E WORKSH P BLACK BEA, V11, P154; Herrero S, 1972, ASPECTS EVOLUTION AD, P221; Hexagon Geospatial, 2012, ERDAS IM 2013; Hijmans RJ., 2015, PACKAGE RASTER R PAC; Hiller TL, 2015, J ZOOL, V296, P200, DOI 10.1111/jzo.12234; Hiller TL, 2015, URSUS, V26, P116, DOI 10.2192/URSUS-D-15-00023.1; Hopkins JB, 2010, URSUS, V21, P154, DOI 10.2192/URSUS-D-10-00005.1; Hostetler JA, 2009, BIOL CONSERV, V142, P2456, DOI 10.1016/j.biocon.2009.05.029; Jones Mark D., 2003, Ursus (Knoxville), V14, P188; Kellert SR, 1996, CONSERV BIOL, V10, P977, DOI 10.1046/j.1523-1739.1996.10040977.x; Kerley LL, 2002, CONSERV BIOL, V16, P97, DOI 10.1046/j.1523-1739.2002.99290.x; Kretser HE, 2008, LANDSCAPE URBAN PLAN, V84, P282, DOI 10.1016/j.landurbplan.2007.08.007; Leigh Jennifer, 2008, Human-Wildlife Conflicts, V2, P175; Lemelin RH, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P91, DOI 10.1079/9781845933456.0091; Manly BFJ., 2002, RESOURCE SELECTION A, P83; Manville A.M, 1983, INT C BEAR RES MANAG, V5, P20; McKinley BK, 2014, HUM-WILDL INTERACT, V8, P228; Merkle JA, 2013, J MAMMAL, V94, P378, DOI 10.1644/12-MAMM-A-002.1; Merkle JA, 2011, J WILDLIFE MANAGE, V75, P1121, DOI 10.1002/jwmg.153; Michigan Department of Natural Resources, 2001, MICH UPP PEN GAP AN; Michigan Department of Natural Resources, 2001, MICH LOW PEN GAP LAN; Michigan Department of Natural Resources, 1992, MIRIS BAS DAT LAND M; Michigan Department of Technology Management and Budget, 2002, MICH GEOGR FRAM STAT; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Pelton M. R., 2003, BLACK BEAR URSUS AM, P547; Peyton RB, 2001, ASSESSMENT SOCIAL CA; Public Sector Consultants, 2001, MICH LAND RES PROJ; Reynolds-Hogland MJ, 2007, J MAMMAL, V88, P1050, DOI 10.1644/06-MAMM-A-072R1.1; Riitters KH, 2003, FRONT ECOL ENVIRON, V1, P125, DOI 10.1890/1540-9295(2003)001[0125:HFTTNR]2.0.CO;2; Shepherd B, 2006, ECOL SOC, V11; Sheskin D. J., 2007, HDB PARAMETRIC NONPA; Stillfried M, 2015, BEHAV PROCESS, V120, P30, DOI 10.1016/j.beproc.2015.08.003; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Tyre AJ, 2000, AUSTRAL ECOL, V25, P327, DOI 10.1111/j.1442-9993.2000.tb00037.x; U.S. Geological Survey, 2011, NAT LAND COV DAT 200; U.S. Geological Survey Earth Resources Observation and Science Center, 2016, EARTHEXPLORER VEG MO; Vaughan MR, 1990, T INT UNION GAME BIO, V19, P581; Wagner KK, 1997, WILDLIFE SOC B, V25, P312; Waller BW, 2014, MAMM STUDY, V39, P115, DOI 10.3106/041.039.0207; Waller JS, 2005, J WILDLIFE MANAGE, V69, P985, DOI 10.2193/0022-541X(2005)069[0985:EOTIOG]2.0.CO;2; Wildlife Division, 2009, 3497 WILDL DIV MICH; Wilton CM, 2014, URSUS, V25, P53, DOI 10.2192/URSUS-D-13-00017.1; Wolgast L. J., 2005, COMPREHENSIVE BLACK; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woodroffe R., 2005, CONSERV BIOL; [No title captured]	81	8	8	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154474	10.1371/journal.pone.0154474	http://dx.doi.org/10.1371/journal.pone.0154474			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119344	Green Published, Green Submitted, gold			2022-12-26	WOS:000374976200081
J	Allen, DJ; Trainor, E; Callaghan, A; O'Brien, SJ; Cunliffe, NA; Iturriza-Gomara, M				Allen, David J.; Trainor, Eamonn; Callaghan, Anna; O'Brien, Sarah J.; Cunliffe, Nigel A.; Iturriza-Gomara, Miren			Early Detection of Epidemic GII-4 Norovirus Strains in UK and Malawi: Role of Surveillance of Sporadic Acute Gastroenteritis in Anticipating Global Epidemics	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; NATIONAL SURVEILLANCE; GENERAL-PRACTICE; UNITED-KINGDOM; COMMUNITY; CHILDREN; OUTBREAKS; ENGLAND; TRANSMISSION; NOMENCLATURE	Noroviruses are endemic in the human population, and are recognised as a leading cause of acute gastroenteritis worldwide. Although they are a highly diverse group of viruses, genogroup-II genotype-4 (GII-4) noroviruses are the most frequently identified strains worldwide. The predominance of GII-4 norovirus strains is driven by the periodic emergence of antigenic variants capable of evading herd protection. The global molecular epidemiology of emerging GII-4 strains is largely based on data from outbreak surveillance programmes, but the epidemiology of GII-4 strains among sporadic or community cases is far less well studied. To understand the distribution of GII-4 norovirus strains associated with gastroenteritis in the wider population, we characterised the GII-4 norovirus strains detected during studies of sporadic cases of infectious gastroenteritis collected in the UK and Malawi between 1993 and 2009. Our data shows that GII-4 norovirus strains that have emerged as strains of global epidemic importance have circulated in the community up to 18 years before their recognition as pandemic strains associated with increases in outbreaks. These data may suggest that more comprehensive surveillance programmes that incorporate strains associated with sporadic cases may provide a way for early detection of emerging strains with pandemic potential. This may be of particular relevance as vaccines become available.	[Allen, David J.; Callaghan, Anna] Publ Hlth England, Virus Reference Dept, London, England; [Trainor, Eamonn; Cunliffe, Nigel A.; Iturriza-Gomara, Miren] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Callaghan, Anna] London Sch Hyg & Trop Med, Pathogen Mol Biol Unit, London WC1, England; [O'Brien, Sarah J.] Univ Liverpool, Dept Epidemiol & Publ Hlth, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Allen, David J.; O'Brien, Sarah J.; Iturriza-Gomara, Miren] Univ Liverpool, NIHR Hlth Protect Res Unit Gastrointestinal Infec, Liverpool L69 3BX, Merseyside, England; [Trainor, Eamonn] St Helens & Knowsley Teaching Hosp NHS Trust, Liverpool, Merseyside, England	Public Health England; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; University of Liverpool	Iturriza-Gomara, M (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England.; Iturriza-Gomara, M (corresponding author), Univ Liverpool, NIHR Hlth Protect Res Unit Gastrointestinal Infec, Liverpool L69 3BX, Merseyside, England.	M.Iturriza-Gomara@liverpool.ac.uk	Gomara, Miren Iturriza/B-4351-2013	Gomara, Miren Iturriza/0000-0001-5816-6423; O'Brien, Sarah Jane/0000-0003-2896-8999; Callaghan, Anna/0000-0003-1160-2376; Allen, David/0000-0002-1194-0415	Wellcome Trust; National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool	MIG receives support from The Wellcome Trust and the National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool. DJA receives support from the National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Alfano-Sobsey E, 2012, EPIDEMIOL INFECT, V140, P276, DOI 10.1017/S0950268811000665; Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Allen DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088978; Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; Cunliffe NA, 2010, J INFECT DIS, V202, pS168, DOI 10.1086/653577; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001807; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Malek Mark, 2009, Clin Infect Dis, V48, P31, DOI 10.1086/594118; Morter S, 2011, J HOSP INFECT, V77, P106, DOI 10.1016/j.jhin.2010.09.035; O'Brien SJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-39; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Shioda K, 2015, VACCINE, V33, P4065, DOI 10.1016/j.vaccine.2015.05.051; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Trainor E, 2013, J MED VIROL, V85, P1299, DOI 10.1002/jmv.23589; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Xerry J, 2008, J CLIN MICROBIOL, V46, P947, DOI 10.1128/JCM.02240-07; Zakikhany K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041625; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	31	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0146972	10.1371/journal.pone.0146972	http://dx.doi.org/10.1371/journal.pone.0146972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115152	Green Published, gold, Green Accepted			2022-12-26	WOS:000374973600006
J	Shen, HC; Tang, SY; Mahapatra, T; Tucker, JD; Huang, SJ; Yang, B; Zhao, JK; Detels, R; Tang, WM				Shen, Hongcheng; Tang, Songyuan; Mahapatra, Tanmay; Tucker, Joseph D.; Huang, Shujie; Yang, Bin; Zhao, Jinkou; Detels, Roger; Tang, Weiming			Condomless Vaginal Intercourse and Its Associates among Men Who Have Sex with Men in China	PLOS ONE			English	Article							BISEXUAL MEN; HIV; METAANALYSIS; PREVALENCE; SYPHILIS	Background HIV prevalence has increased rapidly among men who have sex with men (MSM) in China reaching alarmingly high levels in some cities. Bisexual MSM have potential to transmit HIV and syphilis to their female partners through condomless vaginal intercourse (CVI). Thus, estimation of the burden of CVI and identification of its associates seemed necessary to control this cross-gender transmission. Method In a cross-sectional study, using respondent-driven-sampling and snowball sampling, 2958 MSM were recruited from seven Chinese cities, interviewed and tested for HIV and syphilis. Descriptive analysis of the socio-demographic and behaviors followed by simple and multiple logistic regressions [adjusted for income, city, race and social network size to determine adjusted odds ratio (aOR)] were performed using SAS-9.1. Results Among participating MSM, 19.03% were engaged in CVI. Prevalence of HIV and syphilis among participants involved in CVI were 5.86% and 14.74% respectively. MSM who were older [aOR for aged 40-49 = 2.60 (95% CI: 1.54-4.37)], married [aOR = 6.13 (4.95-7.58)], attended primary school or below [aOR = 3.86 (2.26-6.69)], met male partners at spa/bath-house/sauna/massage parlor [aOR = 3.52 (2.62-4.72)] and had heterosexual orientation [aOR = 13.81 (7.14-26.70)] were more likely to have CVI. Furthermore, correct knowledge regarding HIV [aOR = 0.70 (0.55, 0.88)] and exposure to HIV prevention interventions [aOR = 0.67 (0.54, 0.82)] were negatively associated with CVI. Conclusions CVI was found to be common among MSM in China. To minimize the transmission of HIV and syphilis from bisexual MSM to their relatively female partners, targeted interventions should specifically focus on bisexual MSM especially the older and married subgroups.	[Shen, Hongcheng; Tang, Songyuan; Huang, Shujie; Yang, Bin; Tang, Weiming] Guangdong Prov Ctr Skin Dis & STI Control, Guangzhou, Guangdong, Peoples R China; [Tang, Songyuan; Tucker, Joseph D.; Tang, Weiming] Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China; [Mahapatra, Tanmay; Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Monitoring & Evaluat Unit, Geneva, Switzerland	University of California System; University of California Los Angeles	Tang, WM (corresponding author), Guangdong Prov Ctr Skin Dis & STI Control, Guangzhou, Guangdong, Peoples R China.; Tang, WM (corresponding author), Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China.	weimingtangscience@gmail.com		Zhao, Jinkou/0000-0001-9184-3385; Tucker, Joseph/0000-0003-2804-1181	National Institutes of Health [National Institute of Allergy and Infectious Diseases] [1R01AI114310]; UNC-South China STD Research Training Centre [Fogarty International Centre] [1D43TW009532]; UNC Center for AIDS Research [National Institute of Allergy and Infectious Diseases] [5P30AI050410]; UNC Chapel Hill, Johns Hopkins University, Morehead School of Medicine and Tulane University (UJMT) Fogarty Fellowship [FIC R25TW0093]; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114310, P30AI050410] Funding Source: NIH RePORTER	National Institutes of Health [National Institute of Allergy and Infectious Diseases](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNC-South China STD Research Training Centre [Fogarty International Centre]; UNC Center for AIDS Research [National Institute of Allergy and Infectious Diseases]; UNC Chapel Hill, Johns Hopkins University, Morehead School of Medicine and Tulane University (UJMT) Fogarty Fellowship; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health [National Institute of Allergy and Infectious Diseases 1R01AI114310]; UNC-South China STD Research Training Centre [Fogarty International Centre 1D43TW009532]; UNC Center for AIDS Research [National Institute of Allergy and Infectious Diseases 5P30AI050410]; and the UNC Chapel Hill, Johns Hopkins University, Morehead School of Medicine and Tulane University (UJMT) Fogarty Fellowship [FIC R25TW0093].	[Anonymous], 2014, UNAIDS REPORT GLOBAL; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Cai YuMao, 2007, China Tropical Medicine, V7, P2131; Chow EPF, 2012, INT J INFECT DIS, V16, pE312, DOI 10.1016/j.ijid.2012.01.012; Chow EPF, 2012, AIDS BEHAV, V16, P653, DOI 10.1007/s10461-011-9935-9; Chow EPF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-242; Das A, 2015, INT J STD AIDS, V26, P145, DOI 10.1177/0956462414531560; Fan S, 2012, AIDS PATIENT CARE ST, V26, P148, DOI 10.1089/apc.2011.0277; Godbole S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107439; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Liao MZ, 2011, AIDS PATIENT CARE ST, V25, P683, DOI 10.1089/apc.2010.0371; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu HJ, 2009, AIDS PATIENT CARE ST, V23, P885, DOI 10.1089/apc.2009.0043; Neilands TB, 2008, ARCH SEX BEHAV, V37, P838, DOI 10.1007/s10508-007-9305-x; Qi Jinlei, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P399; Quan SC, 2005, CELL RES, V15, P58; Rutledge SE, 2005, AIDS PATIENT CARE ST, V19, P186, DOI 10.1089/apc.2005.19.186; Tang WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077645; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; Tao J, 2013, AIDS PATIENT CARE ST, V27, P524, DOI 10.1089/apc.2013.0161; Wang C, 2007, CHINESE J HLTH LAB T, V17, P2291; Wang L, 2012, CHINESE MED J-PEKING, V125, P1857, DOI 10.3760/cma.j.issn.0366-6999.2012.11.003; Zhang B., 2000, CHIN J STD AIDS PREV, V3, P155; Zhang B, 2008, CHINJ HUM SEX, V17, P6; Zule WA, 2009, J URBAN HEALTH, V86, pS48, DOI 10.1007/s11524-009-9366-3	26	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154132	10.1371/journal.pone.0154132	http://dx.doi.org/10.1371/journal.pone.0154132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115604	Green Published, Green Accepted, gold			2022-12-26	WOS:000374973600045
J	Zhang, QH; Huang, FF; Liu, ZL; Zhang, N; Mahapatra, T; Tang, WM; Lei, Y; Dai, YL; Tang, SY; Zhang, JP				Zhang, Qinghua; Huang, Feifei; Liu, Zaoling; Zhang, Na; Mahapatra, Tanmay; Tang, Weiming; Lei, Yang; Dai, Yali; Tang, Songyuan; Zhang, Jingping			Cross-Cultural Validation of the High Blood Pressure Health Literacy Scale in a Chinese Community	PLOS ONE			English	Article							HYPERTENSION; PREVALENCE; OUTCOMES; ADULTS; CARE; RECOMMENDATIONS; INTERVENTION; AWARENESS; VALIDITY; DISEASE	Background Considering the importance of health literacy (HL) for the maximum yield from the hypertension control programs, development of a reliable and valid instrument of hypertension-related HL is critical. This study aimed to translate and validate the High Blood Pressure-Health Literacy Scale (HBP-HLS) into Chinese (C-HBP-HLS) and evaluate its psychometric properties in Chinese context. Method Between June 2013 and January 2014, a cross-sectional study was conducted among recruited hypertensive patients belonging to the Han and Kazakh-Chinese communities in Urumqi, Xinjiang, China. Results A pilot sample (n = 242) was selected for the exploratory factor analysis of the translated and modified instrument. Another sample (n = 308) was recruited for the confirmatory factor analysis. C-HBP-HLS consisted of five dimensions (Print Health Literacy, Medication Label, Understanding Ability, Newest Vital Sign Test, and Avoiding Food Allergy) containing 15 items, accounting for 77.7% of the total variance. The 5-factor model demonstrated a good overall fit. The scale-level content validity index was 0.85. Cronbach's alpha of the overall scale was 0.78 and test-retest reliability was 0.96. Education level had a strong positive correlation with the scores for items Q1, Q2, and Q3(r = 0.481, 0.492, 0.475, respectively). Health Literacy scores among Kazakh patients were significantly lower than Han (7.13 +/- 7.90 vs. 30.10 +/- 13.42, Z = -14.573, P<0.001). Conclusion C-HBP-HLS demonstrated suitable factor structure and robust psychometric properties for measuring health literacy level among hypertensive patients in China.	[Zhang, Qinghua; Lei, Yang; Zhang, Jingping] Cent S Univ, Xiang Ya Nursing Sch, Changsha, Hunan, Peoples R China; [Zhang, Qinghua; Dai, Yali] XinJiang Med Univ, Sch Nursing, Urumqi, Xinjiang, Peoples R China; [Huang, Feifei] FuJian Med Univ, Sch Nursing, Fuzhou, Fu Jian, Peoples R China; [Liu, Zaoling] XinJiang Med Univ, Sch Publ Hlth, Urumqi, Xinjiang, Peoples R China; [Zhang, Na] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Mahapatra, Tanmay] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Tang, Weiming; Tang, Songyuan] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China	Central South University; Xinjiang Medical University; Fujian Medical University; Xinjiang Medical University; University of Hong Kong; University of California System; University of California Los Angeles	Zhang, JP (corresponding author), Cent S Univ, Xiang Ya Nursing Sch, Changsha, Hunan, Peoples R China.	jpzhang1965@163.com	Zhang, Jingping/ABA-4179-2020	Zhang, Jingping/0000-0002-7800-9617	Fundamental Research Funds for the Central South University [2013zzts079]; Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China [15YJCZH223]	Fundamental Research Funds for the Central South University; Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China	This study was supported by the Fundamental Research Funds for the Central South University (number 2013zzts079) and the Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China(number 15YJCZH223).	Bryant FB, 1999, ACAD EMERG MED, V6, P54, DOI 10.1111/j.1553-2712.1999.tb00096.x; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Davis T C, 1991, Fam Med, V23, P433; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Fransen Mirjam P, 2013, Ned Tijdschr Geneeskd, V157, pA5581; Gaskin CJ, 2014, INT J NURS STUD, V51, P511, DOI 10.1016/j.ijnurstu.2013.10.005; Hancock G.R., 2001, STRUCTURAL EQUATION, P195; Heinrich C, 2012, J AM ACAD NURSE PRAC, V24, P218, DOI 10.1111/j.1745-7599.2012.00698.x; Howard DH, 2005, AM J MED, V118, P371, DOI 10.1016/j.amjmed.2005.01.010; Jones K, 2014, COMMUNITY DENT HLTH, V31, P37, DOI 10.1922/CDH_3269Jones07; Kim KB, 2014, AM J HYPERTENS, V27, P1199, DOI 10.1093/ajh/hpu041; Kim MT, 2012, PATIENT EDUC COUNS, V87, P165, DOI 10.1016/j.pec.2011.09.005; Leung AYM, 2013, J HEALTH COMMUN, V18, P205, DOI 10.1080/10810730.2013.829138; Markus KA, 2012, STRUCT EQU MODELING, V19, P509, DOI 10.1080/10705511.2012.687667; McNaughton CD, 2014, PATIENT EDUC COUNS, V96, P165, DOI 10.1016/j.pec.2014.05.007; Nguyen TH, 2014, PATIENT, V7, P23, DOI 10.1007/s40271-013-0041-0; Oke AE, 2012, CONSTR ECON BUILD, V12, P89, DOI 10.5130/AJCEB.v12i3.2658; Omachi TA, 2013, J GEN INTERN MED, V28, P74, DOI 10.1007/s11606-012-2177-3; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Parker R, 2010, J HEALTH COMMUN, V15, P20, DOI 10.1080/10810730.2010.501094; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Shi Jingcheng, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P152, DOI 10.3969/j.issn.1672-7347.2012.02.007; Sperber NR, 2013, HEALTH EDUC RES, V28, P502, DOI 10.1093/her/cyt043; Suka M, 2013, ENVIRON HEALTH PREV, V18, P407, DOI 10.1007/s12199-013-0340-z; Tadakamadla SK, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-120; Tao J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-185; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu053; Xi B, 2012, INT J CARDIOL, V158, P326, DOI 10.1016/j.ijcard.2012.04.140; Zhai Yi, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P744; Zhao QL, 2014, APPL DEV NURSING ASS	30	12	15	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0152182	10.1371/journal.pone.0152182	http://dx.doi.org/10.1371/journal.pone.0152182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27116336	Green Published, gold			2022-12-26	WOS:000374973600015
J	Ziemba, AM; Forman, SA				Ziemba, Alexis M.; Forman, Stuart A.			Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of alpha 1 beta 3 gamma 2L GABA(A) Receptors	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN; ETOMIDATE SITES; SUBUNIT; BARBITURATE; CHANNEL; BINDING; IDENTIFICATION; ANESTHETICS; MUTATIONS; BLOCK	Background Pentobarbital, like propofol and etomidate, produces important general anesthetic effects through GABA(A) receptors. Photolabeling also indicates that pentobarbital binds to some of the same sites where propofol and etomidate act. Quantitative allosteric co-agonist models for propofol and etomidate account for modulatory and agonist effects in GABA(A) receptors and have proven valuable in establishing drug site characteristics and for functional analysis of mutants. We therefore sought to establish an allosteric co-agonist model for pentobarbital activation and modulation of alpha 1 beta 3 gamma 2L receptors, using a novel approach to first correct pentobarbital activation data for inhibitory effects in the same concentration range. Methods Using oocyte-expressed alpha 1 beta 3 gamma 2L GABA(A) receptors and two-microelectrode voltage-clamp, we quantified modulation of GABA responses by a low pentobarbital concentration and direct effects of high pentobarbital concentrations, the latter displaying mixed agonist and inhibitory effects. We then isolated and quantified pentobarbital inhibition in activated receptors using a novel single-sweep "notch" approach, and used these results to correct steady-state direct activation for inhibition. Results Combining results for GABA modulation and corrected direct activation, we estimated receptor open probability and optimized parameters for a Monod-Wyman-Changeux allosteric co-agonist model. Inhibition by pentobarbital was consistent with two sites with IC(50)s near 1 mM, while co-agonist model parameters suggest two allosteric pentobarbital agonist sites characterized by K-PB approximate to 5 mM and high efficacy. The results also indicate that pentobarbital may be a more efficacious agonist than GABA. Conclusions Our novel approach to quantifying both inhibitory and co-agonist effects of pentobarbital provides a basis for future structure-function analyses of GABA(A) receptor mutations in putative pentobarbital binding sites.	[Ziemba, Alexis M.; Forman, Stuart A.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Ziemba, Alexis M.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA	Harvard University; Massachusetts General Hospital; Rensselaer Polytechnic Institute	Forman, SA (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	saforman@partners.org	Forman, Stuart/Q-6590-2019; Ziemba, Alexis/GRJ-4381-2022	Forman, Stuart/0000-0001-6340-2478; Ziemba, Alexis M/0000-0001-8947-9617	NIH [P01 GM058448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant to SAF from NIH (P01 GM058448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2000, BRIT J PHARMACOL, V130, P249, DOI 10.1038/sj.bjp.0703335; Akk G, 2004, J PHYSIOL-LONDON, V556, P387, DOI 10.1113/jphysiol.2003.058230; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Bevington P. R., 2002, DATA REDUCTION ERROR; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; CHRISTENSEN HD, 1973, TOXICOL APPL PHARM, V26, P495, DOI 10.1016/0041-008X(73)90287-1; Desai R, 2015, J PHYSIOL-LONDON, V593, P4943, DOI 10.1113/JP270971; Desai R, 2009, ANESTHESIOLOGY, V111, P774, DOI 10.1097/ALN.0b013e3181b55fae; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; Forman SA, 2012, METHODS MOL BIOL, V796, P317, DOI 10.1007/978-1-61779-334-9_17; Gingrich KJ, 2009, J GEN PHYSIOL, V133, P171, DOI 10.1085/jgp.200810081; Guitchounts G, 2012, ANESTHESIOLOGY, V116, P1235, DOI 10.1097/ALN.0b013e3182567df3; Husain SS, 2010, J MED CHEM, V53, P6432, DOI 10.1021/jm100498u; Jayakar SS, 2015, J BIOL CHEM, V290, P23432, DOI 10.1074/jbc.M115.672006; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Krampfl K, 2002, EUR J PHARMACOL, V435, P1, DOI 10.1016/S0014-2999(01)01558-8; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Maldifassi MC, 2016, NEUROPHARMACOLOGY, V105, P207, DOI 10.1016/j.neuropharm.2016.01.003; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Raines DE, 2003, ANESTH ANALG, V96, P112, DOI 10.1097/00000539-200301000-00024; Ruesch D, 2012, ANESTHESIOLOGY, V116, P47, DOI 10.1097/ALN.0b013e31823d0c36; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; Serafini R, 2000, J PHYSIOL-LONDON, V524, P649, DOI 10.1111/j.1469-7793.2000.00649.x; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Thompson SA, 1996, BRIT J PHARMACOL, V117, P521, DOI 10.1111/j.1476-5381.1996.tb15221.x; Tomlin SL, 1999, ANESTHESIOLOGY, V90, P1714, DOI 10.1097/00000542-199906000-00029; Zeller A, 2007, MOL PHARMACOL, V71, P852, DOI 10.1124/mol.106.030049	28	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154031	10.1371/journal.pone.0154031	http://dx.doi.org/10.1371/journal.pone.0154031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110714	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600029
J	Hayat, T; Nawaz, S; Alsaedi, A; Rafiq, M				Hayat, Tasawar; Nawaz, Sadaf; Alsaedi, Ahmed; Rafiq, Maimona			Mixed Convective Peristaltic Flow of Water Based Nanofluids with Joule Heating and Convective Boundary Conditions	PLOS ONE			English	Article							TRANSPORT; FLUID; MHD; CHANNEL; MODEL; MOTION; SLIP; HALL	Main objective of present study is to analyze the mixed convective peristaltic transport of water based nanofluids using five different nanoparticles i.e. (Al2O3, CuO, Cu, Ag and TiO2). Two thermal conductivity models namely the Maxwell's and Hamilton-Crosser's are used in this study. Hall and Joule heating effects are also given consideration. Convection boundary conditions are employed. Furthermore, viscous dissipation and heat generation/absorption are used to model the energy equation. Problem is simplified by employing lubrication approach. System of equations are solved numerically. Influence of pertinent parameters on the velocity and temperature are discussed. Also the heat transfer rate at the wall is observed for considered five nanofluids using the two phase models via graphs.	[Hayat, Tasawar; Nawaz, Sadaf; Rafiq, Maimona] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Nawaz, S (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.	sadafnawaz26@gmail.com	Rafiq, Maimona/AAM-7714-2020; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasi FM, 2015, J MOL LIQ, V207, P248, DOI 10.1016/j.molliq.2015.03.042; Abbasi FM, 2015, J MAGN MAGN MATER, V382, P104, DOI 10.1016/j.jmmm.2015.01.040; Abbasi FM, 2015, PHYSICA E, V68, P123, DOI 10.1016/j.physe.2014.12.026; Abbasi FM, 2015, PHYSICA E, V67, P47, DOI 10.1016/j.physe.2014.11.002; Abbasi FM, 2015, Z NATURFORSCH A, V70, P125, DOI 10.1515/zna-2014-0213; Abbasi FM, 2014, Z NATURFORSCH A, V69, P451, DOI 10.5560/ZNA.2014-0041; Abbasi FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105440; Akram S, 2014, J MAGN MAGN MATER, V358, P183, DOI 10.1016/j.jmmm.2014.01.052; Ali N, 2013, Z NATURFORSCH A, V68, P515, DOI 10.5560/ZNA.2013-0033; [Anonymous], 1967, P WORKSH URET REFL C; Asghar S., 2013, Mathematical and Computational Applications, V18, P198; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; Ebaid A, 2014, COMPUT MATH APPL, V68, P77, DOI 10.1016/j.camwa.2014.05.008; Ellahi R, 2015, J MAGN MAGN MATER, V393, P284, DOI 10.1016/j.jmmm.2015.05.071; HAMILTON RL, 1962, IND ENG CHEM FUND, V1, P187, DOI 10.1021/i160003a005; Hayat T, 2015, INT J BIOMATH, V8, DOI 10.1142/S1793524515500734; Hayat T, 2014, SAINS MALAYS, V43, P1583; Hayat T, 2014, J MOL LIQ, V194, P93, DOI 10.1016/j.molliq.2014.01.021; Hayat T, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14063-9; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4923396; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095070; Hina S, 2014, APPL MATH MECH-ENGL, V35, P73, DOI 10.1007/s10483-014-1773-7; Khan JA, 2015, INT J HEAT MASS TRAN, V86, P158, DOI 10.1016/j.ijheatmasstransfer.2015.02.078; Lin YH, 2015, INT J HEAT MASS TRAN, V84, P903, DOI 10.1016/j.ijheatmasstransfer.2015.01.099; Maxwell JC., 1904, TREATISE ELECT MAGNE, P435; Mekheimer KS, 2013, INT J BIOMATH, V6, DOI 10.1142/S1793524513500265; Munir AF, 2014, J CENT SOUTH UNIV, V21, P1411, DOI 10.1007/s11771-014-2079-0; Shehzad SA, 2015, J MOL LIQ, V209, P723, DOI 10.1016/j.molliq.2015.05.058; Shehzad SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111417; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; SrinivaS S, 2008, INT COMMUN HEAT MASS, V35, P514, DOI 10.1016/j.icheatmasstransfer.2007.08.011; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2014, COMPUT FLUIDS, V94, P139, DOI 10.1016/j.compfluid.2014.02.009; Weinberg Steven Louis, 1970, PHD DISS	35	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153537	10.1371/journal.pone.0153537	http://dx.doi.org/10.1371/journal.pone.0153537			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104596	gold, Green Published, Green Submitted			2022-12-26	WOS:000374565100012
J	Vigna, BBZ; Santos, JCS; Jungmann, L; do Valle, CB; Mollinari, M; Pastina, MM; Pagliarini, MS; Garcia, AAF; Souza, AP				Vigna, Bianca B. Z.; Santos, Jean C. S.; Jungmann, Leticia; do Valle, Cacilda B.; Mollinari, Marcelo; Pastina, Maria M.; Pagliarini, Maria Suely; Garcia, Antonio A. F.; Souza, Anete P.			Evidence of Allopolyploidy in Urochloa humidicola Based on Cytological Analysis and Genetic Linkage Mapping	PLOS ONE			English	Article							POACEAE PANICOIDEAE PANICEAE; DOSE RESTRICTION FRAGMENTS; SPP. COMMERCIAL CROSS; GENOMIC REGION; PENNISETUM-SQUAMULATUM; BRACHIARIA-BRIZANTHA; CENCHRUS-CILIARIS; MEIOTIC BEHAVIOR; SACCHARUM SPP.; AFLP MARKERS	The African species Urochloa humidicola (Rendle) Morrone & Zuloaga (syn. Brachiaria humidicola (Rendle) Schweick.) is an important perennial forage grass found throughout the tropics. This species is polyploid, ranging from tetra to nonaploid, and apomictic, which makes genetic studies challenging; therefore, the number of currently available genetic resources is limited. The genomic architecture and evolution of U. humidicola and the molecular markers linked to apomixis were investigated in a full-sib F-1 population obtained by crossing the sexual accession H031 and the apomictic cultivar U. humidicola cv. BRS Tupi, both of which are hexaploid. A simple sequence repeat (SSR)-based linkage map was constructed for the species from 102 polymorphic and specific SSR markers based on simplex and double-simplex markers. The map consisted of 49 linkage groups (LGs) and had a total length of 1702.82 cM, with 89 microsatellite loci and an average map density of 10.6 cM. Eight homology groups (HGs) were formed, comprising 22 LGs, and the other LGs remained ungrouped. The locus that controls apospory (apo-locus) was mapped in LG02 and was located 19.4 cM from the locus Bh027.c.D2. In the cytological analyses of some hybrids, bi-to hexavalents at diakinesis were observed, as well as two nucleoli in some meiocytes, smaller chromosomes with preferential allocation within the first metaphase plate and asynchronous chromosome migration to the poles during anaphase. The linkage map and the meiocyte analyses confirm previous reports of hybridization and suggest an allopolyploid origin of the hexaploid U. humidicola. This is the first linkage map of an Urochloa species, and it will be useful for future quantitative trait locus (QTL) analysis after saturation of the map and for genome assembly and evolutionary studies in Urochloa spp. Moreover, the results of the apomixis mapping are consistent with previous reports and confirm the need for additional studies to search for a co-segregating marker.	[Vigna, Bianca B. Z.; Santos, Jean C. S.; Souza, Anete P.] Univ Campinas UNICAMP, CBMEG, CP 6010, BR-13083970 Campinas, SP, Brazil; [Vigna, Bianca B. Z.] Embrapa Pecuaria Sudeste, CP 399, BR-13560970 Sao Carlos, SP, Brazil; [Jungmann, Leticia; do Valle, Cacilda B.] Embrapa Gado Corte, Av Radio Maia 830, BR-79106550 Campo Grande, MS, Brazil; [Mollinari, Marcelo; Garcia, Antonio A. F.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Genet, CP 83, BR-13400970 Piracicaba, SP, Brazil; [Pastina, Maria M.] Embrapa Milho & Sorgo, Rod MG 424,Km 65, BR-35701970 Sete Lagoas, MG, Brazil; [Pagliarini, Maria Suely] Univ Maringa UEM, Dept Genet & Cell Biol, Av Colombo,5790,Zona 7, BR-87020900 Maringa, Parana, Brazil; [Souza, Anete P.] Univ Campinas UNICAMP, Inst Biol, Dept Plant Biol, CP6109, BR-13083970 Campinas, SP, Brazil; [Jungmann, Leticia] Embrapa Agroenergia, CP 40-315, BR-70770901 Brasilia, DF, Brazil	Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Souza, AP (corresponding author), Univ Campinas UNICAMP, CBMEG, CP 6010, BR-13083970 Campinas, SP, Brazil.; Souza, AP (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Plant Biol, CP6109, BR-13083970 Campinas, SP, Brazil.	anete@unicamp.br	Garcia, Antonio A F/A-4538-2010; Vigna, Bianca BZ/H-8853-2013; DE SOUZA, ANETE PEREIRA/B-8663-2012; Vigna, Bianca BZ/B-7640-2012; Mollinari, Marcelo/E-7678-2012; Pastina, Maria Marta/F-9216-2011	Garcia, Antonio A F/0000-0003-0634-3277; Vigna, Bianca BZ/0000-0003-0192-9877; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Vigna, Bianca BZ/0000-0003-0192-9877; Mollinari, Marcelo/0000-0002-7001-8498; Pastina, Maria Marta/0000-0002-9112-3457	Brazilian Agricultural Research Corporation (Embrapa); Brazilian National Council for Scientific and Technological Development (CNPq) [478262/2004-3, 502336/2005-6, 482458/2007-0]; State of Sao Paulo Research Foundation (FAPESP) [2005/51010-0, 2008/52197-4]; Foundation for Science and Technological Development of the State of Mato Grosso do Sul (Fundect); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPESP [2007/57022-5, 2010/50032-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - EMBRAPA Program); CNPq [304914/2010-0]; CNPq	Brazilian Agricultural Research Corporation (Embrapa)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Foundation for Science and Technological Development of the State of Mato Grosso do Sul (Fundect); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - EMBRAPA Program); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to acknowledge the financial support of the Brazilian Agricultural Research Corporation (Embrapa), the Brazilian National Council for Scientific and Technological Development (CNPq, http://www.cnpq.br/, grant numbers 478262/2004-3, 502336/2005-6 and 482458/2007-0), the State of Sao Paulo Research Foundation (FAPESP, http://www.fapesp.br/, grant numbers 2005/51010-0 and 2008/52197-4), and the Foundation for Science and Technological Development of the State of Mato Grosso do Sul (Fundect, http://fundect.ledes.net/) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/, Computacional Biology Program). BBZV was the recipient of graduate fellowships (2007/57022-5; 2010/50032-8) from FAPESP; JCS is the recipient of a graduate fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - EMBRAPA Program); APS is the recipient of a research fellowship from CNPq (304914/2010-0); AAFG is the recipient of a research fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adantowski EV, 2007, GENET MOL RES, V6, P616; Aitken KS, 2007, GENOME, V50, P742, DOI 10.1139/G07-056; Akiyama Y, 2005, THEOR APPL GENET, V111, P1042, DOI 10.1007/s00122-005-0020-5; ALJANABI SM, 1993, GENETICS, V134, P1249; Barcaccia G., 2014, Diversity, V6, P633, DOI 10.3390/d6040633; Mendes-Bonato A, 2006, J GENET, V85, P83, DOI 10.1007/BF02728976; Bernini C, 2001, CYTOBIOS, V104, P157; Bethel CM, 2006, THEOR APPL GENET, V112, P727, DOI 10.1007/s00122-005-0177-y; Bitencourt GA, 2007, AN 54 C BRAS GEN 200; Bitencourt GA, 2008, B PESQUISA, V23; Boldrini KR, 2009, GENET MOL RES, V8, P888, DOI [10.4238/vol8-3gmr617, 10.4238/vol8-4gmr679]; Boldrini KR, 2006, J GENET, V85, P225, DOI 10.1007/BF02935337; Boldrini KR, 2010, J GENET, V89, P91, DOI 10.1007/s12041-010-0016-z; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Castiglioni P, 1999, THEOR APPL GENET, V99, P425, DOI 10.1007/s001220051253; Cervantes-Flores JC, 2008, MOL BREEDING, V21, P511, DOI 10.1007/s11032-007-9150-6; Chiappe LM, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3594[1:JBFTEC]2.0.CO;2; Clevenger J, 2015, MOL PLANT, V8, P831, DOI 10.1016/j.molp.2015.02.002; Conner JA, 2008, PLANT PHYSIOL, V147, P1396, DOI 10.1104/pp.108.119081; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; DASILVA JAG, 1993, GENOME, V36, P782, DOI 10.1139/g93-103; de Penteado MIO, 2000, DETERMINACAO PLOIDIA; do Valle CB, 2008, INT C SEX PLANT REPR, V20, P197; Do Valle CD., 1996, BRACHIARIA BIOL AGRO, P147; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Ebina Masumi, 2005, Grassland Science, V51, P71, DOI 10.1111/j.1744-697X.2005.00011.x; Gallo PH, 2007, EUPHYTICA, V154, P255, DOI 10.1007/s10681-006-9294-1; Garcia AAF, 2006, THEOR APPL GENET, V112, P298, DOI 10.1007/s00122-005-0129-6; Garcia AAF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03399; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Goel S, 2006, GENETICS, V173, P389, DOI 10.1534/genetics.105.054429; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Gualtieri G, 2006, PLANT PHYSIOL, V140, P963, DOI 10.1104/pp.105.073809; Hackett CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063939; Hoarau JY, 2001, THEOR APPL GENET, V103, P84, DOI 10.1007/s001220000390; Hojsgaard D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00082; Huo HQ, 2009, THEOR APPL GENET, V119, P199, DOI 10.1007/s00122-009-1029-y; Ishigaki G, 2010, GRASSL SCI, V56, P240, DOI 10.1111/j.1744-697X.2010.00200.x; Jessup RW, 2003, GENOME, V46, P304, DOI [10.1139/g03-005, 10.1139/G03-005]; Jungmann L, 2009, CONSERV GENET RESOUR, V1, P475, DOI 10.1007/s12686-009-9111-y; Jungmann L, 2010, GENOME, V53, P698, DOI [10.1139/G10-055, 10.1139/g10-055]; Keller-Grein G., 1996, BRACHIARIA BIOL AGRO, P16; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Leach LJ, 2010, P NATL ACAD SCI USA, V107, P4270, DOI 10.1073/pnas.0908477107; Lewis MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000815; Lewis MS, 2004, GENETICS, V167, P931, DOI 10.1534/genetics.103.026203; Maliepaard C, 1997, GENET RES, V70, P237, DOI 10.1017/S0016672397003005; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; Mendes DV, 2006, BOT J LINN SOC, V150, P441, DOI 10.1111/j.1095-8339.2006.00493.x; Mendes-Bonato AB, 2006, GENET MOL BIOL, V29, P122, DOI 10.1590/S1415-47572006000100023; Mendes-Bonato AB, 2002, CELL BIOL INT, V26, P641, DOI 10.1006/cbir.2002.0929; Miles JW, 1997, CAN J PLANT SCI, V77, P105, DOI 10.4141/P95-187; Miller JM, 2014, HEREDITY, V112, P240, DOI 10.1038/hdy.2013.99; Ming R, 1998, GENETICS, V150, P1663; Mollinari M, 2009, RES 55 C BRAS GEN AG; Nielen S, 2010, SEX PLANT REPROD, V23, P45, DOI 10.1007/s00497-009-0124-1; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Oliveira KM, 2007, MOL BREEDING, V20, P189, DOI 10.1007/s11032-007-9082-1; Ozias-Akins P, 1998, P NATL ACAD SCI USA, V95, P5127, DOI 10.1073/pnas.95.9.5127; Ozias-Akins Peggy, 2003, Functional & Integrative Genomics, V3, P94, DOI 10.1007/s10142-003-0084-8; Pagliarini MS, 2008, EUPHYTICA, V164, P181, DOI 10.1007/s10681-008-9697-2; Pastina MM, 2012, THEOR APPL GENET, V124, P835, DOI 10.1007/s00122-011-1748-8; Pessino SC, 1997, THEOR APPL GENET, V94, P439, DOI 10.1007/s001220050434; Pessino SC, 1998, HEREDITAS, V128, P153, DOI 10.1111/j.1601-5223.1998.00153.x; Pikaard CS, 2000, PLANT MOL BIOL, V43, P163, DOI 10.1023/A:1006471009225; Porceddu A, 2002, THEOR APPL GENET, V104, P273, DOI 10.1007/s001220100659; Ricci GL, 2011, EUPHYTICA, V182, P355, DOI 10.1007/s10681-011-0486-y; Rife TW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1404-9; Ripol MI, 1999, GENE, V235, P31, DOI 10.1016/S0378-1119(99)00218-8; Risso-Pascotto C, 2006, GENET MOL RES, V5, P797; Risso-Pascotto C, 2006, GENET RESOUR CROP EV, V53, P7, DOI 10.1007/s10722-005-7762-4; Saha MC, 2005, THEOR APPL GENET, V110, P323, DOI 10.1007/s00122-004-1843-1; Santos Jean C S, 2015, BMC Res Notes, V8, P83, DOI 10.1186/s13104-015-1044-9; Serang O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030906; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Stein J, 2007, MOL BREEDING, V20, P153, DOI 10.1007/s11032-007-9083-0; TANKSLEY SD, 1992, GENETICS, V132, P1141; Tate Jennifer A., 2005, P371, DOI 10.1016/B978-012301463-4/50009-7; Tuna M, 2001, CROP SCI, V41, P831, DOI 10.2135/cropsci2001.413831x; Uitdewilligen JGAML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062355; Utsunomiya KS, 2005, BIOCELL, V29, P295; Vigna BBZ, 2011, BMC RES NOTES, V4, P5; WU KK, 1992, THEOR APPL GENET, V83, P294, DOI 10.1007/BF00224274; Wu RL, 2002, GENET RES, V79, P85, DOI 10.1017/S0016672301005389; Wu RL, 2002, THEOR POPUL BIOL, V61, P349, DOI 10.1006/tpbi.2002.1577; YOUNG BA, 1979, CAN J BOT, V57, P1668, DOI 10.1139/b79-204; Zorzatto C, 2010, PLANT BREEDING, V129, P734, DOI 10.1111/j.1439-0523.2010.01763.x	88	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153764	10.1371/journal.pone.0153764	http://dx.doi.org/10.1371/journal.pone.0153764			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104622	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100021
J	Wu, JX; Fu, LL; Yi, HL				Wu, Juxun; Fu, Lili; Yi, Hualin			Genome-Wide Identification of the Transcription Factors Involved in Citrus Fruit Ripening from the Transcriptomes of a Late-Ripening Sweet Orange Mutant and Its Wild Type	PLOS ONE			English	Article							ABSCISIC-ACID RESPONSE; FINGER PROTEIN ZAT12; SINENSIS L. OSBECK; PRUNUS-AVIUM L.; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; ABIOTIC STRESS; ANTHOCYANIN ACCUMULATION; DOMAIN PROTEINS; WEB SERVER	Fruit ripening is a genetically programmed process. Transcription factors (TFs) play key roles in plant development and ripening by temporarily and spatially regulating the transcription of their target genes. In this study, a total of 159 TFs were identified from a spontaneous late-ripening mutant 'Fengwan' (C. sinensis L. Osbeck) sweet orange (MT) and its wild-type counterpart (' Fengjie 72-1', WT) along the ripening period via the Transcription Factor Prediction of PlantTFDB 3.0. Fifty-two differentially expressed TFs were identified between MT and WT; 92 and 120 differentially expressed TFs were identified in WT and MT, respectively. The Venn diagram analysis showed that 16 differentially expressed TFs were identified between MT and WT and during the ripening of WT and MT. These TFs were primarily assigned to the families of C2H2, Dof, bHLH, ERF, MYB, NAC and LBD. Particularly, the number of TFs of the ERF family was the greatest between MT and WT. According to the results of the WGCNA analysis, a weighted correlation network analysis tool, several important TFs correlated to abscisic acid (ABA), citric acid, fructose, glucose and sucrose were identified, such as RD26, NTT, GATA7 and MYB21/62/77. Hierarchical cluster analysis and the expression analysis conducted at five fruit ripening stages further validated the pivotal TFs that potentially function during orange fruit development and ripening.	[Wu, Juxun; Fu, Lili; Yi, Hualin] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Yi, HL (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China.	yihualin@mail.hzau.edu.cn		Wu, Juxun/0000-0003-0785-1927	National Modern Citrus Industry System [CARS-27]; Ministry of Education Innovation Team [IRT13065]; National Science and Technology Support Project [2013BAD021302]; China Postdoctoral Science Foundation [2015M582242]; Special Project on the Integration of Industry, Education and Research of Guangdong Province [2012B091100169]	National Modern Citrus Industry System; Ministry of Education Innovation Team; National Science and Technology Support Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Special Project on the Integration of Industry, Education and Research of Guangdong Province	This research was supported by the National Modern Citrus Industry System (CARS-27), the Ministry of Education Innovation Team (IRT13065), the National Science and Technology Support Project (2013BAD021302), the China Postdoctoral Science Foundation (2015M582242) and the Special Project on the Integration of Industry, Education and Research of Guangdong Province (2012B091100169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Ballester AR, 2010, PLANT PHYSIOL, V152, P71, DOI 10.1104/pp.109.147322; Benjamini Y, 2001, ANN STAT, V29, P1165; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; Borsani J, 2009, J EXP BOT, V60, P1823, DOI 10.1093/jxb/erp055; Cercos M, 2006, PLANT MOL BIOL, V62, P513, DOI 10.1007/s11103-006-9037-7; Chen XY, 2012, PLANT GROWTH REGUL, V66, P271, DOI 10.1007/s10725-011-9651-5; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Chiang YH, 2012, PLANT PHYSIOL, V160, P332, DOI 10.1104/pp.112.198705; Chung MY, 2010, PLANT J, V64, P936, DOI 10.1111/j.1365-313X.2010.04384.x; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Barajas-Lopez JD, 2012, J EXP BOT, V63, P4887, DOI 10.1093/jxb/ers163; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gaur VS, 2011, MOL BIOL REP, V38, P2827, DOI 10.1007/s11033-010-0429-z; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kielbowicz-Matuk A, 2012, PLANT SCI, V185, P78, DOI 10.1016/j.plantsci.2011.11.015; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Kuang JF, 2012, J EXP BOT, V63, P441, DOI 10.1093/jxb/err290; Kumar R, 2009, MOL BIOL REP, V36, P2209, DOI 10.1007/s11033-008-9436-8; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee JM, 2012, PLANT J, V70, P191, DOI 10.1111/j.1365-313X.2011.04863.x; Leng P, 2014, J EXP BOT, V65, P4577, DOI 10.1093/jxb/eru204; Li JH, 2012, J EXP BOT, V63, P6407, DOI 10.1093/jxb/ers295; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Liu Q, 2007, J EXP BOT, V58, P4161, DOI 10.1093/jxb/erm273; Liu Q, 2009, J EXP BOT, V60, P801, DOI 10.1093/jxb/ern329; [LIU Yongzhong 刘永忠], 2006, [华中农业大学学报, Journal of Huazhong Agricultural University], V25, P300; Ma NN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0351-y; Manfield IW, 2007, PLANT PHYSIOL, V143, P941, DOI 10.1104/pp.106.090761; Medina-Puche L, 2014, J EXP BOT, V65, P401, DOI 10.1093/jxb/ert377; Nicolas P, 2014, PLANT PHYSIOL, V164, P365, DOI 10.1104/pp.113.231977; Paul V, 2012, J FOOD SCI TECH MYS, V49, P1, DOI 10.1007/s13197-011-0293-4; Prasanna V, 2007, CRIT REV FOOD SCI, V47, P1, DOI 10.1080/10408390600976841; Qi TC, 2011, PLANT CELL, V23, P1795, DOI 10.1105/tpc.111.083261; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Rios G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-276; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Shan W, 2012, J EXP BOT, V63, P5171, DOI 10.1093/jxb/ers178; Shen XJ, 2014, PLANT CELL PHYSIOL, V55, P862, DOI 10.1093/pcp/pcu013; Shlizerman L, 2007, PHYSIOL PLANTARUM, V131, P72, DOI 10.1111/j.1399-3054.2007.00935.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tanaka M, 2009, PLANTA, V230, P737, DOI 10.1007/s00425-009-0979-2; Walker RP, 2011, J EXP BOT, V62, P5357, DOI 10.1093/jxb/err189; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Wu J, 2014, J EXPT BOT; Wu JX, 2014, SCI HORTIC-AMSTERDAM, V176, P180, DOI 10.1016/j.scienta.2014.06.040; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; Xie XL, 2014, MOL BIOL REP, V41, P4261, DOI 10.1007/s11033-014-3297-0; Xu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-540; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yang LT, 2011, PLANT SCI, V180, P521, DOI 10.1016/j.plantsci.2010.11.011; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Zhang H, 2014, J EXP BOT, V65, P5795, DOI 10.1093/jxb/eru313; Zhang Y, 2015, NEW MEDIA SOC, V17, P1007, DOI 10.1177/1461444813520477; Zhang ZJ, 2009, PLANT PHYSIOL, V150, P365, DOI 10.1104/pp.109.135830; Zhao CS, 2011, PLANT J, V66, P502, DOI 10.1111/j.1365-313X.2011.04508.x; Zhao Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005051; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P12822, DOI 10.1073/pnas.1202630109	73	18	19	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154330	10.1371/journal.pone.0154330	http://dx.doi.org/10.1371/journal.pone.0154330			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104786	Green Published, Green Submitted, gold			2022-12-26	WOS:000374565100068
J	Autier, P; Boniol, M; Smans, M; Sullivan, R; Boyle, P				Autier, Philippe; Boniol, Mathieu; Smans, Michel; Sullivan, Richard; Boyle, Peter			Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening	PLOS ONE			English	Article							AGE 40; FOLLOW-UP; MORTALITY; MAMMOGRAPHY; WOMEN; COUNTRIES; SURVIVAL; NIJMEGEN; PROGRAM	Background The role of breast screening in breast cancer mortality declines is debated. Screening impacts cancer mortality through decreasing the number of advanced cancers with poor diagnosis, while cancer treatment works through decreasing the case-fatality rate. Hence, reductions in cancer death rates thanks to screening should directly reflect reductions in advanced cancer rates. We verified whether in breast screening trials, the observed reductions in the risk of breast cancer death could be predicted from reductions of advanced breast cancer rates. Patients and Methods The Greater New York Health Insurance Plan trial (HIP) is the only breast screening trial that reported stage-specific cancer fatality for the screening and for the control group separately. The Swedish Two-County trial (TCT)) reported size-specific fatalities for cancer patients in both screening and control groups. We computed predicted numbers of breast cancer deaths, from which we calculated predicted relative risks (RR) and (95% confidence intervals). The Age trial in England performed its own calculations of predicted relative risk. Results The observed and predicted RR of breast cancer death were 0.72 (0.56-0.94) and 0.98 (0.77-1.24) in the HIP trial, and 0.79 (0.78-1.01) and 0.90 (0.80-1.01) in the Age trial. In the TCT, the observed RR was 0.73 (0.62-0.87), while the predicted RR was 0.89 (0.75-1.05) if overdiagnosis was assumed to be negligible and 0.83 (0.70-0.97) if extra cancers were excluded. Conclusions In breast screening trials, factors other than screening have contributed to reductions in the risk of breast cancer death most probably by reducing the fatality of advanced cancers in screening groups. These factors were the better management of breast cancer patients and the underreporting of breast cancer as the underlying cause of death. Breast screening trials should publish stage-specific fatalities observed in each group.	[Autier, Philippe; Boniol, Mathieu; Boyle, Peter] iPRI, Strathclyde Inst Global Publ Hlth, Lyon, France; [Autier, Philippe; Boniol, Mathieu; Smans, Michel; Boyle, Peter] Int Prevent Res Inst iPRI, Lyon, France; [Sullivan, Richard] Kings Hlth Partners Canc Ctr, Inst Canc Policy, Bermondsey Wing,Guys Campus, London, England	University of London; King's College London	Autier, P (corresponding author), iPRI, Strathclyde Inst Global Publ Hlth, Lyon, France.; Autier, P (corresponding author), Int Prevent Res Inst iPRI, Lyon, France.	philippe.autier@i-pri.org	Autier, Philippe/A-4402-2014; Boniol, Mathieu/F-9623-2011; Boyle, Peter/A-4380-2014	Autier, Philippe/0000-0003-1538-5321; Boniol, Mathieu/0000-0003-1052-5604; Boyle, Peter/0000-0001-6251-0610; Sullivan, Richard/0000-0002-6435-1825	International Prevention Research Institute (iPRI)	International Prevention Research Institute (iPRI)	This work was supported by the International Prevention Research Institute (iPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJ, 2004, HUM PATHOL, V35, P1252, DOI 10.1016/j.humpath.2004.07.011; ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Autier P, 2012, JNCI-J NATL CANCER I, V104, P1080, DOI 10.1093/jnci/djs272; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Biesheuvel C, 2011, CANCER EPIDEMIOL, V35, P545, DOI 10.1016/j.canep.2011.02.008; Birnbaum J, 2016, ANN INTERN MED, V164, P236, DOI 10.7326/M15-0754; Bjurstam N, 2003, CANCER-AM CANCER SOC, V97, P2387, DOI 10.1002/cncr.11361; Bleyer A, 2015, INT J CANC; Boniol M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008158; Broeders MJM, 2001, INT J CANCER, V92, P303, DOI 10.1002/1097-0215(200102)9999:9999&lt;::AID-IJC1186&gt;3.0.CO;2-B; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; DUFFY SW, 1991, BRIT J CANCER, V64, P1133, DOI 10.1038/bjc.1991.477; FINK R, 1968, PUBLIC HEALTH REP, V83, P479, DOI 10.2307/4593330; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Harding C, 2015, JAMA INT MED; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; International Agency for Research on Cancer, 2002, BREAST CANC SCREEN; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; LAARA E, 1987, LANCET, V1, P1247; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Miller AB, 2001, LANCET, V358, P2164, DOI 10.1016/S0140-6736(01)07189-6; MILLER AB, 1976, INT J CANCER, V17, P602, DOI 10.1002/ijc.2910170508; Mook S, 2011, JNCI-J NATL CANCER I, V103, P585, DOI 10.1093/jnci/djr043; MORRISON AS, 1988, JNCI-J NATL CANCER I, V80, P1540, DOI 10.1093/jnci/80.19.1540; MORRISON AS, 1991, INT J EPIDEMIOL, V20, P642, DOI 10.1093/ije/20.3.642; Moss S, 2005, BRIT J CANCER, V92, P955, DOI 10.1038/sj.bjc.6602395; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Nystrom L, 1993, LANCET, P341; Ouakrim DA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4970; PEER PGM, 1994, J NATL CANCER I, V86, P436, DOI 10.1093/jnci/86.6.436; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; SHAPIRO S, 1977, CANCER, V39, P2772, DOI 10.1002/1097-0142(197706)39:6<2772::AID-CNCR2820390665>3.0.CO;2-K; Shapiro S, 1985, Natl Cancer Inst Monogr, V67, P65; Shapiro S, 1987, SCREEN BREAST CANC, P3; Stang A, 2015, CANCER; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; TABAR L, 1992, LANCET, V339, P412, DOI 10.1016/0140-6736(92)90090-P; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H	43	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154113	10.1371/journal.pone.0154113	http://dx.doi.org/10.1371/journal.pone.0154113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100174	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000374898500147
J	Carrer, F; Colonese, AC; Lucquin, A; Guedes, EP; Thompson, A; Walsh, K; Reitmaier, T; Craig, OE				Carrer, Francesco; Colonese, Andre Carlo; Lucquin, Alexandre; Guedes, Eduardo Petersen; Thompson, Anu; Walsh, Kevin; Reitmaier, Thomas; Craig, Oliver E.			Chemical Analysis of Pottery Demonstrates Prehistoric Origin for High-Altitude Alpine Dairying	PLOS ONE			English	Article							ARCHAEOLOGICAL POTTERY; BRONZE-AGE; ALPS; MILK; EXPLOITATION; SWITZERLAND; PASTORALISM; PRODUCTS; RESIDUES; IMPACT	The European high Alps are internationally renowned for their dairy produce, which are of huge cultural and economic significance to the region. Although the recent history of alpine dairying has been well studied, virtually nothing is known regarding the origins of this practice. This is due to poor preservation of high altitude archaeological sites and the ephemeral nature of transhumance economic practices. Archaeologists have suggested that stone structures that appear around 3,000 years ago are associated with more intense seasonal occupation of the high Alps and perhaps the establishment of new economic strategies. Here, we report on organic residue analysis of small fragments of pottery sherds that are occasionally preserved both at these sites and earlier prehistoric rock-shelters. Based mainly on isotopic criteria, dairy lipids could only be identified on ceramics from the stone structures, which date to the Iron Age (ca. 3,000-2,500 BP), providing the earliest evidence of this practice in the high Alps. Dairy production in such a marginal environment implies a high degree of risk even by today's standards. We postulate that this practice was driven by population increase and climate deterioration that put pressure on lowland agropastoral systems and the establishment of more extensive trade networks, leading to greater demand for highly nutritious and transportable dairy products.	[Carrer, Francesco; Walsh, Kevin] Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Colonese, Andre Carlo; Lucquin, Alexandre; Craig, Oliver E.] Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England; [Guedes, Eduardo Petersen] Univ Fed Rio Grande do Sul, Inst Biociencias, Porto Alegre, RS, Brazil; [Thompson, Anu] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Reitmaier, Thomas] Archaeol Serv Canton Grisons, Chur, Switzerland; [Carrer, Francesco] Newcastle Univ, Sch Hist Class & Archaeol, McCord Ctr Landscape, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of York - UK; University of York - UK; Universidade Federal do Rio Grande do Sul; University of Liverpool; Newcastle University - UK	Carrer, F (corresponding author), Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England.; Carrer, F (corresponding author), Newcastle Univ, Sch Hist Class & Archaeol, McCord Ctr Landscape, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	francesco.carrer@newcastle.ac.uk	Colonese, Andre Carlo/AAA-9266-2020; Lucquin, Alexandre/K-9045-2017	Colonese, Andre Carlo/0000-0002-0279-6634; Walsh, Kevin/0000-0003-1621-2625; Lucquin, Alexandre/0000-0003-4892-6323	Archaeological Service of the Canton of Grisons; EU; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil	Archaeological Service of the Canton of Grisons; EU(European Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by The Archaeological Service of the Canton of Grisons, 7th EU framework Marie Curie Intra-European Fellowship (FP7-PEOPLE-2012-IEF), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Alther Y., 2014, ARCHAOLOGIE GRABUNDE; Arbos Ph., 1922, VIE PASTORALE ALPES; Carrer F, 2015, J MEDITERR ARCHAEOL, V28, P3, DOI 10.1558/jmea.v28i1.27499; Collis J., 2003, EUROPEAN IRON AGE; Copley MS, 2002, P NATL ACAD SCI US; Correa-Ascencio M, 2014, ANAL METHODS-UK, V6, P1330, DOI 10.1039/c3ay41678j; Craig OE, 2005, ANTIQUITY, V79, P882, DOI 10.1017/S0003598X00115017; Craig OE, 2012, RAPID COMMUN MASS SP, V26, P2359, DOI 10.1002/rcm.6349; Curdy P., 2007, PREISTORIA ALP, V42, P99, DOI DOI 10.1111/J.1472-4642.2012.00930.X; Della Casa P, 2013, PREISTORIA ALPINA, V47, P39; Dietre B, 2014, QUATERN INT, V353, P3, DOI 10.1016/j.quaint.2014.05.001; Dudd SN, 1999, J ARCHAEOL SCI, V26, P1473, DOI 10.1006/jasc.1998.0434; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Festi D, 2014, QUATERN INT, V353, P17, DOI 10.1016/j.quaint.2013.07.052; Frodin JOH, 1940, I SAMMENLIGNENDE K B; Giguet-Covex C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4211; Gleirscher P, 2010, ARCHAOLOGIE ALPEN AL, P43; Grasseni C, 2011, ANTHR FOOD, V8; Greenfield HJ, 2010, WORLD ARCHAEOL, V42, P29, DOI 10.1080/00438240903429722; Grillo KM, 2014, AFR ARCHAEOL REV, V31, P105, DOI 10.1007/s10437-014-9147-6; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Horvat J, 2010, ARCHAOLOGIE ALPEN AL, P89; Kern A, 2013, HALLSTATT 7000; Kindstedt PS., 2012, CHEESE CULTURE HIST; Kothieringer K, 2015, Z GEOMORPHOL, V59, P177, DOI 10.1127/zfg_suppl/2015/S-59210; Krause R., 2009, MONTAFON, P10; Laland KN, 2010, J ARCHAEOL METHOD TH, V17, P303, DOI 10.1007/s10816-010-9096-6; Leiber F, 2004, ANIM SCI, V78, P451, DOI 10.1017/S1357729800058859; Leuzinger U, 2014, JB ARCHAOLOGIE SCHWE, V97, P153; Marini L, 2011, ENVIRON SCI POLICY, V14, P258, DOI 10.1016/j.envsci.2010.12.003; Marzatico F., 2009, GLOBE, V149, P117, DOI DOI 10.3406/GLOBE.2009.1558; Moe D, 2007, VEG HIST ARCHAEOBOT, V16, P431, DOI 10.1007/s00334-006-0088-0; Orland B., 2004, Environment and History, V10, P327, DOI 10.3197/0967340041794286; Papakosta V, 2015, MICROCHEM J, V123, P196, DOI 10.1016/j.microc.2015.06.013; Putzer A, 2009, ARCHAEOL AUSTRIACA, P33, DOI 10.1553/archaeologia93s33; Putzer A, 2014, PRAEHIST Z, V89, P55, DOI 10.1515/pz-2014-0005; Raven AM, 1997, J ANAL APPL PYROL, V40-1, P267, DOI 10.1016/S0165-2370(97)00036-3; Regert M, 2011, MASS SPECTROM REV, V30, P177, DOI 10.1002/mas.20271; Reitmaier T., 2012, LETZTE JAGER ERSTE H; Riedel A., 2001, PREISTORIA ALPINA, V35, P105; Ropke A, 2011, HOLOCENE, V21, P485, DOI 10.1177/0959683610385727; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; SHERRATT A, 1983, WORLD ARCHAEOL, V15, P90, DOI 10.1080/00438243.1983.9979887; Spangenberg JE, 2006, J ARCHAEOL SCI, V33, P1, DOI 10.1016/j.jas.2005.05.013; Spangenberg JE, 2008, ISOT ENVIRON HEALT S, V44, P189, DOI 10.1080/10256010802066349; Steiner H, 2010, ALPINE BRANDOPFERPLA; Stopp B., 2015, END LAKE DWELLINGS C; Vigne Jean-Denis, 2007, Anthropozoologica, V42, P9; Walsh K, 2014, QUATERN INT, V353, P52, DOI 10.1016/j.quaint.2013.08.060; Walsh K, 2011, EUR J ARCHAEOL, V14, P88, DOI 10.1179/146195711798369427; Weishaupl B, 2014, CONSERVATUM EST FEST, P457	52	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0151442	10.1371/journal.pone.0151442	http://dx.doi.org/10.1371/journal.pone.0151442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DK4OR	27100391	Green Published, Green Accepted, gold			2022-12-26	WOS:000374898500005
J	Grassme, KS; Garza-Garcia, A; Delgado, JP; Godwin, JW; Kumar, A; Gates, PB; Driscoll, PC; Brockes, JP				Grassme, Kathrin S.; Garza-Garcia, Acely; Delgado, Jean-Paul; Godwin, James W.; Kumar, Anoop; Gates, Phillip B.; Driscoll, Paul C.; Brockes, Jeremy P.			Mechanism of Action of Secreted Newt Anterior Gradient Protein	PLOS ONE			English	Article							LIMB REGENERATION; XENOPUS-LAEVIS; AGR2; METASTASIS; GENE; CONVERGENCE; THIOREDOXIN; EXPRESSION; REQUIRES; GROWTH	Anterior gradient (AG) proteins have a thioredoxin fold and are targeted to the secretory pathway where they may act in the ER, as well as after secretion into the extracellular space. A newt member of the family (nAG) was previously identified as interacting with the GPI-anchored salamander-specific three-finger protein called Prod1. Expression of nAG has been implicated in the nerve dependence of limb regeneration in salamanders, and nAG acted as a growth factor for cultured newt limb blastemal (progenitor) cells, but the mechanism of action was not understood. Here we show that addition of a peptide antibody to Prod1 specifically inhibit the proliferation of blastema cells, suggesting that Prod1 acts as a cell surface receptor for secreted nAG, leading to S phase entry. Mutation of the single cysteine residue in the canonical active site of nAG to alanine or serine leads to protein degradation, but addition of residues at the C terminus stabilises the secreted protein. The mutation of the cysteine residue led to no detectable activity on S phase entry in cultured newt limb blastemal cells. In addition, our phylogenetic analyses have identified a new Caudata AG protein called AG4. A comparison of the AG proteins in a cell culture assay indicates that nAG secretion is significantly higher than AGR2 or AG4, suggesting that this property may vary in different members of the family.	[Grassme, Kathrin S.; Delgado, Jean-Paul; Godwin, James W.; Kumar, Anoop; Gates, Phillip B.; Brockes, Jeremy P.] UCL, Inst Struct & Mol Biol, Div Biosci, London, England; [Garza-Garcia, Acely; Driscoll, Paul C.] Francis Crick Inst, Mill Hill Lab, London, England; [Grassme, Kathrin S.] Boston Healthcare Associates Int Gmbh, Berlin, Germany; [Delgado, Jean-Paul] Univ Antioquia, Inst Biol, Grp Genet Regenerac & Canc, Medellin, Colombia; [Godwin, James W.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia	University of London; Birkbeck University London; University College London; Francis Crick Institute; Universidad de Antioquia; Australian Regenerative Medicine Institute; Monash University	Driscoll, PC (corresponding author), Francis Crick Inst, Mill Hill Lab, London, England.	paul.driscoll@crick.ac.uk	delgado, jean paul/AAH-4374-2021	Godwin, James/0000-0002-9234-7807; Garza-Garcia, Acely/0000-0003-0307-0138; Driscoll, Paul/0000-0002-4124-6950	Medical Research Council (MRC grant) [G1000870]; MRC [U117574559]; Medical Research Council [G1000870, G0701297] Funding Source: researchfish; MRC [G0701297, G1000870] Funding Source: UKRI	Medical Research Council (MRC grant)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The JB group is supported by the Medical Research Council, http://www.mrc.ac.uk (MRC grant code G1000870), and a Non-clinical Research Professorship to JPB. PD and AG were funded by the MRC (file reference U117574559). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullayev I, 2013, EXP CELL RES, V319, P1187, DOI 10.1016/j.yexcr.2013.02.013; Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Arumugam T, 2015, MOL CANCER THER, V14, P941, DOI 10.1158/1535-7163.MCT-14-0470; Baddar NWA, 2015, METHODS MOL BIOL, V1290, P321, DOI 10.1007/978-1-4939-2495-0_25; Bergstrom JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104186; Blassberg RA, 2011, J CELL SCI, V124, P47, DOI 10.1242/jcs.076331; Brychtova V, 2011, CANCER LETT, V304, P1, DOI 10.1016/j.canlet.2010.12.023; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034408; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Clarke C, 2015, MOL CELL BIOCHEM, V408, P245, DOI 10.1007/s11010-015-2502-3; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; Dong AW, 2015, J BIOL CHEM, V290, P8016, DOI 10.1074/jbc.M114.623207; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta A, 2013, J BIOL CHEM, V288, P4321, DOI 10.1074/jbc.M112.433086; Gupta A, 2012, J BIOL CHEM, V287, P4773, DOI 10.1074/jbc.M111.301531; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ivanova AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08123; Ivanova AS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01279; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Keane T.M., 2004, MODELGENERATOR AMINO; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kumar Anoop, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5367; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Looso M, 2015, METHODS MOL BIOL, V1290, P337, DOI 10.1007/978-1-4939-2495-0_26; Nguyen VD, 2011, CRYSTAL STRUCTURE HU, V3; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Patel P, 2013, J MOL BIOL, V425, P929, DOI 10.1016/j.jmb.2012.12.009; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ryu J, 2013, BIOCHEM BIOPH RES CO, V430, P610, DOI 10.1016/j.bbrc.2012.11.105; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Tereshina MB, 2014, BIOL OPEN, V3, P192, DOI 10.1242/bio.20147401; Thompson DA, 1997, J STEROID BIOCHEM, V62, P143, DOI 10.1016/S0960-0760(97)00029-0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008	38	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154176	10.1371/journal.pone.0154176	http://dx.doi.org/10.1371/journal.pone.0154176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100463	Green Submitted, Green Published, gold			2022-12-26	WOS:000374898500161
J	Hou, JJ; Jiang, PP; Qi, SM; Zhang, K; He, QX; Xu, CZ; Ding, ZH; Zhang, KW; Li, KP				Hou, Jiajia; Jiang, Pingping; Qi, Shoumei; Zhang, Ke; He, Qiuxia; Xu, Changzheng; Ding, Zhaohua; Zhang, Kewei; Li, Kunpeng			Isolation and Functional Validation of Salinity and Osmotic Stress Inducible Promoter from the Maize Type-II H+-Pyrophosphatase Gene by Deletion Analysis in Transgenic Tobacco Plants	PLOS ONE			English	Article							ENHANCES SALT TOLERANCE; ROOT-SPECIFIC GENE; HETEROLOGOUS EXPRESSION; MOLECULAR-CLONING; THELLUNGIELLA-HALOPHILA; REGULATORY ELEMENTS; DROUGHT TOLERANCE; DNA ELEMENTS; PPASE GENE; ARABIDOPSIS	Salinity and drought severely affect both plant growth and productivity, making the isolation and characterization of salinity-or drought-inducible promoters suitable for genetic improvement of crop resistance highly desirable. In this study, a 1468-bp sequence upstream of the translation initiation codon ATG of the promoter for ZmGAPP (maize Type-II H+-pyrophosphatase gene) was cloned. Nine 5' deletion fragments (D1-D9) of different lengths of the ZmGAPP promoter were fused with the GUS reporter and translocated into tobacco. The deletion analysis showed that fragments D1-D8 responded well to NaCl and PEG stresses, whereas fragment D9 and CaMV 35S did not. The D8 segment (219 bp; -219 to -1 bp) exhibited the highest promoter activity of all tissues, with the exception of petals among the D1-D9 transgenic tobacco, which corresponds to about 10% and 25% of CaMV 35S under normal and NaCl or PEG stress conditions, respectively. As such, the D8 segment may confer strong gene expression in a salinity and osmotic stress inducible manner. A 71-bp segment (-219 to -148 bp) was considered as the key region regulating ZmGAPP response to NaCl or PEG stress, as transient transformation assays demonstrated that the 71-bp sequence was sufficient for the salinity or osmotic stress response. These results enhance our understanding of the molecular mechanisms regulating ZmGAPP expression, and that the D8 promoter would be an ideal candidate for moderating expression of drought and salinity response genes in transgenic plants.	[Hou, Jiajia; Jiang, Pingping; Qi, Shoumei; Zhang, Ke; Zhang, Kewei; Li, Kunpeng] Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Shanda South Rd 27, Jinan 250100, Shandong, Peoples R China; [He, Qiuxia] Shandong Acad Sci, Inst Biol, Jinan, Shandong, Peoples R China; [Xu, Changzheng] Southwest Univ, Coll Resources & Environm, RCBB, Tiansheng Rd 2, Chongqing 400716, Peoples R China; [Ding, Zhaohua] Shandong Acad Agr Sci, Maize Inst, Jinan, Shandong, Peoples R China	Shandong University; Qilu University of Technology; Southwest University - China; Shandong Academy of Agricultural Sciences	Li, KP (corresponding author), Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Shanda South Rd 27, Jinan 250100, Shandong, Peoples R China.	likp@sdu.edu.cn	zhang, ke/AAH-8217-2019; Xu, Changzheng/AAD-4043-2021	Xu, Changzheng/0000-0002-4048-3620; Li, Kunpeng/0000-0003-1807-4545	National Program of Transgenic Variety Development of China [2014ZX0800922B]; State Key Laboratory of Crop Biology [2015KF03]; Shandong Province Agricultural Seed Project of China [SDLZGC2014960302]	National Program of Transgenic Variety Development of China; State Key Laboratory of Crop Biology; Shandong Province Agricultural Seed Project of China	This work was supported by grants from the National Program of Transgenic Variety Development of China (2014ZX0800922B), State Key Laboratory of Crop Biology (2015KF03) and Shandong Province Agricultural Seed Project of China (SDLZGC2014960302)	Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; BALLAS N, 1995, P NATL ACAD SCI USA, V92, P3483, DOI 10.1073/pnas.92.8.3483; Bang SW, 2013, PLANTA, V237, P211, DOI 10.1007/s00425-012-1764-1; Bao AK, 2009, PLANT SCI, V176, P232, DOI 10.1016/j.plantsci.2008.10.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carre IA, 1995, PLANT CELL, V7, P2039, DOI 10.2307/3870149; CASTRESANA C, 1988, EMBO J, V7, P1929, DOI 10.1002/j.1460-2075.1988.tb03030.x; Chen AP, 2007, J PLANT RES, V120, P337, DOI 10.1007/s10265-006-0058-8; Chen L, 2015, PLANT CELL TISS ORG, V121, P259, DOI 10.1007/s11240-014-0682-2; Cheon BY, 2004, TRANSGENIC RES, V13, P541, DOI 10.1007/s11248-004-2737-3; CORNEJO MJ, 1993, PLANT MOL BIOL, V23, P567, DOI 10.1007/BF00019304; De Wilde C, 2000, PLANT MOL BIOL, V43, P347, DOI 10.1023/A:1006464304199; Delaney SK, 2007, PLANT CELL PHYSIOL, V48, P1426, DOI 10.1093/pcp/pcm111; Dong Q, 2015, APPL BIOCHEM BIOTECH, V175, P1344, DOI 10.1007/s12010-014-1277-4; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Drozdowicz YM, 2000, PLANT PHYSIOL, V123, P353, DOI 10.1104/pp.123.1.353; Furtado A, 2005, PLANT BIOTECHNOL J, V3, P421, DOI 10.1111/j.1467-7652.2005.00135.x; Gao F, 2006, J EXP BOT, V57, P3259, DOI 10.1093/jxb/erl090; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Guo SL, 2006, PLANT MOL BIOL, V60, P41, DOI 10.1007/s11103-005-2417-6; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P283, DOI 10.1016/j.tibtech.2005.04.009; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Han YJ, 2015, PLANT CELL REP, V34, P265, DOI 10.1007/s00299-014-1705-5; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; Huda KMK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057803; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeon JS, 1999, PLANT MOL BIOL, V39, P35, DOI 10.1023/A:1006157603096; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kaur C, 2015, MOL BIOL REP, V42, P1139, DOI 10.1007/s11033-015-3851-4; KOLTUNOW AM, 1990, PLANT CELL, V2, P1201, DOI 10.1105/tpc.2.12.1201; Kumpatla SP, 1998, TRENDS PLANT SCI, V3, P97, DOI 10.1016/S1360-1385(97)01194-1; Lai CX, 2009, PLANT CELL REP, V28, P851, DOI 10.1007/s00299-009-0689-z; LAURSEN NB, 1994, PLANT CELL, V6, P659, DOI 10.1105/tpc.6.5.659; Lee JT, 2003, PLANT CELL ENVIRON, V26, P1181, DOI 10.1046/j.1365-3040.2003.01048.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li B, 2008, PLANT BIOTECHNOL J, V6, P146, DOI 10.1111/j.1467-7652.2007.00301.x; Li XJ, 2014, J EXP BOT, V65, P683, DOI 10.1093/jxb/ert442; Li ZG, 2010, PLANT CELL ENVIRON, V33, P272, DOI 10.1111/j.1365-3040.2009.02080.x; Liu L, 2011, J INTEGR PLANT BIOL, V53, P731, DOI 10.1111/j.1744-7909.2011.01066.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv SL, 2009, PLANTA, V229, P899, DOI 10.1007/s00425-008-0880-4; Lv S, 2008, PLANT CELL PHYSIOL, V49, P1150, DOI 10.1093/pcp/pcn090; Lv SL, 2015, PLANT CELL ENVIRON, V38, P2433, DOI 10.1111/pce.12557; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Marraccini P, 2003, PLANT PHYSIOL BIOCH, V41, P17, DOI 10.1016/S0981-9428(02)00004-9; MATZKE MA, 1995, TRENDS GENET, V11, P1, DOI 10.1016/S0168-9525(00)88973-8; Mitsuda N, 2001, FEBS LETT, V488, P29, DOI 10.1016/S0014-5793(00)02400-5; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Opsahl-Sorteberg HG, 2004, GENE, V341, P49, DOI 10.1016/j.gene.2004.06.059; Pan YL, 2015, PLANTA, V241, P57, DOI 10.1007/s00425-014-2164-5; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pasapula V, 2011, PLANT BIOTECHNOL J, V9, P88, DOI 10.1111/j.1467-7652.2010.00535.x; PAUL W, 1992, PLANT MOL BIOL, V19, P611, DOI 10.1007/BF00026787; Peremarti A, 2010, PLANT MOL BIOL, V73, P363, DOI 10.1007/s11103-010-9628-1; Potenza C, 2004, IN VITRO CELL DEV-PL, V40, P1, DOI 10.1079/IVP2003477; Qu LQ, 2004, PLANT BIOTECHNOL J, V2, P113, DOI 10.1111/j.1467-7652.2004.00055.x; Rai M, 2009, TRANSGENIC RES, V18, P787, DOI 10.1007/s11248-009-9263-2; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; SCHLEDZEWSKI K, 1994, TRANSGENIC RES, V3, P249, DOI 10.1007/BF02336778; Sun QH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-90; Tao YB, 2015, PLANTA, V241, P823, DOI 10.1007/s00425-014-2222-z; Tavakol E, 2014, GENE, V549, P24, DOI 10.1016/j.gene.2014.07.020; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thilmony R, 2009, PLANT BIOTECHNOL J, V7, P867, DOI 10.1111/j.1467-7652.2009.00449.x; Verdaguer B, 1996, PLANT MOL BIOL, V31, P1129, DOI 10.1007/BF00040830; Vijayan J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00371; VOELKER T, 1987, EMBO J, V6, P3571, DOI 10.1002/j.1460-2075.1987.tb02687.x; Wu G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00198; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V236, P331, DOI 10.1007/BF00277130; YAMAMOTO YT, 1991, PLANT CELL, V3, P371, DOI 10.1105/tpc.3.4.371; Yang YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087283; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Yue GD, 2008, DNA SEQUENCE, V19, P79, DOI 10.1080/10425170701445519; Zavallo D, 2010, PLANT CELL REP, V29, P239, DOI 10.1007/s00299-010-0816-x; Zhang Y, 2008, PLANT CELL REP, V27, P585, DOI 10.1007/s00299-007-0459-8; Zhao JS, 2007, PLANT CELL REP, V26, P1521, DOI 10.1007/s00299-007-0362-3; Zhou J, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-29	81	29	30	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154041	10.1371/journal.pone.0154041	http://dx.doi.org/10.1371/journal.pone.0154041			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101137	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500130
J	Matsudaira, I; Yokota, S; Hashimoto, T; Takeuchi, H; Asano, K; Asano, M; Sassa, Y; Taki, Y; Kawashima, R				Matsudaira, Izumi; Yokota, Susumu; Hashimoto, Teruo; Takeuchi, Hikaru; Asano, Kohei; Asano, Michiko; Sassa, Yuko; Taki, Yasuyuki; Kawashima, Ryuta			Parental Praise Correlates with Posterior Insular Cortex Gray Matter Volume in Children and Adolescents	PLOS ONE			English	Article							ANTERIOR INSULA; PREDICTS; PERSONALITY; LINKS	A positive parenting style affects psychological and cognitive development in children. Neuroimaging studies revealed that a positive parenting style influenced brain structure in children. Parental praise is a concrete behavior observed in positive parenting. Although previous psychological studies revealed a positive effect of parental praise on children, little is known about the relationship between parental praise and brain structure in children. Thus, the purpose of the present study was to determine whether there was a correlation between the parental attitude towards praising their child and gray matter volume in the children (116 boys and 109 girls; mean age, 10.6 years old). We examined the correlation between regional gray matter volume and parental praise using voxel-based morphometry (VBM) following magnetic resonance imaging (MRI). In addition, to confirm the positive effects of parental praise, we analyzed the correlation between the frequency of parental praise and personality traits in children. We showed that the parental attitude towards praising their child was significantly and positively correlated with the gray matter volume of the left posterior insular cortex in children. Moreover, we found a significant positive correlation between parental attitude towards praising their child and the personality traits of conscientiousness and openness to experience in the children. Prior studies said that gray matter volume in the posterior insula was correlated with empathy, and the functional connectivity between this area and the amygdala was associated with emotional regulation. Furthermore, the posterior insula relates to auditory function, and therefore, was likely involved in the processing of parental praise. Considering the possibility of experience-dependent plasticity, frequent parental praise would lead to increased posterior insular gray matter volume in children. Our study is the first to elucidate the relationship between a specific positive parenting behavior and brain structure in children.	[Matsudaira, Izumi; Taki, Yasuyuki] Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Yokota, Susumu; Hashimoto, Teruo; Takeuchi, Hikaru; Asano, Kohei; Asano, Michiko; Sassa, Yuko; Taki, Yasuyuki; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki] Tohoku Univ, Div Med Neuroimaging Anal, Dept Community Med Supports, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Smart Aging Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Yokota, S (corresponding author), Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	yokota.e1@tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011; Hashimoto, Teruo/C-4196-2013	Hashimoto, Teruo/0000-0002-5327-0667; Takeuchi, Hikaru/0000-0002-8022-9694	Ministry of Education, Culture, Sports, Science and Technology [20790875]; Kumon Institute of Education Co., Ltd.	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kumon Institute of Education Co., Ltd.	This study was funded by a Grant-in-Aid for Young Scientists (B), 20790875, from the Ministry of Education, Culture, Sports, Science and Technology. This study was also funded by Kumon Institute of Education Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2010, AM J NEURORADIOL, V31, P131, DOI 10.3174/ajnr.A1789; Azuma H, 2002, FAMILY DIAGNOSTIC TE; Bamiou DE, 2003, BRAIN RES REV, V42, P143, DOI 10.1016/S0165-0173(03)00172-3; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; Baumrind D, 1989, REARING COMPETENT CH, P349; Brummelman E, 2014, J EXP PSYCHOL GEN, V143, P9, DOI 10.1037/a0031917; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Denny BT, 2014, SOC COGN AFFECT NEUR, V9, P1660, DOI 10.1093/scan/nst160; Ebisch SJH, 2011, HUM BRAIN MAPP, V32, P1013, DOI 10.1002/hbm.21085; FELSON RB, 1989, J MARRIAGE FAM, V51, P727, DOI 10.2307/352171; Giuliani NR, 2011, NEUROIMAGE, V58, P10, DOI 10.1016/j.neuroimage.2011.06.028; Goerlich-Dobre KS, 2015, HUM BRAIN MAPP, V36, P3805, DOI 10.1002/hbm.22879; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Gunderson EA, 2013, CHILD DEV, V84, P1526, DOI 10.1111/cdev.12064; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Kamins ML, 1999, DEV PSYCHOL, V35, P835, DOI 10.1037/0012-1649.35.3.835; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Luby JL, 2012, P NATL ACAD SCI USA, V109, P2854, DOI 10.1073/pnas.1118003109; Malhi P, 2014, INDIAN J PEDIATR, V81, P333, DOI 10.1007/s12098-013-1154-0; Mesulam EJM M.M., 1985, CEREB CORTEX, V4, P179; Mesurado B, 2013, CHILDRENS PERCEPTION, P1; Michiaki Nagai, 2002, ADV RES NERV SYST IG, V46, P157; Murakami Y., 1997, JPN J PERSONAL, V6, P29, DOI DOI 10.2132/JJPJSPP.6.1_29; Murakami Y., 2010, JAPANESE J BEHAV, V37, P93; Nakagawa S, 2015, NEUROIMAGE, V105, P248, DOI 10.1016/j.neuroimage.2014.11.004; Nieuwenhuys R, 2012, PROG BRAIN RES, V195, P123, DOI 10.1016/B978-0-444-53860-4.00007-6; O'Connor BP, 2002, J PERS SOC PSYCHOL, V83, P962, DOI 10.1037//0022-3514.83.4.962; Ohira Hideki, 2014, Brain Nerve, V66, P417; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen DJ, 2012, CLIN CHILD FAM PSYCH, V15, P364, DOI 10.1007/s10567-012-0120-0; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; Polcari A, 2014, CHILD ABUSE NEGLECT, V38, P91, DOI 10.1016/j.chiabu.2013.10.003; Raboteg-Saric Z, 2014, APPL RES QUAL LIFE, V9, P749, DOI 10.1007/s11482-013-9268-0; Reti IM, 2002, PSYCHIAT RES, V111, P55, DOI 10.1016/S0165-1781(02)00128-2; Roopnarine JL, 2006, EARLY CHILD RES Q, V21, P238, DOI 10.1016/j.ecresq.2006.04.007; Seay A, 2014, NURS FORUM, V49, P200, DOI 10.1111/nuf.12093; Sheikh HI, 2014, NEUROIMAGE-CLIN, V6, P77, DOI 10.1016/j.nicl.2014.08.013; Shinohara R, 2010, J EPIDEMIOL, V20, pS441, DOI 10.2188/jea.JE20090168; Sutton Carole, 2008, Community Pract, V81, P19; Takeuchi H, 2015, CEREB CORTEX, V25, P1188, DOI 10.1093/cercor/bht315; Takeuchi H, 2015, J NEUROSCI, V35, P2233, DOI 10.1523/JNEUROSCI.0598-14.2015; Taki Y, 2012, NEUROIMAGE, V59, P1023, DOI 10.1016/j.neuroimage.2011.08.092; Taki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015213; Tamura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08799; Terasawa Y, 2014, COGNITION EMOTION, V28, P1435, DOI 10.1080/02699931.2014.888988; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; Villemure C, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00281; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Wechsler D, 1991, WISC III MANUAL; Wechsler D., 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WAIS III WMS III TEC; Whittle S, 2014, DEV COGN NEUROS-NETH, V8, P7, DOI 10.1016/j.dcn.2013.10.006	52	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154220	10.1371/journal.pone.0154220	http://dx.doi.org/10.1371/journal.pone.0154220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101139	gold, Green Published			2022-12-26	WOS:000374898500166
J	Jung, W; Campbell, RL; Gwak, Y; Kim, JI; Davies, PL; Jin, E				Jung, Woongsic; Campbell, Robert L.; Gwak, Yunho; Kim, Jong Im; Davies, Peter L.; Jin, EonSeon			New Cysteine-Rich Ice-Binding Protein Secreted from Antarctic Microalga, Chloromonas sp.	PLOS ONE			English	Article							HYPERACTIVE ANTIFREEZE PROTEIN; HORIZONTAL GENE-TRANSFER; SP-NOV VOLVOCALES; SEA-ICE; CONTINENTAL ANTARCTICA; ELECTRON-MICROSCOPY; WINDMILL ISLANDS; SNOW; EXPRESSION; CHLOROPHYCEAE	Many microorganisms in Antarctica survive in the cold environment there by producing ice-binding proteins (IBPs) to control the growth of ice around them. An IBP from the Antarctic freshwater microalga, Chloromonas sp., was identified and characterized. The length of the Chloromonas sp. IBP (ChloroIBP) gene was 3.2 kb with 12 exons, and the molecular weight of the protein deduced from the ChloroIBP cDNA was 34.0 kDa. Expression of the ChloroIBP gene was up-and down-regulated by freezing and warming conditions, respectively. Western blot analysis revealed that native ChloroIBP was secreted into the culture medium. This protein has fifteen cysteines and is extensively disulfide bonded as shown by in-gel mobility shifts between oxidizing and reducing conditions. The open-reading frame of ChloroIBP was cloned and over-expressed in Escherichia coli to investigate the IBP's biochemical characteristics. Recombinant ChloroIBP produced as a fusion protein with thioredoxin was purified by affinity chromatography and formed single ice crystals of a dendritic shape with a thermal hysteresis activity of 0.4 +/- 0.02 degrees C at a concentration of 5 mg/ml. In silico structural modeling indicated that the three-dimensional structure of ChloroIBP was that of a right-handed beta-helix. Site-directed mutagenesis of ChloroIBP showed that a conserved region of six parallel T-X-T motifs on the beta-2 face was the ice-binding region, as predicted from the model. In addition to disulfide bonding, hydrophobic interactions between inward-pointing residues on the beta-1 and beta-2 faces, in the region of ice-binding motifs, were crucial to maintaining the structural conformation of ice-binding site and the ice-binding activity of ChloroIBP.	[Jung, Woongsic; Gwak, Yunho; Jin, EonSeon] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Kim, Jong Im] Chungnam Natl Univ, Dept Biol, Daejeon, South Korea; [Campbell, Robert L.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Hanyang University; Chungnam National University; Queens University - Canada	Jin, E (corresponding author), Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea.; Davies, PL (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	peter.davies@queensu.ca; esjin@hanyang.ac.kr	Jin, EonSeon/AAW-6839-2020	Jin, EonSeon/0000-0001-5691-0124; Campbell, Robert/0000-0002-5473-5876	Korea CCS R&D Center (KCRC) of National Research Foundation [NRF-2014M1A8A1049273]; Basic Core Technology Development Program for the Oceans and the Polar Regions of National Research Foundation - Korean government (Ministry of Science, ICT. & Future Planning) [NRF-2015M1A5A1037053]; CIHR	Korea CCS R&D Center (KCRC) of National Research Foundation; Basic Core Technology Development Program for the Oceans and the Polar Regions of National Research Foundation - Korean government (Ministry of Science, ICT. & Future Planning)(Ministry of Science, ICT & Future Planning, Republic of Korea); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by funding to EJ, who holds Korea CCS R&D Center (KCRC) of National Research Foundation (NRF-2014M1A8A1049273) and by funding from the Basic Core Technology Development Program for the Oceans and the Polar Regions of National Research Foundation (NRF-2015M1A5A1037053) funded by the Korean government (Ministry of Science, ICT. & Future Planning). PLD, who holds a Canada Research Chair in Protein Engineering, acknowledges funding from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Austin BP, 2012, PROTEIN EXPRES PURIF, V82, P116, DOI 10.1016/j.pep.2011.11.015; Baardsnes J, 2002, BBA-PROTEINS PROTEOM, V1601, P49, DOI 10.1016/S1570-9639(02)00431-4; Basu K, 2015, P NATL ACAD SCI USA, V112, P737, DOI 10.1073/pnas.1422272112; Battaglia B, 1997, ANTARCTIC COMMUNITIE; Bayer-Giraldi M, 2010, ENVIRON MICROBIOL, V12, P1041, DOI 10.1111/j.1462-2920.2009.02149.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Chattopadhyay MK, 2001, POLAR BIOL, V24, P386; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Cockell Charles S., 2000, Environmental Reviews, V8, P1, DOI 10.1139/er-8-1-1; Davies PL, 2014, TRENDS BIOCHEM SCI, V39, P548, DOI 10.1016/j.tibs.2014.09.005; DeLano WL, 2002, THE PYMOL MOLECULAR; Deming JW, 2002, CURR OPIN MICROBIOL, V5, P301, DOI 10.1016/S1369-5274(02)00329-6; Ehn JK, 2013, LIMNOL OCEANOGR, V58, P893, DOI 10.4319/lo.2013.58.3.0893; Eicken H, 2000, COLD REG SCI TECHNOL, V31, P207, DOI 10.1016/S0165-232X(00)00016-1; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Friis DS, 2014, FEBS LETT, V588, P1767, DOI 10.1016/j.febslet.2014.03.032; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Garnham CP, 2008, BIOCHEM J, V411, P171, DOI 10.1042/BJ20071372; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gauthier SY, 1998, EUR J BIOCHEM, V258, P445, DOI 10.1046/j.1432-1327.1998.2580445.x; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graether SP, 2004, EUR J BIOCHEM, V271, P3285, DOI 10.1111/j.1432-1033.2004.04256.x; Graether SP, 2003, J MOL BIOL, V327, P1155, DOI 10.1016/S0022-2836(03)00235-3; Graether SP, 2001, BIOPHYS J, V80, P1169, DOI 10.1016/S0006-3495(01)76093-6; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Gupta R., PREDICTION N G UNPUB; Gwak IG, 2010, MAR BIOTECHNOL, V12, P630, DOI 10.1007/s10126-009-9250-x; Gwak Y, 2014, FASEB J, V28, P4924, DOI 10.1096/fj.14-256388; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoham RW, 2002, J PHYCOL, V38, P1051, DOI 10.1046/j.1529-8817.2002.t01-1-01227.x; Huang L, 2009, APPL MICROBIOL BIOT, V84, P301, DOI 10.1007/s00253-009-1982-z; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kondo H, 2012, P NATL ACAD SCI USA, V109, P9360, DOI 10.1073/pnas.1121607109; Kristiansen E, 2011, INSECT BIOCHEM MOLEC, V41, P109, DOI 10.1016/j.ibmb.2010.11.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2012, J BIOL CHEM, V287, P11460, DOI 10.1074/jbc.M111.331835; Li HY, 2009, PROG NAT SCI-MATER, V19, P1059, DOI 10.1016/j.pnsc.2008.10.012; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Ling HU, 1998, POLAR BIOL, V20, P320, DOI 10.1007/s003000050309; LING HU, 1993, EUR J PHYCOL, V28, P77, DOI 10.1080/09670269300650131; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Mao XF, 2011, CRYOBIOLOGY, V62, P91, DOI 10.1016/j.cryobiol.2011.01.001; Marshall CB, 2005, J BIOL CHEM, V280, P17920, DOI 10.1074/jbc.M500622200; Marshall CB, 2002, FEBS LETT, V529, P261, DOI 10.1016/S0014-5793(02)03355-0; Matsuzaki R, 2014, PHYCOLOGIA, V53, P293, DOI 10.2216/14-3.1; Matsuzaki R, 2013, PHYCOLOGIA, V52, P239, DOI 10.2216/12-083.1; Middleton AJ, 2009, FEBS LETT, V583, P815, DOI 10.1016/j.febslet.2009.01.035; Mock T, 2005, ENVIRON MICROBIOL, V7, P605, DOI 10.1111/j.1462-2920.2005.00781.x; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PRIDDLE J, 1986, BIOL REV, V61, P199, DOI 10.1111/j.1469-185X.1986.tb00718.x; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Qin WS, 2006, INSECT BIOCHEM MOLEC, V36, P210, DOI 10.1016/j.ibmb.2006.01.017; RAYMOND JA, 1989, P NATL ACAD SCI USA, V86, P881, DOI 10.1073/pnas.86.3.881; RAYMOND JA, 1994, POLAR BIOL, V14, P71; Raymond JA, 2000, POLAR BIOL, V23, P721, DOI 10.1007/s003000000147; Raymond JA, 2003, CRYOBIOLOGY, V46, P174, DOI 10.1016/S0011-2240(03)00023-3; Raymond JA, 2000, ANTARCT SCI, V12, P418; Raymond JA, 2014, EXTREMOPHILES, V18, P987, DOI 10.1007/s00792-014-0668-3; Raymond JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059186; Raymond JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035968; Raymond JA, 2009, J PHYCOL, V45, P130, DOI 10.1111/j.1529-8817.2008.00623.x; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SAUNDERS GW, 1994, CAN J BOT, V72, P1250, DOI 10.1139/b94-153; SCHMIDT S, 1991, ANTARCT SCI, V3, P379, DOI 10.1017/S0954102091000482; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; Smallwood M, 2002, PHILOS T R SOC B, V357, P831, DOI 10.1098/rstb.2002.1073; SONNICHSEN FD, 1995, PROTEIN SCI, V4, P460; Sorhannus U, 2011, EVOL BIOINFORM, V7, P279, DOI 10.4137/EBO.S8321; STEINER JJ, 1995, NUCLEIC ACIDS RES, V23, P2569, DOI 10.1093/nar/23.13.2569-a; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Uhlig C, 2011, CRYOBIOLOGY, V63, P220, DOI 10.1016/j.cryobiol.2011.08.005; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314	81	13	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154056	10.1371/journal.pone.0154056	http://dx.doi.org/10.1371/journal.pone.0154056			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097164	Green Published, Green Submitted, gold			2022-12-26	WOS:000374543600084
J	Mastorci, K; Muraro, E; Pasini, E; Furlan, C; Sigalotti, L; Cinco, M; Dolcetti, R; Fratta, E				Mastorci, Katy; Muraro, Elena; Pasini, Elisa; Furlan, Chiara; Sigalotti, Luca; Cinco, Marina; Dolcetti, Riccardo; Fratta, Elisabetta			Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; NF-KAPPA-B; BORRELIA-BURGDORFERI; HUMAN MONOCYTES; ACTIVATION; INFECTION; PATHWAYS; TUMOR; CD40; MICROENVIRONMENT	Mantle cell lymphoma (MCL) is an aggressive B-cell non-Hodgkin's lymphoma with a still undefined etiology. Several lines of evidence are consistent with the possible involvement of peculiar microenvironmental stimuli sustaining tumor cell growth and survival, as the activation of Toll-like receptors (TLR) 4 and 9. However, little is known about the contribution of other TLRs of pathogenic relevance in the development of MCL. This study reports evidence that MCL cell lines and primary MCL cells express different levels of TLR2 and TLR5, and that their triggering is able to further activate the Akt, MAPK, and NF-kappa B signaling cascades, known to be altered in MCL cells. This leads to the enhancement of cyclin D1 and D3 over-expression, occurring at post-translational level through a mechanism that likely involves the Akt/GSK-3 alpha/beta pathway. Interestingly, in primary B cells, TLR1/2 or TLR5 ligands increase protein level of cyclin D1, which is not usually expressed in normal B cells, and cyclin D3 when associated with CD40 ligand (CD40L), IL-4, and anti-human-IgM costimulus. Finally, the activation of TLR1/2 and TLR5 results in an increased proliferation of MCL cell lines and, in the presence of co-stimulation with CD40L, IL-4, and anti-human-IgM also of primary MCL cells and normal B lymphocytes. These effects befall together with an enhanced IL-6 production in primary cultures. Overall, our findings suggest that ligands for TLR1/2 or TLR5 may provide critical stimuli able to sustain the growth and the malignant phenotype of MCL cells. Further studies aimed at identifying the natural source of these TLR ligands and their possible pathogenic association with MCL are warranted in order to better understand MCL development, but also to define new therapeutic targets for counteracting the tumor promoting effects of lymphoma microenvironment.	[Mastorci, Katy; Muraro, Elena; Pasini, Elisa; Furlan, Chiara; Sigalotti, Luca; Dolcetti, Riccardo; Fratta, Elisabetta] IRCCS Natl Canc Inst, Canc Bioimmunotherapy Unit, Dept Translat Res, Ctr Riferimento Oncol, Aviano, PN, Italy; [Pasini, Elisa] Univ Hlth Network, Princess Margaret Canc Ctr, Room 11-314,101 Coll St, Toronto, ON M5G 1L7, Canada; [Pasini, Elisa] TECHNA Inst Adv Technol Hlth, TMDT, Room 11-314,101 Coll St, Toronto, ON M5G 1L7, Canada; [Cinco, Marina] Univ Trieste, Dept Life Sci, Spirochete Lab, Trieste, Italy; [Dolcetti, Riccardo] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia	IRCCS Aviano (CRO); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Trieste; University of Queensland	Muraro, E; Fratta, E (corresponding author), IRCCS Natl Canc Inst, Canc Bioimmunotherapy Unit, Dept Translat Res, Ctr Riferimento Oncol, Aviano, PN, Italy.	elemuraro@gmail.com	Muraro, Elena/ABB-6507-2020; Muraro, Elena/ABH-2798-2021; Fratta, Elisabetta/J-8707-2016; Sigalotti, Luca/AAC-2926-2020; Dolcetti, Riccardo/O-3832-2015	Muraro, Elena/0000-0001-9514-8224; Fratta, Elisabetta/0000-0002-7472-8841; Sigalotti, Luca/0000-0002-1436-2358; Dolcetti, Riccardo/0000-0003-1625-9853	Associazione Italiana per la Ricerca sul Cancro [10301]; Fondazione Umberto Veronesi	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	This study was supported by a grant from Associazione Italiana per la Ricerca sul Cancro to RD (contract 10301; http://www.airc.it/). KM and EP are fellows of the Fondazione Italiana per la Ricerca sul Cancro (http://www.fondazionefirc.it/). EM was supported by a Fondazione Umberto Veronesi Fellowship (http://www.fondazioneveronesi.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter A, 2017, HEMATOL ONCOL, V35, P79, DOI 10.1002/hon.2251; Andersen NS, 2000, BLOOD, V96, P2219; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Berende A, 2010, EUR CYTOKINE NETW, V21, P7, DOI 10.1684/ecn.2009.0179; Bernardino ALF, 2008, INFECT IMMUN, V76, P4385, DOI 10.1128/IAI.00394-08; Boyd RS, 2009, MOL CELL PROTEOMICS, V8, P1501, DOI 10.1074/mcp.M800515-MCP200; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Cabral ES, 2006, J INFECT DIS, V193, P849, DOI 10.1086/500467; Castillo R, 2000, LEUKEMIA, V14, P292, DOI 10.1038/sj.leu.2401664; Cato MH, 2011, MOL CELL BIOL, V31, P127, DOI 10.1128/MCB.00650-10; Cerroni L, 1997, J CUTAN PATHOL, V24, P457, DOI 10.1111/j.1600-0560.1997.tb01318.x; Chiron D, 2008, BLOOD, V112, P2205, DOI 10.1182/blood-2008-02-140673; Cortelazzo S, 2012, CRIT REV ONCOL HEMAT, V82, P78, DOI 10.1016/j.critrevonc.2011.05.001; Dal Col J, 2008, BLOOD, V111, P5142, DOI 10.1182/blood-2007-07-103481; De J, 2010, INT J CLIN EXP MED, V3, P55; Dennis VA, 2009, INFECT IMMUN, V77, P1238, DOI 10.1128/IAI.01078-08; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ding Hu, 2009, J Hematop, V2, P195, DOI 10.1007/s12308-009-0049-5; Feng T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035918; Ferreri AJM, 2013, SEMIN CANCER BIOL, V23, P431, DOI 10.1016/j.semcancer.2013.09.004; Fu LC, 2006, BLOOD, V107, P4540, DOI 10.1182/blood-2005-10-4042; Gladkikh A, 2010, EXP HEMATOL, V38, P1047, DOI 10.1016/j.exphem.2010.08.002; Hasanali Z, 2012, BEST PRACT RES CL HA, V25, P143, DOI 10.1016/j.beha.2012.03.001; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Isaza-Correa JM, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0057-5; Jahrsdorfer B, 2005, CLIN CANCER RES, V11, P1490, DOI 10.1158/1078-0432.CCR-04-1890; Jares P, 2008, BRIT J HAEMATOL, V142, P149, DOI 10.1111/j.1365-2141.2008.07124.x; Kauppila JH, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23620; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Medina DJ, 2012, HAEMATOL-HEMATOL J, V97, P1255, DOI 10.3324/haematol.2011.040659; Munksgaard L, 2004, LEUKEMIA LYMPHOMA, V45, P1721, DOI 10.1080/10428190410001683723; Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210; Nodit L, 2003, HUM PATHOL, V34, P1030, DOI 10.1053/S0046-8177(03)00410-6; Orchard J, 2003, BLOOD, V101, P4975, DOI 10.1182/blood-2002-06-1864; Parthasarathy G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0274-z; Pham LV, 2003, J IMMUNOL, V171, P88, DOI 10.4049/jimmunol.171.1.88; Pighi C, 2011, CELL ONCOL, V34, P141, DOI 10.1007/s13402-011-0019-7; Pileri SA, 2009, HAEMATOL-HEMATOL J, V94, P1488, DOI 10.3324/haematol.2009.013359; Ponzoni M, 2011, ONCOLOGIST, V16, P1582, DOI 10.1634/theoncologist.2011-0108; Purdue MP, 2009, CARCINOGENESIS, V30, P275, DOI 10.1093/carcin/bgn262; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rinaldi A, 2006, BRIT J HAEMATOL, V132, P303, DOI 10.1111/j.1365-2141.2005.05883.x; Rook GAW, 2011, IMMUNOL REV, V240, P141, DOI 10.1111/j.1600-065X.2010.00987.x; Schollkopf C, 2008, BLOOD, V111, P5524, DOI 10.1182/blood-2007-08-109611; Scott DW, 2014, NAT REV CANCER, V14, P517, DOI 10.1038/nrc3774; Singh SK, 2006, CLIN MICROBIOL INFEC, V12, P705, DOI 10.1111/j.1469-0691.2006.01440.x; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Vaque JP, 2014, HAEMATOLOGICA, V99, P222, DOI 10.3324/haematol.2013.096248; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Visser HPJ, 2000, LEUKEMIA, V14, P1483, DOI 10.1038/sj.leu.2401829; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang LJ, 2013, CANCER-AM CANCER SOC, V119, P782, DOI 10.1002/cncr.27792; Zhang L, 2012, BLOOD, V120, P3783, DOI 10.1182/blood-2012-04-424630	56	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153823	10.1371/journal.pone.0153823	http://dx.doi.org/10.1371/journal.pone.0153823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123851	Green Published, gold			2022-12-26	WOS:000375211700033
J	Li, F; Ma, J				Li, Fan; Ma, Jun			Pattern Selection in Network of Coupled Multi-Scroll Attractors	PLOS ONE			English	Article							SPATIAL COHERENCE RESONANCES; SPIRAL WAVES; NEURONAL NETWORKS; CARDIAC FIBRILLATION; NOISE; DYNAMICS; BREAKUP; SYSTEMS; MECHANISMS; GENERATION	Multi-scroll chaotic attractor makes the oscillator become more complex in dynamic behaviors. The collective behaviors of coupled oscillators with multi-scroll attractors are investigated in the regular network in two-dimensional array, which the local kinetics is described by an improved Chua circuit. A feasible scheme of negative feedback with diversity is imposed on the network to stabilize the spatial patterns. Firstly, the Chua circuit is improved by replacing the nonlinear term with Sine function to generate infinite aquariums so that multi-scroll chaotic attractors could be generated under appropriate parameters, which could be detected by calculating the Lyapunov exponent in the parameter region. Furthermore, negative feedback with different gains (D-1, D-2) is imposed on the local square center area A(2) and outer area A(1) of the network, it is found that spiral wave, target wave could be developed in the network under appropriate feedback gain with diversity and size of controlled area. Particularly, homogeneous state could be reached after synchronization by selecting appropriate feedback gain and controlled size in the network. Finally, the distribution for statistical factors of synchronization is calculated in the two-parameter space to understand the transition of pattern region. It is found that developed spiral waves, target waves often are associated with smaller factor of synchronization. These results show that emergence of sustained spiral wave and continuous target wave could be effective for further suppression of spatiotemporal chaos in network by generating stable pacemaker completely.	[Li, Fan] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan 430071, Peoples R China; [Li, Fan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Ma, Jun] Lanzhou Univ Technol, Dept Phys, Lanzhou 730050, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University of Technology	Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou 730050, Peoples R China.	hyperchaos@163.com	Li, Fan/AGX-5549-2022; Ma, Jun/G-2376-2010	Li, Fan/0000-0002-9205-203X; Ma, Jun/0000-0002-6127-000X	National Natural Science Foundation of China [11265008, 11365014, 61164006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is partially supported by the National Natural Science Foundation of China under Grant Nos. 11265008, 11365014, and 61164006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi H, 1999, J Cardiol, V33 Suppl 1, P53; BAR M, 1994, J CHEM PHYS, V100, P1202, DOI 10.1063/1.466650; Cai MC, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016208; Chen JX, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/34002; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Demirkol AS, 2008, IEEE INT SYMP CIRC S, P2374; Erichsen R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061917; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Gollub JP, 1999, REV MOD PHYS, V71, pS396, DOI 10.1103/RevModPhys.71.S396; Goryachev A, 1996, PHYS REV LETT, V76, P1619, DOI 10.1103/PhysRevLett.76.1619; Gosak M, 2009, PHYSICA D, V238, P506, DOI 10.1016/j.physd.2008.11.007; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Gu HG, 2013, PHYSICA A, V392, P1361, DOI 10.1016/j.physa.2012.11.049; He DH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055204; HEAGY JF, 1994, PHYS REV E, V50, P1874, DOI 10.1103/PhysRevE.50.1874; Holden AV, 1997, NATURE, V387, P655, DOI 10.1038/42597; Hou ZH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.280601; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Jiang LL, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103001; Jiang MX, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056202; Li F, 2016, NONLINEAR DYNAM, V84, P2305, DOI 10.1007/s11071-016-2646-z; Li WB, 2009, PHYS REV E, V79; Lu JH, 2004, IEEE T CIRCUITS-I, V51, P2476, DOI 10.1109/TCSI.2004.838151; Luo JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016214; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Ma J, 2014, NONLINEAR DYNAM, V76, P1951, DOI 10.1007/s11071-014-1260-1; Ma J, 2013, SCI CHINA PHYS MECH, V56, P1126, DOI 10.1007/s11433-013-5096-3; Ma J, 2013, SCI CHINA PHYS MECH, V56, P952, DOI 10.1007/s11433-013-5070-0; Ma J, 2013, COMMUN NONLINEAR SCI, V18, P1665, DOI 10.1016/j.cnsns.2012.11.016; Pecora LM, 1998, PHYS REV LETT, V80, P2109, DOI 10.1103/PhysRevLett.80.2109; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Pisarchik AN, 2014, PHYS REP, V540, P167, DOI 10.1016/j.physrep.2014.02.007; Qin H, 2014, SCI CHINA PHYS MECH, V57, P1918, DOI 10.1007/s11433-014-5466-5; Roth BJ, 2001, PHYSICA D, V150, P127, DOI 10.1016/S0167-2789(01)00145-2; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Sevilla-Escoboza R, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2015.0005; Sevilla-Escoboza R, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032804; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Stich M, 2006, PHYSICA D, V215, P38, DOI 10.1016/j.physd.2006.01.011; SUYKENS JAK, 1993, IEEE T CIRCUITS-I, V40, P861, DOI 10.1109/81.251829; Tang WKS, 2001, IEEE T CIRCUITS-I, V48, P1369, DOI 10.1109/81.964432; Tang Z, 2012, COMMUN THEOR PHYS, V57, P61, DOI 10.1088/0253-6102/57/1/10; Wang QY, 2008, PHYS LETT A, V372, P5681, DOI 10.1016/j.physleta.2008.07.005; Wang QY, 2013, CHAOS SOLITON FRACT, V56, P19, DOI 10.1016/j.chaos.2013.05.003; Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055403; Xiao JH, 2005, EUROPHYS LETT, V69, P29, DOI 10.1209/epl/i2004-10310-7; Xu Y, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215501647; Yagisita H, 1998, PHYSICA D, V124, P126, DOI 10.1016/S0167-2789(98)00182-1; Yalcin ME, 2002, INT J BIFURCAT CHAOS, V12, P23, DOI 10.1142/S0218127402004164; Yalcin ME, 2007, CHAOS SOLITON FRACT, V34, P1659, DOI 10.1016/j.chaos.2006.04.058	54	11	11	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154282	10.1371/journal.pone.0154282	http://dx.doi.org/10.1371/journal.pone.0154282			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119986	gold, Green Published, Green Submitted			2022-12-26	WOS:000374976200055
J	Bartsch, SM; Lopman, BA; Ozawa, S; Hall, AJ; Lee, BY				Bartsch, Sarah M.; Lopman, Benjamin A.; Ozawa, Sachiko; Hall, Aron J.; Lee, Bruce Y.			Global Economic Burden of Norovirus Gastroenteritis	PLOS ONE			English	Article							ACUTE GASTROINTESTINAL ILLNESS; SEEKING BEHAVIOR; UNITED-STATES; DIARRHEAL DURATION; COST-EFFECTIVENESS; DISEASE BURDEN; CARE-SEEKING; US ADULTS; CHILDREN; COMMUNITY	Background Despite accounting for approximately one fifth of all acute gastroenteritis illnesses, norovirus has received comparatively less attention than other infectious pathogens. With several candidate vaccines under development, characterizing the global economic burden of norovirus could help funders, policy makers, public health officials, and product developers determine how much attention and resources to allocate to advancing these technologies to prevent and control norovirus. Methods We developed a computational simulation model to estimate the economic burden of norovirus in every country/area (233 total) stratified by WHO region and globally, from the health system and societal perspectives. We considered direct costs of illness (e.g., clinic visits and hospitalization) and productivity losses. Results Globally, norovirus resulted in a total of $4.2 billion (95% UI: $3.2-5.7 billion) in direct health system costs and $60.3 billion (95% UI: $44.4-83.4 billion) in societal costs per year. Disease amongst children < 5 years cost society $39.8 billion, compared to $20.4 billion for all other age groups combined. Costs per norovirus illness varied by both region and age and was highest among adults >= 55 years. Productivity losses represented 84-99% of total costs varying by region. While low and middle income countries and high income countries had similar disease incidence (10,148 vs. 9,935 illness per 100,000 persons), high income countries generated 62% of global health system costs. In sensitivity analysis, the probability of hospitalization had the largest impact on health system cost estimates ($2.8 billion globally, assuming no hospitalization costs), while the probability of missing productive days had the largest impact on societal cost estimates ($35.9 billion globally, with a 25% probability of missing productive days). Conclusions The total economic burden is greatest in young children but the highest cost per illness is among older age groups in some regions. These large costs overwhelmingly are from productivity losses resulting from acute illness. Low, middle, and high income countries all have a considerable economic burden, suggesting that norovirus gastroenteritis is a truly global economic problem. Our findings can help identify which age group(s) and/or geographic regions may benefit the most from interventions.	[Bartsch, Sarah M.; Lee, Bruce Y.] Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Computat & Operat Res, Baltimore, MD USA; [Lopman, Benjamin A.; Hall, Aron J.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Ozawa, Sachiko] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lee, BY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Computat & Operat Res, Baltimore, MD USA.	brucelee@jhu.edu	Ozawa, Sachiko/Z-4944-2019	Ozawa, Sachiko/0000-0001-7608-9038	Agency for Healthcare Research and Quality (AHRQ) [R01HS023317]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Office of Behavioral and Social Sciences Research (OBSSR); Global Obesity Prevention Center (GOPC) [U54HD070725]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS023317] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD086861, U54HD070725] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Office of Behavioral and Social Sciences Research (OBSSR); Global Obesity Prevention Center (GOPC); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Agency for Healthcare Research and Quality (AHRQ) via grant R01HS023317, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Office of Behavioral and Social Sciences Research (OBSSR) and the Global Obesity Prevention Center (GOPC) via grant U54HD070725. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Adlam SB, 2011, EPIDEMIOL INFECT, V139, P302, DOI 10.1017/S0950268810000932; Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Bartsch SM, 2012, VACCINE, V30, P7097, DOI 10.1016/j.vaccine.2012.09.040; Baumann-Popczyk A, 2012, EPIDEMIOL INFECT, V140, P1173, DOI 10.1017/S0950268811001853; BLACK RE, 1984, AM J CLIN NUTR, V39, P87, DOI 10.1093/ajcn/39.1.87; Burke RM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-642; Cates SC, 2015, J FOOD PROTECT, V78, P484, DOI 10.4315/0362-028X.JFP-14-313; Chen Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-456; Danial J, 2011, J HOSP INFECT, V79, P354, DOI 10.1016/j.jhin.2011.06.018; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Grimwood Keith, 2010, Paediatr Drugs, V12, P235, DOI 10.2165/11537200-000000000-00000; GUERRANT RL, 1992, AM J TROP MED HYG, V47, P28, DOI 10.4269/ajtmh.1992.47.28; Hall AJ, 2014, MMWR-MORBID MORTAL W, V63, P491; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Head MG, 2014, J ROY SOC MED, V107, P110, DOI 10.1177/0141076813511450; Howidi M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-74; Institute for Health Metrics and Evaluation ( IHME), 2010, GLOB BURD DIS GBD DA; Institute for Health Metrics and Evaluation ( IHME), GLOB BURD DIS GLOB H; Johnston CP, 2007, CLIN INFECT DIS, V45, P534, DOI 10.1086/520666; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lee BY, 2008, CLIN INFECT DIS, V46, P1139, DOI 10.1086/529441; Lee BY, 2011, INFECT CONT HOSP EP, V32, P191, DOI 10.1086/657910; Loganathan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125878; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Marshall JA, 2003, J MED VIROL, V69, P568, DOI 10.1002/jmv.10346; Motlagh ME, 2012, INT J PREVENTIVE MED, V3, P60; Patel AB, 2012, INDIAN J PEDIATR, V79, P472, DOI 10.1007/s12098-011-0561-3; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Pires SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142927; Porter CK, 2012, CLIN INFECT DIS, V55, P915, DOI 10.1093/cid/cis576; Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022; Rheingans RD, 2009, J INFECT DIS, V200, pS16, DOI 10.1086/605026; Robinson AE, 2014, GLOBAL TRENDS CARE S; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; Saha D, 2013, AM J TROP MED HYG, V89, P13, DOI 10.4269/ajtmh.12-0751; Saito M, 2014, CLINICAL INFECTIOUS, V8, P483; Sang XL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-787; Scallan E, 2005, INT J EPIDEMIOL, V34, P454, DOI 10.1093/ije/dyh413; Scavia G, 2012, EPIDEMIOL INFECT, V140, P1193, DOI 10.1017/S0950268811002020; SCHORLING JB, 1990, INT J EPIDEMIOL, V19, P728, DOI 10.1093/ije/19.3.728; Simanjuntak CH, 2004, J HEALTH POPUL NUTR, V22, P119; Sur D, 2004, J HEALTH POPUL NUTR, V22, P130; Tate JE, 2009, J INFECT DIS, V200, pS76, DOI 10.1086/605058; Tee GH, 2011, SE ASIAN J TROP MED, V42, P424; The World Bank, 2015, GNI CAP ATL METH CUR; U. S. Census Bureau, NAT POP EST 2010; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; United Nations Statistics Division, 2015, UNDATA GNI CAP; United States Department of Health & Human Services, 2012, HCUP FACTS FIG STAT; Van Cauteren D, 2012, EPIDEMIOL INFECT, V140, P697, DOI 10.1017/S0950268811000999; Verhoef L, 2013, EPIDEMIOL INFECT, V141, P496, DOI 10.1017/S0950268812000799; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000768; World Bank, 2014, UPD INC CLASS; World Health Organization, 2019, CHOOSING INT AR COST; World Health Organization, 2009, WHO GUID ID EC CONS; World Health Organization, 2013, GLOB HLTH OBS COUNTR; World Health Organization, GLOB BURD DIS REG US; Zingg W, 2005, INFECT CONT HOSP EP, V26, P263, DOI 10.1086/502537	59	273	300	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0151219	10.1371/journal.pone.0151219	http://dx.doi.org/10.1371/journal.pone.0151219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115736	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600010
J	Bowden, JA; Cantu, TM; Chapman, RW; Somerville, SE; Guillette, MP; Botha, H; Hoffman, A; Luus-Powell, WJ; Smit, WJ; Lebepe, J; Myburgh, J; Govender, D; Tucker, J; Boggs, ASP; Guillette, LJ				Bowden, John A.; Cantu, Theresa M.; Chapman, Robert W.; Somerville, Stephen E.; Guillette, Matthew P.; Botha, Hannes; Hoffman, Andre; Luus-Powell, Wilmien J.; Smit, Willem J.; Lebepe, Jeffrey; Myburgh, Jan; Govender, Danny; Tucker, Jonathan; Boggs, Ashley S. P.; Guillette, Louis J., Jr.			Predictive Blood Chemistry Parameters for Pansteatitis-Affected Mozambique Tilapia (Oreochromis mossambicus)	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; CROCODILE CROCODYLUS-NILOTICUS; CLARIAS-GARIEPINUS BURCHELL; NILE CROCODILE; OLIFANTS RIVER; SHARPTOOTH CATFISH; SOUTH-AFRICA; CLINICAL-CHEMISTRY; OXIDATIVE STRESS; HEAVY-METALS	One of the largest river systems in South Africa, the Olifants River, has experienced significant changes in water quality due to anthropogenic activities. Since 2005, there have been various "outbreaks" of the inflammatory disease pansteatitis in several vertebrate species. Large-scale pansteatitis-related mortality events have decimated the crocodile population at Lake Loskop and decreased the population at Kruger National Park. Most pansteatitis-related diagnoses within the region are conducted post-mortem by either gross pathology or histology. The application of a non-lethal approach to assess the prevalence and pervasiveness of pansteatitis in the Olifants River region would be of great importance for the development of a management plan for this disease. In this study, several plasma-based biomarkers accurately classified pansteatitis in Mozambique tilapia (Oreochromis mossambicus) collected from Lake Loskop using a commercially available benchtop blood chemistry analyzer combined with data interpretation via artificial neural network analysis. According to the model, four blood chemistry parameters (calcium, sodium, total protein and albumin), in combination with total length, diagnose pansteatitis to a predictive accuracy of 92 percent. In addition, several morphometric traits (total length, age, weight) were also associated with pansteatitis. On-going research will focus on further evaluating the use of blood chemistry to classify pansteatitis across different species, trophic levels, and within different sites along the Olifants River.	[Bowden, John A.; Boggs, Ashley S. P.] NIST, Mat Measurement Lab, Div Chem Sci, Environm Chem Sci Grp,Hollings Marine Lab, Charleston, SC USA; [Cantu, Theresa M.; Somerville, Stephen E.; Guillette, Matthew P.; Guillette, Louis J., Jr.] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA; [Chapman, Robert W.; Tucker, Jonathan] South Carolina Dept Nat Resources, Marine Resources Res Inst, Hollings Marine Lab, Charleston, SC USA; [Botha, Hannes; Hoffman, Andre] Mpumalanga Tourism & Pk Agcy, Sci Serv, Nelspruit, South Africa; [Botha, Hannes; Luus-Powell, Wilmien J.; Smit, Willem J.; Lebepe, Jeffrey] Univ Limpopo, Dept Biodivers, Sovenga, South Africa; [Myburgh, Jan; Govender, Danny; Guillette, Louis J., Jr.] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa; [Govender, Danny] South African Natl Pk, Sci Serv, Skukuza, South Africa	National Institute of Standards & Technology (NIST) - USA; Medical University of South Carolina; University of Limpopo; University of Pretoria	Bowden, JA (corresponding author), NIST, Mat Measurement Lab, Div Chem Sci, Environm Chem Sci Grp,Hollings Marine Lab, Charleston, SC USA.	john.bowden@nist.gov	Govender, Danny/AAH-1699-2022; Govender, Danny/AFL-9589-2022; Botha, Hannes/J-1288-2019	Botha, Hannes/0000-0001-6870-5494; Lebepe, Jeffrey/0000-0001-9802-2846	CoEE Center for Marine Genomics; MUSC Center for Global Health; Heinz Foundation: Environmental Health and Sentinel Species; Biodiversity Research Chair, University of Limpopo	CoEE Center for Marine Genomics; MUSC Center for Global Health; Heinz Foundation: Environmental Health and Sentinel Species; Biodiversity Research Chair, University of Limpopo	This work was partially funded in part by the CoEE Center for Marine Genomics (LJG), MUSC Center for Global Health, Heinz Foundation: Environmental Health and Sentinel Species (2011, LJG), and the Biodiversity Research Chair, University of Limpopo (WJLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shayea QK, 2011, INT J COMPUT SCI ISS, V8, P150; Alharbi KB, 2012, TROP ANIM HEALTH PRO, V44, P173, DOI 10.1007/s11250-011-9905-2; [Anonymous], 1950, SRM D SRM; Ashton PJ, 2010, AQUAT CONSERV, V20, P489, DOI 10.1002/aqc.1132; Atkins A, 2010, J ZOO WILDLIFE MED, V41, P585, DOI 10.1638/2009-0023.1; Baral RM, 2014, J FELINE MED SURG, P1; BARSOTTI DA, 1976, FOOD COSMET TOXICOL, V14, P99, DOI 10.1016/S0015-6264(76)80251-9; Bertin MJ, 2014, AQUAT TOXICOL, V146, P1, DOI 10.1016/j.aquatox.2013.09.026; Bevelhimer MS, 2014, ENVIRON TOXICOL CHEM, V33, P1903, DOI 10.1002/etc.2622; BOLTEN AB, 1992, J WILDLIFE DIS, V28, P407, DOI 10.7589/0090-3558-28.3.407; Botha H, 2011, WATER SA, V37, P103; Bouwman H, 2014, ECOTOX ENVIRON SAFE, V104, P393, DOI 10.1016/j.ecoenv.2013.12.005; Bury NR, 1996, J EXP BIOL, V199, P1319; Caliendo Valentina, 2010, Journal of Herpetological Medicine and Surgery, V20, P117, DOI 10.5818/1529-9651-20.4.117; Ceron JJ, 2005, VET CLIN PATH, V34, P85, DOI 10.1111/j.1939-165X.2005.tb00019.x; Chen CY, 2003, AQUACULTURE, V218, P89, DOI 10.1016/S0044-8486(02)00499-4; da Silva AOF, 2014, AQUAT TOXICOL, V156, P161, DOI 10.1016/j.aquatox.2014.08.009; Dabrowski J, 2014, FRESHWATER BIOL, V59, P1484, DOI 10.1111/fwb.12360; Dabrowski J, 2013, WATER SA, V39, P675, DOI 10.4314/wsa.v39i5.12; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Dove ADM, 2010, AQUAT BIOL, V9, P177, DOI 10.3354/ab00252; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Ferreira SM, 2011, AQUAT CONSERV, V21, P155, DOI 10.1002/aqc.1175; Ferri J, 2011, MAR ENVIRON RES, V71, P218, DOI 10.1016/j.marenvres.2011.01.006; Firat O, 2010, ARCH ENVIRON CON TOX, V58, P151, DOI 10.1007/s00244-009-9344-5; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; German AJ, 2003, J SMALL ANIM PRACT, V44, P449, DOI 10.1111/j.1748-5827.2003.tb00104.x; Goodwin AE, 2006, J FISH DIS, V29, P61, DOI 10.1111/j.1365-2761.2005.00686.x; Gopal V, 1997, ENVIRON MONIT ASSESS, V48, P117, DOI 10.1023/A:1005767517819; Greenacre CB, 2008, J AVIAN MED SURG, V22, P291, DOI 10.1647/2007-034.1; Huchzermeyer KDA, 2013, J FISH DIS, V36, P897, DOI 10.1111/jfd.12010; Huchzermeyer KDA, 2011, J FISH DIS, V34, P489, DOI 10.1111/j.1365-2761.2011.01267.x; Huchzermeyer K. David A., 2012, J. S. Afr. Vet. Assoc., V83, P41; Huchzermeyer KDA, 2012, THESIS U PRETORIA; Hussein SY, 1996, B ENVIRON CONTAM TOX, V57, P503, DOI 10.1007/s001289900218; Jooste A, 2015, ECOTOX ENVIRON SAFE, V112, P96, DOI 10.1016/j.ecoenv.2014.10.033; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kodama H, 2014, J FISH DIS, V37, P619, DOI 10.1111/jfd.12154; Kumar N, 2016, ENVIRON TOXICOL, V31, P106, DOI 10.1002/tox.22026; Lane EP, 2013, J ZOO WILDLIFE MED, V44, P899, DOI 10.1638/2012-0264R.1; LARSEN RE, 1983, J AM VET MED ASSOC, V183, P1202; Lattin CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102106; Mahlatji ML, 2014, IMPACT WATER SEDIMEN; Masango MG, 2010, J WILDLIFE DIS, V46, P95, DOI 10.7589/0090-3558-46.1.95; McCain SL, 2010, VET CLIN PATH, V39, P474, DOI 10.1111/j.1939-165X.2010.00258.x; McKinney P, 2007, NEWSLETTER MIDDLE E, P32; Misra S, 2012, TOXICOL IN VITRO, V26, P621, DOI 10.1016/j.tiv.2012.02.001; Mooney A., 2013, THESIS U JOHANNESBUR; Myburgh J., 2009, VET NEWS, P20; Nalabotu SK, 2011, INT J NANOMED, V6, P2327, DOI 10.2147/IJN.S25119; National Institute of Standards Technology, CERT AN STAND REF MA; Niza MMRE, 2003, J FELINE MED SURG, V5, P271, DOI 10.1016/S1098-612X(03)00051-2; Oberholster PJ, 2012, ECOTOX ENVIRON SAFE, V75, P134, DOI 10.1016/j.ecoenv.2011.08.018; Oberholster PJ, 2009, SIL NEWS, V55, P8; Obuchowski NA, 2004, CLIN CHEM, V50, P1118, DOI 10.1373/clinchem.2004.031823; OLIVEIRA RF, 1995, J FISH BIOL, V46, P1055, DOI 10.1006/jfbi.1995.0100; Osthoff G, 2010, COMP BIOCHEM PHYS A, V155, P64, DOI 10.1016/j.cbpa.2009.09.025; Palmeiro BS, 2007, JAVMA-J AM VET MED A, V230, P708, DOI 10.2460/javma.230.5.708; Pleadin J, 2012, B ENVIRON CONTAM TOX, V88, P1043, DOI 10.1007/s00128-012-0615-x; Rea LD, 1998, COMP BIOCHEM PHYS A, V120, P617, DOI 10.1016/S1095-6433(98)10074-0; Roberts RJ, 2008, J FISH DIS, V31, P83, DOI 10.1111/j.1365-2761.2007.00901.x; ROLETTO J, 1993, J ZOO WILDLIFE MED, V24, P145; Sepulveda MS, 2012, J AQUAT ANIM HEALTH, V24, P135, DOI 10.1080/08997659.2012.675927; Sharafeldin K, 2014, OREOCHROMIS NILOTICU, V4, P8; St Aubin DJ, 2001, ARCTIC, V54, P317, DOI 10.14430/arctic791; Stegeman N, 2010, J EXOT PET MED, V19, P298, DOI 10.1053/j.jepm.2010.10.009; Swanepoel D, 2000, ONDERSTEPOORT J VET, V67, P141; Tape TG, 2015, AREA ROC CURVE; Truter JC, 2016, J FISH DIS, V39, P69, DOI 10.1111/jfd.12324; Use of Fish in Research Committee (joint committee of the American Fisheries Society the American Institute of Fishery Research Biologists and the American Society of Ichthyologists and Herpetologists), 2014, GUID US FISH RES; Vonck APMA, 1998, COMP BIOCHEM PHYS A, V119, P441, DOI 10.1016/S1095-6433(97)00450-9; Whiting Scott D., 2007, Comparative Clinical Pathology, V16, P109, DOI 10.1007/s00580-006-0646-y; Wolf KN, 2008, JAVMA-J AM VET MED A, V233, P470, DOI 10.2460/javma.233.3.470; Woodborne S, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00170.1; ZWEIG MH, 1993, CLIN CHEM, V39, P561	75	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153874	10.1371/journal.pone.0153874	http://dx.doi.org/10.1371/journal.pone.0153874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115488	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600032
J	Han, YW; Niu, J; Wang, D; Li, YY				Han, Yuewen; Niu, Jun; Wang, Dong; Li, Yuanyuan			Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular Carcinoma	PLOS ONE			English	Article							REPLICATION; NS5A; P53; APOPTOSIS; EXPRESSION; LANDSCAPE; PATHWAYS; COMPLEX; NS3	Epidemiological studies have validated the association between hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC). An increasing number of studies show that protein-protein interactions (PPIs) between HCV proteins and host proteins play a vital role in infection and mediate HCC progression. In this work, we collected all published interaction between HCV and human proteins, which include 455 unique human proteins participating in 524 HCV-human interactions. Then, we construct the HCV-human and HCV-HCC protein interaction networks, which display the biological knowledge regarding the mechanism of HCV pathogenesis, particularly with respect to pathogenesis of HCC. Through in-depth analysis of the HCV-HCC interaction network, we found that interactors are enriched in the JAK/STAT, p53, MAPK, TNF, Wnt, and cell cycle pathways. Using a random walk with restart algorithm, we predicted the importance of each protein in the HCV-HCC network and found that AKT1 may play a key role in the HCC progression. Moreover, we found that NS5A promotes HCC cells proliferation and metastasis by activating AKT/GSK3 beta/beta-catenin pathway. This work provides a basis for a detailed map tracking new cellular interactions of HCV and identifying potential targets for HCV-related hepatocellular carcinoma treatment.	[Han, Yuewen; Li, Yuanyuan] Xian Ctr Dis Control & Prevent, Xian, Peoples R China; [Niu, Jun] Gen Hosp Shenyang Mil, Shenyang, Peoples R China; [Wang, Dong; Li, Yuanyuan] Air Force Aviat Med Identificat & Training Ctr, Dalian, Peoples R China		Li, YY (corresponding author), Xian Ctr Dis Control & Prevent, Xian, Peoples R China.; Li, YY (corresponding author), Air Force Aviat Med Identificat & Training Ctr, Dalian, Peoples R China.	wudui220@163.com	li, yuanyuan/GZA-4435-2022					Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; [Anonymous], HEP C FACTSH; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Chen QL, 2010, CELL BIOCHEM BIOPHYS, V56, P49, DOI 10.1007/s12013-009-9069-0; Choudhari SR, 2007, MOL CANCER THER, V6, P112, DOI 10.1158/1535-7163.MCT-06-0561; De Beeck AO, 2001, J GEN VIROL, V82, P2589, DOI 10.1099/0022-1317-82-11-2589; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gurtsevitch VE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P504, DOI 10.1134/S0006297908050039; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Igaki T, 2011, ADV EXP MED BIOL, V691, P45, DOI 10.1007/978-1-4419-6612-4_5; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kao CF, 2004, ONCOGENE, V23, P2472, DOI 10.1038/sj.onc.1207368; Kasprzak A, 2008, HEPATOL RES, V38, P1, DOI 10.1111/j.1872-034X.2007.00261.x; Knoess M, 2006, WORLD J GASTROENTERO, V12, P5870, DOI 10.3748/wjg.v12.i36.5870; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kwofie SK, 2011, INFECT GENET EVOL, V11, P1971, DOI 10.1016/j.meegid.2011.09.001; Kwun HJ, 2001, J GEN VIROL, V82, P2235, DOI 10.1099/0022-1317-82-9-2235; Li SS, 2012, CELL MICROBIOL, V14, P994, DOI 10.1111/j.1462-5822.2012.01773.x; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lorenz IC, 2010, VIRUSES-BASEL, V2, P1635, DOI 10.3390/v2081635; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Park KJ, 2001, VIRUS RES, V74, P89, DOI 10.1016/S0168-1702(00)00251-3; Prikhod'ko EA, 2004, VIROLOGY, V329, P53, DOI 10.1016/j.virol.2004.08.012; Qadri I, 2002, BBA-MOL CELL RES, V1592, P193, DOI 10.1016/S0167-4889(02)00315-4; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tripathi LP, 2010, MOL BIOSYST, V6, P2539, DOI 10.1039/c0mb00103a; Tsao TT-H, 2011, PREDICTION ANAL INTE, P322; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839	41	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153882	10.1371/journal.pone.0153882	http://dx.doi.org/10.1371/journal.pone.0153882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115606	Green Submitted, gold, Green Published			2022-12-26	WOS:000374973600033
J	Peng, JM; Du, B; Wang, Q; Weng, L; Hu, XY; Wu, CY; Shi, Y				Peng, Jin-Min; Du, Bin; Wang, Qian; Weng, Li; Hu, Xiao-Yun; Wu, Chan-Yuan; Shi, Yan			Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients	PLOS ONE			English	Article							SYSTEMIC RHEUMATIC-DISEASES; CRITICALLY-ILL PATIENTS; INTERSTITIAL LUNG-DISEASE; LONG-TERM OUTCOMES; LUPUS-ERYTHEMATOSUS; PROGNOSTIC-FACTORS; AMYOPATHIC DERMATOMYOSITIS; AUTOIMMUNE-DISEASES; PERIPHERAL-BLOOD; INFECTIONS	Introduction Patients with idiopathic inflammatory myopathies (IIMs) are sometimes complicated with life-threatening conditions requiring intensive care unit (ICU) admission. In the past, owing to the low incidence of IIM, little was known about such patients. Our aim was to investigate the clinical features and outcomes of these patients and identify their risk factors for mortality. Methods A retrospective study was performed of IIM patients admitted over an 8-year period to the medical ICU of a tertiary referral center in China. We collected data regarding demographic features, IIM-related clinical characteristics, reasons for admission, organ dysfunction, and outcomes. Independent predictors of ICU mortality were identified through multivariate logistic regression analysis. Results Of the 102 patients in our cohort, polymyositis (PM), dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM) accounted for 23.5%, 64.7%, and 11.7% respectively. The median duration from the onset of IIM to ICU admission was 4.3 months (interquartile range [IQR], 2.6-9.4 months). Reasons for ICU admission were infection alone (39.2%), acute exacerbation of IIM alone (27.5%), the coexistence of both (27.5%), or other reasons (5.8%). Pneumonia accounted for 97% of the infections; 63.2% of infections with documented pathogens were caused by opportunistic agents. Rapid progressive interstitial lung disease (RP-ILD) was responsible for 87.5% of acute exacerbation of IIM. The median Acute Physiology and Chronic Health Evaluation II (APACHE II) score on ICU day 1 was 17 (IQR 14-20). On ICU admission, acute respiratory failure (ARF) was the most common type (80.4%) of organ failure. The mortality rate in the ICU was 79.4%. Factors associated with increased ICU mortality included a diagnosis of DM (including CADM), a high APACHE II score, the presence of ARF, a decreased PaO2/FiO(2) ratio, and a low lymphocyte count at the time of ICU admission. Conclusions The outcome of IIM patients admitted to the ICU was extremely poor. A diagnosis of DM/CADM, the presence and severity of ARF, and the lymphocyte counts at ICU admission were shown to be valuable for predicting outcome. Opportunistic infections and rapidly progressive interstitial lung disease warrant concern in treating these patients.	[Peng, Jin-Min; Du, Bin; Weng, Li; Hu, Xiao-Yun] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Med, Intens Care Unit, Beijing 100021, Peoples R China; [Peng, Jin-Min; Du, Bin; Wang, Qian; Weng, Li; Hu, Xiao-Yun; Wu, Chan-Yuan; Shi, Yan] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wang, Qian; Wu, Chan-Yuan] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Shi, Yan] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen, Intens Care Unit, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Wang, Q (corresponding author), Chinese Acad Med Sci, Beijing 100730, Peoples R China.; Wang, Q (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	wangqian@pumch.cn		Wang, Qian/0000-0002-4541-9898; Weng, Li/0000-0003-0403-0752	National Natural Science Foundation of China [81471615]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant number: 81471615, URL: http://www.nsfc.gov.cn/, to W. Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton JM, 2012, CLIN EXP RHEUMATOL, V30, P338; Befort P, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-27; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Camargo JF, 2005, LUPUS, V14, P315, DOI 10.1191/0961203305lu2082oa; Cavallasca JA, 2010, JCR-J CLIN RHEUMATOL, V16, P400, DOI 10.1097/RHU.0b013e3181ffe517; Chen IJ, 2010, RHEUMATOLOGY, V49, P2429, DOI 10.1093/rheumatology/keq279; Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dumas G, 2015, CHEST, V148, P927, DOI 10.1378/chest.14-3098; Faguer S, 2013, EUR J INTERN MED, V24, pE40, DOI 10.1016/j.ejim.2012.11.018; Falagas ME, 2007, CLIN RHEUMATOL, V26, P663, DOI 10.1007/s10067-006-0441-9; Fujisawa T, 2005, J RHEUMATOL, V32, P58; Fujisawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098824; Ghazi E, 2013, CLIN EXP RHEUMATOL, V31, P128; Godeau B, 1997, J RHEUMATOL, V24, P1317; Harigai M, 2007, NEW ENGL J MED, V357, P1874, DOI 10.1056/NEJMc070728; HELLMANN DB, 1987, MEDICINE, V66, P341, DOI 10.1097/00005792-198709000-00002; Hsu CL, 2005, CRIT CARE, V9, pR177, DOI 10.1186/cc3481; Huh JW, 2007, RESP MED, V101, P1761, DOI 10.1016/j.rmed.2007.02.017; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Khan SA, 2007, CHEST, V131, P972, DOI 10.1378/chest.06-2464; Lee J, 2012, RHEUMATOL INT, V32, P3353, DOI 10.1007/s00296-011-2158-6; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Marie I, 2011, SEMIN ARTHRITIS RHEU, V41, P48, DOI 10.1016/j.semarthrit.2010.08.003; Migita K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078699; Moreels M, 2005, INTENS CARE MED, V31, P591, DOI 10.1007/s00134-005-2563-y; Murray SG, 2015, ARTHRIT CARE RES, V67, P673, DOI 10.1002/acr.22501; Namendys-Silva SA, 2009, LUPUS, V18, P1252, DOI 10.1177/0961203309345720; OGORMAN MRG, 1995, CLIN DIAGN LAB IMMUN, V2, P205, DOI 10.1128/CDLI.2.2.205-208.1995; Quintero OL, 2013, AUTOIMMUN REV, V12, P380, DOI 10.1016/j.autrev.2012.06.002; Radhakrishna SM, 2012, PEDIATR CRIT CARE ME, V13, pE181, DOI 10.1097/PCC.0b013e318238955c; Shalev T, 2006, CLIN EXP RHEUMATOL, V24, P380; Sherer Y, 2007, CLIN RHEUMATOL, V26, P1851, DOI 10.1007/s10067-007-0588-z; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Thong BYH, 2001, ANN ACAD MED SINGAP, V30, P254; Viguier M, 2003, MEDICINE, V82, P82, DOI 10.1097/00005792-200303000-00002; Whitelaw DA, 2005, CLIN RHEUMATOL, V24, P223, DOI 10.1007/s10067-004-1007-3; Yu KH, 2011, CLIN RHEUMATOL, V30, P1595, DOI 10.1007/s10067-011-1840-0	39	26	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154441	10.1371/journal.pone.0154441	http://dx.doi.org/10.1371/journal.pone.0154441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115138	Green Published, gold, Green Submitted			2022-12-26	WOS:000374973600066
J	Rossi, D; Barbosa, NM; Galvao, FC; Boldrin, PEG; Hershey, JWB; Zanelli, CF; Fraser, CS; Valentini, SR				Rossi, Danuza; Barbosa, Natalia M.; Galvao, Fabio C.; Boldrin, Paulo E. G.; Hershey, John W. B.; Zanelli, Cleslei F.; Fraser, Christopher S.; Valentini, Sandro R.			Evidence for a Negative Cooperativity between eIF5A and eEF2 on Binding to the Ribosome	PLOS ONE			English	Article							ELONGATION-FACTOR P; YEAST SACCHAROMYCES-CEREVISIAE; SYNTHESIS INITIATION-FACTORS; TRANSLATION INITIATION; PROTEIN-SYNTHESIS; EF-P; HYPUSINE MODIFICATION; TRANSFER-RNA; EUKARYOTIC RIBOSOME; CELL VIABILITY	eIF5A is the only protein known to contain the essential and unique amino acid residue hypusine. eIF5A functions in both translation initiation due to its stimulation of methionyl-puromycin synthesis and translation elongation, being highly required for peptide-bound formation of specific ribosome stalling sequences such as poly-proline. The functional interaction between eIF5A, tRNA, and eEF2 on the surface of the ribosome is further clarified herein. Fluorescence anisotropy assays were performed to determine the affinity of eIF5A to different ribosomal complexes and reveal its interaction exclusively and directly with the 60S ribosomal subunit in a hypusine-dependent manner (K-i(60S-eIF5A-Hyp) = 16 nM, K-i(60S-eIF5A-Lys) = 385 nM). A 3-fold increase in eIF5A affinity to the 80S is observed upon charged-tRNA(i)(Met) binding, indicating positive cooperativity between P-site tRNA binding and eIF5A binding to the ribosome. Previously identified conditional mutants of yeast eIF5A, eIF5A(Q22H/L93F) and eIF5A(K56A), display a significant decrease in ribosome binding affinity. Binding affinity between ribosome and eIF5A-wild type ormutants eIF5A(K56A), but not eIF5A(Q22H/L93F), is impaired in the presence of eEF2 by 4-fold, consistent with negative cooperativity between eEF2 and eIF5A binding to the ribosome. Interestingly, high-copy eEF2 is toxic only to eIF5A(Q22H/L93F) and causes translation elongation defects in this mutant. These results suggest that binding of eEF2 to the ribosome alters its conformation, resulting in a weakened affinity of eIF5A and impairment of this interplay compromises cell growth due to translation elongation defects.	[Rossi, Danuza; Barbosa, Natalia M.; Galvao, Fabio C.; Boldrin, Paulo E. G.; Zanelli, Cleslei F.; Valentini, Sandro R.] UNESP Univ Estadual Paulista, Sch Pharmaceut Sci, Dept Biol Sci, BR-14801 Araraquara, SP, Brazil; [Rossi, Danuza; Hershey, John W. B.; Fraser, Christopher S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Universidade Estadual Paulista; University of California System; University of California Davis	Valentini, SR (corresponding author), UNESP Univ Estadual Paulista, Sch Pharmaceut Sci, Dept Biol Sci, BR-14801 Araraquara, SP, Brazil.	valentsr@fcfar.unesp.br	Valentini, Sandro R/C-4353-2012; Zanelli, Cleslei Fernando/AAE-1003-2019; Zanelli, Cleslei Fernando/C-1916-2013	Zanelli, Cleslei Fernando/0000-0001-7831-1149; Barbosa, Natalia/0000-0002-3952-558X; Valentini, Sandro Roberto/0000-0003-4453-5413	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/50044-6]; Faculdade de Ciencias Farmaceuticas - UNESP; National Institute of General Medical Sciences [R01GM092927]; FAPESP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092927] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Faculdade de Ciencias Farmaceuticas - UNESP; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to SRV from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant number 10/50044-6), PADC from Faculdade de Ciencias Farmaceuticas - UNESP and CSF was supported by grant number R01GM092927 from National Institute of General Medical Sciences. We also thank FAPESP for fellowships awarded to the authors (DR; NMB; PEGB; FCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; BENNE R, 1978, J BIOL CHEM, V253, P3078; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dias CAO, 2008, FEBS J, V275, P1874, DOI 10.1111/j.1742-4658.2008.06345.x; Dias CAO, 2012, AMINO ACIDS, V42, P697, DOI 10.1007/s00726-011-0985-0; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Firczuk H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.73; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Galvao FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060140; Graifer D, 2015, INT J MOL SCI, V16, P7173, DOI 10.3390/ijms16047173; Graifer D, 2013, MOLECULES, V18, P14455, DOI 10.3390/molecules181214455; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; HERSHEY JWB, 1990, BIOCHIM BIOPHYS ACTA, V1050, P160, DOI 10.1016/0167-4781(90)90159-Y; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Lassak J, 2015, NAT CHEM BIOL, V11, P266, DOI [10.1038/nchembio.1751, 10.1038/NCHEMBIO.1751]; Moreno JMP, 1998, BIOCHEM BIOPH RES CO, V252, P465, DOI 10.1006/bbrc.1998.9664; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Park JH, 2011, PROTEIN ENG DES SEL, V24, P301, DOI 10.1093/protein/gzq110; PARK MH, 1984, J BIOL CHEM, V259, P2123; Park MH, 1998, J BIOL CHEM, V273, P1677, DOI 10.1074/jbc.273.3.1677; PARK MH, 1993, BIOFACTORS, V4, P95; PELTZ SW, 1992, MOL CELL BIOL, V12, P5778, DOI 10.1128/MCB.12.12.5778; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Puljung Michael C, 2012, Curr Protoc Protein Sci, VChapter 14, DOI 10.1002/0471140864.ps1414s70; Rossi D, 2014, WIRES RNA, V5, P209, DOI 10.1002/wrna.1211; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; Sokabe M, 2014, J BIOL CHEM, V289, P31827, DOI 10.1074/jbc.M114.602870; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Sulima SO, 2014, NUCLEIC ACIDS RES, V42, P2049, DOI 10.1093/nar/gkt1107; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Thompson GM, 2003, FEBS LETT, V555, P464, DOI 10.1016/S0014-5793(03)01305-X; Toseland Christopher P, 2013, J Chem Biol, V6, P85, DOI 10.1007/s12154-013-0094-5; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Woolstenhulme CJ, 2015, CELL REP, V11, P13, DOI 10.1016/j.celrep.2015.03.014; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195	48	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154205	10.1371/journal.pone.0154205	http://dx.doi.org/10.1371/journal.pone.0154205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115996	Green Published, gold, Green Submitted			2022-12-26	WOS:000374973600048
J	Wang, YJ; Zhang, BW; Zhang, XP; Wang, XM; Cheng, J; Chen, BA				Wang, Yujie; Zhang, Bowen; Zhang, Xiaoping; Wang, Xuemei; Cheng, Jian; Chen, Baoan			Detection and Identification of Hematologic Malignancies and Solid Tumors by an Electrochemical Technique	PLOS ONE			English	Article							GLASSY-CARBON ELECTRODE; DIFFERENTIAL-PULSE VOLTAMMETRY; MINIMAL RESIDUAL DISEASE; CANCER-CELLS; SENSITIVE DETECTION; CYCLIC VOLTAMMETRY; LEUKEMIA; INTERFACE; RESPONSES; ACID	Purpose Develop and evaluate an electrochemical method to identify healthy individuals, malignant hematopathic patients and solid tumor patients by detecting the leukocytes in whole-blood. Methods A total of 114 individual blood samples obtained from our affiliated hospital in China (June 2015-August 2015) were divided into three groups: healthy individuals (n = 35), hematologic malignancies (n = 41) and solid tumors (n = 38). An electrochemical workstation system was used to measure differential pulse voltammetry due to the different electrochemical behaviors of leukocytes in blood samples. Then, one-way analysis of variance (ANOVA) was applied to analyze the scanning curves and to compare the peak potential and peak current. Results The scanning curve demonstrated the specific electrochemical behaviors of the blank potassium ferricyanide solution and that mixed with blood samples in different groups. Significant differences in mean peak potentials of mixture and shifts (Delta Ep (mV)) were observed of the three groups (P< = 0.001). 106.00+/-9.00 and 3.14+/-7.48 for Group healthy individuals, 120.90+/-11.18 and 18.10+/-8.81 for Group hematologic malignancies, 136.84+/-11.53 and 32.89+/-10.50 for Group solid tumors, respectively. In contrast, there were no significant differences in the peak currents and shifts. Conclusions The newly developed method to apply the electrochemical workstation system to identify hematologic malignancies and solid tumors with good sensitivity and specificity might be effective, suggesting a potential utility in clinical application.	[Wang, Yujie; Zhang, Xiaoping; Cheng, Jian; Chen, Baoan] Southeast Univ, Zhongda Hosp, Dept Hematol & Oncol, Key Discipline Jiangshu Prov,Sch Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Bowen; Wang, Xuemei] Southeast Univ, Chien Shiung Wu Lab, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Chen, BA (corresponding author), Southeast Univ, Zhongda Hosp, Dept Hematol & Oncol, Key Discipline Jiangshu Prov,Sch Med, Nanjing, Jiangsu, Peoples R China.	cba8888@hotmail.com	Wang, Xuemei/GXF-3702-2022	Zhang, Xiao-Ping/0000-0003-0995-4989	Health Research Projects of Jiangsu Province; National High Technology Research and Development Program 863 of People's Republic of China [2012AA022703]; Key Medical Projects of Jiangsu Province [BL2014078]; Key Discipline of Jiangsu Province	Health Research Projects of Jiangsu Province; National High Technology Research and Development Program 863 of People's Republic of China(National High Technology Research and Development Program of China); Key Medical Projects of Jiangsu Province; Key Discipline of Jiangsu Province	XPZ was supported by the Health Research Projects of Jiangsu Province (2013-2016). BAC was supported by the National High Technology Research and Development Program 863 of People's Republic of China (Grant no 2012AA022703), as well as the Key Medical Projects of Jiangsu Province (Grant no BL2014078), and the Key Discipline of Jiangsu Province (2011-2015). All the funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jaroudi SS, 2014, BIOMETALS, V27, P1115, DOI 10.1007/s10534-014-9771-2; Alves A, 2015, J PHYS CHEM B, V119, P7968, DOI 10.1021/acs.jpcb.5b03419; Baronian KHR, 2002, APPL MICROBIOL BIOT, V60, P108, DOI 10.1007/s00253-002-1108-3; Brett AMO, 1999, ANAL CHIM ACTA, V385, P401; Chamjangali MA, 2015, MEASUREMENT, V71, P23, DOI 10.1016/j.measurement.2015.04.012; Chen J, 2005, CHEM-EUR J, V11, P1467, DOI 10.1002/chem.200400956; Chen JH, 2008, ANAL CHEM, V80, P8028, DOI 10.1021/ac801040e; Ci YX, 1998, ELECTROANAL, V10, P921; Dachs GU, 1997, NAT MED, V3, P515, DOI 10.1038/nm0597-515; Du D, 2005, BIOCHEMISTRY-US, V44, P11539, DOI 10.1021/bi0507332; Feng LY, 2011, BIOMATERIALS, V32, P2930, DOI 10.1016/j.biomaterials.2011.01.002; Foletti A, 2015, ELECTROMAGN BIOL MED, V34, P147, DOI 10.3109/15368378.2015.1036073; Goda T, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00029; Halper B, 2015, EXERC IMMUNOL REV, V21, P154; Hayakawa T, 2014, J MOL CELL CARDIOL, V77, P178, DOI 10.1016/j.yjmcc.2014.09.010; He F, 2009, TALANTA, V77, P1009, DOI 10.1016/j.talanta.2008.07.063; Hebart H, 2002, BLOOD, V100, P4521, DOI 10.1182/blood-2002-01-0265; Hourigan CS, 2013, NAT REV CLIN ONCOL, V10, P460, DOI 10.1038/nrclinonc.2013.100; Hu JQ, 2010, ACTA PHYS-CHIM SIN, V26, P2205, DOI 10.3866/PKU.WHXB20100632; Huan SY, 2004, ELECTROANAL, V16, P1019, DOI 10.1002/elan.200302879; JULIUSSON G, 1993, J CLIN ONCOL, V11, P679, DOI 10.1200/JCO.1993.11.4.679; Keynes R D, 1975, Ciba Found Symp, P191; Kim K, 2014, BIOL SPORT, V31, P39, DOI 10.5604/20831862.1086731; Kim Y, 2009, CURR MOL MED, V9, P425, DOI 10.2174/156652409788167113; Laputkova G, 2002, BIOELECTROCHEMISTRY, V56, P185, DOI 10.1016/S1567-5394(02)00044-0; Lee AC, 2014, ANALYST, V139, P4223, DOI 10.1039/c3an01156a; Legeai S, 2005, ELECTROCHIM ACTA, V50, P4089, DOI 10.1016/j.electacta.2005.01.024; Levar CE, 2014, MBIO, V5, DOI 10.1128/mBio.02034-14; Li XL, 2006, SENSOR ACTUAT B-CHEM, V117, P35, DOI 10.1016/j.snb.2005.10.044; Liu JF, 2015, BIOSENS BIOELECTRON, V71, P82, DOI 10.1016/j.bios.2015.04.012; Lu S, 2014, CHEM RES CHINESE U, V30, P437, DOI 10.1007/s40242-014-4153-4; MATSUNAGA T, 1984, ANAL CHEM, V56, P798, DOI 10.1021/ac00268a047; Musolino A, 2010, TUMORI, V96, P24, DOI 10.1177/030089161009600104; Oberacher H, 2015, MASS SPECTROM REV, V34, P64, DOI 10.1002/mas.21409; Pandey CM, 2011, BIOMACROMOLECULES, V12, P2925, DOI 10.1021/bm200490b; Promsuwicha Orathai, 2014, Journal of the Medical Association of Thailand, V97, P1296; Scherer A, 2002, RADIOLOGE, V42, P222, DOI 10.1007/s00117-002-0721-6; Sharma A, 2012, BIOSENS BIOELECTRON, V38, P107, DOI 10.1016/j.bios.2012.05.010; Skapare E, 2011, CELL BIOCHEM FUNCT, V29, P171, DOI 10.1002/cbf.1723; Smith A, 2015, BRIT J CANCER, V112, P1575, DOI 10.1038/bjc.2015.94; Sun DP, 2015, ANAL CHIM ACTA, V885, P166, DOI 10.1016/j.aca.2015.05.027; Sun YM, 2015, BIOSENS BIOELECTRON, V68, P358, DOI 10.1016/j.bios.2015.01.017; van der Velden VHJ, 2003, LEUKEMIA, V17, P1013, DOI 10.1038/sj.leu.2402922; Venuta F, 1997, EUR J CARDIO-THORAC, V11, P218, DOI 10.1016/S1010-7940(96)01055-X; Wang J, 1999, ANAL CHEM, V71, p328R; Wei W, 2012, FOOD CHEM, V135, P888, DOI 10.1016/j.foodchem.2012.06.037; Winters N, 2015, SCI TOTAL ENVIRON, V526, P153, DOI 10.1016/j.scitotenv.2015.03.149; Wu WA, 2008, CHINESE J ANAL CHEM, V36, P1721; Wu YZ, 2014, CANCER LETT, V345, P164, DOI 10.1016/j.canlet.2013.08.014; Zhang SL, 2014, ANALYST, V139, P3629, DOI 10.1039/c4an00420e; Zhao XC, 2010, CAN J CHEM, V88, P569, DOI 10.1139/V10-051; Zheng TT, 2013, NANOSCALE, V5, P10360, DOI 10.1039/c3nr02903d; Zhu XL, 2013, ANAL CHIM ACTA, V764, P59, DOI 10.1016/j.aca.2012.12.024	53	3	3	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153821	10.1371/journal.pone.0153821	http://dx.doi.org/10.1371/journal.pone.0153821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115355	Green Published, Green Submitted, gold			2022-12-26	WOS:000374973600031
J	Kawachi, Y				Kawachi, Yousuke			Visual Mislocalization of Moving Objects in an Audiovisual Event	PLOS ONE			English	Article							PERCEPTION; CUES	The present study investigated the influence of an auditory tone on the localization of visual objects in the stream/bounce display (SBD). In this display, two identical visual objects move toward each other, overlap, and then return to their original positions. These objects can be perceived as either streaming through or bouncing off each other. In this study, the closest distance between object centers on opposing trajectories and tone presentation timing (none, 0 ms, +/- 90 ms, and +/- 390 ms relative to the instant for the closest distance) were manipulated. Observers were asked to judge whether the two objects overlapped with each other and whether the objects appeared to stream through, bounce off each other, or reverse their direction of motion. A tone presented at or around the instant of the objects' closest distance biased judgments toward "non-overlapping," and observers overestimated the physical distance between objects. A similar bias toward direction change judgments (bounce and reverse, not stream judgments) was also observed, which was always stronger than the non-overlapping bias. Thus, these two types of judgments were not always identical. Moreover, another experiment showed that it was unlikely that this observed mislocalization could be explained by other previously known mislocalization phenomena (i.e., representational momentum, the Frohlich effect, and a turn-point shift). These findings indicate a new example of crossmodal mislocalization, which can be obtained without temporal offsets between audiovisual stimuli. The mislocalization effect is also specific to a more complex stimulus configuration of objects on opposing trajectories, with a tone that is presented simultaneously. The present study promotes an understanding of relatively complex audiovisual interactions beyond simple one-to-one audiovisual stimuli used in previous studies.	[Kawachi, Yousuke] Tohoku Fukushi Univ, Kansei Fukushi Res Inst, Sendai, Miyagi, Japan		Kawachi, Y (corresponding author), Tohoku Fukushi Univ, Kansei Fukushi Res Inst, Sendai, Miyagi, Japan.	kawachi@tfu-mail.tfu.ac.jp	Kawachi, Yousuke/P-9683-2019; Kawachi, Yousuke/O-1041-2019	Kawachi, Yousuke/0000-0003-3976-8386	Japan Society for the Promotion of Science (JSPS) [25530173, 26350995]; MEXT; Grants-in-Aid for Scientific Research [16K00212] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid of the Japan Society for the Promotion of Science (JSPS) for Scientific Research (no. 25530173 and 26350995) and MEXT-Supported program for the Strategic Research Foundation at Private Universities, 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertelson P., 1999, COGNITIVE CONTRIBUTI, P347, DOI DOI 10.1016/S0166-4115(99)80034-X; BERTENTHAL BI, 1993, PERCEPTION, V22, P193, DOI 10.1068/p220193; Chien S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00070; Choi H, 2006, PERCEPTION, V35, P385, DOI 10.1068/p5462; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Frohlich FW., 1923, Z SINNESPHYSIOL, V54, P58; GOLDBERG DM, 1982, J EXP PSYCHOL HUMAN, V8, P547, DOI 10.1037/0096-1523.8.4.547; Grassi M, 2012, SEEING PERCEIVING, V25, P223, DOI 10.1163/187847612X626372; Grove PM, 2012, J VISION, V12, DOI 10.1167/12.8.5; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Heron J, 2004, VISION RES, V44, P2875, DOI 10.1016/j.visres.2004.07.001; Kanai R, 2007, VISION RES, V47, P937, DOI 10.1016/j.visres.2006.12.009; Kawachi Y, 2006, PERCEPTION, V35, P1289, DOI 10.1068/p5594; Kawachi Y, 2014, J VISION, V14, DOI 10.1167/14.8.16; Kawachi Y, 2011, I-PERCEPTION, V2, P428, DOI 10.1068/i0399; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Makovski T, 2009, VIS COGN, V17, P180, DOI 10.1080/13506280802211334; Michotte A. E, 1963, PERCEPTION CAUSALITY; Nieman D, 2010, J VISION, V10, DOI 10.1167/10.6.9; QIAN N, 1994, J NEUROSCI, V14, P7357; Rolfs M, 2013, CURR BIOL, V23, P250, DOI 10.1016/j.cub.2012.12.017; Sekuler AB, 1999, PERCEPTION, V28, P415, DOI 10.1068/p2909; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Teramoto W, 2010, ATTEN PERCEPT PSYCHO, V72, P2215, DOI [10.3738/APP.72.8.2215, 10.3758/APP.72.8.2215]; Thornton IM, 2002, SPATIAL VISION, V15, P219, DOI 10.1163/15685680252875183; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; Watanabe K., 2001, CROSSMODAL INTERACTI; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Witt JK, 2015, PERCEPTION, V44, P289, DOI 10.1068/p7908; Yamada Y, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00166; Zhou F, 2007, EXP BRAIN RES, V180, P641, DOI 10.1007/s00221-007-0897-0	35	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154147	10.1371/journal.pone.0154147	http://dx.doi.org/10.1371/journal.pone.0154147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111759	Green Published, Green Submitted, gold			2022-12-26	WOS:000374970600036
J	Masia, M; Padilla, S; Fernandez, M; Rodriguez, C; Moreno, A; Oteo, JA; Antela, A; Moreno, S; del Amo, J; Gutierrez, F				Masia, Mar; Padilla, Sergio; Fernandez, Marta; Rodriguez, Carmen; Moreno, Ana; Oteo, Jose A.; Antela, Antonio; Moreno, Santiago; del Amo, Julia; Gutierrez, Felix		CoRIS Biobanco	Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARDIOVASCULAR RISK; OXIDANT STRESS; MALONDIALDEHYDE; INFLAMMATION; INCREASE; BIOBANK; PLASMA; MARKER; COHORT	Objective We aimed to assess whether oxidative stress is a predictor of mortality in HIV-infected patients. Methods We conducted a nested case-control study in CoRIS, a contemporary, multicentre cohort of HIV-infected patients, antiretroviral-naive at entry, launched in 2004. Cases were patients who died with available stored plasma samples collected. Two age and sex-matched controls for each case were selected. We measured F2-isoprostanes (F-2-IsoPs) and malondialdehyde (MDA) plasma levels in the first blood sample obtained after cohort engagement. Results 54 cases and 93 controls were included. Median F-2-IsoPs and MDA levels were significantly higher in cases than in controls. When adjustment was performed for age, HIV-transmission category, CD4 cell count and HIV viral load at cohort entry, and subclinical inflammation measured with highly-sensitive C-reactive protein (hsCRP), the association of F-2-IsoPs with mortality remained significant (adjusted OR per 1 log10 increase, 2.34 [1.23-4.47], P = 0.009). The association of MDA with mortality was attenuated after adjustment: adjusted OR (95% CI) per 1 log10 increase, 2.05 [0.91-4.59], P = 0.080. Median hsCRP was also higher in cases, and it also proved to be an independent predictor of mortality in the adjusted analysis: OR (95% CI) per 1 log10 increase, 1.39 (1.01-1.91), P = 0.043; and OR (95% CI) per 1 log10 increase, 1.46 (1.07-1.99), P = 0.014, respectively, when adjustment included F-2-IsoPs and MDA. Conclusion Oxidative stress is a predictor of all-cause mortality in HIV-infected patients. For plasma F-2-IsoPs, this association is independent of HIV-related factors and subclinical inflammation.	[Masia, Mar; Padilla, Sergio; Gutierrez, Felix] Univ Miguel Hernandez, Hosp Gen Elche, Infect Dis Unit, Alicante, Spain; [Fernandez, Marta] Hosp Gen Elche, Infect Dis Res Lab, Alicante, Spain; [Rodriguez, Carmen] Ctr Sanitario Sandoval, HIV AIDS & Sexually Transmitted Dis Clin, Madrid, Spain; [Moreno, Ana; Moreno, Santiago] Hosp Ramon & Cajal, Inst Ramon & Cajal Invest Sanitaria, Infect Dis Serv, E-28034 Madrid, Spain; [Oteo, Jose A.] Hosp San Pedro La Rioja, Infect Dis Serv, Logrono, Spain; [Antela, Antonio] Hosp Clin Santiago, Infect Dis Unit, La Coruna, Spain; [del Amo, Julia] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain	Universidad Miguel Hernandez de Elche; Hospital Universitario Ramon y Cajal; Complexo Hospitalario Universitario de Santiago de Compostela; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE)	Gutierrez, F (corresponding author), Univ Miguel Hernandez, Hosp Gen Elche, Infect Dis Unit, Alicante, Spain.	gutierrez_fel@gva.es	Oteo, Jose A./AAB-3134-2020; Padilla, Sergio/U-7682-2017; Garcia, Elena/GWR-0291-2022; Rodero, Félix Gutiérrez/Q-7880-2018; Fernández-González, Marta/U-7492-2017; DEL AMO VALERO, JULIA/M-7020-2015; Masia, Mar/U-7510-2017	Oteo, Jose A./0000-0001-7080-6542; Rodero, Félix Gutiérrez/0000-0002-9485-6867; Fernández-González, Marta/0000-0001-9949-8504; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Masia, Mar/0000-0001-9878-2458; Padilla, Sergio/0000-0002-8420-7310	Plan Nacional R + D + I [RD12/0017/0023]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) [FIS (PI08/893), FIS (PI13/02256), FISABIO UGP-14-197]; Contrato de Intensificacion de la Actividad Investigadora [INT 14/00207]; ISCIII [RD06/0006/0035]; FIPSE	Plan Nacional R + D + I; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Contrato de Intensificacion de la Actividad Investigadora; ISCIII(Instituto de Salud Carlos III); FIPSE	This work has been (partially) funded by the RD12/0017/0023 project as part of the Plan Nacional R + D + I and cofinanced by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), FIS (PI08/893), FIS (PI13/02256), FISABIO UGP-14-197, and Contrato de Intensificacion de la Actividad Investigadora INT 14/00207. The HIV Biobank, integrated in the RIS, is also supported by the ISCIII (RD06/0006/0035) and FIPSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Aukrust P, 2005, BLOOD, V105, P4730, DOI 10.1182/blood-2004-11-4272; Balfour L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085607; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; Bestilny LJ, 2000, AIDS, V14, P771, DOI 10.1097/00002030-200005050-00002; Blanco JR, 2015, JAIDS-J ACQ IMM DEF, V68, P21, DOI 10.1097/QAI.0000000000000398; Chehne F, 2001, PROSTAG LEUKOTR ESS, V64, P307, DOI 10.1054/plef.2001.0277; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; Herbein G, 2008, CURR HIV RES, V6, P117, DOI 10.2174/157016208783884985; Hernando V, 2012, AIDS, V26, P1829, DOI 10.1097/QAD.0b013e328352ada4; Hulgan T, 2003, CLIN INFECT DIS, V37, P1711, DOI 10.1086/379776; Hulgan T, 2006, JAIDS-J ACQ IMM DEF, V42, P450, DOI 10.1097/01.qai.0000226792.16216.1c; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Ingle SM, 2014, CLIN INFECT DIS, V59, P287, DOI 10.1093/cid/ciu261; Irlam JH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003650.pub3; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Lorente L, 2013, CRIT CARE, V17, DOI 10.1186/cc13155; Manda KR, 2011, FREE RADICAL BIO MED, V50, P801, DOI 10.1016/j.freeradbiomed.2010.12.029; Masia M, 2007, CLIN THER, V29, P1448, DOI 10.1016/j.clinthera.2007.07.025; Masia M, 2007, ATHEROSCLEROSIS, V195, P167, DOI 10.1016/j.atherosclerosis.2006.09.013; Masia M, 2013, AIDS, V27, P181, DOI 10.1097/QAD.0b013e32835a1156; McComsey GA, 2003, JAIDS-J ACQ IMM DEF, V34, P45, DOI 10.1097/00126334-200309010-00006; Montuschi P, 2007, CURR MED CHEM, V14, P703, DOI 10.2174/092986707780059607; Nielsen F, 1997, CLIN CHEM, V43, P1209; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Pyo CW, 2008, BIOCHEM BIOPH RES CO, V376, P180, DOI 10.1016/j.bbrc.2008.08.114; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Roest M, 2008, J CLIN LIPIDOL, V2, P298, DOI 10.1016/j.jacl.2008.06.004; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Schottker B, 2015, J GERONTOL A-BIOL, V70, P518, DOI 10.1093/gerona/glu111; Sharma B, 2014, CURR HIV RES, V12, P13, DOI 10.2174/1570162X12666140402100959; Sinha JK, 2014, NEUROSCIENCE, V269, P256, DOI 10.1016/j.neuroscience.2014.03.040; Sobrino-Vegas P, 2011, ENFERM INFEC MICR CL, V29, P645, DOI 10.1016/j.eimc.2011.06.002; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steiner J, 2006, ANTIOXID REDOX SIGN, V8, P2089, DOI 10.1089/ars.2006.8.2089; Suresh DR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-61; Tang AM, 2000, J ACQ IMMUN DEF SYND, V25, pS12, DOI 10.1097/00126334-200010001-00003; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Vassimon HS, 2010, CURR HIV RES, V8, P364, DOI 10.2174/157016210791330347	44	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153456	10.1371/journal.pone.0153456	http://dx.doi.org/10.1371/journal.pone.0153456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111769	Green Published, Green Submitted, gold			2022-12-26	WOS:000374970600015
J	Segura-Noguera, M; Blasco, D; Fortuno, JM				Segura-Noguera, Mariona; Blasco, Dolors; Fortuno, Jose-Manuel			Taxonomic and Environmental Variability in the Elemental Composition and Stoichiometry of Individual Dinoflagellate and Diatom Cells from the NW Mediterranean Sea	PLOS ONE			English	Article							MARINE-PHYTOPLANKTON; CHEMICAL-COMPOSITION; NUTRIENT RATIOS; EVOLUTIONARY INHERITANCE; GLYCINE BETAINE; CARBON CONTENT; SINGLE CELLS; TIME-SERIES; GROWTH-RATE; PHOSPHORUS	Here we present, for the first time, the elemental concentration, including C, N and O, of single phytoplankton cells collected from the sea. Plankton elemental concentration and stoichiometry are key variables in phytoplankton ecophysiology and ocean biogeochemistry, and are used to link cells and ecosystems. However, most field studies rely on bulk techniques that overestimate carbon and nitrogen because the samples include organic matter other than plankton organisms. Here we used X-ray microanalysis (XRMA), a technique that, unlike bulk analyses, gives simultaneous quotas of C, N, O, Mg, Si, P, and S, in single-cell organisms that can be collected directly from the sea. We analysed the elemental composition of dinoflagellates and diatoms (largely Chaetoceros spp.) collected from different sites of the Catalan coast (NW Mediterranean Sea). As expected, a lower C content is found in our cells compared to historical values of cultured cells. Our results indicate that, except for Si and O in diatoms, the mass of all elements is not a constant fraction of cell volume but rather decreases with increasing cell volume. Also, diatoms are significantly less dense in all the measured elements, except Si, compared to dinoflagellates. The N: P ratio of both groups is higher than the Redfield ratio, as it is the N: P nutrient ratio in deep NW Mediterranean Sea waters (N: P = 20-23). The results suggest that the P requirement is highest for bacterioplankton, followed by dinoflagellates, and lowest for diatoms, giving them a clear ecological advantage in P-limited environments like the Mediterranean Sea. Finally, the P concentration of cells of the same genera but growing under different nutrient conditions was the same, suggesting that the P quota of these cells is at a critical level. Our results indicate that XRMA is an accurate technique to determine single cell elemental quotas and derived conversion factors used to understand and model ocean biogeochemical cycles.	[Segura-Noguera, Mariona; Blasco, Dolors; Fortuno, Jose-Manuel] CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Spain; [Segura-Noguera, Mariona] Univ Sheffield, Dept Chem & Biol Engn, Adv Biomfg Ctr, ChELSI Inst, Sheffield, S Yorkshire, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Sheffield	Segura-Noguera, M (corresponding author), CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Spain.	mariona@marionasegura.cat	Segura-Noguera, Mariona/C-4524-2012	Segura-Noguera, Mariona/0000-0003-4832-7590; Fortuno, Jose-Manuel/0000-0003-3486-0685	Spanish Ministry of Economy and Competitiveness [REN2003-06637-C02]; I3P fellowship (CSIC, Spanish Ministry of Education and Culture)	Spanish Ministry of Economy and Competitiveness(Spanish Government); I3P fellowship (CSIC, Spanish Ministry of Education and Culture)	`This work was supported by project PUDEM (REN2003-06637-C02, Spanish Ministry of Science and Technology, now Spanish Ministry of Economy and Competitiveness); and by an I3P fellowship (CSIC, Spanish Ministry of Education and Culture) to M. Segura-Noguera. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaras M., 1985, P435; Alonso-Saez L, 2008, ECOSYSTEMS, V11, P397, DOI 10.1007/s10021-008-9129-0; ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Angles S, 2010, DEEP-SEA RES PT II, V57, P210, DOI 10.1016/j.dsr2.2009.09.002; Arin L, 2013, ESTUAR COAST SHELF S, V133, P116, DOI 10.1016/lecss2013.08.018; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Baines SB, 2012, NAT GEOSCI, V5, P886, DOI [10.1038/ngeo1641, 10.1038/NGEO1641]; BANSE K, 1974, LIMNOL OCEANOGR, V19, P695, DOI 10.4319/lo.1974.19.4.0695; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bethoux JP, 1998, MAR CHEM, V63, P155, DOI 10.1016/S0304-4203(98)00059-0; Bethoux JP, 2002, DEEP-SEA RES PT II, V49, P2007, DOI 10.1016/S0967-0645(02)00024-3; BIENFANG PK, 1984, MAR ECOL PROG SER, V14, P297, DOI 10.3354/meps014297; BLASCO D, 1982, J PHYCOL, V18, P58, DOI 10.1111/j.0022-3646.1982.00058.x; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; COPINMONTEGUT C, 1983, DEEP-SEA RES, V30, P31, DOI 10.1016/0198-0149(83)90031-6; d'Alcala MR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001650; Deutsch C, 2012, ANNU REV MAR SCI, V4, P113, DOI 10.1146/annurev-marine-120709-142821; Diaz J, 2008, SCIENCE, V320, P652, DOI 10.1126/science.1151751; DORTCH Q, 1983, MAR ECOL PROG SER, V13, P61, DOI 10.3354/meps013061; Estrada M., 1991, OECOLOGIA AQUATICA, V10, P157; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Falster DS, 2006, SMATR STANDARISED MA; FANNING KA, 1992, J GEOPHYS RES-OCEANS, V97, P5693, DOI 10.1029/92JC00007; Flynn KJ, 2010, PROG OCEANOGR, V84, P52, DOI 10.1016/j.pocean.2009.09.006; Fraga F, 2001, SCI MAR, V65, P153, DOI 10.3989/scimar.2001.65s2153; Fraga F, 1998, SCI MAR, V62, P161, DOI 10.3989/scimar.1998.62n1-2161; FRAGA F, 1990, Scientia Marina, V54, P69; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Gisselson LA, 2001, LIMNOL OCEANOGR, V46, P1237, DOI 10.4319/lo.2001.46.5.1237; Guadayol O, 2009, MAR ECOL PROG SER, V381, P139, DOI 10.3354/meps07939; Gundersen K, 2002, LIMNOL OCEANOGR, V47, P1525, DOI 10.4319/lo.2002.47.5.1525; Hall EK, 2011, ECOSYSTEMS, V14, P261, DOI 10.1007/s10021-010-9408-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARRISON PJ, 1977, MAR BIOL, V43, P19, DOI 10.1007/BF00392568; Hedges JI, 2002, MAR CHEM, V78, P47, DOI 10.1016/S0304-4203(02)00009-9; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; Hinder SL, 2012, NAT CLIM CHANGE, V2, P271, DOI [10.1038/nclimate1388, 10.1038/NCLIMATE1388]; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Ivancic I, 2012, LIMNOL OCEANOGR, V57, P1721, DOI 10.4319/lo.2012.57.6.1721; Keller MD, 1999, MAR BIOL, V135, P237, DOI 10.1007/s002270050621; Keller MD, 1999, MAR BIOL, V135, P249, DOI 10.1007/s002270050622; Krom MD, 2010, PROG OCEANOGR, V85, P236, DOI 10.1016/j.pocean.2010.03.003; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Lomas MW, 2000, J PHYCOL, V36, P903, DOI 10.1046/j.1529-8817.2000.99029.x; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Margalef R., 1998, ACTA BOT BARCINO, V45, P633; Margalef R, 1945, FITOPLANCTON NERITIC; Markaki Z, 2010, MAR CHEM, V120, P187, DOI 10.1016/j.marchem.2008.10.005; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; MATRAI PA, 1994, MAR BIOL, V119, P61, DOI 10.1007/BF00350107; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; MOAL J, 1987, OCEANOL ACTA, V10, P339; MONTAGNES DJS, 1994, LIMNOL OCEANOGR, V39, P1044, DOI 10.4319/lo.1994.39.5.1044; Mostajir B, 1998, OCEANOL ACTA, V21, P589, DOI 10.1016/S0399-1784(98)80041-8; MULLIN MM, 1966, LIMNOL OCEANOGR, V11, P307, DOI 10.4319/lo.1966.11.2.0307; NORLAND S, 1995, APPL ENVIRON MICROB, V61, P1357, DOI 10.1128/AEM.61.4.1357-1362.1995; Nunez-Milland DR, 2010, J SYNCHROTRON RADIAT, V17, P560, DOI 10.1107/S0909049510014020; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; PARSONS TR, 1961, J FISH RES BOARD CAN, V18, P1001, DOI 10.1139/f61-063; Paulmier A, 2009, BIOGEOSCIENCES, V6, P923, DOI 10.5194/bg-6-923-2009; Pujo-Pay M, 2011, BIOGEOSCIENCES, V8, P883, DOI 10.5194/bg-8-883-2011; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Quigg A, 2011, P ROY SOC B-BIOL SCI, V278, P526, DOI 10.1098/rspb.2010.1356; Redfield A.C., 1963, SEA; REDFIELD AC, 1958, AM SCI, V46, P205; Reynolds C.S., 1997, VEGETATION PROCESSES, V9, DOI 10.1017/S0025315400036432; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Rios AF, 1998, SCI MAR, V62, P257; Romero E, 2012, MAR ECOL PROG SER, V464, P69, DOI 10.3354/meps09846; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Scheffer M, 2003, HYDROBIOLOGIA, V491, P9, DOI 10.1023/A:1024404804748; Segura-Noguera M, 2016, BIOGEOCHEMI IN PRESS, p80S1; Segura-Noguera M, 2012, LIMNOL OCEANOGR-METH, V10, P666, DOI 10.4319/lom.2012.10.666; Segura-Noguera M, 2011, SCI MAR, V75, P321, DOI 10.3989/scimar.2011.75n2321; SICKOGOAD LM, 1984, LIMNOL OCEANOGR, V29, P1170, DOI 10.4319/lo.1984.29.6.1170; Sigee DC, 1999, AQUAT MICROB ECOL, V19, P177, DOI 10.3354/ame019177; Simo R, 2002, LIMNOL OCEANOGR, V47, P53, DOI 10.4319/lo.2002.47.1.0053; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Spector D.L., 1984, P107; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sterner RW, 2008, LIMNOL OCEANOGR, V53, P1169, DOI 10.4319/lo.2008.53.3.1169; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; Thingstad TF, 1998, LIMNOL OCEANOGR, V43, P88, DOI 10.4319/lo.1998.43.1.0088; Twining BS, 2010, LIMNOL OCEANOGR, V55, P492, DOI 10.4319/lo.2009.55.2.0492; Twining BS, 2003, ANAL CHEM, V75, P3806, DOI 10.1021/ac034227z; Twining BS, 2004, LIMNOL OCEANOGR, V49, P2115, DOI 10.4319/lo.2004.49.6.2115; Van Lenning K, 2007, J PHYCOL, V43, P892, DOI 10.1111/j.1529-8817.2007.00396.x; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Velasquez Z, 1997, THESIS TU CATALONIA; VERITY PG, 1992, LIMNOL OCEANOGR, V37, P1434, DOI 10.4319/lo.1992.37.7.1434; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403	97	9	9	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154050	10.1371/journal.pone.0154050	http://dx.doi.org/10.1371/journal.pone.0154050			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111067	Green Published, Green Accepted, gold			2022-12-26	WOS:000374970600030
J	Shumayla; Sharma, S; Pandey, AK; Singh, K; Upadhyay, SK				Shumayla; Sharma, Shailesh; Pandey, Ajay K.; Singh, Kashmir; Upadhyay, Santosh Kumar			Molecular Characterization and Global Expression Analysis of Lectin Receptor Kinases in Bread Wheat (Triticum aestivum)	PLOS ONE			English	Article							S-LOCUS; DIFFERENTIAL EXPRESSION; HIGH-TEMPERATURE; GENE; ARABIDOPSIS; DOMAIN; EVOLUTION; DUPLICATION; STRESS; FAMILY	Lectin receptor kinases (LRKs) play a critical role in plants during development and stress conditions, but a comprehensive analysis at genome level is still not carried out in Triticum aestivum. Herein, we performed the genome wide identification, characterization and expression analysis of these genes in T. aestivum (TaLRK). In-total 263 TaLRK genes were identified, which were further classified into three groups based on the nature of lectin domain. We identified, two TaLRKs consisted of calcium-dependent lectin (C-LRK), while 84 legume-lectin (L-LRK) and 177 bulb-lectin (B-LRK) domains. The L-LRK and B-LRK genes were distributed throughout the genome of T. aestivum. Most of the TaLRKs were clustered as homologs, which were distributed either in proximity on same chromosome or on homoeologous chromosomes of A, B and D sub-genomes. A total of 9 and 58 duplication events were also predicted in L-LRK and B-LRK, respectively. Phylogenetic analysis indicated conserved evolutionary relationship of homologous and orthologous genes from multiple plant species. Gene ontology analysis indicated TaLRKs role in binding, signaling and receptor activities. Most of the TaLRKs consisted of a trans-membrane domain and predicted to be localized in the plasma-membrane. A diverse expression pattern of TaLRK genes was found in various developmental stages and stress conditions. Some TaLRKs were found to be highly affected during a particular stress, which indicated a specialized role of each LRK gene in a specific stress condition. These results described various characteristic feature and expression pattern of TaLRK genes, which will pave the way for functional characterization in wheat.	[Shumayla; Upadhyay, Santosh Kumar] Panjab Univ, Deparment Bot, Chandigarh 160014, India; [Sharma, Shailesh; Pandey, Ajay K.] Govt India, Natl Agrifood Biotechnol Inst, Dept Biotechnol, C 127 Ind Area, Mohali 1600711, Punjab, India; [Shumayla; Singh, Kashmir] Panjab Univ, Deparment Biotechnol, Chandigarh 160014, India	Panjab University; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University	Upadhyay, SK (corresponding author), Panjab Univ, Deparment Bot, Chandigarh 160014, India.	santoshnbri@hotmail.com	Singh, Kashmir/ABA-3329-2020; Upadhyay, Santosh/ABD-2302-2020	Singh, Kashmir/0000-0002-9646-9043; Upadhyay, Santosh/0000-0001-6991-0502; Pandey, Ajay Kumar/0000-0003-1064-139X; ., Shumayla/0000-0001-6445-0703	Panjab University, Chandigarh, India; National Agri-Food Biotechnology Institute, Mohali, Punjab, India	Panjab University, Chandigarh, India; National Agri-Food Biotechnology Institute, Mohali, Punjab, India	Authors are thankful to Panjab University, Chandigarh, India and National Agri-Food Biotechnology Institute, Mohali, Punjab, India for providing support and research facilities. Authors are also thankful to URGI and NCBI for the availability of RNA sequences data and various other tools. S is grateful to UGC for JRF. Authors are grateful to Dr. Praveen C Verma for critical evaluation and language editing of manuscript.	Agarwal G., 2016, PLANT BIOTECHNOL J, P1; Akpinar BA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1641-y; Babbitt CC, 2007, CELL, V131, P225, DOI 10.1016/j.cell.2007.10.001; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhati KK, 2014, PLANT SCI, V224, P74, DOI 10.1016/j.plantsci.2014.04.009; Bonaventure G, 2011, PLANT SIGNAL BEHAV, V6, P2060, DOI 10.4161/psb.6.12.18324; Bouwmeester K, 2009, J EXP BOT, V60, P4383, DOI 10.1093/jxb/erp277; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Deng KQ, 2009, J PLANT BIOL, V52, P493, DOI 10.1007/s12374-009-9063-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Garcia-Hernandez Margarita, 2002, Funct Integr Genomics, V2, P239, DOI 10.1007/s10142-002-0077-z; Gilardoni PA, 2011, PLANT CELL, V23, P3512, DOI 10.1105/tpc.111.088229; Glover NM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0754-6; Herve C, 1999, PLANT MOL BIOL, V39, P671, DOI 10.1023/A:1006136701595; Herve C, 1996, J MOL BIOL, V258, P778, DOI 10.1006/jmbi.1996.0286; Hirsch AM, 1999, CURR OPIN PLANT BIOL, V2, P320, DOI 10.1016/S1369-5266(99)80056-9; Hofberger JA, 2015, GENOME BIOL EVOL, V7, P720, DOI 10.1093/gbe/evv020; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jiang SY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-79; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joshi A, 2010, GLYCOCONJUGATE J, V27, P133, DOI 10.1007/s10719-009-9265-6; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; Magadum S, 2013, J GENET, V92, P155, DOI 10.1007/s12041-013-0212-8; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McClung CR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-55; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naithani S, 2007, P NATL ACAD SCI USA, V104, P12211, DOI 10.1073/pnas.0705186104; Navarro-Gochicoa MT, 2003, PLANT PHYSIOL, V133, P1893, DOI 10.1104/pp.103.027680; Nishiguchi M, 2002, MOL GENET GENOMICS, V267, P506, DOI 10.1007/s00438-002-0683-4; Ohno S., 1970, P1; Pfeifer M, 2014, SCIENCE, V345, DOI 10.1126/science.1250091; Pingault L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0601-9; Pradhan GP, 2012, FUNCT PLANT BIOL, V39, P190, DOI 10.1071/FP11245; Prasad PVV, 2011, J AGRON CROP SCI, V197, P430, DOI 10.1111/j.1439-037X.2011.00477.x; Ramachandraiah G, 2000, PROTEINS, V39, P358, DOI 10.1002/(SICI)1097-0134(20000601)39:4<358::AID-PROT80>3.0.CO;2-M; Riou C, 2002, PLANT PHYSIOL BIOCH, V40, P431, DOI 10.1016/S0981-9428(02)01390-6; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy SW, 2007, MOL BIOL EVOL, V24, P171, DOI 10.1093/molbev/msl159; Sherman-Broyles S, 2007, PLANT CELL, V19, P94, DOI 10.1105/tpc.106.048199; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Singh P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00124; Singh P, 2012, PLANT CELL, V24, P1256, DOI 10.1105/tpc.112.095778; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vaid N, 2012, PLANT MOL BIOL, V80, P365, DOI 10.1007/s11103-012-9952-8; Van Damme EJM, 2007, BIOCHEM J, V404, P51, DOI 10.1042/BJ20061819; Wan JR, 2008, PLANT MOL BIOL, V67, P469, DOI 10.1007/s11103-008-9332-6; Wang Y, 2015, J EXP BOT, V66, P6731, DOI 10.1093/jxb/erv379; Wang Y, 2014, MOL PLANT MICROBE IN, V27, P1390, DOI 10.1094/MPMI-06-14-0191-R; Wendel JF, 2002, MOL BIOL EVOL, V19, P2346, DOI 10.1093/oxfordjournals.molbev.a004062; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x; Xing SL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-69; Yamamoto E, 2001, MOL BIOL EVOL, V18, P1522, DOI 10.1093/oxfordjournals.molbev.a003938; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-898; Zuo KJ, 2004, DNA SEQUENCE, V15, P58, DOI 10.1080/1042517042000191454	68	36	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153925	10.1371/journal.pone.0153925	http://dx.doi.org/10.1371/journal.pone.0153925			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111449	Green Published, gold			2022-12-26	WOS:000374970600023
J	Sudo, T; Yokota, T; Okuzaki, D; Ueda, T; Ichii, M; Ishibashi, T; Isono, T; Habuchi, Y; Oritani, K; Kanakura, Y				Sudo, Takao; Yokota, Takafumi; Okuzaki, Daisuke; Ueda, Tomoaki; Ichii, Michiko; Ishibashi, Tomohiko; Isono, Tomomi; Habuchi, Yoko; Oritani, Kenji; Kanakura, Yuzuru			Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury	PLOS ONE			English	Article							BMP4-DEPENDENT STRESS ERYTHROPOIESIS; STEM-CELL; ERYTHROID-DIFFERENTIATION; IN-VIVO; GATA-1; GENE; PROGENITORS; ANEMIA; MACROPHAGES; HOMEOSTASIS	Numerous red blood cells are generated every second from proliferative progenitor cells under a homeostatic state. Increased erythropoietic activity is required after myelo-suppression as a result of chemo-radio therapies. Our previous study revealed that the endothelial cell-selective adhesion molecule (ESAM), an authentic hematopoietic stem cell marker, plays essential roles in stress-induced hematopoiesis. To determine the physiological importance of ESAM in erythroid recovery, ESAM-knockout (KO) mice were treated with the anticancer drug, 5-fluorouracil (5-FU). ESAM-KO mice experienced severe and prolonged anemia after 5-FU treatment compared to wild-type (WT) mice. Eight days after the 5-FU injection, compared to WT mice, ESAM-KO mice showed reduced numbers of erythroid progenitors in bone marrow (BM) and spleen, and reticulocytes in peripheral blood. Megakaryocyte-erythrocyte progenitors (MEPs) from the BM of 5-FU-treated ESAM-KO mice showed reduced burst forming unit-erythrocyte (BFU-E) capacities than those from WT mice. BM transplantation revealed that hematopoietic stem/progenitor cells from ESAM-KO donors were more sensitive to 5-FU treatment than that from WT donors in the WT host mice. However, hematopoietic cells from WT donors transplanted into ESAM-KO host mice could normally reconstitute the erythroid lineage after a BM injury. These results suggested that ESAM expression in hematopoietic cells, but not environmental cells, is critical for hematopoietic recovery. We also found that 5-FU treatment induces the up-regulation of ESAM in primitive erythroid progenitors and macrophages that do not express ESAM under homeostatic conditions. The phenotypic change seen in macrophages might be functionally involved in the interaction between erythroid progenitors and their niche components during stress-induced acute erythropoiesis. Microarray analyses of primitive erythroid progenitors from 5-FU-treated WT and ESAM-KO mice revealed that various signaling pathways, including the GATA1 system, were impaired in ESAM-KO mice. Thus, our data demonstrate that ESAM expression in hematopoietic progenitors is essential for erythroid recovery after a BM injury.	[Sudo, Takao; Yokota, Takafumi; Ueda, Tomoaki; Ichii, Michiko; Ishibashi, Tomohiko; Isono, Tomomi; Habuchi, Yoko; Oritani, Kenji; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr, Suita, Osaka 565, Japan	Osaka University; Osaka University	Yokota, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka, Japan.	yokotat@bldon.med.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020	Okuzaki, Daisuke/0000-0002-4552-783X; ISONO, TOMOMI/0000-0002-0652-2331; Ishibashi, Tomohiko/0000-0003-1953-5016	JSPS [25461416]; Grants-in-Aid for Scientific Research [15H06373] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (JSPS KAKENHI) Grant Number 25461416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Dev A, 2010, BLOOD, V116, P5334, DOI 10.1182/blood-2009-12-258947; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Dzierzak E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011601; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; FEINSTEIN E, 1992, ONCOGENE, V7, P1853; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hirata K, 2001, J BIOL CHEM, V276, P16223, DOI 10.1074/jbc.M100630200; Inoue M, 2010, MICROVASC RES, V80, P179, DOI 10.1016/j.mvr.2010.04.005; Ishida T, 2003, J BIOL CHEM, V278, P34598, DOI 10.1074/jbc.M304890200; Jacobs-Helber SM, 2002, J BIOL CHEM, V277, P4859, DOI 10.1074/jbc.M107243200; Kimura R, 2010, GENES CELLS, V15, P385, DOI 10.1111/j.1365-2443.2010.01387.x; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Malinge S, 2013, BLOOD, V121, P2440, DOI 10.1182/blood-2012-08-450627; Marques-Garcia F, 2009, J BIOL CHEM, V284, P21139, DOI 10.1074/jbc.M109.026849; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Minami R, 2003, EXP HEMATOL, V31, P355, DOI 10.1016/S0301-472X(03)00040-7; Ooi AGL, 2009, STEM CELLS, V27, P653, DOI 10.1634/stemcells.2008-0824; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Perry JM, 2009, BLOOD, V113, P911, DOI 10.1182/blood-2008-03-147892; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Soni S, 2006, J BIOL CHEM, V281, P20181, DOI 10.1074/jbc.M603226200; Sudo T, 2012, J IMMUNOL, V189, P200, DOI 10.4049/jimmunol.1200056; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001; Yokota T, 2009, BLOOD, V113, P2914, DOI 10.1182/blood-2008-07-167106; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154189	10.1371/journal.pone.0154189	http://dx.doi.org/10.1371/journal.pone.0154189			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111450	Green Submitted, Green Published, gold			2022-12-26	WOS:000374970600044
J	Azimi, P; Benzel, EC; Montazeri, A				Azimi, Parisa; Benzel, Edward C.; Montazeri, Ali			Predictive Score Card in Lumbar Disc Herniation: Is It Reflective of Patient Surgical Success after Discectomy?	PLOS ONE			English	Article							SPINE; OUTCOMES; SATISFACTION; SURGERY; ISSUES; PAIN	Does the Finneson-Cooper score reflect the true value of predicting surgical success before discectomy? The aim of this study was to identify reliable predictors for surgical success two year after surgery for patients with LDH. Prospective analysis of 154 patients with LDH who underwent single-level lumbar discectomy was performed. Pre- and post-surgical success was assessed by the Oswestry Disability Index (ODI) over a 2-year period. The Finneson-Cooper score also was used for evaluation of the clinical results. Using the ODI, surgical success was defined as a 30% (or more) improvement on the ODI score from the baseline. The ODI was considered the gold standard in this study. Finally, the sensitivity, specificity, and positive and negative predictive power of the Finneson-Cooper score in predicting surgical success were calculated. The mean age of the patients was 49.6 (SD = 9.3) years and 47.4% were male. Significant improvement from the pre- to post-operative ODI scores was observed (P < 0.001). Post-surgical success was 76.0% (n = 117). The patients' rating on surgical success assessments by the ODI discriminated well between sub-groups of patients who differed with respect to the Finneson-Cooper score. Regarding patients' surgical success, the sensitivity, specificity, and accuracy of the Finneson-Cooper ratings correlated with success rate. The findings indicated that the Finneson-Cooper score was reflective of surgical success before discectomy.	[Azimi, Parisa] Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Tehran, Iran; [Benzel, Edward C.] Cleveland Clin Fdn, Dept Neurosurg, Cleveland, OH 44195 USA; [Montazeri, Ali] ACECR, Iranian Inst Hlth Sci Res, Hlth Metr Res Ctr, Mental Hlth Res Grp, Tehran, Iran	Shahid Beheshti University Medical Sciences; Cleveland Clinic Foundation; Academic Center for Education, Culture & Research (ACECR)	Azimi, P (corresponding author), Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Tehran, Iran.	parisa.azimi@gmail.com	Sciences, Functional Neurosurgery Research Center Shahid Beheshti University of Medical/AAN-2817-2020; Montazeri, Ali/C-9276-2009	Montazeri, Ali/0000-0002-5198-9539				Alodaibi FA, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-40; Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006; Finneson B E, 1979, Spine (Phila Pa 1976), V4, P141, DOI 10.1097/00007632-197903000-00008; Freedman MK, 2011, SPINE, V36, P290, DOI 10.1097/BRS.0b013e3181ef9d8c; Kirkwood BR, 2004, ESSENTIAL MED STAT, P430; Mauffrey C, 2008, BRIT J HOSP MED, V69, P344, DOI 10.12968/hmed.2008.69.6.29625; Motiei-Langroudi R, 2014, ASIAN SPINE J, V8, P446, DOI 10.4184/asj.2014.8.4.446; Mousavi SJ, 2006, SPINE, V31, pE454, DOI 10.1097/01.brs.0000222141.61424.f7; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; SIMPSON JM, 1993, J BONE JOINT SURG AM, V75A, P1823, DOI 10.2106/00004623-199312000-00013; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; SPENGLER DM, 1990, J BONE JOINT SURG AM, V72A, P230, DOI 10.2106/00004623-199072020-00010; Stromqvist B, 2013, EUR SPINE J, V22, P953, DOI 10.1007/s00586-013-2758-9; Verbeek J H A M, 2005, Ned Tijdschr Geneeskd, V149, P1493; Voorhies RM, 2007, SPINE J, V7, P516, DOI 10.1016/j.spinee.2006.10.013; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; White Andrew P, 2012, Evid Based Spine Care J, V3, P45, DOI 10.1055/s-0031-1298600; Yuan S, 2014, ACTA ORTHOP BELG, V80, P575	19	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154114	10.1371/journal.pone.0154114	http://dx.doi.org/10.1371/journal.pone.0154114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100287	gold, Green Published			2022-12-26	WOS:000374898500148
J	Ni, GY; Chen, S; Yang, YD; Cummins, SF; Zhan, J; Li, ZX; Zhu, B; Mounsey, K; Walton, S; Wei, MQ; Wang, YJ; Zhou, YQ; Wang, TF; Liu, XS				Ni, Guoying; Chen, Shu; Yang, Yuedong; Cummins, Scott F.; Zhan, Jian; Li, Zhixiu; Zhu, Bin; Mounsey, Kate; Walton, Shelley; Wei, Ming Q.; Wang, Yuejian; Zhou, Yaoqi; Wang, Tianfang; Liu, Xiaosong			Investigation the Possibility of Using Peptides with a Helical Repeating Pattern of HydroPhobic and Hydrophilic Residues to Inhibit IL-10	PLOS ONE			English	Article							STRUCTURE-BASED DESIGN; HUMAN-PAPILLOMAVIRUS TYPE-16; ANTIGEN-EXPERIENCED HOST; T-CELL RESPONSES; IFN-GAMMA; VIROSOMAL FORMULATION; SIGNALING BLOCKADE; RECEPTOR ANTIBODY; VIRAL-INFECTION; DENDRITIC CELLS	Blockade of IL-10 signalling clears chronic viral and bacterial infections. Immunization together with blockade of IL-10 signalling or relatively low level of IL-10 further enhances viral and bacterial clearance. IL-10 functions through binding to interleukin 10 receptor (IL-10R). Here we showed that peptides P1 and P2 with the hydrophobic and hydrophilic pattern of the IL10R-binding helix in IL-10 could bind with either IL-10R1 or IL-10, and inhibit inflammatory signals with long duration and negligible cytotoxicity in vitro. Furthermore, P2 can enhance antigen specific CD8+ T cell responses in mice induced by the vaccine based on a long peptide of protein E7 in a human papillomavirus type 16.	[Ni, Guoying; Cummins, Scott F.; Wang, Tianfang; Liu, Xiaosong] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Australia; [Mounsey, Kate; Walton, Shelley] Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Australia; [Ni, Guoying; Wei, Ming Q.] Griffith Univ, Griffith Hlth Inst, Sch Med Sci, Gold Coast, Australia; [Yang, Yuedong; Zhan, Jian; Zhou, Yaoqi] Griffith Univ, Inst Glyc, Gold Coast, Australia; [Yang, Yuedong; Zhan, Jian; Zhou, Yaoqi] Griffith Univ, Sch Informat & Commun Technol, Gold Coast, Australia; [Li, Zhixiu] Univ Queensland, Diamantina Inst, Woolloongabba, Qld, Australia; [Chen, Shu; Zhu, Bin; Wang, Yuejian; Liu, Xiaosong] Foshan First Peoples Hosp, Canc Res Inst, Foshan, Guangdong, Peoples R China	University of the Sunshine Coast; University of the Sunshine Coast; Griffith University; Menzies Health Institute Queensland; Griffith University; Griffith University; University of Queensland	Wang, TF; Liu, XS (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Australia.; Zhou, YQ (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Australia.; Zhou, YQ (corresponding author), Griffith Univ, Sch Informat & Commun Technol, Gold Coast, Australia.; Liu, XS (corresponding author), Foshan First Peoples Hosp, Canc Res Inst, Foshan, Guangdong, Peoples R China.	yaoqi.zhou@griffith.edu.au; twang@usc.edu.au; xliu@usc.edu.au	Walton, Shelley/A-9767-2012; Wang, Tianfang/L-5192-2016; Wang, Tianfang/AAG-4290-2020; Wang, Tianfang/GRO-0844-2022; Zhou, Yaoqi/B-3284-2009; Jian, Zhan/AAM-2759-2021; Yang, Yuedong/C-9394-2009; Li, Zhixiu/AAK-4021-2021; Cummins, Scott/I-6420-2016	Walton, Shelley/0000-0002-5857-6913; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Zhou, Yaoqi/0000-0002-9958-5699; Jian, Zhan/0000-0003-0856-2385; Yang, Yuedong/0000-0002-6782-2813; Li, Zhixiu/0000-0002-2924-9120; Mounsey, Kate/0000-0003-0579-9424; Cummins, Scott/0000-0002-1454-2076	National Natural Science Foundation of China [81472451]; National Health and Medical Research Council of Australia [1059775]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by the National Natural Science Foundation of China (www.nsfc.gov.cn/publish/portal1/), 81472451 to XL and TW; and the National Health and Medical Research Council of Australia (www.nhmrc.gov.au), 1059775 to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaji K, 2011, J MED CHEM, V54, P7962, DOI 10.1021/jm200870n; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Barrera D, 2012, CYTOKINE, V57, P316, DOI 10.1016/j.cyto.2011.11.020; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Berezhnoy A, 2012, MOL THER, V20, P1242, DOI 10.1038/mt.2012.18; Bich C, 2009, CURR OPIN STRUC BIOL, V19, P632, DOI 10.1016/j.sbi.2009.08.004; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Brooks DG, 2008, J EXP MED; Carriero MV, 2009, MOL CANCER THER, V8, P2708, DOI 10.1158/1535-7163.MCT-09-0174; Caspar-Bauguil S, 2000, J INFECT DIS, V182, P1394, DOI 10.1086/315856; Chen S, 2014, CELL IMMUNOL, V290, P145, DOI 10.1016/j.cellimm.2014.06.002; Chen SM, 2013, J IMMUNOL, V191, P5097, DOI 10.4049/jimmunol.1300467; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Clutton G, 2015, HUM VACC IMMUNOTHER, V11, P1030, DOI 10.1080/21645515.2015.1009809; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Cua DJ, 1999, J EXP MED, V189, P1005, DOI 10.1084/jem.189.6.1005; De Bruijn MLH, 1998, CANCER RES, V58, P724; Diaz-Valdes N, 2011, HEPATOLOGY, V53, P23, DOI 10.1002/hep.23980; Dings RPM, 2007, ACCOUNTS CHEM RES, V40, P1057, DOI 10.1021/ar700086k; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Ejrnaes M, 2007, AUTOIMMUN REV, V6, P267, DOI 10.1016/j.autrev.2006.09.002; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461; Griffioen AW, 2001, BIOCHEM J, V354, P233, DOI 10.1042/0264-6021:3540233; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Heal WP, 2011, CHEM SOC REV, V40, P246, DOI 10.1039/c0cs00004c; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; Hu DM, 2013, BIOSENSORS-BASEL, V3, P297, DOI 10.3390/bios3030297; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Josephson K, 2001, ACTA CRYSTALLOGR D, V57, P1908, DOI 10.1107/S0907444901016249; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Khammanivong V, 2003, IMMUNOL CELL BIOL, V81, P1, DOI 10.1046/j.1440-1711.2003.01130.x; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Liu XS, 2006, J IMMUNOL, V177, P2873, DOI 10.4049/jimmunol.177.5.2873; Liu XS, 2009, J IMMUNOL, V183, P51, DOI 10.4049/jimmunol.0802047; Liu XS, 2003, J IMMUNOL, V171, P4765, DOI 10.4049/jimmunol.171.9.4765; Lofgren JA, 2007, J IMMUNOL, V178, P7467, DOI 10.4049/jimmunol.178.11.7467; Lyons A, 1997, ANN SURG, V226, P450, DOI 10.1097/00000658-199710000-00006; Madler S, 2013, TOP CURR CHEM, V331, P1, DOI 10.1007/128_2011_311; MATHESON RR, 1978, MACROMOLECULES, V11, P819, DOI 10.1021/ma60064a038; Matilainen JM, 2010, BBA-MOL CELL RES, V1803, P1276, DOI 10.1016/j.bbamcr.2010.07.009; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; Naiyer MM, 2013, HUM IMMUNOL, V74, P28, DOI 10.1016/j.humimm.2012.09.002; Ni GY, 2015, CELL IMMUNOL, V293, P126, DOI 10.1016/j.cellimm.2014.12.012; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Okitsu SL, 2007, CHEM BIOL, V14, P577, DOI 10.1016/j.chembiol.2007.04.008; PAULING L, 1953, NATURE, V171, P59, DOI 10.1038/171059a0; Pitt JM, 2012, J IMMUNOL, V189, P4079, DOI 10.4049/jimmunol.1201061; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Siegel M, 2007, BIOORGAN MED CHEM, V15, P6253, DOI 10.1016/j.bmc.2007.06.020; Stevenson CL, 2009, CURR PHARM BIOTECHNO, V10, P122, DOI 10.2174/138920109787048634; TAN JC, 1995, J BIOL CHEM, V270, P12906, DOI 10.1074/jbc.270.21.12906; Terai M, 2009, CANCER IMMUNOL IMMUN, V58, P1307, DOI 10.1007/s00262-008-0644-9; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Torrens I, 2005, VACCINE, V23, P5768, DOI 10.1016/j.vaccine.2005.07.049; van der Burg SH, 2011, TRENDS IMMUNOL, V32, P97, DOI 10.1016/j.it.2010.12.006; van der Sluis TC, 2015, CURR OPIN IMMUNOL, V35, P9, DOI 10.1016/j.coi.2015.05.002; Vashist SK, 2012, PROCEDIA CHEM, V6, P184, DOI 10.1016/j.proche.2012.10.145; Vicari Alain P, 2004, Novartis Found Symp, V256, P241; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/281912; Whitehead M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-367; Wilson EB, 2011, CURR TOP MICROBIOL, V350, P39, DOI 10.1007/82_2010_96; Wortmann A, 2007, ANALYST, V132, P199, DOI 10.1039/b615411e; Zompra AA, 2009, FUTURE MED CHEM, V1, P361, DOI 10.4155/FMC.09.23	70	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153939	10.1371/journal.pone.0153939	http://dx.doi.org/10.1371/journal.pone.0153939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100390	gold, Green Published			2022-12-26	WOS:000374898500101
J	Okabe, H; Kinoshita, H; Imai, K; Nakagawa, S; Higashi, T; Arima, K; Uchiyama, H; Ikegami, T; Harimoto, N; Itoh, S; Ishiko, T; Yoshizumi, T; Beppu, T; Monga, SPS; Baba, H; Maehara, Y				Okabe, Hirohisa; Kinoshita, Hiroki; Imai, Katsunori; Nakagawa, Shigeki; Higashi, Takaaki; Arima, Kota; Uchiyama, Hideaki; Ikegami, Toru; Harimoto, Norifumi; Itoh, Shinji; Ishiko, Takatoshi; Yoshizumi, Tomoharu; Beppu, Toru; Monga, Satdarshan P. S.; Baba, Hideo; Maehara, Yoshihiko			Diverse Basis of beta-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis	PLOS ONE			English	Article							MUTATIONS; GROWTH; CANCER; CELLS; LIVER; METABOLISM; PATHWAY; TARGETS; AXIN2; GENE	Aim beta-catenin signaling is a major oncogenic pathway in hepatocellular carcinoma (HCC). Since beta-catenin phosphorylation by glycogen synthase kinase 3 beta (GSK3 beta) and casein kinase 1 epsilon (CK1 epsilon) results in its degradation, mutations affecting these phosphorylation sites cause beta-catenin stabilization. However, the relevance of missense mutations in non-phosphorylation sites in exon 3 remains unclear. The current study explores significance of such mutations in addition to addressing the clinical and biological implications of beta-catenin activation in human HCC. Methods Gene alteration in exon3 of CTNNB1, gene expression of beta-catenin targets such as glutamate synthetase (GS), axin2, lect2 and regucalcin (RGN), and protein expression of beta-catenin were examined in 125 human HCC tissues. Results Sixteen patients (12.8%) showed conventional missense mutations affecting codons 33, 37, 41, and 45. Fifteen additional patients (12.0%) had other missense mutations in codon 32, 34, and 35. Induction of exon3 mutation caused described beta-catenin target gene upregulation in HCC cell line. Interestingly, conventional and non-phosphorylation site mutations were equally associated with upregulation of beta-catenin target genes. Nuclear localization of beta-catenin was associated with poor overall survival (p = 0.0461). Of these patients with nuclear beta-catenin localization, loss of described beta-catenin target gene upregulation showed significant poorer overall survival than others (p = 0.0001). Conclusion This study suggests that both conventional and other missense mutations in exon 3 of CTNNB1 lead to beta-catenin activation in human HCC. Additionally, the mechanism of nuclear beta-catenin localization without upregulation of described beta-catenin target genes might be of clinical importance depending on distinct mechanism.	[Okabe, Hirohisa; Kinoshita, Hiroki; Imai, Katsunori; Nakagawa, Shigeki; Higashi, Takaaki; Arima, Kota; Ishiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan; [Okabe, Hirohisa; Monga, Satdarshan P. S.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Monga, Satdarshan P. S.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Uchiyama, Hideaki; Ikegami, Toru; Harimoto, Norifumi; Itoh, Shinji; Yoshizumi, Tomoharu; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Kumamoto University; Kumamoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kyushu University	Baba, H (corresponding author), Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp	Harimoto, Norifumi/AAF-6070-2020; Ikegami, Toru/GRI-9889-2022	Monga, Satdarshan/0000-0002-8437-3378				Audard V, 2007, J PATHOL, V212, P345, DOI 10.1002/path.2169; Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Cieply B, 2009, HEPATOLOGY, V49, P821, DOI 10.1002/hep.22695; Dal Bello B, 2010, CLIN CANCER RES, V16, P2157, DOI 10.1158/1078-0432.CCR-09-1978; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Legoix P, 1999, ONCOGENE, V18, P4044, DOI 10.1038/sj.onc.1202800; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Okabe H, 2012, INT J CANCER, V131, P2234, DOI 10.1002/ijc.27496; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Wei W, 2010, INT J CANCER, V126, P2426, DOI 10.1002/ijc.24810; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607; Zhang XF, 2010, HEPATOLOGY, V52, P954, DOI 10.1002/hep.23747	25	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152695	10.1371/journal.pone.0152695	http://dx.doi.org/10.1371/journal.pone.0152695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100093	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000374898500014
J	Rainard, P; Cunha, P; Gilbert, FB				Rainard, Pascal; Cunha, Patricia; Gilbert, Florence B.			Innate and Adaptive Immunity Synergize to Trigger Inflammation in the Mammary Gland	PLOS ONE			English	Article							AUREUS LIPOTEICHOIC ACID; ESCHERICHIA-COLI; DAIRY-COWS; BOVINE MASTITIS; LIPOPOLYSACCHARIDE; VACCINATION; RESPONSES; EXPRESSION; ANTIBODY; CELLS	The mammary gland is able to detect and react to bacterial intrusion through innate immunity mechanisms, but mammary inflammation can also result from antigen-specific adaptive immunity. We postulated that innate and adaptive immune responses could synergize to trigger inflammation in the mammary gland. To test this hypothesis, we immunized cows with the model antigen ovalbumin and challenged the sensitized animals with either Escherichia coli lipopolysaccharide (LPS) as innate immunity agonist, ovalbumin as adaptive immunity agonist, or both agonists in three different udder quarters of lactating cows. There was a significant amplification of the initial milk leukocytosis in the quarters challenged with the two agonists compared to leukocytosis in quarters challenged with LPS or ovalbumin alone. This synergistic response occurred only with the cows that developed the ovalbumin-specific inflammatory response, and there were significant correlations between milk leukocytosis and production of IL-17A and IFN-gamma in a whole-blood ovalbumin stimulation assay. The antigen-specific response induced substantial concentrations of IL-17A and IFN-gamma in milk contrary to the response to LPS. Such a synergy at the onset of the reaction of the mammary gland suggests that induction of antigen-specific immune response with bacterial antigens could improve the initial immune response to infection, hence reducing the bacterial load and contributing to protection.	[Rainard, Pascal; Cunha, Patricia; Gilbert, Florence B.] Univ Tours, INRA, ISP, Nouzilly, France	INRAE; Universite de Tours	Rainard, P (corresponding author), Univ Tours, INRA, ISP, Nouzilly, France.	pascal.rainard@tours.inra.fr		Rainard, Pascal/0000-0002-5477-2626	Region Centre (Mamimmunotypage project) [00073634]	Region Centre (Mamimmunotypage project)(Region Centre-Val de Loire)	This work was funded partly by the Region Centre (Mamimmunotypage project, Convention 2012 00073634, www.regioncentre.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; Bougarn S, 2010, CLIN VACCINE IMMUNOL, V17, P1797, DOI 10.1128/CVI.00268-10; Bruno DR, 2010, VET IMMUNOL IMMUNOP, V138, P15, DOI 10.1016/j.vetimm.2010.06.009; DECUENINCK BJ, 1979, INT ARCH ALLER A IMM, V59, P394, DOI 10.1159/000232286; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Erskine RJ, 2012, VET CLIN N AM-FOOD A, V28, P257, DOI 10.1016/j.cvfa.2012.03.002; Green BB, 2014, VET IMMUNOL IMMUNOP, V157, P49, DOI 10.1016/j.vetimm.2013.10.015; Herbelin C, 1997, J DAIRY SCI, V80, P2025, DOI 10.3168/jds.S0022-0302(97)76147-2; Heriazon A, 2013, VET IMMUNOL IMMUNOP, V154, P83, DOI 10.1016/j.vetimm.2013.03.014; Ibeagha-Awemu EM, 2008, VET RES, V39, DOI 10.1051/vetres:2007047; Kandasamy S, 2011, J DAIRY SCI, V94, P5963, DOI 10.3168/jds.2011-4288; Kim KW, 2011, COMP IMMUNOL MICROB, V34, P347, DOI 10.1016/j.cimid.2011.04.004; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kossaibati MA, 1997, VET J, V154, P41, DOI 10.1016/S1090-0233(05)80007-3; Leigh JA, 2000, ADV EXP MED BIOL, V480, P307; Middleton JR, 2008, EXPERT REV VACCINES, V7, P805, DOI 10.1586/14760584.7.6.805; NONNECKE BJ, 1984, J REPROD IMMUNOL, V6, P365, DOI 10.1016/0165-0378(84)90046-9; Porcherie A, 2016, J IMMUNOL, V196, P803, DOI 10.4049/jimmunol.1500705; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Prenafeta A, 2010, VET IMMUNOL IMMUNOP, V134, P208, DOI 10.1016/j.vetimm.2009.09.020; Rainard P, 1997, VET RES, V28, P231; Rainard P, 2010, CLIN VACCINE IMMUNOL, V17, P848, DOI 10.1128/CVI.00447-09; Rainard P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137755; Rainard P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063471; Rainard P, 2008, VET RES, V39, DOI 10.1051/vetres:2008034; Riollet C, 2000, CLIN DIAGN LAB IMMUN, V7, P161, DOI 10.1128/CDLI.7.2.161-167.2000; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; SHUSTER DE, 1991, RES VET SCI, V51, P272, DOI 10.1016/0034-5288(91)90077-2; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Strandberg Y, 2005, CYTOKINE, V31, P72, DOI 10.1016/j.cyto.2005.02.010; Tao WJ, 2007, VET IMMUNOL IMMUNOP, V120, P201, DOI 10.1016/j.vetimm.2007.06.019; TARGOWSKI SP, 1975, AM J VET RES, V36, P1561; TARGOWSKI SP, 1982, AM J REPROD IMMUNOL, V2, P29, DOI 10.1111/j.1600-0897.1982.tb00081.x; Thompson-Crispi K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00493; Wedlock DN, 2014, VET IMMUNOL IMMUNOP, V160, P51, DOI 10.1016/j.vetimm.2014.03.012; Wellnitz O, 2004, VET IMMUNOL IMMUNOP, V101, P191, DOI 10.1016/j.vetimm.2004.04.019; Whelehan CJ, 2011, VET IMMUNOL IMMUNOP, V140, P181, DOI 10.1016/j.vetimm.2010.11.013; Wilson DJ, 2007, CLIN VACCINE IMMUNOL, V14, P693, DOI 10.1128/CVI.00104-07; Zhao YY, 2016, PHARM BIOL, V54, P130, DOI 10.3109/13880209.2015.1021816	39	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154172	10.1371/journal.pone.0154172	http://dx.doi.org/10.1371/journal.pone.0154172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100324	gold, Green Submitted, Green Published			2022-12-26	WOS:000374898500160
J	Tsang, JLY; Jia, SH; Parodo, J; Plant, P; Lodyga, M; Charbonney, E; Szaszi, K; Kapus, A; Marshall, JC				Tsang, Jennifer L. Y.; Jia, Song Hui; Parodo, Jean; Plant, Pamela; Lodyga, Monika; Charbonney, Emmanuel; Szaszi, Katalin; Kapus, Andras; Marshall, John C.			Tyrosine Phosphorylation of Caspase-8 Abrogates Its Apoptotic Activity and Promotes Activation of c-Src	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; T-CELL PROLIFERATION; HEPATOCELLULAR-CARCINOMA; SIGNAL-TRANSDUCTION; SH3 DOMAIN; KINASE; DEATH; PROTEIN; CANCER; CD95	Src family tyrosine kinases (SFKs) phosphorylate caspase-8A at tyrosine (Y) 397 resulting in suppression of apoptosis. In addition, the phosphorylation of caspase-8A at other sites including Y465 has been implicated in the regulation of caspase-8 activity. However, the functional consequences of these modifications on caspase-8 processing/activity have not been elucidated. Moreover, various Src substrates are known to act as potent Src regulators, but no such role has been explored for caspase-8. We asked whether the newly identified caspase-8 phosphorylation sites might regulate caspase-8 activation and conversely, whether caspase-8 phosphorylation might affect Src activity. Here we show that Src phosphorylates caspase-8A at multiple tyrosine sites; of these, we have focused on Y397 within the linker region and Y465 within the p12 subunit of caspase-8A. We show that phosphomimetic mutation of caspase-8A at Y465 prevents its cleavage and the subsequent activation of caspase-3 and suppresses apoptosis. Furthermore, simultaneous phosphomimetic mutation of caspase-8A at Y397 and Y465 promotes the phosphorylation of c-Src at Y416 and increases c-Src activity. Finally, we demonstrate that caspase-8 activity prevents its own tyrosine phosphorylation by Src. Together these data reveal that dual phosphorylation converts caspase-8 from a pro-apoptotic to a pro-survival mediator. Specifically, tyrosine phosphorylation by Src renders caspase-8 uncleavable and thereby inactive, and at the same time converts it to a Src activator. This novel dynamic interplay between Src and caspase-8 likely acts as a potent signal-integrating switch directing the cell towards apoptosis or survival.	[Tsang, Jennifer L. Y.] McMaster Univ, Dept Med, Div Crit Care, Hamilton, ON, Canada; [Tsang, Jennifer L. Y.] Niagara Hlth Syst, Dept Med, Div Crit Care, Niagara, ON, Canada; [Jia, Song Hui; Parodo, Jean; Plant, Pamela; Szaszi, Katalin; Kapus, Andras; Marshall, John C.] Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Lodyga, Monika] Univ Toronto, Fac Dent, Matrix Dynam Grp, Lab Tissue Repair & Regenerat, Toronto, ON, Canada; [Charbonney, Emmanuel] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Charbonney, Emmanuel] Hop Sacre Coeur, Ctr Rech, Montreal, PQ H4J 1C5, Canada; [Szaszi, Katalin; Kapus, Andras] St Michaels Hosp, Dept Surg, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Marshall, John C.] St Michaels Hosp, Dept Crit Care Med, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Marshall, John C.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada	McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; Universite de Montreal; Universite de Montreal; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Tsang, JLY (corresponding author), McMaster Univ, Dept Med, Div Crit Care, Hamilton, ON, Canada.; Tsang, JLY (corresponding author), Niagara Hlth Syst, Dept Med, Div Crit Care, Niagara, ON, Canada.	tsangj10@mcmaster.ca		Kapus, Andras/0000-0002-6610-9530	Canadian Institutes of Health Research [MOP129493]; McMaster Medicine Internal Career Research Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McMaster Medicine Internal Career Research Award	This work was supported by Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html, grant number: MOP129493 to JM), and McMaster Medicine Internal Career Research Award (http://fhs.mcmaster.ca/medicine/research_awards.htm, E.J. Moran Campbell Internal Career Research Award to JT).; Dr. D. Flynn from West Virginia provided the constitutively active avian Src (Y527 Src) in pCMV1 vector. Jennifer LY Tsang is the recipient of the McMaster Medicine Internal Career Research Award.	Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Cam WR, 2001, CANCER, V92, P61, DOI 10.1002/1097-0142(20010701)92:1<61::AID-CNCR1292>3.0.CO;2-D; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Erpel T, 1996, J BIOL CHEM, V271, P16807, DOI 10.1074/jbc.271.28.16807; Falk M, 2004, J IMMUNOL, V173, P5077, DOI 10.4049/jimmunol.173.8.5077; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Finlay D, 2009, CELL CYCLE, V8, P3441, DOI 10.4161/cc.8.21.9649; Finlay D, 2009, CANCER RES, V69, P5023, DOI 10.1158/0008-5472.CAN-08-3731; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Golks A, 2006, CELL DEATH DIFFER, V13, P489, DOI 10.1038/sj.cdd.4401766; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Hynes NE, 2000, BREAST CANCER RES, V2, P154, DOI 10.1186/bcr48; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Jia SH, 2008, J BIOL CHEM, V283, P5402, DOI 10.1074/jbc.M706462200; Jones RJ, 2002, BRIT J CANCER, V87, P1128, DOI 10.1038/sj.bjc.6600594; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Lodyga M, 2002, AM J PHYSIOL-LUNG C, V283, pL265, DOI 10.1152/ajplung.00492.2001; Luciano F, 2001, ONCOGENE, V20, P4935, DOI 10.1038/sj.onc.1204661; Luschen S, 2005, EXP CELL RES, V310, P33, DOI 10.1016/j.yexcr.2005.07.022; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Martin GS, 2004, ONCOGENE, V23, P7910, DOI 10.1038/sj.onc.1208077; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Masaki T, 1999, HEPATOLOGY, V29, P379, DOI 10.1002/hep.510290239; Masaki T, 1998, HEPATOLOGY, V27, P1257, DOI 10.1002/hep.510270511; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; PARK J, 1995, MOL CELL BIOL, V15, P2374; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Shen J, 2006, CANCER RES, V66, P11194, DOI 10.1158/0008-5472.CAN-04-1444; Shivapurkar N, 2002, CANCER BIOL THER, V1, P65, DOI 10.4161/cbt.1.1.45; Smart JE, 1981, CHARACTERIZATION SIT; Son JW, 2006, CANCER GENET CYTOGEN, V169, P121, DOI 10.1016/j.cancergencyto.2006.04.001; Soung YH, 2005, CANCER RES, V65, P815; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Sugimura M, 2000, JPN J CANCER RES, V91, P395, DOI 10.1111/j.1349-7006.2000.tb00958.x; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	64	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153946	10.1371/journal.pone.0153946	http://dx.doi.org/10.1371/journal.pone.0153946			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101103	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500106
J	Tseng, CL; Chen, ZY; Renn, TY; Hsiao, SH; Burnouf, T				Tseng, Ching-Li; Chen, Zhi-Yu; Renn, Ting-Yi; Hsiao, Shun-Hung; Burnouf, Thierry			Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BENZALKONIUM CHLORIDE; THERAPEUTIC-EFFICACY; SURFACE DISEASE; EPIGALLOCATECHIN GALLATE; GROWTH-FACTORS; ANIMAL-MODELS; WORKSHOP 2007; BLOOD-DONORS; PLASMA	Application of autologous serum eye drops (SEDs) is a recognized means to treat severe dry-eye syndrome (DES). Due to the inconvenience and difficulty of preparing SEDs from some patients, producing SEDs from allogeneic blood donations is gaining popularity. A major safety concern associated with allogeneic blood is virus transmission. We therefore herein evaluated the possibility of applying a solvent/detergent (S/D) treatment to inactivate viruses and studied the impacts of such treatment of SEDs to resolve DES in a rabbit model. Sera prepared from the blood of five rabbits were pooled and divided into two sub-pools. One was untreated (SEDs), while the other was virally-inactivated with 1% Tri-n-butyl phosphate/1% Triton X-45 at 31 degrees C for 1 h (S/D-SEDs). DES was induced in rabbits using 0.1% benzalkonium chloride (BAC). Rabbits were divided into five groups of two rabbits each. One group was untreated (control), three were treated twice daily for 3 weeks using PBS, SEDs, or S/D-SEDs, and the last received an additional 0.1% BAC (as the negative control). The DES condition was determined by measuring aqueous tear secretion (Schirmer's test), corneal fluorescein staining, a corneal histologic examination, TUNEL stain apoptosis, and corneal inflammatory marker (tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL8, and IL-6) expressions. We first confirmed that SEDs and S/D-SEDs had similar protein profiles and transforming growth factor (TGF)-beta contents. Animal experiments showed that tear secretion did not significantly differ between the SED and S/D-SED groups but was significantly higher than in the PBS group. Eye fluorescein staining revealed dramatic improvements in epithelial defects in groups treated with SEDs or S/D-SEDs, and hematoxylin/eosin staining revealed microscopic epithelial layers similar to those of the untreated controls. Inflammatory markers and TUNEL studies showed that healthy epithelium had been restored in groups treated with SEDs or S/D-SEDs. In conclusion, this preclinical study supports the possibility of using S/D virally inactivated SEDs to treat DES and restore a normal epithelium.	[Tseng, Ching-Li; Chen, Zhi-Yu; Renn, Ting-Yi; Hsiao, Shun-Hung; Burnouf, Thierry] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan	Taipei Medical University	Burnouf, T (corresponding author), Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan.	thburnouf@gmail.com	Burnouf, Thierry/H-4784-2019	Burnouf, Thierry/0000-0002-0507-9243; Tseng, Ching-Li/0000-0001-9446-4030	National Health Research Institute, Taiwan [NHRI-EX103-10334EI]	National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by a project grant from the National Health Research Institute, Taiwan (NHRI-EX103-10334EI), awarded to CLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acera A, 2008, OPHTHALMIC RES, V40, P315, DOI 10.1159/000150445; Al-Abdulla I, 2014, J IMMUNOL METHODS, V402, P15, DOI 10.1016/j.jim.2013.11.001; Alio JL, 2015, CURR OPIN OPHTHALMOL, V26, P325, DOI 10.1097/ICU.0000000000000169; Azari AA, 2015, EYE CONTACT LENS, V41, P133, DOI 10.1097/ICL.0000000000000104; Barabino S, 2004, INVEST OPHTH VIS SCI, V45, P1641, DOI 10.1167/iovs.03-1055; Bitko V, 2007, J VIROL, V81, P783, DOI 10.1128/JVI.01437-06; Blajchman MA, 2009, TRANSFUS CLIN BIOL, V16, P70, DOI 10.1016/j.tracli.2009.04.004; Bradley JC, 2009, CORNEA, V28, P200, DOI 10.1097/ICO.0b013e318186321e; Burnouf T, 2013, VOX SANG, V104, P1, DOI 10.1111/j.1423-0410.2012.01621.x; Burnouf T, 2000, BLOOD REV, V14, P94, DOI 10.1054/blre.2000.0129; Burnouf T, 2008, TRANSFUSION, V48, P1090, DOI 10.1111/j.1537-2995.2008.01691.x; Burnouf T, 2009, ANAL BIOCHEM, V389, P69, DOI 10.1016/j.ab.2009.03.016; BURSTEIN NL, 1980, INVEST OPHTH VIS SCI, V19, P308; Cavet ME, 2011, MOL VIS, V17, P533; Celebi ARC, 2014, GRAEF ARCH CLIN EXP, V252, P619, DOI 10.1007/s00417-014-2599-1; Chiang CC, 2009, EYE, V23, P290, DOI 10.1038/sj.eye.6703079; Chiang CC, 2007, CORNEA, V26, P861, DOI 10.1097/ICO.0b013e3180645cd7; Chou ML, 2012, VOX SANG, V102, P277, DOI 10.1111/j.1423-0410.2011.01560.x; Chou ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117800; Dichtelmuller HO, 2009, TRANSFUSION, V49, P1931, DOI 10.1111/j.1537-2995.2009.02222.x; Dodd RY, 2012, BRIT J HAEMATOL, V159, P135, DOI 10.1111/bjh.12031; El-Ekiaby M, 2010, TRANSFUSION MED, V20, P48, DOI 10.1111/j.1365-3148.2009.00963.x; Espinosa A, 2015, TRANSFUS APHER SCI, V53, P88, DOI 10.1016/j.transci.2015.05.014; Geerling G, 2004, BRIT J OPHTHALMOL, V88, P1467, DOI 10.1136/bjo.2004.044347; Harritshoj LH, 2014, ACTA OPHTHALMOL, V92, P783, DOI 10.1111/aos.12386; Higuchi A, 2007, CURR EYE RES, V32, P83, DOI 10.1080/02713680601147690; Kojima T, 2008, CORNEA, V27, pS25, DOI 10.1097/ICO.0b013e31817f3a0e; Lee HS, 2011, CORNEA, V30, P1465, DOI 10.1097/ICO.0b013e31821c9b5a; Lemp MA, 2007, OCUL SURF, V5, P75; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Lin ZR, 2011, MOL VIS, V17, P257; Marks DC, 2015, TRANSFUS APHER SCI, V53, P92, DOI 10.1016/j.transci.2015.05.015; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Mondy P, 2015, TRANSFUS APHER SCI; Na KS, 2012, J OCUL PHARMACOL TH, V28, P479, DOI 10.1089/jop.2012.0002; Noble BA, 2004, BRIT J OPHTHALMOL, V88, P647, DOI 10.1136/bjo.2003.026211; Nubling CM, 2009, TRANSFUSION, V49, P1850, DOI 10.1111/j.1537-2995.2009.02212.x; Ogawa Y, 2003, BONE MARROW TRANSPL, V31, P579, DOI 10.1038/sj.bmt.1703862; Pisella PJ, 2002, BRIT J OPHTHALMOL, V86, P418, DOI 10.1136/bjo.86.4.418; Prowse CV, 2013, VOX SANG, V104, P183, DOI 10.1111/j.1423-0410.2012.01662.x; Renn TY, 2015, VOX SANG, V109, P138, DOI 10.1111/vox.12264; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Segatchian J, TRANSFUS AP IN PRESS; Seghatchian J, 2015, TRANSFUS APHER SCI, V53, P85, DOI 10.1016/j.transci.2015.05.013; Shih DTB, 2011, TRANSFUSION, V51, P770, DOI 10.1111/j.1537-2995.2010.02915.x; Smith JA, 2007, OCUL SURF, V5, P93; Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070; Su CY, 2009, VOX SANG, V97, P119, DOI 10.1111/j.1423-0410.2009.01180.x; Su CY, 2008, TRANSFUSION, V48, P2414, DOI 10.1111/j.1537-2995.2008.01862.x; Tseng CL, 2015, TRANSFUS APHER SCI, V53, P95, DOI 10.1016/j.transci.2015.05.016; Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P390, DOI 10.1136/bjo.83.4.390; van der Meer PF, 2015, TRANSFUS APHER SCI, V53, P99, DOI 10.1016/j.transci.2015.05.017; VANSETTEN GB, 1992, ACTA OPHTHALMOL, V70, P54; Weusten J, 2011, TRANSFUSION, V51, P203, DOI 10.1111/j.1537-2995.2010.02804.x; Xiong C, 2008, INVEST OPHTH VIS SCI, V49, P1850, DOI 10.1167/iovs.07-0720; Yamada C, 2008, TRANSFUSION, V48, P1245, DOI 10.1111/j.1537-2995.2008.01665.x; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581	58	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153573	10.1371/journal.pone.0153573	http://dx.doi.org/10.1371/journal.pone.0153573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100624	Green Published, Green Submitted, gold			2022-12-26	WOS:000374898500042
J	Bourrelly, A; McIntyre, J; Morio, C; Despretz, P; Luyat, M				Bourrelly, Aurore; McIntyre, Joseph; Morio, Cedric; Despretz, Pascal; Luyat, Marion			Perception of Affordance during Short-Term Exposure to Weightlessness in Parabolic Flight	PLOS ONE			English	Article							PERCEIVING AFFORDANCES; EYE HEIGHT; PROLONGED WEIGHTLESSNESS; VISUAL INFORMATION; SCALED INFORMATION; SYMMETRY DETECTION; REFERENCE FRAMES; SIZE PERCEPTION; MICROGRAVITY; ORIENTATION	We investigated the role of the visual eye-height (VEH) in the perception of affordance during short-term exposure to weightlessness. Sixteen participants were tested during parabolic flight (0g) and on the ground (1g). Participants looked at a laptop showing a room in which a doorway-like aperture was presented. They were asked to adjust the opening of the virtual doorway until it was perceived to be just wide enough to pass through (i. e., the critical aperture). We manipulated VEH by raising the level of the floor in the visual room by 25 cm. The results showed effects of VEH and of gravity on the perceived critical aperture. When VEH was reduced (i. e., when the floor was raised), the critical aperture diminished, suggesting that widths relative to the body were perceived to be larger. The critical aperture was also lower in 0g, for a given VEH, suggesting that participants perceived apertures to be wider or themselves to be smaller in weightlessness, as compared to normal gravity. However, weightlessness also had an effect on the subjective level of the eyes projected into the visual scene. Thus, setting the critical aperture as a fixed percentage of the subjective visual eye-height remains a viable hypothesis to explain how human observers judge visual scenes in terms of potential for action or "affordances".	[Bourrelly, Aurore; Luyat, Marion] Univ Lille, EA 4072, PSITEC Psychol Interact Temps Emot, F-59000 Lille, France; [McIntyre, Joseph] Univ Paris 05, CNRS, UMR 8119, CNPP, F-75270 Paris, France; [McIntyre, Joseph] Tecnalia Hlth Res Labs, E-20009 San Sebastian, Spain; [McIntyre, Joseph] IKERBASQUE Res Fdn, E-48013 Bilbao, Spain; [Morio, Cedric] Decatlhon SportsLab, F-59650 Villeneuve Dascq, France; [Despretz, Pascal] INSERM CIC IT 807, F-5900 Lille, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Basque Foundation for Science; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bourrelly, A (corresponding author), Univ Lille, EA 4072, PSITEC Psychol Interact Temps Emot, F-59000 Lille, France.	aurore.bourrelly@hotmail.fr	Luyat, Marion/HIR-3502-2022; Morio, Cédric/B-8489-2011; McIntyre, Dr Joseph/K-6395-2015	Luyat, Marion/0000-0002-5640-5002; Morio, Cédric/0000-0002-7695-0315; McIntyre, Dr Joseph/0000-0003-4974-4257	Centre National d'Etudes Spatiale (CNES); Centre National pour la Recherche Scientifique (CNRS); University of Caen	Centre National d'Etudes Spatiale (CNES); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Caen	Aurore Bourrelly was supported by a postdoctoral research fellowship from the Centre National d'Etudes Spatiale (CNES). The authors are grateful to the Centre National d'Etudes Spatiale (CNES) and the Centre National pour la Recherche Scientifique (CNRS) for the financial support of this study. They also wish to thank the many people at CNES/CADMOS, Novespace, ESA and the University of Caen who have supported this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AJ, 1990, PERCEPTION CONTROL S; Bertamini M, 1998, PERCEPT PSYCHOPHYS, V60, P673, DOI 10.3758/BF03206054; Bourrelly A, 2015, COGN PROCESS, V16, pS171, DOI 10.1007/s10339-015-0692-y; CARELLO C, 1989, Ecological Psychology, V1, P27, DOI 10.1207/s15326969eco0101_3; Cheron G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082371; CHEUNG BSK, 1990, EXP BRAIN RES, V81, P391; CLEMENT G, 1989, AVIAT SPACE ENVIR MD, V60, P1194; Clement G., 2005, FUNDAMENTALS SPACE M; Clement G, 2007, GRAVIT SPACE RES, V20, P1; Clement G, 2008, ACTA ASTRONAUT, V63, P828, DOI 10.1016/j.actaastro.2008.01.002; Clement G, 2007, NEUROSCI LETT, V413, P150, DOI 10.1016/j.neulet.2006.11.047; Clement G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132317; Clement Gilles, 2013, Life-Basel, V3, P524, DOI 10.3390/life3040524; Clement G, 2012, NEUROSCI LETT, V507, P143, DOI 10.1016/j.neulet.2011.12.006; Clement G, 2009, ACTA ASTRONAUT, V64, P678, DOI 10.1016/j.actaastro.2009.01.001; Clement G, 2008, NEUROSCI LETT, V447, P179, DOI 10.1016/j.neulet.2008.10.012; Coelho T, 2014, IFIP ADV INF COMM TE, V425, P3; Davis TJ, 2010, PERCEPTION, V39, P1624, DOI 10.1068/p6712; De Saedeleer C, 2013, EXP BRAIN RES, V226, P95, DOI 10.1007/s00221-013-3414-7; Dixon MW, 2000, J EXP PSYCHOL HUMAN, V26, P582, DOI 10.1037/0096-1523.26.2.582; EBENHOLTZ SM, 1975, VISION RES, V15, P713, DOI 10.1016/0042-6989(75)90291-6; Fajen BJ, 2003, ADAPT BEHAV, V11, P276, DOI 10.1177/1059712303114004; Fath AJ, 2011, PERCEPTION, V40, P887, DOI 10.1068/p6917; FRIEDERICI AD, 1990, PERCEPT PSYCHOPHYS, V47, P253, DOI 10.3758/BF03205000; Gibson J.J., 1986, ECOLOGICAL APPROACH; Glasauer S, 1998, BRAIN RES REV, V28, P185, DOI 10.1016/S0165-0173(98)00038-1; GORDON C, 1986, AVIAT SPACE ENVIR MD, V57, P236; Harris LR, 2011, PROG BRAIN RES, V191, P133, DOI 10.1016/B978-0-444-53752-2.00008-4; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Howard IP., 1986, HDB HUMAN PERCEPTION, P1; Jenkin HL, 2005, ACTA ASTRONAUT, V56, P1025, DOI 10.1016/j.actaastro.2005.01.030; JIANG Y, 1994, PERCEPT PSYCHOPHYS, V56, P691, DOI 10.3758/BF03208362; Kim JI, 2000, J VESTIBUL RES-EQUIL, V10, P291; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; Leone G, 1998, BRAIN RES REV, V28, P203, DOI 10.1016/S0165-0173(98)00040-X; Leone G, 1995, ACTA ASTRONAUT, V36, P743, DOI 10.1016/0094-5765(95)00165-4; LEONE G, 1995, SPATIAL VISION, V9, P127, DOI 10.1163/156856895X00142; Leone G, 1998, ACTA ASTRONAUT, V42, P281, DOI 10.1016/S0094-5765(98)00125-8; Lepecq JC, 2009, VIRTUAL REAL-LONDON, V13, P141, DOI 10.1007/s10055-009-0118-1; Lipshits M, 2005, PERCEPTION, V34, P545, DOI 10.1068/p5358; Luyat M, 2009, ANN PSYCHOL, V109, P297; Makowski AL, 2011, AVIAT SPACE ENVIR MD, V82, P683, DOI 10.3357/ASEM.2750.2011; Marcilly R., 2008, CURRENT PSYCHOL LETT, V24, P12; MARK LS, 1987, J EXP PSYCHOL HUMAN, V13, P361, DOI 10.1037/0096-1523.13.3.361; Massion J, 1997, EXP BRAIN RES, V114, P384, DOI 10.1007/PL00005647; MATIN L, 1995, J VESTIBUL RES-EQUIL, V5, P499, DOI 10.1016/0957-4271(95)02003-B; Michaels C.F., 1981, DIRECT PERCEPTION; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Oman CM, 2006, SPATIAL PROCESSING N, V2006, P1; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; Ramenzoni VC, 2008, COGNITION, V106, P1059, DOI 10.1016/j.cognition.2007.04.008; Rand KM, 2011, PERCEPTION, V40, P143, DOI 10.1068/p6843; Regia-Corte T, 2013, VIRTUAL REAL-LONDON, V17, P17, DOI 10.1007/s10055-012-0216-3; Russomano T, 2005, SCI MED, V15, P124; Sedgwick H. A., 1980, PERCEPTION PICTURES, V1, P33; STOPER AE, 1989, PERCEPT PSYCHOPHYS, V46, P469, DOI 10.3758/BF03210862; Viel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010259; Villard E, 2005, NEUROREPORT, V16, P1395, DOI 10.1097/01.wnr.0000174060.34274.3e; Warren W.H., 2007, CLOSING GAP SCI WRIT, P253; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; White E, 2005, PERCEIVING PASS UNDE; Wraga M, 1999, J EXP PSYCHOL HUMAN, V25, P518, DOI 10.1037/0096-1523.25.2.518; Wraga M, 1999, PERCEPT PSYCHOPHYS, V61, P490, DOI 10.3758/BF03211968; YOUNG LR, 1986, EXP BRAIN RES, V64, P291	65	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153598	10.1371/journal.pone.0153598	http://dx.doi.org/10.1371/journal.pone.0153598			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27097218	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600045
J	Neves, JV; Caldas, C; Ramos, MF; Rodrigues, PNS				Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.			Hepcidin-Dependent Regulation of Erythropoiesis during Anemia in a Teleost Fish, Dicentrarchus labrax	PLOS ONE			English	Article							IRON-METABOLISM; TRANSCRIPTION FACTORS; MITOCHONDRIAL HEME; PEPTIDE HEPCIDIN; EXPRESSION; GENE; OVERLOAD; LIVER; BMP6; INFLAMMATION	Anemia is a common disorder, characterized by abnormally low levels of red blood cells or hemoglobin. The mechanisms of anemia development and response have been thoroughly studied in mammals, but little is known in other vertebrates, particularly teleost fish. In this study, different degrees of anemia were induced in healthy European sea bass specimens (Dicentrarchus labrax) and at pre-determined time points hematological parameters, liver iron content and the expression of genes involved in iron homeostasis and hematopoiesis, with particular attention on hepcidins, were evaluated. The experimental anemia prompted a decrease in hamp1 expression in all tested organs, in accordance to an increased need for iron absorption and mobilization, with slight increases in hamp2 in the kidney and intestine. The liver was clearly the major organ involved in iron homeostasis, decreasing its iron content and showing a gene expression profile consistent with an increased iron release and mobilization. Although both the spleen and head kidney are involved in erythropoiesis, the spleen was found to assume a more preponderant role in the recovery of erythrocyte levels. The intestine was also involved in the response to anemia, through the increase of iron transporting genes. Administration of Hamp1 or Hamp2 mature peptides showed that only Hamp1 affects hematological parameters and liver iron content. In conclusion, the molecular mechanisms of response to anemia present in sea bass are similar to the ones described for mammals, with these results indicating that the two hepcidin types from teleosts assume different roles during anemia.	[Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.] Univ Porto, IBMC, Iron & Innate Immun, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Rodrigues, Pedro N. S.] Univ Porto, ICBAS, Rua Campo Alegre 823, P-4100 Porto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Neves, JV (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal.; Neves, JV (corresponding author), Univ Porto, IBMC, Iron & Innate Immun, Rua Campo Alegre 823, P-4100 Porto, Portugal.	jneves@ibmc.up.pt	Neves, Jessika M. M./F-9215-2017; Mott, Tamí/I-5317-2012; Caldas, Carlos/U-7250-2019; Rodrigues, Pedro/B-3228-2008; Pereira, Ricardo J/K-7451-2017	Neves, Jessika M. M./0000-0003-3983-5171; Mott, Tamí/0000-0002-5896-4780; Caldas, Carlos/0000-0003-3547-1489; Rodrigues, Pedro/0000-0002-3799-1544; Pereira, Ricardo J/0000-0002-8076-4822; Caldas, Carolina/0000-0003-3967-6211; Lima, Sergio Maia Queiroz/0000-0001-9365-4879; Neves, Joao/0000-0003-1993-0999	FEDER-Fundo Europeu de Desenvolvimento Regional funds through COMPETE - Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274, FCOMP-01-0124-FEDER-029339 (PTDC/MAR-BIO/3204/2012)]; FCT [SFRH/BPD/86380/2012]	FEDER-Fundo Europeu de Desenvolvimento Regional funds through COMPETE - Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the projects "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274) and FCOMP-01-0124-FEDER-029339 (PTDC/MAR-BIO/3204/2012). JVN is supported by FCT under the grant SFRH/BPD/86380/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen P, 1999, CURR OPIN CHEM BIOL, V3, P200, DOI 10.1016/S1367-5931(99)80033-7; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; Barnes AC, 2011, FISH SHELLFISH IMMUN, V31, P350, DOI 10.1016/j.fsi.2011.05.027; Boldt DH, 1999, AM J MED SCI, V318, P207, DOI 10.1097/00000441-199910000-00001; Bury N, 2003, COMP BIOCHEM PHYS C, V135, P97, DOI 10.1016/S1532-0456(03)00021-8; Bury NR, 2001, J EXP BIOL, V204, P3779; CATTON WT, 1951, BLOOD, V6, P39, DOI 10.1182/blood.V6.1.39.39; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Cho YS, 2009, DEV COMP IMMUNOL, V33, P46, DOI 10.1016/j.dci.2008.07.009; Clark SF, 2008, NUTR CLIN PRACT, V23, P128, DOI 10.1177/0884533608314536; Conrad ME, 1999, AM J MED SCI, V318, P213, DOI 10.1097/00000441-199910000-00002; Darshan D, 2009, BIOMETALS, V22, P77, DOI 10.1007/s10534-008-9187-y; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; ESTEBAN MA, 1989, ARCH HISTOL CYTOL, V52, P407, DOI 10.1679/aohc.52.407; Fleming MD, 2012, J CLIN INVEST, V122, P4328, DOI 10.1172/JCI66607; Ganz T, 2005, BEST PRACT RES CL HA, V18, P171, DOI 10.1016/j.beha.2004.08.020; Ganz T, 2004, CURR OPIN HEMATOL, V11, P251, DOI 10.1097/00062752-200407000-00004; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hilton KB, 2008, GENE, V415, P40, DOI 10.1016/j.gene.2008.02.016; Hu XY, 2007, COMP IMMUNOL MICROB, V30, P55, DOI 10.1016/j.cimid.2006.10.004; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Imagawa S, 1997, BLOOD, V89, P1430, DOI 10.1182/blood.V89.4.1430; Ingley E, 2004, IUBMB LIFE, V56, P177, DOI 10.1080/15216540410001703956; Kautz L, 2011, HAEMATOL-HEMATOL J, V96, P199, DOI 10.3324/haematol.2010.031963; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nam YK, 2011, FISH SHELLFISH IMMUN, V31, P1251, DOI 10.1016/j.fsi.2011.09.007; Neves JV, 2011, FISH SHELLFISH IMMUN, V31, P1154, DOI 10.1016/j.fsi.2011.10.006; Neves JV, 2015, J IMMUNOL, V195, P2696, DOI 10.4049/jimmunol.1501153; Neves JV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-106; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pereiro R, 2012, FISH SHELLFISH IMMUN, V32, P879, DOI 10.1016/j.fsi.2012.02.016; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Rodrigues PNS, 2006, DEV COMP IMMUNOL, V30, P1156, DOI 10.1016/j.dci.2006.02.005; Saboor Muhammad, 2011, J Ayub Med Coll Abbottabad, V23, P115; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Torrance J.D., 1980, METHODS HEMATOLOGY, P104; Viatte L, 2009, BIOCHIMIE, V91, P1223, DOI 10.1016/j.biochi.2009.06.012; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Wessling-Resnick M, 1999, CRIT REV BIOCHEM MOL, V34, P285, DOI 10.1080/10409239991209318; Worthen CA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00034; Zhou JG, 2011, FISH SHELLFISH IMMUN, V30, P559, DOI 10.1016/j.fsi.2010.11.021	50	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153940	10.1371/journal.pone.0153940	http://dx.doi.org/10.1371/journal.pone.0153940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27309356	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500102
J	Wang, W; Zhang, WS; Alayi, A; Yan, C; Zhang, WW; Cao, MQ				Wang Wei; Zhang Wei-Sheng; Alayi Ahan; Yan Ci; Zhang Wei-Wen; Cao Ming-Qin			The Characteristics of TB Epidemic and TB/HIV Co-Infection Epidemic: A 2007-2013 Retrospective Study in Urumqi, Xinjiang Province, China	PLOS ONE			English	Article							SPATIAL-ANALYSIS; DRUG-USERS; TUBERCULOSIS; MIGRANTS; SHANGHAI	Objective This study was aimed to find out epidemiologic characteristic of tuberculosis (TB) cases, and Human Immunodeficiency Virus (HIV) positive cases among TB patients (TB/HIV co-infection) through demographic, temporal, and spatial study in Urumqi. Methods Descriptive statistics and multivariate logistic regression were applied to identify the epidemiologic characteristics and risk factors of TB epidemic and TB/HIV co-infection epidemic. All addresses of each TB case, TB/HIV co-infection case, and administrative street were transformed into geographical coordinate. Subsequently, the geocoded address for 82 streets was transformed into a dot map used as the basis of spatial datasets. In addition, the paper also used quantile map and the spatial scan statistic in order to identify the spatial distribution and spatial clusters of TB epidemic and TB/HIV co-infection epidemic. Result There was a declining trend of the notification rates of TB epidemic from 2007 to 2009, as well as a rising trend from 2010 to 2013. However, the notification rates of TB/HIV co-infection epidemic showed a rising trend from 2007 to 2010, and a declining trend from 2011 to 2013. Moreover, a significant share of TB epidemic and TB/HIV co-infection epidemic happened between the age of 15 to 45 years old, indicating an increase in risk of TB and TB/HIV infection. It is worth noting that the risk of HIV infection for male TB patients was 2.947 times (95% CI [2.178, 3.988]) than that of female patients. Han ethnicity and Uygur ethnicity in urban region accounted for a large proportion of total TB and TB/HIV co-infection cases. Most of the TB cases of minorities in Urumqi showed a statistically significant increase in risk of HIV infection than Han ethnicity in Urumqi. In addition, the spatial distribution of TB epidemic and TB/HIV co-infection epidemic was highly skewed. Most of the local clusters were located in urban area and rural-urban continuum where showed an increase in risk of TB and TB/HIV infection. Conclusion The epidemiologic and spatial-temporal analysis of TB epidemic and TB/HIV co-infection epidemic demonstrates a potential connection between TB and HIV in Urumqi. Demographic, temporal, geographic factors are the reasons of causing TB and TB/HIV co-infection epidemic.	[Wang Wei; Alayi Ahan; Yan Ci; Zhang Wei-Wen; Cao Ming-Qin] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Urumqi, Xinjiang, Peoples R China; [Zhang Wei-Sheng] Urumqi Ctr Dis Control & Prevent CDC, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University	Cao, MQ (corresponding author), Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Urumqi, Xinjiang, Peoples R China.	573596229@qq.com	Yin, Xue-ren/B-3893-2008; Ge, Hang/GZB-0729-2022	Yin, Xue-ren/0000-0002-1282-4432; 	Natural Science Fund of Xinjiang Uyghur Autonomous Region [2016D01C167]	Natural Science Fund of Xinjiang Uyghur Autonomous Region	This study was funded by the Natural Science Fund of Xinjiang Uyghur Autonomous Region (grant number: 2016D01C167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article was funded by the Natural Science Fund of Xinjiang Uyghur Autonomous Region (grant number: 2016D01C167). We would like to express our gratitude to anonymous peer reviewers for carefully revising our manuscript and for his or her useful comments.	Ahmed AB, 2007, THORAX, V62, P672, DOI 10.1136/thx.2006.072611; Chen YangGui, 2012, Modern Preventive Medicine, V39, P5410; Chimoyi LA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-555; Chinese Center for Disease Control Prevention, DAT REP NOT INF DIS; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Feng W, 2002, INT MIGR REV, V36, P520, DOI 10.1111/j.1747-7379.2002.tb00091.x; Vendramini SHF, 2010, REV SOC BRAS MED TRO, V43, P536, DOI 10.1590/S0037-86822010000500013; Gelaw Sifrash Meseret, 2016, Tuberc Res Treat, V2016, P6207457, DOI 10.1155/2016/6207457; Goujon-Bellec S, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-53; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Kulldorff M, 2006, AM J PREV MED, V30, pS37, DOI 10.1016/j.amepre.2005.09.009; Li WG, 2015, TRANSPL P, V47, P2456, DOI 10.1016/j.transproceed.2015.09.017; Pereira AGL, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005470; Martinez AN, 2014, INT J ENV RES PUB HE, V11, P3937, DOI 10.3390/ijerph110403937; MIJITI Peierdun, 2016, CHIN J ANTITUBERE, V38, P93; Uthman OA, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-65; Wang LY, 2010, JAIDS-J ACQ IMM DEF, V53, pS61, DOI 10.1097/QAI.0b013e3181c7db2e; Wang YP, 2000, INT J URBAN REGIONAL, V24, P397, DOI 10.1111/1468-2427.00254; Wei XL, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-9; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Wubuli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144010; Zhang Y, 2007, J INFECTION, V54, P285, DOI 10.1016/j.jinf.2006.06.001; Zhao RL, 2009, CHIN J ANTITUBERCUL, V31, P308	24	66	72	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164947	10.1371/journal.pone.0164947	http://dx.doi.org/10.1371/journal.pone.0164947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768740	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400039
J	Wang, F; Chen, W; Bruening, KS; Raj, S; Larsen, DA				Wang, Fang; Chen, Wei; Bruening, Kay Stearns; Raj, Sudha; Larsen, David A.			Nutrition Screening Tools and the Prediction of Clinical Outcomes among Chinese Hospitalized Gastrointestinal Disease Patients	PLOS ONE			English	Article							MALNUTRITION; RISK; PREVALENCE; UNDERNUTRITION; SUPPORT; IDENTIFICATION; POPULATION; ADMISSION	Nutrition risk Screening 2002 (NRS-2002) and Subjective Global Assessment (SGA) are widely used screening tools but have not been compared in a Chinese population. We conducted secondary data analysis of a cross-sectional study which included 332 hospitalized gastrointestinal disease patients, collected by the Gastrointestinal department of Peking Union Medical College Hospital (PUMCH) in 2008. Results of NRS-2002 and SGA screening tools, complications, length of stay (LOS), cost, and death were measured. The agreement between the tools was assessed via Kappa (kappa) statistics. The performance of NRS-2002 and SGA in predicting LOS and cost was assessed via linear regression. The complications and death prediction of tools was assessed using receiver operating characteristic (ROC) curves. NRS-2002 and SGA identified nutrition risk at 59.0% and 45.2% respectively. Moderate agreement (kappa > 0.50) between the two tools was found among all age groups except individuals aged <= 20, which only slight agreement was found (kappa = 0.087). NRS-2002 (R square 0.130) and SGA (R square 0.140) did not perform differently in LOS prediction. The cost prediction of NRS-2002 (R square 0.198) and SGA (R square 0.190) were not significantly different. There was no difference between NRS-2002 (infectious complications: area under ROC (AUROC) = 0.615, death: AUROC = 0.810) and SGA (infectious complications: AUROC = 0.600, death: AUROC = 0.846) in predicting infectious complication and death, but NRS-2002 (0.738) seemed to perform better than SGA (0.552) in predicting non-infectious complications. The risk of malnutrition among patients was high. NRS-2002 and SGA have similar capacity to predict LOS, cost, infectious complications and death, but NRS-2002 performed better in predicting non-infectious complications.	[Wang, Fang] Peking Union Med Coll Hosp, Dept Nutr, Beijing, Peoples R China; [Chen, Wei] Peking Union Med Coll Hosp, Parenteral & Enteral Dept, Beijing, Peoples R China; [Bruening, Kay Stearns; Raj, Sudha; Larsen, David A.] Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Syracuse University	Larsen, DA (corresponding author), Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA.	dalarsen@syr.edu	Larsen, David/D-4027-2016	Larsen, David/0000-0002-1876-6536; Raj, Sudha/0000-0002-3409-5920				Baldwin C, 2004, CLIN NUTR, V23, P1267, DOI 10.1016/j.clnu.2004.07.018; Bruun LI, 1999, CLIN NUTR, V18, P141, DOI 10.1016/S0261-5614(99)80003-X; Christensson L, 2002, EUR J CLIN NUTR, V56, P810, DOI 10.1038/sj.ejcn.1601394; Edington J, 2000, CLIN NUTR, V19, P191, DOI 10.1054/clnu.1999.0121; Gout BS, 2009, NUTR DIET, V66, P206, DOI 10.1111/j.1747-0080.2009.01372.x; Jensen GL, 2010, CLIN NUTR, V29, P151, DOI 10.1016/j.clnu.2009.11.010; Jensen GL, 2009, JPEN-PARENTER ENTER, V33, P710, DOI 10.1177/0148607109344724; Kubrak C, 2007, INT J NURS STUD, V44, P1036, DOI 10.1016/j.ijnurstu.2006.07.015; Kyle UG, 2005, CURR OPIN CLIN NUTR, V8, P397, DOI 10.1097/01.mco.0000172579.94513.db; Kyle UG, 2003, CLIN NUTR, V22, P473, DOI 10.1016/S0261-5614(03)00049-9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liang XK, 2008, NUTRITION, V24, P969, DOI 10.1016/j.nut.2008.05.001; Liang XK, 2009, ASIA PAC J CLIN NUTR, V18, P54; Marshall JA, 1999, J AM DIET ASSOC, V99, P315, DOI 10.1016/S0002-8223(99)00081-4; Mason P., 2006, HOSP PHARM, V13, P353, DOI [10.7748/ns2003, DOI 10.7748/NS2003.]; Natl Alliance Infusion Therapy, 2010, NUTR CLIN PRACT, V25, P548, DOI 10.1177/0884533610378524; Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005; Putwatana P, 2005, NUTRITION, V21, P691, DOI 10.1016/j.nut.2004.10.015; Raslan M, 2010, NUTRITION, V26, P721, DOI 10.1016/j.nut.2009.07.010; Rasmussen HH, 2004, CLIN NUTR, V23, P1009, DOI 10.1016/j.clnu.2004.01.001; Sherein A.I., 2003, EGYPT J NUTR, V18, P95; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; Valero M.ª A., 2005, Nutr. Hosp., V20, P259; van Bokhorst-de van der Schueren MAE, 2005, EUR J CLIN NUTR, V59, P1129, DOI 10.1038/sj.ejcn.1602222; Velasco C, 2011, EUR J CLIN NUTR, V65, P269, DOI 10.1038/ejcn.2010.243; Waitzberg DL, 2001, NUTRITION, V17, P573, DOI 10.1016/S0899-9007(01)00573-1; Wei C, 2005, CHINESE J CLIN NUTR, V3; White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285; Winter TA, 2000, EUR J GASTROEN HEPAT, V12, P191, DOI 10.1097/00042737-200012020-00010; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929; ZWEIG MH, 1993, CLIN CHEM, V39, P561	31	228	272	15	212	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159436	10.1371/journal.pone.0159436	http://dx.doi.org/10.1371/journal.pone.0159436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490480	gold, Green Published, Green Submitted			2022-12-26	WOS:000381368900010
J	Wang, WQ; Zhang, J; Ge, H; Li, SJ; Li, X; Yin, XR; Grierson, D; Chen, KS				Wang, Wen-qiu; Zhang, Jing; Ge, Hang; Li, Shao-jia; Li, Xian; Yin, Xue-ren; Grierson, Donald; Chen, Kun-song			EjMYB8 Transcriptionally Regulates Flesh Lignification in Loquat Fruit	PLOS ONE			English	Article							SECONDARY WALL BIOSYNTHESIS; CHILLING INJURY; LIGNIN BIOSYNTHESIS; DIRECT TARGET; ARABIDOPSIS; GENES; PATHWAY; EXPRESSION; MYB46; REPRESSOR	Transcriptional regulatory mechanisms underlying lignin metabolism have been widely studied in model plants and woody trees, but seldom in fruits such as loquat, which undergo lignification. Here, twelve EjMYB genes, designed as EjMYB3-14, were isolated based on RNA-seq. Gene expression indicated that EjMYB8 and EjMYB9 were significantly induced in fruit with higher lignin content resulting from storage at low temperature (0 degrees C), while two treatments (low temperature conditioning, LTC; heat treatment, HT) both alleviated fruit lignification and inhibited EjMYB8 and EjMYB9 expression. Dual-luciferase assays indicated that EjMYB8, but not EjMYB9, could trans-activate promoters of lignin-related genes EjPAL1, Ej4CL1 and Ej4CL5. Yeast one-hybrid assay indicated that EjMYB8 physically bind to Ej4CL1 promoter. Furthermore, the putative functions of EjMYB8 were verified using transient over-expression in both N. tabacum and loquat leaves, which increased lignin content. Moreover, combination of EjMYB8 and previously isolated EjMYB1 generated strong transactivation effects on the Ej4CL1 promoter, indicating that EjMYB8 is a novel regulator of loquat fruit lignification.	[Wang, Wen-qiu; Zhang, Jing; Ge, Hang; Li, Shao-jia; Li, Xian; Yin, Xue-ren; Grierson, Donald; Chen, Kun-song] Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Wen-qiu; Zhang, Jing; Li, Xian; Yin, Xue-ren; Chen, Kun-song] Zhejiang Univ, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China; [Grierson, Donald] Univ Nottingham, Plant & Crop Sci Div, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England	Zhejiang University; Zhejiang University; University of Nottingham	Yin, XR (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.; Yin, XR (corresponding author), Zhejiang Univ, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	xuerenyin@zju.edu.cn	Yin, Xue-ren/B-3893-2008; Ge, Hang/GZB-0729-2022	Yin, Xue-ren/0000-0002-1282-4432; 	Program of the International Science and Technology Cooperation [2011DFB31580]; National Basic Research Program of China [2013CB127104]; National Natural Science Foundation of China [31372041, 31471922]; Natural Science Foundation of Zhejiang Province, China [LR16C150001]	Program of the International Science and Technology Cooperation; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was supported by the Program of the International Science and Technology Cooperation [2011DFB31580], National Basic Research Program of China [2013CB127104], the National Natural Science Foundation of China [31372041, 31471922], and the Natural Science Foundation of Zhejiang Province, China [LR16C150001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhargava A, 2013, PLANTA, V237, P1199, DOI 10.1007/s00425-012-1821-9; Cai C, 2006, POSTHARVEST BIOL TEC, V41, P252, DOI 10.1016/j.postharvbio.2006.04.015; Cai C, 2006, POSTHARVEST BIOL TEC, V40, P155, DOI 10.1016/j.postharvbio.2005.12.014; Craven-Bartle B, 2013, PLANT J, V74, P755, DOI 10.1111/tpj.12158; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin P, 2014, FOOD BIOPROCESS TECH, V7, P2259, DOI 10.1007/s11947-013-1232-3; Kamdee C, 2014, POSTHARVEST BIOL TEC, V97, P68, DOI 10.1016/j.postharvbio.2014.06.004; Kosma DK, 2014, PLANT J, V80, P216, DOI 10.1111/tpj.12624; Legay S, 2007, PLANT SCI, V173, P542, DOI 10.1016/j.plantsci.2007.08.007; Liu XF, 2013, PLANT CELL TISS ORG, V115, P285, DOI 10.1007/s11240-013-0361-8; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Min T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097043; Ohman D, 2013, PLANT J, V73, P63, DOI 10.1111/tpj.12018; Tang XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12240; Tian J, 2015, PLANT BIOTECHNOL J, V13, P948, DOI 10.1111/pbi.12331; Velez-Bermudez IC, 2015, PLANT CELL, V27, P3245, DOI 10.1105/tpc.15.00545; Vermerris W, 2015, CURR OPIN BIOTECH, V32, P104, DOI 10.1016/j.copbio.2014.11.024; Xu Q, 2015, POSTHARVEST BIOL TEC, V102, P25, DOI 10.1016/j.postharvbio.2015.02.002; Xu Q, 2014, J EXP BOT, V65, P4349, DOI 10.1093/jxb/eru208; Yang CY, 2007, PLANT CELL, V19, P534, DOI 10.1105/tpc.106.046391; Yauk YK, 2014, PLANT J, V80, P317, DOI 10.1111/tpj.12634; Yin XR, 2012, PLANTA, V235, P895, DOI 10.1007/s00425-011-1553-2; Yin XR, 2012, POSTHARVEST BIOL TEC, V66, P1, DOI 10.1016/j.postharvbio.2011.11.009; Ying Z, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0388-y; Zeng JK, 2015, PLANT BIOTECHNOL J, V13, P1325, DOI 10.1111/pbi.12351; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	34	66	72	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154399	10.1371/journal.pone.0154399	http://dx.doi.org/10.1371/journal.pone.0154399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27768740	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600065
J	Wang, FJ; Wang, CL; Liu, PQ; Lei, CL; Hao, W; Gao, Y; Liu, YG; Zhao, KJ				Wang, Fujun; Wang, Chunlian; Liu, Piqing; Lei, Cailin; Hao, Wei; Gao, Ying; Liu, Yao-Guang; Zhao, Kaijun			Enhanced Rice Blast Resistance by CRISPR/Cas9-Targeted Mutagenesis of the ERF Transcription Factor Gene OsERF922	PLOS ONE			English	Article							CRISPR-CAS SYSTEM; NEGATIVELY REGULATES RESISTANCE; EFFICIENT TARGETED MUTAGENESIS; TAL EFFECTOR NUCLEASES; DISEASE RESISTANCE; SALT TOLERANCE; TRANSGENIC RICE; GUIDE RNA; GENOME MODIFICATION; MAGNAPORTHE-GRISEA	Rice blast is one of the most destructive diseases affecting rice worldwide. The adoption of host resistance has proven to be the most economical and effective approach to control rice blast. In recent years, sequence-specific nucleases (SSNs) have been demonstrated to be powerful tools for the improvement of crops via gene-specific genome editing, and CRISPR/Cas9 is thought to be the most effective SSN. Here, we report the improvement of rice blast resistance by engineering a CRISPR/Cas9 SSN (C-ERF922) targeting the OsERF922 gene in rice. Twenty-one C-ERF922-induced mutant plants (42.0%) were identified from 50 T-0 transgenic plants. Sanger sequencing revealed that these plants harbored various insertion or deletion (InDel) mutations at the target site. We showed that all of the C-ERF922-induced allele mutations were transmitted to subsequent generations. Mutant plants harboring the desired gene modification but not containing the transferred DNA were obtained by segregation in the T-1 and T-2 generations. Six T-2 homozygous mutant lines were further examined for a blast resistance phenotype and agronomic traits, such as plant height, flag leaf length and width, number of productive panicles, panicle length, number of grains per panicle, seed setting percentage and thousand seed weight. The results revealed that the number of blast lesions formed following pathogen infection was significantly decreased in all 6 mutant lines compared with wild-type plants at both the seedling and tillering stages. Furthermore, there were no significant differences between any of the 6 T2 mutant lines and the wild-type plants with regard to the agronomic traits tested. We also simultaneously targeted multiple sites within OsERF922 by using Cas9/Multi-target-sgRNAs (C-ERF922S1S2 and C-ERF922S1S2S3) to obtain plants harboring mutations at two or three sites. Our results indicate that gene modification via CRISPR/Cas9 is a useful approach for enhancing blast resistance in rice.	[Wang, Fujun; Liu, Piqing] Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China; [Wang, Fujun; Wang, Chunlian; Lei, Cailin; Hao, Wei; Gao, Ying; Zhao, Kaijun] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China; [Liu, Yao-Guang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Guangxi University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; South China Agricultural University	Zhao, KJ (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	zhaokaijun@caas.cn	Larsen, David/D-4027-2016	Larsen, David/0000-0002-1876-6536; Raj, Sudha/0000-0002-3409-5920	Major Science and Technology Project [2014ZX0801001B]	Major Science and Technology Project	This research was supported by a grant from the Major Science and Technology Project to Create New Crop Cultivars using Gene Transfer Technology (grant number 2014ZX0801001B.	Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Bundo M, 2016, PLANT BIOTECHNOL J, V14, P1357, DOI 10.1111/pbi.12500; Cao YF, 2006, J PLANT PHYSIOL, V163, P1167, DOI 10.1016/j.jplph.2005.11.004; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen XJ, 2008, INT J MOL SCI, V9, P2601, DOI 10.3390/ijms9122601; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Feng C, 2016, J GENET GENOMICS, V43, P37, DOI 10.1016/j.jgg.2015.10.002; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Ikeda T, 2015, GENES GENET SYST, V90, P231, DOI 10.1266/ggs.15-00030; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jia Y. L., 2003, Pesticide Outlook, V14, P150, DOI 10.1039/b308503c; Jiang CJ, 2009, MOL PLANT MICROBE IN, V22, P820, DOI 10.1094/MPMI-22-7-0820; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kobayashi N., 2007, WORK REP, V53, P17; Lai Y, 2013, PLANT PHYSIOL BIOCH, V62, P70, DOI 10.1016/j.plaphy.2012.10.010; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li W, 2008, MOL BREEDING, V22, P141, DOI 10.1007/s11032-008-9163-9; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Liu DF, 2012, J EXP BOT, V63, P3899, DOI 10.1093/jxb/ers079; Liu WZ, 2015, MOL PLANT, V8, P1431, DOI 10.1016/j.molp.2015.05.009; Liu WD, 2014, ANNU REV PHYTOPATHOL, V52, P213, DOI 10.1146/annurev-phyto-102313-045926; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma J, 2015, MOL PLANT MICROBE IN, V28, P558, DOI 10.1094/MPMI-11-14-0367-R; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Ma XL, 2015, MOL PLANT, V8, P1285, DOI 10.1016/j.molp.2015.02.012; McGinnis KM, 2010, BRIEF FUNCT GENOMICS, V9, P111, DOI 10.1093/bfgp/elp052; Miah G, 2013, MOL BIOL REP, V40, P2369, DOI 10.1007/s11033-012-2318-0; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Muller M, 2015, PLANT PHYSIOL, V169, P32, DOI 10.1104/pp.15.00677; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; Rojo E, 2003, J PLANT GROWTH REGUL, V22, P82, DOI 10.1007/s00344-003-0027-6; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Sherif S, 2013, PLANT CELL REP, V32, P1111, DOI 10.1007/s00299-013-1405-6; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tian ZD, 2015, PLANT CELL PHYSIOL, V56, P992, DOI 10.1093/pcp/pcv025; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Vogel MO, 2014, PLANT CELL, V26, P1151, DOI 10.1105/tpc.113.121061; Wang C, 2015, J GENET GENOMICS, V42, P703, DOI 10.1016/j.jgg.2015.09.011; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wang MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122755; Wang SH, 2015, PLANT CELL REP, V34, P1473, DOI 10.1007/s00299-015-1816-7; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Yara A, 2008, BIOCHEM BIOPH RES CO, V376, P460, DOI 10.1016/j.bbrc.2008.08.157; Yara A, 2007, PLANT CELL PHYSIOL, V48, P1263, DOI 10.1093/pcp/pcm107; Zhang H, 2016, PLANT BIOTECHNOL J, V14, P186, DOI 10.1111/pbi.12372; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhu JJ, 2016, J GENET GENOMICS, V43, P25, DOI 10.1016/j.jgg.2015.10.006	83	228	272	15	212	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154027	10.1371/journal.pone.0154027	http://dx.doi.org/10.1371/journal.pone.0154027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27490480	Green Submitted, Green Published, gold			2022-12-26	WOS:000374973600037
J	Neves, JMM; Lima, SMQ; Mendes, LF; Torres, RA; Pereira, RJ; Mott, T				Neves, Jessika M. M.; Lima, Sergio M. Q.; Mendes, Liana F.; Torres, Rodrigo A.; Pereira, Ricardo J.; Mott, Tami			Population Structure of the Rockpool Blenny Entomacrodus vomerinus Shows Source-Sink Dynamics among Ecoregions in the Tropical Southwestern Atlantic	PLOS ONE			English	Article							REEF FISH; LARVAL DISPERSAL; PHYLOGEOGRAPHY; BIOGEOGRAPHY; NEUTRALITY; TELEOSTEI; MIGRATION; PATTERNS; GENETICS; COASTAL	The Tropical Southwestern Atlantic is characterized by prominent ecosystems with large-scale oceanographic complexity. Yet, the evolutionary processes underlying genetic differentiation and connectivity in this region remain largely unknown. Entomacrodus vomerinus (Valenciennes, 1836) is a demersal fish with planktonic larvae endemic to this marine province, inhabiting shallow tidal pools in continental and oceanic reef environments. We evaluated the population structure, genetic diversity and gene flow of E. vomerinus using mitochondrial data (CYTB and COI) and nuclear (rhodopsin, RHO) DNA sequences. We sampled a total of 85 individuals, comprising 46 from three oceanic archipelagos with varying distance from the coast (Sao Pedro and Sao Paulo-SS, Fernando de Noronha-FE and Rocas Atoll-RA) and 39 from two localities in northeastern Brazilian coast (Rio Grande do Norte-RN and Bahia-BA). Multilocus analysis revealed the presence of three Evolutionarily Significant Units-ESUs (SS, FE+RA, and RN+BA), which are in accordance with distinct marine ecoregions. Coalescent analyses showed that the central ESU has a larger effective population size than the other two, suggesting strong asymmetries in the genetic diversity across the species range. Moreover, they showed that gene flow is highly asymmetric, suggesting a source-sink dynamics from the central ESU into the remaining ones, in agreement with oceanic currents. Together, these results provide insights in the evolutionary mechanisms facilitating diversification in this marine province.	[Neves, Jessika M. M.; Mott, Tami] Univ Fed Alagoas, Setor Biodiversidade, Lab Diversidade Mol, Maceio, Alagoas, Brazil; [Lima, Sergio M. Q.] Univ Fed Rio Grande do Norte, Dept Bot & Zool, Lab Ictiol Sistemat & Evolut, BR-59072970 Natal, RN, Brazil; [Mendes, Liana F.] Univ Fed Rio Grande do Norte, Dept Ecol, Lab Oceano, BR-59072970 Natal, RN, Brazil; [Torres, Rodrigo A.] Univ Fed Pernambuco, Dept Zool, Lab Genom Evolutiva & Ambiental, Recife, PE, Brazil; [Pereira, Ricardo J.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	Universidade Federal de Alagoas; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal de Pernambuco; University of Copenhagen	Neves, JMM (corresponding author), Univ Fed Alagoas, Setor Biodiversidade, Lab Diversidade Mol, Maceio, Alagoas, Brazil.	neves.jmm@gmail.com	Neves, Jessika M. M./F-9215-2017; Mott, Tamí/I-5317-2012; Caldas, Carlos/U-7250-2019; Rodrigues, Pedro/B-3228-2008; Pereira, Ricardo J/K-7451-2017	Neves, Jessika M. M./0000-0003-3983-5171; Mott, Tamí/0000-0002-5896-4780; Caldas, Carlos/0000-0003-3547-1489; Rodrigues, Pedro/0000-0002-3799-1544; Pereira, Ricardo J/0000-0002-8076-4822; Caldas, Carolina/0000-0003-3967-6211; Lima, Sergio Maia Queiroz/0000-0001-9365-4879; Neves, Joao/0000-0003-1993-0999	Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes); Financiadora de Estudos e Projetos (FINEP) [1312/10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301208/2012-3]; European Union's Horizon research and innovation program under the Marie Sklodowska-Curie (MSCA) [658706]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Union's Horizon research and innovation program under the Marie Sklodowska-Curie (MSCA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes - http://www.fundepes.br/) and Financiadora de Estudos e Projetos (FINEP - http://www.finep.gov.br/) grant #1312/10 (TM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - http://www.cnpq.br/) grant #301208/2012-3 (RAT); and the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie (MSCA - http://ec.europa.eu/research/mariecurieactions/index_en.htm) grant #658706 (RJP). Scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - http://www.capes.gov.br/) (JMMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baldwin CC, 2009, ZOOTAXA, P1; Barroso R, 2010, MAR BIOL, V157, P69, DOI 10.1007/s00227-009-1296-9; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cruzan MB, 2000, TRENDS ECOL EVOL, V15, P491, DOI 10.1016/S0169-5347(00)01998-4; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EDWARDS A, 1983, J BIOGEOGR, V10, P65, DOI 10.2307/2844583; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feitoza Bertran M., 2003, Aqua (Miradolo Terme), V7, P61; Fitzpatrick BM, 2009, MOL ECOL, V18, P3961, DOI 10.1111/j.1365-294X.2009.04314.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Francisco SM, 2011, J EXP MAR BIOL ECOL, V403, P14, DOI 10.1016/j.jembe.2011.03.020; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2015, MOL ECOL, V24, P1543, DOI 10.1111/mec.13129; Gama-Maia DJ, 2016, J MAR BIOL ASSOC UK, V96, P1677, DOI 10.1017/S0025315415002052; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Jacobina UP, 2014, HELGOLAND MAR RES, V68, P17, DOI 10.1007/s10152-013-0365-0; Joyeux JC, 2001, J BIOGEOGR, V28, P831, DOI 10.1046/j.1365-2699.2001.00602.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Leao Zelinda M. A. N., 2000, Marine Pollution Bulletin, V41, P112, DOI 10.1016/S0025-326X(00)00105-3; Leao ZMAN, 2005, MAR POLLUT BULL, V51, P599, DOI 10.1016/j.marpolbul.2005.04.024; Leigh JW, POPART POPULATION AN; Macedo-Soares LCP, 2012, MAR ECOL PROG SER, V444, P207, DOI 10.3354/meps09436; Macieira RM, 2015, ENVIRON BIOL FISH, V98, P385, DOI 10.1007/s10641-014-0269-0; Mai ACG, 2014, ESTUAR COAST SHELF S, V149, P80, DOI 10.1016/j.ecss.2014.07.013; Medeiros Paulo R., 2007, Pan-American Journal of Aquatic Sciences, V2, P288; Mendes LF, 2000, THESIS; Mendes LD, 2006, REV BRAS ZOOL, V23, P817, DOI 10.1590/S0101-81752006000300029; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Motoki A, 2009, REM-REV ESC MINAS, V62, P331, DOI 10.1590/S0370-44672009000300011; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1554/0014-3820(2001)055[0561:POOTRO]2.0.CO;2; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; Nielsen R, 2001, GENETICS, V158, P885; Paiva Maria Isabel G., 2015, Pan-American Journal of Aquatic Sciences, V10, P19; Pinheiro HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118180; Pringle JM, 2001, P NATL ACAD SCI USA, V108, P15288; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rangel Carlos A., 2010, Revista Brasileira de Zoociencias, V12, P17; Rangel CA, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2006.1.4; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Rodriguez-Rey GT, 2016, J EXP MAR BIOL ECOL, V474, P204, DOI 10.1016/j.jembe.2015.10.016; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sacramento LA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/264270; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; SMITH MF, 1993, BIOL J LINN SOC, V50, P149, DOI 10.1111/j.1095-8312.1993.tb00924.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stephens M, 2004, DOCUMENTATION PHASE, P35; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Ward Robert D, 2012, Methods Mol Biol, V858, P423, DOI 10.1007/978-1-61779-591-6_21; Wares JP, 2001, EVOLUTION, V55, P295; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Williams JT, 2014, ENTOMACRODUS VOMERIN, DOI [10.2305/IUCN.UK.2014-3.RLTS.T185176A1776911.en, DOI 10.2305/IUCN.UK.2014-3.RLTS.T185176A1776911.EN]	65	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157472	10.1371/journal.pone.0157472	http://dx.doi.org/10.1371/journal.pone.0157472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309356	Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800079
